COMMON_DRUGBANK_ALIAS	MINED_ALIAS	DRUGBANK_SYNONYS_AND_PRODUCTS	DRUGBANK_ID	CIR_ALIAS	PUBCHEM_ALIAS	CAS_NUMBER	UNII	ASSOCIATED_PMIDs_from_2606_corpus	OLDEST_PMID_FROM_2606_CORPUS	OLDEST_PMID_DATE_FROM_2606_CORPUS	OLDEST_PMID_manually cured	OLDEST_DATE_OF_PUBLICATION_manually_cured	OLDEST_DATE_OF_PUBLICATION_manual_five_years	CONGRESS_ABSTRACT_FOR_UNPUBLISHED_EARLY_CLINICAL_TRIAL	Under_1992_FDA_Accelerated_Approval_regulations_after1989	DRUG_TO_KEEP_FOR_ANALYSIS	FDA_APPROVAL	DRUG_DEVELOPPED_AS_ANA	DRUG_DEVELOPPED_AS_ANA_BIN	FDA_SubmissionStatusDates	FDA_SubmissionStatus	FDA_SponsorName	FDA_ActiveIngredient	FIRST_FDA_SubmissionStatusDate	FIRST_FDA_SponsorName	DELAY_FROM_OLDEST_PMID_TO_FDA_APPROVAL_or_DDN	Number_of_patients_included	Max_age	All_tumors_type_considered	Tumor_type_enrichement_or_selection	Specific_tumor_type_included	Drug_target_emphasized_in_abstract	Main_target	Healthy_volonteers_included	Dose_escalation_cohort	Dose_expansion_cohort	Number_of_patients_included_in_expansion	Biomarker_molecular_considered	Biomarker_pathology_considered	Biomarker_circulating_considered	Clinical_activity_detected_as following_recurrent_responder_OR_clinical_activity_OR_prolonged_stability	DLT_identified_or_MTD_reached	"Best_ORR_in_cohort_or_subcohort_percent_IN_EVALUABLE_PATIENTS_RADIOLOGICAL OR OTHER APPROVED RESPONSE ASSESSMENT (PSA;)"	Unexpected_rapid_progression_or_cancer_onset	Complete_response_achieved	Complete_response_reported	Disease_control_rate	gradeV_TRAE	TR_cardiac_event_type	TR_cardiac_event	TR_neuropsychological_or_CNS_event_type	TR_neuropsychological_or_CNS_event	development_or_study_closed_or_aborted	Number_of_PDDI_known_in_DB	AE_associated_SNP_known_in_DB	match_in_DB_data
Kappadione	menadiol	Menadiol sodium diphosphate	DB09332	"tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate hexahydrate;tetrasodium (2-methyl-4-phosphonatooxy-1-naphthyl) phosphate hexahydrate;tetrasodium (2-methyl-4-phosphato-1-naphthyl) phosphate hexahydrate;tetrasodium (2-methyl-4-phosphonatooxy-naphthalen-1-yl) phosphate hexahydrate;6700-42-1;Kappadione;1,4-Naphthalenediol, 2-methyl-, bis(dihydrogen phosphate), tetrasodium salt, hexahydrate;2-Methyl-1,4-naphthalenediol, bis(dihydrogen phosphate), tetrasodium salt, hexahydrate;Menadiol sodium diphosphate hexahydrate;Menadiol sodium phosphate hexahydrate;D04908;Kappadione (TN);Menadiol sodium diphosphate (USP);Menadiol sodium diphosphate"	"Kappadione;Procoagulo;Synkavit;Synkavite;Thylokay;Kipca water soluble;Synkayvite;Menadiol sodium diphosphate;Menadione sodium phosphate;Sodium menadione diphosphate;Menadiol Sodium Diphosphate Anhydrous;UNII-R2L46WE615;Menadiol tetrasodium diphosphate;EINECS 205-012-1;Menadione diphosphate tetrasodium salt;1:4-Naphthaquinol-bisdisodium phosphate;131-13-5;Menadiol sodium diphosphate anhydrous [USAN];R2L46WE615;2-Methyl-1,4-naphthaquinol bis(disodium phosphate);Tetrasodium 2-methyl-1,4-naphthalenediol diphosphate;Tetrasodium 2-methyl-1,4-naphthohydroquinone diphosphate;1,4-Naphthalenediol, 2-methyl-, diphosphate, tetrasodium salt;Tetrasodium 2-methyl-1,4-naphthahydroquinone diphosphoric acid ester;Tetrasodium 2-methyl-1,4-naphthalenediol bis(dihydrogen phosphate);2-Methyl-1,4-naphthohydroquinone diphosphoric acid ester tetrasodium salt;1,4-Naphthalenediol, 2-methyl-, bis(dihydrogen phosphate), tetrasodium salt;Phosphoric acid, diester with 2-methyl-1,4-naphthalenediol, tetrasodium salt;Tetrasodium 2-methyl-1,4-naphthylenebis(phosphate);1,4-NAPHTHALENEDIOL, 2-METHYL-, BIS(DIHYDROGEN PHOSPHATE), TETRASODIUM;Synka-Vit;menadiol diphosphate tetrasodium salt;AC1Q1UMF;AC1L1R8G;84-98-0 (Parent);DTXSID80156832;DB09332;LS-94581;tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate"	131-13-5	R2L46WE615	15868379	15868379	01/05/2005	14026380	01/09/1962	Bef. 1989		0	0	0	Yes	1					30/07/2018		669,5	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Prednimustine	prednimustine		DB12832	"[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate;4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester;4-[4-[bis(2-chloroethyl)amino]phenyl]butyric acid [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-3-keto-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-keto-ethyl] ester;29069-24-7;11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);BRN 2826967;CCRIS 6741;Chlorambucil ester of prednisolone;Chlorambucil prednisolone ester;EINECS 249-410-3;HSDB 6882;(11beta)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoate;NSC 134087;D05602;Prednimustine (USAN);Prednimustine [USAN:INN];Prednimustinum [INN-Latin];Prednisolone 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate) (8CI);PREDNIMUSTINE;Prednimustina [INN-Spanish];Pregna-1,4-diene-3,20-dione, 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-"	"PREDNIMUSTINE;Sterecyt;29069-24-7;Stereocyt;LEO 1031;Prednimustine [USAN:INN];Prednimustinum [INN-Latin];Prednimustina [INN-Spanish];C35H45Cl2NO6;Chlorambucil prednisolone ester;NSC 134087;UNII-9403SIO2S8;CCRIS 6741;HSDB 6882;Chlorambucil ester of prednisolone;EINECS 249-410-3;BRN 2826967;CHEBI:82524;9403SIO2S8;Pregna-1,4-diene-3,20-dione, 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-;Prednisolone 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);prednisolone chlorambucil ester;Prednimustina;Prednimustinum;NSC-134087;(11beta)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoate;Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);Leo-1031;AC1L1RLF;Prednimustine (USAN/INN);SCHEMBL8246;CHEMBL2103751;DTXSID4021183;HFVNWDWLWUCIHC-GUPDPFMOSA-N;ZINC4214173;AKOS030530618;DB12832;LS-7668;S110;C19512;D05602;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate;21-[4-[4-[Bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11,17-dihydroxypregna-1,4-diene-3,20-dione;Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate);Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate) (8CI)"	29069-24-7	9403SIO2S8	8890711	8890711	01/10/1996	767114	01/12/1965	Bef. 1989		0	0	0	Yes	1					30/07/2018		630,6	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Idronoxil	phenoxodiol	"Dehydroequol;Haginin E;3-(4-hydroxyphenyl)-2H-chromen-7-ol;Phenoxodiol"	DB04915	"3-(4-hydroxyphenyl)-2H-chromen-7-ol;81267-65-4;Phenoxodiol;D04498;Idronoxil (USAN);2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-;3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol;CCRIS 8949;Dehydroequol;Haginin E;Idronoxil;NV 06"	"Phenoxodiol;Dehydroequol;Idronoxil;Haginin E;81267-65-4;3-(4-Hydroxyphenyl)-2H-chromen-7-ol;NV 06;3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol;NV-06;7,4'-Dihydroxyisoflav-3-ene;CCRIS 8949;UNII-995FT1W541;Idronoxil (USAN/INN);2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-;995FT1W541;Idronoxil [USAN:INN];Haganin E;7-hydroxy-3-hydroxyphenyl-1H-benzopyran;4',7-Dihydroxyisoflavene;D03YOS;isoflav-3-ene4',7-diol;2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl);phenoxodiolhaginin eidronoxil;isoflav-3-ene-4',7-diol;MLS006010720;SCHEMBL149612;4',7-dihydroxyisoflav-3-ene;AC1L561Y;CHEMBL1957038;CTK5E8665;Phenoxodiol, >=98% (HPLC);DTXSID50231029;ZZUBHVMHNVYXRR-UHFFFAOYSA-N;ZINC1491943;BDBM50419932;CP-265;MFCD06636630;AKOS015918005;DB04915;3-(4-hydroxy-phenyl)-2H-chromen-7-ol;NCGC00346822-01;AJ-26342;AN-36327;CJ-23670;KB-45996;SMR004701684;LS-182407;FT-0602222;2H-1-Benzopyran-7-ol,3-(4-hydroxyphenyl)-;D04498;Z-3308;267P654;I14-8946"	81267-65-4	995FT1W541	16524966	16524966	01/03/2006	4580118	01/09/1973	Bef. 1989		0	0	0	No	0					30/07/2018		537,8	#N/A																							0						1
Tocladesine	analogue 8-chloro-camp		DB13046	"(1S,6R,8R,9R)-8-(6-amino-8-chloropurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;(1S,6R,8R,9R)-8-(6-amino-8-chloro-purin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;(1S,6R,8R,9R)-8-(6-amino-8-chloro-9-purinyl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;(1S,6R,8R,9R)-8-(6-amino-8-chloro-purin-9-yl)-3-hydroxy-3-keto-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;133561-53-2;55601-41-7;8-chloro-cyclic AMP;CCRIS 846;NCS 614491;Tocladesine;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-8-chloro-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-;8-Cl-cAMP;AIDS-212161;AIDS212161;D06173;Tocladesine (USAN);8-Chloro-cAMP;8-Chloro-cyclic adenosine monophosphate;8-Chloroadenosine 3',5'-monophosphate"	"Tocladesine;8-Chloro-cAMP;8-Cl-cAMP;8-chloro-cyclic AMP;UNII-BQ94Z7E5OR;CCRIS 846;8-Chloroadenosine 3',5'-monophosphate;41941-56-4;NCS 614491;8-Chloro-cyclic adenosine monophosphate;BQ94Z7E5OR;ICN-1256;8-Chloroadenosine 3',5'-cyclic phosphate;8-Chloroadenosine-3',5'-O-monophosphate;8-Chloroadenosine-cyclic-3',5'-monophosphate dihydrate;Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate);C10H11ClN5O6P;Tocladesine [USAN:INN:BAN];c-amp;ADENAZOLE;AC1L2OHG;Tocladesine (USAN/INN);SCHEMBL125595;CHEMBL2107085;ZINC4214493;MFCD00153938;DB13046;NSC 614491;LS-15107;8-chloroadenosine 3',5'-cyclic monophosphate;D06173;W-202723;(4aR,6R,7R,7aS)-6-(6-amino-8-chloro-purin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol;(4aR,6R,7R,7aS)-6-(6-amino-8-chloropurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-8-chloro-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-"	41941-56-4	BQ94Z7E5OR	10430069	10430069	01/08/1999	174244	01/10/1975	Bef. 1989		0	0	0	No	0					30/07/2018		512,9	#N/A																							0						1
Somatostatin	somatostatin	"Stilamin - Pws Liq IV;Stilamin - Pws IV  3mg/amp"	DB09099	"53126-12-8;56451-83-3;38916-34-6;51110-01-1;52500-64-8;AY 24910;Aminopan;CCRIS 7071;EINECS 256-969-7;Growth hormone release-inhibiting factor;Growth hormone release-inhibiting hormone;Panhibin;SRIF;SRIF 14;Somatostatin 1-14;Somatostatin 14;Somatostatin-14;Somatotropin release-inhibiting factor;Somatotropin release-inhibiting hormone;Somiaton;S0885_SIGMA;S9129_SIGMA;Somatostatin;85480_FLUKA;Growth hormone release inhibiting factor;Somatotropin release inhibiting factor;S1763_SIGMA;S4508_SIGMA;[D-Trp8, D-Cys14]-Somatostatin"	"SOMATOSTATIN;38916-34-6;Somatostatine;Somatostatina;Somatostatinum;Somatostatin, cyclic;Somatostatin (sheep);Somatostatin-14;Synthetic somatostatin-14;15-28-Somatostatin-28;Somatostatine [INN-French];Somatostatinum [INN-Latin];Cyclic Somatostatin;Somatostatina [INN-Spanish];CCRIS 3629;Somatostatin acetate;EINECS 254-186-5;Aminopan;CHEBI:64628;Synthetic growth hormone release-inhibiting hormone;C76H104N18O19S2;SRIF;UNII-F6R2N217HS;F6R2N217HS;Somatotropin release-inhibiting hormone;Growth hormone-release inhibiting factor: L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide;Somatostatin (rat);Somatostatin (human);Somatostatin (pigeon);Somatostatin [BAN:INN];Somatostatin [INN:BAN];Somatostatin-1;Somatotropin release inhibiting factor;UNII-6E20216Q0L;Growth hormone release inhibiting factor;SR 9357;D0T5RO;CHEMBL1823872;BDBM81767;MolPort-006-823-896;NHXLMOGPVYXJNR-ATOGVRKGSA-N;51110-01-1 (Parent);MFCD00076762;AKOS015994634;6E20216Q0L;HS-2027;NCGC00167137-01;H664;CAS_38916-34-6;CB6417646;LS-174755;916S346;BRD-K14681867-015-01-6;Synthetic cyclic growth hormone release-inhibiting factor;Ala-Gly-cyclo-[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys];52769-04-7;55914-64-2;Growth hormone-release inhibiting factor: L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3->14) disulfide;L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide;L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide"	38916-34-6	6E20216Q0L	"15650261;12218590;7535186;7540120;7686764"	7686764	01/01/1993	773950	01/05/1976	Bef. 1989		0	0	0	No	0					30/07/2018		505,9	#N/A																							0						1
(4R)-limonene 1α,2α-epoxide	"d-limonene;limonene"	"D-limonene 1,2-epoxide;(4R)-limonene 1alpha,2alpha-epoxide;1α,2α-epoxy-4βH-p-menth-8-ene;(+)-trans-limonene oxide;(1S,4R,6R)-4-isopropenyl-1-methyl-7-oxabicyclo[4.1.0]heptane"	"DB02924;EXPT02019"			6909-30-4	KBX06MQJ5Y	"9654110;8723738"	8723738	01/05/1996	790944	01/11/1976	Bef. 1989		0	0	0	No	0					30/07/2018		499,9	#N/A																							0						1
Treosulfan	treosulfan	"DIHYDROXYBUSULFAN;OVASTAT"	DB11678	"(2,3-dihydroxy-4-methylsulfonyloxybutyl) methanesulfonate;(2,3-dihydroxy-4-methylsulfonyloxy-butyl) methanesulfonate;methanesulfonic acid (2,3-dihydroxy-4-methylsulfonyloxybutyl) ester;methanesulfonic acid (2,3-dihydroxy-4-methylsulfonyloxy-butyl) ester;21106-06-9;299-75-2;1947-62-2;2,3-dihydroxybutane-1,4-diyl dimethanesulfonate;NCIOpen2_006538;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,R*)]-;1,4-Bis mesyl ester of D-threitol;CB 40065;D-Threitol, 1,4-bis(methanesulfonate);NSC39068;(2S,3S)-Threitol 1,4-bismethanesulfonate;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, [S-(R*,R*)]-;CB 40067;DIHYDROXYBUSULFAN;Dihydroxymyleran;L-Threitol 1,4-dimethanesulfonate;L-Threitol, 1,4-bis(methanesulfonate);L-Threitol-1,4-bis(methanesulfonate);L-Threityl dimesylate;NSC-39069;NSC39069;Threitol, 1,4-dimethanesulfonate, (2S,3S)-;Threitol, 1,4-dimethanesulfonate, L-;Threitol, 1,4-dimethanesulfonate, L-(+)-;Treosulfan;Tresulfan;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (R*,R*)- (9CI);NSC 260698;Threitol, 1,4-dimethanesulfonate (8CI);(S-(R*,R*))-1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate;1,2,3,4-BUTANETETROL, 1,4-DIMETHANESULFONATE;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (S-(R*,R*))-;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (S-(R*,R*))- (9CI);CCRIS 2781;EINECS 206-081-0;HSDB 6963;L-Threitol, 1,4-bismethanesulfonate;NSC 39069;Threitol, 1,4-dimethanesulfonate, (2S,3S)- (8CI);Treosulfan [BAN:INN];Treosulfano [INN-Spanish];Treosulfanum [INN-Latin];Treosulphan;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (R*,S*)- (9CI);1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (R-(R*,S*))-;NSC 94160;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (R*,R*)-;1,4-Bis(methylsulfonyloxy)threitol;NSC260698;Threitol 1,4-bis(methanesulfonate);Threitol, 1,4-dimethanesulfonate"	"Treosulfan;Treosulphan;Ovastat;299-75-2;Tresulfan;Dihydroxybusulfan;Treosulfan [INN:BAN];UNII-CO61ER3EPI;Treosulfanum [INN-Latin];Treosulfano [INN-Spanish];NSC 39069;l-Threitol-1,4-bis(methanesulfonate);Dihydroxymyleran;CCRIS 2781;HSDB 6963;(2S,3S)-Threitol 1,4-bismethanesulfonate;EINECS 206-081-0;NSC-39069;CO61ER3EPI;L-Threityl dimesylate;L-Threitol, 1,4-bis(methanesulfonate);threosulphan;CB 40067;Threitol, 1,4-dimethanesulfonate, L-(+)-;CHEBI:82557;L-Threitol, 1,4-bismethanesulfonate;L-Threitol 1,4-dimethanesulfonate;C6H14O8S2;Treosulfano;Treosulfanum;(S-(R*,R*))-1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate;1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (S-(R*,R*))-;L-dihydroxybusulfan;L-threitol-1,4-bismethanesulfonate;Treosulfan (INN);Ovastat (TN);CHEMBL455186;SCHEMBL5399430;YCPOZVAOBBQLRI-WDSKDSINSA-N;(S-(R*,R*))- 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate;ZINC1671094;l-threitol-1,4-bis-methanesulfonate;AKOS030231132;L-threitol 1,4-bis(methanesulfonate);CS-3889;DB11678;LS-1145;HY-16503;KB-81245;C19557;D07253;Threitol, 1,4-dimethanesulfonate, (2S,3S)-;Z-3265;Threitol, 1,4-dimethanesulfonate, (2S,3S)- (8CI);1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (S-(R*,R*))- (9CI);14461-01-9;27863-55-4;5592-88-1"	299-75-2	CO61ER3EPI	"11106234;9654108"	9654108	01/07/1998	870013	01/04/1977	Bef. 1989		1	1	0	Yes	1					30/07/2018		494,9	36	NA	0	1	OVARIAN CANCER	0	NA	0	0	1	36	0	0	0	1	NA	0,63	0	1	1	NA	0	0	0	0	0	0	21	0	1
Methylthioinosine	6-methylmercaptopurine	"6-methyl MP riboside;6-methyl MP-riboside;6-(Methylthio)purine ribonucleoside;6-methyl-9-ribofuranosylpurine-6-thiol;6-S-methyl-6-thioinosine;6-methylmercaptopurine ribonucleoside;6-methylthiopurine riboside;6-methylmercaptopurine riboside;6-methylthioinosine;MMPR;6-MMPR;methylmercaptopurine riboside;Me6MPR"	"DB02896;EXPT02248"	"2-(hydroxymethyl)-5-(6-methylsulfanylpurin-9-yl)oxolane-3,4-diol;2-(hydroxymethyl)-5-(6-methylsulfanylpurin-9-yl)tetrahydrofuran-3,4-diol;2-(hydroxymethyl)-5-[6-(methylthio)-9-purinyl]tetrahydrofuran-3,4-diol;2-methylol-5-[6-(methylthio)purin-9-yl]tetrahydrofuran-3,4-diol;15397-51-0;342-69-8;13153-62-3;M4002_SIGMA;.beta.-D-Ribosyl-6-methylthiopurine;6-(Methylmercapto)purine ribonucleoside;6-(Methylthio)purine ribonucleoside;6-(Methylthio)purine riboside;6-MMPR;6-Methyl MP riboside;6-Methyl MP-riboside;6-Methylmercaptopurine riboside;6-Methylthioinosine;9H-Purine, 6-(methylthio)-9-.beta.-D-ribofuranosyl-;9H-Purine, 6-(methylthio)-9-.beta.-D-ribofuranosyl-, dihydrate;9H-Purine, 6-(methylthio)-9.beta.-D-ribofuranosyl-;Inosine, 6-(methylthio)-;MMPR;Me6MPR;Methylthioinosine;NCI-C04784;NSC 40774;NSC40774;Purine-6-thiol, 6-methyl-9-ribofuranosyl-;SQ 21,977;SQ 21977;WLN: T56 BN DN FN HNJ IS1 D- BT5OTJ CQ DQ E1Q;WLN: T56 BN DN FN HNJ ISH I1 D-BT5OTJ CQ DQ E1Q;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methylsulfanylpurin-9-yl)oxolane-3,4-diol;NSC110341;NSC95103;NSC408753;NSC49555;NCGC00096121-01;Oprea1_544049"	"6-Methylmercaptopurine riboside;342-69-8;MMPR;Me6MPR;6-Methyl MP riboside;6-Methyl MP-riboside;6-Methylthiopurine riboside;6-Methylmercaptopurine ribonucleoside;6-MMPR;Methylmercaptopurine riboside;6-Methylthioinosine;METHYLTHIOINOSINE;6-(Methylthio)purine ribonucleoside;6-Methyl-9-ribofuranosylpurine-6-thiol;6-S-methyl-6-thioinosine;UNII-Y5G39SHR0V;beta-D-Ribosyl-6-methylthiopurine;EINECS 206-442-2;6-(Methylthio)-9-beta-D-ribofuranosyl-9H-purine;BRN 0042871;Y5G39SHR0V;Inosine, 6-S-methyl-6-thio-;(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylthio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol;AI3-50295;CHEMBL388931;CHEBI:44081;Inosine, 6-(methylthio)-;9H-Purine, 6-(methylthio)-9beta-D-ribofuranosyl-;9H-Purine, 6-(methylthio)-9-beta-D-ribofuranosyl-;2-HYDROXYMETHYL-5-(6-METHYLSULFANYL-PURIN-9-YL)-TETRAHYDRO-FURAN-3,4-DIOL;NCI-C04784;9H-Purine, 6-(methylthio)-9-beta-D-ribofuranosyl-, dihydrate;NSC 40774;SQ 21977;6-(methylsulfanyl)-9-beta-D-ribofuranosyl-9H-purine;Purine-6-thiol, 6-methyl-9-ribofuranosyl-;6MMPr;6-Methylmercapto-9-(b-D-ribofuranosyl)purine;S-methyl-6-thioinosine;6-(methylthio) inosine;AC1L1TC4;AC1Q4H5M;4-26-00-01992 (Beilstein Handbook Reference);SCHEMBL672035;DTXSID5030454;CTK8F7173;ZDRFDHHANOYUTE-IOSLPCCCSA-N;ZINC519128;BDBM50412071;MFCD00022826;AKOS027320756;DB02896;LS-1219;FT-0631985;9-BETA-D-RIBOFURANOSYL-6-METHYLTHIOPURINE;9H-Purine, 6-(methylthio-9-beta-D-ribofuranosyl-;6-(Methylthio)-9-|A-D-ribofuranosyl-9H-purine, 98%;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methylsulfanylpurin-9-yl)oxolane-3,4-diol;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methylsulfanylpurin-9-yl)tetrahydrofuran-3,4-diol;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylsulfanyl)-9H-purin-9-yl]oxolane-3,4-diol"	342-69-8	Y5G39SHR0V	8529282	8529282	01/01/1996	369690	01/01/1979	Bef. 1989		0	0	0	Yes	1					30/07/2018		473,9	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Curcumin	curcumin		DB11672	"(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione;(1E,6E)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione;15845-47-3;8024-37-1;33171-04-9;73729-23-4;79257-48-0;91884-86-5;KBioSS_002445;(1E,6E)-1,7-bis[4-hydroxy-3-(methyloxy)phenyl]hepta-1,6-diene-3,5-dione;C7727_SIGMA;KBio2_005007;MLS000069631;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)-;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-;1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione;2,7-Nonadiene-4,6-dione, 1,9-bis(4-hydroxy-3-methoxyphenyl)-;4-08-00-03697 (Beilstein Handbook Reference);BRN 2306965;CCRIS 3257;CI 75300;CI Natural Yellow 3;Curcumin I;Diferaloylmethane;E 100;EINECS 207-280-5;Golden seal;HSDB 4334;Hydrastis;Indian turmeric;Kurkumin [Czech];NCI-C61325;NSC 32982;NSC 687842;Natural yellow 3;Orange Root;Yellow puccoon;Zlut prirodni 3 [Czech];Curcumin; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;K00009;Cucurmin;Bio1_001383;Bio1_000405;NSC687842;(E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;C1386_SIGMA;Diferulylmethane;NCI60_002883;cMAP_000052;KBioGR_002439;NCGC00023332-03;AIDS-040146;SMR000058237;SMP1_000082;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-;C.I. 75300;C.I. Natural Yellow 3;Curcuma;Diferuloylmethane;Gelbwurz;Haidr;Halad;Haldar;Halud;Indian Saffron;Merita Earth;NSC32982;Safran d'Inde;Souchet;Terra Merita;Tumeric yellow;Turmeric;Turmeric yellow;WLN: 1OR BQ E1U1V1V1U1R DQ CO1;Yellow Ginger;Yellow Root;Yo-Kin;KBio3_002917;(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;CHEBI:3962;KBio2_007575;SBB006495;Turmeric (>98% curcurmin);NCIMech_000700;Curcumin, <i>Curcuma longa</i> L.;AIDS040146;KBio2_002439;Turmeric oleoresin (79%-85% curcumin);NSC-32982;Bio1_000894"	"curcumin;458-37-7;Diferuloylmethane;Natural yellow 3;Turmeric yellow;Curcuma;Turmeric;Kacha haldi;Gelbwurz;Curcumin I;Souchet;Haidr;Halad;Haldar;Halud;Indian saffron;Merita earth;Terra Merita;Yellow Ginger;Yellow Root;Safran d'Inde;Yo-Kin;Golden seal;Orange Root;C.I. Natural Yellow 3;Curcumine;Hydrastis;Indian turmeric;Yellow puccoon;Curcuma oil;Diferaloylmethane;Turmeric extract;Oils, curcuma;Kurkumin [Czech];(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;Tumeric yellow;Turmeric oil;Oil of turmeric;CI Natural Yellow 3;Turmeric oleoresin;Curcuma longa oils;Zlut prirodni 3 [Czech];Cucurmin;Kurkumin;C.I. 75300;Tumeric oleoresin;Zlut prirodni 3;Turmeric root oil;Turmeric, oleoresin;Curcuma oil (Curcuma longa);curouma;E 100;Curcurmin;Diferulylmethane;kachs haldi;safra d'inde;Turmeric oil (Curcuma longa L.);Curcuma longa l. root oil;1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;NSC32982;UNII-IT942ZTH98;NSC 32982;Tu rmeric root oil;Turmeric (>98% curcurmin);98% curcurmin);FEMA No. 3085;FEMA No. 3086;CCRIS 3257;CCRIS 5804;CHEBI:3962;1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione;MLS000069631;Turmeric oleoresin (79%-85% curcumin);Curcuma longa l. oil;HSDB 4334;Turmeric root oleoresin;1,5-Di(vanillyliden)acetylaceton;NCI-C61325;C21H20O6;1,5-Divanillyliden-2,4-pentandion;EINECS 207-280-5;Turmeric extract (Curcuma longa L.);8024-37-1;1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione;CHEMBL140;Curcuma longa l. oleoresin;NSC 687842;BRN 2306965;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-;CI 75300;SMR000058237;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)-;IT942ZTH98;Curcuma longa l. root oleoresin;VFLDPWHFBUODDF-FCXRPNKRSA-N;(E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;NSC-32982;NSC687842;NCGC00017159-05;DSSTox_CID_1421;(1E,6E)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione;(1E,6E)-1,7-bis[4-hydroxy-3-(methyloxy)phenyl]hepta-1,6-diene-3,5-dione;DSSTox_RID_78861;DSSTox_GSID_31077;CU-01000001305-2;CURCUMIN (SEE ALSO TUMERIC, OLEORESIN (10105-J));2,7-Nonadiene-4,6-dione, 1,9-bis(4-hydroxy-3-methoxyphenyl)-;Oils, galangal;PREVENTION 4 (CURCUMIN) (SEE ALSO TUMERIC, OLEORESIN (10105-J));TURMERIC, OLEORESIN (CURCUMIN) (SEE ALSO CURCURMIN (458-37-7));Yellow, Turmeric;91884-86-5;CAS-458-37-7;1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-;(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;SR-01000000149;diferuloylmethan;E 100 (Dye);Haldar, Souchet;Natural Yellow3;Curcumin,(S);Curcumin (Natural);trans,trans-Curcumin;Opera_ID_1627;D07SDQ;D0H8LC;AC1LJ6T6;SCHEMBL8440;SCHEMBL8441;Curcumin, analytical standard;4-08-00-03697 (Beilstein Handbook Reference);MLS001148449;BIDD:ER0479;turmeric root oil CO2 extract;AC1Q46A0;cid_969516;GTPL7000;turmeric root oil hydrodistilled;DTXSID8031077;SCHEMBL13521974;BDBM29532;cid_5281767;BIC8500;cMAP_000052;MolPort-001-763-682;HMS2233K04;HMS3649K06;ZINC899824;BB_NC-01422;HY-N0005;ZX-AT003872;Tox21_110803;Tox21_111505;Tox21_201116;BBL027711;BDBM50067040;BDBM50140172;BG0601;CC0179;CCG-36020;CCG-36107;GP8291;LS-125;MFCD00008365;SBB006495;STL371943;AKOS001305497;BCP9000557;CS-1490;curcuma longa l. root oil CO2 extract;DB11672;LS-2189;NSC-687842;OR24598;RTR-032605;curcuma longa l. root oil hydrodistilled;NCGC00017159-04;NCGC00017159-06;NCGC00017159-07;NCGC00017159-09;NCGC00017159-10;NCGC00017159-11;NCGC00017159-12;NCGC00023332-03;NCGC00023332-04;NCGC00023332-05;NCGC00258668-01;AC-24238;AN-23454;BC678109;M212;SC-17381;ST055629;BCP0726000035;DB-002681;KB-251224;TR-032605;WLN: 1OR BQ E1U1V1V1U1R DQ CO1;N1839;1,3-Di(3-methoxy-4-hydroxystyryl)propanedial;1790-EP2305629A1;1790-EP2308861A1;J10108;K00009;W-5038;Curcumin, from Curcuma longa (Turmeric), powder;458C377;Curcumin, primary pharmaceutical reference standard;1,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-;I06-0010;I06-2497;SR-01000000149-2;SR-01000000149-5;BRD-K07572174-001-02-2;BRD-K07572174-001-19-6;BRD-K07572174-001-22-0;I14-19358;Curcumin, >=94% (curcuminoid content), >=80% (Curcumin);1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione;1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-heptadiene-3,5-dione;1,7-DI(4-HYDROXY-3-METHOXYPHENYL)HEPTA-1,6-DIENE-3;Curcumin, matrix substance for MALDI-MS, >=99.5% (HPLC);Curcumin, United States Pharmacopeia (USP) Reference Standard;1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione;1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione);(1E,6E)-1,7-bis(3-methoxy-4-oxidanyl-phenyl)hepta-1,6-diene-3,5-dione;(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione #;(1E,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione;(1Z,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione;1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, (E,E)-;5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one;5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one;Curcumin; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione;(1E,4Z,6E)-5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one;15845-47-3;33171-04-9;73729-23-4;79257-48-0;Curcumin solution, ~0.1 % (w/v) (in ethanol with 2M HCl (99:1 v/v)), for TLC derivatization"	458-37-7	IT942ZTH98	"15501961;11712783"	11712783	01/11/2001	7390600	01/01/1980	Bef. 1989		0	0	0	No	0					30/07/2018		462,0	#N/A																							0						1
Selenious acid	sodium selenite	"Selenous acid;selenige Säure;Prolynium Vitamin and Mineral Supplement;Q.T. Vitamin and Mineral Drink Mix;Golf Vitamin and Mineral Supplement;Alkadrenergy Tablets;Neutral C + Coenzyme Q10 Plus Vitamins & Minerals;I-care Multivitamin and Multimineral Tablets;Selenium;Women's Formula;Vitamins C Plus E W.beta Carotene and Se;Micro Plus 6 (regular);Super 7 Vitamin and Mineral Supplement;Nutrilite Double X;Selenium Supplement;Formula-SE;Tianshi Vital Powder I;M.T.E.-6 Concentrated;C. Vit-min Formula;V-V Dietary Supplement;Tianshi Vital Powder II;Vege 1 Daily Tab;Super-cell;Children's Chewable Tab;Multitrace-5"	DB11127	"Selenous acid;11140-60-6;7783-00-8;Selenious acid (USP);selenige Saeure;dihydroxidooxidoselenium;84920_FLUKA;NCI60_003085;229857_ALDRICH;CHEBI:26642;[SeO(OH)2];CCRIS 5530;EINECS 231-974-7;HSDB 6065;D05814;Monohydrated selenium dioxide;SELENIOUS ACID;Selenious acid (H2SeO3);Selenium dioxide, monohydrated;Selenous acid;NCIMech_000026;211176_ALDRICH"	"SELENIOUS ACID;Selenous acid;7783-00-8;Selenious acid (H2SeO3);Monohydrated selenium dioxide;UNII-F6A27P4Q4R;Selenium dioxide, monohydrated;CCRIS 5530;HSDB 6065;Selenious acid [USP];EINECS 231-974-7;F6A27P4Q4R;CHEBI:26642;Selenious acid (USP);selenious acid,selenous acid,monohydrated selenium dioxide;Selenium, Reference Standard Solution;selenige Saeure;selenige Saure;Selenite ion(2-);dihydroxidooxidoselenium;Selenous acid, 98%;Selenite (SeO32-);AC1L1APE;DSSTox_CID_4300;Selenite ion (SeO32-);EC 231-974-7;NCIMech_000026;Selenous acid, Puratronic?;DSSTox_RID_77360;Selenous acid, 97%  5g;DSSTox_GSID_24300;[SeO(OH)2];AC1Q59Y9;CHEMBL2009089;DTXSID9024300;CTK2H8628;MCAHWIHFGHIESP-UHFFFAOYSA-N;Selenous acid, p.a., 95.0%;Tox21_200407;CCG-35433;MFCD00011331;AKOS015960374;DB11127;UN-3283;VZ36877;KS-0000193L;NCGC00248596-01;NCGC00257961-01;NCI60_003085;CAS-7783-00-8;LS-144800;TR-024855;Selenous acid, 99.999% trace metals basis;SELENIOUS ACID, H<V>2<D>SeO<V>3<D>;D05814;I04-10294;11140-60-6;1408288-83-4"	7783-00-8	F6A27P4Q4R	26102212	26102212	01/06/2015	7019785	01/05/1981	Bef. 1989		0	0	0	No	0					30/07/2018		446,0	#N/A																							0						1
Gossypol	"at-101;gossypol;r-(-)-gossypol acetic acid"		DB13044	"7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde;7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde;7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-1-naphthalenecarboxaldehyde;2,3,8-trihydroxy-6-methyl-4-propan-2-yl-7-(1,6,7-trihydroxy-8-methanoyl-3-methyl-5-propan-2-yl-naphthalen-2-yl)naphthalene-1-carbaldehyde;40112-23-0;20300-26-9;90141-22-3;303-45-7;(2,2'-BINAPHTHALENE)-8,8'-DICARBOXALDEHYDE, 1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIME;Spectrum3_001102;KBio2_000839;CAS-303-45-7;NCGC00016423-01;(+/-)-Gossypol;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6'7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2,2'-bisnaphthalene;NSC56817;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;NCIMech_000271;SPECTRUM1504019;Spectrum5_001035;MLS000028490;NSC624336;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)-;NCI60_001588;Spectrum2_001624;(-)-Gossypol;DivK1c_000173;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (-)-;NSC728875;(2,2'-BINAPHTHALENE)-8,8'-DICARBOXALDEHYDE, 1,1',6,6',7,7'-HEXAHYDROXY-5,5'-DIIS;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahyd;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene);4-08-00-03754 (Beilstein Handbook Reference);AI3-22957;(+)1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;AIDS-001235;AIDS001235;NSC 624336;Tash 1;SPBio_002694;SpecPlus_000602;BPBio1_000851;SPBio_001687;2,2&#8242;-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene);KBio3_002691;Prestwick_1031;G8761_SIGMA;NSC-19048;Gossypol from cotton seeds;1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;(+-)-Gossypol;(2,2-BINAPHTHALENE)-8,8'-DICARBOXALDEHYDE, 1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMET;(2,2-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (+-)-;racemic-Gossypol;(R)-(-)-Gossypol;(R)-Gossypol;NSC726190;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'- hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2R)-;UPCMLD-DP103:002;BRN 1917878;CCRIS 2689;NSC 56817;BSPBio_000773;Prestwick2_000677;KBio1_000173;KBioGR_002303;Prestwick1_000677;Spectrum4_000846;Spectrum4_001931;LMPR01030019;NCI60_004391;KBioSS_000839;BSPBio_002804;Prestwick3_000677;Spectrum5_000693;NCGC00025331-06;NCGC00025331-07;KBio2_003407;KBio2_005975;SMP2_000170;NCGC00025331-01;Tocris-1964;SMR000058386;NCGC00025331-02;NCGC00025331-03;Prestwick0_000677;SPBio_001423;1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-2,2'-binaphthalene-8,8'-dicarbaldehyde;Spectrum_000359;(+)-Gossypol;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-, (+)-;BSPBio_003191;NINDS_000173;KBioGR_001451;nchembio875-comp1;Spectrum3_001516;Spectrum2_001472;Spectrum_001521;SBB012338;KBioSS_002001;IDI1_000173;DivK1c_006698;KBio2_002001;KBio2_004569;KBio2_007137;C07667;Gossypol;UPCMLD-DP103:001;KBio3_002024;12542-36-8 (ACETIC ACID);7-(8-Formyl-1,6,7-trihydroxy-3-methyl-5-(methylethyl)(2-naphthyl))-2,3,8-trihydroxy-6-methyl-4-(methylethyl)naphthalenecarbaldehyde;AIDS-044146;AIDS044146;(-)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;(-)-2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene);AIDS-000457;AIDS000457;Pogosin;KBio1_001642"	"gossypol;303-45-7;(-)-Gossypol;(+)-Gossypol;Pogosin;90141-22-3;Tash 1;racemic-Gossypol;(R)-(-)-Gossypol;(R)-Gossypol;(+-)-Gossypol;(+/-)-Gossypol;CCRIS 2689;AT101;NSC56817;NSC 56817;NSC 624336;BRN 1917878;gosipol;gossypol sodium;CHEMBL51483;AI3-22957;1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-[2,2'-binaphthalene]-8,8'-dicarbaldehyde;20300-26-9;gossypol potassium;2,2'-bi[8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene];gossypol dipotassium;2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene);NSC624336;Gossypol acetate;NCGC00016423-03;CAS-303-45-7;ST065835;8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2,2'-bisnaphthalene;DSSTox_CID_3110;DSSTox_RID_76879;DSSTox_GSID_23110;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (-)-;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-, (+)-;(2,2-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (+-)-;4-08-00-03754 (Beilstein Handbook Reference);7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde;7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde;No Fertil;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahyd;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-;(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-;40112-23-0;7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde;7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(methylethyl)(2-naphthyl)]-2,3,8-trihy droxy-6-methyl-4-(methylethyl)naphthalenecarbaldehyde;Gossypol Sodium Salt;Gissypol, (R)-;NSC-19048;Sodium Salt, Gossypol;Gossypol, (+)-Isomer;Gossypol, (-)-Isomer;SR-01000597521;Gossypol Dipotassium Salt;UNII-XNA7DR63CQ;Gossypol, (+-)-Isomer;Dipotassium Salt, Gossypol;UNII-8DY2X8LXW4;UNII-KAV15B369O;Gossyol;HSDB 7872;Gossypol, 4;BL 193;Prestwick_1031;Gossypol, (R)-;Gossypol, (S)-;Spectrum_000359;Spectrum_001521;Tocris-1964;SpecPlus_000602;AC1Q2QPP;Prestwick0_000677;Prestwick1_000677;Prestwick2_000677;Prestwick3_000677;Spectrum2_001472;Spectrum2_001624;Spectrum3_001102;Spectrum3_001516;Spectrum4_000846;Spectrum4_001931;Spectrum5_000693;Spectrum5_001035;Gossypol from cotton seeds;XNA7DR63CQ;AT-101/GOSSYPOL;D0Z0HH;UPCMLD-DP103;NCIMech_000271;AC1L1G2Z;cid_3503;SCHEMBL3939;8DY2X8LXW4;BSPBio_000773;BSPBio_002804;BSPBio_003191;KBioGR_001451;KBioGR_002303;KBioSS_000839;KBioSS_002001;MLS000028490;DivK1c_000173;DivK1c_006698;SPECTRUM1504019;SPBio_001423;SPBio_001687;SPBio_002694;BPBio1_000851;cid_227456;GTPL4204;KAV15B369O;DTXSID5023110;UPCMLD-DP103:001;UPCMLD-DP103:002;BDBM23223;BDBM46555;CTK8G0094;KBio1_000173;KBio1_001642;KBio2_000839;KBio2_002001;KBio2_003407;KBio2_004569;KBio2_005975;KBio2_007137;KBio3_002024;KBio3_002691;EX-A068;MolPort-003-665-510;NINDS_000173;QBKSWRVVCFFDOT-UHFFFAOYSA-N;HMS1570G15;HMS2097G15;HMS3262J15;HMS3268O22;HMS3651C18;ZINC3775575;Tox21_110434;Tox21_500847;2,2'-bis[8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene];BN0226;CCG-35400;MFCD00017352;NSC-56817;NSC726190;NSC728875;SBB012338;STK063457;AKOS002140475;Tox21_110434_1;BCP9000332;CS-2106;DB13044;LMPR0103330002;LP00847;MCULE-2539927675;NSC-624336;NSC-726190;NSC-728875;PXT0004725;IDI1_000173;KS-0000183E;SMP2_000170;NCGC00016423-01;NCGC00016423-02;NCGC00016423-04;NCGC00016423-05;NCGC00016423-06;NCGC00016423-07;NCGC00016423-08;NCGC00016423-09;NCGC00016423-10;NCGC00016423-14;NCGC00016423-15;NCGC00025331-01;NCGC00025331-02;NCGC00025331-03;NCGC00025331-04;NCGC00025331-06;NCGC00025331-07;NCGC00261532-01;4CA-0193;AC-20251;AC-30274;AJ-45571;AK148510;AN-44192;BC216252;HY-13407;LS-43993;LS-43994;LS-43996;LS-43997;NCI60_001588;NCI60_004391;SC-79036;SMR000058386;BCP0726000183;AB00052921;FT-0631917;N2135;ST24036539;V0195;A11202;C07667;S-7805;156767-EP2284178A2;156767-EP2284179A2;303G457;C-23051;J-017920;SR-01000597521-1;SR-01000597521-5;SR-01000597521-6;(+/-)-Gossypol from cotton seeds, >=95% (HPLC);BRD-K19295594-001-06-9;BRD-K19295594-001-10-1;BRD-K19295594-015-02-8;1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,;8-Formyl-1,7-trihydroxy-5-isopropyl-3-methyl-2,2'-bisnaphthalene;(+/-)-2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene);(-)-2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene);(2,8'-dicarboxaldehyde, 1,1',6,6'7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-;(+)1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;(-)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;(-)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde,1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2R)-;[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'- hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2R)-;[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)-;[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-;1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-2,2'-binaphthalene-8,8'-dicarbaldehyde;1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde;1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-di(propan-2-yl)-2,2'-binaphthalene-8,8'-dicarbaldehyde;1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbaldehyde;1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthyl-8,8'-dicarbaldehyde;1,1',6,6'-Tetrahydroxy-3,3'-dimethyl-5,5'-diisopropyl-8,8'-bis(hydroxymethylene)-2,2'-binaphthalene-7,7'(8H,8'H)-dione;123732-23-0;7-(8-Formyl-1,6,7-trihydroxy-3-methyl-5-(methylethyl)(2-naphthyl))-2,3,8-trihydroxy-6-methyl-4-(methylethyl)naphthalenecarbaldehyde;732279-01-5;acetic acid;7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-yl-2-naphthalenyl)-2,3,8-trihydroxy-6-methyl-4-propan-2-yl-1-naphthalenecarboxaldehyde;acetic acid;7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde;acetic acid;7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde;ethanoic acid;7-[8-methanoyl-3-methyl-1,6,7-tris(oxidanyl)-5-propan-2-yl-naphthalen-2-yl]-6-methyl-2,3,8-tris(oxidanyl)-4-propan-2-yl-naphthalene-1-carbaldehyde;Pogosin|||AT-101|||7-(8-Formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde"	303-45-7	8DY2X8LXW4	"1394805;19366825"	1394805	01/01/1992	6793420	01/07/1981	Bef. 1989		0	0	0	No	0					30/07/2018		444,0	#N/A																							0						1
Sodium aurothiomalate	aurothiomalate	"Gold sodium thiomalate;Sodium Aurothiomalate Injection BP;Myochrysine"	DB09276	"sodium; gold(+1) cation; hydron; 2-sulfidobutanedioate;sodium; gold(+1) cation; hydron; 2-sulfidosuccinate;Myochrysine (TN);Sodium aurothiomalate (JP15);Sodium aurothiomalate;D00992;Gold sodium thiomalate (USP)"	"Sodium aurothiomalate;Chrysothios;Myocrisin;Tauredon;Myochrysine;Miochrysin;Myocrisine;Kidon;GOLD SODIUM THIOMALATE;Taure(o)don;Aurothiomala-Natrium;Aurothiomalate sodium;Aurothiomalato sodico;Aurothiomalate;Dinatrium 2-(aurothio)succinat;Gold Thiomalate;HSDB 7173;Natrii aurothiomalas [INN-Latin];Aurotiomalato sodico [INN-Spanish];EINECS 235-479-7;Aurothiomalate de sodium [INN-French];12244-57-4;Succinic acid, mercapto-, gold sodium salt;Butanedioic acid, mercapto-, monogold(1+) sodium salt;disodium aurothiomalate;Myocrysine;Miocrisin;Aurotiomalato sodico;Natrii aurothiomalas;Sodium Gold Thiomalate;Sodium Thiomalatoaurate;Aurothiomalate de sodium;disodium [2-(sulfanyl-kappaS)butanedioato(3-)]aurate(2-);Gold sodium thiomalate [USAN:USP];Na2[Au(thiomalate)];C4H3AuO4S;sodium aurum(I) thiomalate;SCHEMBL8548;Sodium aurothiomalate [INN];Mercaptobutanedioic Acid Monogold(1+) Sodium Salt;disodium thiomalato-S-gold(I);disodium thiomalato-S-aurate(I);CHEBI:35864;sodium (1,2-dicarboxylatoethylthio)gold;LS-73046;[(1,2-dicarboxyethyl)thio]gold disodium salt;39377-38-3 (di-hydrochloride salt, mono-hydrate);12544-40-0;14481-64-2;16905-00-3;18911-13-2;23164-93-4;3504-43-6;3829-87-6;3845-05-4;554-42-7;62695-99-2;62696-00-8"	12244-57-4	E4768ZY6GM	23962904	23962904	01/08/2013	6813482	01/07/1982	Bef. 1989		1	0	0	No	0					30/07/2018		432,1	#N/A																							0						1
Triciribine	triciribine		DB12405	"35943-35-2;AIDS002725;1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-;1,4,5,6,8-Pentaazaacenaphthylene, 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-;1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl- (9CI);1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine;3-Amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene;BRN 1171593;NSC 154020;NSC-154020;Pentaazacentopthylene;TCN;Triciribina [INN-Spanish];Triciribine;Triciribinum [INN-Latin];Tricyclic nucleoside;BiomolKI2_000078;NCGC00092314-02;AIDS-002725"	"Triciribine;35943-35-2;Pentaazacentopthylene;Tricyclic nucleoside;NSC 154020;Triciribine [INN];Tricirbine;Triciribinum [INN-Latin];Triciribina [INN-Spanish];UNII-2421HMY9N6;API-2;BRN 1171593;C13H16N6O4;NSC-154020;1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine;CHEBI:65310;TCN;2421HMY9N6;Inhibitor V;1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-;1,4,5,6,8-Pentaazaacenaphthylene, 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-;3-Amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene;DSSTox_CID_25743;DSSTox_RID_81088;DSSTox_GSID_45743;Triciribina;Triciribinum;5-methyl-1-(beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine;CAS-35943-35-2;VD-0002;6-ARPPP;Akt/PKB Signaling Inhibitor-2;CHEMBL331237;NCGC00092314-01;NCGC00092314-04;API-2;Triciribine;Triciribine/API-2;NSC 154120;BiomolKI2_000078;SCHEMBL61268;MLS006011145;AC1L236J;DTXSID6045743;CTK8F0953;AOB5912;EX-A415;MolPort-021-805-017;BCPP000034;ZINC3808299;Tox21_111192;2082AH;2765AH;ABP000410;BDBM50369528;MFCD16879015;s1117;API-2;NSC 154020;TCN;AKOS024456958;Tox21_111192_1;CCG-100678;DB12405;1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-;3-amino-1,5-dihydro-5-methyl-I-beta-D-ribofuranosyl-1,4,5,6,8- pentaazaacenaphthylene;6-amino-4-methyl-8-(beta-D-ribofuranosyl)-(4H,8H)pyrrolo(4,3,2-de)pyrimido(4,5-c)pyridazine;NCGC00092314-02;4CA-1279;AN-16846;BC638573;SMR002530325;SRI-10809-03;DB-048898;KB-333886;LS-101390;TX-018033;FT-0639291;W-5227;943T352;BRD-K80431395-001-01-6;BRD-K80431395-001-09-9;1,4,5,6,8-Pentaazaacenaphthylen-3-amine,1,5-dihydro-5-methyl-1-b-D-ribofuranosyl-;1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-;1,5-Dihydro-5-methyl-1-?-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine;1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8pentaazaacenaphthylen-3-amine;(2R,3R,4S,5R)-2-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.0^{4,12}]dodeca-1(11),3,5,8(12),9-pentaen-2-yl}-5-(hydroxymethyl)oxolane-3,4-diol;1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl- (9CI)"	35943-35-2	2421HMY9N6	8529286	8529286	01/01/1996	6825123	01/02/1983	Bef. 1989		1	1	0	Yes	1					30/07/2018		425,0	20	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	1	0	0	1
Dichloroacetic Acid	dichloroacetate	"dichloroacetate;dichloracetic acid;DCA;Bichloracetic Acid 100%"	DB08809	"2,2-Dichloroacetic acid;2,2-dichloroethanoic acid;79-43-6;42428-47-7;MLS000028893;SMR000059158;InChI=1/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6;4-02-00-00498 (Beilstein Handbook Reference);AI3-18370;BRN 1098596;Bichloracetic acid;CCRIS 4016;DCA (acid);Dichloroacetic acid (IUPAC);Dichloroacetic acid [UN1764]  [Corrosive];EINECS 201-207-0;HSDB 6894;Kyselina dichloroctova [Czech];NSC 2654;C11149;Acetic acid, dichloro- (8CI,9CI);47657U_SUPELCO;Dichloroacetic acid solution;2,2-Dichloroacetic acid;Acetic acid, dichloro-;Dichloracetic acid;Dichlorethanoic acid;Dichloroacetic acid;Dichloroethanoic acid;NSC2654;Urner's liquid;WLN: QVYGG;NCGC00091444-01;DKhUK;NCGC00091444-02;UN1764;36545_RIEDEL;TF4;442559_SUPELCO;CHEBI:36386;DICHLORO-ACETIC ACID;Dichloressigsaeure;D54702_SIAL;49431_FLUKA"	"DICHLOROACETIC ACID;2,2-Dichloroacetic acid;79-43-6;Dichloracetic acid;Dichloroethanoic acid;Acetic acid, dichloro-;Urner's liquid;Dichlorethanoic acid;Bichloracetic acid;DCA (acid);Bichloroacetic Acid;DICHLORO-ACETIC ACID;Kyselina dichloroctova;Acetic acid, 2,2-dichloro-;UNII-9LSH52S3LQ;NSC 2654;C2H2Cl2O2;Dichloroacetic acid (IUPAC);Kyselina dichloroctova [Czech];CCRIS 4016;HSDB 6894;EINECS 201-207-0;UN1764;BRN 1098596;DCA;9LSH52S3LQ;AI3-18370;CHEBI:36386;JXTHNDFMNIQAHM-UHFFFAOYSA-N;NCGC00091444-02;DSSTox_CID_428;DSSTox_RID_75580;DSSTox_GSID_20428;Dichloroaceticacid;CAS-79-43-6;SMR000059158;TF4;Dichloressigsaeure;DKhUK;WLN: QVYGG;AC1L1MVS;ACMC-1BLM2;2,2-dichloro-acetic acid;AC1Q71RC;AC1Q71RD;SCHEMBL7777;4-02-00-00498 (Beilstein Handbook Reference);KSC377O2D;MLS000028893;MLS001074861;MLS001424165;CHEMBL13960;DTXSID2020428;CTK2H7721;KS-00000VOI;NSC2654;MolPort-001-779-958;BDBM227588;HMS2051P22;HMS2232H11;HMS3370D12;HMS3393P22;Dichloroacetic acid, 99%  250g;13425-80-4 (Parent);NSC-2654;ZINC3830689;Dichloroacetic acid, puriss., 99%;Tox21_111133;Tox21_202363;Tox21_300419;Acetic acid, dichloro- (8CI,9CI);ANW-37297;BBL011449;LMFA01090070;MFCD00004223;STL146561;AKOS005720869;Tox21_111133_1;CCG-101070;DB08809;LS-1783;MCULE-1246638159;NC00320;NE10301;RP19829;RTR-025261;TRA0083432;UN 1764;Dichloroacetic acid, analytical standard;NCGC00091444-01;NCGC00091444-03;NCGC00091444-04;NCGC00167845-02;NCGC00254261-01;NCGC00259912-01;AN-23997;AS-14228;CPD000059158;K407;SAM001246870;SC-18205;DB-056364;Dichloroacetic acid [UN1764] [Corrosive];TL8005376;TR-025261;D0308;Dichloroacetic acid [UN1764]  [Corrosive];Dichloroacetic acid, biotech. grade, >=98%;FT-0624700;ST24038419;Dichloroacetic acid, ReagentPlus(R), >=99%;EN300-20014;C11149;11029-EP2269610A2;11029-EP2289510A1;11029-EP2316457A1;11029-EP2316458A1;11029-EP2316825A1;11029-EP2316826A1;11029-EP2316827A1;11029-EP2316828A1;12408-EP2277848A1;12408-EP2277878A1;12408-EP2295503A1;12408-EP2298772A1;12408-EP2301918A1;12408-EP2305649A1;12408-EP2316974A1;DCA Deblock (0.36M dichloroacetic acid in toluene);I04-0427;Dichloroacetic acid, PESTANAL(R), analytical standard;WATER DISINFECTION MODEL (DICHLOROACETIC ACID);DICHLOROACETIC ACID (SEE ALSOTRICHLOROACETIC ACID);F2191-0226;InChI=1/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6;Dichloroacetic acid 1000 ng/microl in Methyl-tert. butyl ether;Dichloroacetic acid solution, for DNA synthesis, 3% in methylene chloride;WATER DISINFECTION BYPRODUCTS(DICHLOROACETIC ACID) (DICHLOROACETIC ACID);42428-47-7"	79-43-6	9LSH52S3LQ	"25762000;24297161"	24297161	01/12/2013	2708190	01/01/1985	Bef. 1989		1	0	0	No	0					30/07/2018		402,1	#N/A																							0						1
Thalidomide	"thalidomid;thalidomide"	"N-Phthalylglutamic acid imide;Thalidomidum;(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide;2,6-dioxo-3-phthalimidopiperidine;(±)-N-(2,6-dioxo-3-piperidyl)phthalimide;alpha-(N-Phthalimido)glutarimide;N-(2,6-dioxo-3-piperidyl)phthalimide;N-Phthaloylglutamimide;α-(N-phthalimido)glutarimide;α-N-phthalylglutaramide;α-phthalimidoglutarimide;1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;3-Phthalimidoglutarimide;(±)-thalidomide;N-Phthalyl-glutaminsaeure-imid;Talidomida;alpha-N-Phthalylglutaramide;(+-)-Thalidomide;Thalomid;Thalidomide Celgene"	"DB01041;APRD01251"	"2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;2-(2,6-dioxo-3-piperidinyl)isoindoline-1,3-dione;2-(2,6-diketo-3-piperidyl)isoindoline-1,3-quinone;14088-68-7;50-35-1;731-40-8;841-67-8;KBio2_000496;KBio2_003064;KBio2_005632;Talidomida [INN-Spanish];SPBio_002064;Talidomide [DCIT];Thalidomide [USAN:BAN:INN];Thalidomidum [INN-Latin];Thalomid;NSC91729;WLN: T56 BVNVJ C- DT6VMVTJ -D;Thalomide;(-)-Thalidomide;1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)-;L-Thalidomide;alpha-(N-Phthalimido)glutarimide;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (-)-;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, L-(-)-;WLN: T56 BVNVJ C- DT6VMVTJ -L;T144_SIGMA;alpha-N-Phthalylglutaramide;alpha-Phthalimidoglutarimide;Bio1_000876;KBio3_002550;Bio2_000418;Synovir;Talizer;(&#8722;)-Thalidomide;S(&#8722;)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;T150_SIGMA;Prestwick0_000192;Spectrum3_001715;Prestwick2_000192;KBio1_000051;BSPBio_003330;BSPBio_001156;IDI1_000051;KBio3_000911;R-()-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;T151_SIGMA;Spectrum2_000707;cMAP_000022;UPCMLD-DP139:001;SPBio_000893;(+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;Bio1_000387;NCIOpen2_003188;NINDS_000051;NSC91730;()-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;KBioGR_002322;KBio3_002802;SPECTRUM1503607;KBioSS_002324;()-Thalidomide;IDI1_002173;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;AIDS-000513;AIDS000513;Thalomid (TM);Lopac0_001224;Prestwick3_000192;KBio2_002322;KBio2_004890;KBio2_007458;.alpha.-(N-Phthalimido)glutarimide;.alpha.-N-Phthalylglutaramide;.alpha.-Phthalimidoglutarimide;1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-;2,6-Dioxo-3-phthalimidopiperidine;3-Phthalimidoglutarimide;Algosediv;Asidon 3;Asmadion;Asmaval;Bonbrain;Bonbrrin;Calmore;Calmorex;Contergan;Corronarobetin;Distaval;Distaxal;Distoval;E-217;Ectiluran;Enterosediv;Gastrinide;Glupan;Glutanon;Glutarimide, 2-phthalimido-;Grippex;Hippuzon;Imida-Lab;Imidan (peyta);Imidene;Isomin;K 17;K-17;Kedavon;Kevadon;Lulamin;N-(2,6-Dioxo-3-piperidyl)phthalimide;N-Phthaloylglutamimide;N-Phthalyl-glutaminsaeure-imid;N-Phthalylglutamic acid imide;NSC66847;Neo;Neosedyn;Neosydyn;Nerosedyn;Neufatin;Neurodyn;Neurosedin;Neurosedym;Nevrodyn;Nibrol;Noctosediv;Noxodyn;Pangul;Pantosediv;Phthalimide, N-(2,6-dioxo-3-piperidyl)-;Poly-Giron;Polygripan;Predni-Sediv;Pro-ban M;Profarmil;Psycholiquid;Psychotablets;Quetimid;Quietoplex;Sandormin;Sedalis sedi-lab;Sedimide;Sedin;Sedisperil;Sedoval;Shin-naito S;Shinnibrol;Sleepan;Slipro;Softenil;Softenon;Talargan;Talimol;Talismol;Telagan;Telargean;Tensival;Thalidomide (soluble form);Thalin;Thalinette;Theophilcholine;Ulcerfen;Valgis;Valgraine;WLN: T56 BVNVJ C- DT6VMVTJ;Yodomin;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)-;C07910;Thalidomide;Thalidomide (+ and -);(+/-)-THALIDOMIDE;MLS000069353;SMR000058524;Prestwick1_000192;NCI60_023904;NCGC00024708-03;NCGC00024708-04;BPBio1_000159;(+-)-Thalidomide;KBio3_000912;Spectrum5_001791;1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;D00754;Thalidomide (JAN/USP/INN);Thalomid (TN);5-22-13-00224 (Beilstein Handbook Reference);KBioGR_001474;AI3-50606;2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;Actimid;BRN 0030233;NSC527179;Bio1_001365;Spectrum4_001087;CC 4047;DRG-0184;EINECS 200-031-1;ENMD 0995;DivK1c_000051;EU-0101224;BSPBio_000143;HSDB 3586;KBioGR_000496;KBioSS_000496;N-Phthalyl-glutaminsaeure-imid [German];2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;Bio2_000898;NSC 527179;NCGC00024708-05;NSC-66847;NCGC00024708-07;Neaufatin;NCGC00024708-08;Prestwick_463;Pro-Bam M"	"thalidomide;50-35-1;Thalomid;Sedoval;(+/-)-THALIDOMIDE;2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;Corronarobetin;Psycholiquid;Psychotablets;Theophilcholine;Algosediv;Asmadion;Bonbrain;Calmorex;Contergan;Distaval;Ectiluran;Enterosediv;Gastrinide;Glutanon;Hippuzon;Neosedyn;Neosydyn;Nerosedyn;Neufatin;Neurodyn;Neurosedin;Neurosedym;Nevrodyn;Noctosediv;Pantosediv;Polygripan;Profarmil;Quetimid;Quietoplex;Sandormin;Sedimide;Sedisperil;Shinnibrol;Softenil;Softenon;Talargan;Talismol;Telargean;Tensival;Thalinette;Valgraine;Asmaval;Calmore;Glupan;Grippex;Imidene;Isomin;Kevadon;Nibrol;Noxodyn;Pangul;Sleepan;Slipro;Talimol;Telagan;Thalin;Valgis;Yodomin;N-Phthaloylglutamimide;Sedin;Predni-Sediv;Imida-lab;Poly-Giron;Sedalis sedi-lab;Shin-naito S;Neaufatin;Asidon 3;Pro-ban M;Imidan (peyta);N-Phthalylglutamic acid imide;Talidomida;3-Phthalimidoglutarimide;alpha-Phthalimidoglutarimide;Thalidomidum;Bonbrrin;Distaxal;Distoval;Thalomide;Kedavon;(+-)-Thalidomide;K-17;2,6-Dioxo-3-phthalimidopiperidine;N-Phthalyl-glutaminsaeure-imid;Thalidomide Celgene;Pro-Bam M;Talidomide [DCIT];alpha-N-Phthalylglutaramide;Neurosedyn;Sedalis;Talidomide;Telargan;N-(2,6-Dioxo-3-piperidyl)phthalimide;Glutarimide, 2-phthalimido-;NSC-66847;alpha-(N-Phthalimido)glutarimide;Talidomida [INN-Spanish];Thalidomidum [INN-Latin];Thalidomine USP26;K 17;E-217;Synovir;Talizer;Thaled;ENMD 0995;1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-;1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;Thalomid (TM);Thalomid (TN);Thalidomide Pharmion;.alpha.-N-Phthalylglutaramide;Thaled (TN);N-Phthalyl-glutaminsaeure-imid [German];Thalidomide [USAN:INN:BAN];N-Phthalimidoglutamic acid imide;2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;HSDB 3586;Phthalimide, N-(2,6-dioxo-3-piperidyl)-;C13H10N2O4;EINECS 200-031-1;IN1061;CHEMBL468;Thalidomide (soluble form);NSC 527179;BRN 0030233;.alpha.-Phthalimidoglutarimide;Thalidomide (JAN/USP/INN);AI3-50606;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;(+-)-N-(2,6-Dioxo-3-piperidyl)phthalimide;CHEBI:74947;UEJJHQNACJXSKW-UHFFFAOYSA-N;.alpha.-(N-Phthalimido)glutarimide;NSC66847;THALIDOMIDE (AIDS INITIATIVE);N-(2,6-dioxo-3-piperidinyl)phthalimide;NCGC00015989-09;2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;DSSTox_CID_2524;DSSTox_RID_76611;(+/-)-N-(2,6-Dioxo-3-piperidinyl)phthalimide;DSSTox_GSID_22524;2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione;(?)-Thalidomide;Phthalimide,6-dioxo-3-piperidyl)-;(+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (+-)-;WLN: T56 BVNVJ C- DT6VMVTJ;1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-;SR-01000076184;Thalidomide (+ and -);Celgene;Pharmion;Talinol;CCRIS 8148;(y)-Thalidomide;Thalidomide,(S);CAS-50-35-1;Prestwick_463;Thalomid, Thalidomide;Thalidomide [USAN:USP:INN:BAN:JAN];(A+/-)-Thalidomide;Thalidomide (+ and-);AC1L1KBZ;AC1Q6FJA;Prestwick0_000192;Prestwick1_000192;Prestwick2_000192;Prestwick3_000192;Spectrum2_000707;Spectrum3_001715;Spectrum4_001087;Spectrum5_001791;(.+/-.)-Thalidomide;D0U7GK;UPCMLD-DP139;Thalomid (TN) (Celgene);SCHEMBL7581;Celgene Brand of Thalidomide;NCIOpen2_003188;Lopac0_001224;BSPBio_000143;BSPBio_001156;BSPBio_003330;KBioGR_000496;KBioGR_001474;KBioGR_002322;KBioSS_000496;KBioSS_002324;MLS000069353;ARONIS24496;DivK1c_000051;SPECTRUM1503607;SPBio_000893;SPBio_002064;BPBio1_000159;GTPL7327;DTXSID9022524;SCHEMBL15197560;UPCMLD-DP139:001;CTK8B6291;HMS500C13;KBio1_000051;KBio2_000496;KBio2_002322;KBio2_003064;KBio2_004890;KBio2_005632;KBio2_007458;KBio3_000911;KBio3_000912;KBio3_002550;KBio3_002802;cMAP_000022;MolPort-003-665-582;NINDS_000051;Bio1_000387;Bio1_000876;Bio1_001365;Bio2_000418;Bio2_000898;HMS1362J17;HMS1568H05;HMS1792J17;HMS1922E12;HMS1990J17;HMS2090O05;HMS2093G15;HMS2095H05;HMS2234C07;HMS3259C22;HMS3263F10;HMS3266F13;HMS3373E06;HMS3373G15;HMS3403J17;HMS3654A20;HMS3712H05;Pharmakon1600-01503607;BCP19772;NSC91729;NSC91730;(inverted question mark)-Thalidomide;Tox21_110275;Tox21_300580;Tox21_501224;AC-917;ANW-53225;BBL023439;BDBM50070114;CCG-39878;LS-140;MFCD00153873;NSC-91729;NSC-91730;NSC527179;NSC758479;STL356025;( inverted question mark)-Thalidomide;AKOS009529198;Tox21_110275_1;CS-1084;DB01041;LP01224;MCULE-6327754946;NC00600;NSC-527179;NSC-758479;RP29207;(+/-)-Thalidomide, >=98%, powder;IDI1_000051;IDI1_002173;KS-00000H64;n-(2,6-dioxopiperidin-3-yl)phthalimide;NCGC00015989-03;NCGC00015989-04;NCGC00015989-05;NCGC00015989-06;NCGC00015989-07;NCGC00015989-08;NCGC00015989-10;NCGC00015989-11;NCGC00015989-12;NCGC00015989-13;NCGC00015989-14;NCGC00015989-16;NCGC00015989-17;NCGC00024708-02;NCGC00024708-03;NCGC00024708-04;NCGC00024708-05;NCGC00024708-06;NCGC00024708-07;NCGC00024708-08;NCGC00024708-09;NCGC00024708-10;NCGC00024708-11;NCGC00254343-01;NCGC00261909-01;731-40-8;AN-15419;AS-12367;BC204656;CPD000058524;HY-14658;KB-61574;NCI60_023904;SAM002564245;SC-18573;SMR000058524;WLN: T56 BVNVJ C- DT6VMVTJ -D;WLN: T56 BVNVJ C- DT6VMVTJ -L;SBI-0051191.P003;AB0011813;AB2000009;LS-109463;Phthalimide,6-dioxo-3-piperidyl)-, (+)-;Phthalimide,6-dioxo-3-piperidyl)-, (-)-;TC-141970;AB00052362;EU-0101224;FT-0600001;FT-0631211;S1193;ST24027458;ST51039042;Phthalimide,6-dioxo-3-piperidyl)-, D-(+)-;Phthalimide,6-dioxo-3-piperidyl)-, L-(-)-;(+/-)-N-(2,6-dioxo-3-piperidyl)phthalimide;C07910;D00754;J90042;M-1523;AB00052362-11;AB00052362-12;AB00052362-13;AB00052362_14;AB00052362_15;153T873;I06-0197;SR-01000076184-1;SR-01000076184-3;SR-01000076184-5;SR-01000076184-8;W-105969;BRD-A93255169-001-04-4;BRD-A93255169-001-06-9;BRD-A93255169-001-24-2;I14-23643;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)-;Z1550675451;1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)-;1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)-;2-(2,6-dioxoazaperhydroin-3-yl)benzo[c]azoline-1,3-dione;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione #;[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;Thalidomide, United States Pharmacopeia (USP) Reference Standard;( inverted question mark)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;1012310-87-0;14088-68-7"	50-35-1	4Z8R6ORS6L	"20729242;19675744;18787470;18251177;16899362;16828852;16520988;14997189;12525736;11806984"	11806984	01/01/2002	14296025	01/05/1965	Bef. 1989		0	0	1	No	0	"28/10/1999 00:00;01/11/2001 00:00;03/08/2010 00:00;27/06/2017 00:00;27/10/2003 00:00;16/11/2001 00:00;08/02/2013 00:00;30/11/2017 00:00;04/09/2001 00:00;15/11/2013 00:00;05/08/2015 00:00;12/02/1999 00:00;05/03/2004 00:00;29/12/2017 00:00;25/05/2006 00:00;19/06/2014 00:00;22/04/2016 00:00;03/04/2000 00:00;10/01/2007 00:00;13/09/2015 00:00;01/12/2015 00:00;27/10/2015 00:00;12/09/2014 00:00;27/01/2017 00:00;16/07/1998 00:00;17/01/2003 00:00;03/02/2012 00:00;15/05/2000 00:00;28/05/1999 00:00"	AP	CELGENE	THALIDOMIDE	16/07/1998	CELGENE	397,7	#N/A																							0						1
Doxifluridine	doxifluridine		DB12947	"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-2-tetrahydrofuranyl]-5-fluoropyrimidine-2,4-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-quinone;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-oxolan-2-yl]-5-fluoro-pyrimidine-2,4-dione;3094-09-5;D01309;Doxifluridine (JP15);Furtulon (TN);EU-0100537;Doxifluridine [INN:JAN];1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil;5'-Deoxy-5-fluorouridine;5'-Dfur;5'-Doxifluridine;DOXIFLURIDINE;Doxifluridina [INN-Spanish];NCGC00093926-03;Doxifluridinum [INN-Latin];EINECS 221-440-1;Flutron;Furtulon;Ro 21-9738;Ro 219738;Uridine, 5'-deoxy-5-fluoro-;Uridine-5'-deoxy-5-fluoro-;AIDS-184530;AIDS184530;5&#8242;dFUrd;5-Fluoro-5&#8242;-deoxyuridine;F8791_SIGMA;Lopac0_000537;1-((4S,2R,3R,5R)-3,4-Dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione;5-DFUR;Ro-21-9738;()-5-Fluoro-5&#8242;-deoxyuridine;537314_ALDRICH"	"doxifluridine;5'-Deoxy-5-fluorouridine;3094-09-5;5-fluoro-5'-deoxyuridine;Furtulon;5'-Dfur;Uridine, 5'-deoxy-5-fluoro-;Flutron;Doxifluridina;Doxifluridinum;5'-Doxifluridine;Furtulon (TN);Uridine-5'-deoxy-5-fluoro-;5'dFUrd;Ro 21-9738;Doxifluridine [INN:JAN];5-DFUR;UNII-V1JK16Y2JP;Ro 219738;Doxifluridinum [INN-Latin];CHEMBL1130;V1JK16Y2JP;Doxifluridina [INN-Spanish];CHEBI:31521;1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil;EINECS 221-440-1;NCGC00093926-03;Doxifluridine (5-Fluoro-5'-deoxyuridine);DSSTox_CID_2967;5'FDUR;DSSTox_RID_76809;DSSTox_GSID_22967;1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione;doxyfluridine;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione;5'-dFUrd;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione;SMR000326811;CAS-3094-09-5;SR-01000075886;1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5'-Deoxy-5-fluorouridine);38817-29-7;(+)-Doxifluridine;PubChem21074;AC1L2BUF;5-Deoxy-5-fluorouridine;5-Fluoro-5;-deoxyuridine;D03KXY;AC1Q29PS;SCHEMBL8094;Doxifluridine (JP17/INN);Lopac0_000537;KSC492G6N;MLS001332579;MLS001332580;MLS002172440;MLS002207077;URI004;DTXSID2022967;CTK3J2366;KS-00000EUP;MolPort-003-936-171;ZWAOHEXOSAUJHY-ZIYNGMLESA-N;HMS2090C22;HMS2231I05;HMS3261L15;ACN-S003358;HY-B0021;ZINC1319177;ZX-AP001976;Tox21_111231;Tox21_500537;ANW-13803;BDBM50132295;CD-197;MFCD00866530;PC5775;s2045;AKOS015852921;AKOS015896821;Tox21_111231_1;API0015889;CCG-204627;CS-1270;DB12947;Doxifluridine/5-Fluoro-5'-deoxyuridine;KS-5065;LP00537;NCGC00093926-01;NCGC00093926-02;NCGC00093926-05;NCGC00261222-01;Ro-21-9738;AK163078;CJ-04859;KB-50427;SRI-11552-08;SRI-11552_09;SY017052;ZB016270;5''-Deoxy-5-Fluorouridine (5''-Dfur);LS-160821;EU-0100537;C12739;D01309;F 8791;W-5145;15185-EP2272827A1;15185-EP2275420A1;15185-EP2295055A2;15185-EP2295416A2;15185-EP2295426A1;15185-EP2295427A1;15185-EP2298748A2;15185-EP2298764A1;15185-EP2298765A1;15185-EP2298768A1;15185-EP2298778A1;15185-EP2305642A2;15185-EP2311453A1;15185-EP2311808A1;15185-EP2311829A1;15185-EP2316832A1;15185-EP2316833A1;094F095;A820661;SR-01000075886-1;SR-01000075886-5;(+)-1-(beta-D-5'-Deoxyribofuranosyl)-5-fluorouracil;BRD-K58262659-001-09-7;Capecitabine impurity B, European Pharmacopoeia (EP) Reference Standard;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-2-oxolanyl]-5-fluoropyrimidine-2,4-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-3H-pyrimidine-2,4-dione;5-fluoranyl-1-[(2R,3R,4S,5R)-5-methyl-3,4-bis(oxidanyl)oxolan-2-yl]pyrimidine-2,4-dione;Capecitabine Related Compound B, United States Pharmacopeia (USP) Reference Standard;1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione;1-((2R,5R)-3,4-Dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione;1-((4S,2R,3R,5R)-3,4-Dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione"	05/09/3094	V1JK16Y2JP	8249177	8249177	01/08/1993	2948731	01/01/1986	Bef. 1989		1	1	0	Yes	1					30/07/2018		390,1	18	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	"ataxia;unsteadiness;diplopia;dysarthria;confusion"	1	0	56	0	1
Suramin	suramin	"Naganol;Suramine;Naphuride;8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid;Belganyl;Suramin"	DB04786	"8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid;8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid;8-[[[4-methyl-3-[[[3-[[[[3-[[[2-methyl-5-[oxo-[(4,6,8-trisulfo-1-naphthyl)amino]methyl]phenyl]amino]-oxomethyl]phenyl]amino]-oxomethyl]amino]phenyl]-oxomethyl]amino]phenyl]-oxomethyl]amino]naphthalene-1,3,5-trisulfonic acid;8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]phenyl]carbonylamino]phenyl]carbonylamino]naphthalene-1,3,5-trisulfonic acid;145-63-1;8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC;1,3,5-Naphthalenetrisulfonic acid, 8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-;1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt;3-14-00-02267 (Beilstein Handbook Reference);8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid;BRN 3230873;Belganyl;Carbanilide, 3,3'-bis((5-((4,6,8-trisulfo-1-naphthyl)carbamoyl)-o-tolyl)carbamoyl)-;EINECS 205-658-4;Farma;Farma 939;Fourneau;Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure;Naphuride;m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure);8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid;1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI);1,3,5-naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-;8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid;8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid;8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid;Suramine;sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide;Spectrum_001877;NCGC00163318-01;SGCTO-001;1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI);8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid;1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt;SpecPlus_000662;1,3,5-Naphthylenetrisulfonic acid, 8,8'-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di-;129-46-4(HEXASODIUM SALT);SVR;AIDS-000067;AIDS000067;Naganil;NSC34936;KBio3_001468;Naganol 6 Na;KBioSS_002402;DivK1c_006758;WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6;Spectrum3_000724;KBioGR_001774;KBio1_001702;Spectrum4_001247;KBio2_002397;KBio2_004965;KBio2_007533;8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID;8,8'-{carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]}dinaphthalene-1,3,5-trisulfonic acid;CHEBI:45906;1,3,5-Naphthylenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt;C07974;Suramin"	"suramin;Naganol;Naphuride;Suramine;Belganyl;Germanin;Fourneau;Farma;Naganin;145-63-1;Sodium suramin;Farma 939;Antrypol;Moranyl;Naganil;Naganine;Suramine sodium;Bayer 205;Naganol 6 Na;UNII-6032D45BEM;EINECS 205-658-4;BRN 3230873;SGCTO-001;m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure);CHEMBL265502;Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure;SVR;CHEBI:45906;NSC 34936;6032D45BEM;NSC34936;Metaret;Carbanilide, 3,3'-bis((5-((4,6,8-trisulfo-1-naphthyl)carbamoyl)-o-tolyl)carbamoyl)-;NCGC00163318-01;DSSTox_CID_26344;DSSTox_RID_81548;DSSTox_GSID_46344;1,3,5-Naphthalenetrisulfonic acid, 8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-;8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid;8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid;8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid;Moranil;sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide;1,3,5-naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-;1,3,5-Naphthylenetrisulfonic acid, 8,8'-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di-;8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid;8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid;8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC;8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID;8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid;8-[(4-methyl-3-{[3-({[3-({2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl}carbamoyl)phenyl]carbamoyl}amino)benzene]amido}benzene)amido]naphthalene-1,3,5-trisulfonic acid;8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid;CAS-145-63-1;NSC-34936;Suramin, Hexasodium Salt;C51H40N6O23S6;Germanin (TN);Spectrum_001877;5,5'',5''''-[1,3,6-naphthalenetriyltris(sulfonylimino)]tris[1,3-benzenesulfonate analogue;SpecPlus_000662;Spectrum3_000724;Spectrum4_001247;D0H2UB;AC1L1K6K;SCHEMBL3161;Lopac0_001182;US8835659, Suramin;BSPBio_002248;KBioGR_001774;KBioSS_002402;3-14-00-02267 (Beilstein Handbook Reference);DivK1c_006758;GTPL1728;DTXSID1046344;CTK7G6721;KBio1_001702;KBio2_002397;KBio2_004965;KBio2_007533;KBio3_001468;HY-B0879;Tox21_112045;BDBM50336799;CCG-36173;MMV637953;AKOS030526554;Tox21_112045_1;129-46-4 (hexa-hydrochloride salt);CS-4444;DB04786;NCGC00025177-08;NCGC00163318-02;NCGC00163318-03;AN-43641;LS-95867;C07974;29479-EP2269996A1;29479-EP2275420A1;29479-EP2295055A2;29479-EP2295416A2;29479-EP2298748A2;29479-EP2298764A1;29479-EP2298765A1;29479-EP2305642A2;29479-EP2311453A1;29479-EP2311494A1;29479-EP2311808A1;29479-EP2311829A1;29479-EP2311842A2;104283-EP2298761A1;104283-EP2301627A1;L000585;BRD-K70327167-348-01-9;BRD-K70327167-348-09-2;1-(3-Benzamido-4-methylbenzamido)naphthalene-4,8-trisulfonic acid sym-3''-urea sodium salt;1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI);1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-(9CI);1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI);1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-(8CI);1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt;1,3,5-Naphthalenetrisulfonicacid,8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-;1,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt;1,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt;1,5-Naphthylenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt;8,8''-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid;8,8''-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid(suramin);8,8''-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID;8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonic acid;8,8'-{carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]}dinaphthalene-1,3,5-trisulfonic acid;8,8-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid;8-{4-methyl-3-[3-({[3-({2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl}carbamoyl)phenyl]carbamoyl}amino)benzamido]benzamido}naphthalene-1,3,5-trisulfonic acid;WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6"	145-63-1	6032D45BEM	"15928663;12960116;12478189;12111104;9626459;8941013;8995493;8270974;8468719"	8468719	01/04/1993	3005375	01/01/1986	Bef. 1989		1	0	0	No	0					30/07/2018		390,1	#N/A																							0						1
Interferon Alfa-2a, Recombinant	interferon alpha-2a	"Recombinant human interferon alfa-2a;Interferon alfa-2a, recombinant;Recombinant human interferon-alfa-2a;Interferon alfa-2a;SH-polypeptide-46;rIFN-alpha-2a;Interferon-alfa-2a;Interferon alpha-2a;Interferon alfa-2a (recombinant);Interferon alfa-2a,recombinant;Roferon-A Soln-liq Im Sc 4.5million I.u/ml;Roferon-A Solution 18 Million I.U./3ml;Roferon-A Sol Inj 3million Iu/vial;Roferon-A Solution Inj 36000000unit/ml;Roferon-A Soln-liq Im Sc 9million I.U./ml;Roferon-A Solution 6 Million I.U./ml;Roferon A Soln Inj 6 Million;Roferon A Sterile Pws 18m Unit/vial;Roferon-A  Solution Inj. 9million I.U./0.9ml;Roferon-A Solution 3 Million I.U./ml;Roferon A Sterile Pws 3m Unit/vial;Roferon A Sterile Pws 9m Unit/vial"	"DB00034;BTD00095;BTD00012;BIOD00095;BIOD00012;DB00037"			76543-88-9	47RRR83SK7	8590891	8590891	01/01/1995	3485011	01/04/1986	Bef. 1989		1	1	0	Yes	1					30/07/2018		387,1	20	NA	0	1	MELANOMA	0	NA	0	1	0	NA	0	0	1	1	0	0,1	0	1	1	0,2	0	0	0	0	0	0	8	0	1
Azacitidine	"arabinosyl-5-azacytidine;azacitidine;fazarabine"	"4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one;5 AZC;5-Azacytidine;Azacitidina;Azacitidine;Azacitidine Azacitidine;Azacitidine for Injection;Azacitidinum;Azacytidine;Reddy-azacitidine;Vidaza"	"APRD00809;DB00928"	"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-1,3,5-triazin-2-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-s-triazin-2-one;320-67-2;Vidaza (TN);A1287_SIGMA;KBio2_005124;1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-;2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one;4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one;4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one;5-AC;5-AZCR;Antibiotic U 18496;Azacitidina [INN-Spanish];Azacitidine [USAN:INN];Azacitidinum [INN-Latin];Azacytidine;BRN 0620461;CCRIS 60;EINECS 206-280-2;HSDB 6879;Ladakamycin;Mylosar;NCI-C01569;NSC 102816;NSC-102816;U 18496;Vidaza;WR-183027;s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI);BSPBio_003157;BCBcMAP01_000083;KBio2_002556;DivK1c_000125;IDI1_000125;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;NINDS_000125;KBioGR_001444;KBio2_007692;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;A2385_SIGMA;KBio2_001742;Spectrum4_000922;Spectrum5_001166;KBio1_000125;4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one;5-AZAC;AIDS-000615;AIDS000615;KBioSS_001742;SPBio_000892;Spectrum_001262;EU-0100035;pyrimidine antimetabolite: inhibits nucleic acid replication;SPECTRUM1502111;CHEBI:2038;ZINC03861768;cMAP_000082;U-18496;NCGC00090851-01;MolMap_000062;KBio2_004310;KBio2_006878;Lopac0_000035;Spectrum3_001509;KBio3_003034;NCGC00090851-04;ST056940;4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;5-Azacytidine;Azacitidine;C11262;KBioSS_002565;KBio3_002657;Azacitidine (USAN);5-aza-CR;NS-17;Spectrum2_000786;KBioGR_002556;D03021"	"5-azacytidine;Azacitidine;320-67-2;Ladakamycin;Azacytidine;Vidaza;Mylosar;Azacitidina;Azacitidinum;5-azacitidine;Azacitidinum [INN-Latin];Azacitidina [INN-Spanish];5-AZAC;Antibiotic U 18496;5 AZC;NSC-102816;mylo sar;U-18496;Azacitidine [USAN:INN];CCRIS 60;UNII-M801H13NRU;NSC102816;5AzaC;Vidaza (TN);4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one;5-aza-CR;HSDB 6879;WR-183027;5-AZCR;4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one;EINECS 206-280-2;U 18496;BRN 0620461;5-AC;Azacitidine (JAN/USAN/INN);CHEBI:2038;M801H13NRU;4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one;NS-17;wr 183027;NSC 102816;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one;4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;NCGC00090851-04;4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one;NCI-C01569;1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;DSSTox_CID_116;A 2385;DSSTox_RID_75378;DSSTox_GSID_20116;Ledakamycin;4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one;pyrimidine antimetabolite: inhibits nucleic acid replication;5 Azacytidine;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one;SMR000857239;SR-01000075662;Azacitidine [USAN:INN:BAN];1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-amino-1,3,5-tri azin-2-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one;CAS-320-67-2;Azacitidine (Vidaza);Vidaz (TN);Antibiotic U18496;PubChem14167;Spectrum_001262;Spectrum2_000786;Spectrum3_001509;Spectrum4_000922;Spectrum5_001166;D09FAZ;MolMap_000062;AC1L1T1Y;SCHEMBL3741;CHEMBL1489;Lopac0_000035;BSPBio_003157;KBioGR_001444;KBioGR_002556;KBioSS_001742;KBioSS_002565;KSC222S1T;MLS001333121;MLS001333122;MLS002153249;MLS002548894;Pharmion Brand of Azacitidine;DivK1c_000125;SPECTRUM1502111;SPBio_000892;EOS113;GTPL6796;Jsp005945;DTXSID9020116;BCBcMAP01_000083;CTK1C2919;HMS500G07;KBio1_000125;KBio2_001742;KBio2_002556;KBio2_004310;KBio2_005124;KBio2_006878;KBio2_007692;KBio3_002657;KBio3_003034;NMUSYJAQQFHJEW-KVTDHHQDSA-;cMAP_000082;MolPort-003-665-502;NINDS_000125;NMUSYJAQQFHJEW-KVTDHHQDSA-N;HMS1921J22;HMS2092D08;HMS2231F15;HMS3259D19;HMS3260G11;Pharmakon1600-01502111;ZINC3861768;5-Azacytidine, >=98% (HPLC);Tox21_111032;Tox21_302985;Tox21_500035;ABP001093;ANW-27256;BDBM50424715;CCG-39046;EBD145507;MFCD00006539;NSC758186;s1782;SBB066305;AKOS015896938;Tox21_111032_1;AM83944;API0003444;CS-1287;DB00928;LP00035;LS-1189;MCULE-8318770472;NC00672;NSC-758186;NSC103-627;RP28647;RTR-013523;IDI1_000125;5-azacytidine;Mylosar;Ladakamycin;Vidaza;NCGC00090851-01;NCGC00090851-02;NCGC00090851-03;NCGC00090851-05;NCGC00090851-06;NCGC00090851-07;NCGC00090851-08;NCGC00090851-10;NCGC00178234-01;NCGC00256541-01;NCGC00260720-01;AS-13697;CC-21195;CPD000857239;HY-10586;KB-41704;SAM002264595;SC-09078;SRI-10756_10;SRI-10756_12;ST056940;WR183027;AB2000290;AX8008347;DB-006955;SL-000003;TR-013523;A5777;EU-0100035;FT-0081170;FT-0601307;ST24044344;TL80073599;C11262;D03021;J10124;U18496;33795-EP2275420A1;33795-EP2295055A2;33795-EP2295416A2;33795-EP2298748A2;33795-EP2298764A1;33795-EP2298765A1;33795-EP2305642A2;33795-EP2311453A1;33795-EP2311840A1;124679-EP2270008A1;124679-EP2292617A1;124679-EP2295426A1;124679-EP2295427A1;320A672;C-14788;J-700085;SR-01000075662-1;SR-01000075662-3;SR-01000075662-7;U-18,496;BRD-K03406345-001-02-1;BRD-K03406345-001-27-8;5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine;s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-;Z1522566611;4-Amino-1-(bet.-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI);S-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-(8CI);Azacitidine, United States Pharmacopeia (USP) Reference Standard;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; Ladakamycin;Azacitidine, Pharmaceutical Secondary Standard; Certified Reference Material;4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-;5-Azacytidine, Hybri-Max(TM), gamma-irradiated, lyophilized powder, BioXtra, suitable for hybridoma;5AE;InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1"	320-67-2	M801H13NRU	"10492074;21576646;21767242;23354011;24877181;7514963;7678714;9815635"	7678714	01/02/1993	19051503	01/06/1972	Bef. 1989		0	1	1	Yes	1	"23/08/2016 00:00;17/12/2015 00:00;10/01/2014 00:00;19/05/2004 00:00;06/05/2013 00:00;30/01/2017 00:00;24/01/2012 00:00;29/04/2016 00:00;20/07/2018 00:00;17/08/2011 00:00;29/09/2016 00:00;28/07/2017 00:00;23/06/2017 00:00;10/01/2018 00:00;02/07/2018 00:00;20/08/2008 00:00;29/06/2005 00:00;19/12/2012 00:00;16/09/2013 00:00;26/01/2007 00:00;28/04/2016 00:00;23/02/2015 00:00;04/05/2018 00:00;22/02/2008 00:00"	AP	"ACTAVIS LLC;#N/A;NATCO PHARMA LTD;MYLAN INSTITUTIONAL;CELGENE;SHILPA MEDICARE;DR REDDYS LABS LTD"	AZACITIDINE	19/05/2004	CELGENE	382,8	30	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,63	0	1	1	NA	0	0	0	0	0	0	58	0	1
Fotemustine	fotemustine	"Fotemustinum;Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate;(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate;Fotemustina"	"DB04106;EXPT03300"	"1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea;1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitroso-urea;92118-27-9;Muphoran;S-10036;(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate;CCRIS 6337;Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate;Fotemustina [Spanish];Fotemustine;Fotemustine [BAN:INN];Fotemustinum [Latin];Phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester;S 10036;Servier-10036;1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea"	"Fotemustine;92118-27-9;Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate;Muphoran;Mustophorane;Servier-10036;Fotemustinum [Latin];Fotemustina [Spanish];S 10036;C9H19ClN3O5P;CCRIS 6337;S-10036;Fotemustinum;Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate;(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate;Mustoforan;1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea;Fotemustine [BAN:INN];P-[1-[[[(2-Chloroethyl)nitrosoamino]carbonyl]amino]ethyl]-phosphonic acid diethyl ester;Phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester;SMR002529685;Fotemustine [INN:BAN];HSDB 7762;Muphoran (TN);AC1L2XIN;Fotemustine (INN/BAN);D0S1ZB;SCHEMBL8880;MLS006010211;MLS006010716;CHEMBL549386;CTK8B6565;Fotemustine, >=98% (HPLC);CHEBI:131852;MolPort-006-169-506;HY-B0733;ANW-53672;MFCD00866278;AKOS015920275;API0002769;CS-2977;DS-1395;MP-0676;KS-00001F83;NCGC00346829-01;AT-19291;BR-72800;CC-28847;K679;AB0014328;AX8131574;KB-251384;LS-106511;TR-028962;4CH-007333;FT-0630979;ST24030324;D07255;118F279;A844148;C-19451;SR-01000944936;SR-01000944936-1;Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphote;diethyl 1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate;1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitroso-urea;diethyl (1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl)phosphonate;diethyl (1-{[N-(2-chloroethyl)-N'-oxohydrazinecarbonyl]amino}ethyl)phosphonate;Muphoran|||Mustoforan|||S-10036|||1-(2-Chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea"		GQ7JL9P5I2	"11508814;9624243;8528641"	8528641	01/08/1995	3677107	01/12/1987	Bef. 1989		1	1	0	Yes	1					30/07/2018		367,2	22	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,13	0	1	1	NA	0	0	0	0	0	0	21	0	1
Etanidazole	"etanidazole;sr-2508;sr2508"		DB12736	"N-hydroxy-1-[2-(2-hydroxyethylamino)-2-oxoethyl]imidazol-2-amine oxide;N-(2-hydroxyethyl)-2-(2-nitroimidazol-1-yl)acetamide;N-(2-hydroxyethyl)-2-[2-(hydroxy-oxidoamino)imidazol-1-yl]acetamide;N-(2-hydroxyethyl)-2-[2-(hydroxy-oxido-amino)imidazol-1-yl]acetamide;N-hydroxy-1-[2-(2-hydroxyethylamino)-2-oxo-ethyl]imidazol-2-amine oxide;N-(2-hydroxyethyl)-2-[2-(hydroxy-oxidoamino)-1-imidazolyl]acetamide;N-hydroxy-1-[2-(2-hydroxyethylamino)-2-oxoethyl]-2-imidazolamine oxide;N-(2-hydroxyethyl)-2-(2-nitro-1-imidazolyl)acetamide;N-hydroxy-1-[2-(2-hydroxyethylamino)-2-keto-ethyl]imidazol-2-amine oxide;N-(2-hydroxyethyl)-2-(2-nitroimidazol-1-yl)ethanamide;N-(2-hydroxyethyl)-2-[2-(hydroxy-oxido-amino)imidazol-1-yl]ethanamide;22668-01-5;74083-16-2;Radinyl (TN);CAS-22668-01-5;NCGC00095848-01;NSC-301467;SP-2508;SR-2508;NCGC00016767-01;SPECTRUM1503412;SPBio_002578;E3016_SIGMA;Prestwick3_000649;DuP-435;KBio2_002054;NCI60_002528;KBio2_004622;KBio2_007190;BPBio1_000723;Spectrum4_001183;KBioGR_001845;1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-;2-Nitroimidazole-1-acetamide, N-(2-hydroxyethyl)-;ETANIDAZOLE;NSC301467;Prestwick1_000649;(RADINYL);2-(2-Nitro-imidazol-1-yl)-N-2-hydroxyethylacetamide;AIDS-029888;AIDS029888;Prestwick2_000649;IDI1_000305;Spectrum5_001667;Prestwick0_000649;DivK1c_000305;NINDS_000305;BSPBio_000657;5-23-04-00478 (Beilstein Handbook Reference);BRN 0919296;Etanidazol [Spanish];Etanidazole [USAN:INN];Etanidazolum [Latin];Ethanidazole;N-(2-Hydroxyethyl)-1-(2-nitro-1-imidazolyl)acetamide;N-(2-Hydroxyethyl)-2-nitro-1H-imidazole-1-acetamide;N-(2-Hydroxyethyl)-2-nitroimidazole-1-acetamide;NSC 301467;Radinyl;SR 2508;KBio1_000305;SPBio_000760;Spectrum_001574;Spectrum2_000910;Prestwick_1056;KBioSS_002054;D04075;Etanidazole (USAN)"	"etanidazole;22668-01-5;Radinyl;Etanidazolum;Ethanidazole;Etanidazol;1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-;Etanidazol [Spanish];Etanidazolum [Latin];Etandazole;Etanidazole [USAN:INN];UNII-30DKA3Q1HL;N-(2-Hydroxyethyl)-2-nitro-1H-imidazole-1-acetamide;NSC 301467;NSC-301467;SR 2508;SR-2508;NSC301467;N-(2-Hydroxyethyl)-2-nitroimidazole-1-acetamide;BRN 0919296;30DKA3Q1HL;N-(2-Hydroxyethyl)-1-(2-nitro-1-imidazolyl)acetamide;MLS003115757;CHEBI:75473;NCGC00016767-02;CAS-22668-01-5;DSSTox_CID_25434;DSSTox_RID_80876;DSSTox_GSID_45434;N-(2-hydroxyethyl)-2-(2-nitroimidazol-1-yl)acetamide;C7H10N4O4;N-(2-hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide;SR-05000001859;Radinyl(TM);Radinyl (TN);Prestwick_1056;Spectrum_001574;AC1L1FKH;Prestwick0_000649;Prestwick1_000649;Prestwick2_000649;Prestwick3_000649;Spectrum2_000910;Spectrum4_001183;Spectrum5_001667;Etanidazole (USAN/INN);D0LJ6P;AC1Q5AX1;Etanidazole (SR-2508);SCHEMBL4414;BSPBio_000657;KBioGR_001845;KBioSS_002054;CHEMBL47405;DivK1c_000305;SPECTRUM1503412;DuP-435;SPBio_000760;SPBio_002578;BPBio1_000723;DTXSID8045434;HMS500P07;KBio1_000305;KBio2_002054;KBio2_004622;KBio2_007190;NINDS_000305;WCDWBPCFGJXFJZ-UHFFFAOYSA-N;HMS1570A19;HMS2093E13;HMS2097A19;HMS3714A19;ZINC1873938;Tox21_110599;CCG-39747;AKOS028109842;Tox21_110599_1;API0002614;DB12736;SP-2508;IDI1_000305;NCGC00016767-01;NCGC00016767-05;NCGC00095848-01;LS-77976;NCI60_002528;QC-10761;SMR001233273;SBI-0051823.P002;AB00052354;D04075;33815-EP2275420A1;33815-EP2295055A2;33815-EP2295416A2;33815-EP2298748A2;33815-EP2298764A1;33815-EP2298765A1;33815-EP2305642A2;33815-EP2311453A1;33815-EP2311808A1;33815-EP2311829A1;2-Nitroimidazole-1-acetamide, N-(2-hydroxyethyl)-;SR-05000001859-1;SR-05000001859-2;2-(2-Nitro-imidazol-1-yl)-N-2-hydroxyethylacetamide;Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-;N-(2-hydroxyethyl)-2-(2-nitro-1-imidazolyl)acetamide;74083-16-2"	22668-01-5	30DKA3Q1HL	"12654425;9422559"	9422559	01/01/1998	2522919	01/04/1989	1989-1994		1	1	0	Yes	1					30/07/2018		351,2	21	NA	1	0	NA	1	HYPOXIA	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Fenretinide	fenretinide	"N-(4-Hydroxyphenyl)All-Trans Retinamide;4-hydroxy(phenyl)retinamide;4-HPR"	"DB05076;DB03922"	"N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide;(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide;65646-68-6;Bio2_000619;KBioGR_000139;(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide;nchembio873-comp11;KBioSS_000139;4-Hydroxyphenyl retinamide;BRN 5769490;CCRIS 3260;FENRETINIDE;Fenretinida [Spanish];Fenretinide [USAN:INN];Fenretinidum [Latin];McN-R-1967;N-(4-Hydroxyphenyl)retinamide;Retinamide, N-(4-hydroxyphenyl)-;Retinoic acid p-hydroxyphenylamide;all-trans-4'-Hydroxyretinanilide;AIDS-210898;AIDS210898;Retinal, 15-[(4-hydroxyphenyl)amino]-;Bio1_000134;HSCI1_000112;4-HPR;KBio2_000139;15-[(4-hydroxyphenyl)amino]retinal;Bio2_000139;CBiol_001848;KBio3_000277;KBio3_000278;ST-602;BSPBio_001419;H7779_SIGMA;Retinoic acid p-hydroxyanilide;SYT-101;KBio2_005275;IDI1_033889;NCGC00090752-04;N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE;Bio1_001112;FEN;NCGC00090752-06;2,4,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)-;KBio2_002707;NCGC00090752-07;NSC374551;NCGC00090752-08;EU-0100625;4-Hydroxyphenylretinamide;4HPR;N-(4-Hydroxyphenyl)-all-<i>trans</i> Retinamide;Lopac0_000625;Spectrum5_001939;NSC-374551;4-(hydroxyphenyl)retinamide;NCGC00090752-01;Bio1_000623;D04162;Fenretinide (USAN)"	"FENRETINIDE;65646-68-6;N-(4-Hydroxyphenyl)retinamide;4-HPR;4-hydroxyphenylretinamide;4-Hydroxyphenyl retinamide;Retinoic acid p-hydroxyanilide;all-trans-4'-Hydroxyretinanilide;Fenretinida;Fenretinidum;McN-R-1967;Fenretinidum [Latin];Fenretinida [Spanish];4HPR;N-(4-Hydroxyphenyl)all-Trans Retinamide;Retinoic acid p-hydroxyphenylamide;Fenretinide [USAN:INN];Retinamide, N-(4-hydroxyphenyl)-;UNII-187EJ7QEXL;4-(hydroxyphenyl)retinamide;4-hydroxy(phenyl)retinamide;CCRIS 3260;15-[(4-hydroxyphenyl)amino]retinal;BRN 5769490;187EJ7QEXL;CHEMBL7301;MLS002701698;CHEBI:42588;SYT-101;AKJHMTWEGVYYSE-FXILSDISSA-N;MFCD00792674;ST-602;NSC-374551;NCGC00090752-03;N-(4-Hydroxyphenyl)-all-trans Retinamide;DSSTox_CID_12005;DSSTox_RID_78900;DSSTox_GSID_32005;(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide;Fenretinimide;(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide;(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide;SMR001456303;CAS-65646-68-6;SR-01000075917;N-(4-Hydroxyphenyl)-trans-Retinamide;Fenretinide (4-HPR);AC1NRB1E;Spectrum5_001939;Fenretinide (USAN/INN);D08JAC;LXS/4-HPR;AC1Q1QV3;4 HPR;Lopac0_000625;SCHEMBL11703;SCHEMBL11704;BSPBio_001419;MLS001055399;MLS006010811;BML2-E08;N-(4-hydroxyphenyl)-retinamide;DTXSID2032005;SCHEMBL15703189;CHEBI:92493;AOB6402;Retinamide,N-(4-hydroxyphenyl)-;15-(4-Hydroxyanilino)retinal #;MolPort-003-666-842;Fenretinide (oral, AMD), Sytera;HMS1361G21;HMS1791G21;HMS1989G21;HMS2089B17;HMS3261N12;HMS3402G21;Pharmakon1600-01505602;4-HPR;(4-Hydroxyphenyl)retinamide;ZINC3871023;Tox21_111007;Tox21_200989;Tox21_500625;1-enyl)nona-2,4,6,8-tetraenamide;3670AH;BDBM50092055;HSCI1_000112;LS-282;NSC374551;NSC760419;RT-101;AKOS024456572;Tox21_111007_1;AN-7467;CCG-204713;CS-0789;DB05076;LP00625;N-(4-hydroxyphenyl)retinamide, 4-HPR;NSC-760419;all-trans-n-(4-hydroxyphenyl)retinamide;dimethyl-9-(2,6,6-trimethylcyclohex-;IDI1_033889;Retinoic acid p-hydroxyanilide, >=95%;NCGC00090752-01;NCGC00090752-02;NCGC00090752-04;NCGC00090752-05;NCGC00090752-06;NCGC00090752-07;NCGC00090752-09;NCGC00090752-10;NCGC00090752-11;NCGC00090752-12;NCGC00258542-01;NCGC00261310-01;(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamide;BP-13369;HY-15373;KB-77316;SC-76490;SMR000677938;Fenretinide (iv), Children's Hospital LA;AB0109574;EU-0100625;FT-0081247;Fenretinide (soft gel capsule, AMD), Sirion;D04162;H 7779;W-5119;(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-;33819-EP2275420A1;33819-EP2295055A2;33819-EP2295406A1;33819-EP2295416A2;33819-EP2295426A1;33819-EP2295427A1;33819-EP2298748A2;33819-EP2298764A1;33819-EP2298765A1;33819-EP2305642A2;33819-EP2311453A1;33819-EP2311808A1;33819-EP2311829A1;AB00172992-07;646F686;A835178;Fenretinide (Ewing's sarcoma), Cancer Research UK;SR-01000075917-1;SR-01000075917-4;Fenretinide (ILE formulation), Children's Hospital LA;Fenretinide (intravenous, cancer), SciTech Development;Fenretinide (soft gel capsule, AMD), ReVision Therapeutics;4-(HYDROXYPHENYL)-RETINAMIDE (SEE RETINOID PROJECTS 1 AND 2.);Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products;Fenretinide (topical, actinic keratosis and cancer), SciTech Development;RETINOID PROJECT 6 (4-HPR) (SEE RETINOID PROJECTS 1,2,3,4,5);Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles;RETINOID PROJECT 2 (4-(HYDROXYPHENYL)RETINAMIDE) (SEE RETINOID PROJECT 1,3,4, 5,6);RETINOID PROJECT 4 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, AND 3);RETINOID PROJECT 5 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, 3, 4);(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide;2,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)-;3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide;Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx;Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University;N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraeneamide;N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide"	65646-68-6	187EJ7QEXL	"23813912;21498721;21117610;18066548;17035399;16849757;12796365"	12796365	01/06/2003	2525470	01/05/1989	1989-1994		1	1	0	Yes	1					30/07/2018		350,2	25	NA	0	0	NA	0	NA	1	1	0	NA	0	0	0	NA	0	NA	0	NA		NA	0	0	0	0	0	0	21	0	1
Amonafide	"amonafide;nsc 308847"		DB05022	"69408-81-7;MLS000757039;SMR000528907;NCIMech_000383;BIDA;CGX-571;M-FA-142;Quinamed;Xanafide;1H-Benz[de]isoquinoline-1,3(2H)-dione, 5-amino-2-[2-(dimethylamino)ethyl]-;NSC308847;1H-Benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)-;1H-Benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(dimethylamino)ethyl-;3-Amino-N-(2-(dimethylamino)ethyl)-1,8-naphthalindicarboximid;3-Amino-N-(2-(dimethylamino)ethyl)naphthalimide;5-Aminomitonafide;Amonafida [Spanish];Amonafide;Amonafide [INN];Amonafidum [Latin];Amonifide;BRN 5344673;Benzisoquinolinedione;FA 142;M-FA 142;NAPHTHALIMIDE, 3-AMINO-N-(2-(DIMETHYLAMINO)ETHYL)-;NSC 308847;NSC-308847;Nafidimide;NCI60_002643;1H-Benz[de]isoquinoline-1,3(2H)-dione,5-amino-2-[2-(dimethylamino)ethyl]-;AIDS-112769;AIDS112769;Amonafide;Benzisoquinolinedione;Nafidimide"	"Amonafide;69408-81-7;Nafidimide;Benzisoquinolinedione;Quinamed;Xanafide;5-Aminomitonafide;Amonifide;NSC-308847;Amonafidum [Latin];Amonafida [Spanish];M-FA 142;FA 142;NSC308847;UNII-1Q8D39N37L;AS-1413(Amonafide);AS1413;3-Amino-N-(2-(dimethylamino)ethyl)naphthalimide;NSC 308847;AS-1413;BRN 5344673;MLS000757039;CHEMBL428676;UPALIKSFLSVKIS-UHFFFAOYSA-N;1Q8D39N37L;M-FA-142;NAPHTHALIMIDE, 3-AMINO-N-(2-(DIMETHYLAMINO)ETHYL)-;3-Amino-N-(2-(dimethylamino)ethyl)-1,8-naphthalindicarboximid;1H-Benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)-;1H-Benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(dimethylamino)ethyl-;Amonafidum;Amonafida;5-amino-2-(2-dimethylaminoethyl)benzo[de]isoquinoline-1,3-dione;5-amino-2-(2-(dimethylamino)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione;Amonafide [INN];SMR000528907;Amonafide [USAN:INN];Amonofide;5-Amino-2-[2-(dimethylamino)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione;Quinamed (TN);Amonafide (USAN);BIDA;PubChem22415;D0HR7P;NCIMech_000383;SCHEMBL27226;MLS006010419;MLS006011267;AC1L199T;CHEBI:94661;CTK8E8409;KS-00001CTO;CGX-571;DTXSID30219562;MFA 142;MFA-142;MolPort-005-942-714;HMS3654H19;ZINC4214836;BDBM50033894;CCG-35694;s1367;AKOS015850731;AN-5827;API0010542;BCP9000321;CS-0496;DB05022;NCI-308847;VA10270;NCGC00346513-01;4CA-0152;AC-22581;HY-10982;K157;LS-95109;NCI60_002643;TC-070521;FT-0662118;A24926;D10090;W-5143;AS1413, Xanafide, Quinamed, 69408-81-7;408A817;3-Amino-N-(2-dimethylaminoethyl)-1,8-naphthalimide;BRD-K56334280-001-02-8;BRD-K56334280-001-03-6;1H-Benz[de]isoquinoline-1, 5-amino-2-[2-(dimethylamino)ethyl]-;5-Amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione;5-amino-2-(2-dimethylaminoethyl)benzo(de)isoquinolin-1,3-dione;5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione;1H-Benz[de]isoquinoline-1,3(2H)-dione,5-amino-2-[2-(dimethylamino)ethyl]-;5-Amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione (amonafide);5-Amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione(Amonafide);5-Amino-2-[2-(dimethylamino)ethyl]-1H-benz[de]isoquinoline-1,3(2H)-dione;Amonafide.;5-Amino-2-[2-(dimethylamino)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione #"	69408-81-7	1Q8D39N37L	"8689426;8485716"	8485716	01/05/1993	2549205	01/07/1989	1989-1994		1	1	0	Yes	1					30/07/2018		348,2	38	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,05	0	1	1	NA	0	0	0	tinnitus	1	0	21	0	1
Aviscumine	"aviscumine;r viscumin"		DB12684			223577-45-5	4B18YVW82N	"18602257;15913988"	15913988	01/05/2005	2758413	01/09/1989	1989-1994		1	1	0	Yes	1					30/07/2018		346,2	NA	NA	1	0	NA	0	NA	1	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Indole-3-carbinol	indole-3-carbinol		DB12881	"1H-indol-3-ylmethanol;700-06-1;EINECS 211-836-2;INDOLE-3-METHANOL;Indole-3-carbinol;NSC 525801;NCGC00090701-03;NCGC00090701-02;Spectrum3_001973;KBio3_002949;Spectrum2_001710;ZINC00158743;SPBio_001700;BSPBio_003573;SMP2_000172;1H-indol-3-ylmethanol;CHEBI:24814;I3C;SPECTRUM1505320;SDCCGMLS-0065970.P002;NCGC00090701-01;Prevention 4 (indole-3-carbinol);NSC525801;HSCI1_000097;3-Indolemethanol;I7256_SIGMA;SDCCGMLS-0065970.P001;SBB004095;1H-Indole-3-methanol (9CI);3-Hydroxymethylindole;3-Indolylcarbinol;5-21-03-00045 (Beilstein Handbook Reference);AI3-60090;BRN 0121323;CCRIS 3261"	"Indole-3-carbinol;700-06-1;3-Indolemethanol;(1H-Indol-3-yl)methanol;INDOLE-3-METHANOL;1H-Indole-3-methanol;1H-indol-3-ylmethanol;3-Hydroxymethylindole;3-Indolylcarbinol;Indinol;3-Indole methanol;Indole 3 carbinol;3-(Hydroxymethyl)indole;(1H-Indol-3-yl)-methanol;CCRIS 3261;UNII-C11E72455F;EINECS 211-836-2;1H-Indol-3-Yl-Methanol;C9H9NO;NSC 525801;BRN 0121323;AI3-60090;I3C;CHEBI:24814;IVYPNXXAYMYVSP-UHFFFAOYSA-N;Prevention 4 (indole-3-carbinol);IN1455;C11E72455F;NCGC00090701-06;indol-3-ylmethan-1-ol;I0496;SMR000385784;I3C cpd;3-Indolecarbinol;3-Indolylmethanol;indole-3-carbinole;Indole-3-carbinol;3-Indole methanol;zlchem 356;3-Hydroxymethylindoll;PubChem7265;3-hydroxymethyl indole;AC1L1GJH;Spectrum2_001710;Spectrum3_001973;ACMC-209oc7;AC1Q7C3V;DSSTox_CID_11458;DSSTox_RID_78876;DSSTox_GSID_31458;BSPBio_003573;MLS001333161;MLS001333162;SCHEMBL195520;SPECTRUM1505320;SPBio_001700;3-Indolemethanol, 97%  1g;CHEMBL155625;1H-Indole-3-methanol (9CI);DTXSID7031458;CTK5D1676;KBio3_002949;ZLC0198;MolPort-000-139-921;HMS1789O22;HMS2235E10;HMS3369B02;HMS3651I18;ZINC158743;ACN-S002804;ACT03591;HY-N0170;INDOLE-3-CARBINOL  (I3C);KS-000008ZG;Tox21_400055;9344AF;AM1155;ANW-35813;CCG-38786;HSCI1_000097;MFCD00005632;NSC525801;s2313;SBB004095;AKOS001075120;AC-7583;AN-8864;CS-7780;DB12881;GS-0916;LS-2173;LS20980;MCULE-6344603304;NSC-525801;RP01522;RTC-020178;SDCCGMLS-0065970.P001;SDCCGMLS-0065970.P002;VI30396;Indole-3-methanol (Indole-3-carbinol);SMP2_000172;TRA-0190502;NCGC00090701-01;NCGC00090701-02;NCGC00090701-03;NCGC00090701-04;NCGC00090701-05;NCGC00090701-07;AJ-15333;BC226969;BR-53373;CAS-700-06-1;CJ-01822;KB-52660;SC-06380;SY015976;ZB007051;AB0008317;AB1009801;KB-143577;KB-183011;KB-202551;ST2402099;TL8004925;4CH-018038;A9256;FT-0615875;ST50308202;00I061;I-2100;M-3233;A836732;SR-01000838318;I10-0077;SR-01000838318-3;BRD-K01815685-001-02-3;BRD-K01815685-001-07-2;Z85923165"	700-06-1	C11E72455F	16103443	16103443	01/08/2005	2342128	01/06/1990	1989-1994		1	0	0	No	0					30/07/2018		337,2	#N/A																							0						1
Deoxyspergualin	deoxyspergualin		DB12991	"3-[4-[[2-[7-(diaminomethylideneamino)heptanoylamino]-2-hydroxyacetyl]amino]butylamino]propylazanium chloride;3-[4-[[2-(7-guanidinoheptanoylamino)-2-hydroxy-acetyl]amino]butylamino]propylammonium chloride;3-[4-[[2-[(7-guanidino-1-oxoheptyl)amino]-2-hydroxy-1-oxoethyl]amino]butylamino]propylammonium chloride;3-[4-[[2-[7-(diaminomethylideneamino)heptanoylamino]-2-hydroxy-ethanoyl]amino]butylamino]propylazanium chloride;Deoxyspergualin;NSC356894"	"Gusperimus;Deoxyspergualin;15-deoxyspergualin;Gusperimus [INN];104317-84-2;98629-43-7;IDINUJSAMVOPCM-UHFFFAOYSA-N;Gusperimus (INN);Gusperimus HCl;(+/-)-Deoxyspergualin;NSC356894;Gusperimus hydrochloride;BMS 181173;NCGC00183869-01;AC1L1IXJ;AC1Q5PCX;(+-)-15-Deoxyspergualin;SCHEMBL28026;N-[4- butylcarbamoyl-hydroxy-methyl]-7- heptanamide;CHEMBL406117;CHEBI:135609;DB12692;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;LS-74244;NCI60_003229;FT-0631032;D08032;N-(2-(4-(3-aminopropylamino)butylamino)-1-hydroxy-2-oxoethyl)-7-guanidinoheptanamide;N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxo-ethyl]-7-guanidino-heptanamide;N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamido)-2-hydroxyethanamide;N-[Hydroxy[[4-(3-aminopropylamino)butyl]carbamoyl]methyl]-7-guanidinoheptanamide;7-([Amino(imino)methyl]amino)-N-[2-((4-[(3-aminopropyl)amino]butyl)amino)-1-hydroxy-2-oxoethyl]heptanamide #;Heptanamide, 7-(aminoiminomethyl)amino-N-2-[4-(3-aminopropylamino-butyl)amino)]-1-hydroxy-2-oxoethyl-;n-[2-({4-[(3-aminopropyl)amino]butyl}amino)-1-hydroxy-2-oxoethyl]-7-carbamimidamidoheptanamide;N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide"	89149-10-0	57F9XM233R	"7606728;7795272"	7795272	01/04/1995	2389420	01/08/1990	1989-1994		1	0	0	No	0					30/07/2018		335,2	#N/A																							0						1
Gusperimus	"bms-181173;bmy-42215-1;gusperimus;nkt-01"		DB12692	"Gusperimus (-)-form trihydrochloride;Heptanamide, 7-((aminoiminomethyl)amino)-N-((1S)-2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)-;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (S)-;(-)-(15S)-1-Amino-19-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione 3HCl;(-)-15-Deoxyspergualin trihydrochloride;GUSPERIMUS  HYDROCHLORIDE;Gusperimus"	"Gusperimus;Deoxyspergualin;15-deoxyspergualin;Gusperimus [INN];104317-84-2;98629-43-7;IDINUJSAMVOPCM-UHFFFAOYSA-N;Gusperimus (INN);Gusperimus HCl;(+/-)-Deoxyspergualin;NSC356894;Gusperimus hydrochloride;BMS 181173;NCGC00183869-01;AC1L1IXJ;AC1Q5PCX;(+-)-15-Deoxyspergualin;SCHEMBL28026;N-[4- butylcarbamoyl-hydroxy-methyl]-7- heptanamide;CHEMBL406117;CHEBI:135609;DB12692;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;LS-74244;NCI60_003229;FT-0631032;D08032;N-(2-(4-(3-aminopropylamino)butylamino)-1-hydroxy-2-oxoethyl)-7-guanidinoheptanamide;N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxo-ethyl]-7-guanidino-heptanamide;N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamido)-2-hydroxyethanamide;N-[Hydroxy[[4-(3-aminopropylamino)butyl]carbamoyl]methyl]-7-guanidinoheptanamide;7-([Amino(imino)methyl]amino)-N-[2-((4-[(3-aminopropyl)amino]butyl)amino)-1-hydroxy-2-oxoethyl]heptanamide #;Heptanamide, 7-(aminoiminomethyl)amino-N-2-[4-(3-aminopropylamino-butyl)amino)]-1-hydroxy-2-oxoethyl-;n-[2-({4-[(3-aminopropyl)amino]butyl}amino)-1-hydroxy-2-oxoethyl]-7-carbamimidamidoheptanamide;N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide"	98629-43-7	UJ0ZJ76DO9	7781137	7781137	01/01/1995	2389420	01/08/1990	1989-1994		1	0	0	No	0					30/07/2018		335,2	#N/A																							0						1
Diethylstilbestrol	fosfestrol	"Diethylstilbestrol;Diethylstilbestrolum;4,4'-Dihydroxy-alpha,beta-diethylstilbene;trans-Diethylstilbestrol;Dietilestilbestrol;Distilbene;trans-Diethylstilbesterol;trans-Diethylstilboesterol;alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol;(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;DES;(E)-3,4-bis(4-hydroxyphenyl)-3-hexene;trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol;Stilboestrol;α,α'-diethyl-(E)-4,4'-stilbenediol;4,4'-dihydroxy-α,β-diethylstilbene;Stilbestrol 0.5mg Tablet;Stilbestrol 1.0mg Tablet;Stilbestrol Tablets 0.5 mg;Stilboestrol Tab 0.1mg;Stilboestrol Tab 0.5mg;Stilbestrol Tablets 0.1 mg;Stilbestrol Tablets 1.0 mg;Honvol Ampoules 250mg;Honvol Tablets 100mg;Stilbestrol Tab 1mg"	"DB00255;APRD00920;EXPT01164"	"4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;4-[(E)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol;4-[1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol;56-53-1;8026-45-7;8028-09-9;8030-34-0;8049-42-1;8053-00-7;6898-97-1;22610-99-7;Stilbestrol;Stilbestrol, diethyl-;Stilbestrone;Stilbetin;Stilboefral;Stilboestroform;Stilboestrol;Stilbofolin;Stilkap;Synestrin;Synthoestrin;Synthofolin;Syntofolin;TRANS-DIETHYSTILBESTEROL;Vagestrol;WLN: QR DY2&UY2&R DQ;neo-Oestranol 1;trans-.alpha.,.alpha.'-Diethyl-4,4'-stilbenediol;trans-.alpha.,.alpha.'-diethyl-4-4'-stilbenediol;trans-Diethylstilbesterol;trans-Diethylstilbestrol;trans-Diethylstilboesterol;NCGC00090749-01;Prestwick1_000756;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (Z)-;KBioGR_001083;NCGC00090749-04;BSPBio_000772;KBio1_000519;D4628_SIGMA;D00577;Spectrum2_000148;Prestwick0_000756;SPBio_002711;AI3-17297;Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-;Diethylstilbestrol (USP/INN);4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;NINDS_000519;Stilbestrol (TN);Prestwick_1070;4,4'-(3E)-hex-3-ene-3,4-diyldiphenol;(E)-3,4-Bis(4-hydroxyphenyl)-3-hexene;(E)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;(E)-Diethylstilbestrol;4,4'-Dihydroxy-alpha,beta-diethylstilbene;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (E)-;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (E)- (8CI);4-06-00-06856 (Beilstein Handbook Reference);Acnestrol;BRN 2056095;CCRIS 240;Climaterine;Diaethylstilboestrolum;Dibestrol;Dibestrol '2' premix;Dicorvin;Diethylstilbestrol [Nonsteroidal oestrogens];Diethylstilbestrol [USAN:INN];Diethylstilbestrolum [INN-Latin];Dietilestilbestrol [INN-Spanish];Dietilestilbestrol [Spanish];Dietilstilbestrolo [DCIT];E-Diethylstilbestrol;EINECS 200-278-5;Estilbin MCO;Gynopharm;HSDB 3060;Idroestril;Menostar;Oestrol vetag;Oestromensil;Oestromon;Phenol 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-;Phenol, 4,4'-((1E)-1,2-diethyl-1,2-ethenediyl)bis-;Protectona;RCRA waste no. U089;RCRA waste number U089;Sedestran;Sintestrol;Stibilium;Stilbol;Tampovagan stilboestrol;Tylosterone;alpha,alpha'-Diethyl-(E)-4,4'-stilbenediol;alpha,alpha'-Diethylstilbenediol;trans-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;Phenol, 4,4'-(1,2-diethyl-1,2-ethylenediyl)bis-, (Z)- (9CI);Spectrum_000940;BSPBio_002201;IDI1_000519;cis-Diethylstilbesterol;46207_RIEDEL;Spectrum5_000799;SPECTRUM1500244;NCGC00090749-02;NCGC00090749-03;SPBio_000256;Spectrum3_000391;C07620;Diethylstilbestrol;(E)-4,4'-(hex-3-ene-3,4-diyl)diphenol;nchembio.76-comp3;diethylstilbestrol (DES);Prestwick2_000756;Oprea1_042748;(Z)-4,4'-(1,2-Diethyl-1,2-ethylenediyl)bisphenol;MLS000028447;SMR000058263;cis-Des;KBioSS_001420;cis-Diethylstilbestrol;cis-alpha,alpha'-Diethyl-4,4'-stilbenediol;Spectrum4_000512;ZINC00001290;Prestwick3_000756;CHEBI:41922;KBio2_001420;KBio2_003988;BPBio1_000850;KBio2_006556;KBio3_001421;218944_ALDRICH;Diethylstilbestrol, mixture of cis and trans;DivK1c_000519;STOCK1S-10082;.alpha.,.alpha.'-Diethyl-4,4'-stilbenediol;.alpha.,.alpha.'-Diethylstilbenediol;3,4'(4,4'-Dihydroxyphenyl)hex-3-ene;3,4-Bis(p-hydroxyphenyl)-3-hexene;3-Hexene,3,4-bis(p-hydroxyphenyl)-;4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;4,4'-Dihydroxy-.alpha.,.beta.-diethylstilbene;4,4'-Dihydroxydiethylstilbene;4,4'-Stilbenediol, .alpha.,.alpha.'-diethyl-;4,4'-Stilbenediol, .alpha.,.alpha.'-diethyl-, (E)-;4,4'-Stilbenediol, .alpha.,.alpha.-diethyl-;4,4'-Stilbenediol, 2,2'-diethyl-;Agostilben;Antigestil;Bio-des;Bufon;Comestrol;Comestrol estrobene;Cyren;Cyren A;DES;DES (synthetic estrogen);Dawe's destrol;Desma;Di-Estryl;DiBestrol ""2"" Premix;DiBestrol 2 Premix;Diastyl;Diethylstilbesterol;Diethylstilboesterol;Dietilestilbestrol;Distilbene;Domestrol;Dyestrol;Estilbin ''MCO'';Estrobene;Estromenin;Estrosyn;Fonatol;Grafestrol;Hi-Bestrol;Iscovesco;Makarol;Menostilbeen;Micrest;Microest;Milestrol;NSC-3070;NSC3070;Neo-Oestranol I;OeKolp;Oestrogenine;Oestromenin;Oestromensyl;Oestromienin;Pabestrol;Palestrol;Percutatrine oestrogenique iscovesco;Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-;Rumestrol 1;Rumestrol 2;STIL;Serral;Sexocretin;Sibol;Stil-Rol"	"diethylstilbestrol;56-53-1;Stilbestrol;Stilboestrol;Distilbene;Agostilben;Estrobene;Estromenin;Stilboestroform;Antigestil;Palestrol;Stilbetin;Synestrin;Vagestrol;Fonatol;Diethylstilbesterol;Menostilbeen;Oestrogenine;Oestromensyl;Oestromienin;Stilbestrone;Synthoestrin;Comestrol;Cyren A;Domestrol;Dyestrol;Estrosyn;Grafestrol;Iscovesco;Microest;Milestrol;Oestromenin;Pabestrol;Sexocretin;Stilboefral;Stilbofolin;Synthofolin;Syntofolin;Diastyl;Makarol;Micrest;Serral;Stilkap;Bufon;Cyren;Desma;Sibol;OeKolp;Dawe's destrol;Hi-Bestrol;Di-Estryl;Dietilestilbestrol;Neo-Oestranol I;Rumestrol 1;Rumestrol 2;Stil-Rol;Acnestrol;Climaterine;Dibestrol;Dicorvin;Gynopharm;Idroestril;Oestromensil;Oestromon;Protectona;Sedestran;Sintestrol;Stibilium;Tylosterone;Comestrol estrobene;Stilbol;Diethylstilboesterol;Oestrol vetag;DiBestrol 2 Premix;Bio-des;Estilbin MCO;(E)-Diethylstilbestrol;trans-Diethylstilbestrol;STIL;neo-Oestranol 1;Tampovagan stilboestrol;Dibestrol '2' premix;Synthestrin;Tampovagan;Destrol;Estril;DES (synthetic estrogen);Stilbestrol, diethyl-;cis-Des;(E)-3,4-Bis(4-hydroxyphenyl)-3-hexene;New-Estranol 1;DES;Diethyl stilbestrol;trans-Diethylstilbesterol;Diethylstilbestrolum;Percutatrine oestrogenique iscovesco;4,4'-Dihydroxydiethylstilbene;trans-Diethylstilboesterol;E-Diethylstilbestrol;Rcra waste number U089;strobene;Diaethylstilboestrolum;Estrogenine;Stilbestroform;Stilbofollin;cis-Diethylstilbesterol;Dietilstilbestrolo;Stilbene Estrogen;diethylstilbestrol (DES);(E)-4,4'-(hex-3-ene-3,4-diyl)diphenol;Dietilstilbestrolo [DCIT];Dietilestilbestrol [Spanish];4,4'-(3E)-hex-3-ene-3,4-diyldiphenol;hibestrol;oestrolmensil;alpha,alpha'-Diethylstilbenediol;anti gestil;Diethylstilbestrolum [INN-Latin];Dietilestilbestrol [INN-Spanish];4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;NSC-3070;neo-oe stranol 1;UNII-731DCA35BT;MG 137;Stilbestrol (TN);CCRIS 240;cis-Diethylstilbestrol;Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-;Diethylstilbestrol BP;Diethylstilbestrol [USAN:INN];6898-97-1;Diethylstilbestrol, (Z)-Isomer;(E)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;Estilbin ''MCO'';trans-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;4,4'-Dihydroxy-alpha,beta-diethylstilbene;HSDB 3060;alpha,alpha'-Diethyl-(E)-4,4'-stilbenediol;ST IL;3,4-Bis(p-hydroxyphenyl)-3-hexene;EINECS 200-278-5;CHEMBL411;RCRA waste no. U089;BRN 2056095;Diethylstilbestrol (USP/INN);TRANS-DIETHYSTILBESTEROL;731DCA35BT;Phenol, 4,4'-[(1E)-1,2-diethyl-1,2-ethenediyl]bis-;cis-alpha,alpha'-Diethyl-4,4'-stilbenediol;CHEBI:41922;RGLYKWWBQGJZGM-ISLYRVAYSA-N;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (E)-;.alpha.,.alpha.'-Diethylstilbenediol;3,4-bis(4-hydroxyphenyl)hex-3-ene;(Z)-4,4'-(1,2-Diethyl-1,2-ethylenediyl)bisphenol;Phenol 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-;4,4'-(Hex-3-ene-3,4-diyl)diphenol;alpha,alpha'-Diethyl-4,4'-stilbenediol;Diethylstilbestrol, Disodium Salt;TRANSGENIC MODEL EVALUATION (DES);C18H20O2;Diethylstilboestrol (DE);Diethylstilbestrol [Nonsteroidal oestrogens];DSSTox_CID_465;DSSTox_RID_75608;DSSTox_GSID_20465;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (Z)-;4-[(3E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;4,4'-Stilbenediol, .alpha.,.alpha.'-diethyl-, (E)-;4-[(E)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol;Phenol, 4,4'-((1E)-1,2-diethyl-1,2-ethenediyl)bis-;Apstil;Stilbesterol, DES;MFCD00002373;4,4'-hex-3-ene-3,4-diyldiphenol;diethylstilboestrol;Estrogen, Stilbene;SMR000058263;4,4'-(3-HEXENE-3,4-DIYL)DIPHENOL;4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol;SR-01000745070;22610-99-7;Bertrol;3erd;CAS-56-53-1;NCGC00090749-04;Diethylstilbestrol [USP:INN:BAN];Estilbin (MCO);Prestwick_1070;PubChem2439;DiBestrol ""2"" Premix;Prestwick2_000756;Prestwick3_000756;Spectrum5_000799;4, 2,2'-diethyl-;D0Y2NE;AC1L9M2H;AC1Q2C9S;SCHEMBL9223;BSPBio_000772;BSPBio_002201;MLS000028447;MLS002174252;MLS002222298;ARONIS23859;BIDD:ER0159;SPECTRUM1500244;BPBio1_000850;GTPL2801;trans-.alpha.,4'-stilbenediol;ZINC1290;4, .alpha.,.alpha.-diethyl-;APS Brand of Diethylstilbestrol;DTXSID3020465;REGID_for_CID_448537;BDBM20625;CHEBI:92795;HMS501J21;RGLYKWWBQGJZGM-ISLYRVAYSA-;4, .alpha.,.alpha.'-diethyl-;Gerda Brand of Diethylstilbestrol;NSC3070;WLN: QR DY2&UY2&R DQ;3,4'-Dihydroxyphenyl)hex-3-ene;MolPort-001-785-868;HMS1570G14;HMS1920G08;HMS2090C14;HMS2091M18;HMS2097G14;HMS2232N11;HMS3650A09;HMS3714G14;Pharmakon1600-01500244;Phenol, 4,4'-(1,2-diethyl-1,2-ethylenediyl)bis-, (Z)-;3-Hexene,4-bis(p-hydroxyphenyl)-;NSC 3070;Tox21_202407;Tox21_300526;CCG-38961;Diethylstilbestrol, >=99% (HPLC);LS-220;NSC756736;Phenol, 4,4'-(1,2-diethyl-1,2-ethylenediyl)bis-, (Z)- (9CI);s1859;STK366318;3,4-Bis(4-hydroxyphenyl)-3-hexene;Co Pharma Brand of Diethylstilbestrol;Co-Pharma Brand of Diethylstilbestrol;AKOS005111142;DIETHYLSTILBESTROL (diethylstilbestr;4,2-Diethyl-1,2-ethenediyl)bisphenol;CS-2338;NSC-756736;IDI1_000519;3,4'(4,4'-Dihydroxyphenyl)hex-3-ene;63528-82-5 (di-hydrochloride salt);NCGC00090749-01;NCGC00090749-02;NCGC00090749-03;NCGC00090749-05;NCGC00090749-06;NCGC00090749-07;NCGC00090749-08;NCGC00090749-09;NCGC00254539-01;NCGC00259956-01;4, .alpha.,.alpha.'-diethyl-, (E)-;AJ-07997;AN-41690;AS-13377;CJ-00040;HY-14598;I027;KB-76580;SC-05383;SC-65252;ZB000303;SBI-0051346.P003;3,4-Bis(p-hydroxyphenyl)-3-hexene, trans;4,4'-dihydroxy-alph a,beta-diethylstilbene;AB1009528;LS-146816;D0526;Diethylstilbestrol, mixture of cis and trans;ST24046566;.alpha.,.alpha.'-Diethyl-4,4'-stilbenediol;3,4-(Di-4-hydroxyphenyl)hex-3-ene, (E)-;3-Hexene,3,4-bis(p-hydroxyphenyl)-, (E)-;trans-alpha,alpha'-Diethyl-4,4'-Stilbenediol;(E)-alpha, alpha'-diethyl-4,4'-stilbened iol;(E)-alpha, alpha'-diethyl-4,4'-stilbenediol;4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol;4,4'-Dihydroxy-.alpha.,.beta.-diethylstilbene;C07620;D00577;Z-0795;.alpha.,.alpha.'-Diethyl-(E)-4,4'-stilbenediol;002D373;A831077;Diethylstilbestrol, mixture of cis and trans, 97%;SR-01000745070-3;SR-01000745070-4;SR-01000745070-5;SR-01000745070-9;trans-.alpha.,.alpha.'-Diethyl-4,4'-stilbenediol;trans-.alpha.,.alpha.'-diethyl-4-4'-stilbenediol;4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol, trans;4,4'-Stilbenediol, .alpha.,.alpha.-diethyl-, (E)-;BRD-K17084514-001-01-7;BRD-K45330754-001-09-2;Diethylstilbestrol, VETRANAL(TM), analytical standard;I14-11699;Phenol,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-;trans-4,4 '-(1,2-diethyl-1,2-ethenediyl)bisphenol;4,4'-Stilbenediol, alpha,alpha'-diethyl-, (E)- (8CI);Diethylstilbestrol, European Pharmacopoeia (EP) Reference Standard;Diethylstilbestrol, United States Pharmacopeia (USP) Reference Standard;DIETHYLSTILBESTROL (SEE ALSO TRANSGENIC MODEL EVALUATION (DIETHYLSTILBESTROL));8026-45-7;8028-09-9;8030-34-0;8049-42-1;8053-00-7;InChI=1/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+"	56-53-1	731DCA35BT	"7508621;8428334"	8428334	01/02/1993	21007328	01/08/1945	Bef. 1989		0	0	1	Yes	1	30/05/1973 00:00	AP	TABLICAPS	DIETHYLSTILBESTROL	30/05/1973	TABLICAPS	333,2	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Samarium (153Sm) lexidronam	"153sm-edtmp;samarium sm 153 lexidronam pentasodium"	"Samarium (153 Sm) lexidronam;Samarium-153 lexidronam;153SM-EDTMP;Samarium Sm-153 lexidronam;Samarium-153-EDTMP"	DB05273		"Samarium sm-153 lexidronam;Sm-Edtmp;Samarium-153-edtmp;153Sm-Edtmp;Samarium-153 lexidronam;Samarium (153Sm) lexidronam;122575-21-7;UNII-745X144DZY;745X144DZY;Samarium (153Sm) lexidronam [INN];Samarium sS-153 lexidronam [USAN];Samarate(5)-153Sm, (((1,2-ethanediylbis(nitrilobis(methylene)))tetrakis(phosphonato))(8-)-N,N',O(P),O(P'),O(P''),O(P'''))-, pentahydrogen, (OC-6-21)-;Samarium Sm-153 lexidronam [USAN]"	122575-21-7	745X144DZY	15526021	15526021	01/11/2004	1720321	01/01/1991	1989-1994		1	0	0	No	0					30/07/2018		330,2	#N/A																							0						1
Nedaplatin	nedaplatin	"(glycolato-O,O')diammineplatinum(II);cis-Diammine(glycolato)platinum(II);CDGP;cis-diammine(glycolato)platinum;cis-Diammine (glycolato)platinum"	DB13145	"azanide; 2-hydroxyacetic acid; platinum(+2) cation;azanide; glycolic acid; platinum(+2) cation;azanide; 2-hydroxyethanoic acid; platinum(+2) cation;95734-82-0;Platinum, diammine(hydroxy-kappaO)acetato(2-)-kappaO)-, (SP-4-3)-;Platinum, diammine(hydroxyacetato(2-)-O(sup 1),O(sup 2))-, (SP-4-3)-;cis-Diammine (glycolato)platinum;cis-Diammine(glycolato)platinum;cis-Diammine(glycolato)platinum(II);cis-Diammine(glycolato-O(sup 1),O(sup 2))platinum;Aqupla;Aqupla (TN);D01416;Nedaplatin (JAN);C12862;(Glycolato-O,O')diammineplatinum(II);254-S;CCRIS 4088;NSC 375101D;Nedaplatin;Nedaplatin [INN]"	"Nedaplatin;Nedaplatin [INN];95734-82-0;cis-Diammine(glycolato)platinum;NSC 375101D;CCRIS 4088;cis-Diammine (glycolato)platinum;254-S;cis-Diammine(glycolato)platinum(II);UNII-8UQ3W6JXAN;(Glycolato-O,O')diammineplatinum(II);NCGC00181152-01;NSC-375101D;cis-Diammine(glycolato-O(sup 1),O(sup 2))platinum;8UQ3W6JXAN;Platinum, diammine(hydroxy-kappaO)acetato(2-)-kappaO)-, (SP-4-3)-;Platinum, diammine(hydroxyacetato(2-)-O(sup 1),O(sup 2))-, (SP-4-3)-;Platinum,O(2))-, (SP-4-3)-;Platinum,O(2)]-, (SP-4-3)-;CGDP-II;cis-diammine(glycolato)platinum II;(glycolato-O,O')diammineplatinum II;Aqupla (TN);Nedaplatin (JAN/INN);C2H6N2O3Pt;DSSTox_CID_26878;DSSTox_RID_81982;DSSTox_GSID_46878;DTXSID8046878;EBD53555;Tox21_112756;NSC375101;AKOS015854028;AC-1433;NSC-375101;BC679461;CAS-95734-82-0;LS-117704;FT-0602668;C12862;D01416;(Glycolato-O,O')diammineplatinum(II); cis-Diammine(glycolato)platinum(II)"	95734-82-0	8UQ3W6JXAN	"26831498;24480865;22199335;18021215;16889822"	16889822	01/08/2006	1997185	01/03/1991	1989-1994		1	1	0	Yes	1					30/07/2018		328,3	15	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	24	0	1
Binetrakin	"il-4;il4;interleukin-4;interleukin-4 pe38kdel immunotoxin;nbi-3001;rhil-7;rhuil-4"	"Interleukin 4 human;Interleukin-4;Interleukin-4 (human; nonglycosylated);IL-4;Interleukin 4 (human)"	DB12182			207137-56-2	751635Z921	"16000956;15292712;10801077"	10801077	01/05/2000	1637669	01/07/1992	1989-1994		1	1	0	Yes	1					30/07/2018		312,3	NA	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	22	0	1
Chlorsulfaquinoxaline	"chloroguinoxaline sulfonamide;chloroquinoxaline sulfonamide"	Chloroquinoxaline sulfonamide	DB12921	"4-amino-N-(5-chloroquinoxalin-2-yl)benzenesulfonamide;4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide;97919-22-7;4-25-00-02607 (Beilstein Handbook Reference);4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide;5-Chloroquinoxaline-2-sulfanilamide;BRN 0312075;Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-;Benzenesulfonamide,4-amino-N-(5-chloro-2-quinoxalinyl)-;CCRIS 689;CQS;Chlorsulfaquinoxaline;NSC 339004;NSC-339004;chloroquinoxaline sulfonamide;NSC339004;Benzenesulfonamide, 4-amino-N-[5-chloro-2-quinoxalinyl]-;AIDS-008357;AIDS008357;NCIMech_000335;NCI60_002995"	"Chlorsulfaquinoxaline;chloroquinoxaline sulfonamide;4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide;97919-22-7;NSC-339004;5-Chloroquinoxaline-2-sulfanilamide;CCRIS 689;UNII-O0408QB48D;MLS002701830;NSC339004;NSC 339004;BRN 0312075;O0408QB48D;4-amino-N-(5-chloroquinoxalin-2-yl)benzenesulfonamide;CQS;Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-;SMR001565423;C14H11ClN4O2S;Benzenesulfonamide,4-amino-N-(5-chloro-2-quinoxalinyl)-;Benzenesulfonamide, 4-amino-N-[5-chloro-2-quinoxalinyl]-;AC1Q6UFH;NCIMech_000335;AC1L2I4D;4-25-00-02607 (Beilstein Handbook Reference);cid_72462;SCHEMBL6375915;CHEMBL1905073;BDBM97028;DTXSID10243340;CTSNHMQGVWXIEG-UHFFFAOYSA-N;ZINC1578344;CCG-35544;AKOS028110694;DB12921;LS-31236;NCI60_002995;4-azanyl-N-(5-chloranylquinoxalin-2-yl)benzenesulfonamide"	97919-22-7	O0408QB48D	"1423306;7497583;7882456"	1423306	01/12/1992	1423306	01/12/1992	1989-1994		1	1	0	Yes	1					30/07/2018		307,3	88	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,08	0	0	0	NA	0	Supraventricular tachyarrhythmia	1	0	0	0	2	0	1
Lobaplatin	lobaplatin		DB13049			135558-11-1	OX5XK1JD8C	8431374	8431374	01/02/1993	8431374	01/02/1993	1989-1994		1	1	0	Yes	1					30/07/2018		305,2	27	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,07	0	1	1	NA	0	0	0	0	0	0	0	0	1
Bryostatin 1	"bryostatin 1;bryostatin-1"		DB11752	"AIDS-001549;AIDS001549;Bryostatin-1;Bryostatin 1"	"Bryostatin 1;UNII-37O2X55Y9E;83314-01-6;CHEMBL449158;Bryostatin-1;CHEBI:88353;37O2X55Y9E;BRYOSTATIN;NSC 339555;BRN 4349157;NSC-339555;NCGC00181150-01;(1S-(1R*,3R*,5Z,7S*,8E,11R*,12R*(2E,4E),13E,15R*,17S*(S*),21S*,23S*,25R*))-25-(Acetyloxy)-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo(21.3.1.13,7.111,15)nonacos-8-en-12-yl 2,4-octadienoate;2,4-Octadienoic acid, 25-(acetyloxy)-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo(21.3.1.13,7.111,15)nonacos-8-en-12-yl ester, (1S-(1R*,3R*,5Z,7S*,8E,11R*,12R*(2E,4E),13E,15R*,17S*(S*),21S*,23S*,25R*))-;DSSTox_CID_26876;DSSTox_RID_81981;DSSTox_GSID_46876;SCHEMBL182960;DTXSID8046876;Bryostatin 1, >=99%, solid;MJQUEDHRCUIRLF-TVIXENOKSA-N;2,4-Octadienoic acid, (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(acetyloxy)-1,11,21-trihydroxy-17-((1R)-1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo(21.3.1.13,7.111,15)nonacos-8-en-12-yl ester, (2E,4E)-;Tox21_112754;BDBM50258529;BMY-45618;MFCD00893832;AKOS032946513;ZINC169357315;CAS-83314-01-6;(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.1(3,7).1(11,15)]nonacos-8-en-12-yl (2E,4E)-octa-2,4-dienoate"	83314-01-6	37O2X55Y9E	"10499603;12432257;19221754;7640233;7954524;8347500;9440723;9533528"	8347500	01/08/1993	8347500	01/08/1993	1989-1994		1	1	0	Yes	1					30/07/2018		299,3	19	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	30	0	1
Apaziquone	"apaziquone;e09;eo9"	EOQUIN	DB12593	"5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methylindole-4,7-dione;5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione;5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methyl-indole-4,7-dione;5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-indole-4,7-dione;5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methylindole-4,7-dione;5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione;5-ethylenimino-2-(3-hydroxyprop-1-enyl)-1-methyl-3-methylol-indole-4,7-quinone;5-ethylenimino-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-3-methylol-indole-4,7-quinone;114560-48-4;E-85/050;EO9;EOquin;NSC-382456;Neoquin;NCI60_003655;E09;NSC382459;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-;ANTINEOPLASTIC-382459;Apaziquone (USAN/INN);D02965;Eoquin (TN);(E)-5-(1-Azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-((1E)-3-hydroxy-1-propenyl)-1-methyl-;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-, (E)-;5-(Azridin-1-yl)-3-(hydroxymethyl)-2-((1E)-3-hydroxyprop-1-enyl)-methyl-1H-indole-4,7-dione;Apaziquone;Apaziquone [USAN:INN];Apaziquonum;Apaziquonum [INN-Latin];E 09;E-85/053;EO 9 (pharmaceutical);NOR-701;NSC 382456;NSC 382459"	"Apaziquone;EOquin;Apaziquonum;114560-48-4;NOR-701;EO 9 (pharmaceutical);EO-9;Apaziquone [USAN:INN];Apaziquonum [INN-Latin];NSC-382459;Neoquin;E 09;NSC 382459;UNII-H464ZO600O;Eoquin (TN);E-09;E-85/053;Apaziquone (USAN/INN);EO9;NSC 382456;H464ZO600O;(E)-5-(1-Azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione;5-(Azridin-1-yl)-3-(hydroxymethyl)-2-((1E)-3-hydroxyprop-1-enyl)-methyl-1H-indole-4,7-dione;3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione)prop-beta-en-alpha-ol;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-, (E)-;E09;E-85/050;C15H16N2O4;Qapzola;5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-((1E)-3-hydroxy-1-propenyl)-1-methyl-;EO 9;Apaziquone/EOquin;NSC 382,459;AC1NXQZI;D08ICH;D0FP0R;CHEMBL73822;SCHEMBL367964;SCHEMBL367965;ANTINEOPLASTIC-382459;ZINC1536777;NSC382459;BCP9000309;DB12593;141304-51-0;AN-16588;LS-83017;D02965;1H-Indole-4, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-;5-Aziridin-1-yl-3-hydroxymethyl-2-((E)-3-hydroxy-propenyl)-1-methyl-1H-indole-4,7-dione;(E)-5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-en-1-yl)-1-methyl-1H-indole-4,7-dione;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-,(E)-;1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1E)-3-hydroxy-1-propen-1-yl]-1-methyl-;5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-indole-4,7-dione"	114560-48-4	H464ZO600O	"18485407;16952628;8911111;7620220"	7620220	01/01/1994	7620220	01/01/1994	1994-1998		1	1	0	Yes	1					30/07/2018		294,3	59	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Buthionine Sulfoximine	buthionine sulfoximine		DB12870	"2-amino-4-(butylsulfonimidoyl)butyric acid;71765-30-5;5072-26-4;19176_FLUKA;DL-Buthionine-sulfoximine;NCI60_002827;EU-0100231;Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-, (2S)-;Buthionine-S,R-sulfoximine, L-;L-Buthionine (SR)-sulfoximine;L-Buthionine-(S,R)-sulfoximine;NCGC00093696-02;2-Amino-4-(S-butylsulfonimidoyl)butanoic acid;BRN 2367136;Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-;Buthione sulfoximine;Buthionine sulfoxamine;Buthionine sulphoximine;Buthionine-S,R-sulfoximine;Butionine sulfoximine;NSC 326231;NSC 381100;Sulfoximine, S-(3-amino-3-carboxypropyl)-S-butyl-;BSPBio_002464;Lopac0_000231;71765-30-5 (DELETED);AIDS-026783;AIDS026783;DL-Buthionine-S,R-sulfoximine;B2640_SIGMA;2-Amino-4-(butylsulfonimidoyl)butanoic acid;Buthionine sulfoximine;C04543;S-Butyl-DL-homocysteine-[S,R]-sulfoximine;ST5307007;L-Buthionine-(S,R)-sulphoximine;SPECTRUM1505108;BSO;L-Buthionine sulfoximine;NSC326231;NSC381100"	"BUTHIONINE SULFOXIMINE;5072-26-4;DL-Buthionine-[S,R]-sulfoximine;Buthionine sulfoxamine;Buthione sulfoximine;Buthionine-S,R-sulfoximine;2-Amino-4-(S-butylsulfonimidoyl)butanoic acid;Butionine sulfoximine;Buthionine sulphoximine;2-Amino-4-(butylsulfonimidoyl)butanoic acid;DL-Buthionine-sulfoximine;NSC 381100;Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-;BRN 2367136;DL-Buthionine-S,R-sulfoximine;CHEBI:28714;DL-Buthionine-(S,R)-sulfoximine;D,L-Buthionine-(S,R)-sulfoximine;DL-butathionine-(S,R)-sulfoximine;Sulfoximine, S-(3-amino-3-carboxypropyl)-S-butyl-;NSC326231;NSC381100;S-butyl-DL-homocysteine (S,R)-sulfoximine;S-Butyl-DL-homocysteine-[S,R]-sulfoximine;2-amino-4-(S-butylsulfonimidoyl)butyric acid;NSC 326231;71765-30-5;C8H18N2O3S;L-Buthionine (SR)-sulfoximine;Buthionine-S,R-sulfoximine, L-;L-Buthionine-(S,R)-sulphoximine;dl-buthionine (s,r)-sulfoximine;BSO;beta-Glutamylcysteine;AC1L2HQW;D0K8LM;Lopac0_000231;SCHEMBL62033;BSPBio_002464;SPECTRUM1505108;CHEMBL1256575;CHEMBL1627290;DTXSID6044434;CTK8F8906;OR9025T;KJQFBVYMGADDTQ-UHFFFAOYSA-N;MolPort-001-770-865;HMS3260P03;KS-000018ET;ZX-AT019574;Tox21_500231;MFCD00070309;S-(n-butyl)homo cysteine sulfoximine;STL328818;AKOS022106364;API0009406;CCG-204326;DB12870;LP00231;MCULE-8178742509;NSC-381100;NCGC00015148-03;NCGC00015148-04;NCGC00015148-05;NCGC00015148-06;NCGC00015148-07;NCGC00093696-01;NCGC00093696-02;NCGC00093696-03;NCGC00260916-01;LS-46081;LS-46082;NCI60_002827;EU-0100231;FT-0624379;ST51012445;2-Amino-4-(butylsulfonimidoyl);butanoic acid;DL-Buthionine-sulfoximine, >=99.0% (TLC);2-Amino-4-(butylsulfonimidoyl)butanoic acid #;2-Amino-4-(S-butylsulfoninidoyl)butanoic acid;2-Amino-4-(S-butylsulphonimidoyl)butanoic acid;B 2640;C04543;S-(3-Amino-3-carboxypropyl)-S-butylsulphoximine;SR-01000075713;SR-01000075713-1;(S)-2-Amino-4-((R)-butylsulfonimidoyl)butanoic acid;BRD-A04020513-001-01-9;2-amino-4-[butyl(imino)oxo-|E6-sulfanyl]butanoic acid"	5072-26-4	LW4108Q0BV	8101766	8101766	01/08/1993	8270977	01/01/1994	1994-1998		1	1	0	Yes	1					30/07/2018		294,3	28	NA	1	0	NA	1	GCLC	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Tridolgosir	swainsonine	"(1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol;Swainosine"	"DB02034;EXPT02983;DB06425"	"(8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,2,8-triol;(8R,8aR)-indolizidine-1,2,8-triol;NCI60_004937;(-)-Swainsonine;1,2,8-Indolizinetriol, octahydro-, (1S,2R,8R,8aR)-;1,2,8-Indolizinetriol, octahydro-,[1S-(1.alpha.,2.alpha., 8.beta.,8a.beta.)]-;NSC614553;Tridolgosir"	"swainsonine;Tridolgosir;72741-87-8;(-)-Swainsonine;Tridolgosir [INN];UNII-RSY4RK37KQ;RSY4RK37KQ;CHEBI:9367;CHEMBL371197;FXUAIOOAOAVCGD-WCTZXXKLSA-N;(1S,2R,8R,8aR)-Octahydro-1,2,8-indolizinetriol;1S-8AB-OCTAHYDRO-INDOLIZIDINE-1A,2A,8B-TRIOL;NCGC00163481-02;(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol;(1S,2R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,2,8-triol;1,2,8-Indolizinetriol, octahydro-, (1S-(1alpha,2alpha,8beta,8abeta))-;SWA;Swainosine;Locoweed deriv.;NSC614553;1hww;Octahydro-1,2,8-indolizinetriol hydrochloride;AC1L1BJG;(1S,2R,8R,8aR)-1,2,8-Octahydroindolizidinetriol;AC1Q1GU1;DSSTox_CID_26356;DSSTox_RID_81558;CBiol_001919;DSSTox_GSID_46356;BSPBio_001148;KBioGR_000488;KBioSS_000488;SCHEMBL765848;DTXSID5046356;KBio2_000488;KBio2_003056;KBio2_005624;KBio3_000895;KBio3_000896;MolPort-003-850-377;Bio1_000205;Bio1_000694;Bio1_001183;Bio2_000414;Bio2_000894;HMS1362J09;HMS1792J09;HMS1990J09;HMS3403J09;ZINC3875041;Tox21_112058;2057AH;BDBM50168995;MFCD00017554;(1S,2R,8aR)-Octahydroindolizinetriol;AKOS016344385;CCG-208274;DB02034;NSC-614553;IDI1_002169;SMP1_000286;NCGC00163481-03;NCGC00163481-04;LS-83623;CAS-72741-87-8;B7316;BB 0261154;FT-0630815;C10173;(1S, 2R, 8R, 8AR)-1,2,8-Indolizidinetriol;8|A,|A-Octahydroindolizidine-1|A,2|A,8|A-triol;SR-05000002325;SR-05000002325-2;(1S,2R,8R,8aR)-Octahydro-indolizine-1,2,8-triol;1,8-Indolizinetriol, octahydro-, (1S,2R,8R,8aR)-;1,2,8-Indolizinetriol,octahydro-, (1S,2R,8R,8aR)-;CFCE4066-9132-492F-B4E1-B50B974FE148;1,2,8-Indolizinetriol, octahydro-, (1S-(1-alpha,2-alpha,8-beta,8a-beta))-;1,8-Indolizinetriol, octahydro-,[1S-(1.alpha.,2.alpha., 8.beta.,8a.beta.)]-;SWS"	72741-87-8	RSY4RK37KQ	9815786	9815786	01/07/1997	8137247	01/03/1994	1994-1998		1	1	0	Yes	1					30/07/2018		292,4	19	NA	1	0	NA	1	alpha-mannosidase II	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	1	0	0	0	0	0	0	0	1
Tirapazamine	"sr 4233;tirapazamine"	"1,2,4-benzotriazin-3-amine, 1,4-dioxide;3-Amino-1,2,4-benzotriazine 1,4-dioxide"	DB04858	"4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine;(4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-ylidene)amine;27314-97-2;1,2,4-Benzotriazin-3-amine, 1,4-dioxide;1,2,4-Benzotriazine, 3-amino-, 1,4-dioxide;3-Amino-1,2,4-benzotriazine 1,4-dioxide;3-Amino-1,2,4-benzotriazine-1,4-dioxide;4-26-00-01120 (Beilstein Handbook Reference);BRN 0179322;D06167;Tirapazamine (USAN);Tirapazamine [USAN:INN];WIN 59075;SR 4233;1,4-Dioxido-1,2,4-benzotriazin-3-ylamine;NSC-130181;TIRAPAZAMINE;SR-4233;Tirazone;Win-59075;SR-259075"	"TIRAPAZAMINE;27314-97-2;Tirazone;3-Amino-1,2,4-benzotriazine 1,4-dioxide;3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide;Win-59075;1,2,4-Benzotriazin-3-amine, 1,4-dioxide;SR 4233;SR-4233;WIN 59075;Tirapazamine [USAN:INN];3-Amino-1,2,4-benzotriazine-1,4-dioxide;UNII-1UD32YR59G;1,2,4-benzotriazin-3-amine,1,4-dioxide;BRN 0179322;1,2,4-Benzotriazin-3-amine 1,4-Dioxide;1UD32YR59G;C7H6N4O2;CHEBI:78887;4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine;SR-259075;1,2,4-Benzotriazine, 3-amino-, 1,4-dioxide;TPZ;NSC 130181;Tirapazamine (USAN/INN);D09XQU;AC1L1Q8I;SCHEMBL4048;SCHEMBL4049;4-26-00-01120 (Beilstein Handbook Reference);CHEMBL50882;SCHEMBL872285;CTK4F9457;Tirapazamine, >=98% (HPLC);MolPort-003-844-460;ORYDPOVDJJZGHQ-UHFFFAOYSA-N;ZINC1607808;AN-556;FCH839658;AKOS006271584;API0004429;CS-2781;DB04858;QC-4587;SR-4482;KS-0000185B;4CA-1255;BC228150;HY-13767;LS-41511;BCP0726000167;AB0020793;AX8083649;KB-234686;SR 259075;FT-0661586;V1806;D06167;J-016728"	27314-97-2	1UD32YR59G	"10760430;9815534;8195037"	8195037	01/05/1994	8195037	01/05/1994	1994-1998		1	1	0	Yes	1					30/07/2018		290,4	NA	NA	1	0	NA	1	HYPOXIA	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	26	0	1
Tesmilifene	"dppe;n,n-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-hcl;tesmilifene"	"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine;DPPE;Depmpe"	DB04905	"N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine;2-[4-(benzyl)phenoxy]ethyl-diethyl-amine;Depmpe;Ethanamine, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-;N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine;Tesmilifene;NCGC00024762-01;Tocris-0743;NCGC00024762-02"	"Tesmilifene;Depmpe;98774-23-3;2-(4-benzylphenoxy)-N,N-diethylethanamine;UNII-I43T3ID6G2;(2-(4-benzylphenoxy)ethyl)diethylamine;DPPE hydrochloride;N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine;CHEMBL26424;I43T3ID6G2;92981-78-7 (hydrochloride);n,n-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine;Ethanamine, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-;NCGC00024762-02;YMB1002;N,N-Diethyl-2-(4-benzylphenoxy)ethanamine;2-((alpha-Phenyl-p-tolyl)oxy)triethylamine;2-(4-benzylphenoxy)-N,N-diethyl-ethanamine;DSSTox_CID_25661;DSSTox_RID_81038;DSSTox_GSID_45661;N,N-diethyl-2-(4-(phenylmethyl)phenoxy)ethanamine;BMS 217380-01;[2-(4-benzylphenoxy)ethyl]diethylamine;Tesmilifene [INN];CAS-98774-23-3;N,N-diethyl-2-(4-(phenylmethyl)phenoxy)ethanamine hydrochloride;BMS-217380;N,N-DIETHYL-2-[4-BENZYLPHENOXY]ETHANAMINE;Ethanamine, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-;DPPE hydrocloride;PubChem19631;Tocris-0743;DPPE, BMS;D0X9PW;AC1L33BQ;AC1Q56YN;SCHEMBL112525;ZINC2139;DTXSID1045661;CHEBI:93414;CTK5H1969;NFIXBCVWIPOYCD-UHFFFAOYSA-N;YMB-1002;Tox21 110924;Tox21_110924;6924AC;AN-474;Anticancer, BMS/Manitoba Univ/MTCR;BDBM50085260;AKOS016010778;Tox21_110924_1;API0005334;DB04905;NCGC00024762-01;NCGC00024762-03;NCGC00024762-04;NCGC00024762-05;AJ-08137;Ethanamine, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-;SC-88231;N,N-Diethyl-2-(p-benzylphenoxy)ethylamine;AX8148623;LS-178389;[2-(4-Benzyl-phenoxy)-ethyl]-diethyl-amine;Triethylamine, 2-(.alpha.-phenyl-p-tolyloxy)-;BRD-K80315159-051-01-2"	98774-23-3	I43T3ID6G2	8201390	8201390	01/06/1994	8201390	01/06/1994	1994-1998		1	1	0	Yes	1					30/07/2018		289,3	48	NA	1	0	NA	1	HISTAMINE	0	1	0	NA	0	0	0	1	0	0,17	0	0	0	0,77	0	0	0	Acute CNS symptoms	1	0	344	0	1
Mitomycin	mitomycin	"Mitomycin C;Mitamycin;7-Amino-9alpha-methoxymitosane;Mitocin-C;MMC;Ametycine;Mitomycin;Mitomycin for Injection USP;Mutamycin Inj 20mg/vial;Mitomycin for Injection;Mutamycin;Mutamycin Inj 5mg/vial;Mitomycin;Mitosol"	"DB00305;APRD00284"	"50-07-7;7481-68-7;144085-53-0;Bio1_000702;Mitomycin (USP/INN);AIDS-031090;AIDS031090;Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-;M4287_SIGMA;CHEBI:27504;C06681;Mitomycin;Mitomycin C;Mitocin C;Mitomycin C, <i>Streptomyces caespitosus</i>, Carrier-Free;6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester);7-Amino-9alpha-methoxymitosane;AI3-26199;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester);Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))- (9CI);CCRIS 414;EINECS 200-008-6;HSDB 3239;Mitomycin [USAN:BAN:INN];Mitomycin-C;Mitomycinum C;Mitomycyna C [Polish];Mitozytrex;Mytozytrex;NSC 26980;RCRA waste no. U010;RCRA waste number U010;KBio2_003175;[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate;KBioSS_000607;Bio2_000944;KBio2_005743;Muamycin;KBio3_001074;[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate;Bio1_001191;M0440_SIGMA;Mitomycin C Streptomyces caespitosus;IDI1_002219;SMP1_000307;KBioGR_000607;M0503_SIGMA;Bio2_000464;CBiol_001927;Ametycin;Ametycine;D00208;Mitomycin (TN);Bio1_000213;Mitomycin C (JP15);Mitocin-C;Muamycin (TN);Mutamycin;Mitomycin C, <i>Streptomyces caespitosus;Mitamycin;KBio3_001073;BSPBio_001267;KBio2_000607"	"mitomycin C;Mitomycin;50-07-7;Ametycine;Mutamycin;Mitocin-C;Ametycin;Mitomycin-C;Mitomycinum;Mytomycin;Mytozytrex;Mitozytrex;Mitomycinum C;Mitocin C;Mitomycins;Mitamycin;Mitosol;MMC;7-Amino-9alpha-methoxymitosane;Mitomycyna C;NSC-26980;Mitomycyna C [Polish];Mito-C;Mit-C;Mitomicina;Mitomycine;Mitomycin (TN);Mitomycine [INN-French];Mitomycinum [INN-Latin];Mitomicina [INN-Spanish];Muamycin;NCI-C04706;RCRA waste number U010;NSC26980;NSC 26980;Muamycin (TN);CCRIS 414;Mitomycin [USAN:INN:BAN];UNII-50SG953SK6;HSDB 3239;C15H18N4O5;Mitomycin (USP/INN);EINECS 200-008-6;Mitomycin C, Streptomyces caespitosus;RCRA waste no. U010;AI3-26199;CHEBI:27504;50SG953SK6;Mitomycin C, Streptomyces caespitosus, Carrier-Free;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-;Mitomycin C from Streptomyces caespitosus;Mitomycin C (JP15);DSSTox_CID_898;DSSTox_RID_75853;DSSTox_GSID_20898;6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester);Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-;CAS-50-07-7;((1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate;[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester);Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-;Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-;MLS002702984;(amino-methoxy-methyl-dioxo-[?]yl)methyl carbamate;7-Amino-9.alpha.-methoxymitosane;Mitomycin [USAN:USP:INN:BAN];NCGC00095258-01;[(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2'',3'':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate;[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate;7-Amino-9&alpha;Mitomycin C (JP17);CHEMBL105;D0NZ1U;D0Y0GH;AC1L1L1Q;SCHEMBL3760;CBiol_001927;BSPBio_001267;KBioGR_000607;KBioSS_000607;1404-00-8;MLS001332654;Mitozytrex (TN) (Supergene);AMETYCIN pound notmitomycin C;GTPL7089;DTXSID2020898;KBio2_000607;KBio2_003175;KBio2_005743;KBio3_001073;KBio3_001074;EX-A501;MolPort-003-938-644;NWIBSHFKIJFRCO-WUDYKRTCSA-N;ZX-AFC000411;BCPP000410;Bio1_000213;Bio1_000702;Bio1_001191;Bio2_000464;Bio2_000944;HMS1362O09;HMS1792O09;HMS1990O09;HMS2089F16;HMS3403O09;Tox21_111493;BDBM50428658;GR-311;LS-136;MFCD00078109;s8146;ZINC30726187;AKOS015895703;Tox21_111493_1;ACN-038344;BCP9000285;CCG-208564;CS-0564;DB00305;KS-5148;IDI1_002219;SMP1_000307;NCGC00163468-02;NCGC00163468-03;NCGC00163468-05;NCGC00163468-06;AN-15420;Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))- (9CI);BC208285;CC-30970;HY-13316;SC-17000;SMR000058401;BCP0726000181;KB-145809;LS-173087;M2320;C06681;D00208;W-5071;AB00918689-03;AB00918689-04;078M109;C-20147;Mitomycin C, Antibiotic for Culture Media Use Only;Q-201410;BRD-K59670716-001-02-6;BRD-K59670716-001-06-7;UNII-V03E10691T component NWIBSHFKIJFRCO-WUDYKRTCSA-N;WLN: T D3 B556 BN EM JV MVTTT&J GO1 H1OVZ KZ L1;Mitomycin C from Streptomyces caespitosus, >=970 mug/mg (USP XXIV);Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture;Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer;(1ar)-6-amino-8-(((aminoc arbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione;(1ar)-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione;[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0;{2,7}.0;{4,6}]trideca-1(9),11-dien-8-yl]methyl carbamate;[1aR-(1aalpha,8beta,8aalpha,8balpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-alpha]indole-4,7-dione;[1aS-(1a?,8?,8a?,8b?)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione;[1aS-(1aalpha,8beta,8aalpha,8balpha)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione;144085-53-0;6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino[2',3':3, 4]pyrrolo[1,2-a]indole-4,7-dione, carbamate (ester);6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, carbamate (ester);6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-azirino[2',3':3,4]pyrrol o[1,2a]indole-4,7-dione;6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-azirino[2',3':3,4]pyrrolo[1,2a]indole-4,7-dione;74349-48-7;7481-68-7;Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl -, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-;Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-5-methyl-, carbamate (ester);Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-5-methyl-, [1aR-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-;Mitomycin C from Streptomyces caespitosus, >=98% (HPLC), potency: >=970 mug per mg (USP XXIV), gamma-irradiated, suitable for cell culture"	50-07-7	50SG953SK6	"26172205;16875750;16142489;16084053;15256243;9713051;8895675"	8895675	01/10/1996	13637797	01/01/1958	Bef. 1989		0	0	1	No	0	"28/02/2001 00:00;30/04/1998 00:00;13/10/2017 00:00;14/05/2001 00:00;12/05/2000 00:00;08/08/2000 00:00;19/04/1995 00:00;12/07/2000 00:00;18/06/1999 00:00;23/12/1999 00:00;22/12/2017 00:00;25/09/2014 00:00;30/07/2001 00:00;01/04/2009 00:00;06/01/2000 00:00;02/12/2009 00:00;07/02/2012 00:00;24/08/1981 00:00;29/11/1995 00:00;11/08/2009 00:00;11/10/2000 00:00;11/07/2011 00:00;20/01/2016 00:00;16/09/1991 00:00;02/11/2000 00:00;14/11/2002 00:00;17/07/2000 00:00;02/06/1999 00:00;28/11/1988 00:00;22/02/1999 00:00;31/01/1997 00:00;15/05/2000 00:00;22/01/1999 00:00;17/04/2000 00:00"	AP	"ACCORD HLTHCARE;#N/A;WEST-WARD PHARMS INT;MOBIUS THERAP;SUPERGEN;HOSPIRA;BRISTOL MYERS"	MITOMYCIN	24/08/1981	BRISTOL MYERS	283,1	#N/A																							0						1
Satraplatin	"bms-182751;bmy-45594;jm216;satraplatin"		DB04996	"acetic acid; azane; cyclohexanamine; dichloroplatinum;acetic acid; ammonia; cyclohexanamine; dichloroplatinum;acetic acid; ammonia; cyclohexylamine; dichloroplatinum;azane; cyclohexanamine; dichloroplatinum; ethanoic acid;D05807;Satraplatin (USAN);BMS-182751;BMY-45594;YHI-601;Satraplatin"		129580-63-8	8D7B37T28G	"25556988;23429330;21828377;21184645;11561689;11095134;9932162;9654114;7554035"	7554035	01/01/1995	7554035	01/01/1995	1994-1998		1	1	0	Yes	1					30/07/2018		282,3	37	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	0	0,03	0	0	0	NA	0	0	0	0	0	0	24	0	1
Rubitecan	"9-amino-20(s)-camptothecin;9-aminocamptothecin;9-nitrocamptothecin;aminocamptothecin;nsc-603071;rfs 2000;rfs-2000;rfs2000;rubitecan"	"RF-2000;Camptogen;9-nitrocamptothecin;9NC"	DB06159	"ST-2617;9-Nitrocamptothecin;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-;9NC;AIDS-072618;AIDS072618;RFS-2000;Rubitecan"	"Rubitecan;9-Nitrocamptothecin;91421-42-0;Orathecin;9-nitro-20(S)-camptothecin;Camptogen;9-NC;RFS 2000;RFS-2000;UNII-H19C446XXB;Nitrocamptothecin;H19C446XXB;CHEBI:90225;C20H15N3O6;(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;NCGC00167969-01;9NC;Q-100889;(4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione;(s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione;Rubitecan [USAN:INN];rubetican;rubitecanum;Inhaled Orathecin;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-;Rubitecan (inhaled);9-nitro camptothecin;9-Nitro-CPT;AC1LAOVR;Rubitecan (USAN/INN);L9NC;D0I5XO;D0Y1FO;SCHEMBL8640;DSSTox_CID_26752;DSSTox_RID_81877;DSSTox_GSID_46752;9-Nitrocamptothecin (9-NC);ethyl-hydroxy-nitro-[?]dione;9-nitro-(20S)-camptothecin;CHEMBL77305;9-nitro-20(s)-camptothecine;Rubitecan (inhaled), SuperGen;AC1Q21R5;Camptothecin, 9-nitro-20(S);DTXSID7046752;camptothecin, 9-nitro-20(s)-;CTK8B3048;MolPort-003-850-214;VHXNKPBCCMUMSW-FQEVSTJZSA-N;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-;EBD39671;ZINC3827362;9-nitrocamptothecin    (rubitecan);Tox21_112597;3600AC;ABP001092;ANW-41681;CN-061;AKOS015895332;AKOS025149224;RL05757;ST-2617;KS-000017A1;NCGC00167969-02;NCGC00167969-03;AC-13389;AC-25083;AJ-45745;AS-14856;BC206171;M884;SC-54565;AB3000004;AX8022905;CAS-91421-42-0;KB-211552;TR-038378;FT-0630977;N0822;ST24036187;D04031;421R420;(S)-4-Ethyl-4-hydroxy-9-nitro-1H-pyrano[3',4';Aerosolized liposomal 9 nitro-20 (S) camptothecin;I06-2270;BRD-K79821389-001-01-9;(4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin; Orathecin;4|A-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione;Rubitecan; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-, (4S)-"	91421-42-0	H19C446XXB	"21191594;16702815;16505951;15297407;12819941;12796369;12394266;11592343;10561279;10561232;10416008;10340914;10200331;9667269;9619763;9516917;9508199;9491790;9193345;8993530;8993518;8648379;9815982"	9815982	01/03/1995	9815982	01/03/1995	1994-1998		1	1	0	Yes	1					30/07/2018		280,4	31	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Molgramostim	molgramostim		DB12525			99283-10-0	B321AL142J	"11313178;9296215"	9296215	01/07/1997	7540147	01/05/1995	1994-1998		1	1	0	Yes	1					30/07/2018		278,4	18	NA	0	1	AML	1	GM-CSF-R	0	0	1	18	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Pyrazoloacridine	"nsc366140;pd115934;pyrazoloacridine"		DB12549	"99009-21-9;AIDS156282;Pyrazolo[3,4,5-kl]acridine-2(6H)-propanamine, 9-methoxy-N, N-dimethyl-5-nitro-, monomethanesulfonate;{Pyrazolo[3,4,5-kl]acridine-2(6H)-propanamine,} 9-methoxy-N, N-dimethyl-5-nitro-, monomethanesulfonate;NSC366140;PYRAZOLOACRIDINE;Pyrazolo[3,4,5-kl]acridine-2(6H)-propanamine, 9-methoxy-N,N-dimethyl-5-nitro-, monomethanesulfonate;NSC 366140;2-(3-(Dimethylamino)propyl)-5-(hydroxy(oxido)amino)-9-methoxy-2,6-dihydropyrazolo(3,4,5-kl)acridine methanesulfonate;2-(3-(Dimethylamino)propyl)-5-(hydroxy(oxido)amino)-9-methoxy-2,6-dihydropyrazolo[3,4,5-kl]acridine methanesulfonate;AIDS-156282"	"Pyrazoloacridine;PD-115934;UNII-L24XJN68OW;NSC 366140;99009-20-8;PD 115934;NSC627168;NSC-366140;BRN 4211902;L24XJN68OW;Pyrazolo-acridine (free base);PD 115,934;NSC-627168;N,N-Dimethyl-9-methoxy-5-nitropyrazolo(3,4,5-kl)acridine-2(6H)-propanamine;C19H21N5O3;Pyrazolo(3,4,5-kl)acridine-2(6H)-propanamine, N,N-dimethyl-9-methoxy-5-nitro-;CCRIS 9408;D0L5MF;NCIMech_000572;Neuro_000206;Neuro_000260;SCHEMBL867991;CHEMBL118841;SCHEMBL6350605;HZCWPKGYTCJSEB-UHFFFAOYSA-N;ZINC3778885;CCG-35612;AKOS024419418;DB12549;MCULE-2955179343;99009-21-9 (methanesulfonate salt);NCI60_003371;NCI60_008612;2-[(3-N',4,5-kl]acridine, free base;LS-128928;3-(9-methoxy-5-nitropyrazolo[3,4,5-kl]acridin-2(1h)-yl)-n,n-;Pyrazolo[3,4,5-kl]acridine-2(6H)-propanamide, 9-methoxy-N,N-dimethyl-;2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]-pyrazolo[3,4,5-kl]acridine;2-[3-(Dimethylamino)propyl]-9-methoxy-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine;3-(9-Methoxy-5-nitropyrazolo[3,4,5-kl]acridin-2(6H)-yl)-N,N-dimethyl-1-propanamine;3-(9-Methoxy-5-nitropyrazolo[3,4,5-kl]acridin-2(6H)-yl)-N,N-dimethyl-1-propanamine #;9-Methoxy-N,N-dimethyl-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine-2-propanamine"	99009-20-8	L24XJN68OW	"12114415;9440741;9815948"	9815948	01/12/1995	7636538	01/08/1995	1994-1998		1	1	0	Yes	1					30/07/2018		275,4	NA	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	"neuropsychiatric;neuromotor effects"	1	0	21	0	1
Liarozole	liarozole		DB13066	"6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole;6-[(3-chlorophenyl)-imidazol-1-yl-methyl]-1H-benzimidazole;6-[(3-chlorophenyl)-(1-imidazolyl)methyl]-1H-benzimidazole;1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-;Liarozol [INN-Spanish];Liarozole;Liarozolum [INN-Latin];R 61405;R-61405"	"Liarozole;Liazal;LIAROZOLE FUMARATE;R-75251;115575-11-6;Liarozole [INN:BAN];Liarozol [INN-Spanish];Liarozolum [INN-Latin];R 75251;R 61405;R-61405;R085246;R 085246;R-085246;UNII-17NYD2210B;CHEMBL389433;UNII-090Y06W08H;17NYD2210B;6-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-benzo[d]imidazole;090Y06W08H;Liarozolum;Liarozol;1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-;NCGC00181034-01;liarozole monohydrochloride;Liarozole, (+)-;Liarozole, (-)-;AC1L1TNN;D08UGX;AC1Q3M3B;SCHEMBL18597;GTPL5210;DTXSID9048277;SCHEMBL15944205;CHEBI:135316;UGFHIPBXIWJXNA-UHFFFAOYSA-N;145858-52-2 (fumarate);BDBM50157605;BDBM50176808;DB13066;145858-50-0 (mono-hydrochloride);DA-15205;LS-172294;FT-0745508;6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole;5-[(3-Chloro-phenyl)-imidazol-1-yl-methyl]-1H-benzoimidazole;6-[(3-chlorophenyl)(1h-imidazol-1-yl)methyl]-1h-benzimidazole;5-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-1,3-benzodiazole;5-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-benzimidazole;5-[(S)-3-Chlorophenyl(1H-imidazol-1-yl)methyl]-1H-benzimidazole;1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (+)-;1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (-)-;171849-18-6;172282-43-8"	115575-11-6	K0Q29TGV9Y	8591087	8591087	01/11/1995	8591087	01/11/1995	1994-1998		1	1	0	Yes	1					30/07/2018		272,4	38	NA	0	1	PROSTATE	1	CYP450	0	1	0	NA	0	0	0	1	1	0,1	0	0	0	NA	0	MYOCARDIAL INFARCTION	1	lethargy, somnolence, paresthesias	1	0	23	0	1
Nolatrexed	"ag337;nolatrexed"		DB12912	"2-amino-6-methyl-5-pyridin-4-ylsulfanyl-1H-quinazolin-4-one;2-amino-6-methyl-5-(4-pyridylsulfanyl)-1H-quinazolin-4-one;2-amino-6-methyl-5-(4-pyridylthio)-1H-quinazolin-4-one;147149-76-6;2-Amino-6-methyl-5-(4-pyridylthio)-4(3H)-quinazolinone.;Nolatrexed;Nolatrexed [INN];2-Amino-6-methyl-5-(4-pyridinylthio)-4-quinazolinol hydrochloride;AIDS-157719;AIDS157719;NSC648316 (HYDROCHLORIDE SALT);NCI60_016753"	"Nolatrexed;147149-76-6;UNII-K75ZUN743Q;CHEMBL320775;K75ZUN743Q;Nolatrexed [INN];AG337;AG 337;NSC648316;NCGC00181023-01;AC1L33IB;SCHEMBL18489;ZINC8107;DTXSID3048281;MolPort-039-141-273;8186AH;BDBM50046657;AKOS025401776;AKOS028110746;API0005262;DB12912;AC-25494;NCI60_016753;ZB000665;LS-187627;FT-0712501;149N766;2-amino-6-methyl-5-(4-pyridylsulfanyl)quinazolin-4-ol;2-amino-6-methyl-5-(4-pyridylthio)-1h-quinazolin-4-one;2-Amino-6-methyl-5-(4-pyridylthio)-4(3H)-quinazolinone.;2-amino-6-methyl-5-(pyridin-4-ylthio)quinazolin-4(1H)-one;2-amino-6-methyl-5-(pyridin-4-ylthio)quinazolin-4(3H)-one;2-amino-6-methyl-5-pyridin-4-ylsulfanyl-1H-quinazolin-4-one;2-Azanyl-6-Methyl-5-Pyridin-4-Ylsulfanyl-3h-Quinazolin-4-One;4(1H)-Quinazolinone, 2-amino-6-methyl-5-(4-pyridinylthio)-;2-amino-6-methyl-5-(pyridin-4-ylsulfanyl) -3h-quinazolin-4-one;2-Amino-6-methyl-5-(pyridin-4-ylsulfanyl)-3H-quinazolin-4-one;7Z9"	147149-76-6	K75ZUN743Q	"10070890;9918208;9508200;9443631"	9443631	01/01/1998	9815922	01/11/1995	1994-1998		1	1	0	Yes	1					30/07/2018		272,4	13	NA	1	0	NA	1	THYMIDYLATE SYNTHASE	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Lycopene	lycopene	PreQue 10	DB11231	"(6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;502-65-8;KBio2_004714;Spectrum4_001998;Lycopene all-trans-;(6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;CHEBI:15948;Lycopene;LMPR01070257;LYC;BSPBio_003389;NCI60_003882;C.I. 75125;CCRIS 7925;CI 75125;EINECS 207-949-1;Lycopene (VAN);Lycopene 7;Lycopene, all-trans- (8CI);NSC 407322;Natural yellow 27;Psi,psi-carotene;all-trans-Lycopene;trans-Lycopene;Spectrum3_001805;C05432;2,6,10,14,19,23,27,31-Octamethyl-dotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;L9879_SIGMA;KBioSS_002146;Spectrum_001666;KBio3_002892;KBioGR_002563;KBio2_002146;NCGC00166291-01;KBio2_007282"	"LYCOPENE;502-65-8;Psi,psi-carotene;all-trans-Lycopene;trans-Lycopene;Lycopene 7;lycored;Lycopene (VAN);Lycopene, all-trans-;UNII-SB0N2N0WV6;NSC 407322;CCRIS 7925;C.I. 75125;EINECS 207-949-1;SB0N2N0WV6;CI 75125;CHEBI:15948;OAIJSZIZWZSQBC-GYZMGTAESA-N;(6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;NCGC00166291-01;.psi.,.psi.-Carotene;Q-100561;Redivivo;LYC-O-MATO;Mexoryl SAQ;Tomat-O-Red;LYC;NSC407322;15-cis-Lycopene;Lycopene all-trans-;Lycopene, dispersion;AC1L9K9C;DSSTox_CID_26593;DSSTox_RID_81750;DSSTox_GSID_46593;BSPBio_003389;Lycopene, analytical standard;E160d;BIL502;CHEMBL501174;DTXSID2046593;Lycopene, >=90%, from tomato;AOB5502;MolPort-001-790-546;ZX-AFC000887;(all-E)-2,6,10,14,19,23,27,31-Octamethyl-2,6,8,10,12,14,16,18,20,22,24,26,30-dotriacontatridecaene;2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;ACT03296;HY-N0287;ZINC8214943;Tox21_112395;CL-020;LMPR01070257;MFCD00017350;AKOS015961276;CS-6378;DB11231;EBD2157929;NCGC00166291-02;AC-13571;AN-45378;CAS-502-65-8;CC-30098;SC-14049;AB0012241;LS-175138;TL8006536;TR-017971;N2800;3048-EP2298768A1;3048-EP2305825A1;C05432;502L658;UNII-32A47J0H1R component OAIJSZIZWZSQBC-GYZMGTAESA-N;UNII-N53I4V2IA6 component OAIJSZIZWZSQBC-GYZMGTAESA-N;Lycopene, United States Pharmacopeia (USP) Reference Standard;Lycopene, Pharmaceutical Secondary Standard; Certified Reference Material;Lycopene, Redivivo(TM), 10% FS, ~10% in corn oil, >=95.0% (sum of isomers);2,6,10,14,19,23,27,31-Octamethyl-dotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene;2,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaene, 2,6,10,14,19,23,27,31-octamethyl-, (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-;2,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaene, 2,6,10,14,19,23,27,31-Octamethyl-, (all-E)-;25453-98-9;360790-67-6;7634-65-3;LYC,  LYCOPENE,  Lycopene 7,  Lycopene all-trans-,  Lycopene, all-trans-,  Lycopene, all-trans- (8CI),  Lycopene (VAN),  Natural yellow 27,  NCGC00166291-01,  NCGC00166291-02,  NSC407322,  NSC 407322"	502-65-8	SB0N2N0WV6	"17571945;16765186"	16765186	01/06/2006	8598422	01/12/1995	1994-1998		1	0	0	No	0					30/07/2018		271,4	#N/A																							0						1
Batimastat	"batimastat;bb-94;bb94"		"DB03880;EXPT00627"	"(2S,3R)-N-hydroxy-N'-[(2S)-1-methylamino-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide;(2R)-2-[(1S)-2-(hydroxyamino)-2-oxo-1-(2-thienylsulfanylmethyl)ethyl]-4-methyl-N-[(1S)-2-methylamino-2-oxo-1-(phenylmethyl)ethyl]pentanamide;(2R)-2-[(1S)-2-(hydroxyamino)-2-oxo-1-[(2-thienylthio)methyl]ethyl]-4-methyl-N-[(1S)-2-methylamino-2-oxo-1-(phenylmethyl)ethyl]pentanamide;(2R)-N-[(1S)-1-(benzyl)-2-keto-2-methylamino-ethyl]-2-[(1S)-2-(hydroxyamino)-2-keto-1-[(2-thienylthio)methyl]ethyl]-4-methyl-valeramide;(2S,3R)-N-hydroxy-N'-[(2S)-1-methylamino-1-oxo-3-phenyl-propan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide;130370-60-4;BB94, BB-94;Batimastat (USAN);D03061;ISV-120;(2S,3R)-5-Methyl-3-(((alphaS)-alpha-(methylcarbamoyl)phenethyl)carbamoyl)-2-((2-thienylthio)methyl)hexanohydroxamic acid;AIDS043101;4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE;BB-94;BB94;ISV-615;BB-99;DSX;AIDS-043101;BB 94;BATIMASTAT;BAT;Batimastat [USAN:BAN:INN];Butanediamide, N(sup 4)-hydroxy-N(sup 1)-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-;Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-"	"batimastat;130370-60-4;BB-94;Batimastat (BB-94);BB 94;UNII-BK349F52C9;BB94;Batimastat(BB-94);C23H31N3O4S2;CHEMBL279786;BK349F52C9;Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-;(2S,3R)-5-Methyl-3-(((alphaS)-alpha-(methylcarbamoyl)phenethyl)carbamoyl)-2-((2-thienylthio)methyl)hexanohydroxamic acid;4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE;(2R)-N-[(1S)-1-benzyl-2-(methylamino)-2-oxo-ethyl]-2-[(1S)-2-(hydroxyamino)-2-oxo-1-(2-thienylsulfanylmethyl)ethyl]-4-methyl-pentanamide;(2R,3S)-N-hydroxy-N'-[(1S)-1-(methylcarbamoyl)-2-phenylethyl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide;Butanediamide, N(sup 4)-hydroxy-N(sup 1)-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-;SMR002530309;Batimastat [USAN:BAN:INN];Batimastat [USAN:INN:BAN];AC1NSFYO;1rm8;Batimastat (USAN/INN);D0P8YC;SCHEMBL4332;Batimastat (MMP Inhibitor);MLS006010631;MLS006011226;GTPL5145;Batimastat, >=98% (HPLC);CTK8E8474;DTXSID20156497;ISV-120;ISV-615;2j83;MolPort-006-822-709;BB-99;BB94, BB-94;EX-A1671;ZINC3789788;2251AH;BDBM50063918;IN2061;MFCD00866533;s7155;AKOS024457355;CS-1655;DB03880;QC-8335;(4-(N-hydroxyamino)-2-isobutyl-3-(thiophen-2-ylthiomethyl)succinyl)phenylalanine-N-methylamide;KS-000001A9;NCGC00346877-01;AN-32348;HY-13564;LS-45637;AB0097216;RT-011417;A2577;FT-0696362;D03061;370B604;J-005800;BRD-K82818427-001-01-4;BRD-K82818427-001-04-8;(2R,3S)-N*4*-Hydroxy-2-isobutyl-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide;(2r,3s)-n4-hydroxy-n1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide;(2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide;(2S,3R)-N-hydroxy-N'-[(2S)-1-methylamino-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide;(2S,3R)-N1-hydroxy-3-isobutyl-N4-((S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl)-2-((thiophen-2-ylthio)methyl)succinamide;4-Methyl-2-[1-methyl-2-(thiophen-2-ylsulfanyl)-ethyl]-pentanoic acid (1-methylcarbamoyl-2-phenyl-ethyl)-amide;BB-94; (2R,3S)-N4-Hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide;Butanediamide, N4-hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]-, (2R,3S)-;DSX;N*4*-Hydroxy-2-isobutyl-N*1*-(1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide"	130370-60-4	BK349F52C9	"10100701;9717817;9484924;8913840"	8913840	01/01/1996	8913840	01/01/1996	1994-1998		1	1	0	Yes	1					30/07/2018		270,4	NA	NA	1	0	NA	1	MMP	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	91	0	1
Intoplicine	"intoplicine;nsc 645008;rp 60475"		DB12868	"7H-Benzo[e]pyrido[4,3-b]indole, 11-[3-(dimethylamino)propylamino]-3-hydroxy-8-methyl-, dimethanesulfonate;Intoplicine;NSC645008"	"Intoplicine;125974-72-3;UNII-FB2CIN6HMI;RP-60475;FB2CIN6HMI;Intoplicine [INN];11-((3-(Dimethylamino)propyl)amino)-8-methyl-7H-benzo(e)pyrido(4,3-b)indol-3-ol;11-[[3-(Dimethylamino)propyl]amino]-8-methyl-7H-benzo[e]pyrido[4,3-b]indol-3-ol;11-{[3-(dimethylamino)propyl]amino}-8-methyl-7h-benzo[e]pyrido[4,3-b]indol-3-ol;D05GUK;AC1L24BH;AC1Q4YV6;Intoplicine < Rec INN >;Neuro_000335;SCHEMBL420414;CHEMBL1908351;DTXSID80155022;CHEBI:135474;ZINC1629400;CS-6640;DB12868;NCI60_015286;HY-101647;[3-(dimethylamino)propylamino]-methyl-[?]ol;11-[3-(Dimethylamino)propylamino]-8-methyl-7H-benzo[e]pyrido[4,3-b]indol-3-ol;7H-Benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl-"	125974-72-3	FB2CIN6HMI	"10630356;10194543;8740721"	8740721	01/02/1996	8740721	01/02/1996	1994-1998		1	1	0	Yes	1					30/07/2018		269,3	33	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	1	0	0	0	0	0	0	0	1
Lurtotecan	"gg 211;gi-147211;gi147211;gi147211c;liposomal lurtotecan;lurtotecan;lurtotecan liposome;nx 211;nx211;osi-211"		DB12222	"149882-10-0;GI-147211;GI-147211C;GW-211;NX-211;11H-1,4-Dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8H,14H)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (8S)-;GG 211;Gi 147211;Lurtotecan;NX 211;OSI-211;GG-211"	"Lurtotecan;OSI-211;Lurtotecan [INN];149882-10-0;UNII-4J1L80T08I;OSI 211;GG 211;NX 211;Gi 147211;4J1L80T08I;C28H30N4O6;CHEMBL341028;11H-1,4-Dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8H,14H)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (8S)-;GG-211;GW-211;GI-147211C;GI-147211;lurtotecan liposome;Liposomal lurtotecan;D0W5FA;AC1L1U8C;SCHEMBL19208;CHEMBL305666;DTXSID30164422;BDBM50036130;NX-211;ZINC22010625;DB12222;LS-173358;8-ethyl-8-hydroxy-15-(4-methylhexahydro-1-pyrazinylmethyl)-(8S)-2,3,8,9,12,14-hexahydro-11H-[1,4]dioxino[2,3-g]pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-9,12-dione with trifluoroaceticacid"	149882-10-0	4J1L80T08I	"15042679;15122073;8611374;9533526"	8611374	01/03/1996	8611374	01/03/1996	1994-1998		1	1	0	Yes	1					30/07/2018		268,4	19	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	21	0	1
Labradimil	"drg-0182;lobradimil"	RMP-7	DB06549	"2-[[2-[[1-[2-[[2-[[2-[[1-[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-(diaminomethylideneamino)pentanoic acid;2-[[2-[[1-[2-[[2-[[2-[[1-[1-(2-amino-5-guanidino-pentanoyl)pyrrolidine-2-carbonyl]-4-hydroxy-pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-(2-thienyl)propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-guanidino-pentanoic acid;2-[[2-[[[1-[2-[[2-[[2-[[[1-[[1-(2-amino-5-guanidino-1-oxopentyl)-2-pyrrolidinyl]-oxomethyl]-4-hydroxy-2-pyrrolidinyl]-oxomethyl]amino]-1-oxoethyl]amino]-1-oxo-3-(2-thienyl)propyl]amino]-3-hydroxy-1-oxopropyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-guanidinopentanoic acid;2-[[2-[[1-[2-[[2-[[2-[[1-[1-(2-amino-5-guanidino-pentanoyl)pyrrolidine-2-carbonyl]-4-hydroxy-pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-(2-thienyl)propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-guanidino-valeric acid;2-[[2-[[1-[2-[[2-[2-[[1-[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidin-2-yl]carbonyl-4-hydroxy-pyrrolidin-2-yl]carbonylamino]ethanoylamino]-3-thiophen-2-yl-propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidin-2-yl]carbonylamino]-3-(4-methoxyphenyl)propyl]amino]-5-(diaminomethylideneamino)pentanoic acid;139183-63-4;159768-75-9;173220-35-4;L-Prolinamide, L-arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-(2-((4-((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-((4-methoxyphenyl)methyl)ethyl)-, (S-(R*,R*))-;Labradimil;Labradimil [INN];Lobradimil;Lobradimil [USAN];N2-((S)-2-(L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-L-prolinamido)-3-(p-methoxyphenyl)propyl)-L-arginine;RMP 7;RMP-7;NSC724318;(S-(R*,R*))-L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-(2-((4-((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-((4-methoxyphenyl)methyl)ethyl)-L-prolinamide;Bradykinin, 3-(trans-4-hydroxy-L-proline)-5-(3-(2-thienyl)-L-alanine)-8-de-L-phenylalanine-9-(N2-(2-amino-3-(4-methoxyphenyl)propyl)-L-arginine)-, (S)-;Cereport;DRG-0182;L-Arginine, L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-L-prolyl-O-methyl-L-tyrosyl-psi(CH2-NH)-"	"Labradimil;Lobradimil;Cereport;RMP-7;RMP 7;159768-75-9;UNII-2MK663C346;DRG-0182;Receptor mediated permeabilizer;2MK663C346;(S-(R*,R*))-L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-(2-((4-((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-((4-methoxyphenyl)methyl)ethyl)-L-prolinamide;N2-((S)-2-(L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-L-prolinamido)-3-(p-methoxyphenyl)propyl)-L-arginine;(Hyp3,b-(2-thienyl)-Ala5,Tyr(Me)8-psi(CH2NH)Arg9)-Bradykinin;(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-(diaminomethylideneamino)pentanoic acid;Labradimil [USAN:INN];AC1OCF8R;D0G0IZ;GTPL672;SCHEMBL411837;CHEMBL2105864;768L759;[Hyp3,Thi5,4-Me-Tyr8psi(CH2-NH)Arg9]bradykinin;(Hyp3,beta-(2-thienyl)-Ala5,Tyr(Me)8-(R)-Arg9)-Bradykinin;(S-(R*,R*))-L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-N-(2-((4-(aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-((4-methoxyphenyl)methyl)ethyl)-L-prolinamide;139183-63-4;173220-35-4;Bradykinin, 3-(trans-4-hydroxy-L-proline)-5-(3-(2-thienyl)-L-alanine)-8-de-L-phenylalanine-9-(N2-(2-amino-3-(4-methoxyphenyl)propyl)-L-arginine)-, (S)-;L-Arginine, L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-L-prolyl-O-methyl-L-tyrosyl-psi(CH2-NH)-;L-Prolinamide, L-arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-(2-((4-((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-((4-methoxyphenyl)methyl)ethyl)-, (S-(R*,R*))-;N(sup 2)-((S)-2-(L-Arginyl-L-prolyl-trans-4-hydroxy-L-prolyglycyl-3-(2-thienyl)-L-alanyl-L-seryl-L-prolinamido)-3-(p-methoxyphenyl)propyl)-L-arginine"	159768-75-9	2MK663C346				18611707	01/04/1996	1994-1998		1	0	0	No	0					30/07/2018		267,4	#N/A																							0						1
Raltitrexed	"[14c]-raltitrexed;d1694;ici-d1694;raltitrexed;zd1694"	"Raltitrexed;Tomudex"	"APRD00430;DB00293;EXPT01092"	"(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;(2S)-2-[[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]-2-thienyl]-oxomethyl]amino]pentanedioic acid;(2S)-2-[[5-[(4-keto-2-methyl-1H-quinazolin-6-yl)methyl-methyl-amino]thiophene-2-carbonyl]amino]glutaric acid;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]carbonylamino]pentanedioic acid;112887-68-0;NSC-639186;ZD-1694;ZN-D1694;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;D 1694;D-1694;D1694;ICI-D1694;L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-;N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;ZD 1694;D16;AIDS106596;Raltitrexed (JAN/USAN/INN);Tomudex (TN);ICI-D-1694;C11372;ICI D1694;Raltitrexed;Tomudex;ZD1694;(S)-2-[(1-{5-[Methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-thiophen-2-yl}-methanoyl)-amino]-pentanedioic acid;AIDS-106596;NCI60_013008;D01064;NSC639186"	"Raltitrexed;Tomudex;112887-68-0;ZD1694;ZD-1694;ICI-D1694;D-1694;ZD 1694;ICI D1694;UNII-FCB9EGG971;D1694;Tomudex (TN);D 1694;CHEBI:5847;C21H22N4O6S;Raltitrexed (Tomudex);ZD-16;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;FCB9EGG971;Raltitrexed (JAN/USAN/INN);CHEMBL225071;N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;ICI-D-1694;ZN-D1694;NSC-639186;KS-5069;NCGC00229704-01;DSSTox_CID_26482;DSSTox_RID_81653;DSSTox_GSID_46482;(S)-2-(5-(methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid;N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid;N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid;(2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid;(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)-methyl)amino)thiophene-2-carboxamido)pentanedioic acid;D16;L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-;CAS-112887-68-0;1hvy;2kce;2tsr;Raltitrexed(Tomudex);SA-Detection Disk Kit;AC1L2XFZ;D01KKQ;D0V5YQ;TS antisense + raltitrexed;Zeneca brand of raltitrexed;SCHEMBL7438;MLS001424225;MLS006010125;Arkomedika brand of raltitrexed;Raltitrexed [USAN:INN:BAN];GTPL7403;AstraZeneca brand of raltitrexed;DTXSID0046482;BDBM18795;QCR-125;1i00;IVTVGDXNLFLDRM-HNNXBMFYSA-N;MolPort-003-850-114;MolPort-006-167-509;HMS2052I03;HMS3715P08;ZINC3832372;Tox21_112237;BDBM50027655;NSC639186;s1192;AKOS015894877;AKOS015994729;Tox21_112237_1;API0004034;CCG-101075;CCG-221273;CS-2894;DB00293;NC00325;RL00529;Tomudex, TDX, ZD 1694, Raltitrexed;AN-15568;CPD000469217;HY-10821;L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-;LS-71840;NCI60_013008;SAM001246796;SMR000469217;SMR002529608;BCP0726000267;FT-0631066;C11372;D01064;S-7682;AB00698356-05;134189-EP2275102A1;134189-EP2292233A2;887R680;SR-01000763351;Tomudex, TDX, ZD 1694, 112887-68-0;J-524216;SR-01000763351-3;BRD-K89839824-001-01-2;(2S)-2-[(5-{methyl[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;(5-(methyl((2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carbonyl)-L-glutamic acid;N-(5-(N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid;N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid"	112887-68-0	FCB9EGG971	"10499608;10645210;11038040;11597383;12649103;15025739;15719490;15756014;8622063;9619761;9820178"	8622063	01/05/1996	8622063	01/05/1996	1994-1998		1	1	0	Yes	1					30/07/2018		266,4	61	73	1	0	NA	1	THYMIDYLATE SYNTHASE	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	0	0	0	0	0	27	0	1
Miltefosine	hexadecylphosphocholine	"Miltefosin;Monohexadecylphosphocholine;Hexadecylphosphocholine;HDPC;Miltefosina;Miltéfosine;Hexadecylphosphorylcholine;Monohexadecylphosphorylcholine;hexadecyl 2-(trimethylazaniumyl)ethyl phosphate;Miltefosine;Impavido"	DB09031	"hexadecyl 2-trimethylazaniumylethyl phosphate;hexadecyl 2-trimethylammonioethyl phosphate;cetyl 2-trimethylammonioethyl phosphate;58066-85-6;n-Hexadecylphosphorylcholine;SPECTRUM1505329;3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide;Choline, hexadecyl hydrogen phosphate, inner salt;NCGC00095169-02;D-18506;HDPC;D02494;Miltefosine (INN);Impavido;Miltex;TF-002;AIDS-130571;AIDS130571;Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate;Miltefosin C;NSC605583;NCGC00095169-01;1-Hexadecylphosphorylcholine;HePC;2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt;4-04-00-01460 (Beilstein Handbook Reference);BRN 3690495;Choline hydroxide, hexadecyl hydrogen phosphate, inner salt;Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI);D 18506;Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt;Hexadecylphosphocholine;Hexadecylphosphorylcholine;Miltefosina [INN-Spanish];Miltefosine;Miltefosine [BAN:INN];Miltefosinum [INN-Latin]"	"Miltefosine;58066-85-6;Hexadecylphosphocholine;Impavido;Miltex;Hexadecylphosphorylcholine;HePC;Miltefosina;HDPC;Miltefosinum;n-Hexadecylphosphorylcholine;Miltefos;Miltefosin C;n-hexadecylphosphocholine;hexadecyl 2-(trimethylammonio)ethyl phosphate;Miltefosinum [INN-Latin];1-Hexadecylphosphorylcholine;Miltefosina [INN-Spanish];miltefosin;Miltefosine [INN:BAN];D-18506;UNII-53EY29W7EC;NSC605583;Miltefosine (INN);D 18506;monohexadecylphosphocholine;hexadecyl 2-(trimethylazaniumyl)ethyl phosphate;IN1227;Choline hexadecyl phosphate;CHEMBL125;BRN 3690495;monohexadecylphosphorylcholine;hexadecyl phosphocholine;53EY29W7EC;CHEBI:75283;M-7200;PQLXHQMOHUQAKB-UHFFFAOYSA-N;TF-002;2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt;Choline hydroxide, hexadecyl hydrogen phosphate, inner salt;NCGC00095169-01;Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI);H-1850;DSSTox_CID_25942;DSSTox_RID_81240;Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt;Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt;DSSTox_GSID_45942;Choline phosphate, hexadecyl ester, hydroxide, inner salt;Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate;Fos-choline 16;CAS-58066-85-6;C21H46NO4P;Miltextrade mark;HePC Hydrate;Impavidotrade mark;Impavido (TN);Choline, inner salt;Miltefosine and HePC;NSC 605583;Miltefosine[INN:BAN];AC1L1GAH;Hexadecyl Phosphorylcholine;D00FGR;Baxter brand of miltefosine;D18506;SCHEMBL26215;4-04-00-01460 (Beilstein Handbook Reference);Prasfarma brand of miltefosine;SPECTRUM1505329;ETH098;DTXSID7045942;CTK8G1121;C15H32.C7H17NO4P;MolPort-003-665-519;Hexadecyl Phosphorylcholine Hydrate;HMS1922D16;HMS2089J15;HMS3649I09;Pharmakon1600-01505329;hexadecylphosphocholine, miltefosine;Baxter Oncology brand of miltefosine;miltefosine (hexadecylphosphocholine);Tox21_111466;BDBM50034220;BG0492;CCG-35584;CCG-36097;CCG-40025;DL-131;MFCD00133396;MMV688990;NSC758968;s3056;1-N-HEXADECYLPHOSPHORYLCHOLINE;AKOS015914886;Tox21_111466_1;AN-8651;BCP9000927;CS-2933;DB09031;NSC-605583;NSC-758968;KS-00000L54;NCGC00095169-02;NCGC00095169-03;NCGC00095169-05;AK163678;HY-13685;LS-65132;BCP0726000071;FT-0608148;M2445;hexadecyloxy-2-trimethylammonioethylphosphorate;D02494;hexadecyl (2-(trimethylAmmonio)ethyl) phosphate;AB00642217-03;AB00642217_04;Choline, hexadecyl hydrogen phosphate, inner salt;Miltefosine, >=98% (perchloric acid titration);A831718;I14-7244;Hexadecyl 2-(Trimethylammonio)ethyl Phosphate Hydrate;2-[hexadecoxy(hydroxy)phosphoryl]oxyethyl-trimethyl-ammonium;Phosphoric Acid Hexadecyl 2-(Trimethylammonio)ethyl Ester;[2-(Hexadecyloxy-hydroxy-phosphoryloxy)-ethyl]-trimethyl-ammonium;2-[[(Hexadecyloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium;3, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide;hexadecyl 2-(trimethyl-lambda~5~-azanyl)ethyl hydrogen phosphate;Phosphoric Acid Hexadecyl 2-(Trimethylammonio)ethyl Ester Hydrate;2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide;Ethanaminium, 2-[[(hexadecyloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt;3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide;93597-88-7"	58066-85-6	53EY29W7EC	"8245262;1438799"	1438799	01/01/1992	1325463	01/01/1992	1989-1994		1	1	1	Yes	1	"04/01/2016 00:00;04/11/2015 00:00;10/04/2015 00:00;19/03/2014 00:00"	AP	KNIGHT THERAPS	MILTEFOSINE	19/03/2014	KNIGHT THERAPS	266,0	54	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	112	0	1
Tiomolibdate ion	tetrathiomolybdate	ATN-224	DB05088			16330-92-0	91U3TGV99T	10656425	10656425	01/02/2000	8859064	01/10/1996	1994-1998		1	0	0	No	0					30/07/2018		261,4	#N/A																							0						1
Eniluracil	eniluracil	"5-ethynyl-2,4(1H,3H)-Pyrimidinedione;5-Ethynyluracil;Compound 776C"	"DB03516;EXPT03299"	"5-ethynyl-1H-pyrimidine-2,4-dione;5-ETHYNYLURACIL;59989-18-3;D03998;AIDS225909;GW-776;GW776C85;2,4(1H,3H)-Pyrimidinedione, 5-ethynyl-;5-ETHYNYLURACIL;776C85;Compound 776C;Eniluracil;Eniluracil [USAN];Eniluracil (USAN);5-EU;ADH-300004;NSC687296;AIDS-225909"	"Eniluracil;5-ETHYNYLURACIL;59989-18-3;5-ethynylpyrimidine-2,4(1H,3H)-dione;Compound 776C;776C85;UNII-2E2W0W5XIU;GW776C85;5-ethynyl-1H-pyrimidine-2,4-dione;5-Ethynylpyrimidine-2,4-diol;5-Ethynyl-2,4(1H,3H)-pyrimidinedione;5-Ethynyl-2,4(1H,3H)pyrimidinedione;2E2W0W5XIU;5-Ethynyl-2-hydroxypyrimidin-4(1H)-one;5-Ethynyl-2-hydroxypyrimidin-4(3H)-one;5-Ethynyl-4-hydroxypyrimidin-2(1H)-one;5-Ethynyl-6-hydroxypyrimidin-2(1H)-one;2,4(1H,3H)-Pyrimidinedione, 5-ethynyl-;C6H4N2O2;CHEMBL355200;Eniluracil [USAN];Eniluracil [USAN:INN:BAN];Eniluracil (USAN/INN);D09QOR;SCHEMBL37817;5-EU;AC1L299R;ZINC5467;CTK8J5272;DTXSID10208696;JOZGNYDSEBIJDH-UHFFFAOYSA-N;8945AB;BDBM50124202;FCH991289;GEO-02731;GW-776;NSC687296;AKOS006240058;AKOS016009479;ADH-300004;API0005199;DB03516;NSC 687296;NSC-687296;AJ-08248;KB-50532;AX8066012;LS-176055;E1096;FT-0667865;D03998;33865-EP2275420A1;33865-EP2295055A2;33865-EP2295416A2;33865-EP2298748A2;33865-EP2298764A1;33865-EP2298765A1;33865-EP2305642A2;33865-EP2311453A1;2,4(1H,3H)-Pyrimidinedione, 5-ethynyl- (9CI)"	59989-18-3	2E2W0W5XIU	14967434	14967434	01/02/2004	8955653	01/12/1996	1994-1998		1	1	0	Yes	1					30/07/2018		259,4	12	NA	1	0	NA	1	DPD	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Canertinib	"canertinib;ci-1033;pd183805"		DB05424	"N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-[(3-chloro-4-fluoro-phenyl)amino]-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(3-morpholinopropoxy)-6-quinazolinyl]prop-2-enamide;N-[4-[(3-chloro-4-fluoro-phenyl)amino]-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;N-[4-[(3-chloro-4-fluoro-phenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;267243-28-7;Canertinib;Canertinib [INN];N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide"	"Canertinib;267243-28-7;CI-1033;Canertinib (CI-1033);PD-183805;UNII-C78W1K5ASF;CI1033;N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;CI-1033(Canertinib);N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide;C78W1K5ASF;CHEMBL31965;CHEBI:61399;PD183805;Canertinib HCl;NCGC00182713-01;N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide;Canertinib [INN:BAN];6-acrylamido-N-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazolin-4-amine;canertinibumcanertinib;PubChem22407;Canertinib (CI1033;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride;Canertinib, CI 1033;Caneritinib; CI-1033;D0YB3W;Canertinib - CI-1033;CI-1033 (Canertinib);AC1L4G5R;DSSTox_CID_28869;DSSTox_RID_83138;DSSTox_GSID_48943;SCHEMBL54837;MLS004774146;PD 183805 dihydrochloride;BDBM4779;cid_156414;GTPL5675;DTXSID8048943;CTK8E6872;KS-00000XPE;AOB6938;EX-A078;QCR-127;SYN1030;MolPort-006-170-085;OMZCMEYTWSXEPZ-UHFFFAOYSA-N;BCPP000301;HMS3244M17;HMS3244M18;HMS3244N17;Tox21_113361;ABP000862;AN-562;s1019;ZINC27439698;AKOS005145818;BCP9000481;BCP9000482;BCP9000525;CS-0121;DB05424;RL02901;CI-1033(Canertinib)/PD-183805;NCGC00182713-02;AT-17081;BC256329;HY-10367;KB-55795;KB-75873;SC-22834;SMR003500789;AB0035841;PD0183805;RT-011909;CAS-267243-28-7;FT-0654215;Y0252;A25038;Z-3276;32335-EP2281815A1;32335-EP2292615A1;32335-EP2301933A1;32335-EP2305640A2;32335-EP2305671A1;32335-EP2311827A1;499C452;I06-1255;I14-8433;Canertinib, PD-183805, CI1033, PD183805;Canertinib|267243-28-7|PD-183805|CI1033|CI 1033|PD183805|PD 183805;n-(4-(3-chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-;CI-1033|||N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide"	267243-28-7	C78W1K5ASF	"17505003;16899614"	16899614	01/08/2006	9387046	01/01/1997	1994-1998		1	1	0	Yes	1					30/07/2018		258,4	25	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,07	0	0	0	NA	0	0	0	"DIZZINESS;HEADACHE;LOSS OF COORDINATION;LOSS OF CONSCIOUSNESS;NERVOUSNESS"	1	0	381	0	1
Diethylnorspermine	"denspm;diethylnorspermine;n(1),n(11)-diethylnorspermine;n1-n11-diethylnorspermine;n1n11"		DB06445		"DENSPM;N1,N11-Bis(ethyl)norspermine;N1,N11-Diethylnorspermine;DE-333;N(1),N(11)-Diethylnorspermine;BENSM;BENSPM;Diethylnorspermine;UNII-HLI827Z1ST;1,11-bis(ethylamino)-4,8-diazaundecane;BE 3-3-3;De 333;121749-39-1;HLI827Z1ST;N(sup 1),N(sup 11)-Diethylnorspermine;N(sup 1),N(sup 11)-Bis(ethyl)norspermine;N,N'-Bis(3-(ethylamino)propyl)-1,3-propanediamine;1,3-Propanediamine, N,N'-bis(3-(ethylamino)propyl)-;bis(ethyl)norspermine;N(1),N(11)-bis(ethyl)norspermine;BE-333;Tocris-0468;AC1L1HTB;D0W0WU;AC1Q4U0K;CHEMBL44083;SCHEMBL429527;n1,n1'-propane-1,3-diylbis(n3-ethylpropane-1,3-diamine);Bio1_000478;Bio1_000967;Bio1_001456;C13H32N4;ZINC3780932;NCGC00024603-01;LS-119759;N-ethyl-N'-[3-[3-(ethylamino)propylamino]propyl]propane-1,3-diamine"	121749-39-1	HLI827Z1ST	"24121453;11895896;11291831;9387045"	9387045	01/01/1997	9387045	01/01/1997	1994-1998		1	1	0	Yes	1					30/07/2018		258,4	15	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	"HEADACHE;UNILATERAL WEAKNESS;DYSPHAGIA;DYSARTHRIA;NUMBNESS;PARESTHESIAS;ATAXIA"	1	0	228	0	1
Broxuridine	bromodeoxyuridine	BROMODEOXYURIDINE	DB12028	"5-bromo-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;5-bromo-1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione;5-bromo-1-[4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione;5-bromo-1-(4-hydroxy-5-methylol-tetrahydrofuran-2-yl)pyrimidine-2,4-quinone;59-14-3;(+)-5-Bromo-2'-deoxyuridine;TULIP028889;5-BDU;5-BROMODEOXYURIDINE;5-Bromo-2'-deoxyuridine;5-Bromodesoxyuridine;5-Bromouracil deoxyriboside;5-Bromouracil-2-deoxyriboside;5-Budr;BDU;BRDU;BUDR;Bromodeoxyuridine;Bromoouridine;Bromouracil deoxyriboside;Broxuridine;Brudr;NSC 38297;NSC38297;Radibud;Uridine, 5-bromo-2'-deoxy-;WLN: T6NVMVJ EE A- ET5OTJ B1Q CQ;NCI60_003667;5-Bromo-2&#8242;-deoxyuridine-2-14C;B8150_SIGMA"	"5-BROMO-2'-DEOXYURIDINE;59-14-3;Broxuridine;Bromodeoxyuridine;5-Bromodeoxyuridine;BRDU;5-BrdU;BUDR;5-Bromouracil deoxyriboside;Bromouracil deoxyriboside;5-Bromodesoxyuridine;5-Bdu;Broxuridinum;Broxuridina;5-Bromouracil-2-deoxyriboside;5-Bromo-2-deoxyuridine;bromodeoxyuridine (brdu);Broxuridinum [INN-Latin];Broxuridina [INN-Spanish];Uridine, 5-bromo-2'-deoxy-;C9H11BrN2O5;Bromoouridine;NSC-38297;Radibud;CCRIS 818;Brudr;UNII-G34N38R2N1;HSDB 7477;CHEBI:472552;EINECS 200-415-9;5-Budr;BRN 0030395;CHEMBL222280;G34N38R2N1;5-Bromo-2'-deoxyuridine (BRDU);NCGC00090770-05;NSC 38297;5-bromo-2'-desoxyuridine;5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil;DSSTox_CID_13105;DSSTox_RID_79051;DSSTox_GSID_33105;brdurd;BDU;5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione;CAS-59-14-3;1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihydropyrim idine-2,4-dione;5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;SMR001227189;Broxuridine [INN];Broxuridine [INN:JAN];5-Bromo-dURD;AC1L1LNR;Broxuridine (JAN/INN);Maybridge4_003385;D0M4MA;Epitope ID:138105;5-bromo-2'-deoxy uridine;AC1Q24DG;cid_6035;Lopac0_000212;SCHEMBL27755;4-24-00-01234 (Beilstein Handbook Reference);KSC911S7T;MLS001055406;MLS002153366;DTXSID7033105;CTK8B1979;5-Bromo-2'-deoxyuridine(BRDU);5-Bromo-2'-deoxyuridine, 97%;MolPort-000-784-028;MolPort-002-527-651;WOVKYSAHUYNSMH-RRKCRQDMSA-N;ZX-AFC000364;HMS1619B05;HMS3039G15;HMS3260L05;KS-00000JJ3;ZINC1081243;5-BROMO-2''-DEOXY URIDINE;Tox21_111016;Tox21_200106;Tox21_500212;ANW-33171;BDBM50207303;BI2048;CB-072;HG1160;LS-250;MFCD00006529;SBB002964;AKOS001715166;AKOS016015753;Tox21_111016_1;CCG-204307;CS-3028;DB12028;LP00212;MCULE-5086148258;uridine, 3-15N-5-bromo-2'-deoxy-;NCGC00090770-01;NCGC00090770-02;NCGC00090770-03;NCGC00090770-04;NCGC00090770-06;NCGC00090770-07;NCGC00090770-08;NCGC00090770-09;NCGC00175901-01;NCGC00257660-01;NCGC00260897-01;AJ-24922;AK-44014;AN-15303;AS-11762;BR-44014;CC-21273;HY-15910;SC-18439;ST057095;AB0010697;AX8021654;DB-053327;5-Bromo-2'-deoxyuridine, >=99% (HPLC);EU-0100212;5-Bromo-2'-deoxyuridine, BioUltra, >=99%;5-Bromo-1-(2-deoxy-|A-D-ribofuranosyl)uracil;5-Bromo-2'-deoxyuridine, >=99.0% (HPLC);B 5002;D01763;S-2807;5- Br-2 inverted exclamation mark -deoxyuridine;006B529;140455-EP2277565A2;140455-EP2277566A2;140455-EP2277567A1;140455-EP2277568A2;140455-EP2277569A2;140455-EP2277570A2;140455-EP2292280A1;156905-EP2284178A2;156905-EP2284179A2;5-Bromo-2 inverted exclamation marka-deoxyuridine;C-30689;SR-01000075718;J-700086;SR-01000075718-1;Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil;Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone;1236362-78-9;3445-26-9;396726-49-1;5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione;5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione;723-73-9"	59-14-3	G34N38R2N1	9069304	9069304	01/01/1997	9069304	01/01/1997	1994-1998		1	1	0	Yes	1					30/07/2018		258,4	15	NA	0	1	PANCREAS	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	1	1	NA	0	0	0	0	0	0	21	0	1
TNP-470	"agm-1470;tnp-470"	"O-(chloroacetylcarbamoyl)fumagillol;O-chloroacetylcarbamoylfumagillol"	"DB08633;DB12828"	"[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate;N-(2-chloro-1-oxoethyl)carbamic acid [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)-2-oxiranyl]-1-oxaspiro[2.5]octan-6-yl] ester;N-(2-chloroacetyl)carbamic acid [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] ester;[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-(2-chloroethanoyl)carbamate;129298-91-5;AIDS-042739;AIDS042739;Carbamic acid, (chloroacetyl)-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester;tnp 470;AGM-1470;Carbamic acid, (chloroacetyl)-, (3R,4S,5S,6R)-5-methoxy-4-[ (2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester;NSC642492;Tnp-470;NCI60_014346"	"Tnp-470;AGM-1470;O-(chloroacetylcarbamoyl)fumagillol;129298-91-5;Agm 1470;tnp 470;O-Chloroacetylcarbamoylfumagillol;DRG-0148;UNII-X47GR46481;NSC 642492;CHEMBL424278;CHEBI:90748;X47GR46481;CCRIS 8049;(3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (2-chloroacetyl)carbamate;(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (chloroacetyl)carbamate;(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl N-(2-chloroacetyl)carbamate;[(3R,6R,7S,8S)-7-methoxy-8-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-2-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate;AC1L803A;SCHEMBL1652694;DTXSID0041141;BDBM17446;MolPort-044-561-343;MSHZHSPISPJWHW-PVDLLORBSA-N;O-Chloracetyl-carbamoyl fumagillol;Carbamic acid, (chloroacetyl)-, 5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl ester, (3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-;ZINC3914617;NSC642492;API0009209;CCG-208103;CS-8106;DB08633;NSC-642492;NCI60_014346;HY-101932;TNP-470, >=98% (HPLC);298T915;J-005665;BRD-K53597484-001-01-9;(Chloracetyl) carbamic acid (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester;(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER;333999-83-0;Carbamic acid, (3R,4S,5S,6R)-5-methoxy-4-[ (2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester;Carbamic acid, (chloroacetyl)-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester"	129298-91-5	X47GR46481	"11350884;10473076;9815836;9017768"	9017768	01/01/1997	9017768	01/01/1997	1994-1998		1	1	0	Yes	1					30/07/2018		258,4	NA	NA	0	1	KAPOSI	0	NA	0	1	0	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Carboxyamidotriazole	"carboxyamido-triazole;carboxyamidotriazole"	CAI	DB11960	"5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]triazole-4-carboxamide;5-amino-1-[[3,5-dichloro-4-[(4-chlorophenyl)-oxomethyl]phenyl]methyl]-4-triazolecarboxamide;5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]triazole-4-carboxamide;5-amino-1-[[3,5-dichloro-4-(4-chlorophenyl)carbonyl-phenyl]methyl]-1,2,3-triazole-4-carboxamide;99519-84-3;RFE-007;NCIStruc2_001836;1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]-;CAI;L 651582;NSC609974;1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-;4-CAI;5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide;Carboxyamido-triazole;L-651582;L651582;NSC 609974;NCI609974;NCI60_004782;5-amino-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1H-1,2,3-triazole-4-carboxamide;NCIStruc1_001699;AIDS-096375;AIDS096375;Carboxyamidotriazole;NCGC00014926;NSC-609974"	"Carboxyamidotriazole;99519-84-3;Carboxyamido-triazole;5-amino-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1H-1,2,3-triazole-4-carboxamide;CAI;L-651582;4-CAI;L651582;UNII-6ST3ZF52WB;NSC609974;C17H12Cl3N5O2;MLS003373924;L 651582;L-651,582;NSC 609974;NSC-609974;6ST3ZF52WB;5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]triazole-4-carboxamide;SMR002048715;1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-;5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide;5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1h-1,2,3-triazole-4-carboxamide;CCRIS 9404;5-amino-1-(4-(4-chlorobenzoyl)-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide;5-amino-1-(4-[4-chlorobenzoyl]-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide;5-amino-1-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide;1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]-;5-AMINO-1-[[3,5-DICHLORO-4-(4-CHLOROBENZOYL)PHENYL]METHYL]-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE;PubChem13343;Carboxyamidotriazole (CAI);D05IIP;AC1Q5G1W;NCIStruc1_001699;NCIStruc2_001836;SCHEMBL18866;MLS006010700;CHEMBL95431;AC1L33F8;cid_108144;MERCK L651582;BDBM97191;CTK3I6744;DTXSID40244108;RFE-007;MolPort-008-155-743;WNRZHQBJSXRYJK-UHFFFAOYSA-N;ZINC538116;CA-820;CCG-37684;NCGC00014926;NCI609974;AKOS024457417;Carboxyamidotriazole, >=98% (HPLC);AC-6332;API0015863;DB11960;NCGC00014926-02;NCGC00014926-03;NCGC00098026-01;AN-10130;BC677923;KB-78072;NCI60_004782;LS-178419;B7269;FT-0740142;X7001;519A843;SR-01000902267;SR-01000902267-2;5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]triazole-4-carboxamide;1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-5-amino-1h-1,2,3-triazole-4-carboxamide;5-amino-1(4-[4-chlorobenzoyl]-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide;5-amino-1-(4-(4-chlorobenzoyl)-3,5-dichlorobenzyl)- 1,2,3-triazole-4-carboxamide;5-amino-1-(4-(4-chlorobenzoyl)-3,5-dichlorobenzyl)1,2,3-triazole-4-carboxamide;5-Amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1H-[1,2,3]triazole-4-carboxamide;5-amino-1-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1h-1,2,3-triazole-4-carboxamide;5-amino-l-(4-(4-chlorobenzoyl)-3,5-dichlorobenzyl)- 1,2,3-triazole-4-carboxamide;1h-1,2,3-triazole-4-carboxamide-5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl];1H-1,3-Triazole-4-carboxamide, 5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]-;5-amino-1-[[3,5-dichloro-4-(4-chloro-benzoyl)-phenyl]methyl]-1h-1,2,3-triazole-4-carboxamide;5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]-4,5-dihydrotriazole-4-carboxamide;5-amino-1-[[3,5-dichloro-4-[(4-chlorophenyl)-oxomethyl]phenyl]methyl]-4-triazolecarboxamide;5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1h-[1,2,3]triazole-4-carboxylic acid amide;5-azanyl-1-[[3,5-bis(chloranyl)-4-(4-chlorophenyl)carbonyl-phenyl]methyl]-1,2,3-triazole-4-carboxamide;5-Chloro-1-[1-[3-(2-oxo-1,3-dihydrobenzoimidazol-1-yl)propyl]-4-piperidyl]-1,3-dihydrobenzoimidazol-2-one maleate"	99519-84-3	6ST3ZF52WB	"11801543;15235824;9053505;9164210;9816048"	9816048	01/08/1995	9053505	01/02/1997	1994-1998		1	1	0	Yes	1					30/07/2018		257,3	29	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	CEREBELLAR DYSFUNCTION	1	0	143	0	1
Decitabine	"5-aza-2'-deoxycytidine;decitabine"	"Azadc;4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one;5-aza-2'-deoxycytidine;Decitabine;5-Azadeoxycytidine;Dezocitidine;Decitabine;Dacogen"	DB01262	"4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;4-amino-1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one;4-amino-1-[4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-1,3,5-triazin-2-one;4-amino-1-(4-hydroxy-5-methylol-tetrahydrofuran-2-yl)-s-triazin-2-one;105597-46-4;123795-43-7;2353-33-5;22432-95-7;NCI60_000632;1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-;NSC127716;s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-.beta.-D-erythro-pentofuranosyl-;NSC127717;s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-.alpha.-D-erythropentofuranosyl)-;BCBcMAP01_000220;1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-;2-Desoxy-5-azacytidine;4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one;5-AZA-2'-DEOXYCYTADINE;5-Aza-2'-deoxycytidine;5-Azadeoxycytidine;BRN 0617982;Dac;Dacogen;Decitabine;Decitabine [USAN:BAN:INN];EINECS 219-089-4;NSC 127716;s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-"	"Decitabine;5-Aza-2'-deoxycytidine;2353-33-5;Dacogen;2'-Deoxy-5-azacytidine;5-Azadeoxycytidine;AzadC;Dezocitidine;5-aza-CdR;5-aza-dC;Dacogen (TN);UNII-776B62CQ27;5A2dc;5-aza-2-deoxycytidine;5-AZAdC;decitabine mesylate;NCGC_5ADOC;Decitabine (USAN/INN);4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;5-Deoxy-2&prime;-azacytidine;MLS001332587;5-Aza-2&prime;-Deoxycytidine;CHEBI:50131;decitabine mesilate;4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one;NSC 127716;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;776B62CQ27;4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;SMR000857076;2-Desoxy-5-azacytidine;E-7373;DSSTox_CID_10432;DSSTox_RID_78849;DSSTox_GSID_30432;Decitabine [USAN:INN:BAN];C8H12N4O4;EINECS 219-089-4;4-Amino-1-(2-deoxy-beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;2-deoxyazacytidine;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one;BRN 0617982;CAS-2353-33-5;5-Aza-deoxycytidine;CCRIS 8227;NSC127716;4-amino-1-(2-deoxy-beta-d-erythro-pentofuranosyl)-s-triazin-2(1h)-on;NCGC00166088-01;5-Deoxy-2&prime;deoxy-5-azacytidine;5-Aza-2&prime;PubChem19115;JNJ 30979754;JNJ-30979754;D0X5XU;MolMap_000063;AC1L9PS9;SCHEMBL4006;cc-571;MLS001332588;MLS006010136;BIFK0051;cid_451668;EOS114;GTPL6805;CHEMBL1201129;DTXSID7030432;s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-;BDBM96274;CTK1A2018;EX-A961;SYN3036;1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-;MolPort-003-925-958;XAUDJQYHKZQPEU-KVQBGUIXSA-N;HMS2235O03;ACT00147;HY-A0004;5-Aza-2'-deoxycytidine, >=97%;Tox21_112311;ABP001084;ANW-25144;CA-714;MFCD00043011;s1200;ZINC16929327;AKOS015895047;Tox21_112311_1;AC-1135;API0002229;BCP9000593;CCG-208143;CS-0372;DB01262;RL02744;Decitabine (NSC127716, 5AZA-CdR);NCGC00166088-02;NCGC00166088-05;AS-17558;BC677683;CC-26303;KB-41703;SC-19951;BCP0726000271;AB0020011;DB-029060;TL8001944;FT-0082622;V0702;D03665;J10097;W-5049;AB00918337-07;AB00918337_08;353A335;C-13049;SR-01000838879;J-700084;SR-01000838879-4;decitabine (2 inverted exclamation marka-deoxy-5-azacytidine).cd;4-Amino-1-(2-deoxy-?-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;4-Amino-1-(2-deoxy-bet.-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;Dacogen, 5-aza-2'-deoxycytidine,NSC 127716, Dacogen, DAC, Decitabine;1,3, 5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy--D-erythro-pentofuranosyl)-;105597-46-4;123795-43-7;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one"	2353-33-5	776B62CQ27	"26055299;24723466;20456354;19470736;17564707;17020984;15753459;14604977;12655442;11548839;10830142;9180389"	9180389	01/04/1997	2433702	01/01/1985	Bef. 1989		1	0	1	Yes	1	"03/05/2017 00:00;14/08/2014 00:00;31/05/2017 00:00;05/05/2017 00:00;28/08/2014 00:00;16/03/2018 00:00;16/03/2016 00:00;16/11/2017 00:00;22/09/2017 00:00;06/05/2013 00:00;07/04/2015 00:00;11/07/2013 00:00;15/01/2014 00:00;27/02/2017 00:00;23/01/2014 00:00;11/03/2010 00:00;02/05/2006 00:00;08/03/2016 00:00"	AP	"ACCORD HLTHCARE;OTSUKA PHARM CO LTD;SUN PHARMA GLOBAL;#N/A;PHARMASCIENCE INC;SANDOZ INC;DR REDDYS LABS LTD"	DECITABINE	02/05/2006	OTSUKA PHARM CO LTD	255,4	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
WX-G250	"cg250;g250;girentuximab;iodine i 131 chimeric monoclonal antibody g-250;iodine i 131 girentuximab;iodine-131-g250;iodine-131-labeled chimeric monoclonal antibody g250"		DB05304					"20512580;9193349;9529296"	9193349	01/04/1997	9193349	01/04/1997	1994-1998		1	1	0	Yes	1					30/07/2018		255,4	16	NA	0	1	MRCC	0	NA	0	0	1	16	0	1	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Penclomedine	"crc 88-04;nsc 338720;penclomedine"		DB12987	"3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine;108030-77-9;NSC338720;NCI60_002989;NCIMech_000533;AIDS-010588;AIDS010588;3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine;NSC 338720;NSC-338720;PENCLOMEDINE;Pyridine, 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)-"	"PENCLOMEDINE;3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine;108030-77-9;UNII-66Q80IL7CW;NSC-338720;NSC338720;NSC 338720;66Q80IL7CW;DZVPGIORVGSQMC-UHFFFAOYSA-N;Pyridine, 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)-;C8H6Cl5NO2;Penclomidine;CCRIS 9406;AC1L1SRN;AC1Q3LDP;D0PR6H;NCIMech_000533;SCHEMBL188460;CHEMBL273124;ZINC3868;DTXSID50148365;CCG-35550;CRC-88-04;DB12987;NCI60_002989;LS-131366;3,5-dichloro-2,4-dimethoxy-6-trichloromethylpyridine;Pyridine,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)-;3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine #"	108030-77-9	66Q80IL7CW	"11895899;9514062;9164209"	9164209	01/05/1997	9164209	01/05/1997	1994-1998		1	1	0	Yes	1					30/07/2018		254,4	NA	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	"ataxia;vertigo;nystagmus;motor aphasia"	1	0	21	0	1
Lithium	lithium gammalinolenate	"Lithium, ion (li1+);Lithium, ion;Li(+);Lithium ion;Lithium cation;Lithium carbonate;Euro Lithium;Lithane;PHL-lithium Carbonate;Duralith Tab 300mg;Lithium Hydroxide Monohydrate;Lithmax;Carbolith Cap 300mg;PMS-lithium Carbonate - Cap 300mg;Lithium Carbonate;PMS-lithium Carbonate - Cap 600mg;Lithium;Lithizine Cap 150mg;Lithizine Cap 300mg;Carbolith Cap 150mg;Carbolith Capsules 600mg;Apo-lithium Carbonate;Pal-lithium Carbonate;PMS-lithium Citrate;PMS-lithium Carbonate - Cap 150mg;Dom-lithium Carbonate;Lithium Carbonate ER;Lithobid;Lithium Carbonate Lithium Carbonate"	DB01356	"LITHIUM;7439-93-2;159577-72-7;64975-42-4;Lithium standard for ICP;EINECS 231-484-3;HSDB 549;Hydrure de lithium [French];Lithium hydride (LiH);Lithium hydride [UN1414]  [Dangerous when wet];Lithium hydride, fused solid [UN2805]  [Dangerous when wet];Lithium monohydride;UN1414;UN2805;265977_ALDRICH;265969_ALDRICH;265993_ALDRICH;248827_ALDRICH;266000_ALDRICH;228508_ALDRICH;320080_ALDRICH;444456_ALDRICH;207241_ALDRICH;Lithium atomic absorption standard solution;62369_FLUKA;Lithium standard for IC;62373_FLUKA;Lithium standard for AAS;3Li;CHEBI:30145;litio;340421_ALDRICH;201049_ALDRICH;499811_ALDRICH;Lithium-6Li;265985_ALDRICH;HSD690000;HSDB 6900;Lithium compounds;C15473;EINECS 231-102-5;HSDB 647;LITHIUM;Lithium [UN1415]  [Dangerous when wet];Lithium, elemental;Lithium, metallic;UN1415;278327_ALDRICH;220914_ALDRICH;62500_FLUKA;17073_FLUKA;Lithium nitrate solution"	"Lithium;7439-93-2;litio;Litium;Lithium, metallic;Lithium, elemental;Lithium monohydride;UNII-9FN79X2M3F;HSDB 647;Lithium hydride (LiH);EINECS 231-102-5;UN1415;Hydrure de lithium [French];9FN79X2M3F;HSDB 549;CHEBI:30145;EINECS 231-484-3;UN1414;UN2805;MFCD00134051;Lithium compounds;Lithium Ingot, 5.7cm (2.2in) Dia x 8.6cm (3.4in) Long (Metals Basis);3Li;monolithium;Lithium Metal;Normothymin-E (TN);Epitope ID:114079;EC 231-102-5;AC1MHL68;Lithium, 99%, low sodium;Lithium, 99%, high sodium;CHEMBL2146126;DTXSID5036761;CTK2H7939;HSDB 6900;MolPort-003-927-072;MolPort-035-944-309;WHXSMMKQMYFTQS-UHFFFAOYSA-N;LITHIUM HYDRIDE, 98.6%;KS-000000QV;7321AH;AKOS015833388;AKOS015902481;HSD6900000;RP18202;TRA-0204977;Lithium [UN1415] [Dangerous when wet];LS-88055;LS-88066;AB1003835;Lithium [UN1415]  [Dangerous when wet];Lithium, granular, 99% trace metals basis;RT-004483;FT-0627883;FT-0627905;C15473;D08133;EC 231-484-3;Lithium hydride [UN1414] [Dangerous when wet];Lithium hydride [UN1414]  [Dangerous when wet];Lithium, shot, 99%, 4-16 mesh, in mineral oil;I14-19663;I14-115177;Lithium, wire, diam. 3.2 mm, in mineral oil, >=98%;Lithium, ~25 wt % dispersion in mineral oil, high sodium;Lithium, ingot, diam. 5.7 cm, 99.9% trace metals basis;Lithium, rod, diam. 12.7 mm, 99.9% trace metals basis;Lithium hydride, fused solid [UN2805]  [Dangerous when wet];Lithium hydride, fused solid [UN2805] [Dangerous when wet];Lithium ingot, 5.7cm (2.2in) dia x 8.6cm (3.4in) long;Lithium, Oil based standard solution, Specpure, Li 5000g/g;Lithium, rod, 12.7 mm diameter, length 165 mm, purity 99%;Lithium, rod, 12.7 mm diameter, length 200 mm, purity 99%;Lithium, foil, 25x100mm, thickness 0.6mm, as rolled, 99.9%;Lithium foil, 0.75mm thick x 19mm wide, 99.9% trace metals basis  25g;Lithium, foil, thickness 0.6 mm, size 25 x 300 mm, purity 99.9%;Lithium, wire (in mineral oil), diam. 3.2 mm, 99.9% trace metals basis;Lithium, foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%;Lithium, foil, not light tested, 38x500mm, thickness 0.20mm, as rolled, 99.9%;Lithium, foil, not light tested, 45x200mm, thickness 0.12mm, as rolled, 99.9%;Lithium, granular, 4-10 mesh particle size, high sodium, 99% (metals basis);Lithium, ribbon, thickness x W 0.38 mm x 23 mm, 99.9% trace metals basis;Lithium, ribbon, thickness x W 0.75 mm x 19 mm, 99.9% trace metals basis;Lithium, ribbon, thickness x W 0.75 mm x 45 mm, 99.9% trace metals basis;Lithium, ribbon, thickness x W 1.5 mm x 100 mm, 99.9% trace metals basis;159577-72-7;64975-42-4"	7439-93-2	8H8Z5UER66	8687143	8687143	01/03/1996	18142718	01/09/1949	Bef. 1989		0	0	1	No	0	"10/11/1986 00:00;29/08/1990 00:00;19/02/1982 00:00;23/01/1979 00:00;29/03/1982 00:00;22/02/1979 00:00;11/09/1981 00:00;08/11/2002 00:00;01/07/1975 00:00;27/09/1979 00:00;26/03/1985 00:00;17/06/2003 00:00;08/06/2015 00:00;27/03/1980 00:00;29/08/1975 00:00;06/01/1982 00:00;11/05/2015 00:00;08/08/2012 00:00;26/02/2016 00:00;30/08/1994 00:00;25/10/2016 00:00;02/10/1980 00:00;06/03/2012 00:00;13/09/1979 00:00;18/07/1985 00:00;25/03/1994 00:00;19/06/2007 00:00;05/06/2017 00:00;28/08/1996 00:00;03/02/2009 00:00;16/04/1980 00:00;26/11/1989 00:00;27/01/2012 00:00;28/09/2007 00:00;14/08/2016 00:00;27/07/2015 00:00;13/10/1988 00:00;25/09/2009 00:00;29/07/1987 00:00;13/02/1979 00:00;20/09/1979 00:00;06/12/2000 00:00;03/06/1976 00:00;02/02/1995 00:00;18/11/1988 00:00;01/05/1986 00:00;26/11/2001 00:00;07/09/2010 00:00;26/11/1980 00:00;12/08/1994 00:00;17/08/2000 00:00;26/05/1995 00:00;24/04/1972 00:00;01/02/2000 00:00;19/03/1976 00:00;27/12/2010 00:00;01/07/2014 00:00;01/08/1994 00:00;06/08/1999 00:00;29/05/1985 00:00;06/12/2011 00:00;17/10/2003 00:00;24/03/1983 00:00;22/04/1997 00:00;03/05/2018 00:00;24/11/1981 00:00;06/05/2016 00:00;11/07/1997 00:00;12/06/2015 00:00;28/06/1988 00:00;06/01/2000 00:00;25/09/1981 00:00;14/02/2011 00:00;07/04/1989 00:00;10/06/2002 00:00;31/01/2007 00:00;20/04/1990 00:00;27/06/2002 00:00;26/11/1987 00:00;24/04/1979 00:00;15/10/2002 00:00;21/01/1983 00:00;06/04/1970 00:00;30/01/1978 00:00;21/05/1986 00:00;29/09/1987 00:00;26/02/1979 00:00;26/12/2007 00:00;25/03/1987 00:00;06/04/1981 00:00;20/10/2003 00:00;03/03/2015 00:00;29/01/1982 00:00;27/04/1979 00:00;27/05/2016 00:00;12/01/2009 00:00;26/01/1978 00:00;23/07/1976 00:00;04/02/1982 00:00;20/10/2011 00:00;21/08/2003 00:00;25/01/1978 00:00;13/04/1990 00:00;05/10/2007 00:00;07/10/2002 00:00;30/11/1984 00:00;16/06/1997 00:00;04/01/1980 00:00;21/09/2000 00:00;24/06/2010 00:00;28/06/1994 00:00;23/08/1974 00:00;05/02/1996 00:00;24/08/1988 00:00;04/05/1981 00:00;28/01/1987 00:00;20/10/1995 00:00;31/10/2007 00:00;28/12/2010 00:00;31/01/1983 00:00;22/12/2000 00:00;10/02/1988 00:00;19/12/1984 00:00;14/06/1983 00:00;06/08/1981 00:00;06/02/1980 00:00;05/08/2002 00:00;14/06/2001 00:00;13/08/2012 00:00;02/05/1990 00:00;19/09/1980 00:00;01/10/2006 00:00;27/01/1983 00:00;23/07/1982 00:00;02/10/1996 00:00;27/09/2001 00:00;22/11/2004 00:00;21/11/2001 00:00;31/01/2003 00:00;23/07/1984 00:00;03/10/1979 00:00;17/06/1974 00:00;06/04/2000 00:00;25/02/1983 00:00;29/09/2016 00:00;30/04/2018 00:00;28/03/1980 00:00;02/12/1981 00:00;24/02/2003 00:00;23/12/1980 00:00;08/05/2002 00:00;19/04/1982 00:00;24/06/1974 00:00;15/04/2008 00:00;28/04/2008 00:00;24/03/2016 00:00;01/08/1977 00:00;11/11/1977 00:00;04/10/1977 00:00;13/05/1980 00:00;15/11/1984 00:00;11/03/2004 00:00;05/01/2015 00:00;16/07/1992 00:00;21/04/2003 00:00;02/04/1976 00:00;11/04/1990 00:00;07/04/2006 00:00;17/02/1987 00:00;29/06/2004 00:00;09/09/1982 00:00;16/10/2001 00:00;06/10/1993 00:00;29/07/1999 00:00;27/03/1989 00:00;05/01/2004 00:00;28/10/2004 00:00;10/02/2003 00:00;25/07/2012 00:00;26/03/1984 00:00;20/12/1978 00:00;29/06/2012 00:00;18/11/1982 00:00;03/06/1998 00:00;29/04/1982 00:00"	AP	"MYLAN PHARMS INC;BAYER PHARMS;HIKMA INTL PHARMS;HERITAGE PHARMA;SUN PHARM INDS INC;WEST-WARD PHARMS INT;WOCKHARDT BIO AG;HETERO LABS LTD III;JDS PHARMS;ALEMBIC LTD;GLENMARK PHARMS INC;ABLE;NOVEN THERAP;APOTEX INC;SOLVAY;BARR;GLENMARK GENERICS;PFIZER;ALEMBIC PHARMS LTD;UNIQUE PHARM LABS;ANI PHARMS INC"	"LITHIUM CARBONATE;LITHIUM CITRATE"	06/04/1970	SOLVAY	246,6	#N/A																							0						1
Labetuzumab	"labetuzumab;mn-14"	"(131I)-MN-14;MAb hMN14;hMN-14;monoclonal antibody hMN-14"	DB05097			219649-07-7	EFE6X5M3UY	"10647610;9441773"	9441773	01/01/1998	9441773	01/01/1998	1994-1998		1	1	0	Yes	1					30/07/2018		246,4	14	NA	0	1	OVARIAN CANCER	1	CEA	0	1	0	NA	0	0	0	1	0	0,07	0	1	1	NA	0	0	0	0	0	0	26	0	1
Tributyrin	tributyrin		DB12709	"1,3-di(butanoyloxy)propan-2-yl butanoate;[2-butanoyloxy-1-(butanoyloxymethyl)ethyl] butanoate;butanoic acid [2-(1-oxobutoxy)-1-(1-oxobutoxymethyl)ethyl] ester;butyric acid [2-butyryloxy-1-(butyryloxymethyl)ethyl] ester;60-01-5;Butyryl triglyceride;EINECS 200-451-5;FEMA No. 2223;Glycerin tributyrate;Glycerol tributanoate;Glycerol tributyrate;Glyceroltributyrin;Glyceryl tributyrate;HSDB 878;Kodaflex tripropionin;NSC 661583;TRIBUTYRIN;Tri-n-butyrin;Tributin;Tributyrinine;Tributyrl glyceride;Tributyroin;Tributyryl glyceride;NCI60_021427;T8626_SIGMA;InChI=1/C15H26O6/c1-4-7-13(16)19-10-12(21-15(18)9-6-3)11-20-14(17)8-5-2/h12H,4-11H2,1-3H;113026_ALDRICH;1,2,3-Tributyrylglycerol;2,3-Bis(butyryloxy)propyl butyrate;AIDS-142910;AIDS142910;NSC661583;W222305_ALDRICH;C13870;1,2,3-Propanetriyl tributanoate;4-02-00-00799 (Beilstein Handbook Reference);AI3-01776;BRN 1714746;Butanoic acid, 1,2,3-propanetriyl ester;Butyric acid triester with glycerin;Butyrin;Butyrin, tri-"	"TRIBUTYRIN;Glyceryl tributyrate;60-01-5;Glycerol tributyrate;Tributin;Butyrin;Propane-1,2,3-triyl tributyrate;Butyryl triglyceride;Glycerol tributanoate;Glyceroltributyrin;Tri-n-butyrin;Tributyrinine;Tributyroin;Glycerin tributyrate;Tributyryl glyceride;Butanoic acid, 1,2,3-propanetriyl ester;Butyrin, tri-;Tributyrl glyceride;1,2,3-Tributyrylglycerol;1,2,3-Propanetriyl tributanoate;Butyric acid triester with glycerin;NSC 661583;UNII-S05LZ624MF;FEMA No. 2223;HSDB 878;1,2,3-Propanetriol, tributyrate;2,3-Bis(butyryloxy)propyl butyrate;2,3-di(butanoyloxy)propyl butanoate;EINECS 200-451-5;BRN 1714746;AI3-01776;S05LZ624MF;CHEBI:35020;UYXTWWCETRIEDR-UHFFFAOYSA-N;NSC661583;Kodaflex;tri-butyrin;1,3-Tributyrylglycerol;Tributyrin, 97%, FG;1,2,3-tributanoylglycerol;AC1L1LP0;SCHEMBL23825;4-02-00-00799 (Beilstein Handbook Reference);ACMC-20976i;Glyceryl tributyrate, >=99%;AC1Q63D4;CHEMBL118722;FEMA 2223;KS-00000VMH;MolPort-003-925-905;s163;propane-1,2,3-triyl tributanoate;ZINC3860906;ANW-13576;2,3-Bis(butyryloxy)propyl butyrate #;AKOS015903304;DB12709;NSC-661583;RTR-020777;TRA0067540;Glyceryl tributyrate, analytical standard;AJ-46079;AK159889;AN-23626;LS-48211;NCI60_021427;SC-43896;1,3-bis(butanoyloxy)propan-2-yl butanoate;TR-020777;ST24049042;T0364;C13870;Glyceryl tributyrate, puriss., >=98.5% (GC);Glyceryl tributyrate, technical, >=94.0% (GC);I14-19298;InChI=1/C15H26O6/c1-4-7-13(16)19-10-12(21-15(18)9-6-3)11-20-14(17)8-5-2/h12H,4-11H2,1-3H"	60-01-5	S05LZ624MF	9533530	9533530	01/05/1998	9533530	01/05/1998	1994-1998		1	1	0	Yes	1					30/07/2018		242,5	13	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	lightheadedness	1	0	0	0	1
ABT-751	"abt-751;e7010"		DB12254	"N-[2-[(4-hydroxyphenyl)amino]pyridin-3-yl]-4-methoxybenzenesulfonamide;N-[2-[(4-hydroxyphenyl)amino]-3-pyridyl]-4-methoxy-benzenesulfonamide;N-[2-[(4-hydroxyphenyl)amino]-3-pyridyl]-4-methoxybenzenesulfonamide;N-[2-[(4-hydroxyphenyl)amino]pyridin-3-yl]-4-methoxy-benzenesulfonamide;141430-65-1;N-(2-((4-Hydroxyphenyl)amino)-3-pyridinyl)-4-methoxybenzenesulfonamide;Benzenesulfonamide, N-(2-((4-hydroxyphenyl)amino)-3-pyridinyl)-4-methoxy-;ABT-751;E-7010;E 7010"	"ABT-751;141430-65-1;ABT 751;E-7010;ABT751;UNII-WDT5V5OB9F;E 7010;ABT-751 (E7010);WDT5V5OB9F;CHEMBL20684;N-[2-[(4-HYDROXYPHENYL)AMINO]-3-PYRIDYL]-4-METHOXYBENZENESULFONAMIDE;N-(2-((4-Hydroxyphenyl)amino)-3-pyridinyl)-4-methoxybenzenesulfonamide;Benzenesulfonamide,N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-;N-(2-(4-hydroxyphenylamino)pyridin-3-yl)-4-methoxybenzenesulfonamide;Benzenesulfonamide, N-(2-((4-hydroxyphenyl)amino)-3-pyridinyl)-4-methoxy-;n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide;N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide;N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide;N-[2-[(4-Hydroxyphenyl)amino]pyridin-3-yl]-4-methoxybenzenesulfonamide;AC1MHZUG;ACMC-20n0gr;D09EHO;MLS006011263;SCHEMBL111645;CHEBI:95043;CTK4C2623;EX-A517;MolPort-009-679-422;URCVCIZFVQDVPM-UHFFFAOYSA-N;BCPP000447;HMS3654C14;ZINC598089;KS-00000XH2;ABP000587;BDBM50101086;NSC742134;s1165;AKOS024457996;API0005108;BCP9000219;CS-0495;DB12254;E7010(ABT-751);NSC-742134;RL01733;ABT-751(E 7010);NCGC00346494-01;4CA-0101;857447-92-8;AN-16578;BC659988;HY-13270;KB-74397;LS-31613;QC-11705;SMR004703014;E7010;FT-0700194;X7522;W-5211;J-007498;J-523312;BRD-K91623615-001-01-9;ABT751, E7010, ABT 751, 141430-65-1;N-[2-(4-hydroxyanilino)-3-pyridyl]-4-methoxy-benzenesulfonamide;N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzenesulfonamide;N-[2-(4-Hydroxy-phenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide;N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-benzenesulfonamide;Benzenesulfonamide, N-?[2-?[(4-?hydroxyphenyl)?amino]?-?3-?pyridinyl]?-?4-?methoxy-;E70"	141430-65-1	WDT5V5OB9F	"23147218;16166440;9654112"	9654112	01/07/1998	9654112	01/07/1998	1994-1998		1	1	0	Yes	1					30/07/2018		240,5	57	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	0	0	1
Omacetaxine mepesuccinate	"(14)c-omacetaxine;homoharringtonine;omacetaxine;omacetaxine mepesuccinate"	"HHT;Homoharringtonine;(−)-homoharringtonine;Homoharringtonin;(2'R,3S,4S,5R)-(−)-homoharringtonine;Synribo"	DB04865	"NCI60_000917;CGX-635;CGX-635-14 (formulation);Ceflatonin;HHT;Myelostat;NSC-141633;Omacetaxine mepesuccinate;ZJ-C;Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), [3(R)]-;NSC141633;ST056357"	"homoharringtonine;Omacetaxine mepesuccinate;Ceflatonin;Myelostat;Synribo;26833-87-4;CGX-635;Omapro;(-)-homoharringtonine;Synribo (TN);NSC 141633;UNII-6FG8041S5B;NSC-141633;(2'R,3S,4S,5R)-(-)-homoharringtonine;CHEBI:71019;6FG8041S5B;cephalotaxine 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate;C29H39NO9;Tekinex;BRN 5687925;Homoharringtonin;NSC141633;NCGC00025155-01;Omacetaxine mepesuccinate [USAN:INN];omacetaxini mepesuccinas;AC1Q5YWQ;Homoharringtonine (8CI);ZJ-C;mepesuccinate d'omacetaxine;D0M4XY;mepesuccinato de omacetaxina;MLS001424293;CHEMBL46286;CGX-635-14 (formulation);GTPL7454;SCHEMBL12745687;CTK8E8620;CGX 635;Omacetaxine mepesuccinate (USAN);Cephalotaxine, 4-methyl-, 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester);HYFHYPWGAURHIV-JFIAXGOJSA-N;MolPort-003-983-592;HMS3267H22;AC1L6273;Homoharringtonine, >=98% (HPLC);ZINC26011099;AKOS024456585;ACN-035229;CS-2872;DB04865;NC00395;Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester);o3-[(2r)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine;NCGC00025155-02;NCGC00025155-03;NCGC00025155-04;HY-14944;NCI60_000917;SAM001246822;SMR000469230;ST056357;AB0019750;TR-031859;Homoharringtonine|||Omacetaxine mepesuccinate;N1504;V0232;D08956;AB00642561-02;SR-01000597562;SR-01000597562-1;BRD-K76674262-001-01-7;BRD-K76674262-001-02-5;Cephalotaxine 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate;(2S,3S,6S)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0<2,6>.0<6,10>.0<15,1 9>]icosa-1(20),4,13,15(19)-tetraen-3-yl methyl (2R)-2-hydroxy-2-(4-hydroxy-4-m ethylpentyl)butane-1,4-dioate;1-((1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H- cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2R)-2- hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate;Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI);Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), (3(R))- (9CI)"	26833-87-4	6FG8041S5B	"27221729;17154172"	17154172	01/12/2006	1434802	01/11/1992	1989-1994		1	1	1	Yes	1	"26/10/2012 00:00;10/02/2014 00:00;22/11/2013 00:00;01/05/2014 00:00;21/06/2017 00:00;13/06/2016 00:00"	AP	TEVA PHARMS INTL	OMACETAXINE MEPESUCCINATE	26/10/2012	TEVA PHARMS INTL	239,3	66	81	0	1	AML	0	NA	0	1	0	NA	0	0	0	1	1	0,16	0	1	1	NA	0	ARRHYTHMIA	1	0	0	0	212	0	1
Paricalcitol	paricalcitol	"19-Nor-1alpha,25-dihydroxyvitamin D2;Paricalcitol;Zemplar;Paricalcitol"	"DB00910;APRD01165"	"(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[2-[(1R,3aS,7aR)-1-[(2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[2-[(1R,3aS,7aR)-1-[(1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethylhex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[2-[(1R,3aS,7aR)-1-[(1R,4S)-5-hydroxy-1,4,5-trimethylhex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethyl-hept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R)-5-[2-[(1R,3aS,7aR)-1-[(2R,5S)-6-hydroxy-5,6-dimethyl-hept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;131918-61-1;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;ABT-358;D00930;19-Nor-1alpha,25-dihydroxyvitamin D2;C08127;Paricalcitol;19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol, (1alpha,3beta,7E,22E)-;Paracalcin;LS-172812;Paricalcitol (USAN/INN);(1alpha,3beta,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol;(7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1alpha,3beta,25-triol;19-Nor-1,25-(OH)2D2;Zemplar;Compound 49510;Paricalcitol [USAN];Zemplar (TN);Compound-49510"	"Paricalcitol;Zemplar;131918-61-1;Compound 49510;19-Nor-1alpha,25-dihydroxyvitamin D2;Paracalcin;Paricalcitol [USAN];19-Nor-1,25-(OH)2D2;Zemplar (TN);19-Nor-1-alpha,25-dihydroxyvitamin D2;UNII-6702D36OG5;HSDB 7360;CHEBI:7931;ABT-358;(7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1alpha,3beta,25-triol;6702D36OG5;(1R,3R,7E)-17beta-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9,10-secoestra-5,7-diene-1,3-diol;Ab 122358;NCGC00182706-01;(1alpha.3beta,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol;Paricalcitol, 19-nor-(OH)2-vitD2, paracalcin;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol, (1alpha,3beta,7E,22E)-;19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol,(1alpha,3beta,7E,22E);Paricalcitol [USAN:USP:INN];Compound-49510;PubChem18825;AC1NQY0Z;Paricalcitol (USAN/INN);D0N1TP;SCHEMBL3655;Abbott brand of paricalcitol;DSSTox_CID_28566;DSSTox_RID_82838;DSSTox_GSID_48640;BIDD:GT0330;GTPL2791;Paricalcitol (JAN/USAN/INN);CHEMBL1200622;DTXSID4048640;BPKAHTKRCLCHEA-UBFJEZKGSA-N;MolPort-006-167-660;BDBM233195;ACT07192;19-Nor-1,25-dihydroxyvitamin D2;Tox21_112987;LMST04030163;ZINC13911941;AKOS005145562;BCP9001050;CS-0705;DB00910;AN-15155;BC680819;HY-50919;SC-20905;LS-172812;CAS-131918-61-1;C08127;D00930;W-5365;918P611;(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;(1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol"	131918-61-1	6702D36OG5	16361554	16361554	01/12/2005	205382	01/05/1978	Bef. 1989		0	0	1	No	0	"27/09/2013 00:00;11/01/2017 00:00;27/03/2014 00:00;04/02/2016 00:00;13/09/2000 00:00;07/10/2016 00:00;26/05/2005 00:00;24/06/2014 00:00;01/02/2000 00:00;21/10/2014 00:00;29/08/2014 00:00;06/04/2011 00:00;24/04/2015 00:00;31/03/2004 00:00;30/11/2016 00:00;06/12/2002 00:00;11/06/2010 00:00;22/07/2013 00:00;18/11/2014 00:00;24/02/2003 00:00;25/01/2002 00:00;08/01/2002 00:00;02/09/2005 00:00;17/10/2013 00:00;02/02/2000 00:00;30/11/2015 00:00;20/08/2009 00:00;17/07/2007 00:00;28/06/2012 00:00;18/06/2008 00:00;18/08/2015 00:00;17/08/2016 00:00;17/10/2014 00:00;18/10/2016 00:00;27/05/2015 00:00;02/11/2017 00:00;13/01/2016 00:00;09/03/2017 00:00;29/06/2009 00:00;01/02/2011 00:00;14/01/2016 00:00;18/10/1999 00:00;05/11/2013 00:00;13/06/2015 00:00;14/05/2015 00:00;17/04/1998 00:00;24/02/2016 00:00;16/10/2017 00:00;27/07/2011 00:00"	"AP;TA"	"ACCORD HLTHCARE;RISING PHARMS INC;#N/A;TEVA PHARMS USA;ABBVIE;HIKMA PHARMS;AUROBINDO PHARMA LTD;SANDOZ INC;AMNEAL PHARMS;AMNEAL PHARMS CO;DR REDDYS LABS LTD;MARKSANS PHARMA;HOSPIRA INC;LOTUS PHARM CO LTD;BIONPHARMA INC"	PARICALCITOL	17/04/1998	ABBVIE	239,0	#N/A																							0						1
Alvocidib	flavopiridol	"Flavopiridol;Alvocidib freebase"	"DB03496;EXPT00998"	"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one hydrochloride;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]chromen-4-one hydrochloride;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-4-chromenone hydrochloride;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]chromone hydrochloride;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one hydrochloride;131740-09-5;Alvocidib;Flavopiridol hydrochloride;Alvocidib (USAN/INN);D02880;(-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3s,4r)-3-hydroxy-1-methyl-4-piperidinyl]-4h-1-benzopyran-4-one hydrochloride;F3055_SIGMA;L-86-8276"	"Flavopiridol;Alvocidib;146426-40-6;Flavopiridol (Alvocidib);FLAVO;L 868275;L-868275;Flavopiridol hydrochloride;L86-8275;Alvocidib [INN];UNII-45AD6X575G;HMR 1275;HMR-1275;HMR 1274;L 86-8275;CHEMBL428690;45AD6X575G;(-)cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one;MDL-107826A;C21H20ClNO5;2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE;2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one;Flavoperidol;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]chromen-4-one;2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one;(-)-cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one;4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-((3R,4S)-3-hydroxy-1-methyl-4-piperidinyl)-, rel-(-)-;4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, cis-(-)-;Alvocidib [USAN:INN];alvocidibum;CCRIS 9399;Alvocidib freebase;L-86-8275;AC1NRALK;NSC649890;Tube001;1c8k;1e1y;L868275;Alvocidib (USAN/INN);D0LF1U;SCHEMBL3652;BDBM5655;GTPL5680;NSC 649890 HCl;CHEBI:47344;MolPort-006-169-102;Flavopiridol,Alvocidib, HMR-1275;HMR-1274;KS-00000XH5;AN-500;s1230;ZINC21288966;AKOS022182942;AM84422;DB03496;AJ-78086;AN-16495;BC220865;HY-10005;KB-51876;LS-173272;FT-0601569;A25160;D09868;HMR-1275, Alvocidib, L868275, Flavopiridol;104780-EP2289877A1;104780-EP2292601A1;104780-EP2292603A1;104780-EP2298739A1;104780-EP2298771A2;J-008219;BRD-K87909389-001-01-2;HMR-1275, L868275, 146426-40-6;2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one;Alvocidib;358739-39-6;4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-2,3-dihydro-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-;5,7-Dihydroxy-2-(2-chlorophenyl)-8-(1-methyl-3beta-hydroxypiperidin-4beta-yl)-4H-1-benzopyran-4-one;Alvocidib|||L-868275|||HMR-1275|||2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one"	146426-40-6	45AD6X575G	"27118540;24241210;23959599;20938713;18981292;17003373;12569299;12451473;12351605;9738567"	9738567	01/09/1998	9738567	01/09/1998	1994-1998		1	1	0	Yes	1					30/07/2018		238,4	76	NA	1	0	NA	1	CDK	0	1	0	NA	0	0	0	1	0	0,01	0	0	0	0,05	0	0	0	0	0	0	27	0	1
Triptorelin	triptorelin	"triptorelina;triptoreline;(6-D-Tryptophan)luteinizing hormone-releasing hormone;Luteinizing hormone-releasing factor (pig), 6-D-tryptophan;triptorelinum;(D-Trp6)-GnRH;;pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2"		"57773-63-4;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide;CL 118,532;Luteinizing hormone-releasing factor (pig), 6-D-tryptophan;TRIPTORELIN;Triptorelin [USAN:BAN:INN];Triptorelina [INN-Spanish];Triptoreline [INN-French];Triptorelinum [INN-Latin]"	"TRIPTORELIN;57773-63-4;Triptoreline;Triptorelina;Triptorelinum;Decapeptyl;(D-Trp6)-GnRH;Arvekap;Trelstar;Triptodur;Diphereline;(6-D-Tryptophan)luteinizing hormone-releasing hormone;CL 118532;CL-118532;pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2;tryptorelin;Triptorelin pamoate;Luteinizing hormone-releasing factor (pig), 6-D-tryptophan;CHEBI:63633;Pamorelin;D-Tryptophan-LH-RH;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide;Trelstar LA;Wy 42462;(D-Trp6)-LH-RH;[D-Trp6]-LH-RH;Triptoreline [INN-French];Triptorelinum [INN-Latin];Triptorelina [INN-Spanish];AY 25650;Triptorelin [USAN:INN:BAN];Diferelin;UNII-08AN7WA2G0;Wy 42422;08AN7WA2G0;Trelstar depot;AY-25650;CL 118,532;Salvacyl;Trellasar;Moapar;Decapeptyl SR;Pamorelin LA;UNII-9081Y98W2V;BIM 21003;D-Trp6-LHRH;Gonapeptyl depot (TN);Debio-8206;Triptorelin (USAN/INN);D03QRS;[D-Trp6] LH-RH amide;GTPL1177;SCHEMBL5079698;CHEMBL1201334;MolPort-016-581-127;VXKHXGOKWPXYNA-PGBVPBMZSA-N;HMS2090C17;BIM-21003;MFCD00167541;AKOS030213249;AKOS030529557;9081Y98W2V;CS-5745;DB06825;NCGC00167301-01;BN-52014;HY-12551;[D-Trp6]-Luteinizing hormone releasing hormone;73T634;D06247;[D-Trp6]-LH-RH, >=97% (HPLC), powder;AB01275488-01;(S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6,15-bis((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide"	"Triptodur;Trelstar;Decapeptyl"	DB06825	9701702	9701702	01/08/1998	6449891	01/09/1980	Bef. 1989		0	0	1	No	0	"03/07/2014 00:00;14/04/2008 00:00;19/05/2011 00:00;29/06/2001 00:00;26/01/2015 00:00;16/03/2010 00:00;16/02/2007 00:00;12/03/2013 00:00;11/07/2014 00:00;20/06/2001 00:00;10/03/2010 00:00;11/04/2013 00:00;20/10/2005 00:00;29/06/2017 00:00;14/03/2014 00:00;15/01/2002 00:00;19/06/2013 00:00;19/04/2013 00:00;25/04/2013 00:00;03/02/2015 00:00;17/03/2010 00:00;15/06/2000 00:00;15/07/2014 00:00;23/10/2000 00:00;20/01/2015 00:00;14/01/2011 00:00"	AP	"ALLERGAN SALES LLC;ARBOR PHARMS LLC"	TRIPTORELIN PAMOATE	15/06/2000	ALLERGAN SALES LLC	237,0	#N/A																							0						1
LS11	"ls11;me2906;npe6;talaporfin"		DB05918		"Talaporfin sodium;Laserphyrin;Talaporfin (sodium);Mono-L-aspartyl chlorin e6;LS-11;NPe6;UNII-L63605PZ70;Aspartyl chlorin;L63605PZ70;220201-34-3;220680-62-6;ME-2906;Aptocine;Taporfin sodium;Laserphyrin (TN);AC1NUQ3F;LS 11 (photosensitizer);Talaporfin sodium [USAN];LS11;Talaporfin sodium (JAN/USAN);CHEMBL2107806;DTXSID70420519;JLWROAPZCOJYGT-OBJGRMLXSA-J;LS 11;AKOS030526721;CS-2958;HY-16477;D01985;L-Aspartic acid, N-(((7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl)acetyl)-, tetrasodium salt;L-Aspartic acid, N-(((7S,8S,)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl)acetyl)-, tetrasodium salt;Tetrasodium (2S)-2-((((7S,8S)-3-carboxylato-7-(2-carboxylatoethyl)-13-ethenyl-18-ethyl-2,8,12,17-tetramethyl-7,8-dihydroporphyrin-5-yl)acetyl)amino)butanedioate;tetrasodium (2S)-2-[[2-[(2S,3S)-7-carboxylato-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-3-(3-oxido-3-oxopropyl)-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate"			9829737	9829737	01/11/1998	9829737	01/11/1998	1994-1998		1	1	0	Yes	1					30/07/2018		236,4	11	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	0	NA	0	0	0	0,66	0	0	0	0	0	0	0	0	1
Cyclopentolate	phenylacetate	"Ciclopentolato;2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester;Cyclopentolate;(+-)-Cyclopentolate;beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate;(±)-cyclopentolate;alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester;β-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate;2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate;Cyclopentolatum;beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate;α-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester;1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester;Cyclomydril;Ak-pentolate;Cyclopentolate Hydrochloride;Cyclopentolate;PMS-cyclopentolate HCl Oph Solution 1%;Cyclogyl;Minims Cyclopentolate Hydrochloride 0.5%;Minims Cyclopentolate Hydrochloride 1%;Odan-cyclopentolate;Dom-cyclopentolate HCl Ophthalmic Solution-1%"	"DB00979;APRD00893"	"2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;2-(1-hydroxycyclopentyl)-2-phenylacetic acid 2-dimethylaminoethyl ester;2-(1-hydroxycyclopentyl)-2-phenyl-acetic acid 2-dimethylaminoethyl ester;2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenyl-ethanoate;512-15-2;Benzeneacetic acid, .alpha.-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester;DivK1c_000610;C06932;Cyclopentolate;Prestwick0_001095;1-hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester;nchembio747-comp4;BSPBio_002097;KBio1_000610;Spectrum3_000369;KBioSS_001336;Spectrum_000856;BSPBio_001170;Spectrum4_000303;Prestwick2_001095;KBio3_001317;IDI1_000610;Prestwick3_001095;2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;Spectrum5_000793;KBio2_001336;Spectrum2_001122;KBio2_003904;KBio2_006472;BPBio1_001288;SPBio_000983;NINDS_000610;Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester;Ciclopentolato [INN-Spanish];Cyclopentolatum [INN-Latin];EINECS 208-136-4;KBioGR_000886;Prestwick1_001095;SPBio_003055"	"cyclopentolate;512-15-2;Ciclopentolato;Cyclopentolatum;Cyclopentylate;Cyclogyl;Cyclopentolatum [INN-Latin];Ciclopentolato [INN-Spanish];Cyclopentoiate;Diopentolate;Mydrilate;Cyclopentolate [INN:BAN];Cylate;Ocu-Pentolate;Minims Cyclopentolate;(+-)-cyclopentolate;2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;Cyclopentolate (INN);Bell Pentolate (TN);EINECS 208-136-4;CHEBI:4024;2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate;1-hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester;alpha-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester;Benzeneacetic acid, .alpha.-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester;Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester;b-dimethylaminoethyl(1-hydroxycyclopentyl)phenylacetate;beta-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate;2-(Dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate;2-Dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetat;2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;beta-(Dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate;2-phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester;Bell Pentolate;cyclo-pentolatum;Cyclogyl (Salt/Mix);Mydrilate (Salt/Mix);Spectrum_000856;(+/-)-cyclopentolate;AC1L1EQK;Prestwick0_001095;Prestwick1_001095;Prestwick2_001095;Prestwick3_001095;Spectrum2_001122;Spectrum3_000369;Spectrum4_000303;Spectrum5_000793;D0B1EV;AC1Q67OG;BSPBio_001170;BSPBio_002097;KBioGR_000886;KBioSS_001336;DivK1c_000610;SCHEMBL132500;SPBio_000983;SPBio_003055;BPBio1_001288;GTPL7153;CHEMBL1201338;DTXSID3048528;BDBM82375;CTK8H5258;KBio1_000610;KBio2_001336;KBio2_003904;KBio2_006472;KBio3_001317;MolPort-005-935-560;NINDS_000610;s114;SKYSRIRYMSLOIN-UHFFFAOYSA-N;NSC_2905;ACM512152;STL430452;AKOS015962137;API0009075;DB00979;IDI1_000610;NCGC00018213-02;AC-15991;AN-34337;AS-16057;CAS_512-15-2;CC-26105;SBI-0051324.P003;LS-175236;AB00053445;FT-0624265;C06932;D07759;M-1318;AB00053445_12;C-23922;L000802;BRD-A77291778-003-05-5;BRD-A77291778-003-15-4;.beta.-(Dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate;2-(Dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate #;2-Dimethylaminoethyl 1-hydroxy-.alpha.-phenylcyclopentaneacetate;2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;(+)-alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester;(?)-alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester;1-Hydroxy-.alpha.-phenylcyclopentaneacetic acid, 2-(dimethylamino)ethyl ester;Cyclopentaneacetic acid, 1-hydroxy-.alpha.-phenyl-, 2-(dimethylamino)ethyl ester"	512-15-2	I76F4SHP7J	"12879279;7773944;8137283"	8137283	01/04/1994	13207293	01/12/1954	Bef. 1989		0	0	1	No	0	"13/10/1989 00:00;03/04/1996 00:00;07/05/1999 00:00;18/04/2001 00:00;24/01/1991 00:00;19/11/1998 00:00;17/12/1985 00:00;20/11/1989 00:00;18/05/2000 00:00;19/07/2017 00:00;17/02/1998 00:00;23/03/1999 00:00;04/08/1995 00:00;13/01/1997 00:00;03/08/1994 00:00;09/10/2001 00:00;20/11/2001 00:00;07/03/2001 00:00;11/10/2002 00:00;12/09/1975 00:00;20/02/1991 00:00;04/06/1993 00:00;31/10/2003 00:00;20/06/1994 00:00;07/06/1996 00:00;05/11/1992 00:00;28/05/1996 00:00;20/03/1995 00:00;05/10/2000 00:00;31/07/1974 00:00;02/12/1993 00:00;28/04/2000 00:00;23/12/2002 00:00;22/11/1974 00:00;13/04/2015 00:00;29/04/1994 00:00;07/06/1999 00:00;04/03/1999 00:00;12/10/1982 00:00;16/04/1996 00:00;29/07/1992 00:00;24/12/1996 00:00;30/03/2001 00:00;19/12/2002 00:00;16/01/1997 00:00;30/10/1989 00:00;09/03/1989 00:00;05/10/1995 00:00;18/03/1996 00:00;20/10/1988 00:00;10/02/1998 00:00;11/07/2001 00:00;28/08/1989 00:00;25/07/2012 00:00;27/06/2000 00:00;09/12/1998 00:00;27/11/2001 00:00;07/04/2000 00:00;24/03/1989 00:00;04/08/1994 00:00;08/12/1983 00:00;15/05/2000 00:00;09/12/2015 00:00"	AP	"BAUSCH AND LOMB;ALCON LABS INC;ALCON PHARMS LTD;SOLA BARNES HIND;AKORN INC;AKORN"	" PHENYLEPHRINE HYDROCHLORIDE;CYCLOPENTOLATE HYDROCHLORIDE"	31/07/1974	ALCON LABS INC	235,5	#N/A																							0						1
Acridine Carboxamide	"acridine carboxamide;n-[2-(dimethylamino)ethyl]acridine-4-carboxamide;n-[2-dimethylaminoethyl]acridine;xr5000"	DACA	DB11880	"acridine-1-carboxamide;1-acridinecarboxamide"	"Daca;Acridine carboxamide;DACA-N;89459-25-6;NSC 601316;UNII-0N3V8R4E13;CCRIS 4457;N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide;NSC-601316;BRN 6066471;SN 22995;0N3V8R4E13;N-(2-(Dimehtylamino)ehtyl)acridine-4-carboxamide;N-(2-(Dimethylamino)ethyl)-4-acridinecarboxamide;4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-;N-(2-(dimethylamino)ethyl)acridine-4-carboxamide;N-[2-(dimethylamino)ethyl]acridine-4-carboxamide;N-[2-(dimethylamino)ethyl]-4-acridinecarboxamide;4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]-;CHEMBL9940;SCHEMBL105276;AC1L32S3;DTXSID60237739;XBGNERSKEKDZDS-UHFFFAOYSA-N;ZINC3787606;AKOS028110743;DB11880;LS-14254;KB-272048;N-(2-dimethylaminoethyl)acridine-4-carboxamide;4-Acridinecarboxamide,N-[2-(dimethylamino)ethyl]-"	89459-25-6	0N3V8R4E13	"10367747;10468297"	10367747	01/06/1999	10367747	01/01/1999	1999-2003		1	1	0	Yes	1					30/07/2018		234,4	31	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	21	0	1
motexafin gadolinium	"gadolinium texaphyrin;motexafin gadolinium"		DB05428	"156436-89-4;Xcytrin;D05080;Motexafin gadolinium (USAN);Xcytrin (TN);Motexafin gadolinium"	"Motexafin gadolinium;Xcytrin;Gadolinium texaphyrin;GD-Tex;PCI-0120;GdT2B2;156436-89-4;246252-06-2;gadolinium diacetate (1Z,7Z,12E,20E)-4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-10,23-dimethyl-13,20,25,26,27-pentaazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaen-27-ide;DTXSID4037083"		0BG5NE3APZ	"10213207;16133531"	10213207	01/04/1999	10213207	01/04/1999	1999-2003		1	1	0	Yes	1					30/07/2018		231,5	38	77	1	1	NSCLC	1	HYPOXIA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	23	0	1
Dolastatin 10	"dolastatin 10;dolastatin-10;nsc 376128"		DB12730	"2-[(2-dimethylamino-3-methylbutanoyl)amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide;2-[(2-dimethylamino-3-methyl-butanoyl)amino]-N-[2-methoxy-4-[2-[1-methoxy-2-methyl-3-oxo-3-[(2-phenyl-1-thiazol-2-yl-ethyl)amino]propyl]pyrrolidin-1-yl]-4-oxo-1-sec-butyl-butyl]-N,3-dimethyl-butanamide;2-[(2-dimethylamino-3-methyl-1-oxobutyl)amino]-N-[2-methoxy-4-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-4-oxo-1-sec-butylbutyl]-N,3-dimethylbutanamide;2-[(2-dimethylamino-3-methyl-butanoyl)amino]-N-[4-keto-4-[2-[3-keto-1-methoxy-2-methyl-3-[(2-phenyl-1-thiazol-2-yl-ethyl)amino]propyl]pyrrolidin-1-yl]-2-methoxy-1-sec-butyl-butyl]-N,3-dimethyl-butyramide;2-[(2-dimethylamino-3-methyl-butanoyl)amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxo-heptan-4-yl]-N,3-dimethyl-butanamide;110417-88-4;NSC 376128;C11280;Dolastatin 10;Neuro_000215;CCRIS 7310;Dolastatin-10;L-Valinamide, N,N-dimethyl-L-valyl-N-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenyl-1-(2-thiazolyl)ethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-N-methyl-, (2S-(1(1R*(R*),2S*),2R*(1S*,2S*,3(R*))))-"	"Dolastatin 10;110417-88-4;UNII-EI946JT51X;CCRIS 7310;Dolastatin-10;NSC 376128;EI946JT51X;CHEBI:67357;isodolastatin 10;L-Valinamide, N,N-dimethyl-L-valyl-N-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenyl-1-(2-thiazolyl)ethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-N-methyl-, (2S-(1(1R*(R*),2S*),2R*(1S*,2S*,3(R*))))-;Dolastin;C42H68N6O6S;Dolostatin 10;deo-dolastatin 10;CHEMBL39541;SCHEMBL6423272;ZINC95803508;CS-1825;DB12730;DLS 10;NSC 376128;Dolastatin-10;HY-15580;LS-161286;L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-"	110417-88-4	EI946JT51X	"19068085;18214483;17136542;15897580;15033678;10778954;10100703"	10100703	01/04/1999	10100703	01/04/1999	1999-2003		1	1	0	Yes	1					30/07/2018		231,5	30	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
6-O-benzylguanine	"nsc637037;o6-benzylguanine;o6-benzylguanine 8-oxo-o6-benzylguanine"	O6-benzylguanine	DB11919	"6-(phenylmethoxy)-7H-purin-2-amine;[6-(benzyloxy)-7H-purin-2-yl]amine;19916-73-5;O6-Substituted Guanine Deriv. 31;NCGC00015144-01;EU-0100181;6-Benzyloxyguanine;NSC637037;1H-Purin-2-amine, 6-(phenylmethoxy)-;2-Amino-6-(benzyloxy)purine;2-Amino-6-(phenylmethoxy)-9H-purine;6-(Benzyloxy)guanine;6-(Phenylmethoxy)-1H-purin-2-amine;6-BENZYLGUANINE;6-O-Benzylguanine;NSC 637037;O(6)-Benzylguanine;O(6)-Bgua;O6-Benzylguanine;Purine, 2-amino-6-(benzyloxy)-;Lopac-B-2292;Lopac0_000181;6-(Benzyloxy)-7H-purin-2-amine;6-(Benzyloxy)-7H-purin-2-ylamine;AIDS-160581;AIDS160581;Purine, 2-amino-6-(benzyloxy)- (, );NCI60_012280;B2292_SIGMA"	"o6-benzylguanine;6-O-Benzylguanine;19916-73-5;6-(Benzyloxy)-7H-purin-2-amine;O(6)-Benzylguanine;2-amino-6-benzyloxypurine;O(6)-Bgua;6-(Benzyloxy)guanine;6-(benzyloxy)-9H-purin-2-amine;2-Amino-6-(benzyloxy)purine;6-Benzyloxyguanine;6-Benzyloxy guanine;6-(Phenylmethoxy)-1H-purin-2-amine;2-Amino-6-(phenylmethoxy)-9H-purine;UNII-01KC87F8FE;1H-Purin-2-amine, 6-(phenylmethoxy)-;6-BENZYLGUANINE;Purine, 2-amino-6-(benzyloxy)-;NSC 637037;O6-BG;01KC87F8FE;CHEMBL407874;6-benzyloxy-7H-purin-2-amine;NSC637037;1000874-21-4;SMR000326791;916B735;CCRIS 9383;6-(benzyloxy)-3h-purin-2-amine;O6 -benzylguanine;O-6-Benzylguanine;O(6) Benzylguanine;PubChem9681;Purine, 8CI);AC1Q4XUE;Lopac-B-2292;D0B5BG;AC1L1IH7;6-benzyloxy-2-amino-purine;Lopac0_000181;SCHEMBL61740;KSC542O1R;MLS000859930;MLS001074887;MLS006010145;6-benzyloxy-9H-purin-2-amine;BDBM5491;2-Amino-6-benzyloxy-9H-purine;0.4 CH3OH;CTK4E2718;6-Benzyloxy-9H-purin-2-ylamine;DTXSID20173700;KRWMERLEINMZFT-UHFFFAOYSA-N;MolPort-001-769-965;MolPort-019-918-664;6-(phenylmethoxy)purine-2-ylamine;6-phenylmethoxy-7H-purin-2-amine;HMS2234P23;HMS3260F03;HMS3369A16;KRX-0402;KS-00000DP7;O6-Substituted Guanine Deriv. 31;ZINC5425464;6-(Benzyloxy)-7H-purin-2-ylamine;Tox21_500181;AN-984;ANW-43110;MFCD00269931;SBB069180;AKOS015919415;AKOS015963409;AKOS028109331;9H-Purin-2-amine,6-(phenylmethoxy)-;AC-1076;CB-1184;CCG-204276;CS-W002585;DB11919;KS-5281;LP00181;LS20601;NSC-637037;RL02491;RTR-030959;9H-Purin-2-amine, 6-(phenylmethoxy)-;NCGC00015144-01;NCGC00015144-02;NCGC00015144-03;NCGC00015144-04;NCGC00093660-01;NCGC00093660-02;NCGC00260866-01;AJ-54058;BC215630;BR-47518;H350;NCI60_012280;Purine, 2-amino-6-(benzyloxy)- (, );SC-02184;SY008080;O6-Benzylguanine, >=98% (TLC), solid;AB0013002;AB1003839;LS-126405;TR-030959;4CH-006286;AM20060538;EU-0100181;FT-0650712;ST24033084;Y2972;A-1974;B 2292;J10132;SR-01000075709;S07-0157;SR-01000075709-1;W-201741;OBG"	19916-73-5	01KC87F8FE	"22250189;12953345;10344750"	10344750	01/05/1999	10344750	01/05/1999	1999-2003		1	1	0	Yes	1					30/07/2018		230,5	30	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Cytidine 3'-monophosphate	cytidine	"Cytidine 3'-phosphate;Cytidine-3'-Monophosphate;3'-CMP;3'-Cytidylic acid"	"DB01961;EXPT00809"	"[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1-pyrimidinyl)-4-hydroxy-2-(hydroxymethyl)-3-tetrahydrofuranyl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-keto-pyrimidin-1-yl)-4-hydroxy-2-methylol-tetrahydrofuran-3-yl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate;C3P;CYTIDINE-3'-MONOPHOSPHATE;3'-CMP;C05822;Cytidine 3'-phosphate;NCGC00142494-01;SBB002949;3'-Cytidylic acid;Cytidine 3'-monophosphate;EINECS 201-537-5"	"Cytidine-3'-Monophosphate;84-52-6;Cytidine 3'-monophosphate;3-Cytidylic acid;3'-Cytidylic acid;Cytidine 3'-phosphate;3'-CMP;UNII-6DZL5I6D4D;Cytidine 3-monophosphate;6DZL5I6D4D;CHEMBL258728;CHEBI:53013;ST057096;(3S,2R,4R,5R)-5-(4-amino-2-oxohydropyrimidinyl)-4-hydroxy-2-(hydroxymethyl)oxo lan-3-yl dihydrogen phosphate;C3P;EINECS 201-537-5;3/'-Cytidylic acid;cytidine-3'-phosphate;cytidine-3''-monophosphate;SCHEMBL79966;AC1L25L9;Cytidine 3'-monophosphoric acid;CTK8C5691;UOOOPKANIPLQPU-XVFCMESISA-;UOOOPKANIPLQPU-XVFCMESISA-N;ZINC4096919;BDBM50233301;IN1968;SBB002949;AKOS015856718;AKOS015895646;DB01961;NCGC00142494-01;TR-033471;FT-0624319;C05822;006C543;[(2S,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxola;(2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-keto-pyrimidin-1-yl)-4-hydroxy-2-methylol-tetrahydrofuran-3-yl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate;[(2R,3S,4R,5R)-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] dihydrogen phosphate;InChI=1/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1"	84-52-6	6DZL5I6D4D	"16680461;10360604"	10360604	01/06/1999	10360604	01/06/1999	1999-2003		1	1	0	Yes	1					30/07/2018		229,5	10	NA	0	1	NSCLC	1	ribonucleoside diphosphate reductase	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Elacridar	"elacridar;gf120918"		DB04881	"N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide;N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-9-keto-5-methoxy-10H-acridine-4-carboxamide;143664-11-3;4-Acridinecarboxamide, N-(4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-;Elacridar;GF 120918;GF-120918;GG 918;GG918;N-(4-(2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide;N-(4-(2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide"	"Elacridar;143664-11-3;GF-120918;Elacridar (GF120918);GF120918;UNII-N488540F94;GG 918;GF 120918;CHEMBL396298;N488540F94;N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide;Elacridar [INN];N-(4-(2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide;N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide;GG918;AC1L3OOW;D09FGX;MLS006010053;N-(4-(2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide;SCHEMBL536983;Elacridar, >=98% (HPLC);KS-00001DVJ;DTXSID90162489;MolPort-005-943-147;ZINC3915436;BDBM50206310;GG-918;GP5778;GW-918;MFCD00912604;s7772;AKOS016842744;ACN-041486;AM84395;AN-1496;BCP9000638;CS-1112;DB04881;NCGC00263219-01;AC-30265;AK133066;AS-18773;BC225800;HY-50879;SC-83931;SMR002529556;AB0029924;GW-120918;FT-0667833;X2085;Q-9186;664E113;J-007851;4-Acridinecarboxamide, N-(4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-;5-Methoxy-9-oxo-9,10-dihydro-acridine-4-carboxylic acid {4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-amide;N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide;N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-2-carboxamide;N-4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl}-9,10-dihydro-5-methoxy-9-oxo-4-acridone carboxamide"	143664-11-3	N488540F94	17545533	17545533	01/06/2007	10573204	01/09/1999	1999-2003		1	1	0	Yes	1					30/07/2018		226,5	46	NA	1	0	NA	1	PGP	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	2	0	1
Annamycin	annamycin	AR-522	DB06420	"(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyl-2-tetrahydropyranyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;92689-49-1;2'-Iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin;5,12-Naphthacenedione, 7-((2,6-dideoxy-2-iodo-alpha-L-mannopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S-cis)-;Annamycin;AR-522"	"Annamycin;92689-49-1;UNII-SNU299M83Q;SNU299M83Q;2'-Iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin;(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione;5,12-Naphthacenedione, 7-((2,6-dideoxy-2-iodo-alpha-L-mannopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S-cis)-;C26H25IO11;AC1L3GQH;AC1Q6JJ6;SCHEMBL19368;(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,6-dideoxy-2-iodo-|A-l-mannopyranoside;ZINC3918134;AR-522;LS-178181;689A491"	92689-49-1	SNU299M83Q	23763920	23763920	01/06/2013	11127949	01/01/2000	1999-2003		1	1	0	Yes	1					30/07/2018		222,5	36	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	251	0	1
Tanomastat	"bay 12-9566;bay12-9566;tanomastat"		DB06276	"4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid;4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-[(phenylthio)methyl]butanoic acid;4-[4-(4-chlorophenyl)phenyl]-4-keto-2-[(phenylthio)methyl]butyric acid;179545-77-8;215258-80-3;Tanomastat;(1,1'-Biphenyl)-4-butanoic acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (S)-;(1,1'-Biphenyl)-4-butanoic acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (alphaS)-;(S)-4'-Chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1'-biphenyl)-4-butanoic acid;BAY 12-9566"	"Tanomastat;179545-77-8;BAY 12-9566;UNII-AM1ZX94EXH;(S)-4-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4-oxo-2-((phenylthio)methyl)butanoic acid;BAY-12-9566;Tanomastat (USAN/INN);AM1ZX94EXH;CHEMBL261932;BAY-129566;(2S)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid;Tanomastat [USAN:INN];C23H19ClO3S;AC1OCFB0;D0Q1CD;SCHEMBL153066;bay12-9566;GTPL6468;MolPort-003-850-390;ZINC538656;9415AA;BDBM50084661;AKOS015911399;(S)-4'-Chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1'-biphenyl)-4-butanoic acid;AJ-23404;KB-74857;AX8227704;FT-0674808;D03802;545T778;I14-38421;(1,1'-Biphenyl)-4-butanoic acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (S)-;(S)-3-((4'-Chloro-4-biphenylyl)carbonyl)-2-((phenylthio)methyl)propionic acid;4-(4''-Chloro-biphenyl-4-yl)-4-oxo-2-phenylsulfanylmethyl-butyric acid(Bay-12-9566);(1,1'-Biphenyl)-4-butanoic acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (alphaS)-;215258-80-3"	179545-77-8	AM1ZX94EXH	"11710626;11332153;11275992;11205466;10623708"	10623708	01/01/2000	10623708	01/01/2000	1999-2003		1	1	0	Yes	1					30/07/2018		222,5	21	NA	1	0	NA	1	MMP	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Tipifarnib	"farnesyl protein transferase inhibitor;r115777;tipifarnib"	Zarnestra	DB04960	"6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one;6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methyl-quinolin-2-one;6-[(R)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone;6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methyl-carbostyril;192185-72-1;NSC-702818;(R)-( )-R-115777;(R)-( )-R115777;(R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone;2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2(1H )-quinolinone;Tipifarnib [USAN];Zarnestra;D03720;Tipifarnib (USAN);6-[(S)-AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN-2(1H)-ONE;JAN;R115777;TIPIFARNIB"	"Tipifarnib;192185-72-1;Zarnestra;R115777;Tipifarnib [USAN];R-115777;Tipifarnib (Zarnestra);UNII-MAT637500A;Tipifarnib (USAN/INN);MAT637500A;(R)-( )-R115777;R-11577;IND 58359;(R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone;6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one;6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one;6-[(S)-AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN-2(1H)-ONE;JAN;Q-102509;(R)-6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one;2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, (+)-;2(1H)-Quinolinone,6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-;Tipifarnib [USAN:INN];R 115777;Tipifarneb;CCRIS 9329;NSC-702818;PubChem22490;Tipifarnib - Zarnestra;(R)-TIPIFARNIB;AC1Q3OVC;D07NPS;AC1L4LN0;SCHEMBL8097;MLS006011105;GTPL8025;DTXSID5041140;Tipifarnib, >=98% (HPLC);CTK4E0919;1x81;MolPort-006-170-037;MolPort-046-033-675;BCPP000044;HMS3654B10;KS-00001CS7;ABP000933;AN-483;BDBM50370385;s1453;ZINC24809155;AKOS027326864;CS-0475;DB04960;NCGC00250406-01;HY-10502;KB-81163;SMR002530065;LS-184411;LS-187005;LS-187640;FT-0675247;Tipifarnib(R115777)/zarnestraIND 58359;X1029;(R)-R115777;A25612;D03720;W-5357;Zarnestra, IND 58359, R115777, Tipifarnib;185T721;BRD-K62965247-001-01-5;Zarnestra, IND 58359, R115777, 192185-72-1;IND 58359;R115777;IND-58359;IND58359;R-115777;R 115777;(R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone;R115777;2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-;2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2(1H )-quinolinone;2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2(1H)-quinolinone;6-[(R)-Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl}-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone;6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methyl-quinolin-2-one"	192185-72-1	MAT637500A	"26189058;21625235;17570606;14581347;12039935;11996329;11290865"	11290865	01/04/2001	10673536	01/02/2000	1999-2003		1	1	0	Yes	1					30/07/2018		221,4	27	NA	1	0	NA	1	farnesyltransferase	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	21	0	1
Uridine triacetate	"pn401;rg2133;uridine triacetate"	"2',3',5'-Triacetyluridine;Triacetyluridine;Vistonuridine;Tri-O-acetyluridine;Triacetyl uridine;2',3',5'-tri-O-acetyluridine;Uridine 2',3',5'-triacetate;Xuriden;Vistogard"	"DB09144;DB05425"		"Uridine triacetate;4105-38-8;2',3',5'-Tri-O-acetyluridine;Triacetyluridine;Tri-O-acetyluridine;Vistonuridine;Uridine 2',3',5'-triacetate;Xuriden;PN401;(2R,3R,4R,5R)-2-(ACETOXYMETHYL)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-3,4-DIYL DIACETATE;UNII-2WP61F175M;Uridine, 2',3',5'-triacetate;PN 401;RG 2133;2WP61F175M;2 ,3 ,5 -Triacetyluridine;triacetyl uridine;Uridine triacetate [USAN:INN];EINECS 223-881-5;Xuriden (TN);PubChem14176;AC1L2FGB;D0OL7F;KSC495Q6D;MLS006009982;SCHEMBL871011;URI007;CHEMBL2107381;Uridine triacetate (USAN/INN);CHEBI:90914;CTK3J5861;AUFUWRKPQLGTGF-FMKGYKFTSA-N;MolPort-005-940-324;ZINC3843198;AN-158;ANW-29551;MFCD00023795;AKOS015964563;API0001026;DB09144;AK-73070;SMR004701034;SY004945;AX8007900;2',3',5'-Tri-O-acetyluridine, >=98%;FT-0081134;D09985;105T388;J-700012;[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate;[(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate;293738-13-3"	4105-38-8	2WP61F175M	9193347	9193347	01/04/1997	9193347	01/04/1997	1994-1998		1	1	1	Yes	1	"07/06/2016 00:00;04/09/2015 00:00;11/12/2015 00:00;29/03/2016 00:00"	AP	WELLSTAT THERAP	URIDINE TRIACETATE	04/09/2015	ALLERGAN	220,7	38	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Daclizumab	"anti-tac;daclizumab"	"Dacliximab;Daclizumab beta;Zinbryta Pen;Zenapax;Zenapax 5mg/ml;Zinbryta"	"DB00111;BTD00007;BIOD00007"			152923-56-3	CUJ2MVI71Y	25267440	25267440	01/10/2014	9428817	01/01/1998	1994-1998		1	0	1	No	0	"26/05/2017 00:00;27/05/2016 00:00;28/08/2017 00:00;01/11/2017 00:00"	AP	BIOGEN	DACLIZUMAB	27/05/2016	BIOGEN	220,4	#N/A																							0						1
Lonafarnib	"lonafarnib;sch 66336;sch-66336;sch66336"		DB06448	"193275-84-2;(+)-4[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6] cyclohepta[1,2-b]-pyridin-11(R)-yl-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide;NSC719467;SCH-66336;( )4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide;1-Piperidinecarboxamide, 4-(2-(4-((11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-;4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide;Lonafarnib;Lonafarnib [USAN];Sarasar;Sch 66336;D04768;Lonafarnib (USAN);4-{2-[4-(3,10-DIBROMO-8-CHLORO-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERIDIN-1-YL]-2-OXOETHYL}PIPERIDINE-1-CARBOXAMIDE;SCH66336"	"Lonafarnib;193275-84-2;Sarasar;Sch 66336;Sch66336;Sch-66336;Lonafarnib [USAN];UNII-IOW153004F;Lonafarnib (USAN/INN);Lonafarnib (SCH66336);CHEMBL298734;4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide;4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide;IOW153004F;SCH-066336;(+)-4-(2-(4-(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-piperidin-1-yl))-2-oxoethyl)-piperidine-1-carboxamide;4-{2-[4-(3,10-DIBROMO-8-CHLORO-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERIDIN-1-YL]-2-OXOETHYL}PIPERIDINE-1-CARBOXAMIDE;(R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxamide;1-Piperidinecarboxamide, 4-(2-(4-((11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-;1-Piperidinecarboxamide, 4-(2-(4-((11R-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-;193275-86-4;SMR004701448;Lonafarnib [USAN:INN];C27H31Br2ClN4O2;lonafarnibum;1-PIPERIDINECARBOXAMIDE, 4-[2-[4-[(11R)-3,10-DIBROMO-8-CHLORO-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL]-1-PIPERIDINYL]-2-OXOETHYL]-;1o5m;AC1L3WMQ;D0W4HZ;(non-labelled)Lonafarnib-d9;SCHEMBL19032;Sarasar|||SCH 66336;MLS006010423;MLS006011106;GTPL8024;Lonafarnib, >=98% (HPLC);BDBM14459;CHEBI:47097;DTXSID90172927;MolPort-006-170-150;EX-A1630;ZINC3950115;NSC719467;s2797;AKOS005145760;CS-0792;NSC-719467;RL02439;NCGC00346707-01;( )4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide;AN-16567;HY-15136;LS-184039;FT-0670837;Y0240;Lestaurtinib/CEP-701/KT-5555/SPM-924;D04768;S-7680;W-5338;117735-EP2295426A1;117735-EP2295427A1;117735-EP2298768A1;J-514232;(+)-4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide;(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidin-yl]-2-oxo-ethyl]-1-piperidinecarboxamide;(+)-4[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6] cyclohepta[1,2-b]-pyridin-11(R)-yl-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide;(+)-4[2-[4-(8-Chloro-3,11-dihydro-5H-benzo[5,6] cyclohepta[1,2-b]-pyridin-11(R)-yl-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide;4-(2-{4-[(11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidin-1-yl}-2-oxoethyl)piperidine-1-carboxamide;4-(2-{4-[(2R)-6,15-dibromo-13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl]piperidin-1-yl}-2-oxoethyl)piperidine-1-carboxamide;4-[2-[4-[(11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[1,2]cyclohepta[2,4-b]pyridin-11-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide;4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5h-Benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-Piperidinyl]-2-oxoethyl]-1-Piperidi necarboxamide"	193275-84-2	IOW153004F	"20972873;12441264;10766174"	10766174	01/04/2000	10766174	01/04/2000	1999-2003		1	1	0	Yes	1					30/07/2018		219,5	20	NA	1	0	NA	1	farnesyltransferase	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	0	0	1
Exatecan	"de-310;dx-8951f;exatecan"		DB12185	"171335-80-1;10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S,9S)-;10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S-trans)-;Dx 8951;Exatecan;Exatecan [INN]"	"Exatecan;171335-80-1;Exatecan [INN];Exatecan mesylate;Dx 8951;UNII-OC71PP0F89;DX-8951f;OC71PP0F89;DX-8951a;C24H22FN3O4;exatecan hydrochloride;(1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione;10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S,9S)-;10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S-trans)-;DX-8951;(1s,9s)-1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10h,13h-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione;D01FUC;AC1L45P9;SCHEMBL2512959;UM-1;UM-2;CHEMBL1614650;DTXSID60169061;CHEBI:135709;ZINC3800855;3663AH;AKOS005146469;BCP9000674;CS-2951;DB12185;RL02202;AN-16570;HY-13631;LS-39381;FT-0701735;DX8951;DX 8951;DX-8951;335E801;I06-2374;J-521361;(1S,9S)-1-amino-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1,2,3,9,12,15-hexahydro-10H,13H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione"	171335-80-1	OC71PP0F89	"15701859;12855627;12796030;12114413;11751488;11595695;11230496;11099328;10963644"	10963644	01/08/2000	10963644	01/08/2000	1999-2003		1	1	0	Yes	1					30/07/2018		215,5	36	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	21	0	1
Larotaxel	"larotaxel;rpr 109881;rpr 109881a;xrp9881"		DB12984		"Larotaxel;UNII-TWQ8K8A81Y;XRP9881;XRP 9881;156294-36-9;PNU 100940;TWQ8K8A81Y;Larotaxel [INN];D0J0RV;SCHEMBL125697;DXOJIXGRFSHVKA-BZVZGCBYSA-N;ABP000646;ZINC95627892;DB12984;PNU-100940;Larotaxel/TAX-109/109881/XRP-9881/RPR-109881A;Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (1S,2S,4S,7R,8aR,9aS,10aR,12aS,12bR)-7,12a-bis(acetyloxy)-1-(benzoyloxy)-1,3,4,7,8,9,9a,10,10a,12,12a,12b-dodecahydro-2-hydroxy-5,13,13-trimethyl-8-oxo-2,6-methano-2H-cyclodeca(3,4)cyclopropa(4,5)benz(1,2-b)oxet-4-yl ester, (alphaR,betaS)-"	156294-36-9	TWQ8K8A81Y	"19437020;11118471;10963645"	10963645	01/08/2000	10963645	01/08/2000	1999-2003		1	1	0	Yes	1					30/07/2018		215,5	19	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,11	0	0	0	0,22	0	0	0	0	0	0	0	0	1
LM-609	vitaxin		DB05787					10955784	10955784	01/08/2000	10955784	01/08/2000	1999-2003		1	1	0	Yes	1					30/07/2018		215,5	17	NA	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	1	1	0,07	0	0	0	0,8	0	0	0	0	0	0	0	0	1
Nimustine	"acnu;nimustine"		DB13069	"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea;3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitroso-urea;3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea;42471-28-3;KBio3_002543;1-(4-Amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea;3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-1-(2-chloroethyl)-1-nitrosourea;3-(4-Amino-2-methyl-5-pyrimidinyl)methyl-1-(2-chloroethyl)-1-nitrosourea;BSPBio_003323;BRN 0685903;CCRIS 2751;EINECS 255-838-1;NIMUSTINE;Nimustin;Nimustina [INN-Spanish];Nimustine [INN];Nimustinum [INN-Latin];Urea, N'-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(2-chloroethyl)-N-nitroso-;SpecPlus_000878;Spectrum3_001632;Lopac0_000820;EU-0100820;SPBio_000953;KBio1_001918;KBioGR_001098;Lopac-N-8659;Spectrum5_001510;N'-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea hydrochloride;N8659_SIGMA;NCGC00015755-01;NCGC00094151-02;5-25-12-00136 (Beilstein Handbook Reference);NCGC00094151-03;Spectrum2_000877;KBioSS_000869;Spectrum_000389;Spectrum4_000599;SPECTRUM1504151;NCGC00094151-04;DivK1c_006974;KBio2_000869;KBio2_003437;KBio2_006005"	"NIMUSTINE;42471-28-3;Nimustin;Nimustina;Nimustinum;Nimustine [INN];Nimustinum [INN-Latin];Nimustina [INN-Spanish];CCRIS 2751;UNII-0S726V972K;EINECS 255-838-1;BRN 0685903;CHEBI:75270;Nimustine (INN);1-(4-Amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea;3-(4-Amino-2-methyl-5-pyrimidinyl)methyl-1-(2-chloroethyl)-1-nitrosourea;Urea, N'-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(2-chloroethyl)-N-nitroso-;0S726V972K;NCGC00015755-03;3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea;DSSTox_CID_25179;DSSTox_RID_80727;DSSTox_GSID_45179;W-106271;3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-1-(2-chloroethyl)-1-nitrosourea;3-((4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL)-1-(2-CHLOROETHYL)-1-NITROSOUREA;CAS-42471-28-3;SR-01000076036;C9H13ClN6O2;nimustine cation;3-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-1-(2-CHLOROETHYL)-1-NITROSOUREA;nimustine(1+);NSC 245382;Spectrum_000389;1-((4-Amino-2-methylpyrimidin-5-yl)methyl)-3-(2-chloroethyl)-3-nitrosourea;SpecPlus_000878;Spectrum2_000877;Spectrum3_001632;Spectrum4_000599;Spectrum5_001510;Lopac-N-8659;AC1L21AA;SCHEMBL8414;C9H15ClN6O2;Lopac0_000820;BSPBio_003323;KBioGR_001098;KBioSS_000869;5-25-12-00136 (Beilstein Handbook Reference);DivK1c_006974;SPECTRUM1504151;SPBio_000953;CHEMBL136737;DTXSID0045179;CHEBI:75271;CTK8G1883;KBio1_001918;KBio2_000869;KBio2_003437;KBio2_006005;KBio3_002543;MolPort-003-665-513;HMS1922D21;HMS3262D21;Pharmakon1600-01504151;ZINC3979156;Tox21_110214;Tox21_500820;CCG-40318;NSC758675;STK644766;AKOS005575851;Tox21_110214_1;AB07535;API0003580;DB13069;LP00820;MCULE-1724127345;NSC-758675;NCGC00015755-01;NCGC00015755-02;NCGC00015755-04;NCGC00015755-05;NCGC00015755-06;NCGC00015755-07;NCGC00015755-08;NCGC00015755-10;NCGC00094151-01;NCGC00094151-02;NCGC00094151-03;NCGC00094151-04;NCGC00094151-05;NCGC00094151-06;NCGC00261505-01;AC-10562;CC-32862;SBI-0050797.P003;LS-158849;EU-0100820;FT-0630626;D08276;N 8659;AB00053171_06;471N283;C-17170;SR-01000076036-1;SR-01000076036-5;N'-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-N-(2-CHLORETHYL)-N-NITROSOUREA;N'-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-N-(2-CHLOROETHYL)-N-NITROSOUREA"	42471-28-3	0S726V972K	"27725524;11026699"	11026699	01/10/2000	11026699	01/10/2000	1999-2003		1	1	0	Yes	1					30/07/2018		213,5	30	71	0	1	GLIOMA	1	DNA	0	1	0	NA	0	0	0	1	1	0,17	0	0	0	0,44	0	0	0	0	0	0	21	0	1
Glufosfamide	glufosfamide		DB06177	"(2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)oxane-3,4,5-triol;(2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;(2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-methylol-tetrahydropyran-3,4,5-triol;132682-98-5;Glucosylifostamide mustard;Glufosfamide;HSDB 7024;beta-D-Glucopyranose, 1-(N,N'-bis(2-chloroethyl)phosphorodiamidate);D-19575;glc-IPM;D 19575;Glucosyl-ifosfamide mustard"	"Glufosfamide;Glucosyl-ifosfamide mustard;Glucosylifostamide mustard;132682-98-5;D 19575;UNII-1W5N8SZD9A;glc-IPM;HSDB 7024;D-19575;1W5N8SZD9A;beta-D-Glucopyranose 1-(N,N'-bis(2-chloroethyl)phosphorodiamidate;beta-D-Glucopyranose, 1-(N,N'-bis(2-chloroethyl)phosphorodiamidate);(2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)oxane-3,4,5-triol;Glufosfamide [INN];C10H21Cl2N2O7P;D0L9IA;SCHEMBL18241;AC1L3X04;CHEMBL2107143;ZINC3918137;AN-32160;LS-71462;Z-3304;682G985;glufosfamide,b-d-glucopyranose, 1-(n,n'-bis(2-chloroethyl)phosphorodiamidate)-;(2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol"	132682-98-5	1W5N8SZD9A	"19479254;11032596"	11032596	01/10/2000	11032596	01/10/2000	1999-2003		1	1	0	Yes	1					30/07/2018		213,5	21	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,05	0	1	1	0,19	0	0	0	0	0	0	0	0	1
Pirfenidone	pirfenidone	Esbriet	DB04951	"5-methyl-1-phenylpyridin-2-one;5-methyl-1-phenyl-pyridin-2-one;5-methyl-1-phenyl-2-pyridinone;5-methyl-1-phenyl-2-pyridone;53179-13-8;Bio1_001375;Bio1_000397;D01583;Pirfenidone (JAN/USAN);Lopac-P-2116;NCGC00015806-01;2(1H)-Pyridinone, 5-methyl-1-phenyl-;2(1H)-Pyridone, 5-methyl-1-phenyl-;5-21-07-00197 (Beilstein Handbook Reference);5-Methyl-1-phenyl-2(1H)-pyridone;AMR 69;AMR-69;BRN 1526549;Deskar;PIRFENIDONE;Pirfenidona [INN-Spanish];Pirfenidone [USAN:INN];Pirfenidonum [INN-Latin];S-7701;5-Methyl-1-phenyl-2-(1H)-pyridone;P2116_SIGMA;NCGC00024992-01;Tocris-1093;EU-0100907;Bio1_000886;Lopac0_000907"	"PIRFENIDONE;53179-13-8;5-methyl-1-phenylpyridin-2(1H)-one;Esbriet;Deskar;Pirespa;AMR-69;5-Methyl-1-phenyl-2-(1H)-pyridone;Pirfenidonum;Pirfenidona;AMR 69;5-Methyl-1-phenyl-1H-pyridin-2-one;5-methyl-1-phenyl-2(1H)-pyridinone;2(1H)-Pyridinone, 5-methyl-1-phenyl-;Pirfenidone [USAN:INN];Pirfenidonum [INN-Latin];Pirfenidona [INN-Spanish];5-methyl-1-phenyl-2-pyridinone;UNII-D7NLD2JX7U;5-Methyl-1-phenyl-2(1H)-pyridone;Pirfenidone (Deskar);5-methyl-1-phenylpyridin-2-one;D7NLD2JX7U;BRN 1526549;glaspia;Pirfenidone (JAN/USAN/INN);5-Methyl-1-phenyl-2-pyridone;CHEBI:32016;5-methyl-1-phenyl-pyridin-2-one;ISWRGOKTTBVCFA-UHFFFAOYSA-N;Pirfenidone-d5;KS-5041;2(1H)-Pyridone, 5-methyl-1-phenyl-;NCGC00015806-03;5-METHYL-N-PHENYL-2-1H-PYRIDONE;F-647;P 2116;S-7701;DSSTox_CID_25183;DSSTox_RID_80731;DSSTox_GSID_45183;CAS-53179-13-8;SR-01000076061;Prfendone;Esbriet (TN);PERFENIDONE;Pirfenidone(AMR69);Tocris-1093;Lopac-P-2116;ACMC-209t1g;D02WCI;SCHEMBL4708;Lopac0_000907;5-21-07-00197 (Beilstein Handbook Reference);MLS000860042;GTPL7532;ZINC1958;CHEMBL1256391;DTXSID4045183;1-phenyl-5-methyl-2-pyridinone;CTK8B3176;HSDB 8340;Pirfenidone, >=97% (HPLC);MolPort-003-666-737;Bio1_000397;Bio1_000886;Bio1_001375;HMS2234G24;HMS3262F16;HMS3267I06;HMS3372A08;HMS3651P08;AC1L2454;AOB31717;EBD52457;HY-B0673;Tox21 110225;Tox21_110225;Tox21_500907;ANW-41906;BDBM50005201;BN0421;CP0088;FCH842465;GP4948;MFCD00866047;NSC748456;s2907;AKOS006273697;Tox21_110225_1;AB07515;AC-6797;AM84939;AN-5207;API0003873;CCG-204989;CS-2905;DB04951;LP00907;NSC-748456;RP24541;RTR-018809;5-methyl-1-phenyl-2-(1H)-pyridinone;;NCGC00015806-01;NCGC00015806-02;NCGC00015806-04;NCGC00015806-05;NCGC00015806-06;NCGC00024992-01;NCGC00024992-02;NCGC00024992-03;NCGC00261592-01;AJ-08117;AK-72929;BC678265;BR-72929;CC-33825;EN000704;H960;SC-17366;SMR000326900;ZB000448;AB0006721;AX8028958;KB-246459;LS-133834;ST2418816;4CH-013041;B2288;EU-0100907;FT-0082541;FT-0602686;P1871;D01583;J90039;M-2515;179P138;A829431;C-07370;I01-1466;J-523979;SR-01000076061-1;SR-01000076061-3;5-METHYL-1-PHENYL-1,2-DIHYDROPYRIDIN-2-ONE;BRD-K96862998-001-03-1;BRD-K96862998-001-09-8;Pirfenidone, European Pharmacopoeia (EP) Reference Standard"	53179-13-8	D7NLD2JX7U	17509460	17509460	01/05/2007	9143872	01/01/1997	1994-1998		1	0	1	No	0	"15/10/2014 00:00;11/01/2017 00:00;08/06/2016 00:00;24/09/2015 00:00"	AP	GENENTECH INC	PIRFENIDONE	15/10/2014	GENENTECH INC	213,0	#N/A																							0						1
Tezacitabine	"(e)-2'-fluoromethylene-2'-deoxycytidine;mdl 101,731;tezacitabine"	"2'-deoxy-2'-((E)-fluoromethylene)cytidine;(E)-2'-deoxy-2'-(fluoromethylene)-cytidine;FMdC"	DB06433	"4-amino-1-[(2R,4S,5S)-5-[(E)-2-fluoro-1-hydroxyethenyl]-4-hydroxyoxolan-2-yl]pyrimidin-2-one hydrate;4-amino-1-[(2R,4S,5S)-5-[(E)-2-fluoro-1-hydroxy-vinyl]-4-hydroxy-tetrahydrofuran-2-yl]pyrimidin-2-one hydrate;4-amino-1-[(2R,4S,5S)-5-[(E)-2-fluoro-1-hydroxyvinyl]-4-hydroxy-2-tetrahydrofuranyl]-2-pyrimidinone hydrate;4-amino-1-[(2R,4S,5S)-5-[(E)-2-fluoro-1-hydroxy-ethenyl]-4-hydroxy-oxolan-2-yl]pyrimidin-2-one hydrate;171176-43-5;(E)-2'-Deoxy-2'-(fluoromethylene)cytidine;Cytidine, 2'-deoxy-2'-(fluoromethylene)-, monohydrate, (2'E)-;Tezacitabine [USAN];Tezacitabine;Tezacytabine"	"Tezacitabine;130306-02-4;Fmdc cpd;Mdl 101,731;UNII-7607Y95N9S;Mdl 101731;(E)-2'-Deoxy-2'-(fluoromethylene) cytidine;MDL-101731;2'-Deoxy-2'-(fluoromethylene)cytidine;7607Y95N9S;Cytidine, 2'-deoxy-2'-(fluoromethylene)-, (2E)-;(E)-2'-Deoxy-2'-(fluoromethylene)cytidine;Tezacitabine [INN];tezaciabine;Tezacitabine, anhydrous;AC1O5KIG;D05HZI;SCHEMBL18724;SCHEMBL18725;Tezacitabine, anhydrous [INN];CHEMBL2105467;C10H12FN3O4;DTXSID10156446;GFFXZLZWLOBBLO-ASKVSEFXSA-N;ZINC3777826;2'-(Fluoromethylene)-2'-deoxycytidine;KW-2331;MDL-101,731;LS-172761;cytidine, 2'-deoxy-2'-(fluoromethylene-14C)-;cytidine, 2'-deoxy-2'-(fluoromethylene)-(2E)-;177956-36-4;4-amino-1-((2R,4S,5R,E)-3-(fluoromethylene)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3E,4S,5R)-3-(fluoromethylidene)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one"	171176-43-5	7607Y95N9S	"12231523;11079170"	11079170	01/11/2000	11079170	01/11/2000	1999-2003		1	1	0	Yes	1					30/07/2018		212,5	NA	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	0	0	NA	0	0	0	0	0	0	21	0	1
Pixantrone	"aza-anthracenedione;bbr 2778;pixantrone dimaleate"	"PIX;6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione;Pixuvri"	DB06193	"6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione;6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-quinone;144510-96-3;6,9-Aea-biqdo;6,9-Bis((2-aminoethyl)amino)benz(g)isoquinoline-5,10-dione;6,9-Bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione;Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-;Pixantrone;D05522;Pixantrone (USAN);5,8-Bis((2-aminoethyl)amino)-2-aza-anthracene-9,10-dione"	"Pixantrone;144510-96-3;6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione;UNII-F5SXN2KNMR;Pixantrone dimaleate;Pixuvri (TN);F5SXN2KNMR;BBR 2778;6,9-Bis[(2-aminoethyl)amino]benz[g]isoquinoline-5,10-dione;Pixantrone maleate;6,9-Bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione;BBR-2778;6,9-Bis((2-aminoethyl)amino)benz(g)isoquinoline-5,10-dione;6,9-bis((2-aminoethyl)amino)benzo[g]isoquinoline-5,10-dione;6,9-Aea-biqdo;144675-97-8;6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione;Pixantrone [USAN:INN:BAN];Pixantrone (USAN/INN);D0Q4OW;AC1L33UF;SCHEMBL7825;Pixantrone (BBR 2778);CHEMBL167731;GTPL7544;DTXSID10162744;CHEBI:135945;PEZPMAYDXJQYRV-UHFFFAOYSA-N;5,8-Bis((2-aminoethyl)amino)-2-aza-anthracene-9,10-dione;ZINC1535903;AKOS005145782;AM84406;API0005281;CS-2913;DB06193;NCGC00274280-01;AC-26441;AN-31477;BC656858;HY-13727;FT-0673961;FT-0689753;D05522;510P963;A808224;6,9-bis(2-azanylethylamino)benzo[g]isoquinoline-5,10-dione;6,9-bis[(2-aminoethyl)amino]-benz[g]isoquinoline-5,10-dione;Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-"	144510-96-3	F5SXN2KNMR	"11432625;11205916;11094309"	11094309	01/11/2000	11094309	01/11/2000	1999-2003		1	1	0	Yes	1					30/07/2018		212,5	24	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	NA	0	LEFT VENTRICULAR DYSFONCTION	1	LETHARGY	1	0	21	0	1
Tariquidar	"tariquidar;xr9576"		DB06240	"N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide;N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxy-phenyl]quinoline-3-carboxamide;N-[2-[[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]amino]-oxomethyl]-4,5-dimethoxyphenyl]-3-quinolinecarboxamide;206873-63-4;3-Quinolinecarboxamide, N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)-;N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide;Tariquidar;Tariquidar [USAN];XR 9576;XR9576;D06008;Tariquidar (USAN)"	"Tariquidar;206873-63-4;XR9576;XR 9576;UNII-J58862DTVD;Tariquidar (USAN/INN);N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide;XR-9576;CHEMBL348475;J58862DTVD;N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide;tariquidarth;3-QUINOLINECARBOXAMIDE, N-[2-[[[4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL]AMINO]CARBONYL]-4,5-DIMETHOXYPHENYL]-;N-(2-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenylcarbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide;N-[2-[[4-[2-(6,7-DIMETHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)ETHYL]PHENYL]CARBAMOYL]-4,5-DIMETHOXY-PHENYL]QUINOLINE-3-CARBOXAMIDE;Tariquidar [USAN:INN:BAN];C38H38N4O6;3-Quinolinecarboxamide, N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)-;Tariquidar (XR9576);D04RLX;AC1L3WN5;MLS006011218;SCHEMBL104163;Tariquidar, >=98% (HPLC);DTXSID10174746;EX-A231;QCR-212;MolPort-027-835-494;HMS3653L21;AOB87165;ZINC4214704;BDBM50075373;s8028;AKOS016008964;AN-1493;CS-0722;PB29709;VA11819;KS-0000003W;NCGC00346448-01;4CA-1211;AK110701;BC282768;DA-08376;HY-10550;KB-80813;SC-50718;SMR004702980;AB0035964;FT-0700261;ST24049327;Y0469;D06008;Q-4385;873T634;J-013523;1N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]phenyl}-4,5-dimethoxy-2-(3-quinolylcarboxamido)benzamide;3-Quinolinecarboxamide,N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)-;N-[2-((4-[2-(6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)ETHYL]PHENYL)CARBAMOYL)-4,5-DIMETHOXYPHENYL]QUINOLINE-3-CARBOXAMIDE"	206873-63-4	J58862DTVD	"19417029;12576431"	12576431	01/02/2003	11106230	01/11/2000	1999-2003		1	1	0	Yes	1					30/07/2018		212,5	NA	NA	1	0	NA	0	NA	1	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
CT-2584	ct-2584 hms		DB13098	"1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dimethylpurine-2,6-dione;1-[11-(dodecylamino)-10-hydroxy-undecyl]-3,7-dimethyl-purine-2,6-dione;1-[10-hydroxy-11-(laurylamino)undecyl]-3,7-dimethyl-xanthine;160944-05-8;166981-13-1;1H-Purine-2,6-dione, 1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-;CT 2584;CT-2584;1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione"	"CT-2584;166981-13-1;160944-05-8;CT 2584;AC1MIWQX;D0V0DI;SCHEMBL107843;MZNMZWZGUGFQJP-UHFFFAOYSA-N;Apra (Cell Therapeutics, US, US);DB13098;1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione;1-[11-(Dodecylamino)-10-hydroxyundecyl]-3,7-dimethylxanthine;1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dimethylpurine-2,6-dione;1H-Purine-2,6-dione, 1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-"	166981-13-1	67E5N3R22H	11104552	11104552	01/12/2000	11104552	01/12/2000	1999-2003		1	1	0	Yes	1					30/07/2018		211,5	30	NA	1	0	NA	1	PHOSPHATIDIC ACID	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	NA	0	0	0	LETHARGY	1	0	0	0	1
Troxacitabine	troxacitabine	(-)-ODDC	DB04961	"4-amino-1-[(2S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one;4-amino-1-[(2S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]-2-pyrimidinone;4-amino-1-[(2S)-2-methylol-1,3-dioxolan-4-yl]pyrimidin-2-one;145918-75-8;(-)-BCH 204;(-)-Occc;2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-;2(1H)-Pyrimidinone, 4-amino-1-(-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-, (2S-cis)-;L-Oddc;Troxacitabine;Troxacitabine [USAN:INN];Troxatyl"	"Troxacitabine;145918-75-8;Troxatyl;Bch-4556;UNII-60KQZ0388Y;(-)-ODDC;SPD-758;60KQZ0388Y;L-Oddc;alpha-L-Dioxolane-C;(-)-Occc;4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)pyrimidin-2(1H)-one;Troxacitabine [USAN:INN];Bch 4556;cis-Dioxolane-C;4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one;(-)-BCH 204;NSC668281;4-Amino-1-[(2s,4s)-2-(Hydroxymethyl)-1,3-Dioxolan-4-Yl]pyrimidin-2(1h)-One;Beta-L-OddC;AC1L9RGX;Troxacitabine < Prop INN;D0D6SZ;(-)-L-.b.-DioxolaneC;Troxacitabine (USAN/INN);SCHEMBL18548;((-))-OddC;(-)-beta-L-Dioxolanecytidine;(-)-1-((2S,4S)-2-(Hydroxymethyl)-1,3-dioxolan-4-yl)cytosine;CHEMBL359164;(2S-cis)-4-Amino-1-(2-(hydroxymethyl)-1,3-dioxolan-4-yl)-2(1H)-pyrimidinone;2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-;2(1H)-Pyrimidinone, 4-amino-1-(-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-, (2S-cis)-;CHEBI:134886;BCPP000031;(-)-L-.beta.-Dioxolane-cytosine;ZINC1642845;AKOS015967351;API0005342;DB04961;PB17193;RL01834;AJ-28647;FT-0771967;Z5463;D06255;Q-4344;918T758;J-525143;(-)-(2S,4S)-1-[2-Hydroxymethyl)-1,3-dioxolan-4-yl]cytosine;4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]-1,2-dihydropyrimidin-2-one;LTT"	145918-75-8	60KQZ0388Y	"17325846;17146106;16609029;11773159;11157029"	11157029	01/02/2001	11157029	01/02/2001	1999-2003		1	1	0	Yes	1					30/07/2018		209,4	42	79	1	0	"AML;ALL;MDS"	0	NA	0	1	0	NA	0	0	0	1	1	0,12	0	1	1	0,2	0	0	0	0	0	0	21	0	1
Incyclinide	"cmt-3;col 3;col-3;incyclinide"		DB11647	"(2Z,4aS,5aR,12aS)-2-(amino-hydroxymethylidene)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione;(2Z,4aS,5aR,12aS)-2-(amino-hydroxy-methylene)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione;(2Z,4aS,5aR,12aS)-2-(amino-hydroxymethylene)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione;(2Z,4aS,5aR,12aS)-2-(amino-hydroxy-methylidene)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione;15866-90-7;Incyclinide;Metastat;D04519;Incyclinide (USAN);Metastat (TN);NSC-683551"	"Incyclinide;Metastat;CMT-3;COL-3;15866-90-7;UNII-21G64WZQ4I;21G64WZQ4I;Tetracycline CMT-3;Incyclinide [USAN:INN];CMT 3;COL 3;4-De(dimethylamino)sancycline;NSC-683551;Metastat (TN);Incyclinide (USAN);NSC 683551;D0IJ7O;4-De(dimethylamino)-6-demethyl-6-deoxytetracycline;SCHEMBL1649092;SCHEMBL8070405;CHEMBL2104970;ZINC1649503;CS-7504;DB11647;HY-13648;D04519;4-Desmethylamino-6-desmethyl-6-desoxy-tetracyclin;(4AS,5AR,12AS)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-2-NAPHTHACENECARBOXAMIDE;15867-23-9;2-Naphthacenecarboxamide, 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4aS,5aR,12aS)-;2-Naphthacenecarboxamide, 1,4,4a,5,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4aS-(4aalpha,5aalpha,12aalpha))-"	15866-90-7	21G64WZQ4I	"15475438;11773164;11208854"	11208854	01/02/2001	11208854	01/02/2001	1999-2003		1	0	0	No	0					30/07/2018	BRAINTREE	209,4	35																							0						1
Plevitrexed	"bgc 9331;plevitrexed;zd9331"	BGC-9331	DB06163	"(2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid;(2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynyl-amino]-2-fluoro-benzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid;(2S)-2-[[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorophenyl]-oxomethyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid;(2S)-2-[[2-fluoro-4-[(4-keto-2,7-dimethyl-1H-quinazolin-6-yl)methyl-propargyl-amino]benzoyl]amino]-4-(2H-tetrazol-5-yl)butyric acid;(2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynyl-amino]-2-fluoro-phenyl]carbonylamino]-4-(2H-1,2,3,4-tetrazol-5-yl)butanoic acid;172521-94-7;153537-73-6;(2S)-2-((4-(((2,7-Dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-2-fluorobenzoyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid;1H-Tetrazole-5-butanoic acid, alpha-((4-(((1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl)-2-propynylamino)-2-fluorobenzoyl)amino)-, (S)-;1H-Tetrazole-5-butanoic acid, alpha-((4-(((1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl)-2-propynylamino)-2-fluorobenzoyl)amino)-, (alphaS)-;NSC 696259;Plevitrexed;Plevitrexed [INN];ZD 9331;ZD9331;NCI60_034390"	"Plevitrexed;ZD 9331;ZD9331;153537-73-6;Plevitrexed [INN];ZD-9331;NSC 696259;UNII-L9P2881C3H;CHEMBL126648;(2s)-2-[(2-fluoro-4-{[(4-hydroxy-2,7-dimethylquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}benzoyl)amino]-4-(2h-tetrazol-5-yl)butanoic acid;L9P2881C3H;Plevitrexed (INN);172521-94-7;(2S)-2-((4-(((2,7-Dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-2-fluorobenzoyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid;(2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid;1H-Tetrazole-5-butanoic acid, alpha-((4-(((1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl)-2-propynylamino)-2-fluorobenzoyl)amino)-, (alphaS)-;1H-Tetrazole-5-butanoic acid, alpha-((4-(((1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl)-2-propynylamino)-2-fluorobenzoyl)amino)-, (S)-;Plevitrexed [INN:BAN];BGC9331;Plevitrexed (R)-isomer;AC1Q6OHR;D04FYZ;D04LYZ;D0I9GR;AC1L4U3V;SCHEMBL177609;GTPL8278;SCHEMBL10067655;CTK4D4270;DTXSID10165351;IEJSCSAMMLUINT-NRFANRHFSA-N;ZINC1654736;BDBM50081252;NSC696259;AKOS027461095;NSC-696259;NCI60_034390;LS-184649;FT-0673968;D10803;UNII-N094EYQ29D component IEJSCSAMMLUINT-NRFANRHFSA-N;(|AS)-|A-[[4-[[(1,4-Dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-1H-tetrazole-5-butanoic Acid;(2S)-2-({4-[[(2,7-Dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino]-2-fluorobenzoyl}amino)-4-(1H-tetrazol-5-yl)butanoic acid;(S)-2-{4-[(2,7-Dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-2-fluoro-benzoylamino}-4-(1H-tetrazol-5-yl)-butyric acid;1H-Tetrazole-5-butanoic acid,4-dihydro-2,7- dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-, (S)-"	153537-73-6	L9P2881C3H	"12796367;12684399;11919253;11230494"	11230494	01/03/2001	11230494	01/03/2001	1999-2003		1	1	0	Yes	1					30/07/2018		208,5	74	NA	1	0	NA	1	THYMIDYLATE SYNTHASE	0	1	0	NA	0	0	0	1	1	0,01	0	0	0	NA	0	0	0	0	0	0	21	0	1
7-Hydroxystaurosporine	"7-hydroxystaurosporine;ucn-01"		"DB01933;EXPT03167"	"112953-11-4;AIDS001278;7-Hydroxystaurosporine;8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one, 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-;9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)-;NSC 638850;UCN-01;UCN01;Ucn 01;NCI60_012974;UCN;KW-2401;NSC-638850;KRX-0601;9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3R,9S,10R,11R,13R)-;AIDS-001278"	"7-Hydroxystaurosporine;UCN-01;Ucn 01;112953-11-4;UCN01;UNII-7BU5H4V94A;NSC 638850;7BU5H4V94A;(5s,6r,7r,9r,16r)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one;7-hydroxystaurosporine (UCN-01);KRX-0601;NSC638850;UCN-02;NSC-638850;8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one, 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-;UCN;C28H26N4O4;KW-2401;9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)-;9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3R,9S,10R,11R,13R)-;1okz;D0Z9VY;AC1Q6PB4;GTPL7907;SCHEMBL1551632;CHEMBL1236539;BDBM17054;DTXSID20150238;MolPort-044-561-474;(5S,6R,7R,9R,16R)-16-Hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[;ZINC3814435;AKOS030230764;(+)-UCN-01;DB01933;LS-64044;NCI60_012974;hydroxy-methoxy-methyl-(methylamino)[?]one;J-002880;(5S,6R,7R,9R,16R)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14(5H)-one;2,10,11,12,13-Hexahydro-3-hydroxy-10-methoxy-9-methyl- 11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]-benzodiazonin-1-one;9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one,2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)-;9,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo [3,4-j][1,7]-benzodiazonin-1-one, 2,3,10,11,12,13- hexahydro-3-hydroxy-10-methoxy-9-methyl- 11-(methylamino)-, [3R-(3.alpha., 9.beta., 10.alpha.,11.alpha., 13.beta.)]-"	112953-11-4	7BU5H4V94A	"21745173;15701854;11304786"	11304786	01/04/2001	11304786	01/04/2001	1999-2003		1	1	0	Yes	1					30/07/2018		207,5	47	NA	1	0	NA	1	PKC	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	0,04	0	0	0	0	0	0	21	0	1
Irofulven	"irofulven;mgi 114"	"HMAF;6-hydroxymethylacylfulvene"	"DB05786;DB11733"	"(5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethylspiro[cyclopropane-1,6'-indene]-4'-one;(5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethyl-spiro[cyclopropane-1,6'-indene]-4'-one;(5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethyl-4'-spiro[cyclopropane-1,6'-indene]one;(5'R)-5'-hydroxy-2',5',7'-trimethyl-1'-methylol-spiro[cyclopropane-1,6'-indene]-4'-one;158440-71-2;NSC 683863;NCI60_030149;Acylfulvene, 6-(hydroxymethyl)-;Irofulven;MGI 114;6-(Hydroxymethyl)acylfulvene;Spiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one, 6'-hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethyl-, (R)-;NSC683863;6-Hydroxymethylacylfulvene;HMAF;D04614;Irofulven (USAN)"	"Irofulven;HMAF;158440-71-2;MGI 114;6-Hydroxymethylacylfulvene;6-(Hydroxymethyl)acylfulvene;MGI-114;(-)-Irofulven;NSC 683863;UNII-6B799IH05A;Acylfulvene, 6-(hydroxymethyl)-;6B799IH05A;(R)-6'-hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro[cyclopropane-1,5'-inden]-7'(6'H)-one;(R)-6'-Hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'-(5H)inden)-7'(6'H)-one;Spiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one, 6'-hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethyl-, (R)-;Irofulven [USAN:INN];(R)-Irofulven;Irofulven (USAN/INN);AC1L3WMB;D00EPT;SCHEMBL8800;CHEMBL118218;(-)-(Hydroxymethyl)acylfulvene;DTXSID50166423;CHEBI:135002;NICJCIQSJJKZAH-AWEZNQCLSA-N;ZINC3916310;BDBM50410835;NSC683863;AKOS027256650;DB05786;NSC-683863;AN-16738;KB-78850;NCI60_030149;LS-146017;E7850;FT-0670419;D04614;(5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethylspiro[cyclopropane-1,6'-indene]-4'-one;(6'R)-6'-Hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro[cyclopropane-1,5'-[5H]inden]-7'(6'H)-one"	158440-71-2	6B799IH05A	"16317728;15161692;11291829"	11291829	01/04/2001	11291829	01/04/2001	1999-2003		1	1	0	Yes	1					30/07/2018		207,5	20	NA	0	1	"AML;ALL;MDS"	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	1	1	NA	0	PULMONARY OEDEMA	1	0	0	0	21	0	1
Becatecarin	rebeccamycin	"rebeccamycin;XL 119"	DB06362	"134598-30-4;Becatecarin (USAN);D03220;BMS 181176;Becatecarin;NSC 655649;XL 119;1,11-Dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione;5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-"	"Becatecarin;119673-08-4;Bms-181176;UNII-A60X6MBU6G;XL-119;A60X6MBU6G;BMY-27557;Bmy 27557;Becatecarin [USAN:INN];C33H34Cl2N4O7;Bms 181176;NSC-655649;DEAE-Rebeccamycin;XL 119;Becatecarin < USAN;NSC 655649;Becatecarin (USAN/INN);D0N1FR;AC1L2R0J;SCHEMBL5953787;CHEMBL2107313;BMY-27557-14 (tartrate);MolPort-027-720-812;XL119;ZINC3950898;BMY-27557-01 (HCl);1,11-Dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione;X2117;D03220;1,11-Dichloro-6-(2-(diethylamino)ethyl)-12-(4-O-methyl-beta-D-glucopyranosyl)-12,13-dihydro-5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione;1,11-Dichloro-6-[2-(diethylamino)ethyl]-12-(4-O-methyl-beta-D-glucopyranosyl)-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione;134598-30-4;5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-"	119673-08-4	A60X6MBU6G	"12114420;11387367;11304785"	11304785	01/04/2001	11304785	01/04/2001	1999-2003		1	1	0	Yes	1					30/07/2018		207,5	30	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,1	0	0	0	0,5	0	0	0	0	0	0	0	0	1
Tacedinaline	"ci-994;tacedinaline"		DB12291	"4-acetamido-N-(2-aminophenyl)benzamide;112522-64-2;D05988;Tacedinaline (USAN);Acetyldinaline;CI-994;Goe-5549;PD-123654;4-(Acetylamino)-N-(2-aminophenyl)benzamide;Benzamide, 4-(acetylamino)-N-(2-aminophenyl)-;C.I. 994;Goe 5549;PD 123654;Tacedinalina;Tacedinalina [INN-Spanish];Tacedinaline;Tacedinaline [USAN:INN]"	"112522-64-2;ci-994;Tacedinaline;Acetyldinaline;4-acetamido-N-(2-aminophenyl)benzamide;CI 994;4-acetylamino-N-(2'-aminophenyl)benzamide;Tacedinalina;CI994 (Tacedinaline);N-acetyldinaline;Goe 5549;Goe-5549;Tacedinaline [USAN:INN];Tacedinalina [INN-Spanish];PD-123654;4-(Acetylamino)-N-(2-aminophenyl)benzamide;C.I. 994;PD 123654;UNII-UMF554N5FG;Tacedinaline (USAN/INN);4-acetamido-n-(2-aminophenyl)benzamid;UMF554N5FG;CHEBI:90195;C15H15N3O2;CI994;Benzamide, 4-(acetylamino)-N-(2-aminophenyl)-;AC1L1EDE;AC1Q5NOJ;D0W9NH;MLS006010120;SCHEMBL144794;CHEMBL235191;GTPL8367;ZINC3803;BDBM19422;CTK8E7056;AOB2104;DTXSID60150095;EX-A224;MolPort-009-197-463;VAZAPHZUAVEOMC-UHFFFAOYSA-N;BCPP000281;HMS3651P13;KS-00000IO6;CI?994;MFCD00866266;s2818;AKOS015890391;AN-1245;API0005380;BCP9000527;CCG-208757;CS-1280;DB12291;MCULE-7745808196;QC-9196;N-(2-aminophenyl)-4-acetamidobenzamide;4CA-0375;AJ-08180;AK-29781;AS-19557;CC-17639;CI-994, >=98% (HPLC), powder;HY-50934;KB-36156;LS-25188;SMR002530306;ZB000547;4-Acetamino-N-(2'-aminophenyl)-benzamide;AB0035912;AX8017570;DB-006613;RT-012019;A4102;FT-0650475;ST24043175;Y0359;D05988;S-7681;522A642;C-35003;SR-01000944935;I01-6962;J-002788;SR-01000944935-1;BRD-K52313696-001-01-6;BRD-K52313696-001-08-1;4-Acetylamino-N-(2 inverted exclamation marka-aminophenyl)benzamide"	112522-64-2	UMF554N5FG	11291827	11291827	01/04/2001	11291827	01/04/2001	1999-2003		1	1	0	Yes	1					30/07/2018		207,5	53	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	0,08	0	0	0	0	0	0	0	0	1
Arzoxifene	arzoxifene		DB06249	"2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol;2-(4-methoxyphenyl)-3-[4-[2-(1-piperidyl)ethoxy]phenoxy]benzothiophen-6-ol;2-(4-methoxyphenyl)-3-[4-[2-(1-piperidyl)ethoxy]phenoxy]-6-benzothiophenol;2-(4-methoxyphenyl)-3-[4-(2-piperidinoethoxy)phenoxy]benzothiophen-6-ol;182133-25-1;Arzoxifene [INN];2-(p-Methoxyphenyl)-3-(p-(2-piperidinoethoxy)phenoxy)benzo(b)thiophene-6-ol;Arzoxifene"	"Arzoxifene;182133-25-1;UNII-E569WG6E60;LY 353381;E569WG6E60;2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol;Arzoxifene [INN];Benzo(b)thiophene-6-ol, 2-(4-methoxyphenyl)-3-(4-(2-(1-piperidinyl)ethoxy)phenoxy)-;Benzo[b]thiophene-6-ol, 2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-;LY-353381;D06LOQ;SCHEMBL285277;CHEMBL226267;BDBM19442;DTXSID10171255;AC1L4522;ZINC1544683;AN-538;AKOS030631785;KB-05502;FT-0751607;124708-EP2292576A2;124708-EP2292592A1;124708-EP2295426A1;124708-EP2295427A1;2-(4-methoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)benzo[b]thiophen-6-ol;2-(4-methoxyphenyl)-3-[4-[2-(1-piperidyl)ethoxy]phenoxy]benzothiophen-6-ol;2-(4-methoxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol;2-(p-Methoxyphenyl)-3-(p-(2-piperidinoethoxy)phenoxy)benzo(b)thiophene-6-ol"	182133-25-1	E569WG6E60	15328178	15328178	01/08/2004	11283133	01/04/2001	1999-2003		1	1	0	Yes	1					30/07/2018		207,5	32	76	0	1	BREAST	1	SERM	0	1	0	NA	0	1	0	1	1	0	0	0	0	0,19	0	0	0	0	0	0	0	0	1
BMS-184476	"bms-184476;bms-188797;taxane analogue"	7-methylthiomethylpaclitaxel	DB12633	"B;M;S;-;1;8;4;4;7;6"	"BMS-184476;7-methylthiomethylpaclitaxel;UNII-3811W2NBZ8;3811W2NBZ8;160237-25-2;7-((Methylthio)methyl)paclitaxel;7-O-((Methylthio)methyl)paclitaxel;Paclitaxel, 7-((Methylthio)methyl)-;BMS 184476;D07LAP;SCHEMBL12168429;7-O-(Methylsulfanylmethyl)paclitaxel;DB12633;10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benz[1,2-b]oxet-9-yl ester;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-,    (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-     2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-4-((methylthio)methoxy)-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-"	160237-25-2	3811W2NBZ8	"14613998;12231518;11331328"	11331328	01/05/2001	11331328	01/05/2001	1999-2003		1	1	0	Yes	1					30/07/2018		206,5	34	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	0,06	0	0	0	0	0	0	0	0	1
Tecemotide	"blp25;emepepimut-s"		DB12568		"Tecemotide;Lipopeptide BLP 25;Tecemotide [USAN:INN];BP 1-148;221214-84-2;420086-91-5;Glycine, L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-L-alanyl-L-histidylglycyl-L-valyl-L-threonyl-L-seryl-L-alanyl-L-prolyl-L-alpha-aspartyl-L-threonyl-L-arginyl-L-prolyl-L-alanyl-L-prolylglycyl-L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-N6-(1-oxohexadecyl)-L-lysyl-"	221214-84-2	Q7Y026G2CX	21393255	21393255	01/03/2011	14656392	01/08/2001	1999-2003		1	1	0	Yes	1					30/07/2018		203,5	17	NA	0	1	NSCLC	1	VACCINE	0	1	0	NA	0	1	0	1	1	0	0	0	0	0,3	0	0	0	0	0	0	401	0	1
Tretazicar	"cb1954;tretazicar"		"DB04253;EXPT00837;DB12772"		"Tretazicar;CB 1954;CB1954;21919-05-1;5-(1-Aziridinyl)-2,4-dinitrobenzamide;5-Aziridino-2,4-dinitrobenzamide;CB-1954;5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE;5-Aziridinyl-2,4-dinitrobenzamide;Tretazicar [INN];2,4-Dinitroethyleneiminobenzamide;2,4-Dinitro-5-ethyleneiminobenzamide;CHEMBL23330;CCRIS 1631;UNII-7865D5D01M;7865D5D01M;NSC 115829;BRN 5825582;Benzamide,5-(1-aziridinyl)-2,4-dinitro-;Benzamide, 5-(1-aziridinyl)-2,4-dinitro-;CB1;C9H8N4O5;SMR000326847;aziridine dinitrobenzamide;CB1954(Tretazicar);AC1Q1YAR;CB 1954, solid;Lopac-C-2235;D07ZHV;Lopac0_000200;MLS000859988;MLS001066333;SCHEMBL366755;AC1L3H57;SCHEMBL15691893;CTK4E7975;DTXSID00176335;MolPort-006-169-612;HMS2233F04;HMS3260H21;HMS3369C05;WLN: T3NTJ AR CVZ DNW FNW;ZINC4475105;Tox21_500200;BDBM50004681;CB 954;MFCD00869490;NSC115829;s7829;AKOS030239859;API0005340;CCG-204295;DB04253;LP00200;NSC-115829;5-aziridin-1-yl-2,4-dinitro-benzamide;NCGC00015220-01;NCGC00015220-02;NCGC00015220-03;NCGC00015220-04;NCGC00093675-01;NCGC00093675-02;NCGC00260885-01;5-(aziridyn-1-yl)-2,4-dinitrobenzamide;LS-25723;NCI60_000357;EU-0100200;C 2235;28334-EP2269990A1;28334-EP2280001A1;28334-EP2281824A1;28334-EP2301923A1;28334-EP2301930A1;28334-EP2308869A1;28334-EP2314578A1;919A051;SR-01000075746;J-014359;SR-01000075746-1"	21919-05-1	7865D5D01M	"19367257;11555577"	11555577	01/09/2001	11555577	01/09/2001	1999-2003		1	1	0	Yes	1					30/07/2018		202,5	30	78	1	1	GASTRO-INTESTINAL	1	DNA	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Squalamine	squalamine	MSI-1246	DB06461	"[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate;[(1R,4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-isopropyl-pentyl] hydrogen sulfate;[(1R,4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-isopropylpentyl] hydrogen sulfate;[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-heptan-3-yl] hydrogen sulfate;148717-90-2;(3beta,5alpha,7alpha,24R)-3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate);3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-;3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate;Cholestane-7,24-diol, 3-((3-(4-(aminobutyl)amino)propyl)amio)-, 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-;Squalamine;Squalamine [INN]"	"Squalamine;Squalamine [INN];148717-90-2;UNII-F8PO54Z4V7;F8PO54Z4V7;CHEBI:80765;(3beta,5alpha,7alpha,24R)-3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate);3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-;3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate;3beta-N-1-(N-[3-(4-aminobutyl)]- 1,3-diaminopropane)-7alpha,24R-dihydroxy-5alpha-cholestane 24-sulfate;Cholestane-7,24-diol, 3-((3-(4-(aminobutyl)amino)propyl)amio)-, 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-;D07PVB;AC1L2I6B;SCHEMBL12836;CHEMBL444929;C34H67N3O5S;UIRKNQLZZXALBI-MSVGPLKSSA-N;MSI-1256;LMST05050024;ZINC30160243;AKOS030526099;HY-16468;LS-173336;C16841;Z-3106;[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate"	148717-90-2	F8PO54Z4V7	"12855619;11751482"	11751482	01/12/2001	11751482	01/12/2001	1999-2003		1	1	0	Yes	1					30/07/2018		199,5	19	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,1	0	0	0	NA	0	0	0	0	0	0	23	0	1
Oblimersen	"g3139;oblimersen sodium"		DB13811			190977-41-4	85J5ZP6YSL	"16322117;15722787;15297406;15277270;11895895;11685732"	11685732	01/10/2001	11751483	01/12/2001	1999-2003		1	1	0	Yes	1					30/07/2018		199,5	26	NA	0	1	PROSTATE	1	BCL2	0	1	0	NA	0	0	0	1	0	0,07	0	0	0	NA	0	0	0	0	0	0	21	0	1
Sabarubicin	"bms-195615;men-10755;sabarubicin"		DB12410		"Sabarubicin;UNII-XS499WOZ93;XS499WOZ93;211100-13-9;44D;MEN-10755;Sabarubicin [INN];D01UGG;AC1L479K;SCHEMBL5953752;CHEMBL1230227;MEN 10959;AKOS032946602;BMS-195615;DB12410;151938-EP2269977A2;151938-EP2272517A1;151938-EP2289868A1;4'-(O-ALPHA-L-DAUNOSAMINYL)-4-DEMETHOXYDOXORUBICIN;(7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-{(4-O-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy}-6,9,11-trihydroxy-9-(hydroxyacetyl)-7,8,9,10-tetrahydrotetracene-5,12-dione;5,12-Naphthacenedione, 7-((4-O-(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S,9S)-"	211100-13-9	XS499WOZ93	"11996468;11761453"	11761453	01/01/2002	11996468	01/03/2002	1999-2003		1	1	0	Yes	1					30/07/2018		196,6	24	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	LEFT VENTRICULAR DYSFONCTION	1	0	0	0	244	0	1
Bizelesin	"bizelesin;nsc 615291;u-77779"		DB12352	"1,3-bis[2-[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-1H-indol-5-yl]urea;1,3-bis[2-[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-1H-indol-5-yl]urea;1,3-bis[2-[[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-6-yl]-oxomethyl]-1H-indol-5-yl]urea;1,3-bis[2-[[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-6-yl]carbonyl]-1H-indol-5-yl]urea;129655-21-6;Bizelesin [USAN:INN];U-77,779;1,3-Bis(2-(((S)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)indol-5-yl)urea;BIZELESIN;Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*))-"	"BIZELESIN;129655-21-6;Bizelesin [USAN:INN];UNII-L0O9OBI87E;U-77779;L0O9OBI87E;U-77,779;U 77779;1,3-Bis(2-(((S)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)indol-5-yl)urea;Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*))-;C43H36Cl2N8O5;Bizelesin < Rec INN;Bizelesin (USAN/INN);AC1L1TXW;D09HJS;AC1Q3H6Q;SCHEMBL4433;CHEMBL284642;DTXSID00156213;NSC615291;ZINC85536995;DB12352;NSC 615291;NSC-615291;LS-172734;FT-0663409;D03137;(8S,8'S)-6,6'-[Carbonylbis(imino-1H-indole-5,2-diylcarbonyl)]bis[8-(chloromethyl)-3,6,7,8-tetrahydro-1-methylbenzo[1,2-b:4,3-b']dipyrrol-4-ol;(S,S)-1,3-Bis[2-[1-(Chloromethyl)-5-hydroxy-8-methyl-1,2,3,6-tetrahydrobenzo[1,2-b:4,3-b']dipyrrol-3-ylcarbonyl]-1H-indol-5-yl]urea;1,3-bis(2-{[(1s)-1-(chloromethyl)-5-hydroxy-8-methyl-1,6-dihydropyrrolo[3,2-e]indol-3(2h)-yl]carbonyl}-1h-indol-5-yl)urea;1,3-bis[2-[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-1H-indol-5-yl]urea;Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*)));Benzo[1,3-b']dipyrrol-4-ol, 6,6'-[carbonylbis(imino- 1H-indole-5,2-diylcarbonyl)]bis[8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, [S-(R*,R*)];N,N'-Bis[2-[[(1S)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo[1,2-b:4,3-b']dipyrrol-3(2H)-yl]carbonyl]-1H-indol-5-yl]urea"	129655-21-6	L0O9OBI87E	"12702533;11895900"	11895900	01/03/2002	11895900	01/03/2002	1999-2003		1	1	0	Yes	1					30/07/2018		196,6	19	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	21	0	1
Atrasentan	atrasentan		DB06199	"(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid;(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxo-ethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid;(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid;(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-keto-ethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid;(+)-A-127722;Xinlay;(+)-A 127722;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R-(2alpha,3beta,4alpha))-;ABT 627;Arasentan;Atrasentan;2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid;A-147627;ABT-627;NSC720763;Atrasentan [INN]"	"Atrasentan;ABT-627;Atrasentan [INN];173937-91-2;Xinlay;ABT 627;A-147627;UNII-V6D7VK2215;A-127722;(+)-A 127722;CHEMBL9194;(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid;V6D7VK2215;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-;(+)-A-127722;A 127722;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R-(2alpha,3beta,4alpha))-;(11C)ABT-627;Xinlay (TN);ABT 147627;D0Y6UU;AC1L4M3F;SCHEMBL34654;A 147627;A-127722.5;GTPL3487;CHEBI:135810;MOTJMGVDPWRKOC-QPVYNBJUSA-N;4-Benzo[1,3]dioxol-5-yl-1-dibutylcarbamoylmethyl-2-(4-methoxy-phenyl)-pyrrolidine-3-carboxylic acid;ZINC3812144;BDBM50051007;NSC720763;AKOS030255123;CS-1372;NSC-720763;2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid;HY-15403;LS-184352;W-5233;181701-EP2269989A1;937A912;2R-(4-methoxyphenyl)-4S(1,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid;(2r,3r,4s)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid;(2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid;(2R,3R,4S)-4-Benzo[1,3]dioxol-5-yl-1-dibutylcarbamoylmethyl-2-(4-methoxy-phenyl)-pyrrolidine-3-carboxylic acid;2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid"	173937-91-2	V6D7VK2215	"15240529;12912943;11956279"	11956279	01/04/2002	11956279	01/04/2002	1999-2003		1	1	0	Yes	1					30/07/2018		195,5	31	NA	1	1	"ADENOCARCINOMA;PROSTATE"	1	ENDOTHELIN-A	0	1	1	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	HEADACHE	1	0	0	0	1
Patupilone	patupilone	"Epothilone B;Epo B;(−)-epothilone B"	"DB03010;EXPT01349"	"(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[1-methyl-2-(2-methylthiazol-4-yl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[1-methyl-2-(2-methyl-4-thiazolyl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methyl-4-thiazolyl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[1-methyl-2-(2-methylthiazol-4-yl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-quinone;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-quinone;152044-54-7;C12154;Epothilone B;Epothilon B;NSC684363;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;LMPK01000046;nchembio853-comp4;EPO 906;EPO-906;NCI60_030305;7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[1-METHYL-2-(2-METHYL-THIAZOL-4-YL)VINYL]-4,17-DIOXABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE;(-)-Epothilone B;4,17-Dioxabicyclo(1410)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-;4,17-Dioxabicyclo(1410)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S-(1R*,3R*(E),7R*,10S*,11R*,12R*,16S*))-;(&#8722;)-Epothilone B;E2656_SIGMA;EPO906;EpoB;Patupilone"	"Epothilone B;Patupilone;152044-54-7;(-)-Epothilone B;Epo B;EpoB;EPO906;UNII-UEC0H0URSE;EPO 906;EPO 906A;GNF-PF-193;CHEBI:31550;UEC0H0URSE;Epothilone B (EPO906, Patupilone);(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;Epothilon B;(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;4,17-Dioxabicyclo(1410)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-;4,17-Dioxabicyclo(1410)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S-(1R*,3R*(E),7R*,10S*,11R*,12R*,16S*))-;7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[1-METHYL-2-(2-METHYL-THIAZOL-4-YL)VINYL]-4,17-DIOXABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE;Patupilone [INN];patupilona;patupilonum;C27H41NO6S;Epothilone B/;NCGC00181131-01;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;EPO 906;Patupilone;epothilone b(epo906);Epothilone B(Patupilone);D0CV7Z;epothilone b house standard;AC1L9LI4;SCHEMBL3808;EPO906; EpoB; Patupilone;CHEMBL94657;DTXSID4046862;CHEBI:94639;AOB2930;EPO-906;MolPort-029-886-745;QXRSDHAAWVKZLJ-PVYNADRNSA-N;BCPP000100;681125-91-7;EX-A1244;ZINC3951737;ABP000730;AN-940;BDBM50103627;CE-141;LMPK04000041;MFCD02101921;NSC684363;s1364;Patupilone (EPO906, Epothilone B);AKOS015951072;CS-0714;DB03010;NSC-684363;AC-22614;AK163080;BC658516;HY-17029;LS-62193;QC-11859;SC-90126;()-epothilone b,epo906, epob, patupilone;AB1008467;AX8226819;ST24048876;C12154;W-5284;EPO906, EpoB, Patupilone, 152044-54-7;150322-43-3 pound not389574-19-0;A809247;BRD-K48935217-001-01-3;(-)-Epothilone B, from Sorangium cellulosum, >=98% (HPLC);(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-4-thiazolyl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-7,11-bis(oxidanyl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;[1S-[1R*,3R*(E),7R*,10S*,11R*,12R*,16S*]]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione"	152044-54-7	UEC0H0URSE	"24937505;22918719;22688083;22027708;21220503;19879067;19451434"	19451434	01/05/2009	12721265	01/05/2002	1999-2003		1	1	0	Yes	1					30/07/2018		194,6	27	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	30	0	1
Falnidamol	bibx 1382		DB12966	"N-(3-chloro-4-fluorophenyl)-N'-(1-methylpiperidin-4-yl)pyrimido[4,5-e]pyrimidine-4,6-diamine;N-(3-chloro-4-fluoro-phenyl)-N'-(1-methyl-4-piperidyl)pyrimido[4,5-e]pyrimidine-4,6-diamine;N-(3-chloro-4-fluorophenyl)-N'-(1-methyl-4-piperidinyl)pyrimido[4,5-e]pyrimidine-4,6-diamine;[4-[(3-chloro-4-fluoro-phenyl)amino]pyrimido[4,5-e]pyrimidin-6-yl]-(1-methyl-4-piperidyl)amine;N-(3-chloro-4-fluoro-phenyl)-N'-(1-methylpiperidin-4-yl)pyrimido[4,5-e]pyrimidine-4,6-diamine;BIBX-1382BS;BIBX-1382;NCGC00161422-01;Falnidamol"	"Falnidamol;BIBX 1382;196612-93-8;BIBX1382;BIBX-1382;UNII-0MU316797D;CHEMBL258940;FTFRZXFNZVCRSK-UHFFFAOYSA-N;0MU316797D;N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine;Bibx 1382bs;Falnidamol [INN];NCGC00161422-01;AC1OCFIP;D00RMC;BIBX-1382BS;BIBX-1382BX;SCHEMBL158563;GTPL7646;DTXSID0048399;CHEBI:93243;AOB5489;EX-A570;MolPort-039-136-623;KS-00001CR9;ZINC1494443;BDBM50375639;AKOS025396660;API0007916;CS-0691;DB12966;NCGC00161422-03;AC-30284;AK174047;AS-16894;HY-10322;KB-57368;DB-014915;FT-0700465;W-5417;BRD-K70914287-300-01-0;8-(3-Chloro-4-fluoroanilino)-2-((1-methyl-4-piperidyl)amino)pyrimido(5,4-d)pyrimidine;8-(3-chloro-4-fluorophenylamino)-2-(1-methylpiperidin-4-ylamino)pyrimido[5,4-d]pyrimidine;4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine;N-(3-chloro-4-fluorophenyl)-N'-(1-methylpiperidin-4-yl)pyrimido[4,5-e]pyrimidine-4,6-diamine;N4-(3-chloro-4-fluoro-phenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine;N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine;Pyrimido(5,4-d)pyrimidine-2,8-diamine, N8-(3-chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-"	196612-93-8	0MU316797D	12008195	12008195	01/05/2002	12008195	01/05/2002	1999-2003		1	1	0	Yes	1					30/07/2018		194,6	11	NA	1	0	NA	1	EGFR	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1
OXI-4503	"combretastatin;combretastatin a1 diphosphate;combretastatin a4 phosphate;combretastatin-a4-phosphate;oxi4503"	"CA1P;Combretastatin A-1 bis(phosphate);Combretastatin A1 diphosphate;OXI4503"	DB05143	"tetrasodium [3-methoxy-2-phosphonatooxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] phosphate;tetrasodium [3-methoxy-2-phosphonatooxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)vinyl]phenyl] phosphate;tetrasodium [3-methoxy-2-phosphato-6-[(Z)-2-(3,4,5-trimethoxyphenyl)vinyl]phenyl] phosphate;CA1P;Combretastatin A-1 phosphate;OXI-4503"	"UNII-JH6Z94GLUD;CA1P;Combretastatin A-1 bis(phosphate);JH6Z94GLUD;OXi4503;OXI-4503;288847-35-8;1,2-Benzenediol,3-methoxy-6-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-,1,2-bis(dihydrogen phosphate);Combretastatin A1 Diphosphate;OXI 4503;AC1OCFKI;CHEMBL1205402;SCHEMBL12677563;ZINC3994214;DB05143;1,2-Benzenediol, 3-methoxy-6-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, 1,2-bis(dihydrogen phosphate);KB-64255;[3-methoxy-2-phosphonooxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate"	288847-35-8	JH6Z94GLUD	"12067983;12807934;12807935;14645433;14734457;19547986;19549771;21276042;21765046;22235096;24500030"	12067983	01/06/2002	12067983	01/06/2002	1999-2003		1	1	0	Yes	1					30/07/2018		193,5	25	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	1	1	NA	0	ACUTE CORONARY SYNDROME	1	0	0	0	0	0	1
Midostaurin	"cgp 41251;cgp41251;midostaurin;pkc 412;pkc412"	"4'-N-benzoylstaurosporine;Rydapt"	DB06595	"D05029;Midostaurin;CGP-41251;PKC-412;Midostaurin (USAN)"	"Midostaurin;PKC412;120685-11-2;Cgp 41251;4'-N-Benzoylstaurosporine;CGP-41251;Benzoylstaurosporine;PKC-412;RYDAPT;PKC 412;UNII-ID912S5VON;Midostaurin (PKC412);Midostaurin (USAN/INN);N-Benzoylstaurosporine;ID912S5VON;CHEMBL608533;CHEBI:63452;Cgp 41 251;N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide;PKC-412(Midostaurin);Midostaurin [USAN:INN];CGP 41231;CPG 41251;Rydapt (TN);Midostaurin(PKC412);4-N-benzoylstaurosporine;D07NVU;D0KL7G;D0V2BO;NVP-PKC412;GTPL5702;SCHEMBL8295379;MolPort-023-276-626;HMS3229K17;EX-A1741;BDBM50326053;CGP-41521;s8064;AKOS024457372;ZINC100013130;ACN-036840;AN-5669;CCG-101288;CS-3331;DB06595;NCGC00241102-01;NCGC00241102-02;HY-10230;KB-75409;D05029;Z-3116;J-004379;BRD-K13646352-001-01-2;MCL-1-specific antisense oligonucleotide + midostaurin(PKC412);[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl)-N-methylbenzamide;N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-4-yl]-N-methylbenzamide"	120685-11-2	ID912S5VON	"22627678;10463595"	10463595	01/08/1999	11230495	01/03/2001	1999-2003		1	1	1	Yes	1	"28/04/2017 00:00;21/06/2018 00:00"	AP	NOVARTIS PHARMS CORP	MIDOSTAURIN	28/04/2017	NOVARTIS PHARMS CORP	193,5	32	NA	1	0	NA	1	PKC	0	1	0	NA	0	0	0	1	0	0,06	0	0	0	NA	0	0	0	0	0	0	524	0	1
Perifosine	"d-21266;nsc 639966;perifosine"		DB06641	"(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate;(1,1-dimethyl-4-piperidin-1-iumyl) octadecyl phosphate;(1,1-dimethylpiperidin-1-ium-4-yl) stearyl phosphate;157716-52-4;D 21266;KRX-0401;Piperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt;NSC-639966;4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt;NSC 639966;Perifosine [INN];Piperidinium, 4-((hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethyl-, inner salt;NSC639966;D-21266;Perifosine;NKA17"	"Perifosine;157716-52-4;1,1-Dimethylpiperidin-1-ium-4-yl octadecyl phosphate;KRX-0401;(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate;Perifosine (KRX-0401);NSC 639966;D 21266;UNII-2GWV496552;1,1-dimethylpiperidinium-4-yl octadecyl phosphate;NKA17;CHEBI:67272;D-21266;4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt;NSC639966;2GWV496552;NSC-639966;NCGC00187909-01;Piperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt;J-500086;Piperidinium, 4-((hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethyl-, inner salt;Perifosine [INN];C25H52NO4P;KRX 0401;PubChem22480;AC1L3WLE;D0R1VU;octadecyl-(1,1-dimethyl-4-piperidylio)phosphate;DSSTox_CID_28872;DSSTox_RID_83141;DSSTox_GSID_48946;SCHEMBL93872;CHEMBL372764;GTPL7424;DTXSID3048946;CTK8B6739;KS-00000XOT;AOB3006;QCR-270;MolPort-005-943-222;YHI-1003;Tox21_113365;ABP000409;AN-933;ANW-54211;BDBM50431630;Perifosine/D21266 /D-21266;s1037;Piperidinium,1-dimethyl-, inner salt;AKOS005146344;CS-0209;EX-3388;GS-3834;RL02027;NCGC00187909-02;4CA-0986;AC-25019;AK-48419;AM808092;BR-48419;HY-50909;SC-27664;AB0022540;KRX-0401, NSC 639966;TC-061681;CAS-157716-52-4;FT-0083490;FT-0651459;ST24026716;W3423;A23834;S-7469;139318-EP2270008A1;139318-EP2292617A1;Octadecyl-(1,1-dimethyl-4-piperidylio) phosphate;I14-1991;1,1-dimethyl-4-{[(octadecyloxy)phosphinato]oxy}piperidin-1-ium;4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-piperidinium Inner Salt;4-Hydroxy-1,1-dimethylpiperidinium hydroxide, octadecyl hydrogen phosphate, inner salt"	157716-52-4	2GWV496552	"27649927;20079628;16914220;15569974;12142051"	12142051	01/07/2002	12142051	01/07/2002	1999-2003		1	1	0	Yes	1					30/07/2018		192,6	22	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	4	0	1
AN-9	pivaloyloxymethyl butyrate	"Pivanex;Pivaloyloxymethylbutyrate;Pivaloyloxymethyl butyrate"	DB05103	"butanoyloxymethyl 2,2-dimethylpropanoate;2,2-dimethylpropanoic acid 1-oxobutoxymethyl ester;2,2-dimethylpropionic acid butyryloxymethyl ester;37380-45-3;122110-53-6;((2,2-Dimethylpropanoyl)oxy)methyl butanoate;AN 9;AN-9;BRN 4861411;Butanoic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester;Pivalyloxymethyl butyrate;AN 9 (ion exchanger);Pivanex"	"Pivanex;AN-9;Pivaloyloxymethyl butyrate;122110-53-6;Pivalyloxymethyl butyrate;AN 9;AN 9 (ion exchanger);UNII-55VNK5440P;BRN 4861411;Butanoic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester;((2,2-Dimethylpropanoyl)oxy)methyl butanoate;55VNK5440P;37380-45-3;Butanoic acid,(2,2-dimethyl-1-oxopropoxy)methyl ester;C10H18O4;ACMC-20mpwb;pivaloyloxymethylbutyrate;AC1L1TUK;SCHEMBL356482;CHEMBL100014;CTK4B2954;DTXSID40190818;ZINC1545115;MFCD00209896;AKOS030571025;API0000914;DB05103;ACM37380453;AN-9, >=95% (HPLC);LS-46268;Butyric acid 2,2-dimethyl-propionyloxymethyl ester;J-004762;Butyric acid 2,2-dimethyl-propionyloxymethyl ester(AN9)"	122110-53-6	55VNK5440P	12114414	12114414	01/07/2002	12114414	01/07/2002	1999-2003		1	1	0	Yes	1					30/07/2018		192,6	28	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	0,04	0	0	0	0	0	0	0	0	1
Triapine	"3-aminopyridine;triapine"		DB11940	"[(3-aminopyridin-2-yl)methylideneamino]thiourea;[(3-amino-2-pyridyl)methyleneamino]thiourea;143621-35-6;236392-56-6;NCI60_021728;NSC663249;Triapine;OCX 191;3-Aminopyridine-2-carboxaldehyde thiosemicarbazone;3-Apct;Hydrazinecarbothioamide, 2-((3-amino-2-pyridinyl)methylene)-;AIDS179996;3-Aminopyridine-2-carboxaldehyde- thiosemicarbazone;AIDS-179996"	"Triapine;236392-56-6;3-Apct;143621-35-6;Pan 811;3-AP;3-Aminopyridine-2-carboxaldehyde thiosemicarbazone;UNII-U4XIL4091C;NSC 663249;OCX 191;200933-27-3;2-((3-Aminopyridin-2-yl)methylene)hydrazinecarbothioamide;C7H9N5S;U4XIL4091C;PAN-811;3-aminopyridine-2-carbaldehyde-thiosemicarbazone;[(E)-(3-amino-2-pyridyl)methyleneamino]thiourea;3-Aminopyridine-2-carboxaldehyde- thiosemicarbazone;Hydrazinecarbothioamide, 2-((3-amino-2-pyridinyl)methylene)-;(E)-2-((3-aminopyridin-2-yl)methylene)hydrazinecarbothioamide;PAN811;NSC663249;[(3-aminopyridin-2-yl)methylideneamino]thiourea;D0DT1R;3-Aminopyridine-2-carboxaldehyde-thiosemicarbazone;SCHEMBL29370;CHEMBL231616;MolPort-027-836-579;AIDS-179996;ZINC8665373;7050AA;s7470;AKOS006273720;API0005341;CS-3106;DB11940;FCH1438351;FCH3689060;NSC-663249;QC-5408;AK120530;AN-29354;AS-16679;HY-10082;KB-52511;LS-76467;AX8245946;KB-180784;ST24038965;Y1881;392T566;2-[(3-Amino-2-pyridinyl)methylene]hydrazinecarbothioamide;Hydrazinecarbothioamide,2-(3-amino-2-pyridinyl)methylene-"	143621-35-6	U4XIL4091C	"14519631;22105720"	14519631	01/10/2003	12203104	01/08/2002	1999-2003		1	1	0	Yes	1					30/07/2018		191,5	27	NA	1	0	NA	1	ribonucleotide reductase	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,17	0	0	0	0	0	0	0	0	1
Amifostine	amifostine	"Amifostina;Amifostinum;Aminopropylaminoethyl thiophosphate;Ethyol - Pws IV 500mg/vial;Amifostine;Ethyol"	"DB01143;APRD00021"	"2-(3-aminopropylamino)ethylsulfanylphosphonic acid;[2-(3-aminopropylamino)ethylthio]phosphonic acid;20537-88-6;53028-04-9;DivK1c_006743;NCI60_002485;2-(3-aminopropylamino)ethylsulfanylphosphonic acid;NCIMech_000622;KBio1_001687;Amifostine;C06819;SMP2_000335;MLS000028473;SMR000058413;Lopac0_000029;2-((3-Aminopropyl)amino)-ethanethiol, dihydrogen phosphate ester (9CI);Acide ((amino-3 propylamino)-2 ethyl)-S-phosphorothioique [French];Amifostine [USAN:BAN:INN];Apaetp;BRN 2088122;Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester);KBioSS_000812;Phosphorothioic acid, S-(2-(3-aminopropylamino)ethyl) ester;S,2-(3-Aminopropylamino)ethyl-phosphorothioic acid;S-(2-((3-Aminopropyl)amino)ethyl) dihydrogen phosphorothioate;S-2-(3-Aminopropylamino)ethyl phosphorothioic acid;S-omega-(3-Aminopropylamino)ethyl dihydrogen phosphorothioate;Lopac-A-5922;Spectrum5_001920;SpecPlus_000647;WR-1065;2-(3-Aminopropyl)aminoethyl phosphorothioate;A5922_SIGMA;WR2721;KBio2_000812;KBio2_003380;KBio2_005948;S-{2-[(3-aminopropyl)amino]ethyl} dihydrogen thiophosphate;NCGC00015073-01;EU-0100029;AIDS-041359;AIDS041359;Ethanethiol, {S-[(3-aminopropyl)amino]-,} dihydrogen phosphate- (ester);{S-[2-(3-Aminopropylamino)ethyl]} phosphorothioate;{S-[2-[(3-Aminopropyl)amino]ethyl]} dihydrogen phosphorothioate;2-(3-Aminopropylamino)ethyl thiophosphate;AU-95722;Aminopropylaminoethyl thiophosphate;Ethanethiol, 2-[(3-aminopropyl)amino]-, dihydrogen phosphate (ester);Ethanethiol, S-[(3-aminopropyl)amino]-, dihydrogen phosphate- (ester);Ethiofos;Gammaphos;NSC296961;Phosphorothioic acid, S-[2-[(3-aminopropyl)amino]ethyl] ester;Phosphorothioic acid, S-[2-[(3-aminopropyl)amino]ethyl]ester;S-(2-(3-Aminopropylamino)ethyl) phosphorothioate;S-[2-(3-Aminopropylamino)ethyl] phosphorothioate;S-[2-[(3-Aminopropyl)amino]ethyl] dihydrogen phosphorothioate;SAPEP;WR 2721;WR 2721C;Spectrum_000332"	"amifostine;20537-88-6;Ethiofos;Gammaphos;Ethyol;Sapep;Apaetp;Aminopropylaminoethyl thiophosphate;WR 2721;2-(3-Aminopropylamino)ethyl thiophosphate;Amifostina;NSC-296961;AU-95722;YM-08310;UNII-ILA426L95O;Amifostine Ethiofos;NSC296961;Amifostinum;C5H15N2O3PS;Amifostine [USAN:INN:BAN];WR-2721;NSC 296961;S-(2-(3-Aminopropylamino)ethyl) phosphorothioate;BRN 2088122;CHEBI:2636;ILA426L95O;JKOQGQFVAUAYPM-UHFFFAOYSA-N;2-(3-aminopropylamino)ethylsulfanylphosphonic acid;WR 2721C;S,2-(3-Aminopropylamino)ethyl-phosphorothioic acid;S-2-(3-Aminopropylamino)ethyl phosphorothioic acid;NCGC00015073-02;S-omega-(3-Aminopropylamino)ethyl dihydrogen phosphorothioate;S-(2-((3-Aminopropyl)amino)ethyl) dihydrogen phosphorothioate;Acide ((amino-3 propylamino)-2 ethyl)-S-phosphorothioique [French];DSSTox_CID_2585;Ethiofos Anhydrous;DSSTox_RID_76644;DSSTox_GSID_22585;S-2-(3-aminopropylamino)-ethylphosphorothioic acid;S-{2-[(3-aminopropyl)amino]ethyl} dihydrogen thiophosphate;Phosphorothioic acid, S-(2-(3-aminopropylamino)ethyl) ester;Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester);S-(2-((3-aminopropyl)amino)ethyl) O,O-dihydrogen phosphorothioate;CAS-20537-88-6;S-[2-(3-Aminopropylamino)ethyl] phosphorothioate;SR-01000075680;YM 08310;S-[2-[(3-Aminopropyl)amino]ethyl] dihydrogen phosphorothioate;CCRIS 9316;HSDB 7560;Amifostine,(S);Spectrum_000332;SpecPlus_000647;Spectrum5_001920;Lopac-A-5922;D06CIE;NCIMech_000622;S 8744;AC1L1D0F;CHEMBL1006;Lopac0_000029;SCHEMBL18464;KBioSS_000812;MLS000028473;BIDD:GT0059;DivK1c_006743;DTXSID8022585;CTK8F7705;KBio1_001687;KBio2_000812;KBio2_003380;KBio2_005948;Acide ((amino-3 propylamino)-2 ethyl)-S-phosphorothioique;63717-27-1 (monohydrate);MolPort-003-666-801;HMS2090I03;HMS3260E19;HMS3713C06;Pharmakon1600-01503081;2-((3-Aminopropyl)amino)-ethanethiol, dihydrogen phosphate ester;HY-B0639;KS-00001F8B;Phosphorothioic acid, S-[2-[(3-aminopropyl)amino]ethyl] ester;WR-2721C;Tox21_110077;Tox21_500029;CCG-35734;Ethanethiol, 2-[(3-aminopropyl)amino]-, 1-(dihydrogen phosphate);NSC758236;ZINC21992285;AKOS015895196;Tox21_110077_1;AC-1126;API0001443;CS-2875;DB01143;LP00029;NSC-758236;RL02548;WR-1064;SMP2_000335;59178-37-9 (di-hydrochloride salt);NCGC00015073-01;NCGC00015073-03;NCGC00015073-04;NCGC00015073-05;NCGC00093549-01;NCGC00093549-02;NCGC00260714-01;AN-15218;AS-13020;BC215613;Ethanethiol, dihydrogen phosphate (ester);NCI60_002485;SC-18798;SMR000058413;Ethanethiol, dihydrogen phosphate- (ester);SBI-0050018.P003;AB0012846;LS-108362;EU-0100029;FT-0622272;37A886;A 5922;C06819;[2-(3-aminopropylamino)ethylthio]phosphonic acid;33870-EP2275420A1;33870-EP2295055A2;33870-EP2295416A2;33870-EP2295426A1;33870-EP2295427A1;33870-EP2298748A2;33870-EP2298764A1;33870-EP2298765A1;33870-EP2305642A2;33870-EP2311453A1;33870-EP2311808A1;33870-EP2311829A1;AB00053311-04;AB00053311-05;AB00053311_06;A814662;{S-[2-(3-Aminopropylamino)ethyl]} phosphorothioate;2-(3-azanylpropylamino)ethylsulfanylphosphonic acid;I06-0333;J-013390;J-519582;SR-01000075680-1;SR-01000075680-3;SR-01000075680-5;2-(3-Aminopropyl)aminoethyl phosphorothioate; WR2721;BRD-K73947551-001-01-0;({2-[(3-aminopropyl)amino]ethyl}sulfanyl)phosphonic acid;Phosphorothioic acid, S-[2-[(3-aminopropyl)amino]ethyl]ester;S-2-(3-aminopropylamino)ethyl O,O-dihydrogen phosphorothioate;{S-[2-[(3-Aminopropyl)amino]ethyl]} dihydrogen phosphorothioate;2-((3-Aminopropyl)amino)-ethanethiol, dihydrogen phosphate ester (9CI);Ethanethiol, {S-[(3-aminopropyl)amino]-,} dihydrogen phosphate- (ester);53028-04-9"	20537-88-6	ILA426L95O	"19185169;14767498;11704320;11459207;9516919"	9516919	01/05/1998	6254682	01/01/1980	Bef. 1989		0	1	1	Yes	1	"11/02/1999 00:00;14/03/2008 00:00;15/01/2016 00:00;04/02/2011 00:00;07/11/2008 00:00;17/07/2017 00:00;11/03/1999 00:00;30/12/1996 00:00;01/04/1999 00:00;21/11/1996 00:00;10/10/1997 00:00;26/08/2013 00:00;24/06/1999 00:00;08/12/1995 00:00;28/03/2006 00:00;20/02/2002 00:00;20/02/1997 00:00;23/01/1996 00:00;27/03/2003 00:00;25/05/2017 00:00;10/09/1999 00:00;09/03/2016 00:00;15/03/1996 00:00;15/12/2016 00:00;18/12/1996 00:00"	AP	"MYLAN LABS LTD;SUN PHARMA GLOBAL;CLINIGEN HLTHCARE"	AMIFOSTINE	08/12/1995	CLINIGEN HLTHCARE	190,8	NA	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	264	0	1
Vadimezan	"5,6-dimethylxanthenone-4-acetic acid;as1404;asa404;vadimezan"	"DMXAA;AS1404"	"DB06235;DB13081"		"DMXAA;117570-53-3;Vadimezan;5,6-Dimethylxantheonone-4-acetic Acid;5,6-Mexaa;2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid;5,6-Dimethylxanthenone-4-acetic acid;DMXAA (Vadimezan);AS-1404;Dimethyloxoxanthene acetic acid;ASA404;(5,6-Dimethyl-9-oxo-xanthen)-4-acetic acid;5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid;NSC 640488;(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid;9H-Xanthene-4-acetic acid, 5,6-dimethyl-9-oxo-;ASA-404;UNII-0829J8133H;6-MeXAA;NSC-640488;AS 1404;CHEBI:75934;9H-Xanthene-4-aceticacid, 5,6-dimethyl-9-oxo-;0829J8133H;R-1564;Vadimezan [INN];ASA 404;vadimezanum;4qxo;4qxq;4qxr;1YE;PubChem22437;ACMC-20ene9;AC1L3XMV;D08UOY;5,6-dimethylxanthenone-4-acetic acid (DMXAA);EC 700-141-4;ASA404?DMXAA?;MLS006011075;CHEMBL71263;SCHEMBL111183;DTXSID2040949;CTK0H6185;AOB5328;EX-A010;MolPort-009-679-427;XGOYIMQSIKSOBS-UHFFFAOYSA-N;BCPP000255;HMS3654J22;ACT07556;KS-00000G3V;ZINC3777432;CD-994;IN2410;MFCD00870555;DMXAA, >=98% (HPLC), solid;AKOS015918030;API0005183;BCP9000616;CS-5277;DB06235;NCGC00165783-01;NCGC00165783-02;4CA-0075;AC-24559;AJ-45574;AK-44878;AN-16676;AS-16852;HY-10964;KB-81421;SMR004702863;AB0004810;AX8126695;RT-012393;ST2403982;FT-0084526;FT-0630255;S1537;(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid;Z-3175;2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid;2-(5,6-dimethyl-9-oxo-xanthen-4-yl)acetic acid;570D533;C-33250;I14-8760;J-003637;J-516547;5,6-Dimethyl-9-oxo-9H-xanthene-4-aceticacid;DMXAA,ASA404;AS-1404, 5,6-MeXAA, NSC-640488, Vadimezan, 117570-53-3;5,6-Dimethylxanthenone-4-acetic acid; 5,6-Dimethylxantheonone-4-acetic Acid"		0829J8133H	"22212299;18381951;16551862;12799625;12228202"	12228202	01/09/2002	12228202	01/09/2002	1999-2003		1	1	0	Yes	1					30/07/2018		190,5	16	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	47	0	1
Semaxanib	"semaxanib;su5416;sugen 5416"		DB06436	"(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2-indolinone;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2-indolinone;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]oxindole;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]oxindole;204005-46-9;194413-58-6;S8442_SIGMA;2H-Indol-2-one, 3-[(3,5-dimethyl-2-pyrrolyl)methylene]-;NSC696819;HSCI1_000303;NCI60_034480;2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (3Z)-;2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (Z)-;3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone;3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole;Semaxanib;Semaxanib [INN];Lopac0_001110;SU5416;H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-;SU 5416;Semaxinib;InSolution&trade; VEGF Receptor 2 Kinase Inhibitor III;NSC-696819;SU-5416;Semoxind;TSU-16;D05819;Semaxanib (USAN);EU-0101110;3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one;nchembio778-comp2;3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one;VEGF Receptor 2 Kinase Inhibitor III;1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"	"Semaxanib;SU5416;SU 5416;Semaxinib;204005-46-9;Semoxind;194413-58-6;Semaxanib (SU5416);SU-5416;Semaxnib;TSU 16;UNII-71IA9S35AJ;VEGF Receptor 2 Kinase Inhibitor III;TSU-16;Semaxanib (USAN/INN);(Z)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one;(Z)-SU 5416;methylene]-2H-indol-2-one;VEGFR2 Kinase Inhibitor III;71IA9S35AJ;CHEMBL276711;3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole;NSC-696819;3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one;3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone;1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one;H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-;S 8442;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one;1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl);3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one;InSolution&trade; VEGF Receptor 2 Kinase Inhibitor III;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one;(3Z)-3-[(3,5-DIMETHYL-1H-PYRROL-2-YL)METHYLIDENE]-2,3-DIHYDRO-1H-INDOL-2-ONE;Semaxanib(SU5416);SMR000568416;SR-01000076044;Semaxanib [USAN:INN];Sugen 5416;Romiplostim;Z-Semaxanib;NCGC00094381-03;NSC 696819;2x2m;D01PZD;D04ADG;D0QY0V;SCHEMBL8190;Lopac0_001110;SCHEMBL19571;MLS001074896;MLS001332519;MLS001332520;3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one;AC1NS627;BDBM4810;GTPL5056;QCR-86;CHEBI:91083;cid_5329098;AOB6828;MolPort-003-959-606;SIBNPBQTUXWRMZ-ZSOIEALJSA-N;WUWDLXZGHZSWQZ-WQLSENKSSA-N;HMS2234L12;HMS3229O13;HMS3263M22;HMS3268J13;HMS3648O12;Tox21 111271;Tox21_501110;2033AH;2712AH;BS0306;HSCI1_000303;MFCD01940922;NSC696819;s2845;SU5146;ZINC12410091;AKOS015994557;AN-3643;CCG-205186;CS-1225;DB06436;ES-0010;LP01110;NCGC00094381-01;NCGC00094381-02;NCGC00094381-04;NCGC00094381-05;NCGC00261795-01;AK174866;AK174898;BC600544;DA-43377;HY-10374;LS-83886;QC-11357;SC-96714;AB0094985;LS-193151;RT-016226;EU-0101110;D05819;W-5403;2H-Indol-2-one,5-dimethyl-2-pyrrolyl)methylene]-;J-013281;SR-01000076044-2;SR-01000076044-8;BRD-K63504947-001-05-5;3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone;3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-indolin-2-one;3-[(3,5-Dimethyl-2H-pyrrol-2-ylidene)methyl]-1H-indol-2-ol;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one;3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro- 2H-indol-2-one;3-[(3,5-dimethyl-1h-pyrrol-2-yl)methylene]-1,3-dihydro-2h-indol-2-one;2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (3Z)-;2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (Z)-;2H-Indol-2-one, 3-(3,5-dimethyl-1H-pyrrol-2-yl)methylene)- 1,3-dihydro-, (Z)-;3-[1-(3,5-dimethyl-1h-pyrrol-2-yl)-meth-(z)-ylidene]-2-oxo-2,3-dihydro-indole;267639-76-9"	194413-58-6	71IA9S35AJ	"19065567;12231519"	12231519	01/09/2002	12231519	01/09/2002	1999-2003		1	1	0	Yes	1					30/07/2018		190,5	22	NA	1	0	NA	1	VEGFR	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	0,21	0	0	0	0	0	0	21	0	1
CHS-828	"chs 828;chs-828"		DB12980	"2-[6-(4-chlorophenoxy)hexyl]-3-cyano-1-pyridin-4-ylguanidine;2-[6-(4-chlorophenoxy)hexyl]-3-cyano-1-(4-pyridyl)guanidine;2-[6-(4-chlorophenoxy)hexyl]-3-cyano-1-pyridin-4-yl-guanidine;200484-11-3;CHS 828;CHS-828;Guanidine, N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinyl-;N-(6-(4-Chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinylguanidine"	"CHS-828;200484-11-3;GMX1778;CHS 828;UNII-8LAP87DNSZ;GMX1778(CHS-828);8LAP87DNSZ;CHEMBL17289;Guanidine, N-[6-(4-chlorophenoxy)hexyl]-N'-cyano-N''-4-pyridinyl-;GMX 1778;CHS828;Guanidine, N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinyl-;GMX-1778;AC1L3WMZ;D0Y1NC;SCHEMBL504150;Cancer therapeutics, LEO Pharma;SCHEMBL12083293;SCHEMBL16312347;BDBM81396;CHEBI:95016;KS-00001CPH;EX-A713;BOIPLTNGIAPDBY-UHFFFAOYSA-N;MolPort-039-139-609;MolPort-044-560-292;MolPort-044-724-622;N-(6-(4-Chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinylguanidine;GMX1778 (CHS828);3544AH;BDBM50435350;s8117;ZINC13282570;AKOS026674121;AKOS026750302;AKOS028109359;AKOS032960393;CS-3852;DB12980;NCGC00345782-01;HY-10079;KB-76081;LS-73363;FT-0700257;J-012977;BRD-K47335880-001-01-3;1-[6-(4-Chlorophenoxy)hexyl]-3-cyano-2-pyridin-4-ylguanidine;1-(6-(4-chlorophenoxy)hexyl)-2-cyano-3-(pyridin-4-yl)guanidine;N-(6-(4-chlorophenoxy)-hexyl)-N'-cyano-N''-(4-pyridyl)-guanidine;N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine;N-Cyano-N'-(6-(p-chlorophenoxy)hexyl)-N""-(4-pyridyl)guanidine"	200484-11-3	8LAP87DNSZ	"12231525;15763645"	12231525	01/09/2002	12231525	01/09/2002	1999-2003		1	1	0	Yes	1					30/07/2018		190,5	16	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Endostar	endostatin	Endostatin, N-terminal-MGGSHHHHH	DB11727				GVG18ZDN65	"17426445;12525513;12228200;12228199;12228197"	12228200	01/09/2002	12228200	01/09/2002	1999-2003		1	1	0	Yes	1					30/07/2018		190,5	25	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	1
DOTMP HO-166	166ho-dotmp	"166Ho-DOTMP;Holmium Ho-166 DOTMP"	DB05380		"UNII-9F972459OC;Holmium Ho-166 dotmp;166Ho-DOTMP;DOTMP Ho-166;9F972459OC;166Ho-1,4,7,10-tetraazacyclododecane-1,4,7,10- tetramethylene-phosphonic acid;633308-23-3"	633308-23-3	9F972459OC	12368378	12368378	01/10/2002	12368378	01/10/2002	1999-2003		1	1	0	Yes	1					30/07/2018		189,5	32	NA	0	1	MYELOMA	0	NA	0	1	0	NA	0	0	0	NA	0	NA	0	NA		NA	0	0	0	0	0	0	0	0	1
Siltuximab	siltuximab	Sylvant	DB09036			541502-14-1	T4H8FMA7IM	"25655379;23659971;20808314;20179212"	20179212	01/02/2010	9722307	01/08/1998	1994-1998		1	1	1	Yes	1	"23/04/2014 00:00;31/05/2018 00:00;24/03/2017 00:00"	AP	JANSSEN BIOTECH	SILTUXIMAB	23/04/2014	JANSSEN BIOTECH	188,3	12	NA	0	1	MYELOMA	1	IL6	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	590	0	1
Epirubicin	epirubicin	"Pidorubicinum;Pidorubicine;Epirubicin;4'-Epiadriamycin;Pidorubicina;Epirubicine;Epirubicinum;Epirubicina;Epiadriamycin;Epirubicin Hydrochloride Injection;Pharmorubicin Rdf;Pharmorubicin Rdf Inj 50mg/vial;PMS-epirubicin;Pharmorubicin PFS;Epirubicin Hydrochloride for Injection;Epirubicin for Injection;Epirubicin Hydrochloride;Ellence"	"DB00445;APRD00361"	"(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyethanoyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;57918-25-9;56420-45-2;CCRIS 2261;Epi-DX;Epiadriamycin;Epirubicina [INN-Spanish];Epirubicina [Spanish];C11230;Epirubicin;Epirubicinum [INN-Latin];Epirubicinum [Latin];HSDB 6962;IMI 28;NChemBio.2007.10-comp15;Pidorubicina [INN-Spanish];Pidorubicine [INN-French];Pidorubicinum [INN-Latin];Ridorubicin;WP 697;10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione;56390-09-1 (HYDROCHLORIDE SALT);56420-45-2 (FREE BASE);AIDS-154877;AIDS154877;NSC256942 (HYDROCHLORIDE SALT);Epirubicine [French];Epirubicine [INN-French];(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;MLS000759412;(7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside;4-Epidoxorubicin;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;BRN 1445813"	"Epirubicin;Epiadriamycin;Epidoxorubicin;4'-Epiadriamycin;56420-45-2;4'-epidoxorubicin;Ellence;Epirubicina;Epirubicine;Epirubicinum;Pidorubicina;Pidorubicine;Pidorubicinum;Ridorubicin;Epi-DX;Epirubicine [French];Epirubicinum [Latin];4-Epidoxorubicin;Epirubicina [Spanish];IMI 28;Epirubicine [INN-French];Epirubicinum [INN-Latin];Epirubicina [INN-Spanish];Pidorubicine [INN-French];Pidorubicinum [INN-Latin];Pidorubicina [INN-Spanish];Epirubicin [INN:BAN];Farmorubicin;4'-epi-Doxorubicin;4'-Epi-DXR;Pharmorubicin Pfs;WP 697;Epirubicin (INN);Epirubicin hydrochloride;Farmorubicin (TN);Pidorubicin;UNII-3Z8479ZZ5X;CCRIS 2261;HSDB 6962;4'-epi-DX;NSC 256942;BRN 1445813;epirarubicin;farmarubicin;farmarubicine;pharmarubicin;CHEBI:47898;AOJJSUZBOXZQNB-VTZDEGQISA-N;3Z8479ZZ5X;Epirubicin HCl;Ellence (TN);Triferric doxorubicin;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside;(7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;NSC256942;NSC-256942;Epirubicin (TN);Pharmorubicin (TN);Ebewe (TN);Acid, 8;AC1Q6JIV;CHEMBL417;D0C9XJ;AC1L26NP;SCHEMBL8582;DTXSID0022987;EPIRUBICIN(Hydrochloride form);BDBM43839;CTK8F9465;56390-09-1 (hydrochloride);Doxorubicin-13CD3 (discontinued);ZINC3938704;AKOS027327569;CS-2824;DB00445;VA10821;NCGC00263918-04;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;AK326115;AN-40147;HY-13624;LS-93992;SBI-0206890.P001;LS-187190;FT-0630692;C11230;D07901;15206-EP2269994A1;15206-EP2270008A1;15206-EP2270018A1;15206-EP2272827A1;15206-EP2275420A1;15206-EP2280012A2;15206-EP2281815A1;15206-EP2289892A1;15206-EP2292615A1;15206-EP2292617A1;15206-EP2295055A2;15206-EP2295416A2;15206-EP2295426A1;15206-EP2295427A1;15206-EP2298748A2;15206-EP2298764A1;15206-EP2298765A1;15206-EP2298768A1;15206-EP2298778A1;15206-EP2298780A1;15206-EP2301928A1;15206-EP2301933A1;15206-EP2305640A2;15206-EP2305642A2;15206-EP2305671A1;15206-EP2305689A1;15206-EP2308855A1;15206-EP2308861A1;15206-EP2311453A1;15206-EP2311808A1;15206-EP2311825A1;15206-EP2311827A1;15206-EP2311829A1;15206-EP2311840A1;15206-EP2311842A2;15206-EP2316832A1;15206-EP2316833A1;AB00698552-11;AB00698552-13;AB00698552-14;AB00698552_15;AB00698552_16;A831042;BRD-K04548931-003-16-5;(7S,9S)-7-[(2R,4S,5R,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione;4'-Epidoxorubicin|||4'-Epiadriamycin|||(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-;57918-25-9"	56420-45-2	3Z8479ZZ5X	"26903311;17513804;16721369;16642371;10394119;9167749"	9167749	01/06/1997	6390286	01/01/1984	Bef. 1989		1	1	1	Yes	1	"20/07/2000 00:00;14/09/2011 00:00;27/06/2007 00:00;15/10/2007 00:00;09/01/2013 00:00;19/07/2017 00:00;24/06/2009 00:00;22/10/2007 00:00;22/05/2009 00:00;23/12/2015 00:00;15/12/2014 00:00;12/03/2012 00:00;23/03/2016 00:00;09/08/2007 00:00;19/12/2014 00:00;15/09/2006 00:00;15/04/2011 00:00;15/09/1999 00:00;03/12/2014 00:00;19/04/2007 00:00;25/03/2010 00:00;28/11/2007 00:00;22/12/2009 00:00;16/04/2015 00:00;03/04/2003 00:00;24/05/2010 00:00;20/12/2014 00:00;20/08/2007 00:00;02/03/2005 00:00;20/06/2013 00:00;07/05/2014 00:00;19/02/2013 00:00;18/09/2008 00:00"	AP	"HISUN PHARM HANGZHOU;CIPLA LTD;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS TOTOWA;WEST-WARD PHARMS INT;MYLAN INSTITUTIONAL;FRESENIUS KABI ONCOL;MUSTAFA NEVSAT;IMPAX LABS INC;HOSPIRA;PFIZER INC;AKORN INC;EBEWE PHARMA"	EPIRUBICIN HYDROCHLORIDE	15/09/1999	PFIZER INC	188,1	26	NA	0	1	AML_LYMPHOMA	0	NA	0	0	1	26	0	0	0	1	0	0,9	0	1	1	1	0	0	0	0	0	0	286	0	1
KRN-7000	"krn7000;α-galactosylceramide"		DB12232	"N-[(3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide;N-[(2S,3R)-2,3-dihydroxy-1-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]heptadecyl]hexacosanamide;N-[(2S,3R)-2,3-dihydroxy-1-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]heptadecyl]hexacosanamide;N-[(2S,3R)-2,3-dihydroxy-1-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]heptadecyl]cerotamide;N-[(3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-octadecan-2-yl]hexacosanamide;158021-47-7;CCRIS 8968;Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-;Krn 7000;Krn-7000"	"Krn 7000;alpha-GalCer;KRN7000;Krn-7000;158021-47-7;UNII-WX671898JF;CCRIS 8968;Galalpha-Cer(t18:0/26:0);CHEBI:466659;alpha-Galactosylceramide;AGL-582;alpha-GalCer(t18:0/26:0);WX671898JF;1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine;(2S,3S,4R)-1-O-(alpha-D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide;N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE;RGI-2001;alpha-GC(C26);alpha-GC (C26);AC1MCVU8;Epitope ID:130694;SCHEMBL512949;CHEMBL384200;MolPort-044-561-093;VQFKFAKEUMHBLV-BYSUZVQFSA-N;CHEMID158021477;Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-;ZINC87496076;DB12232;FT-0670688;C16892;1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine;(2S,3S,4R)-1-O-(|A-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;N-[(1S,2S,3R)-1-[(|A-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide;(2S,3S,4R)-1-O-(alpha-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (TLC);hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;Hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9CI);Hexacosanamide, N-[1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-;N-((2S,3S,4R)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide;N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide"	158021-47-7	WX671898JF	"15756017;12473579"	12473579	01/12/2002	12473579	01/12/2002	1999-2003		1	1	0	Yes	1					30/07/2018		187,5	24	NA	1	0	NA	1	NK	NA	1	0	NA	0	0	0	1	1	0	0	0	0	0,29	0	0	0	0	0	0	21	0	1
Zosuquidar	"ly335979;zosuquidar"		DB06191		"Zosuquidar;167354-41-8;UNII-AB5K82X98Y;AB5K82X98Y;Zosuquidar Trihydrochloride;Zosuquidar Hydrochloride;(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol;Zosuquidar [INN];NCGC00274062-01;AC1MI1NN;CHEMBL444172;CHEMBL3907347;DTXSID9057894;SCHEMBL12432743;CHEBI:94717;ABP000556;BDBM50420186;ZINC95092809;AKOS027325798;ZINC100029945;ZINC253633622;API0007914;CS-0921;RL02146;HY-15255;AB0165466;FT-0701653;RS 33295-198;W-5412;J-500908;BRD-K70557564-305-01-0;(|AR)-4-[(1a|A,6|A,10b|A)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-|A-[(5-quinolinyloxy)methyl]-1-piperazineethanol Hydrochloride;(2R)-1-{4-[(1aR,6R,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-y loxy)propan-2-ol;(2R)-1-{4-[(2R,4S,11R)-3,3-difluorotetracyclo[10.4.0.0^{2,4}.0^{5,10}]hexadeca-1(12),5(10),6,8,13,15-hexaen-11-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol;(R)-1-(4-((1aR,6r,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl)-3-(quinolin-5-yloxy)propan-2-ol;1-Piperazineethanol, 4-((1aalpha,6alpha,10balpha)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo(a,e)cyclopropa(c)cycloheptan-6-yl)-alpha-1((5-quinolinyloxy)methyl-, (alphaR)-;ZQU"	167354-41-8	AB5K82X98Y	12473580	12473580	01/12/2002	12473580	01/12/2002	1999-2003		1	1	0	Yes	1					30/07/2018		187,5	38	NA	1	0	NA	1	PGP	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	"CEREBELLAR DYSFUNCTION;HALLUCINATIONS;PALINOPSIA"	1	0	0	0	1
2-chloroethyl-3-sarcosinamide-1-nitrosourea	sarcnu	"Sarmustine;SARCNU"	DB11688		"Sarcnu;Sarmustine;81965-43-7;Sarcosinamide chloroethylnitrosourea;UNII-BHB013S3MO;2-Chloroethyl-3-sarcosinamide-1-nitrosourea;Sarcosinamide chloroethyl nitrosourea;NSC 364432;BHB013S3MO;NSC-364432;1-(Carbamoylmethyl)-3-(2-chloroethyl)-1-methyl-3-nitrosourea;Urea, 1-(carbamoylmethyl)-3-(2-chloroethyl)-1-methyl-3-nitroso-;2-[[2-chloroethyl(nitroso)carbamoyl]-methylamino]acetamide;CCRIS 9380;Sar CNU;Sarcosinamide nitrosourea;D0D1EV;AC1L2PG9;AC1Q5IC2;CHEMBL166937;SCHEMBL11056837;DTXSID90231487;n2-[(2-chloroethyl)(nitroso)carbamoyl]-n2-methylglycinamide;ZINC3811824;NSC364432;DB11688;NCI60_003356;LS-159291;2-[{[(2-chloroethyl)(nitroso)amino]carbonyl}(methyl)amino]acetamide;Acetamide, 2-((((2-chloroethyl)nitrosoamino)carbonyl)methylamino)-;Acetamide, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl] methylamino]-"	81965-43-7	BHB013S3MO	12525514	12525514	01/01/2003	12525514	01/01/2003	1999-2003		1	1	0	Yes	1					30/07/2018		186,5	43	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,19	0	0	0	0	0	0	21	0	1
Cantuzumab ravtansine	cantuzumab		DB05594			868747-45-9	RNQ8JQ4R9P	"18301896;15240523;12525512"	12525512	01/01/2003	12525512	01/01/2003	1999-2003		1	1	0	Yes	1					30/07/2018		186,5	37	NA	1	0	NA	1	CANAG	0	1	0	NA	0	1	0	1	1	0	0	0	0	0,16	0	0	0	0	0	0	0	0	1
Vinflunine	vinflunine	Javlor	DB11641	"20',20'-difluoro-3',4'-dihydrovinorelbine;InChI=1/C45H54F2N4O8/c1-8-42-14-11-16-51-17-15-43(36(42)51)30-19-31(34(56-5)20-33(30)49(4)37(43)45(55,40(54)58-7)38(42)59-25(2)52)44(39(53)57-6)21-26-18-27(41(3,46)47)23-50(22-26)24-29-28-12-9-10-13-32(28)48-35(29)44/h9-14,19-20,26-27,36-38,48,55H,8,15-;aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(6R,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-me;methyl rel-(2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-(1,1-difluoroethyl)-8-(methoxycarbonyl)-1,3,4,5,6,7,8,9-octahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-met;vinflunine"	"Vinflunine;162652-95-1;Javlor (TN);C45H54F2N4O8;Javlor;L-0070;D0OT9S;SCHEMBL8403;ZINC95627889;CC-35593;Z-3112;652V951;C-23860;Q-101876"	162652-95-1	5BF646324K	"24283925;23299791;22996801;16211365;12649112"	12649112	01/03/2003	12649112	01/03/2003	1999-2003		1	1	0	Yes	1					30/07/2018		184,6	31	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,1	0	0	0	0	0	0	34	0	1
Picoplatin	"amd473;cis-diamminedichloro2-methylpyridine;nx 473;picoplatin;zd0473"	(SP-4-3)-Amminedichloro(2-methylpyridine)platinium	DB04874	"azane; dichloroplatinum; 2-methylpyridine;azane; 2-methylpyridine; platinum(+2) cation; dichloride;ammonia; dichloroplatinum; 2-methylpyridine;ammonia; 2-methylpyridine; platinum(+2) cation; dichloride;ammonia; $a-picoline; dichloroplatinum;ammonia; $a-picoline; platinum(+2) cation; dichloride;181630-15-9;NX-473;ZD-0473;ZD-473;(SP-4-3)-Amminedichloro(2-methylpyridine)platinium;AMD-473;JM-473;Picoplatin;Picoplatin [INN];ZD0473"		181630-15-9	B5TAN0L720	"12671715;12645906"	12645906	01/03/2003	12645906	01/03/2003	1999-2003		1	1	0	Yes	1					30/07/2018		184,6	9	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,33	0	0	0	0	0	1	0	0	1
Anhydrovinblastine	anhydrovinblastine		DB12586	"119264-84-5;120478-94-6;57694-66-3;3',4'-Dehydroisoleurosine;3',4'-Dehydrovinblastine;3',4'-Didehydro-4'-deoxuvincaleukoblastine;3',4'-Didehydroisoleurosine;3',4'-Didehydrovinblastine;Anhydrovinblastine;Anhydrovincaleukoblastine;F 81097;Vincaleukoblastine, 3',4'-didehydro-4'-deoxy-"	"Anhydrovinblastine;3',4'-Anhydrovinblastine;AVLB;CHEBI:1322;38390-45-3;AC1L9EFQ;CHEMBL509507;Anhydrovinblastin;3',4'-anhydro-vinblastine;SCHEMBL1650232;FFRFGVHNKJYNOV-DOVUUNBWSA-N;MolPort-039-338-209;ZINC95616067;AKOS015895947;FT-0689380;V1482;C11641;390A453;I06-1259;Q-101866"	38390-45-3	5B622U08B3	12655441	12655441	01/03/2003	12655441	01/03/2003	1999-2003		1	1	0	Yes	1					30/07/2018		184,6	24	NA	1	1	NSCLC	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,17	0	0	0	0	0	0	0	0	1
Repifermin	repifermin		DB06434			219527-63-6	PW4W1FNC33	15623608	15623608	01/12/2004	12786629	01/03/2003	1999-2003		1	0	0	No	0					30/07/2018		184,6	#N/A																							0						1
IMC-1C11	imc-1c11		DB06101					12684400	12684400	01/04/2003	12684400	01/04/2003	1999-2003		1	1	0	Yes	1					30/07/2018		183,6	14	NA	0	1	COLORECTAL	1	VEGFR2	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,07	0	0	0	0	0	0	25	0	1
Cilengitide	"cilengitide;emd 121974"		DB11890	"2-[(2S,5R,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-5-(benzyl)-11-(3-guanidinopropyl)-8-isopropyl-3,6,9,12,15-pentaketo-7-methyl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]ethanoic acid;188968-51-6;Cilengitide;EMD 121974;Cilengitide (USAN);D03497;EMD-121974;EMD-85189;NSC-707544;Cilengitide [USAN:INN];Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl)"	"Cilengitide;188968-51-6;EMD-121974;Cilengitide [USAN:INN];UNII-4EDF46E4GI;EMD-12192;EMD121974;EMD 121974;4EDF46E4GI;CHEMBL429876;Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl);Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-N-methyl-L-valyl);2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl);2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;EMD-85189;cyclo-(Arg-Gly-Asp-DPhe-NMeVal);NSC-707544;C27H40N8O7;c(RGDfMeV);Cilengitide (USAN/INN);D09ZXO;AC1L42EK;SCHEMBL34082;GTPL6597;DTXSID9044035;CTK4D9964;AMLYAMJWYAIXIA-VWNVYAMZSA-N;MolPort-008-156-037;MolPort-035-395-751;EX-A1775;ZINC3952216;2322AH;BDBM50235980;AKOS024257893;AKOS030525213;AN-5595;CS-1211;cyclo(Arg-Gly-Asp-D-Phe-[N-Me]Val);DB11890;KS-0000000K;BC680157;HY-16141;LS-55820;SC-94175;D03497;W-5315;968C516;[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13pentaaza-cyclopentadec-2-yl]-acetic acid;2-((2S,5R,8S,11S)-5-benzyl-11-(3-((diaminomethylene)amino)propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;2-[(2S,5R,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid"	188968-51-6	4EDF46E4GI	"20839028;20439646;18281665;12706360"	12706360	01/04/2003	12706360	01/04/2003	1999-2003		1	1	0	Yes	1					30/07/2018		183,6	37	NA	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Epratuzumab	"90y-epratuzumab;90y-epratuzumab tetraxetan;amg 412;cd22ab;epratuzumab"	"anti-CD22 IgG;humanised anti-CD22 antibody"	DB04958			205923-57-5	3062P60MH9	"12837807;15328168;25150258"	12837807	01/07/2003	12837807	01/07/2003	1999-2003		1	1	0	Yes	1					30/07/2018		180,6	55	NA	0	1	NHL_B	1	CD22	0	1	0	NA	0	0	0	1	0	0,43	0	1	1	NA	0	0	0	0	0	0	26	0	1
Brostallicin	"brostallicin;pnu-166196a"		DB06598		"Brostallicin;UNII-RPC6R41K4I;203258-60-0;RPC6R41K4I;PNU-166196A;Brostallicin [INN];AC1OCFEA;D0OY5G;SCHEMBL3678233;CHEMBL1189025;DTXSID70174222;ZINC3979512;Z-3228;4-(2-Bromoacrylamido)-N'''-(2-guanidinoethyl)-1,1',1',1'''-tetramethyl-N,4':N',4':N',4'''-quater(pyrrole-2-carboxamide);4-[[4-[[4-[[4-(2-bromoprop-2-enoylamino)-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-N-[2-(diaminomethylideneamino)ethyl]-1-methylpyrrole-2-carboxamide"	203258-60-0	RPC6R41K4I	14760067	14760067	01/02/2004	12912942	01/08/2003	1999-2003		1	1	0	Yes	1					30/07/2018		179,6	27	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	NA	0	0	0	0	0	0	0	0	1
SRT501	"resveratrol;srt501"		DB05073		"resveratrol;501-36-0;trans-resveratrol;3,4',5-Trihydroxystilbene;3,5,4'-Trihydroxystilbene;(E)-5-(4-Hydroxystyryl)benzene-1,3-diol;(E)-resveratrol;3,4',5-Stilbenetriol;Resvida;3,4',5-Trihydroxy-trans-stilbene;5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol;SRT-501;SRT501;Resveratol;SRT 501;3,5,4'-Trihydroxy-trans-stilbene;5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol;5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol;3,4',5-trihydroxy-stilbene;Resveratrol, natural;UNII-Q369O8926L;CHEBI:45713;trans-3,4',5-trihydroxystilbene;(E)-5-(p-Hydroxystyryl)resorcinol;trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene;5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol;CHEMBL165;NSC 327430;(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol;MLS000069735;1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-;LUKBXSAWLPMMSZ-OWOJBTEDSA-N;KUC104385N;PREVENTION 8 (RESVERATROL);C14H12O3;trans-3,4',5 - trihydroxystilbene;NSC327430;KSC-10-164;Q369O8926L;5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol;RM-1812;trans-3,4&prime;,5-Trihydroxystilbene;SMR000058206;R 5010;DSSTox_CID_11980;DSSTox_RID_78898;DSSTox_GSID_31980;CU-01000001503-3;(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol;(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol;1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-;MFCD00133799;STL;SR-01000000163;5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol;CHEBI:27881;CCRIS 8952;HSDB 7571;3fts;4jaz;4qer;Resveratrol, E-;Resveratrol,(S);Stilbene, 2f;NCGC00015894-02;CAS-501-36-0;Prestwick_619;Trans-3,4&prime;Resveratrol, trans-;Resveratrol, synthetic;Opera_ID_586;AC1L9HIC;Prestwick2_000508;Prestwick3_000508;Spectrum5_000552;D0U3EP;Lopac0_001111;REGID_for_CID_6240;SCHEMBL19425;BSPBio_000435;BSPBio_001114;BSPBio_003461;MLS001055357;MLS001076538;MLS001424228;MLS002207121;MLS002222231;ARONIS24568;SPECTRUM1502223;BPBio1_000479;cid_445154;GTPL8741;SGCUT00007;trans-Stilbene-3,4',5-triol;ZINC6787;Resveratrol, analytical standard;DTXSID4031980;REGID_for_CID_445154;BDBM23926;Resveratrol, >=99% (HPLC);BBC/741;BIK9013;2l98;MolPort-002-499-801;BCPP000091;HMS1362H15;HMS1569F17;HMS1792H15;HMS1921N04;HMS1990H15;HMS2052I09;HMS2096F17;HMS2232A18;HMS3263O04;HMS3403H15;HMS3649A20;ACT09778;to_000079;ZX-AS004941;ZX-AT013797;Tox21_110257;Tox21_201374;Tox21_303376;Tox21_501111;ABP000376;AC-727;AN-865;BBL028252;BS0159;CCG-38874;CR-003;GP2549;GP5884;LMPK13090005;s1396;SBB055452;STL146386;AKOS005720936;Tox21_110257_1;ACN-034773;API0000480;CS-1050;DB02709;KS-5047;LP01111;LS-2146;MCULE-5678456463;NC00349;NSC-327430;OR46018;RP17549;SDCCGMLS-0002998.P003;IDI1_002152;Resveratrol solution, 100 mM in DMSO;NCGC00017352-05;NCGC00017352-06;NCGC00017352-07;NCGC00017352-08;NCGC00017352-09;NCGC00017352-10;NCGC00017352-11;NCGC00017352-12;NCGC00017352-13;NCGC00017352-14;NCGC00017352-15;NCGC00017352-16;NCGC00017352-17;NCGC00017352-18;NCGC00017352-19;NCGC00017352-24;NCGC00024003-00;NCGC00024003-04;NCGC00024003-05;NCGC00024003-06;NCGC00024003-07;NCGC00024003-08;NCGC00024003-09;NCGC00024003-10;NCGC00024003-11;NCGC00024003-12;NCGC00024003-13;NCGC00024003-14;NCGC00257465-01;NCGC00258925-01;NCGC00261796-01;375823-41-9;4CN-0696;AJ-08292;AK-39118;AS-12413;BC202036;BR-39118;CC-34242;CJ-00111;CPD000058206;HY-16561;KB-02515;SAM001246888;SC-11924;ST057251;SY014849;ZB000650;AB0006623;AX8004672;ST2408097;TL8003323;EU-0101111;FT-0082623;N1848;R0071;Resveratrol, Vetec(TM) reagent grade, 98%;01R360;C03582;J10118;N88795;5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol;AB00052942-29;AB00052942_31;A827984;5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol;I06-0437;SR-01000000163-3;SR-01000000163-4;SR-01000000163-9;5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol;5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol;5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol;5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol;BRD-K25591257-001-01-2;BRD-K80738081-001-06-2;BRD-K80738081-001-07-0;BRD-K80738081-001-09-6;BRD-K80738081-001-10-4;BRD-K80738081-001-23-7;SR-01000000163-10;SR-01000000163-11;SR-01000000163-16;(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene;(E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene;5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol;Resveratrol, certified reference material, TraceCERT(R);1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-;Resveratrol, European Pharmacopoeia (EP) Reference Standard;533C1DA0-4104-42B5-9D32-9265F40857E4;trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard;3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol;(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol;InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1;trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol"			21680702	21680702	01/06/2011	14586044	01/11/2003	1999-2003		1	0	0	No	0					30/07/2018		176,6	#N/A																							0						1
LY-295501	"ilx 295501;ilx-295501"		DB12574	"3-(3,4-dichlorophenyl)-1-(2,3-dihydro-1-benzofuran-5-ylsulfonyl)urea;3-(3,4-dichlorophenyl)-1-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea;150869-74-2;5-Benzofuransulfonamide, N-(((3,4-dichlorophenyl)amino)carbonyl)-2,3-dihydro-;LY 295501;LY-295501;N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide;N-(5-(2,3-Dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea"	"LY-295501;UNII-240Y4YO0TN;240Y4YO0TN;150869-74-2;N-(5-(2,3-Dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea;AC1L2SJT;D0BA8M;SCHEMBL30351;CHEMBL307177;DTXSID20164633;ly295501;N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide;DB12574;ILX-295501;1-(3,4-Dichlorophenyl)-3-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea;1-(3,4-dichlorophenyl)-3-(2,3-dihydro-1-benzofuran-5-ylsulfonyl)urea;N1-(3,4-Dichlorophenyl)-N2-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea;5-Benzofuransulfonamide, N-(((3,4-dichlorophenyl)amino)carbonyl)-2,3-dihydro-"	150869-74-2	240Y4YO0TN	14654534	14654534	01/12/2003	14654534	01/12/2003	1999-2003		1	1	0	Yes	1					30/07/2018		175,6	49	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	NA	0	0	0	0	0	0	0	0	1
Trabectedin	"ecteinascidin;ecteinascidin 743;ecteinascidin-743;et 743;et-743;trabectedin"	"Ecteinascidin 743;Yondelis"	DB05109	"Ect 743;Ecteinascidine 743;Et 743;NSC 648766;Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6R-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20R*))-;Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (1'R,6R,6aR,7R,13S,14S,16R)-;Trabectedin;Yondelis;NSC-684766"	"Trabectedin;Ecteinascidin;Yondelis;ecteinascidin 743;ET-743;114899-77-3;Et 743;Ecteinascidine 743;Ect 743;UNII-ID0YZQ2TCP;ET743;ID0YZQ2TCP;NSC 648766;NSC 684766;ecteinascidine;CHEBI:84050;DSSTox_CID_26880;DSSTox_RID_81984;DSSTox_GSID_46880;Yondelis (TN);(1'R,6R,6aR,7R,13S,14S,16R)-6',8,14-Trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro(6,16-(epithiopropanooxymethano)-7,13-imino-6aH-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-5-yl acetate;Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6R-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20R*))-;Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (1'R,6R,6aR,7R,13S,14S,16R)-;Trabectedin [INN];CAS-114899-77-3;Trabectedin [USAN:INN:BAN];CCRIS 8133;C39H43N3O11S;NCGC00181159-01;NCGC00181159-02;Ecteinascidin-743;D03RTK;AC1L33FK;CHEMBL450449;GTPL2774;DTXSID2046880;SCHEMBL12119916;PKVRCIRHQMSYJX-AIFWHQITSA-N;Tox21_112762;Tox21_113236;AKOS025401985;ZINC150338708;AN-5365;CS-1608;DB05109;NSC-684766;AC-27767;Ecteinascidin 743;ET-743;Ecteinascidin;HY-50936;LS-146121;X5006;Z-3121;87541-EP2298780A1;87541-EP2305689A1;Ecteinascidin 743|||ET-743|||Yondelis|||NSC-684766;(1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1;{3,11}.0;{2,13}.0;{4,9}.0;{15,23}.0;{16,20}]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate;(6R,6aR,7R,13S,14S,16R,20R)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'H,6aH-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetate"	114899-77-3	ID0YZQ2TCP	"25591040;25100135;24696229;22088484;21660618;19417019;12932661;11801542;11234874;11230466;11230465"	11234874	01/03/2001	11230466	01/03/2001	1999-2003		1	1	1	Yes	1	"20/07/2016 00:00;18/05/2017 00:00;29/06/2018 00:00;23/10/2015 00:00"	AP	JANSSEN PRODS	TRABECTEDIN	23/10/2015	JANSSEN PRODS	175,4	52	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	0,13	0	0	0	0	0	0	234	0	1
Matuzumab	"emd 72000;emd-72000;emd72000;matuzumab"		DB05101			339186-68-4		14701780	14701780	01/01/2004	14701780	01/01/2004	2004-2008		1	1	0	Yes	1					30/07/2018		174,6	22	NA	1	0	NA	1	EGFR	0	1	0	NA	0	0	0	1	1	0,23	0	0	0	0,5	0	0	0	0	0	0	26	0	1
Soblidotin	"soblidotin;synthetic dolastatin 10 derivative;tzt-1027"		DB12677	"(2S)-2-[[(2S)-2-dimethylamino-3-methylbutanoyl]amino]-N-[(3R,4R,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide;(2S)-2-[[(2S)-2-dimethylamino-3-methyl-butanoyl]amino]-N-[(1R,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-4-oxo-1-sec-butyl-butyl]-N,3-dimethyl-butanamide;(2S)-2-[[(2S)-2-dimethylamino-3-methyl-1-oxobutyl]amino]-N-[(1R,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]-1-pyrrolidinyl]-4-oxo-1-sec-butylbutyl]-N,3-dimethylbutanamide;(2S)-2-[[(2S)-2-dimethylamino-3-methyl-butanoyl]amino]-N-[(1R,2R)-4-keto-4-[(2S)-2-[(1R,2R)-3-keto-1-methoxy-2-methyl-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-2-methoxy-1-sec-butyl-butyl]-N,3-dimethyl-butyramide;(2S)-2-[[(2S)-2-dimethylamino-3-methyl-butanoyl]amino]-N-[(3R,4R,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-5-methyl-1-oxo-heptan-4-yl]-N,3-dimethyl-butanamide;149606-27-9;Soblidotin;Soblidotin (JAN);D01919"	"Auristatin PE;Soblidotin;Tzt-1027;149606-27-9;UNII-DQC51A0WQH;DQC51A0WQH;YHI-501;NSC-654663;Soblidotin [INN];Dolastatin derivative;AC1OCFA4;D04TLJ;SCHEMBL4966327;CHEMBL3989512;ZINC3951627;CS-6022;DB12677;ZT-1027;HY-14672;(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(phenethylamino)propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide"	149606-27-9	DQC51A0WQH	"19068085;18214483;17136542;15897580;15033678"	15033678	01/03/2004	15033678	01/03/2004	2004-2008		1	1	0	Yes	1					30/07/2018		172,6	31	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,33	0	0	0	0	0	0	21	0	1
Rebimastat	"bms-275291;d2163;rebimastat"		DB06573	"(2S)-3,3-dimethyl-2-methylamino-N-[(2S)-4-methyl-2-[[(2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butanoyl]amino]pentanoyl]butanamide;(2S)-3,3-dimethyl-2-methylamino-N-[(2S)-4-methyl-2-[[(2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)butanoyl]amino]pentanoyl]butanamide;(2S)-N-[(2S)-2-[[(2S)-2-mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl]amino]-4-methyl-1-oxopentyl]-3,3-dimethyl-2-methylaminobutanamide;(2S)-N-[(2S)-2-[[(2S)-4-(2,5-diketo-3,4,4-trimethyl-imidazolidin-1-yl)-2-mercapto-butanoyl]amino]-4-methyl-pentanoyl]-3,3-dimethyl-2-methylamino-butyramide;259188-38-0;BMS-275291;D 2163;L-Valinamide, N-((2S)-2-mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-;N-((2S)-2-Mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-L-valinamide;Rebimastat;BMS 275291"	"Rebimastat;Bms-275291;259188-38-0;UNII-1B47R6ZX4K;CHEMBL76222;1B47R6ZX4K;D2163;Rebimastat [USAN:INN];Rebimastat (USAN/INN);SCHEMBL645121;ZINC3939175;BDBM50108168;API0008115;BMS 275291-01;BMS-275291-01;D-2163;D03800;(2S)-N-((1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl)-4-methyl-2-(((2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butanoyl)amino)pentanamide;2-[2-Mercapto-4-(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)-butyrylamino]-4-methyl-pentanoic acid (2,2-dimethyl-1-methylcarbamoyl-propyl)-amide(BMS-275291);L-Valinamide, N-((2S)-2-mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-;n-((2s)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-l-leucyl-n,3- dimethyl-l-valinamide;N-[2(S)-Sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butyryl]-L-leucyl-L-tert-leucine methylamide"	259188-38-0	1B47R6ZX4K	"18224669;15041713"	15041713	01/03/2004	15041713	01/03/2004	2004-2008		1	1	0	Yes	1					30/07/2018		172,6	44	NA	1	1	"COLORECTAL;NSCLC"	1	MMP	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Galiximab	"galiximab;idec-114"	Anti-CD80 monoclonal antibody	DB04901			357613-77-5	S9OX9692ZB	15994148	15994148	01/07/2005	15093549	01/04/2004	2004-2008		1	0	0	No	0					30/07/2018		171,6	#N/A																							0						1
Albendazole	albendazole	"Albendazol;Albendazole;Albendazolum;5-(propylthio)-2-carbomethoxyaminobenzimidazole;(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester;Proftril;O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate;Eskazole;Albenza"	"DB00518;APRD00782"	"methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate;N-[6-(propylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester;54965-21-8;KBio1_000704;ChemDiv1_000190;LS-50618;NCGC00022896-05;SMR000036735;NINDS_000704;ZINC01529287;Prestwick_675;KBio2_004580;KBioGR_000801;Albendazole;C01779;Prestwick0_000247;Oprea1_429292;NCGC00022896-03;Prestwick3_000247;IDI1_000704;STOCK2S-67946;DivK1c_000704;Spectrum_001532;KBio2_007148;ZINC03977745;BAS 00439961;Albendazole (JAN/USP/INN);Albenza (TN);D00134;BSPBio_002548;BPBio1_000038;NCGC00022896-04;methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate;Oprea1_585016;Prestwick1_000247;MLS000069722;(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester;methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate;CAS-54965-21-8;ChemDivAM_000003;SPBio_002253;SPECTRUM1503903;NCGC00016876-01;Spectrum4_000201;BSPBio_000034;Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester;Methyl 5-(propylthio)-2-benzimidazolecarbamate;NSC220008;SK&F 62979;SKF 62979;Valbazen;Oprea1_640007;Prestwick2_000247;CHEBI:16664;A4673_SIGMA;SK&F-62979;Spectrum5_001567;ST012016;AIDS-007895;AIDS007895;SKF-62979;[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester;methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate;KBio2_002012;KBioSS_002012;((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French];(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester;5-(Propylthio)-2-carbomethoxyaminobenzimidazole;Albendazol [INN-Spanish];Albendazole [USAN:BAN:INN:JAN];Albendazolum [INN-Latin];Albenza;Bilutac;CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER;DRG-0277;EINECS 259-414-7;Eskazole;NSC 220008;O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate;Proftril;Zental;Zentel"	"albendazole;54965-21-8;Albenza;Eskazole;Valbazen;Zentel;Proftril;Albendazol;Albendazolum;Bilutac;Zental;SK&F 62979;SKF 62979;Metiazol;Methyl 5-(propylthio)-2-benzimidazolecarbamate;SK&F-62979;Albendazol [INN-Spanish];Albendazolum [INN-Latin];5-(Propylthio)-2-carbomethoxyaminobenzimidazole;Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate;(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester;methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate;O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate;SKF-62979;Albenza (TN);NSC 220008;UNII-F4216019LN;HSDB 7444;Albendazole [USAN:INN:BAN:JAN];EINECS 259-414-7;albamelin;albendol;Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester;CHEMBL1483;Albendazole (JAN/USP/INN);CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER;methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate;((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle;CHEBI:16664;HXHWSAZORRCQMX-UHFFFAOYSA-N;Methyl-5-[propylthio]-2-benzimidazole carbamate;((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French];F4216019LN;methyl 5-(propylthio)-1H-benzo[d]imidazol-2-ylcarbamate;methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate;methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate;NCGC00016876-01;[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester;CPD000036735;(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester;CAS-54965-21-8;DSSTox_CID_2563;Methyl 5-(propyl-thio)-2-benzimidazolecarbamate;DSSTox_RID_76632;DSSTox_GSID_22563;methoxy-N-(5-propylthiobenzimidazol-2-yl)carboxamide;methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate;methyl N-(5-propylsulfanyl-1H-benzimidazol-2-yl)carbamate;Albendoral;Andazol;Bendapar;Digezanol;Disthelm;Endoplus;Gascop;Lurdex;[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester;methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate;Mediamix V Disthelm;Albendazole Monohydrochloride;Monohydrochloride, Albendazole;Zenteltrade mark;Andazol);Albenzatrade mark;Andazoltrade mark;Eskazoletrade mark;Albendazole,(S);Eskazole (TN);SKF62979;Prestwick_675;Albendazole(Albenza);SK&F62979;Zentel (TN);Disthelm, Mediamix V;V Disthelm, Mediamix;Albendazole (Albenza);Albendazole [USAN:USP:INN:BAN:JAN];Albendazole Diba Brand;Spectrum_001532;Albendazole Pfizer Brand;AC1L1CVL;AC1Q2YKD;Albendazole Fustery Brand;Albendazole Hormona Brand;Prestwick0_000247;Prestwick1_000247;Prestwick2_000247;Prestwick3_000247;Spectrum4_000201;Spectrum5_001567;ChemDivAM_000003;Diba Brand of Albendazole;Albendazole Liferpal Brand;ChemDiv1_000190;Albendazole Armstrong Brand;Albendazole Sanicoopa Brand;D00KVO;Pfizer Brand of Albendazole;Albendazole Valdecasas Brand;Albendazole, 98%  10g;Fustery Brand of Albendazole;Hormona Brand of Albendazole;Oprea1_429292;Oprea1_585016;Oprea1_640007;SCHEMBL44682;BSPBio_000034;BSPBio_002548;KBioGR_000801;KBioSS_002012;KSC492E0L;Liferpal Brand of Albendazole;MLS000069722;BIDD:GT0615;DivK1c_000704;SPECTRUM1503903;Armstrong Brand of Albendazole;Sanicoopa Brand of Albendazole;SPBio_002253;Albendazole Noe-Socopharm Brand;BPBio1_000038;Valdecasas Brand of Albendazole;DTXSID0022563;CTK3J2205;HMS502D06;HMS587I14;HXHWSAZORRCQMX-UHFFFAOYSA-;KBio1_000704;KBio2_002012;KBio2_004580;KBio2_007148;KS-00000KMZ;MolPort-000-726-929;MolPort-000-760-571;MolPort-001-932-918;NINDS_000704;HMS1568B16;HMS1922K04;HMS2090G19;HMS2093K13;HMS2095B16;HMS2231O03;HMS3259B05;HMS3369C03;HMS3651C15;HMS3712B16;Pharmakon1600-01503903;Noe Socopharm Brand of Albendazole;Noe-Socopharm Brand of Albendazole;HY-B0223;Tox21_110659;Tox21_302300;AC-015;ANW-42170;BBL005883;BDBM50241293;CCG-39620;MFCD00083232;N-[6-(propylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester;NSC220008;NSC758644;s1640;SBB056658;STK387550;STL046130;ZINC17146904;AKOS000540882;AKOS005431684;AKOS005699352;Tox21_110659_1;CCG-220247;CS-2170;DB00518;KS-5159;MCULE-5872469561;NC00615;NE41026;NSC-220008;NSC-758644;RP29454;RTR-019407;IDI1_000704;SmithKline Beecham Brand of Albendazole;NCGC00016876-02;NCGC00016876-03;NCGC00016876-04;NCGC00016876-05;NCGC00016876-06;NCGC00016876-07;NCGC00016876-08;NCGC00016876-09;NCGC00016876-10;NCGC00016876-12;NCGC00022896-03;NCGC00022896-04;NCGC00022896-05;NCGC00022896-06;NCGC00022896-07;NCGC00022896-08;NCGC00255250-01;Albendazole, analytical standard, >=98%;AN-16210;BAS 00439961;BC202024;CJ-15743;LS-50618;SAM002548932;SAM002589939;SC-17581;SMR000036735;ST012016;SBI-0051849.P002;Smith Kline & French Brand of Albendazole;AB0012898;AB1009519;KB-334951;TL8003543;TR-019407;AB00052377;FT-0621945;methyl 5-propylthio-2-benzimidazolecarbamate;T9034;EN300-49850;methyl 5-propylthio-2-benzimidazole carbamate;VU0239747-6;BIM-0051849.0001;C01779;D00134;J10424;AB00052377-13;AB00052377-14;AB00052377_15;AB00052377_16;Albenza, Eskazole, Zentel, Andazol, Albendazole;A830429;Albendazole, Antibiotic for Culture Media Use Only;SR-01000000171;SR-05000001875;I01-0380;methyl 5-(propylthio)-1H-benzimidazol-2-ylcarbamate;Q-200603;Q-200604;SR-01000000171-2;SR-05000001875-1;BRD-K79131256-001-04-7;BRD-K79131256-001-08-8;methyl 6-(propylthio)-1H-benzo[d]imidazol-2-ylcarbamate;Z1245635850;2-[(Methoxycarbonyl)amino]-5-propylthio-1H-benzimidazole;Albendazole, European Pharmacopoeia (EP) Reference Standard;Methyl (6-(propylthio)-1H-benzo[d]imidazol-2-yl)carbamate;Methyl 5-(propylsulfanyl)-1H-benzimidazol-2-ylcarbamate #;MethylN-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate;Albendazole, United States Pharmacopeia (USP) Reference Standard;Albendazole, Pharmaceutical Secondary Standard; Certified Reference Material;InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)"	54965-21-8	F4216019LN	19904538	19904538	01/11/2009	7041665	01/03/1982	Bef. 1989		1	0	1	No	0	"11/06/2015 00:00;20/08/2007 00:00;20/10/2009 00:00;11/06/1996 00:00;20/12/2017 00:00"	AP	"AMEDRA PHARMS LLC;IMPAX LABS INC"	ALBENDAZOLE	11/06/1996	IMPAX LABS INC	171,0	#N/A																							0						1
Parthenolide	parthenolide		DB13063	"20554-84-1;119325-19-8;120852-67-7;344906-67-8;4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone;Germacra-1(10),11(13)-dien-12-oic acid, 4,5-alpha-epoxy-6-beta-hydroxy-, gamma-lactone;NSC 157035;Oxireno(9,10)cyclodeca(1,2-b)furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bS)-;C07609;Parthenolide;LMPR01030018;ZINC05125148"	"parthenolide;20554-84-1;(-)-Parthenolide;CHEBI:7939;Parthenolide, Tanacetum parthenium;4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone;partenolide;C15H20O3;Prestwick2_000550;Prestwick3_000550;D0M4KE;Epitope ID:115014;SCHEMBL8220;BSPBio_000599;BSPBio_001308;MLS002153872;BPBio1_000659;CHEMBL465158;SCHEMBL13367522;BCBcMAP01_000041;Parthenolide, >=98% (HPLC);MolPort-003-959-089;MolPort-008-268-168;HMS1361B10;HMS1569N21;HMS1791B10;HMS1989B10;HMS2096N21;HMS3402B10;HMS3713N21;HY-N0141;ZINC4492886;MFCD00134592;AKOS016010226;CCG-208244;CS-1919;IDI1_033778;NCGC00163415-01;AJ-51217;AS-17479;Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-;SMR001233226;AB0019832;AB00513860;ST24048874;V0355;X-1866;552P418;Q-100253;Parthenolide, United States Pharmacopeia (USP) Reference Standard;(1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one;(3aS,10R,11R,11aS,6E)-3-Methylene-6,10-dimethyl-10,11-epoxy-1-oxa-2,3,3a,4,5,8,9,10,11,11a-decahydro-1H-cyclopentacyclodecene-2-one"	20554-84-1	2RDB26I5ZB	15122077	15122077	01/05/2004	15122077	01/05/2004	2004-2008		1	1	0	Yes	1					30/07/2018		170,6	NA	NA	0	0	NA	0	NA	1	0	1	NA	0	0	0	NA	0	NA	0	NA		NA	0	0	0	0	0	0	492	0	1
Canfosfamide	"canfosfamide;telcyta;tlk286"		DB04972		"Canfosfamide;Ter-286;TER286;canfosfamide HCl;UNII-1RS284BFUI;1RS284BFUI;Ter 286;TLK286;Canfosfamide [INN];AC1NSM0R;SCHEMBL4914495;CHEMBL2111086;CHEBI:135883;DB04972;N-(3-((2-((Bis(bis(2-chloroethyl)amino)phosphinyl)oxy)ethyl)sulfonyl)-N-glutamyl-alanyl)-2-phenyl-glycine;(2R)-L-gamma-Glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy) ethyl)sulfonyl)- L-alanyl-2-phenylglycine;(2R)-L-gamma-Glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy)ethyl)sulfonyl)-L-alanyl-2-phenylglycine;(2S)-2-amino-5-[[(2R)-3-[2-[bis[bis(2-chloroethyl)amino]phosphoryloxy]ethylsulfonyl]-1-[[(1R)-2-hydroxy-2-oxo-1-phenylethyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;Glycine, L-gamma-glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy)ethyl)sulfonyl)-L-alanyl-2-phenyl-, (2R)-"	158382-37-7	1RS284BFUI	"19701107;15173075"	15173075	01/06/2004	15173075	01/06/2004	2004-2008		1	1	0	Yes	1					30/07/2018		169,6	37	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,3	0	0	0	0	0	0	0	0	1
MKC-1	"mkc-1;r440;ro 31-7453"		DB05608		"MKC-1;125313-92-0;UNII-DNZ11VPY7Q;Bisindolylmaleimide deriv. 44;Ro-31-7453;3-(1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione;DNZ11VPY7Q;Ro 31-7453;3-(1-methyl-1H-indol-3-yl)-4-(1-methyl-6-nitro-1H-indol-3-yl)-1H-pyrrole-2,5-dione;R-440;443912-18-3;MKC 1;m-kc1;AC1NS2UU;R 440;D01UMT;CHEMBL52885;SCHEMBL608128;BDBM2622;DTXSID60154735;MolPort-044-723-396;OVSKGTONMLKNPZ-UHFFFAOYSA-N;ZINC602485;AKOS030228212;Ro-317453;1H-pyrrole-2,5-dione, 3-(1-methyl-1h-indol-3-yl)-4-(1-methyl-6-nitro-1h-indol-3-yl)-;FT-0769873;KS-00000043;3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1H-pyrrole-2,5-dione;3-(1-methyl-1H-indol-3-yl)-4-(1-methyl-6-nitro-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione"	125313-92-0	DNZ11VPY7Q	"21225315;15310782;15240525"	15240525	01/07/2004	15240525	01/07/2004	2004-2008		1	1	0	Yes	1					30/07/2018		168,6	37	77	1	1	COLORECTAL	1	MITOSIS	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	0	0	0	0	0	0	0	1
Ispinesib	ispinesib		DB06188	"N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)quinazolin-2-yl]-2-methylpropyl]-4-methylbenzamide;N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)quinazolin-2-yl]-2-methyl-propyl]-4-methyl-benzamide;N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;N-(3-aminopropyl)-N-[(1R)-1-[3-(benzyl)-7-chloro-4-keto-quinazolin-2-yl]-2-methyl-propyl]-4-methyl-benzamide;nchembio.2007.34-comp1;Ispinesib"	"Ispinesib;336113-53-2;Ispinesib (SB-715992);UNII-BKT5F9C2NI;SB 715992;SB-715992;BKT5F9C2NI;Ispinesib mesilate;Ispinesib (SB-715992 /CK0238273);CHEMBL2347651;Ispinesib [INN];N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide;N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;CK0238273;CK 0238273;G7X;SB715992;D0PW4N;AC1OA9A4;SB-715992/Carbamic acid;Ispinesib - SB-715992;CHEMBL228814;SCHEMBL3582165;CHEBI:94692;DTXSID20187307;MolPort-006-394-712;QJZRFPJCWMNVAV-HHHXNRCGSA-N;BCPP000200;(R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide;AOB87364;Benzamide,N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methyl-;ABP000752;BDBM50382559;BDBM50431891;s1452;ZINC11680799;AKOS025147361;BCP9000797;CS-0891;RL03239;NCGC00263174-01;AN-16698;BC252558;EN002662;HY-50759;Ispinesib,SB-715992, CK0238273;SB-715992, CK0238273,Ispinesib;FT-0670573;S-7742;J-019272;J-521615;BRD-K64881305-001-01-1;SB-715992, 336113-53-2;(R)-N-(3-amino-propyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-quinazolin-2-yl)-2-methyl-propyl]-4-methyl-benzamide;(R)-N-(3-amino-propyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-quinazolin-2-yl)-2-methyl-propyl]4-methyl-benzamide;Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-;N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-quinazolin-2-yl)-2-methyl-propyl]-4-methyl-benzamide"	336113-53-2	BKT5F9C2NI	"22123335;20069338"	20069338	01/01/2010	18319713	01/07/2004	2004-2008	DOI: 10.1200/jco.2004.22.14_suppl.2004	1	1	0	Yes	1					30/07/2018		168,6	27	78	1	0	NA	1	KSP	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,08	0	0	0	0	0	0	0	0	1
Porfimer sodium	photofrin	"Porfimerum natricum;Porfimer sodico;Porfimère sodique;Porfimer natrium;Photofrin"	"DB00707;APRD00078"	"87806-31-3;Photofrin 2;Photofrin Porfimer sodium;Polyhematoporphyrin ether;Porfimer sodico [INN-Spanish];Porfimer sodium;Porfimer sodium [USAN:BAN:INN];Porfimere sodique [INN-French];Porfimerum natricum [INN-Latin];CL 184,116"	"Porfimer;Dhp ether;DIHEMATOPORPHYRIN ETHER;Porfimer Sodium;UNII-625J2HS54G;625J2HS54G;97067-70-4;21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-;Dihematoporphyrin Ester;C68H74N8O11;AC1L1MGD;SCHEMBL19272;CS-3097;HY-13729;LS-178340;3-[13-[1-[1-[8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21,24-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-8-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid"	87806-31-3	Y3834SIK5F	15309918	15309918	01/08/2004	6276108	01/03/1982	Bef. 1989		1	1	1	Yes	1	"10/09/1996 00:00;22/12/1998 00:00;06/07/2000 00:00;01/08/2003 00:00;29/09/2005 00:00;04/04/2011 00:00;27/12/1995 00:00;15/06/2001 00:00;08/09/2008 00:00;25/09/2001 00:00;24/06/2011 00:00;19/07/2002 00:00;17/03/1999 00:00;09/01/1998 00:00;08/05/2001 00:00"	AP	"AXCAN SCANDIPHARM;CONCORDIA LABS INC"	PORFIMER SODIUM	27/12/1995	CONCORDIA LABS INC	165,5	13	NA	0	1	NSCLC	0	NA	0	0	1	13	0	0	0	1	0	NA	0	1	1	1	0	0	0	0	0	0	40	0	1
CP-609754	cp-609,754		DB12640		"UNII-L0S47W9GPY;CP-609754;L0S47W9GPY;1190094-64-4;SCHEMBL4277842;DTXSID40152294;JAHDAIPFBPPQHQ-GDLZYMKVSA-N;DB12640;6-[(r)-(4-chlorophenyl)-hydroxy-(3-methylimidazol-4-yl)methy"	1190094-64-4	L0S47W9GPY	15534083	15534083	01/11/2004	15534083	01/11/2004	2004-2008		1	1	0	Yes	1					30/07/2018		164,6	21	NA	1	0	NA	1	farnesyltransferase	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
ING-1	"anti-ep-cam monoclonal antibody;ing 1;ing-1"		DB05831					15569986	15569986	01/12/2004	15569986	01/12/2004	2004-2008		1	1	0	Yes	1					30/07/2018		163,6	25	NA	0	1	ADENOCARCINOMA	1	EPCAM	0	1	0	NA	0	0	0	1	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Lestaurtinib	lestaurtinib		DB06469	"111358-88-4;156256-78-9;CEP-701;KT 5555;KT-5555;KT5555;Lestaurtinib;SP 924;D04696;Lestaurtinib (USAN);SPM-924;9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-;9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S-(9alpha,10beta,12alpha))-;A 1544750;CEP 701"	"Lestaurtinib;111358-88-4;CEP-701;KT-5555;CEP 701;KT5555;SP 924;KT 5555;SP924;UNII-DO989GC5D1;SPM-924;Lestaurtinib (USAN/INN);CHEMBL603469;DO989GC5D1;C26H21N3O4;A 1544750;SP-924;NCGC00168772-01;9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-;Lestaurtinib [USAN:INN];CEP701;4otg;9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-;A-1544750;D0V9WF;DSSTox_CID_26778;DSSTox_RID_81897;DSSTox_GSID_46778;cc-713;GTPL5672;SCHEMBL1649693;DTXSID5046778;CHEBI:91471;CTK8F0849;BIL2000;MolPort-003-848-372;UIARLYUEJFELEN-LROUJFHJSA-N;ZINC3781738;Tox21_112633;BDBM50308060;KT-555;MFCD12828858;AKOS024457603;AC-5243;AM81228;NCGC00168772-02;NCGC00168772-03;NCGC00168772-04;AN-11201;RT-013568;CAS-111358-88-4;FT-0670762;V0246;D04696;A-154475;J-002567;BRD-K23192422-001-01-1;A 154475.0;A-154475.0;(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one;(5R,7S,8S)-7-hydroxy-7-(hydroxymethyl)-8-methyl-5,6,7,8,13,14-hexahydro-15H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-15-one;(5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one;(9S,10S,12R)-10-Hydroxy-10-(hydroxymethyl)-9-methyl-2,3,9,10,11,12-hexahydro-9,12-epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one;(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3 inverted exclamation mark ,2 inverted exclamation mark ,1 inverted exclamation mark -kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one;(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one;156256-78-9;16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one;2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoic acid;9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S-(9alpha,10beta,12alpha))-;CEP-701|||KT-5555|||(5S,6S,8R)-6-Hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one"	111358-88-4	DO989GC5D1	21340605	21340605	01/02/2011	15528978	01/01/2005	2004-2008		1	1	0	Yes	1					30/07/2018		162,6	30	NA	1	0	NA	1	NEUROTROPHINE RECEPTOR	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,23	0	0	0	0	0	0	0	0	1
Tanespimycin	"17-(allylamino)-17-demethoxygeldanamycin;17-allylamino-17-demethoxygeldanamycin;17-allylamino-demethoxy-geldanamycin;17-allylaminogeldanamycin;cnf1010;tanespimycin"	17AAG	"DB05134;DB06398"		"Tanespimycin;17-AAG;17-Allylaminogeldanamycin;75747-14-7;17-(Allylamino)geldanamycin;NSC-330507;17-Demethoxy-17-allylamino geldanamycin;KOS-953;UNII-4GY0AVT3L4;17AAG;17-(Allylamino)-17-demethoxygeldanamycin;CHEBI:64153;17-AAG (Tanespimycin);BMS-722782;4GY0AVT3L4;Cp 127374;NSC 330507;NCGC00163424-01;17-N-allylamino-17-demethoxygeldanamycin;Geldanamycin, 17-demethoxy-17-(2-propenylamino)-;17-AG;NSC330507;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;[(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate;Geldanamycin, 17-(Allylamino)-17-demethoxy-;17-demethoxy-17-(2-propenylamino)geldanamycin;Tanespimycin [USAN:INN];CNF-101;tanespimycina;tanespimycine;tanespimycinum;CCRIS 9401;17-Demethoxy-17-allylaminogeldanamycin;C31H43N3O8;CP-127374;D0XV0T;AC1O6S9N;DSSTox_CID_26352;DSSTox_RID_81555;DSSTox_GSID_46352;BSPBio_001434;SCHEMBL2604976;DTXSID5046352;SCHEMBL13037468;SCHEMBL16226295;CHEBI:94756;AYUNIORJHRXIBJ-TXHRRWQRSA-N;MolPort-003-983-836;HMS1361H16;HMS1791H16;HMS1989H16;HMS3402H16;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16- tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa- 1(21),4,6,10,18-penten-9-yl carbamate;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate;NSC-330507D;Tox21_112054;BDBM50008057;MFCD04973892;s1141;AKOS024456643;ZINC100014666;BCP9000064;CCG-208039;CS-0161;DB05134;NSC-704057;RL04887;IDI1_033904;NCGC00163424-02;NCGC00163424-04;NCGC00163424-05;NCGC00163424-06;NCGC00163424-07;17-allylamino-17-desmethoxy-geldanamycin;HY-10211;SC-22451;Geldanamycin, des-O-methyl-17-allylamino-;AB2000717;CAS-75747-14-7;Geldanamycin, 17-allylamino-17-demethoxy-;X7553;D06650;W-5317;747A147;Geldanamycin,17-demethoxy-17-(2-propenylamino)-;J-504153;BRD-K81473043-001-03-9;BRD-K81473043-001-08-8;CP 127374, 75747-14-7;17-(Allylamino)-17-demethoxygeldanamycin, >=98% (HPLC), solid;17-Demethoxy-17-allylaminogeldanamycin; Tanespimycin; 17-Allylaminogeldanamycin;(8S,9S,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(allylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate;17-AAG|||17-(Allylamino)-17-demethoxy-geldanamycin|||[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate"	75747-14-7	4GY0AVT3L4	"15718306;17062684;17363531;17363532;17363534;20618337;23564374"	15718306	01/02/2005	15718306	01/02/2005	2004-2008		1	1	0	Yes	1					30/07/2018		161,5	21	NA	1	0	NA	1	HSP90	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Laromustine	"cloretazine;vnp40101m"	"Onrigin;Cloretazine"	"DB05817;DB12324"	"1-(2-chloroethyl-methylsulfonylamino)-3-methyl-1-methylsulfonylurea;1-(2-chloroethyl-methylsulfonyl-amino)-3-methyl-1-methylsulfonyl-urea;1-(2-chloroethyl-mesyl-amino)-1-mesyl-3-methyl-urea;173424-77-6;1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino) carbonyl]hydrazine;NSC734246;Laromustine;VNP-40101M;1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine;101M;Cloretazine;Methanesulfonic acid, 1-(2-chloroethyl)-2-((methylamino)carbonyl)-2-(methylsulfonyl)hydrazide;VNP 40101M;VNP40101M"	"Cloretazine;Laromustine;Onrigin;VNP40101M;VNP-40101M;173424-77-6;101M;VNP 40101M;UNII-14J2G0U3NQ;14J2G0U3NQ;Methanesulfonic acid, 1-(2-chloroethyl)-2-((methylamino)carbonyl)-2-(methylsulfonyl)hydrazide;Laromustine [USAN:INN];Cloretazine [INN];SHP, Vion;Laromustine (USAN);Alkylating agents, Vion;AC1MIWR0;D0E5DB;CHEMBL167691;SCHEMBL2416976;VNP-4090-CE;DTXSID30169614;Sulfonyl hydrazine prodrugs, Vion;PVCULFYROUOVGJ-UHFFFAOYSA-N;ZINC1544545;NSC734246;VN-40101M;1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine;DB05817;NSC-734246;1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-((2-methylamino)carbonyl)hydrazine;ACM173424776;LS-183701;D08939;424C776;1-[2-chloroethyl(methylsulfonyl)amino]-3-methyl-1-methylsulfonylurea;2'-(2-Chloroethyl)-N-methyl-1',2'-bis(methylsulfonyl)carbamohydrazide;2-(2-chloroethyl)-N-methyl-1,2-bis(methylsulfonyl)hydrazinecarboxamide;1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino) carbonyl]hydrazine"	173424-77-6	14J2G0U3NQ	"18281546;15744588"	15744588	01/03/2005	15744588	01/03/2005	2004-2008		1	1	0	Yes	1					30/07/2018		160,6	26	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Entinostat	"entinostat;ms-275;sndx-275"		DB11841		"Entinostat;ms-275;209783-80-2;SNDX-275;MS 275;MS-27-275;SNDX 275;MS 27-275;Histone Deacetylase Inhibitor I;Entinostat (USAN/INN);Entinostat (MS-275);MS-275 (Entinostat);UNII-1ZNY4FKK9H;1ZNY4FKK9H;CHEMBL27759;pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate;pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate;INVTYAOGFAGBOE-UHFFFAOYSA-N;MS275;N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide;pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate;Entinostat (MS-275,SNDX-275);IN1470;NSC706995;BAY86-5274;NSC-706995;BAY 86-5274;pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate;pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate;3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate;Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester;W-201831;3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate;N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide;pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate;Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester;N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester;442532-99-2;entinostatum;pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate;N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide;3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate;PubChem24433;AC1L1HRM;AC1Q5NOI;Entinostat [USAN:INN];MS-275 - Entinostat;D0M8FD;benzamide-type inhibitor, 3;MLS006010183;SCHEMBL148309;GTPL7007;DTXSID0041068;BDBM19410;CTK8F0220;AOB2570;EX-A038;SYN3039;CHEBI:132082;MolPort-005-942-713;BCPP000155;HMS3648K12;HMS3654O11;ACT06782;MS-275,Entinostat,SNDX-275/;ZINC1488870;ABP000145;BN0881;GP3697;s1053;AKOS024262667;AC-8968;AN-1299;BCP9000967;Carbamic acid, 3-pyridinylmethyl ester;CCG-208680;CS-0511;DB11841;Entinostat (MS-275, SNDX-275);RL02591;KS-0000063I;NCGC00165833-01;NCGC00165833-02;NCGC00165833-03;NCGC00165833-04;AJ-26331;AK158952;AS-17906;BC654076;HY-12163;KB-55107;MS27-275;NCI60_038022;SMR004458705;MS-275, A HDAC1 and HDAC3 inhibitor;AB0021206;AX8140473;KB-302728;LS-185285;RT-013958;ST2406823;FT-0667871;V2451;D09338;W-5370;48247-EP2298768A1;48247-EP2305643A1;48247-EP2308868A1;48247-EP2311494A1;48247-EP2311840A1;783M802;A815057;MS-275,Entinostat, SNDX-275, MS-27-275;SR-01000946382;Entinostat, SNDX-275, MS-27-275, MS-275;SR-01000946382-1;BRD-K77908580-001-02-1;BRD-K77908580-001-04-7;(pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate;[4-(2-Amino-phenylcarbamoyl)-benzyl]-carbamic acid pyridin-3-ylmethyl ester;N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid;Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester"	209783-80-2	1ZNY4FKK9H	"18579665;17875771;17179232;16583304"	16583304	01/04/2006	15851766	01/04/2005	2004-2008		1	1	0	Yes	1					30/07/2018		159,6	29	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,29	0	0	0	0	0	0	22	0	1
S-3304	s-3304		DB12149		"S-3304;UNII-BK459F050X;S 3304;203640-27-1;CHEMBL297792;BK459F050X;D-Tryptophan, N-((5-((4-methylphenyl)ethynyl)-2-thienyl)sulfonyl)-;(R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid;(R)-3-(1H-Indol-3-yl)-2-(5-p-tolylethynyl-thiophene-2-sulfonylamino)-propionic acid;D-Tryptophan, N-[[5-[(4-methylphenyl)ethynyl]-2-thienyl]sulfonyl]-;SCHEMBL2380826;CTK0J0531;DTXSID20174292;YWCLDDLVLSQGSZ-JOCHJYFZSA-N;BDBM50063129;AKOS030593350;D-Tryptophan, N-((5-(2-(4-methylphenyl)ethynyl)-2-thienyl)sulfonyl)-;DB12149;DS-19841;HY-106992;CS-0027075;193809-34-6;229165-65-5"	203640-27-1	BK459F050X	17404091	17404091	01/04/2007	15968885	01/06/2005	2004-2008		1	1	0	Yes	1					30/07/2018		157,6	48	NA	0	0	NA	1	MMP	1	1	0	NA	0	0	0	NA	1	NA	0	NA		NA	0	0	0	SOMNOLENCE	1	0	72	0	1
Etalocib	"etalocib;ly293111"		DB12850	"2-[3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]-2-propylphenoxy]benzoic acid;2-[3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxy-phenoxy]propoxy]-2-propyl-phenoxy]benzoic acid;161172-51-6;2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxybiphenyl-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;Benzoic acid, 2-(3-(3-((5-ethyl-4'-fluoro-2-hydroxy(1,1'-biphenyl)-4-yl)oxy)propoxy)-2-propylphenoxy)-;PDSP2_001221;Etalocib [USAN];LY 293111;D04074;Etalocib (USAN);Etalocib;PDSP1_001237"	"Etalocib;LY293111;161172-51-6;UNII-THY6RIW44R;LY 293111;THY6RIW44R;CHEMBL329123;LY-193111;2-[3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]-2-propylphenoxy]benzoic acid;VML295;Etalocib [USAN:INN];Etalocib (USAN);D00GNK;GTPL2948;SCHEMBL1649516;C33H33FO6;CTK8E7596;DTXSID70167073;VML 295;MolPort-009-019-411;YFIZRWPXUYFCSN-UHFFFAOYSA-N;AC1L4328;ZINC3930629;1758AH;BDBM50029450;PDSP1_001237;PDSP2_001221;DB12850;RT-013626;D04074;L001468;J-009797;2-(3-(3-((5-ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxybiphenyl-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;2-[[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenyl]oxy]benzoic acid;2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid;2-{3-[3-(5-Ethyl-4''-fluoro-2-hydroxy-biphenyl-4-yloxy)-propoxy]-2-propyl-phenoxy}-benzoic acid;Benzoic acid, 2-(3-(3-((5-ethyl-4'-fluoro-2-hydroxy(1,1'-biphenyl)-4-yl)oxy)propoxy)-2-propylphenoxy)-"	161172-51-6	THY6RIW44R	15939925	15939925	01/06/2005	15939925	01/06/2005	2004-2008		1	1	0	Yes	1					30/07/2018		157,6	38	NA	1	0	NA	1	"LTB4;PPAR"	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,05	0	0	0	0	0	0	0	0	1
Vatalanib	"cgp-79787;ptk787;ptk787 zk-222584;vatalanib;zk 222584"	"1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate;PTK/ZK;PTK 787"	DB04879	"N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine;N-(4-chlorophenyl)-4-(4-pyridylmethyl)phthalazin-1-amine;N-(4-chlorophenyl)-4-(4-pyridylmethyl)-1-phthalazinamine;(4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-yl]amine;212141-54-3;CGP 79787;1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-;CGP-797870;N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine;Vatalanib;ZK-232934;D06285;Vatalanib (USAN);1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate;nchembio778-comp1"	"Vatalanib;212141-54-3;Vatalanib base;N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine;PTK787;Pynasunate;CGP 79787;PTK-787;Vatalanib (free base);Vatalinib;ZK-232934;CGP-79787;Vatalanib free base;ZK222584;PTK/ZK;CHEMBL101253;N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine;UNII-5DX9U76296;CHEBI:90620;YCOYDOIWSSHVCK-UHFFFAOYSA-N;1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine;Vatalanib (PTK787) 2HCl;5DX9U76296;NCGC00181350-01;1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-;DSSTox_CID_26919;DSSTox_RID_82015;DSSTox_GSID_46919;ZK-222584;1-(4-chloro-anilino)-4-(pyridin-4-yl-methyl)-phthalazine;1-Phtalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-;N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)-1-phthalazinamine;N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phtalazin-1-amine;1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-;CAS-212141-54-3;SR-05000001457;Vatalanib(TM);CGP-797870;Kinome_3657;Vatalanib (USAN/INN);Vatalanib [USAN:INN];D0P6DJ;AC1L45UC;NVP-PTK787;SCHEMBL18286;C20H15ClN4;BDBM4851;BIFK0006;cid_151194;GTPL5705;ZINC7460;DTXSID2046919;CTK4E6114;QCR-126;MolPort-003-850-836;ZX-AFC002994;(A) PTK787;BCPP000021;HMS2089D11;HMS3713O04;ACT06794;CGP-7978;CGP79787;EX-A1398;Tox21 112808;Tox21_112808;AKOS015896483;Tox21_112808_1;API0004576;CCG-220471;CS-5248;DB04879;MCULE-3078477385;BAY-86-5127;NCGC00181350-03;AC-25025;AJ-08301;AN-29745;AS-17435;BC220786;HY-10203;KB-66516;KB-88788;AB0019678;AB1004881;DB-066452;LS-187006;LS-187641;RT-016221;A1778;FT-0657115;VU0549317-1;D06285;AB01275455-01;139368-EP2270008A1;139368-EP2292617A1;141V543;A815203;1-(4-Chloranilino)-4-(4-pyridylmethyl)-phthalazin;1-(4-chloranilino)-4-(4-pyridylmethyl)-phthalazine;I06-1922;K-222584;SR-05000001457-1;SR-05000001457-2;1 -(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine;BRD-K70163715-001-02-8;F9995-0196;1-(4-chlor-anilino)-4-(pyridin-4-yl-methyl)-phthalazine;N-(4-chlorophenyl)-4-(4-pyridylmethyl)phthalazin-1-amine;(4-chlorophenyl)-(4-pyridin-4-ylmethyl-phthalazin-1-yl)amine;(4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-yl]amine;N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine"	212141-54-3	5DX9U76296	"16882767;15867205;14517187"	14517187	01/10/2003	15867205	01/06/2005	2004-2008		1	1	0	Yes	1					30/07/2018		157,6	43	NA	1	0	NA	1	"VEGFR1;VEGFR2;VEGFR3;C-KIT;PDGFR"	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	LIGHTHEADEDNESS	1	0	0	0	1
GTI 2040	gti-2040		DB05801		"UNII-5WY0FWR2CF;GTI2040;GTI 2040;GTI-2040;236391-66-5"			"26895565;24015841;19322566"	19322566	01/03/2009	15824081	01/06/2005	2004-2008		1	1	0	Yes	1					30/07/2018		157,6	36	NA	1	0	NA	1	RNR	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Bleomycin A6	"a6;urokinase plasminogen activator;urokinase-derived peptide a6"	"Zhengguangmycin A6;Boanmycin;Pingyangmycin A6"	DB12992	"[(2S,3R,4R,5S,6S)-2-[(3R,4R,5R,6R)-2-[(1R,2S)-2-[[6-amino-2-[(1S)-3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[(2S,3R,4R)-5-[[(2R,3S)-1-[2-[4-[4-[3-[4-(3-aminopropylamino)butylamino]propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]ethylamino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-4-methyl-5-oxopentan-2-yl]amino]-1-(3H-imidazol-4-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate;[(2S,3R,4R,5S,6S)-2-[(3R,4R,5R,6R)-2-[(1R,2S)-2-[[6-amino-2-[(1S)-3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidin-4-yl]carbonylamino]-3-[[(2S,3R,4R)-5-[[(2R,3S)-1-[2-[4-[4-[3-[4-(3-aminopropylamino)butylamino]propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]ethylamino]-3-hydroxy-1-oxo-butan-2-yl]amino]-3-hydroxy-4-methyl-5-oxo-pentan-2-yl]amino]-1-(3H-imidazol-4-yl)-3-oxo-propoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate;11032-73-8;37293-17-7;Bleomycin A6;Bleomycinamide, N(sup 1)-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)-;Bleomycinamide, N1-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)-;Boanmycin;N(sup 1)-(3-((4-((3-Aminopropyl)amino)butyl)amino)propyl)bleomycinamide"	"Bleomycin A6;UNII-0B19OCB220;Boanmycin;37293-17-7;zhengguangmycin A6;0B19OCB220;Pingyangmycin A6;N(sup 1)-(3-((4-((3-Aminopropyl)amino)butyl)amino)propyl)bleomycinamide;Bleomycinamide, N1-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)-;Bleomycinamide, N(sup 1)-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)-;11032-73-8"	37293-17-7	0B19OCB220	16023182	16023182	01/07/2005	16023182	01/07/2005	2004-2008		1	1	0	Yes	1					30/07/2018		156,6	16	NA	0	1	GYNECOLOGICAL MALIGNANCIES	1	PLASMINOGEN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,13	0	0	0	0	0	0	0	0	1
ONT-093	ont-093				"ONT-093;OC-144-093;216227-54-2;(E)-4,4'-(2-(4-(3-ethoxyprop-1-en-1-yl)phenyl)-1H-imidazole-4,5-diyl)bis(N-isopropylaniline);ONT 093;MDR inhibitors, Ontogen;OC 144-093;D0SR4G;AC1O52DR;CHEMBL313113;RSJCLODJSVZNQA-BQYQJAHWSA-N;API0014044;4-[4,5-Bis[4-(isopropylamino)phenyl]-1H-imidazole-2-yl]-trans-cinnamylethyl ether;4-[2-[4-[(E)-3-ethoxyprop-1-enyl]phenyl]-4-[4-(propan-2-ylamino)phenyl]-1H-imidazol-5-yl]-N-propan-2-ylaniline;Benzenamine, 4,4'-(2-(4-((1E)-3-ethoxy-1-propenyl]phenyl)-1H-imidazole-4,5-diyl)bis(N-(1-methylethyl)-"			16012790	16012790	01/07/2005	16012790	01/07/2005	2004-2008		1	1	0	Yes	1					30/07/2018		156,6	18	NA	1	0	NA	1	PGP	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Corticorelin	corticotropin-releasing factor	"Corticotropin-releasing hormone;CRF;Human corticotropin-releasing factor;Corticoliberin human;Corticorelin (human);Human corticoliberin;hCRF;Corticotropin-releasing factor;Corticotropin-releasing factor (human);Corticotropin releasing hormone human"	DB05394	"178359-01-8;79804-71-0;Amunin;Amunine;Corticorelin;Corticotropin-releasing factor (ovine);Corticotropin-releasing factor (sheep hypothalamus);Corticotropin-releasing factor (sheep);Corticotropin-releasing hormone, ovine;L-Alaninamide, L-seryl-L-glutaminyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-isoleucyl-L-seryl-L-leucyl-L-alpha-aspartyl-L-leucyl-L-threonyl-L-phenylalanyl-L-histidyl-L-leucyl-L-leucyl-L-arginyl-L-alpha-glutamyl-L-valyl-L-leucyl-L-alpha-glutamyl-L-methionyl-L-thronyl-L-lysyl-L-alanyl-L-alpha-aspartyl-L-glutaminyl-L-leucyl-L-alanyl-L-glutaminyl-L-glutaminyl-L-alanyl-L-histidyl-L-seryl-L-asparaginyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-alpha-aspartyl-L-isoleucyl-;Ovine ACTH releasing factor;Ovine CRF;Ovine CRF 41;Ovine CRH;Ovine corticotropin-releasing factor;Ovine corticotropin-releasing hormone;Sheep corticotropin-releasing factor (1-41);oCRH"	"Corticorelin;Corticorelin acetate;Xerecept;Corticotropin-releasing factor (human);UNII-305OE8862Y;corticorelin human;NEU 3002;Human corticotropin-releasing hormone;305OE8862Y;Corticorelin);hCRH;Corticorelin [INN];Corticorelin (human);CRF, NTI/Salk Institute;D06KGV;Corticotropin-releasing factor;CHEMBL2107324;CHEBI:136037;NEU-3002;AKOS024456419;Corticotropin-releasing factor, Neurobiological Laboratories;86297-72-5;CRF;H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2"	86784-80-7	305OE8862Y	9541686	9541686	01/05/1998	6134020	01/05/1983	Bef. 1989		1	0	1	No	0	"04/04/1997 00:00;31/01/2014 00:00;24/04/1997 00:00;16/07/2002 00:00;01/09/2015 00:00;23/05/1996 00:00"	AP	FERRING	CORTICORELIN OVINE TRIFLUTATE	23/05/1996	FERRING	156,4	#N/A																							0						1
OSI-7904L	"gs7904l;osi-7904l"		DB05457		"139987-54-5;TCMDC-131928;GW1843;BW 1843U89;5-amino orotate;UNII-ON177ZCE7M;OSI 7904L;OSI-7904L;ON177ZCE7M;CHEMBL169896;Folate Analog 1843u89;BW-1843U89;1843U89;2-(5-(((1,2-Dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid;S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID;C27H24N4O6;(S)-2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID;(S)-2-(5-(((3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxoisoindolin-2-yl)pentanedioic acid;F89;Pentanedioic acid, 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, (S)-;AC1Q5VEM;1843U;D01GZO;D0M0XI;AC1L1U2O;gw1843u89;SCHEMBL1649579;SCHEMBL6064518;1f28;BRVFNEZMTRVUGW-QFIPXVFZSA-N;ZINC3871820;BDBM50040861;AKOS025290741;(2s)-2-(5-{[(3-methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl]amino}-1-oxo-1,3-dihydro-2h-isoindol-2-yl)pentanedioic acid;AS-50416;KB-75837;LS-173073;C11374;(2S)-2-[6-[(3-methyl-1-oxo-4H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid;(S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl) glutaric acid;(S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid;(s)-2-(5-(((1,2-dihydro3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)ami-no)-1-oxo-2-isoindolinyl)glutaric acid;(S)-2-{5-[(3-Methyl-1-oxo-1,2-dihydro-benzo[f]quinazolin-9-ylmethyl)-amino]-1-oxo-1,3-dihydro-isoindol-2-yl}-pentanedioic acid;206203-16-9;206451-94-7;U18"			16061865	16061865	01/08/2005	16061865	01/08/2005	2004-2008		1	1	0	Yes	1					30/07/2018		155,6	31	NA	1	0	NA	1	PYRIMIDINE	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,3	1	tachyarrhythmia	1	0	0	0	0	0	1
ABT-510	abt-510		DB05434	"(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[[2-[[2-(acetyl-methylamino)acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-ethylpyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[[2-[[2-(acetyl-methyl-amino)acetyl]amino]acetyl]amino]-3-methyl-butanoyl]amino]-3-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]pentanoyl]amino]-3-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]-N-ethyl-pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[[2-[[2-(acetyl-methylamino)-1-oxoethyl]amino]-1-oxoethyl]amino]-3-methyl-1-oxobutyl]amino]-3-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxobutyl]amino]-1-oxopentyl]amino]-3-methyl-1-oxopentyl]amino]-5-guanidino-1-oxopentyl]-N-ethyl-2-pyrrolidinecarboxamide;(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[2-[2-(ethanoyl-methyl-amino)ethanoylamino]ethanoylamino]-3-methyl-butanoyl]amino]-3-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]pentanoyl]amino]-3-methyl-pentanoyl]amino]pentanoyl]-N-ethyl-pyrrolidine-2-carboxamide;ABT-510"	"ABT-510;UNII-CRR8E37XOB;CRR8E37XOB;251579-55-2;ABT 510;Nac-sar-gly-val-(d-allo-ile)-thr-nva-ile-arg-pronet;AC1OCFL6;CHEMBL386115;ABT-526;DB05434;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[[2-[[2-[acetyl(methyl)amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-ethylpyrrolidine-2-carboxamide;442526-86-5;L-Prolinamide, N-acetyl-N-methylglycylglycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-N-ethyl-"	251579-55-2	CRR8E37XOB	18932258	18932258	01/10/2008	16051960	01/08/2005	2004-2008		1	1	0	Yes	1					30/07/2018		155,6	39	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,15	0	0	0	0	0	0	0	0	1
talactoferrin alpha	talactoferrin		DB05426		"Lactoferroxin A;talactoferrin alpha;117667-25-1;Lactoferroxin-A;Tyr-leu-gly-ser-gly-tyr-och3;AC1L4UTF;AC1Q5JQ1;L-Tyrosine,L-tyrosyl-L-leucylglycyl-L-serylglycyl-, methyl ester;CTK4B0386;methyl l-tyrosyl-l-leucylglycyl-l-serylglycyl-l-tyrosinate;L-Tyrosyl-L-leucylglycyl-L-serylglycyl-L-tyrosine methyl ester;DB05426;L-Tyrosine, L-tyrosyl-L-leucylglycyl-L-serylglycyl-, methyl ester;methyl (2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoate"			"19238327;16193240"	16193240	01/09/2005	16193240	01/09/2005	2004-2008		1	1	0	Yes	1					30/07/2018		154,6	10	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,63	0	0	0	0	0	0	0	0	1
T-900607	t900607		DB12068		"UNII-IC9O2HT1X1;IC9O2HT1X1;T-900607;261944-52-9;T900607;D07QFU;T 900607;SCHEMBL2385373;FSXLOWIFSZNIMV-UHFFFAOYSA-N;DB12068;848866-33-1"	261944-52-9	IC9O2HT1X1	16133796	16133796	01/09/2005	16133796	01/09/2005	2004-2008		1	1	0	Yes	1					30/07/2018		154,6	30	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,35	1	"TROPONINE ELEVATION;MYOCARDIAL INFARCTION"	1	LETHARGY	1	0	0	0	1
Plitidepsin	"aplidine;plitidepsin"	"plitidepsine;plitidepsina;Dehydrodidemnin B;Aplidine;plitidepsium"	DB04977		"plitidepsin;Aplidine;aplidin;137219-37-5;Dehydrodidemnin B;plitidepsina;plitidepsine;plitidepsium;UNII-Y76ID234HW;Y76ID234HW;CHEBI:90205;Plitidepsin [INN:BAN];Dihydrodidemnin B;Aplidin (TN);Plitidepsin (INN);D07QJK;Didemnin A, N-(1-(1,2-dioxopropyl)-L-prolyl)-;CHEMBL451930;2-9-Didemnin B, 2-(1-(1,2-dioxopropyl)-L-proline)-;SCHEMBL13413427;AKOS030230703;DB04977;D11032;Z-3094;Y-100032;1-(2-oxopropanoyl)-L-prolyl-N-[(3S,6R,7S,10R,11S,15S,17S,20S,25aS)-10-[(2S)-butan-2-yl]-11-hydroxy-3-(4-methoxybenzyl)-2,6,17-trimethyl-20-(2-methylpropyl)-1,4,8,13,16,18,21-heptaoxo-15-(propan-2-yl)docosahydro-15H-pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosin-7-yl]-N(2)-methyl-D-leucinamide;L-Tyrosine, 1-(1,2-dioxopropyl)-L-prolyl-N-methyl-D-leucyl-L-threonyl-(3S,4R,5S)-4-amino-3-hydroxy-5-methylheptanoyl-(2S,4S)-4-hydroxy-2,5-dimethyl-3-oxohexanoyl-L-leucyl-L-prolyl-N,O-dimethyl-,  (8-3)-lactone"	137219-37-5	Y76ID234HW	"19687728;18483378;16966366;16172454"	16172454	01/09/2005	16172454	01/09/2005	2004-2008		1	1	0	Yes	1					30/07/2018		154,6	67	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,03	0	0	0	0	0	0	0	0	1
Orantinib	"orantinib;su006668;su6668;sugen su6668;tsu 68;tsu-68"		DB12072		"TSU-68;Orantinib;SU-6668;252916-29-3;SU6668;SU 6668;UNII-9RL37ZZ665;210644-62-5;Orantinib (TSU-68);NSC 702827;TSU68;CHEMBL274654;9RL37ZZ665;TSU 68;PDGFR Tyrosine Kinase Inhibitor VI, SU6668;2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid;J-502593;Orantinibum;3-(2,4-dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid;3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid;Orantinib [INN];245036-27-5;3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone;3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid;5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid;PubChem22441;SU006668;Rosiglitazone + metformin;D0A1AQ;D0A1ZQ;AC1NS62A;MLS006011090;SCHEMBL134661;BDBM4811;GTPL7816;TUS-68;EX-A471;SYN1085;(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid;MolPort-002-345-646;BCPP000059;AOB87351;ZINC3834032;Orantinib (TSU-68, SU6668);ABP000880;NSC702827;RS0104;s1470;TSU-68 (SU6668);TSU-68 - SU6668;AKOS024457561;API0010236;CS-0197;DB12072;NSC-702827;SU-6597;3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid;4CA-1186;AC-25028;ACM210644625;AS-16238;BC659953;HY-10517;SMR004702878;Pdgfr tyrosine kinase inhibitor vi,su6668;AB0033762;RT-014974;ST24036518;ST24041377;SU-6668(TSU-68)/SU6668;X7490;D20951;W-5401;J-013813;BRD-K55966568-001-01-3;TSU68, SU6668, 252916-29-3;(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoicacid;5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid;(z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1h-pyrrol-3-yl]-propionic acid;1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid;5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid"	252916-29-3	9RL37ZZ665	"15292716;16406576;20390419;20676674;20676675"	15292716	01/08/2004	16144927	01/09/2005	2004-2008		1	1	0	Yes	1					30/07/2018		154,6	16	NA	1	0	NA	1	"VEGFR2;PDGFR;FGFR1;C-KIT"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Etaracizumab	"etaracizumab;medi-522"		DB12213			892553-42-3	41W9MFI160	"17876527;16278408"	16278408	01/11/2005	16278408	01/11/2005	2004-2008		1	1	0	Yes	1					30/07/2018		152,6	25	NA	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,12	0	0	0	0	0	0	26	0	1
Tremelimumab	tremelimumab	Ticilimumab	DB11771			745013-59-6	QEN1X95CIX	19139427	19139427	01/01/2009	16204013	01/12/2005	2004-2008		1	1	0	Yes	1					30/07/2018		151,6	39	NA	0	1	"MELANOMA;MRCC;COLORECTAL"	1	CTLA4	0	1	0	NA	0	0	0	1	1	0,1	0	1	1	0,33	0	0	0	0	0	0	46	0	1
2-Methoxyestradiol	"2-methoxyestradiol;enmd-1198"	"2-ME2;2-methoxy-17β-estradiol;2-Methoxyestradiol-17beta;2ME2;Panzem;2-Hydroxyestradiol 2-methyl ether;2-Hydroxyestradol 2-methyl ether"	"DB02342;EXPT01362"	"(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;362-07-2;Lopac0_000739;EU-0100739;PulmoLAR;1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER;estra-1(10),2,4-triene-3,17-diol, 2-methoxy-, (17beta)-;2-Methoxyestradiol-17beta;C05302;ESM;2-Methoxyestradiol;2-methoxy-estra-1,3,5(10)-triene-3,17beta-diol;LMST02010035;1,3,5(10)-Estratriene-2,3,17-triol 2-methyl ether;2,3,17beta-Trihydroxy-1,3,5(10)-estratriene 2-methyl ether;2-Hydroxyestradiol 2-methyl ether;3,17beta-Dihydroxy-2-methoxy-1,3,5(10)-estratriene;M6383_SIGMA;(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol;2-Hydroxyestradol 2-methyl ether;2-Methoxyestra-1,3,5(10)-triene-3,17beta-diol;SMP2_000045;2ME2;Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17beta)-;Estra-1,3,5(10)-triene-3,17beta-diol, 2-methoxy-;Estradiol, 2-methoxy-;NSC 659853;Panzem;2-MeOE2;NSC-659853;2-methoxy-17beta-estradiol;CHEBI:28955;MLS000028819;SMR000058478"	"2-Methoxyestradiol;362-07-2;Panzem;2-Methoxyestradiol-17beta;2-Hydroxyestradol 2-methyl ether;Estradiol, 2-methoxy-;2ME2;2-Hydroxyestradiol 2-methyl ether;PulmoLAR;2-Methoxyestra-1,3,5(10)-triene-3,17beta-diol;Panzem NCD;2-methoxy-17beta-estradiol;UNII-6I2QW73SR5;2-Methoxy-estradiol;2-ME2;2-MeOE2;NSC 659853;MLS000028819;(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol;6I2QW73SR5;CHEMBL299613;2-Methoxyestradiol (2-MeOE2);CHEBI:28955;CQOQDQWUFQDJMK-SSTWWWIQSA-N;2-methoxy-estra-1,3,5(10)-triene-3,17beta-diol;Estra-1,3,5(10)-triene-3,17beta-diol, 2-methoxy-;SMR000058478;Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17beta)-;1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER;M 6383;(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;ESM;1,3,5(10)-Estratriene-2,3,17-triol 2-methyl ether;(17beta)-2-methoxyestra-1(10),2,4-triene-3,17-diol;Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17b)-;2-methoxyoestradiol;(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol;2-Methoxy-beta-estradiol;2-Methoxy-.beta.-estradiol;CCRIS 9405;1lhw;NSC-659853;K1002_Kinasechem;Opera_ID_634;2-Methoxyestradiol, powder;D06NYA;AC1L25BI;SCHEMBL8796;Lopac0_000739;2-ME2, 2-Methoxyestradiol;MLS001076279;MLS006010142;AC1Q7A32;DTXSID3040938;MolPort-003-927-295;HMS2230L22;HMS3262C20;ZINC3818826;Tox21_500739;BDBM50060957;LMST02010035;MFCD00010489;s1233;AKOS015901723;2-ME2;NSC-659853;2-Methoxyestradiol, analytical standard;ACN-051090;BCP9000109;CCG-204824;CS-0176;LP00739;SMP2_000045;NCGC00094082-03;NCGC00094082-04;NCGC00261424-01;4CA-0052;AS-19175;HY-12033;LS-64775;SC-27817;EU-0100739;M2530;X5011;C05302;W-5039;AB00639611-09;AB00639611_10;2-ME2, 362-07-2;SR-01000076000;2-methoxy-1,3,5 (10)-estratriene-3,17beta-diol;2-Methoxyestra-1,3,5(10)-triene-3,17-diol #;SR-01000076000-1;BRD-K44408410-001-20-0;I14-14338;(17?)-2-Methoxyestra-1(10),2,4-triene-3,17-diol;(17?)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol;Estra-1,3,5(10)-triene-3,17.beta.-diol, 2-methoxy-;estra-1(10),2,4-triene-3,17-diol, 2-methoxy-, (17beta)-;B3C40B85-1733-48FE-8418-A39011910D19;Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17.beta.)-"	362-07-2	6I2QW73SR5	"20084425;16357512"	16357512	01/12/2005	16357512	01/12/2005	2004-2008		1	1	0	Yes	1					30/07/2018		151,6	20	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	0	0,05	0	0	0	NA	0	0	0	0	0	0	21	0	1
Forodesine	"bcx-1777;bcx1777;forodesine"	"Immucillin-H;Immucillin H;1,4-Dideoxy-4-aza-1-(S)-(9-deazahypoxanthin-9-yl)-D-ribitol"	"DB06185;DB03743"	"7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one;7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one;7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-methylol-pyrrolidin-2-yl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one;Fodosine (TN);Forodesine (USAN);Forodesine;Immucillin H;IMH;1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN-9-YL)-D-RIBITOL;D06596"	"Forodesine;Immucillin H;Immucillin-H;Fodosine;209799-67-7;BCX-1777;Fodosine (TN);1,4-dideoxy-4-aza-1-(s)-(9-deazahypoxanthin-9-yl)-d-ribitol;Forodesine (USAN/INN);mundesine;UNII-426X066ELK;CHEMBL218291;CHEBI:43362;426X066ELK;Forodesine HCl;1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-iminoribitol;(1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol;7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one;IMH;(2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol;7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one;7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one;BCX1777;1b8o;1g2o;1nw4;2ff1;2ff2;AC1L9GFJ;Forodesine [USAN:INN];D02ZUO;D0W7VG;SCHEMBL506383;Fodosine (proposed trade name);GTPL8272;SCHEMBL16321929;AMG 108;IWKXDMQDITUYRK-KUBHLMPHSA-N;TXFGPFIDYBMMJY-KUBHLMPHSA-N;AMX10194;BCX 1777;BDBM50195587;ZINC13492899;AKOS027326672;CS-3781;AS-35282;HY-16210;D06596;Z-3303;799F677;(1S)-1,4-dideoxy-1-c-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-d-ribitol;(-)-7-((2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one;4H-Pyrrolo(3,2-d)pyrimidin-4-one, 7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,5-dihydro-;7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one;7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-hydroxymethyl-2-pyrrolidinyl]-1,5-dihydro-4h-pyrrolo-[3,2-d]-pyrimidin-4-one;79056-01-2"	209799-67-7	426X066ELK	22448814	22448814	01/03/2012	16131572	01/12/2005	2004-2008		1	1	0	Yes	1					30/07/2018		151,6	5	NA	0	1	AML	1	PURINE	0	1	0	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Amrubicin	amrubicin		DB06263	"(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride;(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxytetrahydropyran-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride;(7S,9S)-9-acetyl-9-amino-7-[[(2S,4S,5R)-4,5-dihydroxy-2-tetrahydropyranyl]oxy]-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride;(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxytetrahydropyran-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone hydrochloride;(7S,9S)-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-9-ethanoyl-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride;110311-30-3;Amrubicin;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-6,11-dihydroxy-, hydrochloride, (7S-cis)-;5,12-Naphthacenedione, 9-acetyl-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, hydrochloride, (7S,9S)-;SM 5887;SM5887;Calsed;Amrubicin hydrochloride;SM-5887"	"Amrubicin;110267-81-7;UNII-93N13LB4Z2;C25H25NO9;93N13LB4Z2;Amrubicin HCl;Amrubicin [USAN:INN];AC1MHYLP;Amrubicin (USAN/INN);Amrubicin(SM-5887);SCHEMBL9140;CHEMBL1186894;EX-A161;CHEBI:135779;VJZITPJGSQKZMX-XDPRQOKASA-N;(+-)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione;HY-B0067;ZINC3780800;3441AH;AKOS030526071;CS-2836;DB06263;LS41109;D08854;W-60403;W-200813;(+)-(7S,9S)-9-acetyl-9-amino-7-[(2-deoxy--D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione hydrochloride;(7S,9S)-9-acetyl-9-amino-7-(((2S,4S,5R)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;5,12-Naphthacenedione, 9-acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, (7S,9S)-"	110267-81-7	93N13LB4Z2	"23400695;22237957;19352172;16028099;16012792"	16028099	01/07/2005	16028099	01/02/2006	2004-2008		1	1	0	Yes	1					30/07/2018		149,6	15	NA	1	0	NSCLC	0	NA	0	1	0	NA	0	0	0	1	1	0,06	0	0	0	0,73	0	0	0	ARRHYTHMIA	1	0	251	0	1
Sapacitabine	"cs-682;cyc682;sapacitabine"		DB06365	"N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide;N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-pyrimidin-4-yl]hexadecanamide;N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2-oxo-4-pyrimidinyl]hexadecanamide;N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-2-keto-pyrimidin-4-yl]palmitamide;N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-pyrimidin-4-yl]hexadecanamide;151823-14-2;Sapacitabine;CS 682;CYC-682;Hexadecanamide, N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)-;N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)hexadecanamide;CS-682"	"Sapacitabine;151823-14-2;CS-682;UNII-W335P73C3L;CYC682;CS 682;CYC-682;W335P73C3L;N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)hexadecanamide;Hexadecanamide, N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)-;N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide;Sapacitabine [USAN:INN];CYC 682;CS682;PCNDAC;AC1L4BGC;Sapacitabine (CYC682);Sapacitabine (USAN/INN);D0D4RF;SCHEMBL711854;CHEMBL2105681;DTXSID90164887;LBGFKUUHOPIEMA-PEARBKPGSA-N;EX-A1617;CS0045;ZINC14263648;HY-16445;LS-183264;CS-0006340;D09722;Z-3189;823S142;1-(2-deoxy-2-cyano-|A-d-arabinofuranosyl)cytosine;1-(2-c-cyano-2-deoxy-|A-d-arabino-pentofuranosyl)cytosine;1-(2-cyano-2-deoxy-|A-d-arabinofuranosyl)-4-(palmitoylamino)pyrimidin-2(1h)-one,sapacitabine;4-amino-1-[(3|A-cyano-4|A-hydroxy-5|A-hydroxymethyltetrahydrofuran)-2|A-yl]pyrimidin-2(1h)-one"	151823-14-2	W335P73C3L	"19933907;16788861;16502355"	16502355	01/02/2006	16502355	01/02/2006	2004-2008		1	1	0	Yes	1					30/07/2018		149,6	40	NA	1	1	COLORECTAL	1	PYRIMIDINE	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,15	0	0	0	0	0	0	0	0	1
BMS-275183	"bms-275183;oral analogue of paclitaxel"		DB12144	"B;M;S;-;2;7;5;1;8;3"	"BMS-275183;UNII-UQC681JJIV;UQC681JJIV;355113-98-3;D0DI8J;Oral taxane (cancer), BMS;SCHEMBL13900214;AHXICHPPXIGCBN-GPWPDEGDSA-N;BMS-198246;DB12144;Oral taxane (cancer), Bristol-Myers Squibb"	355113-98-3	UQC681JJIV	"20680660;16551860"	16551860	01/03/2006	16551860	01/03/2006	2004-2008		1	1	0	Yes	1					30/07/2018		148,7	20	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,24	0	0	0	NA	0	0	0	0	0	0	0	0	1
OSI-7836	"4'-thio-arabinofuranosylcytosine;osi-7836"		DB05837		"Thio-ara-C;Thio-1-beta-D-arabinofuranosylcytosine hydrochloride;Cytosine, 1-(beta-D-arabinofuranosyl)-thio-;2(1H)-Pyrimidinethione, 4-amino-1-beta-D-arabinofuranosyl-, hydrochloride;AC1MI2B2;1-Arabinofuranosyl-2-thiocytosine;OSI-7836;DB05837;28419-39-8;LS-135599;4-amino-1-[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2-thione hydrochloride"			"16675579;16528532"	16528532	01/03/2006	16528532	01/03/2006	2004-2008		1	1	0	Yes	1					30/07/2018		148,7	27	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
ZD-6126	"ang453;zd6126"		DB11872		"ZD6126;ZD-6126;219923-05-4;UNII-GBO3S6M9W7;GBO3S6M9W7;N-Acetylcolchicinol dihydrogenphosphate;N-Acetylcochinol-O-phosphate;ZD 6126;D04AMD;CHEMBL257662;SCHEMBL1285000;ANG 453;AZD6126, ANG453;AZD 6126;AZD-6126;ZINC3993833;BCP9000366;DB11872;BCP0726000110;ZM 445526;Acetamide, N-((5S)-6,7-dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo(a,c)cyclohepten-5-yl)-"	219923-05-4	GBO3S6M9W7	"18219445;16574998"	16574998	01/04/2006	16574998	01/04/2006	2004-2008		1	1	0	Yes	1					30/07/2018		147,6	32	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	"LEFT VENTRICULAR DYSFONCTION;PULMONARY EMBOLISM"	1	0	0	0	0	0	1
ATN-161	atn-161		DB05491		"ATN-161;262438-43-7;ATN 161;PHSCN;UNII-XW0H5LE42K;XW0H5LE42K;D00QVT;PHSCN, University of Michigan;SCHEMBL2157375;SCHEMBL17262996;AOB2958;DTXSID60180877;MolPort-044-830-679;ZINC3924034;ATN-161 (Ac-PHSCN-NH2);s8454;AKOS030210988;CS-3327;Ac-PHSCN-NH2, University of Michigan;Integrin antagonists (cancer), Attenuon;HY-13535;Angiogenesis inhibitors (cancer), Attenuon;Acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide;L-Aspartamide, 1-acetyl-L-prolyl-L-histidyl-L-seryl-L-cysteinyl-"			16705310	16705310	01/05/2006	16705310	01/05/2006	2004-2008		1	1	0	Yes	1					30/07/2018		146,7	26	NA	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,15	0	0	0	0	0	0	0	0	1
Pelitinib	"ekb-569;pelitinib"	(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide	DB05524	"(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-dimethylaminobut-2-enamide;(E)-N-[4-[(3-chloro-4-fluoro-phenyl)amino]-3-cyano-7-ethoxy-6-quinolyl]-4-dimethylamino-but-2-enamide;(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolyl]-4-dimethylaminobut-2-enamide;(E)-N-[4-[(3-chloro-4-fluoro-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-dimethylamino-but-2-enamide;257933-82-7;WAY-EKB 569;(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide;2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-;EKB 569;EKB-569;Pelitinib;(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide;WAY-EKB-569;(E)-N-[4-(3-Chloro-4-fluoroanilino)-cyano-7-ethoxyquinolin-6-yl]-4-(dimethlyamino)but-2-enamide,;2-Butenamide, N-[4-(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl-4-(dimethylamino)-, (E)-,;4-Dimethylaminobut-2-enoic Acid, [4-(3-Chloro-4-fluoro phenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide;NSC729742;WAY-172569;D05399;Pelitinib (USAN);CHEBI:38927"	"Pelitinib;257933-82-7;EKB-569;Pelitinib (EKB-569);WAY-EKB 569;EKB 569;UNII-X5DWL380Z6;WAY-EKB-569;(E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;C24H23ClFN5O2;EKB569;X5DWL380Z6;CHEBI:38927;(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide;326894-84-2;Q-101404;(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide;(E)-N-[4-(3-chloro-4-fluoro-anilino)-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide;(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide;(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;(E)-N-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-(dimethylamino)but-2-enamide;Pelitinib [USAN:INN];Pelitinib/;EKI-569;(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;Pelitinib (USAN/INN);Pelitinib - EKB-569;2-Butenamide, (E)-,;cc-21;D0S3PO;AC1O62UE;SCHEMBL93756;SCHEMBL93757;MLS006010062;CHEMBL607707;GTPL7644;BDBM31090;cid_6445562;AOB2168;EX-A061;QCR-124;SYN1141;MolPort-006-395-626;WVUNYSQLFKLYNI-AATRIKPKSA-N;BCPP000118;BCPP000119;ZINC602803;ABP000380;ABP000890;AN-545;NSC729742;s1392;AKOS005146343;NSC-729742;Pelitinib(EKB-569)/WAY-EKB 569;RL02858;WAY-172569;AC-24700;AC-25029;AK170455;AS-16280;BC623068;HY-32718;KB-50522;SC-87072;SMR004701222;Pelitinib (EKB-569; WAY-EKB 569);AB0033761;RT-014977;P2529;X7489;D05399;Q-9254;933P827;A818030;I14-1990;BRD-K08799216-001-01-2;EKB-569, WAY-EKB 569, 257933-82-7;(2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide          pelitinib;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide;(E)-N-[3-Cyano-4-[(4-fluoro-3-chlorophenyl)amino]-7-ethoxyquinoline-6-yl]-4-(dimethylamino)-2-buteneamide;(E)-N-[4-(3-Chloro-4-fluoroanilino)-cyano-7-ethoxyquinolin-6-yl]-4-(dimethlyamino)but-2-enamide, (IUPAC);(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-dimethylaminobut-2-enamide;2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-;4-Dimethylaminobut-2-enoic Acid, [4-(3-Chloro-4-fluoro phenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide;93J"	257933-82-7	X5DWL380Z6	16710023	16710023	01/05/2006	16710023	01/05/2006	2004-2008		1	1	0	Yes	1					30/07/2018		146,7	30	NA	1	0	NA	1	EGFR	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,03	0	0	0	0	0	0	0	0	1
Oxaliplatin	"jm-83;oxaliplatin;rp-54780;sr-96669"	"oxaliplatino;L-OHP;oxaliplatinum;Diaminocyclohexane Oxalatoplatinum;Oxalatoplatinum;oxaliplatine;Oxalatoplatin;PMS-oxaliplatin;Oxaliplatin Injection USP;Eloxatin;Teva-oxaliplatin Injection;Oxaliplatin Injection, USP;Oxaliplatin Injection;Oxaliplatin;Act Oxaliplatin;Oxaliplatin for Injection;Taro-oxaliplatin"	"DB00526;APRD00186"	"cyclohexane-1,2-diamine; oxalate; platinum(+2) cation;(2-aminocyclohexyl)amine; oxalate; platinum(+2) cation;cyclohexane-1,2-diamine; ethanedioate; platinum(+2) cation;61913-68-6;61825-94-3;63121-00-6;(SP-4-3-(cis))-(1,2-Cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')platinum;Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-3-(cis))-;(SP-4-2-(1R-trans))-(1,2-Cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')platinum;1-OHP;Eloxatin;JM-83;NSC 266046;OXALIPLATIN;Oxalato(1R,2R-cyclohexanediammine)platinum(II);Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II);Oxalato(trans-1-1,2-cyclohexanediamine)platinum(II);Oxalatoplatin;Oxalatoplatinum;Oxaliplatin [USAN:INN:BAN];Oxaliplatino [Spanish];Oxaliplatinum [Latin];Oxaloplatine [French];Oxaloplatino [Spanish];Platinum, ((1R,2R)-1,2-cyclohexanediamine-.kappa.N,.kappa.N')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2)-;Platinum, ((1R,2R)-1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2)-;Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(1R-trans))-;RP 54780;SR 96669;cis-((1R,2R)-1,2-Cyclohexanediamine-N,N')(oxalato(2-)-O,O')platinum;trans-l-Diaminocyclohexane oxalatoplatinum;ACT 078;NSC 271670;Oxalato(1,2-diaminocyclohexane)platinum(II);Platinum (II), (cyclohexane-1,2-diammine)oxalato-;Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-;Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-;Platinum, (1,2-cyclohexanediamine-N,N')(propanedioato(2-)-O,O')-, (SP-4-3-(cis))-;Platinum, (cis-cyclohexane-1,2-diammine)malonato-;Platinum, (cis-cyclohexane-1,2-diammine)propanedioato-;cis-1,2-Diaminocyclohexanemalonatoplatinum(II)"		61825-94-3	04ZR38536J	"23394629;21609937;19687731;19322566;19034580;18493824;18251177;18164861;17538173;16702162;16619562;16168057;15274406;14981738;14597876;14523790;12417789;11886004"	11886004	01/03/2002	2348469	01/06/1990	1989-1994		1	1	1	Yes	1	"07/06/2016 00:00;23/05/2017 00:00;25/11/2013 00:00;04/11/2004 00:00;21/05/2008 00:00;24/06/2016 00:00;04/05/2015 00:00;28/12/2011 00:00;12/05/2017 00:00;05/09/2013 00:00;18/06/2014 00:00;31/01/2017 00:00;09/08/2002 00:00;31/12/2015 00:00;13/05/2014 00:00;08/08/2012 00:00;15/11/2013 00:00;10/06/2010 00:00;30/09/2009 00:00;14/01/2003 00:00;05/03/2018 00:00;07/08/2012 00:00;17/11/2006 00:00;09/03/2006 00:00;28/04/2011 00:00;08/04/2014 00:00;01/10/2015 00:00;10/09/2015 00:00;14/11/2017 00:00;20/04/2016 00:00;22/07/2009 00:00;28/02/2013 00:00;10/01/2007 00:00;20/11/2012 00:00;09/01/2004 00:00;21/03/2017 00:00;24/01/2011 00:00;14/01/2010 00:00;11/12/2015 00:00;10/08/2012 00:00;09/12/2016 00:00;11/05/2016 00:00;06/09/2017 00:00;12/10/2012 00:00;20/03/2013 00:00;26/05/2016 00:00;31/01/2005 00:00;07/08/2009 00:00;16/07/2013 00:00;10/02/2017 00:00;02/06/2010 00:00;27/02/2013 00:00;20/01/2015 00:00;13/03/2009 00:00"	"AP;TA"	"MUSTAFA NEVSAT IIAC SANAYII A.S.;ACTAVIS TOTOWA;FRESENIUS KABI ONCOL;ACCORD HLTHCARE;SUN PHARMA GLOBAL;CIPLA LTD;FRESENIUS KABI USA;MYLAN LABS LTD;HOSPIRA INC;SANDOZ;LUITPOLD PHARMS INC;SANDOZ INC;SANOFI AVENTIS US;#N/A;TEVA PHARMS;QILU PHARM CO LTD;HOSPIRA WORLDWIDE;PLIVA LACHEMA;GLAND PHARMA LTD;JIANGSU HENGRUI MED"	OXALIPLATIN	09/08/2002	SANOFI AVENTIS US	146,0	23	NA	0	1	"BREAST;HCC;CHOLANGIOCARCINOMA"	1	DNA	0	1	0	NA	0	0	0	1	1	0,16	0	0	0	NA	0	0	0	0	0	0	100	0	1
Belotecan	"belotecan;ckd-602;ckd602"		DB12459	"256411-32-2;(4S)-4-Ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;Belotecan;Belotecan [INN]"	"Belotecan;Camtobell;256411-32-2;UNII-27Z82M2G1N;CKD602;27Z82M2G1N;CKD 602;Belotecan [INN];SCHEMBL18983;CHEMBL2111084;DTXSID60180332;CHEBI:135702;ZINC3826691;DB12459;AN-29325;Z-3162;411C322;(4S)-11-[2-(Isopropylamino)ethyl]-4-hydroxy-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(4S)-4-Ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;CKD-602|||Camtobell|||(S)-4-Ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"	256411-32-2	27Z82M2G1N	"20626314;19675541"	19675541	01/08/2009	11193913	01/06/2006	2004-2008		1	1	0	Yes	1					30/07/2018		145,6	NA	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Ifosfamide	ifosfamide	"Ifosfamidum;Isophosphamide;Isosfamide;Iphosphamide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;Isofosfamide;Ifosfamida;Ifex Pws 2g/vial;Ifosfamide for Injection;Ifex (ifosfamide) 1 G/vial;Ifosfamide;Ifex Pws 3gm/vial;Ifex Pws 1gm/vial;Ifex (ifosfamide) 3 G/vial;Ifex"	"DB01181;APRD00007"	"(2S)-N,3-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;N,3-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;(2R)-N,3-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;N,3-bis(2-chloroethyl)-2-hydroxy-1,3,2-oxazaphosphinan-2-ium-2-amine;2-chloroethyl-[(2S)-3-(2-chloroethyl)-2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl]amine;2-chloroethyl-[3-(2-chloroethyl)-2-hydroxy-1,3,2-oxazaphosphinan-2-ium-2-yl]amine;2-chloroethyl-[(2R)-3-(2-chloroethyl)-2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl]amine;2-chloroethyl-[3-(2-chloroethyl)-2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl]amine;36341-88-5;3778-73-2;84711-20-6;66849-33-0;66849-34-1;Prestwick0_000833;BPBio1_000865;(+-)-Ifosfamid;(+-)-Ifosphamide;(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;(D,L)-Ifosfamide;(R,S)-Ifosphamide;(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (+-)-;Prestwick1_000833;SPBio_002706;Prestwick2_000833;CAS-3778-73-2;NCGC00016639-01;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide;2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd;2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI);3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;A 4942;ASTA Z 4942;BRN 0611835;CCRIS 352;Cyfos;DRG-0207;EINECS 223-237-3;HSDB 7023;Holoxan;Holoxan 1000;I-Phosphamide;Ifex;Ifosamide;Ifosfamid;NCI60_000233;Ifosfamide;Ifosfamide [USAN:BAN:INN:JAN];Ifosfamidum [INN-Latin];Iphosphamid;Iphosphamide;Isoendoxan;Isofosfamide;Isophosphamide;MJF 9325;MJF-9325;Mitoxana;N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide;N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German];N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide;NCI-C01638;NSC 109724;NSC-109724;Naxamide;Z 4942;Z-4942;Z4942;N,3-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;BSPBio_000785;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-;2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd;2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide;WLN: T6NPOTJ AM2G BO B2G;Ifosfamida [INN-Spanish];D00343;Ifex (TN);Ifosfamide (JAN/USP/INN);(-)-Ifosfamid;(-)-Ifosphamide;(S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (S)-;BRN 5802893;D-Ifosfamide;(+)-Ifosfamide;(+)-Ifosphamide;(R)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;(R)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (R)-;BRN 5802894;L-Ifosfamide;AIDS-126436;AIDS126436;N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide;N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine;NSC109724;{3-(2-Chloroethyl)-2-[(2-;{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide;Prestwick3_000833"	"ifosfamide;Isophosphamide;3778-73-2;Iphosphamide;Isofosfamide;Ifosfamid;Mitoxana;Naxamide;Iphosphamid;Isoendoxan;Ifex;I-Phosphamide;Holoxan;Cyfos;Ifsofamide;Holoxan 1000;ASTA Z 4942;Ifosfamida;Ifosfamidum;Ifosphamide;MJF 9325;(D,L)-Ifosfamide;isosfamide;(+-)-Ifosfamid;(+-)-Ifosphamide;(R,S)-Ifosphamide;NCI-C01638;Iso-Endoxan;MJF-9325;Ifosfamide Sterile;Ifosfamidum [INN-Latin];Ifosfamida [INN-Spanish];2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide;NSC 109724;NSC-109724;A 4942;Z 4942;Z-4942;Iphosphamid(e);Z4942;CCRIS 352;N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide;HSDB 7023;Ifosfamide [USAN:INN:BAN:JAN];N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;EINECS 223-237-3;NSC109724;IFEX (TN);NPFAPI-04;BRN 0611835;dexifosfamide;ifomide;ifosfomide;C7H15Cl2N2O2P;Ifosfamide (JAN/USP/INN);N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;CHEBI:5864;HOMGKSMUEGBAAB-UHFFFAOYSA-N;2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd;N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide;(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide;N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German];N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide;NCGC00016639-01;CAS-3778-73-2;DSSTox_CID_760;N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid;2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (+-)-;2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;DSSTox_RID_75775;DSSTox_GSID_20760;Q-101874;Iso Endoxan;N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine;3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine;2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI);84711-20-6;SR-05000002022;Mitoxana;Ifex;N,3-bis(2-chloroethyl)-2-oxo-1,3,2?^{5}-oxazaphosphinan-2-amine;Ifosfamid A;(R)-Ifosfamide;(S)-Ifosfamide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorineoxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide;Mitoxana (TN);Isophosphamide,(S);Ifosfamide [USAN:USP:INN:BAN:JAN];NSC-109,724;Ifosfamide, >=98%;AC1L1GHW;Prestwick0_000833;Prestwick1_000833;Prestwick2_000833;Prestwick3_000833;D02TLO;Mitoxana, Ifex, Ifosfamide;SCHEMBL4885;CHEMBL1024;BSPBio_000785;KSC948G4P;MLS002154021;3,} 2-oxazaphosphorine oxide;Ifex (TN) (Bristol Meyers);SPBio_002706;BPBio1_000865;GTPL7201;DTXSID7020760;CTK8E8347;KS-00000YBW;MolPort-003-666-704;BDBM189358;HMS1570H07;HMS2090M12;HMS2093N07;HMS2097H07;HMS2232O10;HMS3374B08;HMS3654B15;HMS3714H07;Pharmakon1600-01505480;{3-(2-Chloroethyl)-2-[(2-;WLN: T6NPOTJ AM2G BO B2G;Tox21_110539;Tox21_201815;Tox21_302775;BBL028071;CI0037;NSC759154;s1302;STL058690;AKOS005711213;Tox21_110539_1;AB02316;AC-2113;AN-6958;API0002976;CCG-213464;CS-1424;DB01181;MCULE-1480299331;NSC-759154;Ifosfamide, analytical reference material;NCGC00179435-01;NCGC00179435-02;NCGC00179435-03;NCGC00179435-06;NCGC00179435-07;NCGC00256413-01;NCGC00259364-01;AS-10978;CC-29468;HY-17419;LS-99799;NCI60_000233;SC-12120;SMR001233348;TA-01010;ACM1189701130;SBI-0206804.P001;AB0008491;AB2000039;KB-333868;AB00513932;FT-0603650;C07047;D00343;J10093;M-1494;33899-EP2275420A1;33899-EP2295055A2;33899-EP2295416A2;33899-EP2298748A2;33899-EP2298764A1;33899-EP2298765A1;33899-EP2305642A2;33899-EP2311453A1;AB00513932-06;AB00513932-07;AB00513932-08;AB00513932_09;AB00513932_10;778I732;C-16296;I06-0494;SR-05000002022-1;SR-05000002022-3;SR-05000002022-5;BRD-A67097164-001-11-2;Ifosfamide, British Pharmacopoeia (BP) Reference Standard;Ifosfamide, European Pharmacopoeia (EP) Reference Standard;UNII-UM20QQM95Y component HOMGKSMUEGBAAB-AWEZNQCLSA-N;Ifosfamide, United States Pharmacopeia (USP) Reference Standard;2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-;2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd;2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-;2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd;N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine;(2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2|E5-oxazaphosphinan-2-one;{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide;1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;2H-1,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide;2H-1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide;3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-one;3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one;3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorineoxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,2-oxazaphosphorine 2-oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide;N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphinan-2-amine 2-oxide #;36341-88-5"	3778-73-2	UM20QQM95Y	"18510176;14676103;11127946;10587020"	10587020	01/12/1999	1100226	01/07/1975	Bef. 1989		0	1	1	Yes	1	"21/03/2011 00:00;14/08/1987 00:00;23/03/2011 00:00;21/11/2001 00:00;09/08/1995 00:00;21/09/2015 00:00;10/11/1992 00:00;22/02/1990 00:00;04/04/2007 00:00;06/09/2001 00:00;15/06/1995 00:00;01/03/2012 00:00;13/12/2002 00:00;29/06/2011 00:00;13/06/2014 00:00;20/12/1996 00:00;28/08/2014 00:00;26/02/2002 00:00;27/01/1992 00:00;23/01/1996 00:00;22/09/2009 00:00;28/05/2002 00:00;26/05/2015 00:00;14/05/2015 00:00;17/01/2003 00:00;26/11/2012 00:00"	AP	"TEVA PHARMS USA;MYLAN LABS LTD;FRESENIUS KABI USA;WEST-WARD PHARMS INT;BAXTER HLTHCARE"	" MESNA;IFOSFAMIDE"	14/08/1987	BAXTER HLTHCARE	145,1	23	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	central nervous system toxicity	1	0	244	0	1
Halofuginone	halofuginone	(+/-)-trans-7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone	DB04866	"7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one hydrobromide;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidyl]-2-oxo-propyl]quinazolin-4-one hydrobromide;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4-quinazolinone hydrobromide;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidyl]-2-keto-propyl]quinazolin-4-one hydrobromide;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxo-propyl]quinazolin-4-one hydrobromide;4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel-;NSC713205;NSC-713205;RU-19110;Halofuginone;D04413;Halofuginone hydrobromide (USAN);Stenorol (TN)"	"Halofuginone;55837-20-2;Stenorol;7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one;empostatin;Halofuginone (INN);AC1L8G9K;AC1Q25XG;Halocur [veterinary] (TN);SCHEMBL25596;CHEMBL1199539;DTXSID0048260;BCBcMAP01_000063;BCBcMAP01_000107;MolPort-019-998-685;HY-N1584;ZINC1849659;AKOS026669540;CS-5485;KB-52340;NCI60_039464;FT-0080749;D08034;837H202;A830836;Q-201182;UNII-L31MM1385E component LVASCWIMLIKXLA-LSDHHAIUSA-N;7-Bromo-6-chloro-3-[3-(3alpha-hydroxypiperidin-2beta-yl)-2-oxopropyl]quinazolin-4(3H)-one;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4-quinazolinone;7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one;7-bromanyl-6-chloranyl-3-[2-oxidanylidene-3-[(2S,3R)-3-oxidanylpiperidin-2-yl]propyl]quinazolin-4-one"	55837-20-2	L31MM1385E	16815702	16815702	01/07/2006	16815702	01/07/2006	2004-2008		1	1	0	Yes	1					30/07/2018		144,7	24	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Edotecarin	"edotecarin;j-107088"	"Edotecarinum;Edotecarina;ED-749"	DB04882	"174402-32-5;Edotecarinum [INN-Latin];J 107088;J-107088;PF-804950;5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 12-beta-D-glucopyranosyl-12,13-dihydro-2,10-dihydroxy-6-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-;12-beta-D-Glucopyranosyl-2,10-dihydroxy-6-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-12,13-dihydro-6H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione;12,13-Dihydro-2,10-dihydroxy-6-N-(1-hydroxymethyl-2-hydroxyethylamino)-13 -(beta-d-glucopyranosyl)-5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione;E'dot?carine;E'dot?carine [INN-French];Edotecarin;Edotecarin [USAN:INN];Edotecarina;Edotecarinum"	"Edotecarin;Edotecarinum;174402-32-5;UNII-1V8X590XDP;J-107088;PF-804950;1V8X590XDP;CHEMBL435191;Edotecarina;E'dotecarine;Edotecarin [USAN:INN];Edotecarinum [INN-Latin];E'dotecarine [INN-French];C29H28N4O11;Edotecarin < Prop INN;Edotecarin (USAN/INN);D0I1DW;J 107088;SCHEMBL5177060;ZINC3946372;BDBM50086570;ED-749;CS-6688;DB04882;HY-13618;Z1880;D03954;12-(beta-D-Glucopyranosyl)-2,10-dihydroxy-6-[2-hydroxy-1-(hydroxymethyl)ethylamino]-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione;12-beta-D-Glucopyranosyl-2,10-dihydroxy-6-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-12,13-dihydro-6H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione;5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 12-beta-D-glucopyranosyl-12,13-dihydro-2,10-dihydroxy-6-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-"	174402-32-5	1V8X590XDP	16819636	16819636	01/07/2006	16819636	01/07/2006	2004-2008		1	1	0	Yes	1					30/07/2018		144,7	29	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	0	0	0	0	0	0	0	1
Tioguanine	"6-mercaptopurine;thioguanine"	"2-Amino 6mp;2-Amino-1,7-dihydro-6H-purine-6-thione;2-Amino-6-mercaptopurine;2-Amino-6-merkaptopurin;2-Amino-6-purinethiol;2-Aminopurin-6-thiol;2-Aminopurine-6(1H)-thione;2-amino-1,9-Dihydropurine-6-thione;2-amino-1H-purine-6(7H)-thione;2-aminopurine-6-thiol;6-Mercapto-2-aminopurine;6-Mercaptoguanine;6-TG;6-Thioguanine;Lanvis;TG;Tabloid;ThG;Thioguanine;Tioguanin;Tioguanina;Tioguanine;Tioguaninum"	"APRD00290;DB00352"	"2-amino-3,7-dihydropurine-6-thione;154-42-7;5580-03-0;SPECTRUM1500573;SPBio_000849;KBio3_001494;A4882_SIGMA;NCI60_041643;Spectrum5_001455;KBio2_000715;NINDS_000428;purine antimetabolite: antimetabolite: inhibits nucleic acid replication;Spectrum_000235;NCIOpen2_004153;KBio3_002954;KBioGR_002476;KBioGR_001452;Spectrum2_000695;ST5298909;C07648;Thioguanine;KBioSS_002483;NCGC00094792-01;Spectrum4_000926;NCGC00094792-02;NCGC00094792-03;BSPBio_001994;IDI1_000428;SMP2_000326;2-Amino-6-purinethiol;ST5298831;WLN: T56 BNM FYM INJ FUS HZ;KBio2_002476;NSC752;KBio2_005044;KBio2_005851;KBio2_007612;KBioSS_000715;A4660_SIGMA;2-Amino 6MP;2-Amino-1,7-dihydro-6H-purin-6-thion [Czech];2-Amino-1,7-dihydro-6H-purine-6-thione;2-Amino-6-MP;2-Amino-6-mercaptopurine;2-Amino-6-merkaptopurin [Czech];2-Aminopurin-6-thiol;2-Aminopurin-6-thiol [Czech];2-Aminopurine-6(1H)-thione;2-Aminopurine-6-thiol;2-Thioguanine;6-Mercapto-2-aminopurine;6-Mercaptoguanine;6-TG;6-Thioguanine;6H-Purine-6-thione, 2-amino-1,7-dihydro-;AI3-26078;BW 5071;EINECS 205-827-2;Guanine, thio-;Guanine, thio- (VAN);HSDB 2504;Lanvis;NSC 752;NSC-752;Purine-6(1H)-thione, 2-amino-;Purine-6-thiol, 2-amino-;TG;KBio2_003283;Tabloid;Thioguanine [USAN:BAN];Tioguanin;Tioguanina [INN-Spanish];Tioguanine;Tioguaninum [INN-Latin];Wellcome U3B;X 27;KBio1_000428;2-Amino-9H-purine-6-thiol;AIDS021096;AIDS-021096;Spectrum3_000577;2-amino-3,7-dihydropurine-6-thione;cMAP_000061;DivK1c_000428"	"6-Thioguanine;thioguanine;154-42-7;Tioguanine;2-Amino-6-mercaptopurine;6-Mercaptoguanine;Tioguanin;Tabloid;Lanvis;2-Amino-6-purinethiol;2-Aminopurine-6-thiol;2-Amino 6MP;2-Aminopurin-6-thiol;Wellcome U3B;2-Aminopurine-6(1H)-thione;Tioguaninum;6-Mercapto-2-aminopurine;2-Amino-9H-purine-6-thiol;2-Amino-6-merkaptopurin;Guanine, thio-;6-TG;Tioguanina;2-Thioguanine;6H-Purine-6-thione, 2-amino-1,7-dihydro-;BW 5071;Purine-6-thiol, 2-amino-;Purine-6(1H)-thione, 2-amino-;2-Amino-6-MP;2-Amino-1,7-dihydro-6H-purine-6-thione;Tioguaninum [INN-Latin];2-Amino-1,9-Dihydro-6h-Purine-6-Thione;2-Aminopurin-6-thiol [Czech];TG;Guanine, thio- (VAN);NSC 752;NSC-752;2-Amino-1,7-dihydro-6H-purin-6-thion;2-Amino-6-merkaptopurin [Czech];X 27;6-Thioguanine (6-TG);Thioguanine [USAN:BAN];Tioguanina [INN-Spanish];UNII-WIX31ZPX66;THG;2-amino-3,7-dihydropurine-6-thione;Thioguanine Hemihydrate;Tioguanine (INN);Lanvis (TN);CCRIS 8997;9H-Purine-6-thiol, 2-amino-;HSDB 2504;EINECS 205-827-2;2-Amino-1,7-dihydro-6H-purin-6-thion [Czech];CHEMBL727;WIX31ZPX66;2-amino-6,7-dihydro-3H-purine-6-thione;AI3-26078;CHEBI:9555;NSC752;7H-Purine-6-thiol, 2-amino-;WYWHKKSPHMUBEB-UHFFFAOYSA-N;Tioguanine [INN];2-amino-1,7-dihydropurine-6-thione;2-amino-1,9-dihydropurine-6-thione;1H-Purine-6-thiol, 2-amino- (9CI);NCGC00094792-01;DSSTox_CID_3652;purine antimetabolite: antimetabolite: inhibits nucleic acid replication;DSSTox_RID_77129;DSSTox_GSID_23652;6H-Purine-6-thione, 2-amino-3,7-dihydro- (9CI);ThioguaninGSK;6 Thioguanine;Thioguanin GSK;Thioguanin-GSK;6-Tioguanine;Thioguanine Tabloid;Tioguanina Wellcome;153981-51-2;153981-52-3;154034-61-4;154034-62-5;CAS-154-42-7;DX4;SMR000857244;2 Amino 6 Purinethiol;SR-05000002077;Thioguanine [USAN:USP];Thioguanine Monosodium Salt;Thioquanine;6-thioguanidine;6-thioguano-sine;6-TG/Thioguanine;PubChem9185;6-Thioguanine/6-TG;Spectrum_000235;Guanine, thio-(VAN);ACMC-209dan;Tioguanina[INN-Spanish];Spectrum2_000695;Spectrum3_000577;Spectrum4_000926;Spectrum5_001455;2-Amino-6-mercapto-purin;D02ZXM;6-Thioguanine, Thioguanine;6-Thioguanine, >=98%;SCHEMBL3701;SCHEMBL5898;NCIOpen2_004153;Thioguanine (Guanine analog);BSPBio_001994;C5H7N5S;KBioGR_001452;KBioGR_002476;KBioSS_000715;KBioSS_002483;6-Thioguanine, 98%  1g;KSC491M3F;MLS001333131;MLS001333132;MLS006010896;Wellcome Brand of Thioguanine;DivK1c_000428;SPECTRUM1500573;SPBio_000849;154-42-7|6-Thioguanine;2-amino-6-mercapto-9H-purine;AC1MC379;GTPL6845;Thioguanine (TN) (GlaxoSmith);5580-03-0 (hemihydrate);DTXSID6023652;Tioguanine GlaxoSmithKline Brand;CTK3J1632;HMS501F10;KBio1_000428;KBio2_000715;KBio2_002476;KBio2_003283;KBio2_005044;KBio2_005851;KBio2_007612;KBio3_001494;KBio3_002954;cMAP_000061;MolPort-000-929-106;MolPort-001-813-204;MolPort-003-665-495;NINDS_000428;BCPE000001;HMS1921E09;HMS2092M11;HMS2235F05;Pharmakon1600-01500573;Glaxo Wellcome Brand of Tioguanine;2- degrees +/->>u-6-UIaNssE;2-amino-1H-purine-6(9H)-thione;ALBB-023493;Glaxo Wellcome Brand of Thioguanine;GlaxoSmithKline Brand of Tioguanine;ZINC6382803;GlaxoSmithKline Brand of Thioguanine;Tox21_111035;Tox21_113184;Tox21_202401;Tox21_300275;ABP000905;ANW-21501;BDBM50200099;CCG-39890;CT-117;LS-888;MFCD00233553;NSC757348;s1774;SBB067147;2- degrees +/->>u-6UI>>uaNssE;76078-67-6 (mono-Na salt);AKOS003389499;AKOS015901298;AKOS023778741;Tox21_111035_1;2-Amino-1,7-dihydro-purine-6-thione;2-Amino-1,9-dihydro-purine-6-thione;AC-8421;AN-8030;API0015888;BCP9000197;CCG-213953;CS-1497;DB00352;FCH1448907;MCULE-5787306636;NSC-757348;PS-5007;RP02522;VZ33872;WLN: T56 BNM FYM INJ FUS HZ;IDI1_000428;SMP2_000326;NCGC00094792-02;NCGC00094792-03;NCGC00094792-05;NCGC00094792-06;NCGC00188976-01;NCGC00188976-02;NCGC00254082-01;NCGC00259950-01;NCGC00263442-01;2-amino-1,7-dihydro-6h-purine-6-thion;4CA-0085;AC-23020;CJ-15826;H351;HY-13765;KB-82699;NCI60_041643;SC-01333;SMR004701808;2-amino-3,7-dihydro-6H-purine-6-thione;SBI-0051533.P003;AB0013003;AB2000285;FT-0083572;FT-0611217;LT00455187;R2215;ST45025337;Y7662;2-Amino-1,7-dihydro-6H-purine-6-thione #;C07648;D08603;J10163;W-5092;15151-EP2275420A1;15151-EP2295055A2;15151-EP2295416A2;15151-EP2295426A1;15151-EP2295427A1;15151-EP2298748A2;15151-EP2298764A1;15151-EP2298765A1;15151-EP2305642A2;15151-EP2308833A2;15151-EP2311453A1;15151-EP2311808A1;15151-EP2311825A1;15151-EP2311829A1;15151-EP2311840A1;15151-EP2311842A2;15151-EP2316832A1;15151-EP2316833A1;AB00174074_06;AB00918694_06;AB01273926-01;AB01273926-02;AB01273926_03;120118-EP2270008A1;120118-EP2272827A1;120118-EP2292617A1;120118-EP2298778A1;154T427;I14-1541;SR-05000002077-1;SR-05000002077-5;W-108030;W-205813;I14-18698;Z2768769146;Thioguanine, United States Pharmacopeia (USP) Reference Standard;157646-93-0;6-Thioguanine, Hybri-Max(TM), 50 x, gamma-irradiated, lyophilized powder, BioXtra, suitable for hybridoma"	154-42-7	WIX31ZPX66	"9713314;9815740"	9815740	01/05/1997	13216836	01/01/1954	Bef. 1989		0	0	0	Yes	1					18/01/1966	ASPEN GLOBAL INC	144,3	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Adecatumumab	adecatumumab		DB05006			503605-66-1	000705ZASD	16930989	16930989	01/08/2006	16930989	01/08/2006	2004-2008		1	1	0	Yes	1					30/07/2018		143,6	20	NA	0	1	PROSTATE	1	EPCAM	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	25	0	1
Daunorubicin	"daunorubicin;pnu-159548"	"(+)-Daunomycin;(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione;Acetyladriamycin;Cerubidine 20mg/vial;DaunoXome;Daunomycin;Daunorubicin;Daunorubicin Hydrochloride;Daunorubicin Hydrochloride for Injection;Daunorubicina;Daunorubicine ;Daunorubicinum;Daunoxome Liposomal - IV 2mg/ml, 50mg/vial;Leukaemomycin C;Rubidomycin;Vyxeos"	"APRD00521;DB00694"	"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;20830-81-3;11006-54-5;11048-29-6;1407-15-4;149541-57-1;23942-76-9;27576-81-4;28020-80-6;EINECS 244-069-7;FI6339;HSDB 5095;Leukaemomycin C;NCI-C04693;NSC-82151;RCRA waste no. U059;RP 13057;(7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;CHEBI:41977;STOCK1N-66160;NChemBio.2007.10-comp14;AIDS-000123;(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;LMPK02000005;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;BSPBio_000353;BPBio1_000389;DM1;NCGC00025173-01;Tocris-1467;C01907;Daunomycin;Daunorubicin;(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;nchembio723-comp2;(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;1407-15-4 (DELETED);23541-50-6 (HYDROCHLORIDE);NCGC00024246-05;AIDS000123;Anthracyline;FI 6339;NSC82151 (HYDROCHLORIDE);VS-103;Prestwick3_000487;(+)-Daunomycin;(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione;5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-;5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-;AI3-52942;Acetyladriamycin;BRN 1445583;CCRIS 914;Cerubidin;DRG-0155;Daunamycin;Daunarubicinum;DaunoXome;Daunorrubicina;Daunorubicine;Daunorubicinum [INN-Latin]"	"daunorubicin;Daunomycin;20830-81-3;Rubidomycin;Cerubidine;Daunorubicine;Acetyladriamycin;Leukaemomycin C;Daunamycin;Daunarubicinum;Daunorrubicina;Daunorubicinum;Cerubidin;DaunoXome;Rubomycin C;(+)-Daunomycin;Daunoblastin;Anthracyline;Daunoblastine;Dauno-Rubidomycine;Rubomycin;Daunorubicinum [INN-Latin];Anthracycline;Daunorubicin [INN:BAN];RP 13057;RCRA waste no. U059;FI6339;NSC-82151;DAUNORUBICIN HCL;DaunoXome (TN);Daunorubicin (INN);Daunorubicin (liposomal);UNII-ZS7284E0ZP;CCRIS 914;ZS7284E0ZP;CHEBI:41977;HSDB 5095;C27H29NO10;NCI-C04693;EINECS 244-069-7;Ondena;NSC 83142;VS-103;(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione;FI 6339;BRN 1445583;NCGC00024246-05;AI3-52942;NDC-0082-4155;Antibiotics from Streptomyces coeruleorubidus;DSSTox_CID_2883;DSSTox_RID_76773;Daunomycine;DSSTox_GSID_22883;5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-;Daunomycin, hydrochloride;RP 13057 hydrochloride;Daunorubicin, Hydrochloride;MLS000069508;(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside;(7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-;CAS-20830-81-3;NSC82151;FI-6339;RP-13057;SMR000058559;NDC 0082-4155;Daunorubicina;SR-01000000033;SR-05000001600;Tocris-1467;Daunorubicin(Daunomycin);AC1L1JCP;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;Prestwick3_000487;Daunorubicin(RP13057);CHEMBL178;D01XWG;D08UQF;D0T7QR;Antibiotic F.I. 1762;AC1Q29OI;SCHEMBL3041;BSPBio_000353;cid_62770;BPBio1_000389;GTPL7063;DTXSID7022883;BDBM32017;MolPort-002-533-961;STQGQHZAVUOBTE-VGBVRHCVSA-N;HMS2089H04;HMS2091K06;Pharmakon1600-01500223;DRG-0155;ZINC3917708;Tox21_110896;BDBM50368352;GR-318;HY-13062A;LMPK13050002;LS-997;NSC756717;AKOS027256614;Tox21_110896_1;AN-9539;API0005415;CCG-212559;CS-2004;DB00694;NSC-756717;NCGC00024246-06;NCGC00024246-07;NCGC00024246-09;NCGC00024246-10;NCGC00024246-15;NCGC00025173-01;SC-18793;SBI-0206677.P002;AX8123492;LS-187381;AB00514669;FT-0624457;30D813;C01907;D07776;15159-EP2270008A1;15159-EP2272827A1;15159-EP2277565A2;15159-EP2277566A2;15159-EP2277567A1;15159-EP2277568A2;15159-EP2277569A2;15159-EP2277570A2;15159-EP2289892A1;15159-EP2292280A1;15159-EP2292617A1;15159-EP2295416A2;15159-EP2295426A1;15159-EP2295427A1;15159-EP2298748A2;15159-EP2298778A1;15159-EP2301928A1;15159-EP2305642A2;15159-EP2305679A1;15159-EP2308833A2;15159-EP2308861A1;15159-EP2311808A1;15159-EP2311829A1;15159-EP2311842A2;15159-EP2316832A1;15159-EP2316833A1;16803-EP2272832A1;16803-EP2277565A2;16803-EP2277566A2;16803-EP2277567A1;16803-EP2277568A2;16803-EP2277569A2;16803-EP2277570A2;16803-EP2280012A2;16803-EP2281815A1;16803-EP2286812A1;16803-EP2292280A1;16803-EP2292615A1;16803-EP2298768A1;16803-EP2301928A1;16803-EP2301933A1;16803-EP2305640A2;16803-EP2305671A1;16803-EP2311825A1;16803-EP2311827A1;16803-EP2311840A1;16803-EP2316937A1;AB00514669-09;AB01644616_09;AB01644616_10;SR-01000000033-4;SR-05000001600-1;SR-05000001600-2;BRD-K43389675-001-01-3;BRD-K43389675-003-02-7;BRD-K43389675-003-03-5;BRD-K43389675-003-20-9;(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride;(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione;(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;11006-54-5;11048-29-6;1407-15-4;149541-57-1;182250-71-1;23942-76-9;27576-81-4;28020-80-6"	20830-81-3	ZS7284E0ZP	"10555126;10810429;11841431;12085249;12460785;12792745"	10555126	01/11/1999	5242863	01/01/1968	Bef. 1989		0	0	1	Yes	1	"28/10/1999 00:00;05/02/1980 00:00;24/01/2000 00:00;11/03/1992 00:00;01/09/1994 00:00;26/02/1980 00:00;26/02/1998 00:00;23/03/1999 00:00;03/05/1999 00:00;30/01/1998 00:00;03/09/1998 00:00;03/08/2017 00:00;20/11/2001 00:00;21/02/2002 00:00;03/02/1995 00:00;02/03/2001 00:00;10/12/2001 00:00;19/11/1999 00:00;03/12/1982 00:00;30/06/1995 00:00;26/04/2001 00:00;06/03/1987 00:00;23/06/1998 00:00;28/03/2000 00:00;25/05/1999 00:00;13/12/2000 00:00;24/02/1997 00:00;08/04/1996 00:00;18/02/1999 00:00;29/04/1999 00:00;23/05/2000 00:00;27/08/1996 00:00;10/02/2002 00:00;22/04/1993 00:00;12/06/2002 00:00;11/10/1996 00:00;20/10/1999 00:00;19/12/1979 00:00;11/03/1997 00:00;18/06/2002 00:00"	AP	"TEVA PHARMS USA;FRESENIUS KABI USA;GALEN (UK);CELATOR PHARMS;WEST-WARD PHARMS INT;TEVA PARENTERAL;SANOFI AVENTIS US;WYETH AYERST"	"DAUNORUBICIN CITRATE; DAUNORUBICIN ;CYTARABINE;DAUNORUBICIN HYDROCHLORIDE"	19/12/1979	WYETH AYERST	143,3	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
PI-88	pi-88		DB05808		"PI-88;CHEMBL1627122;Phosphomannopentaose sulfate;2-O-[3-O-[3-O-[3-O-[2-O,3-O,4-O-Tris(sodiooxysulfonyl)-6-O-[bis(sodiooxy)phosphinyl]-alpha-D-mannopyranosyl]-2-O,4-O,6-O-tris(sodiooxysulfonyl)-alpha-D-mannopyranosyl]-2-O,4-O,6-O-tris(sodiooxysulfonyl)-alpha-D-mannopyranosyl]-2-O,4-O,6-O-tris(sodiooxysulfonyl)-alpha-D-mannopyranosyl]-1-O,3-O,4-O,6-O-tetrakis(sodiooxysulfonyl)-alpha-D-mannopyranose"			17000682	17000682	01/09/2006	17000682	01/09/2006	2004-2008		1	1	0	Yes	1					30/07/2018		142,6	42	78	1	0	NA	1	HEPARANASE	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	0,21	0	PULMONARY EMBOLISM	1	0	0	0	0	0	1
Enzastaurin	enzastaurin		DB06486	"3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione;3-(1-methylindol-3-yl)-4-[1-[1-(2-pyridylmethyl)-4-piperidyl]indol-3-yl]pyrrole-2,5-dione;3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione;3-(1-methylindol-3-yl)-4-[1-[1-(2-pyridylmethyl)-4-piperidyl]indol-3-yl]-3-pyrroline-2,5-quinone;170364-57-5;Enzastaurin;Enzstataurin;1H-Pyrrole-2,5-dione, 3-(1-methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-"	"Enzastaurin;170364-57-5;LY317615;Enzastaurin (LY317615);3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione;LY-317615;UNII-UC96G28EQF;UC96G28EQF;CHEMBL300138;3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione;LE-0014;DSSTox_CID_24029;DSSTox_RID_80101;DSSTox_GSID_44029;C32H29N5O2;3-(1-methyl-1H-indol-3-yl)-4-{1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione;Enzastaurin [INN];CAS-170364-57-5;3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione;3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione;PubChem24445;Enzastaurin,LY317615;Enzastaurin/LY317615;D0I6VU;AC1L41YQ;Enzastaurin; LY317615;LY317615, Enzastaurin;LY317615 - Enzastaurin;SCHEMBL678748;GTPL5693;DTXSID5044029;CHEBI:91368;CTK4D3565;MolPort-009-194-230;BCPP000241;HMS3265M05;HMS3265M06;HMS3265N05;HMS3265N06;HMS3654A13;EX-A1055;ZINC1494900;Tox21_113367;ABP000244;ABP000991;ANW-46758;BDBM50128285;IN2280;s1055;AKOS015994764;Tox21_113367_1;AC-5900;AN-5292;API0005201;BCP9000648;CS-0132;RL02191;KS-0000062R;NCGC00238452-01;NCGC00238452-02;NCGC00238452-03;4CA-0790;AJ-26352;AK-60903;BC657905;HY-10342;KB-50535;SC-85687;AX8168625;ST2404687;TC-135503;FT-0667873;W3715;W-5459;364E575;J-510442;BRD-K79404599-001-01-0;3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmet;1H-Pyrrole-2,5-dione, 3-(1-methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-;1H-Pyrrole-2,5-dione,3-(1-methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-;3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-1H-pyrrole-2,5-;3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)-piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione;3-(1-Methyl-1H-indol-3-yl)-4-[1-(1-pyridin-2-ylmethyl-piperidin-4-yl)-1H-indol-3-yl]-pyrrole-2,5-dione;3-(1-methyl-1H-indol-3-yl)-4-{1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione;3-(1-methylindol-3-yl)-4-[1-[1-(2-pyridylmethyl)-4-piperidyl]indol-3-yl]pyrrole-2,5-dione"	170364-57-5	UC96G28EQF	25431212	25431212	01/11/2014	16943527	01/09/2006	2004-2008		1	1	0	Yes	1					30/07/2018		142,6	59	NA	1	1	"NSCLC;HEAD&NECK"	1	PKC	0	1	1	12	0	0	0	1	1	0	0	0	0	0,45	0	QT	1	0	0	0	0	0	1
Milataxel	mac-321		"DB12334;DB05523"	"Milataxel;MAC-321;TL-00139;TL-139"	"Milataxel;MAC-321;UNII-J41Q4S20GS;Milataxel [INN];J41Q4S20GS;TL-139;TL-00139;393101-41-2;MAC 321;Milataxel (oral);D0JI8B;Milataxel (oral), Taxolog;MAC321;TL-139 (oral), Taxolog/Wyeth;MAC-321 (oral), Taxolog/Wyeth;TL-00139 (oral), Taxolog/Wyeth;TL-139 (injectable), Taxolog/Wyeth;DB12334;MAC-321 (injectable), Taxolog/Wyeth;TL-00139 (injectable), Taxolog/Wyeth;352425-37-7;M-10;1,10beta-Dihydroxy-9-oxo-5beta,20-epoxy-3zeta-tax-11-ene-2alpha,4,7beta,13alpha-tetrayl 4-acetate 2-benzoate 13-((2R,3R)-3-(tert-butoxycarbonylamino)-3-(furan-2-yl)-2-hydroxypropanoate) 7-propanoate;2-Furanpropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(1-oxopropoxy)-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaR)-"	352425-37-7	J41Q4S20GS	17091249	17091249	01/11/2006	17091249	01/11/2006	2004-2008		1	1	0	Yes	1					30/07/2018		140,6	18	NA	1	0	NA	1	MDR	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,22	0	0	0	0	0	1	0	0	1
BZL101	"bzl101;scutellaria barbata"		DB05051					"20054647;17111207"	17111207	01/11/2006	17111207	01/11/2006	2004-2008		1	1	0	Yes	1					30/07/2018		140,6	21	77	0	1	BREAST	1	EXTRACT_Scutellaria barbata	0	0	1	21	0	0	0	1	1	0	0	0	0	0,19	0	0	0	0	0	0	0	0	1
Seliciclib	"cyc202;seliciclib"	"CYC202;R-roscovitine"	DB06195	"(2R)-2-[[6-(phenylmethylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol;(2R)-2-[[9-isopropyl-6-(phenylmethylamino)purin-2-yl]amino]butan-1-ol;(2R)-2-[[9-isopropyl-6-(phenylmethylamino)-2-purinyl]amino]butan-1-ol;(2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol;(2R)-2-[[6-(phenylmethylamino)-9-propan-2-yl-purin-2-yl]amino]butan-1-ol;186692-46-6;IDI1_002134;HSCI1_000092;Bio2_000379;1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-;NCGC00094374-02;6-(Benzylamino)-2(R)-[[1-(hydroxy&#175;methyl)propyl]amino]-9-isopropylpurine;R7772_SIGMA;KBioGR_000418;KBioSS_000418;NCGC00094374-03;K00020;CYC-202;Seliciclib;NCI60_036420;KBio3_000796;KBio3_000795;KBio2_000418;KBio2_002986;KBio2_005554;Bio1_001280;NSC 701554;Bio1_000791;Bio2_000859;Rosco;2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine;AIDS-022527;AIDS022527;CYC202;CBiol_002016;Bio1_000302;(R)-Roscovitine;BCBcMAP01_000013;2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol;NSC701554;Roscovitine;BiomolKI_000048;SMP1_000266;BSPBio_001078;R-ROSCOVITINE;RRC;InSolution&trade; Roscovitine;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-   yl)amino)-, (2R)-;2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol;CYC 202;Lopac0_001102;BiomolKI2_000054;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (R)-"	"roscovitine;Seliciclib;186692-46-6;R-Roscovitine;(R)-roscovitine;CYC202;CYC-202;CYC 202;Rosco;2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine;UNII-0ES1C2KQ94;NSC 701554;AL-39256;InSolution&trade; Roscovitine;CHEMBL14762;0ES1C2KQ94;BMK1-E12;CHEBI:45307;Roscovitine (Seliciclib,CYC202);(2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol;NSC701554;NSC-701554;(2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol;(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol;(R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol;(2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol;M02443;RRC;C19H26N6O;6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine;(2R)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol;2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol;Seliciclib [INN];CYC202, Seliciclib, R-roscovitine, Roscovitine;1unl;3ddq;(2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol;2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol;Roscovitine/CYC202;2a4l;BiomolKI_000048;1-Butanol, (2R)-;ROSCOVITINE(Seliciclib);BiomolKI2_000054;D02TIZ;D05ADP;AC1L4NH4;AC1Q4VI5;CBiol_002016;Lopac0_001102;SCHEMBL94728;BSPBio_001078;KBioGR_000418;KBioSS_000418;MLS006011028;BDBM7533;cid_160355;GTPL6035;Roscovitine, >=98% (TLC);BCBcMAP01_000013;CTK4D9313;KBio2_000418;KBio2_002986;KBio2_005554;KBio3_000795;KBio3_000796;AOB2095;DTXSID20171928;EX-A052;BTIHMVBBUGXLCJ-OAHLLOKOSA-N;MolPort-003-959-463;BCPP000087;Bio1_000302;Bio1_000791;Bio1_001280;Bio2_000379;Bio2_000859;CC205;HMS1362F19;HMS1792F19;HMS1990F19;HMS3229N13;HMS3403F19;Roscovitine (Seliciclib, CYC202);ZINC1649340;ABP000228;BS0304;GP3424;HSCI1_000092;MFCD02266401;s1153;AKOS005146319;AC-2416;AN-1311;CCG-100652;RL02372;IDI1_002134;SMP1_000266;2,6,9-Trisubstituted purine deriv. 28;NCGC00094374-01;NCGC00094374-02;NCGC00094374-03;NCGC00094374-04;NCGC00094374-05;AJ-28787;BC683378;HY-30237;KB-60358;NCI60_036420;SC-85946;SMR004702823;AB1010069;CYC202, Seliciclib, 186692-46-6;LS-182554;RT-015440;FT-0674460;X7381;K00020;S-7720;692R466;J-011999;J-524224;BRD-K07691486-001-03-1;BRD-K07691486-001-05-6;UNII-AIR55KO85E component BTIHMVBBUGXLCJ-OAHLLOKOSA-N;(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol;(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol;(2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol;(R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (2R)-;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (R)-;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (2R)-;1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (R)-;1-Butanol,2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-;2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol;2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol; 6-(Benzylamino) -2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine;Seliciclib|||CYC-202|||(2R)-2-[[6-(Benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol"	186692-46-6	0ES1C2KQ94	"20822897;17179992"	17179992	01/12/2006	17179992	01/12/2006	2004-2008		1	1	0	Yes	1					30/07/2018		139,6	33	NA	1	0	NA	1	"CDK1;CDK2;CDK7;CDK9"	0	1	1	12	0	0	0	0	1	0	0	0	0	0,05	0	0	0	0	0	0	21	0	1
Gimatecan	"camptothecin gimatecan;gimatecan;lbq707;st1481;sti481"		DB06721	"292618-32-7;292620-90-7;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-, 11-(O-(1,1-dimethylethyl)oxime), (4S)-;7-tert-Butoxyiminomethylcamptothecin;CPT 184;ST 1481;ST1481;(4S)-11-((E)-((1,1-Dimethylethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3?,4?:6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-, 11-(O-(1,1-dimethylethyl)oxime), (C(E),4S)-;Gimatecan;Gimatecan [INN]"	"Gimatecan;292618-32-7;Gimatecan [INN];UNII-7KKS9R192F;ST1481;ST 1481;7KKS9R192F;LBQ-707;ST-1481;(4S)-11-((E)-((1,1-DImethylethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-, 11-(O-(1,1-dimethylethyl)oxime), (C(E),4S)-;LBQ707;7-t-Butoxyiminomethylcamptothecin;CPT 184;LBQ 707;7-tert-Butoxyiminomethylcamptothecin;7-cyano-camptothecin;D00BZS;DSSTox_CID_31491;DSSTox_RID_97376;DSSTox_GSID_57702;SCHEMBL130586;CHEMBL113051;Camptothecin analogs, Sigma-Tau;DTXSID0057702;CPT-184;Tox21_113726;AN-5640;API0002825;NCGC00253588-01;292620-90-7;LS-184222;CAS-292618-32-7;618G327;(4S)-11-((E)-((1,1-Dimethylethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3 ,4 :6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;(S,E)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-11-carbaldehyde O-(tert-butyl) oxime;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-, 11-(O-(1,1-dimethylethyl)oxime), (4S)-"	292618-32-7	7KKS9R192F	17150998	17150998	01/12/2006	17150998	01/12/2006	2004-2008		1	1	0	Yes	1					30/07/2018		139,6	108	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	3	0	1
Indibulin	"d-24851;indibulin"		DB06169		"Indibulin;204205-90-3;d-24851;2-(1-(4-chlorobenzyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide;UNII-80K4H2RB8P;80K4H2RB8P;ZIO-301;D 24851;IN1366;2-[1-(4-chlorobenzyl)-1h-indol-3-yl]-2-oxo-n-(pyridin-4-yl)acetamide;N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]-glyoxyl Amide;Indibulin [USAN:INN];2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-(4-pyridyl)acetamide;2-{1-[(4-chlorophenyl)methyl]indol-3-yl}-2-oxo-N-(4-pyridyl)acetamide;Indibulin (USAN/INN);AC1L1ESK;D04NXL;AC1Q5NS8;MLS006011745;CHEMBL49642;SCHEMBL3165856;CTK8E8280;DTXSID70174368;QCR-111;MolPort-002-739-496;SOLIIYNRSAWTSQ-UHFFFAOYSA-N;ZERO/005632;SBB013544;STK783524;ZINC37866151;AKOS005619980;AN-3573;API0002198;MCULE-2626264660;NCGC00160428-01;NCGC00160428-02;AJ-94323;LS-82075;SC-84469;SMR004703467;AX8251733;KB-220047;RT-013331;FT-0745397;D10013;SR-01000883991;J-013299;SR-01000883991-1;2-[1-(4-CHLOROBENZYL)-1H-INDOL-3-YL]-2-OXO-N-(4-PY;2-[1-(4-Chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(4-pyridinyl)acetamide;2-[1-(4-chlorobenzyl)-1h-indol-3-yl]-2-oxo-n-pyridin-4-ylacetamide;2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide;1H-Indole-3-acetamide, 1-((4-chlorophenyl)methyl)-alpha-oxo-N-4-pyridinyl-;1H-Indole-3-acetamide, 1-[(4-chlorophenyl)methyl]-.alpha.-oxo-N-(4-pyridinyl)-;2-(1-(4-Chlorophenylmethyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide"	204205-90-3	80K4H2RB8P	"19404582;17146730"	17146730	01/12/2006	17146730	01/12/2006	2004-2008		1	1	0	Yes	1					30/07/2018		139,6	14	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
NV1020	"nv1020;oncolytic herpes simplex virus"		DB04969					21895536	21895536	01/09/2011	17107303	01/12/2006	2004-2008		1	1	0	Yes	1					30/07/2018		139,6	12	NA	0	1	COLORECTAL	1	VIRUS	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
CP-724714	cp-724,714		DB12302		"CP-724714;383432-38-0;CP 724714;CP-724,714;CP724714;(E)-2-methoxy-N-(3-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-6-yl)allyl)acetamide;2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide;UNII-I05QZ0S4V3;CHEMBL483321;I05QZ0S4V3;2-Methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide;J-501857;C27H27N5O3;2-methoxy-N-[(2E)-3-[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-6-yl]prop-2-en-1-yl]acetamide;2-methoxy-N-[(E)-3-[4-[3-methyl-4-[(6-methyl-3-pyridyl)oxy]anilino]quinazolin-6-yl]allyl]acetamide;(E)-2-methoxy-N-(3-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)quinazolin-6-yl)allyl)acetamide;Acetamide, 2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propen-1-yl)-;ACETAMIDE, 2-METHOXY-N-[3-[4-[[3-METHYL-4-[(6-METHYL-3-PYRIDINYL)OXY]PHENYL]AMINO]-6-QUINAZOLINYL]-2-PROPEN-1-YL]-;D0CN9Q;SCHEMBL95109;MLS006011185;GTPL7883;SCHEMBL4617807;BDBM31340;CHEBI:91331;cid_9874913;SYN1033;LLVZBTWPGQVVLW-SNAWJCMRSA-N;MolPort-009-679-456;BCPP000275;ZINC3817105;2337AH;RS0037;s1167;AKOS005146427;BCP9000546;CS-0262;DB12302;EX-8511;845680-17-3;AM808085;AN-16843;AS-16200;HY-14674;SMR004702954;DB-028138;FT-0083520;X7480;A15542;CP724714, >=98% (HPLC);W-5593;CP724,714, CP-724,714;BRD-K76908866-001-02-7;(E)-Ethyl (3-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)pheny)amino)quinazolin-6-yl)allyl)carbamate;2-methoxy-N-(3-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)quinazolin-6-yl)allyl)acetamide;2-methoxy-N-[(E)-3-[4-[[3-methyl-4-(6-methylpyridin-3-yl)oxy-phenyl]amino]quinazolin-6-yl]prop-2-enyl]ethanamide;2-methoxy-N-[(E)-3-[4-[[3-methyl-4-(6-methylpyridin-3-yl)oxyphenyl]amino]quinazolin-6-yl]prop-2-enyl]acetamide;2-methoxy-N-[(E)-3-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]prop-2-enyl]acetamide;2-methoxy-N-[(E)-3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide;E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide"	537705-08-1	I05QZ0S4V3	"17317835;17285315"	17317835	01/02/2007	17317835	01/02/2007	2004-2008		1	1	0	Yes	1					30/07/2018		137,6	30	71	0	1	HER2_POSITIVE	1	HER2	0	1	0	NA	0	1	0	1	1	0	0	0	0	0,29	0	0	0	0	0	0	0	0	1
Banoxantrone	"aq4n;banoxantrone"	AQ4N	DB04975		"Banoxantrone;AQ4N;UNII-W5H7E45YT3;136470-65-0;W5H7E45YT3;Banoxantrone [INN:BAN];AQ 4N;AQ4M;D00PIE;AQ4N, AstraZeneca/Novacea;AQ-4N;CHEMBL117391;SCHEMBL3676563;YZBAXVICWUUHGG-UHFFFAOYSA-N;AZD-1689;ZINC3776950;DB04975;1,4-Bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-9,10-anthracenedione N,N'-dioxide;NCGC00346890-01;AN-16649;2-[[4-[2-[dimethyl(oxido)azaniumyl]ethylamino]-5,8-dihydroxy;1,4-Bis(2-(dimethylazinoyl)ethylamino)-5,8-dihydroxy-9,10-anthraquinone;9,10-Anthracenedione, 1,4-bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-, N,N'-dioxide;9,10-Anthracenedione, 1,4-bis((2-(dimethyloxidoamino)ethyl)amino)-5,8-dihydroxy-;2,2'-((5,8-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethan-1-amine oxide);2-[[4-[2-[dimethyl(oxido)ammonio]ethylamino]-5,8-dihydroxy-9,10-dioxo-1-anthryl]amino]-N,N-dimethyl-ethanamine oxide"	136470-65-0	W5H7E45YT3	18981010	18981010	01/11/2008	17442658	01/04/2007	2004-2008		1	1	0	Yes	1					30/07/2018		135,7	22	NA	0	1	OESOPHAGAL	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	0	0,14	0	0	0	0,54	0	0	0	0	0	0	95	0	1
Catumaxomab	catumaxomab	Removab	DB06607			509077-98-9	M2HPV837HO	"27058902;17410361"	17410361	01/04/2007	17410361	01/04/2007	2004-2008		1	1	0	Yes	1					30/07/2018		135,7	NA	NA	0	1	NSCLC	1	"EPCAM;CD3"	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	47	0	1
Intetumumab	"cnto 95;intetumumab"		DB12701			725735-28-4	GQE1BJE2NI	"21331745;17404096"	17404096	01/04/2007	17404096	01/04/2007	2004-2008		1	1	0	Yes	1					30/07/2018		135,7	24	NA	1	0	NA	1	INTEGRIN	0	1	1	6	0	0	0	1	1	0,04	0	0	0	NA	0	0	0	0	0	0	25	0	1
PX-12	"px-12;thioredoxin-1 inhibitor px-12"	1-methylpropyl 2-imidazolyl disulfide	DB05448		"141400-58-0;PX-12;2-(sec-butyldisulfanyl)-1h-imidazole;PX 12;2-[(1-methylpropyl)dithio]-1H-imidazole;2-(butan-2-yldisulfanyl)-1H-imidazole;CHEMBL406050;2-((1-Methylpropyl)dithio)-1H-imidazole;1H-Imidazole,2-[(1-methylpropyl)dithio]-;1H-Imidazole, 2-((1-methylpropyl)dithio)-;1H-Imidazole, 2-[(1-methylpropyl)dithio]-;Iv 2 Compound;IV-2 compound;1-Methylpropyl-2-imidazolyl disulfide;ACMC-20ckye;AC1Q7EBH;D04JTD;SCHEMBL775481;IV-2;C7H12N2S2;CHEBI:94291;CTK4C2614;KS-00000RXW;MolPort-006-170-091;AC1L5624;3122AH;BDBM50426071;EBD149897;s7947;AKOS022175532;CS-3052;DB05448;FCH1137657;NCGC00346876-01;PX 12, >=98% (HPLC), powder;AK143053;HY-13734;AB0081834;AX8282606;RT-015159;J-007491;BRD-A56592690-001-01-9"		8PQ9CZ8BTJ	"22711542;21863237;17404093"	17404093	01/04/2007	17404093	01/04/2007	2004-2008		1	1	0	Yes	1					30/07/2018		135,7	38	NA	1	0	NA	1	TRDX1	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,18	0	0	0	0	0	0	0	0	1
Imexon	"aop99;imexon"		DB05003	"4-amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one;59643-91-3;4-Amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one;4-Imino-1,3-diazabicyclo(3.1.0)hexan-2-one;BM 06002;EINECS 261-838-2;Imexon;Imexon [INN];Imexonum [INN-Latin];NSC 313425;1,3-Diazabicyclo[3.1.0]hex-3-en-2-one, 4-amino-;NSC313425;NSC714597;4-Imino-1,3-diazabicyclo-[3.1.0]-hexan-2-one;NCI60_002705;4-amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one;4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one;I1631_SIGMA;AOP-990001;Amplimexon;BM-06002;AIDS-000351;AIDS000351;BM 06 002"	"Imexon;59643-91-3;Amplimexon;Imexonum [INN-Latin];BM 06002;4-Imino-1,3-diazabicyclo(3.1.0)hexan-2-one;BM-06002;EINECS 261-838-2;4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one;NSC 313425;4-Amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one;C4H5N3O;MLS002702958;4-Imino-1,3-diazabicyclo-[3.1.0]hexan-2-one;4-Amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one;NSC313425;NCGC00181304-01;Imexonum;Imexon [INN];Imexon [USAN:INN];Amplimexon (TN);Imexon (USAN/INN);AC1L2AGD;D0Z5XT;DSSTox_CID_26895;DSSTox_RID_81997;DSSTox_GSID_46895;SCHEMBL154584;AC1Q6C46;CHEMBL146428;GTPL8273;DTXSID1046895;Amplimexon (proposed trade name);CTK5B0232;HMS3264B05;Tox21_112779;NSC714597;AKOS006273819;AKOS027381087;AOP-990001;API0002979;CCG-213631;CS-6825;DB05003;NSC-313425;NSC-714597;AN-39580;HY-15385;KB-52542;NCI60_002705;SMR001566772;BM 06 002;CAS-59643-91-3;LS-176018;FT-0692514;D08932;AB01013867_03;4-Imino-1,3-diazabicyclo-[3.1.0]-hexan-2-one;643I913;C-44234;1,3-Diazabicyclo[3.1.0]hex-3-en-2-one,4-amino-"	59643-91-3	8F63U28T2V	"20571355;17470869"	17470869	01/05/2007	17470869	01/05/2007	2004-2008		1	1	0	Yes	1					30/07/2018		134,7	49	NA	1	0	NA	1	ROS	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	NA	0	0	0	0	0	0	0	0	1
Atacicept	atacicept	TACI-Ig	DB06399			845264-92-8	K3D9A0ICQ3	18281543	18281543	01/02/2008	17473917	01/05/2007	2004-2008		1	0	0	No	0					30/07/2018		134,7	#N/A																							0						1
AI-850	"ai-850;microparticle hydrophobic drug delivery system for paclitaxel"		DB05842					17545535	17545535	01/06/2007	17545535	01/06/2007	2004-2008		1	1	0	Yes	1					30/07/2018		133,7	22	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,09	0	0	0	NA	0	0	0	0	0	0	0	0	1
Motesanib	"amg 706;motesanib;motesanib diphosphate"		DB05575	"N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)pyridine-3-carboxamide;N-(3,3-dimethyl-6-indolinyl)-2-(4-pyridylmethylamino)-3-pyridinecarboxamide;N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)nicotinamide;453562-69-1;AMG 706;D06678;Motesanib"	"Motesanib;453562-69-1;AMG-706;AMG 706;N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide;UNII-U1JK633AYI;AMG706;N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide;U1JK633AYI;CHEBI:51098;N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide;N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-3-pyridinecarboxamide;C22H23N5O;Motesanib [USAN:INN];N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide;AMG706/ Motesanib;PubChem22412;AMG-706(Motesanib)/;D00DQX;SCHEMBL187470;CHEMBL572881;GTPL5660;QCR-80;BDBM24773;CTK8D4046;DTXSID10196488;EX-A487;SYN1055;cid_11667893;MolPort-009-679-440;BCPP000407;HMS3244A09;HMS3244A10;HMS3244B09;HMS3265G19;HMS3265G20;HMS3265H19;HMS3265H20;AOB87176;KS-00000XP7;AMG 706; AMG-706;ABP000879;AN-560;RS0100;ZINC18710082;AKOS005146333;BCP9000289;EX-8571;NCGC00263205-01;4CA-0148;AK326502;AS-16212;BC659946;HY-10228;KB-78947;SC-28323;AB0007900;TC-063059;FT-0706483;X4931;A19395;D06678;W-5450;562M691;J-522983;BRD-K99616396-316-01-2;N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethyl;N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)nicotinamide;N-(3,3-dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide;N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)-3-pyridinecarboxamide;N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)pyridine-3-carboxamide;3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-;894356-47-9"	453562-69-1	U1JK633AYI	"17557949;20107802"	17557949	01/06/2007	17557949	01/06/2007	2004-2008		1	1	0	Yes	1					30/07/2018		133,7	71	NA	1	0	NA	1	"VEGFR;PDGFR;C-KIT"	0	1	0	NA	0	0	0	1	1	0,07	0	0	0	0,49	0	0	0	0	0	0	0	0	1
Figitumumab	"cp-751,871;figitumumab"		DB11685		"Figitumumab;D0U6KH"	943453-46-1	VE267FC2UB	"22025154;20036194;19745765;17908976"	17908976	01/10/2007	17908976	01/10/2007	2004-2008		1	1	0	Yes	1					30/07/2018		129,7	24	NA	1	0	NA	1	IGF1R	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,66	0	0	0	0	0	0	25	0	1
Lexatumumab	"hgs-etr2;lexatumumab"	"HGS-ETR2;TRAIL-R2"	DB06599			845816-02-6	967Q0SJD77	19633048	19633048	01/07/2009	17947486	01/10/2007	2004-2008		1	1	0	Yes	1					30/07/2018		129,7	37	NA	1	0	NA	1	TRAIL-R2	0	1	1	12	0	1	0	1	1	0	0	0	0	0,32	0	0	0	0	0	0	25	0	1
Cediranib	"azd2171;cediranib"		"DB04849;DB12033"	"4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-1-pyrrolidinylpropoxy)quinazoline;AZD-2171;Cediranib;Recentin"	"Cediranib;288383-20-0;Recentin;AZD2171;Cedirannib;AZD 2171;AZD-2171;UNII-NQU9IPY4K9;Cediranib (AZD2171);4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Cediranib (AZD217);Cediranib (USAN/INN);NQU9IPY4K9;ZD-2171;4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;CHEMBL491473;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;M6294;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Q-101399;C25H27FN4O3;NSC-732208;Cediranib [USAN:INN:BAN];4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;Cediranib,AZD2171;Kinome_3318;Cediranib dihydrochloride;AZD2171, Cediranib;Cediranib - AZD2171;D09VMI;SCHEMBL63147;MLS006010063;GTPL5664;QCR-93;AZD2171, Recentin, Cediranib;Cediranib (AZD2171)/Recentin;CHEBI:94782;AOB1949;DTXSID10183035;MolPort-006-169-995;XXJWYDDUDKYVKI-UHFFFAOYSA-N;BCPP000295;HMS3654G05;KS-00000LF1;ZINC3948085;ABP000861;AN-567;BDBM50331096;s1017;AKOS005145767;BCP9000500;CS-0119;DB04849;ES-0052;RL02984;ZD 2171;NCGC00263097-01;AC-25033;AT-19598;BC667561;HY-10205;SC-23199;SMR004701223;AB0030443;FT-0751000;X2636;A24280;D08881;W-5429;P111005;BRD-K86930074-001-01-9;4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;557795-03-6;790713-41-6;Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-"	288383-20-0	NQU9IPY4K9	"19308410;17458505"	17458505	01/04/2007	17458505	01/10/2007	2004-2008		1	1	0	Yes	1					30/07/2018		129,7	26	NA	0	1	PROSTATE	1	VEGFR	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	0,11	0	0	0	0	0	0	21	0	1
SNS-032	"bms-387032;cdk inhibitor sns-032;sns-032"		DB05969	"N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; (2R,3R)-2,3-dihydroxybutanedioic acid;N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide; N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide; (2R,3R)-2,3-dihydroxybutanedioic acid;N-[5-[(5-tert-butyl-2-oxazolyl)methylthio]-2-thiazolyl]-4-piperidinecarboxamide; N-[5-[(5-tert-butyl-2-oxazolyl)methylthio]-2-thiazolyl]-4-piperidinecarboxamide; (2R,3R)-2,3-dihydroxybutanedioic acid;N-[5-[(5-tert-butyloxazol-2-yl)methylthio]thiazol-2-yl]isonipecotamide; N-[5-[(5-tert-butyloxazol-2-yl)methylthio]thiazol-2-yl]isonipecotamide; tartaric acid;SNS-032;BMS-387032"	"SNS-032;345627-80-7;BMS-387032;SNS 032;BMS 387032;N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide;N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide;SNS-032 (BMS-387032);UNII-9979I93686;BMS-387072;CHEMBL296468;SNS032;C17H24N4O2S2;OUSFTKFNBAZUKL-UHFFFAOYSA-N;BMS387032;N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide;N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide;N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide;9979I93686;4-Piperidinecarboxamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-;n-(5-((5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl)-1,3-thiazol-2-yl)piperidine-4-carboxamide;Kinome_3820;PubChem16670;Tube004;AC1MHGD4;D0S5RC;MLS006011029;SCHEMBL187401;BDBM5931;GTPL5670;CHEBI:91399;cid_3025986;CTK4H2598;DTXSID50188100;EX-A054;MolPort-005-942-660;BCPP000066;HMS3654G10;ACT06674;ZINC3816409;ABP000845;s1145;AKOS015898717;AN-3519;API0007075;RL03281;BMS-3870032;KS-0000063E;N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-peridinecarboxamide;N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide;NCGC00263167-01;NCGC00263167-02;4CA-1169;AC-26846;AJ-45713;AK113734;AS-35116;BC224785;BMS-387032, SNS-032;HY-10008;SC-84716;SMR004702824;SNS-032(BMS-387032);SNS-032, BMS-387032;AB0033696;AB1008461;AX8165410;LS-186036;SNS-032 - BMS-387032;A6078;FT-0674612;X7382;A20554;W-5410;627B807;I09-1579;J-019645;J-523350;BRD-K43389698-001-01-6;SNS-032, 345627-80-7;SNS-032(BMS387032)/SNS032,BMS-387032;N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide;SNS-032;N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide;4-Piperidinecarboxamide,N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-;56H;936487-64-8;N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; SNS-032;n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]-thio]-2-thiazolyl]-4-piperidinecarboxamide;SNS-032|||N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide"	345627-80-7	9979I93686	17938863	17938863	01/10/2007	17938863	01/10/2007	2004-2008		1	1	0	Yes	1					30/07/2018		129,7	21	NA	1	0	NA	1	"CDK2;CDK7;CDK9"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,15	0	0	0	0	0	1	0	0	1
Telbivudine	thymidine	"L-thymidine;Epavudine;L-DT;beta-L-2'-Deoxythymidine;2'-Deoxy-L-thymidine;L-deoxythymidine;Beta-l-thymidine;1-(2-Deoxy-beta-L-ribofuranosyl)-5-methyluracil;LDT;Telbivudin;Sebivo;Tyzeka"	DB01265	"1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-5-methylpyrimidine-2,4-dione;1-[(2S,4R,5S)-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-quinone;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione;3424-98-4;Telbivudine[USAN];Sebivo;Tyzeka;AIDS-112549;AIDS112549;L-Deoxythymidine;L-Thymidine;L-dT;NV 02B;Telbivudine;Thymine, 1-(2-deoxy-.beta.-L-erythro-pentofuranosyl)-;2'-Deoxy-L-thymidine;2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-methyl-;Epavudine;LDT600;NB 02B;NV-02B;Telbivudin;LDT-600;Thymine, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-;beta-L-Thymidine;ZINC00002159;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione"	"Telbivudine;Epavudine;2'-Deoxy-L-thymidine;beta-L-Thymidine;Tyzeka;Telbivudin;Sebivo;L-dT;L-Thymidine;3424-98-4;L-Deoxythymidine;NV-02B;Telbivudine [USAN];LDT600;LdT;UNII-2OC4HKD3SF;Tyzeka (TN);NB 02B;NV 02B;CHEBI:63624;2OC4HKD3SF;Telbivudine (USAN/INN);LDT-600;1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione;1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione;1-(2-deoxy-beta-L-ribofuranosyl)-5-methyluracil;1-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;Thymine, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-;beta-L-2'-Deoxythymidine;2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-methyl-;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione;1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione;LLT;Telbivudine [USAN:INN:BAN];Sebivo;Tyzeka;2-Deoxy-L-thymidine;Tyzake/Sebivo (TN);1-(2-Deoxy-beta-D-ribofuranosyl)-5-methyluracil;AC1L4LJI;b-L-2'-deoxy-thymidine;D0CL9S;Telbivudine(Tyzeka, Sebivo);Tyzeka, Sebivo, Telbivudine;SCHEMBL124279;Telbivudine (Sebivo, Tyzeka);CHEMBL374731;ZINC2159;Telbivudine, >=98% (HPLC);DTXSID30187813;IQFYYKKMVGJFEH-CSMHCCOUSA-N;MolPort-006-167-757;HY-B0017;BDBM50088372;CT-990;GC4386;MFCD02683612;s1651;AKOS025117349;AC-5632;API0025947;CS-1934;DB01265;1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-Pyrimidinedione;NCGC00346560-01;AN-10762;AS-35209;BC257880;KB-81600;ZB000493;AB2000195;LS-186402;LS-187347;D06675;AB01274717-01;AB01274717_02;I14-8810;BRD-K15976406-001-01-7;Thymine, 1-(2-deoxy-.beta.-L-erythro-pentofuranosyl)-;Z2574360267;1-[(2s,4r,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione;1-((2S,4S,5S)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione"	3424-98-4	2OC4HKD3SF	"23749894;19363470;11733970;10561372;8630682"	8630682	01/01/1996	8630682	01/01/1996	1994-1998		1	1	1	Yes	1	"29/03/2011 00:00;28/03/2018 00:00;23/01/2009 00:00;10/09/2010 00:00;23/12/2011 00:00;04/03/2010 00:00;30/01/2014 00:00;25/10/2006 00:00;05/05/2011 00:00;28/04/2009 00:00;28/01/2013 00:00;06/12/2013 00:00;11/12/2015 00:00;08/05/2009 00:00"	AP	NOVARTIS	TELBIVUDINE	25/10/2006	NOVARTIS	129,5	60	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,02	0	NA	0	NA	0	0	0	0	0	1	3	0	1
Cintredekin Besudotox	interleukin 13-pe38qqr		DB05305				ZL04JX89M7	15739554	15739554	01/03/2005	18091279	01/11/2007	2004-2008		1	1	0	Yes	1					30/07/2018		128,7	22	NA	0	1	GLIOMA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	CONFUSION	1	0	0	0	1
Nimotuzumab	nimotuzumab	TheraCIM h-R3	DB06192			780758-10-3	6NS400BXKH	"25760761;24046058;21901403;20563810;20454832;20451284;18049099"	18049099	01/12/2007	18049099	01/12/2007	2004-2008		1	1	0	Yes	1					30/07/2018		127,7	9	NA	0	1	GLIOMA	1	EGFR	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	26	0	1
Ridaforolimus	"ap23573;deforolimus;mk-8669;mk8669;ridaforolimus"	Deforolimus	DB06233		"Deforolimus;Ridaforolimus;Taltorvic;572924-54-0;MK-8669;jenzyl;AP23573;UNII-48Z35KB15K;48Z35KB15K;AP-23573;CHEBI:79700;MK8669;MK 8669;Ridaforolimus (Deforolimus, MK-8669);697252-87-2;AP 23573;Deforolimus (MK-8669);Ridaforolimus [USAN:INN];SCHEMBL7719298;CHEMBL2103839;C53H84NO14P;MolPort-016-633-169;Rapamycin, 42-(dimethylphosphinate);s1022;AKOS030526165;CS-0122;RL04162;HY-50908;Rapamycin, 42-?(dimethylphosphinate?) (9CI);W-5561;Deforolimus,Ridaforolimus, AP23573, MK-8669;924D540;BRD-K62304154-001-04-2;Deforolimus|||AP-23573|||MK-8669|||Rapamycin 42-(dimethylphosphinate);(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-((1R)-2- ((1S,3R,4R)-4-((Dimethylphosphinoyl)oxy)-3-methoxycyclohexyl)-1-methylethyl)-1,18- dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4- azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene- 2,3,10,14,20-pentone"	572924-54-0	48Z35KB15K	"18202410;22037923"	18202410	01/01/2008	18202410	01/01/2008	2004-2008		1	1	0	Yes	1					30/07/2018		126,7	32	NA	1	0	NA	1	MTOR	0	1	0	NA	0	0	0	1	1	0,13	0	0	0	0,22	0	0	0	0	0	0	30	0	1
Mocetinostat	"mgcd0103;mocetinostat"		"DB11830;DB05651"		"Mocetinostat;726169-73-9;MGCD0103;MGCD-0103;MGCD 0103;N-(2-AMINOPHENYL)-4-([[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO]METHYL)BENZAMIDE;UNII-A6GWB8T96J;MGCD0103 (Mocetinostat);A6GWB8T96J;Mocetinostat (MGCD0103);CHEMBL272980;N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide;N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide;Mocetinostat (MGCD0103, MG0103);Mocetinostat (USAN/INN);MG-0103;N-(2-aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide;N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide;Mocetinostat [USAN:INN];N-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide;MG0103;MG4230;MG4915;MG5206;MG 0103;MG 4230;MG 4915;MG 5026;MG-4230;MG-4915;MG-5026;Myeloperoxidase (USAN);MGCD010,3Mocetinostat;MGCD0103/Mocetinostat;D00FHR;MGCD0103(Mocetinostat);MGCD0103, Mocetinostat;Mocetinostat, MGCD0103;MGCD0103 - Mocetinostat;MLS006010181;SCHEMBL157027;GTPL7008;BDBM24624;CHEBI:94525;DTXSID80222945;EX-A049;QCR-116;HRNLUBSXIHFDHP-UHFFFAOYSA-N;MolPort-009-679-400;BCPP000163;HMS3654K06;AOB87751;ABP000144;AN-405;s1122;ZINC13986811;AKOS016340325;BCP9000925;BD-0114;CCG-208763;CS-0502;DB11830;RL04767;KS-00000T71;NCGC00263182-01;NCGC00263182-02;AC-30281;BC219534;HY-12164;KB-55057;SC-85911;SMR004701289;AB0008035;FT-0741876;X7532;D09641;D09643;W-5447;169M739;J-522866;BRD-K16485616-001-01-4;BRD-K16485616-001-04-8;MGCD-0103, 726169-73-9;N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2;Benzamide, N-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-;N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;MGCD0103;Mocetinostat;MGCD0103(Mocetinostat)"	726169-73-9	A6GWB8T96J	18421048	18421048	01/04/2008	18421048	01/04/2008	2004-2008		1	1	0	Yes	1					30/07/2018		123,7	38	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,16	0	0	0	0	0	0	1	0	1
Dovitinib	"14c-dovitinib;chir-258;dovitinib;tki258"		DB05928		"Dovitinib;405169-16-6;CHIR-258;UNII-I35H55G906;Chir 258;I35H55G906;TKI-258;804551-71-1;C21H21FN6O;4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;TKI258;Dovitinib [INN];(3Z)-4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]-2(3H)-quinolinone;1027263-12-2;4-Amino-5-Fluoro-3-(6-(4-Methylpiperazin-1-yl)-1H-Benzo[D]Imidazol-2-yl)Quinolin-2(1H)-One;CHIR258;TKI 258;TK-258;CHIR-258(Dovitinib);D07OZR;D0K3OY;SCHEMBL172687;GTPL5962;SCHEMBL9975396;BDBM25118;CHEBI:91395;QCR-175;SYN1029;4-Amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one;MolPort-009-679-406;MolPort-042-652-594;BCPP000286;BDBM153731;(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one;38O;4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one;ABP000878;MFCD10565680;AKOS005146311;ZINC100270141;ACN-050735;BCP9000518;CS-0120;RL03559;BC251851;HY-50905;KB-76711;SC-54643;AB0007885;KB-277044;Y0345;TKI-258, Dovitinib, CHIR258, TKI258;326D834;J-514396;S14-2675;BRD-K85402309-001-01-7;4-AMINO-5-FLUORO-3-[ 5- (4-METHYLPIPERAZIN-1-YL)-1;4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2 (1h)-one;(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazino)-1,3-dihydrobenzimidazol-2-ylidene]carbostyril;(Z)-4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)quinolin-2(3H)-one;4-AMINO-5-FLUORO-3-[ 5- (4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE;4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2,3-dihydroquinolin-2-one;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydroquinolin-2-one"	405169-16-6	I35H55G906	"27681579;27100354;25193431;23010851;21976540;18381947"	18381947	01/04/2008	18381947	01/04/2008	2004-2008		1	1	0	Yes	1					30/07/2018		123,7	35	NA	1	0	NA	1	RTKs	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	0,09	0	0	0	0	0	0	0	0	1
Selumetinib	"arry-142886;azd6244;selumetinib"		DB11689		"Selumetinib;606143-52-6;AZD6244;AZD 6244;ARRY-142886;AZD-6244;5-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE;ARRY 142886;ARRY-886;AZD6244 (Selumetinib);Selumetinib (AZD6244);UNII-6UH91I579U;ARRY142886;AZD6244(Selumetinib);5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide;CHEMBL1614701;CHEBI:90227;6UH91I579U;5-(4-broMo-2-chlorophenylaMino)-4-fluoro-N-(2-hydroxyethoxy)-1-Methyl-1H-benzo[d]iMidazole-6-carboxaMide;NCGC00189073-01;NCGC00189073-02;C17H15BrClFN4O3;DSSTox_CID_28870;DSSTox_RID_83139;DSSTox_GSID_48944;1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;Q-101405;CAS-606143-52-6;Selumetinib [USAN:INN];selumetinibum;MEK inhibitors;1H-Benzimidazole-6-carboxamide, 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;PubChem21092;AZD 6244 Selumetinib;Selumetinib (USAN/INN);AZD-6244(Selumetinib);AZD6244 - Selumetinib;D0T5DP;D0TH0Z;AZD 6244 (Selumetinib);JSPY-st000254;SCHEMBL155456;GTPL5665;QCR-91;Selumetinib, ARRY-142886;DTXSID3048944;CTK8B4577;EX-A020;SYN1016;CYOHGALHFOKKQC-UHFFFAOYSA-N;MolPort-009-679-426;BCPP000367;CC-49;HMS3244G03;HMS3244G04;HMS3244H03;HMS3265K01;HMS3265K02;HMS3265L01;HMS3265L02;HMS3654O03;NSC 741O78;AOB87732;API01002;Tox21_113362;ABP000918;ANW-45526;BDBM50355497;IN2233;NSC741078;RS0061;s1008;ZINC31773258;ARRY142886/AZD6244;AKOS015904255;Tox21_113362_1;ACN-031539;AN-4474;BCP9000354;CS-0059;DB11689;EX-8621;NSC-741078;KS-0000003K;4CA-0236;AC-25059;AJ-84328;AK-40782;AM808016;AZD6244,Selumetinib, ARRY-142886;BC004624;BC660025;CJ-17817;HY-50706;SC-85661;AZD6244 (Selumetinib ARRY-142886);AZD6244 (Selumetinib, ARRY142886);AB0007973;AX8165426;KB-135452;TX-013341;FT-0674552;ST24031611;X2640;D09666;S-7764;143A526;BRD-K57080016-001-01-9;I14-17010;ARRY-142886, Selumetinib, AZD-6244, ARRY142886, AZD6244;3EW;5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide;5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxami;6-(4-bromo-2-chloro-anilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamide;6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy -ethoxy)-amide;6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide;6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxy-ethoxy)-amide;6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide;6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxyethoxy)-amide;6-(4-bromo-2-chlorophenylamino)-N-(2-hydroxyethoxy)-3,7-dimethyl-3H-benzo[d]imidazole-5-carboxamide;6-(4-bromo-2chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide;865610-79-3;AZD 6244;5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide"	606143-52-6	6UH91I579U	"20179232;18390968"	18390968	01/04/2008	18390968	01/04/2008	2004-2008		1	1	0	Yes	1					30/07/2018		123,7	57	NA	1	1	MELANOMA	1	MEK	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,16	0	0	0	0	0	0	0	0	1
BMS-690514	bms-690514		DB11665		"BMS-690514;859853-30-8;BMS 690514;(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol;UNII-VKU5X213Q7;VKU5X213Q7;BMS690514;(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol;(3R,4R)-4-amino-1-({4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl}methyl)piperidin-3-ol;(3R,4R)-4-amino-1-[[4-(3-methoxyanilino)pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol;EVRI;(3R,4R)-4-Amino-1-((4-((3-methoxyphenyl)amino)pyrrolo[2,1-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol;D0R6UV;GTPL7879;SCHEMBL1219326;CHEMBL3545396;DTXSID3042689;NOCAS_42689;QCR-141;CSGQVNMSRKWUSH-IAGOWNOFSA-N;MolPort-020-393-325;BCPP000325;BDBM185148;947688-34-8;0913AF;ABP000331;ZINC43152599;AKOS005266712;AKOS015949393;BCP9000434;CS-0244;DB11665;RP08048;BMS-6690514;3-Piperidinol, 4-amino-1-((4-((3-methoxyphenyl)amino)pyrrolo(2,1-f)(1,2,4)triazin-5-yl)methyl)-, (3R,4R)-;AN-16656;HY-10333;KB-75638;AB1009199;FT-0685176;BMS690514/BMS-690514/;A25026;Q-4521;J-501257;(3R,4R)-4-amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol;(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-o"	859853-30-8	VKU5X213Q7	22878519	22878519	01/08/2012	22878519	01/05/2008	2004-2008	DOI: 10.1200/jco.2008.26.15_suppl.2564	1	1	0	Yes	1					30/07/2018		122,7	125	77	1	1	NSCLC_EGFR_MUTANT	1	"EGFR;HER2;VEGFR1-3"	0	1	1	65	1	0	0	1	1	0,03	0	0	0	0,4	0	"LEFT VENTRICULAR DYSFONCTION;PULMONARY EMBOLISM"	1	0	0	0	0	0	1
CT-011	"ct-011;mdv9300;pidilizumab"		DB05916					18483370	18483370	01/05/2008	18483370	01/05/2008	2004-2008		1	1	0	Yes	1					30/07/2018		122,7	17	NA	0	1	HEMATOLOGIC MALIGNANCIES	1	PD-1	0	1	0	NA	0	0	0	1	0	0,33	0	1	1	NA	0	0	0	0	0	0	0	0	1
AZD3409	azd3409		DB04893					18506143	18506143	01/05/2008	18506143	01/05/2008	2004-2008		1	1	0	Yes	1					30/07/2018		122,7	29	NA	1	0	NA	1	PRENYL TRANSFERASE	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Bendamustine	"14c-bendamustine;bendamustine"	"Ribomustine;Bendeka;Treanda"	DB06769	"4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid;4-[5-[bis(2-chloroethyl)amino]-1-methyl-2-benzimidazolyl]butanoic acid;4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butyric acid;5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid;Bendamustina [Spanish];Bendamustine;Bendamustine [INN];Bendamustinum [Latin];SDX-105;omega-(1-Methyl-5-bis(beta-chloroethyl)aminobenzimidazole-(2)-butyric acid;InChI=1/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23;4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid;5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid;DD6304600;1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-;1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-;2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-"	"Bendamustine;16506-27-7;4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid;Bendamustinum [Latin];Bendamustina [Spanish];Treanda (TN);UNII-9266D9P3PQ;Bendamustine [INN];SDX 105;9266D9P3PQ;Ribomustine;Bendeka;Levact;Bendamustine (INN);NCGC00181170-01;DSSTox_CID_26888;DSSTox_RID_81991;DSSTox_GSID_46888;Bendamustina;Bendamustinum;5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid;2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-;5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid;1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-;4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;omega-(1-Methyl-5-bis(beta-chloroethyl)aminobenzimidazole-(2)-butyric acid;CAS-16506-27-7;Bendamustine [INN:BAN];bendamustin;1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-;5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid;HSDB 7763;Zimet 3393;D01CYA;AC1L23NB;SCHEMBL26319;CHEMBL487253;GTPL7478;DTXSID2046888;NIOSH/DD6304600;3543-75-7 (hydrochloride);CTK0H6928;CHEBI:135515;MolPort-003-844-702;YTKUWDBFDASYHO-UHFFFAOYSA-N;BDBM173621;ZINC4214955;Tox21_112771;AKOS022181343;Tox21_112771_1;API0005688;BCP9000389;DB06769;NCGC00181170-02;NCGC00181170-03;4CA-0265;AC-22488;BC645220;CC-24269;LS-32675;SC-19231;BCP0726000100;LS-173588;TX-012243;DD63046000;FT-0742187;ST24042979;D07501;AB01273966-01;AB01273966-02;AB01273966_03;US9096627, CY190602;506B277;C-23733;J-010179;BRD-K17068645-003-02-6;1H-Benzimidazole-2-butanoicacid, 5-[bis(2-chloroethyl)amino]-1-methyl-;gamma-(1-methyl-5-bis(beta-chloroethyl)aminobenzimidazole)-(2)-butyric acid;4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid;InChI=1/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23"	16506-27-7	9266D9P3PQ	"24965340;24072240;23322528;22578814;20594195;17486132;17414628;17340070;16292542;10942063;10641748"	10641748	01/01/2000	9860292	01/01/1998	1994-1998		1	1	1	Yes	1	"27/03/2014 00:00;23/09/2016 00:00;09/02/2017 00:00;15/12/2017 00:00;02/09/2015 00:00;15/06/2018 00:00;26/02/2010 00:00;24/03/2016 00:00;26/04/2018 00:00;19/05/2016 00:00;15/05/2018 00:00;10/03/2015 00:00;28/08/2013 00:00;23/06/2016 00:00;06/02/2017 00:00;18/10/2016 00:00;13/09/2013 00:00;05/11/2015 00:00;18/08/2017 00:00;22/04/2009 00:00;21/12/2010 00:00;20/03/2008 00:00;01/05/2009 00:00;31/10/2008 00:00;29/12/2016 00:00;26/06/2012 00:00;07/12/2015 00:00;08/07/2015 00:00"	"AP;TA"	"ACCORD HLTHCARE;APOTEX INC;GLENMARK PHARMS LTD;#N/A;CEPHALON;INNOPHARMA LICENSING;BRECKENRIDGE PHARM;EAGLE PHARMS;HOSPIRA INC"	BENDAMUSTINE HYDROCHLORIDE	20/03/2008	CEPHALON	122,3	37	NA	0	1	BREAST	1	DNA	0	0	1	37	0	0	0	1	1	0,27	0	1	1	NA	0	0	0	0	0	0	50	0	1
Cositecan	karenitecin	Karenitecin	DB05806		"Karenitecin;Cositecan;203923-89-1;BNP1350;BNP 1350;Karenitecin (TN);UNII-24R60NVC41;24R60NVC41;Cositecan [USAN:INN];Cositecan (USAN);DB 172;D02CZK;AC1L3WN8;SCHEMBL2315201;7-Trimethylsilylethylcamptothecin;CHEMBL1997373;DTXSID90174340;POADTFBBIXOWFJ-VWLOTQADSA-N;BNP-1350;NSC710270;ZINC169746728;DB05806;NSC-710270;AN-29989;HY-14812;KB-75647;NCI60_038797;CS-0003573;D09327;Z-3161;923K891;(4S)-4-Ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione;(4S)-4-Ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-, (4S)-"	203923-89-1	24R60NVC41	18577560	18577560	01/06/2008	18577560	01/06/2008	2004-2008		1	1	0	Yes	1					30/07/2018		121,7	32	NA	0	1	GLIOMA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Terameprocol	terameprocol	TETRA-O-METHYL NORDIHYDROGUAIARETIC ACID	DB12226		"terameprocol;24150-24-1;EM-1421;UNII-53YET703F2;Terameprocol (INN/USAN);meso-Tetra-O-methylnordihydroguaiaretic acid;53YET703F2;meso-Tetramethoxy-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol;tetra-O-methyl nordihydroguaiaretic acid;Benzene,4-[(2R,3S)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxy-,rel-;meso-1,4-Bis-(3,4-dimethoxyphenyl)-2,3-dimethylbutane;4-[(2r,3s)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene;4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene;EM 1421;Terameprocol [USAN:INN];tetramethyl NDGA;Tube007;AC1L9VRA;D00UDP;MLS006010717;CHEMBL90983;SCHEMBL194588;CTK6J7182;Terameprocol, >=98% (HPLC);ORQFDHFZSMXRLM-IYBDPMFKSA-N;Tetramethylnordihydroguaiaretic acid;tetramethyl Nordihydroguaiaretic Acid;2065AH;ZINC16953163;API0005333;DB12226;NCGC00346832-01;KB-74998;SMR004701682;D09014;Z-3250;2,3-Dimethyl-1,4-bis-(3,4-dimethoxyphenyl)butane;J-015367;Butane, 1,4-bis(3,4-dimethoxyphenyl)-2,3-dimethyl-, meso-;4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethyl-butyl]-1,2-dimethoxy-benzene;rel-4-[(2R,3S)-4-(3,4-Dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene;M4N"	24150-24-1	53YET703F2	"25523151;22323663"	22323663	01/02/2012	18418294	01/06/2008	2004-2008		1	0	0	No	0					30/07/2018		121,7	#N/A																							0						1
Elacytarabine	"cp-4055;elacytarabine"		DB05494		"Elacytarabine;ELACYT;CP-4055;UNII-TA7WJG93AR;TA7WJG93AR;188181-42-2;101235-34-1;5'-Oleoyl cytarabine;5'-Oleyl-ara-C;Elacytarabine [USAN:INN];5'-Oleoyl cytosine arabinoside;CP 4055;Elaidic acid-Cytarabine;AC1O5QKM;Elacytarabine (USAN/INN);CHEMBL2105665;SCHEMBL15140172;DB05494;2(1H)-Pyrimidinone, 4-amino-1-(5-O-((9E)-1-oxo-9-octadecenyl)-beta-D-arabinofuranosyl)-;(E)-((2R,3S,4S,5R)-5-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL OCTADEC-9-ENOATE;J3.633.560B;D09712;P-4055;Z-3188;5'-O-[9(E)-Octadecenoyl]-1-beta-D-arabinofuranosylcytosine;2(1H)-Pyrimidinone, 4-amino-1-(5-O-(1-oxo-9-octadecenyl)-beta-D-arabinofuranosyl)-, (Z)-;[(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (E)-octadec-9-enoate;675837-43-1"	188181-42-2	TA7WJG93AR	"21909644;18607882"	18607882	01/07/2008	18607882	01/07/2008	2004-2008		1	1	0	Yes	1					30/07/2018		120,7	34	NA	0	1	"MELANOMA;OVARIAN;NSCLC"	0	NA	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	0	0	0	0	0	0	0	1
Plicamycin	mithramycin	"Plicamycin;Mithramycinum;Aureolic acid;Mithramycine;Plicamycinum;Plicamycine;Mithramycin"	DB06810	"(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one;(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxo-pentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one;(2S,3S)-2-[[(2S,4R,5R,6R)-4-[[(2S,4R,5R,6R)-4-[[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyl-2-tetrahydropyranyl]oxy]-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[[(2S,4R,5R,6R)-4-[[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one;(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-2-keto-1-methoxy-pentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one;(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyl-oxan-2-yl]oxy-5-hydroxy-6-methyl-oxan-2-yl]oxy-5-hydroxy-6-methyl-oxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxo-pentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-5-hydroxy-6-methyl-oxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one;18378-89-7;(2S-(2alpha,3beta(1R*,3R*,4S*)))-6-((2,6-Dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-alpha-D-lyxo-hexopyranosyl-(1->3)-2,6-dideoxy-beta-D-arabino-hexopyranosyl)oxy)-3-(3,4-dihydroxy-1-methyl-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-1(2H)-anthracenone;1(2H)-Anthracenone, 6-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-H)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribohexopyranosyl-(1,4)-O-2,6-dideoxy-alpha-D-lyxo-hexpyranosyl-(1-3)-2,6-dideoxy-beta-D-arabino-hexpyranosyl)oxy)-3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-, (2S-alpha,3beta(1R*,3R*4S*)))-;Aurlelic acid;CCRIS 5629;HSDB 3238;Mithramycine [INN-French];Mithramycinum [INN-Latin];Mitramicina [INN-Spanish];Mitramycine;Mitramycinum;NSC 24559;PA 144;Plicamicina [INN-Spanish];Plicamicina [Spanish];Plicamycin [USAN:BAN:INN];Plicamycine [French];Plicamycine [INN-French];Plicamycinum [INN-Latin];Plicamycinum [Latin];Aureolic acid;MITHRAMYCIN;Mithracin;D00468;Mithracin (TN);Plicamycin (USP/INN);C12389;C07364;Plicamycin"	"MITHRAMYCIN;plicamycin;Mithracin;Mithramycinum;mithramycin a;Aureolic acid;Mithramycine;Mitramycine;Mitramycinum;Plicamycine;Plicamycinum;Aurelic acid;Aurlelic acid;Mitramycin;Plicamycine [French];Plicamycinum [Latin];Plicamicina [Spanish];Plicamycine [INN-French];Plicamycinum [INN-Latin];Mithramycine [INN-French];Mithramycinum [INN-Latin];Mitramicina [INN-Spanish];Plicamicina [INN-Spanish];UNII-NIJ123W41V;CCRIS 5629;HSDB 3238;NSC 24559;PA 144;18378-89-7;Plicatomycin;Antibiotic LA 7017;NIJ123W41V;A-2371;Mitramicina;Plicamicina;SR-05000002335;mith;Plicamycin [USAN:BAN:INN];C52H76O24;PA-144;Mithracin (TN);Plicamycin [USAN:USP:INN:BAN];Plicamycin (USP/INN);AC1L4TCM;SCHEMBL4517;GTPL8394;CHEBI:31856;HY-A0122;DB06810;97666-60-9;LS-91528;CS-0014261;C12389;D00468;32318-EP2280012A2;32318-EP2281815A1;32318-EP2292615A1;32318-EP2301928A1;32318-EP2301933A1;32318-EP2305640A2;32318-EP2305671A1;32318-EP2311825A1;32318-EP2311827A1;SR-05000002335-2;SR-05000002335-3;DDA-(1-3)DDA-(1-6)CRH-(2-1)DDA-(3-1)DDL-(3-1)MDA;D-threo-2-Pentulose, 5-deoxy-1-C-((2S,3S)-7-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-3-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-beta-D-lyxo-hexopyranosyl-"	18378-89-7	NIJ123W41V	28735378	28735378	01/07/2017	13858517	01/06/1960	Bef. 1989		0	0	1	Yes	1	"05/05/1970 00:00;08/12/1999 00:00"	AP	PFIZER	PLICAMYCIN	05/05/1970	PFIZER	118,9	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
oportuzumab monatox	"oportuzumab monatox;vb4-845"	VB4-845	DB05319				945CY7ZMI2	19016010	19016010	01/11/2008	19016010	01/11/2008	2004-2008		1	1	0	Yes	1					30/07/2018		116,7	24	NA	1	0	HEAD&NECK_SCC	1	EPCAM	0	1	0	NA	0	1	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Volociximab	volociximab	Eos200-4	DB06647			558480-40-3	496K5Z02NW	19047123	19047123	01/12/2008	19047123	01/12/2008	2004-2008		1	1	0	Yes	1					30/07/2018		115,7	21	NA	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,09	0	0	0	0	0	0	25	0	1
Rigosertib	"on_01910.na;rigosertib"		DB12146		"Rigosertib;592542-59-1;UNII-67DOW7F9GL;67DOW7F9GL;ON-01910;ON-01910.Na;Rigosertib [USAN:INN];N-[2-Methoxy-5-({[(E)-2-(2,4,6-Trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine;6FS;Rigosertib (USAN);AC1OCFT5;D0KF9Q;Estybon (proposed trade name);SCHEMBL498623;SCHEMBL498624;GTPL7833;CHEMBL1241855;ON01910.Na;DTXSID30207984;CHEBI:124939;OWBFCJROIKNMGD-BQYQJAHWSA-N;1910 Na;ZINC3942646;4006AH;BDBM50060917;AKOS015966442;DB12146;2-[[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl]amino]acetic Acid;AS-35249;KB-62978;AB0107341;D10154;ON-01910;ON01910;ON 01910;BRD-K55187425-236-01-1;(E)-2-((2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenyl)amino)acetic acid;(e)-2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetic acid;2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid;N-(2-Methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl) phenyl)glycine;Glycine, N-(2-methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl) methyl)phenyl)-;ON-01910|||2-[2-Methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid"	592542-59-1	67DOW7F9GL	"24947095;24493827;23486532"	23486532	01/03/2013	18955447	01/12/2008	2004-2008		1	1	0	Yes	1					30/07/2018		115,7	20	73	1	0	NA	1	PLK1	0	1	0	0	0	0	0	1	1	0,05	0	0	0	0,05	0	0	0	0	0	0	0	0	1
Obatoclax	"gx15-070;obatoclax"		"DB12191;DB05567"	"(2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole; methanesulfonic acid;(2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-4-methoxy-pyrrol-2-ylidene]indole; methanesulfonic acid;(2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-4-methoxy-2-pyrrolylidene]indole; methanesulfonic acid;(2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-4-methoxy-3-pyrrolin-2-ylidene]indole; methanesulfonic acid;(2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxy-pyrrol-2-ylidene]indole; methanesulfonic acid;3-Carboxy-2,3-dihydroxy-propionate 2-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-5-(1H-indol-2-yl)-3-methoxy-2H-pyrrolium, mesylate salt;NSC729280;Obatoclax"	"Obatoclax;803712-79-0;Obatoclax mesylate;2-(2-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole methanesulfonate;Obatoclax mesylate (GX15-070);UNII-39200FJ43J;Obatoclax mesilate;GX15-070MS;(Z)-2-(2-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole methanesulfonate;39200FJ43J;GX15-070;Obatoclax Mesylate/GX15-070;CHEMBL2107358;AOB6156;EX-A333;MolPort-009-198-790;MolPort-044-559-850;ABP000480;NSC729280;CS-0133;NSC-729280;QC-2085;RL05094;BR-72812;HY-10969;Obatoclax  inverted exclamation markY97%;SC-94560;ST2403811;W-5699;J-505411;(Z)-2-((Z)-5-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-4-methoxy-1,5-dihydro-2H-pyrrol-2-ylidene)-2H-indole methanesulfonate;3-Carboxy-2,5-dimethyl-1H-pyrrol-2-ylmethylene)-5-(1H-indol-2-yl)-3-methoxy-2H-pyrrolium, mesylate salt"	803712-67-6	QN4128B52A	20538761	20538761	01/06/2010	18931344	01/01/2009	2009-2012		1	1	0	Yes	1					30/07/2018		114,7	26	NA	0	1	CLL	1	BCL2	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	NA	0	0	0	"SOMNOLENCE;EUPHORIA;ATAXIA"	1	0	0	0	1
Everolimus	"everolimus;rad001"	"40-O-(2-hydroxyethyl)-rapamycin;Afinitor Disperz;Zortress;Certican;Votubia;Afinitor"	DB01590	"159351-69-6;NVP-RAD-001;RAD-001;RAD-001C;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;42-O-(2-Hydroxy)ethyl rapamycin;Certican;Everolimus;Everolimus [USAN];RAD 001;RAD001;Rapamycin, 42-O-(2-hydroxyethyl)-;SDZ-RAD"	"Everolimus;Afinitor;Certican;Zortress;RAD001;SDZ-RAD;42-O-(2-Hydroxyethyl)rapamycin;Votubia;40-O-(2-hydroxyethyl)-rapamycin;Afinitor Disperz;159351-69-6;CHEBI:68478;UNII-9HW64Q8G6G;RAD 001;9HW64Q8G6G;Rapamycin, 42-O-(2-hydroxyethyl)-;NCGC00167512-01;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;Everolimus [USAN];RAD;XIENCE V;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;NVP-RAD-001;RAD-001C;everolimusum;RAD-001;NSC733504;Everolimus (INN);PubChem20048;Everolimus - RAD001;SCHEMBL4378;DSSTox_CID_20599;DSSTox_RID_79508;DSSTox_GSID_40599;Everolimus [USAN:INN:BAN];Everolimus, analytical standard;CHEMBL1908360;DTXSID0040599;HSDB 8255;MolPort-003-847-342;C53H83NO14;Tox21_112510;BDBM50088378;AKOS015850977;CS-0064;DB01590;RL02051;AS-16971;AT-22180;HY-10218;LS-143292;CAS-159351-69-6;V2036;351E696;Q-101413;BRD-K13514097-001-01-2;BRD-K13514097-001-05-3;1245613-55-1;dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone;Everolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material"	159351-69-6	9HW64Q8G6G	"26178426;25682600;25673697;24074921;23514360;23325902;22805244;21538343;21232120;20972652;18332470;18332469;17947729"	17947729	01/10/2007	10551636	01/10/1999	1999-2003		1	0	1	No	0	"12/10/2016 00:00;26/09/2017 00:00;18/09/2015 00:00;04/02/2016 00:00;21/06/2013 00:00;12/04/2018 00:00;10/04/2018 00:00;26/04/2012 00:00;01/07/2014 00:00;21/11/2011 00:00;26/02/2016 00:00;29/01/2016 00:00;16/12/2016 00:00;29/10/2010 00:00;27/01/2015 00:00;05/05/2011 00:00;30/03/2012 00:00;01/03/2016 00:00;12/01/2018 00:00;20/04/2010 00:00;18/02/2016 00:00;20/10/2014 00:00;06/11/2013 00:00;01/07/2015 00:00;18/12/2014 00:00;13/05/2010 00:00;20/07/2012 00:00;05/11/2015 00:00;02/05/2012 00:00;24/08/2015 00:00;02/10/2012 00:00;30/03/2009 00:00;14/06/2016 00:00;15/02/2013 00:00;09/07/2010 00:00;22/05/2015 00:00;14/11/2013 00:00;26/03/2013 00:00;05/12/2013 00:00;29/08/2012 00:00;20/02/2014 00:00;12/09/2014 00:00;24/06/2015 00:00;23/01/2015 00:00"	"AP;TA"	"#N/A;NOVARTIS;WEST-WARD PHARMS INT;NOVARTIS PHARM"	EVEROLIMUS	30/03/2009	NOVARTIS	113,7	NA	NA	0	1	MRCC		MTOR	0	1	0	NA	0	0	0										0						1
Vinorelbine	vinorelbine	"Vinorelbine;Vinorelbinum;5'-Noranhydrovinblastine;Vinorelbina;Vinorelbin;Vinorelbine Injection;Vinorelbine;Vinorelbine Tartrate;Vinorelbine tartrate;Vinorelbine Injection, USP;Vinorelbine Tartrate for Injection;Aj-vinorelbine;Vinorelbine Tartrate Injection USP;Navelbine"	"DB00361;APRD00101"	"125317-39-7;D01935;KW 2307;Navelbine (TN);Vinorelbine ditartrate (JAN);Vinorelbine tartrate (USP);Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (1:2) (salt);C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:2) (salt);Navelbine;Nor-5'-anhydrovinblastine ditartrate;VINORELBINE;Vinorelbine ditartrate;Vinorelbine tartrate;Vinorelbine tartrate [USAN]"	"vinorelbine;Navelbine;Vinorelbinum;Exelbine;Vinorelbina;Navelbine base;71486-22-1;Nor-5'-anhydrovinblastine;Eunades;Vinorelbine [INN:BAN];KW 2307 base;Navelbine (TN);UNII-Q6C979R91Y;Vinorelbine (INN);Vinorelbine(Navelbine);Vinorelbinum [Latin];Vinorelbina [Spanish];Navelbin;ANX-530;CHEBI:480999;SDP-012;KW-2307;Q6C979R91Y;5'-anhydrovinblastine;VINORELBIN DITARTRATE;noranhydrovinblastine tartrate;Vinorelbin;C45H54N4O8;Vinorelbine Ditartarate;methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate;methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate;SR-05000001504;KW 2307;C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-;HSDB 7665;Vinorelbine(Navelbine)/;NVB;D01HTL;SCHEMBL4765;CHEMBL553025;GTPL7105;DTXSID8040640;GBABOYUKABKIAF-IELIFDKJSA-N;MolPort-006-823-869;Aspidospermidine-3-carboxylic acid;HMS2090E13;Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)-;Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-;ABP000672;ZINC85536958;AKOS024457606;AT-7140;CCG-208616;CS-0212;NCGC00165966-03;HY-12053;K210;FT-0657343;D08680;AB01275493-01;AB01566877_01;486V221;SR-05000001504-1;SR-05000001504-2"	71486-22-1	Q6C979R91Y	"27094927;26206720;23718900;23429330;21621337;21613934;21373895;20809205;19808873;19417029;18520801;18465342;17541591;16673059;16179099;15122074;12201494;11843245;11822766;11564034;11458813;11342309;10963843;10776969;10690391;9923543;9790795;9493980;9486588;9157072;7931480"	7931480	01/10/1994	4016723	01/07/1985	Bef. 1989		1	1	1	Yes	1	"26/09/2012 00:00;27/09/2016 00:00;12/05/2000 00:00;10/06/2003 00:00;22/02/1996 00:00;09/01/2013 00:00;31/08/2012 00:00;27/10/2016 00:00;02/06/2005 00:00;29/11/2000 00:00;02/10/2001 00:00;23/05/2014 00:00;18/04/2005 00:00;26/05/2010 00:00;13/02/2008 00:00;11/12/2003 00:00;26/10/2015 00:00;23/10/2015 00:00;16/10/1998 00:00;25/08/2000 00:00;22/06/2018 00:00;06/01/1998 00:00;16/04/1998 00:00;13/08/2014 00:00;14/03/2014 00:00;22/07/2009 00:00;29/08/1997 00:00;21/08/2015 00:00;24/05/1996 00:00;03/02/2003 00:00;27/10/2015 00:00;23/12/1994 00:00;03/04/2002 00:00;12/09/2013 00:00;16/09/1998 00:00;05/11/2002 00:00;08/06/2000 00:00"	AP	"DR REDDYS LABS LTD;PIERRE FABRE;TEVA PHARMS USA;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS TOTOWA;WEST-WARD PHARMS INT;HOSPIRA;EBEWE PHARMA;JIANGSU HANSOH PHARM"	VINORELBINE TARTRATE	23/12/1994	PIERRE FABRE	113,5	20	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,3	0	0	0	0	0	0	245	0	1
Siplizumab	"medi-507;siplizumab"		DB06371			288392-69-8	KUW1QG1ZM3	19293260	19293260	01/03/2009	19293260	01/03/2009	2009-2012		1	1	0	Yes	1					30/07/2018		112,7	29	NA	0	1	T CELL MALIGNANCIES	1	CD2	0	1	0	NA	0	0	0	1	1	NA	1	0	0	NA	0	0	0	0	0	0	26	0	1
SJG-136	"bn2629;dna minor groove binding agent sg2000;nsc 694501;sg2000;sjg-136"		DB11965		"SJG-136;SJG 136;232931-57-6;UNII-KT0ZQ64X1A;NSC-694501;UP 2001;KT0ZQ64X1A;SJG136;NSC694501;NSC 694501;AC1L95GE;AC1Q4FE1;(6as)-3-[3-[[(6as)-2-methoxy-8-methylene-11-oxo-7,9-dihydro-6ah-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-8-methylene-7,9-dihydro-6ah-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;CHEMBL16498;SCHEMBL12020905;DTXSID20177864;MolPort-044-728-887;ZINC3994495;AKOS027326601;BN-2629;CS-4593;DB11965;HY-14573;NCI60_033825;(6aS)-3-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;1,1'-((Propane-1,3-diyl)dioxy)bis(7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5,11-dione);5H-Pyrrolo[2,4]benzodiazepin-5-one, 8,8'-[1,3-propanediylbis(oxy)]bis[1,2,3,11a-tetrahydro- 7-methoxy-2-methylene-, (11aS, 11'aS)-"	232931-57-6	KT0ZQ64X1A	19276288	19276288	01/03/2009	19276288	01/03/2009	2009-2012		1	1	0	Yes	1					30/07/2018		112,7	16	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,13	0	0	0	0	0	0	13	0	1
Denibulin	"denibulin;mn-029"		DB05932		"Denibulin;284019-34-7;UNII-K7037M241U;MN-029;K7037M241U;C18H19N5O3S;Denibulin [INN];MN 029;ANG-600 series;D0X1BJ;CHEMBL2111088;SCHEMBL14704035;ANG-615;DTXSID90182627;Second generation VTAs, MediciNova;2364AH;ZINC11726215;Second generation VTAs, Angiogene Pharmaceuticals;019D347;Vascular targeting agents (benzimidazole carbamates), MediciNova;(S)-methyl (5-((4-(2-aminopropanamido)phenyl)thio)-1H-benzo[d]imidazol-2-yl)carbamate;Vascular targeting agents (benzimidazole carbamates), Angiogene Pharmaceuticals"	284019-34-7	K7037M241U	"21305290;19434370"	19434370	01/05/2009	19434370	01/05/2009	2009-2012		1	1	0	Yes	1					30/07/2018		110,7	20	NA	1	0	NA	1	VASCULAR DISRUPTION	0	1	0	NA	0	0	0	1	0	0,05	0	0	0	NA	0	acute substernal chest pain	1	0	0	0	0	0	1
Trebananib	"amg 386;trebananib"		DB12056			894356-79-7	X8Y5U6NC7E	"28074547;25019569;23124648;19546406"	19546406	01/06/2009	19546406	01/06/2009	2009-2012		1	1	0	Yes	1					30/07/2018		109,7	32	NA	1	0	NA	1	ANGIOPOIETINE	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	0,13	0	0	0	0	0	0	21	0	1
Masitinib	masitinib	"AB-1010;AB1010;AB 1010"	DB11526		"Masitinib;790299-79-5;AB1010;Masatinib;AB-1010;Masitinib (AB1010);Masivet;AB 1010;UNII-M59NC4E26P;Masitinib [INN];M59NC4E26P;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide;CHEMBL1908391;CHEBI:63450;Masitinib (INN);N-(4-Methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;Masitinib mesilate;Q-201339;C28H30N6OS;4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide;N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide;masican;Mastinib;Masitinib/AB1010;D0MW0N;MLS006010167;Masican (proposed trade name);SCHEMBL717239;GTPL5656;CTK8E8465;EX-A080;SYN1053;MolPort-006-394-850;WJEOLQLKVOPQFV-UHFFFAOYSA-N;HMS3244J04;HMS3244J08;HMS3244J12;HMS3654I13;ABP000249;BDBM50355495;RS0047;s1064;ZINC34177219;AKOS005146325;AC-1908;AN-5305;API0025916;BCP9000897;CS-0134;GS-6164;KS-000001C9;NCGC00241103-01;NCGC00241103-03;NCGC00241103-04;4CA-0798;AJ-87321;BC686818;HY-10209;KB-55999;SC-23334;SMR004701275;AB0008058;RT-013665;FT-0652399;D10229;W-5430;AB01274735-01;AB01274735_02;299M795;A839556;I14-1978;BRD-K71035033-001-01-4;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino) -phenyl]-benzamide;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)thiazol-2-yl]amino]phenyl]benzamide;G65"	790299-79-5	M59NC4E26P	"22031830;19541476"	19541476	01/06/2009	19541476	01/06/2009	2009-2012		1	1	0	Yes	1					30/07/2018		109,7	40	NA	1	1	GIST	1	C-KIT	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,38	0	0	0	0	0	0	21	0	1
Salirasib	salirasib		DB12681	"2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid;2-(3,7,11-trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid;2-[[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]thio]benzoic acid;2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid;NSC685986;EU-0100517;Lopac0_000517;Lopac-F-8175;NCGC00015448-01;Farnesylthiosalicylic acid;Salirasib;NCI60_030968"	"Salirasib;Farnesylthiosalicylic acid;162520-00-5;S-Farnesylthiosalicylic acid;UNII-MZH0OM550M;FTS;Farnesylthiosalicyclic acid;MZH0OM550M;CHEMBL23293;2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid;2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic Acid;2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid;2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic acid;Benzoic acid, 2-(((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)thio)-;Salirasib [USAN];Salirasib [USAN:INN];S-trans;FTS, Thyreos;Farnesylthiosalicylate;S-trans,trans-farnesylthiosalicylic acid;Ras antagonists, Thyreos;Salirasib (INN/USAN);Lopac-F-8175;D00KTV;D05YQY;AC1NV5Y3;Lopac0_000517;MLS006010835;Trans-farnesylthiosalicylicacid;GTPL6281;FTS (oral, cancer), Concordia;Salirasib, >=98% (HPLC);Th-101;MolPort-003-847-356;WUILNKCFCLNXOK-CFBAGHHKSA-N;KD032;EX-A1170;ONO-7056;Ras-inhibitors (cancer), Concordia;trans,trans-Farnesylthiobenzoic acid;ZINC1650377;FTS (oral, cancer), Concordia/Ono;2030AH;BDBM50034278;IN2128;KD-032;NSC685986;s7684;AKOS024458453;CCG-204607;CS-0681;DB12681;NSC-685986;trans,trans Farnesyl Thiosalicylic Acid;NCGC00015448-01;NCGC00015448-02;NCGC00015448-03;NCGC00093912-01;NCGC00093912-02;AK186909;BC600693;HY-14754;SMR004701762;LS-186975;LS-187617;EU-0100517;D08995;F 8175;W-5109;Farnesylthiosalicylic acid, >98% (HPLC), solid;SR-01000075885;J-009946;SR-01000075885-1;Farnesylthiosalicyclic acid (oral, cancer), Concordia;2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic acid;(E,E)-2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic Acid;2-((2E,6E)-3,7,11-Trimethyl-dodeca-2,6,10-trienylsulfanyl)-benzoic acid;166445-40-5"	162520-00-5	MZH0OM550M	"25795639;19484470"	19484470	01/06/2009	19484470	01/06/2009	2009-2012		1	1	0	Yes	1					30/07/2018		109,7	24	NA	1	0	NA	1	RAS	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,29	0	0	0	0	0	0	21	0	1
Veliparib	"abt-888;veliparib"	"(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium;2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide"	DB07232		"Veliparib;912444-00-9;ABT-888;ABT 888;Veliparib (ABT-888);ABT-888 (Veliparib);ABT888;UNII-01O4K0631N;2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide;CHEBI:62880;2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide;01O4K0631N;2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benimidazole-4-;(R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide;Veliparib dihydrochloride;2-((2r)-2-methyl-2-pyrrolidinyl)-1h-benzimidazole-7-carboxamide;(2r)-2-(7-Carbamoyl-1h-Benzimidazol-2-Yl)-2-Methylpyrrolidinium;(R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-7-carboxamide;2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide;ABT-888(Veliparib);NSC-737664;Veliparib [USAN:INN];2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide;2-[(2R)-2-methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide;78P;ABT-888 Veliparib;ABT888 (free base);D0Q7UD;A861695;benzimidazole carboxamide, 3a;MLS006010184;Veliparib (JAN/USAN/INN);SCHEMBL422318;CHEMBL506871;GTPL7417;QCR-33;BDBM27135;ABT-695;DTXSID90238456;EX-A001;MolPort-016-633-168;BDBM209932;AOB87114;EBD52357;1H-Benzimidazole-7-carboxamide, 2-[(2R)-2-methyl-2-pyrrolidinyl]-;ABP000419;AN-034;BN0721;IN2264;NSC737664;s1004;ZINC84610155;AKOS015951440;AKOS017343746;API0024782;CS-0076;DB07232;EX-7209;RL05736;ABT-888(Veliparib)/MX-1,ABT888;NCGC00250404-01;AC-23330;AN-26402;AS-19397;BC623040;EN002695;HY-10129;KB-67929;SMR004701290;ABT-888 (Veliparib, NSC 737664);AB1010175;FT-0660949;X7540;A24888;D09692;W-5661;A-861695;J-505211;BRD-K87142802-001-02-7;Veliparib;ABT-888;ABT888;ABT 888;912444-00-9;1H-Benzimidazole-4-carboxamide, 2-((2R)-2-methyl-2-pyrrolidinyl)-;2-[(2R)-2-methylpyrrolidin-2-yl]-3H-1,3-benzodiazole-4-carboxamide;(R)-2-(2-Methylpyrrolidin-2-yl)-1H-benimidazole-4-carboxamide (VELIPARIB);ABT-888;2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benimidazole-4- carboxamide;(R)-2-(2-methylpyrrolidin-2-yl)-3H-benzo[d]imidazole-4-carboxamide"	912444-00-9	01O4K0631N	"28665051;28109627;26508094;25682091;25053388;24908656;24452810"	24452810	01/01/2014	19364967	01/06/2009	2009-2012		1	1	0	Yes	1					30/07/2018		109,7	13	NA	1	0	NA	1	PARP	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
TAS-102	"tas-102;trifluridine/tipiracil"		DB08937			733030-01-8		"28760399;26370544;18798063;18528634;16902987"	16902987	01/08/2006	16902987	01/08/2006	2004-2008		1	1	1	Yes	1					22/09/2015		109,5	14	NA	1	0	NA	1	PYRIMIDINE	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Veltuzumab	"ha20;veltuzumab"		DB05656			728917-18-8	BPD4DGQ314	"26389849;25150258"	25150258	01/08/2014	19451441	01/07/2009	2009-2012		1	1	0	Yes	1					30/07/2018		108,7	88	NA	0	1	NHL	1	CD20	0	1	0	NA	0	0	0	1	1	0,83	0	1	1	0	0	0	0	0	0	0	26	0	1
Beloranib	ckd-732		DB12671		"Beloranib;CKD-732;UNII-FI471K8BU6;251111-30-5;ZGN 440;ZGN-433;ZGN-440;FI471K8BU6;O-(4-(2-Dimethylaminoethoxy)-trans-cinnamoyl)fumagillol;Beloranib [INN];ZGN 433;AC1OCFID;ZGN-440(Beloranib);D0E4VQ;D0WI4R;GTPL8445;US9682965, Compound A;SCHEMBL14648763;DTXSID40179800;HRK-429;HRK-512;ZEZFKUBILQRZCK-MJSCXXSSSA-N;BDBM148430;Fumagillin analogs, Chong Kun Dang;ZINC3982162;AKOS027326543;DB12671;(3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-yl (2E)-3-(4-(2-(dimethylamino)ethoxy)phenyl)prop-2-enoate;O-(4-Dimethylaminoethoxycinnamoyl)fumagillol;[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-(2-dimethylaminoethoxy)phenyl]prop-2-enoate;[(3R,6R,7S,8S)-7-methoxy-8-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-2-oxaspiro[2.5]octan-6-yl] (E)-3-[4-(2-dimethylaminoethyloxy)phenyl]prop-2-enoate;3-[4-[2-(Dimethylamino)ethoxy]phenyl]acrylic acid (3R)-4beta-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-5alpha-methoxy-1-oxaspiro[2.5]octane-6alpha-yl ester;609845-93-4"	251111-30-5	FI471K8BU6	19585083	19585083	01/07/2009	19585083	01/07/2009	2009-2012		1	1	0	Yes	1					30/07/2018		108,7	19	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	"CONFUSION;INSOMNIA"	1	0	0	0	1
Pralatrexate	"10-propargyl-10-deazaaminopterin;pralatrexate"	"(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid;Pralatrexato;Pralatrexatum;10-Propargyl-10-deazaaminopterin;PDX;(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid;N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid;Folotyn"	"DB06813;DB05527"	"(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid;(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid;(2S)-2-[[[4-[1-[(2,4-diamino-6-pteridinyl)methyl]but-3-ynyl]phenyl]-oxomethyl]amino]pentanedioic acid;(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]glutaric acid;(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]phenyl]carbonylamino]pentanedioic acid;146464-95-1;D05589;Pralatrexate;Pralatrexate (USAN);10-Propargyl-10-deazaaminopterin;L-Glutamic acid, N-(4-(1-((2,4-diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-;N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid"	"Pralatrexate;146464-95-1;Folotyn;10-Propargyl-10-deazaaminopterin;HSDB 7786;Folotyn (TN);Pralatrexate(Folotyn);N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid;CHEBI:71223;(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic acid;NCGC00242596-01;N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-L-glutamic Acid;(2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid;N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid;(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid;(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid;Pralatrexate [USAN:INN];pralatrexato;pralatrexatum;N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-L-glutamic Acid;Pralatrexate(Folotyn)/;AC1L3WHA;D02LWU;DSSTox_CID_28504;DSSTox_RID_82776;DSSTox_GSID_48578;SCHEMBL21633;GTPL6840;Pralatrexate (JAN/USAN/INN);CHEMBL1201746;DTXSID3048578;SCHEMBL15075302;KS-00001CSH;MolPort-009-679-397;OGSBUKJUDHAQEA-WMCAAGNKSA-N;BCPP000101;Tox21_112906;2667AH;ABP000543;NSC754230;s1497;AKOS015966891;AM84423;AN-6340;API0005288;CS-0504;DB06813;NSC-754230;QC-3214;AC-28388;AK162224;HY-10446;SC-21536;AB0095450;AB2000123;AX8248565;CAS-146464-95-1;FT-0673988;ST24049028;D05589;AB00443251-02;AB00443251_04;464P951;SR-01000941578;J-008227;SR-01000941578-1;(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic acid;L-Glutamic acid, N-(4-(1-((2,4-diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-;(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid"	146464-95-1	A8Q8I19Q20	"26242208;22394596;10999734"	10999734	01/09/2000	10999734	01/09/2000	1999-2003		1	1	1	Yes	1	"07/01/2011 00:00;26/04/2010 00:00;30/05/2012 00:00;13/05/2016 00:00;21/01/2016 00:00;15/02/2012 00:00;24/09/2009 00:00"	"AP;TA"	"ALLOS;TEVA PHARMS USA INC"	PRALATREXATE	24/09/2009	ALLOS	108,5	33	NA	0	1	NSCLC	1	FOLATE	0	1	0	NA	0	0	0	1	1	0,07	0	0	0	0,19	0	0	0	0	0	0	207	0	1
Sagopilone	"epothilone sagopilone;sagopilone"		"DB05654;DB12391"		"Sagopilone;ZK-EPO;305841-29-6;UNII-KY72JU32FO;KY72JU32FO;DE-03757;ZK-219477;EPO-477;SH-Y03757A;ZK epothilone;Sagopilone (USAN/INN);Sagopilone [USAN:INN];D0F6YW;SCHEMBL423579;CHEMBL2304041;Bay 86-5302;SH Y03757A;ZINC3964449;DB12391;SH-Y-03757;BAY-86-5302;AN-28960;DE 03757;ZK 219477;D09721;841S296;(1S,3S,7S,10R,11S,12S,16R)-10-allyl-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-(prop-2-enyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione;4,17-Dioxabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,12,16- tetramethyl-3-(2-methyl-5-benzothiazolyl)-10-(2-propenyl)-, (1S,3S,7S,10R,11S,12S,16R)-"	305841-29-6	KY72JU32FO	"19773753;19880436;22139065"	19773753	01/09/2009	19773753	01/09/2009	2009-2012		1	1	0	Yes	1					30/07/2018		106,7	23	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	9	0	1
Tasquinimod	tasquinimod	TASQ	DB05861		"Tasquinimod;254964-60-8;ABR-215050;UNII-756U07KN1R;TASQ;756U07KN1R;4-Hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-(4-(trifluoromethyl)-phenyl)-1,2-dihydroquinoline-3-carboxamide;4-Hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-(4-(trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide;Tasquinimod [INN];D02JMU;Tasquinimod(ABR-215050);GTPL8098;SCHEMBL4476895;CHEMBL2107784;DTXSID90180183;MolPort-035-789-708;ONDYALNGTUAJDX-UHFFFAOYSA-N;ZINC602397;AOB87360;2746AH;s7617;AKOS027250776;AM84841;CS-0898;DB05861;AS-35208;HY-10528;KB-80816;SC-96760;W-5727;4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide;N-Methyl-N-(4-trifluoromethyl-phenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide"	254964-60-8	756U07KN1R	19755981	19755981	01/09/2009	19755981	01/09/2009	2009-2012		1	1	0	Yes	1					30/07/2018		106,7	32	NA	0	1	PROSTATE	1	indoleamine 2,3-dioxygenase	0	1	0	NA	0	0	0	1	1	0,06	0	0	0	0,66	0	SINUS TACHYCARDIA	1	0	0	0	0	0	1
Zibotentan	"zd4054;zibotentan"		DB06629		"Zibotentan;186497-07-4;Zibotentan (ZD4054);ZD4054;ZD-4054;UNII-8054MM4902;Zd 4054;2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-N-(3-methoxy-5-methylpyrazin-2-yl)pyridine-3-sulfonamide;8054MM4902;N-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide;N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-[4-(1,3,4-OXADIAZOL-2-YL)PHENYL]PYRIDINE-3-SULFONAMIDE;Zibotentan, ZD-4054;Zibotentan [USAN:INN:JAN];Zibotentan,ZD4054;ZD4054, Zibotentan;Zibotentan (JAN/INN);Zibotentan(ZD4054)/;D02HVW;Zibotentan (ZD 4054);MLS006011121;SCHEMBL847090;Zibotentan (JAN/USAN/INN);GTPL3539;CHEMBL1628688;Zibotentan, >=98% (HPLC);CHEBI:94573;CTK4D9252;MolPort-005-943-325;HMS3654H10;KS-00001CP7;Zibotentan pound ZD4054 pound(c);ZINC1491485;ABP000461;s1456;AKOS015909372;API0005352;CS-0492;N-(3-Methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide;NCGC00242479-01;NCGC00242479-02;AN-16670;BC226080;HY-10088;KB-81562;SC-71677;SMR004702902;trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid;AB0000419;LS-194046;A5489;FT-0768122;X7520;D07741;W-3828;L001670;BRD-K31553034-001-01-4;I14-33339;ZD4054, 186497-07-4;3-Pyridinesulfonamide, N-(3-methoxy-5-methylpyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-;3-Pyridinesulfonamide,N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-"	186497-07-4	8054MM4902	19763400	19763400	01/09/2009	19763400	01/09/2009	2009-2012		1	1	0	Yes	1					30/07/2018		106,7	16	NA	0	1	PROSTATE	1	ENDOTHELIN-A	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	INTRAVENTRICULAR HEMORRHAGE	1	0	0	0	1
ABT-869	"abt-869;linifanib"		DB06080		"Linifanib;796967-16-3;ABT-869;Linifanib (ABT-869);ABT 869;1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea;AL-39324;N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea;UNII-CO93X137CW;ABT869;RG-3635;CHEMBL223360;CO93X137CW;1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea;N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea;J-503186;1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methyl-phenyl)urea;3-[4-(3-amino-1H-indazol-4-yl)phenyl]-1-(2-fluoro-5-methylphenyl)urea;N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea;Linifanib [USAN:INN];linifanibum;Aminoindazole, 3;Urea, N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)-;UREA, N-[4-(3-AMINO-1H-INDAZOL-4-YL)PHENYL]-N'-(2-FLUORO-5-METHYLPHENYL)-;Kinome_532;S1003_Selleck;ABT-869,Linifanib;PubChem22400;Linifanib (USAN/INN);Linifanib - ABT-869;D0M9QZ;SCHEMBL93804;JSPY-st000257;MLS006010276;GTPL5657;QCR-97;BDBM21079;CHEBI:91435;CTK8F0042;DTXSID40229834;EX-A014;SYN1002;cid_11485656;MolPort-009-679-408;MPVGZUGXCQEXTM-UHFFFAOYSA-N;BCPP000446;HMS3244D06;HMS3244D10;HMS3244D14;HMS3654E03;AOB87120;KS-00000I9Z;ZINC6718813;ABP000856;AN-503;IN2257;RG3635;RS0095;s1003;AKOS015919098;AL39324;BCP9000220;CS-0115;PB34634;VZ31170;NCGC00250403-01;4CA-0745;AC-24279;AJ-56734;AK-40846;AL 39324;AS-16177;BC640336;HY-50751;KB-08836;PC402063;SC-87820;SMR004701346;AB0008062;AB1008464;RT-011155;FT-0670795;X7465;D09635;Q-2136;ABT-869(Linifanib)/AL-39324,RG3635/;ABT869, Linifanib, AL-39324, RG3635;S06-0034;BRD-K99749624-001-01-3;1-[4-(3-azanyl-1H-indazol-4-yl)phenyl]-3-(2-fluoranyl-5-methyl-phenyl)urea"			"24094464;22382879"	22382879	01/03/2012	19720910	01/10/2009	2009-2012		1	1	0	Yes	1					30/07/2018		105,7	33	NA	1	0	NA	1	RTKs	0	1	0	NA	0	0	0	1	1	0,09	0	0	0	0,57	0	0	0	0	0	0	0	0	1
Bacitracin	"s-1;tegafur-gimeracil-oteracil"	"Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-;Bacitracin a2a;Family Care Triple Antibiotic Plus Pain Relief;Polysporin Cold Sore Ointment;First Aid Triple Antibiotic;Bioderm Ointment;Neo-poly-bac Hydro;Careone Bacitracin;ARC FIRST AID Contains 303 PIECES;BLUE ACME SLEEVE FIRST AID Contains 1000 PIECES;Up and Up Antibiotic;Safeway Bacitracin Zinc;Polyderm Ointment USP;Adventure Medical Kits 1-4 Person First Aid;Sheffield Triple Antibiotic Plus Pain Relief;Good Neighbor Pharmacy Triple Antibiotic Plus Pain Relief;Water-Jel 3-in-1 Antibiotic;Jampolycin;Bacitracin USP;OLP Antibiotic Bacitracin Zinc;Antibiotic Ointment USP;WalgreensTriple Antibiotic;ULTRA SEAL Triple Antibiotic;Poly Antibiotic;Exchange Select triple antibiotic;Neomycin and Polymyxin B Sulfates and Bacitracin Zinc;Baciguent First Aid Ointment;First Aid Antibiotic Plus Pain Relief Maximum Strength;North Triple Antibiotic;Equate First Aid Antibiotic;Triple Antiobiotic;ACME Small Cuts and Burns;GENUINE FIRST AID Emergency Preparedness Contains 167 PIECES HARDCASE;Up and Up First Aid Antibiotic;Atopalm First Aid Triple Antibiotic;Smart Sense Antibiotic;Polysporin Complete;Polysporin Topical First Aid Antibiotic Ointment;The New Parent First Aid;Topical Antibiotic Ointment;Polysporin Antibiotic Ointment;Tripleantibioticointmentandpainrelief;TheraPlusPlus Plus;American Red Cross First Aid Kit;Walgreens Bacitracin Zinc;First Aid Antibiotic Bacitraycin Plus;Bacitracin Antibiotic;WinCo Maximum Strength Triple Antibiotic;Bacitracin;CareALL Triple Antibiotic;CVS Cuts and Scrapes Refill Pack;ProcureTriple Antibiotic Triple Antibiotic;Large ANSI First Aid Kit;First Aid Triple Antibiotic with Pain Reliever;Good Neighbor Pharmacy Bacitracin Zinc;Tribioticlc Lc Lc;Market Basket First Aid Triple Antibiotic;Premier Value Bacitracin Zinc;Tribiotic;Healthy Accents Triple Antibiotic;First Aid Bacitracin Zinc;Goodsense First Aid Antibiotic;Neosporin Plus Pain Relief;Our Family Triple Antibiotic;Gerigentle-Bacitracin zinc;Dr Teals Triple Antibiotic;Polysporin Triple Antibiotic Ointment;Sheffield Triple Antibiotic;Ozonol Antibiotic Plus - Ointment;Meijer Triple Antibiotic Plus Pain Relief;Sunmark Triple Antibiotic Plus Pain Relief;Western Family Triple Antibiotic plus Pain Relief;Antibiotic Application;Bacitracin Zinc;Publix antibiotic;ShopRite Triple Antibiotic;Triple Antibiotic Extra Strength;DAYMARK FAK-35 First Aid;Schein Bacitracin;Formucare Triple Antibiotic Original Strength;Bacitracin Zinc Ointment USP;Ultra Seal Bacitracin;Well At Walg Triple Antibiotic Well At Walgreens;Triple Antibiotic with Pain Relief Maximum Strength;Live Better Triple Antibiotic plus Pain Relief;Up and Up Antibiotic Plus Pain Relief;CVS First Aid Kit;Antibiotic Bacitracin Zinc;GFA First Aid 36 Unit Metal Case;Family Care Bacitracin;Budpak Triple Antibiotic Maximum Strength;Optimyxin Ophthalmic Ointment;Smart Sense triple antibitotic plus pain relief;Omnisporin;Shopko Triple Antibiotic Plus;FIRST AID Contains 404 PIECES;Bacitracin Ont 500unit/gm;Neomycin and polymyxin B sulfates and bacitracin zinc;Leader Triple Antibiotic Plus;Aerosoothe;Biotic-Plus;Polycin;Bacitracin for Injection;Meijer Triple Antibiotic Plus;Quality Choice Bacitracin;Walgreens Triple Antibiotic;Walgreens Maximum Strength Triple Antibiotic With Pain Relief;Aftate Triple Antibiotic;Shoprite Bacitracin;Neo Polycin HC;ACME FIRST AID Contains 404 PIECES;Polytopic;Good Sense First Aid Antibiotic;Complete Antibiotic Ointment;Neo Bace Ophthalmic Ointment;WinCo Original Strength Triple Antibiotic;Jamp-bacitracine;Cuadriderma;Western Family Bacitracin Zinc;10 Person ANSI;Cardinal Health First Aid Antibiotic;ARC FIRST AID Contains 1000 PIECES;Baciguent Oph Ont 500unit/gm;Shopko Triple Antibiotic;MediChoice Triple Antibiotic;ARC FIRST AID Contains 404 PIECES;Lucky SuperSoft First Aid;Neosporin Pain Itch Scar;Single Antibiotic with bacitracin;ReCellTis;First Aid Antibiotic;First Aid Macimum Sterngth Bacitraycin Plus;Equaline Triple Antibiotic Plus;Premier Value Triple Antibiotic;Up and Up multi action antibiotic;Baciguent Ointment 500 Units;Harris Teeter Poly Antibiotic;Neo-polycin;Standard ANSI First Aid;Select Medical Products Triple Antibiotic;GFA First Aid 16 Unit Metal Case;Neomycin Sulfate, Polymyxin B Sulfate and Bacitracin Zinc;DG Health Triple Antibiotic;Kaiser Permanente Bacitracin Zinc;Face Values Bacitracin;Small Cuts and Burns;Bacitin;Berkley and Jensen Triple Antibiotic;TopCare Triple Antibiotic Plus Pain Relief;Ecolab Triple Antibiotic;Equaline Bacitracin Zinc;Exchange Select First Aid Triple Anitbiotic Pain Relieving;Circle K Triple Antibiotic;Triple Antibiotic plus Pain Relief Maximum Strength;Triple Antibiotic Plus Pain Relief Maximum Strength;Poly Bacitracin;Equate First Aid Antibiotic Plus Pain Relief;Fonow;K-Mart SmartSense First Aid Contains 303 Pieces;Smart Sense Bacitracin;Aftate Bacitracin Zinc;Ozonol Antibiotic Plus Ont;Ozonol Antibiotics Plus;Meijer Triple Antibiotic;Meijer Bacitracin Zinc;Shoprite Triple Antibiotic;First Aid Pocket Pack - 40 Pieces;MediChoice Bacitracin;7 Select First Aid Triple Antibiotic;Pomada De La Campana Triple Antibiotic Pain Relief;procureFirst Aid Antibio First Aid Antibiotic;OLP Triple Antibiotic Plus;Double Antibiotic;Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc;Advanced First Aid Bacitracin;Dr Bells Pomade;First Aid Antibiotic Bacitraycin Plus Maximum Strength;Bus and Classroom Yellow;First Aid Antibiotic Ointment;Polysporin;First Aid Triple Antibiotic Pain and Scar;Lanabiotic Ont;Antibiotic and Pain Relief Maximum Strength;Publix antibiotic plus pain relief;Makesense First Aid;Basic Care First Aid Antibiotic;Healthy Accents triple antibiotic;First Aid Triple Antibiotic and Pain Relief Maximum Strength;Triple Antibiotic plus pain relief;Polyderm Antibiotic Ointment;Triple Antibiotic First Aid;Triple Antibiotic GRX;Atopalm First Aid Triple Antibiotic Protection Moisturizing and Pain Relief;Cortomycin;Triple Antibiotic and Pain Relief Maximum Strength;Neotopic Ointment;Sunmark Triple Antibiotic;Lincoln;McKesson Bacitracin Zinc;Pentrexcilina Triple Antibiotic;DG Health Poly Antibiotic;Quality Choice Maximum Strength Triple Antibiotic;Careone Original Strength Triple Antibiotic;Neosporin Original;Winco Bacitracin;TopCare Bacitracin Zinc;Up and Up First Aid Antibiotic Pain Relieving;GFA First Aid 24 Unit Metal Case;Neosporin Ophthalmic Ointment;Good Neighbor Pharmacy Triple Antibiotic;Touchless Care FIRST AID ANTIBIOTIC;Band-aid-S-1;Kit Large Office First Aid;Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone;Bacitracine 500 Iu Ointment;Sandoz Cortimyxin;Bacimyxin Onguent;Baciject 50,000 Units/vial;Genuine First Aid - Auto First Aid;Cicatrin Powder;Good Neighbor Pharmacy First Aid;CAREALL Bacitracin;Leader Triple Antibiotic;Antibiotic Maximum Strength;First Aid Antibiotic Bacitracin with Zinc;Kaiser Permanente Double antibiotic;Rash Relief Antibacterial;Genuine First Aid Industrial First Aid;CVS Bacitracin with Pain Relief;Doubleantibioticointment;Family Wellness Antiseptic and Pain Relief;Antibiotic;Fulton Street Market Triple Antibiotic Original Strength;FIRST AID Contains 303 PIECES HARDCASE;Neo Polycin;Triple Antibiotic First Aid Antibiotic;Leader First Aid Antibiotic;Quality Choice Triple Antibiotic;Repara Triple Antibiotic;Onguent Antibiotique;Diosporin Ointment;Baciguent Plus Pain Reliever Ont;Mountain Series Weekender Medical;CVS Health Triple Antibiotic;Triple Antibiotic;Medi-First;Triple Antibiotic Plus Maximum Strength;First Aid Original Bacitraycin Plus;Polytopic Ont;Polysporin First Aid Antibiotic;Bacitracin Ointment;50 Person ANSI;Neo-polycin HC;Adventure Medical Kits 1-2 Person National Ski Patrol First Aid;Triple Antibiotic HC;Western Family Triple Antibiotic;Best Choice Bacitracin Zinc;Family Care Bacitracin Anti-Infection;Health Mart Pharmacy Bacitracin Zinc First Aid Antibiotic;Harris Teeter Triple Antibiotic Plus Pain Relief;Baciguent First Aid Ointment 500units/gm;OLP Triple Antibiotic;Up and Up Bacitracin first aid;Neo-poly-bac;Bacitracin Zinc and Polymyxin B Sulfate;Family Care Antibiotic;Genuine First Aid - Home First Aid;Equaline First Aid Antibiotic;TopCare Triple Antibiotic;Equate First Aid Antibiotic Pain Relieving;CVS Health Medication and Topical Refill Pouch;GFA First Aid;Sterisporin;Signature Care First Aid Antibiotic;Easy Care First Aid;Bacitracin zinc;CVS Triple Antibiotic;GLINT TRIPLE ANTIBIOTIC First Aid;ProCoMycin;Refill 2;Taro-bacitracin Ointment 500units/gm;Ready America First Aid Pocket - 33 Pieces;Shopko Bacitracin Zinc;Good Neighbor Pharmacy Emergency Preparedness and First Aid Contains 167 Pieces;Neosporin Plus Pain Relief Neo To Go First Aid Antibiotic Pain Relieving;Polysporin Sterile Ophthalmic Ointment;Band-aid Brand Adhesive Bandages Plus Antibiotic;GENUINE FIRST AID Emergency Preparedness Contains 167 Pieces;Live Better Triple Antibiotic;Neosporin Plus Pain Relief Neo to Go;Sheffield Bacitracin Zinc;Leader Bacitracin;Emergency Preparedness;Equaline Triple Antibiotic;Premier Value Triple Antibiotic Plus;Smart Sense Triple Antibiotic;Good Sense Triple Antibiotic;ARC FIRST AID Contains 303 PIECES HARDCASE;Emercreme No4 Ont Efa;Triple Antibiotic CVS;Triple Antibiotic Plus Pain Relief;Ready America First Aid Outdoor- 107 Pieces;Careone Triple Antibiotic;Neomycin and Polymyxin B sulfates, Bacitracin zinc;Live Better Bacitracin Zinc;Family Wellness;ARC FIRST AID Emergency Preparedness Contains 167 PIECES;Publix Bacitracin Zinc;Acme Home/Office/Auto Kit;Care Bus and Classroom Yellow;Original Bacitraycin;Rexall Antibiotic;CVS Health Bacitracin Zinc;Family wellness;Extra Strength Bacitraycin Plus;Sunmark Double Antibiotic;Antibiotic Ointment;Medpride First Aid;Triple Antibiotic Ointment;Genuine Triple Antibiotic;Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone;Good Sense Triple Antibiotic and Pain Relief;Antibiotic Original Strength;Gercillin;First Aid Maximum Strength Bacitraycin Plus;GFA First Aid 75 Person Metal Case;Neocidin;Shopko Triple Antibiotic plus Pain Relief;25 Person ANSI;Zapotol Bacitracin;Easy Care First Aid Kit - Sports and Travel;Harris Teeter Triple Antibioitic;Antibiotic, Pain and Scar;Quality Choice Triple Antibiotic Plus Pain Reliever;Wal-Sporin;Polycidin Ophthalmic Ointment;CVS All Purpose First Aid Kit;Polysporin for Stitches;Neomycin and Polymyxin B Sulfates and Bacitracin Zinc with Hydrocortisone Acetate;BACiiM;Kit Breakroom Office First Aid;Face Values Triple Antibiotic;Triple Antibiotic Maximum Strength;Easy Care First Aid Kit - Outdoor and Travel;Triple Antibiotic Plus;First Aid Research Bacitracin with Zinc;Walgreens Wal-Sporin First Aid Antibiotic;Ak-poly-bac;GFA First Aid Kit Essentials - 33 Pieces;Polvos de Sulpha First Aid Antibiotic;Bacitracin Zinc, Neomycin Sulfate and Polymyxin B Sulfate;Easy Care First Aid - All Purpose;Budpak Bacitracin;Schein Triple Antibiotic;Cortisporin;Neosporin Ointment;First Aid Research Bacitraycin Plus Maximum Vertical;Signature Care Triple Antibiotic;Paraid Triple Antibiotic;Antibiotique Onguent;Adventure Medical Kits 1-2 Person First Aid;First Aid Value Pack - 77 Pieces;Bacitracin Ointment 500 Units/g;Eurosporin;DG Health Antibiotic;Antibiotic and Pain Relief;Cvp Triple Antibiotic;CVS Health Triple Antibiotic with Pain Relief;LEADER Triple Antibiotic;Easy Care First Aid Chest - Home and Workshop;Family Care Triple Antibiotic;GLINT First Aid"	"DB00626;APRD00816"	"(4R)-4-[[(2S)-2-[[2-(1-amino-2-methylbutyl)4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[4-[(2S,5R,8S,11R,14S,17R,20S)-20-(2-amino-2-oxoethyl)-5-(3-aminopropyl)-8-[(2S)-butan-2-yl]-17-(carboxymethyl)-14-(3H-imidazol-4-ylmethyl)-3,6,9,12,15,18,21-heptaoxo-11-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]butylamino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid;(4R)-4-[[(2S)-2-[[2-(1-amino-2-methyl-butyl)4,5-dihydrothiazole-4-carbonyl]amino]-4-methyl-pentanoyl]amino]-5-[[(1S,2S)-1-[4-[(2S,5R,8S,11R,14S,17R,20S)-20-(2-amino-2-oxo-ethyl)-5-(3-aminopropyl)-17-(carboxymethyl)-14-(3H-imidazol-4-ylmethyl)-3,6,9,12,15,18,21-heptaoxo-11-(phenylmethyl)-8-sec-butyl-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]butylcarbamoyl]-2-methyl-butyl]amino]-5-oxo-pentanoic acid;(4R)-4-[[(2S)-2-[[[2-(1-amino-2-methylbutyl)-4,5-dihydrothiazol-4-yl]-oxomethyl]amino]-4-methyl-1-oxopentyl]amino]-5-[[(1S,2S)-1-[[4-[(2S,5R,8S,11R,14S,17R,20S)-20-(2-amino-2-oxoethyl)-5-(3-aminopropyl)-17-(carboxymethyl)-14-(3H-imidazol-4-ylmethyl)-3,6,9,12,15,18,21-heptaoxo-11-(phenylmethyl)-8-sec-butyl-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]butylamino]-oxomethyl]-2-methylbutyl]amino]-5-oxopentanoic acid;(4R)-5-[[(1S,2S)-1-[4-[(2S,5R,8S,11R,14S,17R,20S)-20-(2-amino-2-keto-ethyl)-5-(3-aminopropyl)-11-(benzyl)-17-(carboxymethyl)-14-(3H-imidazol-4-ylmethyl)-3,6,9,12,15,18,21-heptaketo-8-sec-butyl-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]butylcarbamoyl]-2-methyl-butyl]amino]-4-[[(2S)-2-[[2-(1-amino-2-methyl-butyl)4,5-dihydrothiazole-4-carbonyl]amino]-4-methyl-pentanoyl]amino]-5-keto-valeric acid;(4R)-4-[[(2S)-2-[[2-(1-amino-2-methyl-butyl)-4,5-dihydro-1,3-thiazol-4-yl]carbonylamino]-4-methyl-pentanoyl]amino]-5-[[(2S,3S)-1-[4-[(2S,5R,8S,11R,14S,17R,20S)-20-(2-amino-2-oxo-ethyl)-5-(3-aminopropyl)-8-[(2S)-butan-2-yl]-17-(carboxymethyl)-14-(3H-imidazol-4-ylmethyl)-3,6,9,12,15,18,21-heptaoxo-11-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]butylamino]-3-methyl-1-oxo-pentan-2-yl]amino]-5-oxo-pentanoic acid;Bacitracin"		1405-87-4	DDA3RRX0P7	"26891913;25877225;25074036;24895802;24480865;23292146;22623066;22199335;22156392;22155856;21372498;20946314;20041339;18613376;17437021;17189072;16786333;12538461;12114411;10894878"	10894878	01/07/2000	18869358	01/06/1948	Bef. 1989		0	0	1	No	0	"17/03/1989 00:00;31/01/1996 00:00;22/09/1993 00:00;12/01/1965 00:00;11/08/1967 00:00;30/03/1999 00:00;06/04/1965 00:00;08/04/1994 00:00;03/03/1999 00:00;06/07/1983 00:00;13/08/2001 00:00;04/11/1998 00:00;20/06/1996 00:00;08/06/1965 00:00;24/02/1967 00:00;19/07/1999 00:00;30/10/1995 00:00;12/05/1966 00:00;23/06/1998 00:00;06/09/1950 00:00;09/12/1994 00:00;28/04/2000 00:00;24/02/1995 00:00;17/10/1972 00:00;14/04/1981 00:00;22/01/1981 00:00;07/06/1999 00:00;06/01/1965 00:00;18/07/2002 00:00;26/03/1957 00:00;11/01/1965 00:00;05/01/1994 00:00;11/05/2010 00:00;31/10/2015 00:00;27/06/2000 00:00;27/08/1996 00:00;29/07/1994 00:00;20/01/1967 00:00;27/11/2001 00:00;06/08/2002 00:00;20/10/1981 00:00;14/07/1995 00:00;04/08/1999 00:00;17/11/1988 00:00;19/04/1954 00:00;02/07/1968 00:00;22/03/1965 00:00;31/07/2002 00:00;07/12/1993 00:00;26/11/2002 00:00;23/07/1999 00:00;22/12/1964 00:00;19/05/1995 00:00;05/02/2002 00:00;20/02/1991 00:00;12/09/2001 00:00;09/05/1997 00:00;21/04/2000 00:00;12/06/1995 00:00;04/10/1963 00:00;10/02/1967 00:00;21/11/2003 00:00;09/02/1995 00:00;01/05/2000 00:00;25/06/1984 00:00;24/05/1962 00:00;05/04/2000 00:00;20/10/1993 00:00;20/07/1967 00:00;13/06/1995 00:00;23/05/1973 00:00;18/08/2014 00:00;26/05/1999 00:00;11/08/1970 00:00;19/04/1999 00:00;16/10/1972 00:00;01/05/2013 00:00;07/04/1970 00:00;05/07/1972 00:00;24/08/2000 00:00;10/05/1994 00:00;15/10/2002 00:00;06/09/1960 00:00;26/01/1995 00:00;03/09/1997 00:00;20/10/2017 00:00;05/05/2004 00:00;07/04/1986 00:00;05/03/1999 00:00;20/03/1967 00:00;14/08/1968 00:00;18/05/1992 00:00;08/07/1969 00:00;17/10/1963 00:00;21/12/1972 00:00;25/08/2014 00:00;23/06/1972 00:00;26/03/1982 00:00;07/03/2001 00:00;15/06/1970 00:00;10/08/1992 00:00;10/05/1971 00:00;16/05/1986 00:00;11/05/1998 00:00;24/07/1963 00:00;02/12/1999 00:00;03/03/1967 00:00;26/08/1966 00:00;22/03/2004 00:00;10/03/1995 00:00;15/08/2014 00:00;04/03/1969 00:00;16/09/1996 00:00;09/11/1971 00:00;29/07/1948 00:00;23/02/1999 00:00;07/08/2002 00:00;06/04/1967 00:00;17/01/1996 00:00;05/08/2002 00:00;23/11/1998 00:00;23/03/1993 00:00;28/05/1999 00:00;03/12/2002 00:00;03/11/1966 00:00;25/05/1970 00:00;06/01/1972 00:00;27/02/2002 00:00;31/01/2006 00:00;12/02/1974 00:00;29/12/1998 00:00;06/02/2004 00:00;27/10/1995 00:00;26/04/1973 00:00;30/01/1995 00:00;20/06/1994 00:00;16/06/1974 00:00;24/07/1970 00:00;17/04/1970 00:00;13/01/1967 00:00;06/05/1977 00:00;10/03/2017 00:00;19/06/1978 00:00;30/04/2004 00:00;07/03/1996 00:00;01/06/1962 00:00;18/12/1967 00:00;25/09/2000 00:00;13/01/1977 00:00;04/05/1998 00:00;22/12/1994 00:00;25/07/2012 00:00;10/08/1995 00:00;15/03/1996 00:00;30/10/2001 00:00;16/04/1974 00:00;24/04/1974 00:00;04/12/1985 00:00;22/10/1998 00:00"	AP	"MONARCH PHARMS;CASPER PHARMA LLC;#N/A;XELLIA PHARMS APS;FRESENIUS KABI USA;BAUSCH AND LOMB;DOW PHARM;MYLAN ASI;X GEN PHARMS;PHARMACIA AND UPJOHN;PERRIGO CO TENNESSEE;APOTHEKERNES;AKORN;PFIZER"	" POLYMYXIN B SULFATE;BACITRACIN; HYDROCORTISONE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE;BACITRACIN ZINC"	26/03/1957	PHARMACIA AND UPJOHN	105,6	#N/A																							0						1
Etodolac	r-etodolac	"1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid;1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid;Etodolsäure;Etodolaco;Etodolacum;Etodolic acid;Etodolac;Étodolac;(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid;Lodine;Ultradol - Cap 200mg;Novo-etodolac 200 mg;Gen-etodolac 200mg;Nu-etodolac;Etodolac;Gen-etodolac 300mg;Novo-etodolac 300 mg;Ultradol - Cap 300mg;Taro-etodolac;Taro-etodolac 200 mg"	"DB00749;APRD00067"	"2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid;2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)ethanoic acid;41340-25-4;{Pyrano[3,} 4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;RAK-591;IDI1_000147;BSPBio_003138;EU-0100479;Spectrum5_001347;Prestwick2_000231;AIDS-128510;NINDS_000147;Lopac0_000479;E0516_SIGMA;KBioGR_000680;D00315;Etodolac (JP15/USP/INN);Lodine (TN);SPBio_002222;1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;AY 24236;AY-24,236;Etodolic acid;NSC282126;Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;Osteluc;KBioSS_001724;Spectrum_001244;Prestwick0_000231;1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid;1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;CCRIS 3923;ETODOLAC;Etodolac [USAN:BAN:INN];Etodolaco [INN-Spanish];Etodolacum [INN-Latin];Lodine;Lodine XL;NSC 282126;Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;Ultradol;Hypen;KBio3_002358;KBio2_001724;KBio2_004292;KBio2_006860;KBio1_000147;Spectrum2_001387;SPBio_001374;Edolan;Prestwick1_000231;SPECTRUM1501005;AY-24236;Spectrum4_000410;DivK1c_000147;SMR000058443;Spectrum3_001429;2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid;Prestwick3_000231;NCGC00089769-03;BPBio1_000333;Lodine SR;Prestwick_209;MLS000028474;BSPBio_000301;(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid;NCGC00089769-04;AIDS128510;{1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic} acid"	"etodolac;41340-25-4;Etodolic acid;Lodine;Ultradol;Lodine XL;Etodolaco;Etodolacum;Ramodar;AY 24236;Etodolacum [INN-Latin];Etodolaco [INN-Spanish];AY-24236;AY-24,236;Edolan;Hypen;CCRIS 3923;2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid;CHEMBL622;NSC 282126;1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid;1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;etodine;Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;MLS000028474;CHEBI:4909;RAK-591;NNYBQONXHNTVIJ-UHFFFAOYSA-N;2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid;(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid;2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid;Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;NSC282126;SMR000058443;DSSTox_CID_615;(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid;(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;DSSTox_RID_75691;DSSTox_GSID_20615;Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)-;SR-01000000100;Etodolac [USAN:BAN:INN];Etodolac [USAN:INN:BAN];Etodolsaure;Osteluc;Tedolan;Zedolac;etodolac o;Etodlic Acid;[1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid;Etodolac(Lodine);Lodine SR;KS-1056;Etodolac [USAN:USP:INN:BAN];NCGC00016849-01;Etodolac,(S);Prestwick_209;Etodolacetodolic acid;CAS-41340-25-4;Lodine (TN);Spectrum_001244;Opera_ID_1774;Prestwick0_000231;Prestwick1_000231;Prestwick2_000231;Prestwick3_000231;Spectrum2_001387;Spectrum3_001429;Spectrum4_000410;Spectrum5_001347;D0N1WU;AC1L1FN2;SCHEMBL3903;Lopac0_000479;BSPBio_000301;BSPBio_003138;KBioGR_000680;KBioSS_001724;MLS001077315;MLS006011566;DivK1c_000147;SPECTRUM1501005;Etodolac (JP17/USP/INN);SPBio_001374;SPBio_002222;BPBio1_000333;GTPL7185;DTXSID9020615;CTK4I4719;HMS500H09;KBio1_000147;KBio2_001724;KBio2_004292;KBio2_006860;KBio3_002358;MolPort-001-759-084;NINDS_000147;HMS1568P03;HMS1921B09;HMS2092O20;HMS2095P03;HMS2231D04;HMS3259P10;HMS3261O20;HMS3374G09;HMS3712P03;Pharmakon1600-01501005;Tox21_110644;Tox21_202218;Tox21_500479;ANW-42024;BDBM50016799;CCG-39005;CE0096;MFCD00133313;NSC757821;AKOS015838610;Tox21_110644_1;AC-4231;CS-0832;DB00749;LP00479;LS-7393;NC00718;NSC-282126;NSC-757821;RTR-036749;IDI1_000147;KS-0000000W;NCGC00015399-03;NCGC00015399-04;NCGC00015399-05;NCGC00015399-06;NCGC00015399-07;NCGC00015399-08;NCGC00015399-09;NCGC00015399-11;NCGC00015399-12;NCGC00015399-13;NCGC00015399-15;NCGC00015399-16;NCGC00089769-02;NCGC00089769-03;NCGC00089769-04;NCGC00089769-05;NCGC00089769-06;NCGC00089769-07;NCGC00259767-01;NCGC00261164-01;AN-12214;BC651843;CPD000058443;HY-76251;SAM002589968;SBI-0050463.P003;110781-63-0 (mono-hydrochloride salt);AB0012214;TR-036749;AB00052194;E0858;EU-0100479;FT-0607046;C06991;D00315;E 0516;K-8734;Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-;AB00052194_17;340E254;Q-201099;SR-01000000100-2;SR-01000000100-4;SR-01000000100-7;BRD-A74667430-001-05-3;BRD-A74667430-001-15-2;1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;Etodolac, European Pharmacopoeia (EP) Reference Standard;F2173-0681;Z1820178466;Etodolac, United States Pharmacopeia (USP) Reference Standard;1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic acid;1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid;1,8-Diethyl-1,3,4,9-tetrahydropyranol[3,4-b]indole-1-acetic acid;(RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid;Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard"	41340-25-4	2M36281008	18094935	18094935	01/12/2007	6212554	01/05/1982	Bef. 1989		1	0	1	No	0	"13/11/2007 00:00;30/04/1998 00:00;16/10/2000 00:00;29/01/2001 00:00;07/11/1997 00:00;24/02/2000 00:00;08/02/2001 00:00;22/09/2006 00:00;04/10/1991 00:00;07/05/2001 00:00;25/03/2002 00:00;22/01/2001 00:00;16/12/1997 00:00;29/07/2002 00:00;31/01/1991 00:00;26/04/2001 00:00;11/09/2002 00:00;08/10/1998 00:00;26/02/2007 00:00;18/07/2002 00:00;29/10/2002 00:00;11/04/1997 00:00;06/02/1998 00:00;23/01/2014 00:00;04/04/2006 00:00;28/04/1998 00:00;23/04/1999 00:00;22/08/2002 00:00;19/04/2001 00:00;17/04/2000 00:00;23/01/1998 00:00;28/07/2006 00:00;12/04/2001 00:00;14/08/2006 00:00;21/12/2015 00:00;21/07/1999 00:00;25/05/2005 00:00;17/12/2015 00:00;02/11/2001 00:00;26/07/2002 00:00;11/04/2000 00:00;12/03/2001 00:00;26/11/1997 00:00;25/11/1991 00:00;30/10/1997 00:00;15/10/1999 00:00;26/02/2010 00:00;25/03/2016 00:00;27/06/1997 00:00;17/11/2006 00:00;02/02/2000 00:00;11/03/1998 00:00;03/12/2015 00:00;05/02/2016 00:00;11/07/1997 00:00;08/12/1997 00:00;28/12/1999 00:00;29/10/1998 00:00;11/01/2007 00:00;03/02/1998 00:00;12/03/2002 00:00;05/02/2001 00:00;17/07/1997 00:00;19/04/1999 00:00;25/02/1998 00:00;29/01/2002 00:00;23/12/1997 00:00;22/01/2016 00:00;21/03/2000 00:00;11/02/1992 00:00;02/03/2006 00:00;17/09/1999 00:00;30/11/2001 00:00;16/04/1997 00:00;27/05/1999 00:00;08/03/2006 00:00;23/09/2004 00:00;28/02/1997 00:00;16/05/1997 00:00;30/01/1998 00:00;29/10/1999 00:00;28/10/1992 00:00;28/06/1996 00:00;16/09/1999 00:00;20/11/2002 00:00;08/08/2006 00:00;16/04/1998 00:00;05/10/2001 00:00;18/01/2006 00:00;12/01/1993 00:00;02/12/1999 00:00;08/07/1997 00:00;11/08/2000 00:00;11/07/2002 00:00;24/11/1998 00:00;20/12/2000 00:00;16/05/2001 00:00;08/12/1994 00:00;02/10/2000 00:00;26/08/1999 00:00;05/11/2002 00:00;03/12/2002 00:00;28/01/2000 00:00;25/04/2000 00:00;20/09/2002 00:00;25/04/2008 00:00;19/03/1993 00:00;09/05/2016 00:00;10/05/2002 00:00;11/10/2007 00:00;31/07/2000 00:00;30/09/1998 00:00;22/10/1999 00:00;01/02/1999 00:00;08/05/2002 00:00;20/11/1998 00:00;15/11/2002 00:00;03/03/2000 00:00;07/06/2018 00:00;28/07/2000 00:00;25/10/1996 00:00;09/02/2000 00:00;02/06/2015 00:00;15/11/2001 00:00;24/05/2005 00:00;29/07/1993 00:00;07/02/2013 00:00;20/11/2000 00:00;23/11/1999 00:00;07/12/1998 00:00;29/08/1997 00:00;22/11/2002 00:00;29/08/2002 00:00;30/04/1999 00:00;13/03/2003 00:00;22/07/2016 00:00;09/12/1998 00:00;25/01/2001 00:00;20/01/1998 00:00;30/09/1997 00:00;25/04/2006 00:00;14/01/2009 00:00"	AP	"IVAX SUB TEVA PHARMS;MYLAN PHARMS INC;ANI PHARMS INC;OXFORD PHARMS;WYETH PHARMS INC;RANBAXY LABS LTD;TARO;ZYDUS PHARMS USA INC;APOTEX INC;SANDOZ;WATSON LABS;APOTEX;ECI PHARMS LLC;TEVA;#N/A;WATSON LABS FLORIDA;CHARTWELL MOLECULES;ACTAVIS ELIZABETH;MYLAN;TARO PHARM INDS"	ETODOLAC	31/01/1991	WYETH PHARMS INC	104,8	#N/A																							0						1
Rilotumumab	"amg 102;rilotumumab"	AMG 102	DB11972			872514-65-3	51WEW898IJ	20068101	20068101	01/01/2010	20068101	01/01/2010	2009-2012		1	1	0	Yes	1					30/07/2018		102,7	40	NA	1	0	NA	1	HGF	0	1	1	NA	0	0	0	0	1	0	0	0	0	0,7	0	0	0	0	0	0	25	0	1
Alvespimycin	"17-dimethylaminoethylamino-17-demethoxygeldanamycin;17-n-allylamino-17-demethoxygeldanamycin;alvespimycin;bms-826476;kos-1022"	"17-(dimethylaminoethylamino)-17-demethoxygeldanamycin;17-DMAG"	DB12442		"alvespimycin;17-DMAG;467214-20-6;UNII-001L2FE0M3;CHEBI:65324;17-(dimethylaminoethylamino)-17-demethoxygeldanamycin;NSC 707545;001L2FE0M3;17-dimethylaminoethylamino-17-demethoxygeldanamycin;150270-08-9;NSC707545;(4E,6Z,10E,12S,13R,16R)-19-(2-(Dimethylamino)ethylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-{[2-(dimethylamino)ethyl]amino}-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;Alvespimycin [INN];DMAG;KOS1022;17-Dimethylaminogeldanamycin;KOS 1022;C32H48N4O8;AC1NRBWB;17-DMAG/;GTPL9828;SCHEMBL5449716;CHEBI:94772;17-DMAG/17 DMAG,Geldanamycin;KUFRQPKVAWMTJO-LMZWQJSESA-N;MolPort-006-666-027;EX-A1103;ABP000223;ABP000584;BDBM50005781;ZINC100030312;CS-0912;DB12442;((4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(2-dimethylaminoethylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo(16.3.1)docosa-4,6,10,18,21-pentaen-9-yl) carbamate;HY-10389;X8446;M03709;W-5374;214D206;BRD-K83988098-001-02-0;BRD-K83988098-003-01-8;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(2-dimethylaminoethylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-[2-(dimethylamino)ethylamino]-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate"	467214-20-6	001L2FE0M3	"17363533;19945858;20111068;20177028"	17363533	01/03/2007	19945858	01/01/2010	2009-2012		1	1	0	Yes	1					30/07/2018		102,7	31	NA	1	0	NA	1	HSP90	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,29	0	0	0	0	0	0	0	0	1
Panobinostat	"lbh589;panobinostat"	"panobinostat;(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide;Farydak"	DB06603	"(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide;(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid;Panobinostat;Faridak;LBH-589;LBH-589B;NVP-LBH-589"	"Panobinostat;404950-80-7;LBH589;LBH-589;Farydak;Faridak;LBH 589;(E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide;Panobinostat (LBH589);NVP-LBH589;UNII-9647FM7Y3Z;LBH-589B;NVP-LBH-589;(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE;CHEBI:85990;9647FM7Y3Z;Farydak (TN);(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide;N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide;panobinostat lactate anhydrous;(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid;(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide;2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-;Panobinostat [USAN:INN];2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-;N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide;PubChem19147;Panobinostat(LBH589);AC1OCFY8;LBH589 - Panobinostat;Panobinostat (USAN/INN);D0E3SH;MLS006011216;SCHEMBL164801;SCHEMBL183197;CHEMBL483254;GTPL7489;BDBM29589;CHEBI:93774;DTXSID40193506;EX-A169;FPOHNWQLNRZRFC-ZHACJKMWSA-N;MolPort-005-933-338;BCPP000187;BDBM198124;LBH-589/Panobinostat /LBH589;AOB87727;LBH58,9NVP-LBH589,Panobinostat;ABP000143;s1030;ZINC22010649;AKOS005146046;ACN-025765;BCP9000844;CCG-208762;CS-0267;DB06603;EX-8456;RL03555;Panobinostat, NVP-LBH589, LBH589;4CA-0964;AC-28652;AJ-80437;AK-77283;AM808102;AS-17046;BC203264;BR-77283;HY-10224;KB-59423;QC-10419;SC-85907;SMR004702978;AB0007883;AX8223959;DB-025426;RT-014934;ST2402529;A8178;FT-0083488;W6096;A25218;D10319;W-5406;139304-EP2270008A1;139304-EP2292617A1;J-523585;BRD-K02130563-001-07-2;(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide;(E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indole-3-yl)ethyl]amino]methyl]phenyl]acrylamide;N-hydroxy-3 -[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide;Panobinostat;(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide"	404950-80-7	9647FM7Y3Z	"26903311;26821711;25939707;25377157;25253045;23385375;23377661;21964801;21484248;18628465"	18628465	01/07/2008	16899611	01/08/2006	2004-2008		1	1	1	Yes	1	"23/02/2015 00:00;06/06/2016 00:00"	AP	NOVARTIS PHARMS CORP	PANOBINOSTAT LACTATE	23/02/2015	NOVARTIS PHARMS CORP	102,6	15	87	0	1	HEMATOLOGIC MALIGNANCIES	1	HDAC	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	QT	1	0	0	0	431	0	1
Pomalidomide	pomalidomide	"Pomalyst;Imnovid"	DB08910		"Pomalidomide;19171-19-8;Actimid;4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;Pomalyst;CC-4047;Imnovid;4-Aminothalidomide;4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;CC 4047;Pomalidomide (CC-4047);3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide;1H-Isoindole-1,3(2H)-dione, 4-amino-2-(2,6-dioxo-3-piperidinyl)-;IMID-3;CHEBI:72690;443919-33-3;4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;4-amino-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione;4-amino-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;IMiD 3;Pomalidomide [USAN:INN];HSDB 8222;Pomalyst (TN);Actimid (TN);IMiD1;PubChem22200;AC1Q6NYN;D0A3ZU;3-Aminophthalimidoglutarimide;MLS006011261;CHEMBL43452;Pomalidomide (Immunomodulator);SCHEMBL369172;AC1L358B;GTPL7348;Pomalidomide (JAN/USAN/INN);SCHEMBL19250920;BDBM65456;CTK4I8155;IMID-4047;CDC-394;Pomalidomide, >=98% (HPLC);MolPort-016-633-239;UVSMNLNDYGZFPF-UHFFFAOYSA-N;HMS3655G05;Actimid|||CC 4047|||IMiD3;EBD24712;ANW-69609;s1567;AKOS013400288;ACN-034796;CS-0165;DB08910;LS40023;RL02421;NCGC00346551-01;AC-26970;AK104087;AS-17905;BC213119;HY-10984;KB-71997;SMR004703012;BCP0726000263;AB0021203;AX8235626;KB-239921;KB-239922;TC-158354;4CH-001846;CC-4047, Actimid, 19171-19-8;FT-0697903;P2074;ST24023268;V2447;D08976;W-5536;AB01565777_02;171P198;SR-01000941573;J-012392;J-514302;Phthalimide, 3-amino-N-(2,6-dioxo-3-piperidyl)-;SR-01000941573-1;4-amino-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione;4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione;4-Amino-2-(2,6-dioxo-3-piperidyl) isoindoline -1,3-dione;4-AMINO-2-(2,6-DIOXO-PIPERIDIN-3-YL)ISOINDOLE-1,3-DIONE;443912-23-0"	19171-19-8	D2UX06XLB5	"27863194;26292221;22875080"	22875080	01/08/2012	15249589	01/08/2004	2004-2008		1	1	1	Yes	1	"22/04/2016 00:00;27/10/2015 00:00;14/09/2015 00:00;15/11/2013 00:00;27/06/2017 00:00;13/03/2014 00:00;12/09/2014 00:00;20/03/2018 00:00;29/12/2017 00:00;23/04/2015 00:00;01/12/2015 00:00;08/02/2013 00:00;30/06/2016 00:00;03/10/2013 00:00;30/11/2017 00:00"	AP	CELGENE	POMALIDOMIDE	08/02/2013	CELGENE	102,1	24	NA	0	1	MYELOMA	1	IMMUNOMODULATION	0	1	0	NA	0	0	0	1	1	0,67	0	1	1	0,79	0	0	0	0	0	0	502	0	1
Mogamulizumab	"kw-0761;mogamulizumab"		DB12498			1159266-37-1	YI437801BE	20177026	20177026	01/02/2010	20177026	01/02/2010	2009-2012		1	1	0	Yes	1					30/07/2018		101,7	16	NA	0	1	T CELL LYMPHOMA	1	CCR4	0	1	0	NA	0	0	0	1	0	0,31	0	1	1	NA	0	0	0	0	0	0	26	0	1
RAV12	"raag12 moab;rav12"		DB05140					20179219	20179219	01/02/2010	20179219	01/02/2010	2009-2012		1	1	0	Yes	1					30/07/2018		101,7	53	NA	1	1	ADENOCARCINOMA	1	RAAG12	0	1	1	20	0	0	0	1	1	0,02	0	0	0	0,08	0	0	0	0	0	0	0	0	1
Vosaroxin	voreloxin	Voreloxin	"DB11999;DB05517"		"Voreloxin;vosaroxin;175414-77-4;SNS-595;UNII-K6A90IIZ19;AG 7352;SNS 595;SPC 595;SPC-595;AG-7352;K6A90IIZ19;C18H19N5O4S;Quinprezo;Vosaroxin [USAN:INN];Voreloxin (TN);Vosaroxin (USAN);(+)-AG-7352;D00NVM;CHEMBL68117;SCHEMBL674441;EX-A847;MolPort-035-395-891;SNS 595 (TN);SNS-595 (TN);SPC 595 (TN);Voreloxin;SNS-595;AG 7352;2795AH;AG 7352 (TN);ZINC26186622;AKOS030526660;CS-0790;DB11999;1,4-Dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid;AN-16673;BC600784;HY-10534;KB-81456;SC-96710;Vosaroxin hydrochloride, >=98% (HPLC);D08024;W-5566;J-690243;1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-methoxy-4-(methylamino)-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-, (3S-trans)-;7-((3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-thiazol-2-yl-1,8-naphthyridine-3-carboxylic acid"	175414-77-4	K6A90IIZ19	20233886	20233886	01/03/2010	20233886	01/03/2010	2009-2012		1	1	0	Yes	1					30/07/2018		100,8	62	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	0,5	0	0	0	0	0	0	0	0	1
Neratinib	"hki-272;neratinib"	Nerlynx	DB11828		"Neratinib;698387-09-6;HKI-272;Neratinib (HKI-272);Nerlynx;UNII-JJH94R3PWB;Neratinib(HKI-272);PB-272;JJH94R3PWB;CHEMBL180022;WAY-179272;(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;(E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;C30H29ClN6O3;Q-101402;(2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;(E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;Neratinib [USAN:INN];PB 272;Neratinib HKI 272;PubChem22399;Tube708;Neratinib (USAN/INN);Neratinib - HKI-272;cc-32;D0Q9CY;JSPY-st000262;Neratinib (ERBB2 inhibitor);SCHEMBL571762;SCHEMBL571763;BIFK0031;GTPL5686;CDP-820;DTXSID70220132;EX-A062;QCR-104;SYN1140;MolPort-006-069-389;Neratinib(HKI-272)/HKI272;ZX-AFC000299;BCPP000151;AOB87125;ZINC3916214;ABP000871;AN-546;BDBM50161957;s2150;WAY-179272-B;AKOS005146340;AKOS025149637;BCP9000984;DB11828;RL04677;NCGC00241101-01;AC-25073;AK170454;AS-16279;BC256322;HY-32721;KB-58129;SC-28031;AB0008022;X2638;A25338;D08950;Z-3202;387N096;I06-2375;BRD-K85606544-001-01-8;698387-09-6, HKI272, HKI 272, HKI-272,;(2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide                                              neratinib;(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;HKI-272;(E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylami;(E)-N-[4-[3-chloro-4-(2-pyridylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide;2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-;4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide;736156-77-7;N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide"	698387-09-6	JJH94R3PWB	19318484	19318484	01/03/2009	19318484	01/03/2009	2009-2012		1	1	1	Yes	1	"28/06/2018 00:00;17/07/2017 00:00"	AP	PUMA BIOTECH	NERATINIB MALEATE	17/07/2017	PUMA BIOTECH	100,3	73	NA	1	1	"BREAST;LUNG"	1	HER	0	1	0	NA	0	0	0	1	1	0,32	0	0	0	0,43	0	0	0	0	0	0	86	0	1
Fostamatinib	fostamatinib		DB12010		"Fostamatinib;901119-35-5;R788;Fostamatinib(R788);Tavalisse;Fostamatinib (R788);UNII-SQ8A3S5101;R-788 Free acid;R 788;R-788;R-935788 Free acid;SQ8A3S5101;Fostamatinib/R788;R7935788;[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxo-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate;2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-;Fostamatinib [USAN:INN];R-935788;(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate;[6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate;2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-;6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-2h-pyrido(3,2-b)-1,4-oxazin-3(4h)-one;6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one;Fostamatinib (USAN);R788 (Fostamatinib);D0V8HJ;GTPL7796;QCR-82;SCHEMBL1201371;CHEMBL2103830;KS-00000XGF;EX-A108;GKDRMWXFWHEQQT-UHFFFAOYSA-N;MolPort-021-804-956;BCPP000226;HMS3651H09;ABP000970;AN-576;BDBM50431381;HY-13038A;s2625;ZINC43131420;AKOS025404920;AM81257;BCP9000704;CS-2152;DB12010;PB25570;RL05675;VA12036;NCGC00346622-01;4CA-0549;AC-30126;AK174913;KB-80322;SC-47719;AB0008135;FT-0699180;D09347;Q-4555;J-517972;(6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate;[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate;[6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[2,3-e][1,4]oxazin-4-yl]methyl dihydrogen phosphate;2RC;6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-2h-pyrido(3,2-b)-1,4-oxazi n-3(4h)-one;945745-48-2"	901119-35-5	SQ8A3S5101	19965662	19965662	01/12/2009	19965662	01/12/2009	2009-2012		1	1	1	Yes	1	17/04/2018 00:00	AP	RIGEL PHARMS INC	FOSTAMATINIB DISODIUM	17/04/2018	RIGEL PHARMS INC	100,3	68	NA	0	1	"NHL;CLL"	1	SYK	0	1	0	NA	0	0	0	1	0	0,55	0	0	0	NA	0	0	0	0	0	0	0	0	1
Etoposide	"bmy-40481;dimethylaminoetoposide;etoposide;nk611;vp-16;water-soluble etoposide prodrug"	"(−)-etoposide;4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside);4-demethylepipodophyllotoxin β-D-ethylideneglucoside;9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one;Dom-etoposide;Eposin;Etopophos;Etoposide;Etoposide - Liq IV 20mg/ml;Etoposide Injection;Etoposide Injection USP;Etoposide Injection, USP;Etoposido;Etoposidum;PMS-etoposide;Toposar;Vepesid;Vepesid Inj 20mg/ml;trans-Etoposide"	"APRD00239;DB00773"	"(5R,5aR,9S)-9-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[5,6-d][1,3]dioxin-6-yl]oxy]-5-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,8,8a,9-tetrahydro-5H-isobenzofurano[6,5-f][1,3]benzodioxol-6-one;(5R,5aR,9S)-9-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[5,6-d][1,3]dioxin-6-yl]oxy]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5a,8,8a,9-tetrahydro-5H-isobenzofurano[6,5-f][1,3]benzodioxol-6-one;nchembio873-comp2;Prestwick_211;Etoposide;Prestwick0_000396;Prestwick2_000396;Prestwick1_000396;SPBio_002532"	"etoposide;33419-42-0;VePesid;Toposar;trans-Etoposide;Lastet;(-)-Etoposide;VP-16;Zuyeyidal;Etoposidum;Etoposido;Vepesid J;Eposin;Etoposidum [INN-Latin];Eposide;Etosid;Etoposide (VP16);VP 16-213;VP-16-213;Etoposido [INN-Spanish];VP 16 (pharmaceutical);Etopophos (phosphate salt);VP 16;Epipodophyllotoxin VP-16213;Vepeside;Etopol;4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside;VP 16213;UNII-6PLQ3CP4P3;NK 171;NSC 141540;CCRIS 2392;HSDB 6517;Etoposide [USAN:INN:BAN:JAN];4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside);VePESID (TN);4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside);EINECS 251-509-1;NSC-141540;Demethylepipodophyllotoxin-beta-D-ethylideneglucoside;fytosid;6PLQ3CP4P3;CHEMBL44657;CHEBI:4911;Demethyl-epiodophyllotoxin ethylidene glucoside;4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin;Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside);CPD000112002;EPEG;Epipodophyllotoxin-beta-D-ethyliden-glucoside, 4'-demethyl-;[1,3]benzodioxol-8-one;9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-;9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one;C29H32O13;NSC141540;Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside;4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside;Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI);Etoposide (VP-16);(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one;(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside;9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-;SMR000112002;4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside;Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside;Etopophos (TN);Etoposide,(S);(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f];EVP;Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-.beta.-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-;Eposin (TN);E0675;Etoposide [USAN:USP:INN:BAN:JAN];Prestwick3_000396;D09NIB;D0B7EB;4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside;Demethyl Epipodophyllotoxin Ethylidine Glucoside;AC1L1VT3;SCHEMBL4259;BSPBio_000611;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-;MLS000049957;MLS001074951;MLS001424283;MLS002153463;MLS002207239;MLS002222184;[1,3]dioxol-6(5aH)-one;Etoposide (JP15/USP/INN);Etoposide (JP17/USP/INN);BPBio1_000673;GTPL6815;MES-012;Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside);MolPort-006-069-121;VJJPUSNTGOMMGY-MRVIYFEKSA-N;HMS2052N05;HMS2089F14;HMS2096O13;HMS2232L03;HMS3713O13;VP-16 (TN);EX-A1207;ZINC3938684;BDBM50127140;MFCD00869325;s1225;AKOS007930275;AB07572;BCP9000669;CCG-101165;CS-1774;DB00773;EBD2157958;Etoposide, synthetic, >=98%, powder;LS-1214;NC00415;ETOPOSIDE 4'-DIHYDROGENPHOSPHATE;NCGC00179504-02;AS-35312;CC-28332;HY-13629;SAM001246880;SBI-0051910.P002;KB-308978;AB00438905;ST24047199;Demethyl EpipodophyllotoxinEthylidine Glucoside;Eposin, Vepesid, VP-16, Toposar, Etoposide;A-8109;C01576;D00125;13165-EP2269989A1;13165-EP2270008A1;13165-EP2270014A1;13165-EP2270018A1;13165-EP2272827A1;13165-EP2272832A1;13165-EP2275413A1;13165-EP2275420A1;13165-EP2277565A2;13165-EP2277566A2;13165-EP2277567A1;13165-EP2277568A2;13165-EP2277569A2;13165-EP2277570A2;13165-EP2277865A1;13165-EP2277876A1;13165-EP2280012A2;13165-EP2281815A1;13165-EP2287156A1;13165-EP2289892A1;13165-EP2292280A1;13165-EP2292614A1;13165-EP2292615A1;13165-EP2292617A1;13165-EP2295055A2;13165-EP2295416A2;13165-EP2295426A1;13165-EP2295427A1;13165-EP2298305A1;13165-EP2298746A1;13165-EP2298748A2;13165-EP2298764A1;13165-EP2298765A1;13165-EP2298768A1;13165-EP2298772A1;13165-EP2298778A1;13165-EP2298780A1;13165-EP2301928A1;13165-EP2301933A1;13165-EP2305640A2;13165-EP2305642A2;13165-EP2305671A1;13165-EP2305679A1;13165-EP2305689A1;13165-EP2308812A2;13165-EP2308833A2;13165-EP2308839A1;13165-EP2308855A1;13165-EP2308861A1;13165-EP2311453A1;13165-EP2311807A1;13165-EP2311808A1;13165-EP2311825A1;13165-EP2311827A1;13165-EP2311829A1;13165-EP2311840A1;13165-EP2311842A2;13165-EP2314574A1;13165-EP2316832A1;13165-EP2316833A1;13165-EP2316834A1;13165-EP2374454A1;AB00438905-17;AB00438905-18;AB00438905_19;419E420;C-23291;SR-01000763196;SR-01000763196-3;BRD-K37798499-001-02-5;BRD-K37798499-001-05-8;BRD-K37798499-001-10-8;BRD-K37798499-001-14-0;BRD-K37798499-001-27-2;DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE;Etoposide, European Pharmacopoeia (EP) Reference Standard;Etoposide, United States Pharmacopeia (USP) Reference Standard;4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside);4-DESMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-ETHYLIDENE)-BETA-D-GLUCOPYRANOSIDE;Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard;(10r,11r,15r,16s)-16-([(2r,4ar,7r,8r,8as)-7,8-dihydroxy-2-methyl-hexahydro-2h-pyrano[3,2-d][1,3]diox;(10R,11R,15R,16S)-16-([(2R,4AR,7R,8R,8AS)-7,8-DIHYDROXY-2-METHYL-HEXAHYDRO-2H-PYRANO[3,2-D][1,3]DIOXIN-6-YL]OXY)-10-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-4,6,13-TRIOXATETRACYCLO[7.7.0.0(3,7).0(11,15)]HEXA;(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0;{3,7}.0;{11,15}]hexadeca-1(9),2,7-trien-12-one;(5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one;(5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d];(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one;(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside;[5R-[5?,5a?,8a?,9?(R*)]]-9-[(4,6-?-Ethylidene-?-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-(5aH)-one;121471-01-0;136598-18-0;201594-04-9;35317-32-9;51854-34-3;76576-58-4;9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one"	33419-42-0	6PLQ3CP4P3	"10426664;10430070;11052632;12579475;12826307;23445779;24868080;25776193;8636778;8652278;8683232;8765440;8826608;8845473;8932836;9053503;9157073;9547675;9815892"	9815892	01/01/1995	1100224	01/07/1975	Bef. 1989		0	1	1	Yes	1	"12/12/1996 00:00;20/11/2017 00:00;27/06/1995 00:00;02/03/1993 00:00;28/05/2004 00:00;11/10/2002 00:00;31/01/2012 00:00;27/02/1998 00:00;30/07/2015 00:00;03/04/2001 00:00;09/11/2016 00:00;10/02/1994 00:00;13/05/1998 00:00;03/08/2000 00:00;09/01/1998 00:00;15/12/1998 00:00;05/12/2002 00:00;20/05/1987 00:00;08/01/2013 00:00;19/01/1999 00:00;30/08/1993 00:00;27/02/1995 00:00;21/08/1984 00:00;06/03/1985 00:00;10/04/2002 00:00;17/05/1995 00:00;08/08/1995 00:00;26/10/1998 00:00;20/06/1997 00:00;28/04/1988 00:00;21/02/2002 00:00;18/12/2001 00:00;21/11/2000 00:00;06/11/1986 00:00;26/08/1986 00:00;16/09/1994 00:00;17/10/1995 00:00;17/05/1996 00:00;09/05/1997 00:00;09/08/2000 00:00;22/04/1997 00:00;02/02/2000 00:00;11/02/1988 00:00;16/06/1998 00:00;23/06/2000 00:00;19/03/1987 00:00;30/06/1986 00:00;04/09/1990 00:00;02/04/1999 00:00;12/03/2002 00:00;12/03/1985 00:00;14/03/2001 00:00;19/09/2001 00:00;24/07/1996 00:00;26/03/1987 00:00;11/04/2002 00:00;16/08/1999 00:00;14/07/1989 00:00;30/12/1986 00:00;23/08/1995 00:00;19/11/1999 00:00;08/12/2000 00:00;24/02/2011 00:00;01/08/2000 00:00;10/04/1989 00:00;04/09/1986 00:00;05/06/2001 00:00;11/10/2001 00:00;28/07/1999 00:00;31/08/1998 00:00;10/11/1983 00:00;23/02/1999 00:00;17/07/1995 00:00;11/06/1997 00:00;05/11/2002 00:00;29/10/1986 00:00;24/08/1987 00:00;23/05/2017 00:00;14/03/1996 00:00;22/02/1996 00:00;04/04/1990 00:00;27/08/1999 00:00;23/07/1993 00:00;25/04/1996 00:00;30/09/1998 00:00;24/08/1993 00:00;20/12/1993 00:00;25/01/1988 00:00;11/12/1995 00:00;20/11/1996 00:00;01/11/1991 00:00;21/12/2001 00:00;16/07/2002 00:00;29/08/2002 00:00;30/08/1995 00:00;23/04/2018 00:00;31/10/2017 00:00;27/09/1996 00:00;25/10/2000 00:00;29/08/2006 00:00;19/09/2000 00:00;22/12/1986 00:00;28/09/1999 00:00;17/03/2011 00:00"	AP	"BRISTOL MYERS SQUIBB;ACCORD HLTHCARE;WATSON LABS INC;#N/A;TEVA PHARMS USA;CORDEN PHARMA;FRESENIUS KABI USA;TEVA PARENTERAL;PHARMACHEMIE BV;WEST-WARD PHARMS INT;DAVA PHARMS INC;HOSPIRA;MYLAN"	"ETOPOSIDE PHOSPHATE;ETOPOSIDE"	10/11/1983	CORDEN PHARMA	100,1	30	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,72	0	0	0	NA	0	0	0	0	0	0	221	0	1
Foretinib	foretinib		"DB12307;DB05030"		"Foretinib;849217-64-7;XL880;EXEL-2880;GSK1363089;XL-880;GSK089;GSK 1363089;XL 880;GSK-1363089;Foretinib (GSK1363089);EXEL 2880;GSK1363089G;UNII-81FH7VK1C4;81FH7VK1C4;N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Foretinib (XL-880);C34H34F2N4O6;88Z;937176-80-2;n-(3-fluoro-4-((6-methoxy-7-(3-(4-morpholinyl)propoxy)-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;MET inhibitors;1-N'-[3-FLUORO-4-((6-METHOXY-7-[3-(MORPHOLIN-4-YL)PROPOXY]QUINOLIN-4-YL)OXY)PHENYL]-1-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE;1-N'-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl]oxy)phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;PubChem22993;Foretinib?XL-880?;Foretinib (USAN/INN);Foretinib [USAN:INN];D0D1GF;MLS006010302;SCHEMBL371804;EXEL-288;Foretinib - GSK1363089;GTPL5679;QCR-49;CHEMBL1230609;CHEBI:91418;AOB6031;EX-A050;GSK 089;GSK-089;SYN1129;CXQHYVUVSFXTMY-UHFFFAOYSA-N;MolPort-009-679-450;BCPP000236;HMS3654G04;ABP000883;BDBM50399540;GSK 1363089G;s1111;ZINC43204048;Foretinib,XL880, GSK1363089;AKOS015904319;BCP9000675;CS-0153;DB12307;Foretinib (GSK1363089,XL880);Foretinib?GSK1363089??XL880?;PB27007;RL05228;Foretinib (GSK1363089, XL880);NCGC00263104-01;AC-25081;AS-16268;BC622993;HY-10338;KB-52303;SMR003599144;AB0008088;W8766;A25642;D09618;Q-4937;S-7795;XL880, GSK1363089G, Exel 2880;Z-3260;EXEL-2880/XL880/GSK1363089/Foretinib;J-523004;BRD-K03449891-001-01-1;I14-17014;GSK089, EXEL-2880, 849217-64-7;GSK1363089, GSK089, foretinib, EXEL-2880, XL880;1,1-Cyclopropanedicarboxamide, N-(3-fluoro-4-((6-methoxy-7-(3-(4-morpholinyl)propoxy)-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-;1-N-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;GSK1363089;EXEL-2880;Foretinib;N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;N-(3-Fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-(3-FLUORO-4-((6-METHOXY-7-(3-MORPHOLINOPROPOXY)QUINOLIN-4-YL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANEDICARBOXAMIDE;N-(3-FLUORO-4-((6-METHOXY-7-(3-MORPHOLINOPROPOXY)QUINOLIN-4-YL)OXY)PHENYL)-N-(4-FLUOROPHENYL)CYCLOPROPANE DICARBOXAMIDE;N-(3-Fluoro-4-{[6-Methoxy-7-(3-Morpholin-4-Ylpropoxy)quinolin-4-Yl]oxy}phenyl)-N'-(4-Fluorophenyl)cyclopropane-1,1-Dicarboxamide;N-(4-(7-(3-MORPHOLINOPROPOXY)-6-METHOXYQUINOLIN-4-YLOXY)-3-FLUOROPHENYL)-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE;N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin 4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"	849217-64-7	81FH7VK1C4	"25998042;20842406;20472683"	20472683	01/05/2010	20472683	01/05/2010	2009-2012		1	1	0	Yes	1					30/07/2018		98,8	40	NA	1	0	NA	1	"MET;VEGFR2;RON;AXL"	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	0,6	0	0	0	0	0	0	0	0	1
Vitamin C	ascorbic acid	"acide ascorbique;Ascorbate;L-(+)-ascorbic acid;L-Ascorbate;Ascorbic Acid;acidum ascorbicum;ácido ascórbico;L-Ascorbic Acid;Ascorbinsäure;acidum ascorbinicum;Ascorbicap;Super Citro Cee Srt 500mg;Multiple Vitamins;Metreton Tab;Bio C 300 Tab;Multiple Vitamins & Minerals Tablets;Reno Caps;Dinosaurs Im-rap;Stress B Complex With C,e, Zinc and Copper;Vitamin C Tablets Sustained Release 500mg;Stress B&c Tab;Swiss Camu C Tab 150mg;Niacinamide 250mg With 50mg C;Prenate Essential;Multi-vitamins With Minerals;Bio Efferlife Vitamin C 1000mg;Multiple Vitamins Tab;Envive;Nutrifer Plus Tablets;Spectra 301 Vitamin and Mineral Supp;Innersource Tab;Eky Efferlife Vitamin C 1000mg With Zinc;Twin Ultra Liquid Grape Flavor;Tandem OB;Multiple Vitamins and Minerals Capsules;Vitamin C Tab 100mg Chewable Orange;Vitamin C Tab 500 mg;Vitamine C 250mg Tab Masticable;Vitamin and Mineral Supplement Capsules;Children's Chewable Multivitamin and Multimineral;Meplex T 750;Osteo Formula Tab;Vitamin C 250mg Chewable;Vitamin C Chewable 250mg;Rhume Et De LA Grippe (extra-fort);Vitamine C 500mg 5-fruits Tab;Appedrine;FeRivaFA;Right Choice A.M. Multi Formula - Caplet;Calcium Ascorbate Powder;Vitamin B Complex + C 300mg Cap;Tandem Plus;Extra C 500;Zinc Lozenge With Vitamin C;Chew C Berry Tablets - 125mg;Chewable Multiple Vitamins for Children;Calcium Ascorbate Cap 850mg;C-1000 Plus Zinc & Potassium;Ascorbex 500 Tab;Bio Flavono C Tab 100mg;Multivitamines Et Mineraux;Samson;Twin Ultra Liquid Orange Flavor;Virt-Pn;Se-Tan DHA;Vitamin C 400mg Tab;Paramettes Chewable Multivitamins Plus Iron;Ocuvel;Multi Vitamin & Minerals;P.R.O. Complex;INATAL Ultra;Ascorbic Acid 500mg;Formula Osg;Chelated Cal/mag/zn With Vitamins;Astral C Tab;Cal Mag Drink With Vitamin C;Vit C Chew Tab 250mg;Hi Potency B52 B Complex Tab;Multivitamines Pour Enfants (chewable Tablets);Ester-C Calcium Ascorbate Capsules;Avon Nutrivance Vitamin E Plus;EC + Complex;Super Stress Capsules;Vimeral Tab;Mega C 1000 Complex Tab 1000mg;Prenaissance;Ester-C Vitamin C With Calcium;Vitamin C Tablets Chewable 250mg;Tender Age Vit Adc Drops;Vitafol Plus;Vitamin C 500mg Tab;Multi-phyto Capsules;Timed Release Vitamin C Tablet With Bioflavanoids;B Complex Plus C 300mg Tab;Senior Multi One;Enrich Core Pack - Children Vitamin and Mineral Supplement;Iron Vitamins B6,b12,c,folic Acid Tab;Ester-C 500 mg;Prenatal Plus;Folcaps Omega-3;Vitamine C  500 Mg Raisin  -  Tablet;Complete Multivitamins and Minerals Tablets Timed Release;Formula Cw;PRENATE Enhance;Acetabolan-II Vitamin and Mineral Supplement;Hot Lemon for Colds Powder;C-500 Caplet;Energy 80 Prolonged Release Tab;Vitamin C 500mg With Non-medicinal Echinacea;Multivitamins and Multiminerals Formula Regular Tablet;Vitamins C Plus E W.beta Carotene and Se;Multiple Vitamins With Minerals Tablets;Feminique W Iron and Calcium Tab;Neo-vites & Minerals Tab;PNV Prenatal Plus Multivitamin;Extra Strength Pharmacitron;Tonimol Cap Liq;Vitamin C Tablets 500mg;Vitamin C Orange Chewable Tab 500mg USP;Vitamin C Tab 250mg;Liqui Vita;Paramettes Syrup;Vitamin B Complex Plus 300mg Vitamin C;No440 Cap;C-curity-vitamin C Cap;B C Antistress Cap;Prenate Star;CitraNatal DHA;Vitamin C Srt 1500mg;Virt-Vite Plus;Ester C Tab Chewable;Hvp Chelated Cal/mag With Zinc and Vitamins C and D;Vitamin C Tablets 1500mg Timed Release;Vtb Vitamin and Mineral Supplement;Virt-Pn DHA;Chewable Vitamin C 500mg;Sopalamine 3b Plus;Vitarich C;Fortamines-10 Comprimes;Women's Biomultiple Vitamin and Mineral Supplement;Vitamine C 500;Calcium Ascorbate Fcc;Replavite;Ester C;Multivitamins and Minerals for Women;Multiple Vitamins - Tablet;Cal-mag Vitamin C and Zinc Tab;Daily Balance Tab;Hi-potent-C - Cap;Paramettes Multivits Plus Iron Tab (teens);Folet One;C-1000 Tr Srt 1000mg;Kids Stuff With Iron Tablets;Triple-Vitamin Drops with Fluoride;Alkadrenergy Tablets;Folic Acid With Vitamin B12 and Vitamin C;Neutral C + Coenzyme Q10 Plus Vitamins & Minerals;Orti C;Orange C Tablets 150mg;Cal & Mag Hvp Chel Plus C Potass & Zinc Tab;Phytopure;Super C 1000mg;Tozal;Ester C Calcium Ascorbate Cap;Infants' Vitamin Drops;Vit C Ctr 500mg;Vitaday Tab;Vitamin C 500 Mg (mixed Citrus Flavour);Vitamin C Srt 1000mg;Vitamines Et Mineraux;Derma-force;Mega C500 Complex Tab 500mg;Wellness Formula;Childrens Chew Multi Vitamin Tab;Ester-C Calcium Ascor Tab;Poly Vi Flor Chewable Tab;Virt-PN Plus;C-1000 Tab 1000mg;Iron With Vitamins C and E - Tab;Kanga-V Multivitamins & Minerals;Iron Polysaccharides Folic Acid DHA;Hematogen Forte;Vitamin C Tab 500mg Chewable;Vitreat Chewable Vitamin Tab;TriAdvance;Folivane-PRx DHA;BABOR Baborganic Biological Enzyme Cleanser;Kanga-B Vitamin B Group + C;Chewable Multiple Vit Plus Iron for Children;Children's Chewable Multiple Vit.plus Iron;Vitamin C Sustained Release Tabs 1000mg;Vitamin C Tab USP;Formula 14 Dietary Supplement;Cell-wise;Pregvit Folic 5;Chewable Multivitamins Plus Iron;Vitamin C Tab 1000mg Timed Release;Vitamin C Tab 250mg USP;Spectrum 2 Cap;Vitamin C 1500mg Timed Release Tablet;Vitamune;Central-vite 18 Essential;B-complex With Vitamin C, Biotin, Folic Acid;C 350;EnLyte;Multi-Vitamin Fluoride;Coen.q10w.vit.c and E Beta-car.se Cu Zn Mn;Ester-C 600 mg;Liquid Vitamin C;PreferaOB ONE;Chewable Vitamin C Tab. 500 Mg Grape Flavour;Prenatal Vitamins Plus Low Iron;Stress Complex 600 Avec Vit E Cuivre Zinc;Stress Formula + Iron;C-crystals With Calcium;Ascorbic Acid Powder;Beminal With C Fortis Cap;C.A.G. Tab;Gesticare DHA;A & C Powder;PreQue 10;Vitamins A, C & E Cap.;Multiple Vitamins With Iron;Now Ester-C 1000;Vitamin C and Zinc Lozenges;PreNatal Vitamins Plus;N.U.T. Complex;Kamu Jay Multi Complex Tab;Calplus;Cellular Formula;C-rolla-250 Tab 250mg Chewable;Pregvit;Iron 25mg With Vit B-cmplx, Vit C, Cu & Mo;Dialyvite;Citron Chaud DM Cumberland Pws;Stress Formula;Trinatal GT;Kanga-kid Vitamin C;Vitreat Chewable Vitamins Plus Iron;Multi Vitamines - Liq;Acti-megascorb Crystals Pwr;Kidmag Vitamins W Magnesium Tab;Vitamin C Tablets Time Release 500mg;Release;Chelated Cal-mag(2:1)with Zn Vit.c and D;Vit C Tab 500mg;L.C. Supplement;Timedose Vitamin C 1000mg;Vitamine C 150 mg;Ce Vi Sol Dps;Pnv-dha;Vitamin C-force 1000mg Tablets;S.H. Drink Mix;B Stress C + Iron & Vite;Vitamin C 500mg Caps Time Release;Vitamine C Tab 100mg Masticables;Grippalin & C Tab;Iron Plus Tab;Poly-VI-sol Drops;Beta C and E Tab;Good Night/pm Formula Tab;Prenavite Tablets;Kenwood Liquid Supplement;Betacept Special Formula Vitamins Cap;Pregvit Folic 4;Time Release C 500mg;Forty Plus Vitamin Supplement;Vitamine C 1000mg-liq;Maximum Once A Day;B Complex With C 300mg Tab;C-force;Milk Calcium With Vitamins C, D, and Phosphorous;50 Plus;Ester C 500 Tab;Hot Lemon Relief Powder Regular Strength;FeRiva;Kanga C;NuFera;Formula Csp With Vitamins A C and Zinc Loz;healthy mamaBE WELL ROUNDED BE WELL ROUNDED;Fem - Protect;Multi #2;Foltabs Prenatal;Vitamin C 100mg Capsules;Women's Change Formula;C500 Tab;Multiple Vitamins W Minerals Tab;Citron Chaud DM Option + Pws;Stress B & C  Caplet;P.N. Vitamin-mineral Drink;Cedevita Plus Vitamin Supplement;Childrens Chewable Multiple Vitamins W.iron;Timed Release Ester-C 1000mg;Hot Lemon Relief-extra Strength Pck-pws;Multicaps;Fem - Pmt;Vit C Timed Release Tab 500mg;MaxFe;Hot Lemon Relief for Symptoms Of Cold and Flu;Stresstabs + Zinc-copper;Vitamin C Tab 250mg Chewable;Vitamine C Croquable Tab 500mg;Cda-21 Vitamins With Non-medicinal Probiotic Complex;Zinc 50mg W Vitamin C;Mega Capsules;Se-Care Chewable;Kids Stuff Tablets;Tri-Vit with Fluoride Drops;Kamu Jay Tab 150mg;Children's Chewable Multi-vitamin Complete With Minerals;Zinc-C-lozenges;Vitamin C Timed Release Tab 1000mg;Contac Extend-C Sustained Release Capsules;Fortamines 10 Capsules;Stress Tab With Iron and Vitamin E;Vitamin C 1000mg;Formula Imgrd - Tab;Vitamin C Tab 250mg Chewable Orange;Femitab Tab;Calcium Ascorbate Crystals Vitamin C 1gm/ml;Formula Hh;Scorbatate;Biovita;Sago-C-500 Tab 500mg;Adrenergy Tablets;Tonicol Et A-D-C Ampoules/comprimes;Usana Procosa Tablets;Vitamin C 250mg With Non-medicinal Rose Hips Dietary Supplement;Multiple Vitamin Tab;Cataplex C Tab 5.7mg;Lemon Time;B-plus - Tab;Vitamine C Tab 100mg;Multivitamines Plus Fer Pour Enfants (chewable Tablets);Formula Inf;Vitamin C 1000;Vita C 550 Ampoules Buvables 550mg/amp;Vitamin C 1000 Mg  -  Tablet;PNV-First;Usana Megavitamin Tablets - Tab;Mega 13 Multivitamin Formula;Phytomin-C 500 Tab 500mg;Formula No. 2 Plus K Liq;Vitamin C Ultra Fine Pwr 1000mg/tsp;V-Natal;Cell-wise Natural Source;Vitamin C 1500mg Time Released Srt;Chewable C Tab 100mg;Ester-C Tablet;Softgel Vit.c 200mg From Ester-C Br.ca Asc.;Time Rel Vit C Tab 1000mg;Folic Acid 1mg With C 20mg;Evc - Liq;VemaVite-PRx 2 with Fish-Based DHA;Ocuvite Tab;Ascor L 500;Liqud Vitamin C;Kama Caze Syrup;B Complex With C 550mg;Vitamin C and Calcium Tab;Itabs Plus;O-Cal FA multivitamin;Comprime De Vitamine C 250mg;C-Nate DHA;Stress Ctr Srt;C Forte;Ester-C With Non-medicinal Bioflavonoids, Quercetin, and Grape Seed Extract;Niferex;Ester C Powder;Adult Infuvite Multiple Vitamins;Phytomin C Tab 500mg;Prenate Pixie;Vitamin C 1000mg Dietary Supplement;Life Vit C Timed Release Tab 500mg;Vitamine C  250 Mg Masticable  -  Tablet;Hot Lemon Relief Pck-pws;Vitafol Caplet;Se-Natal One;Stress Vitamin B With C Complex Tablets;Prenatal Plus Multivitamin Plus DHA MiniCaps;Tar-end;Supplement De Multivitamines Infusion Arome Fruits Rouges;Food Nutrition Inc. Men's Vitamin and Mineral Supplement;Vitamin C Tab 1500mg Timed Release;Men's Biomultiple Vitamin and Mineral Supplement;Extra Once A Day;Vitaday Junior Tab;PNV Prenatal Vitamin;Viva Kids - Tab;Orifer F;Evc Liquid Vitamins A,c,b6 With Beta Caro&zn;Multivitamin;Escavite;Vitamin C 1000mg From Ester-C Brand Ca Asc.;Feminex 300 Tab;Multi Vitamin Drops with Fluoride with Iron;Vitamine C 100mg 5 Fruits-tab;B & J Formula Dietary Supplement;Prenatal Formula Tab;Original Bioscal Forte Multi-vitamin Supplement Capsules;Vit C Ctr 1000mg;Allbee C 800 Tab;Multiple Vitamin Plus Minerals Tab;Multi-12/k1 Pediatric;Powertech Vitamin and Mineral Supplement;Neo Citran A Powder;Mr. Tumee Multi-vitamin;Supplement De Vitamines Et Mineraux;Imm Formula Cap;Mega C 500 Complex;Garfield Chewable Multivits Plus Iron Tab;Kimchi Vitamin chewable multivitamin;One A Day Tab;Ascorbic Acid Cap 500mg;Procosa II;Buffered Vitamin C Plus Magnesium;Multi Vitamins & Minerals;Isotonix Multitech Vitamin Mineral Supplemen;Fib-C Melts;Vitamin C 1500mg - Tab;Multivitamine;Tropicana Vitamin C Supplement;Natelle One;Chela-manganese 50 Plus;Lipall Plus Tab;Reaphirm Plant Source DHA;Vitamin C 500 Mg With Rosehips;Children Choice Multivit Chewable Tab;Folic Acid & Vitamin C;C-500 Liq 50mg/ml;Iberet 500;Acetabolan III Vitamin and Mineral Supplement;Formula C-500 Caplet;Multivitamin Drops with Fluoride;B With C 500 Cap;Chewable Vit C 100mg;Vitamine C Tab 500mg;I-care Multivitamin and Multimineral Tablets;Now Ester-C Caps;Buffered Vitamin C Powder With Ca Mg and K;Gemvites Jr Tab Chewable;Sveets Orange Burst;Penta-thion Pwr;Vitamin C  Chew Sug Fr 500mg;C1000 W Flavanoids Tab;Stress Formula Tab;Nestabs ONE;Se-Tan PLUS;Floriva Plus;PrePLUS;G.A.S. Complex;Vitamin C 500mg;One A Day Multiple Vit W Minerals;Lipo-B-C Tab;Db-7 Dietary Supplement;Lysamine Diet Supp Amp-tab;One-A-day Advance Fem - Tablets;Multivitamins for Children;Bugs Bunny Chew Multi Vit Plus Iron;Cedevita Sugar-free Vitamin Supplement;Multi-actin;Vitamin C 600mg;Prenatal Mega Antioxidant;Sodium Ascor Crystal 888.8mg/gm USP;N.E.U. Complex;Hill.vite;Vitamin C;PNV Ferrous Fumarate Docusate Folic Acid;Multi-Vit with Fluoride;Fusion Activator Formula Tab;Dual Mix;Supravite Stress Avec Vit E Et Fer;Chewable Wafers Vitamin C 500 Mg  -  Tablet;Formula Cp Cap;Multivitamins W Minerals Extra Strength;Twin Ultra Liquid Lemon-lime Flavor;Vitamin C Ascorbic Acid Tab 1000mg;Strovite Forte Caplet;Complete Multivitamins and Minerals for Children;Multi-vitamin Dietary Supplement;PreTAB;Calcium Ascorbate Pwr;Children's Chewable Multiple Vitamins - Tab;Se-Natal 19 Chewable;Multi 1000;Cyruta Tab;Good Health Formula;Hot Lemon Cold and Flu Relief Extra Strength;Paramettes Beta Carotene With Vitamins C & E;Floriva;BioFerr 90;EnBrace HR;Bodysmarts With Vitamins A, C and E;Supravite Pour Enfants;Vitamin C & Zinc Tab;Multi Vite Liq Junior;Zoo Chews;PreferaOB One;Multi Vitamin Drops with Fluoride;Calmax;Virt-Bal DHA Plus;Liqui Infant Vitamins;Armax;Zinc With C Lozenge;Vitamin C 500mg Time Release;Vitamin C Tab 100mg Chewable;B Complex 500 Tab;Zinc Plus Extra C;Children Choice Multivitamin W Iron Chew Tab;Flintstones Multiple Vitamins;Niron Komplete;Prenatal Vitamins Plus;All Natural Source Juicy Orange Vitamin C;Prenatal Plus Iron;VP-HEME One;Redoxon-cal;Hematogen FA;Hot Lemon Relief for Symptoms Of Cold and Flu Regular Strength;Vitamin C Chewable 500mg;Vitamin C Tab 1000mg Chewable;Vitamin C 1000mg Cap;Formula Gly;C-plus - Tab;Allbee With Vitamin C Cap;Moviprep;Mvc;PreNatal 19;Z Bec Tab;Amd;Carbaway;Vitamin C 60mg;Vitogen B Stress C Vit E Zinc & Cop;C Wafer 500 Chewable 500mg;Calcium With Mg Zn Mn Cu CR Si and Vit. C & D;Super Daily No 2;Vitamin E + 3 Extra Strength With Zinc;Multi-12 Pediatric;Hot Lemon Relief - Extra Strength;Aces Formula/formule A A S;Vitamin C 250 Mg Chewable  -  Tablet;Dia-vite;Formule No 204 Profil Tab;Cmp Plex;Multi Nt-OX;Glyco-aide Tab;B-plex;Ultra Hr;Hematogen;Multra With Iron;Tianshi Beneficial Capsules;Vitafol OB Caplet;Ocuvite Vitamin and Mineral Supplement;Vitamin C Tablets Time Release 1000mg;Lexazin;L.G.I.T.;E.S.T. Complex;Vitamin C 1000mg Time Release Form;Stress Tab With Zinc, Copper and Vitamin E;Ascorbic 500 Tab 500mg;Pro-ace;Vitamin C Tab 1000mg USP;Tricare Prenatal;A/o-26 - Caplet;Ester-C Powder;Gnc Timed Release Vitamin C Tablets 500mg;Surbex 500 Filmtab;Vitamin C + Zinc Tab;Body Rox;Golf Vitamin and Mineral Supplement;Ascorbic Acid Tab 1000mg;FeRiva FA;Vitamin C Tab 100mg;Synergisti-C;Mr. Tumee Worms;C 500mg Ascorbic Acid;Multi-vitamines Enfants Comprime;Stress Formula Multi-B Comp + 500mg Vit C Cap;Vitamin C 500 Mg Chewable  -  Tablet;Diaplex;J.T. Formula;Vitamin C 500 Mg  Tab;Extra C 1000;Multiple Vitamins and Minerals Tab;Vitogen Multiple Vitamins W Iron;Multi-vitamins;Chewable Acerola C 500mg;Tri Adrenopan;Vitamin B Complex W C Tab;Chewable Vitamin C 500mg Tab;Hot Lemon Relief for Symptoms Of Cold and Flu Extra Strength;Now Ester-C Complex;C-B Complex;Hot Lemon Relief for Symptoms Of Cold and Flu Forte;Century Complete;Supravite Stress Avec Vit E;Vitamines Et Mineraux Enfants 970;Carti-aide Tab;Stress Formula B-comp + 500mg Vit C Tab;Vitamin C Crystals Pwr 4000mg/tsp;Cran C;Tri-VI-sol Drops;Vitamin C Tab 500mg USP;Tropicana Calcium and Vitamin C Supplement;Macuzin;MultiVitamin Drops with Fluoride and Iron;Vitamin B + C Cap;Childrens Chewable Multiple Vitamins;Zinc Lozenges With Vitamin C In A Nonmedicinal Base With Echinacea Lozenge;Vitamin B Complex W C 300mg Tab;Iron Plus Manganese, B12, Folic Acid & C;Children's Chewable Multi Vitamins With Iron Tablets;Pediatric Infuvite Multiple Vitamins for Infusion;Vitamine C - Liq Orl 50mg/ml;Children's Vitamins Chewable;Hot Lemon Relief for Cold Symptoms Pws;P.N.P. Vitamin Drink;Vitamin C Tablets USP 500mg;Chew.multiple Vits.with Extra C for Children;Vit B Complex Plus Vit C 550mg;Acti-scorb 1000 Caplet 1000mg;Effervescent Vit C 1000mg;Livron Plus Tab;Sun-rype Vitaburst;Ferralet 90;Vitamin C Crystals 5gm/5ml;Imedeen;Vitamin C Tablets 1000mg;Ester-C (1000 Mg);Mega C Acid Inj 500mg/ml;Vi-daylin Adc Vitamins Drops for Infants;Vitamin C 500mg Src Time Release;Vitamin C Timed Release Tab 1500mg;NataFort;Maxi 10 Tab;Concept DHA;Advanced B & T Formula;Vitamin B Complex Plus C 300mg Timed Release;For Kids Only Chewable Multivit. Plus Iron;Calcium Ascorbate Crystals 1250mg/0.25tsp;Duo Cvp Cap 200mg;Insur-all Vitamin Supplement;B Complex W C Forte Cap;Kindervites;Multivitamin with Fluoride;Chromagen;Multivitamins and Minerals for Young Women;Calcium With Vitamins C and D Tab;Prevital Tab;Tender Age Multi Vitamins;M.V.I. Adult;Vitamine C 500mg 5-fruits - Tab;Stress B-complex Plus Iron With Vitamins C&e;Guardyn Tab;Biovim Tab;C 500 Mg Chewable;Super 7 Vitamin and Mineral Supplement;Vigo Multivitamins Drops/lozenge;Vit C Sustained Release Tab 1000mg;PureVit DualFe Plus;Hi Potency Stress B Tension With C;Vita-worth Vitamin C Tablets 500mg;Multivitamines;Hemarexin Tab;Beta-carotene 10,000 Iu With Vitamins C & E;Prenatal, DHA;Total Living Concepts Formula One - Tab;Tri-Vitamin with Fluoride;Viamon Ampoules Et Comprimes;O-Cal Prenatal Vitamin;Obagi;Folic Acid 1mg With Vitamin C;Reebok;Fem - Control;Vitamin C 500mg Timed Release Tab USP;Vitafant;Zinc Lozenges With Vitamin C and Non-medicinal Echinacea;Daily Support C;Inatal Advance;Remedium - Liq Orl;Vitamin C Src 500mg Timed Release;Polymine Avec Zinc Et Cuivre;Vit C Chew Tab 500mg;Chewable Multiple Vitamins Tab;Vitamin C Calcium Pwr;Vitamin C Srt 1.5gm;Prenavite Forte Tablets;Revival 1 Tab;Ascorbic Acid Tab 250mg;Ocuvite Vitamin and Mineral Supplement Capsules;Timed Release and Esterified Vitamin C-500;Tropicana Calcium & Vitamin C Supplement;Supplement De Vitamine C;Synergistic Manganese Capsules;Ester C 1000mg;Vitalife  -  Capsule;MoviPrep;Vitamin C Powder;Neutral C + Coenzyme Q10 - Cap;Somavit Brand Vitamins and Minerals Complex;Revit Plus Cap;Se-Natal 19;PNV Prenatal Vitamin Plus Vitamin A;Vitamin C Tab 250mg Watkins;Super C Crystals W Calcium;Tricon;Children's Chewable Multi-vitamin;Ester C Vitamin C and Calcium Pws;Multi Vitamin with Fluoride;Active FE;Stress Tablets;Vitamin C 500mg Timed Release Tablets;Childrens Multiple Vit and Min Chew Tab;Myhephron Dialysis and Stress Supplement;Paramettes Chewable Multivits With Iron Tab;Ferra Naka Plus Vitamins;Supplements De Vitamines Et Mineraux;Vita Plex Tab;Vitafol One;Vitamine C Liq 500mg/10ml;C-apnto-B6 Vitamins W Magnesium Tab;Chewable Multiple Vitamins Plus Extra C;Sopalamine/3b Plus C;One A Day With Non-medicinal Echinacea;B Virol;Chewable Multiple Vitamins Plus Iron Tab;Multi-min Electro C Pow Plus B2;Betafant Tab;Neutral C With Echinacea & Lemon Bioflavonoids - Cap;Timed Release Vit. C-1000 Caplet;B Totum 500;Childrens Chewable Vitamin Tab;Hy C 3000 Anatabs;Vitamine C 1000 Action Prolongee;24 Multivitamins + Minerals;Bseltzer;Multivit Et Fer Ampoules Et Comprimes;Niacinamide 250mg With Vitamin C;Vita-Rx Diabetic Vitamin;Multi Vitamin - Mineral;C Vite 150 Tab 150mg;M.V.I. Paediatric;Mega-C-acid Plus;Vit C Chew Tab 300mg;Imm Formula;CitraNatal 90 DHA;Nighttime Extra Strength Contac Complete Cough, Cold & Flu Plus Vitamin C;Ascorbic Acid Inj 500mg/ml;Perfect Harvest;Croq-vit Pour Enfants;Childrens Chewable Multivitamins;Iron Complex;Multi - N.T.O.x Formula - Tab;Multivitamines Et Mineraux Junior Regulier;Prenavite Forte;Zinc With C - Loz;Ascorbic Acid Tab 500mg USP W Non-med Cherry;Betac Ascorbic Acid Injection, USP 500mg/ml;Multivitamins W Iron;Twin Ultra Liquid Fruit Punch Flavor;Somarexin and C 1000;Stress Formula Vit B With C Complex;B Complex With C 300mg;Concept OB;L.I.P. Complex;Children's Chewable Multiple Vitamins With Extra Vitamin C (chewable Tablets);Vitamin C Tablets Chewable 500mg;Vit.c With N-M.bioflav.rose Hips and Rutin;Stress B With 1000 Mg Vitamin C;Super C With Non-medicinal Rosehips Tab;Formula B;Osteo Tablets;Tl-hem 150;C Vite 100 Tab 100mg;Zinc Plus Lozenges;Multiple Vitamins Plus Iron Tab;PNV-Omega;Fizz Multivitamins for Kids W C Loz;Z-force Vitamin and Mineral Supplement;Formula O;Multivitamines Et Mineraux Reguliers / Regular Multivitamins and Minerals;Multivitamins and Minerals for Young Men;Munit-E Tablet;Ascorbic Acid Tab 250mg Orange Flavor;Infant Multivitamin Drops;Acti-scorb 500 Caplet 500mg;Triple Vitamin Drops with Fluoride;Phytoplex B Liq;Vitamin B Compound W C Tab 500mg;Ascor;Selenium Plus;Vitamin E + 3 (extra Strength);CitraNatal B-Calm;Children Vitamin Drops;Children's Chewable Multi Vitamins;Pediatric Infuvite Multiple Vitamins;Life Vit C Timed Release Tab 1000mg;Palm Springs Multvit and Min Tab;Stress Forte Plus Lipotropic Factors;Hot Lemon Extra Strength;Super Charged Energy;Multi-11;Vita Day Tab;Permathene-12  -  Caplet;Mvc 9 Plus 3 Inj;Hot Lemon Relief for Cold Symptoms Ext Str;Everyday Multiple Vitamins;Chewable Vitamin C 100mg;Formula Lf;Timed C 1000 + Caplet 1000mg;Ascorbic Acid Injection USP 500 mg/ml;Calcium Ascorbate Tab 550mg;Vit C Tab 1000mg;Vitamin B Cpd W Vit C Tab;Integra F;Vitamin C Tab 1000mg;Formula Im-vitamins and Minerals Tab;Vitamine C 1000 Tab 1000mg;Thiamine HCl 100mg W C 20mg;Rocky Mountain Oj's Chewable Vitamin C Tab;C.E.b12 Complex Pwr;Vitamin B Compound W Vit C 250mg Tab;Exitox Tab 200mg;Renal Caps Dialysis/Stress Vitamin Supplement;Carbassist Tablets;Nutrol C Cap 150mg;One A Day Advance Adults 50+;Vitalis;Zinc and Vitamin C Lozenges;Super B.P. Vitamin C;Calcium Ascorbate Pwr 1.3gm/1.25ml;Chewable Vitamin C Wafers 500mg;Multiple Vit Plus Iron Tab;MVC-Fluoride;Vege 1 Daily Tab;Hypo Vites Tab;Now;Vitafol Ultra;Vitamin C 250 mg;Total Flu;C 500 Complete Tab 500mg;Multiple Vitamins Plus Iron for Women;Onccor;Citron Chaud Cumberland Pws;Vitamine C  250 Mg USP  -  Tablet;Prenate Elite;Nexa Plus;Stress B Complex With C, E & Iron;Calcium Complex High Grade;Cataplex A-C Tab;Vitogen Multiple Vitamins Tab;Bev C 1725 Tab 1000mg;Vitamin C Tab 500mg;B Complex W Vit C W Non-med Yeast&liver Tab;Folic Acid Plus;Timed Release C 1000mg Tab;High Potency Vitamin B Complex + C Tab;Antlerviron;Children's Vitamins W Iron Chewable;Ester C Capsule;CitraNatal Bloom;Cold and Sinus;Kamu Jay Liq 300mg/tsp;Multi Vitamin and Fluoride;Multi Vitamin-mineral Formula;Super-pote Vitamin Supplement;Tri Vi Flor Tab;Thymunase Tab;Bacmin;Virt-Caps;Children Pediatric Vitamins Drops;Leritone Junior;Kid's Choice Children's Chewable Vitamins - Tab;Adc Comprimes;C 106 Tab;Timed Release C 1000mg Srt;Multivitamins and Minerals With Betacarotene Tablets;Effervescent Vitamin C Powder With Ca and mg;Formula A.R.-th Dietary Supplement;Multivitamins and Minerals - Complete;Nephrocaps;Supravite C 1000;50 Plus Multiple Vitamins & Minerals;Kanga Sport Vitamins B & C Plus Minerals;Vitamin C 500mg Timed Release;Pneumodyn Tab;PreNexa;Infantol Drops;Acti-MN + B1 + C Caplet;Mvc 9+4 Inj;Ester C 1000 mg;Vitamin C Tab 500mg Chewable Orange;Multivitamin with fluoride;Natura Magnesium Plus Vitamin C;C. Vit-min Formula;Multi-Vitamin With Fluoride;Vitamin C 500 Tab Chewable;Revit Tab;Mega C 500 Complex Tab 500mg;Vitamines Pour Bebes Et Enfants;Flinstones Multiple Plus Iron;Chewable Vitamin C Tab 250mg;Childrens Chewable Vitamins;Multi Vitamin Infusion;Vitamin C 250mg With Non-medicinal Echinacea & Lemon Bioflavonoids;Multi-fruits Chewable Vitamin C 500mg Tablet;Vasodyn Tab;Children's Chewable Tab;Zoo Chews Plus Iron;Children's Chewable Multi Vit W Iron;Nexa Select Rx Prenatal Vitamin with Plant-Based DHA;Gnc Timed Release Vitamin C 1500mg Tablets;Super C 500mg Tab;Vitamin C 1000mg Time Release;Calcium Ascorbate 1000 Mg  -  Tablet;Vitamin B Compound With Vitamin C Fortis Capsule Dtc;Beminal With C Fortis Pws;Efferlife Calcium 500mg + Vitamin D3 440 Iu + Vitamin C 125mg;Vitamin B Complex + C 600mg Tab;Multi Vitamin, Iron and Fluoride;Vitogen B Stress C600;Natural Source C 250 Tab 250mg Chewable;Vitamin C-force 500mg Tablets;Formula Fm Vitamins & Minerals Tab;Vitamine C Cap 500mg;Allbee With C 550 Cap;Dexatrim Tablets;Formula F.E.S. Vitamins Tab;Bio-cee Dietary Supplement;Infa Drops Multivitamins;Optivite Vitamin and Mineral Supplement Tablet;Chewable C Vitamin 300 Mg With Acerola;Zinc-C Lozenges;Citron Chaud Extra Fort;Multi-Vitamin;Opti-manganese + B1 + C Caplet;Multitabs;Kanga-kid Multi-vitamin & Mineral;UltimateCare ONE NF;Vitamin C Srt 500mg;Theraplex Acp;Mega-C-sodium Inj 250mg/ml;Am Caps;Maxaron Forte;Defense Caplets;Vit C Tab 250mg;Integra Plus;Childrens Chewable Multiple Vitamins Plus Fe;Stressmates;CitraNatal Rx;Ascorbic Acid Tab 100mg;Flintstones Multiple Vitamins Plus Iron;Formula Cn;Fortistress Tab;Mynephrocaps Dialysis/stress Vitamin Supplement;Orange Flavored Crystal Chews Tab;Vitamin C 1000mg W/rose Hips Timed Release Tablet;Vitamin C Crystals;Icaps;Pharmacitron;Multiple Vitamins Plus Iron - Tab;Tandem DHA;Vitamine C 500 Action Prolongee;Formula CF;Vitamin C 1000mg Timed Release Tablets;Super Pantoplex;Vitamin C 500mg (chewable Orange);Folcal DHA;Infuvite Adult Multiple Vitamins;Chewable Vitamin C 250 mg;Vitamin C 1000 Mg Timed Release  -  Tablet;Tri-Vit With Fluoride And Iron Drops;Multi Vitamin Plus Iron;Ester-C Calcium Ascorbate Tablets;Vitamin C Tablets 250mg;Only One - Tablet;C 1000;Children's Chewable Multiple Vitamins With Iron Tablets (chewable Tablets);Childrens Chewable Multiple Vitamins Tab;Neo Vites Tab;Vitamin C Timed Release Tab 500mg;Zymain Tab;Tgi Tab 50mg;Super-cell;Vitamine C Timed Release Tab 500mg;Ester-C 500mg;PM Caps;Maxi 6 Liq;Zinc Lozenges With Vitamin C;B-2 100mg With C 20mg;Icaps Time Release;B Complex W C and B12 Inj;Cal-mag Complete With Zinc, C and D;Flintstones Multiple Vitamins Tab;Now Ester-C Powder;Ester-C 500;Formula R Tab;Supravite Stress Avec Vit E Cuivre Et Zinc;Vitamin C Cap 1000mg;Sincera - Tablets;Natavite;Super Stress Mega B Plus 1000mg Vit C Tab;Efferlife Multivitamins and Minerals;Isotonix Atx Vitamin Mineral Formula;Vitamine C 100mg Tab Masticable;Chewable Vitamin C 250mg;Enzogenol;Animal Shaped Chew Vit C Tab 250mg;Q.T. Vitamin and Mineral Drink Mix;Ester-C;Mangadyn;Sveets;Vitachrom Gc;Vita C Tab 150mg;Women's Support Tablets;Fruity Bita C Tablets 125mg;Vitamine C  500 Mg USP  -  Tablet;Zinc Plus Vitamins C & B6 Lozenges;Vit C W Calc-mag and Potass Powder;Multivitamin and Mineral;Fero Grad 500;Buffered Vitamin C 1000mg;Ascorbate C-500;Ester - C;Hot Lemon Relief Regular Strength;C 3000;D Pantothenic 500mg With 100mg C;B.G. Plus Formula;M.V.I. 12;Extra P.N. Vitamin-mineral Drink Mix;Hot Lemon Relief Powder Extra Strength;Stress Formula Multivitamin Tablets USP;Stress B Complex With C, E and Iron Tab;Infant's Multiple Vitamin Drops;Vit-HA Multi Vitamin and Zinc Supplement;Cold & Flu;Multi Tabs;M.V.I. Pediatric;Surbex-500 With Iron;Everyday Multiple Vitamins With Iron;Premium Prenatal;Nutrol C Tab 150mg;Vitamin C 250mg With Non-medicinal Rose Hips;Vital Be-100;FE C Tab Plus;Gestamine Comprimes;Bio C 600 Tab;Enviroflex - Tab;Flintstones W Extra C Tab;Nutrilite Double X;Stress Tab;Timedose Vitamin C Tab 500mg;Multiple Vitamins With Iron Tablets;Vitaplex;Vita B + C 500 Tab;Hot Lemon Relief for Symptoms Of Cough and Cold;V-V Dietary Supplement;Vitamin C Tab 500mg Orange Flavor;Sustained Release Vitamin C 500mg;Vitamine C Tab 100mg USP;Calcium Ascorbate Ctr Srt 450mg;Dr Cellapy SR Premium;Mor-vites Tab;Childrens Chewable Multivitamins W Iron;Vitamin C 500mg Tablets;Multi Enfants Tab;Spd Tab;Formule 7561 Caps;Ascorbic Acid Tab 100mg Orange Flavor;Liquid Vitamin C 500mg;C Rola Tab 100mg;Cyroplex;Multi 12 Injection;Calcium Ascorbate 1000mg;E.V.C. Vitamins Tab;Multi-Vit with Fluoride and Iron;One A Day Advance Fem;Hot Lemon Regular - Pwr;B Complex W Vitamin C Fortis Cap;PNV-Select;Women's Formula;One A Day Advance Adults;FE C Tab;Chewable Vitamin C 100mg - Tab;Surbex-500 With Zinc;Folcaps Care One;Vitamines Et Mineraux Comprimes;Vitamin C 1000mg W/ Non-medicinal Echinacea;Triveen-PRx RNF;Soin Solaire Complete SPF30;Dynam Ampoule Et Tablet;B Plus C 300mg Timed Release;Ply Vi Sol Chewable Tab;Vitaflex Dietary Suplement;Formula Tc Vitamin C Tab 200mg USP;Multivitamins and Minerals for Men;Vitogen B Compound W C Fortis Capsules;Nata Komplete;Homosistrox Capsules;Stress B Complex With C and E Tab;Ascorbic Acid;Fortifi-plus;Orange Chewable;Buffered Vitamin C Pwr W Cal-mag-potassium;Natural Source Spectrum With Beta Carotene;Vitamin C 1000 Mg Chewable  -  Tablet;Chewable Vitamin C Tab 1000mg;Ester-C 787mg;Formula Cw-caplet;Super B Compound W 500mg Vit C;Extra-Virt Plus DHA;Super-A Vitamins With Selenium Dietary Supplement;Beminal W C Fortis Inj;Ester-C Calcium Ascorbate Tab;Floravit - Syr;Homosistrol Capsules;Calcium Magnesium Avec Vitamine C;Earthpals Children's Chewables Multi-vitamin & Mineral Tablets;Timed Release Vitamin C 500 mg;Neo Citran Powder;Formula Vitamin C Tab 15mg;Balance Ace - Cap;Hot Lemon Relief Powder;PRENATE Restore;Vitamin C 1000 mg;VITAMINS A, C, D and FLUORIDE;Natural Fruit Chew  C 250mg Tangy Orange Flavour;Calcium Ascorbate Tab 500mg;Chewable Vitamin C 250mg With Orange Juice;Formula # 2 Pwr 15mg/g;Reliv So Sense Daily Vitamin Supplement;Super Kids Chewable Multivitamin Multimineral (chewable Tablets);Vitamin C 500mg With Non-medicinal Rose Hips;Chewable Multivitamins;Vitamin C Extra Time Released Tab 1800mg;Vasula Tab;For Kids Only Chewable Multivitamins - Tab;C.H.V. Formula;Stress B Capsules With Vitamin C;Oncovite;Balanced B-complex Vit + Vit C&e Tab;Hot Lemon Cold and Flu Relief Regular Strength;Premium Prenatal - Tablets;Zinc With Vitamin C Lozenges;Vitamin C Tab 500mg Orange Flavoured Chewable;Vitamin C 350 Tab 350mg;Megavites Tab;Acerotab;Bugs Bunny and Friends Multiple Vitamins;Ascorbic Acid Tab 500mg;Children's Chewable Multiple Vitamins (chewable Tablets);Vitamine C Tab 250mg"	"DB00126;NUTR00001;APRD00084;EXPT00568;DB11167;DB11316;DB11170;DB09541;DB11317"	"2-(1,2-dihydroxyethyl)-4,5-dihydroxyfuran-3-one;2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one;2-(1,2-dihydroxyethyl)-4,5-dihydroxy-3-furanone;62624-30-0;89924-69-6;50-81-7;Oprea1_099167;EINECS 263-644-3;Vicomin C;LS-2352;NCGC00094971-01;ST040521;NCGC00094971-02;iso-Ascorbic acid;3-Keto-L-gulofuranolactone;3-Oxo-L-gulofuranolactone;AA;Adenex;Allercorb;Antiscorbic vitamin;Antiscorbutic vitamin;Arco-Cee;Ascoltin;Ascor-B.I.D.;Ascorb;Ascorbajen;Ascorbicap;Ascorbutina;Ascorin;Ascorteal;Ascorvit;C-Level;C-Long;C-Quin;C-Span;C-Vimin;Cantan;Cantaxin;Catavin C;Ce lent;Ce-Mi-Lin;Ce-Vi-Sol;Cebicure;Cebid;Cebion;Cebione;Cecon;Cee-Caps TD;Cee-Vite;Cegiolan;Ceglion;Celaskon;Celin;Cemagyl;Cemill;Cenetone;DL-Ascorbic acid;Cereon;Cergona;Cescorbat;Cetamid;Cetane-Caps TD;Cetemican;Cevatine;Cevex;Cevi-Bid;Cevimin;Cevital;Cevitamic acid;Cevitamin;Cevitan;Cevitex;Ciamin;Cipca;Citriscorb;Colascor;Concemin;Davitamon C;Dora-C-500;Hicee;Hybrin;IDO-C;Iron-ascorbic acid complexes;L(+)-Ascorbic acid;L-3-Ketothreohexuronic acid lactone;L-Ascorbic acid, iron(2+) salt;L-Ascorbic acid-iron complexes;L-Lyxoascorbic acid;L-Xyloascorbic acid;L-threo-Hex-2-enonic acid, .gamma.-lactone;Laroscorbine;Lemascorb;Liqui-Cee;Meri-C;NCI-C54808;NSC33832;Natrascorb injectable;Planavit C;Proscorbin;Araboascorbic acid;Araboascorbic acid, D-;D-ASCORBIC ACID, ISO;Scorbu-C;D-Erythorbic acid;D-Isoascorbic acid;D-erythro-Hex-2-enonic acid, .gamma.-lactone;Erycorbin;Erythorbic acid;Glucosaccharonic acid;Isoascorbic acid;Isovitamin C;Mercate ""5"";NSC8117;Neo-Cebicure;Saccharosonic acid;Vitamisin;Vitascorbol;WLN: T5OV EHJ CQ DQ EYQ1Q;Secorbate;Xyloascorbic acid, L-;component of Cortalex;component of Ferancee;Technetium-99 labeled ferrous ascorbate;Testascorbic;Vicelat;Redoxon;L-ascorbate;L-ascorbate (vitamin C);L-ascorbate acid;ascorbic acid;vitamin C;Viforcit;Viscorin;Vitace;Ribena;Vitacee;Vitacimin;Vitacin;SMP2_000183;Roscorbic;Xitix;ARONIS020784;NCI60_002981;NSC218455;Prestwick_683;HSCI1_000271"	"l-ascorbic acid;ascorbic acid;vitamin C;50-81-7;L-ascorbate;Ascorbicap;L(+)-Ascorbic acid;Cevitamic acid;ascorbate;Ascoltin;Hybrin;Allercorb;Ascorbajen;Ascorbutina;Ascorteal;Cescorbat;Cetemican;Cevitamin;Citriscorb;Laroscorbine;Lemascorb;Natrascorb;Proscorbin;Roscorbic;Secorbate;Testascorbic;Vitacimin;Vitamisin;Vitascorbol;Ascorin;Ascorvit;Cantaxin;Cebicure;Cebione;Cegiolan;Ceglion;Celaskon;Cemagyl;Cenetone;Cenolate;Cergona;Cetamid;Cevalin;Cevatine;Cevimin;Cevital;Cevitan;Cevitex;Colascor;Concemin;Redoxon;Vicelat;Viforcit;Viscorin;Vitacee;Vitacin;Adenex;Ascorb;Cantan;Cebid;Cebion;Cecon;Celin;Cemill;Cereon;Cevex;Ciamin;Cipca;Hicee;Ribena;Vitace;Xitix;Davitamon C;Arco-cee;Planavit C;Catavin C;Ce lent;Liqui-Cee;Vicomin C;Cee-Vite;Cevi-Bid;Scorbu-C;C-Level;C-Vimin;Cetane-Caps TD;Duoscorb;Scorbacid;Cewin;Antiscorbic vitamin;C-Long;C-Quin;C-Span;Meri-C;Cee-Caps TD;L-Lyxoascorbic acid;L-Xyloascorbic acid;Antiscorbutic vitamin;Cetane-Caps TC;Acidum ascorbinicum;3-Oxo-L-gulofuranolactone;Ce-Mi-Lin;IDO-C;Natrascorb injectable;Acidum ascorbicum;L-(+)-Ascorbic Acid;CE-VI-Sol;Ferrous ascorbate;Ascor-B.I.D.;Acido ascorbico;Acide ascorbique;Dora-C-500;Kyselina askorbova;3-Keto-L-gulofuranolactone;Ascorbicab;Cortalex;Ferancee;Stuartinic;Tolfrinic;Antiscorbutic factor;L-3-Ketothreohexuronic acid lactone;L-Threoascorbic acid;Chromagen;Magnorbin;Cetebe;Kyselina askorbova [Czech];Caswell No. 061B;Vicin;Acide ascorbique [INN-French];Acido ascorbico [INN-Spanish];Acidum ascorbicum [INN-Latin];Semidehydroascorbate;Sodascorbate;Ascorbicin;Magnesium Ascorbicum;(R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one;NCI-C54808;L-threo-Hex-2-enonic acid, gamma-lactone;L-threo-Ascorbic acid;cevibid;Ascorbinsaeure;Sunkist;Ascorbic Acid, Monosodium Salt;3-Oxo-L-gulofuranolactone (enol form);roscorbi c;Acid Ascorbic;UNII-PQ6CK8PD0R;Oral Vitamin C;ascor-b.i.d;Ascorbicap (TN);CCRIS 57;Ascoltin (TN);antiscorbic vita min;Ascorbin;FEMA No. 2109;component of Cortalex;component of Ferancee;HSDB 818;[14C]ascorbic acid;Ascorbic acid [BAN:INN:JAN];Ascorbic acid [INN:BAN:JAN];[14C]-ascorbic acid;Hex-2-enonic acid gamma-lactone, L-threo-;ascorbic acid (vit C);EINECS 200-066-2;NSC 33832;Iron(II) ascorbate;PQ6CK8PD0R;Iron-ascorbic acid complexes;L-3-ketothreohexuronic acid;component of E and C-Level;component of Endoglobin Forte;CHEBI:29073;Sodium Ascorbate (Ascorbic Acid);L-threo-hex-2-enono-1,4-lactone;L-Ascorbic acid, free radical form;(+)-Ascorbic acid;NCGC00164357-01;E300;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one;(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one;DSSTox_CID_106;DSSTox_RID_75370;Ascorbinsaure;DSSTox_GSID_20106;Kangbingfeng;Chewcee;Citrovit;Juvamine;Ceklin;CALCIUM ASCORBATE;Vasc;(+)-Sodium L-ascorbate;Rovimix C;Scorbu C;Parentrovite;Cell C;(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one;Viscorin 100M;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one;1-Xyloascorbic Acid;Ronotec 100;Suncoat VC 40;(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one;Rontex 100;Xyloascorbic acid, L-;89924-69-6;3-Keto-1-Gulofuranolactone;L-Ascorbic acid, meets USP testing specifications;2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one;Cevitamate;Ascor;L-lyxoascorbate;L-xyloascorbate;.Ascorbinsaure;vitamin-c;L-AscorbicAcid;Vitamin B mixture with vitamin C;3eka;cee-caps  td;Ester C;Ester-C;l-threo-hex-1-eofuranos-3-ulose;(+)-ascorbate;L(+)-ascorbate;L-(+)-ascorbate;Ascorbic acid [USP:INN:BAN:JAN];Ascorbic acid mixture with Vitamin B;Vitamin C,(S);E 300;178101-88-7;PubChem18445;Prestwick3_000325;L-Ascorbic acid, 99%;Ascorbic Acid mixture with Vitamin B Complex;SCHEMBL785;bmse000182;D06NNE;D07AHW;D0U4HT;Vitamin C (Ascorbic acid);AC1L1L4T;SCHEMBL4430;L-Ascorbic acid, FCC, FG;BSPBio_000329;KSC925A7P;MLS002153776;CHEMBL40274;AC1Q77S6;BPBio1_000363;GTPL4532;GTPL4781;L-Ascorbic acid, reagent grade;DTXSID5020106;L-Ascorbic acid, >=99.0%;CTK8C5077;134-03-2 (monosodium salt);BIA0602;Ascorbic acid (JP15/USP/INN);Ascorbic acid (JP17/USP/INN);CIWBSHSKHKDKBQ-JLAZNSOCSA-N;MolPort-001-792-501;ZX-AFC000785;HMS2096A11;HMS2231N16;HMS3713A11;154170-90-8;HY-B0166;KS-00000EU9;Tox21_110315;Tox21_112104;Tox21_202127;Tox21_302958;ANW-73969;gamma-lactone L-threo-Hex-2-enonate;L-Ascorbic acid, analytical standard;L-Ascorbic acid, AR, >=99.5%;LS-145;MFCD00064328;s3114;Tox21_112104_1;ZINC100006770;ZINC100019304;CCG-207946;DB00126;FCH1121413;L-Ascorbic acid, mixt. with vitamin B;RP23765;RTR-032643;VIT0000113;gamma-lactone L-threo-Hex-2-enonic acid;L-Ascorbic acid, ACS reagent, >=99%;NCGC00091517-01;NCGC00091517-02;NCGC00091517-03;NCGC00091517-06;NCGC00188972-01;NCGC00256504-01;NCGC00259676-01;14536-17-5;53262-66-1;AK-96407;BP-12831;SC-18563;SMR001233160;L-Ascorbic acid, plant cell culture tested;AB0010512;AB1002440;AX8021086;L-Ascorbic acid, reagent grade, crystalline;A0537;A8158;AB00376923;Ascorbic Acid (L-Ascorbic Acid; Vitamin C);E-300;ST24026436;L-Ascorbic acid, BioUltra, >=99.5% (RT);L-Ascorbic acid, tested according to Ph.Eur.;3466-EP2269610A2;3466-EP2269978A2;3466-EP2269985A2;3466-EP2269988A2;3466-EP2269991A2;3466-EP2270000A1;3466-EP2270002A1;3466-EP2270008A1;3466-EP2270011A1;3466-EP2270505A1;3466-EP2272516A2;3466-EP2272537A2;3466-EP2272822A1;3466-EP2272834A1;3466-EP2272835A1;3466-EP2272844A1;3466-EP2275413A1;3466-EP2277848A1;3466-EP2277865A1;3466-EP2281823A2;3466-EP2284149A1;3466-EP2284150A2;3466-EP2284151A2;3466-EP2284152A2;3466-EP2284153A2;3466-EP2284155A2;3466-EP2284156A2;3466-EP2284164A2;3466-EP2284171A1;3466-EP2284178A2;3466-EP2284179A2;3466-EP2287140A2;3466-EP2287148A2;3466-EP2287150A2;3466-EP2287153A1;3466-EP2287156A1;3466-EP2289510A1;3466-EP2289883A1;3466-EP2289890A1;3466-EP2289892A1;3466-EP2292227A2;3466-EP2292228A1;3466-EP2292592A1;3466-EP2292612A2;3466-EP2292617A1;3466-EP2295055A2;3466-EP2295401A2;3466-EP2295409A1;3466-EP2295416A2;3466-EP2295419A2;3466-EP2295426A1;3466-EP2295427A1;3466-EP2295435A1;3466-EP2298735A1;3466-EP2298742A1;3466-EP2298748A2;3466-EP2298768A1;3466-EP2298770A1;3466-EP2298776A1;3466-EP2301536A1;3466-EP2301538A1;3466-EP2301929A1;3466-EP2301931A1;3466-EP2301935A1;3466-EP2301940A1;3466-EP2305219A1;3466-EP2305257A1;3466-EP2305636A1;3466-EP2305637A2;3466-EP2305648A1;3466-EP2305651A1;3466-EP2305668A1;3466-EP2305674A1;3466-EP2305679A1;3466-EP2305683A1;3466-EP2308854A1;3466-EP2308857A1;3466-EP2308861A1;3466-EP2308867A2;3466-EP2308870A2;3466-EP2311453A1;3466-EP2311455A1;3466-EP2311805A1;3466-EP2311807A1;3466-EP2311809A1;3466-EP2311824A1;3466-EP2311839A1;3466-EP2311842A2;3466-EP2314295A1;3466-EP2314584A1;3466-EP2314585A1;3466-EP2314588A1;3466-EP2314589A1;3466-EP2314590A1;3466-EP2314593A1;3466-EP2316452A1;3466-EP2316457A1;3466-EP2316458A1;3466-EP2316470A2;3466-EP2316825A1;3466-EP2316826A1;3466-EP2316827A1;3466-EP2316828A1;3466-EP2316832A1;3466-EP2316833A1;3466-EP2316837A1;3466-EP2374792A1;3466-EP2377510A1;3466-EP2380568A1;C 1000;C00072;D00018;L-Ascorbic acid, p.a., ACS reagent, 99.0%;93398-EP2380568A1;AB00376923_04;AB00376923_05;L-Ascorbic acid, JIS special grade, >=99.0%;L-Ascorbic acid, Vetec(TM) reagent grade, 99%;L-Ascorbic acid, BioXtra, >=99.0%, crystalline;L-Ascorbic acid, puriss. p.a., >=99.0% (RT);L-Threoascorbic acid, Antiscorbutic factor, Vitamin C;L-Threoascorbic acid; Antiscorbutic factor; Vitamin C;47A605F0-4187-47A8-B0CE-F9E7DA1B0076;L-Ascorbic acid, p.a., ACS reagent, reag. ISO, 99.7%;Ascorbic acid, British Pharmacopoeia (BP) Reference Standard;Ascorbic acid, European Pharmacopoeia (EP) Reference Standard;L-Ascorbic acid, certified reference material, TraceCERT(R);L-Ascorbic acid, powder, cell culture tested, gamma-irradiated;3,4-Dihydroxy-5beta-[(S)-1,2-dihydroxyethyl]furan-2(5H)-one;Ascorbic acid, United States Pharmacopeia (USP) Reference Standard;L-Ascorbic acid solution, 1.0 mg/mL in acetonitrile: water, certified reference material;L-Ascorbic acid, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%;L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, >=98%;1018124-03-2;129940-97-2;259133-78-3;30208-61-8;50976-75-5;56172-55-5;56533-05-2;57304-74-2;57606-40-3;623158-95-2;882690-91-7;884381-69-5;885512-24-3;88845-26-5;L-Ascorbic Acid (Vitamin C)-13C6 solution, 500 mug/mL in acetonitrile: water, certified reference material, ampule of 1 mL;L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.7-100.5% (oxidimetric);L-Threoascorbic acid,Antiscorbutic factor,Vitamin C;(R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one;Valeryl fentanyl hydrochloride solution, 100 mug/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL"	50-81-7	PQ6CK8PD0R	23670640	23670640	01/05/2013	29011848	01/05/1939	Bef. 1989		0	0	0	No	0					28/07/1947	ROCHE	98,7	#N/A																							0						1
IPH 1101	"brhpp;bromohydrin pyrophosphate;iph 1101"		DB05754					20563721	20563721	01/06/2010	20563721	01/06/2010	2009-2012		1	1	0	Yes	1					30/07/2018		97,7	28	NA	1	0	NA	1	Vgamma9Vdelta2	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Selenic acid	sodium selenate	"Balance Ace - Cap;Optivite Vitamin and Mineral Supplement Tablet;Total Living Concepts Formula One - Tab;Ocuvite Tab;Super-A Vitamins With Selenium Dietary Supplement"	DB11068	"Selenic acid;141676-86-0;63090-47-1;CHEBI:18170;H2SeO4;[SeO2(OH)2];dihydroxidodioxidoselenium;481513_ALDRICH;Selenic acid solution;EINECS 231-979-4;HSDB 675;Selenic acid (H2SeO4);Selenic acid [UN1905]  [Corrosive];UN1905;C05697;Selenic acid"	"SELENIC ACID;7783-08-6;Selenic(VI) acid;CHEBI:18170;Selenic acid (H2SeO4);UNII-HV0Y51NC4J;HV0Y51NC4J;HSDB 675;EINECS 231-979-4;UN1905;Acid, Selenic;Selenate, Sodium;Selenate, Calcium;Monosodium Selenate;Selenate, Ammonium;Selenate, Disodium;Selenate, Magnesium;Selenate, Potassium;Selenate, Monosodium;selenic acid, calcium salt;selenic acid, ammonium salt;selenic acid, magnesium salt;selenic acid, potassium salt;SELENic acid ion;dihydroxidodioxidoselenium;H2SeO4;H2SO4e;selenic acid, disodium salt, 75Se-labeled;Selenic Acid aq. Soln.;AC1L1AP8;[SeO2(OH)2];O[Se](O)(=O)=O;CHEMBL2097002;DTXSID2064818;CTK2H8128;7783-21-3 (ammonium salt);7790-59-2 (potassium salt);14019-91-1 (calcium salt);14986-91-5 (magnesium salt);8698AF;BDBM50147596;AKOS025213270;Selenic acid [UN1905] [Corrosive];DB11068;RL05002;RTR-024857;Selenic acid [UN1905]  [Corrosive];LS-144791;FT-0695270;C05697;SELENIC ACID, 40% SOLN (SP GRADE -1.4);Selenic acid solution, 40 wt. % in H2O, 99.95% trace metals basis;141676-86-0;63090-47-1"	06/08/7783	HV0Y51NC4J	20648008	20648008	01/07/2010	20648008	01/07/2010	2009-2012		1	1	0	Yes	1					30/07/2018		96,8	19	NA	0	1	PROSTATE	1	PP2A	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	0	0	1
MLN8054	mln8054		"DB13061;DB05957"		"MLN8054;869363-13-3;MLN-8054;MLN 8054;UNII-BX854EHD63;BX854EHD63;CHEMBL259084;4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid;4-((9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)benzoic acid;4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid;4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzoic acid;4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,9,11,13-heptaen-4-yl]amino}benzoic acid;ZZL;Kinome_1204;D0A5MC;4-(9-chloro-7-(2,6-difluorophenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)benzoic acid;cc-475;MLS006011043;C25H15ClF2N4O2;SCHEMBL621589;GTPL5696;BDBM31093;CHEBI:91366;CTK3E6235;KS-00000XGQ;DTXSID10235987;cid_11712649;HHFBDROWDBDFBR-UHFFFAOYSA-N;MolPort-016-633-177;HMS3265K23;HMS3265K24;HMS3265L23;HMS3265L24;HMS3654C21;MLN8054/MLN-8054;2558AH;ABP000124;s1100;ZINC18825334;AKOS022177375;CS-0010;DB13061;KIN0000331;RL05388;NCGC00346488-01;4CA-0865;AJ-70670;Benzoic acid, 4-((9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-;HY-10180;SMR004700647;FT-0672434;W-5492;363C133;J-513180;US8853193, 32-40;BRD-K83963101-001-01-0;MLN 8054, MLN-8054, 869363-13-3;4-(9-Chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)benzoicacid;4-(9-Chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)benzoic acid;4-[[7-[2,6-bis(fluoranyl)phenyl]-9-chloranyl-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid"	869363-13-3	BX854EHD63	20607239	20607239	01/07/2010	20607239	01/07/2010	2009-2012		1	1	0	Yes	1					30/07/2018		96,8	61	NA	1	0	NA	1	AURORAK	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,05	0	0	0	SOMNOLENCE	1	0	0	0	1
Rucaparib	rucaparib	Rubraca	DB12332		"RUCAPARIB;283173-50-2;Rubraca;AG-14447;UNII-8237F3U7EH;Rucaparib (free base);8237F3U7EH;6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-;8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one;8-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-4,5-DIHYDRO-1H-AZEPINO[5,4,3-CD]INDOL-6(3H)-ONE;PF01367338;8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one;8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one;Rucaparib [USAN:INN];AG 014699;8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one;8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one;RPB;Rubraca (TN);Kinome_3180;Tube725;Rucaparib (USAN/INN);D01SHZ;Rucaparib(AG-014447);SCHEMBL844585;GTPL7736;CHEMBL1173055;CHEBI:94311;CTK4G1217;ZINC25958;DTXSID10182563;CHEBI:134689;HMABYWSNWIZPAG-UHFFFAOYSA-N;MolPort-028-744-762;BDBM50446130;HY-10617A;AKOS015898427;AG14447;CS-2785;DB12332;NCGC00263173-01;NCGC00263173-03;6H-Azepino(5,4,3-cd)indol-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-;6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-;AC-24390;AK317822;KB-73984;FT-0696622;PF 01367338;D10079;Z-3241;I10-0690;BRD-K88560311-011-01-4;8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON"	283173-50-2	8237F3U7EH	28882436	28882436	01/09/2017	19047122	01/12/2008	2004-2008		1	1	1	Yes	1	"06/04/2018 00:00;19/12/2016 00:00"	AP	CLOVIS ONCOLOGY INC	RUCAPARIB CAMSYLATE	19/12/2016	CLOVIS ONCOLOGY INC	96,4	33	NA	1	0	NA	1	PARP	0	1	1	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	791	0	1
Cevipabulin	"cevipabulin;tti 237;tti-237"		DB12533		"Cevipabulin;849550-05-6;UNII-P14M0DWS2J;P14M0DWS2J;TTI-237;TTI 237;Cevipabulin [INN];cevipabulin (tti-237);Cevipabulin(TTI 237);SCHEMBL4042827;CHEMBL1182714;AOB5715;DTXSID00233997;EX-A607;ZUZPCOQWSYNWLU-VIFPVBQESA-N;ZINC13981125;AKOS030526926;CS-4196;DB12533;BC600753;HY-14949;LS-194089;B5922;FT-0700375;550C056;J-690362;5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine;5-chloro-6-{2,6-difluoro-4-[3-(methylamino) propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine;5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine;5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(2S)-1,1,1-trifluoropropan-2-yl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine;5-chloro-6{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine"	849550-05-6	P14M0DWS2J	20697774	20697774	01/08/2010	20697774	01/08/2010	2009-2012		1	1	0	Yes	1					30/07/2018		95,7	28	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	1	0	0	1
Picropodophyllin	"axl1717;picropodophyllin"		DB12802	"(5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofurano[5,6-f][1,3]benzodioxol-8-one;477-47-4;17434-18-3;NCGC00161923-01;Spectrum5_000631;SPBio_000479;Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.alpha.,8a.alpha.,9.alpha.)]-;NSC36407;WLN: T E5 C665 FVO NO PO OHTT&&J DR CO1 DO1 EO1& JQ;SDCCGMLS-0066757.P001;KBio3_002701;5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(.alpha.-5a.alpha.,8a.alpha.,9.alpha.)];AIDS-006792;AIDS006792;Picropodophyllin;Spectrum4_001836;KBioSS_002116;Spectrum_001636;BSPBio_003481;Spectrum3_001671;KBio2_002116;KBio2_004684;KBio2_007252;KBioGR_002538;IGF-1R Inhibitor, PPP;Insulin-like Growth Factor-1 Receptor Inhibitor;SPECTRUM1504410;BRN 0099161;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-;NSC 36407;Picropodophyllin (8CI);Picropodophyllotoxin;Spectrum2_000520"	"Picropodophyllin;Picropodophyllotoxin;477-47-4;AXL1717;Picropodophyllin (PPP);IGF-1R Inhibitor, PPP;NSC 36407;UNII-0F35AOI227;AXL1717 (Picropodophyllotoxin);NSC36407;17434-18-3;BRN 0099161;CHEBI:75251;0F35AOI227;C22H22O8;Insulin-like Growth Factor-1 Receptor Inhibitor;(5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-;4354-76-1;AXL 1717;Spectrum_001636;Picropodophyllin (8CI);Spectrum2_000520;Spectrum3_001671;Spectrum4_001836;Spectrum5_000631;AC1L2I2M;BSPBio_003481;KBioGR_002538;KBioSS_002116;SCHEMBL159598;SPECTRUM1504410;SPBio_000479;CHEMBL283120;GTPL7873;KBio2_002116;KBio2_004684;KBio2_007252;KBio3_002701;DTXSID80197245;MolPort-003-665-514;YJGVMLPVUAXIQN-HAEOHBJNSA-N;HMS1923O05;KS-00000TA3;ZINC4098919;CCG-39920;IN1989;NSC-36407;s7668;AKOS015965529;CS-1184;DB12802;SDCCGMLS-0066757.P001;NCGC00161923-01;NCGC00161923-02;NCGC00161923-04;AC-20289;AJ-48021;HY-15494;LS-70860;SC-94922;X1203;Picropodophyllotoxin, >=96% (HPLC), powder;W-5271;BRD-K81829253-001-02-9;BRD-K81829253-001-03-7;Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer;WLN: T E5 C665 FVO NO PO OHTT&&J DR CO1 DO1 EO1& JQ;(10R,11S,15R,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0?,?.0??,??]hexadeca-1(9),2,7-trien-12-one;(5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one;(5R,5aS,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one;(5R,5aS,8aR,9R)-9-Hydroxy-5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)furo[3 inverted exclamation marka,4 inverted exclamation marka:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one;(5R,5aS,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one;5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(.alpha.-5a.alpha.,8a.alpha.,9.alpha.)];Furo[3',7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.alpha.,8a.alpha.,9.alpha.)]-"	477-47-4	0F35AOI227				20698809	01/08/2010	2009-2012		1	1	0	Yes	1					30/07/2018		95,7	4	NA	1	1	SNSCLC	1	IGF1R	0	1	0	NA	0	0	0	1	NA	NA	0	NA	0	1	0	0	0	0	0	0	0	0	1
Mitoxantrone	"mitoxantrone;pegylated liposomal mitoxantrone;plm60-s"	"1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione;Mitoxantrona;Mitoxantrone;Mitoxantrone Hydrochloride;Mitoxantrone Injection;Mitoxantrone Injection USP;Mitoxantronum;Novantrone;Novantrone Inj 2mg/ml;mitoXANTRONE"	"APRD00371;DB01204"	"1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;137635-96-2;70945-62-9;IDI1_000516;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-;Spectrum4_000866;Prestwick2_000385;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-;DHAQ;Mitoxantrone (free base);NSC279836;KBio2_004703;MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE;DivK1c_000516;NCGC00015693-01;1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone;1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione;1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon;5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI);C11195;Mitoxantrone;CCRIS 7604;Mitoxanthrone;Mitoxantron;Mitoxantrona [INN-Spanish];Mitoxantronum [INN-Latin];Mitozantrone;NSC 279836;AIDS-005213;Prestwick1_000385;NINDS_000516;CAS-70476-82-3;NCGC00015693-02;SPBio_002490;KBioGR_001531;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;KBio1_000516;SMP2_000179;Spectrum5_001205;NCI60_002535;KBioSS_002135;Prestwick0_000385;Spectrum2_000908;KBio3_002660;1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE;ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-;Spectrum_001655;Lopac0_000779;BPBio1_000627;BRN 2795126;1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone;AN-584/42007670;KBio2_002135;Dihydroxyanthraquinone;Spectrum3_001590;KBio2_007271;BSPBio_003160;Neuro_000153;SPBio_000756;1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione;70476-82-3 (DIHYDROCHLORIDE);70711-41-0 (DIACETATE SALT);Prestwick3_000385;AIDS005213;DHAQ (*Diacetate salt*);NSC299195 (DIACETATE SALT);NSC301739 (DIHYDROCHLORIDE);BSPBio_000569;NChemBio.2007.10-comp17;Lopac-M-6545;NCI60_002276"	"mitoxantrone;65271-80-9;Mitoxanthrone;Mitozantrone;Dihydroxyanthraquinone;DHAQ;Mitoxantron;Novantrone;Mitoxantrona;Mitoxantronum;Mitoxantronum [INN-Latin];Mitoxantrona [INN-Spanish];Mitoxantrone [INN];NSC 279836;UNII-BZ114NVM5P;DHAD;Mitoxantrone 2HCl;NSC279836;Misostol (TN);Mitoxantrone (INN);CCRIS 7604;DHAQ HCl;C22H28N4O6;Mitoxantrone (free base);NSC-279836;DHAQ (*Diacetate salt*);BRN 2795126;nimitoxantron;BZ114NVM5P;1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone;5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone;1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione;1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;MLS002703044;Mitozantrone hydrochloride;1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon;CHEBI:50729;KKZJGLLVHKMTCM-UHFFFAOYSA-N;1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE;1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone;Liposome Encapsulated Mitoxantrone (LEM);NSC299195;NSC301739;NSC-299195;NSC-301739;1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione;1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-;ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-;AN-584/42007670;MIX;Novantrone(R) (mitoxantrone for injection concentrate);MLS001333711;1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione;MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE;MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE;NCGC00015693-02;SMR000058480;Mitoxantrone [INN:BAN];CAS-70476-82-3;Misostol;SR-01000076001;2fum;1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione;Novantrone (TN);NSC-301739D;Immunex (Salt/Mix);NSC-287836;Spectrum_001655;AC1L1HNY;CHEMBL58;Prestwick0_000385;Prestwick1_000385;Prestwick2_000385;Prestwick3_000385;Spectrum2_000908;Spectrum3_001590;Spectrum4_000866;Spectrum5_001205;Lopac-M-6545;D0R3JB;cid_4212;Neuro_000153;SCHEMBL3000;BIDD:PXR0181;Lopac0_000779;BSPBio_000569;BSPBio_003160;KBioGR_001531;KBioSS_002135;DivK1c_000516;SPBio_000756;SPBio_002490;BPBio1_000627;GTPL7242;DTXSID4046947;BDBM67690;cid_5458171;CTK8A5416;KBio1_000516;KBio2_002135;KBio2_004703;KBio2_007271;KBio3_002660;70711-41-0 (acetate);MolPort-003-849-239;NINDS_000516;70476-82-3 (hydrochloride);HMS2090D05;HMS3655E20;KUC108634N;EBD32557;ZINC3794794;CCG-36371;CM0184;s1889;STK631833;Mitoxantrone hydrochloride (Salt/Mix);AKOS005564036;API0003408;BCP9000931;CS-2524;DB01204;KSC-19-204;MCULE-5513787065;IDI1_000516;SMP2_000179;NCGC00015693-01;NCGC00015693-03;NCGC00015693-04;NCGC00015693-05;NCGC00015693-06;NCGC00015693-08;NCGC00162251-01;AN-14761;AN-38696;AS-35321;BC651765;HY-13502;K061;LS-20638;NCI60_002276;NCI60_002535;SC-22733;SMR001549953;SBI-0050757.P003;TX-017756;AB00053716;FT-0630752;VU0244399-2;71M809;C11195;D08224;13181-EP2270008A1;13181-EP2270505A1;13181-EP2272827A1;13181-EP2275420A1;13181-EP2277876A1;13181-EP2289892A1;13181-EP2292617A1;13181-EP2295055A2;13181-EP2295412A1;13181-EP2295413A1;13181-EP2295416A2;13181-EP2295426A1;13181-EP2295427A1;13181-EP2298748A2;13181-EP2298764A1;13181-EP2298765A1;13181-EP2301928A1;13181-EP2305642A2;13181-EP2305660A1;13181-EP2311453A1;13181-EP2311808A1;13181-EP2311829A1;13181-EP2311837A1;13181-EP2311840A1;13181-EP2311842A2;13181-EP2316832A1;13181-EP2316833A1;13181-EP2316834A1;AB00053716-18;AB00053716-19;AB00053716-22;AB00053716_23;AB00053716_24;SR-01000076001-7;BRD-K21680192-001-01-5;BRD-K21680192-001-11-4;BRD-K21680192-300-05-2;BRD-K21680192-300-07-8;BRD-K21680192-300-09-4;BRD-K21680192-300-10-2;BRD-K21680192-300-12-8;1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone;1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone;1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone;9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-;1,4-Bis[[2-[(2-hydroxyethyl)amino]ethyl]imino]-1,4-dihydroanthracene-5,8,9,10-tetrol;1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI);1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride;137635-96-2;70945-62-9;9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI);Mitozantrone|||Novantron|||CL-232325|||1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione"	65271-80-9	BZ114NVM5P	"10854132;25034977;7573726;8890711"	7573726	01/10/1995	7460190	01/01/1980	Bef. 1989		0	1	1	Yes	1	"04/02/2000 00:00;24/03/2017 00:00;13/01/2003 00:00;19/02/1992 00:00;23/12/1987 00:00;08/05/1997 00:00;23/09/1994 00:00;22/02/1990 00:00;05/12/2012 00:00;31/03/2009 00:00;27/04/2005 00:00;08/05/1998 00:00;11/02/2009 00:00;23/03/2012 00:00;17/03/1988 00:00;26/11/1990 00:00;13/10/2000 00:00;12/11/2009 00:00;14/05/2008 00:00;11/04/2006 00:00;13/04/2009 00:00;20/08/2009 00:00;10/04/1995 00:00;19/10/2000 00:00;30/07/1990 00:00;13/08/1998 00:00;31/01/2001 00:00;13/06/2010 00:00;13/11/1996 00:00;20/02/2002 00:00;19/09/1997 00:00;26/04/2011 00:00;23/05/1997 00:00;01/06/2015 00:00;30/01/2015 00:00;14/11/2012 00:00;11/04/2007 00:00;05/12/2014 00:00;11/12/2012 00:00;18/10/1996 00:00;09/02/2001 00:00;13/11/2012 00:00;15/04/1994 00:00"	AP	"TEVA PHARMS USA;FRESENIUS KABI USA;MYLAN LABS LTD;WEST-WARD PHARMS INT;MYLAN INSTITUTIONAL;EMD SERONO;FRESENIUS KABI ONCOL;SERONO INC;HOSPIRA"	MITOXANTRONE HYDROCHLORIDE	23/12/1987	EMD SERONO	95,5	9	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,3	0	NA	0	NA	0	0	0	0	0	0	120	0	1
Radium Ra 223 Dichloride	"bay 88-8223;bay88-8223;racl2;radium ra 223 dichloride;xofigo;²²³ra-dichloride;²²³racl2"	"RADIUM CHLORIDE RA-223;Radium-223 chloride;Radium-223 dichloride;Radium Ra-223 dichloride;Xofigo"	"DB08913;DB05677;DB09566"			444811-40-9	RJ00KV3VTG	"24562070;23653243"	23653243	01/05/2013	15958630	01/06/2005	2004-2008		1	1	1	Yes	1					15/05/2013	BAYER HLTHCARE	95,2	25	NA	0	1	"BREAST;PROSTATE"	0	NA	0	1	0	NA	0	0	0	1	0	0,6	0	0	0	NA	0	0	0	0	0	0	21	0	1
Farletuzumab	farletuzumab	Fareletuzumab	DB05595			896723-44-7	2O09BG0OWA	"25380636;22955257;20855460"	20855460	01/09/2010	20855460	01/09/2010	2009-2012		1	1	0	Yes	1					30/07/2018		94,7	25	NA	0	1	OVARIAN CANCER	1	FOLATE RECEPTOR	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,36	0	0	0	0	0	0	26	0	1
Saracatinib	saracatinib		DB11805		"Saracatinib;379231-04-6;AZD0530;AZD-0530;Saracatinib (AZD0530);AZD 0530;UNII-9KD24QGH76;9KD24QGH76;CHEMBL217092;N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine;Q-201699;H8H;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine;nchembio866-comp19;Saracatinib [USAN:INN];4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline;2h8h;Saracatinib,AZD0530;Saracatinib (USAN/INN);cc-81;D0M0XB;Saracatinib - AZD0530;Saracatinib, AZD 0530;SCHEMBL41547;MLS006011166;SARACATINIB, FREE BASE;GTPL7731;QCR-70;BDBM12255;KS-00001CQC;AOB1916;DTXSID90191355;MolPort-008-155-961;OUKYUETWWIPKQR-UHFFFAOYSA-N;BCPP000364;HMS3265E21;HMS3265E22;HMS3265F21;HMS3265F22;HMS3654K03;EBD54002;EX-A1576;ABP000854;AN-592;ZINC24811973;AKOS005145757;AC-5249;API0006245;BCP9000358;CS-0101;DB11805;RL03446;Saracatinib, AZD-0530, AZD0530;NCGC00241099-01;NCGC00241099-03;AS-16692;BC656814;HY-10234;KB-80481;SC-22885;SMR004702935;AZD0530/Saracatinib,AZD0530 difumarate;BCP0726000126;AB0030444;LS-193231;FT-0657225;X2639;AZ-10353926;D09664;W-5405;231S046;A823939;I14-1980;BRD-K19540840-001-05-2;4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-;N-(5-chloranyl-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(4-oxanyloxy)-4-quinazolinamine;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-amine;N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4-amine"	379231-04-6	9KD24QGH76	20805299	20805299	01/09/2010	20805299	01/09/2010	2009-2012		1	1	0	Yes	1					30/07/2018		94,7	81	NA	1	0	NA	1	SRC	0	1	1	51	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
TAS-106	"3'-c-ethynylcytidine;tas-106"	"4-Amino-1-((2R,3R,4R,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one;3'-C-Ethynylcytidine"	DB06656	"4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2-pyrimidinone;4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidin-2-one;180300-43-0;1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine;TAS 106;TAS-106;2(1H)-Pyrimidinone, 4-amino-1-(3-C-ethynyl-.beta.-D-ribofuranosyl)-;3'-C-Ethynylcytidine;AIDS-241582;AIDS241582;ECyd"	"ethynylcytidine;ECyd;180300-43-0;TAS-106;3'-C-Ethynylcytidine;UNII-Y3O05I09ZK;3'-ethynylcytidine;ETHYNYCYTIDINE;cytidine, 3'-c-ethynyl-;Y3O05I09ZK;4-Amino-1-((2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;NSC722662;TAS 106;AC1L42EV;SCHEMBL543763;CHEMBL573352;JFIWEPHGRUDAJN-DYUFWOLASA-N;ZINC3813525;AKOS025290187;API0015752;PB24694;4-Amino-1-((2R,3R,4R,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one;AK172331;AS-35187;HY-16200;CS-0006185;Q-4368;1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine;2(1H)-Pyrimidinone, 4-amino-1-(3-C-ethynyl-.beta.-D-ribofuranosyl)-;4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;4-amino-1-[(2R,3R,4S,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one"	180300-43-0	Y3O05I09ZK	"22593447;20839029"	20839029	01/09/2010	20839029	01/09/2010	2009-2012		1	1	0	Yes	1					30/07/2018		94,7	30	NA	1	0	NA	1	RNA POLYMERASE	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Testosterone	testosterone	"Testosteron;Testosterona;Testosteronum;Mertestate;17beta-hydroxy-4-androsten-3-one;17beta-Hydroxy-4-androsten-3-one;Testostérone;Virosterone;4-androsten-17β-ol-3-one;Intrinsa;Fortesta;Testosterone;Taro-testosterone Gel;Striant;Testim;Axiron;Testopel;Vogelxo;Androderm;Malogen Aqueous 100 Sus 100mg/ml;Natesto;Livensa;Testim 1%;Androgel"	"DB00624;APRD00433;DB05720;DB05275"	"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;58-22-0;Androst-4-en-17beta-ol-3-one;(17beta)-17-Hydroxyandrost-4-en-3-one;17-Hydroxy-(17-beta)-androst-4-en-3-one;17-Hydroxy-(17beta)-androst-4-en-3-one;17-beta-Hydroxy-delta(sup 4)-androsten-3-one;17-beta-Hydroxyandrost-4-en-3-one;17beta-Hydroxy-delta(sup4)-androsten-3-one;17beta-Hydroxyandrost-4-en-3-one;17beta-Hydroxyandrost-4-ene-3-one;7-beta-Hydroxyandrost-4-en-3-one;9-beta,10-alpha-ANDROST-4-EN-3-ONE, 17-beta-HYDROXY-;AA 2500;Andro 100;Oreton;Androderm;Andropatch;Perandren;Androst-4-en-3-one, 17-beta-hydroxy-;Androst-4-en-3-one, 17-hydroxy-, (17-beta)-;Androst-4-en-3-one, 17-hydroxy-, (17beta)-;Androst-4-en-3-one, 17beta-hydroxy-;CCRIS 574;CDB 111C;COL 1621;CP 601B;Cristerone T;EINECS 200-370-5;HSDB 3398;LibiGel;Malestrone (amps);NSC 9700;Neo-testis;Oreton-F;Relibra;Sustason 250;Testim;Testoderm;Testogel;Testoject-50;Testosterona [INN-Spanish];Testosterone [Androgenic steroids, anabolic];Testosterone [BAN:INN];Testosterone and its esters;Testosterone hydrate;Testosteronum [INN-Latin];delta(sup 4)-Androsten-17(beta)-ol-3-one;delta4-Androsten-17beta-ol-3-one;Androderm (TN);Androgel (TN);D00075;Striant;Striant (TN);Testim (TN);Testosterone (JAN/USP);ZINC03814409;17beta-Hydroxy-3-oxo-4-androstene;46923_RIEDEL;LMST02020002;Testosterone;  4-Androsten-17?-ol-3-one;  17?-Hydroxy-4-androsten-3-one;BB_NC-0117;T1500_SIGMA;17b-hydroxy-4-androsten-3-one;4-androstene-17beta-ol-3-one;Halotensin;Virilon;c1014;delta4-androsten-17b-ol-3-one;T5411_SIGMA;Testosterone solution;4-androsten-17beta-ol-3-one;CHEBI:17347;Androlin;Andronaq;Andrusol;Cristerona T;Geno-cristaux Gremy;Homosteron;Homosterone;Malerone;Malogen, aquaspension injection;Mertestate;Orquisteron;Percutacrine androgenique;Primotest;Primoteston;Sustanone;Synandrol F;Teslen;Testandrone;Testiculosterone;Testobase;Testopropon;Testosteroid;Testosteron;Testostosterone;Testoviron Schering;Testoviron T;Testrone;Testryl;Virormone;Virosterone;trans-Testosterone;TES;AIDS-070519;AIDS070519;Androst-4-en-3-one, 17-hydroxy, (17.beta.)-;DEA No. 4000;(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;S00309;NCGC00091018-01;beta testosterone;CMC_13449;Testolin;AndroGel;17beta-Hydroxy-4-androsten-3-one;C00535;Testosterone;Testro AQ"	"testosterone;58-22-0;Testosteron;Androderm;Mertestate;Sustanon;Testoderm;Virosterone;Androlin;Oreton;Testim;AndroGel;Synandrol F;Testosteroid;Andronaq;Andropatch;Andrusol;Homosteron;Homosterone;Malerone;Orquisteron;Perandren;Primotest;Primoteston;Sustanone;Testandrone;Testobase;Testogel;Testopropon;Testoviron;Testrone;trans-Testosterone;Relibra;Teslen;Testryl;Testiculosterone;Cristerona T;Cristerone T;Testoviron T;Testosteronum;Testostosterone;Neotestis;Testosterona;Testoviron Schering;Geno-cristaux gremy;LibiGel;17beta-Hydroxyandrost-4-en-3-one;Neo-Hombreol F;Oreton-F;Testoject-50;Striant;Testolin;Andro 100;Testosterone hydrate;Percutacrine androgenique;Neo-testis;Sustason 250;Testoderm Tts;beta testosterone;Malestrone (amps);Intrinsa;Virormone;Malogen, aquaspension injection;Testosteronum [INN-Latin];Testosterona [INN-Spanish];Testro AQ;Androst-4-en-17beta-ol-3-one;Testopel Pellets;Oreton F;CDB 111C;Testosterone and its esters;17beta-Hydroxy-4-androsten-3-one;7-beta-Hydroxyandrost-4-en-3-one;COL 1621;delta4-Androsten-17beta-ol-3-one;17beta-Hydroxyandrost-4-ene-3-one;17-beta-Hydroxyandrost-4-en-3-one;Halotensin;Androsorb;Testaqua;4-Androsten-17beta-ol-3-one;CP 601B;T-Cypionate;Testosterone [INN:BAN];Malogen in Oil;Virilon IM;17-Hydroxy-(17beta)-androst-4-en-3-one;17beta-Hydroxy-delta(sup4)-androsten-3-one;delta(sup 4)-Androsten-17(beta)-ol-3-one;Testrin-P.A;17-Hydroxy-(17-beta)-androst-4-en-3-one;Androderm (TN);UNII-3XMK78S47O;Androgel (TN);Andronate 100;Andronate 200;Andropository 200;CCRIS 574;Striant (TN);Testamone 100;17-beta-Hydroxy-delta(sup 4)-androsten-3-one;AA 2500;Androst-4-en-3-one, 17beta-hydroxy-;Testim (TN);Androst-4-en-3-one, 17-hydroxy-, (17beta)-;Everone 200;Androst-4-en-3-one, 17-beta-hydroxy-;Andryl 200;CHEBI:17347;HSDB 3398;Scheinpharm Testone-Cyp;Testred Cypionate 200;NSC 9700;EINECS 200-370-5;Testosterone (JAN/USP);(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;(17beta)-17-Hydroxyandrost-4-en-3-one;3XMK78S47O;Testosterone [Androgenic steroids, anabolic];4-androstene-17beta-ol-3-one;17b-hydroxy-4-androsten-3-one;delta4-androsten-17b-ol-3-one;MUMGGOZAMZWBJJ-DYKIIFRCSA-N;Androst-4-en-3-one, 17-hydroxy-, (17-beta)-;17beta-testosterone;CMC_13449;Androst-4-en-3-one, 17-hydroxy-, (17b)-;Fortesta;Nasobol;Natesto;Vogelxo;Axiron;Tefina;CompleoTRT;Androgel 1%;17.beta.-Testosterone;SMR000058344;Bio-T-Gel;Androgel 1.62%;Androst-4-en-3-one, 17-hydroxy-, (17.beta.)-;Androst-4-en-3-on-17B-ol;CHEMBL386630;component of Duogen (Salt/Mix);component of Tostrex (Salt/Mix);component of Di-Met (Salt/Mix);component of Intrinsa (Salt/Mix);4-Androsten-17.beta.-ol-3-one;4-Androsten-3-one-17.beta.-ol;Tlando;component of Di-Genik (Salt/Mix);4-Androsten-3-one, 17b-hydroxy-;Testosterone [USP:INN:BAN];component of Mal-O-Fem (Salt/Mix);LPCN 1021;Testosterone, 1;3kdm;17-.beta.-Hydroxyandrost-4-en-3-one;NCGC00091018-01;CPD000058344;Testosterone solution;Axiron (TN);mpp10;17.beta.-Hydroxy-.DELTA.4-androsten-3-one;Androderm, Delatestryl;17-Hydroxyandrost-4-en-3-one, (17.beta.)-;Testosterone, >=98%;DSSTox_CID_2371;D06XMU;Epitope ID:135865;EC 200-370-5;AC1L1LM0;SCHEMBL8452;4-androsten-17-ol-3-one;DSSTox_RID_76563;DSSTox_GSID_22371;MLS000563091;MLS001032098;MLS001306401;MLS001424262;MLS002174283;BIDD:ER0555;BDBM8885;GTPL2858;17-Hydroxy-4-androsten-3-one;DTXSID8022371;17beta-hydroxy-4-androsten-3one;Testosterone, cell culture tested;1i37;HMS2052N11;HMS2272B03;HMS2272P03;(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;17beta-Hydroxy-3-oxo-4-androstene;Tox21_200689;HY-15554A;LMST02020002;RB3046;AKOS015894897;ZINC118912393;CCG-101189;CS-1415;DB00624;MCULE-1294118086;NC00439;RP29985;CAS-58-22-0;Testosterone 1.0 mg/ml in Acetonitrile;(17?)-17-Hydroxyandrost-4-en-3-one;NCGC00258243-01;AC-14899;AN-23597;BC208298;SC-15109;SMR001261453;Testosterone, purum, >=99.0% (HPLC);LS-148813;Testosterone 100 microg/mL in Acetonitrile;BIM-0061761.0001;C00535;D00075;S00309;W-5033;AB00973630-03;Testosterone, VETRANAL(TM), analytical standard;003T654;Androst-4-en-3-one, 17-hydroxy, (17.beta.)-;C-18145;Q-101251;B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E;Testosterone, European Pharmacopoeia (EP) Reference Standard;(8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one;Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard;Testosterone;  4-Androsten-17?-ol-3-one;  17?-Hydroxy-4-androsten-3-one;Testosterone for impurity D identification, European Pharmacopoeia (EP) Reference Standard;Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard;(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one;(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;1050678-68-6;Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material"	58-22-0	3XMK78S47O	21385795	21385795	01/03/2011	21019393	01/02/1946	Bef. 1989		0	0	1	No	0	"09/01/2017 00:00;28/02/2000 00:00;18/09/2009 00:00;04/08/1998 00:00;10/08/2006 00:00;15/09/1972 00:00;16/07/1974 00:00;15/07/2010 00:00;04/04/2018 00:00;27/02/2014 00:00;24/12/1953 00:00;26/02/2016 00:00;28/01/1985 00:00;20/04/1993 00:00;28/10/2015 00:00;08/10/1998 00:00;03/02/2015 00:00;24/07/1972 00:00;28/04/1998 00:00;23/10/1989 00:00;08/09/2015 00:00;16/10/1986 00:00;17/08/2015 00:00;25/08/1997 00:00;15/08/1994 00:00;17/04/1991 00:00;28/11/1986 00:00;10/03/2011 00:00;13/04/2018 00:00;29/06/1998 00:00;07/05/2002 00:00;15/04/1991 00:00;16/10/1996 00:00;22/04/1997 00:00;14/12/1999 00:00;03/11/1992 00:00;10/02/1987 00:00;15/11/1982 00:00;05/04/2000 00:00;12/05/1997 00:00;23/11/2010 00:00;14/06/1988 00:00;09/12/2016 00:00;11/12/1991 00:00;20/08/1996 00:00;28/05/2002 00:00;15/05/1991 00:00;17/12/1997 00:00;20/09/2012 00:00;27/03/2017 00:00;11/06/2015 00:00;19/11/2012 00:00;20/10/2011 00:00;31/03/2011 00:00;14/11/2014 00:00;03/12/1973 00:00;09/11/1983 00:00;17/07/1986 00:00;06/03/1989 00:00;21/11/2014 00:00;24/07/1990 00:00;16/06/2017 00:00;02/02/1977 00:00;07/07/1983 00:00;27/01/1983 00:00;26/07/2016 00:00;01/05/2012 00:00;31/10/1988 00:00;30/11/2011 00:00;08/05/1992 00:00;25/07/2007 00:00;05/08/2015 00:00;12/03/2013 00:00;02/08/1988 00:00;22/10/2002 00:00;10/01/1989 00:00;05/11/2015 00:00;02/08/1979 00:00;10/03/2016 00:00;07/05/1992 00:00;29/04/1982 00:00;03/11/2003 00:00;11/07/1991 00:00;12/05/2016 00:00;01/02/1991 00:00;30/08/2013 00:00;24/03/1993 00:00;05/09/1984 00:00;05/05/1997 00:00;04/06/2014 00:00;16/08/2005 00:00;28/08/1996 00:00;30/04/1986 00:00;24/02/1995 00:00;25/05/1989 00:00;03/06/2013 00:00;21/03/2014 00:00;02/02/1999 00:00;19/05/2006 00:00;04/03/1992 00:00;17/11/2014 00:00;18/03/1998 00:00;05/09/2001 00:00;18/08/1989 00:00;09/04/2015 00:00;31/07/1985 00:00;08/03/2002 00:00;30/04/2015 00:00;26/11/2013 00:00;28/02/2017 00:00;09/12/1991 00:00;08/12/1997 00:00;03/02/2017 00:00;05/01/1988 00:00;30/07/1981 00:00;20/09/1991 00:00;07/03/2007 00:00;15/04/1998 00:00;25/09/2015 00:00;07/08/2017 00:00;23/05/2007 00:00;23/01/2017 00:00;29/04/2011 00:00;27/12/2007 00:00;19/10/2000 00:00;25/01/2017 00:00;10/04/1989 00:00;28/06/1985 00:00;15/07/2015 00:00;22/11/1982 00:00;30/06/1994 00:00;04/12/1996 00:00;14/02/2012 00:00;09/02/1981 00:00;18/12/1997 00:00;26/01/2017 00:00;01/07/1988 00:00;20/07/2015 00:00;21/09/2015 00:00;02/05/1974 00:00;05/03/2014 00:00;29/09/1995 00:00;27/10/2016 00:00;11/05/1989 00:00;30/04/1997 00:00;08/08/1994 00:00;19/06/2018 00:00;26/09/2003 00:00;11/08/2005 00:00;28/05/1996 00:00;31/07/2014 00:00;13/03/1986 00:00;14/06/2006 00:00;19/01/1990 00:00;27/03/1991 00:00;10/05/1993 00:00;19/11/2004 00:00;29/10/1997 00:00;03/07/2002 00:00;04/11/2002 00:00;17/02/2015 00:00;11/05/2015 00:00;05/05/1989 00:00;25/10/2016 00:00;03/11/1982 00:00;16/02/1990 00:00;24/03/2014 00:00;15/04/1982 00:00;27/01/2006 00:00;13/08/1999 00:00;23/05/2002 00:00;22/11/2011 00:00;22/03/1990 00:00;15/07/1977 00:00;08/03/1983 00:00;24/01/2018 00:00;13/07/2000 00:00;31/10/2002 00:00;04/06/1982 00:00;17/10/2016 00:00;29/05/1985 00:00;04/08/2015 00:00;24/07/1989 00:00;02/01/2014 00:00;13/07/2017 00:00;28/05/2014 00:00;09/08/2001 00:00;02/11/1989 00:00;19/04/1999 00:00;24/11/1982 00:00;06/07/1988 00:00;07/05/1981 00:00;21/12/1988 00:00;10/03/2000 00:00;11/09/1984 00:00;03/03/2015 00:00;25/08/2015 00:00;11/06/1985 00:00;13/07/1972 00:00;16/07/1991 00:00;15/07/1994 00:00;09/08/2002 00:00;07/06/2000 00:00;07/05/1998 00:00;08/05/2017 00:00;29/05/2013 00:00;14/12/1998 00:00;15/01/2014 00:00;09/10/1991 00:00;12/07/2017 00:00;11/09/2013 00:00;12/10/1993 00:00;16/06/2004 00:00;05/10/2009 00:00;07/09/2012 00:00;13/06/1980 00:00;18/09/2015 00:00;29/06/1982 00:00;22/02/1996 00:00;09/06/1986 00:00;01/02/1980 00:00;07/04/1992 00:00;12/08/2016 00:00;19/03/2009 00:00;17/02/1988 00:00;06/01/2009 00:00;29/12/2010 00:00;01/11/1982 00:00;21/12/1992 00:00;31/12/1997 00:00;22/12/2011 00:00;05/10/1988 00:00;13/12/2007 00:00;21/06/1974 00:00;03/05/1996 00:00;13/01/1983 00:00;10/12/1980 00:00;03/08/1993 00:00;16/01/2014 00:00;30/04/1998 00:00;01/05/2014 00:00;18/09/2017 00:00;23/06/1982 00:00;02/09/2015 00:00;26/04/2012 00:00;25/07/1979 00:00;02/05/1997 00:00;05/11/1982 00:00;28/11/1989 00:00;11/12/2006 00:00;10/09/1984 00:00;31/12/1996 00:00;31/01/1984 00:00;23/06/1986 00:00;09/10/1998 00:00;14/10/2016 00:00;27/11/2002 00:00;26/06/1996 00:00;23/12/1988 00:00;18/09/2012 00:00;01/08/2016 00:00;29/05/1992 00:00;20/11/1992 00:00;23/01/2001 00:00;01/09/1987 00:00;08/10/1976 00:00;19/06/2014 00:00;03/04/2000 00:00;24/10/2000 00:00;22/06/1989 00:00;08/04/1996 00:00;27/06/2001 00:00;17/09/2003 00:00;31/01/2005 00:00;19/06/2003 00:00;23/07/2014 00:00;10/07/1996 00:00;18/08/1998 00:00;23/10/2017 00:00;17/10/1974 00:00;20/05/2013 00:00;10/09/1986 00:00;30/03/1993 00:00;06/06/2002 00:00;01/05/2015 00:00;24/05/1991 00:00;12/03/1990 00:00;18/12/1990 00:00;19/05/1982 00:00;22/07/2015 00:00;14/07/2006 00:00;31/01/2013 00:00;30/06/2015 00:00;18/09/2002 00:00;20/07/1989 00:00;13/06/1984 00:00;28/02/2014 00:00;05/07/1991 00:00;05/11/2004 00:00;29/01/2018 00:00;05/05/1986 00:00;09/09/2013 00:00;16/07/1984 00:00;02/05/1986 00:00;15/01/2002 00:00;19/02/1999 00:00;03/08/1982 00:00;13/03/2013 00:00;12/11/2014 00:00;12/10/1990 00:00;23/06/1978 00:00"	"AP;TA"	"ABBVIE;AUXILIUM PHARMS LLC;UPSHER-SMITH LABS;LUPIN ATLANTIS;ALLERGAN SALES LLC;AYTU BIOSCIENCE INC;IMPAX LABS;PADDOCK LLC;BEL MAR;PERRIGO UK FINCO;ALZA;WEST-WARD PHARMS INT;INWOOD LABS;ENDO PHARMS INC;IMPAX LABS INC;PHARMACIA AND UPJOHN;KV PHARM;SAVAGE LABS;STAR PHARMS FL;LANNETT;ENDO PHARMS;WATSON PHARMS INC;AUXILIUM PHARMS INC;WATSON LABS;ELI LILLY AND CO;LUITPOLD PHARMS INC;ACTAVIS LABS UT INC;SANDOZ INC;PADDOCK LABS;SUN PHARM INDS LTD;PERRIGO ISRAEL;#N/A;HIKMA FARMACEUTICA;MYLAN INSTITUTIONAL;TABLICAPS;VALEANT PHARM INTL;PAR PHARM;ANI PHARMS INC;NEXUS PHARMS;VALEANT PHARMS NORTH"	"ESTRADIOL VALERATE; TESTOSTERONE CYPIONATE;TESTOSTERONE ENANTHATE;METHYLTESTOSTERONE;TESTOSTERONE UNDECANOATE; TESTOSTERONE ENANTHATE;TESTOSTERONE;ESTRADIOL CYPIONATE;TESTOSTERONE PROPIONATE;TESTOSTERONE CYPIONATE"	24/12/1953	ENDO PHARMS	94,5	#N/A																							0						1
Conatumumab	conatumumab		DB11646		"Conatumumab;New analgesic drugs;D00WME;D04RDE;D0VX6J;AZD1940"	896731-82-1	1P48L61KM0	"21161528;20947515"	20947515	01/10/2010	20947515	01/10/2010	2009-2012		1	1	0	Yes	1					30/07/2018		93,7	37	NA	1	1	"COLORECTAL;NSCLC"	1	HDR5	0	1	1	17	0	0	0	1	0	0,06	0	0	0	0,41	0	0	0	0	0	0	25	0	1
Barasertib	"azd1152;barasertib"		DB11747		"Barasertib;AZD1152;722543-31-9;AZD-1152;957881-03-7;UNII-16XC2U7W8N;AZD1152 (Barasertib);16XC2U7W8N;CHEMBL415049;2-(ETHYL(3-((4-((5-(2-((3-FLUOROPHENYL)AMINO)-2-OXOETHYL)-1H-PYRAZOL-3-YL)AMINO)QUINAZOLIN-7-YL)OXY)PROPYL)AMINO)ETHYL DIHYDROGEN PHOSPHATE;5-[[7-[3-[Ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide;2-(Ethyl(3-((4-((3-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-5-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl dihydrogen phosphate;3-[[7-[3-[Ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-5-acetamide;Barasertib [INN];2-{ethyl[3-({4-[(5-(2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate;2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate;Kinome_3324;PubChem16656;D0Q7RE;SCHEMBL613582;GTPL7332;SCHEMBL16671950;DTXSID00222583;MolPort-044-561-175;BCPP000362;AOB87338;CS-D0326;ABP000116;BDBM50241089;ZINC43129461;AKOS022175627;AZD1152/AZD-1152/;AN-1226;BCP9000360;CS-0978;CS-W000582;DB11747;AZD1152, 33;AS-17018;HY-10127;KB-65305;DB-074538;A9414;FT-0662378;FT-0736007;W-5588;543E319;881A037;S14-2315;1H-Pyrazole-3-acetamide, 5-((7-(3-(ethyl(2-   (phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-N-(3-fluorophenyl)-;1H-Pyrazole-3-acetamide,5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-;2-(ethyl(3-(4-(5-(2-(3-fluorophenylamino)-2-oxoethyl)-1H-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl dihydrogen phosphate;2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate;2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxo-ethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate;2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate;2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)proplyl]amino}ethyl dihydrogen phosphate;2-ethyl3-4-5-2-3-fluorophenylamino)-2-oxoethyl)-1H-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl dihydrogen phosphate;936487-68-2;N-(3-Fluorophenyl)-3-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propyloxy]quinazoline-4-yl]amino]-1H-pyrazole-5-acetamide"	722543-31-9	16XC2U7W8N	"21565405;20924078"	20924078	01/10/2010	20924078	01/10/2010	2009-2012		1	1	0	Yes	1					30/07/2018		93,7	59	NA	1	0	NA	1	AURORAK	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,25	0	0	0	0	0	0	0	0	1
Idarubicin	idarubicin	"4-Demethoxydaunorubicin;4-Demethoxydaunomycin;Idarubicinum;5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-;Idarubicina;Idarubicine;(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;Idamycin - Cap 10mg;Idamycin Powder -10mg/vial;Idamycin - Cap 5mg;Aj-idarubicin;Idamycin Pws 10mg/vial;Idarubicin Hydrochloride;Idamycin Powder  -5mg/vial;Idamycin PFS;Idamycin Pws 5mg/vial;Idarubicin;Idarubicin Hydrochloride Injection;Idamycin - Cap 25mg"	"DB01177;APRD00126"	"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;Lopac0_000600;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;AIDS-156185;4-DMD;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-;57852-57-0 (HYDROCHLORIDE);KBioSS_002388;AIDS156185;NSC256439 (HYDROCHLORIDE);EU-0100600;(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;CHEBI:42068;(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione;DMDR;I1656_SIGMA;IMI-30;DM5;4-Demethoxydaunomycin;4-Demethoxydaunorubicin;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-;5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-;CCRIS 5083;Daunomycin, 4-demethoxy-;IDARUBICIN;Idarubicina [INN-Spanish];Idarubicine [INN-French];Idarubicinum [INN-Latin];NSC 256439;NSC-256439;(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;MLS000759470"	"IDARUBICIN;58957-92-9;4-Demethoxydaunorubicin;Idarubicina;4-Demethoxydaunomycin;Idarubicinum;Idarubicine;Idamycin;Idarubicin Hcl;Idarubicine [INN-French];Idarubicinum [INN-Latin];Idarubicina [INN-Spanish];Idarubicin [INN:BAN];IMI 30;IMI-30;4-Desmethoxydaunorubicin;Daunomycin, 4-demethoxy-;UNII-ZRP63D75JW;Idarubicin (INN);Idarubicin Hcl Pfs;Zavedos (TN);Zavedos;NSC-256439;CCRIS 5083;4-DMD;ZRP63D75JW;CHEBI:42068;demethoxydaunorubicin;5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-;Idamycin PFS;Idamycin (TN);DMDR;I 1656;(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;DM5;MLS001401448;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-;C26H27NO9;NCGC00093976-03;SMR000466355;SR-01000075934;(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione;D01XDL;AC1L28SA;AC1Q6JJ4;SCHEMBL3750;CHEMBL1117;Lopac0_000600;KBioSS_002388;Idarubicin hydrochloride, solid;cid_636362;GTPL7083;DTXSID7023142;IDARUBICIN(Hydrochloride form);BDBM58490;MolPort-006-167-730;XDXDZDZNSLXDNA-TZNDIEGXSA-N;BCPP000207;HMS2089D05;HMS3261H22;ZINC3920266;Tox21_500600;AKOS015895563;AC-9384;API0002970;BCP9000773;CCG-204689;DB01177;LP00600;NCGC00093976-01;NCGC00093976-02;NCGC00093976-04;NCGC00093976-05;NCGC00261285-01;57852-57-0 (HYDROCHLORIDE);AN-11145;CC-29462;LS-94015;SC-17016;EU-0100600;FT-0621481;D08062;Z-3092;15158-EP2270008A1;15158-EP2272827A1;15158-EP2275420A1;15158-EP2277879A1;15158-EP2280012A2;15158-EP2281815A1;15158-EP2289892A1;15158-EP2292615A1;15158-EP2292617A1;15158-EP2295055A2;15158-EP2295416A2;15158-EP2295426A1;15158-EP2295427A1;15158-EP2298748A2;15158-EP2298764A1;15158-EP2298765A1;15158-EP2301928A1;15158-EP2301933A1;15158-EP2305640A2;15158-EP2305642A2;15158-EP2305671A1;15158-EP2308833A2;15158-EP2308855A1;15158-EP2311453A1;15158-EP2311808A1;15158-EP2311825A1;15158-EP2311827A1;15158-EP2311829A1;15158-EP2311842A2;15158-EP2316832A1;15158-EP2316833A1;AB00698511-06;AB00698511-08;AB00698511-09;AB00698511-10;AB00698511_11;957I929;A832088;C-22925;I06-1097;SR-01000075934-1;BRD-K69650333-001-01-1;BRD-K69650333-001-02-9;BRD-K69650333-003-14-0;Idarubicin, United States Pharmacopeia (USP) Reference Standard;(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside;(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside;(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(7S,9S)-9-acetyl-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride;(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;4-Demethoxydaunorubicin|||IMI-30|||NSC-256439|||(7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-"	58957-92-9	ZRP63D75JW	"27342239;26750985;24738629;8916310"	8916310	01/10/1996	6962779	01/12/1982	Bef. 1989		1	1	1	Yes	1	"22/04/1998 00:00;29/06/1993 00:00;14/12/2006 00:00;27/09/1990 00:00;29/03/2011 00:00;11/10/2002 00:00;21/11/2000 00:00;15/05/2007 00:00;11/09/1997 00:00;25/04/1995 00:00;17/09/1996 00:00;12/08/1999 00:00;02/04/2002 00:00;01/05/2002 00:00;30/09/2002 00:00;11/10/2012 00:00;01/05/2003 00:00;17/02/1997 00:00;07/04/2000 00:00;31/05/2000 00:00;07/01/1991 00:00;22/11/2011 00:00;05/11/2002 00:00;04/12/2014 00:00;04/08/2009 00:00"	AP	"SANDOZ;TEVA PHARMS USA;FRESENIUS KABI USA;MYLAN LABS LTD;WEST-WARD PHARMS INT;TEVA PARENTERAL;PHARMACIA AND UPJOHN"	IDARUBICIN HYDROCHLORIDE	27/09/1990	PHARMACIA AND UPJOHN	93,7	16	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	394	0	1
Navitoclax	navitoclax		"DB12340;DB05764"		"Navitoclax;ABT-263;923564-51-6;ABT 263;ABT263;UNII-XKJ5VVK2WD;ABT-263 (Navitoclax);XKJ5VVK2WD;Navitoclax (ABT-263);CHEMBL443684;(R)-4-(4-((2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide;4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-morpholin-4-yl-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide;4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide;Navitoclax [USAN:INN];S1001_Selleck;ABT-263 Navitoclax;ABT-263,Navitoclax;ABT263, Navitoclax;PubChem16672;Navitoclax (USAN/INN);ABT-263 - Navitoclax;D06ETI;MLS006011021;SCHEMBL522847;C47H55ClF3N5O6S3;GTPL8319;DTXSID2042640;CHEBI:94128;CTK8E8268;KS-00001COV;NOCAS_42640;AOB1912;EX-A055;MolPort-006-391-499;ABT-263(Navitoclax)/ABT263;ABP000127;BDBM50270877;s1001;AKOS015896297;ZINC150338726;AN-1321;DB12340;RG-7433;RL05817;NCGC00188344-01;NCGC00188344-02;NCGC00188344-03;NCGC00188344-05;4CA-0894;AS-16690;BC660006;HY-10087;KB-79259;SMR004702817;AB0008156;AB1010838;RT-011151;FT-0658020;X7535;A10937;D09935;564A516;I06-2050;J-519525;BRD-K82746043-001-01-1;BRD-K82746043-001-02-9;BRD-K82746043-001-03-7;BRD-K82746043-001-04-5;A-855071.0;(R)-4-(4-((2-(4-Chlorophenyl)-5,5-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)p;(R)-4-(4-((4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfon;(R)-4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide;1000696-69-4;4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-trifluoromethanesulfonylbenzenesulfonyl)benzamide;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-mo;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide;ABT 263;Benzamide, 4-(4-((2-(4-chlorophenyl)-5,5-dime;4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(1R)-3-morpholino-1-(phenylsulfanylmethyl)propyl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonyl-benzamide;ABT-263|||4-[4-[[2-(4-Chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide;Benzamide, 4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(4-morpholinyl)-1-((phenylthio)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)-;N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethyl-cyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-4-((r)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-3-trifluoromethanesulfonyl-benzenesulfonamide"	923564-51-6	XKJ5VVK2WD	"22184378;21094089"	21094089	01/11/2010	21094089	01/11/2010	2009-2012		1	1	0	Yes	1					30/07/2018		92,7	55	67	0	1	LYMPHOID MALIGNANCIES	1	"BCL2;BCL-XL"	0	1	0	NA	0	0	0	1	1	0,22	0	0	0	NA	0	ARRHYTHMIA	1	0	0	0	21	0	1
LY2181308	"gataparsen sodium;ly2181308"		DB05141		"Gataparsen [USAN:INN];LY 2181308;LY-2181308;1065019-70-6;LY2181308;1107664-45-8"			21079959	21079959	01/11/2010	21079959	01/11/2010	2009-2012		1	1	0	Yes	1					30/07/2018		92,7	14	73	1	0	NA	1	SURVIVIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,08	0	0	0	0	0	0	0	0	1
Ipilimumab	"bms-734016;ipilimumab;mdx-010"	"MDX-CTLA-4;MOAB-CTLA-4;MDX-010;MDX-101;Yervoy"	DB06186			477202-00-9	6T8C155666	"28729151;26873574;26534966;25034862;24145345;23924790;23833564;23535954;22878899;22326924;19808874"	19808874	01/10/2009	12826605	01/07/2003	1999-2003		1	1	1	Yes	1	"26/10/2012 00:00;16/03/2015 00:00;16/04/2018 00:00;19/03/2015 00:00;21/07/2017 00:00;05/12/2013 00:00;03/03/2017 00:00;16/02/2012 00:00;20/10/2017 00:00;13/12/2017 00:00;25/03/2011 00:00;08/02/2018 00:00;22/05/2013 00:00;28/07/2011 00:00;10/07/2018 00:00;28/10/2015 00:00;17/08/2015 00:00"	AP	BRISTOL MYERS SQUIBB	IPILIMUMAB	25/03/2011	BRISTOL MYERS SQUIBB	92,6	14	NA	0	1	MELANOMA	1	CTLA4	0	1	0	NA	0	0	0	1	1	0,21	0	1	1	NA	0	0	0	0	0	0	48	0	1
Romidepsin	"depsipeptide;fk228;fr901228;nsc 630176;romidepsin"	"chromodax;Istodax;Romidepsin"	DB06176	"(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;128517-07-7;D06637;Romidepsin (USAN);HDInhib_000006;L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide;Romidepsin;NSC-630176;FK-901228;FR-901228;Probes1_000153;FK-228;Antibiotic FR 901228;FK 228;FR 901228;FR901228;Chromadax (TN);L-Valine, N-(3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-, xi-lactone, cyclic (1-2)-disulfide, (S-(E))-;NSC 630176;Chromadax;Probes2_000337"	"Romidepsin;Istodax;FK228;Chromadax;Antibiotic FR 901228;Depsipeptide;FR901228;FK-228;128517-07-7;FR 901228;FR-901228;Istodax (TN);NSC-630176;C24H36N4O6S2;HDInhib_000006;NSC 630176;CHEMBL343448;CHEBI:61080;FK 228;NSC630176;NSC754143;FK-901228;UNII-CX3T89XQBK;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide;CX3T89XQBK;romidepsina;romidepsine;romidepsinum;OXA-12,8,20,23-TETRAZABICYCLO[8.7.6]TRICOSANE, CYCLIC PEPTIDE DERIV.;Chromadax (TN);L-Valine, N-(3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-, xi-lactone, cyclic (1-2)-disulfide, (S-(E))-;Romidepsin (USAN);D0L7LC;Probes1_000153;Probes2_000337;AC1NS1N3;Romidepsin (JAN/USAN/INN);SCHEMBL677497;GTPL7006;Romidepsin, >=98% (HPLC);BDBM19151;AOB1853;MolPort-035-395-708;Romidepsin (FK228 ,depsipeptide);Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl] Cyclic (35)-Disulfide;ZINC3935130;2692AH;s3020;API0005301;CS-0985;NSC-754143;HY-15149;LS-161318;D06637;W-5757;49300-EP2298768A1;49300-EP2311840A1;AB01273968-01;SR-01000941579;SR-01000941579-1;L-Valine,3-didehydro-2- aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide;L-Valine,3-didehydro-2-aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide;(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;[S-(E)]-N-(3-Hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-L-valine (4-1)-Lactone Cyclic (12)-Disulfide;Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"";Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide"	128517-07-7	CX3T89XQBK	"27637428;23757352;21377994;18245545;16877737;15466934;12440223;11895901;11675364"	11675364	01/10/2001	11895901	01/03/2002	1999-2003		1	1	1	Yes	1	"13/06/2013 00:00;27/07/2016 00:00;12/04/2011 00:00;05/11/2009 00:00;13/09/2013 00:00;15/10/2014 00:00;30/09/2011 00:00;16/06/2011 00:00"	AP	CELGENE	ROMIDEPSIN	05/11/2009	CELGENE	92,0	37	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	"ATRIAL FIBRILLATION;ST/T changes"	1	0	0	0	139	0	1
Palbociclib	"palbociclib;pd 0332991"	"6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one;Ibrance"	DB09073		"Palbociclib;571190-30-2;PD0332991;PD-0332991;Ibrance;PD 0332991;UNII-G9ZF61LE7G;PD-332991;6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;G9ZF61LE7G;Palbociclib(PD0332991);PD 332991;6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one;CHEBI:85993;6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE;LQQ;C24H29N7O2;2euf;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one;571190-30-2 pound not827022-32-2;PD-0332991-0054;Palbociclib [USAN:INN];PF-00080665-73;Ibrance (TN);Palbociclib free base;Kinome_3823;Kinome_3824;PubChem16671;AC1NS8RV;Palbociclib (JAN/USAN);D00UZR;D07QXO;SCHEMBL462630;BDBM6309;CHEMBL189963;GTPL7380;EX-A408;QCR-200;2euf; PD 0332991;AHJRHEGDXFFMBM-UHFFFAOYSA-N;MolPort-009-679-393;BCPP000125;HMS3265M09;HMS3265M10;HMS3265N09;HMS3265N10;AOB87334;EBD24067;HMR-2934;ZINC3938686;571190-30-2 (free base);ABP000842;MFCD11840850;AKOS022205241;BCP9001058;CA10003;DB09073;KIN0000560;Pyrido-[2,3-d]-pyrimidin-7-one 43;NCGC00263129-01;AC-25485;AK173631;AN-16841;AS-17016;BC654107;HY-50767;KB-79781;SC-92588;AX8167187;PD-033299;FT-0697059;X7379;D10372;Z-3143;190P302;PD 0332991,PD0332991;A1-04309;PD-0332991, PD0332991;S14-2748;BRD-K51313569-001-01-1;P-0332991;PD-0332991/PD0332991,PD332991;PD 332991, PD 0332991, PD0332991;PD 332991, PD 0332991, 827022-32-2;6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one;6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one hydrochloride;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrido[2,3-d]pyrimidin-7-one;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino] pyrido[2,3-d]pyrimidin-7-one;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[6,5-d]pyrimidin-7-one;6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one;8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one;Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"	571190-30-2	G9ZF61LE7G	"22090362;26991823"	22090362	01/11/2011	21610706	01/06/2007	2004-2008		1	1	1	Yes	1	"31/03/2017 00:00;06/02/2018 00:00;17/12/2015 00:00;03/02/2015 00:00;19/02/2016 00:00"	AP	PFIZER INC	PALBOCICLIB	03/02/2015	PFIZER INC	91,9	33	NA	1	1	RB_POSITIVE	1	"CDK4;CDK6"	0	1	0	NA	0	1	0	1	1	0,03	0	0	0	0,29	0	0	0	0	0	0	630	0	1
Zoptarelin doxorubicin	"aezs-108;zoptarelin doxorubicin"		DB12755		"Zoptarelin doxorubicin;AEZS-108;AN-152;UNII-27844X2J29;139570-93-7;ZEN-008;27844X2J29;Zoptrex;D02HBB;Zoptarelin doxorubicin [INN];Zoptarelin doxorubicin [USAN];AEZS 108;CHEMBL3544954;AN 152;Luteinizing hormone-releasing factor (pig), 6-(N6-(5-(2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethoxy)-1,5-dioxopentyl)-D-lysine)-, (2S-cis)-;Luteinizinghormone-releasing factor (swine),6-[N6-[5-[2-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-oxoethoxy]-1,5-dioxopentyl]-D-lysine]-"	139570-93-7	27844X2J29	25278449	25278449	01/10/2014	20828803	01/12/2010	2009-2012		1	1	0	Yes	1					30/07/2018		91,7	17	NA	0	1	"BREAST;UTERINE;OVARIAN"	1	LHRHR	0	1	0	NA	0	1	0	1	1	0,33	0	0	0	NA	0	0	0	0	0	0	244	0	1
Icotinib	icotinib	BPI-2009	DB11737		"Icotinib;610798-31-7;Conmana;BPI-2009;UNII-9G6U5L461Q;BPI-2009H;CHEMBL2087361;9G6U5L461Q;N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine;N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine;Icotinib(Lcotinib);icotinib,BPI-2009H;GTPL7641;SCHEMBL5843603;BPI2009;DTXSID20209952;EX-A306;MolPort-035-395-730;QQLKULDARVNMAL-UHFFFAOYSA-N;HMS3651F12;BPI 2009;2468AH;BDBM50391089;HY-15164A;s2922;ZINC43207566;AKOS030231301;DB11737;4CA-0630;KB-77833;SC-94666;FT-0701617;Z-3130;(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-;(3-Ethynyl-phenyl)(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diazacyclododeca[b]naphthalen-4-yl)-amine"	610798-31-7	9G6U5L461Q	"27789778;26162563;22088449;21144613"	21144613	01/12/2010	21144613	01/12/2010	2009-2012		1	1	0	Yes	1					30/07/2018		91,7	36	70	1	1	NSCLC	1	EGFR	0	1	0	NA	1	0	0	1	0	0,21	0	0	0	0,42	0	0	0	0	0	0	102	0	1
Brivanib alaninate	brivanib		DB11865		"Brivanib alaninate;649735-63-7;BMS-582664;BMS582664;Brivanib (alaninate);Brivanib alaninate (BMS-582664);UNII-U2Y5OFN795;BMS 582664;U2Y5OFN795;(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-yl (2S)-2-aminopropanoate;L-Alanine, (1R)-2-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl ester;brivanib alinate;Brivanib alaninate [USAN:INN];D03WQS;SCHEMBL483382;CHEMBL270995;GTPL8097;Brivanib alaninate (INN/USAN);KS-00000XPL;DTXSID20215295;EX-A012;SYN1135;Brivanib alaninate,BMS-582664;MolPort-016-633-184;BMS-582664, Brivanib alaninate;L-Alanine,(1R)-2-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-1-methylethylester;Brivanib alaninate (JAN/USAN/INN);Brivanib alaninate - BMS-582664;s1138;ZINC29134440;AKOS025401744;CS-0159;DB11865;RL04475;AC-25066;AN-27666;AS-16274;BC630637;HY-10336;A2633;FT-0663602;A20636;D08878;W-5958;J-519933;BMS-582664, 649735-63-7;(1R)-2-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1- f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl (2S)-2-aminopropanoate;[(1R)-2-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy-1-methyl-ethyl] (2S)-2-aminopropanoate;[(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[5,1-f][1,2,4]triazin-6-yl]oxypropan-2-yl] (2S)-2-aminopropanoate;924262-84-0;L-Alanine, (1R)-2-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5- methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl ester"	649735-63-7	U2Y5OFN795	"23719718;21629245;21131369"	21131369	01/12/2010	21131369	01/12/2010	2009-2012		1	1	0	Yes	1					30/07/2018		91,7	90	NA	1	0	NA	1	"VEGFR;FGFR"	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	0	0	1
Plinabulin	"npi-2358;plinabulin"		DB05992		"Plinabulin;714272-27-2;NPI-2358;Plinabulin (NPI-2358);NPI 2358;UNII-986FY7F8XR;NPI-2358 (Plinabulin);986FY7F8XR;Plinabulin [USAN:INN];Plinabulin (USAN/INN);D0ZE1O;KPU-2;SCHEMBL79095;MLS006011262;CHEMBL1096380;EX-A292;MolPort-009-679-475;AOB87757;ZINC3819466;BDBM50030765;s1176;AKOS005145762;AKOS024463284;API0005263;BCP9000994;CS-0506;AJ-45728;AN-27472;HY-14444;SC-96616;SMR004703013;BCP0726000116;AX8293302;ST24048941;X7519;Plinabulin, NPI2358, 714272-27-2;D09655;W-5700;BRD-K99498722-001-01-8;(3Z,6Z)-3-benzylidene-6-((5-(tert-butyl)-1H-imidazol-4-yl)methylene)piperazine-2,5-dione;(3Z,6Z)-3-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]-6-(phenylmethylidene)piperazine-2,5-dione;(3Z,6Z)-3-[[5-(1,1-dimethylethyl)-1H-imidazol-4-yl]methylene]-6-(phenylmethylene)-2,5-Piperazinedione;2,5-Piperazinedione, 3-((5-(1,1-dimethylethyl)-1H-imidazol-4-yl)methylene)-6-(phenylmethylene)-, (3Z,6Z)-"	714272-27-2	986FY7F8XR	21138873	21138873	01/12/2010	21138873	01/12/2010	2009-2012		1	1	0	Yes	1					30/07/2018		91,7	38	NA	1	0	NA	1	VASCULAR DISRUPTION	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Verubulin	"mpc-6827;verubulin"		DB05585		"827031-83-4;Verubulin;N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine;Azixa;MPC-6827;UNII-X97O9FTB92;Verubulin, MPC-6827;MX-128495;X97O9FTB92;Verubulin [USAN:INN];EP-128495;MPC 6827;Verubulin (USAN/INN);D09BOH;CHEMBL492399;N-(4-methoxyphenyl)-N,2-dimethyl-quinazolin-4-amine;SCHEMBL2232326;CTK3D7545;KS-00002WSD;Caspase inducer (cancer), Myriad;MolPort-009-194-124;Apoptosis inducer (cancer), Myriad;Tubulin inhibitor (cancer), Myriad;2781AC;ANW-53682;ZINC35978229;AKOS015994561;API0005258;EE-0048;AC-25267;AK-80585;AX8226155;Cell cycle arrest inducer (cancer), Myriad;DB-075865;ST2407392;TC-142427;4CH-018160;FT-0703165;D10029;P111224;N-(4-methoxyphenyl)-N,2-dimethyl-4-Quinazolinamine;N-(4-Methoxyphenyl)-N,2-dimethylquinazoline-4-amine;(4-Methoxyphenyl)(methyl)(2-methylquinazolin-4-yl)amine;4-Quinazolinamine, N-(4-methoxyphenyl)-N,2-dimethyl-;88U"	827031-83-4	X97O9FTB92	21159616	21159616	01/12/2010	21159616	01/12/2010	2009-2012		1	1	0	Yes	1					30/07/2018		91,7	48	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,1	0	MYOCARDIAL INFARCTION	1	0	0	0	0	0	1
Dacomitinib	"dacomitinib;pan-her inhibitor pf299804;pf-00299804;pf299804"	Dacomitinib anhydrous	DB11963		"Dacomitinib;1110813-31-4;PF299804;Dacomitinib (PF299804, PF299);UNII-2XJX250C20;PF-00299804;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide;2XJX250C20;PF 00299804-03;(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide;PF-00299804-03;pf00299804;C24H25ClFN5O2;J-500784;Dacomitinib [USAN:INN];dacomitinibum;(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide;(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide;Dacomitinib anhydrous;PF-299804;Dacomitinib (USAN/INN);PF 00299804;D06XXH;Dacomitinib, PF299804;MLS006011275;GTPL7422;CHEMBL2110732;PF-00299804  dacomitinib;CHEBI:91466;DTXSID50149493;EX-A030;QCR-174;CHEBI:132268;MolPort-023-293-536;BDBM112499;AOB87383;AOB87735;ABP000126;PF-299;s2727;ZINC72266312;AKOS025401818;CS-0500;DB11963;RL00451;US8623883, No. 2;AC-25915;BC261945;HY-13272;KB-76397;SC-94589;SMR004703025;PF299804|||PF299;AB0035896;D5450;Y0338;D09883;Dacomitinib (PF299804, PF-00299804);PF-299804 (Dacomitinib PF-00299804);Q-4059;1110813-31-4 pound not PF 299804 pound not PF-299804;(2E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide;(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;1006885-28-4;2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-"	1110813-31-4	2XJX250C20	"21220471;22249430;25937431"	21220471	01/01/2011	21220471	01/01/2011	2009-2012		1	1	0	Yes	1					30/07/2018		90,7	121	NA	1	1	NCSLC	1	"HER1;HER2;HER4"	0	1	0	NA	1	0	0	1	1	0,07	0	0	0	NA	0	0	0	0	0	0	0	0	1
Pegdinetanib	"bms-844203;ct-322;ct-322 bms-844203;pegdinetanib"		DB05931		"PEGDINETANIB;Adnectin;Angiocept;Pegdinetanib [USAN:INN];UNII-SSB56T0M0L;SSB56T0M0L;CT 322;BMS-844203;906450-24-6"	906450-24-6	SSB56T0M0L	21224368	21224368	01/01/2011	21224368	01/01/2011	2009-2012		1	1	0	Yes	1					30/07/2018		90,7	39	NA	1	0	NA	1	VEGFR2	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,82	0	LEFT VENTRICULAR DYSFONCTION	1	PRES	1	0	0	0	1
E-7820	e7820		DB12505		"E7820;289483-69-8;E-7820;UNII-TVH5K7949N;E 7820;TVH5K7949N;3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide;N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide;LWGUASZLXHYWIV-UHFFFAOYSA-N;N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzenesulfonamide;D02BQE;AC1L52N5;SCHEMBL1581157;ZINC8704;DTXSID20183142;3-Cyano-N-(3-cyano-4-methyl-1H-indole-7-yl)benzensulfonamide;BCP25835;NSC719239;AKOS032944953;CS-6075;DB12505;DC10784;NSC-719239;HY-14571;KB-76741;FT-0714239;E-7820;E 7820;ER68203-00;N-(3-cyano-4-methyl-1H -indol-7-yl)3-cyanobenzenesulfonamide;Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-"	289483-69-8	TVH5K7949N	"27039386;21387147;21208908"	21208908	01/01/2011	21208908	01/01/2011	2009-2012		1	1	0	Yes	1					30/07/2018		90,7	37	82	1	0	NA	1	INTEGRIN	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,22	0	0	0	0	0	0	0	0	1
Temozolomide	"14c-temozolomide;ccrg-81045;m & b 39831;rp-46161;sch 52365;temozolomide"	"Temozolodida;3-methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide;Methazolastone;3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide;Temozolomida;3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide;8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one;Temozolomid;Témozolomide;Temozolomidum;Ach-temozolomide;Temozolomide Hexal;Temozolomide Capsules;Apo-temozolomide;Emozolomide Accord;Temozolomide;Temodal;Temozolomide Sun;Act Temozolomide;Taro-temozolomide;Temodar;Temozolomide Sandoz;Temomedac;Temozolomide Teva"	"DB00853;APRD00557"	"3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide;4-keto-3-methyl-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;85622-93-1;AIDS129717;D06067;Temodal (TN);Temozolomide (JAN/USAN);M&B-39831;NSC362856;3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide;AIDS-129717;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide;3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide;8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one;BRN 5547136;{Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-;Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;M & B 39831;CCRG 81045;NSC 362856;Sch 52365;Temodal;Temodar;Temozolodida [Spanish];Temozolomide [BAN:INN];Temozolomidum [Latin];NSC-362856;Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;MB 39831;3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;Methazolastone;CCRG-81045;MLS000759447;SMR000466338;Sch-52365;Temozolomide;Temozolamide;LS-80558;NCI60_003316;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide"	"temozolomide;85622-93-1;Methazolastone;Temodal;Temodar;Temozolamide;Temozolomidum;3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;Temozolomidum [Latin];Temozolodida [Spanish];Temozolodida;CCRG-81045;Sch 52365;CCRG 81045;NSC 362856;M&B-39831;temomedac;CCRIS 8996;Sch-52365;MB 39831;Temozolomide [INN:BAN];M&B 39831;UNII-YF1K15M17Y;M & B 39831;Temodal (TN);Temodar (TN);NSC-362856;BRN 5547136;8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one;CHEMBL810;M-39831;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide;3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide;MLS002701861;C6H6N6O2;YF1K15M17Y;Temozolomide (JAN/USAN/INN);CHEBI:72564;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide;3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide;Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;NSC362856;NCGC00167429-01;3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide;4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide;DSSTox_CID_23714;DSSTox_RID_80068;DSSTox_GSID_43714;3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;TMZ-Bioshuttle;3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide;8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE;Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;SMR000466338;CAS-85622-93-1;Temozolomide, VETRANAL(TM), analytical standard;SR-01000759347;temozolomida;Temozolomid;Temozolomide [USAN:INN:BAN];zlchem 2;PubChem17413;D0C8EU;Essex brand of temozolomide;Temodar (TN) (Schering);AC1L1K9B;SCHEMBL3739;Scheringbrand of temozolomide;MLS000759447;MLS001424028;BIDD:GT0204;GTPL7301;DTXSID5043714;CTK8B3724;KS-00000XGV;AOB1657;Temozolomide, >=98% (HPLC);ZLA0002;BPEGJWRSRHCHSN-UHFFFAOYSA-N;MolPort-003-850-406;HMS2051O12;HMS2090B08;HMS2232N13;HMS3264I14;HMS3269P05;HMS3372K13;HMS3393O12;HMS3654N05;HMS3713H16;Pharmakon1600-01502289;ALBB-021358;ZINC1482184;Tox21_112433;AC-758;ANW-43023;BDBM50034562;CT0139;DL-190;MFCD00866492;NSC759883;s1237;Schering-Plough brand of temozolomide;STK623541;AKOS005557098;Tox21_112433_1;AN-5907;CCG-100870;CS-0943;DB00853;KS-1216;MCULE-9414994158;NC00120;NSC-759883;NCGC00167429-02;NCGC00167429-04;NCGC00167429-05;4CA-1225;AJ-26318;BC206085;BR-72945;CJ-23657;CPD000466338;HY-17364;KB-80840;LS-80558;NCI60_003316;SAM001246636;SC-17333;BCP0726000154;AB0007590;M B 39831;TL8005593;AM20110227;FT-0630936;D06067;M-2350;AB00639915-06;AB00639915-08;AB00639915-09;AB00639915_10;AB00639915_11;199366-EP2275425A1;622T931;A841386;I06-0149;I14-1943;Q-201786;SR-01000759347-4;SR-01000759347-5;BRD-K32107296-001-04-5;Z1551429743;3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide;3-methyl-8-carbamoyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one;Temozolomide, United States Pharmacopeia (USP) Reference Standard;3-methyl-4-oxidanylidene-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3-Methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one;Imidazo[5,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;{Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-;3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide;Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material;3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide);3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide(Temozolomide)"	85622-93-1	YF1K15M17Y	"28586949;28116649;27876012;27725524;27688162;27117900;26966095;26508094;26019185;25366363;25145500;25140039;24995786;24908656;24380758;24194293;23894304;23425509;20932651;20729242;20439646;20431907;19683876;19637327;19367282;18834673;18337651;17971589;16134182;15925979;12149298;11489806;10576660;10561328;10037179;9815639;9766665;9738573;9815788"	9815788	01/07/1997	1739631	01/02/1992	1989-1994		1	1	1	Yes	1	"28/07/2010 00:00;29/06/2016 00:00;26/04/2017 00:00;18/09/2015 00:00;09/11/2015 00:00;05/07/2018 00:00;04/02/2011 00:00;18/04/2017 00:00;11/03/2003 00:00;03/06/2011 00:00;31/07/2017 00:00;20/03/2014 00:00;01/03/2010 00:00;27/02/2017 00:00;22/04/2005 00:00;15/07/2004 00:00;23/11/2015 00:00;18/05/2001 00:00;19/09/2014 00:00;12/01/2016 00:00;10/10/2013 00:00;13/09/2011 00:00;27/02/2009 00:00;05/01/2015 00:00;19/10/2006 00:00;27/04/2016 00:00;05/03/2002 00:00;15/03/2005 00:00;12/02/2014 00:00;29/06/2004 00:00;02/04/2015 00:00;11/08/1999 00:00;22/09/2017 00:00;08/01/2013 00:00;10/02/2016 00:00;31/03/2006 00:00;12/02/2016 00:00;13/07/2016 00:00;18/01/2002 00:00;24/02/2017 00:00;23/11/2016 00:00;26/04/2010 00:00;10/06/2015 00:00;30/03/2005 00:00;05/05/2014 00:00;09/06/2000 00:00;08/05/2015 00:00;30/04/2013 00:00;06/10/2017 00:00;12/04/2016 00:00"	AP	"IDT AUSTRALIA LTD;ACCORD HLTHCARE;SUN PHARMA GLOBAL;BARR;#N/A;AMERIGEN PHARMS LTD;MYLAN PHARMS INC;RISING PHARMS INC;DEVA HOLDING AS;MERCK SHARP DOHME;AMNEAL PHARMS;CHEMI SPA;ZYDUS PHARMS USA INC;LANNETT CO INC;WATSON LABS TEVA"	TEMOZOLOMIDE	11/08/1999	MERCK SHARP DOHME	90,1	51	NA	1	1	MELANOMA	0	NA	0	1	0	NA	0	0	0	1	1	0,17	0	1	1	NA	0	0	0	0	0	0	62	0	1
Pracinostat	"pracinostat;sb939"		DB05223		"Pracinostat;929016-96-6;SB 939;SB939;SB-939;Pracinostat (SB939);UNII-GPO2JN4UON;GPO2JN4UON;CHEMBL1851943;(E)-3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzo[d]imidazol-5-yl)-N-hydroxyacrylamide;2-Propenamide, 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-, (2E)-;Pracinostat [INN];2-Propenamide, 3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzimidazol-5-yl)-N-hydroxy-, (2E)-;SB939,Pracinostat;Pracinostat(SB939);SB939 (Pracinostat);cc-70;D0L2UQ;MLS006011217;SCHEMBL833105;GTPL8365;CHEBI:95071;DTXSID00239196;EX-A351;MolPort-009-679-502;AOB87709;ABP000582;BDBM50105330;s1515;SB 939SB-939;ZINC43152558;AKOS027250824;SB-939, SB939;CS-0567;DB05223;RL05848;AS-19395;BC660004;HY-13322;KB-80084;QC-10486;SC-86253;SMR004702979;AB0008159;X7533;W-5687;(2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide;(2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1,3-benzodiazol-5-yl}-N-hydroxyprop-2-enamide;(E)-3-[2-butyl-1-(2-diethylaminoethyl)benzimidazol-5-yl]prop-2-enehydroxamic acid;(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(2E)-3-(2-Butyl-1-[2-(diethylamino)ethyl]-1h-1,3-benzodiazol-5-yl)-n-hydroxyprop-2-enamide"		GPO2JN4UON	21285985	21285985	01/02/2011	21285985	01/02/2011	2009-2012		1	1	0	Yes	1					30/07/2018		89,7	38	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	1	0	1
AT7519	"at7519;at7519m"		DB05037		"AT7519;844442-38-2;AT-7519;AT 7519;UNII-X1BF92PW9T;4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide;N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide;X1BF92PW9T;OVPNQJVDAFNBDN-UHFFFAOYSA-N;4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide;4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide;4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide;LZE;pyrazole diamide, 33;PubChem22418;Tube005;D07DTV;MLS006010064;SCHEMBL955568;C16H17Cl2N5O2;CHEMBL445813;GTPL5662;JMC514986 Compound 33;BDBM24654;CHEBI:91326;DTXSID30233420;EX-A225;MolPort-016-633-226;BCPP000381;HMS3265A09;HMS3265A10;HMS3265B09;HMS3265B10;HMS3654F20;ABP000847;AT-519;BDBM50113281;s1524;ZINC16052857;1H-Pyrazole-3-carboxamide, 4-((2,6-dichlorobenzoyl)amino)-n-4-piperidinyl;4-[(2,6-dichlorobenzoyl)amino]-N-(4-piperidyl)-2H-pyrazole-3-carboxamide;AKOS026674096;AT7519/AT-7519;BCP9000335;CS-0017;DB08142;RL05190;4-(2,6-Dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid N-(piperidin-4-yl)amide;KS-0000063F;AT 7519, AT7519;NCGC00263091-01;NCGC00263091-02;4CA-0197;AC-29010;AS-19551;AT-7519(;BC659983;HY-50940;KB-74756;QC-11815;SC-94179;SMR004701224;FT-0754016;X7377;Y0270;W-5562;J-523077;BRD-K13390322-001-01-4;AT7519;AT-7519;AT 7519;844442-38-2;4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-5-carboxamide;4-N-(2,6-dichlorobenzene)-3-N-(piperidin-4-yl)-1H-pyrazole-3,4-diamido;4-[(2,6-dichlorobenzene)amido]-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide"			21325451	21325451	01/02/2011	21325451	01/02/2011	2009-2012		1	1	0	Yes	1					30/07/2018		89,7	28	NA	1	0	NA	1	CDK	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	0,18	1	"ST SEGMENT ELEVATION;QT"	1	0	0	0	0	0	1
Estramustine	estramustine	"Estramustinum;Estradiol 3-(N,N-bis(2-chloroethyl)carbamate);Estramustina;17beta-Estradiol 3-(bis(2-chloroethyl)carbamate);17β-Estradiol 3-(bis(2-chloroethyl)carbamate);Estramustine;Emcyt;Emcyt Cap 140mg"	"DB01196;APRD00625"	"[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate;N,N-bis(2-chloroethyl)carbamic acid [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] ester;2998-57-4;NCI60_041982;C11228;Estramustine;Estra-1,3,5(10)-triene-3,17-diol, 3-[bis(2-chloroethyl)carbamate], (17.beta.)-;Estradiol 3-[bis(2-chloroethyl)carbamate];Estradiol, 3-[bis(2-chloroethyl)carbamate];17.beta.-Estradiol 3-[bis(2-chloroethyl)carbamate];LMST02010038;estra-1,3,5(10)-triene-3,17beta-diol, 3-[bis(2-chloroethyl)carbamate];Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate];NCGC00164581-01;D04066;Estramustine (USAN)"	"estramustine;2998-57-4;Estramustina;Estramustinum;Estracyt;UNII-35LT29625A;Estradiol 3-(N,N-bis(2-chloroethyl)carbamate);Estramustine (USAN/INN);17beta-Estradiol 3-(bis(2-chloroethyl)carbamate);estracty;CHEMBL1575;Estradiol 3-[bis(2-chloroethyl)carbamate];CHEBI:4868;Estramustinum [INN-Latin];Estramustina [INN-Spanish];35LT29625A;[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate;NCGC00164581-01;Estradiol 3-(bis(2-chloroethyl)carbamate);DSSTox_CID_26458;DSSTox_RID_81632;DSSTox_GSID_46458;C23H31Cl2NO3;17.beta.-Estradiol 3-[bis(2-chloroethyl)carbamate];Estramustine [USAN:INN:BAN];EINECS 221-076-3;(17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate;estra-1,3,5(10)-triene-3,17beta-diol, 3-[bis(2-chloroethyl)carbamate];CAS-2998-57-4;Estradiol, 3-[bis(2-chloroethyl)carbamate];Estradiol 3-[N,N-Bis(2-chloroethyl)carbamate];Estramustin Sodium Phosphate;MLS002701936;estramustin;NSC89201;Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate];Estradiol, 3-(bis(2-chloroethyl)carbamate);Ro 22-2296/000;D03SRY;AC1L60XG;SCHEMBL4252;BIDD:GT0482;GTPL9076;DTXSID8046458;CTK8F9501;Carbamic acid, bis(2-chloroethyl)-, 17beta-hydroxyestra-1,3,5(10)-trien-3-yl ester;Estra-1,3,5(10)-triene-3,17-diol, 3-(bis(2-chloroethyl)carbamate), (17beta)-;FRPJXPJMRWBBIH-RBRWEJTLSA-N;MolPort-006-114-857;HMS3715D22;ZINC4099032;Tox21_112207;BDBM50333646;LMST02010038;NSC-89201;AKOS025402444;Tox21_112207_1;AC-9163;API0024779;CCG-221220;DB01196;NCGC00164581-02;AS-12259;NCI60_041982;Ro-222296000;Ro-22-2296000;Ro-22-2296-000;Ro-22-2296/000;C11228;D04066;15163-EP2272827A1;15163-EP2275420A1;15163-EP2295055A2;15163-EP2295416A2;15163-EP2298748A2;15163-EP2298764A1;15163-EP2298765A1;15163-EP2305642A2;15163-EP2308833A2;15163-EP2308861A1;15163-EP2311453A1;15163-EP2311840A1;15163-EP2316832A1;15163-EP2316833A1;998E574;W-106963;Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate) (9CI);Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate];Estra-1,5(10)-triene-3,17-diol, 3-[bis(2-chloroethyl)carbamate], (17.beta.)-;(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl bis(2-chloroethyl)carbamate;Bis-(2-chloro-ethyl)-carbamic acid 17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl ester"	2998-57-4	35LT29625A	"20878951;15378520;15129427;11844837"	11844837	01/02/2002	4835492	01/07/1974	Bef. 1989		0	1	1	Yes	1	"10/02/1999 00:00;16/03/1995 00:00;15/10/1998 00:00;28/10/2003 00:00;09/07/2008 00:00;24/12/1981 00:00;22/10/1984 00:00;17/08/1987 00:00;30/06/1982 00:00;25/04/1986 00:00;07/09/2001 00:00;28/04/1993 00:00;18/02/1994 00:00;05/10/1995 00:00;11/01/1996 00:00;18/01/2002 00:00;16/03/1994 00:00;09/10/1998 00:00;14/02/2013 00:00;25/01/1994 00:00"	AP	PHARMACIA AND UPJOHN	ESTRAMUSTINE PHOSPHATE SODIUM	24/12/1981	PHARMACIA AND UPJOHN	89,6	11	NA	0	1	PROSTATE	0	NA	0	1	0	NA	0	0	0	1	0	0,36	0	0	0	NA	0	0	0	0	0	0	295	0	1
AS1409	"as1409;hubc1-huil12 fusion protein"		DB05182		"isoproterenol;Isoprenaline;Isoprenalin;Norisodrine;Novodrin;Isopropydrin;Isopropylarterenol;Asiprenol;Assiprenol;Bellasthman;Respifral;Aludrin;Aludrine;Asmalar;Isadrine;N-Isopropylnoradrenaline;Bronkephrine;Isonorene;Isopropyladrenaline;Lomupren;Neodrenal;Proternol;N-Isopropylnorepinephrine;Isopropylnorepinephrine;neo-Epinine;7683-59-2;Isonorin;Isorenin;Saventrine;Isopropylnoradrenaline;Isopropyl noradrenaline;Racemic isoprenaline;dl-Isadrine;Isuprel;Racemic isoproterenol;(+-)-Isoproterenol;Vapo-N-iso;Epinephrine isopropyl homolog;Isoprenalinum;Isoproterenolum;Aleudrine;Euspiran;Isupren;(+-)-Isoprenaline;dl-Ipr;Isoprenalina;Isadrin;Isoproterenol [JAN];Dihydroxyphenylethanolisopropylamine;WIN 5162;DL(+-)-Isoproterenol;Medihaler-ISO;dl-Isopropylnoradrenaline;DL-Isopropylnorepinephrine;dl-N-Isopropylnoradrenaline;Isoprenalinum [INN-Latin];Isoprenalina [INN-Spanish];Isoproterenol Chloride;1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol;ICI 46399;l-Isoproterenol;d-Isoprenaline;d-Isoproterenol;alpha-(Isopropylaminomethyl)protocatechuyl alcohol;Isuprel Mistometer;N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine;(S)-Isoproterenol;(+)-Isoprenaline;d-Isopropylarterenol;Aleudrin;1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol;Isoprenaline (INN);ISOPROP;CCRIS 3081;4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol;l-Isopropylnoradrenaline;NSC 9975;EINECS 231-687-7;NSC 33791;(S)-(+)-Isoproterenol;Isoproterenol sulfate;Isopropylaminomethyl-3,4-dihydroxyphenyl carbinol;CHEMBL434;d-N-Isopropylnorepinephrine;1,2-Benzenediol, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-;BRN 2213857;3,4-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol;4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;CHEBI:64317;1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-;JWZZKOKVBUJMES-UHFFFAOYSA-N;(S)-Isoprenaline;Isopropylaminomethyl(3,4-dihydroxyphenyl)carbinol;NSC33791;(+)-Isoproterenol;DL-isoprenaline HCl;Isoprenaline [INN];Protocatechuyl alcohol, alpha-(isopropylaminomethyl)-;DL-ISOPROTERENOL;NCGC00015558-06;3,4-Dihydroxy-.alpha.-(isopropylaminomethyl)-benzyl alcohol;Protocatechuyl alcohol,-;Isoprenaline sulfate;Isuprel (TN);DSSTox_CID_3175;1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (+-)-;BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+-)-;DSSTox_RID_76904;DSSTox_GSID_23175;149-53-1;.alpha.-(Isopropylaminomoethyl)protocatechuyl alcohol;4-(1-Hydroxy-2(isopropylamino)ethyl)-benzene 1,2-diol;4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol;3,4-dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol;WLN: QR BQ DYQ1MY1&1;3,4-Dihydroxy-.alpha.-[(isopropylamino)methyl]benzyl alcohol;4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}benzene-1,2-diol;Benzyl alcohol, 3,4-dihydroxy-alpha-((isopropylamino)methyl)-;CAS-7683-59-2;1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-;4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;4-{1-hydroxy-2-[(methylethyl)amino]ethyl}benzene-1,2-diol;Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-;Isoproterenol-l;Isoproterenol;;Isoprenalinesulphate;Isoproterenol (-);Isoproterenol,(+);ISOPROTERONOL;Isuprel (Salt/Mix);Izadrin (Salt/Mix);Euspiran (Salt/Mix);(+/-)-isoprenaline;(+/-)-isoproterenol;Spectrum_000949;AC1L1GOZ;AC1Q1QBS;6700-39-6;Prestwick0_001097;Prestwick1_001097;Prestwick2_001097;Spectrum2_001061;Spectrum3_000474;Spectrum4_000024;Spectrum5_000880;(.+/-.)-Isoprenaline;(.+/-.)-Isoproterenol;D0I8FI;D0IF0C;D0P1IS;SCHEMBL4165;DL(.+/-.)-Isoproterenol;Lopac0_000711;Oprea1_009434;BSPBio_002208;GTPL536;KBioGR_000427;KBioSS_001429;3-13-00-02387 (Beilstein Handbook Reference);DivK1c_000894;SPBio_001042;SPBio_003057;SGCUT00015;BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+)-;DTXSID4023175;BDBM25392;KBio1_000894;KBio2_001429;KBio2_003997;KBio2_006565;KBio3_001428;NSC9975;MolPort-001-783-449;NINDS_000894;HMS2089A12;NSC-9975;to_000062;(A+/-)-Isoproterenol hydrochloride;Tox21_110172;AS1409;NSC-33791;PDSP1_001425;PDSP2_001409;SBB005855;AKOS015913894;Tox21_110172_1;API0006523;CCG-204727;CCG-204796;DB01064;MCULE-6061231962;IDI1_000894;NCGC00015558-04;NCGC00015558-05;NCGC00015558-07;NCGC00015558-08;NCGC00015558-09;NCGC00015558-10;NCGC00015558-11;NCGC00015558-12;NCGC00015558-14;NCGC00016665-02;NCGC00025274-03;NCGC00025274-04;NCGC00162220-01;LS-42866;LS-42868;LS-42869;ST077771;SBI-0050689.P004;FT-0724367;C07056;D08090;EN300-148243;AB00053487-09;AB00053487-10;AB00053487_11;AB00053487_12;683I592;alpha-(Isopropylaminomoethyl)protocatechuyl alcohol;L000936;.alpha.-(Isopropylaminomethyl)protocatechuyl alcohol;I14-45263;Protocatechuyl alcohol,.alpha.-(isopropylamino-methyl),-;3,4-dihydroxy-alpha-[(isopropylamino)methyl]-benzyl alcohol;4-[1-Hydroxy-2-(isopropylamino)ethyl]-1,2-benzenediol #;N-Isopropyl-.beta.-dihydroxyphenyl-.beta.-hydroxyethylamine;4-[1-hydroxy-2-(isopropylamino)ethyl]pyrocatechol;hydrochloride;4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol;4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 2;Benzyl alcohol, 3,4-dihydroxy-.alpha.-((isopropylamino)methyl)-;1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI);1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-(9CI);1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-;1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-(9CI);46388-38-9"			21447719	21447719	01/03/2011	21447719	01/03/2011	2009-2012		1	1	0	Yes	1					30/07/2018		88,8	13	NA	1	1	"MRCC;MELANOMA"	1	ED-B	0	1	0	NA	0	0	0	1	1	0,08	0	0	0	0,46	0	0	0	0	0	0	0	0	1
Evofosfamide	"evofosfamide;th-302"		DB06091		"TH-302;evofosfamide;918633-87-1;TH 302;UNII-8A9RZ3HN8W;TH302;Evofosfamide(TH 302);8A9RZ3HN8W;n,n'-bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1h-imidazol-5-yl)methyl ester;compound 3b;Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester;2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine;Evofosfamide [USAN:INN];Evofosfamide(TH-302);D0H1EA;C9H16Br2N5O4P;CHEMBL260046;Evofosfamide (JAN/USAN/INN);GTPL8695;SCHEMBL2357174;SCHEMBL15691894;KS-00001CSJ;DTXSID60238721;HAP-302;MolPort-023-293-549;EX-A1740;TH-302; Evofosfamide;HAP-302;s2757;ZINC29053729;AKOS026673946;CS-0616;RL05790;4CA-1246;AC-29025;HY-10535;KB-81099;FT-0696771;X5809;J3.504.735B;D10704;W-5941;J-523214;918633-87-1 , C9H16Br2N5O4P , TH302 , TH 302;(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate"	918633-87-1	8A9RZ3HN8W	21415214	21415214	01/03/2011	21415214	01/03/2011	2009-2012		1	1	0	Yes	1					30/07/2018		88,8	57	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	0,47	0	0	0	0	0	0	0	0	1
Tasisulam	"ly573636;tasisulam"	LY573636	DB11941		"Tasisulam;519055-62-0;LY573636;N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide;UNII-1YC4W9MSLJ;LY 573636;1YC4W9MSLJ;LY-573636;N-((5-BROMOTHIOPHEN-2-YL)SULFONYL)-2,4-DICHLOROBENZAMIDE;N-(5-bromothiophen-2-ylsulfonyl)-2,4-dichlorobenzamide;Tasisulam [INN];N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide;C11H6BrCl2NO3S2;Tasisulam(LY573636);Tasisulam (LY573636);SCHEMBL1581371;CHEMBL2110587;DTXSID20199869;MolPort-028-600-032;HMS3653O12;AOB87365;EX-A1367;ZINC3816311;s7326;AKOS027250790;API0005245;BCP9000890;DB11941;QC-5973;RL03913;VT20431;AN-16682;AS-38576;BC294277;KB-78237;AB0032518;FT-0763021;X5833;055T620;J-522818;N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-benzamide;Z442229142;Benzamide, N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichloro-"	519055-62-0	1YC4W9MSLJ	"23370664;21431416"	21431416	01/03/2011	21431416	01/03/2011	2009-2012		1	1	0	Yes	1					30/07/2018		88,8	53	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,33	0	0	0	0	0	0	0	0	1
Tivantinib	"arq 197;tivantinib"		"DB12200;DB06026"		"Tivantinib;905854-02-6;ARQ-197;ARQ 197;ARQ197;Tivantinib (ARQ 197);UNII-PJ4H73IL17;PJ4H73IL17;(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;1000873-98-2;2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-;Tivantinib [USAN:INN];1228508-24-4;905853-99-8;ARQ 197, Tivantinib;ARQ 197 (Tivantinib);Tivantinib (ARQ-197);cc-86;D0ZI1F;SCHEMBL44944;Tivantinib (JAN/USAN/INN);GTPL7948;CHEMBL2103882;CHEBI:91398;QCR-102;MolPort-021-805-013;UCEQXRCJXIVODC-PMACEKPBSA-N;ARQ-197,Tivantinib, ARQ197;ARQ197; ARQ-197;Tivantinib;BCPP000042;Tivantinib; 905854-02-6;AOB87130;KS-00001DU5;CAS:905854-02-6;Tivantinib;BDBM50146168;s2753;AKOS022182739;ZINC100016063;API0024737;DB12200;RL05700;(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;AC-25009;AJ-89918;AS-16991;BC638836;EN002686;HY-50686;KB-81167;SC-86236;J3.496.311H;D10173;W-5506;J-501255;BRD-K33379087-001-01-8;(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoli;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl) pyrrolidine-2,5-dione;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;(_)-trans-3-(5,6-dihydro-4h-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1h-indol-3-yl)pyrrolidine-2,5-dione;(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione;(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-yl)-4-(1H-indole-3-yl)pyrrolidine-2,5-dione;2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-;TIV;trans 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione"	905854-02-6	PJ4H73IL17	"25711511;23287988;21383285"	21383285	01/03/2011	21383285	01/03/2011	2009-2012		1	1	0	Yes	1					30/07/2018		88,8	51	NA	1	0	NA	1	MET	0	1	0	NA	0	0	1	1	1	0	0	0	0	0,27	0	0	0	0	0	0	0	0	1
PHA-793887	"pan-cdk inhibitor pha-793887;pha-793887"		DB12686		"PHA-793887;718630-59-2;3-Methyl-N-[1,4,5,6-tetrahydro-6,6-dimethyl-5-[(1-methyl-4-piperidinyl)carbonyl]pyrrolo[3,4-c]pyrazol-3-yl]butanamide;UNII-MKS45S912B;MKS45S912B;CHEMBL1230607;N-(6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide;C19H31N5O2;N-(6,6-Dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-C)pyrazol-3-yl)-3-methylbutanamide;D0P1CV;MLS006010173;SCHEMBL5110328;CHEBI:91371;CTK5D5171;KS-00000XGS;DTXSID50222134;MolPort-009-679-503;BCPP000110;HMS3265M13;HMS3265M14;HMS3265N13;HMS3265N14;HMS3654B16;AOB87190;ABP000550;BDBM50378657;PHA793887;ZINC52509437;AKOS015995002;DB12686;PHA 793887;QC-8186;RL04741;PHA-793887/;NCGC00263168-01;AS-19371;Butanamide, 3-methyl-N-(1,4,5,6-tetrahydro-6,6-dimethyl-5-((1-methyl-4-piperidinyl)carbonyl)pyrrolo(3,4-C)pyrazol-3-yl)-;HY-11001;KB-79907;SC-96644;SMR004701281;DB-074487;FT-0660374;S1487;X7380;J3.661.625C;PHA793887, PHA-793887;S-7775;Cyclin-dependent kinase inhibitor (cancer), Nerviano;J-512917;BRD-K64800655-001-01-7;N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide;N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1H,4H-pyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide"	718630-59-2	MKS45S912B	21368575	21368575	01/03/2011	21368575	01/03/2011	2009-2012		1	1	0	Yes	1					30/07/2018		88,8	19	NA	1	0	NA	1	"CDK1;CDK2;CDK4"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,26	1	0	0	0	0	1	0	0	1
Inotuzumab ozogamicin	"cmc-544;inotuzumab;inotuzumab ozogamicin;way 207294;way-207294"	Besponsa	DB05889			635715-01-4	P93RUU11P7	20308665	20308665	01/03/2010	20308665	01/04/2010	2009-2012		1	1	1	Yes	1	17/08/2017 00:00	AP	WYETH PHARMS INC	INOTUZUMAB OZOGAMICIN	17/08/2017	WYETH PHARMS INC	88,4	79	NA	0	1	NHL_B	1	CD22	0	1	0	NA	0	0	0	1	1	0,68	0	0	0	NA	0	0	0	0	0	0	32	0	1
AZD-4877	azd4877		DB11671		"AZD-4877;AZD4877;AZD 4877;UNII-19ORU63E06;1176760-49-8;cc-722;CHEMBL1829433;SMFXSYMLJDHGIE-UHFFFAOYSA-N;19ORU63E06;D02AAO;SCHEMBL360703;GTPL7708;BDBM50353788;DB11671;(+)-N-(3-Aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide;KB-74811;Anticancer therapeutic (solid tumors), AstraZeneca;N-(3-amino-propyl)-N-[-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-2-methyl-propyl]-4-methyl-benzamide;N-(3-amino-propyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-2-methyl-propyl]-4-methyl-benzamide;N-(3-aminopropyl)-4-methyl-N-[2-methyl-1-[3-methyl-4-oxo-5-(phenylmethyl)-[1,2]thiazolo[5,4-d]pyrimidin-6-yl]propyl]benzamide"	1176760-49-8	19ORU63E06	21494838	21494838	01/04/2011	21494838	01/04/2011	2009-2012		1	1	0	Yes	1					30/07/2018		87,8	NA	NA	0	1	AML	1	EG5	0	1	1	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1
PD-0325901	"mek inhibitor pd0325901;pd-0325901;pd0332991"		"DB07101;DB11802"		"391210-10-9;PD0325901;PD 0325901;PD-0325901;(R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide;PD-325901;(R)-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE;PD 325901;UNII-86K0J5AK6M;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;PD325901;86K0J5AK6M;CHEMBL507361;CHEBI:88249;SUDAHWBOROXANE-SECBINFHSA-N;870474-62-7;NCGC00189075-01;N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;J-502503;S06-0029;C16H14F3IN2O4;N-((R)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;N-[((R)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide;391209-97-5;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-anilino)benzamide;N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;4BM;PubChem22394;cc-61;D0K0YC;DSSTox_CID_24024;DSSTox_RID_80100;DSSTox_GSID_44024;SCHEMBL172904;GTPL7935;DTXSID0044024;CTK8B5048;EX-A102;SYN1059;(S)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide;Benzamide,N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-;MolPort-009-679-431;N-(2,3-Dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;BCPP000126;BDBM104963;HMS3648A14;AOB87344;ZINC3938683;Tox21_113364;ABP000920;AN-191;ANW-47220;IN2230;MFCD08435926;s1036;AKOS015855518;AN-5314;BCP9001057;CCG-221316;CS-0062;DB07101;EX-8602;RTR-015696;KS-0000007I;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide;AJ-47457;BC245090;BR-78415;HY-10254;KB-03405;KB-74957;KB-79158;US8575391, Q;AB0007877;AX8222618;TR-015696;A6561;BB 0261791;CAS-391210-10-9;FT-0673534;ST24020764;W5947;S-7112;PD-0325901,PD325901;PD 0325901, >=98% (HPLC);PD-0325901/PD0325901;PD0325901 (PD325901);SR-01000946344;SR-01000946344-1;BRD-K49865102-001-01-9;I01-15945;Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide;N-{[(2S)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"	391210-10-9	86K0J5AK6M	"22383795;21516509"	21516509	01/04/2011	21516509	01/04/2011	2009-2012		1	1	0	Yes	1					30/07/2018		87,8	13	NA	0	1	"MELANOMA;COLORECTAL;BREAST"	1	MEK	0	1	0	NA	1	0	0	1	1	0,08	0	1	1	0,39	0	0	0	"GAIT DISTURBANCE;MEMORY IMPAIRMENT;CONFUSION;MENTAL STATUS CHANGES;VISUAL DISTURBANCES;DROPPED-HEAD SYNDROME"	1	0	0	0	1
BMS-599626	"ac480;bms-599626"		DB12318		"BMS-599626;714971-09-2;BMS 599626;AC480;(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate;AC-480;UNII-2252724U5N;AC1480 (free base);AC480 (BMS-599626);CHEMBL1645462;2252724U5N;BMS599626;J-502499;C27H27FN8O3;BMS 599626 dihydrochloride;AC 480;PubChem22432;D0U4FF;GTPL7647;SCHEMBL12065349;CTK8B6780;AOB5594;DTXSID60221714;SYN1142;MolPort-023-279-418;KS-000008GE;ZINC6717782;ANW-54337;BDBM50333373;C27H44O11;IN2101;s1056;AKOS015999853;BCP9000428;CS-0407;DB12318;RL05125;NCGC00346483-01;AK-64843;AS-16281;Carbamic acid, N-(4-((1-((3-fluorophenyl)methyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)-, (3S)-3-morpholinylmethyl ester;HY-10251;KB-75631;BMS-599626 (AC480);AX8216015;TC-143082;FT-0663421;X7467;Y0348;Q-4495;BMS-599626, >=98% (HPLC);J-519990;1,2,3,4-Tetra-O-pivaloyl-??-D-glucopyranuronic acid methyl ester;(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4;(S)-morpholin-3-ylmethyl 4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate;[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate;[4-[[1-(3-Fluorobenzyl)-1H-indazole-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-yl]carbamic acid [(3S)-morpholine-3-yl]methyl ester;[4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid;Carbamic acid, [4-[[1-[(3-Fluorophenyl)methyl]-1h-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-, (3s)-3-morpholiny lmethyl ester;CARBAMIC ACID, [4-[[1-[(3-FLUOROPHENYL)METHYL]-1H-INDAZOL-5-YL]AMINO]-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZIN-6-YL]-, (3S)-3-MORPHOLINYLMETHYL ESTER;N-[4-[[1-[(3-Fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid (3S)-3-Morpholinylmethyl Ester"	714971-09-2	2252724U5N	21576284	21576284	01/05/2011	21576284	01/05/2011	2009-2012		1	1	0	Yes	1					30/07/2018		86,8	45	0	1	0	NA	1	HER	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,24	0	QT	1	0	0	0	0	0	1
Pertuzumab	"pertuzumab;ro4368451"	"Omnitarg;rhuMAb-2C4;2C4 Antibody;Monoclonal Antibody 2C4;MOAB 2C4;Perjeta;Perjeta-herceptin"	DB06366			380610-27-5	K16AIQ8CTM	"19261664;18000498"	18000498	01/11/2007	15699478	01/04/2005	2004-2008		1	1	1	Yes	1	"08/06/2012 00:00;22/03/2016 00:00;17/03/2015 00:00;12/04/2013 00:00;20/12/2017 00:00;30/09/2013 00:00;29/05/2015 00:00"	AP	GENENTECH	PERTUZUMAB	08/06/2012	GENENTECH	86,1	21	NA	1	0	NA	1	HER2	0	1	0	NA	0	0	0	1	0	0,1	0	0	0	0,29	0	0	0	0	0	0	47	0	1
Carboplatin	"carboplatin;jm-8"	"cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II);cis-Diammine(1,1-cyclobutanedicarboxylato)platinum;CBDCA;Carboplatin;cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii);Paraplatin Inj 150mg/vial;Carboplatin Injection BP;Paraplatin-AQ Inj 10mg/ml;Carboplatin Injection, BP;Carboplatin;CARBOplatin;Carboplatin Injection;Carboplatin Injection Liq 10mg/ml"	"DB00958;APRD00466"		"carboplatin;41575-94-4;Carboplatinum;Cbdca;Paraplatin;Carbopaltin;cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II);Ercar;Paraplatin-AQ;Paraplatin (TN);NSC-241240;JM-8;SR-01000076253;cis-Diammine(1,1-cyclobutanedicarboxylato) platinum;Carboplatin ,(S);diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum;SPECTRUM1502106;Carboplatin (JP17/USP/INN);HMS502M14;HMS1921J16;HMS2092B22;CCG-39887;MFCD00070464;AKOS015905301;AC-1457;CS-1121;DB00958;NCGC00094961-01;NCGC00094961-02;NCGC00094961-03;BC204693;HY-17393;ST24046284;D01363;K-8751;1,1-Cyclobutanedicarboxylatodiammineplatinum (II);575C944;SR-05000002039;I14-2390;SR-01000076253-1;SR-01000076253-5;SR-05000002039-1;6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione diamine;Carboplatin, British Pharmacopoeia (BP) Reference Standard;Carboplatin, United States Pharmacopeia (USP) Reference Standard"	41575-94-4	BG3F62OND5	"26705063;24306314;23147218;22907396;22534815;22101221;19745765;19701107;19088046;17498782;15937647;12873681;12562659;12451469;11166863;10755316;11127946;11066051;11052632;10561372;10355578;10022995;9923815;9856662;9486605;9391552;9159348;9054882;8702250;8622027;7547255;7497601"	7497601	01/01/1995	6761010	01/02/1982	Bef. 1989		1	1	1	Yes	1	"13/03/2012 00:00;14/10/2004 00:00;16/11/2004 00:00;28/07/2010 00:00;26/04/2017 00:00;22/07/2011 00:00;09/02/2017 00:00;14/06/2005 00:00;28/12/2007 00:00;05/07/1991 00:00;21/03/2002 00:00;23/11/2004 00:00;24/04/2007 00:00;23/02/1993 00:00;25/02/2009 00:00;07/09/2000 00:00;14/03/2012 00:00;12/12/2014 00:00;02/12/2008 00:00;07/06/2005 00:00;15/02/2017 00:00;29/09/2006 00:00;26/03/2012 00:00;14/07/2003 00:00;18/01/2007 00:00;01/02/2012 00:00;30/04/2001 00:00;06/01/1998 00:00;16/04/2003 00:00;06/02/2012 00:00;03/03/1989 00:00;21/10/2004 00:00;01/02/2010 00:00;15/02/2006 00:00;17/03/1995 00:00;12/06/1990 00:00;02/03/2012 00:00;09/01/2004 00:00;06/06/2011 00:00;17/08/1990 00:00;29/07/2009 00:00;28/03/2016 00:00;15/11/1999 00:00;30/03/2007 00:00;23/11/2011 00:00;18/03/2005 00:00;18/02/2014 00:00;08/05/2008 00:00;03/12/1999 00:00;24/07/2017 00:00;08/03/2013 00:00;05/11/2010 00:00;21/09/2005 00:00;11/07/2005 00:00;20/01/2006 00:00;27/01/2006 00:00;15/10/2004 00:00;09/11/2011 00:00;14/02/2002 00:00;02/11/2000 00:00;29/05/2012 00:00;07/09/2011 00:00;14/09/2000 00:00;19/09/2008 00:00"	"AP;TA"	"ACTAVIS TOTOWA;FRESENIUS KABI ONCOL;ACCORD HLTHCARE;SUN PHARMA GLOBAL;EUGIA PHARMA;CIPLA LTD;FRESENIUS KABI USA;MYLAN LABS LTD;WEST-WARD PHARMS INT;SANDOZ;SANDOZ INC;AKORN;PLIVA;WATSON LABS TEVA;CORDENPHARMA;TEVA PHARMS USA;CORDEN PHARMA;TEVA PARENTERAL;PHARMACHEMIE BV;MYLAN INSTITUTIONAL;INGENUS PHARMS LLC;NANJING KING-FRIEND;PLIVA LACHEMA;GLAND PHARMA LTD;HOSPIRA"	CARBOPLATIN	03/03/1989	CORDEN PHARMA	84,8	60	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	112	0	1
Serdemetan	serdemetan		DB12027		"Serdemetan;881202-45-5;N1-(2-(1H-Indol-3-yl)ethyl)-N4-(pyridin-4-yl)benzene-1,4-diamine;JNJ-26854165;JNJ 26854165;UNII-ID6YB4W3V8;JNJ-26854165 (Serdemetan);JNJ26854165;ID6YB4W3V8;C21H20N4;n-(2-(1h-indol-3-yl)ethyl)-n'-(4-pyridinyl)-1,4-benzenediamine;N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-PYRIDINYL)-1,4-BENZENEDIAMINE;Serdemetan [INN];D0B3GF;MLS006011022;SCHEMBL3012498;CHEMBL2137530;CTK8C1936;DTXSID30236830;EX-A267;MolPort-009-679-468;HMS3654A16;JNJ 26854165 (Serdemetan);AOB87702;ANW-67474;N-(2-(1H-Indol-3-yl)ethyl)-n'-(pyridin-4-yl)benzene-1,4-diamine;QC-534;s1172;ZINC15965745;AKOS016006774;CS-0166;DB12027;RL05488;NCGC00263171-01;4CA-0668;AJ-68048;AK-88191;BC660010;HY-12025;KB-80551;SMR004702818;AB0033788;AX8237346;TC-156219;FT-0689750;ST24048714;X7539;W-5649;202I455;J-522790;Serdemetan, JNJ 26854165, 881202-45-5;1,4-Benzenediamine, N-[2-(1H-indol-3-yl)ethyl]-N'-4-pyridinyl-;1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(pyridin-4-yl)benzene-1,4-diamine;JNJ-26854165|||1-N-[2-(1H-Indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine"	881202-45-5	ID6YB4W3V8	21831953	21831953	01/08/2011	21831953	01/08/2011	2009-2012		1	1	0	Yes	1					30/07/2018		83,8	71	NA	1	0	NA	1	TP53	0	1	0	NA	0	0	0	1	1	0,01	0	0	0	0,39	0	QT	1	0	0	0	0	0	1
Retaspimycin	"ipi-504;retaspimycin"		DB05626		"Retaspimycin;IPI-504;UNII-BZF2ZM0I5Z;BZF2ZM0I5Z;CHEBI:71975;857402-23-4;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(22),4,6,10,18,20-hexaen-9-yl carbamate;Retaspimycin [USAN:INN];Retaspimycin (USAN/INN);D04PRK;D0EG5A;CHEMBL1184904;SCHEMBL12251507;SCHEMBL13199500;ZINC43128334;AN-27116;D09375;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-Trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa-1(21),4,6,10,18(22),19-hexen-9-yl carbamate;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(allylamino)-6,20,22-trihydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16-oxo-17-azabicyclo[16.3.1]docosa-1(22),8,12,14,18,20-hexaen-10-yl] carbamate;Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-;IPI-504|||17 AAGH2|||[(3R,5S,6R,7S,8E,10S,11S,12E,14E)-6,20,22-trihydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16-oxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(22),8,12,14,18,20-hexaen-10-yl] carbamate"	857402-23-4	BZF2ZM0I5Z	"24045182;21851215"	21851215	01/08/2011	21851215	01/08/2011	2009-2012		1	1	0	Yes	1					30/07/2018		83,8	18	NA	0	1	MYELOMA	0	NA	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,22	0	0	0	0	0	0	0	0	1
Nelarabine	"506u78;gw506u78;nelarabine"	"2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine;Nelzarabine;Atriance;Arranon"	DB01280	"(3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;(3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(3S,4S,5R)-2-(2-amino-6-methoxy-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol;(3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;121032-29-9;9H-Purin-2-amine, 9beta-D-arabinofuranosyl-6-methyl-;9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine;Arranon;GW 506U78;Nelarabine;Nelarabine [USAN];Nelzarabine;Nelzarabine [USAN];U78;506U;506U78"	"Nelarabine;Nelzarabine;121032-29-9;Arranon;Atriance;506U78;ArranonG;GW506U78;GW 506U78;GW-506U78;Arranon (TN);Nelzarabine (USAN);Nelarabine (Arranon);506U;UNII-60158CV180;2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine;Arranon (GlaxoSmithKline);NSC-686673;CHEBI:63612;GW-506U;Nelarabine [USAN];9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine;Nelzarabine [USAN];9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine;NCGC00181098-01;2-Amino-6-methoxypurine arabinoside;60158CV180;S1213;(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;(2R,3S,4S,5R)-2-(2-Amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;DSSTox_CID_26842;DSSTox_RID_81952;DSSTox_GSID_46842;U78;2-(2-Amino-6-methoxy-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol;(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;6-O-Methyl Guanosine;MAY;SMR002544682;CAS-121032-29-9;7803-88-5;Nelarabine [USAN:INN:BAN];Arranon/;Atriance (TN);Nelarabine (INN);Arranon, Nelarabine;NSC 686673;AC1MHTJS;Nelarabine (JAN/USAN);D0B8UJ;9H-Purin-2-amine, 9beta-D-arabinofuranosyl-6-methyl-;SCHEMBL18820;MLS003915614;MLS004774135;MLS006010906;Nelarabine (JAN/USAN/INN);2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;GTPL7090;CHEMBL1201112;DTXSID6046842;(2R,3R,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;(3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;IXOXBSCIXZEQEQ-UHTZMRCNSA-N;MolPort-006-167-760;BCPP000392;HMS3715I16;(2R,3R,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol;ZINC3823492;Tox21_112714;ABP000601;CN0033;NSC755985;AKOS015852325;AKOS015920191;Tox21_112714_1;BCP9000318;CS-1607;DB01280;NSC-755985;NCGC00274059-01;AJ-45735;AK-25325;AS-47664;BR-25325;HY-13701;KB-58122;SC-28312;AX8031634;KB-274813;ST2419746;FT-0650169;FT-0671804;D05134;J10096;S-7406;AB01274773-01;AB01274773_02;032N299;A804639;C-58277;SR-01000931847;9-?-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine;SR-01000931847-3;2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9 H-purine;2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9H-purine;BRD-K84466663-001-01-3;2-Amino-6-methoxy-9-beta-D-arabinofuranosyl-9H-purine;9-(beta-D-arabinofuranosyl)-6-methoxy-9H-purin-2-amine;9-beta -D-arabinofuranosyl-2-amino-6-methoxy-9H-purine;9-beta-D-arabinofuranosyl-2-amino-6-methoxy-9 H-purine;2-Amino-6-methoxy-9-(beta-D-arabinofuranosyl)-9H-purine;(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol;(2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(2R,3S,4S,5R)-2-(2-azanyl-6-methoxy-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;(2R,3S,4S,5R)-2-(hydroxymethyl)-5-(2-imino-6-methoxy-3,9-dihydro-2H-purin-9-yl)oxolane-3,4-diol;Arranon|||Nelzarabine|||GW-506U78|||(2R,3S,4S,5R)-2-(2-Amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"	121032-29-9	60158CV180	"18309944;10694549;9817282"	9817282	01/11/1998	9817282	01/11/1998	1994-1998		1	1	1	Yes	1	"06/02/2012 00:00;28/10/2005 00:00;15/12/2009 00:00;03/07/2018 00:00;04/06/2015 00:00"	AP	NOVARTIS PHARMS CORP	NELARABINE	28/10/2005	NOVARTIS PHARMS CORP	83,7	26	NA	0	1	NHL	0	NA	0	1	0	NA	0	0	0	1	0	1	0	1	1	1	0	0	0	0	0	0	59	0	1
Exemestane	"aromasin;aromasine;exemestane;pnu 155971"	"Aromasine;Aromasin;Exemestane;6-Methyleneandrosta-1,4-diene-3,17-dione;Exemestanum;Exemestano;Gd-exemestane;Act Exemestane;Med-exemestane;Aromasin;Exemestane;Teva-exemestane;Mylan-exemestane;Apo-exemestane"	"DB00990;APRD00144"	"(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-quinone;107868-30-4;MLS000759419;SMR000466314;6-Methyleneandrosta-1,4-diene-3,17-dione;Androsta-1,4-diene-3,17-dione, 6-methylene-;Aromasin;Exemestane [USAN:INN:BAN];Exemestano [INN-Spanish];Exemestanum [INN-Latin];Fce 24304;Exemestane (JAN/USP/INN);6-methylideneandrosta-1,4-diene-3,17-dione;FCE-24304;Nikidess;D00963;LS-19329;Aromasin (TN);6-Methylenandrosta-1,4-diene-3,17-dione;NSC713563;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione;Curator_000009;C08162;Exemestane"	"EXEMESTANE;107868-30-4;Aromasin;6-Methyleneandrosta-1,4-diene-3,17-dione;Exemestano;Exemestanum;Aromasine;Aromasil;Exemestanum [INN-Latin];Exemestano [INN-Spanish];Fce 24304;FCE-24304;Exemestance;6-Methylene-androsta-1,4-diene-3,17-dione;Exemestane [USAN:INN:BAN];Nikidess;UNII-NY22HMQ4BX;Aromasin (TN);HSDB 7463;Curator_000009;NY22HMQ4BX;Androsta-1,4-diene-3,17-dione, 6-methylene-;PNU-155971;Exemestane (JAN/USP/INN);6-Methylenandrosta-1,4-diene-3,17-dione;CHEBI:4953;6-methylideneandrosta-1,4-diene-3,17-dione;FCE24304;MFCD00866994;NSC713563;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione;DSSTox_CID_3037;DSSTox_RID_76844;DSSTox_GSID_23037;EXE;SMR000466314;CAS-107868-30-4;(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione;CCRIS 9351;NCGC00095289-01;CPD000466314;Aromasin, Exemestane;Exemestane, Aromasin;PNU 155971;PubChem5810;AC1L1SRB;AC1Q6AAZ;Pfizer brand of exemestane;D0D2VS;SCHEMBL6215;Aromasin (Pharmacia Upjohn);Exemestane(FCE 24304);MLS000759419;MLS001424062;GTPL7073;6-Methylenandrosta-1,17-dione;CHEMBL1200374;DTXSID5023037;Exemestane, >=98% (HPLC);CTK0H9416;AOB5604;SYN3023;BFYIZQONLCFLEV-DAELLWKTSA-N;BCPP000235;HMS2051J04;HMS3713H12;ZINC3973334;Tox21_111499;ANW-63402;BDBM50398447;s1196;AKOS015840113;AKOS015895161;Tox21_111499_1;AC-2171;AN-6407;BCP9000676;CCG-100995;CS-1766;DB00990;KS-5136;NC00245;NSC-713563;NCGC00271596-03;6-methylenandrost-1,4-dien-3,17-dione;AJ-47550;AS-31053;BC666132;CC-28344;CJ-11236;HY-13632;LS-19329;SC-46568;SY015689;BCP0726000226;6-Methylen-androst-1,4-diene-3,17-dione;AB0063735;TC-152147;E0941;C08162;D00963;Z-4332;AB00639936-06;AB00639936-08;AB00639936-09;AB00639936-10;AB00639936_11;868E304;C-18573;SR-01000759393;SR-01000759393-4;BRD-K33425534-001-12-5;Exemestane, European Pharmacopoeia (EP) Reference Standard;Exemestane, United States Pharmacopeia (USP) Reference Standard;(8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione;Exemestane, Pharmaceutical Secondary Standard; Certified Reference Material;Exemestane for system suitability, European Pharmacopoeia (EP) Reference Standard;(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-diene-5,14-dione;(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione;EXM"	107868-30-4	NY22HMQ4BX	"23053261;9823425;9815789"	9815789	01/07/1997	1394219	01/11/1992	1989-1994		1	1	1	Yes	1	"27/04/2018 00:00;03/08/2011 00:00;15/02/2013 00:00;18/05/2018 00:00;24/12/2008 00:00;25/07/2016 00:00;10/03/2017 00:00;21/10/1999 00:00;26/07/2017 00:00;01/04/2011 00:00;06/07/2015 00:00;02/05/2014 00:00;13/11/2003 00:00;23/09/2004 00:00;25/03/2011 00:00;05/10/2005 00:00;04/04/2001 00:00;28/07/2014 00:00"	AP	"#N/A;MYLAN PHARMS INC;UPSHER-SMITH LABS;WEST-WARD PHARMS INT;ALVOGEN MALTA;PHARMACIA AND UPJOHN"	EXEMESTANE	21/10/1999	PHARMACIA AND UPJOHN	83,4	29	NA	0	0	NA	1	AROMATASE	1	1	0	NA	0	0	0	NA	0	NA	0	NA		NA	0	0	0	0	0	0	139	0	1
Abiraterone	"abiraterone;cb7630"	"17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol;Zytiga;Abiraterone acetate"	DB05812	"(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol;154229-19-3;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;Abiraterone;Abiraterone [INN:BAN];Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;CB 7598;CB-7598"	"Abiraterone;154229-19-3;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;(3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol;CB 7598;CB-7598;Abiraterone (CB-7598);CB7598;UNII-G819A456D0;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;CHEMBL254328;Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;CHEBI:68642;(3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol;G819A456D0;17-(pyridin-3-yl)androsta-5,16-dien-3beta-ol;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol;C24H31NO;Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3b)-;Abiraterone [INN:BAN];PubChem20542;Abiraterone/CB-7598;D02STN;(3-beta)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol;Abiraterone (AR inhibitor);Abiraterone - CB-7598;AC1L31XF;CB 7630 [as acetate];SCHEMBL61108;MLS006010235;GTPL6745;BDBM25458;CTK8B7779;EX-A106;QCR-150;GZOSMCIZMLWJML-VJLLXTKPSA-N;MolPort-009-679-392;AMX10150;ZINC3797541;Abiraterone(CB-7598)/CB7598;ABP000222;AN-849;ANW-58538;MFCD00924100;NSC749226;s1123;AKOS005146525;AB07690;AM84498;CS-0156;DB05812;ES-0045;NSC-749226;RL01978;SHG0006431;AC-25764;AJ-45637;AK-80501;BC685739;CJ-10764;HY-70013;KB-47025;SC-26224;SMR002530050;AB0031795;AX8161413;ST2407991;TC-071424;X5008;17-(3-Pyridyl)androsta-5.16-dien-3beta-ol;A24884;S-7705;17-(3-Pyridyl)androsta-5,16-dien-3.beta.-ol;AB01274738-01;AB01274738_02;229A193;SR-01000941584;(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol;J-519524;SR-01000941584-1;BRD-K50071428-001-01-7;BRD-K50071428-001-03-3;CB-7598;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol"	154229-19-3	G819A456D0	"25204404;24787968;23807167;22771826;20159824;19470933"	19470933	01/05/2009	15150570	01/06/2004	2004-2008		1	1	1	Yes	1	"22/05/2018 00:00;03/03/2015 00:00;16/11/2014 00:00;17/06/2013 00:00;17/05/2016 00:00;07/02/2018 00:00;07/02/2014 00:00;17/09/2012 00:00;13/05/2014 00:00;10/12/2012 00:00;03/07/2012 00:00;10/12/2015 00:00;20/05/2015 00:00;28/04/2011 00:00;18/08/2015 00:00;20/03/2015 00:00;01/04/2014 00:00;12/09/2013 00:00;23/01/2015 00:00;17/04/2014 00:00;20/01/2015 00:00"	AP	"SUN PHARMA GLOBAL;JANSSEN BIOTECH"	ABIRATERONE ACETATE	28/04/2011	JANSSEN BIOTECH	82,7	NA	NA	0	1	PROSTATE	1	CYP17	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	559	0	1
GSK-923295	gsk923295		DB06097		"GSK-923295;1088965-37-0;GSK923295;3-Chloro-N-((S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-((S)-1-hydroxyethyl)imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide;3-Chloro-N-((S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-((S)-1-hydroxyethyl)-imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide;D00XEU;MLS006011170;SCHEMBL1492164;UNII-072702W9QD;CTK8C0600;AOB5937;DTXSID50677145;EX-A633;GSK-295;MolPort-023-332-816;WHMXDBPHBVLYRC-OFVILXPXSA-N;GSK-923295A;ANW-64945;s7090;ZINC68151184;AKOS016005270;072702W9QD;CS-0056;EBD2335383;NCGC00346943-01;BC625612;Benzamide, 3-chloro-N-[(1S)-2-[[2-(dimethylamino)acetyl]amino]-1-[[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]methyl]ethyl]-4-(1-methylethoxy)-;HY-10299;KB-77631;SMR004702939;TC-153690;FT-0771470;KS-00000015;W-5627;J-690025;3-Chloro-N-[(2S)-1-[(N,N-dimethylglycyl)amino]-3-(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)propan-2-yl]-4-[(propan-2-yl)oxy]benzamide;GSK-923295A|||3-Chloro-N-[(2S)-1-[[2-(dimethylamino)acetyl]amino]-3-[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]propan-2-yl]-4-propan-2-yloxybenzamide"			22020315	22020315	01/10/2011	22020315	01/10/2011	2009-2012		1	1	0	Yes	1					30/07/2018		81,8	39	NA	1	0	NA	1	CENP-E	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	NA	0	0	0	0	0	0	0	0	1
PR-104	"pr-104;pr104"		DB05968		"851627-62-8;PR-104;UNII-V16D2ZT7DT;PR104;V16D2ZT7DT;2-((2-Bromoethyl)(2,4-dinitro-6-((2-(phosphonooxy)ethyl)carbamoyl)phenyl)amino)ethyl methanesulfonate;2-[(2-bromoethyl)(2,4-dinitro-6-{[2-(phosphonooxy)ethyl]carbamoyl}phenyl)amino]ethyl methanesulfonate;PR 104;D05CFG;SCHEMBL367963;ZINC43131754;AKOS022174966;RL05275;4CA-1041;KB-80083;AX8282408;J-507569;Benzamide, 2-((2-bromoethyl)(2-((methylsulfonyl)oxy)ethyl)amino)-3,5-     dinitro-N-(2-(phosphonooxy)ethyl)-"	851627-62-8	V16D2ZT7DT	"25682597;21982454"	21982454	01/10/2011	21982454	01/10/2011	2009-2012		1	1	0	Yes	1					30/07/2018		81,8	26	70	1	0	NA	1	DNA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
AT9283	at9283		DB05169		"AT9283;896466-04-9;J-504568;1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea;AT 9283;AT-9283;cc-56;D05PZB;GTPL7949;SCHEMBL15005492;EX-A201;MolPort-009-679-504;BCPP000379;3-cyclopropyl-1-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}urea;s1134;ZINC34637502;AKOS016006006;BCP9000337;QC-4297;AS-16186;BC659956;KB-74758;AX8211351;W-5568;BRD-K24576554-001-01-4;AT-9283, AT 9283,  896466-04-9;1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea;1-cyclopropyl-3-[(3E)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea;1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea"			"24355079;24072436;22015452"	22015452	01/10/2011	22015452	01/10/2011	2009-2012		1	1	0	Yes	1					30/07/2018		81,8	40	NA	1	0	NA	1	AURORAK	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,1	0	0	0	0	0	0	0	0	1
Eflornithine	"alpha-difluoromethylornithine;difluoromethylornithine;eflornithine hydrochloride;mdl 71782;rmi-71782"	"(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid;alpha-difluoromethylornithine;α-difluoromethylornithine;DFMO;2-(difluoromethyl)ornithine;Vaniqa"	DB06243	"2,5-diamino-2-(difluoromethyl)pentanoic acid;2,5-diamino-2-(difluoromethyl)valeric acid;67037-37-0;70052-12-9;NSC337250;C07997;DL-Ornithine, 2-(difluoromethyl)-;Eflornithine;CCRIS 3718;D,L-alpha-Difluoromethylornithine;DL-alpha-Difluoromethylornithine;2,5-diamino-2-(difluoromethyl)pentanoic acid;HSCI1_000267;2-(Difluoromethyl)-DL-ornithine;2-(Difluoromethyl)ornithine;BRN 2250529;CCRIS 3295;DFMO (growth regulator);pentane-1,4-diamine;Eflornithinum [Latin];Eflornitina [Spanish];MDL 71782;N-Difluoromethylornithine;Ornithine, 2-(difluoromethyl)-;RMI 71782;alpha,delta-Diamino-alpha-(difluoromethyl)valeric acid;alpha-(Difluoromethyl)-DL-ornithine;alpha-Difluoromethylornithine;CHEBI:41948;Lopac0_000429;DL-alpha-(Difluoromethyl)ornithine;67037-37-0 (FREE BASE);96020-91-6 (HYDROCHLORIDE);AIDS-002149;AIDS002149;DL-.alpha.-Difluoromethylornithine;Difluoromethylornithine"	"EFLORNITHINE;Ornidyl;70052-12-9;2-(Difluoromethyl)ornithine;dfmo;Difluoromethylornithine;Vaniqa;Difluromethylornithine;Eflornithinum;Eflornitina;alpha-Difluoromethylornithine;Eflornithinum [Latin];Eflornitina [Spanish];2,5-diamino-2-(difluoromethyl)pentanoic acid;alpha-(Difluoromethyl)-DL-ornithine;N-Difluoromethylornithine;DFMO (growth regulator);67037-37-0;Eflornithine [INN:BAN];2-(Difluoromethyl)-DL-ornithine;RMI 71782;DL-alpha-(Difluoromethyl)ornithine;MDL 71782;Eflornithine (INN);CCRIS 3295;DL-alpha-Difluoromethylornithine;Ornithine, 2-(difluoromethyl)-;Eflornithine HCl;D,L-alpha-Difluoromethylornithine;DL-.alpha.-Difluoromethylornithine;DL-Ornithine, 2-(difluoromethyl)-;CHEMBL830;DFMO HCl;BRN 2250529;alpha,delta-Diamino-alpha-(difluoromethyl)valeric acid;CHEBI:41948;VLCYCQAOQCDTCN-UHFFFAOYSA-N;Elfornithine;NSC337250;DFMO hydrochloride;MDL 71,782 A;.alpha.-DFMO HCl;DFMO hydrochloride hydrate;CPP-1X;DL-Ornithine, monohydrochloride;Eflornithine hydrochloride anhydrous;2-(Difluoromethyl)-DL-ornithine HCl;BMS 203522;alpha-Difluoromethylornithine hydrochloride;CCRIS 3718;C6H12F2N2O2;HSDB 7923;DL-alpha-Difluoromethylornithine hydrochloride hydrate;alpha-DFMO;RFI 7178;Alpha-DFMO HCl;Ornidyl (TN);2-(Difluoromethyl)-DL-ornithine monohydrochloride.monohydrate;AC1L1EYW;ACMC-20m6r1;D0X7JR;D0Y4DA;Lopac0_000429;SCHEMBL26327;GTPL5176;DTXSID3020467;CTK8F9193;66640-93-5;HY-B0744;2-(difluoromethyl)ornithine (DMFO);BDBM50028197;HSCI1_000267;KM1060;AKOS006281180;AN-6442;API0002526;CCG-204521;CS-2983;DB06243;LS-7332;NSC-337250;NCGC00015316-02;NCGC00015316-03;NCGC00015316-06;NCGC00162152-01;AK174597;AN-10916;AN-38391;K100;SC-35609;1-(3-CHLOROPYRIDIN-4-YL)HYDRAZINE;2-difluoromethyl-2,5-diaminopentanoic acid;LS-185084;FT-0630795;FT-0720946;C07997;D07883;EN300-150187;96020-91-6 (mono-hydrochloride, monohydrate);020E916;(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid;DFMO;MDL71782;RMI71782;|A-difluoromethylornithine"	70052-12-9	ZQN1G5V6SR	"11401916;10589756;9796636;9516915"	9516915	01/05/1998	6422008	01/02/1984	Bef. 1989		1	1	1	Yes	1	"25/06/2001 00:00;03/01/2002 00:00;27/07/2000 00:00;30/08/2013 00:00;15/12/2000 00:00;22/07/2013 00:00;29/02/2016 00:00;28/11/1990 00:00;05/09/2001 00:00;29/06/2001 00:00;17/04/1995 00:00"	AP	"SANOFI AVENTIS US;SKINMEDICA"	EFLORNITHINE HYDROCHLORIDE	28/11/1990	SANOFI AVENTIS US	81,7	22	NA	1	0	NA	1	ORNITHINE DECARBOXYLASE	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Tivozanib	tivozanib		DB11800		"Tivozanib;475108-18-0;AV-951;Tivozanib (AV-951);KRN-951;AV 951;AV951;N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA;UNII-172030934T;KRN951;CHEMBL1289494;KIL8951;1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA;AV-951(Tivozanib);J-502964;172030934T;Kil-8951;Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV;N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N&prime;-(5-methyl-3-isoxazolyl)urea;N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea;Tivozanib hydrochloride monohydrate;ASP-4130;Tivozanib [USAN:INN];fotivda;4ase;1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea;KRN 951;N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea;Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-;1-(2-CHLORO-4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL)-3-(5-METHYL-1,2-OXAZOL-3-YL)UREA;UREA, N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)-;AV-951,Tivozanib;PubChem22421;Tivozanib(AV-951);Tivozanib (USAN/INN);Tivozanib - AV-951;D0W7JZ;MLS006011287;SCHEMBL172883;GTPL6058;CHEBI:91327;KS-00001CTN;EX-A472;SYN1013;MolPort-009-679-467;SPMVMDHWKHCIDT-UHFFFAOYSA-N;HMS3229O09;HMS3244C19;HMS3244C20;HMS3244D19;HMS3265A11;HMS3265A12;HMS3265B11;HMS3265B12;HMS3654G22;AOB87139;ZINC1489430;ASP4130/AV-951;ABP001003;AN-470;BDBM50331095;RS0093;s1207;AKOS022177607;AV951 (KRN951, TIVOZANIB);BCP9000343;CCG-206805;CS-0103;DB11800;EX-8600;KIN0000444;KRN 951 /TIVOZANIB/AV-951;PB28569;NCGC00249390-01;4CA-1259;AC-24702;AJ-26332;AS-16997;BC659936;HY-10977;KB-57339;SC-54549;SMR004703037;AB0007909;FT-0700315;ST24037076;X4932;A24970;D09683;Q-3811;108K180;BRD-K53414658-001-01-7;N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]pheny;AV951, AV-951, 475108-18-0;1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea;N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea;N2-Chloro-4-(6,7-dimethoxy-4-quinolyl)oxyphenyl-N'-(5-methyl-3-isoxazolyl)urea;1-(2-chloro-4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;AV-951;AV9;N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA"	475108-18-0	172030934T	"27128834;23679664"	23679664	01/05/2013	21976547	01/11/2011	2009-2012		1	1	0	Yes	1					30/07/2018		80,8	41	NA	1	0	NA	1	VEGFR	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Volasertib	volasertib		DB12062		"Volasertib;755038-65-4;BI 6727;BI-6727;BI6727 (Volasertib);UNII-6EM57086EA;Volasertib (BI 6727);6EM57086EA;BI6727;Volasertib [USAN:INN];Benzamide, N-(trans-4-(4-(cyclopropylmethyl)-1-piperazinyl)cyclohexyl)-4-(((7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl)amino)-3-methoxy-;BENZAMIDE, N-[TRANS-4-[4-(CYCLOPROPYLMETHYL)-1-PIPERAZINYL]CYCLOHEXYL]-4-[[(7R)-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-8-(1-METHYLETHYL)-6-OXO-2-PTERIDINYL]AMINO]-3-METHOXY-;IBI;N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide;Volasertib (USAN);BI6727,Volasertib;Volasertib(BI6727);BI6727 - Volasertib;Volasertib (BI6727);D00BYM;BI 6727 (Volasertib);BI6727 (Volasertib)/;MLS006011195;SCHEMBL738946;GTPL7947;SCHEMBL2169101;SCHEMBL9888052;CHEMBL1233528;MolPort-016-633-357;BCPP000341;C34H50N8O3;AOB87138;EX-A1364;ABP000330;BDBM50402023;s2235;ZINC39716290;AKOS005266487;AKOS030257530;ZINC100071772;ZINC248087828;BCP9000403;CS-0274;DB12062;PB19742;NCGC00263087-01;AS-16996;HY-12137;KB-81453;SC-95532;SMR004702964;FT-0770519;X7437;D10182;Q-4502;SR-03000003275;SR-03000003275-1;4-{[(7R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino}-3-methoxy-N-[(1r,4r)-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]benzamide;N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide;N-[TRANS-4-[4-(CYCLOPROPYLMETHYL)-1-PIPERAZINYL]CYCLOHEXYL]-4-[[(7R)-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-8-(1-METHYLETHYL)-6-OXO-2-PTERIDINYL] AMINO]-3-METHOXYBENZAMIDE;n-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide;n-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxybenzamide"	755038-65-4	6EM57086EA	"26627079;26471242;24755882;22119200"	22119200	01/11/2011	22119200	01/11/2011	2009-2012		1	1	0	Yes	1					30/07/2018		80,8	65	NA	1	0	NA	1	PLK	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	0,4	0	0	0	0	0	0	0	0	1
Paclitaxel	"abi-007;albumin-bound paclitaxel;dhp107;mucoadhesive paclitaxel formulation;nab-paclitaxel;nanomicellar paclitaxel formulation;nk105;oncogel;paclitaxel;regel/paclitaxel;taxol"	"(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester;5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;Abraxane;Abraxane for Injectable Suspension;Aj-paclitaxel;Apo-paclitaxel Injectable;Paclitaxel;Paclitaxel Injection;Paclitaxel Injection USP;Paclitaxel Injection, USP;Paclitaxel Paclitaxel;Paclitaxel for Injection;Paclitaxel for Injection USP;Paxene;Taxol;Taxol A;Teva-paclitaxel for Injection"	"APRD00259;DB01229;DB05261;DB05526;DB05927"	"33069-62-4;KBio2_005628;Probes2_000350;UPCMLD-DP108:002;Bio1_000851;IDI1_002171;KBio3_000903;KBio3_000904;BSPBio_001152;C07394;Paclitaxel;SPBio_000943;IDI1_000441;SMP1_000228;Abraxane (TN);D00491;Paclitaxel (JAN/USP/INN);Taxol (TN);Spectrum4_001197;BSPBio_002614;EU-0101201;LMPR01040091;Spectrum5_001491;Bio1_000362;Bio2_000416;KBioGR_000492;KBioSS_000492;Spectrum3_001057;Spectrum2_000872;KBioSS_002016;Spectrum_001536;KBioGR_001893;Bio1_001340;NINDS_000441;Bio2_000896;DivK1c_000441;NCGC00024995-04;KBio3_001834;SPECTRUM1503908;SDCCGMLS-0066823.P001;KBio2_002016;KBio2_004584;KBio2_007152;KBio1_000441;Lopac0_001201;KBio2_000492;KBio2_003060;UPCMLD-DP108:001"	"paclitaxel;TAXOL;33069-62-4;Taxol A;Abraxane;Paxene;Paxceed;Plaxicel;Yewtaxan;Onxol;Ebetaxel;Capxol;Genaxol;nab-paclitaxel;LipoPac;ABI-007;Paclitaxel (Taxol);Cyclopax;Genetaxyl;Genexol;Intaxel;Mitotax;Padexol;TaxAlbin;Zisu;OncoGel;EmPAC;Xorane;NSC-125973;ABI 007;UNII-P88XT4IS4D;NSC125973;BMS 181339-01;HSDB 6839;DRG-0190;MBT 0206;QW 8184;nabpaclitaxel;P88XT4IS4D;BMS-181339-01;CHEMBL428647;CHEBI:45863;7-epi-Paclitaxel;Tocosol Paclitaxel;NSC 125973;5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;NCGC00164367-01;(2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester;Anzatax;Cynviloq;Nanoxel;Pacliex;Sindaxel;Cypher select;Coroflex Please;Taxus stent;Taxus Express;Taxus Liberte;(NAB)-Paclitaxel;SMR000857385;EndoTAG 1;EndoTAG-1;LEP-ETU;SR-01000075350;Abraxane I.V. Suspension;Infinnium;Nanotaxel;Paclical;Pacligel;Paxoral;Onxal;Paclitaxel/;CCRIS 8143;Vascular Wrap;Genexol-PM;DHP 107;Paclitaxel,(S);Paclitaxel [USAN:USP:INN:BAN];Abraxane (TN);(2alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;[diacetoxy-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-dihydroxy-tetramethyl-oxo-[?]yl] benzoate;Nanoparticle albumin bound paclitaxel;CAS-33069-62-4;IG 001;NK 105;BMS-181339;Paclitaxel-SSMM-VIP;Liposome-entrapped paclitaxel easy-to-use;P-SSMM-VIP;AC1L1VJI;Prestwick3_000155;DSSTox_CID_3413;TAXOL (TN);SCHEMBL3976;DSSTox_RID_77016;Nova-12005;BIDD:PXR0046;DSSTox_GSID_23413;BSPBio_000290;KBioGR_002509;KBioSS_002517;Paclitaxel (JAN/USP/INN);MLS002154218;MLS002695976;OAS-PAC-100;BPBio1_000320;GTPL2770;MEGxp0_001940;Taxol (TN) (Bristol Meyers);DTXSID9023413;ACon1_002231;KBio2_002509;KBio2_005077;KBio2_007645;KBio3_002987;ANX-513;DHP-107;DHP-208;DTS-301;SDP-013;7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.;cMAP_000068;MolPort-001-742-627;RCINICONZNJXQF-MZXODVADSA-N;ZX-AFC000078;HMS2090D07;HMS2095O12;HMS2231A16;HMS3712O12;Abraxane (albumin-bound suspension);ACT02709;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-R*,beta-S*),11-alpha,12-alpha,12a-alpha, 12b-alpha))-;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-;HY-B0015;MPI-5018;Tox21_112107;ABP000252;BDBM50001839;MFCD00869953;NSC745099;ZINC96006020;AKOS007930675;AKOS015969673;AKOS025312303;ACN-032459;CCG-220155;CS-1145;DB01229;GS-6554;NSC-745099;RL03195;NCGC00164367-02;NCGC00164367-03;NCGC00164367-04;NCGC00164367-05;Paclitaxel, From Taxus brevifolia, 95%;AK108391;NA090030;NCI60_000601;SY016928;Paclitaxel, from Taxus yannanensis, powder;AB0069184;ST2419771;AB00513812;N1361;D00491;M-8858;N88686;10337-EP2269989A1;10337-EP2270018A1;10337-EP2272827A1;10337-EP2272832A1;10337-EP2277507A1;10337-EP2277865A1;10337-EP2277876A1;10337-EP2280012A2;10337-EP2280014A2;10337-EP2281815A1;10337-EP2281820A2;10337-EP2286795A1;10337-EP2287168A2;10337-EP2289876A1;10337-EP2289892A1;10337-EP2292233A2;10337-EP2292234A1;10337-EP2292614A1;10337-EP2292615A1;10337-EP2295412A1;10337-EP2295413A1;10337-EP2295416A2;10337-EP2298748A2;10337-EP2298754A1;10337-EP2298772A1;10337-EP2298780A1;10337-EP2301533A1;10337-EP2301536A1;10337-EP2301538A1;10337-EP2301928A1;10337-EP2301933A1;10337-EP2301940A1;10337-EP2302382A2;10337-EP2302383A2;10337-EP2305243A1;10337-EP2305250A1;10337-EP2305640A2;10337-EP2305642A2;10337-EP2305671A1;10337-EP2305679A1;10337-EP2305689A1;10337-EP2305808A1;10337-EP2308833A2;10337-EP2308839A1;10337-EP2308861A1;10337-EP2311455A1;10337-EP2311808A1;10337-EP2311827A1;10337-EP2311829A1;10337-EP2314295A1;10337-EP2314574A1;10337-EP2316452A1;10337-EP2316832A1;10337-EP2316833A1;AB00513812-02;AB00513812-03;069P624;Paclitaxel, Antibiotic for Culture Media Use Only;7,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.;Q-201533;SR-01000075350-1;SR-01000075350-3;SR-01000075350-6;SR-01000075350-7;SR-01000075350-9;BRD-K62008436-001-03-1;BRD-K62008436-001-05-6;BRD-K62008436-001-22-1;Paclitaxel, from semisynthetic (from Taxus sp.), >=97%;Paclitaxel, European Pharmacopoeia (EP) Reference Standard;Paclitaxel, from Taxus brevifolia, >=95% (HPLC), powder;Paclitaxel, United States Pharmacopeia (USP) Reference Standard;12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;Paclitaxel, Pharmaceutical Secondary Standard; Certified Reference Material;7,11-METHANO-5H-CYCLODECA[3,4]BENZ[1,2-B]OXETE BENZENEPROPANOIC ACID DERIV.;Paclitaxel natural for peak identification, European Pharmacopoeia (EP) Reference Standard;(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0;{3,10}.0;{4,7}]heptadec-13-en-2-yl benzoate;(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro 4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano 5Hcyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate,;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-(benzoylamino)-a-hydroxybenzenepropanoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate;(2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12;1203669-79-7;157069-30-2;4alpha,10beta-bis(acetyloxy)-13alpha-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyloxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate;5?,20-Epoxy-1,7?-dihydroxy-9-oxotax-11-ene-2?,4,10?,13?-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate];Benzenepropanoic acid, 6,12b-bis(acetyl oxy)-12-(benzoyloxy)- 2a,3,4,4a,5,6,9,10,11,12,12a,12b,- dodecahydro-4,11- dihydroxy-4a,8,13,13-tetramethyl-5-oxo- 7,11-methano- 1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR- [2a.alpha.,4.beta.,4a.beta.,6.beta.,9.alpha.(alpha. R*,.beta.S*),11.alpha.,12.alpha.,12a.alpha.,12b.alpha.]]-;Benzenepropanoic acid, b-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)-;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-;Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H;Paclitaxel semi-synthetic for peak identification, European Pharmacopoeia (EP) Reference Standard;Paclitaxel semi-synthetic for system suitability, European Pharmacopoeia (EP) Reference Standard;Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha- hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI);Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI);Tax-11-en-9-one,20-epoxy-1,2.alpha.,4,7.beta., 10.beta.,13.alpha.- hexahydroxy-, 4,10-diacetate 2- benzoate,13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine"	33069-62-4	P88XT4IS4D	"10587020;10760424;10803320;11230480;11237379;11331328;11605177;11745194;12006516;12168878;12426834;12573755;12610186;14566475;14701767;15010068;15035283;15173077;15596915;15752883;16012790;16115934;16258082;16273271;16278406;16626792;16891865;17264760;17409825;17519083;17545535;17668866;18164866;18520792;18565883;18794097;19034451;19100600;19633055;19701107;19745765;20133335;20207133;20680660;20941597;21036487;21372498;21853310;22203732;22695940;23733258;26705063;27595901;28196905;7475290;7551942;8523061;8636011;8636777;8648372;8814705;8826941;8899009;8941405;8996141;8996594;9007118;9007138;9007139;9007140;9045342;9060526;9166489;9225955;9240634;9300570;9331132;9346225;9427267;9440737;9493980;9653500;9773805;9849493;9862057"	7551942	01/06/1995	2871137	01/05/1986	Bef. 1989		1	1	1	Yes	1	"15/02/1995 00:00;05/11/1998 00:00;20/05/2008 00:00;14/07/2011 00:00;10/04/2015 00:00;10/12/2012 00:00;06/12/2002 00:00;25/01/2002 00:00;21/07/2015 00:00;29/09/2011 00:00;14/10/2011 00:00;02/05/2011 00:00;08/01/1999 00:00;20/04/2015 00:00;30/08/2011 00:00;13/12/1996 00:00;15/02/2007 00:00;04/03/2002 00:00;13/08/2010 00:00;16/03/1994 00:00;05/03/1997 00:00;05/03/2003 00:00;06/09/2013 00:00;10/04/2001 00:00;25/04/1997 00:00;12/12/2002 00:00;30/10/2013 00:00;29/12/1992 00:00;26/06/2009 00:00;25/10/1999 00:00;09/04/1998 00:00;01/07/2008 00:00;12/11/2004 00:00;20/06/2000 00:00;28/04/2014 00:00;27/06/2014 00:00;09/12/2009 00:00;14/10/2015 00:00;28/09/2012 00:00;22/07/1994 00:00;17/08/2009 00:00;09/07/2002 00:00;10/09/2008 00:00;05/05/1995 00:00;07/06/2013 00:00;18/11/2011 00:00;26/12/2007 00:00;07/03/2007 00:00;23/08/2016 00:00;03/04/1996 00:00;08/07/2011 00:00;03/03/2015 00:00;04/08/1997 00:00;02/12/2011 00:00;09/01/2013 00:00;13/04/1994 00:00;13/09/2011 00:00;22/06/1994 00:00;07/01/2005 00:00;23/03/2007 00:00;19/12/1997 00:00;01/08/2002 00:00;04/09/2002 00:00;10/12/1999 00:00;11/10/2012 00:00;23/12/2011 00:00;01/04/1998 00:00;14/05/2007 00:00;23/05/2001 00:00;02/11/2015 00:00;15/07/2011 00:00;23/07/1993 00:00;21/04/1994 00:00;19/10/1994 00:00;08/05/2002 00:00;14/08/2002 00:00;28/03/2012 00:00;24/03/2016 00:00;11/12/2014 00:00;28/01/2002 00:00;23/10/2002 00:00;01/04/1996 00:00;29/08/2002 00:00;12/03/2008 00:00;25/06/1993 00:00;19/03/1999 00:00;18/09/1997 00:00;20/04/2005 00:00;28/11/2011 00:00;30/06/1998 00:00;27/11/2006 00:00"	AP	"ACCORD HLTHCARE;TEVA PHARMS USA;TEVA PHARMS;MYLAN LABS LTD;ACTAVIS TOTOWA;WEST-WARD PHARMS INT;SANDOZ INC;PLIVA LACHEMA;FRESENIUS KABI ONCOL;GLAND PHARMA LTD;HOSPIRA;MYLAN;HQ SPCLT PHARMA;ABRAXIS BIOSCIENCE"	PACLITAXEL	29/12/1992	SANDOZ INC	79,8	20	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	800	0	1
Cixutumumab	cixutumumab		"DB12250;DB05759"			947687-12-9	2285XW22DR	"27139036;22184397"	22184397	01/12/2011	22184397	01/12/2011	2009-2012		1	1	0	Yes	1					30/07/2018		79,8	47	28	1	1	EWING	1	IGF1R	0	1	1	35	0	1	0	1	1	0,09	0	0	0	NA	0	0	0	0	0	0	25	0	1
Buparlisib	"bkm120;buparlisib"		DB11666		"944396-07-0;Buparlisib;NVP-BKM120;BKM120;5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine;NVP-BKM-120;BKM-120;BKM 120;1202777-78-3;UNII-0ZM2Z182GD;NVP-BKM 120;5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine;0ZM2Z182GD;CHEMBL2017974;CHEBI:71954;5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine;BKM120 (NVP-BKM120, Buparlisib);C18H21F3N6O2;2-Pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-;5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine;Buparlisib [USAN:INN];BKM 120NX;SD5;Buparlisib; BKM120;3sd5;Buparlisib (USAN/INN);D01QSO;QCR-4;BKM120-NX;MLS006010984;SCHEMBL146956;GTPL7878;BKM120,NVP-BKM120;AMMD00049;CTK8C0567;BMK-120;DTXSID50241486;EX-A189;SYN1200;CWHUFRVAEUJCEF-UHFFFAOYSA-N;MolPort-023-293-494;HMS3655D16;AOB87379;BKM120 (NVP-BKM120);BKM120 - NVP-BKM120;ABP000735;ANW-64908;BDBM50380363;s2247;ZINC43154039;AKOS016005372;ACN-031536;AM85983;BCP9001011;CS-0089;DB11666;RL05935;BKM120 (NVP-BKM120  Buparlisib);NCGC00262604-01;4CA-0929;AK103313;AN-26178;AS-40568;BC638775;HY-70063;KB-79621;SMR004702786;AB0008183;AJ-108243;AX8234852;DB-079882;ST2411649;TC-153653;FT-0755923;X7578;KS-00000637;A25436;D10584;W-5735;J-516601;BRD-K42191735-001-01-2;4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine;5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine;5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine;2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-;5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine;5-[2,6-bis(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine"	944396-07-0	0ZM2Z182GD	"27993796;27793950;27673440;24405565;22162589"	22162589	01/12/2011	22162589	01/12/2011	2009-2012		1	1	0	Yes	1					30/07/2018		79,8	35	NA	1	0	NA	1	PI3K	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	0,2	0	0	0	MOOD ALTERATION	1	0	0	0	1
Filanesib	"arry-520;filanesib"		DB06040		"ARRY-520;Filanesib;885060-09-3;UNII-8A49OSO368;ARRY 520 trifluoroacetate;CHEMBL2347655;8A49OSO368;(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide;ARRY 520;Filanesib [INN];Filanesib [USAN:INN];C20H22F2N4O2S;Arry520;1385020-40-5;ARRY-520; Filanesib;Filanesib(ARRY-520);D04VWJ;SCHEMBL368043;DTXSID50237086;EX-A678;3452AH;BDBM50431893;ZINC43204022;AKOS030526964;CS-0867;RL05514;1,3,4-Thiadiazole-3(2H)-carboxamide, 2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-, (2S)-;HY-15187;FT-0700396;W-5769;ARRY520;ARRY 520;885060-09-3;J-519598;(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide;1,3,4-Thiadiazole-3(2H)-carboxamide,2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-, (2S)-"	885060-09-3	8A49OSO368	"25684345;22139909"	22139909	01/12/2011	22139909	01/12/2011	2009-2012		1	1	0	Yes	1					30/07/2018		79,8	36	88	0	1	"AML;MDS"	1	KSP	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1
Binimetinib	"binimetinib;mek162"		"DB11967;DB05985"		"606143-89-9;Binimetinib;MEK162;MEK-162;ARRY-162;ARRY-438162;5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;ARRY 162;UNII-181R97MR71;Binimetinib (MEK162, ARRY-162, ARRY-438162);181R97MR71;MEK162 (ARRY-162, ARRY-438162);6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide;Binimetinib [USAN:INN];ARRY-162; ARRY-438162; MEK 162; ARRY 162; ARRY 438162;MEK162(Binimetinib);Binimetinib (JAN/USAN);D0C4LF;NVP-MEK162;MLS006011180;C17H15BrF2N4O3;SCHEMBL570088;GTPL7921;CHEMBL3187723;MEK162 (Arry-162);AOB2072;DTXSID70209422;QCR-138;ACWZRVQXLIRSDF-UHFFFAOYSA-N;ARRY-162,MEK-162;MolPort-028-720-357;HMS3652J14;EX-A1024;s7007;ZINC38460704;AKOS026750517;CS-0627;DB11967;RL04283;KS-0000062X;NCGC00345804-01;1073666-70-2;AC-29023;AS-16706;BC600594;HY-15202;KB-78305;SMR004702949;cas:606143-89-9;MEK162;AB0095018;KB-124302;FT-0697088;Y1468;D10604;W-5894;Binimetinib;MEK-162; ARRY-162;ARRY-438162;J-516581;1201685-05-3;1417448-81-7;5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide;5-[(4-Bromo-2-Fluorophenyl)Amino]-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H-Benzimidazole-6-Carboxami;6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide;6-[(4-bromo-2-fluorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide"	606143-89-9	181R97MR71	27071922	27071922	01/04/2016	23414587	01/11/2011	2009-2012	DOI: 10.1158/1535-7163.TARG-11-B243	1	1	1	Yes	1	27/06/2018 00:00	AP	ARRAY BIOPHARMA INC	BINIMETINIB	27/06/2018	ARRAY BIOPHARMA INC	79,7	71	79	1	1	"BILIARY CANCER;COLORECTAL_KRAS-BRAF_MUTANT"	1	MEK	0	1	1	17	1	0	0	1	1	0,06	0	0	0	0,6	0	0	0	0	0	0	0	0	1
Pentosan Polysulfate	pentosan	"Pentosanpolysulfat;Pentosane polysulfate;Pentosan sulfuric polyester;Pentosano polisulfato;Pentosani polysulfas;Elmiron"	"DB00686;APRD01175"	"[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate;[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxy-tetrahydropyran-2-yl]oxy-3-sulfooxy-tetrahydropyran-4-yl] hydrogen sulfate;[(2R,3R,4S,5R)-2-hydroxy-5-[[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxy-2-tetrahydropyranyl]oxy]-3-sulfooxy-4-tetrahydropyranyl] hydrogen sulfate;[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfoxy-tetrahydropyran-2-yl]oxy-3-sulfoxy-tetrahydropyran-4-yl] hydrogen sulfate;[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxy-oxan-2-yl]oxy-3-sulfooxy-oxan-4-yl] hydrogen sulfate;11096-31-4;37300-21-3;39432-58-1;42613-02-5;Pentosan sulfuric polyester;Polypentose sulfate;Xylan, hydrogen sulfate;[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate;PENTOSAN POLYSULFATE"	"pentosan polysulfate;Polypentose sulfate;Pentosan sulfuric polyester;Elmiron;37300-21-3;[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate;Xylan, hydrogen sulfate;UNII-F59P8B75R4;Pentosanpolysulfat;Pentosani polysulfas;Elmiron (TN);Pentosane polysulfate;Pentosano polisulfato;Xylan,hydrogen sulfate;AC1L1YAW;D0F8CM;SCHEMBL157354;DTXSID10190764;F59P8B75R4;116001-96-8 (sodium salt);DB00686;LS-187046;LS-187658;[(2S,3R,4S,5R)-5-hydroxy-2-{[(3R,4S,5R,6R)-6-hydroxy-4,5-bis(sulfooxy)oxan-3-yl]oxy}-3-(sulfooxy)oxan-4-yl]oxidanesulfonic acid;[(2S,3R,4S,5R)-5-hydroxy-2-{[(3R,4S,5R,6R)-6-hydroxy-4,5-bis(sulfooxy)oxan-3-yl]oxy}-4-(sulfooxy)oxan-3-yl]oxidanesulfonic acid;11096-31-4;39432-58-1;42613-02-5"	37300-21-3	F59P8B75R4	"9815633;9006745;7499109"	7499109	01/01/1995	1689537	01/02/1990	1989-1994		1	0	1	No	0	"24/08/2004 00:00;20/09/2006 00:00;08/11/2001 00:00;24/07/2008 00:00;12/12/2008 00:00;26/09/1996 00:00"	AP	JANSSEN PHARMS	PENTOSAN POLYSULFATE SODIUM	26/09/1996	JANSSEN PHARMS	79,6	#N/A																							0						1
Fludarabine	fludarabine	"2-F-ARAA;2-fluoro ARA-A;Fludarabine phosphate;Fludarabine;Fludarabine Phosphate for Injection USP;Fludarabine Phosphate;Aj-fludarabine;Fludarabine Phosphate Injection;Fludarabine Phosphate Injection, USP;Fludara;Fludarabine Phosphate for Injection"	"DB01073;APRD00594"	"(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol;(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;21679-14-1;Fludarabina [Spanish];Fludarabine;Fludarabinum [Latin];HSDB 6964;NSC 118218;NSC 118218H;MLS000028687;2-F-ara-A;SMR000058874;NSC-118218;2-Fluoro Ara-A;2-Fluoro-9-beta-D-arabinofuranosyladenine;9-beta-D-Arabinofuranosyl-2-fluoroadenine;9-beta-D-Arabinosyl-2-fluoroadenine;9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI);Adenine, 9-beta-D-arabinofuranosyl-2-fluoro-;CCRIS 3382;EINECS 244-525-5;F-Ara-A"	"Fludarabine;21679-14-1;F-Ara-A;2-Fluoro Ara-A;9-beta-D-Arabinofuranosyl-2-fluoroadenine;Fludarabine [INN];Fludarabinum [Latin];Fludarabina [Spanish];Fludarabina;Fludarabinum;(2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;2-F-ara-A;FaraA;SQ Fludarabine;Fluradosa (TN);Fludarabine (INN);CCRIS 3382;Fludarabine (Fludara);(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;NSC 118218;2-Fluoro-9-beta-D-arabinofuranosyladenine;MLS000028687;UNII-P2K93U8740;HSDB 6964;2-FLUORO-9-ARABINOADENINE;EINECS 244-525-5;NSC 118218H;(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;P2K93U8740;SMR000058874;2-Fluoroadenine-9-beta-D-arabinofuranoside;Adenine, 9-beta-D-arabinofuranosyl-2-fluoro-;EN300-52641;DSSTox_CID_19657;DSSTox_RID_76857;DSSTox_GSID_39657;9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine;C10H12FN5O4;CAS-21679-14-1;Fluradosa;NSC-118218;NCGC00181336-01;Fludara, Fludarabine;Fludarabine free base;Fludarabine(Fludara)/;2F-Ara-A;Fludarabine des-phosphate;AC1LCW8I;2-FLUORO-ARA-A;D0F2XQ;2-F-ARAA;AC1Q51CF;SCHEMBL3510;CHEMBL1568;MLS006011578;cid_657237;GTPL4802;9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-;DTXSID4039657;BDBM68391;CHEBI:94701;CTK7J7613;AOB2685;EX-A833;HBUBKKRHXORPQB-FJFJXFQQSA-N;MolPort-006-123-542;BCPP000227;HMS2232K13;HMS3259F09;HMS3715F15;HY-B0069;ZINC4216238;Tox21_112795;Tox21_113419;ABP000557;HG1007;MFCD00132942;s1491;AKOS015854911;AKOS015916481;Tox21_113419_1;BCP9000693;CCG-221147;CS-2133;DB01073;DS-1271;MCULE-2497721739;NC00633;NCGC00181336-03;NCGC00182047-03;AJ-48984;AK-72908;BR-72908;CC-28456;CJ-11581;CPD000058874;KB-51877;LS-15061;SAM002548956;SC-17015;AB0066077;ST2407919;AM20090199;FT-0082766;FT-0626438;C21550;D07966;AB00383071-11;AB00383071_13;679F141;SR-01000000270;9-?-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine;I14-4978;SR-01000000270-2;9-(?-D-Arabinofuranosyl)-2-fluoro-9H-purin-6-amine;Z802671516;9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI);9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-(9CI);(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol;(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol;(2R,3S,4S,5R)-2-(6-azanyl-2-fluoranyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;2-Fluoroadenine-9-beta-D-arabinofuranoside, DNA synthesis and methylation inhibitor"	21679-14-1	P2K93U8740	"25234438;23648237;21289367;19270751;17471171;16275653;12688318;12063008;8890711"	8890711	01/10/1996	6204752	01/09/1984	Bef. 1989		1	1	1	Yes	1	"25/03/2014 00:00;21/03/2011 00:00;04/12/1991 00:00;29/07/2010 00:00;17/07/2009 00:00;21/12/2011 00:00;02/04/1992 00:00;17/05/2016 00:00;15/10/2007 00:00;10/02/2009 00:00;21/05/1993 00:00;18/12/2008 00:00;29/01/1996 00:00;07/01/1993 00:00;02/07/2002 00:00;28/10/1992 00:00;01/08/2003 00:00;20/12/2007 00:00;26/09/1994 00:00;11/02/2009 00:00;08/12/2011 00:00;28/06/2008 00:00;29/09/2014 00:00;08/03/2000 00:00;28/08/2003 00:00;05/09/1996 00:00;10/05/2016 00:00;28/02/2017 00:00;01/05/2002 00:00;06/04/2007 00:00;24/05/1999 00:00;28/04/2004 00:00;16/10/2012 00:00;18/04/1991 00:00;24/05/2010 00:00;18/02/2011 00:00;28/03/2002 00:00;03/12/2001 00:00;14/06/2015 00:00;27/09/2010 00:00;12/11/2015 00:00;22/06/2009 00:00;07/09/2011 00:00;21/09/2007 00:00"	AP	"SANDOZ;ACTAVIS LLC;CUSTOPHARM INC;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS TOTOWA;SANOFI AVENTIS US;GENZYME CORP;HOSPIRA;MUSTAFA NEVZAT ILAC;SAGENT PHARMS"	FLUDARABINE PHOSPHATE	18/04/1991	GENZYME CORP	79,3	13	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	SOMNOLENCE	1	0	60	0	1
ADH-1	adh-1		DB05485	"(4R,7S,10S,13S,16R)-16-acetamido-13-(3H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide; 2,2,2-trifluoroacetic acid;(4R,7S,10S,13S,16R)-16-acetamido-13-(3H-imidazol-4-ylmethyl)-7-isopropyl-10-methyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide; 2,2,2-trifluoroacetic acid;(4R,7S,10S,13S,16R)-16-acetamido-13-(3H-imidazol-4-ylmethyl)-7-isopropyl-6,9,12,15-tetraketo-10-methyl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide; 2,2,2-trifluoroacetic acid;(4R,7S,10S,13S,16R)-16-acetamido-13-(3H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide; 2,2,2-trifluoroethanoic acid;229971-81-7;ADH-1;Exherin;L-Cysteinamide, N-Acetyl-L-cysteinyl-L-hisitidyl-L-alanyl-L-valyl-, cyclic (1 5)-disulfide, trifluoroacetate (salt) hydrate;NSC729477"	"Exherin;UNII-B058ME29VU;229971-81-7;ADH-1;B058ME29VU;ADH 1;ADH-1 pepide;Exherin (ADH-1);D0KK9E;ADH-1;ADH1;ADH 1;CHEMBL3818130;SCHEMBL13857500;ZINC3939935;ADH-10001;AKOS030526741;CS-3450;L-Cysteinamide, N-acetyl-L-cysteinyl-L-histidyl-l-alanyl-L-valyl-, cyclic (1-5)-disulfide;HY-13541;C518575000"		B058ME29VU	22280327	22280327	01/01/2012	22280327	01/01/2012	2009-2012		1	1	0	Yes	1					30/07/2018		78,8	46	NA	1	0	NA	1	N-CADHERIN	0	1	0	NA	0	1	0	1	0	0,02	0	0	0	0,26	0	0	0	0	0	0	0	0	1
Axitinib	"ag-013736;axitinib"	"axitinibum;axitinib;Inlyta"	DB06626	"N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide;N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide;N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]thio]benzamide;319460-85-0;790713-39-2;AG-13736;AG 013736;AG-013736;Axitinib;Axitinib [USAN];Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-;N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide"	"Axitinib;319460-85-0;Inlyta;AG-013736;AG 013736;axitinibum;UNII-C9LVQ0YUXG;AG013736;C9LVQ0YUXG;N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide;(E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide;AG-13736;CHEBI:66910;NSC757441;N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide;NCGC00241108-01;S1005;(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide;DSSTox_CID_28975;DSSTox_RID_83240;DSSTox_GSID_49049;C22H18N4OS;N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide;N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide;CAS-319460-85-0;Axitinib (AG 013736);Axitinib [USAN:INN:JAN];4agc;Inlyta (TN);4ag8;Axitinib (JAN/USAN);Axitinib/AG013736;AG-013736;Axitinib;Axitinib,AG-013736;D01ZRI;Axitinib (VEGFR inhibitor);AG-013736, Axitinib;cc-356;MLS006010164;SCHEMBL172918;AC1O51X3;GTPL5659;Axitinib, >=98% (HPLC);CHEMBL1289926;DTXSID3049049;BDBM25117;CHEBI:94568;EX-A337;QCR-109;SYN1014;MolPort-006-392-413;BCPP000372;AOB87786;ZINC3816287;Tox21_113597;ABP000115;AN-501;MFCD09837898;AKOS015902898;Tox21_113597_1;AC-1539;AG13736;BCP9000345;CS-0116;DB06626;KS-1448;NSC-757441;RL03128;NCGC00241108-04;4CA-0215;AJ-45709;BC659937;CJ-10777;HY-10065;KB-02558;KB-74537;SC-22491;SMR002530046;AB0008632;TR-013491;AM20090673;D03218;Q-3279;AB01274739-01;AB01274739_02;460A850;SR-01000941566;I14-1971;J-502064;Q-200662;SR-01000941566-1;BRD-K29905972-001-01-4;BRD-K29905972-001-02-2;Axitinib|319460-85-0|AG 013736|AG013736;Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-;N-Methyl-[[3[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide;N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide;790713-39-2"	319460-85-0	C9LVQ0YUXG	"16027440;16027439"	16027440	01/07/2005	16027439	01/07/2005	2004-2008		1	1	1	Yes	1	"30/03/2016 00:00;01/08/2014 00:00;16/09/2013 00:00;27/01/2012 00:00;16/06/2016 00:00;29/12/2014 00:00"	AP	PF PRISM CV	AXITINIB	27/01/2012	PF PRISM CV	78,7	36	NA	1	0	NA	1	"VEGFR2;PDGFR;C-KIT"	0	1	0	NA	0	0	0	1	1	0,08	0	0	0	NA	0	0	0	0	0	0	143	0	1
Ciclopirox	ciclopirox olamine	"6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone;Ciclopiroxum;Loprox Cream;Stieprox Shampoo;Pedipak;Loprox;Loprox Lotion 1.0%;Ciclopirox Topical Solution;Loprox Lotion 1%;Terbinafine HCl Ciclopirox;Penlac;Loprox Cream 1%;Loprox Crm 1%;Cnl8;Ciclopirox Olamine;Apo-ciclopirox;Ciclopirox;Loprox Lotion;Ciclodan;Taro-ciclopirox;PMS-ciclopirox"	"DB01188;APRD00871"	"2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one;2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one;2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone;2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methyl-2-pyridone;41621-49-2;NSC336278;Prestwick_785;KBio2_000630;KBio1_000705;KBio2_003198;KBio2_005766;IDI1_000705;NCI60_002954;NCGC00094623-02;NCGC00094623-01;2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-, compd. with 2-aminoethanol (1:1);2-Aminoethanol compd. with 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone (1:1);6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone compd. with 2-aminoethanol (1:1);6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridon, 2-aminoethanol-salz [German];6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone compound with 2-aminoethanol (1:1);6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt;6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone, 2-aminoethanol salt;6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, compound with 2-aminoethanol (1:1);Batrafen;CICLOPIROX;Ciclopirox ethanolamine salt (1:1);Ciclopirox olamine;Ciclopirox olamine [USAN:JAN];Ciclopiroxethanolamine salt;Ciclopiroxolamin;Ciclopiroxolamine;EINECS 255-464-9;HOE 296;NSC 336278;Terit;LS-133030;Ciclopirox olamine (JAN/USP);D01364;Loprox (TN);CAS-41621-49-2;NCGC00017112-01;HOE-296;Mycoster;Penlac nail lacquer;SPECTRUM1500189;Ciclochem;DivK1c_000705;KBioSS_000630;NINDS_000705;Spectrum_000150;Loprox;AIDS-108096;AIDS108096;Ciclopirox ethanolamine"	"CICLOPIROX;29342-05-0;Loprox;Penlac;Ciclopiroxum;Batrafen;HOE 296b;Stieprox;Terit;Ciclopiroxum [INN-Latin];cyclopirox;Mycoster;Ciclopirox gel;cyclopyroxolamine;Loprox cream;HOE-296b;Loprox Gel;Ciclopirox Olamin;Ciclopirox-Olamin;Dafnegin-CSC;6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone;2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-;6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one;Loprox Shampoo;6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone;UNII-19W019ZDRJ;Penlac nail lacquer;Ciclopirox [USAN:BAN:INN];Loprox (TN);Penlac (TN);Ciclopirox (Penlac);Ciclopirox (USP/INN);EINECS 249-577-2;HOE-296;19W019ZDRJ;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one;C12H17NO2;CHEBI:453011;SCKYRAXSEDYPSA-UHFFFAOYSA-N;2(1H)-Pyridone, 6-cyclohexyl-1-hydroxy-4-methyl-;6-CYCLOHEXYL-1-HYDROXY-4-METHYL-1H-PYRIDIN-2-ONE;6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one;6-Cyclohexyl-1-hydroxy-4-methyl-2-(1H)-pyridone;(6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone);W-106995;MLS002153867;CNL8;SMR001233223;Ciclopirox [USAN:USP:INN:BAN];Batrafen (TN);Stieprox (TN);2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one;AC1L1EDN;Prestwick0_000541;Prestwick1_000541;Prestwick2_000541;Prestwick3_000541;Spectrum2_000146;Spectrum3_000351;Spectrum4_000288;Spectrum5_000747;D07GRH;CHEMBL1413;SCHEMBL34424;BSPBio_000581;BSPBio_002041;KBioGR_000816;cid_38911;KSC563C4H;BIDD:GT0080;SPBio_000252;SPBio_002502;BPBio1_000641;ZINC1145;DTXSID9048564;BDBM66087;CTK4G3143;KBio3_001261;MolPort-003-845-943;HMS3656I12;HY-B0450;KS-00000L3N;AN-773;BG0571;s2528;AKOS015895717;AB06517;CS-2561;DB01188;KS-5085;NCGC00017112-04;NCGC00017112-05;NCGC00017112-06;NCGC00017112-08;NCGC00017112-11;NCGC00178850-01;NCGC00178850-02;AC-24195;AJ-07970;AK544043;BC205517;CC-25776;SC-17361;SBI-0206690.P002;AB0011605;AB2000628;KB-270156;LS-174247;TL8002303;1-hydroxy-4-methyl-6-cyclohexyl-2-pyridone;FT-0602961;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone;D03488;6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one;AB00053438_09;AB00053438_10;AB00053438_11;342C050;A819878;C-10474;6-Cyclohexenyl-1-hydroxy-4-methyl-2(1h)-pyridone;6-cyclohexyl-1-hydroxy-4-methyl-2(1 H)-pyridinone;Batrafen; Loprox;Mycoster;Stieprox;HOE 296b;Penlac;I06-0862;SR-05000001589-5;6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridinone;6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone #;BRD-K13044802-213-04-1;BRD-K13044802-213-09-0;2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridone;6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one;2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone;2-azanylethanol;6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one"	29342-05-0	19W019ZDRJ	24273151	24273151	01/11/2013	782504	01/07/1976	Bef. 1989		0	0	1	No	0	"20/12/2010 00:00;05/04/2018 00:00;25/02/2016 00:00;06/12/2012 00:00;03/03/2006 00:00;17/08/2001 00:00;08/10/2015 00:00;30/12/1982 00:00;01/12/2014 00:00;29/12/2004 00:00;11/01/2006 00:00;09/06/2003 00:00;10/06/2008 00:00;24/11/2009 00:00;03/12/2004 00:00;22/12/2003 00:00;18/09/2007 00:00;16/02/2010 00:00;28/10/2015 00:00;09/02/2001 00:00;15/09/1998 00:00;23/02/1995 00:00;12/04/2005 00:00;26/04/1989 00:00;14/10/2015 00:00;26/02/2004 00:00;21/05/2013 00:00;25/05/2010 00:00;17/12/1999 00:00;12/06/2006 00:00;29/05/1986 00:00;27/06/2011 00:00;13/01/2016 00:00;03/02/2015 00:00;29/02/2012 00:00;08/05/2013 00:00;10/12/1999 00:00;27/10/2015 00:00;18/04/2014 00:00;28/06/2013 00:00;26/03/2003 00:00;21/07/1997 00:00;08/05/1989 00:00;25/02/1998 00:00;06/08/2004 00:00;30/04/2013 00:00;11/09/1990 00:00;23/02/2011 00:00;10/11/2009 00:00;17/02/2010 00:00;16/01/1985 00:00;17/11/1995 00:00;28/02/2003 00:00;01/07/1999 00:00;07/01/2009 00:00;07/04/2016 00:00;04/10/2016 00:00;30/12/1988 00:00;25/02/2000 00:00;10/08/2005 00:00;15/12/2006 00:00;09/06/1998 00:00"	AP	"MYLAN PHARMS INC;PERRIGO CO;TOLMAR;MEDICIS;PADDOCK LLC;G AND W LABS;VALEANT BERMUDA;HI TECH PHARMA;TARO;APOTEX INC;PERRIGO NEW YORK;GLENMARK GENERICS;AKORN;G AND W LABS INC;#N/A;CNTY LINE PHARMS;TEVA PHARMS;INGENUS PHARMS LLC;MEDIMETRIKS PHARMS;FOUGERA PHARMS;GLENMARK PHARMS;ACTAVIS MID ATLANTIC;TARO PHARM INDS"	CICLOPIROX	30/12/1982	MEDIMETRIKS PHARMS	77,8	#N/A																							0						1
Interferon beta-1b	"interleukin-1 beta;oct-43;rhuifn-beta"	"Betaferon;Betaseron;Extavia;Interferon beta 1b (recombinant);Interferon beta-1b,recombinant;Interferon-beta-1b;Recombinant interferon beta-1b"	"BIOD00078;BTD00078;DB00068"			145155-23-3	TTD90R31WZ	"8938564;9051240"	8938564	01/11/1996	3802098	01/02/1987	Bef. 1989		1	1	1	Yes	1	"26/05/2017 00:00;08/06/2018 00:00;22/06/2011 00:00;26/04/2007 00:00;22/12/2014 00:00;09/11/2006 00:00;12/05/2016 00:00;23/07/1993 00:00;22/12/2015 00:00;08/06/2005 00:00;28/01/2014 00:00;18/03/2012 00:00;19/04/2016 00:00;08/09/2008 00:00;20/10/2006 00:00;26/03/2009 00:00;29/12/2005 00:00;04/04/2006 00:00;28/06/2013 00:00;14/08/2009 00:00;28/07/2005 00:00;07/12/2005 00:00;18/07/2007 00:00;10/10/2003 00:00;11/12/2012 00:00;14/03/2003 00:00;25/09/2015 00:00"	AP	"BAYER HEALTHCARE PHARMS;NOVARTIS PHARMS"	INTERFERON BETA-1B	23/07/1993	BAYER HEALTHCARE PHARMS	77,5	12	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	CONFUSION	1	0	5	0	1
Belinostat	belinostat	Beleodaq	DB05015	"(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide;(E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid;NSC726630;PXD-101;Belinostat;PX-105684;N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide"	"Belinostat;414864-00-9;PXD101;PXD-101;Belinostat (PXD101);PXD 101;N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE;UNII-F4H96P17NZ;Beleodaq;866323-14-0;(E)-N-hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide;NSC726630;PX105684;PX 105684;F4H96P17NZ;(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide;CHEBI:61076;N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE;(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide;PX-105684;N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide;N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide;(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide;N-hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide;(E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid;E-Belinostat;Belinostat [USAN:INN];2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-, (2E)-;2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-;Belinostat Ph3;Beleodaq (TN);PubChem22405;Belinostat - PXD101;AC1OCFO7;Belinostat (USAN/INN);Belinostat  (PXD101);D0XT6W;MLS006011091;N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide;CHEMBL408513;GTPL7496;Belinostat(Random Configuration);BDBM25150;CHEBI:94531;DTXSID60194378;EX-A180;PDX-101;QCR-181;MolPort-009-679-433;NCNRHFGMJRPRSK-MDZDMXLPSA-N;BCPP000351;AOB87787;ZINC3818726;Belinostat,PXD101, PX105684;Belinostat/PXD101,PX105684/;ABP000140;s1085;AKOS025401741;AN-1073;API0003555;BCP9000386;CCG-208758;DB05015;LS41098;NSC-726630;RL03602;AC-25046;AS-17068;BC251660;KB-74881;SC-71101;SMR004702879;AB0007889;AX8144528;RT-014445;A25012;D08870;W-5363;J-523584;BRD-K17743125-001-01-9;N-Hydroxy-3-[(phenylamino)sulfonyl]-trans-cinnamamide;(E)-N-Hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide;N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide;N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR;PX105684, 414864-00-9;2-Propenamide,N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-,(2E)-;5OG"	866323-14-0	F4H96P17NZ	"18510700;18245542"	18245542	01/02/2008	18245542	01/02/2008	2004-2008		1	1	1	Yes	1	"03/07/2014 00:00;12/04/2017 00:00;23/04/2015 00:00"	AP	SPECTRUM PHARMS	BELINOSTAT	03/07/2014	SPECTRUM PHARMS	76,9	46	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,5	0	0	0	0	0	0	31	1	1
CYT997	"cyt997;lexibulin"		DB05147		"LEXIBULIN;917111-44-5;CYT997;CYT-997;CYT997 (Lexibulin);CYT 997;UNII-2GTU230HA1;2GTU230HA1;C24H30N6O2;1-Ethyl-3-(2-methoxy-4-(5-methyl-4-(((1S)-1-(pyridin-3-yl)butyl)amino)pyrimidin-2-yl)phenyl)urea;n-ethyl-n'-(2-methoxy-4-(5-methyl-4-(((1s)-1-(3-pyridinyl)butyl)amino)-2-pyrimidinyl)phenyl)urea;Lexibulin [USAN:INN];1-Ethyl-3-[2-Methoxy-4-(5-Methyl-4-{[(1s)-1-(Pyridin-3-Yl)butyl]amino}pyrimidin-2-Yl)phenyl]urea;N-Ethyl-N'-[2-methoxy-4-(5-methyl-4-{[(1S)-1-pyridin-3-ylbutyl]amino]pyrimidin-2-yl)phenyl]urea;N-Ethyl-N'-[2-methoxy-4-(5-methyl-4-{[(1S)-1-pyridin-3-ylbutyl]amino}pyrimidin-2-yl)phenyl]urea;N-ethyl-N'-[2-methoxy-4-[5-methyl-4-[[(1S)-1-(3-pyridinyl)butyl]amino]-2-pyrimidinyl]phenyl]urea;Lexibulin (USAN);lexibulin (CYT997);MLS006011265;CHEMBL552212;SCHEMBL1122311;CHEBI:95005;CYT997/;DTXSID10238675;MolPort-016-633-306;MTJHLONVHHPNSI-IBGZPJMESA-N;1-ethyl-3-[2-methoxy-4-[5-methyl-4-[[(1S)-1-pyridin-3-ylbutyl]amino]pyrimidin-2-yl]phenyl]urea;ABP000307;s2195;ZINC43024000;AKOS027422819;BCP9000572;CS-3599;CYT9970000;QC-8216;RL05776;NCGC00346574-01;4CA-0740;BC659989;HY-10498;KB-76369;SC-94584;SMR004703016;Urea, N-ethyl-n'-(2-methoxy-4-(5-methyl-4-(((1S)-1-(3-pyridinyl)butyl)amino)-2-pyrimidinyl)phenyl)-;X7569;D10073;Z-3182;CYT997 (Lexibulin)  inverted exclamation markY95%;J-523569;BRD-K23363278-001-01-3;917111-44-5 , CY T997;N--N'-[2--4-[5--4-[[(1S)-1-(3-)]]-2-]];(S)-1-ethyl-3-(2-methoxy-4-(5-methyl-4-(1-(pyridin-3-yl)butylamino)pyrimidin-2-yl)phenyl)urea;3-ethyl-1-[2-methoxy-4-(5-methyl-4-{[(1S)-1-(pyridin-3-yl)butyl]amino}pyrimidin-2-yl)phenyl]urea;LXL;N-Ethyl-N'-[2-methoxy-4-(5-methyl-4-{[(1S)1-pyridin-3-ylbutyl]amino}pyrimidin-2-yl)phenyl]urea"			22451157	22451157	01/03/2012	22451157	01/03/2012	2009-2012		1	1	0	Yes	1					30/07/2018		76,8	21	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Blinatumomab	blinatumomab	Blincyto	DB09052			853426-35-4	4FR53SIF3A	26884582	26884582	01/02/2016	18703743	01/08/2008	2004-2008		1	1	1	Yes	1	"03/05/2017 00:00;03/12/2014 00:00;29/03/2018 00:00;10/04/2018 00:00;11/07/2017 00:00;30/11/2017 00:00;30/08/2016 00:00"	AP	AMGEN	BLINATUMOMAB	03/12/2014	AMGEN	75,9	NA	NA	0	1	NHL	1	CD19	0	1	0	NA	0	0	0	1	0	NA	0	1	1	NA	0	0	0	0	0	0	59	0	1
Zalypsis	"pm00104;zalypsis"		DB12454		"Zalypsis;PM00104;UNII-C21EZR41AY;PM-00104;C21EZR41AY;308359-57-1;(6aS,7R,13S,14S,16R)-8,14-dihydroxy-9-methoxy-4,10,17-trimethyl-16-[({(2E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl}amino)methyl]-6,7,12,13,14,16-hexahydro-6aH-7,13-epimino[1,3]dioxolo[7,8]isoquino[3,2-b][3]benzazocin-5-yl acetate;D0M7PU;SCHEMBL7975282;DTXSID0044026;NOCAS_44026;CS-1940;DB12454;2-Propenamide, N-(((6aS,7R,13S,14S,16R)-5-(acetyloxy)-6,6a,7,13,14,16-hexahydro-8,14-dihydroxy-9-methoxy-4,10,17-trimethyl-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocin-16-yl)methyl)-3-(3-(trifluoromethyl)phenyl)-, (2E)-;HY-16401"	308359-57-1	C21EZR41AY	"26033438;23455428;22688291;22491421;21590449"	21590449	01/05/2011	22491421	01/04/2012	2009-2012		1	1	0	Yes	1					30/07/2018		75,8	47	NA	1	0	NA	1	DNA	0	1	0	NA	0	0	0	1	1	0,02	0	0	0	0,09	0	0	0	0	0	0	0	0	1
Efatutazone	efatutazone		DB11894		"Inolitazone;Efatutazone;223132-37-4;5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-Thiazolidinedione;Efatutazone [INN];RS5444;CS-7017;D0Y8NZ;SCHEMBL3246054;CHEMBL3545280;JCYNMRJCUYVDBC-UHFFFAOYSA-N;Efatutazone;CS-7017;RS5444;AKOS030526729;CS-0778;DB11894;4CA-1384;DA-07988;HY-14792;KB-77905;QC-10456;FT-0737589;5-(4-{[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1-H-benzimidazol-2-yl]methoxy}benzyl)-1,3-thiazolidine-2,4-dione;5-[4-[6-(4-amino-3 ,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione;5-[4-[6-(4-Amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione"	223132-37-4	M17ILL71MC	"25202104;22570147"	22570147	01/05/2012	22570147	01/05/2012	2009-2012		1	1	0	Yes	1					30/07/2018		74,8	31	NA	1	0	NA	1	PPAR?	0	1	0	NA	0	1	0	1	1	0,04	0	0	0	0,47	0	0	0	0	0	0	21	0	1
Bardoxolone methyl	bardoxolone		DB05983		"Bardoxolone methyl;CDDO-Me;CDDO methyl ester;218600-53-4;Bardoxolone (methyl);RTA 402;NSC713200;NSC 713200;RTA-402;methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate;UNII-CEG1Q6OGU1;CEG1Q6OGU1;RTA402;NSC-713200;Bardoxolone methyl (USAN);Bardoxolone methyl [USAN];methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate;2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester;NCGC00186460-01;CDDO-Methyl ester;AC1Q6OIJ;CDDO-Me, 2;D03WYU;AC1L8G9B;DSSTox_CID_28690;DSSTox_RID_82960;DSSTox_GSID_48764;Bardoxolone methyl RTA 402;methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate;2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic Acid Methyl Ester;Bardoxolone Methyl (CDDO-Me);GTPL3443;CHEMBL1762621;DTXSID5048764;SCHEMBL12521530;AOB1215;MolPort-028-720-346;WPTTVJLTNAWYAO-KPOXMGGZSA-N;2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester;BDBM217379;ZINC3982151;Tox21_113229;s8078;TP-155;AKOS025401880;AN-3346;CS-0598;CDDO Methyl Ester, >=98% (HPLC);AC-26830;AJ-47583;BC256359;CSA:218600-53-4;Bardoxolone methyl;HY-13324;CAS-218600-53-4;D09585;NSC 713200; RTA 402; CDDO Methyl ester;(+)-methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate;(4aS,6aR,6bS,8aR,12aS,14bS)-Methyl 11-cyano-2,2,6a,6b,9,9,12a-he;Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester;(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate;methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicene-4a(2H)-carboxylate;RTA-402|||NSC-713200|||CDDO methyl ester|||2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester"	218600-53-4	CEG1Q6OGU1	22634319	22634319	01/05/2012	22634319	01/05/2012	2009-2012		1	1	0	Yes	1					30/07/2018		74,8	NA	NA	1	0	NA	1	"NRF2;NFKB;JAK/STAT"	0	1	0	NA	0	0	0	1	1	NA	0	1	1	NA	0	0	0	0	0	0	0	0	1
Lucatumumab	"chir-12.12;hcd-122;lucatumumab"		DB06360			903512-50-5	P0EP9VFC4R	24219359	24219359	01/11/2013	22475052	01/06/2012	2009-2012		1	1	0	Yes	1					30/07/2018		73,8	26	NA	0	1	CLL	1	CD40	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	0,69	0	0	0	0	0	0	26	0	1
Coltuximab ravtansine	"coltuximab ravtansine;sar3419"	Anti-CD19 humanized monoclonal antibody conjugated to DM4	DB06342			1269764-99-9	MRS84YT9L2	24132920	24132920	01/10/2013	22753910	01/07/2012	2009-2012		1	1	0	Yes	1					30/07/2018		72,8	39	NA	0	1	NHL	1	CD19	0	1	0	NA	0	0	0	1	1	0,74	0	1	1	NA	0	0	0	0	0	0	35	0	1
Alisertib	"alisertib;mln8237"		DB05220		"Alisertib;1028486-01-2;MLN8237;MLN-8237;MLN8237 (Alisertib);4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid;MLN 8237;UNII-T66ES73M18;CHEMBL483158;4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid;T66ES73M18;4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)-2-methoxybenzoic acid;Alisertib [USAN:INN];4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid;Alisertib (USAN);MLN8237,Alisertib;Kinome_3770;PubChem22398;MLN8237 - Alisertib;D0S4JK;C27H20ClFN4O4;JSPY-st000258;MLS006011041;SCHEMBL855823;GTPL7790;CTK8C3885;DTXSID30145539;EX-A024;CHEBI:125628;MolPort-009-679-457;ZLHFILGSQDJULK-UHFFFAOYSA-N;HMS3654E08;AOB87191;ABP000944;ANW-70757;BDBM50277545;s1133;ZINC40939534;AKOS015924647;MLN-8237, MLN8237;ACN-029381;BCP9000956;CS-0106;DB05220;QC-9147;RL00137;KS-0000063G;NCGC00263271-01;NCGC00263271-02;4CA-0132;AC-25236;AK105048;AS-17005;HY-10971;KB-74567;SMR004702834;AB0044042;AJ-103878;AX8239256;TC-159502;FT-0672433;X7389;D10085;W-3697;J-514220;BRD-K75295174-001-03-5;MLN 8237, 1028486-01-2;1186318-95-5;4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxy MLN 8237 (Contain 10% DMSO);4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid;4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-benzoic acid;4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoic acid;4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl) -5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid;A5B"		T66ES73M18	"26689566;26084989;26073352;24879333;24352795;22988055;22767670;22753585"	22767670	01/07/2012	22767670	01/07/2012	2009-2012		1	1	0	Yes	1					30/07/2018		72,8	87	NA	1	0	NA	1	AAK	0	1	0	NA	0	0	0	1	1	0,01	0	0	0	0,23	0	0	0	0	0	0	0	0	1
AZD-8055	azd8055		DB12774		"AZD8055;1009298-09-2;AZD-8055;AZD 8055;UNII-970JJ37FPW;(5-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol;[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol;970JJ37FPW;CHEMBL1801204;KVLFRAWTRWDEDF-IRXDYDNUSA-N;(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol;(5-(2,4-Bis((S)-3-methylmorpholino)pyrido-[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol;(5-{2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol;[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl]methanol;[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol;PubChem22586;cc-79;D0K1VK;QCR-7;MLS006010169;SCHEMBL298416;GTPL7714;CHEBI:91329;CTK3J9362;AOB3532;EX-A044;SYN1166;MolPort-016-633-234;EX-A1549;ABP000902;BDBM50348452;LM1148;s1555;ZINC52509466;AKOS016009126;AN-1309;BCP9000367;CS-0067;DB12774;RL00063;SS-4787;AC-28424;AK109550;BC660053;HY-10422;KB-41413;SMR004701277;AB0033717;AJ-112083;AX8226378;TX-015738;ST24034773;X7420;AZ-12600000;W-5658;J-502775;BRD-K69932463-001-02-3;AZD 8055;1009298-09-2;[5-[2,4-bis((3s)-3-methylmorpholin -4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol;{5-[2,4-bis(3S)(3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl}methanol;5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-benzenemethanol"	1009298-09-2	970JJ37FPW	22843211	22843211	01/07/2012	22935583	01/07/2012	2009-2012		1	1	0	Yes	1					30/07/2018		72,8	49	NA	1	0	NA	1	MTORC	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,14	0	0	0	0	0	0	0	0	1
Sermorelin	"ilmofosine;ilx651;tasidotin"		"BIOD00033;BTD00033;DB00010"	"Sermorelina [Spanish];Sermoreline [French];Sermorelinum [Latin];Somatoliberin (human pancreatic islet), 29-L-argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-deglycine-40-de-L-alanine-41-de-L-arginine-42-de-L-alanine-43-de-L-argininyl-44-de-L-leucinamide;C08192;Sermorelin"	"SERMORELIN;Sermorelina;Sermoreline;Sermorelinum;Sermorelin (INN);Geref (TN);86168-78-7;Sermoreline [French];Sermorelinum [Latin];Sermorelina [Spanish];Sermorelin [INN:BAN];GROWTH HORMONE RELEASING FACTOR, Fragment 1-29 Amide;TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-NH2;D04AQH;CHEBI:9118;AN-7557;C08192;D08509;L000266;Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn- Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln- Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln- Asp-Ile-Met-Ser-Arg-NH2"	86168-78-7	89243S03TE	"14977826;16278403;16278405;16951240;8729947"	8729947	01/01/1995	6240568	01/12/1984	Bef. 1989		1	0	1	No	0	"02/10/2001 00:00;26/08/1991 00:00;28/05/1991 00:00;26/09/1997 00:00;27/03/1998 00:00;03/04/1998 00:00;28/12/1990 00:00"	AP	"EMD SERONO;EMD SERONO INC"	SERMORELIN ACETATE	28/12/1990	EMD SERONO	72,7	#N/A																							0						1
Cisplatin	"cddp;cisplatin;lipoplatin;liposomal cisplatin;micellar nanoparticle-encapsulated cisplatin;nc-6004;pegylated liposomal cisplatin;spi-077;spi-77"	"CDDP;CISplatin;Cis-DDP;Cisplatin;Cisplatin Inj 0.5mg/ml;Cisplatin Inj 1mg/ml;Cisplatin Injection;Cisplatin Injection BP;Cisplatin Injection, BP;Cisplatin Injection, Mylan Std.;PMS-cisplatin;Platinol;Platinol AQ Inj 1mg/ml;Platinol-AQ;cis-diamminedichloroplatinum(II)"	"APRD00359;DB00515"	"azane; dichloroplatinum;azane; platinum(+2) cation; dichloride;ammonia; platinum(+2) cation; dichloride;ammonia; dichloroplatinum;14913-33-8;26035-31-4;14283-03-5;82847-81-2;HSDB 3939;NCI-C55776;NK 801;NSC 119875;NSC-119875;Neoplatin;PDD;Peyrone's chloride;Platiblastin;Platidiam;Platidiam Lachema BRNO;Platinol;Platinum diamminodichloride;Platinum(II), diamminedichloro-, cis-;Platinum, diamminedichloro-, (SP-4-2)-;Platinum, diamminedichloro-, cis-;Platosin;TR 170;TRANS-DIAMMINEDICHLOROPLATINUM;cis Diamminedichloroplatinum;cis-DDP;cis-Diaminodichloroplatinum(II);cis-Diamminedichloroplatinum;cis-Diamminedichloroplatinum(II);cis-Diammineplatinum(II) dichloride;cis-Dichlorodiamine platinum(II);cis-Dichlorodiaminoplatinum;cis-Dichlorodiaminoplatinum(II);cis-Dichlorodiammine platinum(II);cis-Dichlorodiammineplatinum;cis-Dichlorodiammineplatinum(II);cis-Dichlorodiamminoplatinum(II);cis-Platin;cis-Platinous diaminodichloride;cis-Platinous diammine dichloride;cis-Platinum;cis-Platinum diamminedichloride;cis-Platinum(II);cis-Platinum(II) diamine dichloride;cis-Platinum(II) diaminedichloride;cis-Platinum(II) diaminodichloride;cis-Platinum(II) diamminedichloride;cisPt(II);trans-Diamminedichloroplatinum(II);trans-Dichlorodiammine platinum;trans-Dichlorodiammineplatinum(II);trans-Platinum(II) ammonium chloride;trans-Platinumdiammine dichloride;Cisplatin;SPECTRUM1502107;CCRIS 5161;Diamminedichloroplatinum (trans);EINECS 238-980-9;HSDB 3940;NSC 131558;Platinum (II), diamminedichloro-, trans-;Platinum, diamminedichloro-, (SP-4-1)- (9CI);Platinum, diamminedichloro-, trans- (8CI);Transplatin;trans-DDP;trans-Diamminedichloroplatinum (II);trans-Dichlorodiammineplatinum (II);trans-Platinum(II) diamminedichloride;trans-Platinum(II)diamminedichloride;479306_ALDRICH;EINECS 247-419-7;NSC 241517;P1525_SIGMA;trans-Platinum(II)diammine dichloride;CPDC;DDP-H;IA call;Platinol-AQ;Randa;(SP-4-2)-Diaminedichloroplatinum;AIDS-008008;AIDS008008;NSC119875;Platinum ammonium chloride;P4394_SIGMA;cis-Platinum(II) diammine dichloride;Diamminedichloroplatinum;Dichlorodiammineplatinum(II);Platinum diamine dichloride;Platinum, diamminedichloro-;NCGC00094962-01;Cisplatin [USAN:BAN:INN:JAN];NCGC00094962-02;NCGC00094962-03;AI3-62048;Abiplatin;Biocisplatinum;Briplatin;CACP;CCRIS 221;CDDP;CPDD;SPI 77;Cisplatine;Cisplatine [INN-French];Cisplatino [INN-Spanish];Cisplatino [Spanish];Cisplatinum [INN-Latin];Cisplatyl;DDP (antitumor agent);DDPt;EINECS 239-733-8"		15663-27-1	Q20Q21Q62J	"10022995;10440193;10653876;10673534;10738123;10830142;11398881;11821794;12201494;12201498;12826307;14566475;14583758;14701767;15245607;15258698;15459918;15589600;15597408;15756428;15790448;16754599;16875750;16884375;17438100;18520801;19100600;19185169;19221754;19495755;19885925;20670951;20801016;21285987;22451231;23255417;24074921;24868080;25877225;26891913;8622036;8946862;9020278;9424002;9516919;9624250;9740093;9849482"	8622036	01/03/1996	4641756	01/12/1972	Bef. 1989		0	1	1	Yes	1	"16/09/1980 00:00;27/02/1984 00:00;22/02/2002 00:00;11/07/1991 00:00;22/01/1986 00:00;08/11/2002 00:00;10/04/1987 00:00;11/09/1979 00:00;16/09/1985 00:00;08/11/1988 00:00;13/01/1988 00:00;06/10/2015 00:00;19/01/2017 00:00;13/12/1995 00:00;18/08/2015 00:00;22/01/1981 00:00;05/12/2002 00:00;29/05/1990 00:00;06/02/2014 00:00;16/05/2000 00:00;18/04/2012 00:00;05/12/1979 00:00;08/03/2011 00:00;26/08/2011 00:00;19/12/1978 00:00;22/04/1993 00:00;14/11/2000 00:00;19/08/1986 00:00;04/12/1995 00:00;14/05/2001 00:00;13/09/2000 00:00;23/03/1987 00:00;03/07/1985 00:00;02/09/2010 00:00;06/11/1986 00:00;26/08/1986 00:00;11/02/1988 00:00;17/07/2002 00:00;05/03/1985 00:00;23/08/1985 00:00;16/07/1999 00:00;18/12/1979 00:00;01/07/2002 00:00;15/03/2012 00:00;11/12/1990 00:00;30/01/2012 00:00;29/12/2011 00:00;03/03/2015 00:00;26/02/2015 00:00;09/08/1995 00:00;17/10/2008 00:00;31/10/1983 00:00;10/06/1982 00:00;27/07/1992 00:00;23/01/2012 00:00;05/03/1987 00:00;08/06/1987 00:00;27/11/1991 00:00;18/07/1984 00:00;26/02/1980 00:00;04/07/1980 00:00;16/01/2001 00:00;27/09/1990 00:00;05/05/1988 00:00;04/04/1990 00:00;12/03/1981 00:00;25/03/1993 00:00;17/03/2017 00:00;11/05/2001 00:00;01/11/1991 00:00;05/04/2001 00:00;02/05/1986 00:00;26/09/2002 00:00;31/01/1980 00:00;22/09/2015 00:00;17/05/1993 00:00;04/04/1984 00:00;12/01/1988 00:00;18/04/1996 00:00;13/01/1983 00:00;02/03/1989 00:00;05/05/1999 00:00;07/11/2000 00:00;29/12/1981 00:00;13/11/2012 00:00;21/06/2004 00:00"	AP	"BEDFORD;ACCORD HLTHCARE;TEVA PHARMS USA;FRESENIUS KABI USA;MYLAN LABS LTD;WEST-WARD PHARMS INT;PHARMACHEMIE BV;GLAND PHARMA LTD;HQ SPCLT PHARMA"	CISPLATIN	19/12/1978	HQ SPCLT PHARMA	72,4	32	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,13	0	0	0	NA	0	0	0	0	0	0	123	1	1
SF1126	"pan-pi3k/mtor inhibitor sf1126;sf1126"		DB05210		"SF1126;SF-1126;CC-1126;936487-67-1;D03NJY;AN-16875;(3S)-4-[[(1S)-1-carboxy-2-hydroxy-ethyl]amino]-3-[[2-[[(2S)-5-guanidino-2-[[4-oxo-4-[[4-(4-oxo-8-phenyl-chromen-2-yl)morpholin-4-ium-4-yl]methoxy]butanoyl]amino]pentanoyl]amino]acetyl]amino]-4-oxo-butanoic acid acetate"			22921184	22921184	01/08/2012	22921184	01/08/2012	2009-2012		1	1	0	Yes	1					30/07/2018		71,8	44	NA	1	1	LNH_B	1	"PI3K;MTOR"	0	1	1	NA	0	0	0	1	1	0	0	0	0	0,58	0	0	0	0	0	0	0	0	1
PM02734	"elisidepsin;pm02734"		DB05158		"UNII-3I37B5DY4Q;3I37B5DY4Q;Irvalec;Elisidepsin trifluoroacetate;PM-02734;PM02734;PM 02734;915713-02-9;L-Valine, N-((4S)-4-methyl-1-oxohexyl)-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-amino-2-butenoyl-, (13-8)-lactone, 2,2,2-trifluoroacetate (1:1)"			"26964995;25947566;22926637"	22926637	01/08/2012	22926637	01/08/2012	2009-2012		1	1	0	Yes	1					30/07/2018		71,8	42	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	0,29	0	1	1	0,31	0	0	0	0	0	0	0	0	1
Vandetanib	"azd6474;vandetanib;zd6474"	"N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine;Vandetanib;Caprelsa"	"DB05294;DB08764"	"N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine;N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine;N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine;(4-bromo-2-fluoro-phenyl)-[6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-yl]amine;N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine;338992-00-0;443913-73-3;Vandetanib;Vandetanib [INN];ZD 6474;Zactima;AZD-6474;ZD-6474;D06407;Vandetanib (JAN);ZD6474;ZD6;N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine;4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine"	"Vandetanib;443913-73-3;Zactima;ZD6474;Caprelsa;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine;vandetanib (zd6474);ZD 6474;ZD-6474;Vandetanib [INN];UNII-YO460OQ37K;N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine;C22H24BrFN4O2;CHEMBL24828;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine;YO460OQ37K;Vandetanib, Zactima, ZD6474;CHEBI:49960;GNF-PF-2188;AZD-6474;CH 331;CH-331;NCGC00167513-01;4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline;DSSTox_CID_26681;DSSTox_RID_81816;DSSTox_GSID_46681;F9995-0087;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine;4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE;4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-;CAS-443913-73-3;Vandetinib;HSDB 8198;2ivu;Vandetanib [USAN:INN:BAN:JAN];Caprelsa (TN);Vandetanib (Zactima);AC1MIWRU;DMPC Cyclic Urea 1;Kinome_3316;PubChem22460;Zactima, ZD6474;Vandetanib (JAN/INN);BDBM21;D0G6QF;SCHEMBL9044;MLS006011672;Vandetanib (JAN/USAN/INN);Vandetanib (Pan-TK inhibitor);GTPL5717;QCR-37;Vandetanib(Zactima),ZD6474/;DTXSID1046681;cid_3081361;CTK8B9016;EX-A422;SYN1090;MolPort-005-942-399;UHTHHESEBZOYNR-UHFFFAOYSA-N;BCPP000023;HMS3244K03;HMS3244K04;HMS3244L03;HMS3654E11;ZD-64;AOB87780;Tox21_112511;ABP000873;ANW-61824;NSC744325;NSC760766;RS0036;s1046;ZINC53683345;AKOS015902350;Tox21_112511_1;AC-5251;AN-3469;CS-0130;DB05294;MCULE-4705827953;NSC-744325;NSC-760766;4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline;NCGC00167513-02;NCGC00167513-03;NCGC00167513-04;338992-00-0;AJ-45811;AS-11067;BC224441;EN002713;HY-10260;KB-34269;SC-23330;SMR002530472;AB0008635;AB1008463;LS-184394;RT-016214;ST2407381;FT-0656736;A25648;D06407;V-9402;W-5356;68541-EP2298768A1;68541-EP2308855A1;AB01273969-01;AB01273969-02;AB01273969_04;913V733;SR-00000000462;I14-1942;SR-00000000462-2;BRD-K77625799-001-01-0;4-(4-Bromo-2-fluoroanilino)-6-methoxy- 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline;4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-yl)methoxyquinazoline;4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazoline;N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine;(4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(1-methyl-piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine;6-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(5-carboxypentyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]hexanoic acid;Quinazolin-4-amine, N-(4-bromo-2-fluorophenyl)-6-mthoxy-7-[(1-methyl-4-piperidinyl)methoxy]-;Vandetanib;7-((4-aminocyclohexyl)methoxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine"	443913-73-3	YO460OQ37K	"27819766;23099652;22701615;21600385;21247755;20921456;15905307"	15905307	01/05/2005	15905307	01/05/2005	2004-2008		1	1	1	Yes	1	"16/05/2017 00:00;27/11/2013 00:00;24/02/2017 00:00;03/07/2013 00:00;31/03/2014 00:00;22/06/2011 00:00;09/10/2012 00:00;06/04/2011 00:00;28/07/2016 00:00"	AP	GENZYME CORP	VANDETANIB	06/04/2011	GENZYME CORP	71,0	77	NA	1	0	NA	1	"VEGFR;EGFR"	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	245	0	1
Ganitumab	ganitumab		DB12205			905703-97-1	CK1441RCZ8	22810805	22810805	01/07/2012	19786654	01/09/2012	2009-2012		1	1	0	Yes	1					30/07/2018		70,8	53	NA	1	0	NA	1	IGF1R	0	1	0	NA	0	0	0	1	1	0,08	0	1	1	NA	0	0	0	0	0	0	25	0	1
IPH 2101	"iph-2101;iph2101"							23002117	23002117	01/09/2012	23002117	01/09/2012	2009-2012		1	1	0	Yes	1					30/07/2018		70,8	23	NA	0	1	AML_COMPLETE_REMISSION	1	KIR	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Vintafolide	"ec145;vintafolide"		"DB05168;DB12503"			742092-03-1	36O410ZD4I	23032618	23032618	01/10/2012	23032618	01/10/2012	2009-2012		1	1	0	Yes	1					30/07/2018		69,8	NA	NA	1	0	NA	1	FOLATE RECEPTOR	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	21	0	1
Dinaciclib	dinaciclib		DB12021		"Dinaciclib;779353-01-4;SCH727965;Dinaciclib (SCH727965);SCH 727965;SCH-727965;MK-7965;(2S)-1-[3-Ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol;J-501008;C21H28N6O2;(S)-3-(((3-ethyl-5-(2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide;UNII-4V8ECV0NBQ;Tube003;Dinaciclib (USAN/INN);4V8ECV0NBQ;D0D3PX;Sch 727965/Dinaciclib;MLS006011034;GTPL7379;Dinaciclib (SCH-727965);CHEMBL2103840;SCHEMBL12048446;CHEBI:95060;MolPort-023-293-537;AOB87336;ABP001007;BDBM50139171;NSC747135;s2768;ZINC34894449;AKOS030526898;CS-0541;DB12021;NSC-727135;NSC-747135;RL05018;AN-16669;AS-17017;BC261958;HY-10492;KB-76642;QC-11639;SMR004702827;AB0008052;SCH 727965,SCH727965, Dinaciclib;Y0347;D09604;W-5602;BRD-K13662825-001-02-6;779353-01-4 , C21H28N6O2 , SCH 727965 , SCH-727965;1-[3-Ethyl-7[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2(s)-piperidineethanol;1000697-89-1;2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidyl]ethanol;2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol"	779353-01-4	4V8ECV0NBQ	"24131779;23053255"	23053255	01/10/2012	23053255	01/10/2012	2009-2012	DOI: 10.1200/jco.2011.29.15_suppl.3080 	1	1	0	Yes	1					30/07/2018		69,8	81	NA	1	0	NA	1	"CDK1;CDK2;CDK5;CDK9"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,12	0	HYPOTENSION	1	DELIRIUM	1	0	0	0	1
Melphalan	melphalan	"P-L-Sarcolysin;P-Di-(2-chloroethyl)amino-L-phenylalanine;p-N,N-bis(2-chloroethyl)amino-L-phenylalanine;L-PAM;Melphalanum;L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine;L-Phenylalanine mustard;L-Sarcolysine;P-N-Bis(2-chloroethyl)amino-L-phenylalanine;3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine;p-Bis(beta-chloroethyl)aminophenylalanine;3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine;Melfalano;Phenylalanine nitrogen mustard;Phenylalanine mustard;4-(Bis(2-chloroethyl)amino)-L-phenylalanine;Melphalan Hydrochloride;Melphalan;Alkeran;Evomela;Melphalan for Injection"	"DB01042;APRD00118"	"2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propionic acid;13045-94-8;8057-25-8;51-87-6;148-82-3;531-76-0;p-N-Di(chloroethyl)aminophenylalanine;3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine;3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine;3025 C.B.;4-(Bis(2-chloroethyl)amino)-L-phenylalanine;4-14-00-01689 (Beilstein Handbook Reference);Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, L-;3-[p-[Bis(2-chloroethyl)amino]phenyl]-L-alanine;BRN 2816456;3025 C. B.;CCRIS 374;EINECS 205-726-3;HSDB 3234;L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine;SK-15673;L-Phenylalanine mustard;L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-;L-Sarcolysin;L-Sarcolysine;L-Sarkolysin;Levofalan;Levofolan;Levopholan;MELPHALAN;Melfalano [INN-Spanish];Melphalan [USAN:BAN:INN:JAN];Melphalanum [INN-Latin];NCI-C04853;NSC 241286;NSC 8806;NSC-8806;Phenylalanine mustard;Phenylalanine nitrogen mustard;RCRA waste no. U150;RCRA waste number U150;p-Bis(beta-chloroethyl)aminophenylalanine;p-Di-(2-chloroethyl)amino-L-phenylalanine;p-L-Sarcolysin;p-N-Bis(2-chloroethyl)amino-L-phenylalanine;(+)-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;(p-Di(2-chloroethyl)amino-D-phenyl)alanine;3026 C.B.;4-(Bis(2-chloroethyl)amino)-D-phenylalanine;Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, D-;D-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;D-Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-;D-Phenylalanine, 4-(bis(2-chloroethyl)amino)- (9CI);NSC 35051;p-Di(2-chloroethyl)amino-d-phenylalanine;Alanine, 3-[p-[bis(2-chloroethyl)amino]phenyl]-, L-;Sarcolysine;L-3-[p-[Bis(2-chloroethyl)amino]phenyl]alanine;Lopac0_000793;EU-0100793;3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;AY3360000;Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-;NCI60_041947;3-p-[Di(2-chloroethyl)amino] phenyl-L-alanine;WLN: QVYZ1R DN2G2G-L;2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;(+)-3-[p-[Bis(2-chloroethyl)amino]phenyl]alanine;3026 C. B.;4-[Bis(2-chloroethyl)amino]-D-phenylalanine;Alanine, 3-[p-[bis(2-chloroethyl)amino]phenyl]-, D-;CB 3026;CB-3026;D-3-[p-[Bis(2-chloroethyl)amino]phenyl]alanine;D-Alanine, 3-(p-[bis(2-chloroethyl)amino]phenyl)-;D-Phenylalanine mustard;D-Phenylalanine mustard base;D-Phenylalanine, 4-[bis(2-chloroethyl)amino]-;D-Sarcolysin;D-Sarcolysine;Medfalan;Medphalan;NSC35051;WLN: QVYZ1R DN2G2G -D;[p-Di(2-chloroethyl)amino-D-phenyl]alanine;4-(BIS(2-CHLOROETHYL)AMINO)-DL-PHENYLALANINE;AI3-25298;Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, DL-;CB-3307;CCRIS 376;DL-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;DL-Phenylalanine mustard;DL-Phenylalanine, 4-(bis(2-chloroethyl)amino)-;DL-Sarcolysin;DL-Sarcolysine;Merfalan;Merphalan;NCI-CO4944;NSC-14210;Phenylalanin-lost [German];Sarcoclorin;Sarcolisina [INN-Spanish];Sarcolysin;Sarcolysin [INN];Sarcolysine [INN-French];Sarcolysinum [INN-Latin];p-Di(2-chloroethyl)amino-DL-phenylalanine;p-Di-(2-chloraethyl)-amino-DL-phenyl-alanin [German];L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-;Mephalan;NSC241286;NCGC00094128-02;Sarkolysin;NCGC00094128-03"	"melphalan;148-82-3;Alkeran;Melfalan;Phenylalanine mustard;L-Sarcolysine;L-PAM;L-Sarcolysin;L-Phenylalanine mustard;Levofalan;p-L-Sarcolysin;Levopholan;Melphalanum;Levofolan;Melfalano;Phenylalanine nitrogen mustard;4-[Bis(2-chloroethyl)amino]-L-phenylalanine;p-Bis(beta-chloroethyl)aminophenylalanine;Alanine Nitrogen Mustard;p-Di-(2-chloroethyl)amino-L-phenylalanine;L-Sarkolysin;Melfalano [INN-Spanish];Melphalanum [INN-Latin];3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine;p-N-Bis(2-chloroethyl)amino-L-phenylalanine;4-(Bis(2-chloroethyl)amino)-L-phenylalanine;CB 3025;3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine;L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;p-L-sarcolysine;Rcra waste number U150;NCI-C04853;CCRIS 374;UNII-Q41OR9510P;CB-3025;CHEBI:28876;(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;HSDB 3234;Melphalan [USAN:INN:BAN:JAN];At-290;NSC-8806;ALKERAN (TN);p-N,N-bis(2-chloroethyl)amino-L-phenylalanine;EINECS 205-726-3;CHEMBL852;RCRA waste no. U150;NSC 241286;BRN 2816456;L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine;Sarcolysinum;SK-15673;phenylalanine nitrogen mu stard;SGDBTWWWUNNDEQ-LBPRGKRZSA-N;Q41OR9510P;p-N-Di(chloroethyl)aminophenylalanine;Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, L-;Alanine, 3-[p-[bis(2-chloroethyl)amino]phenyl]-, L-;p-N-di(chloroethyl)aminophenylala nine;NCGC00090757-02;NSC 8806;DSSTox_CID_804;L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-;3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine;4-[Bis-(2-chloroethyl)amino]-L-phenylalanine;TRANSGENIC MODEL EVALUATION (MELPHALAN);DSSTox_RID_75797;DSSTox_GSID_20804;8057-25-8;W-108096;TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN);Evomela;(S)-2-amino-3-(4-(bis(2-chloroethyl)amino)phenyl)propanoic acid;(2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid;MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN));Melphalan-d8 Dihydrochloride;4-(Bis(2-chloroethyl)amino)phenylalanine;NSC8806;CAS-148-82-3;SMR000058720;Phenylalanine, 4-[bis(2-chloroethyl)amino]-;L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-;(2S)-2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoic acid;NSC241286;Melphalan, powder;4-[Bis(2-chloroethyl)amino]phenylalanine;Prestwick_1006;Melphalan [USAN:USP:INN:BAN:JAN];Spectrum_000397;3025 C.B.;AC1LA2OE;Spectrum2_000074;Spectrum3_000684;Spectrum4_000882;Spectrum5_001601;D00FGO;Epitope ID:141802;SCHEMBL5872;BSPBio_002407;KBioGR_001284;KBioSS_000877;4-14-00-01689 (Beilstein Handbook Reference);MLS001333666;MLS002153368;BIDD:GT0044;DivK1c_000653;SPECTRUM1500382;SPBio_000287;Melphalan (JP15/USP/INN);Melphalan (JP17/USP/INN);GTPL7620;ZINC1673;DTXSID6020804;NIOSH/AY3360000;CTK5E7915;HMS502A15;KBio1_000653;KBio2_000877;KBio2_003445;KBio2_006013;KBio3_001627;L-phenylalanine mustard (L-PAM);3025 c.b;MolPort-003-665-535;NINDS_000653;HMS2090B09;HMS2091B16;HMS2235D21;Pharmakon1600-01500382;KS-00001D9Q;Tox21_111010;Tox21_202522;AN-976;BDBM50025837;CCG-39704;DL-442;LS-865;NSC757098;s8266;AKOS015895374;Alkeran;L-Phenylalanine mustard;L-PAM;Tox21_111010_1;API0003288;CS-3120;DB01042;NSC-757098;IDI1_000653;SMP2_000174;NCGC00090757-01;NCGC00090757-03;NCGC00090757-04;NCGC00090757-05;NCGC00090757-06;NCGC00260071-01;AS-13314;CC-30199;H877;HY-17575;LS-15868;SBI-0052787.P003;AB0005221;AB2000419;AY3360000;TL8001065;AY33600000;FT-0603357;4-[bis(2-chloroethyl)-amino]-L-phenylalanine;4-[bis(2-chloroethyl)-amino]-l-phenyl-alanine;4-[bis(2-chloroethyl)amino]-(L)-phenylalanine;C07122;D00369;K-4728;AB00053282-07;AB00053282-08;AB00053282_09;148M823;A808810;Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-;C-19011;SR-05000001667;SR-05000001667-1;BRD-K87827419-001-02-8;2-amino-3-[4-bis(2-chloroethyl)amino]phenylpropanoic acid;UNII-A960M0G5TP component SGDBTWWWUNNDEQ-LBPRGKRZSA-N;2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]-propanoic acid;(2S)-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid;(S)-2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid;2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid(L-PAM);2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid (Melphalan);2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid(Melphalan)"	148-82-3	Q41OR9510P	"27184623;22892551;22759762;22453252;21289367;20478715;17999399;16084053;15561001;15526021;15256243;14767498;10656432;10218462;9720737;8996137;7573726"	7573726	01/10/1995	13627765	01/04/1958	Bef. 1989		0	0	1	Yes	1	"09/04/1987 00:00;17/01/1964 00:00;19/07/1984 00:00;19/09/1984 00:00;27/10/2009 00:00;14/06/2005 00:00;29/04/2003 00:00;16/06/1980 00:00;14/07/2011 00:00;28/10/2010 00:00;09/10/2001 00:00;22/07/1998 00:00;22/03/2017 00:00;03/03/2000 00:00;14/05/2003 00:00;09/06/2005 00:00;22/12/2017 00:00;25/09/2017 00:00;02/05/2011 00:00;26/03/1990 00:00;09/06/2011 00:00;25/08/1994 00:00;22/08/2016 00:00;28/02/2017 00:00;07/01/2002 00:00;05/01/1994 00:00;09/06/2009 00:00;10/03/2016 00:00;18/11/1992 00:00;26/09/1989 00:00;27/08/2015 00:00;14/07/1999 00:00;24/05/2001 00:00;19/12/2016 00:00;22/09/1986 00:00;08/12/2017 00:00;24/03/1982 00:00"	AP	"APOTEX INC;ACTAVIS LLC;#N/A;PAR STERILE PRODUCTS;WEST-WARD PHARMS INT;MYLAN INSTITUTIONAL;ALVOGEN MALTA;SPECTRUM PHARMS;SAGENT PHARMS"	"MELPHALAN;MELPHALAN HYDROCHLORIDE"	17/01/1964	APOTEX INC	69,4	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Pemetrexed	"ly231514;pemetrexed"	"Alimta;Act Pemetrexed;Pemetrexed;Pemetrexed Lilly;Pemetrexed Accord Solution for Infusion;Pemetrexed Hospira;Taro-pemetrexed;Ciambra;Pemetrexed for Injection;Pemetrexed Medac;Pemetrexed Sandoz;Pemetrexed Disodium for Injection;Pemetrexed Accord"	"DB00642;APRD00573;EXPT02075"	"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[4,5-e]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;(2R)-2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[4,5-e]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid;(2R)-2-[[4-[2-(2-amino-4-keto-1,7-dihydropyrrolo[4,5-e]pyrimidin-5-yl)ethyl]benzoyl]amino]glutaric acid;(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[4,5-e]pyrimidin-5-yl)ethyl]phenyl]carbonylamino]pentanedioic acid;137281-23-3;(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[4,5-e]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;HSDB 7316;L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-;LY 231,514;N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid;N-[4-[2(2-AMINO-4,7-DIHYDRO-4-OXO-1H-PYRROLO[2,3-D]PYRIMIDIN-5- YL)ETHYL]BENZOYL;Pemetrexed"	"Pemetrexed;137281-23-3;Alimta;Pemetrexed disodium;UNII-04Q9AIZ7NO;Pemetrexed acid;CHEBI:63616;04Q9AIZ7NO;LY-231514;(S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid;N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid;LY-2315;N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid;pemetrexed diacid monohydrate;LY231514;(S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid;J-502393;Pemetrexed sodium hydrate;HSDB 7316;C20H21N5O6;Pemetrexed (INN);Pemetrexed disodium heptahydrate;(S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic;LYA;N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid;N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid;Pemetrexed Sodium;Premetred disodium;1juj;Pemetrexed (TN);2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID;L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-;N-(4-[2-(2-amino-4,7-Dihydro-4-Oxo-1H-Pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl)-L-Glutamic Acid;Alimta (TN) (Lilly);AC1L9JT6;SCHEMBL7968;US9422297, Pemetrexed;CHEMBL225072;DTXSID2048329;MolPort-016-638-470;MolPort-020-179-988;Premetrexed [Common mis-spelling];WBXPDJSOTKVWSJ-ZDUSSCGKSA-N;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;KS-00000GW0;ZINC1540998;BDBM50027656;CP0119;NSC698037;AKOS015896253;AC-1701;CS-1297;DB00642;NSC-698037;RP17940;NCGC00167517-01;NCGC00242485-01;AJ-26845;AK-72902;AS-30680;BC215781;BR-72902;HY-10820;KB-78231;SC-25136;DB-024764;FT-0659328;P2288;D07472;S-4927;41413-EP2270012A1;41413-EP2270013A1;41413-EP2305681A1;41413-EP2311838A1;41421-EP2270012A1;41421-EP2270013A1;41421-EP2305681A1;41421-EP2311838A1;89077-EP2270012A1;89077-EP2270013A1;89077-EP2305681A1;AB01273937-01;281P233;I06-2128;L-Glutamic acid,3-d]pyrimidin-5-yl]ethyl]benzoyl]-;(S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo-[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid;4DW;L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-;N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid;N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo[2,3-d]pyrimi-din-5-yl)ethyl]benzoyl]l-glutamic acid;N-[4-[2-[2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]ethyl]benzoyl]glutamic acid;N-{4-[2-(2-Amino-4-Oxo-4,7-Dihydro-3h-Pyrrolo[2,3-D]pyrimidin-5-Yl)ethyl]benzoyl}-L-Glutamic Acid"	137281-23-3	04Q9AIZ7NO	"23891283;21550200;20091088;19701110;19494788;16940981;10501910;9533527"	9533527	01/05/1998	9533527	01/05/1998	1994-1998		1	1	1	Yes	1	"28/03/2018 00:00;04/06/2012 00:00;18/01/2013 00:00;19/08/2004 00:00;31/07/2015 00:00;31/05/2016 00:00;07/09/2007 00:00;11/10/2017 00:00;11/08/2014 00:00;17/10/2012 00:00;09/11/2012 00:00;04/06/2018 00:00;08/01/2016 00:00;17/04/2018 00:00;02/07/2009 00:00;02/02/2007 00:00;13/03/2013 00:00;27/10/2015 00:00;26/09/2008 00:00;18/04/2016 00:00;19/05/2017 00:00;04/02/2004 00:00;12/09/2013 00:00;18/11/2011 00:00;17/03/2011 00:00;28/07/2006 00:00"	"AP;TA"	"APOTEX INC;TEVA PHARMS USA;QILU PHARM CO LTD;APP PHARMS;LILLY;ACCORD HLTHCARE INC;HOSPIRA INC"	"PEMETREXED SODIUM;PEMETREXED DISODIUM;PEMETREXED"	04/02/2004	LILLY	69,0	38	NA	1	0	NA	1	THYMIDYLATE SYNTHASE	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,08	0	0	0	0	0	0	58	0	1
Gemcitabine elaidate	"co-1.01;co-101;cp-4126;cp-4126, a gemcitabine derivative;gemcitabine elaidate"		DB12564		"Gemcitabine elaidate;Gemcitabine (elaidate);210829-30-4;CP-4126;UNII-231C73W7LG;231C73W7LG;CP-4126 (LVT DERIVATIVE OF GEMCITABINE);SCHEMBL582034;SCHEMBL582036;CHEMBL3039516;DTXSID00175308;Gemcitabine elaidate (USAN/INN);Gemcitabine elaidate [USAN:INN];ZINC14208575;AKOS030526715;CO-1.01;CP 4126;CS-3744;DB12564;RL02603;HY-13538;D10222;J-520106;2'-Deoxy-2',2'-difluorocytidine 5'-(9E)-octadec-9-enoate;Cytidine, 2'-deoxy-2',2'-difluoro-, 5'-(9E)-9-octadecenoate;4-Amino-1-(2-deoxy-2,2-difluoro-5-O-((9E)-octadec-9-enoyl)-alpha-D-erythro- pentofuranosyl)pyrimidin-2(1H)-one"	210829-30-4	231C73W7LG	"26289594;23345000"	23345000	01/01/2013	23345000	01/01/2013	2013-2017		1	1	0	Yes	1					30/07/2018		66,8	26	NA	1	0	NA	0	NA	0	1	1	NA	0	0	0	1	1	0,04	0	0	0	0,34	0	0	0	0	0	0	0	0	1
Alemtuzumab	"alemtuzumab;campath-1h"	"Lemtrada;Mabcampath;Campath"	"DB00087;BTD00109;BIOD00109"			216503-57-0	3A189DH42V	"17506867;11807632"	11807632	01/01/2002	7488279	01/11/1995	1994-1998		1	0	1	No	0	"07/05/2001 00:00;18/09/2015 00:00;14/11/2014 00:00;05/09/2014 00:00;19/05/2004 00:00;13/12/2017 00:00;05/04/2016 00:00;05/10/2017 00:00;19/09/2007 00:00;30/03/2009 00:00"	AP	GENZYME	ALEMTUZUMAB	07/05/2001	GENZYME	66,0	40																							0						1
Carlumab	carlumab		DB12718			915404-94-3	6TC1BB2EV9	23385782	23385782	01/02/2013	23385782	01/02/2013	2013-2017		1	1	0	Yes	1					30/07/2018		65,7	44	NA	1	0	NA	1	CCL2	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,09	0	0	0	0	0	0	25	0	1
Olaparib	"azd2281;ku-0059436;olaparib"	"4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one;Lynparza"	"DB09074;DB05940"		"Olaparib;763113-22-0;AZD2281;Lynparza;AZD-2281;AZD 2281;1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;KU-0059436;UNII-WOH1JD9AR8;4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one;Olaparib (AZD2281, Ku-0059436);WOH1JD9AR8;Acylpiperazine analogue, 47;KU-59436;CHEBI:83766;937799-91-2;AZD2281(olaparib);4-(3-{[4-(Cyclopropylcarbonyl)piperazin-1-Yl]carbonyl}-4-Fluorobenzyl)phthalazin-1(2h)-One;4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one;J-503540;4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one;4-[[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one;OLAPARIB cpd;Olaparib [USAN:INN];Olaparibum;Lynparza (TN);09L;4-((3-{(4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl}-4-fluorophenyl)methyl)phthalazin-1(2H)-one;4-[(3-{[4-(Cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)-one;4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluoro-phenyl]methyl]-2H-phthalazin-1-one;PubChem19148;Olaparib (AZD2281);Olaparib - AZD2281;cc-16;D0J9HW;AZD-2281 (Olaparib);Olaparib (JAN/USAN/INN);MLS006010185;SCHEMBL426568;CHEMBL521686;GTPL7519;BDBM27566;CTK8B3857;KS-00000HXY;AOB1085;EX-A002;FDLYAMZZIXQODN-UHFFFAOYSA-N;MolPort-009-679-395;BCPP000360;HMS3654G13;ABP000423;AN-493;ANW-43329;AZ2281;GP0126;MFCD13185161;NSC747856;s1060;ZINC40430143;AKOS005145764;AC-7939;ACN-032229;AN-5279;API0024518;BCP9000363;CS-0075;DB09074;EX-7210;KU59436;NSC-747856;QC-2660;RL04905;SS-4573;AZD2281,Olaparib, KU-0059436;NCGC00238451-01;NCGC00238451-02;4CA-0938;BC245405;BR-40514;EN002690;HY-10162;Olaparib (AZD2281, KU0059436);SC-65060;SMR004701291;AB0009952;AB1009702;AJ-101717;AX8162101;KU0059436;A9666;BB 0260909;FT-0083489;FT-0651458;D09730;S-3781;S-7836;Z-3275;AZD2281(olaparib)/AZD-2281/KU0059436;I06-2362;BRD-K02113016-001-08-9;BRD-K02113016-001-09-7;1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1;AZD 2281|||KU 0059436|||KU 59436;Olaparib, KU-0059436, AZD2281,KU0059436, AZD2281;(2H)-Phthalazinone, 4-((3-((4-(cyclopropylcarbonyl)-1-piperazinyl)carbonyl)-4-fluorophenyl)methyl)-;1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-;1021843-02-6;4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one;4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one;894104-70-2"	763113-22-0	WOH1JD9AR8	"27993796;27745744;27553432;27422301;26242220;26048134;23315029;22145984"	22145984	01/12/2011	19553641	01/07/2009	2009-2012		1	1	1	Yes	1	"06/02/2018 00:00;19/10/2016 00:00;12/01/2016 00:00;23/10/2017 00:00;19/12/2014 00:00;12/01/2018 00:00;17/08/2017 00:00;26/01/2017 00:00"	AP	ASTRAZENECA PHARMS	OLAPARIB	19/12/2014	ASTRAZENECA PHARMS	65,5	60	NA	1	1	BRCA_MUTANT	1	PARP	0	1	1	22	1	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	603	0	1
Thiotepa	"thiofosfamide;thiophosphamide;thiophosphoramide;thiotepa;triethylene thiophosphoramide;wr 45312"	"Thio Tepa Inj 15mg/vial;Thiotepa;Thiotepa - (pws 15 Mg/vial);Tepadina"	DB04572	"tris(aziridin-1-yl)-sulfanylidenephosphorane;tris(aziridin-1-yl)-thioxo-phosphorane;tris(1-aziridinyl)-thioxophosphorane;triethylenimino-thioxo-phosphorane;tris(aziridin-1-yl)-sulfanylidene-phosphorane;52-24-4;Spectrum4_000208;SPECTRUM1503324;4-20-00-00052 (Beilstein Handbook Reference);AI3-24916;Aziridine, 1,1,1""-phosphinothioylidynetris-;BRN 0145978;CCRIS 586;EINECS 200-135-7;HSDB 3258;Ledertepa;N,N',N""-Triethylenethiophosphamide;N,N',N""-Triethylenethiophosphoramide;N,N',N''-Triethylenethiophosphortriamide;NSC-6396;Thioplex (TN);Phosphorothioic triamide, N,N',N""-triethylene-;Thiophosphamidum;Thiophosphoramide, N,N',N""-triethylene-;Thiotepa [USAN:BAN:INN:JAN];Thiotepum [INN-Latin];Tiotepa [INN-Spanish];Tri-1-aziridinylphosphine sulfide;Tris(1-aziridinyl)phosphine sulphide;Tris(aziridinyl)phosphine sulfide;WR-45312;KBioSS_002169;Tris(aziridinyl)-phosphine sulfide (thio-tepa);KBio2_002169;KBio2_004737;KBio2_007305;KBio3_002688;ST5405494;DivK1c_000817;NCGC00095042-01;NCGC00095042-02;NCGC00095042-03;AIDS-112651;AIDS112651;CBC 806495;Girostan;KBioGR_000815;Spectrum5_001641;NCI60_013117;1,1',1''-phosphorothioyltriaziridine;BSPBio_003188;KBio1_000817;C07641;Thiotepa;NCGC00095042-04;SPBio_001434;T6069_SIGMA;1,1',1''-Phosphinothioylidynetrisaziridine;Aziridine, 1,1',1''-phosphinothioylidynetris-;CBC 806495;Girostan;N,N',N''-Tri-1,2-ethanediylphosphorothioic triamide;N,N',N''-Tri-1,2-ethanediylthiophosphoramide;N,N',N''-Triethylenephosphorothioic triamide;N,N',N''-Triethylenethiophosphamide;N,N',N''-Triethylenethiophosphoramide;NCI-C01649;NSC 6396;NSC6396;Oncotepa;Oncothio-tepa;Oncotiotepa;Phosphine sulfide, tris(1-aziridinyl)-;Phosphorothioic acid triethylenetriamide;Phosphorothioic triamide, N,N',N''-tri-1,2-ethanediyl-;Phosphorothioic triamide, N,N',N''-triethylene;SK 6882;STEPA;TESPA;TIO TEF;TSPA;Tespamin;Tespamine;Thio-Tep;Thio-Tepa;Thio-tepa S;Thiofozil;Thiophosphamide;Thiophosphoramide, N,N',N'' -triethylene-;Thiophosphoramide, N,N',N''-tri-1,2-ethanediyl-;Thiotef;Thiotriethylenephosphoramide;Tifosyl;Tio-tef;Tiofosfamid;Tiofosyl;Tiofozil;Tri(ethyleneimino)thiophosphoramide;Triaziridinylphosphine sulfide;Triethylene thiophosphoramide;Triethylenethiophosphoramide;Triethylenethiophosphorotriamide;Tris(1-aziridinyl)phosphine sulfide;Tris(ethylenimino)thiophosphate;WLN: T3NTJ APS&- AT3NTJ&- AT3NTJ;IDI1_000817;D00583;NINDS_000817;Thioplex;Phosphoric tri(ethyleneamide);Thiotepa (JP15/USP/INN);Spectrum_001689;Spectrum3_001594;Spectrum2_001557"	"thiotepa;THIO-TEPA;52-24-4;Triethylenethiophosphoramide;Thiophosphamide;Tiofosfamid;Tiofosyl;Thiofozil;Tespamin;Thioplex;Tiofozil;Girostan;Oncotepa;Tespamine;Thiotef;Stepa;Tio-tef;Thio-Tep;Oncotiotepa;Tifosyl;Oncothio-tepa;TESPA;TSPA;Thio-tepa S;Ledertepa;Thiotriethylenephosphoramide;TIO TEF;N,N',N''-Triethylenethiophosphoramide;Tris(1-aziridinyl)phosphine sulfide;tepadina;1,1',1''-phosphorothioyltriaziridine;Thiophosphamidum;Triethylene thiophosphoramide;Triaziridinylphosphine sulfide;Tri(aziridin-1-yl)phosphine sulfide;Triethylenethiophosphorotriamide;Tris(ethylenimino)thiophosphate;CBC 806495;Phosphorothioic acid triethylenetriamide;Tris(aziridinyl)phosphine sulfide;Phosphine sulfide, tris(1-aziridinyl)-;Tri(ethyleneimino)thiophosphoramide;Aziridine, 1,1',1''-phosphinothioylidynetris-;NCI-C01649;NSC 6396;NSC-6396;N,N',N''-Triethylenethiophosphamide;SK 6882;Thiotepum [INN-Latin];Tiotepa [INN-Spanish];Tri-1-aziridinylphosphine sulfide;Tris(1-aziridinyl)phosphine sulphide;UNII-905Z5W3GKH;Phosphoric tri(ethyleneamide);C6H12N3PS;CCRIS 586;N,N',N''-Triethylenethiophosphortriamide;AI3-24916;HSDB 3258;NSC6396;1,1',1''-Phosphinothioylidynetrisaziridine;N,N',N''-Triethylenephosphorothioic triamide;N,N',N''-Tri-1,2-ethanediylthiophosphoramide;EINECS 200-135-7;Thiophosphoramide, N,N',N''-tri-1,2-ethanediyl-;BRN 0145978;N,N',N''-Tri-1,2-ethanediylphosphorothioic triamide;WR-45312;MLS001333083;MLS003389372;905Z5W3GKH;CHEBI:9570;Phosphorothioic triamide, N,N',N''-tri-1,2-ethanediyl-;AI 3-24916;FOCVUCIESVLUNU-UHFFFAOYSA-N;Phosphorothioic triamide, N,N',N''-triethylene-;NCGC00095042-04;NCGC00095042-06;DSSTox_CID_1339;tris(aziridin-1-yl)-thioxo-$l^{5}-phosphane;Tris(aziridinyl)-phosphine sulfide (thio-tepa);DSSTox_RID_76093;DSSTox_GSID_21339;triethylenethiophosphortriamide;AZIRIDINE,1,1',1''-PHOSPHINOTHIOYLIDYNETRIS-;Thiotepum;Tiotepa;CAS-52-24-4;SMR000058542;tris(aziridin-1-yl)-sulfanylidene-;SR-05000001855;Thiotepa [USP:INN:BAN:JAN];Thiotepa [USAN:INN:BAN:JAN];N,N',N""-Triethylenethiophosphamide;Tepadina (TN);Thioplex (TN);N,N',N""-Triethylenethiophosphoramide;Spectrum_001689;Thiophosphoramide, N,N',N""-triethylene-;WR 45312;Thiophosphoramide, N,N',N''-triethylene-;AC1L1KDQ;Spectrum2_001557;Spectrum3_001594;Spectrum4_000208;Spectrum5_001641;Aziridine, 1,1,1""-phosphinothioylidynetris-;CHEMBL671;D00YZA;Thioplex (TN) (Immunex);SCHEMBL4760;Phosphorothioic triamide, N,N',N""-triethylene-;Thiotepa (JAN/USP/INN);Triethylenethiop hosphoramide;Thio-TEPA, 98%, solid;BSPBio_003188;KBioGR_000815;KBioSS_002169;4-20-00-00052 (Beilstein Handbook Reference);KSC917M9N;MLS001333084;MLS002207150;MLS006009972;ARONIS24177;BIDD:GT0127;DivK1c_000817;SPECTRUM1503324;SPBio_001434;GTPL7622;DTXSID0021339;CTK8B7696;HMS502I19;KBio1_000817;KBio2_002169;KBio2_004737;KBio2_007305;KBio3_002688;N,N''-Triethylenethiophosphamide;THIOPHOSPHRAMIDE,THIO-TEPA;AOB5373;1,1,1-phosphorothioyltriaziridine;MolPort-001-783-551;NINDS_000817;HMS1922A14;HMS2093E05;HMS2232P17;HMS3372D10;N,N''-Triethylenethiophosphoramide;Pharmakon1600-01503324;KS-000010LT;ZINC1530867;Tox21_111399;Tox21_400065;ANW-58232;BDBM50418086;CCG-39776;LS-170;MFCD00145452;NSC758455;RW2156;AKOS005267118;CS-3119;DB04572;GC10080;MCULE-5478761622;NSC-758455;RL03925;RTR-018556;1,1''-Phosphinothioylidynetrisaziridine;IDI1_000817;Thiophosphoramide,N',N'' -triethylene-;NCGC00095042-01;NCGC00095042-02;NCGC00095042-03;NCGC00095042-05;NCGC00095042-07;NCGC00095042-08;NCGC00095042-09;PHOSPHOROTHIOIC TRI(ETHYLENEAMIDE);AN-41625;AS-16885;HY-17574;KB-81272;N,N''-Triethylenephosphorothioic triamide;NCI60_013117;SC-27282;SBI-0051814.P002;tris(1-aziridinyl)-sulfanylidenephosphorane;tris(aziridin-1-yl)-lambda-phosphanethione;AB0006704;AB2000286;Aziridine,1',1''-phosphinothioylidynetris-;N,N''-Tri-1,2-ethanediylthiophosphoramide;Phosphorothioic triamide,N',N''-triethylene;Thiophosphoramide, N,N',N'' -triethylene-;TR-018556;tris(aziridin-1-yl)-lambda5-phosphanethione;Aziridine,1,1',1'-phosphinothioylidynetris-;FT-0082517;FT-0600281;tris(aziridin-1-yl)-$l;{5}-phosphanethione;tris(aziridin-1-yl)-sulfanylidenephosphorane;WLN: T3NTJ APS&- AT3NTJ&- AT3NTJ;Y0223;1-[Di(1-aziridinyl)phosphorothioyl]aziridine #;C07641;D00583;Phosphorothioic triamide, N,N',N''-triethylene;Thiophosphoramide,N',N''-tri-1,2-ethanediyl-;Z-0841;24126-EP2272827A1;24126-EP2272832A1;24126-EP2275420A1;24126-EP2280012A2;24126-EP2292615A1;24126-EP2295055A2;24126-EP2295416A2;24126-EP2295426A1;24126-EP2295427A1;24126-EP2298748A2;24126-EP2298764A1;24126-EP2298765A1;24126-EP2298768A1;24126-EP2298778A1;24126-EP2301928A1;24126-EP2305642A2;24126-EP2308833A2;24126-EP2311453A1;24126-EP2314590A1;AB00052346-06;AB00052346_07;N,N',N''-Tri-1,2-et hanediylthiophosphoramide;145T452;A828998;N,N''-Tri-1,2-ethanediylphosphorothioic triamide;1-(DI(1-AZIRIDINYL)PHOSPHOROTHIOYL)AZIRIDINE;I09-1625;Q-201826;SR-05000001855-1;SR-05000001855-5;tris(aziridin-1-yl)-sulfanylidene-$l^{5}-phosphane;BRD-K09631521-001-05-7;Phosphorothioic triamide,N',N''-tri-1,2-ethanediyl-;TRIS(AZIRIDIN-1-YL)-LAMBDA(5)-PHOSPHANETHIONE;Tiofosyl;Tiofosfamid;Triethylenethiophosphoramide;Thioplex;Z2574360269;Thiotepa, United States Pharmacopeia (USP) Reference Standard;1631739-26-8;639-23-6;85177-92-0"	52-24-4	905Z5W3GKH	"27184623;11443634;10440193;10373061;7497586"	7497586	01/01/1995	13091480	01/11/1953	Bef. 1989		0	0	1	Yes	1	"02/03/2000 00:00;14/02/1986 00:00;09/03/1959 00:00;21/09/1978 00:00;10/04/1978 00:00;23/02/1993 00:00;17/10/1986 00:00;24/03/1981 00:00;26/11/1997 00:00;26/09/1997 00:00;18/12/1990 00:00;08/07/2015 00:00;08/02/1999 00:00;05/12/2002 00:00;11/07/2002 00:00;22/04/1999 00:00;16/05/2000 00:00;01/10/2002 00:00;02/04/2001 00:00;20/05/1996 00:00;22/12/1994 00:00;20/04/2001 00:00;15/09/1975 00:00;18/09/2002 00:00;20/09/2001 00:00;16/09/1978 00:00;04/05/2018 00:00;12/10/2000 00:00;26/01/2017 00:00"	AP	"#N/A;FRESENIUS KABI USA;TEVA PARENTERAL;IMMUNEX;WEST-WARD PHARMS INT;ADIENNE SA"	THIOTEPA	09/03/1959	IMMUNEX	64,1	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Patritumab	"amg 888;patritumab;u3-1287"		DB12090			1262787-83-6	86780VJI1Q	23591447	23591447	01/04/2013	23591447	01/04/2013	2013-2017		1	1	0	Yes	1					30/07/2018		63,8	57	NA	1	0	NA	1	HER3	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	0,26	0	0	0	0	0	0	25	0	1
Carmustine	"bcnu;bcnu implant;bcnu-fluosol;bcnu-loaded polymer;carmustine;dti-015;gliadel"	"BCNU;BiCNU;Bicnu (tn);Bischloroethyl nitrosourea;Carmustina;Carmustine;Carmustinum;Gliadel;Gliadel Wafer;N,N'-Bis(2-chloroethyl)-N-nitrosourea;bis-chloroethylnitrosourea"	"APRD00006;DB00262"	"1,3-Bis(2-chloroethyl)-1-nitrosourea;1,3-bis(2-chloroethyl)-1-nitroso-urea;154-93-8;Spectrum4_000888;KBio1_000835;NCGC00093665-02;KBioGR_001296;NCI60_003931;Spectrum_000265;Spectrum5_000920;NINDS_000835;Lopac-C-0400;NCGC00015204-01;Lopac0_000188;1,3-Bis(.beta.-chloroethyl)-1-nitrosourea;Bis(chloroethyl)nitrosourea;NSC409962;WLN: ONN2GVM2G;AIDS-000666;AIDS000666;CHEBI:3423;C0400_SIGMA;Prestwick_997;KBioSS_000745;Bicnu (TN);Carmustine (USAN/INN);D00254;1,3-Bis(2-chloroethyl)-1-nitrosourea;1,3-Bis(2-chloroethyl)nitrosourea;1,3-Bis(beta-chloroethyl)-1-nitrosourea;AI3-52216;BCNU;BCNU [Chloroethyl nitrosoureas];BRN 2049744;Becenum;Bi CNU;BiCNU;Bis(2-chloroethyl)1-nitrosourea;Bis(2-chloroethyl)nitrosourea;Bis-N,N'-(chloroethyl)nitrosourea;Bischlorethylnitrosourea;Bischlorethylnitrosurea;Bischloroethyl nitrosourea;Bischloroethyl nitrosourea [Chloroethyl nitrosoureas];Bischloroethylnitrosourea;CCRIS 810;Carmubris;Carmustin;Carmustina [INN-Spanish];Carmustine;Carmustine [USAN:BAN:INN];Carmustinum [INN-Latin];DTI 015;EINECS 205-838-2;FDA 0345;Gliadel;N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA;NCI-C04773;NSC 409962;NSC-409962;Nitrumon;SK 27702;SRI 1720;Urea, 1,3-bis(2-chloroethyl)-1-nitroso-;Urea, N,N'-bis(2-chloroethyl)-N-nitroso-;DivK1c_000835;IDI1_000835;KBio2_000745;KBio2_003313;NCGC00093665-04;KBio2_005881;EU-0100188"	"carmustine;154-93-8;1,3-Bis(2-chloroethyl)-1-nitrosourea;BCNU;Carmustin;Nitrumon;Carmubris;Gliadel;BiCNU;Bi CNU;Bischlorethylnitrosurea;Bischlorethylnitrosourea;Carmustina;Carmustinum;Becenum;Becenun;Bischloroethyl nitrosourea;N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA;Bis(2-chloroethyl)nitrosourea;Urea, N,N'-bis(2-chloroethyl)-N-nitroso-;Gliadel Wafer;Bischloroethylnitrosourea;FDA 0345;SRI 1720;1,3-Bis(2-chloroethyl)nitrosourea;BiCNU (TN);Carmustinum [INN-Latin];Carmustina [INN-Spanish];DTI 015;NCI-C04773;SK 27702;FIVB;NSC-409962;Bis(2-chloroethyl)1-nitrosourea;Bis(chloroethyl)nitrosourea;Bis-N,N'-(chloroethyl)nitrosourea;CCRIS 810;Carmustine [USAN:INN:BAN];NSC 409962;UNII-U68WG3173Y;carmustine in ethanol;1,3-Bis(beta-chloroethyl)-1-nitrosourea;BCNU [Chloroethyl nitrosoureas];EINECS 205-838-2;NSC409962;CHEMBL513;1,3-bis(2-chloroethyl)-3-nitrosourea;BRN 2049744;1,3-bis(2-chloroethyl)-1-nitroso-urea;AI3-52216;CHEBI:3423;Urea, 1,3-bis(2-chloroethyl)-1-nitroso-;DLGOEMSEDOSKAD-UHFFFAOYSA-N;U68WG3173Y;Bischloroethyl nitrosourea [Chloroethyl nitrosoureas];NCGC00015204-05;1,3-Bis(.beta.-chloroethyl)-1-nitrosourea;1,3-BIS(CHLOROETHYL)-1-NITROSOUREA;DSSTox_CID_2743;C 0400;DSSTox_RID_76712;DSSTox_GSID_22743;CAS-154-93-8;SR-01000075736;C5H9Cl2N3O2;Carustine;HSDB 7761;Carmustine [USAN:USP:INN:BAN];Prestwick_997;Gliadel (TN);Carmustine(BiCNU)/;Gliadel (MGI Pharm);Spectrum_000265;Carmustine, >=98%;AC1L1DZQ;Carmustine (USAN/INN);Spectrum4_000888;Spectrum5_000920;Lopac-C-0400;WLN: ONN2GVM2G;D0S9UT;SCHEMBL4503;Lopac0_000188;KBioGR_001296;KBioSS_000745;C5H11Cl2N3O2;MLS001333962;Carmustine (JAN/USAN/INN);DivK1c_000835;GTPL6800;DTXSID8022743;CTK8B8775;HMS502J17;KBio1_000835;KBio2_000745;KBio2_003313;KBio2_005881;AOB6824;MolPort-003-665-505;NINDS_000835;HMS2092J22;HMS2230I05;HMS3260F17;HMS3369D17;Pharmakon1600-01503110;ZINC3830387;Tox21_110097;Tox21_500188;ABP000292;ANW-61236;BDBM50015950;CCG-39925;LS-890;MFCD00057706;NSC758392;STK624770;AKOS005558013;Tox21_110097_1;AN-1123;BCP9000490;CS-2935;DB00262;LP00188;MCULE-3131772074;NSC-758392;IDI1_000835;Urea,3-bis(2-chloroethyl)-1-nitroso-;NCGC00015204-01;NCGC00015204-02;NCGC00015204-03;NCGC00015204-04;NCGC00015204-06;NCGC00015204-07;NCGC00015204-08;NCGC00015204-09;NCGC00093665-01;NCGC00093665-02;NCGC00093665-03;NCGC00093665-04;NCGC00260873-01;Urea,N'-bis(2-chloroethyl)-N-nitroso-;4CA-0349;AC-24196;AS-12106;HY-13585;N,N''-Bis(2-chloroethyl)-N-nitrosourea;NCI60_003931;SC-17305;SMR000058426;1,3-Bis(beta.-chloroethyl)-1-nitrosourea;SBI-0050176.P003;AB0011283;AB2000140;Gliadel;BCNU;NSC-409962;Becenun;BiCNU;KB-216399;TC-149981;EU-0100188;FT-0083563;FT-0602937;ST24036755;BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea;C06873;D00254;13167-EP2270014A1;13167-EP2272827A1;13167-EP2272832A1;13167-EP2275420A1;13167-EP2277876A1;13167-EP2292614A1;13167-EP2295055A2;13167-EP2295416A2;13167-EP2295426A1;13167-EP2295427A1;13167-EP2298748A2;13167-EP2298764A1;13167-EP2298765A1;13167-EP2298768A1;13167-EP2298778A1;13167-EP2305642A2;13167-EP2308861A1;13167-EP2311453A1;13167-EP2311808A1;13167-EP2311825A1;13167-EP2311829A1;13167-EP2311842A2;13167-EP2314590A1;13167-EP2316832A1;13167-EP2316833A1;13167-EP2316834A1;13167-EP2374454A1;15164-EP2272827A1;15164-EP2316832A1;15164-EP2316833A1;AB00052431-07;AB00052431_08;154C938;A809590;Gliadel, BCNU, NSC-409962, Becenun, Carmustine;SR-01000075736-1;SR-01000075736-3;W-108025;I14-11976;Z1563145982;Carmustine, United States Pharmacopeia (USP) Reference Standard;1-(2-Chloroethyl)-1-([(2-chloroethyl)amino]carbonyl)-2-oxohydrazine #;1159711-15-5;1191292-23-5"	154-93-8	U68WG3173Y	"12659665;12721262;12925239;15937647;18679580;19123896;22250189;24739422;24874252;8608540;8630682;8787853;9049862"	8787853	01/11/1995	4334161	01/12/1971	Bef. 1989		0	0	1	Yes	1	"25/02/2003 00:00;17/05/1988 00:00;24/03/2017 00:00;21/04/1987 00:00;03/01/1991 00:00;12/02/1998 00:00;27/09/2000 00:00;07/03/1977 00:00;11/12/1992 00:00;10/02/1999 00:00;08/08/2000 00:00;26/12/2006 00:00;13/07/1992 00:00;15/09/1997 00:00;18/09/2013 00:00;25/10/1999 00:00;29/06/1983 00:00;07/11/2001 00:00;20/11/2014 00:00;19/05/1986 00:00;16/10/1998 00:00;14/09/1989 00:00;25/11/2015 00:00;22/01/1998 00:00;18/10/2013 00:00;13/06/2014 00:00;27/02/2003 00:00;20/10/2005 00:00;23/09/1996 00:00;07/08/1987 00:00;25/03/1999 00:00;10/09/1997 00:00;10/02/1983 00:00;11/07/1986 00:00;17/02/1984 00:00;22/08/1997 00:00;13/03/1984 00:00;08/08/1984 00:00;14/03/2011 00:00;16/08/2013 00:00;13/06/1991 00:00;12/01/1988 00:00;01/06/2015 00:00;10/12/1984 00:00;16/07/1999 00:00;15/05/2001 00:00;11/08/2011 00:00;04/04/1997 00:00;17/08/2007 00:00;09/10/1979 00:00;19/04/1989 00:00;28/04/2016 00:00;08/10/1996 00:00;22/12/1977 00:00;05/03/1987 00:00;03/04/1984 00:00;26/10/1987 00:00;16/02/1982 00:00;12/11/1980 00:00;15/09/1978 00:00"	AP	"ARBOR PHARMS LLC;EMCURE PHARMS LTD"	CARMUSTINE	07/03/1977	EMCURE PHARMS LTD	63,0	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Poziotinib	"hm781;poziotinib"		DB12114		"Poziotinib;1092364-38-9;UNII-OEI6OOU6IK;OEI6OOU6IK;NOV120101;HM-78136B;HM781-36B;NOV-120101;1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one;2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-;Poziotinib [INN];Tube707;D00YER;Poziotinib (HM781-36B);GTPL7903;SCHEMBL3391764;CHEMBL3545154;DTXSID80148853;EX-A528;LPFWVDIFUFFKJU-UHFFFAOYSA-N;MolPort-035-944-321;s7358;ZINC95930125;AKOS026674078;CS-3942;DB12114;HM-781-36B;NOV 120101;1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one;AC-29021;BC600633;DA-47945;HY-15730;Pan-Her/EGFR inhibitors (cancer), Hanmi;KB-144331;B5827;FT-0752903;J-690026;1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one;1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one;1-[4-[4-(3,4-Dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy]-1-piperidinyl]-2-propene-1-one;1346176-39-3"	1092364-38-9	OEI6OOU6IK	25377158	25377158	01/11/2014	25377158	01/05/2013	2013-2017	DOI: 10.1200/jco.2013.31.15_suppl.2565	1	1	0	Yes	1					30/07/2018		62,8	20	NA	1	0	NA	1	EGFR	0	1	0	NA	0	0	0	1	1	0,25	0	0	0	0,56	0	0	0	0	0	0	0	0	1
Gemcitabine	"(dfdc)--gemcitabine;2'-difluorodeoxycytidine;difluorodeoxycytidine;gemcitabine"	"2',2'-Difluorodeoxycytidine;2'-Deoxy-2',2'-difluorocytidine;4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;Act Gemcitabine;Aj-gemcitabine;GEMCITABINE Hydrochloride;Gemcitabin;Gemcitabina;Gemcitabine;Gemcitabine Hydrochloride;Gemcitabine Hydrochloride for Injection;Gemcitabine Injection;Gemcitabine Sun for Injection;Gemcitabine for Injection;Gemcitabine for Injection Concentrate;Gemcitabine for Injection USP;Gemcitabine for Injection, USP;Gemcitabine hydrochloride;Gemcitabinum;Gemzar;Gemzar  (1gm/vial);Gemzar (200mg/vial)"	"APRD00201;DB00441"	"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2-pyrimidinone;4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidin-2-one;95058-81-4;LY188011;dFdC;GEO;D02368;Gemcitabine (USAN);LY-188011;4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;C07650;Gemcitabine;NChemBio.2007.10-comp25;2',2'-Difluorodeoxycytidine;2'-Deoxy-2',2'-difluorocytidine;CCRIS 8984;Cytidine, 2'-deoxy-2',2'-difluoro-;Gemcitabina [INN-Spanish];Gemcitabine [USAN:BAN:INN];Gemcitabinum [INN-Latin];LY 188011;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2,2-difluoro-D-erythropentofuranosyl)- (9CI);Cytosine, 1-(2-deoxy-2,2-difluoro-beta-D-erythro-pentofuranosyl)-;122111-03-9 (HYDROCHLORIDE);2',2'-DiF-dC;2'-Deoxy-.beta.-D-2',2'-difluorocytidine;AIDS-001419;AIDS001419;Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine;Gemzar (hydrochloride)"	"gemcitabine;95058-81-4;2',2'-Difluorodeoxycytidine;Gemcitabinum;Gamcitabine;Gemcitabina;Gemcitabine HCl;dFdC;2'-Deoxy-2',2'-difluorocytidine;Folfugem;Gemcel;Zefei;Cytidine, 2'-deoxy-2',2'-difluoro-;GemLip;Gemcitabinum [INN-Latin];DDFC;Gemcitabina [INN-Spanish];Gemcitabine stereoisomer;Gemcin;Gemtro;UNII-B76N6SBZ8R;DFdCyd;Gemzar (hydrochloride);LY 188011;Gemcitabine (USAN/INN);4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one;103882-84-4;122111-03-9;B76N6SBZ8R;LY-188011;LY188011;2',2'-DiF-dC;2',2'-difluoro-2'-deoxycytidine;CHEBI:175901;SDUQYLNIPVEERB-QPPQHZFASA-N;2'-Deoxy-.beta.-D-2',2'-difluorocytidine;Gemzar (TN);4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;CCRIS 8984;Inno-D07001;Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine;NSC 613327;4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one;4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-;SR-05000001491;Gemcitabin;Gemcitabine [USAN:INN:BAN];HSDB 7567;2vpp;gemcitabine (Gemzar);PubChem16297;4pd5;AC1L1TUQ;CHEMBL888;D03UVS;SCHEMBL4295;GTPL4793;Gemcitabine Hydrochloride/Gemzar;DTXSID3040487;CTK3I6765;2'deoxy-2',2'-difluorocytidine;AOB2689;MolPort-003-987-478;BCPP000219;HMS2089P10;HMS3715N07;2;-Deoxy-2;,2;-difluorocytidine;95058-81-4 (free base);ABP000929;Cytosine, 1-(2-deoxy-2,2-difluoro-beta-D-erythro-pentofuranosyl)-;DL-215;s1714;ZINC18279854;AKOS015920303;BCP9000721;CCG-221183;CS-0643;DB00441;GS-3582;NCGC00168784-02;AJ-70548;BR-23700;HY-17026;KB-23514;LS-59139;SC-18069;AB1004842;ST2413103;TL8005979;FT-0601792;C07650;D02368;J10023;S-2618;AB01274777-01;AB01274777-02;AB01274777_05;AB01274777_06;124814-EP2295426A1;124814-EP2295427A1;882G844;J-001056;SR-05000001491-1;SR-05000001491-2;BRD-K15108141-001-04-1;Z1741982024;1-(2-deoxy-2,2-difluoro-|A-D-erythropentofuranosyl)cytosine;1239668-67-7;2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-2',2'-difluorocytidine;4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one"	95058-81-4	B76N6SBZ8R	"10561277;10690391;10885899;10894879;11157033;11256843;11483344;11489798;11593051;11704320;11821464;12003187;12074325;12085203;12140144;12149290;12172503;12201494;12540024;12576418;12586808;12901280;1428726;14581347;14734004;15008715;15125746;15165093;15197207;15226322;15245607;15245938;15247710;15275733;15380578;15667865;15667962;15744590;16303793;16327288;16414235;16673059;16721369;17018894;17197132;17276612;17309598;17317834;17409896;17434832;17708303;17909804;18251177;18305938;18519780;18556142;18587581;18808686;18977098;19221752;19556122;20056351;20349264;21106728;21150717;21549514;21890225;22234055;22300608;22441342;22515232;22569804;23345000;24316554;24462333;24936582;25074036;25591040;25605849;25614082;25877225;25905586;26056353;26259955;26547917;27685612;27744037;27975152;28980060;7860227;8186164;8695365;8996158;9547676;9818075"	1428726	01/08/1992	1999720	01/03/1991	1989-1994		1	1	1	Yes	1	"23/05/2017 00:00;11/04/2016 00:00;15/05/1996 00:00;18/05/2015 00:00;08/06/2018 00:00;18/09/2017 00:00;27/11/2015 00:00;04/02/2011 00:00;19/05/2004 00:00;05/02/1997 00:00;07/05/2015 00:00;10/06/2014 00:00;05/09/2013 00:00;08/07/2014 00:00;20/07/2018 00:00;03/08/2017 00:00;17/04/2015 00:00;26/01/2018 00:00;18/12/2012 00:00;27/11/2013 00:00;06/09/2011 00:00;08/12/2009 00:00;06/12/2017 00:00;17/05/2011 00:00;18/05/2001 00:00;02/12/2015 00:00;04/01/2001 00:00;06/01/2003 00:00;11/09/2012 00:00;16/07/2018 00:00;03/03/2000 00:00;11/08/2014 00:00;16/10/1998 00:00;25/01/2011 00:00;05/04/2006 00:00;08/05/2014 00:00;02/06/2015 00:00;28/07/2016 00:00;15/11/2010 00:00;23/06/2000 00:00;10/09/2012 00:00;10/10/1997 00:00;13/11/2002 00:00;14/07/2006 00:00;23/06/2016 00:00;05/01/2016 00:00;22/06/2000 00:00;01/05/2002 00:00;02/04/2015 00:00;17/11/2016 00:00;16/05/2011 00:00;30/08/2011 00:00;25/07/2011 00:00;11/04/1997 00:00;13/09/2017 00:00;05/12/2011 00:00;30/06/2015 00:00;07/05/2013 00:00;19/01/2010 00:00;26/04/2005 00:00;26/01/2016 00:00;18/09/1997 00:00;20/04/2005 00:00;25/08/1998 00:00;23/11/1998 00:00;09/06/2000 00:00;01/11/2000 00:00;19/03/2010 00:00;20/06/2013 00:00;07/04/2016 00:00;04/08/2011 00:00;23/01/1998 00:00"	"AP;TA"	"EUROHLTH INTL;ACTAVIS TOTOWA;FRESENIUS KABI ONCOL;SUN PHARM INDS INC;HAMELN RDS GMBH;ACCORD HLTHCARE;SUN PHARMA GLOBAL;CIPLA LTD;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS INC;HOSPIRA INC;SAGENT PHARMS;APOTEX INC;LUITPOLD PHARMS INC;JIANGSU HANSOH PHARM;DR REDDYS LABS LTD;LILLY;#N/A;TEVA PHARMS;TEVA PARENTERAL;EMCURE PHARMS LTD;GLAND PHARMA LTD;HOSPIRA"	"GEMCITABINE;SODIUM CHLORIDE;GEMCITABINE HYDROCHLORIDE;GEMCITABINE 0.9%"	15/05/1996	LILLY	62,4	NA	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	67	1	1
Abituzumab	"anti-human integrin alpha v subunit monoclonal antibody emd 525797;di17e6;emd 525797"		DB12775			1105038-73-0	724QD330RD	23791392	23791392	01/06/2013	23791392	01/06/2013	2013-2017		1	1	0	Yes	1					30/07/2018		61,8	26	NA	0	1	PROSTATE	1	INTEGRIN	0	1	0	NA	0	0	0	1	0	0,07	0	0	0	0,7	0	0	0	0	0	0	26	0	1
AUY922	auy922		DB11881		"NVP-AUY922;747412-49-3;Luminespib;VER-52296;AUY-922;UNII-C6V1DAR5EB;NVP-AUY 922;AUY922;AUY922 (NVP-AUY922);C6V1DAR5EB;CHEBI:83656;5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide;VER-52296/NVP-AUY922;Luminespib (AUY-922, NVP-AUY922);5-[2,4-DIHYDROXY-5-ISOPROPYLPHENYL]-N-ETHYL-4-[4-(4-MORPHOLINYLMETHYL)PHENYL]-3-ISOXAZOLECARBOXAMIDE;Luminespib [USAN:INN];NVR-AUY 922;Isoxazole, 40f;VER 52296;PubChem19135;Luminespib (USAN/INN);D01NHJ;D05BYA;Luminespib; NVP-AUY922;NVP-AUY922-NX;CHEMBL252164;SCHEMBL2682235;AUY922,NVP-AUY922;CHEMBL3900791;BDBM20926;CHEBI:91422;EX-A611;QCR-179;MolPort-009-679-389;BCPP000145;AUY922 - NVP-AUY922;ZX-AT015684;ABP000836;AN-515;s1069;ZINC14974931;AKOS015966502;BCP9001007;CS-0136;OR16660;RL04840;AK174786;AS-17014;BC219616;HY-10215;KB-79617;SC-94101;AB0008043;AX8167191;A9562;X7556;NVP-AUY922/AUY-922,VER-52296;AUY922, VER-52296, NVP-AUY922;CAS:747412-49-3;NVP-AUY922;D10646;W-5583;412D493;J-516600;BRD-K41859756-001-01-9;AUY922, VER-52296, 747412-49-3;AUY922; VER-52296; AUY 922; VER 52296; AUY-922; VER-52296;(5Z)-N-ethyl-5-(4-hydroxy-3-isopropyl-6-oxo-cyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholinomethyl)phenyl]-2H-isoxazole-3-carboxamide;(Z)-N-ethyl-5-(4-hydroxy-3-isopropyl-6-oxocyclohexa-2,4-dien-1-ylidene)-4-(4-(morpholinomethyl)phenyl)-2,5-dihydroisoxazole-3-carboxamide;2GJ;5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide;5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide;5-[2,4-Dihydroxy-5-(1-Methylethyl)phenyl]-N-Ethyl-4-[4-(Morpholin-4-Ylmethyl)phenyl]isoxazole-3-Carboxamide;5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide;AUY-922|||NVP-AUY922|||VER-52296|||(5Z)-N-Ethyl-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholin-4-ylmethyl)phenyl]-2H-1,2-oxazole-3-carboxamide"	747412-64-2	G1G66XE93W	"25059319;23757357"	23757357	01/06/2013	23757357	01/06/2013	2013-2017		1	1	0	Yes	1					30/07/2018		61,8	101	NA	1	0	NA	1	HSP90	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	ATRIAL FLUTTER	1	0	0	0	0	0	1
Irosustat	irosustat	6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate	"DB02292;EXPT00273;DB12437"		"Irosustat;STX64;667-Coumate;288628-05-7;STX-64;667 coumate;BN83495;STX 64;BN-83495;UNII-366037O6O7;CHEMBL286738;6-OXO-8,9,10,11-TETRAHYDRO-7H-CYCLOHEPTA[C][1]BENZOPYRAN-3-O-SULFAMATE;6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate;366037O6O7;(6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta[c]chromen-3-yl) sulfamate;Irosustat [USAN:INN];1ttm;BN 83495;Irosustat (USAN/INN);AC1NR9VI;667COUMATE;D05NJI;SCHEMBL1275983;BDBM13058;CTK8F0400;AOB5998;DTXSID50183059;ZINC1549366;6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta-(c)(1)benzopyran-3-O-sulfamate;AKOS032954035;API0005149;DB02292;STX64, >=98% (HPLC);7-(Aminosulfonyloxy)-3,4-pentanocoumarin;HY-14586;RT-015795;CS-0003463;D09915;J-017303;6-oxo-7H,8H,9H,10H,11H-cyclohepta[c]chromen-3-yl sulfamate;(6-oxo-8,9,10,11-tetrahydro-7h-cyclohepta[c]chromen-3-yl) Su;{9-oxo-8-oxatricyclo[8.5.0.0^{2,7}]pentadeca-1(10),2(7),3,5-tetraen-5-yl} sulfamate;Sulfamic acid, 6,7,8,9,10,11-hexahydro-6-oxobenzo(b)cyclohepta(d)pyran-3-yl ester"	288628-05-7	366037O6O7	25355461	25355461	01/10/2014	23797179	01/07/2013	2013-2017		1	1	0	Yes	1					30/07/2018		60,8	50	NA	0	1	BREAST	1	STEROID SULFATASE	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,1	0	0	0	0	0	0	0	0	1
Nintedanib	"bibf 1120;nintedanib"	"methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate;Ofev"	DB09079		"Nintedanib;Vargatef;656247-17-5;BIBF-1120;BIBF 1120;Intedanib;BIBF1120;928326-83-4;OFEV;Nintedanib (BIBF 1120);UNII-G6HRD2P839;(Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate;nibtedanib;G6HRD2P839;CHEBI:85164;Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylidene)-2-oxo-2,3-dihydro-1h-indole-6-carboxylate;J-502642;C31H33N5O4;(Z)-Methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)-phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate;methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate;methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate;Methyl (3z)-3-{[(4-{methyl[(4-Methylpiperazin-1-Yl)acetyl]amino}phenyl)amino](Phenyl)methylidene}-2-Oxo-2,3-Dihydro-1h-Indole-6-Carboxylate;Nintedanib [USAN:INN];Vargatef (TN);1160294-26-7;XIN;BIBF1120,Vargatef;PubChem20543;Tube722;Bibf1120 - Vargatef;Nintedanib (USAN/INN);Vargatef, BIBF 1120;cc-88;D09HNV;D0J1OJ;Nintedanib (BIBF-1120);MLS006010165;SCHEMBL431006;SCHEMBL431007;GTPL5936;QCR-43;HSDB 8339;AOB5742;EX-A341;SYN1091;MolPort-009-679-380;XZXHXSATPCNXJR-ZIADKAODSA-N;Methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate;methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate;ABP000857;BDBM50026612;RS0107;s1010;AKOS005145820;BIBF 1120|||Intedanib|||Vargatef;BIBF1120,BIBF-1120,Vargatef/;ZINC100014909;ACN-030189;AN-5281;BCP9000405;CS-0104;DB09079;KS-1434;RL05845;BC297819;HY-50904;KB-75518;SC-85732;SMR004701273;AB0035905;AB1006397;X7367;Y0352;A10955;D10481;BRD-K49075727-001-01-0;3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone;methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-1H-indole-6-carboxylate;methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenyl-methylene]-2-oxo-indoline-6-carboxylate"	656247-17-5	G6HRD2P839	"27627050;25012508;20028771;18351351"	18351351	01/03/2008	19846979	01/10/2009	2009-2012		1	1	1	Yes	1	"29/01/2018 00:00;04/02/2016 00:00;09/02/2017 00:00;13/12/2017 00:00;16/06/2016 00:00;04/08/2017 00:00;15/10/2014 00:00"	AP	BOEHRINGER INGELHEIM	NINTEDANIB ESYLATE	15/10/2014	BOEHRINGER INGELHEIM	60,3	17	NA	0	1	MYELOMA	1	ANGIOKINASES	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,12	0	0	0	0	0	0	193	0	1
Daniquidone	batracylin	Batracylin	DB12804	"8-amino-10H-isoindolo[3,2-b]quinazolin-12-one;67199-66-0;8-Aminoisoindolo[1,2-b]quinazolin-12(10H)-one;AIDS-015228;AIDS015228;Quinazolin-12(10H)-one der.;8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one;BRN 0667315;Batracylin;Bay H 2049;CCRIS 6840;Daniquidona [INN-Spanish];Daniquidone;Daniquidone [BAN:INN];Daniquidonum [INN-Latin];Isoindolo(1,2-b)quinazolin-12(10H)-one, 8-amino-;NSC 320846;NSC-320846;NCIMech_000548;BAY-H 2049;NCI60_002776;Batracyclin;Isoindolo[1,2-b]quinazolin-12(10H)-one, 8-amino-;NSC320846"	"Daniquidone;Batracylin;67199-66-0;Bay H 2049;8-Aminoisoindolo[1,2-b]quinazolin-12(10H)-one;NSC-320846;Daniquidonum [INN-Latin];Daniquidona [INN-Spanish];NSC320846;NSC 320846;UNII-E780TX33D2;CCRIS 6840;8-Amino-10H-isoindolo[1,2-b]quinazolin-12-one;BRN 0667315;Isoindolo(1,2-b)quinazolin-12(10H)-one, 8-amino-;CHEMBL114283;E780TX33D2;8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one;C15H11N3O;Daniquidona;Daniquidonum;Daniquidone [BAN:INN];Daniquidone [INN:BAN];d3-Batracylin;d4-Batracylin;D7-Batracylin;BAY H-2049;AC1L2GQV;AC1Q6NWO;Isoindolo[1, 8-amino-;D07BXE;NCIMech_000548;8-aminoisoindolo(1,2-b)quinazolin-12(10H)one;DSSTox_CID_31591;DSSTox_RID_97475;DSSTox_GSID_57802;SCHEMBL93613;ZINC3827;DTXSID3057802;CTK5C5834;Quinazolin-12(10H)-one der.;SRIOCKJKFXAKHK-UHFFFAOYSA-N;BAY-H 2049;BAY-H-2049;Tox21_113867;BDBM50037511;CCG-35968;NSC751453;NSC751454;NSC752895;API0010592;DB12804;NSC-751453;NSC-751454;NSC-752895;NCGC00253752-01;LS-84757;NCI60_002776;CAS-67199-66-0;[1,2,3,4,6,7,9-D7]-8-amino-10,12-dihydro-isoindolo[1,2-b]quinazolin-12(10H)-one(11)"	67199-66-0	E780TX33D2	23912694	23912694	01/08/2013	23912694	01/08/2013	2013-2017		1	1	0	Yes	1					30/07/2018		59,8	31	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,06	0	0	0	0	0	1	0	0	1
E7107	"e7107;pladienolide derivative e7107"		DB12508		"UNII-R60DZX1E2N;E7107;R60DZX1E2N;(3R,6R,7S,8E,10S,11S,12E,14E,16R,18R,19R,20R,21S)-7-[(4-cycloheptylpiperazin-1-yl)carbonyl]oxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoyxtrichosa-8,12,14-trien-11-olide;630100-90-2;E-7107;D00OOZ;E 7107;SCHEMBL3624011;BDBM36359;DB12508;CID16202132;1-Piperazinecarboxylic acid, 4-cycloheptyl-, (2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-((1E,3E,5R)-5-hydroxy-6-((2R,3R)-3-((1R,2S)-2-hydroxy-1-methylbutyl)oxiranyl)-1,5-dimethyl-1,3-hexadienyl)-3,7-dimethyl-12-oxooxacyclododec-4-en-6-yl ester"	630100-90-2	R60DZX1E2N	"24258465;23983259"	23983259	01/08/2013	23983259	01/08/2013	2013-2017		1	1	0	Yes	1					30/07/2018		59,8	40	79	1	0	NA	1	SPLICEOSOME	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Tamoxifen	tamoxifen	"Tamoxifène;1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;Tamoxifene;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine;Tamoxifenum;trans-Tamoxifen;1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;Tamoxifeno;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine;Tamoxifen;Tamoplex Tab 10mg;Apo-tamox Tab 10mg;Tamoxifen Citrate;Tamone  -  (20 Mg);Teva-tamoxifen;Tamone  -  (10 Mg);Tamoxifen;Penta-tamoxifen Tablets;Tamofen 20;Nolvadex Tab 10mg;Tamoxifene - 20;Nolvadex-D Tab 20mg;Soltamox;Tamoxifene - 10;PMS-tamoxifen;Dom-tamoxifen;Tamofen 10;Tamoplex Tab 20mg;Apo-tamox Tab 20mg;Tamone Tab 10mg;Tamone Tab 20mg;Mylan-tamoxifen"	"DB00675;APRD00123"	"2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine;2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine;2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]ethyl-dimethyl-amine;10540-29-1;(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;Lopac0_001203;NCGC00024928-06;BSPBio_000252;IDI1_000258;1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene;BPBio1_000278;AIDS-008877;cMAP_000044;T5648_SIGMA;IDI1_002170;NSC727681;trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine;2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine;CHEBI:41774;NCGC00024928-04;BSPBio_001150;NCGC00024928-05;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC);1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;CCRIS 3275;Citofen;Crisafeno;Diemon;EINECS 234-118-0;Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-;Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-;HSDB 6782;ICI 47699;Istubol;Oncomox;Retaxim;Tamizam;Tamoxen;Tamoxifen (Z);Tamoxifen and its salts;Tamoxifene [INN-French];Tamoxifeno [INN-Spanish];Tamoxifenum [INN-Latin];Valodex;trans-Tamoxifen;Prestwick3_000146;2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine;Prestwick2_000146;(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine;nchembio.76-comp1;QTL1_000079;AIDS008877;nchembio732-comp3;Spectrum5_002043;Spectrum5_001417;BSPBio_001982;C07108;Tamoxifen;NCGC00024928-01;Tocris-0999;TRANS FORM OF TAMOXIFEN;,citrate"	"tamoxifen;10540-29-1;trans-Tamoxifen;Crisafeno;Soltamox;Tamoxifene;Diemon;Tamoxifeno;Tamoxifenum;Citofen;Istubol;Oncomox;Retaxim;Tamizam;Tamoxen;Valodex;Tamoxifene [INN-French];Tamoxifenum [INN-Latin];Tamoxifeno [INN-Spanish];Tamoxifen (Z);Novaldex;Tomaxithen;Tamoxifen [INN:BAN];Tamoxifen and its salts;Nourytam;Tamone;Novo-Tamoxifen;Gen-Tamoxifen;Pms-Tamoxifen;Nolvadex-D;[3H]tamoxifen;Tamoxifen (TN);[3H]-tamoxifen;ICI 47699;ICI-46474;Tamoxifen (INN);Tamoplex (TN);C26H29NO;CCRIS 3275;UNII-094ZI81Y45;HSDB 6782;CHEMBL83;EINECS 234-118-0;1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine;TRANS FORM OF TAMOXIFEN;CHEBI:41774;NKANXQFJJICGDU-QPLCGJKRSA-N;(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine;trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC);2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine;Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-;MFCD00010454;094ZI81Y45;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-;DSSTox_CID_14187;DSSTox_RID_79121;DSSTox_GSID_34187;W-108788;TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1));(E/Z)-Tamoxifen;(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine;(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine;Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-;13002-65-8;SMR000059172;CAS-10540-29-1;Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-;Tamoxifen, 7;Istubal (TN);Valodex (TN);ICI-47699;ICI-46,474;Tocris-0999;1ya4;Tamoxifen, >=99%;(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE;AC1MBZ3R;Prestwick2_000146;Prestwick3_000146;Spectrum5_001417;Spectrum5_002043;D07KSG;D0FP3G;UPCMLD-DP027;EC 234-118-0;SCHEMBL4084;BIDD:PXR0003;Lopac0_001203;Tamoxifen (Hormonal therapy);BSPBio_000252;BSPBio_001150;BSPBio_001982;MLS001332535;MLS001332536;BIDD:ER0008;BIDD:GT0009;Tamoxifen, analytical standard;BPBio1_000278;GTPL1016;GTPL5384;DTXSID1034187;Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-;Tamoxifen Drug Standard Solution;BDBM20607;cid_2733526;AOB5640;54965-24-1 (citrate);cMAP_000044;HMS1362J11;HMS1792J11;HMS1990J11;HMS2090N08;HMS2232C12;HMS3261D09;HMS3403J11;EBD41546;ZINC1530689;Tox21_201243;Tox21_300539;Tox21_500494;2060AH;GA9513;HY-13757A;LS-393;NSC727681;AKOS022143035;AM84324;CCG-205277;CS-2870;DB00675;KS-1472;LP00494;NSC-727681;VA11813;IDI1_000258;IDI1_002170;QTL1_000079;NCGC00024928-01;NCGC00024928-03;NCGC00024928-04;NCGC00024928-05;NCGC00024928-07;NCGC00024928-08;NCGC00024928-09;NCGC00024928-10;NCGC00024928-11;NCGC00024928-12;NCGC00024928-13;NCGC00024928-14;NCGC00024928-15;NCGC00024928-16;NCGC00024928-17;NCGC00024928-18;NCGC00024928-19;NCGC00254455-01;NCGC00258795-01;NCGC00261179-01;AJ-26679;KB-80805;SC-45564;SBI-0051170.P004;AX8001839;KB-282403;B5965;ST24049322;ST24049323;C07108;D08559;10331-EP2270008A1;10331-EP2270018A1;10331-EP2272827A1;10331-EP2272832A1;10331-EP2275102A1;10331-EP2277865A1;10331-EP2277876A1;10331-EP2280012A2;10331-EP2281815A1;10331-EP2289892A1;10331-EP2292233A2;10331-EP2292576A2;10331-EP2292614A1;10331-EP2292617A1;10331-EP2295416A2;10331-EP2295426A1;10331-EP2295427A1;10331-EP2298305A1;10331-EP2298746A1;10331-EP2298748A2;10331-EP2298778A1;10331-EP2298780A1;10331-EP2301536A1;10331-EP2301538A1;10331-EP2301933A1;10331-EP2305640A2;10331-EP2305642A2;10331-EP2305671A1;10331-EP2305689A1;10331-EP2308833A2;10331-EP2308855A1;10331-EP2308861A1;10331-EP2311455A1;10331-EP2311825A1;10331-EP2311827A1;10331-EP2311840A1;10331-EP2311842A2;10331-EP2316452A1;10331-EP2316831A1;10331-EP2316832A1;10331-EP2316833A1;10331-EP2316834A1;10331-EP2374454A1;AB00053547-16;AB00053547-17;AB00053547-18;AB00053547_19;AB00053547_20;540T291;A801229;L024126;BRD-K93754473-001-02-9;BRD-K93754473-048-04-6;BRD-K93754473-048-05-3;BRD-K93754473-048-10-3;Tamoxifen, certified reference material, TraceCERT(R);1-[4-(2-Dimethylaminoethoxy)phenyl]-1,2-diphenyl-1-butene;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine;2-[4-[1,2-di(phenyl)but-1-enyl]phenoxy]-n,n-dimethylethanamine;(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine;(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine;2-[4-[(1Z)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine;2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine;(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene, trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine"	10540-29-1	094ZI81Y45	"21750172;12680157;11352969;11097520"	11097520	01/11/2000	4567104	01/01/1973	Bef. 1989		0	1	1	Yes	1	"11/08/2003 00:00;10/06/2003 00:00;29/03/1982 00:00;25/11/1987 00:00;01/04/1993 00:00;30/01/2003 00:00;15/11/1996 00:00;28/01/2013 00:00;14/03/1991 00:00;01/08/2005 00:00;16/03/1989 00:00;26/03/1996 00:00;03/12/1986 00:00;21/06/1990 00:00;01/02/1995 00:00;20/02/2003 00:00;04/04/2007 00:00;10/12/1985 00:00;31/07/1979 00:00;25/01/2007 00:00;05/04/1984 00:00;21/03/1994 00:00;24/07/1979 00:00;09/03/2006 00:00;29/06/2000 00:00;27/10/2017 00:00;02/02/2007 00:00;17/03/2005 00:00;30/12/1977 00:00;25/05/1978 00:00;29/10/1998 00:00;24/04/2000 00:00;18/08/2005 00:00;02/04/1999 00:00;31/03/2003 00:00;20/08/1985 00:00;04/11/1996 00:00;14/12/2000 00:00;02/10/1978 00:00;29/10/2005 00:00;16/05/2002 00:00;30/10/1998 00:00;23/01/1996 00:00;28/04/2003 00:00;18/12/1984 00:00;30/08/2002 00:00;18/12/1979 00:00;01/12/2006 00:00;31/01/2005 00:00;11/06/1998 00:00;20/04/2005 00:00;23/09/2011 00:00;14/12/2004 00:00;22/04/2015 00:00;02/03/2006 00:00"	AP	"TEVA;AEGIS PHARMS;#N/A;IVAX SUB TEVA PHARMS;ROXANE;PHARMACHEMIE;APOTEX;ACTAVIS LABS FL INC;MIDATECH PHARMA US;MYLAN;MAYNE PHARMA;ASTRAZENECA"	TAMOXIFEN CITRATE	30/12/1977	ASTRAZENECA	59,8	68	NA	0	1	BREAST	1	ER	0	1	0	NA	0	1	0	1	0	0,77	0	1	1	NA	0	0	0	0	0	0	391	1	1
Milatuzumab	"hll1;milatuzumab"		DB12943			899796-83-9	2OP4E0GC6V	25754579	25754579	01/03/2015	24112026	01/09/2013	2013-2017		1	1	0	Yes	1					30/07/2018		58,8	25	NA	1	0	MYELOMA	1	CD74	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,26	0	0	0	0	0	0	26	0	1
Famitinib	famitinib		DB11741		"Famitinib;SHR-1020;UNII-768FW21J3L;SHR1020;CHEMBL1278146;768FW21J3L;1044040-56-3;Famitinib, (Z);D0Z6MT;SCHEMBL137251;GTPL7886;SHR 1020;BDBM50331023;compound 9 [PMID: 21028894];DB11741;945380-27-8;Receptor tyrosine kinase inhibitors (cancer);Tyrosine-kinase inhibitor (oral, cancer), Jiangsu Hengrui;Receptor tyrosine kinase inhibitors (cancer), Shanghai Hengrui;C-Kit/VEGFR2/PDGFR/VEGFR3/Flt1/Flt3 inhibitor (oral, cancer), Jiangsu Hengrui;(Z)-2-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-5-(2-diethylaminoethyl)-3-methyl-1,5,6,7-tetrahydropyrrolo-[3,2-c]pyridin-4-one;5-(2-diethylaminoethyl)-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[4,5-c]pyridin-4-one"	1044040-56-3	768FW21J3L	24043137	24043137	01/09/2013	24043137	01/09/2013	2013-2017		1	1	0	Yes	1					30/07/2018		58,8	54	NA	1	0	NA	1	VEGFR2	0	1	0	NA	0	0	0	1	1	0,15	0	0	0	0,41	0	0	0	0	0	0	0	0	1
Resminostat	resminostat		DB12392		"Resminostat;864814-88-0;4SC-201;Resminostat (RAS2410);UNII-1578EUB98L;RAS2410;1578EUB98L;BYK408740;(E)-3-(1-((4-((dimethylamino)methyl)phenyl)sulfonyl)-1H-pyrrol-3-yl)-N-hydroxyacrylamide;Resminostat [INN];4SC 201;Resminostat 4SC-201;D01UXJ;Resminostat (4SC-201);SCHEMBL295540;SCHEMBL295541;GTPL7502;DTXSID50235587;EX-A542;MolPort-027-720-936;AOB87187;s2693;ZINC13983495;AKOS030526945;API0013984;CS-1521;DB12392;(2E)-3-(1-((4-((Dimethylamino)methyl)phenyl)sulfonyl)-1h-pyrrol-3-yl)-N-hydroxyprop-2-enamide;BC261895;HY-14718;KB-80334;Y0292;W-5771;J-690364;(E)-3-[1-[4-(dimethylaminomethyl)phenyl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[4-[(dimethylamino)methyl]phenyl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide"	864814-88-0	1578EUB98L	24065624	24065624	01/09/2013	24065624	01/09/2013	2013-2017		1	1	0	Yes	1					30/07/2018		58,8	19	70	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	1	0	0,05	0	0	0	0,63	0	0	0	0	0	0	0	0	1
Irinotecan	"(peg-1000) 9-aminocamptothecin;7-t-butyldimethylsilyl-10-hydroxycamptothecin;bax2398;bay 38-3441;bay 56-3722;camptothecin analogue tlc388;camptothecin glycoconjugate;cpt-11;cpx-1;ct-2106;drf-1042;dts-108;dts-108 sn38;etirinotecan;ezn-2208;ihl-305;irinotecan;irinotecan active metabolite;irinotecan hydrochloride liposome;le-sn38;liposomal 9-nitro-20(s)-camptothecin;liposomal sn-38;lipotecan;mag-camptothecin;mag-cpt;nanoliposomal irinotecan;nk012;oral aminocamptothecin;peg-sn38;pegylated liposomal irinotecan;pep02;pnu 166148;polyglutamate camptothecin;silatecan ar-67;sn-38;sn-38-loaded polymeric micelles;sn2310;sn2310, an injectable emulsion that incorporates a new derivative of sn-38;tenifatecan;tlc388;u-101440e"	"Biotecan;Campostar;Camptosar;Camptosar Injection;Camptothecin-11;Irinotecan;Irinotecan Hydrochloride;Irinotecan Hydrochloride Injection;Irinotecan Hydrochloride Injection, USP;Irinotecan Hydrochloride Trihydrate Injection;Irinotecan Hydrochloride Trihydrate for Injection;Irinotecan for Injection;Irinotecan hydrochloride;Onivyde"	"APRD00579;DB00762"	"97682-44-5;BSPBio_002346;NCI60_005051;NSC728073;(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE;IRINOTECAN, CPT-11;CP0;AIDS-108177;(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate;(+)-Irinotecan;(1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12-14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, (S)-;Irinotecan;Irinotecanum [INN-Latin];STOCK1N-71175;AIDS108177"	"irinotecan;97682-44-5;Camptosar;(+)-Irinotecan;Irinotecanum;Irinotecanum [INN-Latin];Campto;Irinotecan Hcl;Irinophore C;Irinotecan mylan;Irinotecan [INN:BAN];product-irinotecan;Irinotecan lactone;CPT-11;Biotecan;IRINOTECAN, CPT-11;Biotecan (TN);Irinotecan (INN);HSDB 7607;CHEMBL481;UNII-7673326042;CHEBI:80630;irinotecan liposome;C33H38N4O6;Onivyde;(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE;CP0;Camptosar (TN);Campto (TN);irinotecan liposome injection;(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate;camptothecin-11;Irinotecan hydrochloride hydrate;(1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12-14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, (S)-;(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate;1,4'-Bipiperidine-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester;U-101440E;1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester;topotecin hydrochloride;PubChem13094;PubChem16441;AC1Q6PGI;D07HOB;AC1L1U0Z;SCHEMBL4034;BSPBio_002346;Irinotecan (TOPO1 inhibitor);GTPL6823;DTXSID1041051;CTK8B3046;KS-00000NVX;1u65;MolPort-003-848-231;UWKQSNNFCGGAFS-XIFFEERXSA-N;EBD36403;ZINC1612996;ANW-41679;BDBM50128267;NSC728073;s1198;AKOS015894969;AB07527;AC-7469;AN-8954;BCP9000793;CS-1138;DB00762;MCULE-1702653278;NSC-728073;Camptosar, Campto, CPT-11, Irinotecan;NCGC00178697-02;NCGC00178697-05;[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester;AK163712;AS-14323;HY-16562;K754;LS-44589;NCI60_005051;SC-17271;AB0014364;TL8006026;TR-031973;FT-0083650;FT-0602416;ST24047421;C16641;D08086;W-5141;AB00698464-07;AB00698464-09;AB00698464-10;AB00698464-11;AB00698464_12;AB00698464_13;AB00698464_14;682I445;BRD-K08547377-003-02-4;(diethyl-hydroxy-dioxo-[?]yl) 4-(1-piperidyl)piperidine-1-carboxylate;(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0;{2,11}.0;{4,9}.0;{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate;(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3'',4'':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4''-BIPIPERIDINE-1''-CARBOXYLATE;(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate;[1,4'']bipiperidinyl-1''-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester;[1,4'']Bipiperidinyl-1''-carboxylic acid 4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester;[1,4']Bipiperidinyl-1'-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester"	97682-44-5	7673326042	"10080615;10188891;10561220;10561231;10561279;10653882;10815927;10873073;11193921;11205914;11291056;11822765;11989591;11990713;12237769;12241109;12714877;12873673;12904897;14630685;14769140;15150611;15187995;15199077;15536463;15592838;15684318;15746053;15768380;16133797;16322117;16328416;16446328;16600980;16608024;16778106;16855842;17908979;18613376;19147776;19637327;19652069;19687340;20068096;20213078;20943763;21630281;21917536;22701615;22907396;23136196;23543270;23839050;23894304;23989300;24271274;24691674;24958824;24962521;25577133;27061418;27920527;28233053;28558150;28817371;7799022;8044782;8275479;8922198;9060548"	8275479	01/01/1994	1653362	01/08/1991	1989-1994		1	1	1	Yes	1	"13/05/2011 00:00;05/11/2001 00:00;26/05/2017 00:00;30/07/2002 00:00;20/12/2010 00:00;18/03/1998 00:00;25/08/2015 00:00;07/10/2016 00:00;28/01/2009 00:00;05/06/1997 00:00;26/11/2008 00:00;21/11/2008 00:00;17/01/2013 00:00;29/04/2013 00:00;13/07/2012 00:00;02/01/2015 00:00;15/04/2010 00:00;20/02/2008 00:00;26/05/2009 00:00;21/10/1997 00:00;29/07/2000 00:00;21/07/2005 00:00;24/06/2004 00:00;07/06/2005 00:00;24/12/2008 00:00;21/06/2010 00:00;22/10/2015 00:00;03/01/1997 00:00;12/08/2013 00:00;12/11/2009 00:00;03/12/2004 00:00;10/12/1997 00:00;19/12/2014 00:00;16/12/2011 00:00;07/03/1997 00:00;20/04/2000 00:00;21/04/2008 00:00;06/08/2001 00:00;27/12/2017 00:00;14/03/2011 00:00;15/01/1998 00:00;14/05/2010 00:00;16/05/2002 00:00;14/06/1996 00:00;01/08/2006 00:00;18/11/2015 00:00;16/09/2009 00:00;03/05/2016 00:00;31/10/2008 00:00;24/01/2013 00:00;18/11/2011 00:00;31/08/2017 00:00;14/02/2012 00:00;22/11/2011 00:00;16/03/2011 00:00;09/06/2014 00:00;22/10/1998 00:00;27/02/2008 00:00"	AP	"HISUN PHARM HANGZHOU;ACTAVIS TOTOWA;FRESENIUS KABI ONCOL;MUSTAFA NEVZAT ILAC;ACCORD HLTHCARE;SUN PHARMA GLOBAL;CIPLA LTD;FRESENIUS KABI USA;WEST-WARD PHARMS INT;IPSEN INC;SANDOZ;SANDOZ INC;DR REDDYS LABS LTD;PFIZER INC;AKORN;#N/A;TEVA PHARMS USA;TEVA PARENTERAL;HIKMA FARMACEUTICA;QILU PHARM CO LTD;INGENUS PHARMS LLC;PLIVA LACHEMA;EMCURE PHARMS LTD;HOSPIRA;JIANGSU HENGRUI MED"	IRINOTECAN HYDROCHLORIDE	14/06/1996	PFIZER INC	58,3	17	NA	0	1	NSCLC	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	0,12	0	0	0	NA	1	0	0	0	0	0	185	1	1
Grn163l	"grn163l;imetelstat"		DB05036					24097866	24097866	01/10/2013	24097866	01/10/2013	2013-2017		1	1	0	Yes	1					30/07/2018		57,8	20	21	1	0	CHILD_UNSPECIFIED	1	TELOMERASE	0	1	0	NA	0	0	1	1	1	0,1	0	0	0	NA	0	0	0	0	0	0	0	0	1
Pilaralisib	"pilaralisib;sar245408"		"DB11772;DB05240"		"Pilaralisib;XL-147;934526-89-3;SAR 245408;UNII-60ES45KTMK;SAR-245408;Pilaralisib (XL147);60ES45KTMK;Pilaralisib [USAN:INN];Pilaralisib, SAR245408;SCHEMBL189422;CHEMBL3360203;SCHEMBL14921345;SCHEMBL16154579;EX-A196;MolPort-039-193-821;s7645;AKOS026750450;ZINC100472223;CS-1546;DB11772;Pilaralisib(XL-147; SAR245408);2-Amino-n-(3-(N-(3-((2-chloro-5-methoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide;BC600761;DA-40388;HY-16526;KB-81504;SC-95575;FT-0744481;KS-00000636;W-6122;2-amino-N-[3-({3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-2-methylpropanamide;2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide"	934526-89-3	60ES45KTMK	"27169794;25840972;24166903"	24166903	01/10/2013	24166903	01/10/2013	2013-2017		1	1	0	Yes	1					30/07/2018		57,8	69	NA	1	0	NA	1	PI3K	0	1	0	NA	0	0	0	1	1	0,01	0	0	0	0,13	0	0	0	0	0	0	0	0	1
Pamidronate	disodium pamidronate	"Acidum pamidronicum;Pamidronic acid;Ribodroat;Acide pamidronique;Acido pamidronico;Pamidronate Disodium Omega 3 mg/ml;Aredia;Aredia 90mg;Pamidronate Disodium Omega 6 mg/ml;PMS-pamidronate;Pamidronate Disodium;Aredia 30mg;Pamidronate Disodium for Injection;Aredia Liq Inj 3mg/ml;Pamidronate Disodium Omega 9 mg/ml;Val-pamidronate Disodium"	"DB00282;APRD01161"	"(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid;(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID;40391-99-9;STOCK1N-12562;C07395;Pamidronate;Pamidronic acid;(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID;(3-Amino-1-hydroxypropylidene)bisphosphonic acid;(3-Amino-1-hydroxypropylidene)diphosphonic acid;Acide pamidronique [INN-French];Acido pamidronico [INN-Spanish];Acidum pamidronicum [INN-Latin];Amidronate;EINECS 254-905-2;Pamidronic acid [BAN:INN];ChemDiv1_025240;HSCI1_000312;109552-15-0 (PENTAHYDRATE);3-Amino-1-hydroxypropylidene-1,1-diphosphonate;40391-99-9 (FREE ACID);57248-88-1 (DISODIUM SALT);AIDS-088658;AIDS088658;Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-;(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid;NCGC00159433-02;NCGC00159433-03;(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid)"	"PAMIDRONIC ACID;pamidronate;40391-99-9;Amidronate;Aredia;Acido pamidronico;Acide pamidronique;Acidum pamidronicum;Aminomux;Acide pamidronique [INN-French];Acido pamidronico [INN-Spanish];Acidum pamidronicum [INN-Latin];PAMIDRONATE DISODIUM;AHPrBP;Pamidronic acid [INN:BAN];Disodium pamidronate;Bisphosphonate 6;UNII-OYY3447OMC;(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid;Ribodroat (TN);aminopropanehydroxydiphosphonate;C3H11NO7P2;Pamidronic acid (INN);aminohydroxypropylidene diphosphonate;EINECS 254-905-2;(3-Amino-1-hydroxypropylidene)bisphosphonic acid;CHEMBL834;pamidronate monosodium;OYY3447OMC;amino-1-hydroxypropane-1,1-diphosphonate;(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid);(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID;(3-Amino-1-hydroxypropylidene)diphosphonic acid;1-hydroxy-3-aminopropane-1,1-diphosphonic acid;3-amino-1-hydroxypropane-1,1-diphosphonic acid;WRUUGTRCQOWXEG-UHFFFAOYSA-N;(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate;Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-;CGP-23339AE;NCGC00159433-02;DSSTox_CID_3414;3-Amino-1-hydroxypropylidene-1,1-diphosphonate;DSSTox_RID_77017;DSSTox_GSID_23414;Pamidronate disodium hydrate;57248-88-1;pamidronate calcium;CAS-40391-99-9;Ribodroat;ChemDiv1_025240;D0BF8G;AC1L1IP4;SCHEMBL18361;(3-amino-1-hydroxypropylidene)-1,1-biphosphonate;BIDD:GT0538;CHEBI:7903;GTPL7259;JMC515594 Compound 62;DTXSID4023414;BDBM12581;CTK8G2260;HMS658L06;HMS2090C13;CCG-2075;HY-B0012;ZINC3812862;Tox21_111664;2631AH;HSCI1_000312;s2063;AKOS003599275;Tox21_111664_1;API0003737;CS-7787;DB00282;MCULE-4373491291;VA11481;ACM40391999;57248-88-1 (di-hydrochloride salt);NCGC00159433-03;NCGC00165862-02;AJ-72818;AK113121;AN-33629;CC-33460;SC-81484;Novartis brand of pamidronate disodium salt;AB2000467;AX8146697;LS-174826;FT-0630610;ST24048873;C07395;D07281;391P999;A825084;C-13855;Propane-1-hydroxy-3-amino-1,1-diphosphonic acid;SR-01000514873;3-amino-1-hydroxypropane-1,1-diyldiphosphonic acid;I14-2407;SR-01000514873-1;(3-azanyl-1-oxidanyl-1-phosphono-propyl)phosphonic acid;Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene)bis-"	40391-99-9	OYY3447OMC	12102162	12102162	01/07/2002	3103730	01/02/1987	Bef. 1989		1	0	1	No	0	"31/10/1991 00:00;21/09/1994 00:00;09/07/2008 00:00;12/07/2002 00:00;25/07/2008 00:00;21/05/2012 00:00;23/12/2008 00:00;28/04/2000 00:00;13/02/2004 00:00;01/09/1995 00:00;16/11/2005 00:00;05/12/2002 00:00;03/01/2002 00:00;04/03/2002 00:00;31/03/2000 00:00;19/05/2006 00:00;31/05/2012 00:00;02/02/2005 00:00;06/05/1993 00:00;13/05/2009 00:00;07/04/2011 00:00;18/09/2008 00:00;10/03/2009 00:00;29/11/2005 00:00;24/02/2009 00:00;21/07/1992 00:00;02/07/2015 00:00;29/09/2004 00:00;24/12/2008 00:00;11/10/2005 00:00;17/05/2002 00:00;30/04/2001 00:00;17/04/1995 00:00;30/10/2015 00:00;24/03/2004 00:00;21/01/2005 00:00;29/11/2016 00:00;27/06/2002 00:00;31/10/2008 00:00;12/02/2002 00:00;19/07/2005 00:00;27/03/2002 00:00;06/05/2002 00:00;12/12/2008 00:00;24/07/2008 00:00;04/12/2014 00:00;15/04/1994 00:00;26/11/2008 00:00;22/09/1998 00:00;17/10/2008 00:00;07/03/2001 00:00;19/08/2008 00:00;27/07/2009 00:00;18/10/2012 00:00;09/09/2009 00:00;05/10/1998 00:00;07/11/2002 00:00;14/07/2006 00:00;14/11/2005 00:00;16/07/1996 00:00;20/08/2001 00:00;15/03/2010 00:00;09/10/2003 00:00;08/12/1994 00:00;13/08/2012 00:00;23/09/2007 00:00;19/01/2007 00:00;15/07/2009 00:00;08/11/2012 00:00;19/03/2009 00:00;18/05/2004 00:00;11/12/2007 00:00;16/10/2009 00:00;09/01/2004 00:00;22/05/2012 00:00;17/05/2012 00:00;05/11/2015 00:00;10/09/1998 00:00;09/06/1993 00:00;23/02/2007 00:00;15/11/2001 00:00;11/05/2005 00:00"	AP	"SUN PHARMA GLOBAL;AESGEN;TEVA PHARMS USA;FRESENIUS KABI USA;AREVA PHARMS;MYLAN LABS LTD;WEST-WARD PHARMS INT;LUITPOLD;PLIVA LACHEMA;HOSPIRA;MN PHARMS;NOVARTIS;SAGENT PHARMS"	PAMIDRONATE DISODIUM	31/10/1991	NOVARTIS	56,8	#N/A																							0						1
Ixabepilone	"bms-247550;bms-310705;epothilone b analogue;ixabepilone"	"Azaepothilone B;Aza-epothilone B;Ixempra"	DB04845	"(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methyl-4-thiazolyl)vinyl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-quinone;219989-84-1;D04645;Ixabepilone (JAN/USAN);17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-;Azaepothilone B;BMS 247550-1;Ixabepilone;Ixabepilone [INN]"	"Ixabepilone;Azaepothilone B;219989-84-1;Ixempra;BMS-247550;Aza-epothilone B;Ixempra (TN);BMS 247550-1;UNII-K27005NP0A;Ixabepilone (BMS-247550);CHEBI:63605;K27005NP0A;NSC747973;BMS 247550-01;BMS-247550-01;17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-;1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione;Ixabepilone [INN];Ixempra kit;Ixempra (TM);16-Aza-epothilone B;D0W2EK;AC1O62ST;SCHEMBL8386;Ixabepilone (JAN/USAN/INN);Ixabepilone [USAN:INN:JAN];GTPL6824;SCHEMBL1890345;CHEMBL1201752;CHEBI:95095;HSDB 7738;MolPort-027-720-838;EX-A1245;ZINC3993846;AN-475;s7930;AKOS025401600;API0004751;CS-0551;DB04845;NSC-710428;NSC-747973;BMS 247550 (Epothilone B analogue);AC-22618;HY-10222;LS-98543;QC-11860;SC-81824;X7258;D04645;W-5316;49309-EP2295426A1;49309-EP2295427A1;49309-EP2298768A1;49309-EP2311840A1;AB01273979-01;989I841;Azaepothilone B;BMS 247550;BMS 247550-1;SR-01000941577;J-014409;SR-01000941577-1;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione;(1r,5s,6s,7r,10s,14s,16s)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[[e]-1-(2-methyl-1,3-thiazol-4-yl]prop-1-en-2-yl)-17-oxa-13-azabicyclo(14,1,0)heptadecane-8,12-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione;(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione;7-Oxa-4-azabicyclo[14.1.0]heptadecane -5, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-, (1S,3S,7S,10R,11S,12S,16R)-"	219989-84-1	K27005NP0A	"20449631;19088046;18644829;18451235;18446338;17761711;17594093;17261851;16144926;14977827"	14977827	01/02/2004	12721265	01/03/2003	1999-2003		1	1	1	Yes	1	"26/07/2016 00:00;18/10/2011 00:00;12/05/2010 00:00;02/10/2009 00:00;22/12/2016 00:00;20/01/2015 00:00;16/10/2007 00:00;13/03/2009 00:00"	AP	R-PHARM US LLC	IXABEPILONE	16/10/2007	R-PHARM US LLC	55,4	27	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	118	0	1
PF-04691502	"pf-04691502;pi3k/mtor kinase inhibitor pf-04691502"		DB11974		"PF-04691502;1013101-36-4;PF 04691502;UNII-4W39NS61KI;4W39NS61KI;CHEMBL1234354;2-amino-8-((1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one;PF04691502;2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one;2-Amino-8-[trans-4-(2-Hydroxyethoxy)cyclohexyl]-6-(6-Methoxypyridin-3-Yl)-4-Methylpyrido[2,3-D]pyrimidin-7(8h)-One;2-Amino-8-(cis-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one;2-Amino-8-(cis-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one;PubChem24348;4tv3;PF-4691502;D0N5JZ;MLS006010979;GTPL7936;SCHEMBL1381425;SCHEMBL1381431;SCHEMBL1984896;SCHEMBL10092210;SCHEMBL13976989;EX-A032;QCR-137;MolPort-023-219-212;XDLYKKIQACFMJG-IYBDPMFKSA-N;XDLYKKIQACFMJG-UHFFFAOYSA-N;HMS3656B21;AOB87714;ABP000986;BDBM50380313;s2743;ZINC58660483;AKOS005266645;AKOS030257531;ZINC100015733;ZINC117704832;CS-0919;DB11974;NCGC00346659-01;AC-28429;AS-17042;HY-15177;KB-79877;SC-96618;SMR004702782;BCP0726000275;AB0033743;X7464;Q-4026;US8633204, 286;J-000360;PF-04691502, >=98% (HPLC);1013101-36-4 pound not PF04691502 pound not PF 04691502;2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-[(1R,4R)-4-(2-hydroxyethoxy)cyclohexyl]-7h,8h-pyrido[2,3-d]pyrimidin-7-one;2-amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-[(1r,4r)-4-(2-hydroxyethoxy)cyclohexyl]pyrido[2,3-d]pyrimidin-7-one;2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one;2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one;Pyrido(2,3-d)pyrimidin-7(8H)-one, 2-amino-8-(trans-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxy-3-pyridinyl)-4-methyl-"	1013101-36-4	4W39NS61KI	24395457	24395457	01/01/2014	24395457	01/01/2014	2013-2017		1	1	0	Yes	1					30/07/2018		54,8	37	NA	1	0	NA	1	"PI3K;MTOR"	0	1	1	14	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Letrozole	letrozole	"Letrozol;Kisqali Femara Co-pack;Letrozole Tablets;Sandoz Letrozole;Ipg-letrozole;Dom-letrozole;Apo-letrozole;Accel-letrozole Tablets USP;Ag-letrozole;Bio-letrozole;Mylan-letrozole;Nat-letrozole;PHL-letrozole;Auro-letrozole;Ach-letrozole;Letrozole;Riva-letrozole;Van-letrozole;Myl-letrozole;Femara;Med-letrozole;Zinda-letrozole;Ccp-letrozole;Mar-letrozole;Letrozole Sun;Teva-letrozole;Femara 2.5mg;Jamp-letrozole;Stason-letrozole;Ran-letrozole;Co Letrozole;PMS-letrozole"	"DB01006;APRD01066"	"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;112809-51-5;4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile;Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-;CGS 20267;Femara;Letrozole [USAN:INN];Prestwick2_001025;D00964;Femara (TN);Letrozole (JAN/USP/INN);CAS-112809-51-5;NCGC00016973-01;Prestwick1_001025;BSPBio_001209;MLS000759455;SMR000466343;Prestwick3_001025;FEM-345;Prestwick0_001025;SPBio_003070;4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile;BPBio1_001331;4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;NSC719345;CGS-20267;C08163;Letrozole"	"letrozole;112809-51-5;Femara;4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile;Letrozol;CGS 20267;CGS-20267;Letoval;LETRAZOLE;Femera;Letrozole [USAN:INN];UNII-7LKK855W8I;4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile;Femara (TN);Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-;LEROZOLE;HSDB 7461;4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE;4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile;C17H11N5;1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole;CHEMBL1444;Letrozole (JAN/USP/INN);4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile;4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile;7LKK855W8I;CHEBI:6413;4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;FEM-345;HPJKCIUCZWXJDR-UHFFFAOYSA-N;MFCD00866241;4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile;NCGC00016973-01;CAS-112809-51-5;DSSTox_CID_3202;DSSTox_RID_76924;1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole;DSSTox_GSID_23202;Q-201291;4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole;4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE;SMR000466343;SR-01000759382;CCRIS 8822;Femara, Letrozole;Letrozole [USAN:USP:INN:BAN];LETROZ;LETROF L LIL;AC1L1GYT;Prestwick0_001025;Prestwick1_001025;Prestwick2_001025;Prestwick3_001025;Femara (TN) (Novartis);D0C1WH;Novartis Brand of Letrozole;SCHEMBL4331;BIDD:PXR0130;BSPBio_001209;MLS000759455;MLS001424038;MLS002584991;MLS006010040;BIDD:GT0015;SPBio_003070;BPBio1_001331;GTPL5209;DTXSID4023202;Letrozole, >=98% (HPLC);BDBM13061;CTK8B5413;EX-A965;QCR-225;4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile);HMS1571M11;HMS2051E08;HMS2089L22;HMS2098M11;HMS2233C23;HMS3369E11;HMS3393E08;HMS3651K05;HMS3715M11;Pharmakon1600-01502354;CGS-20267 pound>>LETROZOLE;KS-00000XA8;ZINC3778874;Tox21_110719;Tox21_303572;ABP001083;ANW-48664;BG0620;NSC719345;NSC759652;s1235;STL451047;AKOS005145822;AB07525;AC-1193;AN-6525;API0024524;BCP9000848;CCG-100849;CS-1776;DB01006;KS-1269;NC00099;NSC-719345;NSC-759652;RP29922;RTC-070977;NCGC00016973-02;NCGC00016973-03;NCGC00016973-06;NCGC00257460-01;4CA-0737;AJ-45577;BC205693;BR-59607;CPD000466343;HY-14248;LS-38788;SAM001246649;SC-00402;BCP0726000213;AB0012832;AB1009309;AX8041188;CGS 20267, Femara, Piroxicam, Letrozole;KB-187805;ST2405214;TL8000371;1-Bis(4-cyanophenyl)methyl-1,2,4-triazole;4,2,4-Triazol-1-ylmethylene)dibenzonitrile;AB00514009;FT-0627797;L0248;A25380;C08163;D00964;EN300-264820;J10423;S-4137;AB00514009-05;AB00514009-07;AB00514009-08;AB00514009-09;AB00514009_10;AB00514009_11;809L515;W-60273;4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile;I06-0022;SR-01000759382-4;SR-01000759382-5;BRD-K88789588-001-03-2;4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile;4,4'-(1,2,4-TRIAZOL-1-YLMETHYL)DIBENZONITRILE;4,4'-(1h-1,2,4-triazol-1-ylmethylene)-bisbenzonitrile;F2173-0288;Z1741968261;Letrozole, European Pharmacopoeia (EP) Reference Standard;Letrozole, United States Pharmacopeia (USP) Reference Standard;Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material;4,4 inverted exclamation marka-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile"	112809-51-5	7LKK855W8I	"9815951;7697604"	7697604	01/04/1995	8417819	01/01/1993	1989-1994		1	1	1	Yes	1	"13/07/2011 00:00;05/04/2018 00:00;17/02/2015 00:00;03/06/2011 00:00;21/09/2015 00:00;30/04/2010 00:00;20/01/2010 00:00;19/07/2014 00:00;29/10/2014 00:00;23/12/2015 00:00;10/01/2001 00:00;28/10/2016 00:00;04/05/2017 00:00;24/12/2008 00:00;26/02/2003 00:00;28/12/2005 00:00;10/01/2002 00:00;03/06/2016 00:00;09/08/2010 00:00;02/03/2010 00:00;15/05/2012 00:00;19/04/2012 00:00;26/06/2006 00:00;25/07/1997 00:00;26/06/2014 00:00;13/07/2017 00:00;02/04/2015 00:00;22/04/1999 00:00;15/01/2014 00:00;08/03/2011 00:00;16/05/2013 00:00;05/02/2001 00:00;17/03/1999 00:00;23/04/2018 00:00;07/08/2008 00:00;23/05/2000 00:00;23/12/2011 00:00;11/04/2007 00:00;17/01/2003 00:00;11/07/2013 00:00;13/02/2015 00:00;25/06/2010 00:00;09/02/2015 00:00;07/07/2009 00:00;29/10/2004 00:00"	"AP;TA"	"HIKMA PHARMS;ACTAVIS TOTOWA;FRESENIUS KABI ONCOL;IMPAX LABS;VINTAGE PHARMS LLC;ACCORD HLTHCARE;NOVARTIS PHARMS;WEST-WARD PHARMS INT;NOVARTIS PHARMS CORP;ZYDUS PHARMS USA INC;INDICUS PHARMA;APOTEX INC;NATCO PHARMA LTD;DR REDDYS LABS LTD;LANNETT CO INC;SUN PHARM INDS LTD;TEVA PHARMS;SYNTHON PHARMS;MYLAN;JIANGSU HENGRUI MED"	" RIBOCICLIB SUCCINATE;LETROZOLE"	25/07/1997	NOVARTIS PHARMS	54,6	21	NA	0	1	BREAST	1	AROMATASE	0	1	0	NA	0	0	0	1	0	0,33	0	1	1	0,57	0	0	0	0	0	0	111	0	1
Onartuzumab	onartuzumab		DB11746			1133766-06-9	MS1J9720WC	24493831	24493831	01/02/2014	24493831	01/02/2014	2013-2017		1	1	0	Yes	1					30/07/2018		53,8	45	NA	1	0	NA	1	MET	0	1	1	9	0	0	0	1	0	NA	0	1	1	NA	0	0	0	0	0	0	25	0	1
Dacarbazine	"cb10-277;phenyl dimethyltriazene"	"DIC;5-(dimethyltriazeno)imidazole-4-carboxamide;4-(dimethyltriazeno)imidazole-5-carboxamide;ICDMT;Dacarbazinum;5-(3,3-dimethyltriazeno)imidazole-4-carboxamide;5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide;Dacarbazina;Dacarbazine;DTIC;Dacarbazin;Biocarbazine;4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide;4-(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide;Dacarbazine;Dtic Dome Inj 200mg/vial;Dtic-dome -pws IV 200mg/vial;Dacarbazine for Injection BP"	"DB00851;APRD00331"	"(5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide;(5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide;(5E)-5-(dimethylaminohydrazono)-4-imidazolecarboxamide;37626-23-6;4342-03-4;Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-;Dacarbazinum [INN-Latin];HSDB 3219;Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-;NSC-45388;EINECS 224-396-1;4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or  4)-carboxamide;AI3-52825;Biocarbazine R;Prestwick_904;5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide;D2390_SIGMA;5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide;DACARBAZINE;4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide;D00288;DTIC-Dome (TN);Dacarbazine (JAN/USP/INN);CCRIS 190;DRG-0135;Dacarbazine [USAN:BAN:INN:JAN];Dacarbazino [INN-Spanish]"	"dacarbazine;Biocarbazine;Deticene;DTIC-Dome;Biocarbazine R;4342-03-4;Decarbazine;DTIC;ICDT;Dacarbazinum [INN-Latin];Dacarbazino [INN-Spanish];Dtic-Dome (TN);DTIE;Dacarbazino;Dacatic;ICDMT;Dimethyl Imidazole Carboxamide;Di-me-triazenoimidazolecarboxamide;(Dimethyltriazeno)imidazolecarboxamide;UNII-7GR28W0FJI;Dimethyl Triazeno Imidazole Carboxamide;7GR28W0FJI;Dacarbazinum;CCRIS 190;Dacarbazine (JAN/USP/INN);C6H10N6O;HSDB 3219;4-(Dimethyltriazeno)imidazole-5-carboxamide;Dacarbazine [USAN:INN:BAN:JAN];EINECS 224-396-1;Di-methyl-triazenoimidazolecarboxamide;4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide;5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide;Biocarbazin;(5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide;AI3-52825;5-(Dimethyltriazeno)-4-imidazolecarboxamide;5-(Dimethyltriazeno)imidazole-4-carboximide;4-(Dimethyltriazeno)imidazole-5-c arboxamide;NSC 45388;NSC-45388;5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide;5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide;4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide;5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide;5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide;5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide;5-(Dimethyltriazeno)imidazole-4-carboxamide;Carboxamide, 5-(3,3-dimethyl-1-triazeno)imidazole-4-;1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-;5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide;5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide;5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide;Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-;4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide;4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide;NCI-C04717;4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide;4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide;DTICDome;DTIC Dome;4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide;NPFAPI-05;Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-;Dimethyltriazenoimidazolecarboxamide;4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide;Carboxamide, Dimethyl Imidazole;Imidazole Carboxamide, Dimethyl;Imidazole (TN);Carboxamide (TN);Prestwick_904;AC1NS4BN;5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide;D0Y7ZU;DTIC (TN);DIC (TN);(5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide;5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide;SCHEMBL1014331;DTIC, DTIC-Dome, Dacarbazine;MolPort-003-846-120;MolPort-044-723-991;BDBM233149;HMS1569D10;HMS2090A20;HMS2096D10;HMS3713D10;HY-B0078;LS-119;MFCD00057167;ZINC18099447;AKOS005220502;AKOS026750028;AKOS027327595;CCG-220574;CS-1772;KS-5186;MCULE-7282678858;Dacarbazine [USAN:USP:INN:BAN:JAN];Dacarbazine, antineoplastic purine analog;H539;SC-17180;HE1150000;D3634;ST51014976;C06936;D00288;J10199;342D034;5-[(dimethylamino)diazenyl]imidazole-4-carboxamide;A826278;W-106228;BRD-K35520305-001-07-8;(5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide;Dacarbazine, European Pharmacopoeia (EP) Reference Standard;(5E)-5-(dimethylaminohydrazinylidene)-4-imidazolecarboxamide;1H-Imidazole-4-carboxamide, 5- (3,4-dimethyl-1-triazenyl)-;4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or  4)-carboxamide;Dacarbazine, United States Pharmacopeia (USP) Reference Standard;Imidazole-4(or 5)-carboxamide, 5(or 4)-(3,3-dimethyl-1-triazeno)-;37626-23-6"	04/03/4342	7GR28W0FJI	"8431368;8431367"	8431368	01/02/1993	4946016	01/12/1970	Bef. 1989		0	0	1	Yes	1	"22/05/1986 00:00;29/07/1991 00:00;10/11/1975 00:00;07/11/1996 00:00;29/04/1981 00:00;27/08/1999 00:00;31/10/2002 00:00;21/02/2002 00:00;27/05/1975 00:00;24/09/1998 00:00;18/10/2001 00:00;02/12/1988 00:00;15/06/2001 00:00;22/09/2000 00:00;05/04/1983 00:00;27/10/1980 00:00;24/05/1996 00:00;27/08/1998 00:00;19/04/1989 00:00;15/07/1985 00:00;24/05/1979 00:00"	AP	"TEVA PHARMS USA;FRESENIUS KABI USA;WEST-WARD PHARMS INT;BAYER HLTHCARE;HOSPIRA"	DACARBAZINE	27/05/1975	BAYER HLTHCARE	53,7	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Nivolumab	"bms-936558;mdx-1106;nivolumab;ono-4538"	Opdivo	"DB09035;DB06132"			946414-94-4	31YO63LBSN	"27169994;27733243;27354485;27269947;26873574;25897158;25800770;25482239;24145345"	24145345	01/10/2013	20516446	01/07/2010	2009-2012		1	1	1	Yes	1	"15/02/2018 00:00;17/05/2016 00:00;22/12/2014 00:00;25/04/2017 00:00;31/07/2017 00:00;23/11/2015 00:00;05/03/2018 00:00;30/09/2015 00:00;09/10/2015 00:00;13/09/2016 00:00;09/01/2018 00:00;16/04/2018 00:00;22/09/2017 00:00;23/01/2016 00:00;04/03/2015 00:00;10/07/2018 00:00;06/09/2017 00:00;13/02/2018 00:00;02/02/2017 00:00;10/11/2016 00:00;04/10/2016 00:00;20/12/2017 00:00"	AP	BRISTOL MYERS SQUIBB	NIVOLUMAB	22/12/2014	BRISTOL MYERS SQUIBB	53,6	39	NA	0	1	"MELANOMA;COLORECTAL;PROSTATE;NSCLC;MRCC"	1	PD-1	0	1	1	15	0	1	0	1	0	0,08	0	1	1	NA	0	0	0	0	0	0	47	0	1
Chloroquine	chloroquine	"Chloroquinum;Chloroquine;Cloroquina;Chloroquinium;Chloroquina;N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;Chloraquine;Chlorochin;Chloroquine;Chloroquine Phosphate;Chloroquine phosphate;Teva-chloroquine;Aralen"	"DB00608;APRD00468"	"N'-(7-chloroquinolin-4-yl)-N,N-diethylpentane-1,4-diamine;N'-(7-chloro-4-quinolyl)-N,N-diethyl-pentane-1,4-diamine;N'-(7-chloro-4-quinolyl)-N,N-diethylpentane-1,4-diamine;4-[(7-chloro-4-quinolyl)amino]pentyl-diethyl-amine;N'-(7-chloroquinolin-4-yl)-N,N-diethyl-pentane-1,4-diamine;58175-86-3;58175-87-4;56598-66-4;54-05-7;IDI1_000404;(+)-Chloroquine;BPBio1_000655;(+)-N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;NINDS_000404;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (+)-;Prestwick2_000548;KBioSS_000592;Spectrum3_000341;KBio2_000592;KBio2_003160;KBio2_005728;(-)-Chloroquine;Spectrum2_000127;(R)-(-)-Chloroquine;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (-)-;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (4R)-;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (R)-;Chloroquine (USP);D02366;Spectrum4_000279;SPBio_000174;KBio3_001221;( -)-Chloroquine;1,4-Pentanediamine, N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-;1,4-Pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-;7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline;Amokin;Aralen;Arthrochin;Artrichin;BRN 0482809;Bemaco;Bemasulph;Benaquin;Bipiquin;CCRIS 3439;Capquin;Chloraquine;Chlorochin;Chlorochinum;Chloroquina;Chloroquine (VAN);Chloroquine [USAN:BAN:INN];Chloroquinium;Chloroquinum [INN-Latin];Chlorquin;Cidanchin;Clorochina;Clorochina [DCIT];Cloroquina [INN-Spanish];Cocartrit;Dichinalex;EINECS 200-191-2;Elestol;Gontochin;HSDB 3029;Heliopar;Imagon;Iroquine;Klorokin;Lapaquin;Malaquin;Malaren;Malarex;Mesylith;N(sup 4)-(7-Chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-1,4-pentanediamine;N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;NSC 187208;Neochin;Pfizerquine;Quinachlor;Quinercyl;Quinilon;Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-;Quinoscan;Reumachlor;Ronaquine;Roquine;ST 21;ST 21 (pharmaceutical);Silbesan;Siragan;Solprina;Sopaquin;Tresochin;Trochin;W 7618;WIN 244;3545-67-3 (DIHYDROCHLORIDE);50-63-5 (DIPHOSPHATE);54-05-7 (FREE BASE );AIDS-000733;AIDS000733;Chloroquin;Malaquin (*Diphosphate*);NSC14050 (DIPHOSPHATE);NSC187208 (FREE BASE);Quinoline, 7-chloro-4-(4-diethylamino-1-methyl-butylamino)-;RP-3377;SN-7618;Spectrum5_000707;DivK1c_000404;BSPBio_000595;C07625;Chloroquine;(+-)-N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (+-)-;CHEBI:3638;N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine;N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine;NCI60_000894;BSPBio_002001;7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline;Avlochlor;NSC187208;Nivachine;Quinagamin;Quinagamine;Quinoline, 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]-;Resochen;Resoquina;Reumaquin;SN 6718;WLN: T66 BNJ EMY1&3N2&2 IG;n(sup4)-(7-chloro-4-quinolinyl)-n(sup1),n(sup1)-diethyl-1,4-pentanediamine;Prestwick0_000548;N'-(7-chloroquinolin-4-yl)-N,N-diethylpentane-1,4-diamine;LS-141726;Lopac0_000296;SPBio_002516;KBio1_000404;Prestwick3_000548;Spectrum_000132;MolMap_000009;Prestwick1_000548;SMP2_000034;KBioGR_000778"	"chloroquine;Aralen;Chlorochin;54-05-7;Chloraquine;Artrichin;Chloroquinium;Chloroquina;Reumachlor;Capquin;Chemochin;Chlorquin;Clorochina;Malaquin;Arthrochin;Bemasulph;Benaquin;Bipiquin;Chingamin;Cidanchin;Cocartrit;Dichinalex;Gontochin;Heliopar;Iroquine;Klorokin;Lapaquin;Mesylith;Pfizerquine;Quinachlor;Quinercyl;Quinilon;Quinoscan;Sanoquin;Silbesan;Solprina;Sopaquin;Tresochin;Amokin;Bemaco;Elestol;Imagon;Malaren;Malarex;Neochin;Roquine;Siragan;Trochin;Nivaquine B;Bemaphate;Chloroquinum;Cloroquina;Khingamin;Resoquine;Nivaquine;Chlorochine;Quingamine;Avloclor;Resochin;Ronaquine;Tanakan;Chlorochinum;Avlochlor;Nivachine;Quinagamin;Quinagamine;Resochen;Resoquina;Reumaquin;Arechin;Delagil;Chloroquine phosphate;Chloroquine (VAN);Clorochina [DCIT];Arechine;Arequin;WIN 244;N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine;(-)-Chloroquine;ST 21 (pharmaceutical);Chloroquinum [INN-Latin];Cloroquina [INN-Spanish];RP 3377;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-;3377 RP opalate;Chloroquin;Chloroin;Rivoquine;Arolen;W 7618;(R)-(-)-Chloroquine;ST 21;Aralen HCl;Miniquine;Tanakene;7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline;Chloroquine [USAN:INN:BAN];CCRIS 3439;CHEBI:3638;N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;HSDB 3029;(+)-Chloroquine;Gontochin phosphate;CHEMBL76;Chloroquine (USP/INN);EINECS 200-191-2;Malaquin (*Diphosphate*);NSC 187208;SN 6718;BRN 0482809;Ipsen 225;Chloroquine Bis-Phosphoric Acid;WHTVZRBIWZFKQO-UHFFFAOYSA-N;C18H26ClN3;N(sup 4)-(7-Chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-1,4-pentanediamine;NSC187208;{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine;Chloroquine HCl;NSC-187208;RP-3377;SN-7618;Ro 01-6014/N2;7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline;Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-;1,4-Pentanediamine, N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (+)-;SN 7618;1,4-Pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-;58175-86-3;CQ;CU-01000012392-2;Quinoline, 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]-;N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine;Chloroquine, D-;56598-66-4;( -)-Chloroquine;(+-)-Chloroquine;NSC14050;UNII-WE58C2WV1T;WE58C2WV1T;UNII-34P96M7C4K;{4-[(7-chloro(4-quinolyl))amino]pentyl}diethylamine;Cloroquine;34P96M7C4K;Chloroquine [USP:INN:BAN];Chloroquine, 17;Dawaquin (TN);Resochin (TN);Arechin (Salt/Mix);Delagil (Salt/Mix);Tanakan (Salt/Mix);Chloroquine, (R)-;Chloroquine, (S)-;Bemaphate (Salt/Mix);Resoquine (Salt/Mix);Spectrum_000132;Chloroquine + Proveblue;Chloroquine FNA (TN);Prestwick0_000548;Prestwick1_000548;Prestwick2_000548;Prestwick3_000548;Spectrum2_000127;Spectrum3_000341;Spectrum4_000279;Spectrum5_000707;(.+/-.)-Chloroquine;D09EGZ;Epitope ID:131785;MolMap_000009;AC1L1EB8;AC1Q2ZA7;AC1Q2ZA8;SCHEMBL8933;Lopac0_000296;BSPBio_000595;BSPBio_002001;KBioGR_000778;KBioSS_000592;DivK1c_000404;SPBio_000174;SPBio_002516;GNF-Pf-4216;BPBio1_000655;GTPL5535;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (4R)-;DTXSID2040446;BDBM22985;CTK1H1520;KBio1_000404;KBio2_000592;KBio2_003160;KBio2_005728;KBio3_001221;MolPort-001-783-623;NINDS_000404;HMS2090O03;ALBB-025694;ZX-AN024208;(+)-N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine;SBB072644;AKOS015935106;CCG-204391;CS-W004760;DB00608;HCH0027872;KH-0005;MCULE-3610827164;IDI1_000404;KS-00000F97;SMP2_000034;NCGC00015256-02;NCGC00015256-03;NCGC00015256-04;NCGC00015256-05;NCGC00015256-06;NCGC00015256-07;NCGC00015256-08;NCGC00015256-09;NCGC00015256-10;NCGC00015256-13;NCGC00162120-01;AK116457;BC208405;NCI60_000894;SC-48578;WLN: T66 BNJ EMY1&3N2&2 IG;SBI-0050284.P004;AX8105532;KB-258556;LS-141726;ST2401962;4CH-019706;AB00053436;FT-0623612;ST45028748;C07625;D02366;EN300-120683;MLS-0466768.0001;AB00053436-05;AB00053436_06;AB00053436_07;1, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-;BRD-A91699651-065-01-1;BRD-A91699651-316-06-7;n(sup4)-(7-chloro-4-quinolinyl)-n(sup1),4-pentanediamine;N'-(7-chloroquinolin-4-yl)-N,N-diethylpentane-1,4-diamine;N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine;Quinoline, 7-chloro-4-(4-diethylamino-1-methyl-butylamino)-;4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (-)-;1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, (R)-;N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine;1,4-pentanediamine, N~4~-(7-chloro-4-quinolinyl)-N~1~,N~1~-diethyl-, phosphate (1:2);N(sup4)-(7-chloro-4-quinolinyl)-N(sup1),N(sup1)-diethyl-1,4-pentanediamine"	54-05-7	886U3H6UFF	28980060	28980060	01/10/2017	20282619	01/06/1945	Bef. 1989		0	0	1	No	0	"11/02/1999 00:00;23/06/1992 00:00;14/11/1986 00:00;29/04/1988 00:00;20/03/2001 00:00;26/03/1991 00:00;11/03/1992 00:00;10/01/1992 00:00;14/06/2007 00:00;09/09/1976 00:00;10/09/1996 00:00;20/08/1999 00:00;18/02/1993 00:00;03/01/1989 00:00;05/05/1997 00:00;09/06/1989 00:00;17/06/1983 00:00;31/10/2001 00:00;05/09/1997 00:00;20/06/2007 00:00;05/10/2000 00:00;22/11/1988 00:00;15/05/1981 00:00;07/10/1997 00:00;28/11/2007 00:00;29/05/1990 00:00;01/05/2018 00:00;31/01/1984 00:00;03/01/1985 00:00;29/04/1976 00:00;23/06/1986 00:00;23/09/1993 00:00;13/01/1982 00:00;02/01/1987 00:00;04/08/1989 00:00;19/12/1991 00:00;17/06/1987 00:00;20/01/2015 00:00;12/12/1986 00:00;26/01/1984 00:00;10/09/2002 00:00;12/04/2001 00:00;15/05/1996 00:00;21/12/1982 00:00;20/10/1994 00:00;20/02/2008 00:00;04/08/1988 00:00;26/01/1983 00:00;21/01/2011 00:00;25/03/1997 00:00;15/08/1997 00:00;30/04/2002 00:00;03/11/1992 00:00;13/03/2001 00:00;06/07/2018 00:00;29/06/1990 00:00;21/11/2003 00:00;13/07/2017 00:00;31/05/1996 00:00;03/12/2009 00:00;06/11/2013 00:00;09/07/1997 00:00;31/10/1949 00:00;09/12/1968 00:00;19/08/1998 00:00;09/05/2001 00:00;02/05/2002 00:00;08/05/2018 00:00;23/02/1998 00:00;12/02/2016 00:00;08/01/1980 00:00;11/07/2001 00:00;04/04/1989 00:00;27/01/2017 00:00;15/09/1982 00:00;21/03/2000 00:00;18/06/1987 00:00;11/10/1996 00:00;16/02/1984 00:00;30/11/1995 00:00;11/12/1974 00:00;01/10/1998 00:00;26/02/2001 00:00;17/09/1999 00:00;19/11/1990 00:00;11/10/1995 00:00;21/09/2007 00:00;12/04/1976 00:00;02/04/1991 00:00;29/01/1975 00:00;31/05/2007 00:00;10/10/2000 00:00;13/07/1990 00:00;19/04/2002 00:00;30/09/1988 00:00;18/07/1997 00:00;17/05/1991 00:00;15/05/2018 00:00;01/11/1984 00:00;22/05/1978 00:00;29/05/1998 00:00;18/04/1955 00:00;28/01/1991 00:00;08/07/1997 00:00;09/07/1975 00:00;01/07/1987 00:00;06/11/1991 00:00;04/12/1986 00:00;28/08/2015 00:00;21/03/2006 00:00;27/10/1993 00:00;07/09/1989 00:00;03/03/1987 00:00;24/05/2000 00:00;14/05/1982 00:00;20/07/1989 00:00;14/10/1986 00:00;30/12/1988 00:00;22/07/1985 00:00;15/12/1988 00:00;12/06/2009 00:00;31/03/1976 00:00;29/09/2005 00:00;04/02/1999 00:00;23/03/1999 00:00;20/11/1989 00:00;27/01/1996 00:00;13/06/2003 00:00;30/11/2000 00:00;08/10/2002 00:00;19/02/1980 00:00;31/05/1991 00:00;09/02/2000 00:00;26/05/1994 00:00;30/09/1994 00:00;30/06/1982 00:00;15/08/2007 00:00;17/02/2000 00:00;05/07/1985 00:00;07/02/2002 00:00;23/01/2002 00:00;29/08/2003 00:00;27/03/1987 00:00;02/11/1984 00:00;05/02/2003 00:00;14/02/1991 00:00;08/08/1980 00:00;10/11/2009 00:00;17/06/1985 00:00;03/12/1985 00:00;02/10/1996 00:00"	AP	"IPCA LABS LTD;TEVA;SANDOZ;#N/A;CONCORDIA PHARMS INC;HIKMA PHARMS;TEVA PHARMS;WATSON LABS;NATCO PHARMA LTD;ZYDUS PHARMS USA INC;SANOFI AVENTIS US;MYLAN;IMPAX LABS"	" PRIMAQUINE PHOSPHATE;HYDROXYCHLOROQUINE SULFATE;CHLOROQUINE PHOSPHATE"	31/10/1949	SANOFI AVENTIS US	52,9	#N/A																							0						1
Fresolimumab	"fresolimumab;gc1008"	GC1008	DB12396			948564-73-6	375142VBIA	24618589	24618589	01/03/2014	24618589	01/03/2014	2013-2017		1	1	0	Yes	1					30/07/2018		52,9	29	NA	0	1	"MELANOMA;MRCC"	1	TGFB	0	1	1	7	0	0	0	1	0	0,03	0	0	0	0,24	0	0	0	0	0	0	25	0	1
Voxtalisib	"pi3k/mtor dual kinase inhibitor xl765;sar245409;sar245409 xl765;voxtalisib;xl765"		DB12400		"voxtalisib;SAR245409;934493-76-2;UNII-CVL1685GPH;CVL1685GPH;2-amino-8-ethyl-4-methyl-6-(1h-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7(8h)-one;Voxtalisib (XL765, SAR245409);Voxtalisib [USAN:INN];Voxtalisib (XL-765);SCHEMBL189573;CHEMBL3545366;CHEBI:124914;MolPort-044-728-888;KS-00000LF7;s7646;ZINC35308805;AKOS027338668;ACN-052938;CS-3163;DB12400;SAR 245409;Pyrido(2,3-d)pyrimidin-7(8H)-one, 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)-;Voxtalisib (XL765  SAR245409);AC-29029;HY-15900;QC-11818;J3.527.559B;2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one;1070896-79-5;1380852-52-7"	934493-76-2	CVL1685GPH	"26019185;24583798"	24583798	01/03/2014	24583798	01/03/2014	2013-2017		1	1	0	Yes	1					30/07/2018		52,9	83	NA	1	0	NA	1	"PI3K;MTOR"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,48	0	0	0	0	0	0	0	0	1
Procarbazine	procarbazine	"N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide;p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide;N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide;Procarbazina;Procarbazinum;N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine;N-Isopropyl-α-(2-methylhydrazino)-p-toluamide;2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine;Procarbazin;N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide;1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine;4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide;Matulane"	"DB01168;APRD00695"	"4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;N-isopropyl-4-[(N'-methylhydrazino)methyl]benzamide;4-[(2-methylhydrazinyl)methyl]-N-propan-2-yl-benzamide;671-16-9;Prestwick1_001112;Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]-;CAS-366-70-1;NCGC00016438-01;N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide;SPBio_003112;Prestwick0_001112;NCIOpen2_004074;2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine;4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine;C07402;4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide;BRN 0958270;Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-;Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)- (9CI);CB 400-497;CCRIS 2389;EINECS 211-582-2;HSDB 3250;N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide;N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine;N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide;N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide;Procarbazin [German];Procarbazina [INN-Spanish];Procarbazinum [INN-Latin];Ro 4-6467;p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide;p-(N'-Methylhydrazinomethyl)-N-isopropylbenzamide;p-Toluamide, N-isopropyl-alpha-(2-methylhydrazino)-;p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-;Prestwick2_001112;Prestwick3_001112;Procarbazine;NCI60_041703;BSPBio_001244;BPBio1_001369"	"procarbazine;671-16-9;Procarbazin;Natulan;Ibenzmethyzin;Ibenzmethyzine;Procarbazina;Procarbazinum;Procarbazin [German];Procarbazinum [INN-Latin];Procarbazina [INN-Spanish];N-Isopropyl-4-((2-methylhydrazinyl)methyl)benzamide;Procarbazine [INN:BAN];2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine;p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide;1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine;4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide;Natulanar;Ro 4-6467;N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine;N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide;N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide;N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide;CB 400-497;Procarbazine Monohydrochloride;Procarbazine (INN);CCRIS 2389;Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]-;MIH;N-Isopropyl-4-[(2-methylhydrazino)methyl]benzamide;Ro 4-6467/1;UNII-35S93Y190K;C12H19N3O;HSDB 3250;N-(1-Methylethyl)-4-[(2-methylhydrazino)methyl]benzamide;NSC-77213;EINECS 211-582-2;PCX;p-(N'-Methylhydrazinomethyl)-N-isopropylbenzamide;BRN 0958270;Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-;CHEBI:71417;p-Toluamide, N-isopropyl-alpha-(2-methylhydrazino)-;SRI-10847;35S93Y190K;p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-;Matulane (TN);4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;4-[(2-methylhydrazin-1-yl)methyl]-N-(propan-2-yl)benzamide;MBH;NCGC00016438-01;Ro-4646711;CAS-366-70-1;IBZ;SR-01000763375;Indicarb (TN);Natulan (TN);MBH (Salt/Mix);Matulane (Salt/Mix);Nathulane (Salt/Mix);Natunalar (Salt/Mix);Prestwick0_001112;Prestwick1_001112;Prestwick2_001112;Prestwick3_001112;DSSTox_CID_1189;D08GYO;AC1L1J8E;SCHEMBL4656;CHEMBL1321;DSSTox_RID_75999;NCIOpen2_004074;DSSTox_GSID_21189;BSPBio_001244;BIDD:GT0183;SPBio_003112;BPBio1_001369;GTPL7278;DTXSID4021189;CPTBDICYNRMXFX-UHFFFAOYSA-N;HMS2090J09;Pharmakon1600-01502326;366-70-1 (mono-hydrochloride);Tox21_301738;0319AC;NSC759626;STL483417;ZINC19166988;AKOS015891211;AC-4547;API0006342;CCG-213031;DB01168;LS-7671;MCULE-9065058360;NSC-759626;NCGC00016438-02;NCGC00016438-05;NCGC00255280-01;AJ-72471;AK116452;AN-11892;BC219337;CAS-671-16-9;CC-33928;CJ-15983;NCI60_041703;Ro-4-6467/1;SRI-10847-09;SRI-10847-10;SRI-10847_11;SRI-10847_13;AX8149098;KB-258803;FT-0737820;C07402;D08423;671P169;C-23731;I01-8931;N-Isopropyl-.alpha.-(2-methylhydrazino)-p-toluamide;SR-01000763375-3;N-Isopropyl-4-[(2-methylhydrazino)methyl]benzamide #;4-[(2-methylhydrazinyl)methyl]-N-(propan-2-yl)benzamide;Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)- (9CI);Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-(9CI)"	671-16-9	35S93Y190K	11508814	11508814	01/08/2001	14245179	01/03/1965	Bef. 1989		0	0	1	Yes	1	"09/04/1987 00:00;11/08/1981 00:00;13/03/2002 00:00;24/03/1980 00:00;18/12/1981 00:00;29/04/1986 00:00;17/08/1987 00:00;02/03/2001 00:00;24/07/1980 00:00;16/10/1998 00:00;08/03/1999 00:00;07/05/1986 00:00;08/04/1976 00:00;13/11/2001 00:00;27/11/1978 00:00;02/02/2016 00:00;31/03/1981 00:00;22/07/1969 00:00;09/01/1979 00:00;20/12/2002 00:00;14/11/1979 00:00;05/03/1987 00:00;16/05/1977 00:00"	AP	LEADIANT BIOSCI INC	PROCARBAZINE HYDROCHLORIDE	22/07/1969	LEADIANT BIOSCI INC	52,6	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Litronesib	"litronesib;ly2523355"		DB11861		"Litronesib;910634-41-2;UNII-6611F8KYCV;KF 89617;LY2523355;KF89617;6611F8KYCV;LY-2523355;Litronesib [USAN:INN];Litronesib (USAN/INN);LY 2523355;D0W9SL;SCHEMBL368284;CHEMBL2105661;ZINC56898863;AKOS030526983;CS-5194;DB11861;AN-26576;HY-14846;KB-78022;D09636;LY-2523355;KF-89617;634D412;(-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide;(-)-N-{4-(2,2-dimethylpropanoyl)-5-(({(2-(ethylamino)ethyl)sulfonyl}amino)methyl)-5- phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl}-2,2-dimethylpropanamide;(R)-N-{4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5- phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl}-2,2-dimethyl-propionamiden;N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-propanamide;Propanamide, N-(4-(2,2-dimethyl-1-oxopropyl)-5-((((2-(ethylamino)ethyl)sulfonyl) amino)methyl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl)-2,2-dimethyl-, (-)-"	910634-41-2	6611F8KYCV	24752449	24752449	01/04/2014	24752449	01/04/2014	2013-2017		1	1	0	Yes	1					30/07/2018		51,8	12	NA	1	0	NA	1	EG5	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Ramucirumab	ramucirumab	Cyramza	DB05578			947687-13-0	D99YVK4L0X	"28158463;25787923;20048182"	20048182	01/01/2010	20048182	01/01/2010	2009-2012		1	1	1	Yes	1	"05/11/2014 00:00;12/12/2014 00:00;24/04/2015 00:00;21/04/2014 00:00"	AP	ELI LILLY AND CO	RAMUCIRUMAB	21/04/2014	ELI LILLY AND CO	51,5	37	NA	1	0	NA	1	VEGFR2	0	1	0	NA	0	0	0	1	1	0,15	0	0	0	0,3	0	0	0	0	0	0	47	0	1
Dactinomycin	actinomycin	"Dactinomycin;Dactinomicina;ActD;Dactinomycine;Actinomycin D;Actinomycin C1;2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide;Actinomycin iv;Dactinomycinum;Meractinomycin;Dactinomycin;Cosmegen"	"DB00970;APRD00124"	"2-amino-4,6-dimethyl-3-oxo-N,N'-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide;2-amino-N,N'-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide;2-amino-N,N'-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxamide;2-amino-N,N'-bis(3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide;50-76-0;HBF 386;3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-;ACT D;AD (VAN);AI3-26374;Actinomycin 11 cosmegen;Actinomycin 7;Actinomycin A IV;Actinomycin Aiv;Actinomycin C(sub1);Actinomycin C1;Actinomycin I;Actinomycin I(sub 1);Actinomycin I1;Actinomycin IV;Actinomycin X 1;Actinomycin-(threo-val-pro-sar-meval);Actinomycindioic D acid, dilactone;Acto-D;Antibiotic from Streptomyces parvullus;CCRIS 9;Chounghwamycin B;Cosmegen;Dactinomicina [INN-Spanish];Dactinomycin D;Dactinomycin [USAN:BAN];Dactinomycine [INN-French];Dactinomycinum [INN-Latin];Dilactone actinomycin D acid;Dilactone actinomycindioic D acid;EINECS 200-063-6;HSDB 3220;Lyovac cosmegen;Meractinomycin;NCI-C04682;NSC 3053;Oncostatin K;Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone;Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone;X 97;SMP1_000005;CBiol_002056;-pentone;10,10'-[(2-Amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-Diyl)bis(carbonylimino)]bis-[dodecahydro-6,13-diisopropyl-2,5,9-trimethyl-1H-Pyrrolo-(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine]-1,4,7,11,14;1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine;2-Amino-N,N'-bis-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarb;2-Amino-N,N'-bis[hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,10,13)oxatetraazacyclohexadecin-10-yl]-;3H-phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethy;4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide;Actinomycin D deriv. of 1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine;Actinomycin D deriv. of 3H-phenoxaocardazine;Actinomycin X1;Bis(XI-lactone)N,N'-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis-[carbonylimino(3-hydroxy-1-oxobutylidene)imino(3-methyl-1-oxobutylidene)(tetrahydro-1H-pyrrole-1,2-diyl)carbonyl(methylimin;D Actinomycin;HBF 386 meractinomycin;l-3-oxo-;o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine;ACon0_000471;Neuro_000003;NCGC00025059-02;Actinomycin D;C06770;Dactinomycin;NCI60_030539;Actinomycin D (JP15);Cosmegen (TN);D00214;Dactinomycin (USP);Bio1_000831;Actinomycin D, sodium deoxyribonucleic acid complex;NSC191297;3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-;Actactinomycin A IV;Actinomycin C (sub1);Actinomycin I (sub1);Actinomycin I(sub1);Actinomycin-[threo-val-pro-sar-meval];L-Valine, N,N'-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis[carbonylimino[2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl]imino[2-(1-methylethyl)-1-oxo-2,1-ethanediyl]-1,2-pyrrolidinediylcarbonyl(methylimino)(1-oxo-2,1-ethanediyl)]]bis[N-methyl-, di-.xi.-lactone;NSC-3053;NSC3053;Specific stereoisomer of N,N'-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis[carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl]]bis[N-methyl-L-valine] dilactone;WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1;WLN: TC666 BO EV INJ D1 FZ N1 GVM- OT5-16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1& KVM- OT5-;LMPK03000006;BCBcMAP01_000155;ACon1_001004;MEGxm0_000350;2-amino-4,6-dimethyl-3-oxo-N,N'-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide;Bio1_000342;Bio1_001320"	"DACTINOMYCIN;actinomycin D;Actinomycin C1;Cosmegen;Actinomycin IV;50-76-0;Meractinomycin;ActD;UNII-1CC1JFE158;Dactinomicina;Dactinomycine;Dactinomycinum;Actinomycin 7;GNF-Pf-2290;MLS001424196;1CC1JFE158;CHEBI:27666;Actactinomycin A IV;Dilactone actinomycindioic D acid;NCGC00161622-02;SMR000469227;DSSTox_CID_31;Cosmegen Lyovac;Lyovac-Cosmegen;DSSTox_RID_75330;DSSTox_GSID_20031;Actinomycin;NCI-C04682;NSC 3053;EINECS 200-063-6;CAS-50-76-0;ACT [antibiotic];2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide;AI3-26374;NSC3053;Glycopeptide, 4a;3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-;Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone;Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone;Dactinomycin [USAN:USP:INN:BAN];PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA;UPCMLD-DP055;SCHEMBL3844;CHEMBL1554;DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA;AC1L9W52;cid_457193;CHEMBL3792960;DTXSID9020031;UPCMLD-DP055:001;UPCMLD-DP055:002;BDBM43866;CTK8F7580;MolPort-003-925-177;RJURFGZVJUQBHK-IIXSONLDSA-N;HMS2052O17;2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide;Tox21_111997;Tox21_202482;BDBM50089528;MFCD00005033;AKOS030228553;Tox21_111997_1;CCG-101134;DB00970;NC00384;NCGC00090796-01;NCGC00161622-01;NCGC00260031-01;NCGC00271789-02;CPD000469227;SAM001246846;FT-0080366;15160-EP2272827A1;15160-EP2275420A1;15160-EP2280012A2;15160-EP2281815A1;15160-EP2289892A1;15160-EP2292615A1;15160-EP2295055A2;15160-EP2295416A2;15160-EP2295426A1;15160-EP2295427A1;15160-EP2298748A2;15160-EP2298764A1;15160-EP2298765A1;15160-EP2301928A1;15160-EP2301933A1;15160-EP2305640A2;15160-EP2305642A2;15160-EP2305671A1;15160-EP2308833A2;15160-EP2311453A1;15160-EP2311808A1;15160-EP2311827A1;15160-EP2311829A1;15160-EP2311842A2;15160-EP2316832A1;15160-EP2316833A1;AB00514445-05;050A760;SR-01000763161;SR-01000763161-4;Actinomycin D, from Streptomyces sp., >=95% (HPLC);Actinomycin D, from Streptomyces sp., ~98% (HPLC);BRD-K70578146-001-01-8;BRD-K70578146-001-04-2;UNII-0OCC969V50 component RJURFGZVJUQBHK-IIXSONLDSA-N;Dactinomycin, United States Pharmacopeia (USP) Reference Standard;Actinomycin D, for fluorescence, >=90% (HPLC), from Streptomyces sp.;Actinomycin D, from Streptomyces sp., suitable for cell culture, >=95%;1-N,9-N-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide;2-Amino- 4,6-dimethyl- 3-oxo- 3H-phenoxazine- 1,9-dicarboxylic acid bis- [(5,12-diisopropyl- 9,13,16-trimethyl- 4,7,11,14,17-pentaoxo- hexadecahydro- 10-oxa- 3a,6,13,16-tetraaza- cyclopentacyclohexadecen- 8-yl)- amide];2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis-[(18aS)-10c,14,17-trimethyl-5,8,12,15,18-pentaoxo-6c,13t-di(propan-2-yl)-18ar-hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-9c-yl]-3H-phenoxazine-1,9-dicarboxamide;2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide;2-amino-N,N''''''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide;2-amino-N,N''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide;2-amino-N,N''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide;2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide;2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide;2-azanyl-4,6-dimethyl-3-oxidanylidene-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentakis(oxidanylidene)-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide"	50-76-0	1CC1JFE158	8547961	8547961	01/01/1995	13831299	01/10/1960	Bef. 1989		0	0	1	No	0	"13/03/1998 00:00;17/08/2005 00:00;19/03/2003 00:00;14/02/2001 00:00;07/06/2000 00:00;06/06/1997 00:00;16/03/2010 00:00;22/01/2001 00:00;22/05/1998 00:00;07/04/2015 00:00;30/11/2004 00:00;18/02/1997 00:00;08/02/1999 00:00;10/12/1964 00:00;28/10/2002 00:00;14/02/1996 00:00;22/03/1988 00:00;17/02/1997 00:00;03/02/2012 00:00;23/08/2013 00:00;13/03/2009 00:00;09/11/2017 00:00"	AP	"RECORDATI RARE;LUITPOLD PHARMS INC;WEST-WARD PHARMS INT;#N/A"	DACTINOMYCIN	10/12/1964	RECORDATI RARE	50,2	#N/A																							0						1
Oleandrin	"anvirzel;oleandrin;pbi-05204"	"Anvirzel;Oleandrina"	DB12843	"[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate;[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-(5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl)oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate;acetic acid [(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-[(5-hydroxy-4-methoxy-6-methyl-2-tetrahydropyranyl)oxy]-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ester;acetic acid [(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-(5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl)oxy-17-(5-keto-2H-furan-3-yl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ester;[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-(5-hydroxy-4-methoxy-6-methyl-oxan-2-yl)oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ethanoate;559-83-1;NSC95089;OLEANDRIN;NSC692219;Card-20(22)-enolide, 16-(acetyloxy)-3-[(2,6-dideoxy-3-O-methyl-.alpha.-L-arabino-hexopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta.,16.beta.)-"	"OLEANDRIN;Foliandrin;Neriostene;Oleandrina;Neriolin;Folinerin;465-16-7;Corrigen;UNII-II95UDU7I4;Oleandrine;II95UDU7I4;Neriol;Oleandrina [Spanish];HSDB 3518;C32H48O9;EINECS 207-361-5;NSC 692219;(3beta,5beta,16beta)-16-acetoxy-3-[(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide;Anvirzel;16beta-(Acetyloxy)-3beta-((2,6-dideoxy-3-O-methyl-L-arabino-hexopyranosyl)oxy)-14-hydroxycard-20-(22)-enolide;16beta-Acetoxy-3beta-(2,6-dideoxy-3-O-methyl-L-arabino-hexopyranosyloxy)-14-hydroxycard-20(22)-enolide;Card-20(22)-enolide, 16-(acetyloxy)-3-((2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta,16beta)-;SCHEMBL25049;Oleandrin, >=98% (HPLC);CHEBI:59030;MolPort-002-530-162;(3beta,16beta)-16-(Acetyloxy)-3-((2,6-dideoxy-3-O-methyl-L-arabino-hexopyranosyl)oxy)-14-hydroxy card-20(22)-enolide;Card-20(22)-enolide, 16-(acetyloxy)-3-((2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy)-14-hydroxy-, (3-beta,5-beta,16-beta)-;ZINC8214621;AKOS032430539;CS-5505;DB12843;MCULE-8747175999;HY-13719;N2088;C19987;(3|A,5|A,16|A)-16-(Acetyloxy)-3-[(2,6-dideoxy-3-O-methyl-|A-L-arabino-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide;28933-01-9;5|A,20(22)-Cardenolide-3|A,14,16|A-triol-3-([2,6-dideoxy-3-O-methyl-|A-L-arabinohexopyranosyl]oxy) 16-acetate;53177-88-1;53812-90-1"	465-16-7	II95UDU7I4	"16763787;24919855"	16763787	01/06/2006	24919855	01/06/2014	2013-2017		1	1	0	Yes	1					30/07/2018		49,8	46	NA	1	0	NA	1	"AKT;FGF2;NFKB;P70S6K"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,15	0	ATRIOVENTRICULAR BLOC	1	0	0	0	629	0	1
Topotecan	"nogitecan;topotecan"	"9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin;Act Topotecan;Hycamtin;Mylan-topotecan Hydrochloride for Injection;PMS-topotecan;Potactasol;Topotecan;Topotecan Actavis;Topotecan Hospira;Topotecan Hydrochloride;Topotecan Hydrochloride for Injection;Topotecan Injection;Topotecan Teva;Topotecan for Injection;Topotecan hydrochloride;Topotecane;Topotecanum"	"APRD00687;DB01030"	"123948-87-8;NCI60_004771;(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE;TOPOTECAN, HYCAMTIN;(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;NChemBio.2007.10-comp24;NCIStruc1_001659;(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione;119413-54-6 (HCL);1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-;AIDS-016393;AIDS016393;Hycamptin;NSC609699 (HCL);SKF 104864;SKF-S 104864;BSPBio_002348;C11158;Topotecan;MLS000759456;(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, (S)-;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-;9-Dimethylaminomethyl-10-hydroxycamptothecin;Hycamtamine;Topotecane [INN-French];Topotecanum [INN-Latin];NSC641007;SMP2_000312;Topotecan lactone;HSCI1_000228;SMP2_000327;NCIStruc2_001796"	"topotecan;123948-87-8;Hycamtin;Topotecan lactone;Hycamptamine;Topotecane;Topotecanum;Hycamtamine;Topotecane [INN-French];Topotecanum [INN-Latin];(S)-Topotecan;Hycamptin;Nogitecan;Topotecan [INN:BAN];SKF-104864-A;SK&F-104864-A;9-Dimethylaminomethyl-10-hydroxycamptothecin;UNII-7M7YKX2N15;Topotecan (BAN);Hycamtin (TN);C23H23N3O5;CHEMBL84;NSC609699;TOPOTECAN, HYCAMTIN;potactasol;Topotecan Monohydrochloride, (S)-Isomer;nogitecan HCl;7M7YKX2N15;CHEBI:63632;SKF-S 104864;SK-S-104864-A;SKF 104864;(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione;(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE;9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin;CHEMBL1607;Topophore C;Topotecan Actavis;TopoCED;(S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione;(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione;(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, (S)-;SK&F-S-104864A;SR-01000763672;SK&F 104864 A;CCRIS 8163;HSDB 8213;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (S)-;AC1L1TQZ;AC1Q6APZ;D02PMO;SCHEMBL3836;NCIStruc1_001659;NCIStruc2_001796;BSPBio_002348;cid_60699;GTPL7101;DTXSID3042685;KS-00000PLT;EX-A834;MolPort-003-850-580;UCFGDBYHRUNTLO-QHCPKHFHSA-N;HMS2090B20;HMS3715L03;ZINC1611274;BDBM50008935;BDBM50034026;HSCI1_000228;NSC641007;AKOS015966792;API0004452;AT-2921;CCG-221171;CS-2887;DB01030;NSC-641007;SMP2_000312;SMP2_000327;NCGC00014925-02;NCGC00014925-03;NCGC00014925-04;NCGC00014925-07;NCGC00178695-01;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-;AC-11592;AJ-90579;AN-32741;CC-35105;HY-13768;KB-61805;M965;NCI60_004771;AB0015476;AX8224399;LS-127395;B4982;dimethylaminomethyl-ethyl-dihydroxy-[?]dione;FT-0654504;ST24026008;ST24031920;C11158;D08618;W-1887;AB00641837-09;AB00641837-11;AB00641837-12;AB00641837-13;AB00641837-14;AB00641837_15;AB00641837_16;948T878;C-22083;SR-01000763672-3;SR-01000763672-4;BRD-K55696337-001-03-2;BRD-K55696337-003-08-7;Topotecan hydrochloride hydrate, >=98% (HPLC and enzymatic);(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0;{2,11}.0;{4,9}.0;{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione;(20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;(4-Ethyl-4,9-dihydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-10-ylmethyl)-dimethyl-ammonium;(alphaS)-alpha,8-Dihydroxy-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone;(alphaS)-alpha-Hydroxy-8-oxylato-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminiomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone;(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3'''',4'''':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE;(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride;(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride;10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'''',4'''':6,7]indolizino[1,2-b]quinoline-3,14-dione;10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Topotecan);10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione(Topotecan);10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride;133242-28-1;138121-88-7;1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-"	123948-87-8	7M7YKX2N15	"10549508;10632325;11104627;11161849;11181676;11606103;11721172;11733970;11742479;11818201;11896112;11925142;12109520;12468321;12506183;12510778;14519630;14686734;15013589;15660189;16377584;16501591;17379446;17545533;17848737;18202794;19281729;19381891;19808951;20010424;20630830;21673063;22555194;23604531;25019569;25677219;7602366;7805183;7931489;7949242;8070027;8118810;8120551;8120553;8240998;8382970;8439950;8622064;8648378;8888741;8985046;9060549;9607572;9815806;9816150;9849451;9918204"	8439950	01/03/1993	1312588	01/04/1992	1989-1994		1	1	1	Yes	1	"02/02/2011 00:00;09/05/2003 00:00;21/12/2015 00:00;18/01/2000 00:00;17/11/2015 00:00;08/02/2011 00:00;28/02/2014 00:00;23/09/2014 00:00;11/03/2003 00:00;01/12/2010 00:00;04/02/1998 00:00;11/10/2007 00:00;18/06/2014 00:00;03/10/2013 00:00;09/03/2011 00:00;30/11/2016 00:00;08/08/2012 00:00;26/06/2013 00:00;26/02/2003 00:00;30/11/1998 00:00;30/06/2010 00:00;29/01/2016 00:00;26/02/2016 00:00;26/03/2010 00:00;03/12/2015 00:00;28/05/1996 00:00;02/06/2015 00:00;02/12/2010 00:00;07/10/2011 00:00;14/06/2006 00:00;29/11/2010 00:00;24/11/2017 00:00;16/12/2015 00:00;11/12/2015 00:00;14/11/2016 00:00;10/02/2000 00:00;20/12/2012 00:00;28/08/2012 00:00;29/08/2013 00:00;30/03/2015 00:00;05/09/2008 00:00;25/02/2011 00:00;28/09/2015 00:00;06/03/2002 00:00;23/02/2015 00:00;03/08/2001 00:00;16/02/2016 00:00;26/01/2011 00:00;06/07/2017 00:00;30/04/2013 00:00;20/09/2017 00:00"	AP	"ACCORD HLTHCARE;SUN PHARM INDS LTD;DR REDDYS LABS LTD;#N/A;TEVA PHARMS USA;CIPLA LTD;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS TOTOWA;NOVAST LABS LTD;SANDOZ INC;FRESENIUS KABI ONCOL;NOVARTIS PHARMS CORP;HONG KONG;HOSPIRA INC;SAGENT PHARMS"	TOPOTECAN HYDROCHLORIDE	28/05/1996	NOVARTIS PHARMS CORP	49,8	NA	NA	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	335	0	1
Motolimod	tlr8 agonist vtx-2337		DB12303		"Motolimod;926927-61-9;VTX-2337;Motolimod (VTX-2337);UNII-WP6PY72ZH3;VTX-378;WP6PY72ZH3;Motolimod [USAN:INN];VTX 2337;Motolimod (USAN/INN);D0H3JF;SCHEMBL254984;GTPL9026;CHEMBL3301618;KS-00000SZB;DTXSID10239107;MolPort-039-136-930;EX-A1102;s7161;ZINC34946588;AKOS025289797;DB12303;AK171372;HY-13773;KB-146010;J3.657.311B;D10716;2-Amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide;2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide;1345249-66-2;1370046-37-9"	926927-61-9	WP6PY72ZH3				24807889	01/07/2014	2013-2017		1	1	0	Yes	1					30/07/2018		48,9	33	NA	1	0	NA	1	TLR8	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,24	0	HYPOTENSION	1	0	0	0	0	0	1
Octreotide	octreotide	"Octreotidum;Octrotide;Octreotida;Octreotide Acetate Injection   - 200mcg/ml;Octreotide Acetate Injection   - 100mcg/ml;Sandostatin 200mcg/ml;Octreotide Acetate Omega 50mcg/ml;Sandostatin LAR Depot Demonstration Kit;Octreotide Injection;Sandostatin;Octreotide acetate;Octreotide Acetate Omega 200mcg/ml;Octreotide Acetate Injection   - 500mcg/ml;Octreotide Acetate;Sandostatin 100mcg/ml;Octreotide Acetate Omega 500mcg/ml;Sandostatin 50mcg/ml;Sandostatin 500mcg/ml;Octreotide Acetate Omega 100mcg/ml;Sandostatin Lar 10mg;Sandostatin Lar 20mg;Sandostatin Lar 30mg;Octreotide Acetate Injection  - 50mcg/ml;Octreotide;Sandostatin LAR Depot;Ocphyl"	"DB00104;BTD00088;BIOD00088"	"10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;10-(4-aminobutyl)-19-[(2-amino-1-oxo-3-phenylpropyl)amino]-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-(benzyl)-7-(1-hydroxyethyl)-N-(2-hydroxy-1-methylol-propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaketo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;83150-76-9;C07306;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide;Octreotide;10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2->7)-disulfide;DRG-0115;L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*,R*))-;Longastatin;Octreotida [Spanish];Octreotide [USAN:BAN:INN];Octreotidum [Latin];SMS-201-995;D00442;Octreotide (USAN/INN);NCI60_025753"	"Octreotide;Octreotide acetate;Octreotidum;Octreotida;Sandostatin;79517-01-4;83150-76-9;UNII-RWM8CCW8GP;RWM8CCW8GP;SMS 201-995;CHEMBL1680;Longastatin;Octreotide-LAR;Octreotidum [Latin];Octreotida [Spanish];SMS-201-995;Octrotide;MFCD00871400;HS-2020;AC1L9M4X;Octreotide, >=98% (HPLC);SCHEMBL10044649;DEQANNDTNATYII-OULOTJBUSA-N;MolPort-009-194-181;HMS2090C09;10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-hydroxymethyl-propyl)-amide;79517-01-4 (acetate salt);L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-;BDBM50272772;AKOS015994656;DB00104;KS-000011F3;AC-28733;LS-187135;10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate;17O014;79517-01-4b;AB01275486-01;A840511;Q-201501;H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol disulfide bond acetate salt;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-1-oxo-3-phenylpropyl]amino]-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicosa;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenyl-propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;(4R,7S,10S,13R,16S,19R)-10-(4-azanylbutyl)-19-[[(2R)-2-azanyl-3-phenyl-propanoyl]amino]-N-[(2R,3R)-1,3-bis(oxidanyl)butan-2-yl]-13-(1H-indol-3-ylmethyl)-7-[(1R)-1-oxidanylethyl]-6,9,12,15,18-pentakis(oxidanylidene)-16-(phenylmethyl)-1,2-dithia-5,8,11,14,1;(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide;10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-;2-{[(13R,16S,19R)-10-(4-Amino-butyl)-19-((S)-2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carbonyl]-amino}-3-hydroxy-butyric acid;L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*,R*))-"	83150-76-9	RWM8CCW8GP	9662244	9662244	01/07/1998	6150888	01/10/1984	Bef. 1989		1	0	1	No	0	"10/05/2006 00:00;17/05/1999 00:00;19/05/2014 00:00;14/07/2011 00:00;21/10/1996 00:00;04/10/1991 00:00;23/03/2012 00:00;13/07/1999 00:00;03/01/2002 00:00;17/07/2014 00:00;26/08/2008 00:00;10/07/2017 00:00;04/03/2008 00:00;16/02/1996 00:00;10/02/2006 00:00;18/05/2015 00:00;18/12/1995 00:00;27/06/2017 00:00;17/02/1999 00:00;03/05/1994 00:00;24/07/2002 00:00;04/02/2014 00:00;30/11/2012 00:00;10/10/1995 00:00;23/05/2013 00:00;03/03/2008 00:00;07/07/2017 00:00;02/09/2005 00:00;20/05/2016 00:00;21/11/2005 00:00;28/02/1992 00:00;30/09/1992 00:00;28/05/2002 00:00;12/11/2013 00:00;13/05/2002 00:00;06/02/1995 00:00;16/04/1990 00:00;17/01/2003 00:00;28/06/2017 00:00;21/06/2001 00:00;11/05/2011 00:00;06/12/1994 00:00;17/12/1998 00:00;02/12/2011 00:00;21/08/2014 00:00;30/09/2011 00:00;14/08/2007 00:00;25/11/1998 00:00;03/03/2009 00:00;31/07/1992 00:00;23/06/1989 00:00;12/01/1993 00:00;16/07/1996 00:00;14/08/1996 00:00;03/10/2005 00:00;31/07/1998 00:00;31/01/2013 00:00;19/04/2004 00:00;12/09/2012 00:00;12/06/1996 00:00;21/10/1988 00:00;30/01/2014 00:00;02/01/2013 00:00;02/07/2001 00:00;24/10/1997 00:00;08/04/2005 00:00;14/10/2004 00:00;10/02/2011 00:00;28/03/2005 00:00;12/07/2012 00:00;21/02/2015 00:00;07/11/1995 00:00;28/06/2012 00:00;03/07/1991 00:00;18/12/2003 00:00;12/06/1991 00:00;10/02/2003 00:00;22/07/2016 00:00;09/03/2018 00:00;25/01/2010 00:00"	AP	"TEVA PHARMS USA;FRESENIUS KABI USA;WEST-WARD PHARMS INT;WOCKHARDT USA;MYLAN INSTITUTIONAL;SUN PHARM INDS;NOVARTIS;SAGENT PHARMS"	OCTREOTIDE ACETATE	21/10/1988	NOVARTIS	48,6	#N/A																							0						1
Cetuximab	cetuximab	"Cétuximab;Cetuximab;Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer;Cetuximabum;Erbitux"	"DB00002;BTD00071;BIOD00071"			205923-56-4	PQX0D8J21J	"28012793;26945581;25279959;22701615;22210091;21629245;19701110;19169687;18520806;18317068;17289894;17065274;11432891"	11432891	01/07/2001	10673534	01/02/2000	1999-2003		1	1	1	Yes	1	"17/07/2009 00:00;24/01/2012 00:00;12/09/2008 00:00;19/01/2012 00:00;01/03/2006 00:00;05/06/2018 00:00;10/04/2015 00:00;18/06/2004 00:00;01/09/2005 00:00;11/10/2016 00:00;24/03/2011 00:00;07/11/2011 00:00;20/11/2007 00:00;11/03/2015 00:00;02/10/2007 00:00;06/07/2012 00:00;04/03/2013 00:00;04/05/2018 00:00;12/02/2004 00:00;08/07/2010 00:00"	AP	IMCLONE	CETUXIMAB	12/02/2004	IMCLONE	48,3	52	NA	0	1	"HEAD&NECK_SCC;NSCLC"	1	EGFR	0	1	0	NA	0	0	0	1	1	0,15	0	0	0	0,69	0	0	0	0	0	0	47	0	1
LCL-161	"lcl161;smac mimetic lcl161"		DB12085		"LCL161;1005342-46-0;LCL-161;LCL 161;UNII-6TNS415Y3P;6TNS415Y3P;CHEMBL2431768;(s)-n-((s)-1-cyclohexyl-2-((s)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;D0J7ZF;NVP-LCL161;C26H33FN4O3S;GTPL7912;SCHEMBL1275369;AOB4073;EX-A533;MolPort-035-789-707;2508AH;BDBM50441356;s7009;ZINC95929260;AKOS027422741;CS-1630;DB12085;BC600325;HY-15518;SC-94311;KB-135628;KB-193680;J3.566.398C;Z-3226;(S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylaminopropanamide;Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-;Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-"	1005342-46-0	6TNS415Y3P	25113756	25113756	01/08/2014	25113756	01/08/2014	2013-2017		1	1	0	Yes	1					30/07/2018		47,8	53	NA	1	0	NA	1	IAP	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	21	0	1
CPI-613	"6,8-bis(benzylthio)octanoic acid;cpi 613;cpi-613"		DB12109		"CPI-613;95809-78-2;6,8-bis(benzylthio)octanoic acid;CPI 613;MLS006010202;SCHEMBL1062218;6,8-Bis(benzylsulfanyl)octanoic acid;Octanoic acid, 6,8-bis((phenylmethyl)thio)-;Octanoic acid, 6,8-bis[(phenylMethyl)thio]-;6,8-Bis[(phenylmethyl)thio]octanoic acid;D07NVI;CPI613;CHEMBL3186849;AOB1058;QCR-193;MolPort-023-219-128;C22H28O2S2;HMS3656L06;s2776;AKOS025142095;BCP9000552;CS-0961;DB12109;RL06062;NCGC00344764-01;AK174899;AS-16613;BC261916;HY-15453;SMR004701300;BCP0726000030;AB0035874;KB-293127;Y0307;S-7818;J-518174;6,8-Bis(benzylthio)-octanoic acid, >=98% (HPLC)"	95809-78-2	E76113IR49	25165100	25165100	01/08/2014	25165100	01/08/2014	2013-2017		1	1	0	Yes	1					30/07/2018		47,8	26	NA	1	0	NA	1	MITOCHONDRIA	0	1	0	NA	0	0	1	1	1	0,19	0	0	0	0,29	0	0	0	0	0	0	0	0	1
CUDC-101	"cudc-101;hdac/egfr/her2 inhibitor"		DB12174		"CUDC-101;1012054-59-9;CUDC 101;UNII-1A7Y9MP123;7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide;CHEMBL598797;1A7Y9MP123;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide;7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide;7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;1313875-12-5;PubChem19149;D0Z4RC;CUDC-101, Free Base;SCHEMBL93769;MLS006010163;GTPL8894;AOB6495;DTXSID00143784;EX-A842;QCR-203;CUDC101, CUDC-101;MolPort-009-679-462;HMS3654C20;KS-00000T5B;ABP000148;BDBM50307768;s1194;ZINC43196377;AKOS022526176;BCP9000556;compound 8 [PMID: 20143778];DB12174;RL00075;NCGC00263177-01;AC-28428;AK174946;AS-16955;BC659998;HY-10223;SMR004701272;AB0033785;FT-0665231;X7526;W-5598;J-000340;J-519062;7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide;Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy-"	1012054-59-9	1A7Y9MP123	"25573383;25107918"	25107918	01/08/2014	25107918	01/08/2014	2013-2017		1	1	0	Yes	1					30/07/2018		47,8	25	NA	1	0	NA	1	"HDAC;EGFR;HER2"	0	1	0	NA	0	0	0	1	1	0,04	0	0	0	0,28	0	0	0	0	0	0	0	0	1
Temsirolimus	"cci-779;temsirolimus"	"42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin;Gd-temsirolimus;Torisel"	DB06287		"Temsirolimus;CCI-779;Torisel;162635-04-3;UNII-624KN6GM2T;Temsorolimus;624KN6GM2T;CHEMBL1201182;NCGC00167518-01;Cci 779;Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];WAY-CCI 779;CHEBI:79699;Temserolimus;42-[3-Hydroxy-2-methylpropanoate;NSC-683864;Temsirolimus (CCI-779, NSC 683864);Temsirolimus - Torisel;Rapamycin 42-(2,2-bis(hydroxymethyl)propionate);DSSTox_CID_20945;DSSTox_RID_79605;DSSTox_GSID_40945;SCHEMBL18792;42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin;Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate);DTXSID2040945;HSDB 7931;Temsirolimus, >=98% (HPLC);MolPort-003-850-408;C56H87NO16;Temsirolimus [USAN:INN:BAN:JAN];Tox21_112515;BDBM50343413;MFCD00934421;s1044;AKOS025142069;AM84554;RL02091;NCGC00167518-02;RT-015903;CAS-162635-04-3;T3574;AB01274736-01;AB01274736_02;635T043;SR-01000898799;J-009958;SR-01000898799-3;BRD-K08177763-001-02-6;42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin;1034922-90-1;343261-52-9"	162635-04-3	624KN6GM2T	"28000286;25962426;24373609;23382028;21690471;20921209;20430774;19415181;17020981;15292713;15136596"	15136596	01/05/2004	12796032	01/06/2003	1999-2003		1	1	1	Yes	1	"20/12/2013 00:00;07/04/2014 00:00;09/07/2010 00:00;22/05/2017 00:00;23/03/2018 00:00;26/02/2015 00:00;26/04/2010 00:00;27/07/2016 00:00;30/05/2007 00:00;30/05/2012 00:00;07/10/2014 00:00;09/11/2007 00:00;16/06/2011 00:00"	AP	PF PRISM CV	TEMSIROLIMUS	30/05/2007	PF PRISM CV	47,8	28	NA	1	0	NA	1	MTOR	0	1	1	15	0	0	0	1	1	0,2	0	0	0	NA	1	0	0	0	0	1	322	0	1
Bleomycin	bleomycin	"Bleomicina;Bleomycine;Bleomycinum;Bleocin;Bleomicin;BLM;Bleomycin A2;Bleomycin;Blenoxane Pws 15unit;Bleomycin for Injection;Bleomycin for Injection USP"	"DB00290;APRD00453;EXPT00718"		"bleomycin;Bleomicin;Bleocin;Bleomicina;Bleomycins;Bleomycine;Bleomycinum;Bleomycine [INN-French];Bleomycinum [INN-Latin];Bleomicina [INN-Spanish];bleomycin a2;Bleomycin A(2);Bleomycin B(2);CCRIS 2754;Bleomycin sulfate;HSDB 3208;NDC 0015-3010;Blenoxane;11056-06-7;NSC 125066;Bleo;Bleogin;BLM;Pingyangmyvin A2;Zhengguangmycin A2;Bleomycin [INN];Bleomycin [INN:BAN];Blenoxane (TN);AC1NSEJD;N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide;D06UVD;Bleomycin antibiotic complex;Bleomycin A2 & Bleomycin B2;C55H85N17O21S3;9041-93-4 (sulfate (salt));LMPK14000006;LS-524;DB00290;1400-95-9;Bleomycins (complex consisting of bleomycin A2 and B2);37208-04-1;37293-16-6;37353-43-8"	11056-06-7	40S1VHN69B	"27475428;12416544"	12416544	01/11/2002	5365968	01/09/1969	Bef. 1989		0	0	1	Yes	1	"30/09/1996 00:00;21/11/1997 00:00;25/04/2011 00:00;31/03/1976 00:00;21/10/1983 00:00;14/05/2001 00:00;21/06/2013 00:00;20/03/2002 00:00;10/05/2010 00:00;17/06/2013 00:00;19/10/1983 00:00;23/02/1993 00:00;30/06/2004 00:00;13/12/1982 00:00;10/10/1975 00:00;05/04/1976 00:00;05/03/1975 00:00;15/03/1976 00:00;31/07/1973 00:00;21/12/1976 00:00;12/04/2000 00:00;07/06/2005 00:00;25/08/1999 00:00;07/09/1995 00:00;28/01/2008 00:00;13/04/1983 00:00;20/02/1996 00:00;26/09/1983 00:00;09/08/1974 00:00;17/10/2001 00:00;13/12/2007 00:00;20/04/2018 00:00;30/01/1991 00:00;21/01/1994 00:00;03/07/2000 00:00;30/08/2011 00:00;21/03/2003 00:00;03/06/1996 00:00;03/10/2002 00:00;08/10/1975 00:00;30/04/1999 00:00;27/06/2000 00:00;08/11/2011 00:00;26/10/2011 00:00;20/10/1999 00:00;10/03/2000 00:00;20/08/2015 00:00;05/09/2007 00:00"	AP	"BRISTOL MYERS SQUIBB;#N/A;TEVA PHARMS USA;FRESENIUS KABI USA;TEVA PARENTERAL;WEST-WARD PHARMS INT;PHARMACHEMIE BV;HOSPIRA"	BLEOMYCIN SULFATE	31/07/1973	BRISTOL MYERS SQUIBB	46,9	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
CH-5132799	ch5132799		DB13051		"CH5132799;1007207-67-1;CH-5132799;5-(7-(methylsulfonyl)-2-morpholino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine;CH 5132799;UNII-JCL936W835;CHEMBL1684984;JEGHXKRHKHPBJD-UHFFFAOYSA-N;JCL936W835;C15H19N7O3S;(5-(7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo(2,3-d)pyrimidin-4-yl)pyrimidin-2-yl)amine;5-(7-Methanesulfonyl-2-Morpholin-4-Yl-6,7-Dihydro-5h-Pyrrolo[2,3-D]pyrimidin-4-Yl)-Pyrimidin-2-Ylamine;[5-[7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-yl]amine;D03XAQ;MLS006010989;GTPL7743;QCR-47;SCHEMBL2377154;DTXSID40678540;EX-A997;SYN1146;MolPort-023-219-217;HMS3656H15;AOB87718;2316AH;BDBM50338197;PA-799;s2699;ZINC66074200;AKOS025404886;BCP9000513;CS-0981;DB13051;NCGC00346650-01;4CA-0367;AC-28422;AS-16285;BC600308;HY-15466;KB-05650;SMR004702790;BCP0726000261;AB0094922;CH-5033855;CH-5061565;CH-5089788;CH-5108135;CH-5111436;CH-5138134;Q-4023;J-000203;CH 5132799;CH-5132799;1007207-67-1;5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine;5-[7-(Methanesulfonyl)-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine;5-[7-(Methylsulfonyl)-2-(4-morpholinyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-pyrimidinamine;5-[7-methanesulfonyl-2-(morpholin-4-yl)-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine;5-[7-methanesulfonyl-2-(morpholin-4-yl)-5H,6H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine"	1007207-67-1	JCL936W835	25231405	25231405	01/09/2014	25231405	01/09/2014	2013-2017		1	1	0	Yes	1					30/07/2018		46,8	38	NA	1	0	NA	1	PI3K	0	1	0	NA	0	0	0	1	1	0,05	0	0	0	NA	0	0	0	ENCEPHALOPATHY	1	0	0	0	1
SNX-5422	"hsp90 inhibitor snx-5422 mesylate;pf-04929113;snx-5422;snx5422"		DB06070		"908115-27-5;PF-04929113;SNX-5422;SNX 5422;UNII-BF52J69Q8T;PF 04929113;SNX5422;BF52J69Q8T;PF04929113;PF-04929113 (SNX-5422);PF-4929113;cc-40;D07MPL;MLS006011083;SCHEMBL1220790;SCHEMBL1220791;CHEMBL1195136;SCHEMBL15604989;DTXSID50238270;C25H30F3N5O4;MolPort-023-293-502;BCPP000065;HMS3656B09;ABP000737;s2656;ZINC95616595;AKOS027276395;ZINC100071931;ZINC252517142;API0008143;CS-0272;DB06070;RL05706;SNX-5422 /;NCGC00346640-01;Glycine, trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl)phenyl)amino)cyclohexyl ester;HY-10213;KB-79878;SC-85704;SMR004702871;X7589;SNX-5422(PF04929113);W-5830;PF 04929113, SNX 5422;PF-0492911 - SNX-5422;J-521414;BRD-K73197500-066-01-7;SNX-5422, PF-04929113, 908115-27-5;(1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl 2-aminoacetate;(1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate;(1r,4r)-4-({2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]phenyl}amino)cyclohexyl 2-aminoacetate;1108208-66-7;4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate;Glycine Trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1h-indazol-1-yl)phenyl)amino)cycloh exyl ester;glycine trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1h-indazol-1-yl)phenyl)amino)cyclohexyl ester;SNX-5422|||[4-[2-Carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate"		BF52J69Q8T	25262379	25262379	01/09/2014	25262379	01/09/2014	2013-2017		1	1	0	Yes	1					30/07/2018		46,8	36	NA	1	0	NA	1	HSP90	0	1	0	NA	0	0	0	1	1	0,09	0	1	1	0,19	0	0	0	0	0	0	0	0	1
Linsitinib	"linsitinib;osi-906"		DB06075		"Linsitinib;867160-71-2;OSI-906;OSI 906;Linsitinib(OSI-906);OSI906;OSI-906AA;UNII-15A52GPT8T;Kinome_3532;ASP-7487;OSI-906 (Linsitinib);3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol;15A52GPT8T;CHEMBL1091644;C26H23N5O;cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol;cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol;Linsitinib [USAN:INN];OSI906/Linsitinib/;Linsitinib; OSI-906;Linsitinib (USAN/INN);D01GFX;MLS006010304;SCHEMBL400369;SCHEMBL400734;SCHEMBL400735;GTPL7423;CHEMBL1996234;SCHEMBL10255925;CHEBI:91402;EX-A719;QCR-128;MolPort-027-720-847;BCPP000137;BDBM185150;HMS3654C19;AOB87170;KS-00000T7A;ABP000779;BDBM50315887;MMV676605;s1091;ZINC53239527;AKOS024464740;ZINC100071817;ZINC113742575;BCP9001035;CS-0242;PB22643;RL05373;NCGC00250375-02;AC-26953;AS-16999;BC638839;HY-10191;KB-78160;SC-95136;SMR004700744;FT-0670821;X7473;D09925;W-5542;J-520074;BRD-K07667918-001-01-3;OSI-906, 867160-71-2;(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol;3-(8-amino-1-(2-phenylquinolin-7-yl)-2,3-dihydroimidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol;3-[8-AMINO-1-(2-PHENYL-QUINOLIN-7-YL)-IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYL-CYCLOBUTANOL;CIS-3-[8-AMINO-1-(2-PHENYL-7-QUINOLINYL)IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYL-CYCLOBUTANOL"	867160-71-2	15A52GPT8T	"25212606;25208878"	25212606	01/09/2014	25212606	01/09/2014	2013-2017		1	1	0	Yes	1					30/07/2018		46,8	95	NA	1	1	COLORECTAL	1	IGF1R	0	1	1	NA	0	0	0	1	1	0,01	0	1	1	0,36	0	QT	1	0	0	0	0	0	1
Lenvatinib	"14c-lenvatinib;lenvatinib"	"4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide;Lenvatinib Mesylate;Lenvima"	DB09078		"Lenvatinib;417716-92-8;E7080;Lenvima;E7080 (Lenvatinib);4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E 7080;UNII-EE083865G2;Lenvatinib (E7080);4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide;ER-203492-00;E-7080;CHEMBL1289601;CHEBI:85994;EE083865G2;Lenvatinib mesilate;4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide;4-{3-Chloro-4-[(Cyclopropylcarbamoyl)amino]phenoxy}-7-Methoxyquinoline-6-Carboxamide;Lenvatinib [USAN:INN];Kisplyx;4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide;LEV;LenvatinibE7080);Lenvatinib; E7080;Lenvatinib (USAN/INN);D0R0FO;MLS006011239;SCHEMBL864638;GTPL7426;CTK1D4875;DTXSID50194605;EX-A249;QCR-115;SYN1038;MolPort-009-679-469;WOSKHXYHFSIKNG-UHFFFAOYSA-N;BCPP000247;HMS3244A07;HMS3244A08;HMS3244B07;HMS3654A14;AOB87766;BCP01799;ZINC3816292;ABP000863;BDBM50331094;RS0099;s1164;4-(3-chloro-4-(N'-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide;AKOS025401742;AN-6642;BCP9000633;CS-0109;DB09078;NCGC00263198-01;4CA-0485;AC-25047;AK175809;AS-16203;BC252209;HY-10981;KB-78118;SC-87813;SMR004702999;DB-070219;FT-0700727;KS-00000638;D09919;E7080/E-7080;E-7080, E7080;E7080, E 7080;716C928;A825653;A1-04306;J-513372;BRD-K39974922-001-02-7;4-[3-chloranyl-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide;4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;4-[3-chloro-4-[[(cyclopropylamino)-oxomethyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide;6-Quinolinecarboxamide, 4-(3-chloro-4-     (((cyclopropylamino)carbonyl)amino)phenoxy)-7-methoxy-;942407-57-0"	417716-92-8	EE083865G2	"26500236;26169970;25377392"	25377392	01/11/2014	21372218	01/04/2011	2009-2012		1	1	1	Yes	1	"22/04/2016 00:00;16/10/2015 00:00;13/05/2016 00:00;13/02/2015 00:00;31/07/2017 00:00;06/06/2018 00:00"	AP	EISAI INC	LENVATINIB MESYLATE	13/02/2015	EISAI INC	46,4	27	NA	1	0	NA	0	NA	0	1	0	NA	0	0	1	1	1	0	0	0	0	NA	0	0	0	0	0	0	242	0	1
Aldoxorubicin	aldoxorubicin		DB06013		"INNO-206;1361644-26-9;ALDOXORUBICIN;UNII-C28MV4IM0B;C28MV4IM0B;Doxorubicin-EMCH;151038-96-9;Aldoxorubicin (USAN);CHEMBL2107818;SCHEMBL15221892;OBMJQRLIQQTJLR-LBMCFUDOSA-N;Aldoxorubicin;INNO 206;INNO206;AKOS030526452;ZINC163337436;CS-1186;HY-16261;D10383;W-5595;(8S)-1-Methoxy-6,8alpha,11-trihydroxy-8-[1-[2-[6-(2,5-dioxo-3-pyrroline-1-yl)hexanoyl]hydrazono]-2-hydroxyethyl]-10alpha-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-7,8,9,10-tetrahydronaphthacene-5,12-dione"	1361644-26-9	C28MV4IM0B	"25388939;25312684"	25312684	01/10/2014	25312684	01/10/2014	2013-2017		1	1	0	Yes	1					30/07/2018		45,8	25	NA	1	1	SOFT TISSUE SARCOMA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	1	1	0,38	0	0	0	0,84	0	TROPONINE ELEVATION	1	0	0	0	244	0	1
Demcizumab	"demcizumab;omp-21m18"		DB12734			1243262-17-0	SF168W7FW0	25324140	25324140	01/10/2014	25324140	01/10/2014	2013-2017		1	1	0	Yes	1					30/07/2018		45,8	55	NA	1	0	NA	1	DLL4	0	1	1	25	0	0	0	1	0	NA	0	0	0	0,64	0	"HTA;HEARTH FAILURE"	1	0	0	0	26	0	1
SVV-001	"ntx-010;seneca valley virus;seneca valley virus-001;svv-001"		DB06129					25307519	25307519	01/10/2014	25307519	01/10/2014	2013-2017		1	1	0	Yes	1					30/07/2018		45,8	22	NA	0	1	"CHILD_NEUROBLASTOMA;CHILD_RHABDOMYOSARCOMA"	1	VIRUS	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1
PTC299	ptc299		DB05173		"skf-86002;72873-74-6;Skf 86002;SK&F 86002;PTC299;SK&F 86002-A(2);6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole;UNII-9R6QDF1UO7;9R6QDF1UO7;CHEMBL313417;5-(4-Pyridyl)-6-(4-fluorophenyl)-2,3-dihydroimidazo(2,1-b)-thiazole;4-[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]pyridine;6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridyl)imidazo[2,1-b]thiazole;6-(4-fluorophenyl)-5-(4-pyridyl)-2,3-dihydroimidazo[2,1-b]thiazole;6-(4-Fluorophenyl)-5-(4-pyridyl)-2,3-dihydroimidazo[2,1-b]-thiazole;6-(4-fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydroimidazo[2,1-b]thiazole;6-(4-fluorophenyl)-5-pyridin-4-yl-2,3-dihydroimidazo[2,1-b][1,3]thiazole;Imidazo(2,1-b)thiazole, 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)-;Imidazo[2,1-b]thiazole,6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)-;SKF-86002-A2;6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo[2,1-b]thiazole;Imidazo[2,1-b]thiazole, 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)-;SKF86002;AC1L1JVR;D05VVX;D0H7MW;AC1Q4ON8;SCHEMBL146947;GTPL6040;SCHEMBL9436165;BDBM14832;CHEBI:93705;CTK5D6971;DTXSID70223168;MolPort-003-959-475;YOELZIQOLWZLQC-UHFFFAOYSA-N;HMS3229O12;EX-A1033;GI98581X;KS-00001CZ0;ZINC1842518;HSCI1_000251;MFCD00869367;AKOS016004898;CCG-206882;CS-3880;SK&F-86002;NCGC00092295-02;AJ-31796;BC600724;HY-12511;KB-44262;SK-86002;DB-074637;LS-186851;LS-187511;FT-0700355;SKF-86002, >=98% (HPLC), solid;AB01092382-01;BRD-K96809896-001-01-9;6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)-Imidazo[2,1-b]thiazole;3-(4-fluorophenyl)-2-pyridin-4-yl-6-thia-1,4-diazabicyclo[3.3.0]octa-2,4-diene"			25407389	25407389	01/11/2014	25407389	01/11/2014	2013-2017		1	1	0	Yes	1					30/07/2018		44,8	27	21	0	1	CHILD_GLIOMA	1	VEGFR	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,18	0	0	0	0	0	0	492	0	1
Epofolate	"bms-753493;epothilone folate"	BMS-753493	DB12266		"Epofolate;UNII-Q3XAW4B1DP;Q3XAW4B1DP;958646-17-8;BMS753493;BMS 753493;DTXSID20241993;TURJYGRXEJIBGT-OCOMGVANSA-N"	958646-17-8	Q3XAW4B1DP	25380635	25380635	01/11/2014	25380635	01/11/2014	2013-2017		1	1	0	Yes	1					30/07/2018		44,8	65	NA	1	0	NA	1	FOLATE RECEPTOR	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	1	30	0	1
ME-344	me-344		DB13062		"ME-344;UNII-843G0TDV51;843G0TDV51;D03IXK;4,4'-(7-Hydroxy-8-methylchroman-3,4-diyl)diphenol;GTPL7961;SCHEMBL10073998;MTOR inhibitor (cancer), Novogen;NV-128;NV-344;DB13062;2H-1-Benzopyran-7-ol, 3,4-dihydro-3,4-bis(4-hydroxyphenyl)-8-methyl-, (3R,4S)-;1374524-68-1;MTOR inhibitors (cancer), Marshall Edwards;(3R,4S)-3,4-bis(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol"	1374524-68-1	843G0TDV51	25411085	25411085	01/11/2014	25411085	01/11/2014	2013-2017		1	1	0	Yes	1					30/07/2018		44,8	30	NA	1	0	NA	1	MITOCHONDRIA	0	1	0	NA	0	0	0	1	1	0,03	0	0	0	0,17	0	MYOCARDIAL INFARCTION	1	0	0	0	0	0	1
Glasdegib	"glasdegib;pf-04449913"		DB11978		"Glasdegib;1095173-27-5;PF-04449913;PF 04449913;UNII-K673DMO5H9;1-((2R,4R)-2-(1H-benzo[d]iMidazol-2-yl)-1-Methylpiperidin-4-yl)-3-(4-cyanophenyl)urea;K673DMO5H9;CHEMBL2043437;Glasdegib (PF-04449913);1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea;Glasdegib [USAN:INN];Glasdegib (USAN/INN);D0S5LO;PF-04449913;Glasdegib;GTPL8201;SCHEMBL2068480;Glasdegib(PF-04449913);EX-A858;MolPort-035-789-706;SFNSLLSYNZWZQG-VQIMIIECSA-N;2640AH;BDBM50385635;PF-913;ZINC68251434;AKOS027324121;CS-2731;DB11978;BC600416;DA-47902;HY-16391;KB-79860;QC-11459;PF-4449913;D10636;Z-3230;J-690029;Urea, N-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)-;1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea(PF-04449913);4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)-benzonitrile"	1095173-27-5	K673DMO5H9	"28556364;25388167"	25388167	01/11/2014	25388167	01/11/2014	2013-2017		1	1	0	Yes	1					30/07/2018		44,8	23	NA	1	0	NA	1	SHH	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,35	0	0	0	0	0	0	0	0	1
Galunisertib	"galunisertib;ly-2157299;ly2157299"		DB11911		"700874-72-2;Galunisertib;LY2157299;LY 2157299;LY-2157299;UNII-3OKH1W5LZE;4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide;3OKH1W5LZE;Galunisertib (LY2157299);4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide;4-[2-(6-methylpyridin-2-yl)-4H,5H,6H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide;4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide;6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-;Galunisertib [USAN:INN];galunisertibum;6-Quinolinecarboxamide, 4-(5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-;Galunisertib (USAN);PubChem22590;D06TFI;ly2157299(galunisertib);GTPL7797;CHEMBL2364611;SCHEMBL12922153;CTK2G3146;DTXSID00220362;EX-A009;QCR-234;CHEBI:137064;MolPort-020-000-498;HMS3655D14;AOB87326;EBD30286;ZINC3959536;BDBM50015640;IN2276;s2230;AKOS022175280;CS-0474;DB11911;EX-8675;RL04686;LYL-2157299;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(1,2-b)pyrazol-3-yl)quinoline-6-carboxylic acid amide;AJ-47534;AK-79916;AS-42940;BC638676;CJ-11234;HY-13226;KB-78239;SC-85597;AB0033807;AX8280550;FT-0741808;X7574;D10437;W-5548;A836766;J-514250;LY-2157299,LY 2157299, 700874-72-2;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide, AldrichCPR;4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide;4-[2-(6-Methyl-2-Pyridinyl)-5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazol-3-Yl]-6-Quinolinecarboxamideorly215;4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl]quinoline-6-carboxamide;912477-03-3"	700874-72-2	3OKH1W5LZE	25424852	25424852	01/11/2014	25424852	01/11/2014	2013-2017		1	1	0	Yes	1					30/07/2018		44,8	65	NA	1	1	GLIOMA	1	TGFB	0	1	1	26	0	0	0	1	0	0,13	0	1	1	0,21	0	0	0	0	0	0	0	0	1
Niraparib	"mk-4827;mk4827;niraparib"	Zejula	DB11793		"Niraparib;1038915-60-4;MK-4827;(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide;ZEJULA;UNII-HMC2H89N35;HMC2H89N35;CHEMBL1094636;Niraparib HCl;MK4827;MK 4827;Niraparib hydrochloride;2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide;Niraparib [USAN:INN];2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;2-{4-[(3S)-piperidin-3-yl]phenyl}indazole-7-carboxamide;MK 4827 (Base);Niraparib (USAN);Zejula (TN);MK-4827(Niraparib);D00BMF;GTPL8275;SCHEMBL1421875;CTK8B9123;DTXSID50146129;EX-A290;MolPort-023-219-142;0919AA;ANW-62065;BDBM50316226;s2741;ZINC43206370;AKOS016004869;BCP9000940;compound 56 [PMID 19873981];CS-0780;DB11793;MK-4827/MK4827;NCGC00346435-01;AC-28447;AS-35248;HY-10619;KB-03718;BCP0726000077;AJ-108285;AX8234046;DB-059068;TC-150810;A3617;FT-0770704;D10140;W-5696;2-[4-[(3S)-3-Piperidyl]phenyl]indazole-7-carboxamide;1038915-60-4 pound notMK4827 pound not MK 4827;2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]-;MK-4827,(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide"	1038915-60-4	HMC2H89N35	23810788	23810788	01/07/2013	23810788	01/07/2013	2013-2017		1	1	1	Yes	1	27/03/2017 00:00	AP	TESARO INC	NIRAPARIB TOSYLATE	27/03/2017	TESARO INC	44,8	100	NA	0	1	"BRCA_MUTANT;OVARIAN;PROSTATE"	1	PARP	0	1	1	15	1	0	0	1	1	0,4	0	0	0	NA	0	0	0	0	0	0	21	0	1
Sirolimus	"nab-rapamycin;rapamycin;sirolimus"	"(-)-Rapamycin;Gd-sirolimus;Rapamune;Rapamune Oral Solution;Rapamycin;Sirolimus;sirolimus;sirolimusum;sirolimús"	"APRD00178;DB00877;DB02439"		"Rapamycin;Sirolimus;53123-88-9;Rapamune;(-)-Rapamycin;AY-22989;Rapammune;sirolimusum;Supralimus;RAPA;Rapamycin (Sirolimus);Antibiotic AY 22989;AY 22989;rapalimus;UNII-W36ZG6FT64;CCRIS 9024;CHEBI:9168;W36ZG6FT64;HSDB 7284;C51H79NO13;NSC 226080;DE-109;WY-090217;NCGC00021305-05;DSSTox_CID_3582;DSSTox_RID_77091;DSSTox_GSID_23582;Perceiva;Cypher;SILA 9268A;LCP-Siro;Wy 090217;AY22989;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;Sirolimus (RAPAMUNE);CAS-53123-88-9;Rapamycin C-7, analog 4;Sirolimus [USAN:BAN:INN];MS-R001;NSC226080;1fkb;1pbk;NCGC00181146-01;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone;RAP;S1039;PubChem16645;BiomolKI2_000084;SCHEMBL3463;Rapamycin,Sirolimus,Rapamune;BIDD:PXR0165;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine;Sirolimus [USAN:INN:BAN];DTXSID5023582;BDBM36609;SYN1185;MolPort-003-959-433;HMS2089A21;HMS3403F11;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;EX-A1044;Tox21_110870;Tox21_112750;AC-722;BDBM50064359;MFCD00867594;AKOS015850976;AKOS015961618;CCG-100684;CS-0063;DB00877;RL03960;NCGC00021305-06;NCGC00021305-07;AS-11687;BC207597;HY-10219;LS-143290;UNM-0000358684;A-275;FT-0082351;R0097;Rapamycin, VETRANAL(TM), analytical standard;EC 610-965-5;S-7759;123R889;Q-201659;BRD-K84937637-001-04-0;BRD-K84937637-001-06-5;BRD-K89626439-001-01-0;Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder;Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%;Sirolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro;1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin);1179372-35-0;1189166-54-8;1233221-34-5;1353039-01-6"	53123-88-9	W36ZG6FT64	"18173550;18202410;18215105;18332469;18332470;18757332;20972652;23635552;24089446;26253949;26787751;27286790;28000286"	18215105	01/01/2008	8770969	01/01/1996	1994-1998		1	0	1	No	0	"03/07/2014 00:00;20/12/2013 00:00;07/04/2014 00:00;08/11/2010 00:00;30/01/2007 00:00;26/02/2015 00:00;30/05/2007 00:00;30/05/2012 00:00;31/01/2003 00:00;31/07/2015 00:00;17/03/2000 00:00;07/05/2002 00:00;19/03/2003 00:00;30/06/2005 00:00;08/10/2009 00:00;08/01/2014 00:00;10/12/2012 00:00;02/06/2006 00:00;23/02/2004 00:00;06/03/2015 00:00;06/09/2001 00:00;10/03/2006 00:00;11/04/2003 00:00;12/01/2007 00:00;25/01/2010 00:00;16/06/2011 00:00;27/07/2016 00:00;23/03/2018 00:00;23/05/2018 00:00;25/08/2000 00:00;07/03/2013 00:00;12/01/2018 00:00;02/05/2007 00:00;07/10/2005 00:00;19/10/2006 00:00;15/09/1999 00:00;29/01/2009 00:00;23/01/2003 00:00;05/06/2002 00:00;18/02/2016 00:00;14/01/2008 00:00;06/11/2013 00:00;06/06/2011 00:00;11/07/2011 00:00;30/05/2013 00:00;11/03/2005 00:00;23/11/2010 00:00;05/11/2015 00:00;29/01/2014 00:00;07/10/2014 00:00;22/04/2010 00:00;09/11/2007 00:00;28/05/2015 00:00;14/01/2016 00:00;27/10/2014 00:00;02/10/2003 00:00;09/01/2007 00:00;02/07/2010 00:00;09/07/2010 00:00;22/05/2017 00:00;11/04/2017 00:00;22/08/2002 00:00;30/03/2015 00:00;26/04/2010 00:00;20/07/2004 00:00;05/03/2008 00:00;03/05/2000 00:00;24/09/2009 00:00;17/10/2007 00:00"	AP	"PF PRISM CV;DR REDDYS LABS LTD;ZYDUS PHARMS USA INC"	"SIROLIMUS;TEMSIROLIMUS"	15/09/1999	PF PRISM CV	44,4	#N/A																							0						1
Orteronel	"orteronel;tak-700"		DB12066		"Orteronel;566939-85-3;TAK 700;TAK-700;UNII-UE5K2FNS92;UE5K2FNS92;TAK700;CHEMBL1921976;TAK-700 (Orteronel);TAK-700 (S-form);Orteronel [USAN:INN];Orteronel (JAN/USAN);TAK-700 - Orteronel;TAK700 (S-Enantiomer);SCHEMBL6126076;566939-85-3,Orteronel;AOB5527;EX-A159;MolPort-028-720-386;csa:566939-85-3;Orteronel;ZINC3943521;Orteronel,CAS:566939-85-3;BDBM50358201;AKOS030526849;CS-0580;DB12066;RL04142;6-((7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthalenecarboxamide;AJ-47464;HY-10505;KB-79710;AB0165761;FT-0773259;D10146;S-7761;J-523835;6-[(7s)-7-hydroxy-6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide;6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide;6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide"	566939-85-3	UE5K2FNS92	25537627	25537627	01/12/2014	25537627	01/12/2014	2013-2017		1	1	0	Yes	1					30/07/2018		43,8	15	NA	0	1	PROSTATE	1	17,20-LYASE	0	1	0	NA	0	0	0	1	0	0,87	0	0	0	NA	0	0	0	0	0	0	0	0	1
BMS-908662	"bms-908662;xl281"		DB12854		"BMS-908662;BMS-908662 free base;870603-16-0;D0Z2FD;GTPL7968;CHEMBL3545027;SCHEMBL10049428;EXEL-2819;XL281;BMS908662;Carbamic acid, (5-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydro;XL-281;BMS 908662;DB12854;(+/-)-Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate;Carbamic acid, N-(6-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)-, methyl ester;Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate;Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate, (+/-)-;methyl N-[6-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamate"	870603-16-0	DW2NWI3TFN	25476894	25476894	01/12/2014	25476894	01/12/2014	2013-2017		1	1	0	Yes	1					30/07/2018		43,8	160	NA	1	0	NA	1	RAF	0	1	1	NA	0	0	0	1	1	0,02	0	0	0	0,07	0	0	0	0	0	0	0	0	1
MK-8776	mk-8776		DB11899		"891494-63-6;SCH900776;SCH 900776;SCH-900776;UNII-K2ZSF0992C;(R)-6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine;K2ZSF0992C;CHEMBL2386889;MK-8776 (SCH 900776);MK-8776 (SCH-900776);MK-8776;C15H18BrN7;6-bromo-3-(1-methyl-1h-pyrazol-4-yl)-5-(3r)-3-piperidinylpyrazolo(1,5-a)pyrimidin-7-amine;(R)-6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo(1,5-a)pyrimidin-7-amine;6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine;SCHEMBL2408669;AOB2809;DTXSID00237551;EX-A141;SYN1173;GMIZZEXBPRLVIV-SECBINFHSA-N;MolPort-027-720-922;ABP000983;BDBM50434372;s2735;ZINC60328032;AKOS024464752;CS-1117;DB11899;RL05596;6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-((3R)-piperidin-3-yl)pyrazolo(1,5-a)pyrimidin-7-amine;AS-16307;BC600358;HY-15532;Pyrazolo(1,5-a)pyrimidin-7-amine, 6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinyl-;SC-96733;KB-293295;KB-333882;FT-0700501;Y0217;W-5840;J-518349;(r)-(-)-6-bromo-3-(1-methyl-1h-pyrazol-4-yl)-5-piperidin-3-yl-pyrazolo[1,5-a]pyrimidin-7-ylamine;6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-[(3R)-3-piperidinyl]pyrazolo[1,5-a]pyrimidin-7-amine;Sch-900776|||6-Bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine"	891494-63-6	K2ZSF0992C	25605849	25605849	01/01/2015	25605849	01/01/2015	2013-2017		1	1	0	Yes	1					30/07/2018		42,8	43	NA	1	0	NA	1	CHK1	0	1	0	NA	0	0	0	1	NA	0,07	0	0	0	0,5	0	QT	1	0	0	0	0	0	1
JNJ-40346527	jnj-40346527		DB12504		"JNJ-40346527;UNII-3NU609VYNF;3NU609VYNF;BNVPFDRNGHMRJS-UHFFFAOYSA-N;1142363-52-7;JNJ40346527;US8497376, 15;Edicotinib;edicotinib (proposed INN);GTPL8942;SCHEMBL4238665;CHEMBL3674570;BDBM98634;BCP25086;AKOS030527728;DB12504;1H-Imidazole-2-carboxamide, 5-cyano-N-(2-(4,4-dimethyl-1-cyclohexen-1-yl)-6-(tetrahydro-2,2,6,6-tetramethyl-2H-pyran-4-yl)-3-pyridinyl)-;4-Cyano-1H-imidazole-2-carboxylic acid N-(2-(4,4-dimethylcyclohex-1-enyl)-6-(2,2,6,6-tetramethyltetrahydropyran-4-yl)pyridin-3-yl)amide;4-cyano-1h-imidazole-2-carboxylic acid[2-(4,4-dimethyl-cyclohex-1-enyl)-6-(2,2,6,6-tetramethyl-tetrahydro-pyran-4-yl)-pyridin-3-yl]-amide;4-Cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyl-tetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide;4-cyano-N-[2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide"	1142363-52-7	3NU609VYNF	25628399	25628399	01/01/2015	25628399	01/01/2015	2013-2017		1	1	0	Yes	1					30/07/2018		42,8	21	75	0	1	HL	1	CSF-1R	0	1	0	NA	0	0	0	1	0	0,05	0	1	1	0,57	0	0	0	0	0	0	0	0	1
GPX-150	"5-imino-13-deoxydoxorubicin;anthracycline analogue;gpx-150"		DB13103		"5-Iminodoxorubicin;UNII-7W3RB6E22W;7W3RB6E22W;GPX-150;84275-95-6;DB13103;5(8H)-Naphthacenone, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,9,10,12-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-12-imino-1-methoxy-, (8S,10S)-"	236095-29-7	7W3RB6E22W	25698442	25698442	01/02/2015	25698442	01/02/2015	2013-2017		1	1	0	Yes	1					30/07/2018		41,8	20	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	0	0,2	0	0	0	NA	0	0	0	0	0	0	244	0	1
Docetaxel	"ati-1123;docetaxel;nsc 628503;protein stabilized liposomal docetaxel nanoparticles;rp 56976;taxotere"	"Docefrez;Docetaxel;Docetaxel Accord;Docetaxel Injection;Docetaxel Injection USP;Docetaxel Kabi;Docetaxel Mylan;Docetaxel Non-Alcohol Formula;Docetaxel Teva Pharma;Docetaxel Winthrop;Docetaxel anhydrous;N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel;N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol;PMS-docetaxel;TXL;Taro-docetaxel;Taxespira;Taxotere"	"APRD00932;DB01248"	"114977-28-5;TXL;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate;nchembio853-comp8;C11231;Docetaxel;Docetaxel anhydrous;01885_FLUKA;ANX-514;NSC-628503;RP-56976;SDP-014;XRP-6976L;nchembio.2007.34-comp7"	"docetaxel;Taxotere;114977-28-5;Docetaxel anhydrous;Docetaxol;RP-56976;EmDOC;RP 56976;Docetaxel, Trihydrate;Taxotere(R);Docetaxel [INN];Taxotere (TN);NSC 628503;UNII-699121PHCA;N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol;TXL;N-debenzoyl-N-Boc-10-deacetyl taxol;docetere;taxotel;N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol;CHEBI:4672;docetaxel 114977-28-5;XRP-6976L;ANX-514;SDP-014;699121PHCA;Docetaxel (INN);NSC628503;NSC-628503;N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel;XRP6976;Docetaxolum [INN-Latin];DSSTox_CID_20464;DSSTox_RID_79497;DSSTox_GSID_40464;HSDB 6965;Docetaxolum;Taxoel;Docetaxel Winthrop;(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate;4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate;CAS-114977-28-5;Docecad;Docefrez;Taxotere&reg;;SID 530;Docetaxel (TN);NCGC00181306-01;NCGC00181306-02;5?,20-Epoxy-1,7?,10?-trihydroxy-9-oxotax-11-ene-2?,4,13?-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate];Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester;Taxotere (Aventis);CID148124;Docetaxel - Taxotere;bind-014;Docetaxel (JAN/INN);AC1L3WHJ;CHEMBL92;D0O5WP;SCHEMBL4419;GTPL6809;DTXSID0040464;BDBM36351;SYP-0704A;ZDZOTLJHXYCWBA-VCVYQWHSSA-;MolPort-003-847-005;ZDZOTLJHXYCWBA-VCVYQWHSSA-N;114977-28-5, Docetaxel;HMS2089K08;Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-;EX-A1206;HY-B0011;InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5;Tox21_112781;Tox21_113088;AC-383;CD-195;CD0182;MFCD00800737;ZINC85537053;AKOS015960718;AKOS024457953;Tox21_112781_1;CS-1144;DB01248;KS-1452;MCULE-1930158681;RL00579;Docetaxel, purum, >=97.0% (HPLC);NCGC00181306-04;NCGC00242509-01;AK-72918;BC204088;SC-16998;AB0072965;D4102;C11231;D07866;W-1428;AB01273941-01;AB01273941-02;SR-01000003023;W-60384;Q-100074;SR-01000003023-5;BRD-K30577245-001-04-3;BRD-K30577245-341-01-9;Z1551429742;N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol; Taxotere;Anhydrous Docetaxel, European Pharmacopoeia (EP) Reference Standard;(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0;{3,10}.0;{4,7}]heptadec-13-en-2-yl benzoate;(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10;[2aR-[2a?,4?,4a?,6?,9?(?R*,?S*),11?,12?,12a?,12b?]]-?-[[(1,1-Dimethylethoxy)carbonyl]amino]-?-hydroxy-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid;[acetoxy-[(2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenyl-propanoyl]oxy-trihydroxy-tetramethyl-oxo-[?]yl] benzoate;129522-72-1;216252-50-5;Benzenepropanoic acid,1-dimethylethoxy)carbonyl]amino]-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (.alpha.R,.beta.S)"	114977-28-5	699121PHCA	"10697653;10778964;11138462;11205207;11685732;12172503;12399134;12602908;12736567;12901280;12913084;1359154;14676112;15108042;15143084;15277270;15289734;15297406;15845564;16005105;16020963;16414235;16809732;17403629;17409841;17909805;17940076;18000498;18493840;19020876;19251309;19414670;19884858;19913890;20043166;20926400;21075438;21493186;22199335;22771826;23016517;23274395;23394629;24071537;24176164;24787968;25020206;25204404;25304209;25698064;27777441;8094996;8098059;9193350;9440738;9626217;9704674;9865688;9989521"	1359154	01/12/1992	1359154	01/12/1992	1989-1994		1	1	1	Yes	1	"21/11/2012 00:00;27/09/2017 00:00;21/10/2016 00:00;21/06/2013 00:00;05/11/2014 00:00;11/01/2012 00:00;09/08/2017 00:00;26/06/2013 00:00;07/06/2006 00:00;21/11/2017 00:00;12/04/2013 00:00;22/12/2015 00:00;15/05/2014 00:00;29/06/2011 00:00;20/04/2010 00:00;04/01/2018 00:00;18/08/2004 00:00;15/08/2013 00:00;04/11/2014 00:00;28/09/2007 00:00;08/03/2011 00:00;03/02/2015 00:00;23/01/2014 00:00;28/09/2000 00:00;15/05/1998 00:00;18/05/1999 00:00;31/08/2017 00:00;27/11/2002 00:00;03/07/2014 00:00;30/07/2002 00:00;19/05/2004 00:00;30/01/2003 00:00;31/03/1999 00:00;13/07/2012 00:00;05/11/2005 00:00;08/06/2011 00:00;13/03/2014 00:00;16/09/2015 00:00;06/01/1998 00:00;06/07/2018 00:00;03/04/2015 00:00;06/11/2013 00:00;18/08/2014 00:00;17/09/2014 00:00;09/07/2002 00:00;11/04/2018 00:00;14/05/1996 00:00;10/07/2014 00:00;24/04/2003 00:00;15/03/2012 00:00;02/12/2014 00:00;07/09/2011 00:00;25/07/2016 00:00;17/10/2006 00:00;24/06/2016 00:00;27/05/2016 00:00;05/04/2013 00:00;22/06/1998 00:00;13/04/2012 00:00;23/12/1999 00:00;14/11/2014 00:00;06/12/1999 00:00;02/08/2010 00:00;25/01/2017 00:00;30/10/2014 00:00;13/05/2010 00:00;22/11/1999 00:00;11/12/2015 00:00;22/03/2006 00:00;23/02/1999 00:00;28/04/1997 00:00;15/12/2011 00:00;26/07/2016 00:00;05/05/2015 00:00;17/05/2016 00:00;19/01/2018 00:00;21/10/2015 00:00;21/09/2015 00:00;03/06/2010 00:00;30/11/2000 00:00;15/02/2017 00:00;30/04/2018 00:00;04/11/2013 00:00;23/04/2014 00:00;07/04/2015 00:00;11/08/2005 00:00;02/07/2018 00:00;06/01/2005 00:00;13/12/2013 00:00;03/05/2011 00:00;20/01/2017 00:00"	AP	"ACCORD HLTHCARE;APOTEX INC;SUN PHARMA GLOBAL;SANDOZ;ACTAVIS LLC;#N/A;TEVA PHARMS USA;PFIZER LABS;SANOFI AVENTIS US;DFB ONCOLOGY LTD;EAGLE PHARMS;DR REDDYS LABS LTD;HOSPIRA INC;JIANGSU HENGRUI MED"	DOCETAXEL	14/05/1996	SANOFI AVENTIS US	41,3	39	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,18	0	0	0	NA	0	0	0	0	0	0	662	1	1
RO-4987655	"ch4987655;ro4987655"		DB12933		"RO4987655;874101-00-5;CH-4987655;RO-4987655;UNII-I3733P75ML;CH4987655;CHEMBL1614766;FIMYFEGKMOCQKT-UHFFFAOYSA-N;I3733P75ML;3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide;C20H19F3IN3O5;3,4-Difluoro-2-(2-fluoro-4-iodo-anilino)-N-(2-hydroxyethoxy)-5-[(3-oxooxazinan-2-yl)methyl]benzamide;3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-((3-oxomorpholino)methyl)benzamide;3orn;D09GHB;GTPL9910;SCHEMBL1562083;SYN1188;MolPort-029-944-725;4014AH;BDBM50338038;ZINC43103796;MEK inhibitors (solid tumor), Roche;AKOS005266648;CS-2715;DB12933;compound 24 [PMID: 21316218];3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-5-[(3-oxo-2-oxazinanyl)methyl]benzamide;AS-16322;HY-14719;KB-80403;B3261;RO-04927350;US8575391, 334;3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5-(3-oxo-[1,2]oxazinan-2-ylmethyl)-benzamide;3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-5-[(3-oxooxazinan-2-yl)methyl]benzamide;3OR;Benzamide, 3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-5-[(tetrahydro-3-oxo-2H-1,2-oxazin-2-yl)methyl]-"	874101-00-5	I3733P75ML	25809858	25809858	01/03/2015	25809858	01/03/2015	2013-2017		1	1	0	Yes	1					30/07/2018		40,9	25	NA	1	0	NA	1	MEK	0	1	1	8	0	0	0	1	1	0,04	0	0	0	0,32	0	0	0	0	0	0	0	0	1
JNJ-38877605	jnj-38877605		DB13113		"JNJ-38877605;943540-75-8;JNJ38877605;UNII-15UDG410PN;6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline;JNJ 38877605;15UDG410PN;JRWCBEOAFGHNNU-UHFFFAOYSA-N;C19H13F2N7;6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]-triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline;6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline;6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline;Quinoline, 6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)methyl)-;Quinoline, 6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-;PubChem22454;cc-51;D0YT8P;MLS006010960;SCHEMBL182199;J&J Ex-61;CHEMBL2133806;CHEBI:91417;DTXSID20677253;QCR-226;SYN1047;MolPort-009-679-418;BDBM163243;HMS3244G09;HMS3244G10;HMS3244H09;HMS3654M04;AOB87321;KS-00001DU4;ABP000134;RS0066;s1114;ZINC43170515;AKOS015896605;BCP9000804;DB13113;NCGC00263189-01;AC-27418;AN-16830;AS-16207;BC659966;HY-50683;KB-78000;SC-48063;SMR004702764;AB0008180;DB-000659;FT-0737555;X7476;A19401;C-met inhibitor (solid tumors), ORD/J&J PRD;W-5504;540D758;JNJ-38877605,JNJ38877605;JNJ-38877605/JNJ38877605;I06-2284;J-518058;BRD-K02123250-001-01-8;US9062045, Comparator No. 1 (JNJ-38877605);C-met inhibitor, Ortho Biotech Oncology Research & Development;JNJ-38877605, JNJ 38877605, 943540-75-8;1072116-03-0;6-(Difluoro-[6-(1methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-methyl)-quinoline;6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[3,4-f]pyridazin-3-yl]methyl]quinoline;6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline;6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline;6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]-triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline;6-{difluoro[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline"	943540-75-8	15UDG410PN	25745036	25745036	01/03/2015	25745036	01/03/2015	2013-2017		1	1	0	Yes	1					30/07/2018		40,9	NA	NA	1	0	NA	1	MEK	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1
Elotuzumab	elotuzumab	"Immunoglobulin G1, anti-(human SLAM family member 7 (CD2-like receptor activating cytotoxic cells, CD319 antigen)), humanized mouse monoclonal HuLuc63 gamma-1 heavy chain (222-214')-disulfide with humanized mouse monoclonal HuLuc63 kappa light chain (228-228'';231-231'')-bisdisulfide dimer;Immunoglobulin G1, anti-(human protein CS1) (human-mouse HuLuc63 heavy chain), disulfide with human-mouse HuLuc63 kappa-chain, dimer;HuLuc63;Empliciti"	DB06317			915296-00-3	1351PE5UGS	22184404	22184404	01/12/2011	22184404	01/07/2012	2009-2012		1	1	1	Yes	1	"30/11/2015 00:00;11/05/2017 00:00"	AP	BRISTOL MYERS SQUIBB	ELOTUZUMAB	30/11/2015	BRISTOL MYERS SQUIBB	40,9	35	NA	0	1	MYELOMA	1	CS1	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,27	0	0	0	0	0	0	47	0	1
Erlotinib	"cp-358,774;cp358774;erlotinib;osi-774;osi774"	"Erlotinib;OSI-774;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine;Apo-erlotinib;Teva-erlotinib;Tarceva;PMS-erlotinib"	"DB00530;APRD00951"	"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride;[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride;183319-69-9;OSI-774;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride;CP-358774;NSC-718781;R-1415;Ro-50-8231;Erlotinib;NSC718781;[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride;Tarceva;CP 358774;Erlotinib hydrochloride;Erlotinib hydrochloride [USAN];OSI 774"	"Erlotinib;183321-74-6;Tarceva;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;OSI-774;Erlotinib Base;UNII-J4T82NDH7E;Erlotinib(Tarceva);4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;Erlotinib, OS-774;CHEMBL553;J4T82NDH7E;4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline;CHEBI:114785;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine;OSI 744;NCGC00164574-01;[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE;R 1415;NSC 718781;DSSTox_CID_26454;DSSTox_RID_81628;DSSTox_GSID_46454;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine;CAS-183321-74-6;NSC718781;RG-1415;Erlotinib [INN:BAN];SR-05000001460;Erlotinin;Erotinib;R-1415;CP-358,774-01;erlotinib;;n-(3-ethynylphenyl)(6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amine;n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine;HSDB 8082;Erlotinib free base;nchembio866-comp3;Kinome_3317;CP358774;CP 358,774;CP-358,774;D07POC;AC1L42EI;SCHEMBL8413;BDBM5446;BIFK0019;cid_176870;GTPL4920;QUI124;DTXSID8046454;QCR-100;AAKJLRGGTJKAMG-UHFFFAOYSA-N;MolPort-003-847-084;ZX-AFC000128;HMS2089F05;HMS3244M19;HMS3244M20;HMS3244N19;HMS3713C22;AMX10161;ZINC1546066;Tox21_112202;183321-74-6 (free base);3615AH;AC-399;FC0029;s7786;STK623143;AKOS000282911;Tox21_112202_1;API0024668;CCG-220420;CS-0620;DB00530;MCULE-7764565391;RL02337;Ro-508231;NCGC00164574-03;NCGC00164574-05;NCGC00164574-06;AJ-26877;AK142763;AN-15876;AS-35132;BC215797;BCB03_000783;CJ-05292;EN002711;HY-50896;KB-76817;P443;AB0017012;AB1004620;LS-184395;AM20090621;FT-0083688;FT-0651539;ST24046689;KS-00000642;K00241;S-7717;15214-EP2269994A1;15214-EP2272827A1;15214-EP2281815A1;15214-EP2292234A1;15214-EP2292615A1;15214-EP2295432A1;15214-EP2298778A1;15214-EP2301533A1;15214-EP2301933A1;15214-EP2305640A2;15214-EP2305671A1;15214-EP2305687A1;15214-EP2308855A1;15214-EP2311827A1;15214-EP2311840A1;15214-EP2311842A2;15214-EP2316832A1;15214-EP2316833A1;32334-EP2281815A1;32334-EP2292615A1;32334-EP2301933A1;32334-EP2305640A2;32334-EP2305671A1;32334-EP2311827A1;AB01273955-01;AB01273955-02;AB01273955-03;134172-EP2292233A2;321E746;I01-1241;SR-05000001460-1;SR-05000001460-2;SR-05000001460-3;SR-05000001460-6;BRD-K70401845-003-04-7;Erlortinib; 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline;n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride;4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; Erlotinin; Erlotinib Base"	183321-74-6	J4T82NDH7E	"28073786;27803065;21549514;20231078;20150371;19494788;19322567;16878326;11432895"	11432895	01/07/2001	11432895	01/07/2001	1999-2003		1	1	1	Yes	1	"19/09/2008 00:00;12/09/2008 00:00;17/04/2012 00:00;14/05/2013 00:00;01/06/2016 00:00;16/04/2010 00:00;20/05/2016 00:00;15/03/2016 00:00;27/04/2015 00:00;18/10/2016 00:00;14/04/2014 00:00;27/04/2009 00:00;28/08/2015 00:00;28/09/2016 00:00;02/11/2005 00:00;18/11/2004 00:00;11/06/2014 00:00;06/07/2015 00:00;27/04/2007 00:00"	"AP;TA"	"OSI PHARMS;TEVA PHARMS USA;MYLAN PHARMS INC"	ERLOTINIB HYDROCHLORIDE	18/11/2004	OSI PHARMS	40,5	40	NA	1	0	NA	1	EGFR	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	228	0	1
Idoxuridine	iododeoxyuridine	"Idoxuridina;1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil;1beta-D-2'-Deoxyribofuranosyl-5-iodouracil;5-Iododeoxyuridine;5-Iodouracil deoxyriboside;IdU;Joddeoxiuridin;2'-Deoxy-5-iodouridine;5-iodo-2'-deoxyuridine;Iododeoxyridine;Idoxuridinum;Iodoxuridine;1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil;Idoxuridin;Idoxuridine;(+)-5-Iodo-2'-deoxyuridine;Sandoz Idoxuridine;Herplex D;Herplex"	"DB00249;APRD00504;EXPT01835;DB03778"	"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-5-iodopyrimidine-2,4-dione;1-[(2R,4S,5R)-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-quinone;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-pyrimidine-2,4-dione;1336-77-2;888-04-0;ZINC03834173;Prestwick3_000018;ID2;1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil;1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil;1beta-D-2'-Deoxyribofuranosyl-5-iodouracil;4-24-00-01235 (Beilstein Handbook Reference);AI3-50861;Allergan 201;Antizona;BRN 0030397;CCRIS 2827;EINECS 200-207-8;Heratil;Herpid;Idossuridina [DCIT];Idoxuridina [INN-Spanish];Idoxuridine [USAN:BAN:INN:JAN];Idoxuridinum [INN-Latin];Iduoculos;Iododeoxyridine;Uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-;Virudox;D00342;Dendrid (TN);Herplex (TN);Idoxuridine (JP15/USP/INN);BSPBio_000055;IdUrd;NSC-39661;BPBio1_000061;SMP2_000072;5-I-2'-dUrd;5IdU;AIDS-001857;AIDS001857"	"idoxuridine;5-Iodo-2'-deoxyuridine;54-42-2;5-Iododeoxyuridine;Idoxuridin;Iododeoxyridine;Iodoxuridine;IUDR;Joddeoxiuridin;Idoxene;Allergan 211;IDUR;Virudox;5IUDR;(+)-5-Iodo-2'-deoxyuridine;Idoxuridinum;Antizona;Idoxuridina;Heratil;Allergan 201;Idossuridina [DCIT];IDU;Herpid;Herplex;Stoxil;Iduoculos;Dendrid;IdUrd;Iduridin;Kerecid;2'-Deoxy-5-iodouridine;Herplex liquifilm;Idoxuridinum [INN-Latin];Idoxuridina [INN-Spanish];Ophthalmadine;Spectanefran;Herpesil;Iduviran;Emanil;Herpidu;Idexur;Iducher;Idulea;Synmiol;5IdU;Idu Oculos;SK&F-14287;1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil;1beta-D-2'-Deoxyribofuranosyl-5-iodouracil;1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil;5-Iodouracil deoxyriboside;Iododeoxyuridine;Allergan-211;UNII-LGP81V5245;C9H11IN2O5;CCRIS 2827;URIDINE, 2'-DEOXY-5-IODO-;CHEBI:147675;5-IUDR;EINECS 200-207-8;NSC-39661;BRN 0030397;Idossuridina;Kerecide;(+)-5-Iodo-2-deoxyuridine;AI3-50861;Oftan-IDU;LGP81V5245;NSC 39661;Uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-;Uridine, 5-iodo-2'-deoxy-;1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione;ID2;SKF 14287;SK&F 14287;DSSTox_CID_25238;DSSTox_RID_80769;DSSTox_GSID_45238;Herpes-Gel;(+)-5-Iodo-2 -deoxyuridine;Herpe-Gel;5-Iododesoxyuridine;Idoxuridine [USAN:INN:BAN:JAN];Dendrid (TN);1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione;HERPLEX (TN);5-I-2'-dUrd;SR-05000001510;HSDB 7479;CAS-54-42-2;NCGC00016243-01;5-Iodo-deoxyuridine;33995-05-0;Idoxuridine [USAN:USP:INN:BAN:JAN];5-iodo-2'deoxyuridine;Idoxuridine (5-IdU);PubChem14202;Prestwick3_000018;CHEMBL788;D02IED;Epitope ID:138107;AC1L1LE0;AC1Q77TF;SCHEMBL3683;BSPBio_000055;4-24-00-01235 (Beilstein Handbook Reference);MLS002154175;5-IODO-2-DEOXYURIDINE;BPBio1_000061;Idoxuridine (JP17/USP/INN);DTXSID2045238;SCHEMBL15850897;CTK4D1152;AOB5602;MolPort-001-792-514;XQFRJNBWHJMXHO-RRKCRQDMSA-N;HMS2090M10;HMS2095C17;HMS2230E10;HMS3712C17;HY-B0307;KS-00000JH7;ZINC3834173;Tox21_110324;ANW-32073;BDBM50370388;MFCD00134656;s1883;AKOS015920431;Tox21_110324_1;(+)-5-Iodo-2'-deoxyuridine, 98%;AC-8219;CCG-220018;CS-2346;DB00249;MCULE-5585466189;SMP2_000072;uridine, 2'-deoxy-5-(iodo-131I)-;NCGC00179673-01;NCGC00179673-03;AJ-45810;AK-35587;AS-13469;BR-35587;CJ-10798;I381;SC-16201;SMR001233472;AB0013659;AX8021350;DB-009133;LS-160825;TL8003566;5-Iodo-2'-deoxyuridine, >=99% (HPLC);I0258;1-(2-Deoxy- -D-ribofuranosyl)- 5-iodouracil;C-1149;D00342;16509-EP2281563A1;16509-EP2316459A1;20495-EP2272827A1;20495-EP2298768A1;20495-EP2314585A1;134I656;J-009907;J-700180;SR-05000001510-1;SR-05000001510-3;SR-05000001510-4;BRD-K76634210-001-14-7;Idoxuridine, European Pharmacopoeia (EP) Reference Standard;Idoxuridine, United States Pharmacopeia (USP) Reference Standard;2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-iodo-;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione;1336-77-2;888-04-0"	54-42-2	LGP81V5245	9661893	9661893	01/07/1998	14400595	01/02/1960	Bef. 1989		0	0	1	Yes	1	"13/08/1982 00:00;11/06/1963 00:00;17/10/1988 00:00;12/07/1976 00:00;30/01/1979 00:00;10/01/1997 00:00;22/08/1977 00:00;09/09/1985 00:00;26/07/1994 00:00;15/05/1981 00:00;29/11/1977 00:00;28/06/1963 00:00;03/03/1976 00:00;02/04/1996 00:00;08/11/1989 00:00;28/04/1977 00:00;09/12/1981 00:00;11/05/1977 00:00;08/04/1982 00:00;18/12/1979 00:00;18/01/1978 00:00;03/08/1995 00:00;23/10/1979 00:00"	AP	"ALLERGAN;ALCON"	IDOXURIDINE	11/06/1963	ALLERGAN	40,2	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Aldesleukin	"interleukin 2;interleukin-2;recombinant interleukin-2"	"125-L-serine-2-133-interleukin 2 (human reduced);Interleukin-2 aldesleukin;Interleukin-2(2-133),125-ser;Proleukin;Recombinant interleukin-2 human"	"BIOD00082;BTD00082;DB00041"			110942-02-4	M89N0Q7EQR	"11683284;15447996;17545537;17575227;19639177;8708712;8740799;8869114;9427692;9607578;9819796"	8740799	01/03/1996	2627984	01/01/1989	1989-1994		1	0	1	Yes	1	"08/04/2009 00:00;30/07/2012 00:00;27/06/2000 00:00;06/07/2010 00:00;06/05/2015 00:00;19/07/2011 00:00;05/05/1992 00:00;09/01/1998 00:00;17/03/2010 00:00;16/12/2011 00:00"	AP	CHIRON	ALDESLEUKIN	05/05/1992	CHIRON	40,0	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Rociletinib	rociletinib		DB11907		"CO-1686;1374640-70-6;Rociletinib;AVL-301;UNII-72AH61702G;CO1686;Rociletinib(AVL-301,CNX-419,CO-1686);CNX-419;72AH61702G;CO 1686;Rociletinib (CO-1686, AVL-301);CO-1686 (AVL-301);N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide;Rociletinib [USAN:INN];Tube721;Rociletinib (USAN/INN);D0M4AV;Rociletinib (CO-1686);GTPL7966;SCHEMBL4177736;CHEMBL3545308;EX-A228;C27H28F3N7O3;MolPort-035-395-816;BDBM149404;HMS3653G08;AOB87314;2334AH;s7284;ZINC98043800;AKOS025401943;AKOS032949985;CS-1631;DB11907;KS-0000062U;4CA-0403;AC-27467;AS-17009;BC600382;HY-15729;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide;QC-11547;SC-93171;KB-145935;US8975249, I-4;FT-0696686;D10858;A1-04311;CO-1686|||N-[3-[[2-[4-(4-Acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide"	1374640-70-6	72AH61702G	25923550	25923550	01/04/2015	25923550	01/04/2015	2013-2017		1	1	0	Yes	1					30/07/2018		39,9	130	NA	0	1	NSCLC_EGFR_MUTANT	1	EGFR	0	1	1	73	1	0	0	1	0	0,59	0	0	0	NA	0	0	0	0	0	0	0	0	1
Danusertib	"danusertib;pha-739358"		DB11778		"Danusertib;827318-97-8;PHA-739358;PHA 739358;Danusertib (PHA-739358);UNII-M3X659D0FY;Danusertib, PHA-739358;(R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide;5-Amido-pyrrolopyrazole 9d;CHEMBL402548;M3X659D0FY;J-502504;(R)-N-(5-(2-Methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo-[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide;Danusertib [INN];N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide;PHA739358;N-{5-[(2R)-2-methoxy-2-phenylethanoyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide;PubChem16771;PHA739358 Danusertib;D02RJY;PHA-739358,Danusertib;MLS006011243;SCHEMBL466509;PHA-739358 (danusertib);GTPL7937;Danusertib - PHA-739358;BDBM12985;CHEBI:94490;CTK8D4203;SYN1095;2j50;MolPort-009-679-390;XKFTZKGMDDZMJI-HSZRJFAPSA-N;BCPP000266;(S)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide;916995-51-2;EX-A1599;ZINC6718723;ABP000118;MMV676600;AKOS015896691;AKOS015995140;AC-8443;AN-6523;BCP9000582;CS-0152;DB11778;KIN0000187;KS-0000006W;PHA-739358;;NCGC00263203-01;NCGC00263203-02;AS-16243;BC658455;EN003071;HY-10179;N-(5-((2R)-2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide;SC-27938;SMR004700684;FT-0665468;S1107;X7370;A24232;995M512;I06-2258;BRD-K07881437-001-01-2;(R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrah;PHA-739358, 827318-97-8;Benzamide, 4-(4-methyl-1-piperazinyl)-N-(1,4,5,6-tetrahydro-5-((2R)-     methoxyphenylacetyl)pyrrolo(3,4-c)pyrazol-3-yl)-;N-[5-[(2R)-2-methoxy-2-phenyl-acetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide;N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide;N-{5-[(2R)-2-methoxy-2-phenylacetyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide"	827318-97-8	M3X659D0FY	25887498	25887498	01/04/2015	25887498	01/04/2015	2013-2017		1	1	0	Yes	1					30/07/2018		39,9	37	NA	0	1	CML	1	BCR_ABL	0	1	1	8	1	0	0	1	1	0,11	0	0	0	NA	0	0	0	0	0	0	0	0	1
Imiquimod	"intravesical imiquimod;tmx-101"	"R 837;Imiquimodum;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;Imiquimod;Zartra;1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;Apo-imiquimod;Zyclara;Imiquimod 5%;Vyloma;Imiquimod;Aldara P;Aldara"	"DB00724;APRD01030"	"1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine;1-isobutylimidazo[4,5-c]quinolin-4-amine;1-isobutyl-4-imidazo[4,5-c]quinolinamine;(1-isobutylimidazo[4,5-c]quinolin-4-yl)amine;99011-02-6;1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine;1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;CHEBI:36704;BB_SC-2107;NCGC00070736-02;Aldara (TN);D02500;Imiquimod (JAN/USAN);1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine;1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-;AIDS-070973;AIDS070973;R-837;S-26308;NSC369100;Beselna;DZ-2636;MTD-39;Zartra;MLS000083577;SMR000048307;1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;Aldara;IMIQUIMOD;Imiquimod [USAN:INN];R 837;S 26308;1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine;I5159_SIGMA"	"IMIQUIMOD;99011-02-6;Aldara;Zyclara;Beselna;1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine;Zartra;R 837;1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;Imiquimod acetate;R-837;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline;S-26308;Imiquimodum;Imiquimod [USAN:INN];UNII-P1QW714R7M;Aldara (TN);S 26308;1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine;CHEMBL1282;Imiquimod (JAN/USAN/INN);1-isobutylimidazo[4,5-c]quinolin-4-amine;MTD-39;P1QW714R7M;1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine;CHEBI:36704;TMX-101;DZ-2636;1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-;1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-;NCGC00070736-02;1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine;DSSTox_CID_21047;DSSTox_RID_79617;DSSTox_GSID_41047;CAS-99011-02-6;SR-01000611320;Imiquimod [USAN:INN:BAN];Vyloma;HSDB 8129;zlchem 9;Aldara, Imiquimod;TMX 101;Aldara|||Beselna;Imiquimod,(S);Beselna (TN);Imiquimod - Aldara;Zyclara (TN);PubChem21071;3M Brand of Imiquimod;ACMC-209stx;D06CTE;(non-labelled)Imiquimod-d9;AC1L1N2I;AC1Q4YO9;SCHEMBL26136;MLS000083577;BIDD:GT0859;GTPL5003;DTXSID7041047;CTK8B3025;AOB6939;ZLA0010;DOUYETYNHWVLEO-UHFFFAOYSA-N;MolPort-002-507-845;HMS2090M14;HMS2232G07;HMS3373B13;HMS3715N19;Pharmakon1600-01502351;EBD27815;HY-B0180;KS-000002KB;Tox21_110985;AC-529;ANW-41635;BBL010772;BDBM50240849;BG0561;GP9049;MFCD00866946;NSC369100;NSC759651;s1211;STK583860;ZINC19632912;Imiquimod, >=98% (HPLC), solid;AKOS005507352;Tox21_110985_1;1H-Imidazo[4, 1-(2-methylpropyl)-;API0002986;CCG-208015;CS-2058;DB00724;KS-5218;MCULE-9421195760;NSC-369100;NSC-759651;TRA0092888;NCGC00070736-03;NCGC00070736-04;9050-31-1;AK209015;AN-15735;BC205676;CC-23827;CJ-16235;KB-52632;SC-17224;SMR000048307;SY017571;LS-178395;TL8006059;TR-038644;FT-0080222;FT-0602727;I0747;D02500;J10325;S26308;Z-4416;1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine;1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine;AB00399298-05;AB00399298-06;AB00399298-07;AB00399298_08;AB00399298_09;011I026;1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ylamine;A845945;C-14410;1-(2-methylpropyl)-4-imidazo[4,5-c]quinolinamine;I06-0624;SR-01000611320-2;SR-01000611320-3;BRD-K26657438-001-01-2;BRD-K26657438-001-13-7;1-(2-methylpropyl)-1Himidazo[4,5-c]quinolin-4-amine;1-(2-methylpropyl)-1H-imidazo[4,5-c]-quinolin-4-amine;1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine;;Imiquimod  / 1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]Q;Imiquimod, United States Pharmacopeia (USP) Reference Standard;4-Amino- 1-isobutyl-1H-imidazo[4,5-c]quinoline; 1-(2-Methylpropyl)-1H-imidazo[4,5-C]quinolin-4-amine;6T0"	99011-02-6	P1QW714R7M	"25660383;23206424"	23206424	01/12/2012	8221654	01/11/1993	1989-1994		1	1	1	Yes	1	"27/09/2000 00:00;15/12/2002 00:00;25/02/2010 00:00;18/09/2015 00:00;08/12/2001 00:00;07/09/2010 00:00;07/11/1997 00:00;07/03/2000 00:00;24/06/2014 00:00;15/07/2011 00:00;30/11/2012 00:00;31/07/2013 00:00;28/02/2011 00:00;06/03/2012 00:00;29/09/2011 00:00;15/04/2011 00:00;02/03/2004 00:00;22/09/2014 00:00;25/03/2010 00:00;24/11/2014 00:00;24/03/2011 00:00;08/12/1997 00:00;14/07/2004 00:00;03/09/2002 00:00;06/04/2012 00:00;27/02/1997 00:00;26/11/2014 00:00;03/02/2015 00:00;14/10/2010 00:00;20/02/1998 00:00;18/04/2011 00:00;09/08/2005 00:00;29/08/2016 00:00;14/02/2012 00:00;28/03/2001 00:00;22/03/2007 00:00"	AP	"APOTEX INC;PERRIGO ISRAEL;G AND W LABS INC;GRACEWAY;STRIDES PHARMA;TOLMAR;TARO;FOUGERA PHARMS;MEDICIS;GLENMARK GENERICS"	IMIQUIMOD	27/02/1997	MEDICIS	39,8	14	NA	1	0	NA	1	IMMUNOMODULATION	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	158	0	1
Methotrexate	methotrexate	"4-amino-10-methylfolic acid;Methotrexatum;N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid;MTX;Méthotrexate;Amethopterin;4-amino-N(10)-methylpteroylglutamic acid;Metotrexato;Methotrexat;Methotrexate-liq Im IV Iar Int Ivr 25mg/ml;Trexall;Ratio-methotrexate Sodium;PMS-methotrexate;Methotrexate Injection, USP;Methotrexate Dbl Inj 10mg/ml;Jamp-methotrexate;Methotrexate Sodium Inj 25.0mg/ml;Methotrexate Injection BP;Methotrexate Tab 2.5mg USP;Methotrexate Injection USP;Rasuvo;Apo-methotrexate;Otrexup;Methotrexate Dbl Inj 25mg/ml;Methotrexate Sodium Injection USP;Methotrexate Tablets, USP;Methotrexate Tab 2.5mg;Rheumatrex Tab 2.5mg;Methotrexate Sodium Injection;Methotrexate Sod Inj 25mg/ml USP;Methotrexate Dbl Inj 2.5mg/ml;Methotrexate Sodium Inj 25mg/ml;Nordimet;Methotrexate;Xatmep;Methotrexate Sodium Inj 20mg;Methotrexate Injection, BP;Rheumatrex Dose Pack;Rheumatrex-tab 2.5mg;Methotrexate Sodium Inj 25mg/ml USP;Methotrexate-pws Im IV Iar Int Ivr 20mg/vial;Methotrexate Sodium;Metoject;Metoject Subcutaneous;Methotrexate PF/sa Injection"	"DB00563;APRD00353"	"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid;(2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid;59-05-2;Bio1_000975;Spectrum_001836;Spectrum5_000958;Lopac0_000020;folic acid antagonist;SMP2_000020;C01937;Methotrexate;NCGC00025060-04;NCIMech_000767;KBioGR_001172;KBioSS_002341;NCGC00025060-05;NINDS_000114;Spectrum2_001077;KBio2_002338;DivK1c_000114;APC-2002;G-301;Intradose-MTX;MPI-5004;Maxtrex;Metolate;KBio1_000114;4-amino-N(10)-methylpteroylglutamic acid;KBio2_007474;Prestwick1_000135;N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid;NCGC00025060-06;CHEBI:44185;SPBio_002149;Spectrum3_000497;N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid;SPBio_001094;Bio1_001464;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;EU-0100020;Bio1_000486;MLS000758248;MLS000049968;SMR000112001;NCGC00025060-01;Tocris-1230;Prestwick_322;Mexate;N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid;STOCK1N-71734;D00142;Prestwick2_000135;Mexate (TN);KBio3_001493;IDI1_000114;AIDS-006948;AIDS006948;CL14377;N-[4-[[(2,4-Diamino-6-pteridinyl)methyl] methylamino]benzoyl]-L-glutamic acid;Spectrum4_000616;KBio2_004906;Methotrexate (JP15/USP/INN);()-Amethopterin;4-Amino-N10-methylpteroyl-L-glutamic acid;M9929_SIAL;Prestwick0_000135"	"methotrexate;59-05-2;Abitrexate;Rheumatrex;Amethopterin;Mexate;Metatrexan;Hdmtx;Trexall;Methylaminopterinum;Antifolan;Ledertrexate;Methylaminopterin;Methotrexatum;Methotrexat;Metotrexato;MTX;4-Amino-10-methylfolic acid;L-Amethopterin;(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid;Folex;N-Bismethylpteroylglutamic acid;Amethopterine;Methoxtrexate;Maxtrex;Rasuvo;A-Methopterin;Mexate-Aq;A-Methpterin;Emtexate;Amethopterin L-;Folex-Pfs;Methotrexat-Ebewe;Methotrexate, L-;Methotrexate Lpf;Metotressato [DCIT];Folex Pfs;Methotextrate;METHOTREXATE SODIUM;NSC 740;NSC-740;CL-14377;NCI-C04671;UNII-YL5FZ2Y5U1;[3H]methotrexate;Methotrexatum [INN-Latin];Metotrexato [INN-Spanish];(+)-4-Amino-10-methylfolic acid;[3H]-methotrexate;EMT 25,299;CCRIS 1109;4-Aminomethylpteroylglutamic acid;HSDB 3123;TCMDC-125858;133073-73-1;Abitrexate (Methotrexate);EINECS 200-413-8;R 9985;YL5FZ2Y5U1;CHEMBL34259;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;AI3-25299;NSC740;X 133;4-Amino-N(sup 10)-methylpteroylglutamic acid;CHEBI:44185;L-(+)-N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid;N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid;(2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid;N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-(+)-glutamic acid;Antifolan hydrate;MTX hydrate;Kyselina 4-amino-N(sup 10)-methylpteroylglutamova [Czech];NCGC00025060-04;C20H22N8O5;CL 14377;4-amino-N(10)-methylpteroylglutamic acid;DSSTox_CID_822;Mexate-Aq Preserved;N-(p-(((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid;N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamicacid;DSSTox_RID_75810;Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova [Czech];DSSTox_GSID_20822;Methylaminopterin hydrate;Fauldexato;Medsatrexate;Methoblastin;Metotressato;Brimexate;Emthexat;Emthexate;Lantarel;Lumexon;Metrotex;Novatrex;Otrexup;Tremetex;Trexeron;Trixilem;Metex;Texate;MLS001401431;Methotrexate Preservative Free;MFCD00150847;(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-L-glutamic acid;Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-;N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid;SMR000112001;4-Amino-10-methylfolic acid hydrate;SR-01000075682;SMR000449324;METHOTREXATE SODIUM PRESERVATIVE FREE;Arbitrexate;FBOZXECLQNJBKD-UHFFFAOYSA-N;Methotrate;Metolate;Xatmep;Intradose-MTX;1dhi;1dhj;2drc;4ocx;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid;N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid;N-{4-[[(2,4-diaminopteridin-6-yl)methyl](methyl)amino]benzoyl}-L-glutamic acid;CAS-59-05-2;Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova;(2S)-2-[(4-([(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO)PHENYL)FORMAMIDO]PENTANEDIOIC ACID;MPI-2505;Prestwick_322;Methotrexate [USAN:INN:BAN:JAN];Otrexup (TN);Xatmep (TN);folic acid antagonist;An-PDN;L-METHOTREXATE;Methotrexate  100mg;Methylaminopterin; MTX;DL-Amethopterin hydrate;Intrathecal methotrexate;Methotrexate [USAN:USP:INN:BAN:JAN];Spectrum_001836;Tocris-1230;4kn0;WR-19039;METHYLAMINOPTERINE;N-(4-{[(2,4-Diaminopteridin-1-Ium-6-Yl)methyl](Methyl)amino}benzoyl)-L-Glutamic Acid;Prestwick0_000135;Prestwick1_000135;Prestwick2_000135;Spectrum2_001077;Spectrum3_000497;Spectrum4_000616;Spectrum5_000958;Methotrexate - Abitrexate;D07ALU;D0D3DU;D0SV8E;NCIMech_000767;SCHEMBL3711;BIDD:PXR0175;L-(+)-AMETHOPTERIN;Lopac0_000020;KBioGR_001172;KBioSS_002341;KSC269O8T;Kyselina 4-amino-N(sup 10)-methylpteroylglutamova;MLS000049968;MLS002154208;DivK1c_000114;SPBio_001094;SPBio_002149;AC1L2R79;cid_126941;cid_165528;GTPL4674;GTPL4815;DTXSID4020822;SCHEMBL12421860;BDBM18050;BDBM66082;CTK1G9789;HMS500F16;KBio1_000114;KBio2_002338;KBio2_004906;KBio2_007474;KBio3_001493;Methotrexate (JP17/USP/INN);AOB5585;FBOZXECLQNJBKD-ZDUSSCGKSA-N;g301;MolPort-003-665-521;NINDS_000114;Bio1_000486;Bio1_000975;Bio1_001464;HMS1568K12;HMS2095K12;HMS2233O18;HMS3260C21;HMS3712K12;ACT03341;APC-2002;KS-00000L8X;MPI-5004;ZINC1529323;Tox21_110944;Tox21_300269;Tox21_500020;ANW-72813;CCG-35800;LS-249;s1210;15475-56-6 (hydrochloride salt);AKOS016340329;Tox21_110944_1;7413-34-5 (di-hydrochloride salt);AB02593;ACN-050905;CL14377;CS-1732;DB00563;KS-5093;LP00020;MCULE-6523054194;RTR-020497;IDI1_000114;SMP2_000020;(methyl)amino)benzamido)pentanedioic acid;NCGC00025060-01;NCGC00025060-02;NCGC00025060-03;NCGC00025060-05;NCGC00025060-06;NCGC00025060-07;NCGC00025060-08;NCGC00025060-09;NCGC00025060-10;NCGC00025060-11;NCGC00025060-12;NCGC00025060-13;NCGC00025060-15;NCGC00025060-16;NCGC00254216-01;NCGC00260705-01;AJ-26587;BC202627;BR-77824;HY-14519;SC-19293;4-Amino-N10-methylpteroyl-L-glutamic acid;EU-0100020;FT-0082628;FT-0601523;Methotrexate 1.0 mg/ml in Dimethyl Sulfoxide;1771-EP0930075A1;1771-EP2269989A1;1771-EP2269994A1;1771-EP2270001A1;1771-EP2270008A1;1771-EP2270018A1;1771-EP2270505A1;1771-EP2272825A2;1771-EP2272827A1;1771-EP2272832A1;1771-EP2275413A1;1771-EP2275420A1;1771-EP2277565A2;1771-EP2277566A2;1771-EP2277567A1;1771-EP2277568A2;1771-EP2277569A2;1771-EP2277570A2;1771-EP2277865A1;1771-EP2277876A1;1771-EP2280012A2;1771-EP2281563A1;1771-EP2281815A1;1771-EP2287156A1;1771-EP2289892A1;1771-EP2289894A2;1771-EP2292233A2;1771-EP2292280A1;1771-EP2292595A1;1771-EP2292614A1;1771-EP2292615A1;1771-EP2292617A1;1771-EP2295055A2;1771-EP2295416A2;1771-EP2295426A1;1771-EP2295427A1;1771-EP2298743A1;1771-EP2298748A2;1771-EP2298764A1;1771-EP2298765A1;1771-EP2298768A1;1771-EP2298772A1;1771-EP2298778A1;1771-EP2298780A1;1771-EP2301928A1;1771-EP2301933A1;1771-EP2305243A1;1771-EP2305640A2;1771-EP2305642A2;1771-EP2305660A1;1771-EP2305668A1;1771-EP2305671A1;1771-EP2305679A1;1771-EP2305689A1;1771-EP2308833A2;1771-EP2308839A1;1771-EP2308855A1;1771-EP2308861A1;1771-EP2311453A1;1771-EP2311807A1;1771-EP2311808A1;1771-EP2311825A1;1771-EP2311827A1;1771-EP2311829A1;1771-EP2311840A1;1771-EP2311842A2;1771-EP2311850A1;1771-EP2314590A1;1771-EP2316459A1;1771-EP2316832A1;1771-EP2316833A1;1771-EP2316834A1;1771-EP2371811A2;1771-EP2374454A1;5947-EP0930075A1;5947-EP2269994A1;5947-EP2289892A1;73M731;A-2190;C01937;D00142;J10045;DL-4-Amino-N10-methylpteroylglutamic acid hydrate;SR-01000597411;W-60383;(S)-2-(4-(((2,4-diaminopteridin-6-yl)methyl);I06-2098;Q-201366;SR-01000075682-1;SR-01000075682-2;SR-01000075682-6;SR-01000597411-1;W-105347;2,2'-(9,10-anthracenediylidene)-bis-propanedinitrile;BRD-K59456551-001-09-3;BRD-K59456551-001-11-9;I14-18123;WLN: T66 BN DN GN JNJ CZ EZ H1N1&R DVMYVQ2VQ;Z1541638527;UNII-99ITO15X8S component FBOZXECLQNJBKD-ZDUSSCGKSA-N;Methotrexate, European Pharmacopoeia (EP) Reference Standard;Methotrexate, United States Pharmacopeia (USP) Reference Standard;Glutamic acid,4-diamino-6-pteridinyl)methyl] methylamino]benzoyl]-, L-(+)-;L-Glutamic acid,4-diamino-6-pteridinyl)methyl]- methylamino]benzoyl]-;L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci);L-Glutamicacid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-;Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard;Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard;Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material;N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)L-GLUTAMIC ACID;N-[4-[[(2,4-Diamino-6-pteridinyl)methyl] methylamino]benzoyl]-L-glutamic acid;(2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid;hydrate;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid;hydrate;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;hydrate;(2S)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid;hydrate;(S)-2-(4-[(2,4-DIAMINO-PTERIDIN-6-YLMETHYL)-METHYL-AMINO]-BENZOYLAMINO)-PENTANEDIOIC ACID;1082707-84-3;70359-39-6;Methotrexate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, meets EP, USP testing specifications"	59-05-2	YL5FZ2Y5U1	"22781392;10213209;9605669"	9605669	01/05/1998	14777272	01/09/1950	Bef. 1989		0	0	1	Yes	1	"20/04/1988 00:00;14/12/1978 00:00;13/12/1983 00:00;05/11/1993 00:00;15/01/1993 00:00;03/04/2001 00:00;27/02/2012 00:00;02/12/2015 00:00;26/09/1994 00:00;14/02/1985 00:00;08/07/1988 00:00;12/07/1989 00:00;10/08/2000 00:00;25/04/1995 00:00;01/11/2011 00:00;13/04/1988 00:00;17/09/1986 00:00;30/07/1990 00:00;18/01/1990 00:00;27/07/1987 00:00;21/04/1988 00:00;03/03/2017 00:00;02/01/1979 00:00;08/03/2011 00:00;20/02/2002 00:00;17/06/1999 00:00;02/08/1977 00:00;03/01/2003 00:00;11/06/1980 00:00;22/08/2002 00:00;29/07/1994 00:00;05/02/1998 00:00;18/02/1992 00:00;11/06/1998 00:00;24/08/1982 00:00;19/12/1991 00:00;05/02/2013 00:00;02/12/2002 00:00;20/02/2004 00:00;08/01/2010 00:00;04/04/2014 00:00;09/05/1986 00:00;29/04/1977 00:00;31/05/2006 00:00;05/10/2015 00:00;10/07/1978 00:00;08/08/1978 00:00;06/07/1999 00:00;08/12/1986 00:00;24/10/1990 00:00;20/11/2015 00:00;14/09/1976 00:00;17/11/1999 00:00;30/10/1997 00:00;03/02/2016 00:00;01/08/1994 00:00;08/04/1983 00:00;20/02/1991 00:00;31/05/2017 00:00;20/05/1997 00:00;14/07/1977 00:00;12/02/1999 00:00;20/06/2000 00:00;03/05/1993 00:00;03/12/1980 00:00;22/08/1978 00:00;26/11/2007 00:00;29/04/2002 00:00;14/04/1989 00:00;26/02/1999 00:00;10/05/1991 00:00;02/07/1982 00:00;19/03/1987 00:00;24/07/1991 00:00;28/09/2012 00:00;27/01/2004 00:00;18/03/1977 00:00;05/09/1979 00:00;09/07/2002 00:00;24/08/2015 00:00;16/09/1986 00:00;10/07/2014 00:00;24/02/2017 00:00;28/11/1988 00:00;10/11/1994 00:00;11/05/1981 00:00;29/03/2012 00:00;01/05/1979 00:00;12/05/1995 00:00;23/10/2000 00:00;11/08/1995 00:00;13/09/2006 00:00;09/06/1998 00:00;29/02/1980 00:00;03/04/1996 00:00;13/03/2002 00:00;24/04/1989 00:00;05/10/1990 00:00;30/04/2007 00:00;22/07/1975 00:00;25/04/2017 00:00;15/02/1979 00:00;07/12/1981 00:00;07/12/1953 00:00;08/05/2001 00:00;29/10/1999 00:00;03/04/1992 00:00;07/05/2018 00:00;31/03/2009 00:00;22/06/1998 00:00;07/05/1998 00:00;07/11/2014 00:00;01/12/1982 00:00;18/05/1989 00:00;18/12/1990 00:00;30/03/2012 00:00;06/12/1999 00:00;08/10/2014 00:00;12/08/2005 00:00;02/08/2010 00:00;15/03/2018 00:00;23/01/1992 00:00;16/11/1989 00:00;30/06/1989 00:00;20/12/2016 00:00;22/09/1999 00:00;01/03/1989 00:00;07/04/1988 00:00;31/08/1998 00:00;18/08/1987 00:00;29/06/1976 00:00;24/05/2000 00:00;20/12/2000 00:00;03/06/2002 00:00;04/08/1983 00:00;15/10/1979 00:00;13/01/2017 00:00;25/04/2011 00:00;19/07/1984 00:00;13/04/2005 00:00;24/01/2000 00:00;11/01/2017 00:00;17/02/1989 00:00;06/02/2013 00:00;11/05/2004 00:00;28/01/1999 00:00;26/01/1976 00:00;21/05/2015 00:00;08/11/2000 00:00;31/10/1988 00:00;03/11/1975 00:00;31/03/1982 00:00;07/04/1992 00:00;05/12/1975 00:00;29/01/2016 00:00;04/10/1994 00:00;05/11/1991 00:00;20/11/1998 00:00;07/09/1976 00:00;21/03/2001 00:00;20/05/1999 00:00;16/03/2012 00:00;14/08/2015 00:00;18/04/1990 00:00;24/03/2016 00:00;22/12/2017 00:00;09/02/2000 00:00;29/07/2003 00:00;05/10/1988 00:00;15/10/1990 00:00;25/04/1988 00:00;03/08/1976 00:00;10/08/1959 00:00;28/03/1977 00:00;01/12/1998 00:00;07/03/2017 00:00;16/10/2001 00:00;17/02/2000 00:00;24/07/1987 00:00;18/04/1995 00:00;07/10/2014 00:00;04/02/1983 00:00;04/04/1984 00:00;21/12/1999 00:00;27/08/1987 00:00;15/12/2004 00:00;18/04/1996 00:00;11/10/2013 00:00;13/06/1986 00:00;23/12/1994 00:00;24/10/2003 00:00;19/09/2000 00:00;20/07/1987 00:00;15/05/1992 00:00;18/06/1998 00:00;30/10/2001 00:00;17/08/1998 00:00"	AP	"SILVERGATE PHARMS;NORBROOK;BRISTOL MYERS;ACCORD HLTHCARE;SUN PHARMA GLOBAL;BRISTOL;PHARMACHEMIE USA;FRESENIUS KABI USA;MYLAN LABS LTD;MEDAC PHARMA INC;WEST-WARD PHARMS INT;DURAMED PHARMS BARR;ZYDUS PHARMS USA INC;BRISTOL MYERS SQUIBB;BARR;SANDOZ INC;ABRAXIS PHARM;#N/A;PHARMACHEMIE BV;ANTARES PHARMA INC;DAVA PHARMS INC;HOSPIRA;MYLAN"	"METHOTREXATE;METHOTREXATE SODIUM"	07/12/1953	DAVA PHARMS INC	39,1	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Piroxicam	piroxicam	"Piroxicam;Piroxicamum;Piroxicam betadex;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;Pyroxycam;Gen-piroxicam-cap 10mg;Piroxicam Capsules 10mg;Fexicam;Feldene Cap 20mg;Feldene Sup 20mg;PMS-piroxicam;Pro-piroxicam Cap 10mg;Feldene Sup 10mg;Dom-piroxicam;Feldene Cap 10mg;Penta-piroxicam Capsules;Apo Piroxicam Cap 10mg;Teva-piroxicam;Piroxicam Capsules 20mg;PMS-piroxicam Suppositories -20mg;Therafeldamine;Alti-piroxicam-cap 20mg;Rho-piroxicam - Cap 20mg;PMS-piroxicam Suppositories-10mg;Gen-piroxicam - Cap 20mg;Feldene;Nu-pirox Cap 20mg;Pro-piroxicam Cap 20mg;Piroxicam;Alti-piroxicam-cap 10mg;Rho-piroxicam - 10mg Cap;Apo Piroxicam Cap 20mg;Nu-pirox Cap 10mg"	"DB00554;APRD01187"	"(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxobenzo[e]thiazin-4-one;(3E)-3-[hydroxy-(2-pyridylamino)methylene]-2-methyl-1,1-dioxo-benzo[e]thiazin-4-one;(3E)-3-[hydroxy-(2-pyridylamino)methylene]-2-methyl-1,1-dioxo-4-benzo[e]thiazinone;(3E)-3-[hydroxy-(2-pyridylamino)methylene]-1,1-diketo-2-methyl-benzo[e]thiazin-4-one;(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-benzo[e][1,2]thiazin-4-one;36322-90-4;4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;ST069379;BAS 04381594;4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide;P5654_SIAL;NSC666076;(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxobenzo[e]thiazin-4-one;P0847_SIAL;EU-0100900;SPECTRUM1500491;D00127;Feldene (TN);Piroxicam (JP15/USP/INN);C01608;Piroxicam;Prestwick_573;(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide;4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide, 1,1-dioxide;AIDS-071917;AIDS071917;CP-16171;Felden;Feldene Fast;Feldene Gel;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German];4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide;4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;BAXO;BRN 0627692;CCRIS 3719;CHF 1251;CP 16171;EINECS 252-974-3;Feldene;NSC 666076;Piroftal;Piroxicam [USAN:BAN:INN:JAN];Piroxicamum [INN-Latin];Pyroxycam;Roxicam"	"piroxicam;36322-90-4;Feldene;Piroxicamum;Pyroxycam;Roxicam;Piroftal;BAXO;Artroxicam;Bruxicam;Caliment;Flogobene;Geldene;Improntal;Larapam;Piroflex;Reudene;Roxiden;Sasulen;Solocalm;Erazon;Pirkam;Riacen;Zunden;piroxicam usp;CP-16171;Piroxicam betadex;Piroxicamum [INN-Latin];CP 16171;CHF 1251;Pipoxicam;Felden;Akten;Roxam;Apo-Piroxicam;Feldene Fast;Feldene Gel;UNII-13T4O6VMAM;Feldene (TN);NSC 666076;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;Piroxicam (Feldene);CCRIS 3719;4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide;C15H13N3O4S;Piroxicam [USAN:BAN:INN:JAN];4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide;EINECS 252-974-3;AK1015;CP16171;BRN 0627692;13T4O6VMAM;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;MLS000069644;CHEBI:8249;QYSPLQLAKJAUJT-UHFFFAOYSA-N;4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide;NSC666076;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German];4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;NCGC00015823-02;SMR000035997;CAS-36322-90-4;DSSTox_CID_1170;P 5654;DSSTox_RID_75990;DSSTox_GSID_21170;Rosiden;3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1;(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1;4-Hydroxy-2-methyl-3[pyrid-2-yl-carbamoyl]-2H-1,2-benzothiazine 1,1-dioxide;(4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e;(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide;4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;(Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide;1488516-58-0;SR-01000000199;Roxam;Feldene;4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1?^{6},2-benzothiazine-3-carboxamide;Piroxicam,(S);Brexidol (TN);Feldoral (TN);Proponol (TN);Reumador (TN);Prestwick_573;Hotemin (TN);Mobilis (TN);Brexin (TN);Erazon (TN);Exipan (TN);Felden (TN);Tracam (TN);Vurdon (TN);Veral (TN);Piroxicam [USAN:USP:INN:BAN:JAN];Pirox von ct (TN);Spectrum_001115;Tocris-0960;Opera_ID_442;AC1NQX1P;AC1NSM2R;AC1Q3XLJ;Prestwick0_000211;Prestwick1_000211;Prestwick2_000211;Prestwick3_000211;Spectrum2_001287;Spectrum3_000780;Spectrum4_000968;Spectrum5_001445;Lopac-P-5654;Feldene, Roxam, Piroxicam;CHEMBL527;D00IBN;AC1L1J3Z;BIDD:PXR0154;Lopac0_000900;Oprea1_714707;SCHEMBL13462;SCHEMBL21350;BSPBio_000221;BSPBio_001030;BSPBio_002460;KBioGR_000370;KBioGR_001315;KBioSS_000370;KBioSS_001595;MLS000038002;MLS001148207;MLS001304054;MLS004774122;DivK1c_000369;SPECTRUM1500491;SPBio_001293;SPBio_002142;Piroxicam (JP15/USP/INN);Piroxicam (JP17/USP/INN);BPBio1_000245;GTPL7273;Piroxicam, >=98% (TLC);SCHEMBL3703617;Piroxicam for system suitability;CHEMBL1518938;DTXSID5021170;BCBcMAP01_000176;BDBM85245;CTK7I2700;HMS501C11;KBio1_000369;KBio2_000370;KBio2_001595;KBio2_002938;KBio2_004163;KBio2_005506;KBio2_006731;KBio3_000719;KBio3_000720;KBio3_001680;KS-00000JBT;MolPort-001-888-120;MolPort-035-874-705;NINDS_000369;Piroxicam 1.0 mg/ml in Methanol;Bio1_000363;Bio1_000852;Bio1_001341;Bio2_000355;Bio2_000835;HMS1362D11;HMS1568L03;HMS1792D11;HMS1920H22;HMS1990D11;HMS2089B06;HMS2092A05;HMS2095L03;HMS2231G03;HMS3262D22;HMS3267I03;HMS3369B07;HMS3403D11;HMS3429L03;HMS3655C04;HMS3712L03;Pharmakon1600-01500491;HY-B0253;NSC_4856;Tox21_110231;Tox21_200151;Tox21_500900;ANW-43611;BBL016493;CCG-36403;MFCD00057317;NSC757284;s1713;STK177288;ZINC12466469;ZINC51133897;ZINC87724780;AKOS000714958;AKOS025312555;AKOS026749939;Tox21_110231_1;AM84917;CS-2233;DB00554;KS-5322;LP00900;LS-7663;MCULE-1939282084;NSC-666076;NSC-757284;3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;IDI1_000369;IDI1_002110;NCGC00015823-01;NCGC00015823-03;NCGC00015823-04;NCGC00015823-05;NCGC00015823-06;NCGC00015823-07;NCGC00015823-08;NCGC00015823-09;NCGC00015823-10;NCGC00015823-11;NCGC00015823-12;NCGC00015823-13;NCGC00015823-14;NCGC00015823-15;NCGC00015823-17;NCGC00015823-18;NCGC00021244-03;NCGC00021244-05;NCGC00021244-06;NCGC00021244-07;NCGC00021244-08;NCGC00021244-09;NCGC00188982-01;NCGC00257705-01;NCGC00261585-01;AC-24190;BAS 04381594;BC204217;NCI60_022912;SC-16825;ST069379;BCP0726000299;SBI-0050875.P004;AB0011706;AB2000240;AJ-111664;CAS_36322-90-4;CP-16,171;KB-284635;Piroxicam, meets USP testing specifications;ST2411449;TR-014899;EU-0100900;FT-0080892;FT-0630590;P1905;EN300-70724;A19556;C01608;D00127;J10253;M-9898;AB00052074-21;AB00052074-22;AB00052074_23;AB00052074_24;322P904;SR-01000000199-3;SR-01000000199-5;SR-01000000199-9;W-106626;SR-01000000199-12;F0001-2399;Piroxicam, British Pharmacopoeia (BP) Reference Standard;Z1259192069;Piroxicam, European Pharmacopoeia (EP) Reference Standard;Piroxicam, United States Pharmacopeia (USP) Reference Standard;3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1;(3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1;Piroxicam, Pharmaceutical Secondary Standard; Certified Reference Material;2-methyl-N-(pyridin-2-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide;4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide;4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l;{6},2-benzothiazine-3-carboxamide;4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide;4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide;4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide;4-Hydroxy-3-(pyridin-2-yl-carbamoyl)-2-methyl-2H-1,2-benzothiazin-1,1-dioxide;N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;(E)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide;1044566-76-8;3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4h-1,2-benzothiazin-4-one 1,1-dioxide;3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione;3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione;3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda,2-benzothiazine-1,1,4-trione;3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione;4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1,2-dihydro-1lambda,2-benzothiazine-3-carboxamide"	36322-90-4	13T4O6VMAM	9796636	9796636	01/10/1998	380913	01/01/1979	Bef. 1989		0	0	1	No	0	"14/09/2011 00:00;28/01/1994 00:00;09/03/2000 00:00;02/09/2015 00:00;08/07/1994 00:00;24/03/1993 00:00;23/04/1986 00:00;05/11/1993 00:00;26/07/1996 00:00;08/04/2002 00:00;05/09/1996 00:00;23/07/1987 00:00;03/07/2006 00:00;13/04/2017 00:00;10/09/1984 00:00;07/10/1997 00:00;29/11/2010 00:00;07/10/1993 00:00;16/05/2000 00:00;08/01/2003 00:00;03/06/1996 00:00;04/04/2006 00:00;08/01/2008 00:00;13/08/2010 00:00;05/02/1998 00:00;22/09/1992 00:00;20/06/2017 00:00;21/01/1998 00:00;12/04/2001 00:00;11/08/2017 00:00;09/04/1999 00:00;16/05/1989 00:00;29/05/1992 00:00;26/01/2018 00:00;17/09/1984 00:00;12/02/1999 00:00;17/07/1984 00:00;22/02/1983 00:00;19/11/1984 00:00;12/01/1994 00:00;31/05/1996 00:00;17/07/2018 00:00;02/01/2004 00:00;24/02/1997 00:00;05/12/1997 00:00;12/08/1993 00:00;12/03/2002 00:00;10/12/1984 00:00;21/03/2000 00:00;02/03/2006 00:00;11/12/1992 00:00;08/09/1998 00:00;16/06/1997 00:00;28/08/1992 00:00;14/09/1993 00:00;31/07/1992 00:00;24/08/1988 00:00;25/05/1994 00:00;18/02/2016 00:00;12/03/1993 00:00;02/12/1999 00:00;08/07/1997 00:00;18/03/1983 00:00;22/09/2000 00:00;19/06/2013 00:00;18/09/1985 00:00;30/06/2015 00:00;16/05/1996 00:00;03/05/1984 00:00;26/10/2011 00:00;17/03/1998 00:00;24/01/2006 00:00;28/01/2000 00:00;21/10/2011 00:00;21/10/1983 00:00;05/07/2007 00:00;09/05/2016 00:00;17/03/2006 00:00;23/03/1999 00:00;13/07/1998 00:00;29/09/1995 00:00;21/02/2018 00:00;27/10/1995 00:00;14/05/1998 00:00;11/08/1997 00:00;29/12/2017 00:00;09/09/2016 00:00;27/02/2015 00:00;11/10/2000 00:00;09/03/1994 00:00;08/05/2008 00:00;13/01/1983 00:00;23/07/2018 00:00;08/06/2001 00:00;06/04/1982 00:00;15/06/1993 00:00"	AP	"TEVA;MYLAN IRELAND LTD;#N/A;UNICHEM LABS LTD;IVAX SUB TEVA PHARMS;PII;TEVA PHARMS;WATSON LABS;EGIS;SUN PHARM INDUSTRIES;FLAMINGO PHARMS;SCS;MYLAN;PFIZER"	PIROXICAM	06/04/1982	PFIZER	39,0	#N/A																							0						1
Tositumomab	"131i-tositumomab;tositumomab"	Bexxar Therapy	"DB00081;BTD00085;BIOD00085;DB09557"			208921-02-2	0343IGH41U	"24730538;17325895"	17325895	01/02/2007	10715303	01/03/2000	1999-2003		1	1	1	Yes	1					01/06/2003	CORIXA	38,9	45	NA	0	1	NHL_B	0	NA	0	1	0	NA	0	0	0	1	1	0,6	0	1	1	NA	0	0	0	0	0	0	159	0	1
MK-1775	"adavosertib;azd-1775;azd1775;mk-1775;mk1775"		DB11740		"MK-1775;955365-80-7;MK1775;MK 1775;Adavosertib;UNII-K2T6HJX3I3;AZD-1775;AZD1775;AZD 1775;K2T6HJX3I3;2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one;2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one;1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one;1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)pyrazolo[3,4-d]pyrimidin-3-one;3H-Pyrazolo(3,4-d)pyrimidin-3-one, 1,2-dihydro-1-(6-(1-hydroxy-1-methylethyl)-2-pyridinyl)-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-2-(2-propen-1-yl)-;1-[6-(2-Hydroxypropan-2-Yl)pyridin-2-Yl]-6-{[4-(4-Methylpiperazin-1-Yl)phenyl]amino}-2-(Prop-2-En-1-Yl)-1,2-Dihydro-3h-Pyrazolo[3,4-D]pyrimidin-3-One;3H-Pyrazolo[3,4-d]pyrimidin-3-one, 1,2-dihydro-1-[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]-6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-(2-propen-1-yl)-;8X7;Kinome_2656;D02KKA;MLS006011025;GTPL7702;QCR-46;SCHEMBL1504444;CHEMBL1976040;CHEBI:91414;DTXSID30241868;EX-A331;MolPort-016-633-227;C27H32N8O2;HMS3654H20;AOB87173;ABP000952;s1525;ZINC63539231;AKOS024259153;AM90274;BCP9000937;CS-0105;DB11740;MK-1775/MK1775;KS-0000063H;NCGC00263183-01;4CA-0834;AC-28416;AK-99219;AS-17001;BC283464;HY-10993;KB-19433;SC-94519;SMR004702820;AB0008188;AJ-114406;FT-0699265;ST24039830;X7493;S-7817;BRD-K54256913-001-01-2;MK1775, 955365-80-7;1,2-Dihydro-1-[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]-6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-(2-propen-1-yl)-3h-pyrazolo[3,4-d]pyrimidin-3-one;2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one;2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1H-pyrazo"	955365-80-7	K2T6HJX3I3	25964244	25964244	01/05/2015	25964244	01/05/2015	2013-2017		1	1	0	Yes	1					30/07/2018		38,9	25	NA	1	1	BRCA_MUTANT	1	WEE1	0	1	0	NA	1	0	0	1	1	0,08	0	0	0	NA	0	SUPRAVENTRICULAR_ARRHYTHMIA	1	0	0	0	0	0	1
Lenalidomide	"cc-5013;cdc 501;lenalidomide"	"CDC 501;CC-5013;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;IMid-1;IMiD3;1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline;Revlimid"	"DB00480;APRD01303"	"3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione;3-(4-amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione;3-(4-amino-1-keto-isoindolin-2-yl)piperidine-2,6-quinone;191732-72-6;346670-73-3;443912-14-9;CDC 501;D04687;Lenalidomide (USAN);Revlimid (TN);CDC-501;CDC-5013;ENMD-0997;IMID-5013;IMiD3;2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;CC 5013;CC-5013;3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;Lenalidomide;Revimid;Revlimid"	"Lenalidomide;191732-72-6;Revlimid;Revimid;CC-5013;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;CDC 501;IMiD3;CDC-501;Lenalidomide [USAN];Revlimid (lenalidomide);CC 5013;Lenalidomide (CC-5013);Revlimid (TN);Revlimid (Celgene);3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;Lenalidomide (USAN/INN);3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;CHEBI:63791;ENMD-0997;IMID-5013;CDC-5013;ALBB-015321;NCGC00167491-01;Lenalidomide hydrate;3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;DSSTox_CID_26664;DSSTox_RID_81806;DSSTox_GSID_46664;Q-101410;3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione;Revamid;(3S)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;443912-14-9;CAS-191732-72-6;Thalidomide analog CC-5013;Lenalidomide [USAN:INN:BAN];ENMD 0997;HSDB 8220;IMiD3cpd;CC5013;IMid-1;PubChem19113;CHEMBL848;D0Q5NX;Revlimid (TN) (Celgene);AC1L50II;SCHEMBL32978;Celgene brand of lenalidomide;MLS003899194;Lenalidomide (Immunomodulator);GTPL7331;SCHEMBL1980410;1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline;DTXSID8046664;BDBM65454;CTK8E1915;KS-00000GHH;GOTYRUGSSMKFNF-UHFFFAOYSA-N;MolPort-003-848-370;BCPP000186;HMS3654G07;CC-5013, Revlimid, Lenalidomide;HY-A0003;Revlimid, Lenalidomide, CC-5013;ZX-AN014029;Tox21_112492;ABP001089;AC-914;NSC747972;s1029;STK639603;AKOS005146276;AKOS005174869;Tox21_112492_1;ACN-034469;AN-1103;API0003142;BCP9000847;CS-0125;DB00480;KS-1207;MCULE-9771679074;NSC-747972;RTR-008901;NCGC00167491-02;NCGC00167491-03;NCGC00167491-04;AK-47482;BC220870;BR-47482;KB-53181;SMR002529986;AB0017965;AX8136128;LS-184040;TR-008901;AM20050439;FT-0659651;FT-0670758;T5245;D04687;S-4172;AB01273975-01;AB01273975-02;AB01273975_03;732L726;SR-01000883999;I06-0831;SR-01000883999-1;3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione;Z1741976709;2, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione;3-(4-amino-1,3-dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione;3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-dioxopiperidine;3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione;2,6-piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, (3S)-;346670-73-3;4-amino-2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one;879126-98-4"	191732-72-6	F0P408N6V4	"26947199;26337806;26284823;25617965;25082342;23354011;21879809;21149673;21149652;20978144;20956622;19965642;19451403;18056189;17473661;17257661;16899362;14997189"	14997189	01/03/2004	12384400	01/11/2002	1999-2003		1	1	1	Yes	1	"03/08/2010 00:00;27/06/2017 00:00;21/12/2011 00:00;12/10/2010 00:00;05/06/2013 00:00;22/02/2017 00:00;17/02/2015 00:00;08/02/2013 00:00;30/11/2017 00:00;12/03/2012 00:00;15/11/2013 00:00;04/11/2013 00:00;29/12/2017 00:00;22/04/2016 00:00;27/12/2005 00:00;29/06/2006 00:00;13/09/2015 00:00;01/12/2015 00:00;23/02/2009 00:00;27/10/2015 00:00;09/05/2012 00:00;12/09/2014 00:00;19/12/2013 00:00;15/09/2017 00:00"	AP	CELGENE	LENALIDOMIDE	27/12/2005	CELGENE	37,8	27	71	0	1	MYELOMA	1	IMMUNOMODULATION	0	1	0	NA	0	0	0	1	0	0,71	0	0	0	0,78	0	0	0	0	0	0	96	0	1
Rituximab	"177lu-dota-rituximab;lutetium-177-dota-rituximab;rituximab"	"AntiCD20;Rituxan;Rituxan Hycela;Rituxan Sc"	"BIOD00014;BTD00014;DB00073"			174722-31-7	4F4X42SYQ6	"11226005;11304767;11587374;11756154;11911416;12688318;15073100;15111353;15358617;15447996;19047125;19679883;21544528;23358408;23572496;24821885;28220479"	11226005	01/02/2001	7522629	01/10/1994	1994-1998		1	1	1	Yes	1	"10/02/2006 00:00;24/01/2008 00:00;24/09/2013 00:00;19/04/2011 00:00;22/08/2007 00:00;13/07/2012 00:00;26/11/1997 00:00;17/02/2012 00:00;25/01/2008 00:00;13/04/2012 00:00;22/06/2017 00:00;29/09/2006 00:00;19/10/2012 00:00;07/06/2018 00:00;16/10/2009 00:00;21/02/2007 00:00;09/05/2013 00:00;28/02/2006 00:00;08/09/2008 00:00;28/09/2007 00:00;03/04/2018 00:00;06/10/2010 00:00;06/01/2011 00:00;18/02/2010 00:00;22/09/2009 00:00;12/08/2014 00:00;28/01/2011 00:00"	AP	"GENENTECH INC;GENENTECH"	"RITUXIMAB;HYALURONIDASE"	26/11/1997	GENENTECH	37,8	15	NA	0	1	LNH_B	1	CD20	0	1	0	NA	0	0	0	1	0	0,4	0	0	0	NA	0	0	0	0	0	0	229	0	1
Vorinostat	"suberoylanilide hydroxamic acid;vorinostat"	"Octanedioic acid hydroxyamide phenylamide;SAHA;SHH;Suberanilohydroxamic acid;Suberoylanilide hydroxamic acid;Vorinostatum;Zolinza"	"DB02546;EXPT02902"	"N'-hydroxy-N-phenyloctanediamide;8-(hydroxyamino)-8-oxo-N-phenyl-octanamide;8-(hydroxyamino)-8-oxo-N-phenyloctanamide;8-(hydroxyamino)-8-keto-N-phenyl-caprylamide;N'-hydroxy-N-phenyl-octanediamide;149647-78-9;Suberoylanilide hydroxamic acid;Vorinostat;AIDS-186714;D06320;Vorinostat (USAN);Zolinza (TN);OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE;SAHA;SHH;N'-hydroxy-N-phenyloctanediamide;MK-0683;NSC-701852;SW-064652;Suberanilohydroxamic acid;Zolinza;AIDS186714;MK0683;N-Hyrdroxy-N'-phenyloctanediamide;NSC701852;SAHA, Suberoylanilide hydroxamic acid;N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide;SKI390;WIN64652;nchembio815-comp18;CCRIS 8456;N-hydroxy-N'-phenyloctanediamide;Octanediamide, N-hydroxy-N'-phenyl-;SAHA cpd"	"Vorinostat;149647-78-9;SAHA;suberoylanilide hydroxamic acid;Zolinza;N-hydroxy-N'-phenyloctanediamide;Suberanilohydroxamic acid;N1-hydroxy-N8-phenyloctanediamide;SAHA cpd;MK-0683;Vorinostat [USAN];MK0683;Octanediamide, N-hydroxy-N'-phenyl-;CCRIS 8456;Vorinostat (SAHA, MK0683);N-Hyrdroxy-N'-phenyloctanediamide;Vorinostat MSD;UNII-58IFB293JI;Zolinza (TN);OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE;SHH;N'-hydroxy-N-phenyloctanediamide;CHEMBL98;Vorinostat (JAN/USAN);58IFB293JI;SKI390;CHEBI:45716;WAEXFXRVDQXREF-UHFFFAOYSA-N;WIN64652;NSC701852;SAHA, Suberoylanilide hydroxamic acid;NSC-701852;NCGC00168085-01;NCGC00168085-02;SW-064652;8-(hydroxyamino)-8-oxo-N-phenyl-octanamide;Zolinza (TN) (Merck);DSSTox_CID_21133;DSSTox_RID_79632;DSSTox_GSID_41133;N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide;SMR000486344;NHNPODA;CAS-149647-78-9;SR-05000000373;Vorinostat [USAN:INN];vorinostatum;HSDB 7930;4lxz;N-Hydroxy-N'-phenyl octanediamide;Zolinza; SAHA;Vorinostat (SAHA);Vorinostat - SAHA;MK 0683;1zz1;Merck brand of Vorinostat;cc-95;D0E7PQ;AC1L1K2K;cid_5311;SCHEMBL9018;Vorinostat (HDAC inhibitor);Suberoylanilidehydroxamic Acid;MLS001065855;MLS006011941;GTPL6852;Zolinza, MK-0683, SAHA;DTXSID6041133;BDBM19149;CTK8B4125;AOB6083;n-hydroxy-n'-phenyl-octanediamide;QCR-121;SUBERANILOHYDROXAMINIC ACID;SYN3006;1t69;MolPort-003-850-293;N-hydroxy-N''-phenyloctanediamide;BCPP000018;HMS2219L20;HMS3264D20;HMS3327C12;HMS3650D09;HMS3654G11;HMS3715E22;Pharmakon1600-01502267;KS-00000H3B;N1-hydroxy-N8-phenyl-octanediamide;SAHA, >=98% (HPLC);Vorinostat,SAHA,Zolinza,MK-0683;ZINC1543873;Tox21_112605;Tox21_113623;Vorinostat,CAS:149647-78-9;ANW-43951;MFCD00945317;NSC748799;NSC759852;Octanediamide, N1-hydroxy-N8-phenyl;s1047;SK1390;AKOS015966648;Octanediamide, N1-hydroxy-N8-phenyl-;Tox21_112605_1;AC-1923;AN-5256;CCG-208659;CS-0589;DB02546;DG-0025;MCULE-4234367506;NSC-748799;NSC-759852;RP29421;Suberoylanilide hydroxamic acid (SAHA);NCGC00168085-03;NCGC00168085-04;NCGC00168085-05;BC677687;BP-30216;HY-10221;KB-60639;SC-20040;AB0009911;LS-186548;LS-186997;LS-187780;RT-015807;AM20030018;FT-0082592;FT-0650593;D06320;K-4759;AB00375377-07;AB00375377-08;AB00375377-09;AB01644613_25;647S789;P111011;Vorinostat, SAHA, suberoylanilide hydroxamic acid;SR-05000000373-2;SR-05000000373-6;SR-05000000373-8;W-201327;BRD-K81418486-001-01-2;BRD-K81418486-001-10-3;BRD-K81418486-001-12-9;BRD-K81418486-001-13-7;BRD-K81418486-001-17-8;BRD-K81418486-001-18-6;Z1541632802"	149647-78-9	58IFB293JI	"14506144;19887475;20837947;21473790;21849928;22506596"	14506144	01/09/2003	14506144	01/09/2003	1999-2003		1	1	1	Yes	1	"22/07/2008 00:00;14/11/2011 00:00;24/04/2013 00:00;17/12/2015 00:00;23/09/2009 00:00;06/10/2006 00:00;07/10/2015 00:00;10/06/2011 00:00"	AP	MERCK	VORINOSTAT	06/10/2006	MERCK	37,1	36	NA	1	0	NA	1	HDAC	0	1	0	NA	0	0	0	1	1	0,13	0	0	0	NA	0	0	0	0	0	0	157	0	1
Valproic Acid	valproic acid	"VPA;Valproate;n-DPA;Di-n-propylessigsäure;Valproinsäure;2-propyl-pentanoic acid;2-n-propyl-n-valeric acid;4-heptanecarboxylic acid;ácido valproico;acidum valproicum;di-n-propylacetic acid;2-Propylpentanoic Acid;Dipropylacetic acid;DPA;acide valproïque;2-Propylvaleric Acid;Depakene;Mylan-valproic;Mylan-divalproex;Divalproex Sodium Extended-Release;PMS-divalproex (125mg);Ratio-valproic 50mg/ml Syrup;Divalproex Sodium;Nu-valproic Syrup;Apo-divalproex;Sandoz Valproic;Novo-valproic;Epival ER;Valproic Acid;Divalproex-250;Epiject I.V.;Depakene Cap 500mg;Divalproex-125;Valproic-250;Teva-divalproex;Nu-divalproex 125mg;Valproate Sodium;Penta-valproic Capsules;PMS-valproic Acid;Ftp-valproic Acid;Dom-valproic Acid Syrup;Divalproex;Myl-divalproex;Divalproex Sodium DR;Dom-valproic Acid E.C.;Divalproex Sodium Delayed-Release;Depakote;Dom-divalproex;Ratio-valproic;Divalproex sodium;Deproic Syrup;Divalproex Sodium Extended Release;PMS-valproic Acid E.C.;Nu-divalproex 250mg;PMS-divalproex (500mg);Ratio-valproic - Ecc 500mg;Nu-divalproex 500mg;Divalproex Sodium Delayed Release (Sprinkle);Divalproex-500;Apo-valproic;PHL-valproic Acid E.C.;PHL-valproic Acid;Depacon;Ratio-valproic-cap 250mg;Dom-valproic Acid;Divalproex Sodium Delayed Release;Nu-valproic;Valproic;Divalproex Sodium ER;Divalproex Sodium Extended-release;Depakote ER;Epival;PMS-divalproex (250mg);Apo-valproic Syrup;Divalproex SodiumDelayed-Release Delayed-Release;PHL-divalproex;Depakote Sprinkles;Divalproex Sodium Dr"	"DB00313;APRD00256;DB00510;APRD00066"	"2-Propylpentanoic acid;2-Propylvaleric acid;117039-65-3;99-66-1;n-DPA;Valproic acid (USP);P6273_SIGMA;Spectrum4_000376;SPBio_000912;KBio3_002626;(S)-2-Propyl-4-pentanoic acid;4-Pentanoic acid, 2-propyl-, (S)-;S(-)-4-En-valproic acid;S-2-n-Propyl-4-pentenoic acid;Depakin chrono;Savicol;AIDS-057177;Valproinsaeure;2-n-propyl-n-valeric acid;Spectrum2_000946;2-Propylpentanoic acid solution;P2689_SIGMA;CHEBI:39867;Depakin;KBio2_006137;G2M-777;VPA;KBioSS_002278;KBio2_007413;KBio2_003569;AIDS057177;DivK1c_000273;KBioSS_001001;NINDS_000273;D00399;KBio2_002277;NCGC00091149-02;NCGC00091149-03;Spectrum_000521;2-PROPYL-PENTANOIC ACID;NCGC00091149-01;KBio2_004845;nchembio815-comp21;Di-n-propylessigsaeure;Avugane;KBio1_000273;Stavzor;KBio2_001001;KBioGR_002277;KBio3_002757;KBioGR_000871;2-Propylpentanoic acid;2-Propylvaleric acid;3-02-00-00807 (Beilstein Handbook Reference);4-Heptanecarboxylic acid;AI3-10500;Abbott 44090;Acetic acid, dipropyl-;Acide valproique [INN-French];Acido valproico [INN-Spanish];Acidum valproicum [INN-Latin];BRN 1750447;DRG-0130;Depakine;Di-n-propylacetic acid;Di-n-propylessigsaure [German];Dipropylacetate;Dipropylacetic acid;EINECS 202-777-3;Ergenyl;HSDB 3582;Kyselina 2-propylvalerova [Czech];Mylproin;NSC 93819;Pentanoic acid, 2-propyl-;Propylvaleric acid;VALPROIC ACID;Valeric acid, 2-propyl-;Valproate;Valproic acid [USAN:BAN:INN];n-Dipropylacetic acid;2 PP (base);NSC93819;WLN: QVY3 & 3;Spectrum3_001733;Baceca"	"VALPROIC ACID;2-Propylpentanoic acid;99-66-1;Dipropylacetic acid;Depakene;Depakine;2-Propylvaleric acid;Ergenyl;Di-n-propylacetic acid;Valproate;Mylproin;Pentanoic acid, 2-propyl-;4-Heptanecarboxylic acid;n-Dipropylacetic acid;Propylvaleric acid;Myproic Acid;Di-n-propylessigsaure;n-DPA;Dipropylacetate;Convulex;Depakin;Vupral;Acido valproico;Acide valproique;Acidum valproicum;Avugane;Baceca;Stavzor;Kyselina 2-propylvalerova;2-n-Propyl-n-valeric acid;Acetic acid, dipropyl-;Abbott 44090;Convulsofin;Valproinsaeure;Deproic;Savicol;Depakine chrono;Depakin chrono;Alti-Valproic;Novo-Valproic;Penta-Valproic;Dom-Valproic;Med Valproic;Nu-Valproic;Acide valproique [INN-French];Acido valproico [INN-Spanish];Acidum valproicum [INN-Latin];Di-n-propylessigsaure [German];Valeric acid, 2-propyl-;divalproex;Valproic acid USP;PMS-Valproic Acid;Epilim;Kyselina 2-propylvalerova [Czech];Di-n-propylessigsaeure;Valproic acid (USP);2-PROPYL-PENTANOIC ACID;UNII-614OI1Z5WI;2,2-di-n-propylacetic acid;NSC 93819;Depakene (TN);Depakote (TM);Valproate calcium;Valproic acid USP24;HSDB 3582;Valproic acid [USAN:INN:BAN];2 PP (base);Propylisopropylacetic Acid;EINECS 202-777-3;Valproic Acid, Sodium Salt (2:1);VPA;CHEMBL109;(n-C3H7)2CHCOOH;BRN 1750447;AI3-10500;614OI1Z5WI;CHEBI:39867;divalproex disodium;NIJJYAXOARWZEE-UHFFFAOYSA-N;G2M-777;NCGC00091149-01;Depacon (TN);DSSTox_CID_3733;Epival (TN);Depakote ER (TN);DSSTox_RID_77171;DSSTox_GSID_23733;CAS-99-66-1;SMR000499581;Valproinsaure;Novo-divalproex;Sandoz valproic;Dom-valproate;Gen-divalproex;Apo-valproic;A-44090;APO-divalproex;DOM-divalproex;Epival er;PHL-valproate;PMS-valproate;PMS-Divalproex;Dom-valproic acid;Apo-valproic syrup;PHL-valproic acid;Convulex (TN);Encorate (TN);Winthrop (TN);Epiject I.V.;Stavzor (TN);2-propyl-Pentanoate;Epical (TM);Epilim (Salt/Mix);Epilim (TN);Valproic acid [USAN:USP:INN:BAN];2-PropylpentanoicAcid;Depacon (Salt/Mix);Convulex (Salt/Mix);Eurekene (Salt/Mix);Valparin (Salt/Mix);Novo-Valproic - ECC;Spectrum_000521;Divalproex (Salt/Mix);Dom-valproic acid syrup;Ratio-Valproic - ECC;Valdisoval (Salt/Mix);ACMC-209sdq;2 -propylpentanoic acid;di-n-propyl acetic acid;AC1Q2ULA;S(-)-4-En-valproate;Spectrum2_000946;Spectrum3_001733;Spectrum4_000376;DOM-valproic acid E.C.;PHL-valproic acid E.C.;PMS-valproic acid E.C.;D04WPG;D0Y3KG;Novo-valproic soft gel cap;EC 202-777-3;AC1L1F7T;SCHEMBL2275;S-2-n-Propyl-4-pentenoate;(S)-2-propyl-4-pentanoate;KBioGR_000871;KBioGR_002277;KBioSS_001001;KBioSS_002278;KSC493G8T;MLS001076682;MLS001335927;MLS001335928;MLS002415770;BIDD:GT0858;DivK1c_000273;SPBio_000912;GTPL7009;DTXSID6023733;WLN: QVY3 & 3;CTK3J3389;KBio1_000273;KBio2_001001;KBio2_002277;KBio2_003569;KBio2_004845;KBio2_006137;KBio2_007413;KBio3_002626;KBio3_002757;KS-00000CCR;NIJJYAXOARWZEE-UHFFFAOYSA-;Valproic acid [USAN:BAN:INN];MolPort-001-791-895;NINDS_000273;HMS2089J06;HMS2231E06;HMS3259C18;HMS3370C21;HMS3715B15;ACT05281;NSC93819;Valproic Acid, SodiumSalt (2:1);ZINC3008621;Tox21_111091;Tox21_201963;Tox21_300603;ANW-41052;BDBM50003616;LMFA01020291;MFCD00002672;NSC-93819;SBB065764;STL445581;AKOS009156895;Tox21_111091_1;Valproic Acid 1.0 mg/ml in Methanol;CCG-221127;CS-1765;DB00313;LS-2068;MCULE-7136317196;NC00584;RL06134;RTR-031980;TRA0085608;NCGC00091149-02;NCGC00091149-03;NCGC00091149-04;NCGC00091149-05;NCGC00091149-06;NCGC00091149-08;NCGC00091149-09;NCGC00162288-07;NCGC00254365-01;NCGC00259512-01;AJ-44336;AN-24519;AS-11354;CPD000499581;HY-10585;KB-69563;SAM002564230;SBI-0050864.P003;AB0009719;LS-161170;TR-031980;791-EP2306789A1;FT-0609289;P0823;6400-EP1441224A2;6400-EP2272537A2;6400-EP2272827A1;6400-EP2275420A1;6400-EP2280008A2;6400-EP2298764A1;6400-EP2298765A1;6400-EP2308867A2;6400-EP2308870A2;6400-EP2311494A1;6400-EP2311840A1;6400-EP2314585A1;6400-EP2374790A1;76584-70-8 (hydrochloride salt (2:1));A19450;C07185;D00399;AB00698315-06;I04-0211;Q-200321;Sodium valproate; 2-Propylpentanoic acid sodium salt;SR-01000075242-7;F2191-0115;Z1511532065;Valproic acid, European Pharmacopoeia (EP) Reference Standard;Valproic acid, United States Pharmacopeia (USP) Reference Standard;InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10);Valproic acid for system suitability, European Pharmacopoeia (EP) Reference Standard;Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material;Valproic acid, Pharmaceutical Secondary Standard; Certified Reference Material"	99-66-1	614OI1Z5WI	"17579623;17513804"	17513804	01/05/2007	786678	01/02/1975	Bef. 1989		0	0	1	No	0	"04/05/1999 00:00;25/01/1991 00:00;28/10/1983 00:00;07/01/2015 00:00;10/01/1992 00:00;23/04/2009 00:00;31/07/2013 00:00;11/08/1986 00:00;15/12/2014 00:00;15/01/1993 00:00;15/12/2000 00:00;17/12/2006 00:00;28/02/1986 00:00;01/07/1986 00:00;15/12/1997 00:00;04/11/1981 00:00;31/10/2001 00:00;22/02/2013 00:00;28/05/2010 00:00;13/10/2006 00:00;29/09/1980 00:00;28/08/2014 00:00;26/02/2013 00:00;16/05/2000 00:00;26/12/2015 00:00;01/04/2008 00:00;22/08/2006 00:00;13/04/1987 00:00;11/06/1998 00:00;27/02/2013 00:00;02/12/1987 00:00;02/08/1994 00:00;11/12/2000 00:00;05/07/2001 00:00;12/12/2002 00:00;15/11/1996 00:00;29/10/1991 00:00;12/02/1992 00:00;13/03/2015 00:00;02/12/1996 00:00;19/06/2000 00:00;20/06/2000 00:00;02/06/1997 00:00;08/10/1997 00:00;28/02/1978 00:00;11/06/1987 00:00;23/03/1995 00:00;14/06/2013 00:00;19/06/2014 00:00;06/10/1989 00:00;31/05/1996 00:00;13/01/1995 00:00;12/03/1999 00:00;05/07/1996 00:00;10/12/1986 00:00;13/08/2015 00:00;01/12/2015 00:00;29/07/2008 00:00;02/07/1987 00:00;27/01/2000 00:00;09/12/1981 00:00;24/05/2001 00:00;31/08/1993 00:00;22/04/1988 00:00;07/05/2007 00:00;30/09/1982 00:00;26/02/2001 00:00;15/12/2006 00:00;28/02/2001 00:00;29/06/1993 00:00;02/11/2016 00:00;22/09/1998 00:00;16/01/2015 00:00;29/06/2001 00:00;10/03/2004 00:00;16/06/1980 00:00;20/01/2010 00:00;11/01/2006 00:00;25/08/1992 00:00;08/05/1998 00:00;11/02/1993 00:00;20/11/2014 00:00;25/01/2011 00:00;06/12/1999 00:00;10/12/2014 00:00;23/09/2015 00:00;15/07/1987 00:00;18/02/2016 00:00;22/12/2000 00:00;23/07/1992 00:00;16/05/1995 00:00;04/02/2009 00:00;02/04/2001 00:00;24/11/1993 00:00;13/09/1995 00:00;03/05/1979 00:00;15/03/2010 00:00;14/10/1998 00:00;30/05/1986 00:00;20/12/2000 00:00;12/01/2010 00:00;06/01/2010 00:00;23/09/2007 00:00;30/01/1996 00:00;27/11/1991 00:00;23/09/1987 00:00;23/03/1999 00:00;15/06/1987 00:00;21/03/1989 00:00;11/01/1989 00:00;05/10/2017 00:00;23/12/2015 00:00;12/01/1987 00:00;06/04/1987 00:00;20/12/1979 00:00;30/11/2015 00:00;07/10/2011 00:00;06/03/2017 00:00;18/01/2001 00:00;24/05/2002 00:00;29/07/2005 00:00;21/03/2003 00:00;07/03/2014 00:00;16/11/1990 00:00;20/08/2014 00:00;23/01/2002 00:00;05/08/2014 00:00;28/04/2016 00:00;26/09/1986 00:00;09/06/2014 00:00;04/12/1985 00:00;06/03/2018 00:00"	AP	"ECI PHARMS LLC;APOTEX INC;SUN PHARM INDS LTD;ABBVIE;PHARM ASSOC;WOCKHARDT BIO AG;VISTAPHARM;SCHERER RP;CATALENT;USL PHARMA;PAR PHARM;ANI PHARMS INC;LANNETT CO INC;BIONPHARMA INC;HIGH TECH PHARMA"	VALPROIC ACID	28/02/1978	ABBVIE	36,8	#N/A																							0						1
Bevacizumab	"anti-vegf humanized monoclonal antibody;anti-vegf monoclonal antibody;anti-vegf rhumab;bevacizumab;bevacizumab biosimilar bevz92;bevacizumab biosimilar bi 695502;bevacizumab biosimilar cbt 124;bevacizumab biosimilar fkb238;bevacizumab biosimilar mb02;bevacizumab biosimilar pf-06439535;immunoglobulin g1 (human-mouse monoclonal rhumab-vegf gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhumab-vegf light chain, dimer;recombinant humanized anti-vegf monoclonal antibody;rhumab vegf"	"antiVEGF;bevacizumab-awwb;Avastin"	"DB00112;BTD00087;BIOD00087"			216974-75-3	2S9ZZM9Q9V	"28870792;28760399;27943153;27826680;26084808;24493831;23894304;23449826;22576886;22534815;22405392;22331948;22097147;21247755;20964595;20497685;19547986;19470921;18202416;14613032"	14613032	01/11/2003	11157038	01/02/2001	1999-2003		1	1	1	Yes	1	"26/10/2012 00:00;21/12/2011 00:00;29/09/2005 00:00;08/02/2011 00:00;04/11/2008 00:00;07/05/2015 00:00;30/09/2011 00:00;20/12/2011 00:00;22/12/2004 00:00;14/08/2014 00:00;30/04/2018 00:00;16/12/2013 00:00;14/11/2014 00:00;14/09/2017 00:00;18/04/2006 00:00;30/08/2014 00:00;05/05/2009 00:00;05/12/2017 00:00;20/09/2007 00:00;28/12/2010 00:00;23/01/2013 00:00;20/11/2012 00:00;11/10/2006 00:00;21/09/2006 00:00;31/07/2009 00:00;01/12/2015 00:00;10/03/2008 00:00;03/05/2012 00:00;13/06/2018 00:00;06/12/2016 00:00;20/06/2006 00:00;26/03/2013 00:00;29/09/2015 00:00;22/02/2008 00:00;26/02/2004 00:00"	AP	"AMGEN INC;GENENTECH"	"BEVACIZUMAB;BEVACIZUMAB-AWWB"	26/02/2004	GENENTECH	36,7	25	NA	1	0	NA	1	VEGFR	0	1	0	NA	0	0	0	1	1	0	0	0	0	0,48	0	0	0	0	0	0	497	0	1
Cytarabine	"ap5280;apatinib;ara-c;arabinosyl cytosine;cytarabine;platinum polymer;yn968d1;ynk01"	"1-beta-D-Arabinofuranosylcytosine;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone;Aj-cytarabine;Citarabina;Cytarabine;Cytarabine - Pws 1gn/vial;Cytarabine - Pws 2gm/vial;Cytarabine - Pws 500mg/vial;Cytarabine Inj 100mg/ml;Cytarabine Injection;Cytarabine Injection BP;Cytarabine Injection, Mylan Std.;Cytarabine-pws 100mg/vial;Cytarabinum;Cytosar;Cytosine arabinoside;Cytosine-1-beta-D-arabinofuranoside;DepoCyt;Depocyte;PMS-cytarabine;Vyxeos;cytosine-β-D-arabinofuranoside"	"APRD00499;DB00987"	"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2-pyrimidinone;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidin-2-one;147-94-4;ZINC03795098;C02961;Cytarabine;Cytosine arabinoside;Cytosine-1-beta-D-arabinofuranoside;C1768_SIGMA;CHEBI:28680;2(1H)-Pyrimidinone, 4-amino-1-  -D-arabinofuranosyl- [CAS];MLS001066340;SMR000449317;1-beta-D-Arabinofaranosylcytosine;1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone;1-beta-D-Arabinofuranosylcytosine;1-beta-D-Arabinosylcytosine;1beta-Arabinofuranasylcytosine;1beta-D-Arabinofuranosylcytosine;1beta-D-Arabinosylcytosine;2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-;2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech];4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech];4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone;AI3-52329;Arabitin;Aracytin;Arafcyt;CCRIS 913;Citarabina [INN-Spanish];Cytarabina;Cytarabine [USAN:BAN:INN:JAN];Cytarabinum [INN-Latin];Cytosar-U;Cytosine 1-beta-D-arabinofuranoside;Cytosine arabinofuranoside;Cytosine arabinoside (VAN);Cytosine beta-D-arabinoside;Cytosine, 1-beta-D-arabinofuranosyl-;Cytosine, 1-beta-D-arabinosyl-;Cytosine-beta-D-arabinofuranoside;Cytosinearabinoside;DRG-0038;Depocyt;Depocyt (liposomal);EINECS 205-705-9;HSDB 3049;NSC 287459;Tarabine;Udicil;beta-D-Arabinosylcytosine;D00168;Depocyt (TN);1-.beta.-D-arabinofuranosyl-cytosine;Lopac0_000316;MLS000758310;SR-01000075773-3;30399_FLUKA;AR3;4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;Cytarabine (JP15/USP/INN);NCGC00093356-03;147-94-4 (FREE BASE);69-74-9 (HCL);AIDS-002313;AIDS002313;AraC;NSC287459 (FREE BASE);NSC63878 (HCL)"	"cytarabine;147-94-4;Cytosine arabinoside;Ara-C;Arabinocytidine;Cytosar;Arabinosylcytosine;Aracytidine;Cytarabin;Cytarabinoside;Tarabine;Alexan;Udicil;Cytosar-U;1-beta-D-Arabinofuranosylcytosine;Spongocytidine;Arabitin;Aracytin;Cytarabina;Arafcyt;Depocyt;Erpalfa;DepoCyte;Arabinofuranosylcytosine;Citarabina;Cytarabinum;Aracytine;Cytosinearabinoside;Cytosine-beta-D-arabinofuranoside;Cytonal;beta-D-Arabinosylcytosine;Cytosine arabinofuranoside;Depocyt (liposomal);Cytarabinum [INN-Latin];Citarabina [INN-Spanish];AraC;Cytosine beta-D-arabinoside;Cytosine beta-D-arabinofuranoside;beta-Ara C;Iretin;Cytosine-1-beta-D-arabinofuranoside;4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;1beta-D-Arabinosylcytosine;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone;Cytosine arabinose;Arabinoside C;1beta-Arabinofuranasylcytosine;Cytosine 1-beta-D-arabinofuranoside;1beta-D-Arabinofuranosylcytosine;1-beta-D-Arabinofaranosylcytosine;Cytosine arabinoside (VAN);beta-Arabinosylcytosine;arabinocytosine;Cytarbel;Beta-cytosine arabinoside;Cytosine-beta-arabinoside;Ara-Cytidine;CHX 3311;1-Arabinofuranosylcytosine;cytarabine liposome injection;Arabinosyl Cytosine;Cytosine, beta-D-arabinoside;CCRIS 913;Depocyt (TN);1-beta-D-Arabinosylcytosine;UNII-04079A1RDZ;Cytosine, 1-beta-D-arabinosyl-;1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone;HSDB 3049;(beta-D-Arabinofuranosyl)cytosine;4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one;Cytarabine [USAN:INN:BAN:JAN];EINECS 205-705-9;Cytosine, 1-beta-D-arabinofuranosyl-;CHEMBL803;NSC 287459;U 19920A;U-19,920;Cyclocide;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin;AI3-52329;2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-;AR3;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech];C9H13N3O5;CHEBI:28680;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech];cytarabine liposome;UHDGCWIWMRVCDJ-CCXZUQQUSA-N;04079A1RDZ;1-beta-D-arabinofuranosyl-cytosine;U-19920;1-.beta.-D-arabinofuranosyl-cytosine;4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon;1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside;NCGC00093356-03;2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS];NCI-C04728;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine;Intrathecal cytarabine (also known as ara-C);DSSTox_CID_2877;AC-1075;1-(arabinofuranosyl)cytosine;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;DSSTox_RID_76771;DSSTox_GSID_22877;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one;Intrathecal (injected into the spinal fluid) DepoCyt;2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-;Cytosine beta-D-arabinofuranoside hydrochloride;CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9);CAS-147-94-4;SMR000449317;Cytartbine;1-beta-arabinofuranosylcytosine;SR-01000075773;NSC287459;Cytosar-U (TN);Cytarabine [USAN:USP:INN:BAN:JAN];MK 8242;PubChem14152;beta -arabinosylcytosine;1-b-D-ribosyl-Cytosine;beta -cytosine arabinoside;beta -D-arabinosylcytosine;Cytosine-beta -arabinoside;D07XSN;AC1L1M4F;AC1Q52OJ;SCHEMBL3140;1-b-D-Ribofuranosylcytosine;1beta -D-Arabinosylcytosine;BIDD:PXR0139;cytosine-1b-D-Ribofuranoside;Lopac0_000316;69-74-9 (hydrochloride);KSC917S2P;MLS000758310;MLS001066340;MLS001424023;1-beta-D-Arabinosyl-Cytosine;1-beta-delta-ribosyl-Cytosine;BIDD:GT0371;Cytosine, beta -D-arabinoside;1beta -Arabinofuranasylcytosine;Cytarabine (JP15/USP/INN);Cytarabine (JP17/USP/INN);GTPL4827;PYR287;1-beta-D-ribofuranosyl-Cytosine;cytosine-1b-delta-Ribofuranoside;DTXSID3022877;1beta-delta-Ribofuranosylcytosine;CTK8B7927;1beta -D-Arabinofuranosylcytosine;1-(b-D-Arabinofuranosyl)cytosine;Cytosine, 1-beta -D-arabinosyl-;MolPort-001-792-509;1-beta -d-arabinofuranosylcytosine;1-beta-D-arabinofuranosyl cytosine;1-beta-delta-Ribofuranosylcytosine;Cytosine-beta -D-arabinofuranoside;HMS2051K19;HMS2090A18;HMS2230M16;HMS3713N12;1-beta -D-Arabinofaranosylcytosine;cytosine-1beta-delta-Ribofuranoside;1-beta-delta-ribofuranosyl-Cytosine;BTB15125;ZINC3795098;Tox21_111203;Tox21_301971;ANW-58969;BDBM50087289;CCG-51297;EBD145460;GP6403;LS-860;MFCD00066487;s1648;(non-labelled)Cytarabine-13C-15N2;AKOS007930145;AKOS015896896;AM84428;CS-2177;Cytosine, 1-beta -D-arabinofuranosyl-;DB00987;KS-5063;MCULE-3945147956;NC00070;RL01868;KS-0000022L;NCGC00093356-04;NCGC00093356-05;NCGC00093356-06;NCGC00142483-02;NCGC00255381-01;AJ-45634;AK-54744;CPD000449317;HY-13605;KB-09511;SAM001247012;SRI-10828-19;SRI-10828-20;SRI-10828_24;SY004943;AB0005212;AX8008499;SL-000002;TL8001048;TR-008148;FT-0082880;FT-0624314;ST24043183;C02961;D00168;J10463;K-4708;10163-EP2272828A1;10163-EP2284920A1;10163-EP2287165A2;10163-EP2287166A2;10163-EP2292603A1;10163-EP2292620A2;10163-EP2298764A1;10163-EP2298765A1;10163-EP2298774A1;10163-EP2299509A1;10163-EP2301921A1;10163-EP2301926A1;10163-EP2301936A1;10163-EP2308843A1;10163-EP2314558A1;10163-EP2316452A1;10163-EP2371810A1;10163-EP2372804A1;10163-EP2378585A1;15153-EP2270018A1;15153-EP2272832A1;15153-EP2275420A1;15153-EP2277565A2;15153-EP2277566A2;15153-EP2277567A1;15153-EP2277568A2;15153-EP2277569A2;15153-EP2277570A2;15153-EP2277865A1;15153-EP2292280A1;15153-EP2295055A2;15153-EP2295416A2;15153-EP2295426A1;15153-EP2295427A1;15153-EP2298748A2;15153-EP2298764A1;15153-EP2298765A1;15153-EP2298768A1;15153-EP2298778A1;15153-EP2298780A1;15153-EP2301928A1;15153-EP2305642A2;15153-EP2305689A1;15153-EP2308833A2;15153-EP2308855A1;15153-EP2308861A1;15153-EP2311453A1;15153-EP2311808A1;15153-EP2311825A1;15153-EP2311829A1;15153-EP2311840A1;15153-EP2311842A2;15153-EP2314590A1;15153-EP2316832A1;15153-EP2316833A1;15187-EP2270008A1;15187-EP2280012A2;15187-EP2281815A1;15187-EP2292233A2;15187-EP2292615A1;15187-EP2292617A1;15187-EP2301928A1;15187-EP2301933A1;15187-EP2305640A2;15187-EP2305671A1;15187-EP2308833A2;15187-EP2311827A1;15187-EP2311840A1;15187-EP2316832A1;15187-EP2316833A1;147C944;4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone;C-55053;SR-01000721860;Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine;J-520199;J-700005;J-700166;SR-01000075773-3;SR-01000075773-5;SR-01000721860-6;1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone;2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl;BRD-K33106058-001-07-7;BRD-K33106058-003-20-6;2(1H)-Pyrimidinone, 4-amino-1-|A-D-arabinofuranosyl-;2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-;4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone;Z1522566619;2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-;2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS];Cytarabine, European Pharmacopoeia (EP) Reference Standard;1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine;Cytarabine, United States Pharmacopeia (USP) Reference Standard;Cytarabine; 2(1H)-Pyrimidinone,4-amino-1-a-Darabinofuranosyl-;Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC);1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine;Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%;Cytarabine, Pharmaceutical Secondary Standard; Certified Reference Material;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one"	147-94-4	04079A1RDZ	"11026699;15161693;15459213;20858843;20923544;24015841;24732960;8890711;9766508"	8890711	01/10/1996	5222143	01/06/1966	Bef. 1989		0	0	1	Yes	1	"18/11/2003 00:00;23/02/1979 00:00;21/09/1994 00:00;31/08/1994 00:00;23/09/1994 00:00;09/06/1994 00:00;17/06/1969 00:00;24/02/1987 00:00;13/10/2000 00:00;25/02/1993 00:00;01/04/1999 00:00;16/03/2015 00:00;26/01/1993 00:00;17/10/1994 00:00;28/03/1998 00:00;29/10/1979 00:00;02/10/2003 00:00;23/12/2014 00:00;28/11/2000 00:00;27/09/1994 00:00;09/08/2013 00:00;01/03/2001 00:00;15/01/1991 00:00;04/01/1995 00:00;14/05/2001 00:00;12/05/2000 00:00;17/10/2000 00:00;15/10/1998 00:00;18/05/2000 00:00;09/04/2015 00:00;28/05/1993 00:00;02/08/1989 00:00;11/05/1983 00:00;04/08/2015 00:00;02/06/1997 00:00;11/07/1997 00:00;30/12/1998 00:00;13/08/2014 00:00;03/04/2000 00:00;17/07/2018 00:00;31/08/1990 00:00;30/09/1992 00:00;17/04/1987 00:00;11/08/2011 00:00;21/07/1995 00:00;30/01/2012 00:00;16/04/1997 00:00;25/03/1991 00:00;16/01/2015 00:00;01/11/1995 00:00;03/06/1997 00:00;18/12/1990 00:00;28/02/1994 00:00;18/06/2004 00:00;04/06/1990 00:00;19/04/2007 00:00;22/11/1999 00:00;15/01/2004 00:00;19/04/2004 00:00;28/07/1986 00:00;31/03/1981 00:00;13/10/2015 00:00;31/01/1986 00:00;26/01/2017 00:00;14/06/1995 00:00;21/10/1983 00:00;21/12/1987 00:00;18/09/2015 00:00;08/08/2000 00:00;23/03/1999 00:00;24/01/1996 00:00;03/08/2017 00:00;30/12/1982 00:00;31/12/1990 00:00;09/11/2017 00:00;13/12/2011 00:00;23/04/2014 00:00;23/10/1975 00:00;28/04/1995 00:00;10/03/1976 00:00;27/03/2001 00:00;12/08/2015 00:00;23/05/1994 00:00;22/04/1991 00:00;05/01/2001 00:00;31/12/2002 00:00;15/03/1991 00:00;24/04/1974 00:00;05/07/1994 00:00;08/01/1990 00:00"	AP	"#N/A;TEVA PHARMS USA;FRESENIUS KABI USA;PACIRA PHARMS INC;MYLAN LABS LTD;TEVA PARENTERAL;WEST-WARD PHARMS INT;CELATOR PHARMS;HOSPIRA"	"CYTARABINE; DAUNORUBICIN "	17/06/1969	TEVA PARENTERAL	36,5	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Alitretinoin	"9-cis retinoic acid;alitretinoin;all-trans retinoic acid;all-trans-retinoic acid;alrt1057;lgd1057;tretinoin"	"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;(7E,9Z,11E,13E)-retinoic acid;9(Z)-Retinoic acid;9-cis-Tretinoin;9-cis-retinoic acid;Alitretinoin;Alitretinoinum;Alitretinoína;Alitrétinoïne;Panretin;Toctino"	"APRD00017;DB00523"	"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;5300-03-8;302-79-4;56573-65-0;7005-78-9;Effederm [France];Epi-aberel;Eudyna;HSDB 2169;NSC 122758;NSC-122758;Retin-A;Retinoic acid, all-trans-;TRETINOIN;Tretinoin [USAN:BAN:INN];Tretinoina [INN-Spanish];Tretinoine [INN-French];Tretinoino [INN-Spanish];Tretinoinum [INN-Latin];Vesanoid;Vitamin A acid, all-trans-;Vitamin A1 acid, all-trans-;Vitamin a acid, trans-;beta-RA;LS-1154;(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid;NCI60_000538;KBioGR_000051;Bio2_000220;Retinoic acid, all-trans- (8CI);Vesnaroid;all-trans-b-Retinoic acid;b-Retinoic acid;Prestwick1_000256;Prestwick1_000257;DivK1c_006792;NINDS_000903;Bio1_001084;ATRA;CBiol_001820;BPBio1_000082;Bio2_000215;Bio2_000700;KBio2_002619;Bio1_001086;KBio2_005187;CBiol_001822;(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL);AGN 100335;Acide retinoique (French) (DSL);C00777;Retinoic acid;Ro 1-5488;Tretin M;Tretinoine (French) (EINECS);Vitamin A acid;all-(E)-Retinoic acid;all-trans-Retinoic acid;all-trans-Tretinoin;all-trans-Vitamin A acid;all-trans-Vitamin A1 acid;all-trans-beta-Retinoic acid;beta-Retinoic acid;trans-Retinoic acid;EU-0101061;KBioSS_002156;Retinova;IDI1_000903;SPBio_002165;Prestwick_424;BSPBio_001500;Bio1_000106;KBio3_000101;KBio2_002156;KBio2_004724;KBio2_007292;R2625_SIGMA;Atralin;Bio1_000110;KBio3_000102;KBio3_000430;Retin-A Micro;Spectrum3_001793;Bio2_000531;KBio1_000903;Alitretinoin (USAN);D02815;Panretin (TN);REA;LMPR01090019;Tretinoin/All-Trans Retinoic Acid;KBioGR_000215;KBioSS_000215;KBioGR_000220;KBioSS_000220;Prestwick0_000256;Prestwick0_000257;SpecPlus_000696;KBio2_000215;KBio2_002783;Bio2_000051;KBio2_000220;SPBio_002291;KBio2_002788;SPBio_002293;KBio2_005356;Atragen;MLS000028588;KBioSS_000051;Bio1_000595;TRETINON;Bio1_000597;KBio1_001736;Bio1_000599;CBiol_001824;Bio1_000108;Spectrum4_000901;2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-;AIDS-000179;AIDS000179;KBio3_002847;DivK1c_000903;.beta.-Retinoic acid;2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-;NSC122758;Retionic acid;Tretinoin, all-trans-;WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1;WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1;all trans-Retinoic acid;Retin A;Retin A (TN);Tretinoin (JAN/USP/INN);Tretinoin (TN);Vesanoid (TN);Avita (TN);D00094;KBioGR_001362;Renova;Renova (TN);2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-;9(Z)-Retinoic acid;9-CIS-RETINOIC ACID;9-cis-Tretinoin;AGN 192013;ALRT 1057;Alitretinoin;Alitretinoin [USAN];CCRIS 7098;DRG-0281;HSDB 7186;LGD 100057;LGD 1057;NSC 659772;Panretin;Panretin Gel;Panretyn;Panrexin;Retinoic acid, 9-cis-;Retinoic acid, cis-9,trans-13-;Retacnyl;BSPBio_000074;Prestwick2_000257;SMR000058245;KBio2_005351;Spectrum5_001746;Lopac0_001061;Spectrum5_001933;SPECTRUM1502016;KBio2_000051;Spectrum2_001983;NCGC00021808-09;IDI1_033970;Prestwick3_000257;KBio3_000429;<i>trans</i>-Retinoic Acid;Alltrans-retinoic acid;Bio2_000695;Avitoin [Norway];KBio3_000439;KBio3_000440;3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;CHEBI:15367;Bio1_001088;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;Cordes VAS [Germany];Spectrum_001676;15-Apo-beta-caroten-15-oic acid;2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid;4-09-00-02387 (Beilstein Handbook Reference);A-Acido (Argentina);A-Vitaminsyre [Denmark];Aberel;Aberela [Norway];Acid A Vit (Belgium, Netherlands);Acnavit [Denmark];Airol;Aknefug;Aknoten;ST057075;NCGC00021808-05;BRN 2057223;CCRIS 3294;NCGC00021808-06;Cordes vas;DRG-0147;Dermairol;EINECS 206-129-0;Effederm"	"Alitretinoin;9-CIS-RETINOIC ACID;Panretin;9-cis-Tretinoin;Panrexin;Panretyn;5300-03-8;Panretin Gel;Toctino;9-cis Retinoic Acid;9(Z)-Retinoic acid;(9cis)-retinoic acid;alitretinoina;alitretinoine;alitretinoinum;Panretin (TN);Alitretinoin (USAN);Alitretinoin [USAN];ALRT-1057;trans-Vitamin a acid;9 Cis Retinoic Acid;9-cis RA;ALRT 1057;BAL4079;LGD-1057;Retinoic acid, 9-cis-;9CRA;[3H]9-cis-retinoic acid;CHEMBL705;UNII-1UA8E65KDZ;AGN 192013;AGN-192013;LGD 100057;[3H]-9-cis-retinoic acid;1UA8E65KDZ;9-CRA;9C-RA;Atragen;Retinova;LG-100057;ALRT1057;BML2-E06;CCRIS 7098;CHEBI:50648;HSDB 7186;LGD1057;SHGAZHPCJJPHSC-ZVCIMWCZSA-N;Retinoic acid, cis-9,trans-13-;Tretinoin (TN);BAL-4079;LGD 1057;(7E,9Z,11E,13E)-retinoic acid;(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;NSC 659772;NSC-659772;9-cis-RA;9-cis-Retinoate;Retin A (TN);Ro-04-4079;LG100057;Isotretinoin Retinoic acid;Tretinoina;Tretinoinum;trans-Retinoate;beta-Retinoate;Acid, Retinoic;Retisol-A;Acid, Vitamin A;Vesanoid (TN);trans Retinoic Acid;Tretinoin Zinc Salt;Acid, trans-Retinoic;Salt, Tretinoin Zinc;Zinc Salt, Tretinoin;(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid;(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-;B-retinoate;9-Retinoate;9-Retinoic acid;Isotretinoin retinoate;All-trans-b-retinoate;9-(Z)-retinoic Acid;Tretinoin (JAN/USP);alpha-acido (argentina);All-trans-beta-retinoate;Spectrum5_001935;D09RQU;D0G3PI;D0Y3LW;AC1L9MT9;alpha-vitaminsyre [denmark];DSSTox_CID_20404;DSSTox_RID_79490;all-trans- Vitamin A1 acid;DSSTox_GSID_40404;SCHEMBL18666;BSPBio_001495;Tretinoin/all-trans retinoate;Tretinoin [USAN:BAN:INN];15-Apo-beta-caroten-15-oate;Alitretinoin [USAN:INN:BAN];GTPL2645;GTPL5383;DTXSID6040404;UPCMLD-DP097:001;UPCMLD-DP097:002;BDBM31892;Alitretinoin|||Retinoid analogues;MolPort-002-507-281;HMS1361K17;HMS1791K17;HMS1989K17;HMS3402K17;(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid;Tox21_302195;LMPR01090022;MFCD00270072;NSC659772;STK801887;ZINC12661824;AKOS005622553;CCG-208266;DB00523;LS-1328;IDI1_033965;9-cis-Retinoic acid, >=98% (HPLC);NCGC00161590-01;NCGC00161590-02;NCGC00161590-03;NCGC00161590-04;NCGC00161590-05;NCGC00161590-06;NCGC00161590-07;NCGC00255697-01;AJ-63024;CAS-5300-03-8;BB 0261656;C15493;D02815;42156-EP2295426A1;42156-EP2295427A1;42156-EP2311808A1;42156-EP2311829A1;42156-EP2311840A1;300R038;SR-05000013784;SR-05000013784-1;W-200595;9-CIS-RETINOIC ACID (SEE RETINOID PROJECT 6);BRD-K35483542-001-02-3;(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;(2E,4E.6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexan-1-yl)-2,4,6,8-nonatetraenoic acid"	08/03/5300	1UA8E65KDZ	"10741706;11115156;11142476;11352969;11595692;9025769;9547674;9626460;9816171"	9816171	01/02/1996	9816171	01/02/1996	1994-1998		1	1	1	Yes	1	"22/11/2013 00:00;21/11/2000 00:00;02/02/1999 00:00;12/07/1999 00:00"	AP	EISAI INC	ALITRETINOIN	02/02/1999	VALEANT INTL	36,0	22	NA	1	0	NA	1	RXRA	0	1	0	NA	0	0	0	0	1	0	0	0	0	NA	0	0	0	0	0	0	58	0	1
Sorafenib	"bay 43-9006;sorafenib"	"N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide;Sorafenibum;Nexavar"	"DB00398;APRD01304;DB07438"	"4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;284461-73-0;Sorafenib;Sorafenib [INN];4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAX;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;K00597a;BAY-43-9006;BAY-54-9085;NSC-724772;2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide;4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate;BAY 43-9006;N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea"	"Sorafenib;284461-73-0;Nexavar;BAY 43-9006;Sorafenib [INN];sorafenibum;4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide;UNII-9ZOQ3TZI87;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE;SORAFENIB BASE;N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea;9ZOQ3TZI87;CHEMBL1336;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide;CHEBI:50924;Sorafenib (INN);4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAY-43-9006;Sorafenib tosilate;BAY 545-9085;BAY-545-9085;Nexavar (TN);Sorafenib (Nexavar);2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-;4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate;4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea;100012-18-8;2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-;4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide;BAX;N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea;NSC-724772;BAY-54-9085;NCGC00167488-01;Sorafinib;Sorafenib [USAN:INN:BAN];SR-00000000529;HSDB 8173;1uwh;3gcs;3heg;4asd;Hit compound, 8;Sorafenib, 4;4-[4-([[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL]AMINO)PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAY43-9006;Kinome_766;Sorafenib (USAN/INN);Nexavar (TN) (Bayer);D0W5HK;EC 608-209-4;AC1L50CF;SCHEMBL8218;Sorafenib (Pan-TK inhibitor);cid_216239;GTPL5711;QCR-65;DTXSID7041128;RAF1 KINASE INHIBITOR II;BDBM16673;Nexavar|||BAY 43-9006;SYN1082;MLDQJTXFUGDVEO-UHFFFAOYSA-N;MolPort-003-850-270;BCPP000064;HMS2043A18;HMS3244A15;HMS3244A16;HMS3244B15;HMS3656N20;K00597a;ACT06732;AOB87782;ZINC1493878;284461-73-0 (free base);AN-613;BAY439006;CS0056;MFCD06411450;NSC747971;RS0103;s7397;STK627350;AKOS005560229;AC-1674;ACN-032355;BAY 439006;CS-1590;DB00398;MCULE-6112506696;NSC-747971;PB14443;SF-0529;BAY-43-0006;KS-0000009E;Sorafenib free base (BAY-43-9006);NCGC00167488-02;NCGC00167488-03;NCGC00167488-04;NCGC00167488-05;NCGC00167488-07;BC679588;EN002709;HY-10201;KB-60586;KB-80670;SC-19355;AB0019677;AB1004622;LS-186067;LS-187021;LS-187788;AM20090614;FT-0650736;D08524;J10391;15216-EP2272827A1;15216-EP2298778A1;15216-EP2311840A1;15216-EP2316832A1;15216-EP2316833A1;AB00933189-05;AB00933189-06;AB00933189_08;461S730;I06-0856;Q-201728;SR-00000000529-1;BRD-K23984367-001-01-8;Z89277543;4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido) phenoxy)-N-methylpicolinamide;4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido)phenoxy)-N-methylpicolinamide;N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea;1-(4-(2-(METHYLCARBAMOYL)PYRIDIN-4-YLOXY)PHENYL)-3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREA;4-(4-[3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO]-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID METHYLAMIDE;4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide;4-[4-([[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL]AMINO)PHENOXY]-N-METHYL-2-PYRIDINECARBOXAMIDE;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid;4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide;4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methyl-pyridine-2-carboxamide;N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-((4-(2-(N-METHYL-CARBAMOYL)(4-PYRIDYLOXY))PHENYL)AMINO)CARBOXAMIDE;N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide"	284461-73-0	9ZOQ3TZI87	"28202227;27943153;26972645;26867886;26644411;24554062;23788485;23749944;23449826;22962440;21954442;21726819;20521052;19255312;18477034;17953709;16061863;15598035"	15598035	01/12/2004	12503822	01/12/2002	1999-2003		1	0	1	Yes	1	"22/11/2013 00:00;05/03/2007 00:00;26/10/2010 00:00;16/11/2007 00:00;31/05/2016 00:00;22/03/2011 00:00;01/12/2005 00:00;30/10/2013 00:00;22/12/2017 00:00;14/10/2011 00:00;02/12/2014 00:00;11/06/2013 00:00;24/08/2012 00:00"	"AP;TA"	"BAYER HLTHCARE;MYLAN PHARMS INC"	"SORAFENIB;SORAFENIB TOSYLATE"	01/12/2005	BAYER HLTHCARE	35,9	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Afatinib	afatinib	"Afatinibum;Giotrif;Gilotrif"	DB08916		"Afatinib;439081-18-2;850140-72-6;Tovok;BIBW2992;BIBW 2992;Tomtovok;BIBW-2992;(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;Afatinib (BIBW2992);Gilotrif;afatinibum;UNII-41UD74L59M;Afatinib maleate;Tovok,BIBW2992;(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide;CHEMBL1173655;CHEBI:61390;41UD74L59M;(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide;S1011;(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide;J-500781;J-502300;(2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3s)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-2-butenamide;(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3''S'')-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2-butenamide;C24H25ClFN5O3;Afatinib [USAN:INN];Afatinib E-Isomer;(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl)-amide;(E)-4-Dimethylamino-but-2-enoic acid-[4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl]-amide;2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-;Afatinib, Free Base;Tovok (TN);BIBW2992,Afatinib;PubChem22403;Afatinib (USAN/INN);Tovok, BIBW2992;EGFR inhibitor 2nd gens;BIBW2992 - Afatinib;D05UFG;Tovok|||BIBW 2992;(2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide;MLS006010000;BIFK0010;GTPL5667;CHEBI:94698;EX-A065;QCR-169;MolPort-009-679-394;ULXXDDBFHOBEHA-CWDCEQMOSA-N;ZX-AFC000305;BCPP000338;(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;AMX10177;AOB87785;ZINC3976838;BIBW2992/Tovok,BIBW-2992;3123AC;ABP000859;AN-537;BDBM50322823;NSC750691;AKOS015850681;AKOS015904219;AKOS025149636;BCP9000407;DB08916;EX-8656;NSC-750691;PB28439;RL05240;NCGC00185000-01;AC-26079;AC-27018;AJ-47553;AM808098;DS-14172;KB-47976;KB-74529;SC-66830;SC-87772;SMR004701084;AB0033685;AX8164181;AX8210970;TC-162525;TC-163608;FT-0083487;ST24036355;X7366;A15572;D09724;Q-3651;AB01565886_02;081B182;SR-01000941576;SR-01000941576-1;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino;BRD-K66175015-001-01-7;I14-17009;(2E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-oxolane-3-yl]oxy]quinazoline-6-yl]-4-(dimethylamino)-2-buteneamide;(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6yl)-amide;(E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide;(S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;2-BUTENAMIDE, N-[4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7-[[(3S)-TETRAHYDRO-3-FURANYL]OXY]-6-QUINAZOLINYL]-4-(DIMETHYLAMINO)-;N-[4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7-[[(3S)-TETRAHYDRO-3-FURANYL]OXY]-6-QUINAZOLINYL]-4-(DIMETHYL 2-BUTENAMIDE]"	850140-72-6	41UD74L59M	"26705063;25140039;23813493"	23813493	01/07/2013	20679611	01/08/2010	2009-2012		1	1	1	Yes	1	"15/04/2016 00:00;20/04/2016 00:00;06/11/2017 00:00;21/11/2013 00:00;09/11/2015 00:00;28/12/2015 00:00;12/07/2013 00:00;04/10/2016 00:00;23/07/2013 00:00;12/01/2018 00:00;31/07/2014 00:00"	AP	BOEHRINGER INGELHEIM	AFATINIB DIMALEATE	12/07/2013	BOEHRINGER INGELHEIM	35,3	53	NA	1	0	NA	1	"EGFR;HER2"	0	1	0	NA	1	0	0	1	1	0,06	0	0	0	0,13	0	0	0	0	0	0	271	0	1
Asparaginase Escherichia coli	"l-asparaginase;l-asparaginase encapsulated in red blood cells"	"Asparaginase;Asparaginase (E. coli);Colaspase;Escherichia coli L-asparaginase;Kidrolase;L-asparaginase;L-asparagine amidohydrolase;Spectrila"	"BIOD00011;BTD00011;DB00023"			9015-68-3	G4FQ3CKY5R	"11221967;12833461;21332712;26355551"	11221967	01/02/2001	26355551	01/09/2015	2013-2017		1	1	0	Yes	1					30/07/2018		34,9	12	NA	0	1	PANCREAS	1	ASPARAGINE	0	1	0	NA	0	0	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	22	0	1
Erdafitinib	"erdafitinib;jnj-42756493"		DB12147		"Erdafitinib;1346242-81-6;JNJ-42756493;UNII-890E37NHMV;890E37NHMV;Erdafitinib [USAN:INN];Erdafitinib (USAN/INN);GTPL9039;SCHEMBL2583760;CHEMBL3545376;MolPort-044-560-398;JNJ-42756493 (Erdafitinib);BCP20346;s8401;AKOS030526429;compound 4 [WO2011135376];ZINC168520308;CS-4988;DB12147;JNJ42756493;1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-;AC-30222;AS-35040;HY-18708;JNJ 42756493;KB-333716;D10927;5SF;N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine;N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine"	1346242-81-6	890E37NHMV	26324363	26324363	01/09/2015	26324363	01/09/2015	2013-2017		1	1	0	Yes	1					30/07/2018		34,9	65	NA	1	0	NA	1	FGFR	0	1	0	NA	1	0	0	1	1	0,22	0	0	0	0,91	0	0	0	0	0	0	0	0	1
Defactinib	"defactinib;pf-04554878;vs-6063"		DB12282		"Defactinib;1073154-85-4;VS-6063;PF-04554878;UNII-53O87HA2QU;Defactinib (VS-6063, PF-04554878);53O87HA2QU;PF-4554878;1345713-71-4;Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-;N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide;Defactinib [USAN:INN];Defactinib (USAN/INN);D0V6EV;D0Y1UO;GTPL7910;SCHEMBL1627234;C20H21F3N8O3S;CHEMBL3137331;FAK inhibitors (cancer), Pfizer;Defactinib (PF-04554878);MolPort-035-789-735;AOB87723;EX-A1037;EX-A1049;2361AH;s7654;AKOS026750300;ZINC103297739;CS-3410;DB12282;AS-17045;BC600623;DA-45890;HY-12289;KB-332267;PF-941222;FT-0706351;FT-0721609;Defactinib (VS-6063  PF-04554878);J3.502.756D;D10618;J-690021;7KD;N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide"	1073154-85-4	53O87HA2QU	"27025608;26334219"	26334219	01/09/2015	26334219	01/09/2015	2013-2017		1	1	0	Yes	1					30/07/2018		34,9	46	NA	1	0	NA	1	"FAK;PYK2"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,16	0	0	0	0	0	0	0	0	1
Nirogacestat	"gamma secretase inhibitor pf-03084014;pf-03084014"		DB12005		"Nirogacestat;PF-03084014;PF-3084014;1290543-63-3;UNII-QZ62892OFJ;PF 3084014;PF-03084014 (PF-3084014);QZ62892OFJ;865773-15-5;Z-3181;PF03084014;Nirogacestat [USAN];Nirogacestat (USAN/INN);D00GPQ;GTPL7746;CHEMBL1770916;SCHEMBL13184754;DTXSID60235679;EX-A855;MolPort-039-193-852;(2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide;s8018;ZINC38217837;AKOS030526383;CS-1689;DB12005;(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide;HY-15185;KB-79885;FT-0700381;D10960;PF-03084014;PF-3084014;865773-15-5;;(2S)-2-{[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino}-N-(1-{1-[(2,2-dimethylpropyl)amino]-2-methylpropan-2-yl}-1H-imidazol-4-yl)pentanamide"	1290543-63-3	QZ62892OFJ	26407235	26407235	01/09/2015	26407235	01/09/2015	2013-2017		1	1	0	Yes	1					30/07/2018		34,9	8	43	0	1	"T-ALL;T-LBL"	1	gamma secretase	0	1	0	NA	1	0	0	1	1	0,13	0	1	1	0,13	0	0	0	0	0	0	0	0	1
Bexarotene	"bexarotene;lgd1069"	"Targretyn;4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid;P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid;Bexaroteno;4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid;p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid;Bexarotene;Targrexin;Bexaroten;Bexarotène;Bexarotenum;Targretin;Bexarotene"	"DB00307;APRD00114"	"4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid;4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid;4-[1-(1,1,4,4,7-pentamethyl-6-tetralinyl)vinyl]benzoic acid;153559-49-0;4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid;4-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid;Benzoic acid, 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)-;Bexarotene [USAN];LG 1069;LG100069;LGD 1069;Targretin;Targretyn;Targrexin;LS-38306;Bexarotene;Bexarotene (USAN);D03106;Targretin (TN)"	"Bexarotene;153559-49-0;Targretin;Targrexin;Targretyn;LGD 1069;Targret;bexarotenum;LGD1069;Bexarotene [USAN];bexaroteno;Bexaroten;Targretin-gel;LG100069;LGD-1069;Targretin (TN);UNII-A61RXM4375;LG 1069;HSDB 7453;CHEMBL1023;p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid;LG 100069;LG-100069;166175-31-1;CHEBI:50859;A61RXM4375;4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid;LG1069;4-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid;NCGC00181016-01;4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl]benzoic acid;DSSTox_CID_20619;DSSTox_RID_79514;DSSTox_GSID_40619;4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid;4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]benzoic acid;4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid;4-[1-3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthaleneyl)vinyl]benzene carboxylic acid;Benzoic acid, 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)-;LG69 compound;9RA;3-methyl-TTNEB;CAS-153559-49-0;SR-05000001480;Bexarotene [USAN:INN:BAN];4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl]benzoic acid;LG 69;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]-benzoic acid;4k6i;Elan brand of bexarotene;Bexarotene (USAN/INN);Bexarotene oral(targretin);Ligand brand of bexarotene;D0N0RU;AC1L32UG;SCHEMBL9025;BIDD:PXR0021;MLS006010146;Bexarotene (JAN/USAN/INN);GTPL2807;Bexarotene, >=98% (HPLC);DTXSID1040619;CTK8E7385;AOB1247;QCR-117;MolPort-003-845-030;NAVMQTYZDKMPEU-UHFFFAOYSA-N;HMS2089L14;HMS3655D19;ACT03911;KS-00000NW6;ZINC1539579;Tox21_112666;Tox21_302407;AN-616;BDBM50032675;BG0619;DL-298;MFCD00932428;NSC747528;s2098;AKOS015902814;Tox21_112666_1;BCP9000396;CCG-221823;CS-0626;DB00307;MCULE-3783114634;NSC-747528;RL01964;RTX-011348;SS-4628;NCGC00181016-02;NCGC00181016-03;NCGC00181016-04;NCGC00255426-01;Ro 26-4455;AC-24569;AJ-26838;AK-64115;AT-22934;HY-14171;LS-38306;SC-19638;SC-50515;SMR001614557;SR 11247;BCP0726000106;AB0009892;AB2000502;KB-188553;FT-0657110;FT-0702645;ST24046138;D03106;W-5228;42161-EP2295426A1;42161-EP2295427A1;42161-EP2298768A1;42161-EP2308861A1;42161-EP2311808A1;42161-EP2311829A1;42161-EP2311840A1;AB01275475-01;AB01275475_02;559B490;A809441;I14-1941;J-009026;J-519847;SR-05000001480-1;SR-05000001480-2;BRD-K92441787-001-02-5;4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid;4-[1-(5,6,7,8-TETRAHYDRO-3,5,5,8,8-PENTAMETHYL-2-N;4-[1-(3,5,5,8,8-Pentamethyl-2-5,8-dihydronaphthyl)vinyl]benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-vinyl]benzoic acid;4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid;4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-ethenyl]benzoic acid;Benzoic acid,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-;p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid"	153559-49-0	A61RXM4375	"24723466;18765556;11902983;10430065"	10430065	01/08/1999	9053506	01/02/1997	1994-1998		1	1	1	Yes	1	"21/04/2003 00:00;29/12/1999 00:00;06/01/2012 00:00;14/09/2015 00:00;22/07/2013 00:00;28/06/2000 00:00;29/01/2002 00:00;08/05/2018 00:00;12/08/2014 00:00;29/07/2015 00:00;08/04/2011 00:00;14/03/2002 00:00;09/02/2015 00:00;02/12/2014 00:00;14/02/2001 00:00;16/05/2011 00:00"	AP	"#N/A;VALEANT LUXEMBOURG;BIONPHARMA INC"	BEXAROTENE	29/12/1999	VALEANT LUXEMBOURG	34,8	52	NA	1	0	NA	1	RXRA	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	176	0	1
Avelumab	avelumab	Bavencio	DB11945			1537032-82-8	KXG2PJ551I	"28373007;28373005"	28373007	01/04/2017	27592805	01/05/2014	2013-2017	DOI: 10.1200/jco.2014.32.15_suppl.3064	1	1	1	Yes	1	"12/10/2017 00:00;23/03/2017 00:00;25/04/2017 00:00;09/05/2017 00:00"	AP	EMD SERONO INC	AVELUMAB	23/03/2017	EMD SERONO INC	34,7	27	77	1	0	NA	1	PD-L1	0	1	1	NA	0	0	0	0	1	NA	0	NA	0	NA	0	MYOCARDITIS	1	0	0	0	46	0	1
Leflunomide	"leflunomide;su101"	"5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide;Leflunomida;Leflunomidum;Lefunomide;5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide;alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide;Leflunomide;Mylan-leflunomide;Apo-leflunomide;PHL-leflunomide;Repso;Leflunomide Winthrop;Leflunomide Teva;Leflunomide;Sandoz Leflunomide;Arava 10mg;Leflunomide Ratiopharm;PMS-leflunomide;Teva-leflunomide;Ntp-leflunomide;Arava;Arava 20 mg;Nu-leflunomide;Dom-leflunomide;Odan-leflunomide;Arava 100 mg;Leflunomide Medac"	"DB01097;APRD00205"	"5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide;5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide;75706-12-6;210165-51-8;SPECTRUM1503927;LS-86580;C07905;Leflunomide;AIDS009747;Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-;NSC677411;EU-0100649;IDI1_000916;KBio2_000802;NCGC00015610-01;KBioSS_000802;NCGC00022625-05;AP-501/42475599;NCGC00022625-06;4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl;5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide;L5025_SIGMA;Spectrum_000322;NCGC00022625-07;Spectrum5_000850;CAS-75706-12-6;SU 101;4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-;5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide;5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide;Arava;HSDB 7289;HWA 486;Leflunomida [INN-Spanish];Leflunomide [USAN:INN];Leflunomidum [INN-Latin];N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide;SU 101 (pharmaceutical);alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide;Lopac0_000649;Arava (TN);NCGC00015610-02;Leflunomide (JAN/USAN/INN);KBio2_003370;HWA-486;RS-34821;SU-101;Prestwick2_000772;AIDS-009747;Prestwick1_000772;NINDS_000916;SPBio_002783;LEFUNAMIDE;KBio2_005938;KS-1076;D00749;BPBio1_000930;Prestwick3_000772;Prestwick0_000772;BSPBio_000844;KBio1_000916;5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide;Prestwick_87;ZINC00004840;MLS000069648;DivK1c_000916;Lopac-L-5025;SMR000058209;5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide;CHEBI:6402"	"leflunomide;75706-12-6;Arava;Leflunomidum;lefunamide;Leflunomida;HWA 486;Leflunomidum [INN-Latin];HWA-486;5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide;Leflunomida [INN-Spanish];SU 101 (pharmaceutical);Arava (TN);Leflunomid;Repso;leflunomide medac;Lefunomide [Inn-Spanish];Leflunomide [USAN:INN];SU101;5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide;UNII-G162GK9U4W;SU-101;5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide;5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide;5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide;4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-;alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide;HSDB 7289;CHEMBL960;avara;lefumide;RS-34821;Leflunomide (JAN/USAN/INN);MLS000069648;CHEBI:6402;G162GK9U4W;N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide;5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide);SU 101;N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide;NCGC00015610-02;SMR000058209;5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide;4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-;CAS-75706-12-6;DSSTox_CID_3201;L 5025;DSSTox_RID_76923;DSSTox_GSID_23201;5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide;4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl;4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl);SR-01000000191;Lefunomide;Arabloc;Prestwick_87;Arava, Leflunomide;Leflunomide [USAN:USP:INN:BAN];SULOL;Spectrum_000322;AC1L1GYK;AC1Q2EVA;Opera_ID_1709;Prestwick0_000772;Prestwick1_000772;Prestwick2_000772;Prestwick3_000772;Spectrum5_000850;Lopac-L-5025;D08ROP;SCHEMBL5057;Aventis Brand of Leflunomide;Hoechst Brand of Leflunomide;BIDD:PXR0189;Lopac0_000649;BSPBio_000844;KBioSS_000802;Leflunomide, Immunosuppressant;MLS001076267;DivK1c_000916;SPECTRUM1503927;SPBio_002783;BPBio1_000930;GTPL6825;ISO054;ZINC4840;DTXSID9023201;CTK8G0535;HMS502N18;KBio1_000916;KBio2_000802;KBio2_003370;KBio2_005938;KS-00000KQI;AOB5964;MolPort-002-345-613;NINDS_000916;VHOGYURTWQBHIL-UHFFFAOYSA-N;5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid;HMS1570K06;HMS1922M06;HMS2090O12;HMS2097K06;HMS2235C07;HMS3262A19;HMS3268D12;HMS3371F21;HMS3654F07;HMS3714K06;Pharmakon1600-01503927;ALBB-019233;Aventis Pharma Brand of Leflunomide;EBD46417;HY-B0083;Tox21_110182;Tox21_301873;Tox21_500649;ABP001076;Aventis Behring Brand of Leflunomide;BDBM50054601;DL-433;MFCD00867593;NSC677411;NSC759864;s1247;STL426823;AKOS000265193;Tox21_110182_1;AC-6796;AN-9632;BCP9000846;CCG-204736;CS-1781;DB01097;KS-1076;LP00649;MCULE-9490869974;NSC-677411;NSC-759864;RP29613;IDI1_000916;NCGC00015610-01;NCGC00015610-03;NCGC00015610-04;NCGC00015610-05;NCGC00015610-06;NCGC00015610-07;NCGC00015610-08;NCGC00015610-09;NCGC00015610-10;NCGC00015610-11;NCGC00015610-12;NCGC00015610-13;NCGC00015610-14;NCGC00015610-17;NCGC00015610-18;NCGC00022625-03;NCGC00022625-04;NCGC00022625-05;NCGC00022625-06;NCGC00022625-07;NCGC00022625-08;NCGC00255370-01;NCGC00261334-01;AJ-08231;BC204155;H527;LS-86580;SC-46541;ST079287;ZB000596;AB0007396;TL8005179;A9622;AB00052389;EU-0100649;FT-0621959;L0250;R3926;ST24047486;C07905;D00749;MLS-0003109.0001;AB00052389-17;AB00052389-18;AB00052389_19;AB00052389_21;706L126;AP-501/42475599;A77 1486;I06-2131;Q-201289;SR-01000000191-2;SR-01000000191-4;SR-01000000191-7;BRD-K78692225-001-03-9;BRD-K78692225-001-11-2;5-methyl-4-(4-trifluoromethyl-phenyl)aminocarbonylisoxazole;5-methyl-4-(4-trifluoromethylphenyl)aminocarbonylisoxazole;5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILID;Leflunomide, European Pharmacopoeia (EP) Reference Standard;N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide;5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide;;5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)-anilide;N-(4-trifluoromethylphenyl)-5-methylisoxa-zole-4-carboxamide;(5-methylisoxazol-4-yl)-N-[4-(trifluoromethyl)phenyl]carboxamide;Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-;Leflunomide, United States Pharmacopeia (USP) Reference Standard;Leflunomide, Pharmaceutical Secondary Standard; Certified Reference Material;Leflunomide for peak identification, European Pharmacopoeia (EP) Reference Standard;210165-51-8"	75706-12-6	G162GK9U4W	14999430	14999430	01/03/2004	7488280	01/11/1995	1994-1998		1	0	1	No	0	"28/12/2009 00:00;22/11/2004 00:00;08/07/2011 00:00;09/11/2015 00:00;13/09/2005 00:00;18/04/2017 00:00;29/04/2015 00:00;09/10/2008 00:00;19/10/2005 00:00;02/11/2012 00:00;09/09/2010 00:00;23/04/2008 00:00;30/06/2017 00:00;13/06/2003 00:00;21/11/2011 00:00;11/12/1998 00:00;03/04/2009 00:00;27/04/2011 00:00;14/11/2014 00:00;21/09/2000 00:00;23/02/2000 00:00;04/11/2015 00:00;29/10/2008 00:00;06/06/2017 00:00;05/03/2004 00:00;04/12/2007 00:00;29/04/2011 00:00;30/11/2010 00:00;28/10/2011 00:00;08/11/2007 00:00;09/07/2007 00:00;18/10/2016 00:00;20/07/1999 00:00;28/08/2015 00:00;30/08/2011 00:00;17/08/2009 00:00;31/03/2006 00:00;10/09/1998 00:00;29/02/2016 00:00;28/01/2010 00:00;29/08/2011 00:00;15/02/2016 00:00;02/03/2006 00:00"	AP	"FOSUN PHARMA;SANDOZ;BARR;APOTEX INC;TEVA PHARMS;SANOFI AVENTIS US;HERITAGE PHARMS INC;ALEMBIC PHARMS LTD"	LEFLUNOMIDE	10/09/1998	SANOFI AVENTIS US	34,2	#N/A																							0						1
ODM-201	"bay 1841788;darolutamide;odm 201;odm-201"		DB12941		"ODM-201;1297538-32-9;Darolutamide;BAY-1841788;N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide;Darolutamide [USAN];Darolutamide (JAN/USAN/INN);SCHEMBL1814935;SCHEMBL13733117;KS-00000TSX;EX-A759;BLIJXOOIHRSQRB-PXYINDEMSA-N;MolPort-044-560-277;MolPort-046-033-692;AKOS030526387;BAY1841788;CS-5174;DB12941;BAY 1841788;HY-16985;ODM-201;BAY-1841788;FT-0700158;S7559;J3.501.129C;D11045;J-690121;1-[(2S)-2-Butanyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-car boxamide;1H-Pyrazole-3-carboxamide, N-((1S)-2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-;N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((1RS)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide;N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol -1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide;N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide;N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxy-ethyl)-1H-pyrazole-3-carboxamide"	1297538-32-9	X05U0N2RCO	26463318	26463318	01/10/2015	26463318	01/10/2015	2013-2017		1	1	0	Yes	1					30/07/2018		33,9	30	NA	0	1	PROSTATE	1	AR	0	1	1	NA	0	0	0	1	0	0,83	0	0	0	NA	0	0	0	0	0	0	0	0	1
Pevonedistat	"mln4924;pevonedistat;tak-924"		DB11759		"MLN4924;Pevonedistat;905579-51-3;MLN 4924;MLN-4924;UNII-S3AZD8D215;S3AZD8D215;Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester;C21H25N5O4S;((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate;Pevonedistat [USAN:INN];3gzn;((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate;[(1s,2s,4r)-4-{4-[(1s)-2,3-Dihydro-1h-Inden-1-Ylamino]-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl}-2-Hydroxycyclopentyl]methyl Sulfamate;B39;Pevonedistat (USAN);D0ZD2M;((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate;MLS006010830;SCHEMBL192875;CHEMBL1231160;CHEBI:95028;QCR-143;MolPort-038-387-829;MPUQHZXIXSTTDU-QXGSTGNESA-N;EX-A1472;2557AH;ZINC58660702;AKOS025401927;ACN-036709;CS-0348;DB11759;AC-27394;HY-70062;SMR004701757;D10413;Q-4091;BRD-K67844266-001-01-3;((1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]-pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate;[(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate;Sulfamic acid, ((1S,2S,4R)-4-(4-(((1S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl ester"	905579-51-3	S3AZD8D215	"26561559;26423795"	26423795	01/10/2015	26423795	01/10/2015	2013-2017		1	1	0	Yes	1					30/07/2018		33,9	48	NA	1	0	NA	1	NEDD8-activating enzyme	0	1	1	36	0	0	0	0	1	0	0	0	0	0,74	0	0	0	0	0	0	0	0	1
Olaratumab	olaratumab	Lartruvo	DB06043			1024603-93-7	TT6HN20MVF	24452395	24452395	01/01/2014	24452395	01/01/2014	2013-2017		1	1	1	Yes	1	19/10/2016 00:00	AP	ELI LILLY AND CO	OLARATUMAB	19/10/2016	ELI LILLY AND CO	33,5	19	NA	1	0	NA	1	PDGFR	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,63	0	0	0	0	0	0	46	0	1
Galeterone	galeterone		DB12415		"Galeterone;TOK-001;851983-85-2;VN/124-1;Galaterone;UNII-WA33E149SW;TOK 001;VN/124;WA33E149SW;(3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol;Galeterone [USAN:INN];Galeterone (USAN);3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene;TOK-001(Galeterone);TOK-001; Galeterone;D0U0BU;SCHEMBL939234;GTPL8638;17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol;CHEMBL2105738;Galeterone, >=98% (HPLC);3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene;MolPort-009-682-975;PAFKTGFSEFKSQG-PAASFTFBSA-N;BCPP000040;(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol;EX-A1025;TOK-001/;ZINC6718442;ABP000369;BDBM50435990;AKOS005146524;CM11049;CS-0334;DB12415;RL05280;AC-26549;HY-70006;SC-96681;Y0281;D10125;W-5660;J-501178;(3?)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol;3beta-Hydroxy-17-(1H-benzimidazol-1-yl)-androsta-5,16-diene;3beta-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene;Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-;(3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"	851983-85-2	WA33E149SW	26527750	26527750	01/11/2015	26527750	01/11/2015	2013-2017		1	1	0	Yes	1					30/07/2018		32,9	77	NA	0	1	PROSTATE	1	"CYP17;AR"	0	1	0	NA	0	0	0	1	1	0,73	0	0	0	NA	0	0	0	0	0	0	0	0	1
Omipalisib	"gsk2126458;gsk458;omipalisib"		DB12703		"GSK2126458;1086062-66-9;Omipalisib;GSK-2126458;GSK 2126458;UNII-1X8F5A3NA0;2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide;1X8F5A3NA0;2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide;Omipalisib (GSK2126458, GSK458);2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide;C25H17F2N5O3S;Omipalisib [USAN:INN];GSK-212;2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide;PubChem22430;Omipalisib (USAN/INN);cc-65;D03EZE;MLS006011258;Omipalisib; GSK2126458;SCHEMBL623194;GTPL8974;CHEMBL1236962;CHEBI:95093;DTXSID10148604;EX-A003;GSK-458;SYN1126;3l08;CGBJSGAELGCMKE-UHFFFAOYSA-N;MolPort-023-293-503;HMS3656D09;AOB87781;ABP000103;BDBM50145416;Omipalisib pound GSK-458 pound(c);s2658;ZINC43208634;AKOS015904655;CS-0085;DB12703;QC-7243;RL00368;NCGC00250408-01;4CA-0591;AC-28458;AN-17171;AS-16266;BC638723;Benzenesulfonamide, 2,4-difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-;HY-10297;KB-77620;SC-85404;SMR004703011;AB0033735;FT-0669061;X7449;KS-00000635;A25172;D10718;W-5626;J-507217;I14-17004;2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-yl-6-quinolyl)-3-pyridyl]benzenesulfonamide;2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide;ZIG"	1086062-66-9	1X8F5A3NA0	26603258	26603258	01/11/2015	26603258	01/11/2015	2013-2017		1	1	0	Yes	1					30/07/2018		32,9	170	NA	1	0	NA	1	PI3K	0	1	0	NA	0	0	0	1	1	0,06	0	0	0	NA	0	0	0	0	0	0	0	0	1
Trastuzumab emtansine	"pro132365;ro5304020;t-dm1;trastuzumab emtansine"	"Trastuzumab emtansine;Trastuzumab-MCC-DM1;T-DM1;Ado-trastuzumab emtansine;Trastuzumab-DM1;Ado-trastuzumab;Kadcyla"	DB05773			1018448-65-1	SE2KH7T06F	"25332421;22648179"	22648179	01/06/2012	20421541	01/06/2010	2009-2012		1	1	1	Yes	1	"19/08/2013 00:00;29/08/2013 00:00;25/07/2016 00:00;28/04/2016 00:00;11/07/2014 00:00;22/02/2013 00:00;29/05/2015 00:00"	AP	GENENTECH	ADO-TRASTUZUMAB EMTANSINE	22/02/2013	GENENTECH	32,7	24	NA	0	1	BREAST_HER2	1	HER2	0	1	0	NA	0	0	0	1	1	0,44	0	0	0	0,73	0	0	0	0	0	0	153	0	1
Carfilzomib	"carfilzomib;pr-171"	Kyprolis	DB08889		"Carfilzomib;868540-17-4;Kyprolis;Carfilzomib (PR-171);PR-171;UNII-72X6E3J5AR;72X6E3J5AR;CHEMBL451887;CHEBI:65347;NCGC00249613-01;DSSTox_CID_28616;DSSTox_RID_82886;DSSTox_GSID_48690;N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide;PR 171;(S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide;CAS-868540-17-4;Carfilzomib [USAN:INN];Kyprolis (TN);Carfilzomib(PR171);D00UVA;SCHEMBL85165;MLS006011102;Carfilzomib (JAN/USAN/INN);GTPL7420;QCR-96;Carfilzomib?PR-171?/Kyprolis;DTXSID4048690;BLMPQMFVWMYDKT-NZTKNTHTSA-N;MolPort-027-950-907;C40H57N5O7;AOB87759;KS-00000SR1;ONO-7057;Tox21_113079;AN-217;BDBM50277889;s2853;ZINC49841054;AKOS025401910;Tox21_113079_1;CS-0984;CS-W004540;DB08889;RL05381;NCGC00249613-02;NCGC00249613-03;AC-27051;AS-17059;BC251806;HY-10455;KB-75946;SC-91032;SMR004660024;AB0008111;FT-0696769;PX-171-007;Y0441;D08880;S-7798;AB01565867_02;SR-01000941582;J-501773;SR-01000941582-1;(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide;(2S)-N-((1S)-1-Benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide;(2S)-N-[(1S)-1-benzyl-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]-2-oxo-ethyl]-4-methyl-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]pentanamide;(Alphas)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-l-leucyl-n-((1s)-3-methyl-1-(((2r)-2-methyloxiranyl)carbonyl)butyl)-l-phe nylalaninamide;(alphas)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-l-leucyl-n-((1s)-3-methyl-1-(((2r)-2-methyloxiranyl)carbonyl)butyl)-l-phenylalaninamide;(alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide;(S)-4-Methyl-N-((S)-1-((S)-4-Methyl-1-((R)-2- Methyloxiran-2-yl)-1 -oxopentan-2-ylaMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide;L-Phenylalaninamide, (alphaS)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-L-leucyl-N-((1S)-3-methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)-"	868540-17-4	72X6E3J5AR	"28424963;26732066;25669927;23975329;19903785"	19903785	01/11/2009	19903785	01/11/2009	2009-2012		1	1	1	Yes	1	"24/07/2015 00:00;23/05/2016 00:00;24/04/2015 00:00;21/02/2013 00:00;03/06/2016 00:00;27/03/2015 00:00;07/06/2018 00:00;04/08/2016 00:00;21/01/2016 00:00;03/11/2014 00:00;21/11/2016 00:00;02/06/2014 00:00;17/11/2016 00:00;20/07/2012 00:00;19/04/2013 00:00;25/05/2017 00:00;31/01/2014 00:00;17/01/2018 00:00;21/04/2015 00:00"	AP	ONYX THERAP	CARFILZOMIB	20/07/2012	ONYX THERAP	32,5	29	NA	0	1	HEMATOLOGIC MALIGNANCIES	1	PROTEASOME	0	1	0	NA	0	0	0	1	1	0,14	0	1	1	NA	0	0	0	0	0	0	29	0	1
Refametinib	refametinib		DB06309		"Refametinib;923032-37-5;RDEA119;RDEA 119;UNII-JPX07AFM0N;RDEA-119;BAY 869766;JPX07AFM0N;BAY 86-9766;Refametinib (RDEA119, Bay 86-9766);(S)-N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide;Refametinib [INN];BAY-869766;BAY 8697661;3e8n;Refametinib (RDEA119);D03SKL;SCHEMBL345333;C19H20F3IN2O5S;GTPL7942;Refametinib (BAY86-9766);CHEMBL1236682;DTXSID40238961;MolPort-023-293-525;RDSACQWTXKSHJT-NSHDSACASA-N;923032-38-6;AOB87134;2254AH;s1089;ZINC39187987;AKOS025401896;CS-1818;BAY-86-9766;RDEA119(BAY 869766);NCGC00188380-01;NCGC00188380-02;4CA-0257;AC-26962;AS-16994;BAY 86-97661;HY-14691;KB-80339;J3.661.482J;Z-3246;BAY 869766;BAY 86-97661;RDEA-119;RDEA119;(S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide;Cyclopropanesulfonamide, N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-((2S)-2,3-dihydroxypropyl)-;N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide;N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide;RDEA-119 S enantiomer|||BAY-86-9766 S enantiomer|||N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide;VRA"	923032-37-5	JPX07AFM0N	"27975152;26644411"	26644411	01/12/2015	26644411	01/12/2015	2013-2017		1	1	0	Yes	1					30/07/2018		31,9	62	NA	1	1	HCC	1	MEK	0	1	1	30	1	0	0	1	1	0,03	0	0	0	0,5	0	0	0	0	0	0	0	0	1
Sapanisertib	"ink0128;ink128;mln0128;sapanisertib;tak-228"		DB11836		"1224844-38-5;Sapanisertib;INK-128;MLN0128;INK128;INK 128;TAK-228;UNII-JGH0DF1U03;MLN-0128;INK 128 (MLN0128);JGH0DF1U03;INK-0128;5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine;3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;C15H15N7O;5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine;Sapanisertib; INK128;Sapanisertib [USAN:INN];D03DPZ;MLS006011012;GTPL7933;SCHEMBL7902875;CHEMBL3545097;CHEBI:91450;EX-A951;INK-128/INK128;SYN1157;MolPort-023-219-148;HMS3656H12;INK-128;Sapanisertib;MLN0128;AOB87177;2477AH;s2811;ZINC73069271;AKOS025149512;BCP9000789;CS-0557;DB11836;NCGC00346654-01;AC-26848;AS-16294;HY-13328;KB-77903;SMR004702810;BCP0726000086;A8551;FT-0700125;KS-00000633;W-5898;INK-128,CAS:1224844-38-5;J-004811;5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine;5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine;INK-128|||MLN-0128|||5-(4-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine"	1224844-38-5	JGH0DF1U03	26800393	26800393	01/01/2016	26800393	01/01/2016	2013-2017		1	1	0	Yes	1					30/07/2018		30,9	39	85	0	1	"MYELOMA;NHL;WM"	1	MTOR	0	1	0	NA	0	0	0	1	1	0,09	0	0	0	0,64	0	0	0	0	0	0	0	0	1
Apitolisib	"apitolisib;gdc-0980"		DB12180		"Apitolisib;1032754-93-0;GDC-0980;GDC0980;UNII-1C854K1MIJ;RG7422;GDC 0980;(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one;Apitolisib (GDC-0980, RG7422);GDC-0980 (RG7422);1C854K1MIJ;CHEMBL1922094;RG-7422;J-502360;C23H30N8O3S;(2s)-1-(4-{[2-(2-Aminopyrimidin-5-Yl)-7-Methyl-4-(Morpholin-4-Yl)thieno[3,2-D]pyrimidin-6-Yl]methyl}piperazin-1-Yl)-2-Hydroxypropan-1-One;(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one;GNE 390; GDC 0980; RG 7422;Apitolisib [USAN:INN];GNE 390;RG 7422;PubChem24448;Apitolisib (USAN/INN);Apitolisib(GDC-0980);D0N1BU;D0O6VZ;SCHEMBL466297;GTPL7888;DTXSID50145738;EX-A041;QCR-182;SYN1150;MolPort-023-293-511;YOVVNQKCSKSHKT-HNNXBMFYSA-N;AOB87742;ABP000111;BDBM50358204;GDC-0980,RG7422;GDC-0980/RG7422;GDC0980(RG7422);s2696;ZINC59224388;AKOS027250725;BCP9000717;CS-0590;DB12180;GDC-0980.1;RL00154;KS-0000079T;GDC-0980 - RG7422;AS-16289;BC638866;HY-13246;AB0033740;X7458;D10543;Q-4032;CAS:1032754-93-0;GDC-0980;G-038390;GDC-0980,CAS:1032754-93-0;G-038390.1;RG7422, 1032754-93-0;(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one;(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperaz;(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1 -one"	1032754-93-0	1C854K1MIJ	26787751	26787751	01/01/2016	26787751	01/01/2016	2013-2017		1	1	0	Yes	1					30/07/2018		30,9	120	NA	1	0	NA	1	"MTOR;PI3K"	0	1	1	32	0	0	0	1	1	0,08	0	0	0	NA	0	0	0	0	0	0	0	0	1
Trastuzumab	trastuzumab	"RHUMAB HER2;trastuzumab-dkst;Herceptin;Perjeta-herceptin"	"DB00072;BTD00098;BIOD00098"			180288-69-1	P188ANX8CK	"23436264;20026806;19720923;15297404"	15297404	01/08/2004	8622019	01/03/1996	1994-1998		1	1	1	Yes	1	"19/08/2013 00:00;11/12/2001 00:00;17/03/2016 00:00;25/07/2016 00:00;16/10/2003 00:00;20/11/2013 00:00;28/08/2002 00:00;23/02/2012 00:00;29/05/2015 00:00;22/05/2008 00:00;20/10/2010 00:00;30/06/2014 00:00;11/07/2014 00:00;29/10/2010 00:00;25/09/1998 00:00;01/12/2017 00:00;23/04/2015 00:00;09/02/2000 00:00;22/02/2013 00:00;18/01/2008 00:00;16/11/2006 00:00;27/04/2017 00:00;07/03/2014 00:00;08/04/2009 00:00;29/08/2013 00:00;28/04/2016 00:00;27/03/2017 00:00"	AP	"MYLAN GMBH;GENENTECH"	"TRASTUZUMAB-DKST;TRASTUZUMAB;ADO-TRASTUZUMAB EMTANSINE"	25/09/1998	GENENTECH	30,8	46	NA	0	1	BREAST	1	HER2	0	1	0	NA	0	1	0	1	0	0,12	0	1	1	0,41	0	0	0	0	0	0	559	1	1
Alectinib	alectinib	"9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;Alecensa;Alecensaro"	DB11363		"Alectinib;1256580-46-7;CH5424802;CH 5424802;Alecensa;AF-802;UNII-LIJ4CT1Z3Y;AF 802;LIJ4CT1Z3Y;Alectinib (CH5424802);alectinib HCl;9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;CHEMBL1738797;AF802;9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;RO5424802;CH-5424802;9-Ethyl-6,6-Dimethyl-8-[4-(Morpholin-4-Yl)piperidin-1-Yl]-11-Oxo-6,11-Dihydro-5h-Benzo[b]carbazole-3-Carbonitrile;C30H34N4O2;9-ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-5h-benzo(b)carbazole-3-carbonitrile;RO-5424802;Alectinib [USAN:INN];EMH;Alectinib (USAN/INN);D09TDZ;D0U3SY;CH5424802(Alectinib);cc-247;MLS006010971;SCHEMBL896753;GTPL7739;QCR-83;CHEBI:90936;ALK inhibitor (NSCLC), Chugai;DTXSID50154840;EX-A406;KDGFLJKFZUIJMX-UHFFFAOYSA-N;MolPort-023-293-545;AOB87311;ABP000797;BDBM50362781;s2762;ZINC66166864;AKOS025290737;BCP9000514;CS-0518;DB11363;RL01191;KS-0000062Z;NCGC00346688-01;4CA-0118;AC-29020;AK170451;AS-17008;BC638868;HY-13011;KB-76034;SC-94173;SMR004702775;AB0035866;A8393;FT-0748626;Y0295;CH-5424802/RG-7853;D10542;S-7691;AF 802|||CH 5424802;CH5424802/CH-5424802;J-005256;J-519506;CH5424802,CAS:1256580-46-7;1256580-46-7 , C30H34N4O2 , CH 5424802 , CH-5424802;1416163-60-4;5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-;9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-;9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrileCH5424802;9-Ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazol-3-carbonitril;9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;9-Ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile"		LIJ4CT1Z3Y	"28296581;26487585"	26487585	01/10/2015	23639470	01/06/2013	2013-2017		1	1	1	Yes	1	"04/11/2016 00:00;06/11/2017 00:00;11/12/2015 00:00;05/06/2018 00:00"	AP	HOFFMANN-LA ROCHE	ALECTINIB HYDROCHLORIDE	11/12/2015	HOFFMANN-LA ROCHE	30,3	70	NA	0	1	NSCLC_ALK_MUTANT	1	ALK	0	1	1	46	1	0	0	1	0	0,93	0	1	1	NA	0	0	0	0	0	0	38	0	1
Tocotrienol	d-tocotrienol		DB12647		"Tocotrienol;CCRIS 7711;6829-55-6;Tocotrienols;(R)-3,4-Dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol;D03VFL;CHEMBL120643;SCHEMBL1081622;SCHEMBL1448780;GJJVAFUKOBZPCB-ZGRPYONQSA-N;DB12647;NCGC00186586-01;LS-153943;42152-EP2298776A1;42152-EP2311808A1;42152-EP2311829A1;2-methyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol;2-Methyl-2-[[4,8,12-trimethyl-3(E),7(E),11(E)]-tridecatrienyl]-3,4-dihydro-2H-benzo[b]pyran-6-ol;3,4-Dihydro-2-methyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol;9074-33-3"	6829-55-6	0867I0N41V	26844278	26844278	01/02/2016	26844278	01/02/2016	2013-2017		1	1	0	Yes	1					30/07/2018		29,8	25	0	0	1	PANCREAS	0	NA	0	1	0	NA	0	0	0	0	0	0	0	0	0	NA	0	0	0	0	0	0	0	0	1
Enzalutamide	"asp9785;enzalutamide;mdv3100"	Xtandi	"DB08899;DB05094"		"Enzalutamide;915087-33-1;MDV3100;MDV-3100;4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide;MDV 3100;XTANDI;Enzalutamide (MDV3100);MDV3100 (Enzalutamide);UNII-93T0T9GKNU;MDV3100 Enzalutamide;93T0T9GKNU;CHEBI:68534;4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide;4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide;Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-;Enzalutamide [USAN:INN];Xtandi (TN);PubChem19320;Tube704;Enzalutamide (JAN/USAN);MDV3100, AldrichCPR;D0M1YR;D0QK5X;Enzalutamide (AR inhibitor);MLS006010067;SCHEMBL189749;GTPL6812;C21H16F4N4O2S;CHEMBL1082407;CTK8B6725;EX-A046;MDV3101;QCR-130;MolPort-009-679-470;WXCXUHSOUPDCQV-UHFFFAOYSA-N;BCPP000169;HMS3654L07;NC-54;AMX10212;AOB87731;ASP-9785;MDV3100/MDV-3100;ABP000459;ANW-54164;BDBM50425732;s1250;ZINC34806477;AKOS015851022;ACN-026804;API0007596;BCP9000901;CS-0317;DB08899;RL05765;KS-0000079W;NCGC00263120-01;AC-26924;AN-16279;AS-17047;BC660065;BR-72825;CJ-18592;HY-70002;KB-53497;SC-69109;SMR004701227;AB0008149;AX8165432;TC-142909;FT-0670957;ST24028748;W9480;A25302;D10218;S-3847;AB01565849_02;SR-01000941580;J-519668;SR-01000941580-1;BRD-K56851771-001-01-9;MDV-3100, 915087-33-1;4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-me;4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide;Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-;n-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluo"	915087-33-1	93T0T9GKNU	"26793974;25917876;25698064;20398925"	20398925	01/04/2010	20398925	01/04/2010	2009-2012		1	1	1	Yes	1	"14/07/2016 00:00;19/03/2013 00:00;24/07/2017 00:00;23/05/2014 00:00;05/08/2015 00:00;13/07/2018 00:00;20/10/2016 00:00;06/11/2015 00:00;10/09/2014 00:00;21/07/2015 00:00;31/08/2012 00:00;01/10/2015 00:00"	AP	ASTELLAS	ENZALUTAMIDE	31/08/2012	ASTELLAS	29,0	140	NA	0	1	PROSTATE	1	AR	0	1	0	NA	0	0	1	1	1	0,56	0	0	0	NA	0	0	0	0	0	0	665	0	1
Lorvotuzumab mertansine	"bb-10901;imgn901;lorvotuzumab mertansine"		DB12089			1008106-64-6	0IVD6ASY0W	26961907	26961907	01/03/2016	26961907	01/03/2016	2013-2017		1	1	0	Yes	1					30/07/2018		28,9	52	NA	1	1	"SCLC;MERKEL;OVARIAN"	1	CD56	0	1	1	45	0	0	0	1	1	NA	0	1	1	0,25	0	CHEST PAIN	1	0	0	0	34	0	1
ASP-3026	"asp-3026;asp3026"		DB12729		"ASP3026;1097917-15-1;ASP-3026;ASP 3026;UNII-HP4L6MXF10;N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine;HP4L6MXF10;MGGBYMDAPCCKCT-UHFFFAOYSA-N;2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine;D09GEK;MLS006011176;GTPL7740;SCHEMBL2827739;CHEMBL3545360;C29H40N8O3S;AOB6601;DTXSID90149038;EX-A140;QCR-144;MolPort-028-720-342;2229AH;s8054;ZINC68120928;AKOS025142083;CS-0787;DB12729;RL00420;NCGC00345791-01;AC-28466;AS-16959;BC600355;HY-13326;KB-74746;SMR004702945;AB0095023;FT-0755075;W-5854;J-523409;4-N-[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-2-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine;N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine;N2-(2-(isopropylsulfonyl)phenyl)-N4-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-1,3,5-triazine-2,4-diamine"	1097917-15-1	HP4L6MXF10	26966027	26966027	01/03/2016	26966027	01/03/2016	2013-2017		1	1	0	Yes	1					30/07/2018		28,9	46	NA	1	1	NSCLC	1	ALK	0	1	1	13	1	0	0	1	1	0,5	0	0	0	0,94	0	0	0	0	0	0	0	0	1
Oprozomib	oprozomib		DB11991		"Oprozomib;935888-69-0;ONX-0912;ONX 0912;Oprozomib (ONX-0912);PR-047;UNII-MZ37792Y8J;MZ37792Y8J;Oprozomib (ONX 0912);N-((S)-3-methoxy-1-(((S)-3-methoxy-1-(((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide;Oprozomib [USAN:INN];PR 047;Oprozomib (USAN/INN);D0F9BT;GTPL8739;SCHEMBL1709971;CHEMBL2103884;C25H32N4O7S;EX-A332;MolPort-028-720-441;SWZXEVABPLUDIO-WSZYKNRRSA-N;AOB87341;2614AH;BDBM50398607;PR-141;PR-928;ZINC43202141;AKOS028109171;CS-2767;DB11991;QC-9273;NCGC00345799-01;AS-17020;BC600600;HY-12113;O-Methyl-N-((2-methylthiazol-5-yl)carbonyl)-L-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)- 2-methyloxiran-2-yl)-2-oxoethyl)-L-serinamide;FT-0700414;D10318;S-7831;J-690398;Proteasome inhibitor (oral, cancer), Proteolix Inc/Onyx Pharmaceuticals Inc;Proteasome inhibitor program (oral, cancer), Onyx Pharmaceuticals/Ono Pharmaceutical;1227167-05-6;L-Serinamide, O-methyl-N-((2-methyl-5-thiazolyl)carbonyl)-L-seryl-O-methyl-N-((1S)-2- ((2R)-2-methyl-2-oxiranyl)-2-oxo-1-(phenylmethyl)ethyl)-;L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-;L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-;N-((S)-3-methoxy-1-((S)-3-methoxy-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide;N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide;PR-047|||ONX-0912|||N-[(2S)-3-Methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide"	935888-69-0	MZ37792Y8J	26924128	26924128	01/03/2016	26924128	01/03/2016	2013-2017		1	1	0	Yes	1					30/07/2018		28,9	44	NA	1	0	NA	1	PROTEASOME	0	1	1	19	0	0	0	0	1	0	0	0	0	NA	0	0	0	HALLUCINATION	1	0	0	0	1
Indoximod	indoximod	"1-methyl-D-tryptophan;D-1MT;D-(+)-1-methyltryptophan;(2R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid;D-1-methyltryptophan"	DB12827		"1-Methyl-D-tryptophan;Indoximod;110117-83-4;D-Tryptophan, 1-methyl-;D-1MT;Indoximod (NLG-8189);UNII-TX5CYN1KMZ;D-(+)-1-Methyltryptophan;D-1-methyltryptophan;TX5CYN1KMZ;(R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid;NSC-721782;(2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid;1-MT;(2R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid;D-l-Methyltryptophan;Indoximod [USAN:INN];NLG 8189;PubChem10617;1-Methyl-D-tryptophane;Indoximod (USAN/INN);D-Tryptophen, 1-methyl-;D0B5HS;AC1L8OC2;AC1Q3YR9;AC1Q5R0Q;SCHEMBL934800;1-Methyl-D-tryptophan, 95%;CHEMBL571209;GTPL8226;CTK0H9471;ZINC39102;NLG8189;Indoximod (NLG-8189 pound(c);MolPort-001-792-922;ZADWXFSZEAPBJS-SNVBAGLBSA-N;KS-000018KA;NLG-8189;NSC721782;s7756;AKOS015850753;AKOS015898463;CS-4941;DB12827;RTR-002117;SMP2_000028;NCGC00346842-01;AJ-08821;AK-25289;AS-15999;HY-16724;KB-12920;R767;AX8030153;DB-002380;TR-002117;B4900;FT-0695121;D10640;M-1971;A802144;I10-0489;J-002381;(2R)-2-amino-3-(1-methyl-3-indolyl)propanoic acid;(2R)-2-azanyl-3-(1-methylindol-3-yl)propanoic acid;BRD-K93255255-001-01-3"	110117-83-4	TX5CYN1KMZ	27008709	27008709	01/03/2016	27008709	01/03/2016	2013-2017		1	1	0	Yes	1					30/07/2018		28,9	48	NA	1	0	NA	1	indoleamine 2,3-dioxygenase	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,1	0	0	0	0	0	0	0	0	1
Vismodegib	vismodegib	"Hedgehog Antagonist GDC-0449;Vismodegibum;Erivedge"	DB08828		"Vismodegib;879085-55-9;GDC-0449;Erivedge;2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide;HhAntag691;Vismodegib (GDC-0449);GDC0449;GDC 0449;Erivedge (TN);UNII-25X868M3DS;GDC-0449 (Vismodegib);CHEMBL473417;CHEBI:66903;25X868M3DS;NSC755986;RG3616;2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide;C19H14Cl2N2O3S;2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide;2-chloro-n-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)benzamide;2-chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide;Vismodegib [USAN:INN];NSC 747691;vismodegibum;HSDB 8130;Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-;BENZAMIDE, 2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-;R 3616;NSC747691;Hh-Antag691;NSC-747691;Vismodegib, free base;RG-3616;PubChem19137;GDC-0449,Vismodegib;Vismodegib (USAN/INN);GDC-0449(Vismodegib);D03EDQ;D0LB7J;R-3616;Vismodegib (SHH inhibitor);GDC-0449 - Selumetinib;MLS006012035;SCHEMBL302587;GTPL6975;QCR-40;CTK8B8648;AOB1040;CUR-691;DTXSID40236689;GDC-449;BPQMGSKTAYIVFO-UHFFFAOYSA-N;MolPort-009-679-417;BCPP000223;HMS3604K16;HMS3654E17;KS-000000BH;ABP000894;AN-471;ANW-60962;BDBM50249522;BG0661;s1082;ZINC40899447;GDC-0449(Vismodegib)/GDC0449;GDC-0449,Vismodegib, HhAntag691;AKOS015966534;BCP9000713;CS-0255;DB08828;MCULE-6680076172;NSC-755986;PB15086;RL05479;NCGC00242497-01;NCGC00242497-02;4CA-1325;AC-26969;AK-77261;AS-14066;BC660083;HY-10440;KB-81450;SC-87729;SMR004703564;AB0008125;AJ-103831;AX8167197;KB-308771;TC-149707;FT-0675833;ST24040458;X4669;A10467;D09992;J90022;Q-2305;V-4050;AB01565813_02;085G559;SR-01000941574;J-509076;SR-01000941574-1;C538724000;GDC-0449, GDC0449, GDC 0449, 879085-55-9;2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide;2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methyl sulfonyl)benzamide;2-chloro-N-[4-chloro-3-(2-pyridyl)phenyl]-4-methylsulfonyl-benzamide;2-chloro-N~1~-[4-chloro-3-(2-pyridyl)phenyl]-4-(methylsulfonyl)benzamide;2-Chloranyl-~{n}-(4-Chloranyl-3-Pyridin-2-Yl-Phenyl)-4-Methylsulfonyl-Benzamide;2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-BENZAMIDE;GD 0449|||2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;VIS"	879085-55-9	25X868M3DS	"24077351;23342272;23064958"	23064958	01/10/2012	19726763	01/09/2009	2009-2012		1	1	1	Yes	1	"30/01/2012 00:00;01/08/2017 00:00;02/11/2016 00:00;19/12/2013 00:00;03/06/2013 00:00;21/05/2015 00:00;15/10/2014 00:00;08/05/2013 00:00"	AP	GENENTECH	VISMODEGIB	30/01/2012	GENENTECH	28,9	33	NA	0	1	BASAL CELL CARCINOMA	1	SHH	0	1	0	NA	1	0	0	1	1	0,55	0	1	1	0,88	0	ATRIAL FIBRILLATION	1	0	0	0	143	0	1
Sulindac	"mrp-1;sulindac"	"cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid;Sulindac;Sulindacum;(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;Sulindaco;Sunlindac;Sulindac-200 Tab 200mg;Sulindac;Teva-sulindac;Clinoril Tab 200mg;Penta-sulindac;Nu-sulindac Tab 150mg;Sulindac-150 Tab 150mg;Clinoril Tab 150mg;Apo-sulin Tab 150mg;Nu-sulindac Tab 200mg;Apo-sulin Tab 200mg"	"DB00605;APRD01243"	"2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]-1-indenyl]acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-(4-methylsulfinylbenzylidene)inden-1-yl]acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]ethanoic acid;38194-50-2;32004-68-5;CAS-38194-50-2;NCGC00015970-02;BSPBio_002890;EU-0101070;NCGC00025268-02;cMAP_000021;NCGC00025268-03;Clinoril (TN);SPECTRUM1500556;(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-;Arthrocine;BRN 2951842;CCRIS 3305;Clinoril;EINECS 253-819-2;MK 231;Mobilin;Sulindac [USAN:BAN:INN:JAN];Sulindac sulfoxide;Sulindaco [INN-Spanish];Sulindacum [INN-Latin];cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid;BPBio1_000315;Prestwick3_000073;Spectrum5_001024;D00120;EINECS 250-893-8;Sulindac (JAN/USP/INN);Lopac0_001070;MLS001056554;SMR000326718;BSPBio_000285;C01531;Sulindac;Tocris-1707;IDI1_000601;NCGC00025268-01;NCGC00015970-01;Lopac-S-8139;5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid"	"sulindac;Clinoril;38194-50-2;Arthrocine;Sulindac sulfoxide;Sulindaco;Sulindacum;Mobilin;Arthrobid;Klinoril;MK 231;Sulindacum [INN-Latin];Sulindaco [INN-Spanish];Aflodac;MK-231;Clinoril (TN);Sulreuma;C20H17FO3S;CCRIS 3305;CHEBI:9352;(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid;Sulindac [USAN:BAN:INN:JAN];MK231;cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid;(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid;EINECS 253-819-2;BRN 2951842;Algocetil;Artribid;Citireuma;Clisundac;Imbaral;Reumofil;Sulinol;CHEMBL15770;Sudac;Copal;1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-;NCGC00015970-02;Copals;Copal resin;Resin copal;CAS-38194-50-2;Gum copal;DSSTox_CID_3624;S 8139;{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid;5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid;DSSTox_RID_77117;DSSTox_GSID_23624;Copal rosin varnish;Chibret;Kenalin;Sulindal;Aclin;cis-Sulindac;Novo Sundac;Novo-Sundac;Nu Sulindac;Nu-Sulindac;Sulindac (Clinoril);Apo Sulin;Apo-Sulin;(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid;2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid;SR-01000075237;Moblilin;(Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid;2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid;32004-68-5;EINECS 250-893-8;EINECS 256-402-3;Sulindac [USAN:USP:INN:BAN:JAN];Tocris-1707;Merck Brand of Sulindac;AC1LU7GY;Apotex Brand of Sulindac;Chemia Brand of Sulindac;Clinoril;Aflodac;Sulreuma;KendrickBrand of Sulindac;Prestwick3_000073;Spectrum5_001024;Lopac-S-8139;D0Z5IU;Sulindac, >=98.0%;Novopharm Brand of Sulindac;Nu Pharm Brand of Sulindac;Nu-Pharm Brand of Sulindac;SCHEMBL4202;SCHEMBL4203;Sulindac (JAN/USP/INN);Alphapharm Brand of Sulindac;Lopac0_001070;BSPBio_000285;BSPBio_002890;MLS001056554;SPECTRUM1500556;Sulindac (JP17/USP/INN);BPBio1_000315;GTPL5425;DTXSID4023624;CHEBI:93811;HMS501O03;(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid;{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid;{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid;2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid;cMAP_000021;MLKXDPUZXIRXEP-MFOYZWKCSA-N;MolPort-003-666-287;HMS1921C11;HMS2092K15;HMS2095O07;HMS2231N24;HMS3259K06;HMS3263E22;HMS3649P19;HMS3712O07;Pharmakon1600-01500556;(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid;[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid;HY-B0008;Tox21_110270;Tox21_301418;Tox21_501070;BDBM50012899;BDBM50103504;CCG-39264;NSC757344;s2007;SBB058181;Cahill May Roberts Brand of Sulindac;AKOS015895412;cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid;Tox21_110270_1;CS-0569;DB00605;KS-5153;LP01070;Merck Sharp & Dohme Brand of Sulindac;NC00540;NSC-757344;(Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid;1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-;IDI1_000601;NCGC00015970-01;NCGC00015970-03;NCGC00015970-04;NCGC00015970-05;NCGC00015970-06;NCGC00015970-07;NCGC00015970-08;NCGC00015970-11;NCGC00025268-01;NCGC00025268-02;NCGC00025268-03;NCGC00094349-01;NCGC00094349-02;NCGC00255143-01;NCGC00261755-01;49627-22-7;BP-30208;CPD000326718;LS-81610;SAM002554933;SMR000326718;SBI-0051040.P004;Sulindac, meets USP testing specifications;AB2000418;RT-000169;AB00513800;EU-0101070;ST24026687;ST51015123;U0099;9222-EP2275420A1;9222-EP2277565A2;9222-EP2277566A2;9222-EP2277567A1;9222-EP2277568A2;9222-EP2277569A2;9222-EP2277570A2;9222-EP2280008A2;9222-EP2281815A1;9222-EP2284166A1;9222-EP2292280A1;9222-EP2295055A2;9222-EP2295409A1;9222-EP2298764A1;9222-EP2298765A1;9222-EP2301933A1;9222-EP2305640A2;9222-EP2305652A2;9222-EP2308872A1;9222-EP2311453A1;9222-EP2311827A1;9222-EP2314585A1;9222-EP2314590A1;9222-EP2316829A1;C01531;D00120;W-5115;AB00052105-07;AB00052105_08;AB00052105_09;J-008554;J-012337;SR-01000075237-2;SR-01000075237-3;SR-01000075237-5;SR-01000075237-7;BRD-A13946108-001-04-9;BRD-A13946108-001-08-0;SR-01000075237-13;Sulindac, European Pharmacopoeia (EP) Reference Standard;Sulindac, United States Pharmacopeia (USP) Reference Standard;(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid;(Z)-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidene]-1H-indene-3-acetic Acid;(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)-phenyl]methylene]-1H-indene-3-acetic acid;{(1z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-indene-3-yl}acetic acid;2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid;Sulindac|(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid"	38194-50-2	184SNS8VUH	"16642371;10656435"	10656435	01/02/2000	778987	01/05/1976	Bef. 1989		0	0	1	No	0	"03/04/2006 00:00;26/07/1984 00:00;28/08/2001 00:00;15/07/2010 00:00;23/08/2007 00:00;20/12/2007 00:00;22/12/2015 00:00;13/05/1998 00:00;02/05/1997 00:00;30/07/2010 00:00;05/06/2007 00:00;06/09/1991 00:00;12/05/1981 00:00;16/05/2000 00:00;13/12/1996 00:00;26/11/1984 00:00;31/08/2001 00:00;02/02/1999 00:00;17/12/1993 00:00;13/08/2010 00:00;08/06/2009 00:00;03/03/1988 00:00;05/02/1998 00:00;05/10/2006 00:00;08/08/1979 00:00;27/02/1992 00:00;26/01/1984 00:00;06/02/1989 00:00;22/03/1990 00:00;17/04/1991 00:00;06/05/1991 00:00;17/12/2015 00:00;15/05/2002 00:00;01/04/1993 00:00;08/10/2008 00:00;14/04/1997 00:00;23/07/1979 00:00;23/12/2010 00:00;10/07/1995 00:00;04/06/2010 00:00;28/07/1995 00:00;29/06/1990 00:00;12/01/1994 00:00;28/02/1992 00:00;01/05/2002 00:00;24/02/1997 00:00;05/12/1997 00:00;15/04/2015 00:00;17/02/2006 00:00;13/02/1995 00:00;15/04/1998 00:00;13/08/1984 00:00;20/11/1995 00:00;13/03/2002 00:00;30/08/1991 00:00;16/12/2002 00:00;25/03/1991 00:00;21/12/1981 00:00;30/08/2001 00:00;05/06/1981 00:00;06/08/1979 00:00;24/06/2009 00:00;07/02/2001 00:00;20/11/1984 00:00;01/03/1996 00:00;26/01/1994 00:00;27/04/1981 00:00;31/05/1989 00:00;19/04/2002 00:00;29/06/1983 00:00;05/02/1986 00:00;16/08/1996 00:00;01/10/1979 00:00;02/03/1995 00:00;26/04/1996 00:00;24/10/1994 00:00;25/04/2001 00:00;28/05/2015 00:00;22/06/1993 00:00;27/07/1992 00:00;07/08/1992 00:00;18/09/2002 00:00;22/06/1982 00:00;16/05/2001 00:00;01/06/1995 00:00;14/12/1981 00:00;02/10/2000 00:00;23/06/1997 00:00;25/10/2001 00:00;24/01/2006 00:00;28/01/2000 00:00;20/09/2002 00:00;24/05/1993 00:00;29/06/1982 00:00;17/03/1992 00:00;12/02/1996 00:00;09/05/2016 00:00;07/03/2000 00:00;07/03/1989 00:00;29/05/1984 00:00;01/10/2009 00:00;09/01/1989 00:00;03/05/1988 00:00;31/05/1991 00:00;27/09/1978 00:00;15/10/1990 00:00;05/02/2008 00:00;03/10/1997 00:00;12/05/1993 00:00;22/10/2002 00:00;18/08/1994 00:00;03/10/1995 00:00;30/03/2009 00:00;18/04/1996 00:00;13/06/2002 00:00;08/05/2008 00:00;16/05/2006 00:00;05/05/1999 00:00;14/08/1979 00:00;22/06/1995 00:00;30/10/2001 00:00;05/07/1994 00:00;24/01/1994 00:00"	AP	"FOSUN PHARMA;EPIC PHARMA LLC;MERCK;WATSON LABS;SUN PHARM INDUSTRIES;EPIC PHARMA;MYLAN;ANI PHARMS INC;RADIUS PHARMS"	SULINDAC	27/09/1978	MERCK	28,8	#N/A																							0						1
Isotretinoin	isotretinoin	"(7e,9e,11e,13Z)-Retinoic acid;Isotretinoine;Isotretinoino;13-cis-Vitamin a acid;Isotretinoina;13-cis-Retinoic acid;Neovitamin a acid;cis-RA;Isotretinoinum;13-RA;Zenatane;Myorisan;Accutane Roche;Absorica;Clarus;Amnesteem;Isotrex Gel 0.05%;Ran-isotretinoin;Isotretinoin;Claravis;Epuris"	"DB00982;APRD00140"	"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;97950-17-9;4759-48-2;Isotretinoin;Isotretinoin [USAN:BAN:INN];Isotretinoine [INN-French];Isotretinoino [INN-Spanish];Isotretinoinum [INN-Latin];Isotrex;Neovitamin A acid;RETINOIC ACID, 13-cis-;Retinoic acid 13-cis-form;Ro-4-3780;Roaccutane;Teriosal;SMR000471891;NCGC00094358-02;NCGC00094358-03;R3255_SIGMA;NCGC00094358-07;Accutane (TN);NCGC00094358-04;Isotretinoin (USP);Sotret;Sotret (TN);Spectrum5_001937;SPECTRUM1502013;D00348;Retinoic acid, cis-;Amnesteem;CIP-Isotretinoin;Ro-43780;Roaccutan;Roacutan;NCGC00094358-05;EU-0101081;Spectrum5_001795;Prestwick_642;BSPBio_003345;NCGC00094358-08;IDI1_033801;13-cis-retinoic acid,Isotretinoin;LMPR01090021;AIDS-196303;AIDS196303;NCGC00094358-09;BPBio1_000080;Prestwick2_000256;BSPBio_000072;(13cis)-retinoic acid;Lopac0_001081;Prestwick3_000256;Retinoic acid, (13cis)-;BSPBio_001331;MLS001074662;13-RA;13-cis-Retinoic acid;13-cis-Vitamin A acid;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid;4-09-00-02388 (Beilstein Handbook Reference);Accutane;BRN 1885770;CCRIS 4286;Claravis;DRG-0213;EINECS 225-296-0;HSDB 3929"	"Isotretinoin;13-cis-Retinoic acid;4759-48-2;Accutane;Roaccutane;Claravis;Neovitamin A acid;13-cis-Vitamin A acid;Amnesteem;Isotrex;Teriosal;Sotret;Roaccutan;13-cis retinoic acid;isotretinoino;Isotretinoine;Isotretinoinum;13-RA;Absorica;Isotane;Roacutan;Isotretinoine [INN-French];Isotretinoinum [INN-Latin];Isotretinoino [INN-Spanish];CIP-Isotretinoin;RETINOIC ACID, 13-cis-;Accutane (TN);Isotretinoin (USP);13 cis retinoic acid;UNII-EH28UP18IF;cis-Retinoic acid;Ro 4-3780;Ro-4-3780;Sotret (TN);ISORETINOIN;ISOTRETINON;CCRIS 4286;Isotretinoin [USAN:INN:BAN];HSDB 3929;13 Cis-Retinoic Acid;(13cis)-retinoic acid;13-cis RA;EINECS 225-296-0;Ro-43780;(7E,9E,11E,13Z)-retinoic acid;CHEMBL547;accure;BRN 1885770;EH28UP18IF;BML2-E07;CHEBI:6067;13-cis-retinoic acid,Isotretinoin;SHGAZHPCJJPHSC-XFYACQKRSA-N;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid;CPD000471891;Isotretinoin Retinoic acid;R 3255;(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;Myorisan;Zenatane;Isosuprea Lidose;(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;SR-01000076103;isotretinoina;cis-Retinoate;Isotretinoin [USAN:BAN:INN];cis retinoic acid;Roaccutane (TN);Amnesteem (TN);cis-RA;Absorica (TN);Prestwick_642;CAS-4759-48-2;Claravi (TN);Decutan (TN);Isotane (TN);Isotretinoin [USAN:USP:INN:BAN];Oratane (TN);Clarus (TN);Izotek (TN);Ro 43780;ISOTREXGEL;Isotretinoin Zinc Salt, 13 cis Isomer;Isotretinoin Zinc Salt, 13-cis-Isomer;Ro 4 3780;(13-cis)-Retinoate;AC1NQZZ4;13cRA;Prestwick2_000256;Prestwick3_000256;Spectrum5_001795;Spectrum5_001937;(13-cis)-Retinoic acid;DSSTox_CID_3177;D00DKK;Retinoic acid, (13cis)-;DSSTox_RID_76906;DSSTox_GSID_23177;Lopac0_001081;SCHEMBL38299;BSPBio_000072;BSPBio_001331;BSPBio_003345;4-09-00-02388 (Beilstein Handbook Reference);MLS001074662;SPECTRUM1502013;BPBio1_000080;GTPL7600;DTXSID4023177;MolPort-003-666-394;HMS1361C13;HMS1568D14;HMS1791C13;HMS1921D08;HMS1989C13;HMS2092N07;HMS2095D14;HMS2233A07;HMS3259J09;HMS3263I04;HMS3402C13;HMS3712D14;Pharmakon1600-01502013;ZINC3792789;Tox21_200093;Tox21_501081;BDBM50031459;LMPR01090021;NSC758156;AKOS015841158;AB03039;CCG-205158;CS-1864;DB00982;DS-3367;LP01081;NC00635;NSC-758156;RP17638;IDI1_033801;NCGC00094358-01;NCGC00094358-02;NCGC00094358-03;NCGC00094358-04;NCGC00094358-05;NCGC00094358-06;NCGC00094358-07;NCGC00094358-08;NCGC00094358-09;NCGC00094358-10;NCGC00094358-11;NCGC00094358-12;NCGC00094358-13;NCGC00094358-14;NCGC00094358-15;NCGC00257647-01;NCGC00261766-01;AN-15746;CC-29726;HY-15127;SAM002548955;SC-18589;SMR000471891;13-cis-Retinoic acid, >=98% (HPLC);13-cis-Retinoic acid|||Retinoid analogues;SBI-0051051.P003;LS-143465;EU-0101081;R0088;5952-EP0930075A1;5952-EP2295426A1;5952-EP2311840A1;59I482;C07058;D00348;24210-EP2311808A1;24210-EP2311829A1;24210-EP2314590A1;SR-01000076103-2;SR-01000076103-5;SR-01000076103-6;SR-01000076103-9;BRD-K76723084-001-05-9;I14-16776;SR-01000076103-10;Isotretinoin, European Pharmacopoeia (EP) Reference Standard;Isotretinoin, United States Pharmacopeia (USP) Reference Standard;(2Z,4E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid;Isotretinoin for peak identification, European Pharmacopoeia (EP) Reference Standard;Isotretinoin, Pharmaceutical Secondary Standard; Certified Reference Material;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid;3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2-CIS-4-TRANS-6-TRANS-8-TRANS-NONATETRAENOIC ACID;3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2Z,4E,6E,8E-NONATETRANENOIC ACID"	4759-48-2	EH28UP18IF	"20729242;8689422"	8689422	01/01/1996	7352756	01/01/1980	Bef. 1989		0	0	1	No	0	"22/10/2010 00:00;06/06/1986 00:00;12/04/2002 00:00;08/11/2002 00:00;20/06/2003 00:00;17/06/2017 00:00;24/08/2004 00:00;08/07/2016 00:00;27/11/1984 00:00;20/08/2009 00:00;03/09/2015 00:00;13/01/1994 00:00;02/02/2007 00:00;07/05/1982 00:00;02/05/2018 00:00;07/03/1991 00:00;12/04/2012 00:00;01/02/2010 00:00;17/05/1995 00:00;04/02/2016 00:00;28/04/1989 00:00;08/10/1991 00:00;31/12/2001 00:00;24/12/2002 00:00;16/11/1988 00:00;30/04/1985 00:00;31/05/1984 00:00;01/05/2000 00:00;19/06/1985 00:00;25/03/2010 00:00;25/08/2005 00:00;02/05/2002 00:00;16/12/2015 00:00;03/10/2007 00:00;04/04/1989 00:00;23/02/2015 00:00;16/04/1990 00:00;16/10/1990 00:00;09/08/1989 00:00;13/12/2014 00:00;19/11/2008 00:00;01/06/1987 00:00;19/01/2012 00:00;25/05/2012 00:00;30/04/2012 00:00;02/11/2007 00:00;27/08/2003 00:00;26/02/1987 00:00;12/08/2005 00:00;09/08/1983 00:00;01/11/1984 00:00;26/03/2004 00:00;19/10/1987 00:00;20/10/2014 00:00;28/05/2003 00:00;15/08/2014 00:00;13/01/2006 00:00;26/08/1988 00:00;28/02/1984 00:00;10/08/2005 00:00;03/06/1987 00:00;20/07/2015 00:00;06/02/2007 00:00;07/01/1988 00:00;11/05/2006 00:00;25/03/2013 00:00;23/12/2015 00:00;20/06/2002 00:00;11/04/2003 00:00;27/02/2003 00:00;11/01/2001 00:00;05/07/1985 00:00;23/04/2018 00:00;30/04/1999 00:00;15/02/2002 00:00;30/10/2001 00:00;29/09/2017 00:00;30/07/2014 00:00;30/06/1983 00:00"	AP	"HOFFMANN LA ROCHE;SUN PHARM INDS LTD;#N/A;DOUGLAS PHARMS;MYLAN PHARMS INC;TEVA PHARMS USA;SUN PHARM INDS INC;DR REDDYS LABS LTD"	ISOTRETINOIN	07/05/1982	HOFFMANN LA ROCHE	28,1	#N/A																							0						1
GDC-0917	"cudc-427;gdc-0917;smac mimetic cudc-427"		DB12336		"CUDC-427;UNII-KWH46ZDG32;GDC-0917;1446182-94-0;KWH46ZDG32;SCHEMBL15088334;HSHPBORBOJIXSQ-HARLFGEKSA-N;ZINC206792055;CS-3392;DB12336;HY-15835;L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-"	1446182-94-0	KWH46ZDG32	27076626	27076626	01/04/2016	27076626	01/04/2016	2013-2017		1	1	0	Yes	1					30/07/2018		27,9	42	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	1	1	NA	0	1	1	NA	0	QT	1	0	0	0	0	0	1
Marizomib	"marizomib;npi-0052"		DB11762		"MARIZOMIB;salinosporamide A;437742-34-2;(-)-Salinosporamide A;UNII-703P9YDP7F;NPI 0052;NPI-0052;ML 858;703P9YDP7F;CHEBI:48045;Salinosporamide A (NPI-0052, Marizomib);(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione;Marizomib [USAN:INN];marizomibum;Marizomib (USAN/INN);D0N0RN;SCHEMBL151667;CHEMBL371405;NGWSFRIPKNWYAO-SHTIJGAHSA-N;ZINC3990364;2531AH;BDBM50398608;AKOS027323566;DB11762;D09640;Z-3093;(1R,4R,5S)-4-(2-Chloroethyl)-1-((S)-((S)-cyclohex-2-enyl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione;6-Oxa-2-azabicyclo(3.2.0)heptane-3,7-dione,   4-(2-chloroethyl)-1-((S)-(1S)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1R,4R,5S)-;855517-10-1"	437742-34-2	703P9YDP7F	27117181	27117181	01/04/2016	27117181	01/04/2016	2013-2017		1	1	0	Yes	1					30/07/2018		27,9	86	NA	1	1	MYELOMA	1	PROTEASOME	0	1	0	NA	0	0	0	1	1	0,11	0	1	1	NA	0	0	0	0	0	0	0	0	1
Fluorouracil	"5-fluorouracil;5-fu;fluorouracil;ro-2-9757"	"FU;Fluorouracilo;Fluorouracilum;5-Fluracil;Fluorouracil;5-FU;5-Fluoracil;Fluoruracil;5-Fluoropyrimidine-2,4-dione;5-Fluorouracil;Fluouracil;Fluoro Uracil;Tolak;Actikerall;Fluorouracil Inj 50mg/ml;Efudex Crm 5%;Fluoroplex Cream 1%;Fluorouracil Injection;Fluorouracil;Adrucil Inj 50mg/ml;Fluorouracil Injection USP;Adrucil;Efudex;Carac;Fluoroplex"	"DB00544;APRD00516;EXPT03204"	"5-fluoro-1H-pyrimidine-2,4-dione;5-Fluorouracil;1004-03-1;4921-97-5;51-21-8;79108-01-3;F8423_SIGMA;5-FU (TN);Adrucil (TN);Carac;Carac (TN);Fluoro-uracile;Fluoroplex (TN);Fluorouracil [USAN:BAN:INN:JAN];Spectrum2_000076;NCGC00091349-03;NCGC00091349-04;Fluorouracil, 5-;NCGC00091349-05;2,4-Dioxo-5-fluoropyrimidine;5-Faracil;5-Fluor-2,4(1H,3H)-pyrimidindion [Czech];5-Fluor-2,4-dihydroxypyrimidin [Czech];5-Fluor-2,4-pyrimidindiol [Czech];5-Fluoracil [German];5-Fluoropyrimidin-2,4-diol;5-Fluoruracil [German];AI3-25297;Adrucil;CCRIS 2582;Cinco FU;DRG-0161;EINECS 200-085-6;D00584;Fluoro-uracilo;Fluorouracil (JP15/USP/INN);Fluorouracile [DCIT];Fluorouracilo [INN-Spanish];Fluorouracilum;Fluorouracilum [INN-Latin];Fluracilum;Fluro uracil;Fluroblastin;HSDB 3228;Phthoruracil;Queroplex;KBio1_000054;UPCMLD-DP130:001;NCI60_001652;2,4-Dihydroxy-5-fluoropyrimidine;F6627_SIGMA;2,4-Dioxo-5-fluoropryimidine;5-Fluoracyl;Efurix;Ftoruracil;Phtoruracil;Ro-2-9757;U 8953;5-Fluorouracil-6-3H;F5641_SIGMA;Spectrum_000841;SPBio_000291;SPECTRUM1500305;BSPBio_002048;2,4(1H,3H)-Pyrimidinedione, 5-fluoro-;5-Fluoro-2,4(1H,3H)-pyrimidinedione;5-Fluoro-2,4-pyrimidinedione;5-Fluoropyrimidine-2,4-dione;5-Ftouracyl;Arumel;Carzonal;Effluderm (free base);Efudex;Efudix;FU;Fluoroblastin;Fluoroplex;Fluracil;Fluri;Fluril;Kecimeton;NSC 19893;NSC-19893;NSC19893;Ro 2-9757;Timazin;U-8953;Ulup;Uracil, 5-fluoro-;WLN: T6MVMVJ EF;CHEBI:46345;NCGC00091349-01;KBio3_001268;EU-0100536;KBioGR_001253;KBioSS_001321;MLS000069498;SMR000038082;5FU;KBio2_001321;NCGC00091349-07;KBio2_006457;AIDS008287;T5233394;NINDS_000054;Spectrum3_000434;KBio2_003889;5-fluoropyrimidine-2,4(1H,3H)-dione;InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9;IDI1_000054;AIDS-008287;URF;nchembio809-comp6;858471_ALDRICH;5-FU;5-Fluorouracil;C07649;Fluorouracil;Lopac0_000536;inhibits thymilidate synthetase;pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen;Spectrum4_000557;5-fluoro-1H-pyrimidine-2,4-dione;5 Fluorouracil;STK297802;Spectrum5_000718;Lopac-F-6627;NCGC00015442-01;ZINC00897110;DivK1c_000054;47576_FLUKA"	"5-Fluorouracil;fluorouracil;51-21-8;5-FU;Fluoroplex;Adrucil;Efudex;Carac;Fluracil;Fluoroblastin;5-fluoropyrimidine-2,4(1H,3H)-dione;Kecimeton;Carzonal;Timazin;Arumel;Efudix;Fluril;Fluracilum;Queroplex;Ulup;Phthoruracil;Fluro Uracil;5-Fluoracil;Fluorouracilum;Ftoruracil;Efurix;Fluri;5 Fluorouracil;Effluderm (free base);5-fluoro-1H-pyrimidine-2,4-dione;5-Fluoro-2,4(1H,3H)-pyrimidinedione;Fluorouracilo;Fluroblastin;Phtoruracil;2,4(1H,3H)-Pyrimidinedione, 5-fluoro-;2,4-Dihydroxy-5-fluoropyrimidine;Fluoro-uracile;Fluoro-uracilo;5-Fluoropyrimidine-2,4-dione;Uracil, 5-fluoro-;5-Fluoruracil;5-Faracil;Cinco FU;Fluorouracile;Fluoruracil;Effluderm;Ro 2-9757;5-Fluor-2,4-pyrimidindiol;Fluorouracile [DCIT];5-Fluoracil [German];5-fluoro uracil;5-Fluoracyl;5-Ftouracyl;5-Fluoruracil [German];Fluorouracil, 5-;Fluorouracilum [INN-Latin];Fluorouracilo [INN-Spanish];5-Fluoropyrimidin-2,4-diol;5-fluoropyrimidine-2,4-diol;NSC 19893;2,4-Dioxo-5-fluoropyrimidine;5-Fluoro-2,4-pyrimidinedione;5-Fluor-2,4-dihydroxypyrimidin;U-8953;5-fluoro-uracil;Fluoroplex (TN);FU;5-Fluor-2,4-pyrimidindiol [Czech];NSC-19893;Adrucil (TN);C4H3FN2O2;UNII-U3P01618RT;CCRIS 2582;Carac (TN);5-Fluor-2,4-dihydroxypyrimidin [Czech];HSDB 3228;Fluorouracil (Adrucil);5-Fluor-2,4(1H,3H)-pyrimidindion [Czech];Fluorouracil [USAN:INN:BAN:JAN];EINECS 200-085-6;IN1335;5-Fluor-2,4(1H,3H)-pyrimidindion;CHEMBL185;Ro-2-9757;5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione;5-fluoro-2,4-Pyrimidinediol;inhibits thymilidate synthetase;2,4-Dioxo-5-fluoropryimidine;AI3-25297;MLS000069498;5FU;5-FU (TN);CHEBI:46345;GHASVSINZRGABV-UHFFFAOYSA-N;U 8953;U3P01618RT;1-fluoro-1h-pyrimidine-2,4-dione;NSC19893;191047-65-1;URF;NCGC00015442-02;Fluracedyl;SMR000038082;DSSTox_CID_634;F0151;F 6627;DSSTox_RID_75705;DSSTox_GSID_20634;Flurodex;Neofluor;Onkofluor;Ribofluor;Haemato fu;Haemato-fu;Fluorouracil GRY;Fluorouracil-GRY;Fluorouracil Cream;CAS-51-21-8;191047-64-0;191115-88-5;5 FU Lederle;5-FU Lederle;Fluorouracile Dakota;Fluoro Uracile ICN;Fluoro-Uracile ICN;5 FU medac;5-fluoro-1,3-dihydropyrimidine-2,4-dione;5-FU medac;5 HU Hexal;5-HU Hexal;Dakota, Fluorouracile;5 Fluorouracil biosyn;5-Fluorouracil-biosyn;Fluorouracil Mononitrate;Fluorouracilo Ferrer Far;SR-01000075881;Fluorouracil Potassium Salt;Fluorouracil Monosodium Salt;tetratogen;Fluouracil;Tolak;Fluorouracil Monopotassium Salt;5-fluorourasil;Fluoro Uracil;5-florouracil;5-fluorouacil;5-Fluracil;1upf;5F-uracil;Adrucil (ICN);Efudex (TN);Cantide + 5-FU;Adrucil (Fluorouracil);Fluorouracil - Adrucil;Fluorouracil [USAN:USP:INN:BAN:JAN];Fluorouracil Teva Brand;Spectrum_000841;ACMC-1ATRK;Opera_ID_134;5-Fluorouracil, 99%;TS antisense + 5-FU;AC1L1FTE;Spectrum2_000076;Spectrum3_000434;Spectrum4_000557;Spectrum5_000718;WLN: T6MVMVJ EF;Lopac-F-6627;Gry Brand of Fluorouracil;CSP Brand of Fluorouracil;ICN Brand of Fluorouracil;D05LEO;D08EPN;D0A7VK;D0K7CG;Dermik Brandof Fluorouracil;Teva Brand of Fluorouracil;UPCMLD-DP130;EC 200-085-6;medac Brand of Fluorouracil;AC1Q4N2X;Hexal Brand of Fluorouracil;Roche Brand of Fluorouracil;SCHEMBL3646;5-fluorpyrimidin-2,4-diol;biosyn Brand of Fluorouracil;Dakota Brand of Fluorouracil;Ferrer Brand of Fluorouracil;Lopac0_000536;BSPBio_002048;KBioGR_001253;KBioSS_001321;Haemato Brand of Fluorouracil;KSC270K6T;MLS002415705;Neocorp Brand of Fluorouracil;Riemser Brand of Fluorouracil;5-Fluorouracil, 99%  5g;DivK1c_000054;SPECTRUM1500305;Allergan Brand of Fluorouracil;SPBio_000291;5-fluoro-2,4-dioxo-pyrimidin;5-fluoro-pyrimidine-2,4-diol;Dermatech Brand of Fluorouracil;GTPL4789;Onkoworks Brand of Fluorouracil;DTXSID2020634;UPCMLD-DP130:001;CTK1H0569;CTK8H4220;Fluorouracil (JP15/USP/INN);Fluorouracil (JP17/USP/INN);HMS500C16;KBio1_000054;KBio2_001321;KBio2_003889;KBio2_006457;KBio3_001268;ribosepharm Brand of Fluorouracil;5-Fluoro-2,3H)-pyrimidinedione;2,4-Pyrimidinedione, 5-fluoro-;MolPort-000-156-102;MolPort-003-990-447;NINDS_000054;BCPP000428;HMS1920O18;HMS2090I04;HMS2091F19;HMS3259O03;HMS3261L13;HMS3654K22;HMS3715H03;Pharmakon1600-01500305;5-Fluorouracil, analytical standard;KS-00000DY3;2,3H)-Pyrimidinedione, 5-fluoro-;Tox21_110150;Tox21_202335;Tox21_300112;Tox21_500536;ANW-31214;BBL009635;BDBM50340677;CCG-39879;CF0033;DL-399;LS-153;MFCD00006018;NSC757036;Ro-29757;RW2456;s1209;SBB085751;STK297802;STL367375;ZINC38212689;AKOS000119162;AKOS003237897;AKOS008044307;AKOS022965835;Tox21_110150_1;AN-7240;BCP9000239;CS-0993;DB00544;KS-5129;LP00536;LS40596;MCULE-6338086431;NC00454;NSC-757036;RP19888;IDI1_000054;2,4-Pyrimidinediol, 5-fluoro- (9CI);NCGC00015442-01;NCGC00015442-03;NCGC00015442-04;NCGC00015442-05;NCGC00015442-06;NCGC00015442-07;NCGC00015442-08;NCGC00015442-09;NCGC00015442-10;NCGC00015442-11;NCGC00015442-12;NCGC00015442-15;NCGC00015442-16;NCGC00091349-01;NCGC00091349-02;NCGC00091349-03;NCGC00091349-04;NCGC00091349-05;NCGC00091349-07;NCGC00091349-08;NCGC00254023-01;NCGC00259884-01;NCGC00261221-01;4CA-0544;5-Fluoro-2,4-(1H,3H)-pyrimidinedione;AC-11201;AJ-94651;BC227022;CPD000038082;HY-90006;NCI60_001652;SAM002264615;SC-09038;SRI-10792-04;SRI-10792-05;SRI-10792-06;SRI-10792_07;SRI-10792_08;5-Fluoro-1H-pyrimidine-2,4-dione(5FU);5-Fluorouracil, >=99% (HPLC), powder;SBI-0050519.P004;5-Fluoro-1H-pyrimidine-2,4-dione(5-FU);AB1000177;DB-051923;DB-065735;TL8006093;5-Fluoro-1H-pyrimidine-2,4-dione (5-FU);AM20100252;EU-0100536;FT-0082524;FT-0601511;FT-0707652;ST45025877;5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra);Fluorouracil, meets USP testing specifications;51F218;7375-EP2269989A1;7375-EP2269994A1;7375-EP2270008A1;7375-EP2270018A1;7375-EP2272827A1;7375-EP2272832A1;7375-EP2275102A1;7375-EP2275412A1;7375-EP2275413A1;7375-EP2277876A1;7375-EP2280012A2;7375-EP2281563A1;7375-EP2281815A1;7375-EP2287156A1;7375-EP2289892A1;7375-EP2292233A2;7375-EP2292614A1;7375-EP2292615A1;7375-EP2292617A1;7375-EP2295416A2;7375-EP2295426A1;7375-EP2295427A1;7375-EP2298748A2;7375-EP2298768A1;7375-EP2298772A1;7375-EP2298780A1;7375-EP2301928A1;7375-EP2301933A1;7375-EP2305219A1;7375-EP2305243A1;7375-EP2305640A2;7375-EP2305642A2;7375-EP2305671A1;7375-EP2305689A1;7375-EP2308833A2;7375-EP2308839A1;7375-EP2308855A1;7375-EP2308861A1;7375-EP2311807A1;7375-EP2311808A1;7375-EP2311825A1;7375-EP2311827A1;7375-EP2311829A1;7375-EP2311840A1;7375-EP2314590A1;7375-EP2316459A1;7375-EP2316831A1;7375-EP2316834A1;7375-EP2316974A1;7375-EP2374454A1;C07649;D00584;W-5036;29507-EP2270008A1;29507-EP2270505A1;29507-EP2272827A1;29507-EP2289892A1;29507-EP2292234A1;29507-EP2292617A1;29507-EP2295426A1;29507-EP2295427A1;29507-EP2298305A1;29507-EP2308861A1;29507-EP2311842A2;42164-EP2272827A1;42164-EP2275420A1;42164-EP2277565A2;42164-EP2277566A2;42164-EP2277567A1;42164-EP2277568A2;42164-EP2277569A2;42164-EP2277570A2;42164-EP2277876A1;42164-EP2292280A1;42164-EP2292614A1;42164-EP2295412A1;42164-EP2295413A1;42164-EP2295416A2;42164-EP2298748A2;42164-EP2298764A1;42164-EP2298765A1;42164-EP2298778A1;42164-EP2305642A2;42164-EP2308833A2;42164-EP2311808A1;42164-EP2311829A1;42164-EP2311840A1;2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy- (9CI);4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI);5-Fluorouracil, Vetec(TM) reagent grade, >=99%;W-60379;(5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione;5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil);I07-0022;SR-01000075881-1;SR-01000075881-3;SR-01000075881-5;W-202929;5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil);BRD-K24844714-001-02-1;Z275128052;5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU);5-Fluorouracil, certified reference material, TraceCERT(R);Fluorouracil, European Pharmacopoeia (EP) Reference Standard;Fluorouracil, United States Pharmacopeia (USP) Reference Standard;pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen;2,4-Dihydroxy-5-fluoropyrimidine; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-FU;Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material;InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9;1004-03-1;4921-97-5;79108-01-3"	51-21-8	U3P01618RT	"26541630;26242208;22248601;20378507;19652069;19470921;18251177;16608024;15886473;15783041;15557781;15275732;15050328;14967434;14716778;12853359;12820460;12714877;11862430;11483342;11355147;11319291;9932161;9554592;9516601;9389916;9193347;9069299;9025770;8980409;8716477;8608485;8567347;8529282;8528977"	8528977	01/01/1995	13846613	01/02/1960	Bef. 1989		0	0	1	Yes	1	"14/11/1986 00:00;10/05/2006 00:00;10/06/1985 00:00;02/03/1977 00:00;29/01/2001 00:00;08/12/1992 00:00;14/03/1985 00:00;29/04/2015 00:00;16/12/2003 00:00;20/05/1991 00:00;29/07/2016 00:00;19/09/1974 00:00;13/10/1982 00:00;15/09/1997 00:00;10/03/1982 00:00;20/01/1999 00:00;17/02/2016 00:00;07/05/1975 00:00;13/10/2005 00:00;12/09/1997 00:00;01/07/1986 00:00;04/11/2015 00:00;11/08/2008 00:00;28/05/1986 00:00;02/05/2011 00:00;05/03/2010 00:00;20/04/2015 00:00;18/08/2015 00:00;01/07/1976 00:00;15/05/1981 00:00;05/12/2002 00:00;14/11/2016 00:00;04/11/1999 00:00;27/04/2004 00:00;31/07/1970 00:00;26/06/1985 00:00;30/11/1988 00:00;24/12/1975 00:00;27/11/2002 00:00;01/09/1977 00:00;26/12/2017 00:00;03/09/1976 00:00;17/12/1974 00:00;06/07/1999 00:00;06/01/2017 00:00;07/07/1980 00:00;13/05/1982 00:00;14/12/1977 00:00;06/12/1991 00:00;25/04/1962 00:00;20/06/2000 00:00;16/02/1989 00:00;07/07/2000 00:00;05/04/2000 00:00;12/05/1983 00:00;09/07/1976 00:00;29/09/1976 00:00;16/08/1982 00:00;15/02/1977 00:00;27/01/2000 00:00;06/08/1971 00:00;28/12/2016 00:00;20/07/1988 00:00;26/01/1988 00:00;05/05/1995 00:00;18/12/1979 00:00;20/03/1989 00:00;23/10/1979 00:00;12/05/1994 00:00;03/10/1988 00:00;26/03/1987 00:00;13/08/1984 00:00;25/07/2016 00:00;03/05/1977 00:00;22/07/1975 00:00;30/08/2001 00:00;13/08/1982 00:00;29/09/1978 00:00;27/12/2016 00:00;30/11/1998 00:00;17/04/1978 00:00;20/11/2014 00:00;18/07/1988 00:00;08/11/1979 00:00;24/03/1999 00:00;27/10/2017 00:00;12/08/1983 00:00;28/01/1987 00:00;12/12/2013 00:00;30/07/1999 00:00;15/11/2000 00:00;29/07/1970 00:00;29/12/2014 00:00;26/11/1986 00:00;19/05/1988 00:00;06/12/2016 00:00;14/05/1982 00:00;04/03/1993 00:00;14/03/1983 00:00;12/02/2001 00:00;02/07/2001 00:00;25/02/2000 00:00;29/08/1989 00:00;16/03/1979 00:00;30/06/1975 00:00;24/03/1982 00:00;02/07/2013 00:00;18/06/2002 00:00;19/07/1984 00:00;18/09/2015 00:00;28/08/1991 00:00;04/04/1980 00:00;03/07/2001 00:00;26/04/2007 00:00;11/05/2017 00:00;18/10/1991 00:00;21/11/1978 00:00;05/08/1993 00:00;31/07/2000 00:00;21/10/1986 00:00;06/08/1976 00:00;30/09/1998 00:00;14/12/2016 00:00;24/06/2004 00:00;10/01/1983 00:00;29/01/2016 00:00;12/11/1986 00:00;27/10/2000 00:00;15/11/2002 00:00;04/05/1984 00:00;21/03/1995 00:00;01/03/2016 00:00;02/11/1998 00:00;18/02/1997 00:00;30/06/1997 00:00;01/12/1998 00:00;12/01/1981 00:00;17/07/2012 00:00;13/09/1999 00:00;05/11/2003 00:00;11/04/2008 00:00;06/05/2015 00:00;04/11/1992 00:00;18/09/1980 00:00;10/07/1992 00:00;27/09/1976 00:00"	AP	"HILL DERMACEUTICALS;MYLAN PHARMS INC;ACCORD HLTHCARE;TARO PHARM;FRESENIUS KABI USA;MYLAN LABS LTD;AQUA PHARMS;TARO;EBEWE PHARMA;SAGENT PHARMS;SANDOZ;SPECTRUM PHARMS;BEDFORD;#N/A;TEVA PHARMS USA;TEVA PARENTERAL;VALEANT PHARM INTL;SPEAR PHARMS;ELORAC;VALEANT PHARMS NORTH"	FLUOROURACIL	25/04/1962	SPECTRUM PHARMS	26,7	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Ibritumomab tiuxetan	"ibritumomab;ibritumomab tiuxetan;idec-y2b8;y-90-ibritumomab;yttrium y 90 ibritumomab tiuxetan"	"Ibritumomab;Zevalin;mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)"	"BIOD00069;BTD00069;DB00078"		"Ibritumomab tiuxetan;206181-63-7;Z-3239"	206181-63-7	4Q52C550XK	"10577851;18026153;22906230"	10577851	01/11/1999	10577851	01/12/1999	1999-2003		1	1	1	Yes	1	"03/09/2009 00:00;30/08/2013 00:00;25/03/2008 00:00;04/01/2007 00:00;02/11/2007 00:00;18/11/2011 00:00;13/09/2005 00:00;30/01/2003 00:00;16/12/2010 00:00;22/10/2004 00:00;19/02/2002 00:00;27/07/2005 00:00;29/10/2004 00:00"	AP	SPECTRUM PHARMS	IBRITUMOMAB TIUXETAN	19/02/2002	SPECTRUM PHARMS	26,6	51	NA	1	0	NHL_B	1	CD20	0	1	0	NA	0	0	0	1	1	0,82	0	1	1	NA	0	0	0	0	0	0	139	0	1
Lapatinib	"gsk572016;gw-572016;gw2016;lapatinib"	"N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;Lapatinib tosilate hydrate;N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine;FMM;GW 572016;Tykerb;Tyverb"	"DB01259;DB02584"	"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]-4-quinazolinamine;[5-[4-[[3-chloro-4-(3-fluorobenzyl)oxy-phenyl]amino]quinazolin-6-yl]-2-furyl]methyl-(2-mesylethyl)amine;231277-92-2;FMM;N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE;N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine;nchembio866-comp20;GSK 572016;GW 572016;GW572016;Lapatinib [INN];Lapatinib"	"Lapatinib;231277-92-2;Lapatinib Ditosylate;Tykerb;GW572016;GW 572016;Lapatinib base;Lapatinib tosilate hydrate;Lapatinib [INN];Tyverb;Tycerb;lapatinib tosilate;Lapatinib (INN);Lapatinib free base;GSK 572016;UNII-0VUA21238F;388082-78-8;FMM;CHEMBL554;N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE;CHEBI:49603;Lapatinib, Tykerb, GW572016;0VUA21238F;MFCD09264194;NSC745750;GW 572016X;NCGC00167507-01;Lapatinib Ditosilate;GW572016F;Tykerb (TN);lapatinib ditosilate hydrate;C29H26ClFN4O4S;DSSTox_CID_26675;DSSTox_RID_81812;DSSTox_GSID_46675;N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine;Q-101353;GW-572016;CHEMBL1076241;4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline;4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine;N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine;N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine;N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;CAS-231277-92-2;GW-2016;Lapatinib [INN:BAN];GW 282974X;HSDB 8209;1xkk;N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine;N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine;N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;Lapatinib Ditosylate/;PubChem7650;nchembio866-comp20;Kinome_3684;Kinome_3685;D08CDI;AC1L4LL4;SCHEMBL8100;Lapatinib (ERBB2 inhibitor);BDBM5445;cid_208908;GTPL5692;QCR-63;DTXSID7046675;AOB5254;EX-A402;SYN1052;BCFGMOOMADDAQU-UHFFFAOYSA-N;MolPort-006-069-221;BCPP000188;BCPP000189;HMS2089H10;HMS3244N06;HMS3244N10;HMS3244N14;Tykerb (TN) (Glaxo Smith Kline);AMX10154;KS-00000GH2;ZINC1550477;Tox21_112505;231277-92-2 (free base);ABP000866;ABP000872;GSK572016;AKOS005145766;Tox21_112505_1;AC-1314;AN-5195;AN-5300;API0003126;BCP9000837;BCP9000838;CM14421;DB01259;NSC-745750;RL02729;NCGC00167507-02;NCGC00167507-03;NCGC00167507-04;913989-15-8;AS-14065;BC677691;EN002712;HY-50898;KB-57365;Q570;SC-02676;AB0005824;AB1004631;AX8135884;LS-187029;LS-187771;ST2407069;A3967;AM20090641;FT-0659650;TL80090051;A25184;D08108;J90020;W-3749;49311-EP2298768A1;49311-EP2298778A1;49311-EP2311840A1;AB01273965-01;AB01273965-02;AB01273965-03;AB01273965_04;AB01273965_05;277L922;I01-1247;SR-05000001472-1;BRD-K19687926-001-01-7;BRD-K19687926-379-02-5;GW572016;GW-572016;GW 572016;4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline; GSK572016; GW 572016; GW 572016X; Lapatinib; N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-(methanesulfonyl)ethyl]amino]methyl]-2-f;N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine;N-{3-chloro-4-[(3-fluoro-benzyl)oxy]phenyl}-6-[5-({2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N-{3-Chloro-4[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N3-Chloro-4-(3-fluorophenyl)methoxyphenyl-6-5-(2-methylsulfonylethylamino)methyl-2-furylquinazolin-4-amine"	231277-92-2	0VUA21238F	"24711549;21609937;20713864;19825948;19499221;19171712;15955900"	15955900	01/06/2005	15528979	01/01/2005	2004-2008		1	1	1	Yes	1	"06/04/2017 00:00;12/08/2011 00:00;29/01/2010 00:00;13/03/2007 00:00;31/03/2015 00:00;18/09/2015 00:00;20/08/2007 00:00;02/03/2012 00:00;21/06/2013 00:00;22/12/2014 00:00;07/07/2008 00:00;18/10/2013 00:00;27/04/2007 00:00"	"AP;TA"	"NATCO PHARMA LTD;NOVARTIS PHARMS CORP"	"LAPATINIB;LAPATINIB DITOSYLATE"	13/03/2007	NOVARTIS PHARMS CORP	26,3	27	NA	0	0	NA	1	HER2	1	1	0	NA	0	0	0	NA	1	NA	0	NA		NA	0	0	0	0	0	0	339	1	1
Fruquintinib	fruquintinib		DB11679		"Fruquintinib;HMPL-013;1194506-26-7;Fruquintinib [WHO-DD];UNII-49DXG3M5ZW;Fruquintinib(HMPL-013);49DXG3M5ZW;HMPL013;6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide;6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide;Fruquintinib (HMPL-013);SCHEMBL947183;GTPL9428;HMPL 013;BALLNEJQLSTPIO-UHFFFAOYSA-N;3-Benzofurancarboxamide, 6-((6,7-dimethoxy-4-quinazolinyl)oxy)-N,2-dimethyl-;AKOS026750586;ZINC114898570;CS-5558;DB11679;HY-19912;B5864;6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide;6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide"	1194506-26-7	49DXG3M5ZW	27299749	27299749	01/06/2016	27299749	01/06/2016	2013-2017		1	1	0	Yes	1					30/07/2018		25,9	40	70	1	0	NA	1	"VEGFR1;VEGFR2;VEGFR3"	0	1	0	NA	0	0	0	1	1	0,41	0	0	0	0,82	0	0	0	0	0	0	0	0	1
Dactolisib	bez235		DB11651		"915019-65-7;NVP-BEZ235;dactolisib;BEZ235;NVP-BEZ 235;2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile;BEZ-235;NVPBEZ235;BEZ 235;NVP BEZ235;UNII-RUJ6Z9Y0DT;BEZ235 (NVP-BEZ235);NVP-BEZ-235;RUJ6Z9Y0DT;CHEBI:71952;JOGKUKXHTYWRGZ-UHFFFAOYSA-N;2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile;BEZ235 (NVP-BEZ235, Dactolisib);S1009;2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile;S14-0511;C30H23N5O;2-methyl-2-[3-methyl-2-oxo-8-(3-quinolinyl)-1-imidazo[4,5-c]quinolinyl]propanenitrile;2-(4-(2,3-dihydro-3-methyl-2-oxo-8-(quinolin-3-yl)imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile;2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile;2-methyl-2-[4-(3-methyl-2-oxo-8-(3-quinolyl)(4-imidazolino[4,5-c]quinolinyl))p henyl]propanenitrile;2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile;BENZENEACETONITRILE, 4-[2,3-DIHYDRO-3-METHYL-2-OXO-8-(3-QUINOLINYL)-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL]-ALPHA,ALPHA-DIMETHYL-;Dactolisib [USAN:INN];Benzeneacetonitrile, 4-(2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-;zlchem 311;Kinome_2911;PubChem16657;CT-BEZ;Dactolisib; BEZ-235;Dactolisib (USAN/INN);D0VG0D;mTOR Inhibitor, BEZ235;NVP-BEZ235-NX;bez235  0.6g;SCHEMBL143623;GTPL7950;CHEMBL1879463;BDBM92862;CTK8B6590;DTXSID10238599;EX-A404;QCR-176;SYN1018;ZLC0136;BEZ235(NVP-BEZ235);MolPort-005-737-784;NVP-BEZ235, BEZ235;BCPP000344;HMS3244G21;HMS3244G22;HMS3244H21;ACT04718;AOB87110;BEZ235 - NVP-BEZ235;ABP000081;ANW-53710;CN-628;NSC751249;RS0071;SBB084062;ZINC24760115;AKOS005217097;BCP9000397;CCG-207981;CS-0080;DB11651;ES-0038;KIN0000813;NSC-751249;PB26555;Dactolisib (BEZ235, NVP-BEZ235);NCGC00187481-01;NCGC00187481-02;NCGC00187481-04;NCGC00187481-05;NCGC00187481-06;4CA-0926;AC-25486;AJ-81962;AK-88411;BC657910;HY-50673;KB-58913;SC-50495;AB0008148;AX8157891;BEZ235/NVP-BEZ235/BE-Z235/;ST2404481;TC-142455;FT-0658563;X7430;A10890;D10552;Q-3905;139099-EP2270008A1;139099-EP2292617A1;J-509915;BRD-K12184916-001-01-4;1146702-52-4;2-methyl-2-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)propanenitrile;2-Methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)pr;2-Methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)phenyl)propionitrile;2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile;2-methyl-2-[4-[3-methyl-2-oxo-8-(3-quinolyl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile;2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile;4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4, 5-c]quinolin-1-yl]-.alpha.,.alpha.-dimethylbenzeneacetonitrile;4-[2,3-DIHYDRO-3-METHYL-2-OXO-8-(3-QUINOLINYL)-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL]-ALPHA,ALPHA-DIMETHYL-BENZENEACETONITRILE;BENZENEACETONITRILE, 4-[2,3-DIHYDRO-3-METHYL-2-OXO-8-(3-QUINOLINYL)-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL]-A,A-DIMETHYL-"	915019-65-7	RUJ6Z9Y0DT	27286790	27286790	01/06/2016	27286790	01/06/2016	2013-2017		1	1	0	Yes	1					30/07/2018		25,9	10	NA	0	1	MRCC	1	"MTOR;PI3K"	0	1	0	NA	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Panitumumab	panitumumab	"ABX-EGF;Vectibix"	DB01269			339177-26-3	6A901E312A	"26056353;22210091;19705240;19203894;18223225"	18223225	01/01/2008	15210739	01/08/2004	2004-2008		1	1	1	Yes	1	"27/09/2006 00:00;29/06/2017 00:00;23/06/2008 00:00;26/05/2010 00:00;23/05/2014 00:00;17/07/2009 00:00;17/08/2012 00:00;06/11/2007 00:00;15/03/2011 00:00;27/04/2009 00:00;30/08/2014 00:00;12/12/2011 00:00;11/03/2015 00:00;28/03/2013 00:00"	AP	AMGEN	PANITUMUMAB	27/09/2006	AMGEN	25,8	88	NA	0	1	MRCC	1	EGFR	0	1	0	NA	0	1	0	1	1	0,06	0	0	0	0,5	0	0	0	0	0	0	47	0	1
Nelfinavir	nelfinavir	"Viracept -50mg;Viracept;Viracept -250mg"	"DB00220;APRD00003"	"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[(3-hydroxy-2-methylphenyl)-oxomethyl]amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-phenyl)carbonylamino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;159989-64-7;159989-65-8 (MESYLATE SALT);3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-,  (3S,4aS,8aS)-;AG1343 (*Mesylate salt*);AG1346;AIDS-028590;AIDS028590;NLF;NSC722664 (MESYLATE SALT);VRX496;Viracept (*Mesylate salt*);1UN;2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE;NELFINAVIR MESYLATE AG1343;KS-1089;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;C07257;Nelfinavir;NCGC00090782-03;NCGC00090782-04;AIDS-106820;AIDS106820;Met-SDF-1.beta. & Nelfinavir;Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir;(3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-;N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-;Nelfinavir [INN:BAN]"	"nelfinavir;159989-64-7;Viracept;Nelfinavir [INN:BAN];AG1343;UNII-HO3OGH5D7I;Nelfinavir (INN);Viracept (TN);AG-1343;VRX496;Nelfinavir Monomethane Sulfonate;C32H45N3O4S;Nelfinavir [BAN:INN];HO3OGH5D7I;CHEBI:7496;AG1343 (*Mesylate salt*);Met-SDF-1.beta. & Nelfinavir;Viracept (TM)(*Mesylate salt*);NELFINAVIR MESYLATE AG1343;AG1346;(3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide;1UN;NLF;NFV;2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE;N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-;Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir;CHEMBL1205;ARV-SR0121;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-;SMR000596515;AG 1341;NSC722664;NCGC00090782-03;1ohr;SARS therapy, aRigen;CHEMBL584;D08ZFL;D0L3MP;BIDD:PXR0143;Nelfinavir (SARS infection);SCHEMBL38218;MLS001195634;MLS001304729;BIDD:GT0395;AC1L20J6;DTXSID5035080;QAGYKUNXZHXKMR-HKWSIXNMSA-N;HMS2232I04;Viracept (SARS infection), aRigen;ZINC3833846;AG1341;BDBM50061306;Nelfinavir (SARS infection), aRigen;NSC747167;AKOS000280862;AG-1341;AM84529;CS-0677;DB00220;NSC-747167;MRF-0000208;NCGC00090782-04;NCGC00090782-05;AC-20032;AN-31040;BC216005;HY-15287;LS-85417;89N647;C07257;D08259;159989-65-8 (monomethane sulfonate (salt));AB00698259-15;A810096;Nelfinavir|159989-64-7|AG 1341|AG-1341|AG1341;(3S, 4aS, 8aS)-2-[(2R, 3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide;(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide;(3S,4abeta,8abeta)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(2-methyl-3-hydroxybenzoylamino)-4-(phenylthio)butyl]decahydroisoquinoline-3alpha-carboxamide;(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid;(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[(3-hydroxy-2-methylphenyl)-oxomethyl]amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-[(2-methyl-3-oxidanyl-phenyl)carbonylamino]-2-oxidanyl-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-;3-Isoquinolinecarboxamide,1-dimethyl ethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-;3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3.alpha.,4a.beta.,8a.beta.]]-"	159989-64-7	HO3OGH5D7I	"25752914;25327558;24194293"	24194293	01/11/2013	11361357	01/02/1995	1994-1998		1	0	1	No	0	"21/11/1997 00:00;31/07/2007 00:00;15/09/2000 00:00;31/07/1997 00:00;28/09/2001 00:00;08/11/2000 00:00;14/03/1997 00:00;12/06/1998 00:00;26/11/1997 00:00;19/03/2004 00:00;04/06/2004 00:00;04/06/1997 00:00;17/02/2012 00:00;28/05/2013 00:00;05/02/2002 00:00;13/02/2008 00:00;16/06/1997 00:00;28/09/2005 00:00;06/08/1999 00:00;26/10/2001 00:00;27/03/2015 00:00;15/09/2016 00:00;27/08/2003 00:00;24/11/1999 00:00;24/04/1998 00:00;17/05/2000 00:00;28/03/2000 00:00;25/05/1999 00:00;19/12/1997 00:00;05/04/2001 00:00;01/12/1998 00:00;17/08/1999 00:00;19/06/2001 00:00;30/04/2003 00:00;21/12/2001 00:00;29/08/1997 00:00;06/04/2012 00:00;03/02/1998 00:00;04/05/1998 00:00;05/06/1998 00:00;17/07/1998 00:00;30/10/1998 00:00;19/03/1999 00:00;16/07/1999 00:00;07/02/2000 00:00;06/10/1997 00:00;14/09/1998 00:00;20/12/2002 00:00;25/02/2011 00:00;26/04/2010 00:00;30/09/1997 00:00;22/12/2006 00:00;25/11/2008 00:00"	AP	AGOURON PHARMS	NELFINAVIR MESYLATE	14/03/1997	AGOURON PHARMS	25,3	#N/A																							0						1
Ensituximab	neo-102		DB12342			1092658-06-4	F988K568V2	27449137	27449137	01/07/2016	27449137	01/07/2016	2013-2017		1	1	0	Yes	1					30/07/2018		24,9	19	NA	0	1	"PANCREAS;COLON"	1	MUC5AC	0	1	0	NA	0	1	0	1	1	0,66	0	0	0	NA	0	0	0	0	0	0	0	0	1
Selinexor	selinexor		DB11942		"Selinexor;1393477-72-9;KPT-330;UNII-31TZ62FO8F;KPT 330;Selinexor (KPT-330);31TZ62FO8F;(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide;2-Propenoic acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-pyrazinyl)hydrazide, (2Z)-;Selinexor [USAN:INN];2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2Z)-;KPT330;Selinexor;Tube706;KPT-330(Selinexor);D00LNW;CHEMBL3545185;SCHEMBL14678327;EX-A870;DEVSOMFAQLZNKR-RJRFIUFISA-N;MolPort-035-395-854;2500AH;ZINC96170454;AKOS027325566;DB11942;N-Hydroxy-N'-(2-phenylethyl)isophthalamide;S7252;J-690156"	1393477-72-9	31TZ62FO8F	27458288	27458288	01/07/2016	27458288	01/07/2016	2013-2017		1	1	0	Yes	1					30/07/2018		24,9	54	NA	0	1	SARCOMA	0	NA	0	1	0	NA	0	1	0	1	1	0	0	0	0	0,33	0	0	0	0	0	0	0	0	1
Durvalumab	"durvalumab;medi-4736;medi4736"	Imfinzi	DB11714			1428935-60-7	28X28X9OKV	"28817753;27764686;27269937"	27269937	01/06/2016	26858122	01/05/2015	2013-2017	DOI: 10.1200/jco.2015.33.15_suppl.8032	1	1	1	Yes	1	"01/05/2017 00:00;16/02/2018 00:00"	AP	ASTRAZENECA UK LTD	DURVALUMAB	01/05/2017	ASTRAZENECA UK LTD	24,0	198	87	1	1	NSCLC	1	PD-L1	0	0	1	198	0	1	0	1	1	0,23	0	0	0	0,24	0	0	0	0	0	0	46	0	1
Cladribine	"2-chlorodeoxyadenosine;cladribine"	"Cladribinum;2-CdA;2-chloro-Deoxyadenosine;CldAdo;Cladribina;2-Chloro-2'-deoxy-beta-adenosine;(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;2-Chloro-2'-deoxyadenosine;2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine;2-Chlorodeoxyadenosine;2ClAdo;Cladribine;Mavenclad;Cladribine;Cladribine Injection;Leustatin 1mg/ml"	"DB00242;APRD00260"	"(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol;(2R,3S,5R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-tetrahydrofuranol;(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-methylol-tetrahydrofuran-3-ol;(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;24757-90-2;4291-63-8;AIDS-022294;AIDS022294;Adenosine, 2-chloro-2'-deoxy;(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;2-CdA;2-Chloro-2'-deoxy-beta-adenosine;2-Chloro-2'-deoxyadenosine;2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine;2-Chlorodeoxyadenosine;ADENOSINE, 2-CHLORO-2'-DEOXY-;BRN 0624220;Chlorodeoxyadenosine;Cladribine;Cladribine [USAN:BAN:INN];Leustatin;NSC 105014;NSC 105014-F;RWJ 26251;2 Chlorodeoxyadenosine;MLS000028484;SMR000058553;MLS000759397;Cladribine (JAN/USAN);D01370;Leustatin (TN);MLS000028377"	"Cladribine;2-Chloro-2'-deoxyadenosine;4291-63-8;Leustatin;2-Chlorodeoxyadenosine;2-CdA;Chlorodeoxyadenosine;Cladarabine;Litak;2-Chloro-2'-deoxy-beta-adenosine;CldAdo;ADENOSINE, 2-CHLORO-2'-DEOXY-;Cladaribine;Movectro;Mylinax;cladribina;cladribinum;Leustat;2ClAdo;Leustatin (TN);RWJ 26251;Cladribine [USAN:INN:BAN];UNII-47M74X9YT5;MLS000028377;2 Chlorodeoxyadenosine;2-chloro-deoxyadenosine;NSC 105014-F;RWJ-26251;NSC 105014;BRN 0624220;mavenclad;SMR000058553;Cladribine (JAN/USAN/INN);Adenosine, 2-chloro-2'-deoxy;2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine;CHEBI:567361;47M74X9YT5;(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;RWJ-26251-000;2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine;DSSTox_CID_2828;(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol;DSSTox_RID_76747;DSSTox_GSID_22828;2CdA;CL9;CAS-4291-63-8;SR-01000003063;2'-Deoxy-2-chloroadenosine;Cladiribine;CCRIS 9374;HSDB 7564;NSC-105014;Cladribine [USAN:USP:INN:BAN];NCGC00018167-03;S1199;AC1L2FXP;Opera_ID_1191;D05GJW;SCHEMBL3775;CHEMBL1619;2-chloro-2'-deoxy-adenosine;cid_20279;MLS000028484;MLS000759397;MLS001077345;MLS001424194;GTPL4799;DTXSID8022828;BDBM38920;C10H12ClN5O3.C3H8;CTK8D4033;MolPort-005-935-074;PTOAARAWEBMLNO-KVQBGUIXSA-N;HMS2052K13;HMS2232C23;HMS3715F17;5542-92-7;ACT02615;ZINC3798064;Tox21_110834;Tox21_300596;CC0168;MFCD00153939;AKOS015854898;AKOS015892544;AC-7591;BCP9000538;CCG-101116;CS-2057;DB00242;NC00366;RTC-063884;NCGC00022567-05;NCGC00022567-06;NCGC00022567-07;NCGC00022567-08;NCGC00164384-01;NCGC00254518-01;2-Chloro-2'-deoxyadenosine, antileukemic;AJ-45639;AK-46529;AS-12366;BR-46529;CC-25898;CJ-10765;CPD000058553;HY-13599;KB-22050;LS-15109;SAM001246526;SC-17356;AB0011806;AX8000129;ST2409775;TC-063884;FT-0080707;Leustatin, 2-chlorodeoxyadenosine, Cladribine;D01370;S-7479;AB00382963-17;AB00382963_19;291C638;A826062;C-17986;SR-01000003063-7;SR-01000003063-10;Cladribine, European Pharmacopoeia (EP) Reference Standard;6-amino-2-chloro-9-(2-deoxy-beta-erythropentofuranosyl)purine;Cladribine, United States Pharmacopeia (USP) Reference Standard;6-amino-2-chloro-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine;(2R,3S,5R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol;(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxalan-3-ol;(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol;(2R,3S,5R)-5-(6-azanyl-2-chloranyl-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;Cladribine for peak identification, European Pharmacopoeia (EP) Reference Standard;24757-90-2;Leustatin|||2-Chloro-2'-deoxyadenosine|||2-CdA|||NSC-105014-F|||(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol"	4291-63-8	47M74X9YT5	"9255268;1363233"	1363233	01/11/1992	1671875	01/03/1991	1989-1994		1	1	1	Yes	1	"28/02/2000 00:00;03/04/2001 00:00;22/08/2002 00:00;06/10/2011 00:00;29/09/2015 00:00;20/08/2002 00:00;29/06/2006 00:00;02/08/2012 00:00;26/02/1993 00:00;03/11/2000 00:00;07/02/2007 00:00;22/04/2004 00:00;08/01/2013 00:00"	AP	"JANSSEN PHARMS;FRESENIUS KABI USA;WEST-WARD PHARMS INT;MYLAN LABS LTD"	CLADRIBINE	26/02/1993	JANSSEN PHARMS	23,9	31	NA	0	1	AML	0	NA	0	1	0	NA	0	0	0	1	1	1	0	1	1	NA	1	0	0	0	0	0	66	0	1
Aflibercept	"aflibercept;vegf trap r1r2"	"Ziv-Aflibercept ;VEGF Trap;VEGF Trap-Eye;Eylea;Zaltrap"	DB08885			862111-32-8	15C2VL427D	"28116649;22791883;22002018;20028764;19949018"	20028764	01/12/2009	20028764	01/12/2009	2009-2012		1	1	1	Yes	1	"28/10/2016 00:00;24/10/2016 00:00;29/07/2014 00:00;26/05/2017 00:00;30/07/2015 00:00;17/09/2015 00:00;27/01/2014 00:00;07/06/2013 00:00;25/10/2013 00:00;09/03/2016 00:00;18/11/2011 00:00;25/03/2015 00:00;24/06/2016 00:00;03/08/2012 00:00;21/09/2012 00:00;24/05/2016 00:00;06/10/2014 00:00"	AP	"REGENERON PHARMACEUTICALS;SANOFI AVENTIS US"	"ZIV-AFLIBERCEPT;AFLIBERCEPT"	18/11/2011	REGENERON PHARMACEUTICALS	23,5	38	NA	1	0	NA	1	VEGF	0	1	0	NA	0	0	0	0	1	0	0	0	0	0,47	0	PULMONARY EMBOLISM	1	CEREBRAL ISCHEMIA	1	0	21	0	1
Doxorubicin	"3'-deamino-3'-2-methoxy-4-morpholinyldoxorubicin;4'-epidoxorubicin;4'-o-tetrahydropyranyladriamycin;ad-70;adriamycin;ati-0918;br96;br96-doxorubicin;dextran conjugated doxorubicin;doxil;doxorubicin;doxorubicin hydrochloride liposome injection;duomeisu;liposomal adriamycin;liposomal doxorubicin;liposomal doxorubicin hydrochloride;liposome-encapsulated doxorubicin;mcc-465;methoxymorpholino doxorubicin;micelle-encapsulated doxorubicin;nk911;pegylated doxorubicin hcl liposome;pegylated liposomal doxorubicin;pegylated liposomal doxorubicin hydrochloride;pnu-152243;s-liposomal doxorubicin;stealth liposomal doxorubicin;tlc d-99"	"(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;14-hydroxydaunomycin;14-hydroxydaunorubicine;Adriamycin;Adriamycin PFS;Adriamycin Rdf;Adriamycin Rdf Inj 10mg/vial;Adriamycin Rdf Inj 150mg/vial;Adriamycin Rdf Inj 50mg/vial;Caelyx;DOXOrubicin Hydrochloride;Doxil;Doxorubicin;Doxorubicin HCl for Inj. U.S.P. 10mg/vial;Doxorubicin HCl for Inj. U.S.P. 150mg/vial;Doxorubicin HCl for Inj. U.S.P. 50mg/vial;Doxorubicin Hydrochloride;Doxorubicin Hydrochloride Injection;Doxorubicin Hydrochloride Injection, USP;Doxorubicin Hydrochloride for Injection USP;Doxorubicin Hydrochloride for Injection, USP;Doxorubicin Hydrochloride liposome;Doxorubicin Injection;Doxorubicin hydrochloride;Doxorubicine;Doxorubicinum;Hydroxydaunorubicin;Myocet"	"APRD00185;DB00997;DB05331;DB05847"	"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyethanoyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;29042-30-6;25311-50-6;23214-92-8;24385-08-8;23257-17-2;Doxorubicin [USAN:BAN:INN];Doxorubicina [INN-Spanish];Doxorubicine [INN-French];Doxorubicinum [INN-Latin];EINECS 245-495-6;LMPK02000003;HSDB 3070;NCI-C01514;NDC 38242-874;NSC 123127;BSPBio_001031;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;CHEBI:28748;Prestwick0_000438;nchembio809-comp5;Prestwick2_000438;AIDS-000122;Prestwick3_000438;(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;25316-40-9 (FREE BASE);Probes1_000151;AIDS000122;NSC123127 (FREE BASE);DM2;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;BSPBio_000456;Adriblastina (TN);SMP1_000106;(7S,9R)-7-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;Adriamycin;C01661;Doxorubicin;NChemBio.2007.10-comp13;SPBio_002395;D03899;BPBio1_000502;Prestwick1_000438;Probes2_000129;MLS000759533;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid);(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside;10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;14-Hydroxydaunomycin;14-Hydroxydaunorubicine;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;Doxorubicin (USAN);Adriablastin;Adriamycin semiquinone;CCRIS 739"	"doxorubicin;Adriamycin;Doxil;23214-92-8;Adriablastin;Doxorubicine;Adriblastina;Doxorubicinum;Adriblastin;14-Hydroxydaunomycin;14-Hydroxydaunorubicine;Doxorubicina;Myocet;Rubex;Adriamycin semiquinone;Doxorubicine [INN-French];Doxorubicinum [INN-Latin];Doxorubicina [INN-Spanish];Hydroxydaunorubicin;Caelyx;Doxorubicin HCl;Adriamycin PFS;Adriamycin RDF;FI 106;Doxorubicin [USAN:INN:BAN];Resmycin;DOX-SL;ThermoDox;Adriblas tina;Doxorubicin-hLL1;RDF Rubex;Adriblastina (TN);CCRIS 739;Liposomal Doxorubicin;Aerosolized Doxorubicin;Doxorubicin-P4/D10;HSDB 3070;NDC 38242-874;NCI-C01514;UNII-80168379AG;Doxorubicin citrate;EINECS 245-495-6;Doxorubicin (USAN/INN);Doxorubicin-hLL1 conjugate;Rubex (hydrochloride salt);rubidox;Adriacin (hydrochloride salt);CHEMBL53463;hydroxydaunomycin;Doxorubicin-P4/D10 conjugate;TLC D-99;adiblastine (hydrochloride salt);adriblatina (hydrochloride salt);CHEBI:28748;adriablatina (hydrochloride salt);Adriblastina (hydrochloride salt);adriablastine (hydrochloride salt);Farmablastina (hydrochloride salt);NSC 123127;adr iablatina (hydrochloride salt);Adriamycin PFS (hydrochloride salt);Adriamycin RDF (hydrochloride salt);5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;DM2;hydroxydaunorubicin HCl;80168379AG;ADM;Doxorubicin hydrochloride (hydrochloride salt);Rubex (TN);Triferric doxorubicin;(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid);(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside;10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;Hydroxydaunomycin hydrochloride (hydrochloride salt);Hydroxydaunomycin hydrochlor ide (hydrochloride salt);Hydroxydaunorubicin hydrochloride (hydrochloride salt);MLS000028393;Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74;Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120;Hydroxydaunorubicin hydrochloride;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione;25316-40-9;DOX;Caelyx (TN);Myocet (TN);Cantide + adriamycin;Adriamycin PFS (TN);Adriamycin RDF (TN);Doxorubicin(Adriamycin);(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;Prestwick0_000438;Prestwick1_000438;Prestwick2_000438;Prestwick3_000438;ADR;D07VLY;D0VW5S;Probes1_000151;Probes2_000129;AC1L1M5T;AC1Q29OJ;SCHEMBL3243;BSPBio_000456;BSPBio_001031;Caelyx (liposomal doxorubicin);SPBio_002395;BPBio1_000502;cid_443939;GTPL7069;DTXSID8021480;BDBM22984;BDBM32022;AOJJSUZBOXZQNB-TZSSRYMLSA-N;MolPort-006-124-025;25316-40-9 (hydrochloride);HMS2089H06;ZINC3918087;GR-319;HY-15142A;LMPK13050001;AKOS015951330;CS-2759;DB00997;MCULE-4188577717;SMP1_000106;NCGC00024415-35;NCGC00024415-37;NCGC00024415-38;NCGC00024415-40;NCGC00024415-41;NCGC00024415-42;AN-17965;BP-23114;CC-23807;AB1009243;JT9100000;LS-165655;FT-0601614;14D928;C01661;D03899;10336-EP2270008A1;10336-EP2270014A1;10336-EP2270018A1;10336-EP2270505A1;10336-EP2272827A1;10336-EP2272832A1;10336-EP2275420A1;10336-EP2277565A2;10336-EP2277566A2;10336-EP2277567A1;10336-EP2277568A2;10336-EP2277569A2;10336-EP2277570A2;10336-EP2277865A1;10336-EP2277876A1;10336-EP2280012A2;10336-EP2281815A1;10336-EP2289892A1;10336-EP2292280A1;10336-EP2292614A1;10336-EP2292615A1;10336-EP2292617A1;10336-EP2295055A2;10336-EP2295416A2;10336-EP2295426A1;10336-EP2295427A1;10336-EP2298748A2;10336-EP2298764A1;10336-EP2298765A1;10336-EP2298768A1;10336-EP2298778A1;10336-EP2298780A1;10336-EP2301536A1;10336-EP2301538A1;10336-EP2301928A1;10336-EP2301933A1;10336-EP2302382A2;10336-EP2302383A2;10336-EP2305243A1;10336-EP2305250A1;10336-EP2305640A2;10336-EP2305642A2;10336-EP2305671A1;10336-EP2305679A1;10336-EP2305689A1;10336-EP2308562A2;10336-EP2308812A2;10336-EP2308833A2;10336-EP2308855A1;10336-EP2308861A1;10336-EP2311453A1;10336-EP2311455A1;10336-EP2311808A1;10336-EP2311825A1;10336-EP2311827A1;10336-EP2311829A1;10336-EP2311840A1;10336-EP2311842A2;10336-EP2316452A1;10336-EP2316832A1;10336-EP2316833A1;10336-EP2316834A1;10336-EP2371811A2;10336-EP2374454A1;13171-EP2269989A1;13171-EP2269994A1;13171-EP2270008A1;13171-EP2270018A1;13171-EP2270505A1;13171-EP2275102A1;13171-EP2277865A1;13171-EP2277876A1;13171-EP2281815A1;13171-EP2286812A1;13171-EP2289892A1;13171-EP2292227A2;13171-EP2292233A2;13171-EP2292614A1;13171-EP2292615A1;13171-EP2292617A1;13171-EP2295407A1;13171-EP2295412A1;13171-EP2295413A1;13171-EP2295416A2;13171-EP2298305A1;13171-EP2298736A1;13171-EP2298746A1;13171-EP2298748A2;13171-EP2298768A1;13171-EP2298772A1;13171-EP2298780A1;13171-EP2301933A1;13171-EP2305640A2;13171-EP2305642A2;13171-EP2305671A1;13171-EP2305679A1;13171-EP2305689A1;13171-EP2308833A2;13171-EP2308839A1;13171-EP2308861A1;13171-EP2311827A1;13171-EP2316832A1;13171-EP2316833A1;13171-EP2316834A1;13171-EP2316937A1;45970-EP2275413A1;45970-EP2287156A1;45970-EP2311807A1;C-23275;BRD-K92093830-003-04-3;BRD-K92093830-003-25-8;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1s,3s)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside; Adriamycin; Doxorubicin;(7S,9R)-7-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride;(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen;(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;(8S-cis)-10-(3-Amino-2,3,6-Tr ideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione;(8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione;(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;23257-17-2;24385-08-8;25311-50-6;29042-30-6;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-"	23214-92-8	80168379AG	"10501914;10732743;10811502;10829049;11127946;11148564;11335910;11839652;12473580;12610186;12675215;14735687;14998859;15057152;15196535;15310783;15322827;15477860;15598035;15886473;16019859;16377584;16434821;17317836;17699865;19863161;20693299;21590446;22178041;23153506;23382028;24965180;25019569;25144817;26279503;28802766;7497603;7505268;8840985;9164225;9256884;9332692;9488597;9796961;9815591"	7505268	01/05/1993	4512088	01/09/1972	Bef. 1989		0	1	1	Yes	1	"14/10/1997 00:00;17/03/1989 00:00;05/11/2014 00:00;18/11/2010 00:00;22/11/2010 00:00;29/01/1996 00:00;25/11/1975 00:00;15/09/1997 00:00;13/04/1989 00:00;30/08/2013 00:00;03/04/2001 00:00;21/12/1976 00:00;24/08/1999 00:00;18/04/2002 00:00;01/06/1992 00:00;09/10/2015 00:00;10/10/2013 00:00;30/07/2010 00:00;26/04/1995 00:00;03/11/2014 00:00;25/03/1976 00:00;11/02/1986 00:00;05/09/1997 00:00;10/08/2000 00:00;10/09/2015 00:00;25/08/1975 00:00;15/03/1982 00:00;24/02/1995 00:00;05/12/2002 00:00;04/03/1999 00:00;31/03/1980 00:00;16/04/2015 00:00;10/08/1977 00:00;15/02/2007 00:00;08/03/1996 00:00;13/07/1999 00:00;19/09/2002 00:00;29/11/1996 00:00;20/05/1985 00:00;16/08/2002 00:00;05/05/1975 00:00;16/01/1985 00:00;17/11/1995 00:00;25/09/2002 00:00;09/07/1993 00:00;24/06/2013 00:00;30/03/2000 00:00;20/07/2000 00:00;19/05/1993 00:00;09/01/1978 00:00;29/03/1977 00:00;28/07/2003 00:00;11/08/2017 00:00;13/02/1998 00:00;14/09/1976 00:00;12/12/2014 00:00;02/06/1995 00:00;29/03/2016 00:00;21/03/1986 00:00;06/11/1986 00:00;30/12/1987 00:00;10/06/2008 00:00;26/09/2011 00:00;28/02/2012 00:00;16/10/1975 00:00;28/11/1978 00:00;14/02/2007 00:00;28/07/1995 00:00;04/02/2013 00:00;27/06/2014 00:00;11/07/1997 00:00;26/07/1994 00:00;15/02/2012 00:00;05/12/2011 00:00;03/11/2017 00:00;28/06/1999 00:00;24/05/2001 00:00;21/05/1986 00:00;18/03/2013 00:00;17/02/2017 00:00;31/10/1996 00:00;02/11/2000 00:00;24/07/1996 00:00;25/03/1987 00:00;13/09/1978 00:00;29/07/1996 00:00;03/04/1996 00:00;25/08/1983 00:00;25/08/2015 00:00;10/07/1996 00:00;28/07/1981 00:00;29/11/1994 00:00;23/12/1987 00:00;09/08/2002 00:00;25/03/1988 00:00;01/11/1995 00:00;08/05/2001 00:00;18/07/2012 00:00;10/01/2002 00:00;25/07/1977 00:00;31/03/1992 00:00;03/07/1978 00:00;07/06/1995 00:00;19/02/1987 00:00;13/06/2000 00:00;27/10/2004 00:00;21/05/1990 00:00;12/12/2013 00:00;02/04/2002 00:00;23/10/2013 00:00;12/05/1975 00:00;30/10/1979 00:00;10/08/1983 00:00;27/05/1993 00:00;06/10/1999 00:00;28/04/1987 00:00;23/05/1997 00:00;07/06/1985 00:00;18/09/2002 00:00;12/10/1993 00:00;15/05/2017 00:00;15/02/2001 00:00;05/12/2014 00:00;14/02/2012 00:00;18/08/1977 00:00;13/09/1994 00:00;19/09/2012 00:00;31/10/2013 00:00;31/07/1997 00:00;28/01/1999 00:00;14/05/2007 00:00;19/01/2018 00:00;13/11/1974 00:00;17/05/2007 00:00;28/07/1993 00:00;08/11/2012 00:00;30/04/1997 00:00;31/10/1979 00:00;28/01/2005 00:00;05/01/2011 00:00;22/07/1987 00:00;31/03/1998 00:00;28/12/2015 00:00;22/01/2015 00:00;28/02/1995 00:00;05/10/1989 00:00;07/08/1974 00:00;25/08/2000 00:00;21/12/2014 00:00;11/05/2000 00:00;28/10/2011 00:00;24/02/1983 00:00;08/06/1992 00:00;10/01/1997 00:00;03/02/1992 00:00;01/12/1998 00:00;14/03/1979 00:00;17/12/2002 00:00;14/04/2014 00:00;30/01/1991 00:00;16/11/1993 00:00;13/01/1977 00:00;08/05/2003 00:00;26/10/1995 00:00;03/05/1996 00:00;28/03/2011 00:00;27/03/1987 00:00;19/09/2000 00:00;04/03/1985 00:00;07/12/1978 00:00;25/07/2012 00:00;14/08/2003 00:00;08/06/2000 00:00;22/03/1977 00:00"	AP	"BRISTOL MYERS SQUIBB;SUN PHARMA GLOBAL;#N/A;TEVA PHARMS USA;FRESENIUS KABI USA;MYLAN LABS LTD;ACTAVIS INC;WEST-WARD PHARMS INT;PHARMACHEMIE BV;SANDOZ INC;SUN PHARM INDS;ALVOGEN INC;AMNEAL PHARMS CO;PHARMACIA AND UPJOHN;DR REDDYS LABS LTD;JANSSEN RES AND DEV;SAGENT PHARMS"	DOXORUBICIN HYDROCHLORIDE	07/08/1974	PHARMACIA AND UPJOHN	23,1	13	NA	0	1	OSTEOSARCOMA	0	NA	0	1	0	NA	0	0	0	1	0	0,3	0	1	1	NA	0	0	0	0	0	0	670	1	1
Acalabrutinib	"acalabrutinib;acp-196"	Calquence	DB11703		"Acalabrutinib;1420477-60-6;Calquence;ACP-196;UNII-I42748ELQW;I42748ELQW;Acalabrutinib [INN];Acalabrutinib [USAN:INN];Calquence (TN);Acalabrutinib(ACP196);ACP-196;Acalabrutinib;Acalabrutinib (ACP-196);GTPL8912;Acalabrutinib (JAN/USAN/INN);CHEMBL3707348;SCHEMBL14637368;ACP 196;EX-A881;WDENQIQQYWYTPO-IBGZPJMESA-N;KS-000006AD;KS-000006AT;BDBM50175583;s8116;AKOS030526094;ZINC208774715;CS-5356;DB11703;DS-3326;Benzamide, 4-(8-amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-;HY-17600;SC-41557;Example 6 [US20140155385 A1];D10893;J-690166;(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide;4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide;4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide"	1420477-60-6	I42748ELQW	26641137	26641137	01/12/2015	26641137	01/12/2015	2013-2017		1	1	1	Yes	1	31/10/2017 00:00	AP	ASTRAZENECA	ACALABRUTINIB	31/10/2017	ASTRAZENECA	23,0	61	NA	0	1	CLL	1	BTK	0	1	0	NA	1	0	0	1	0	0,95	0	0	0	1	0	0	0	0	0	0	0	0	1
Tandutinib	tandutinib		DB05465	"4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]-4-quinazolinyl]-1-piperazinecarboxamide;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide;387867-13-2;(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-;CT 53518;CT53518;MLN 518;Tandutinib;D06005;Tandutinib (USAN);NSC726292"	"Tandutinib;387867-13-2;MLN-518;CT53518;MLN518;Tandutinib (MLN518);MLN 518;UNII-E1IO3ICJ9A;CT 53518;CT-53518;E1IO3ICJ9A;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;CHEMBL124660;N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide;CHEBI:90237;MLN-0518;NCGC00241097-01;DSSTox_CID_28873;DSSTox_RID_83142;DSSTox_GSID_48947;Q-201778;4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-(4-propan-2-yloxyphenyl)-1-piperazinecarboxamide;4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide;CAS-387867-13-2;Tandutinib [USAN:INN];tandutinibum;Kinome_3320;MLN518, Tandutinib;Tandutinib(MLN518);Tandutinib - MLN518;AC1MI50F;cc-355;MLS006010972;SCHEMBL927974;DTXSID8048947;BDBM13535;cid_3038522;CTK8E8817;AOB5045;SYN1088;TANDUTINIB (CT53518);MolPort-006-170-097;BCPP000051;HMS3244A21;HMS3244A22;HMS3244B21;HMS3264G08;HMS3654O09;Pharmakon1600-01502277;EX-A1637;KS-00000XG3;ZINC3966243;Tox21_113366;MFCD09954147;NSC726292;NSC759851;s1043;AKOS015902621;Tox21_113366_1;AC-1659;CCG-213017;CS-0128;DB05465;ES-0051;NSC-726292;NSC-759851;NCGC00241097-02;NCGC00241097-03;AN-14710;BC681887;HY-10202;SC-23292;SMR004702776;AB0073004;RT-015876;B1526;FT-0653217;D06005;F10205;Tandutinib pound MLN518, CT53518 pound(c);W-5432;AB01562955_01;867T132;A824282;I14-1975;BRD-K89162000-001-01-5;MLN518;CT53518;MLN 518;CT 53518;MLN-518;CT-53518;1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-;4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide"	387867-13-2	E1IO3ICJ9A	27663390	27663390	01/09/2016	27663390	01/09/2016	2013-2017		1	1	0	Yes	1					30/07/2018		22,9	55	NA	0	1	GLIOBLASTOMA	1	PDGF receptor-?	0	1	1	30	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	1	0	1
TAK-733	tak-733		DB12241		"TAK-733;1035555-63-5;TAK733;TAK 733;UNII-5J61HSP0QJ;(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione;5J61HSP0QJ;CHEMBL1615025;3-[(2r)-2,3-Dihydroxypropyl]-6-Fluoro-5-[(2-Fluoro-4-Iodophenyl)amino]-8-Methylpyrido[2,3-D]pyrimidine-4,7(3h,8h)-Dione;D0I3RD;MLS006011054;GTPL9911;SCHEMBL1528606;DTXSID20648089;MolPort-023-293-497;RCLQNICOARASSR-SECBINFHSA-N;example 18 [US8470837];3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione;AOB87182;BDBM50337926;s2617;ZINC43196550;AKOS027251050;CS-1283;DB12241;compound 17 [PMID: 21310613];NCGC00263187-01;BC600334;HY-13449;SC-96674;SMR004702846;AB0165727;KB-137233;FT-0774097;W-6029;US8470837, 18;TAK733, 1035555-63-5;3-[(2R)-2,3-Dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione;3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido [2,3-d]pyrimidine-4,7(3h,8h)-dione;3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7-dione;IZG"	1035555-63-5	5J61HSP0QJ	27650277	27650277	01/09/2016	27650277	01/09/2016	2013-2017		1	1	0	Yes	1					30/07/2018		22,9	51	NA	1	0	NA	1	MEK	0	1	0	NA	1	0	0	1	1	0,05	0	0	0	NA	0	0	0	0	0	0	0	0	1
Peginterferon alfa-2a	"alpha-2a interferon;pegylated interferon alfa-2a"	"Pegasys;Pegasys Rbv;Pegylated interferon alfa-2a;Pegylated interferon alpha2a"	"BIOD00043;BTD00043;DB00008"			198153-51-4	Q46947FE7K	"11230473;9069300"	9069300	01/01/1997	11106715	01/12/2000	1999-2003		1	0	1	No	0	"13/10/2017 00:00;13/06/2008 00:00;21/12/2004 00:00;16/10/2002 00:00;22/08/2011 00:00;13/05/2005 00:00;27/05/2011 00:00;09/08/2011 00:00;31/10/2003 00:00;29/09/2011 00:00;18/03/2015 00:00;19/06/2007 00:00;18/11/2005 00:00;16/05/2013 00:00;20/04/2009 00:00;25/02/2005 00:00;03/03/2010 00:00;24/05/2010 00:00;31/10/2008 00:00;23/02/2011 00:00;07/08/2009 00:00;05/09/2014 00:00;03/12/2002 00:00;09/05/2011 00:00;02/07/2013 00:00;18/09/2008 00:00"	AP	HOFFMAN-LA ROCHE	PEGINTERFERON ALFA-2A	16/10/2002	HOFFMAN-LA ROCHE	22,4	#N/A																							0						1
Leuprolide	"leuprolide;leuprorelin"	"(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone;Eligard;Eligard 22.5mg;Eligard 30 mg;Eligard 45 mg;Eligard 7.5mg;L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide;Leuprolide Acetate;Leuprolide Acetate Injection;Leuprorelin;Leuprorelina;Leuproreline;Leuprorelinum;Lupaneta Pack;Lupron;Lupron Depot;Lupron Depot-PED;PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5;PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet;Zeulide Depot"	"BIOD00009;BTD00009;DB00007"	"N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;N-[2-[[2-[[2-[[2-[[1-[[1-[[1-[2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide;N-[2-[[2-[[2-[[2-[[1-[[[1-[[[1-[[2-(ethylcarbamoyl)-1-pyrrolidinyl]-oxomethyl]-4-guanidinobutyl]amino]-oxomethyl]-3-methylbutyl]amino]-oxomethyl]-3-methylbutyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxoethyl]amino]-1-(hydroxymethyl)-2-oxoethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-oxoethyl]-5-oxo-2-pyrrolidinecarboxamide;N-[2-[[2-[[2-[[2-[[1-[[1-[[1-[2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(4-hydroxybenzyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide;N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxo-pentan-2-yl]amino]-4-methyl-1-oxo-pentan-2-yl]amino]-4-methyl-1-oxo-pentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxo-propan-2-yl]amino]-3-hydroxy-1-oxo-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxo-propan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxo-propan-2-yl]-5-oxo-pyrrolidine-2-carboxamide;NSC377526;N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;C07612;Leuprolide;Leuprorelin"	"Leuprorelin;leuprolide;53714-56-0;Eligard;Leuprorelina;Leuproreline;Leuprorelinum;Leuprorelin acetate;UNII-EFY6W0M8TG;Lupron;EFY6W0M8TG;leupline;CHEBI:6427;TAP-144;A-43818;Abbott-43818;MFCD00167544;des-Gly10-[D-Leu6]-LH-RH ethylamide;Leuprorelin [INN:BAN];Leuproreline [INN-French];Leuprorelinum [INN-Latin];Leuprorelina [INN-Spanish];Leuprorelin acetate (JAN);Leuprolide acetate (USAN);CCRIS 8462;HSDB 6518;Leuprelin Acetate;LH-RH Leuprolide;Eligard (TN);C59H84N16O12;Viadur (TN);NSC 377526;AC1LCW5J;D0U5FF;SCHEMBL4585;Leuprolide, human, synthetic;GTPL1175;CHEMBL1201199;KS-00002WUT;74381-53-6 (monoacetate);GFIJNRVAKGFPGQ-LIJARHBVSA-N;Leuprorelin Acetate(Prostap SR)/;MolPort-006-069-430;5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide;5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide;(D-Leu(sup 6),des-gly-NH2(sup 10),pro-ethylamide(sup 9))-GNRH;(D-Leu(sup 6),des-gly-NH2(sup 10),pro-ethylamide(sup 9))-LHRH;ABP000580;BDBM50369395;CL-014;AKOS015892744;AKOS030213246;CS-4947;HS-2016;(D-Leu(sup 6),des-gly-NH2(sup 10),pro-ethylamide(sup 9))-gonadotropin-releasing hormone;HY-12553;I025;Luteinizing hormone-releasing factor (pig), 6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-;Leuprolide acetate salt, >=98% (HPLC);FT-0657442;pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt;714L560;pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5;Leuprolide acetate, United States Pharmacopeia (USP) Reference Standard;(D-Leu(6),des-Gly-NH2(10),Pro-ethylamide(9))-gonadotropin-releasing hormone;(S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)pyrrolidine-2-carboxamide;L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide;Luteinizing hormone-releasing hormone (pig), 6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-"	53714-56-0	EFY6W0M8TG	"10953135;8776813;9519419"	8776813	01/01/1996	6408125	01/06/1983	Bef. 1989		1	1	1	Yes	1	"21/03/2011 00:00;11/02/1999 00:00;16/10/2000 00:00;09/09/2003 00:00;04/08/1998 00:00;20/11/2013 00:00;09/05/1994 00:00;13/08/2001 00:00;03/04/2001 00:00;29/04/2014 00:00;26/01/2001 00:00;15/09/2005 00:00;03/12/1996 00:00;23/08/2002 00:00;23/07/2001 00:00;29/07/1998 00:00;09/01/1998 00:00;07/03/1997 00:00;06/06/2016 00:00;21/09/2001 00:00;23/12/2003 00:00;22/12/1995 00:00;18/10/2004 00:00;21/01/1994 00:00;24/09/2002 00:00;26/03/1992 00:00;28/09/2000 00:00;09/11/2005 00:00;19/01/1988 00:00;08/08/2001 00:00;24/01/2001 00:00;13/08/1999 00:00;08/10/2011 00:00;23/05/2002 00:00;27/02/2013 00:00;21/10/1991 00:00;01/03/2001 00:00;25/01/2013 00:00;09/04/2013 00:00;12/05/2000 00:00;10/07/1986 00:00;17/11/2015 00:00;24/04/1996 00:00;12/12/1995 00:00;07/07/1992 00:00;05/07/2001 00:00;30/10/2013 00:00;24/07/2002 00:00;14/12/1990 00:00;22/09/1995 00:00;03/02/2014 00:00;21/02/2002 00:00;08/11/2013 00:00;01/08/2003 00:00;17/05/2002 00:00;09/04/1998 00:00;29/11/2001 00:00;27/06/1997 00:00;16/02/2006 00:00;18/09/2000 00:00;29/10/2010 00:00;29/09/2006 00:00;11/07/2017 00:00;27/06/2014 00:00;08/11/2007 00:00;08/03/2002 00:00;14/01/1987 00:00;03/07/2003 00:00;11/02/2016 00:00;06/07/2008 00:00;10/07/2013 00:00;08/09/2005 00:00;04/10/1999 00:00;12/09/1996 00:00;18/04/2018 00:00;12/01/2004 00:00;30/03/1995 00:00;26/01/1989 00:00;10/07/2014 00:00;19/05/2017 00:00;16/04/1993 00:00;20/09/2001 00:00;23/12/1997 00:00;24/03/1995 00:00;14/12/2004 00:00;30/05/2014 00:00;26/04/1994 00:00;11/08/1995 00:00;13/09/2006 00:00;14/01/2011 00:00;09/08/2012 00:00;30/08/2010 00:00;24/06/2009 00:00;21/12/2000 00:00;14/05/2013 00:00;18/07/2012 00:00;26/10/2015 00:00;08/04/2011 00:00;09/03/2009 00:00;02/03/2004 00:00;22/10/1990 00:00;31/10/2007 00:00;28/04/2010 00:00;06/08/2001 00:00;15/04/2014 00:00;31/01/2013 00:00;03/04/2013 00:00;22/11/1999 00:00;31/07/2008 00:00;16/05/2002 00:00;15/01/2004 00:00;14/12/2012 00:00;26/04/2011 00:00;08/11/1994 00:00;09/05/1988 00:00;14/09/2007 00:00;29/02/2016 00:00;23/01/2012 00:00;13/01/2017 00:00;30/05/1997 00:00;18/11/1998 00:00;20/09/2002 00:00;04/09/1997 00:00;28/10/2003 00:00;14/02/1994 00:00;01/04/2002 00:00;08/02/2013 00:00;27/09/2011 00:00;17/02/2012 00:00;27/05/2009 00:00;14/11/2001 00:00;12/03/1987 00:00;25/09/1998 00:00;03/03/2000 00:00;28/03/2012 00:00;25/11/2003 00:00;28/05/1996 00:00;11/05/2000 00:00;10/01/1997 00:00;02/06/2009 00:00;17/06/2011 00:00;15/08/2011 00:00;21/10/2002 00:00;18/07/2014 00:00;10/10/2014 00:00;07/07/1997 00:00;07/11/1994 00:00;26/10/1995 00:00;08/01/1998 00:00;28/03/2011 00:00;25/10/2000 00:00;23/01/2002 00:00;05/10/2010 00:00;08/06/2001 00:00;09/06/1993 00:00;14/06/2011 00:00;30/06/1998 00:00;08/05/2015 00:00;21/07/1994 00:00;09/04/1985 00:00;13/02/2003 00:00"	AP	"GENZYME;SANDOZ;SUN PHARMA GLOBAL;ABBVIE ENDOCRINE INC;ABBVIE ENDOCRINE;TEVA PHARMS USA;TOLMAR THERAP;ABBOTT LABS;ORTHO MCNEIL JANSSEN"	"LEUPROLIDE ACETATE; NORETHINDRONE ACETATE"	09/04/1985	ABBVIE ENDOCRINE INC	22,2	19	NA	0	1	PROSTATE	1	GNRH	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	236	0	1
Clofarabine	"clofarabine;clofarabine 6-ketoclofarabine"	"(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine;2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine;CAFdA;CL-F-Ara-a;Clofarabin;Clofarabina;Clofarabine;Clofarabinum;Clofarex;Clolar;Evoltra"	"APRD00878;DB00631;DB06189;DB07554"	"5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol;5-(6-amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-tetrahydrofuranol;5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-methylol-tetrahydrofuran-3-ol;5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;Adenine, 2-chloro-9-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-;Adenosine, 2-chloro-2'-deoxy-2'-fluoro-;Clofarabine;NSC606869"	"Clofarabine;123318-82-1;Clolar;Evoltra;Clofarex;CAFdA;clofarabina;clofarabinum;Clofarabine [USAN];Cl-F-Ara-A;C1-F-Ara-A;UNII-762RDY0Y2H;Clolar (TN);2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine;2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine;2-Cl-2'-F-araA;(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;762RDY0Y2H;CHEBI:681569;(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol;2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine;DSSTox_CID_26437;DSSTox_RID_81613;DSSTox_GSID_46437;CFB;3S211048;2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine;Cl-F-araA;9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-;(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol;CAS-123318-82-1;C10H11ClFN5O3;Clofarabin;Clofarabine [USAN:INN:BAN];5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;NCGC00164553-01;Evoltra (TN);PubChem19116;Clofarabine (USAN/INN);D0R5RR;AC1L3OC8;Clofarabine,Clolar, Evoltra;SCHEMBL9040;CHEMBL1750;Clolar, Evoltra, Clofarabine;MLS003915615;Clofarabine (JAN/USAN/INN);BIFK0045;GTPL6802;DTXSID5046437;Clofarabine, >=98% (HPLC);MolPort-005-941-711;WDDPHFBMKLOVOX-AYQXTPAHSA-N;HMS2090A07;ACT05522;HY-A0005;ZINC3798247;Tox21_112182;AC-274;MFCD00871077;s1218;AKOS005063562;AKOS015919355;Tox21_112182_1;API0002064;BCP9000540;CS-0373;DB00631;MCULE-2276059681;SAR-393590;NCGC00164553-02;AN-15999;AS-12958;BC222364;CC-25917;KB-49091;SC-22779;SMR002530055;BCP0726000280;LS-126466;FT-0082882;FT-0601617;ST24046359;KS-00000650;D03546;W-5182;AB00430247-03;AB00430247-04;AB00430247_06;318C821;C-18934;SR-01000930565;SR-01000930565-3;Z1557400138;2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-adenine;2-Chloro-9-(2-deoxy-2-fluoro-?-D-arabinofuranosyl)-9H-purin-6-amine;2-Chloro-9-(2-Deoxy-2-Fluoro-B -D-Arabinofuranosyl)-9h-Purin-6-Amine;9H-Purine-6-amine,2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-;(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine"	123318-82-1	762RDY0Y2H	"27184623;24415560;24130086;23289359;20582417;15571270;14551141;12637486"	12637486	01/03/2003	12637486	01/03/2003	1999-2003		1	1	1	Yes	1	"06/12/2017 00:00;06/11/2017 00:00;10/01/2013 00:00;09/05/2017 00:00;15/09/2014 00:00;04/03/2016 00:00;16/12/2015 00:00;28/12/2004 00:00;27/10/2016 00:00;17/10/2008 00:00;10/06/2011 00:00"	"AP;TA"	"GENZYME;ABON PHARMS LLC;#N/A;AMNEAL PHARMS CO;DR REDDYS LABS LTD;ZYDUS PHARMS USA INC"	CLOFARABINE	28/12/2004	GENZYME	21,9	32	NA	1	1	AML	0	NA	0	1	0	NA	0	0	0	1	1	0,16	0	1	1	NA	0	0	0	0	0	0	245	0	1
Emibetuzumab	"emibetuzumab;ly2875358"		DB11849			1365287-97-3	MO4K3GDN1I	27803065	27803065	01/11/2016	27803065	01/11/2016	2013-2017		1	1	0	Yes	1					30/07/2018		20,9	23	NA	1	1	NSCLC	1	MET	0	1	0	NA	0	1	0	1	0	0,13	0	0	0	NA	0	0	0	0	0	0	26	0	1
Urelumab	"bms-663513;urelumab"		DB12077			934823-49-1	230902QLLC	27756788	27756788	01/11/2016	27756788	01/11/2016	2013-2017		1	1	0	Yes	1					30/07/2018		20,9	346	NA	1	0	NA	1	CD137	0	1	0	NA	0	0	1	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Palifermin	palifermin	"24-163 fibroblast growth factor 7 (human);Kepivance"	"DB00039;BTD00042;BIOD00042"			162394-19-6	QMS40680K6	"22892551;22453252"	22453252	01/03/2012	12697866	01/04/2003	1999-2003		1	0	1	No	0	"27/04/2016 00:00;14/11/2011 00:00;13/03/2015 00:00;12/12/2005 00:00;23/09/2011 00:00;21/01/2010 00:00;30/05/2013 00:00;01/07/2016 00:00;15/12/2004 00:00"	AP	BIOVITRUM AB	PALIFERMIN	15/12/2004	BIOVITRUM AB	20,5	#N/A																							0						1
Mirvetuximab Soravtansine	"imgn853;mirvetuximab"	IMGN853	DB12489		"Mirvetuximab soravtansine;IMGN853;huMov 19;UNII-98DE7VN88D;IMGN 853;Mirvetuximab soravtansine [USAN];98DE7VN88D;SCHEMBL16447449;1453084-37-1;Immunoglobulin G1, anti-(human folate receptor alpha) (human-Mus musculus monoclonal M9346A heavy chain), disulfide with human-Mus musculus monoclonal M9346A light chain, dimer, tetraamide with N2'-(4-((3-carboxy-3-sulfopropyl)dithio)-4-methyl-1-oxopentyl)-N2'-deacetylmaytansine;1401992-35-5"	1453084-37-1	98DE7VN88D	"28440955;28029313"	28029313	01/12/2016	28029313	01/12/2016	2013-2017		1	1	0	Yes	1					30/07/2018		19,9	46	NA	0	1	OVARIAN CANCER	1	FOLATE RECEPTOR	0	1	0	NA	0	0	0	1	1	0,26	0	1	1	NA	0	0	0	0	0	0	35	0	1
Rovalpituzumab Tesirine	"rovalpituzumab;sc16ld6.5"		DB13017		"Rova-t;Rovalpituzumab Tesirine;UNII-P256HB60FF;Rovalpituzumab tesirine [INN];P256HB60FF;Rovalpituzumab tesirine [WHO-DD];Rovalpituzumab tesirine [USAN:INN];SC0002;1613313-09-9"	1613313-09-9	P256HB60FF	27932068	27932068	01/12/2016	27932068	01/12/2016	2013-2017		1	1	0	Yes	1					30/07/2018		19,9	82	NA	0	1	"SCLC;LCNET"	1	DLL3	0	1	1	60	0	1	0	1	1	0,38	0	0	0	NA	0	0	0	0	0	0	0	0	1
Capecitabine	capecitabine	"Capecitabina;Capecitabin;Capecitabinum;(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester;Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate;Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate;Ach-capecitabine;Capecitabine Accord;Sandoz Capecitabine;Teva-capecitabine;Taro-capecitabine;Capecitabine Medac;Apo-capecitabine;Xeloda;Capecitabine;Capecitabine Teva;Ecansya;Capecitabine Sun"	"DB01101;APRD00203"	"pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate;N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-2-tetrahydrofuranyl]-5-fluoro-2-oxo-4-pyrimidinyl]carbamic acid pentyl ester;N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-keto-pyrimidin-4-yl]carbamic acid amyl ester;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-oxolan-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate;154361-50-9;158798-73-3;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester;Capecitabine (JAN/USAN);D01223;Xeloda (TN);C12650;5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine;CAPECITABINE;Capecitabine [USAN];Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester;Cytidine, 5'-deoxy-5-fluoro-N-((pentyloxy)carbonyl)-;N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate;Ro 09-1978;Ro 09-1978/000;Xeloda;R-340;Ro-09-1978"	"CAPECITABINE;154361-50-9;Xeloda;Capiibine;Capecitibine;Caxeta;Xabine;Capecitabine [USAN];capecitabina;capecitabinum;Capecitabin;Ro 09-1978;5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;UNII-6804DJ8Z9U;Xeloda (TN);N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;Ro 09-1978/000;5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine;Captabin;R340;Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate;Capecitabine (JAN/USAN/INN);Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate;C15H22FN3O6;CHEBI:31348;GAGWJHPBXLXJQN-UORFTKCHSA-N;6804DJ8Z9U;RG-340;Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;Ro-09-1978;Ro-091978000;R-340;DSSTox_CID_26451;DSSTox_RID_81625;Capecytabine;DSSTox_GSID_46451;(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester;pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate;Cytidine, 5'-deoxy-5-fluoro-N-((pentyloxy)carbonyl)-;Capecitabine (Xeloda);Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate;SMR002530052;CAS-154361-50-9;HSDB 7656;NCGC00164569-01;Capecitabine [USAN:USP:INN:BAN];PubChem21443;D00HCQ;AC1Q4KU8;SCHEMBL8153;CHEMBL1773;MLS003915642;MLS004774137;Capecitabine (Fluoropyrimidine);Xeloda, Captabin, Capecitabine;AC1L1U83;CYT011;GTPL6799;DTXSID3046451;Capecitabine, analytical standard;CTK0H6126;Capecitabine, >=98% (HPLC);EX-A835;MolPort-005-938-254;BCPP000300;158798-73-3;AMX10125;HY-B0016;KS-00000E7O;ZINC3806413;Tox21_112198;CC0143;s1156;AKOS015920130;Tox21_112198_1;AM84502;BCP9000483;BS-1000;CS-0768;DB01101;MCULE-2851259722;NCGC00164569-02;AJ-45659;AK-72933;AN-16068;BC215614;BR-72933;CC-25374;LS-59070;SC-08810;AB0068959;ST2413659;FT-0082472;FT-0601618;FT-0696497;Ro-09-1978-000;Ro-09-1978/000;C12650;D01223;n4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;S-3173;AB01274776-01;AB01274776-02;AB01274776_04;361C509;5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;C-20872;SR-01000931255;J-700154;Q-200788;SR-01000931255-3;BRD-K61192372-001-08-9;Z1741971721;Capecitabine, European Pharmacopoeia (EP) Reference Standard;Capecitabine, United States Pharmacopeia (USP) Reference Standard;Capecitabine, Pharmaceutical Secondary Standard; Certified Reference Material;958887-39-3;Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrim;pentyl 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-ylcarbamate;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate"	154361-50-9	6804DJ8Z9U	"24983373;24867540;24819683;24574780;24556590;24267968;24231241;23592571;21609937;21184645;19675744;19322566;18398145;18164861;17689023;17394942;17333194;17205868;16314628;16242260;15729602;15684318;15305186;12873672;12351595;12017329;9738566"	9738566	01/09/1998	9063521	01/09/1996	1994-1998		1	1	1	Yes	1	"05/02/2011 00:00;30/04/1998 00:00;04/02/1999 00:00;24/09/2014 00:00;10/12/2013 00:00;12/12/2016 00:00;04/04/2016 00:00;16/10/2014 00:00;22/07/2014 00:00;14/12/2016 00:00;02/03/2015 00:00;15/03/2003 00:00;22/12/2015 00:00;23/04/2015 00:00;17/04/2018 00:00;30/04/2001 00:00;05/01/2015 00:00;14/07/2016 00:00;17/08/1999 00:00;02/07/2018 00:00;18/02/2016 00:00;28/02/2017 00:00;27/02/2015 00:00;02/04/1999 00:00;07/09/2001 00:00;15/06/2005 00:00;24/03/2000 00:00;20/03/2015 00:00;16/09/2013 00:00;05/12/2014 00:00;27/11/2017 00:00;08/08/2014 00:00"	AP	"HOFFMANN LA ROCHE;ACCORD HLTHCARE;SHILPA MEDICARE LTD;#N/A;TEVA PHARMS USA;MYLAN PHARMS INC;WEST-WARD PHARMS INT;AMNEAL PHARMS"	CAPECITABINE	30/04/1998	HOFFMANN LA ROCHE	19,9	11	NA	1	0	NA	0	NA	0	1	0	NA	0	0	0	0	0	NA	0	NA	0	NA	0	0	0	0	0	0	274	1	1
Ofatumumab	ofatumumab	"Ofatumumabum;HuMax-CD20;Ofatumumab;Arzerra"	DB06650		"Ofatumumab;Arzerra (TN);D0Y8ZN;CHEMBL99516;SCHEMBL18300671"	679818-59-8	M95KG522R0	"25805300;25721750;24443277;23456745;20408846"	20408846	01/04/2010	18003886	01/04/2008	2004-2008		1	1	1	Yes	1	"19/01/2016 00:00;24/09/2013 00:00;20/09/2011 00:00;17/04/2014 00:00;26/10/2009 00:00;23/09/2010 00:00;30/08/2016 00:00"	AP	GLAXO GRP LTD	OFATUMUMAB	26/10/2009	GLAXO GRP LTD	18,8	33	NA	0	1	CLL	1	CD20	0	1	1	26	0	0	0	1	0	0,5	0	0	0	NA	1	0	0	0	0	0	47	0	1
Atezolizumab	"atezolizumab;MPDL3280A"	Tecentriq	DB11595			1380723-44-3	52CMI0WC3Y	27363843	27363843	01/07/2016	25428503	01/11/2014	2013-2017		1	1	1	Yes	1	"02/07/2018 00:00;30/04/2018 00:00;18/10/2016 00:00;19/06/2018 00:00;18/05/2016 00:00;17/04/2017 00:00;13/03/2018 00:00;26/06/2018 00:00;14/06/2018 00:00"	AP	GENENTECH INC	ATEZOLIZUMAB	18/05/2016	GENENTECH INC	18,5	NA	NA	0	1	BLADDER	1	PD-L1	0	0	1	NA	0	1	1	1	0	NA	0	1	1	NA	0	0	0	0	0	0	46	0	1
Obinutuzumab	"ga-101;ga101;obinutuzumab;r7159;ro5072759"	"Afutuzumab;Gazyva"	DB08935			949142-50-1	O43472U9X8	"25143487;23046388"	23046388	01/10/2012	22431570	01/05/2012	2009-2012		1	1	1	Yes	1	"26/02/2016 00:00;16/11/2017 00:00;24/12/2014 00:00;01/11/2013 00:00;27/06/2014 00:00;23/09/2015 00:00"	AP	GENENTECH	OBINUTUZUMAB	01/11/2013	GENENTECH	18,0	21	NA	0	1	NHL_B	1	CD20	0	1	0	NA	0	0	0	1	1	0,43	0	1	1	NA	0	0	0	0	0	0	414	0	1
Ublituximab	"lfb-r603;tg-1101;tg-20;tgtx-1101;ublituximab"		DB11850			1174014-05-1	U59UGK3IPC	28220479	28220479	01/02/2017	28220479	01/02/2017	2013-2017		1	1	0	Yes	1					30/07/2018		17,8	35	NA	0	1	NHL	1	CD20	0	1	1	NA	0	0	0	1	0	0,45	0	1	1	NA	0	0	0	0	0	0	0	0	1
Busulfan	"busulfan;busulflex;cb-2041;gt-41;wr-19508"	"Busulfanum;1,4-Dimethanesulfonoxybutane;Myeloleukon;1,4-Dimesyloxybutane;Bisulfex;WR-19508;Mielucin;Leucosulfan;Tetramethylene bis(methanesulfonate);Busulfan;GT-41;1,4-Butanediol dimethanesulfonate;Mablin;Busulflex;Busulfano;Misulban;1,4-Bis(methanesulfonoxy)butane;Mitostan;CB-2041;N/a;Busulfan;Busulfex;Myleran;Busulfan Injection;Busulfan for Injection"	"DB01008;APRD00664"	"4-methylsulfonyloxybutyl methanesulfonate;methanesulfonic acid 4-methylsulfonyloxybutyl ester;55-98-1;B2635_SIGMA;KBio2_003080;KBio2_005648;Spectrum2_000067;NCGC00090905-01;Spectrum5_000928;NCGC00090905-02;NCGC00090905-06;NCGC00090905-03;NCGC00090905-04;NCGC00090905-05;SPECTRUM1500152;KBio2_000512;Prestwick_989;CHEBI:28901;butane-1,4-diyl dimethanesulfonate;1,4-Bis(methanesulfonyloxy)butane;1,4-Bis[methanesulfonoxy]butane;1,4-Butanediol dimethanesulfonate;1,4-Butanediol dimethylsulfonate;1,4-Butanediol, dimethanesulfonate;1,4-Dimesyloxybutane;1,4-Dimethanesulfonoxybutane;1,4-Dimethanesulfonyloxybutane;1,4-Dimethylsulfonoxybutane;1,4-Dimethylsulfonyloxybutane;2041 C. B.;AN 33501;Busulfan;Busulphan;Buzulfan;C.B. 2041;CB 2041;Citosulfan;G.T. 41;GT 2041;GT 41;Leucosulfan;MYLERAN;Mablin;Methanesulfonic acid, tetramethylene ester;Mielevcin;Mielosan;Milecitan;Mileran;Misulban;Mitostan;Myeloleukon;Myelosan;Mylecytan;NCI-C01592;NSC 750;NSC-750;NSC-750sulphabutin;NSC750;Sulfabutin;Sulphabutin;Tetramethylene bis[methanesulfonate];Tetramethylene dimethane sulfonate;WLN: WS1&O4OSW1;X 149;KBioGR_000698;1, 4-Dimethanesulfonoxybutane;1, 4-Dimethylsulfonoxybutane;1, {4-Bis[methanesulfonoxy]butane};4-((Methylsulfonyl)oxy)butyl methanesulfonate;AIDS-123905;AIDS123905;Tetramethylene {bis[methanesulfonate]};SPBio_000253;DivK1c_000847;Spectrum3_000320;4-methylsulfonyloxybutyl methanesulfonate;(1,4-Bis(methanesulfonyloxy)butane);1,4-Bis(methanesulfonoxy)butane;1,4-Butanediol dimethanesulphonate;1,4-Butanediol, dimethanesulphonate;1,4-Dimethane sulfonyl oxybutane;1,4-Dimethanesulfonoxylbutane;1,4-Dimethanesulphonyloxybutane;2041 C.B.;4-04-00-00019 (Beilstein Handbook Reference);AI3-25012;BRN 1791786;Busulfan [INN:JAN];Busulfano [INN-Spanish];Busulfanum [INN-Latin];Busulfex;CCRIS 418;EINECS 200-250-2;Myeleukon;Myelosanum;Sulfabutin (VAN);Tetramethylene bis(methanesulfonate);Tetramethylenester kyseliny methansulfonove [Czech];NCI60_041640;alkylating agent: crosslinks guanine residues;Spectrum4_000259;BSPBio_001920;KBio1_000847;IDI1_000847;KBio3_001420;Spectrum_000092;Busulfan (JP15/USP/INN);D00248;Myleran (TN);NCIMech_000192;KBioSS_000512;NINDS_000847"	"busulfan;55-98-1;Myleran;Busulphan;Sulphabutin;Leucosulfan;Myelosan;Busulfex;Citosulfan;Mielucin;Misulban;Mitostan;Myeloleukon;Mylecytan;Sulfabutin;Mablin;Mielevcin;Milecitan;Mielosan;Mileran;Buzulfan;1,4-Dimesyloxybutane;Myeleukon;1,4-BUTANEDIOL DIMETHANESULFONATE;1,4-Dimethanesulfonoxybutane;Tetramethylene dimethane sulfonate;butane-1,4-diyl dimethanesulfonate;Busulfano;Busulfanum;Busulphane;Glyzophrol;Myelosanum;1,4-Dimethylsulfonyloxybutane;1,4-Butanediol, dimethanesulfonate;1,4-Dimethanesulfonyloxybutane;1,4-Bis(methanesulfonoxy)butane;1,4-Butanediol dimethylsulfonate;1,4-Dimethylsulfonoxybutane;1,4-Bis(methanesulfonyloxy)butane;GT 41;Sulfabutin (VAN);Mitosan;CB 2041;NCI-C01592;AN 33501;Methanesulfonic acid, tetramethylene ester;Tetramethylene bis(methanesulfonate);Busulfanum [INN-Latin];1,4-Dimethanesulphonyloxybutane;Busulfano [INN-Spanish];NSC 750;4-methylsulfonyloxybutyl methanesulfonate;1,4-Butanediol dimethanesulphonate;Tetramethylenester kyseliny methansulfonove;1,4-Dimethanesulfonoxylbutane;C.B. 2041;X 149;Methanesulfonic;Busilvex;Busulfan [INN:JAN];Mylerlan;GT 2041;Myleran tablets;1,4-Dimethane sulfonyl oxybutane;NSC-750;Butanedioldimethanesulfonate;Tetramethylene bis[methanesulfonate];UNII-G1LN9045DK;CCRIS 418;NSC750;1,4-Bis[methanesulfonoxy]butane;C6H14O6S2;1,4-Butanediyl dimethanesulfonate;4-(methanesulfonyloxy)butyl methanesulfonate;n-Butane-1,3-di(methylsulfonate);2041 C. B.;MYLERAN (TN);1,4-Butanediol, dimethanesulphonate;EINECS 200-250-2;G.T. 41;BRN 1791786;1,4-Di(methylsulfonoxy)butane;AI3-25012;G1LN9045DK;CHEBI:28901;COVZYZSDYWQREU-UHFFFAOYSA-N;1,4-Butanedi yl dimethanesulfonate;Tetramethylenester kyseliny methansulfonove [Czech];Tetramethylene {bis[methanesulfonate]};NCGC00090905-06;Methanesulfonic acid, tetram ethylene ester;DSSTox_CID_910;alkylating agent: crosslinks guanine residues;4-((Methylsulfonyl)oxy)butyl methanesulfonate;DSSTox_RID_75857;DSSTox_GSID_20910;BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE);CAS-55-98-1;SR-01000765405;Bisulfex;Busulfan;;Busulfan/Myleran;Myleran;Busulfex;Busulfex IV;Busulfan [USP:INN:BAN:JAN];HSDB 7605;Prestwick_989;ACMC-20aljs;Spectrum_000092;2041 C.B.;AC1L1DRQ;AC1Q4GRQ;Busulfan, 98%  5g;Spectrum2_000067;Spectrum3_000320;Spectrum4_000259;Spectrum5_000928;acid, tetramethylene ester;CHEMBL820;D07SUG;NCIMech_000192;SCHEMBL4373;Myleran, Busulfex, Busulfan;WLN: WS1&O4OSW1;BSPBio_001920;KBioGR_000698;KBioSS_000512;MLS001076666;Busulfan (Myleran, Busulfex);DivK1c_000847;SPECTRUM1500152;Busulfan (JP17/USP/INN);SPBio_000253;GTPL7136;1,4-butanedioldimethanesulfonate;DTXSID3020910;COVZYZSDYWQREU-UHFFFAOYSA-;CTK1G9627;HMS502K09;KBio1_000847;KBio2_000512;KBio2_003080;KBio2_005648;KBio3_001420;MolPort-001-783-406;NINDS_000847;HMS1920I07;HMS2091O09;HMS2233H04;HMS3259G15;HMS3370E11;HMS3655A21;HMS3712A20;Pharmakon1600-01500152;1,{4-Bis[methanesulfonoxy]butane};HY-B0245;KS-000012XA;ZINC1530572;Tox21_111038;Tox21_201848;Tox21_300318;1, {4-Bis[methanesulfonoxy]butane};2041CB;AC-198;CCG-35458;MFCD00007562;NSC755916;s1692;AKOS003614975;Tox21_111038_1;CS-2224;DB01008;KS-5212;LS-1358;MCULE-1840882522;NC00498;NSC-755916;IDI1_000847;NCGC00090905-01;NCGC00090905-02;NCGC00090905-03;NCGC00090905-04;NCGC00090905-05;NCGC00090905-07;NCGC00090905-08;NCGC00090905-09;NCGC00090905-10;NCGC00090905-11;NCGC00090905-12;NCGC00254038-01;NCGC00259397-01;2041 C.B;4-(methylsulfonyloxy)butyl methylsulfonate;AN-16062;BC677894;CPD000058613;NCI60_041640;O994;SAM002554887;SC-22586;SMR000058613;SBI-0051300.P003;2041 C. B;AB0006846;AB2000224;TC-167599;FT-0083567;FT-0623291;ST45022142;C06862;D00248;K-9954;15167-EP2272827A1;15167-EP2272832A1;15167-EP2275420A1;15167-EP2295055A2;15167-EP2295416A2;15167-EP2295426A1;15167-EP2295427A1;15167-EP2298748A2;15167-EP2298764A1;15167-EP2298765A1;15167-EP2298778A1;15167-EP2305642A2;15167-EP2308833A2;15167-EP2308861A1;15167-EP2311453A1;15167-EP2311825A1;15167-EP2311842A2;15167-EP2316832A1;15167-EP2316833A1;32314-EP2280012A2;32314-EP2281815A1;32314-EP2292595A1;32314-EP2292615A1;32314-EP2301928A1;32314-EP2301933A1;32314-EP2305640A2;32314-EP2305671A1;32314-EP2311827A1;32314-EP2311840A1;4-[(Methylsulfonyl)oxy]butyl methanesulfonate #;AB00051929-10;AB00051929-11;AB00051929_12;AB00051929_14;Busulfan, analytical standard, for drug analysis;Tetramethylenester kyseliny methansulfonove[Czech];I09-1371;SR-01000765405-2;SR-01000765405-3;SR-01000765405-7;Busulfan, European Pharmacopoeia (EP) Reference Standard;Z276508890;InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3"	55-98-1	G1LN9045DK	"26210442;25776193;25234438;23648237;23220013;17471171;16578989;16533779;11443634;10373061"	10373061	01/06/1999	13097986	01/01/1953	Bef. 1989		0	0	1	Yes	1	"09/04/1987 00:00;21/11/1975 00:00;20/09/2002 00:00;24/03/2017 00:00;24/01/2018 00:00;04/02/1999 00:00;13/01/2003 00:00;16/01/2015 00:00;20/11/2017 00:00;07/12/1999 00:00;23/06/2011 00:00;13/07/2018 00:00;22/12/2015 00:00;19/05/1986 00:00;07/07/2017 00:00;08/11/1979 00:00;19/05/2016 00:00;17/09/1990 00:00;18/12/2017 00:00;28/10/2015 00:00;19/04/2007 00:00;23/12/2002 00:00;23/01/2003 00:00;13/11/2002 00:00;20/03/1990 00:00;04/09/2014 00:00;15/03/2000 00:00;24/12/2003 00:00;06/09/2000 00:00;26/06/1954 00:00;11/05/1981 00:00;29/07/1994 00:00;23/12/1997 00:00;15/07/1991 00:00;08/12/2017 00:00;10/02/1977 00:00;16/04/2003 00:00;24/04/2002 00:00"	AP	"OTSUKA PHARM;ASPEN GLOBAL;#N/A;PHARMASCIENCE INC;LUITPOLD PHARMS INC;SANDOZ INC"	BUSULFAN	26/06/1954	ASPEN GLOBAL	17,7	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Eribulin	"e7389;eribulin"	Halaven	"DB08871;DB04940"		"Eribulin;253128-41-5;Halaven;UNII-LR24G6354G;ER 086526;CHEBI:63587;LR24G6354G;2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one;E7389;Eribulin [INN];(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1(3,32).1(3,33).1(6,9).1(12,16).0(18,22).0(29,36).0(31,35)]hentetracontan-24-one;NSC-707389;B 1939;e7389-lf;GTPL6813;CHEMBL1683590;SCHEMBL15783821;UFNVPOGXISZXJD-JBQZKEIOSA-N;ZINC169344691;CS-2802;HY-13442;B1939;E7389;ER-086526;441045-16-5"	253128-41-5	LR24G6354G	"26362045;23010853;22041109;21887501"	21887501	01/09/2011	19509146	01/06/2009	2009-2012		1	1	1	Yes	1	"17/02/2012 00:00;27/09/2013 00:00;27/10/2015 00:00;18/11/2015 00:00;19/10/2016 00:00;22/08/2013 00:00;07/11/2012 00:00;24/10/2013 00:00;19/12/2014 00:00;21/07/2016 00:00;28/01/2016 00:00;01/08/2014 00:00;10/04/2015 00:00;15/11/2010 00:00"	AP	EISAI INC	ERIBULIN MESYLATE	15/11/2010	EISAI INC	17,4	21	NA	1	0	NA	1	TUBULIN	0	1	1	6	0	0	0	1	1	0,05	0	0	0	0,62	0	0	0	0	0	0	93	0	1
Cabazitaxel	"cabazitaxel;jevtana;rpr-116258a;xrp6258"	"TXD258;Cabazitaxelum;XRP6258;Taxoid XRP6258;Jevtana"	DB06772		"CABAZITAXEL;183133-96-2;Jevtana;Taxoid XRP6258;Cabazitaxelum;Xrp6258;XRP-6258;TXD 258;Jevtana (TN);TXD258;UNII-51F690397J;javtana;CHEBI:63584;cabazitaxel acetonate;51F690397J;RPR-116258A;XRP 6258;Jevtana Kit;Cabazitaxel (Jevtana);890654-44-1;Cabazitaxel Injection;Cabazitaxel [USAN:INN];Jevanta;RPR 116258A;Cabazitaxel; TXD-258;Cabazitaxel (USAN/INN);D02HSB;SCHEMBL179674;GTPL6798;CHEMBL1201748;DTXSID40171389;EX-A838;BMQGVNUXMIRLCK-OAGWZNDDSA-N;MolPort-023-299-439;C45H57NO14;ABP001072;NSC761432;s3022;ZINC85536932;AKOS032947285;AN-1492;CS-0972;DB06772;NSC-761432;NCGC00346704-01;BC252842;HY-15459;SC-94928;X7252;A25044;D09755;W-5799;AB01273971-01;AB01273971_02;SR-01000941585;J-011721;J-519981;SR-01000941585-1;(((tertbutoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoate1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-((2R,3S)-3-;(1S)-5beta,20-Epoxy-9-oxo-7beta,10beta-dimethoxytaxa-11-ene-1,2alpha,4alpha,13alpha-tetraol 2-benzoate 4-acetate 13-[(2R,3S)-2-hydroxy-3-(tert-butoxycarbonylamino)-3-phenylpropionate];(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0;{3,10}.0;{4,7}]heptadec-13-en-2-yl benzoate;(2alpha,5beta,7beta,10beta,13alpha)-4-acetoxy-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate;1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-ene-2,4,13-triyl 4-acetate 2-benzoate 13-((2R,3S)-3-(((tertbutoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoate)"	183133-96-2	51F690397J	"28058445;27796539;25809824;25486878;24488323;24099585;23299792;22975213;19147780"	19147780	01/01/2009	19147780	01/01/2009	2009-2012		1	1	1	Yes	1	"11/06/2015 00:00;27/05/2016 00:00;02/03/2017 00:00;12/09/2016 00:00;14/09/2017 00:00;09/01/2018 00:00;25/06/2015 00:00;05/01/2015 00:00;19/11/2014 00:00;14/03/2014 00:00;17/06/2010 00:00;13/03/2013 00:00;11/07/2018 00:00;24/10/2016 00:00;11/09/2013 00:00;17/05/2017 00:00;04/10/2012 00:00;17/01/2018 00:00;18/06/2015 00:00;25/04/2013 00:00"	"AP;TA"	"APOTEX INC;ACTAVIS LLC;SANDOZ INC;SANOFI AVENTIS US;ACCORD HLTHCARE INC"	CABAZITAXEL	17/06/2010	SANOFI AVENTIS US	17,4	25	NA	1	0	NA	1	TUBULIN	0	1	0	NA	0	0	0	1	1	0,08	0	0	0	NA	0	0	0	0	0	0	599	0	1
Rasburicase	urate oxidase	"Uricase;Urate oxidase;Fasturtec;Elitek"	"DB00049;BTD00090;BIOD00090"			134774-45-1	08GY9K1EUO	24530972	24530972	01/02/2014	11157020	01/02/2001	1999-2003		1	0	1	No	0	"22/05/2015 00:00;14/09/2017 00:00;10/09/2007 00:00;28/02/2007 00:00;12/07/2002 00:00;03/02/2015 00:00;13/06/2016 00:00;16/10/2009 00:00;15/12/2004 00:00"	AP	SANOFI SYNTHELABO	RASBURICASE	12/07/2002	SANOFI SYNTHELABO	17,2	#N/A																							0						1
Cabozantinib	"bms-907351;cabozantinib;xl184"	"Cometriq;Cabometyx"	"DB08875;DB05153"		"Cabozantinib;849217-68-1;Cometriq;XL-184;XL184;XL 184;BMS-907351;BMS 907351;Cabometyx;UNII-1C39JW444G;Cabozantinib (XL184, BMS-907351);CHEBI:72317;1C39JW444G;Cometriq (TN);BMS907351;Cabozantinib (XL-184);C28H24FN3O5;1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-;N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE;n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;Cabozantinib [USAN:INN];Cabometyx (TN);N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;XL184 free base;Cabozantinib/XL184;Cabozantinib (USAN);Cabozantinib XL-184;PubChem22994;cc-10;D0IQ6P;SCHEMBL360795;GTPL5887;CHEMBL2105717;DTXSID10233968;EX-A075;QCR-122;SYN1138;XL184 free base - Cabozantinib;MolPort-021-804-939;ONIQOQHATWINJY-UHFFFAOYSA-N;BCPP000308;HMS3654G06;XL-184 free base (Cabozantinib);AOB87755;ABP000796;BDBM50021574;s1119;ZINC70466416;AKOS025142112;BCP9000470;CS-0278;DB08875;RL05229;XL-184 (Cabozantinib BMS907351);XL-184,Cabozantinib, BMS-907351;NCGC00263164-01;1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-;AC-25082;AS-16277;BC267213;HY-13016;KB-62285;SC-85393;AB0033751;DB-023624;FT-0664184;X7477;D10062;Q-3907;AB01565831_02;SR-01000941569;J-523016;SR-01000941569-1;BRD-K51544265-001-01-8;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-f;XL 184,  XL-184, 1021950-26-4;1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-;cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide;cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide;N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide;N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide"	849217-68-1	1C39JW444G	"25102375;24827131"	24827131	01/05/2014	21606412	01/07/2011	2009-2012		1	1	1	Yes	1	"20/05/2016 00:00;16/11/2017 00:00;28/02/2014 00:00;12/01/2018 00:00;29/11/2012 00:00;05/10/2017 00:00;25/04/2016 00:00;19/12/2017 00:00"	AP	"EXELIXIS INC;EXELIXIS"	CABOZANTINIB S-MALATE	29/11/2012	EXELIXIS	17,0	85	NA	1	1	MEDULLARY THYROID CANCER	1	"MET;VEGFR2;RET"	0	1	1	37	0	0	0	1	1	0,29	0	0	0	0,68	0	0	0	0	0	0	140	0	1
Sacituzumab govitecan	"immu-132;immu-132 trop-2 sn-38;rs7-sn38;sacituzumab;sacituzumab govitecan"		DB12893		"Sacituzumab govitecan;UNII-M9BYU8XDQ6;hRS 7SN38;hRS7-SN38;Sacituzumab govitecan [USAN];IMMU 132;IMMU-132;M9BYU8XDQ6;1491917-83-9"	1491917-83-9	M9BYU8XDQ6	"28558150;28291390"	28291390	01/03/2017	28291390	01/03/2017	2013-2017		1	1	0	Yes	1					30/07/2018		16,9	69	NA	0	1	TNBC	1	Trop-2	0	1	1	NA	1	1	0	1	0	0,3	0	1	1	0,46	0	0	0	0	0	0	26	0	1
SAR-405838	"mi-773;sar405838"		DB12541		"SAR405838;1303607-60-4;MI-773 (SAR405838);UNII-8570LZ3RCA;SAR-405838;MI-77301;8570LZ3RCA;CHEMBL2381408;IDKAKZRYYDCJDU-AEPXTFJPSA-N;(2'S,3'R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro (indole-3,3'-pyrrolidine)-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide;(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3'-pyrrolidine)-5'-carboxamide;US8680132, MI- 77301 (TFA salt);(2'S,3'R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro [indole-3,3'-pyrrolidine]-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide;(2's,3r,4's,5'r)-6-Chloro-4'-(3-Chloro-2-Fluorophenyl)-2'-(2,2-Dimethylpropyl)-N-(Trans-4-Hydroxycyclohexyl)-2-Oxo-1,2-Dihydrospiro[indole-3,3'-Pyrrolidine]-5'-Carboxamide;SCHEMBL3704267;SCHEMBL5585402;CHEMBL3961782;SCHEMBL10188383;SCHEMBL12230015;EX-A659;IDKAKZRYYDCJDU-HBMMIIHUSA-N;MolPort-035-944-342;BDBM119726;BDBM119727;BDBM50433561;s7649;ZINC96269677;AKOS030526391;ZINC145424989;CS-5003;DB12541;BC600691;HY-18986;Spiro(3H-indole-3,3'-pyrrolidine)-5'-carboxamide, 6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-, (2'S,3R,4'S,5'R)-;KB-334261;FT-0700159;SAR405838 (MI-77301);US8680132, MI- 77301 (free amine);J-690122;(2'S,3'R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro[indole-3,3'-pyrrolidine]-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide;(2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1r,4R)-4-hydroxycyclohexyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide;(3R)-6-Chloro-2'beta-(2,2-dimethylpropyl)-4'beta-(2-fluoro-3-chlorophenyl)-5'alpha-[(4alpha-hydroxycyclohexane-1beta-yl)carbamoyl]spiro[1H-indole-3(2H),3'-pyrrolidine]-2-one;5-[(1-Ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-N-[4-({[5-(2-methyl-2-propanyl)-1,2-oxazol-3-yl]carbamoyl}amino)phenyl]-2-pyridin ecarboxamide;7HC"	1303607-60-4	8570LZ3RCA	28324749	28324749	01/03/2017	28324749	01/03/2017	2013-2017		1	1	0	Yes	1					30/07/2018		16,9	74	NA	0	1	LIPOSARCOMA	1	HDM2	0	1	1	NA	1	0	0	1	1	0	0	0	0	0,56	0	0	0	0	0	0	0	0	1
Abemaciclib	abemaciclib	"LY2835219;Verzenio"	DB12001		"Abemaciclib;1231929-97-7;LY2835219;Verzenio;LY-2835219;UNII-60UAB198HK;LY2835219 (free base);Abemaciclib,LY2835219;LY2835219 free base;N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine;60UAB198HK;LY 2835219;bemaciclib;HY-16297A;CS-1230;Abemaciclib (ly2835219);N-{5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amine;Abemaciclib [USAN:INN];Verzenio (TN);Tube014;Abemaciclib (JAN/USAN);D05SBO;GTPL7382;SCHEMBL2487229;CHEMBL3301610;DTXSID20673119;EX-A521;LY 2835219 (free base);MolPort-039-137-732;UZWDCWONPYILKI-UHFFFAOYSA-N;C27H32F2N8;EX-A1588;3798AH;BDBM50110183;ZINC72318121;1231929-97-7 (free base);AKOS025404907;LY2835219 free base (Abemaciclib);DB12001;KS-00000T51;2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl);AK174895;AS-10230;KB-69638;QC-11713;SC-82423;AX8323622;LY2835219 Ms salt, Abemaciclib Ms salt;FT-0700134;D10688;W-5974;J-690083;[5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine;2-Pyrimidinamine,N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-;6ZV;LY-2835219|||N-[5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-1,3-benzodiazol-5-yl)pyrimidin-2-amine"	1231929-97-7	60UAB198HK	27312735	27312735	01/06/2016	27217383	01/05/2016	2013-2017		1	1	1	Yes	1	"26/02/2018 00:00;28/09/2017 00:00"	AP	ELI LILLY AND CO	ABEMACICLIB	28/09/2017	ELI LILLY AND CO	16,9	225	NA	1	1	"BREAST;NSCLC;GLIOBLASTOMA;MELANOMA;COLORECTAL"	1	"CDK4;CDK6"	0	1	1	192	0	1	0	1	1	0,31	0	0	0	0,61	0	0	0	0	0	0	106	0	1
Nilotinib	nilotinib	"Nilotinibum;Tasigna"	DB04868		"Nilotinib;641571-10-0;Tasigna;AMN107;AMN 107;AMN-107;nilotinibum;Tasigna (Novartis);UNII-F41401512X;Nilotinib(AMN-107);Nilotinib, AMN107, Tasigna;CHEMBL255863;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;C28H22F3N7O;CHEBI:52172;HHZIURLSWUIHRB-UHFFFAOYSA-N;NSC747599;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide;F41401512X;4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide;benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;Nilotinib & its intermediates;Q-101348;Nilotinib hydrochloride hydrate;4-Methyl-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;NIL;SMR002544680;Nilotinib [USAN:INN:BAN];Nilotinib/;Nilotinib;;HSDB 7842;4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl)amino}benzamide;PubChem18272;3gp0;Nilotinib (INN/USAN);Nilotinib (USAN/INN);Nilotinib (AMN-107);D00STL;D06GGT;EC 700-544-5;AC1LD8U3;SCHEMBL7901;cc-353;MLS003915611;MLS006010160;GTPL5697;Tasigna, AMN-107, Nilotinib;DTXSID5042663;CTK8B3214;QCR-112;SYN1057;MolPort-003-987-089;BCPP000149;HMS3244A13;HMS3244A14;HMS3244B13;HMS3654M07;AOB87115;KS-00000GT9;ZINC6716957;ABP000478;AC-647;ANW-41982;BDBM50237710;FC0027;GP5854;MFCD09833716;RS0102;s1033;AKOS005063561;AN-5308;API0003575;BCP9000989;CS-0102;DB04868;NSC-747599;RTX-011143;Nilotinib (BCR-ABL inhibitor 2nd gen);NCGC00183285-01;NCGC00183285-03;NCGC00183285-04;AS-16214;BC224537;BR-59889;EN002707;HY-10159;N-(3-(3-(1H-Imidazolyl)propoxy)phenyl)-4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide;SC-19640;AB0007991;AX8144766;ST2413627;TL8004531;AM20090651;FT-0654026;l-1-yl)-3-(trifluoromethyl)phenyl]benzamide;V0705;D08953;N-8207;S-6060;49312-EP2270008A1;49312-EP2292617A1;49312-EP2305667A2;49312-EP2311840A1;78680-EP2305667A2;AB01273978-01;AB01273978-02;AB01273978_03;139316-EP2270008A1;139316-EP2292617A1;571N100;P111010;SR-01000931150;I01-1225;SR-01000931150-2;BRD-K81528515-001-04-7;MCL-1-specific antisense oligonucleotide + nilotinib (AMN107);4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazo;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide;4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide;4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide;4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide;Benzamide, 4-methyl-N-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-;Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- (9CI);Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-(9CI);Nilotinib,AMN107,Tasigna;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"	641571-10-0	F41401512X	"23052406;21732337;19449194;16775235"	16775235	01/06/2006	16775235	01/06/2006	2004-2008		1	1	1	Yes	1	"22/01/2014 00:00;27/09/2013 00:00;27/09/2016 00:00;15/10/2015 00:00;17/05/2013 00:00;01/05/2012 00:00;21/02/2017 00:00;13/06/2013 00:00;14/08/2013 00:00;27/01/2015 00:00;22/12/2017 00:00;25/09/2014 00:00;17/06/2010 00:00;22/03/2018 00:00;29/10/2007 00:00;22/05/2013 00:00;21/08/2009 00:00;20/12/2012 00:00;15/03/2010 00:00;18/11/2011 00:00;26/10/2011 00:00;14/01/2011 00:00"	AP	NOVARTIS	NILOTINIB HYDROCHLORIDE	29/10/2007	NOVARTIS	16,9	119	NA	0	1	CML	1	BCR_ABL	0	1	0	NA	1	0	0	1	0	0,91	0	1	1	0,91	0	0	0	0	0	0	841	1	1
Sunitinib	"su11248;sunitinib"	"Sunitinibum;Sutent"	"DB01268;DB07417"	"N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-3-indolinylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-keto-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;326914-13-0;557795-19-4;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;SU 11248;SU-11248;Su-011248;K00588a;Sunitinib;SU11248;N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;NSC736511;PDGF TK antagonist;SU-11248J;SU-12662;Sunitanib;CHEBI:38940;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;NCGC00164631-01"	"Sunitinib;557795-19-4;Sutent;Sunitinib malate;SU11248;SU-11248;sunitinibum;Sunitinib Base;Su-011248;SU 11248;Sunitinib (INN);UNII-V99T50803M;Sunitinib (free base);CHEMBL535;342641-94-5;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide;CHEBI:38940;NSC750690;V99T50803M;(Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide;KS-5022;PDGF TK antagonist;Sutent (TN);341031-54-7;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;SU-11248J;Sunitinib [INN:BAN];SU-010398;C22H27FN4O2;Sunitanib;HSDB 7932;1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide;5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE;5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide;Sutent (free base);yrrole-3-carboxamide;D0R0MW;AC1NS62J;SCHEMBL8081;Sunitinib (Pan-TK inhibitor);BDBM4814;GTPL5713;QCR-67;Sutent, Sunitinib, SU11248;CHEBI:91430;EX-A553;MolPort-006-167-758;WINHZLLDWRZWRT-ATVHPVEESA-N;BCPP000057;K00588a;AOB87111;ZINC3964325;CF-876;HY-10255A;s7781;AKOS015908193;AKOS025312424;AN-9681;API0024677;CS-1670;DB01268;NSC-750690;NCGC00164631-02;NCGC00164631-04;AJ-47545;EN002687;KB-80777;Q572;SC-47294;AB0017673;AX8033294;LS-187023;LS-187648;ST2413814;AM20090630;FT-0083556;95S194;D08552;J90060;W-2596;AB01273976-01;AB01273976-02;AB01273976_04;SR-00000000005;I01-1229;SR-00000000005-2;ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide;Z2568722545;N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-;341031-54-7 (malate); 557795-19-4 (free base).;1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-p;326914-13-0;5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid(2-diethylamino-ethyl)-amide;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1 pound not2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2 pound not4-dimethyl-1H-pyrrole-3-carboxamide;N-[2-(Diethylamino)ethyl]-5-(2-oxo-5-fluoroindoline-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-[5-(Trifluoromethyl)-2-pyridinyl]-trans-4-[[(1,1-dimethylethyl)sulfonyl]amino]cyclohexane-1-carboxamide"	557795-19-4	V99T50803M	"27255678;27179958;25321190;24474568;23660867;23635552;23541810;22858558;22179104;21690570;21647871;20043166;19730791;17473195;17088579;16314617"	16314617	01/11/2005	15459012	01/09/2004	2004-2008		1	1	1	Yes	1	"31/03/2009 00:00;20/05/2011 00:00;16/11/2015 00:00;10/05/2006 00:00;30/08/2013 00:00;02/02/2007 00:00;11/06/2014 00:00;20/04/2012 00:00;16/11/2017 00:00;26/01/2006 00:00;16/11/2012 00:00;19/12/2014 00:00;24/04/2015 00:00;08/10/2015 00:00;01/07/2010 00:00;07/11/2008 00:00;08/03/2016 00:00"	"AP;TA"	"CPPI CV;MYLAN PHARMS INC"	SUNITINIB MALATE	26/01/2006	CPPI CV	16,8	29	NA	0	1	AML	1	"FLT3;C-KIT;VEGFR;PDGFR"	0	1	0	NA	1	0	0	1	1	1	0	0	0	NA	0	CARDIAC FAILURE	1	0	0	0	430	1	1
Chlorambucil	"phenylbutyrate;phenylbutyrate sodium"	"Chloraminophen;4-[p-[bis(2-chloroethyl)amino]phenyl]butyric acid;γ-[p-di(2-chloroethyl)aminophenyl]butyric acid;Phenylbutyric Acid Nitrogen Mustard;4-(p-bis(β-chloroethyl)aminophenyl)butyric acid;4-(P-Bis(beta-chloroethyl)aminophenyl)butyric acid;N,N-Di-2-chloroethyl-gamma-P-aminophenylbutyric acid;CHLORAMBUCIL;gamma-[P-Di(2-chloroethyl)aminophenyl]butyric acid;N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid;Ambochlorin;Leukeran"	"DB00291;APRD00115"	"4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid;4-[4-[bis(2-chloroethyl)amino]phenyl]butyric acid;305-03-3;NCGC00015199-01;DivK1c_000688;Prestwick0_001079;NCGC00023250-08;Prestwick2_001079;AIDS-026810;AIDS026810;KBio2_000558;KBio2_003126;KBio2_005694;BPBio1_001208;NCGC00023250-00;Lopac-C-0253;NCGC00023250-05;CAS-305-03-3;NCGC00015199-02;NCI60_002639;.gamma.-(p-bis(2-chloroethyl)aminophenyl)butyric acid;.gamma.-[p-Di(2-chloroethyl)aminophenyl]butyric acid;.gamma.-[p-bis(2-chloroethyl)aminophenyl]butyric acid;4-[Bis(2-chloroethyl)amino]benzenebutanoic acid;4-[Bis(2-chloroethyl)amino]phenylbutyric acid;4-[p-Bis(.beta.-chloroethyl)aminophenyl]butyric acid;4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid;4[p-Bis(.beta.-chloroethyl)aminophenyl]butyric acid;NCGC00023250-06;Amboclorin;NCGC00023250-07;Butyric acid, 4-(p-[bis(2-chloroethyl)amino]phenyl)-;Butyric acid, 4-(p-bis(2-chloroethyl)aminophenyl)-;Butyric acid, 4-[p-[bis(2-chloroethyl)amino]phenyl]-;CB 1348;CHLORAMBUCIL;Cb l348;Ambochlorin;Chloraminophene;Chlorbutin;Chlorbutine;Chloroambucil;Chlorobutin;Chlorobutine;Ecloril;Elcoril;ST5410766;Leukersan;Leukoran;Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]-;Linfolysin;N,N-Di-2-chloroethyl-.gamma.-p-aminophenylbutyric acid;NCI-C03485;NSC 3088;NSC3088;Phenylbutyric acid nitrogen mustard;WLN: QV3R DN2G2G;p-(N,N-Di-2-chloroethyl)aminophenyl butyric acid;p-N,N-Di-(.beta.-chloroethyl)aminophenyl butyric acid;Spectrum5_000677;4-(p-bis(beta-chloroethyl)aminophenyl)butyric acid;4-(4-[Bis(2-chloroethyl)amino]phenyl)butyric acid;4-[Bis(2-chloroethyl)amino]benzenebutyric acid;C0253_SIGMA;Spectrum4_000273;Chloraminophen;KBio3_001191;23125_FLUKA;EU-0100227;KBioSS_000558;Leukeran;SPECTRUM1500171;Linfolizin;KBio1_000688;KBioGR_000766;IDI1_000688;NCGC00023250-03;Spectrum2_000065;Lopac0_000227;4-{4-[bis(2-chloroethyl)amino]phenyl}butanoic acid;Spectrum3_000336;CHEBI:28830;gamma-[p-di(2-chloroethyl)aminophenyl]butyric acid;Chlorambucil (USP/INN);D00266;Leukeran (TN);BSPBio_001098;NINDS_000688;Prestwick1_001079;4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid;MLS000028443;SMR000058372;4-(Bis(2-chloroethyl)amino)benzenebutanoic acid;4-(Bis(2-chloroethyl)amino)phenylbutyric acid;4-(p-(Bis(2-chloroethyl)amino)phenyl)butyric acid;4-14-00-01715 (Beilstein Handbook Reference);AI3-26083;BRN 0999011;Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-;Butanoic acid, 4-(bis(2-chloroethyl)amino) benzene;Butyric acid, 4-(p-(bis(2-chloroethyl)amino)phenyl);CCRIS 126;Chloorambucol;Chlorambucil [BAN:INN];Chlorambucilum [INN-Latin];Chlorbutinum;Clorambucile [DCIT];Clorambucilo [INN-Spanish];EINECS 206-162-0;Elcorin;HSDB 3026;Kyselina 4-(N,N-bis-(2-chlorethyl)-p-aminofenyl)maselna [Czech];Lympholysin;N,N-Di-2-chloroethyl-gamma-p-aminophenylbutyric acid;N,N-Di-2-chloroethyl-gamma-para-aminophenyl butyric acid;NSC-3088;Phenylbuttersaeure-lost [German];RCRA waste no. U035;RCRA waste number U035;gamma-(p-Bis(2-chloroethyl)aminophenyl)butyric acid;gamma-(p-Di(2-chloroethyl)aminophenyl)butyric acid;gamma-(p-bis(2-chloroethyl)aminophenyl)butyricacid;p-(N,N-Di-2-chlorethylaminophenyl)butyric acid;p-N,N-Di-(beta-chloroethyl)aminophenyl butyric acid;para-(Di(2-chloroethyl)aminophenyl)butyric acid;para-N,N-Di(beta-chloroethyl)aminophenyl butyric acid;SPBio_002999;SPBio_000249;BSPBio_001971;Prestwick3_001079;Spectrum_000118"	"chlorambucil;305-03-3;Ambochlorin;Chloroambucil;Leukeran;Chloraminophen;Chlorbutin;Chloraminophene;Chlorobutine;Amboclorin;Chlorbutine;Chlorobutin;Linfolizin;Linfolysin;Ecloril;Elcoril;Phenylbutyric acid nitrogen mustard;Lympholysin;Leukersan;Leukoran;Chlocambucil;Chloorambucol;Chlorbutinum;Elcorin;4-{4-[bis(2-chloroethyl)amino]phenyl}butanoic acid;Cb l348;Chlorambucilum;Clorambucile;Clorambucilo;Clorambucile [DCIT];CB 1348;Phenylbuttersaeure-lost;Leukeran tablets;NSC 3088;NSC-3088;Rcra waste number U035;NCI-C03485;Chlorambucilum [INN-Latin];Clorambucilo [INN-Spanish];4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid;Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]-;N,N-Di-2-chloroethyl-gamma-p-aminophenylbutyric acid;Leuk ersan;Chlorambucil [INN:BAN];4-(p-Bis(beta-chloroethyl)aminophenyl)butyric acid;CCRIS 126;4-(Bis(2-chloroethyl)amino)benzenebutanoic acid;p-(N,N-Di-2-chloroethyl)aminophenyl butyric acid;UNII-18D0SL7309;CHEBI:28830;Phenylbuttersaeure-lost [German];HSDB 3026;NSC3088;LEUKERAN (TN);EINECS 206-162-0;4-[Bis(2-chloroethyl)amino]benzenebutanoic acid;CHEMBL515;RCRA waste no. U035;gamma-[p-Di(2-chloroethyl)aminophenyl]butyric acid;CB-1348;4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid;Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-;BRN 0999011;AI3-26083;MLS000028443;4-(Bis(2-chloroethyl)amino)phenylbutyric acid;4-[Bis(2-chloroethyl)amino]benzenebutyric acid;4-[Bis(2-chloroethyl)aminophenyl]butyric acid;JCKYGMPEJWAADB-UHFFFAOYSA-N;p-(N,N-Di-2-chlorethylaminophenyl)butyric acid;para-(Di(2-chloroethyl)aminophenyl)butyric acid;gamma-(p-bis(2-chloroethyl)aminophenyl)butyricacid;4-(p-(Bis(2-chloroethyl)amino)phenyl)butyric acid;Butanoic acid, 4-(bis(2-chloroethyl)amino) benzene;gamma-(p-Bis(2-chloroethyl)aminophenyl)butyric acid;gamma-(p-Di(2-chloroethyl)aminophenyl)butyric acid;Butyric acid, 4-(p-bis(2-chloroethyl)aminophenyl)-;p-N,N-Di-(beta-chloroethyl)aminophenyl butyric acid;Butyric acid, 4-(p-(bis(2-chloroethyl)amino)phenyl);para-N,N-Di(beta-chloroethyl)aminophenyl butyric acid;18D0SL7309;Kyselina 4-(N,N-bis-(2-chlorethyl)-p-aminofenyl)maselna;N,N-Di-2-chloroethyl-gamma-para-aminophenyl butyric acid;NCGC00015199-08;CAS-305-03-3;SMR000058372;DSSTox_CID_263;Kyselina 4-(N,N-bis-(2-chlorethyl)-p-aminofenyl)maselna [Czech];4-[Bis(2-chloroethyl)amino]phenylbutyric acid;chlorambucil,4-bis(2-chloroethyl)amino]benzenebutanoic acid, n,n-di-2-chloroethyl-;DSSTox_RID_75472;DSSTox_GSID_20263;4-(4-(Bis(2-chloroethyl)amino)phenyl)butanoic acid;W-106940;.gamma.-[p-Di(2-chloroethyl)aminophenyl]butyric acid;4-(p-(N,N-Di-2-chloroethyl)aminophenyl)butyric acid;Butyric acid, 4-[p-[bis(2-chloroethyl)amino]phenyl]-;p-N,N-Di-(.beta.-chloroethyl)aminophenyl butyric acid;4-(p-[bis-(2-Chloroethyl)-amino]-phenyl)-butyric acid;N,N-Di-2-chloroethyl-.gamma.-p-aminophenylbutyric acid;SR-01000000062;4-(4-[Bis(2-chloroethyl)amino]phenyl)butyric acid;4-[4-[Bis(2-chloroethyl)amino]phenyl]butyric Acid;.gamma.-(p-bis(2-chloroethyl)aminophenyl)butyric acid;.gamma.-[p-bis(2-chloroethyl)aminophenyl]butyric acid;4-(p-Bis(.beta.-chloroethyl)aminophenyl)butyric acid;4-[p-Bis(.beta.-chloroethyl)aminophenyl]butyric acid;Butyric acid, 4-(p-[bis(2-chloroethyl)amino]phenyl)-;Chlorambucil [USP:INN:BAN];Chlorambucil,(S);phenyl)butanoic acid;CB1348;Opera_ID_51;PubChem21331;Spectrum_000118;AC1L1EAB;Prestwick0_001079;Prestwick1_001079;Prestwick2_001079;Prestwick3_001079;Spectrum2_000065;Spectrum3_000336;Spectrum4_000273;Spectrum5_000677;Chlorambucil (USP/INN);Lopac-C-0253;D0V8QT;Epitope ID:139977;AC1Q75DO;SCHEMBL4308;Lopac0_000227;WLN: QV3R DN2G2G;BSPBio_001098;BSPBio_001971;KBioGR_000766;KBioSS_000558;4-14-00-01715 (Beilstein Handbook Reference);MLS001076130;DivK1c_000688;SPECTRUM1500171;Chlorambucil (JAN/USP/INN);SPBio_000249;SPBio_002999;Wellcome Brand of Chlorambucil;Phenylbuttersaeure-lost[German];BPBio1_001208;GTPL7143;ZINC1115;DTXSID7020263;CTK8E8346;HMS502C10;KBio1_000688;KBio2_000558;KBio2_003126;KBio2_005694;KBio3_001191;MolPort-000-152-694;NINDS_000688;HMS1571G20;HMS1920M15;HMS2090M19;HMS2091A22;HMS2098G20;HMS2235A04;HMS3259I10;HMS3372O04;HMS3652P08;Pharmakon1600-01500171;4-(4-(bis(2-chloroethyl)amino);Tox21_110096;Tox21_201390;Tox21_302996;BDBM50003677;CCG-39872;Glaxo Wellcome Brand of Chlorambucil;GlaxoSmithKline Brand of Chlorambucil;GP0879;MFCD00021783;NSC756674;s4288;AKOS024319346;Tox21_110096_1;API0003150;Chlorambucil, purum, >=98.0% (T);CS-3118;DB00291;GS-6200;LP00227;LS-1158;MCULE-2575006904;NC00555;NSC-756674;IDI1_000688;NCGC00015199-01;NCGC00015199-02;NCGC00015199-03;NCGC00015199-04;NCGC00015199-05;NCGC00015199-06;NCGC00015199-07;NCGC00015199-09;NCGC00015199-10;NCGC00015199-11;NCGC00015199-12;NCGC00015199-13;NCGC00015199-14;NCGC00015199-15;NCGC00015199-16;NCGC00015199-17;NCGC00015199-19;NCGC00015199-20;NCGC00023250-00;NCGC00023250-03;NCGC00023250-04;NCGC00023250-05;NCGC00023250-06;NCGC00023250-07;NCGC00023250-08;NCGC00023250-09;NCGC00023250-10;NCGC00256464-01;NCGC00258941-01;AN-16019;BC208809;BP-24028;CC-25645;CPD000058372;HY-13593;KB-48833;NCI60_002639;SAM002564202;SC-16653;SC-54759;SBI-0050215.P004;AB0093202;TL8002353;TR-013105;AB00051938;EU-0100227;FT-0083565;FT-0617365;ST50410766;KS-00001815;A18607;C 0253;C06900;D00266;4-(p-bis(2-chloroethyl)aminophenyl)butyric acid;AB00051938-14;AB00051938-15;AB00051938_16;305C033;4-((p-bis(b-chloroethyl)amino)phenyl)butyric acid;C-18948;4[p-Bis(.beta.-chloroethyl)aminophenyl]butyric acid;Butanoic acid, 4-(bis(2-chloroethyl)amino)benzene-;SR-01000000062-2;SR-01000000062-4;SR-01000000062-7;.gamma.-(p-bis(2-chloroethyl)aminophenyl)butyricacid;BRD-K29458283-001-04-2;BRD-K29458283-001-05-9;BRD-K29458283-001-17-4;4-(4-[Bis(2-chloroethyl)amino]phenyl)butanoic acid #;4-(p-N,N-Di-(beta-chloroethyl)aminophenyl)buty ric acid;4-(p-N,N-Di-(beta-chloroethyl)aminophenyl)butyric acid;Z1558572529;4-[4-(N,N-bis(2-chloroethyl)-amino]phenyl)butanoic acid;ETHANAMINE,2-[[4-(1-METHYLETHOXY)PHENYL]SULFONYL]-;N,N-Di-(2-chloroethyl)-gamma-(p-aminophenyl)butyric acid;Chlorambucil, European Pharmacopoeia (EP) Reference Standard;Chlorambucil, United States Pharmacopeia (USP) Reference Standard;Chlorambucil for system suitability, European Pharmacopoeia (EP) Reference Standard"	305-03-3	18D0SL7309	"17053987;15831235;11595694"	11595694	01/10/2001	13269823	01/11/1955	Bef. 1989		0	0	1	Yes	1	"24/07/2001 00:00;14/10/1992 00:00;12/03/1984 00:00;15/02/1979 00:00;04/02/1994 00:00;20/06/2001 00:00;23/04/2010 00:00;28/02/1989 00:00;28/10/2011 00:00;06/03/1990 00:00;24/05/2005 00:00;18/03/1957 00:00;29/06/1995 00:00;08/06/1978 00:00;14/11/2002 00:00;09/03/1977 00:00;09/02/1996 00:00;27/08/1981 00:00;22/03/1978 00:00;22/09/1986 00:00;13/11/2003 00:00"	AP	ASPEN GLOBAL INC	CHLORAMBUCIL	18/03/1957	ASPEN GLOBAL INC	16,5	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Sonidegib	sonidegib	"Erismodegib;N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide;Odomzo"	DB09143		"Erismodegib;LDE225;Sonidegib;956697-53-3;NVP-LDE225;Odomzo;LDE-225;NVP-LDE 225;UNII-0RLU3VTK5M;LDE 225;0RLU3VTK5M;LDE225 (NVP-LDE225,Erismodegib);LDE225 (NVP-LDE225; Erismodegib);NPV-LDE-225;Odomozo;N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide;Sonidegib [USAN:INN];Erismodegib [USAN:INN];N-(6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl)-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;PubChem22446;Sonidegib (USAN/INN);erismodegib (deleted INN);cc-76;D09BNZ;NVP-LDE225(Erismodegib);MLS006011198;SCHEMBL554455;GTPL8199;CHEMBL2105737;NVP-LDE225/LDE225;CHEBI:90863;EX-A409;C26H26F3N3O3;LDE225(NVP-LDE225);MolPort-009-194-121;VZZJRYRQSPEMTK-CALCHBBNSA-N;KS-00000TD3;LDE 225, NVP-LDE225;LDE225 (NVP-LDE225);LDE225 - NVP-LDE225;ABP000896;BDBM50394562;HY-16582A;s2151;ZINC68202099;AKOS015994541;BCP9001014;CS-0904;DB09143;EE-0005;LDE225 (NVP-LDE225, Erismodegib);NCGC00250382-01;4CA-0728;HY-10296;KB-78110;N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide;N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide;SC-85832;SMR004702967;FT-0667957;X7564;D10119;W-5625;956697-53-3, NVP-LDE225;BRD-K19796430-001-01-5;(1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-;[1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(t;[1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-, rel-;1270169-93-1;Erismodegib|||LDE 225|||NVP-LDE 225|||N-[6-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-(6-((2R,6S)-2,6-Dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)biphenyl-3-carboxamide;n-(6-((2r,6s)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide;N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide;N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-3-pyridyl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;rel-N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide"	956697-53-3	0RLU3VTK5M	27467121	27467121	01/10/2016	24523439	01/04/2014	2013-2017		1	1	1	Yes	1	"17/02/2016 00:00;18/09/2017 00:00;12/05/2016 00:00;24/07/2015 00:00"	AP	SUN PHARMA GLOBAL	SONIDEGIB PHOSPHATE	24/07/2015	SUN PHARMA GLOBAL	15,7	103	NA	1	1	"MEDULLOBLASTOMA;BASAL CELL CARCINOMA"	1	SHH	0	1	0	NA	1	1	0	1	1	NA	0	NA	0	NA	0	0	0	0	0	0	107	0	1
Ixazomib	ixazomib	Ninlaro	DB09570		"Ixazomib;MLN2238;1072833-77-2;MLN 2238;MLN-2238;NINLARO;MLN2238(Ixazomib);UNII-71050168A2;(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid;CHEMBL2141296;(R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid;71050168A2;Ixazomib [INN];Ixazomib [USAN:INN];Ixozamib;Ixazomib-d3;Ixazomib (USAN);Ixazomib(MLN2238);Ixazomib (MLN2238);D01MML;C14H19BCl2N2O4;GTPL8450;SCHEMBL3742758;CHEBI:90942;CTK4A5116;KS-00000PQX;EX-A547;MolPort-016-633-297;BCP02410;ABP000732;BDBM50398609;s2180;AKOS015995120;ZINC169946773;BCP9000953;CS-1657;DB09570;RL00318;Boronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-;NCGC00249611-01;NCGC00249611-03;AC-28456;AT-42310;BC659994;HY-10453;KB-78920;SC-94531;AB0033791;FT-0660371;X7547;J3.602.191H;D10130;MLN2238,MLN 2238,MLN-2238/;S-7673;J-001749;BRD-K78659596-001-01-3;1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid;N-[(1R)-1-borono-3-methylbutyl]-N(2)-(2,5-dichlorobenzoyl)glycinamide;(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutylboronic acid;[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acid;[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid;[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid;MLN-2238|||[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid"	1072833-77-2	71050168A2	"27039387;26337806"	26337806	01/09/2015	24904120	01/08/2014	2013-2017		1	1	1	Yes	1	"20/11/2015 00:00;23/11/2016 00:00"	AP	MILLENNIUM PHARMS	IXAZOMIB CITRATE	20/11/2015	MILLENNIUM PHARMS	15,6	60	NA	0	1	MYELOMA	1	PROTEASOME	0	1	0	NA	0	0	0	1	1	0,27	0	0	0	NA	0	0	0	0	0	0	257	0	1
Pembrolizumab	"mk-3475;pembrolizumab;sch 900475"	"Lambrolizumab;Keytruda"	DB09037			1374853-91-4	DPT0O3T46P	"29284010;29095678;28837405;28729151;28551359;28490569;28489510;28291584;28283736;28168303;28081914;27863197;27354476;27247226;27157491;27138582;27092830;27026676;27000274;26951310;26501224;25977344;25891174;25034862"	25034862	01/07/2014	23724846	01/06/2013	2013-2017		1	1	1	Yes	1	"29/11/2017 00:00;23/05/2017 00:00;18/12/2015 00:00;24/10/2016 00:00;10/05/2017 00:00;27/07/2017 00:00;13/06/2018 00:00;05/08/2016 00:00;17/05/2017 00:00;12/06/2018 00:00;19/06/2018 00:00;02/10/2015 00:00;22/09/2017 00:00;14/03/2017 00:00;04/09/2014 00:00;18/05/2017 00:00;19/06/2015 00:00"	AP	MERCK SHARP DOHME	PEMBROLIZUMAB	04/09/2014	MERCK SHARP DOHME	15,1	135	NA	0	1	MELANOMA	1	PD-1	0	1	0	NA	0	0	0	1	0	0,52	0	0	0	NA	0	0	0	0	0	0	47	0	1
Varlilumab	"cdx 1127;cdx-1127;varlilumab"		DB11930			1393344-72-3	0125DUV5XC	28463630	28463630	01/05/2017	28463630	01/05/2017	2013-2017		1	1	0	Yes	1					30/07/2018		14,9	46	NA	0	1	"MRCC;MELANOMA"	1	CD27	0	1	1	31	0	0	0	1	0	0,02	0	0	0	0,19	0	0	0	0	0	0	0	0	1
Roniciclib	roniciclib		DB12974		"roniciclib;BAY 10-00394;BAY 1000394;KB-145902;1223498-69-8;Tube010;D0NV9O;SCHEMBL875845;GTPL7874;(2R,3R)-3-((2-((4-(cyclopropanesulfonimidoyl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)oxy)butan-2-ol"	1223498-69-8	0W9Q8U337A	28463960	28463960	01/05/2017	28463960	01/05/2017	2013-2017		1	1	0	Yes	1					30/07/2018		14,9	104	NA	1	1	"SCLC;OVARIAN"	1	CDK_PAN	0	1	1	64	1	0	0	1	0	0,01	0	0	0	0,41	0	0	0	0	0	0	0	0	1
Idelalisib	idelalisib	"5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one;5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one;Zydelig"	DB09054		"Idelalisib;870281-82-6;CAL-101;Zydelig;CAL 101;GS-1101;CAL101;(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one;UNII-YG57I8T5M0;1146702-54-6;YG57I8T5M0;CHEMBL2216870;CHEBI:82701;5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one;CAL-101 (Idelalisib, GS-1101);Idelalisib; CAL-101;(S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one;5-fluoro-3-phenyl-2-((1s)-1-(9h-purin-6-ylamino)propyl)-4(3h)-quinazolinone;5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one;5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE;Idelalisib [USAN:INN];Zydelig (TN);GS 1101;Tube701;cc-41;D0J5VR;MLS006010985;Idelalisib (JAN/USAN/INN);SCHEMBL356400;C22H18FN7O;GTPL6741;QCR-36;SCHEMBL16782604;CAL-101/CAL101;EX-A330;GS-11CAL-101;IFSDAJWBUCMOAH-HNNXBMFYSA-N;MolPort-016-633-355;BCPP000307;AOB87313;EX-A1242;KS-000007GA;ABP000109;BDBM50403068;s2226;ZINC13986658;AKOS022186334;Idelalisib (CAL-101 GS-1101);BCP9000471;CS-0256;DB09054;LS41100;PB25727;RL05396;CAL-101 (GS-1101);NCGC00262603-01;PBCML-101 (Idelalisib, GS-1101);AC-28394;AJ-64558;AK145603;BC638838;HY-13026;KB-48629;SC-86075;SMR004702787;AX8224801;ST2408278;FT-0699107;FT-0773473;X7435;D10560;Q-4533;J-517532;BRD-K60866521-001-01-4;CAL101;S2226;870281-82-6;5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one;5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-one;(S)-2-(1-(1H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one;(S)-5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one;5-Fluoro-3-Phenyl-2-[(1s)-1-(7h-Purin-6-Ylamino)propyl]quinazolin-4(3h)-One;40L"	870281-82-6	YG57I8T5M0	"24615778;24615777;24615776"	24615778	01/03/2014	24450858	01/05/2013	2013-2017	DOI: 10.1200/jco.2013.31.15_suppl.7003	1	1	1	Yes	1	"29/11/2017 00:00;26/01/2018 00:00;06/02/2018 00:00;19/01/2016 00:00;21/09/2016 00:00;04/01/2017 00:00;22/03/2018 00:00;01/09/2015 00:00;23/07/2014 00:00;02/02/2018 00:00"	AP	GILEAD SCIENCES INC	IDELALISIB	23/07/2014	GILEAD SCIENCES INC	14,7	54	82	0	1	NHL	1	PI3K	0	1	1	23	0	0	0	1	0	0,81	0	1	1	NA	0	0	0	0	0	0	691	0	1
Ruxolitinib	"incb18424;ruxolitinib"	"INCB424;Jakafi;Jakavi"	DB08877		"Ruxolitinib;941678-49-5;Ruxolitinib (INCB018424);INCB-018424;(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;INCB 018424;INCB018424;UNII-82S8X8XX8H;Jakavi;82S8X8XX8H;INCB018424 (Ruxolitinib);CHEBI:66919;INCB18424;C17H18N6;(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile;R-Ruxolitinib;Ruxolitinib [USAN:INN];INCB 18424;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)propanenitrile;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrazol-1-yl)propanenitrile;(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;INC 424;Ruxolitinib (USAN/INN);INCB18424,Ruxolitinib;D04LKS;Ruxolitinib (JAK inhibitor);INCB424;SCHEMBL171319;BIFK0027;GTPL5688;INC424;INCB018424 - Ruxolitinib;CHEMBL1789941;SCHEMBL16546708;HSDB 8259;DTXSID10240930;SYN1120;HFNKQEVNSGCOJV-OAHLLOKOSA-N;MolPort-020-006-045;ZX-AFC000454;Ruxolitinib, 941678-49-5;1160597-27-2;ACT06813;AOB87783;BETA-CYCLOPENTYL-4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-(BETAR)-1H-PYRAZOLE-1-PROPANENITRILE;EX-A1670;KS-000006SM;ABP000827;ABP000833;BDBM50355501;IN2284;s1378;ZINC43207851;ACN-031567;BCP9000784;CS-0864;DB08877;INCB018424(Ruxolitinib)/Ruxolitinib;PB28380;NCGC00244253-01;NCGC00244253-02;AC-24280;AS-18619;BR-48608;HY-50856;KB-80435;QC-11806;AJ-108289;AX8165439;ST2407566;FT-0674485;W9658;INCB018424  /INCB-018424;D09959;Q-4578;AB01565782_02;BRD-K53972329-001-02-1;BRD-K53972329-001-03-9;(3R)-3-cyclopentyl-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H -pyrazol-1-yl)-3-cyclopentylpropanenitrile;3-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(beta-R)-1H-pyrazole-1-propanenitrile;A-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(AR)-1H-pyrazole-1-propanenitrile;1138325-12-8;1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-;BETA-CYCLOPENTYL-4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-(BR)-1H-PYRAZOLE-1-PROPANENITRILE"	941678-49-5	82S8X8XX8H	"26858309;25976292;25441108"	25441108	01/12/2014	20843246	01/09/2010	2009-2012		1	1	1	Yes	1	"12/06/2013 00:00;15/12/2014 00:00;25/11/2013 00:00;25/07/2014 00:00;10/03/2016 00:00;06/12/2017 00:00;07/11/2013 00:00;10/10/2017 00:00;02/12/2015 00:00;06/10/2015 00:00;30/05/2014 00:00;21/06/2012 00:00;04/12/2014 00:00;16/11/2011 00:00"	AP	INCYTE CORP	RUXOLITINIB PHOSPHATE	16/11/2011	INCYTE CORP	14,5	153	NA	0	1	MYELOFIBROSIS	1	"JAK1;JAK2"	0	1	1	33	1	0	0	1	1	0,52	0	0	0	NA	0	0	0	0	0	0	181	0	1
Cyclophosphamide	cyclophosphamide	"Cytophosphane;(+-)-Cyclophosphamide;N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;Cyclophosphamidum;(RS)-Cyclophosphamide;Cyclophosphamid;Cyclophosphamide anhydrous;Ciclofosfamide;Cyclophosphamide;2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide;Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester;Ciclofosfamida;Anhydrous cyclophosphamide;Ledoxina;Procytox 200mg/vial;Procytox Vial 1000mg;Procytox Tab 50mg;Procytox Pws 500mg;Procytox 2000mg/vial;Procytox Vial 200mg;Cytoxan Pws for Inj 2000mg/vial;Procytox 1000mg/vial;Procytox for Injection 2000mg Pws IV;Procytox Tablets 50mg;Procytox Tab 25mg;Cytoxan Tab 25mg;Cyclophosphamide;Procytox 500mg/vial;Cytoxan Pws for Inj 1000mg/vial;Cytoxan Tab 50mg"	"DB00531;APRD00408"	"(2S)-N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;N,N-bis(2-chloroethyl)-2-hydroxy-1,3,2-oxazaphosphinan-2-ium-2-amine;(2R)-N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;bis(2-chloroethyl)-(2-hydroxy-1,3,2-oxazaphosphinan-2-ium-2-yl)amine;bis(2-chloroethyl)-[(2S)-2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl]amine;bis(2-chloroethyl)-[(2R)-2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl]amine;bis(2-chloroethyl)-(2-keto-1-oxa-3-aza-2$l^{5}-phosphacyclohex-2-yl)amine;50-18-0;60007-96-7;60030-72-0;60007-95-6;75526-90-8;(+-)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+-)-;D,L-Cyclophosphamide;(S)-Cyclophosphamide;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (S)-;BRN 4678992;D-Cyclophosphamide;SPBio_001071;NCI60_002097;N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;ZINC00000197;Spectrum2_001146;NCGC00091741-04;KBioGR_000888;DivK1c_000246;Spectrum_000858;Spectrum4_000304;(+)-Cyclophosphamide;(R)-Cyclophosphamide;STK177249;L-Cyclophosphamide;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (R)-;Lopac-C-0768;NCGC00015209-01;ZINC00155694;IDI1_000246;AIDS-002314;AIDS002314;Lopac0_000238;Spectrum3_000370;KBioSS_001338;CHEBI:4027;Spectrum5_000795;KBio1_000246;KBio3_001319;KBio2_001338;KBio2_003906;KBio2_006474;C07888;Cyclophosphamide anhydrous;(+-)-Cyclophosphamide;(RS)-Cyclophosphamide;1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin;2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazophosphorine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide (9CI);2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide;4-27-00-09750 (Beilstein Handbook Reference);4-Hydroxy-cyclophosphan-mamophosphatide;AI3-26198;ASTA B518;BRN 0011744;CCRIS 188;Ciclofosfamida [INN-Spanish];Ciclophosphamide;Ciclophosphamide [INN];Cyclophosphamide (anhydrous form);Cyclophosphamide (anhydrous);Cyclophosphamidum [INN-Latin];Cyclophosphanum;Cyclophosphoramide;Cyklofosfamid [Czech];Cytophosphane;EINECS 200-015-4;HSDB 3047;N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide;N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide;N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid [German];Occupation, cyclophosphamide exposure;RCRA waste no. U058;RCRA waste number U058;Zyklophosphamid [German];EU-0100238;N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide;2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide;BSPBio_002099;NINDS_000246;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (-)-;NSC273033;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+)-;NSC273034;(-)-Cyclophosphamide;(Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate;2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide;2-[Bis(2-chloroethyl)amino]-2H-1,3,2-oxazaphosphorine 2-oxide;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate;ASTA;Asta B 518;B 518;Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester;CB 4564;CB-4564;CY;Clafen;Claphene;Cyclophosphamid;Cyclophosphamide;Cyclophosphamidum;Cyclophosphan;Cyclophosphane;Cyclostin;Cytophosphan;Endoxan;Endoxan R;Endoxan-Asta;Endoxana;Endoxanal;Endoxane;Enduxan;Genoxal;Mitoxan;N,N-Bis(.beta.-chloroethyl)-N',O-propylenephosphoric acid ester amide monohydrate;N,N-Bis(.beta.-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide;N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide;N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide;N,N-Bis-(.beta.-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid;N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide;NCI-C04900;NSC26271;Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester;Procytox;SK 20501;Semdoxan;Sendoxan;Senduxan;WLN: T6MPOTJ BO BN2G2G;Zyklophosphamid;[Bis(chloro-2-ethyl)amino]-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate"	"cyclophosphamide;50-18-0;Cyclophosphamid;Cyclophosphane;Cytophosphan;Procytox;Clafen;Cytoxan;Endoxan;Neosar;Cyclophosphamidum;Cyclophosphan;Cyclostin;Sendoxan;Cytophosphane;Claphene;Endoxana;Endoxanal;Genoxal;Endoxan-Asta;Endoxan R;Zyklophosphamid;Mitoxan;(RS)-Cyclophosphamide;Cyclophosphoramide;Cyklofosfamid;Endoxane;Enduxan;Semdoxan;Senduxan;(+-)-Cyclophosphamide;Ciclofosfamida;Cyclophosphanum;Ciclophosphamide;Lyophilized Cytoxan;Cyclophosphamide anhydrous;Rcra waste number U058;Asta B 518;Cycloblastin;D,L-Cyclophosphamide;ASTA;(-)-Cyclophosphamide;Cyklofosfamid [Czech];Ciclophosphamide [INN];NSC 26271;Zyklophosphamid [German];Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester;B 518;CB 4564;NCI-C04900;Cyclophosphamide (anhydrous);SK 20501;ASTA B518;Ciclofosfamida [INN-Spanish];NSC-26271;Cyclophosphamidum [INN-Latin];Revimmune;Cyclophosphamides;Cytoxan Lyoph;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide;N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide;Occupation, cyclophosphamide exposure;CCRIS 188;Cytoxan (TN);4-Hydroxy-cyclophosphan-mamophosphatide;CHEBI:4027;Cyclophosphamide (TN);Cyclophosphamide (anhydrous form);HSDB 3047;Cyclophosphamide Sterile;Cyclophosphamide (INN);N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;NSC26271;EINECS 200-015-4;RCRA waste no. U058;BRN 0011744;2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide;AI3-26198;1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin;Cyclophosphamide, (+-)-Isomer;B-518;2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide;CMSMOCZEIVJLDB-UHFFFAOYSA-N;N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide;N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide;Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester;CB-4564;CY;N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine;N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide;N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide;EN300-74526;Neosar (TN);2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazophosphorine 2-oxide;C 0768;N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid [German];2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+-)-;60007-95-6;bis(2-Chloroethyl)phosphami de cyclic propanolamide;W-105248;bis(2-Chloroethyl)phosphamide cyclic propanolamide ester;1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine;2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide;2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;SR-01000075737;NCGC00015209-05;Cyclophosphamide [USP:INN];Ciclofosfamide;Cyclofosphamide;Ledoxina;2-(Bis(2-chloroethyl)amino)-2H-1,2-oxazaphosphorine 2-oxide;2-[Bis(2-chloroethyl)amino]-2H-1,2-oxazaphosphorine 2-oxide;Lyophilizedcytoxan;(Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate;[Bis(chloro-2-ethyl)amino]-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate;Revimmune (TN);Procytox (TN);60007-96-7;Endoxan (TN);173547-45-0;Spectrum_000858;Clafen(Cyclophosphamide);AC1L1EQQ;Anhydrous cyclophosphamide;CHEMBL88;Spectrum2_001146;Spectrum3_000370;Spectrum4_000304;Spectrum5_000795;Clafen(Cyclophosphamide)/;Lopac-C-0768;D0CT9C;Epitope ID:131782;SCHEMBL4346;(.+/-.)-Cyclophosphamide;Lopac0_000238;BSPBio_002099;KBioGR_000888;KBioSS_001338;ARONIS24566;DivK1c_000246;SPBio_001071;GTPL7154;SCHEMBL4345553;6055-19-2 (monohydrate);DTXSID5020364;SCHEMBL10262910;CMSMOCZEIVJLDB-UHFFFAOYSA-;CTK2F5582;KBio1_000246;KBio2_001338;KBio2_003906;KBio2_006474;KBio3_001319;KS-00000XHN;BBC/739;CYCLOPHOSPAMIDE MONOHYDRATE;WLN: T6MPOTJ BO BN2G2G;MolPort-001-783-420;NINDS_000246;HMS2090A12;HMS3260P17;HMS3715J05;Pharmakon1600-01500213;ZX-AS004939;Tox21_500238;ABP000629;BBL022697;MFCD00005978;N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid;NSC273033;NSC273034;NSC756711;STK177249;AKOS005410738;AN-6966;API0002151;CS-1425;DB00531;LP00238;LS-1302;MCULE-5327530727;NSC-273033;NSC-273034;NSC-756711;(+-)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;IDI1_000246;N,3,2-oxazaphosphorin-2-amine-2-oxide;N,O-propylen-phosphorsaeure-ester-diamid;NCGC00015209-01;NCGC00015209-02;NCGC00015209-03;NCGC00015209-04;NCGC00015209-06;NCGC00015209-07;NCGC00015209-08;NCGC00015209-09;NCGC00015209-12;NCGC00091741-02;NCGC00091741-03;NCGC00260923-01;ACM173547450;BC200624;HY-17420;LS-99787;NCI60_002097;OR322611;SC-22408;SC-47258;SC-91286;N,O-propylenephosphoric acid ester diamide;SBI-0050226.P003;AB0007927;N,O-propylene-phosphoric acid ester diamide;TC-063558;TR-037249;A2343;EU-0100238;FT-0624276;N,O-trimethylenephosphoric acid ester diamide;ST51005945;3356-EP2269989A1;3356-EP2270001A1;3356-EP2270008A1;3356-EP2270014A1;3356-EP2270018A1;3356-EP2270505A1;3356-EP2272822A1;3356-EP2272825A2;3356-EP2272827A1;3356-EP2275102A1;3356-EP2275412A1;3356-EP2275413A1;3356-EP2275420A1;3356-EP2277865A1;3356-EP2277876A1;3356-EP2280012A2;3356-EP2281815A1;3356-EP2281818A1;3356-EP2287156A1;3356-EP2289892A1;3356-EP2289894A2;3356-EP2292233A2;3356-EP2292595A1;3356-EP2292614A1;3356-EP2292615A1;3356-EP2292617A1;3356-EP2295055A2;3356-EP2295412A1;3356-EP2295413A1;3356-EP2295416A2;3356-EP2295426A1;3356-EP2295427A1;3356-EP2298743A1;3356-EP2298746A1;3356-EP2298748A2;3356-EP2298764A1;3356-EP2298765A1;3356-EP2298767A1;3356-EP2298768A1;3356-EP2298772A1;3356-EP2298778A1;3356-EP2298780A1;3356-EP2301928A1;3356-EP2301933A1;3356-EP2305250A1;3356-EP2305640A2;3356-EP2305642A2;3356-EP2305671A1;3356-EP2305677A1;3356-EP2305689A1;3356-EP2308812A2;3356-EP2308833A2;3356-EP2308839A1;3356-EP2308855A1;3356-EP2308861A1;3356-EP2311453A1;3356-EP2311807A1;3356-EP2311808A1;3356-EP2311825A1;3356-EP2311827A1;3356-EP2311829A1;3356-EP2311837A1;3356-EP2311840A1;3356-EP2311842A2;3356-EP2314587A1;3356-EP2314590A1;3356-EP2316831A1;3356-EP2316832A1;3356-EP2316833A1;3356-EP2316834A1;3356-EP2371811A2;3356-EP2374454A1;C07888;D07760;W-5035;27353-EP2269998A2;27353-EP2272516A2;27353-EP2275404A1;27353-EP2275469A1;27353-EP2284171A1;27353-EP2287940A1;27353-EP2292227A2;27353-EP2295550A2;27353-EP2298762A2;27353-EP2298768A1;27353-EP2308839A1;27353-EP2314587A1;27353-EP2371795A1;AB00053446-09;AB00053446-11;AB00053446-12;AB00053446_13;AB00053446_14;AB00053446_15;005C978;110841-EP2272827A1;110841-EP2298305A1;139301-EP2270008A1;139301-EP2292617A1;W-60377;N,O-propylenephosphoric acid ester amide monohydrate;SR-01000075737-1;SR-01000075737-6;BRD-A09722536-002-02-4;UNII-6UXW23996M component CMSMOCZEIVJLDB-CQSZACIVSA-N;2-(bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide;2-[BIS(2-CHLOROETHYL)AMINO]TETRAHYDRO-2H-1,3,2-OXA;2-[bis(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one;2-[bis(2-chloroethyl)amino]-1,3,2-oxazaphosphaperhydroin-2-one;N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide #;2-(bis(2-Chloroethyl)-amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;2-(di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane 2-oxide;2-(Di(2-chloroethyl)amino)-2-phospha(V)-tetrahydro-2H-1,3-oxazine-2-one;2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide;2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide;2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide;N,N-Bis(.beta.-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide;N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide (H2O);N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide;N,N-Bis-(.beta.-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid;N-bis(beta-Chloroethyl)-N'O,trimethylenephos phoric acid ester diamide;N-bis(beta-Chloroethyl)-N'O,trimethylenephosphoric acid ester diamide;tatrahydro-2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide;(+/-)-2-[Bis(2-chloroethyl)amino]tetrahydro-2 H-1,3,2-oxazaphosphorine 2-oxide;(R)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide;(S)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide;2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+)-;2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (-)-;2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate;2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide (9CI);N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine;N,N-bis(2-chloroethyl)-N'-(3-h ydroxypropyl)phosphorodiamidic acid intramol. ester;N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidic acid intramol. ester;N,N-Bis(2-Chloroethyl)tetrahydro-2H-1,3,2-Oxazaphosphorin-2-Amine, 2-Oxide;Phosphorodiamidic acid,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester;te trahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;tetrahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;75526-90-8;InChI=1/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)"	50-18-0	6UXW23996M	"25765556;25617965;23573824;21925089;18645194;17956583;15918076;15746054;12736567;11459207;11443634;10438711;10373061"	10373061	01/06/1999	13603091	01/09/1958	Bef. 1989		0	0	1	Yes	1	"20/04/1977 00:00;14/02/1986 00:00;06/08/1985 00:00;12/02/1988 00:00;11/10/1990 00:00;21/03/1981 00:00;22/07/2014 00:00;25/03/2002 00:00;20/08/1999 00:00;08/11/1988 00:00;19/07/1978 00:00;26/04/1977 00:00;03/12/1991 00:00;30/04/1979 00:00;17/09/1990 00:00;30/08/1985 00:00;20/11/1987 00:00;27/09/1980 00:00;13/12/1978 00:00;18/06/1985 00:00;03/07/1986 00:00;09/06/1976 00:00;17/10/1984 00:00;17/03/1977 00:00;15/06/2000 00:00;08/07/1983 00:00;02/05/1985 00:00;18/11/1988 00:00;23/05/1978 00:00;20/12/1995 00:00;13/01/1976 00:00;13/05/1988 00:00;28/08/1978 00:00;10/07/1986 00:00;07/11/2003 00:00;28/04/1988 00:00;10/06/1976 00:00;08/08/1978 00:00;20/08/1984 00:00;18/10/1976 00:00;08/12/1986 00:00;19/03/2018 00:00;05/04/1984 00:00;03/12/1979 00:00;29/06/1990 00:00;13/10/1981 00:00;01/11/1976 00:00;03/10/1991 00:00;10/01/2007 00:00;17/07/2002 00:00;16/02/1979 00:00;29/06/1989 00:00;10/12/1984 00:00;16/09/2013 00:00;24/05/1979 00:00;02/11/2000 00:00;16/05/1977 00:00;15/01/1986 00:00;25/04/1977 00:00;21/05/2008 00:00;17/06/2013 00:00;04/01/1984 00:00;24/09/1986 00:00;24/05/1984 00:00;27/02/1981 00:00;13/04/1990 00:00;07/05/2018 00:00;16/08/1978 00:00;10/12/1985 00:00;31/05/1989 00:00;04/12/1985 00:00;16/11/1977 00:00;16/02/2000 00:00;17/08/1999 00:00;11/07/1986 00:00;22/10/1990 00:00;07/05/1991 00:00;27/11/1978 00:00;24/09/1985 00:00;05/12/1985 00:00;01/03/1989 00:00;31/10/2014 00:00;30/01/2001 00:00;14/06/1984 00:00;30/05/1986 00:00;25/10/2014 00:00;29/08/1978 00:00;11/01/1988 00:00;28/05/1999 00:00;06/08/1992 00:00;21/11/2007 00:00;15/06/1984 00:00;04/03/1982 00:00;06/05/1985 00:00;18/07/1984 00:00;31/03/2012 00:00;25/05/2018 00:00;16/11/1959 00:00;30/03/1989 00:00;29/04/1993 00:00;30/08/1982 00:00;29/04/1987 00:00;25/01/1980 00:00;03/08/1979 00:00;27/02/2003 00:00;28/07/1982 00:00;19/08/1993 00:00;19/06/1979 00:00;30/01/1991 00:00;15/03/1983 00:00;12/01/1988 00:00;03/03/1997 00:00;07/05/2013 00:00;16/11/1981 00:00;31/10/2016 00:00;10/08/1984 00:00;18/05/1988 00:00;16/02/1982 00:00;11/12/1981 00:00"	AP	"BEDFORD;#N/A;ROXANE;WEST-WARD PHARMS INT;TEVA PARENTERAL;BAXTER HLTHCARE;JIANGSU HENGRUI MED"	CYCLOPHOSPHAMIDE	16/11/1959	BAXTER HLTHCARE	14,5	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Cobimetinib	cobimetinib	Cotellic	DB05239		"Cobimetinib;934660-93-2;GDC-0973;XL518;Cotellic;Xl-518;GDC 0973;UNII-ER29L26N1X;XL 518;Cobimetinib Butyrate;RG 7420;ER29L26N1X;CHEMBL2146883;RG7420;Cobimetinib (GDC-0973, RG7420);(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone;[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-((s)-3-hydroxy-3-piperidin-2-yl-azetidin-1-yl)-methanone;Cobimetinib [USAN:INN];cometinib;[3,4-Bis(Fluoranyl)-2-[(2-Fluoranyl-4-Iodanyl-Phenyl)amino]phenyl]-[3-Oxidanyl-3-[(2s)-Piperidin-2-Yl]azetidin-1-Yl]methanone;EUI;Cobimetinib (USAN/INN);D0O2FN;SCHEMBL189565;GTPL7626;QCR-87;C21H21F3IN3O2;CHEBI:90851;DTXSID60239435;EX-A673;GDC0973;BSMCAPRUBJMWDF-KRWDZBQOSA-N;MolPort-028-720-358;GDC0973; XL518; Cobimetinib;3556AH;BDBM50391802;s8041;ZINC60325170;AKOS025396263;BCP9000716;CS-0521;DB05239;RG-7421;KS-0000059E;AK173907;BC600781;HY-13064;KB-77527;Methanone, (3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-((2S)-2-piperidinyl)-1-azetidinyl)-;AB0072274;FT-0675878;D10405;W-5863;J-525162;(S)-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone;[3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone;[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone;[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl][3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl]methanone;1029872-29-4"	934660-93-2	ER29L26N1X	27424159	27424159	01/07/2016	25037139	01/09/2014	2013-2017		1	1	1	Yes	1	"26/01/2018 00:00;31/05/2016 00:00;10/11/2015 00:00"	AP	GENENTECH INC	COBIMETINIB FUMARATE	10/11/2015	GENENTECH INC	14,3	129	NA	0	1	MELANOMA_BRAF_MUTANT	1	MET	0	1	0	NA	1	0	0	1	1	0,87	0	1	1	NA	0	QT	1	0	0	0	96	0	1
Gilteritinib	gilteritinib		DB12141		"Gilteritinib;1254053-43-4;ASP2215;UNII-66D92MGC8M;ASP-2215;66D92MGC8M;6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide;Gilteritinib [USAN:INN];ASP 2215;Gilteritinib(ASP2215);Gilteritinib (USAN/INN);Gilteritinib (ASP2215);Gilteritinib (ASP-2215);SCHEMBL282229;GTPL8708;CHEMBL3301622;MolPort-038-934-933;BDBM144315;C29H44N8O3;3694AH;s7754;AKOS030234455;ZINC113476229;CS-3885;DB12141;KS-0000064E;2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-;AC-29030;AS-35199;HY-12432;QC-11768;KB-334412;D10709;US8969336, 547;US8969336, 577;6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide;6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide;6-Ethyl-3-[3-methoxy-4-[4-(4-methylpiperazine-1-yl)piperidino]anilino]-5-[(tetrahydro-2H-pyran-4-yl)amino]pyrazine-2-carboxamide"	1254053-43-4	66D92MGC8M	28645776	28645776	01/06/2017	28645776	01/06/2017	2013-2017		1	1	0	Yes	1					30/07/2018		13,9	252	NA	0	1	AML	1	FLT3	0	1	1	229	1	1	0	1	1	0,4	0	0	0	NA	1	TV	1	0	0	0	0	0	1
Tigecycline	tigecycline	"Tigecyclinum;Tigecycline;Tigeciclina;(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;Tygacil;Tigecycline"	"DB00560;APRD01307"	"N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxymethylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxy-methylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxymethylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxy-methylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-triketo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)ethanamide;220620-09-7;(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;TBG-MINO;(4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide;9-t-Butylglycylamido minocycline;AIDS-094224;AIDS094224;GAR-936;Tygacil(TM);Tigilcycline;D01079;Tigecycline (JAN/USAN);Tygacil;Tygacil (TN);N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxymethylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;Tigecycline[USAN];C12012;GAR 936;Tigecycline;WAY-GAR-936;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,  (4S,4aS,5aR,12aS)-"	"Tigecycline;220620-09-7;Tygacil;WAY-GAR-936;GAR-936;TBG-MINO;GAR 936;Tigilcycline;GAR-936,Tigecycline;Tygacil(TM);Tygacil (TN);Tigecycline [USAN];Tigecycline hydrate;Tigecycline (JAN/USAN);UNII-70JE2N95KR;Glycylcycline;70JE2N95KR;(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;9-t-Butylglycylamido minocycline;CHEBI:149836;Tigecyclin;(4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1;(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide;Q-101396;C29H39N5O8;(4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide;N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;9-t-Butylglycylamido-minocycline hydrate;Tigeciclina;Tigecyclinum;Haizheng Li Xing;NCGC00183095-01;(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide;(4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-[[[(1,1-DIMETHYLETHYL)AMINO]ACETYL]AMINO]-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-;AC1NQZEU;PubChem21336;1229002-07-6;D0G4OD;DSSTox_CID_28507;DSSTox_RID_82779;DSSTox_GSID_48581;MLS006010079;SCHEMBL101795;SCHEMBL105082;SCHEMBL237962;Tigecycline [USAN:INN:BAN];AC1O714W;CHEMBL376140;DTXSID2048581;HSDB 8172;SYN3024;9-tert-Butylglycylamidominocycline;FPZLLRFZJZRHSY-HJYUBDRYSA-N;MolPort-009-199-379;MolPort-028-751-260;SOVUOXKZCCAWOJ-HJYUBDRYSA-N;BCPP000045;HMS3714I13;ACT08710;HY-B0117;Tox21_112910;CT0198;s1403;ZINC14879972;AKOS015895663;AKOS025401452;ZINC100022633;ZINC102200515;AC-1798;AN-6306;CS-1876;DB00560;RL02680;220620-09-7 (anhy.);121GE002;AS-30703;BC677670;BR-73038;SC-20200;SMR002530064;AB0011463;AB2000089;LS-186580;LS-187002;LS-187782;ST2413997;A5226;AM20090708;CAS-220620-09-7;FT-0657279;Tygacil;GAR-936;WAY-GAR-936;TBG-MINO;C12012;D01079;S-5066;AB01566818_01;620T097;Tigecycline, Antibiotic for Culture Media Use Only;I06-1089;Tygacil, GAR-936, WAY-GAR-936, TBG-MINO, Tigecycline;(4S,4AS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxa;(4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,  (4S,4aS,5aR,12aS)-;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;N-((5aR,6aS,7S,10aS,Z)-9-(amino(hydroxy)methylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl)-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9E,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide"	220620-09-7	70JE2N95KR	27734609	27734609	01/10/2016	15220014	01/05/2004	2004-2008		1	0	1	No	0	"29/06/2016 00:00;19/01/2016 00:00;20/03/2009 00:00;10/02/2009 00:00;18/01/2018 00:00;31/05/2016 00:00;24/01/2007 00:00;03/04/2007 00:00;26/06/2009 00:00;23/05/2013 00:00;01/12/2016 00:00;29/01/2009 00:00;09/01/2014 00:00;16/04/2018 00:00;16/07/2010 00:00;27/05/2015 00:00;15/08/2017 00:00;26/09/2013 00:00;15/06/2005 00:00;12/07/2006 00:00;29/09/2017 00:00;18/05/2007 00:00"	AP	"PF PRISM CV;FRESENIUS KABI USA;ACCORD HLTHCARE INC;SANDOZ INC"	TIGECYCLINE	15/06/2005	PF PRISM CV	13,4	#N/A																							0						1
Bosutinib	"bosutinib;ski-606"	"Bosutinib Monohydrate;Bosulif®;Bosutinib;4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile;SKI 606;Bosulif"	DB06616	"4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;4-[(2,4-dichloro-5-methoxy-phenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;380843-75-4;SKI-606;4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile;3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-;4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;Bosutinib;Bosutinib [USAN];4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;Bosutinib (USAN);D03252;CHEBI:39112;K00615a;SKI 606"	"Bosutinib;380843-75-4;SKI-606;SKI 606;SKI606;Bosutinib (SKI-606);BOSULIF;4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;Bosutinib (USAN);UNII-5018V4AEZ0;4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;CHEMBL288441;4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile;CHEBI:39112;5018V4AEZ0;WAY-173606;PF-5208763;4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;Q-200745;1391063-17-4;4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;Bosutinib [USAN:INN];NCGC00241107-01;Bosulif(R);3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-;3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-;DB8;Bosutinib,SKI-606;PubChem22404;Bosutinib (SKI606);Bosutinib(SKI-606);Bosutinib - SKI-606;D0OB0F;EC 700-455-1;AC1NS5P1;xy]-3-quinolinecarbonitrile;MLS006011212;SCHEMBL158390;BDBM4552;GTPL5710;QCR-26;Bosutinib, >=98% (HPLC);EX-A391;SYN1025;MolPort-008-155-956;UBPYILGKFZZVDX-UHFFFAOYSA-N;BCPP000318;HMS2043A22;HMS3244A03;HMS3244A04;HMS3244B03;HMS3651C03;K00615a;AOB87309;ABP000235;AN-465;MFCD07367846;SK 606;SK-606;ZINC22448983;AKOS015902521;AC-2413;API0024729;BCP9000446;CCG-208129;CS-0118;DB06616;PB30881;RL03452;NCGC00241107-03;AS-11064;BC644818;Bosutinib (BCR-ABL inhibitor  3rd gen);HY-10158;KB-75762;SC-23008;SMR002530350;AB0008633;FT-0656231;S1014;X4840;A25014;D03252;Q-4427;AB01565836_03;843B754;Bosutinib|380843-75-4|SKI606|SKI 606;SR-01000941572;I14-1974;J-519931;SR-01000941572-1;BRD-K99964838-001-01-0;BRD-K99964838-001-06-9;4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propo;4-(2,4-dichloro-5-methoxy-anilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;4-(3,5-Dichloro-4-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;SKI-606;4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-quinoline-3-carbonitrile"	380843-75-4	5018V4AEZ0	"26537529;26040495;25540064;24919837;24711212;22179664;21865346"	21865346	01/08/2011	21865346	01/08/2011	2009-2012		1	1	1	Yes	1	"25/11/2014 00:00;13/04/2017 00:00;22/09/2015 00:00;04/04/2016 00:00;17/11/2016 00:00;01/05/2018 00:00;04/09/2012 00:00;08/10/2015 00:00;30/09/2013 00:00;19/12/2017 00:00"	AP	PF PRISM CV	BOSUTINIB MONOHYDRATE	04/09/2012	PF PRISM CV	13,1	288	NA	0	1	CML	1	BCR_ABL	0	1	1	NA	1	0	0	1	1	0,86	0	1	1	0,92	0	0	0	0	0	0	447	0	1
Denileukin diftitox	"dab389il-2;denileukin diftitox"	"NAD(+--diphthamide ADP- ribosyltransferase);DT;Diphtheria toxin precursor;Ontak"	"DB00004;BTD00084;BIOD00084"			173146-27-5	25E79B5CTM	"9674399;9427692"	9427692	01/01/1998	9427692	01/01/1998	1994-1998		1	1	1	Yes	1	"05/03/2010 00:00;05/02/1999 00:00;15/10/2008 00:00;30/08/2011 00:00"	AP	EISAI INC	DENILEUKIN DIFTITOX	05/02/1999	EISAI INC	13,1	73	81	0	1	LYMPHOID MALIGNANCIES_IL2-Rpositive	1	IL2-R	0	1	0	NA	0	1	0	1	1	0,37	0	1	1	NA	0	0	0	0	0	0	21	0	1
Ranibizumab	ranibizumab	"rhuFab V2;Lucentis"	DB01270			347396-82-1	ZL1R02VT79	"27630373;22186988"	22186988	01/12/2011	15885778	01/06/2005	2004-2008		1	0	1	No	0	"25/11/2014 00:00;13/10/2016 00:00;30/06/2006 00:00;06/02/2013 00:00;27/02/2014 00:00;08/03/2013 00:00;05/01/2017 00:00;26/04/2007 00:00;19/05/2010 00:00;22/11/2016 00:00;22/06/2010 00:00;20/03/2018 00:00;15/04/2017 00:00;06/02/2015 00:00;23/04/2008 00:00;10/08/2012 00:00"	AP	GENENTECH	RANIBIZUMAB	30/06/2006	GENENTECH	12,9	#N/A																							0						1
Dabrafenib	"dabrafenib;gsk-2118436a;gsk2118436"	"Dabrafenib;Tafinlar"	DB08912		"Dabrafenib;1195765-45-7;Tafinlar;Dabrafenib (GSK2118436);GSK2118436A;UNII-QGP4HA4G1B;GSK 2118436;QGP4HA4G1B;CHEBI:75045;dabrafenib mesilate;N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide;N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;Dabrafenib Mesylate (GSK-2118436);Dabrafenib [USAN:INN];N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide;N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide;P06;Dabrafenib (USAN);Tube719;Dabrafenib (Free Base);D05ROI;D0BO9V;Dabrafenib (BRAF inhibitor);MLS006011052;SCHEMBL806377;GTPL6494;CHEMBL2028663;C23H20F3N5O2S2;DABRAFENIB, KB-57246;DTXSID20152499;QCR-129;BFSMGDJOXZAERB-UHFFFAOYSA-N;MolPort-028-720-422;HMS3656D12;AOB87722;API01001;EX-A1320;KS-000005OR;ABP001006;BDBM50428286;FD5028;GSK 2118436A;ZINC68153186;(GSK2118436) pound notDabrafenib;1195765-45-7 (free base);AKOS024463285;AKOS032950004;CS-0692;DB08912;NCGC00346716-01;4CA-0431;AC-25889;AS-19634;BC297817;HY-14660;KB-01625;KB-57246;SMR004702844;AB0087834;AX8262770;S2807;Y1871;D10064;W-5688;AB01565833_02;J-004153;BRD-K09951645-066-01-2;Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-;N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide;N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfo;N-{3-(5-(2-aminopyrimidin-4-yl)-2-(1,1-dimethylethyl)thiazol-4-yl)-2-fluorophenyl}-2,6- difluorobenzenesulfonamide;N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide"		QGP4HA4G1B	"22804352;22608338"	22608338	01/05/2012	22608338	01/05/2012	2009-2012		1	1	1	Yes	1	"26/12/2013 00:00;09/01/2014 00:00;30/04/2018 00:00;22/06/2017 00:00;20/04/2018 00:00;16/06/2017 00:00;04/05/2018 00:00;29/05/2013 00:00;25/08/2014 00:00;16/06/2016 00:00;20/11/2015 00:00"	AP	NOVARTIS PHARMS CORP	DABRAFENIB MESYLATE	29/05/2013	NOVARTIS PHARMS CORP	12,9	184	NA	1	1	MELANOMA	1	BRAF	0	1	1	36	1	0	0	1	1	0,69	0	0	0	NA	0	0	0	0	0	0	777	0	1
Vemurafenib	vemurafenib	"BRAF(V600E) Kinase Inhibitor RO5185426;Zelboraf"	"DB08881;DB05238"		"Vemurafenib;918504-65-1;Zelboraf;PLX4032;1029872-54-5;PLX-4032;N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide;PLX 4032;RG7204;Vemurafenib (PLX4032, RG7204);RO5185426;UNII-207SMY3FQT;Vemurafenib (PLX4032);Zelboraf (TN);RG 7204;RO 5185426;N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide;RG-7204;207SMY3FQT;Ro 51-85426;CHEBI:63637;NSC761431;1-PROPANESULFONAMIDE, N-[3-[[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]-2,4-DIFLUOROPHENYL]-;N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-PropanesulfonaMide;Vemurafenib;PLX-4032;RO-5185426;C23H18ClF2N3O3S;N-(3-((5-(4-Chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4- difluorophenyl)propane-1-sulfonamide;n-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-1-propanesulfonamide;N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl]propane-1-sulfonamide;N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide;Vemurafenib [USAN:INN];vemurafenibum;HSDB 8143;N-(3-([5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULFONAMIDE;N-(3-{(5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl}-2,4- difluorophenyl)propane-1-sulfonamide;3og7;D0Y9EW;PLX4032 (Vemurafenib);PLX4032 - Vemurafenib;PLX4032 ,Vemurafenib ,;Vemurafenib (BRAF inhibitor);SCHEMBL298931;Vemurafenib (JAN/USAN/INN);GTPL5893;QCR-44;CHEMBL1229517;CTK8C3113;DTXSID50238710;EX-A053;SYN1161;GPXBXXGIAQBQNI-UHFFFAOYSA-N;MolPort-009-200-481;ZX-AFC000306;HMS3265M03;HMS3265M04;HMS3265N03;HMS3265N04;HMS3654P09;AOB87705;BCP25783;EX-A1335;ABP000429;ANW-69692;BDBM50396483;IN2235;s1267;ZINC52509366;AKOS007930804;ACN-030372;AM81259;AN-1313;CS-0216;DB08881;MCULE-7244406627;ME-0096;NSC-761431;PB11741;RL05788;TRA0082406;KS-0000002Q;NCGC00250399-01;Vemurafenib, RG7204, RO5185426;1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3- yl)carbonyl)-2,4-difluorophenyl)-;4CA-1032;AC-25010;AK-56796;BC626573;HY-12057;KB-59765;SC-54548;AB0031775;AB1009703;AX8212389;TC-158437;FT-0660388;FT-0675792;FT-0689782;ST24048327;Y0473;BRAF(V600E) Kinase Inhibitor RO5185426;PLX-4032(RG7204)/PLX4032;A25476;D09996;Q-3409;R-7204;AB01273970-01;AB01273970_03;SR-01000941568;J-522975;J-690009;SR-01000941568-1;BRD-K56343971-001-02-3;BRD-K56343971-001-05-6;N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine;PLX4032,Vemurafenib, RG7204, RO5185426, Zelboraf;PLX4032, RG7204, RO5185426, 1029872-54-5;[(2S,5R)-2,5-Dimethyl-4-[(tetrahydro-2H-pyran-4-yl)methyl]-1-piperazinyl][3-[(5-fluoro-2-methyl-4-pyrimidinyl)amino]-4,6-dihydro-6,6 -dimethylpyrrolo[3,4-c]pyrazol-5(1H)-yl]methanone;N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)-propane-1-sulfonamide;propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide"	918504-65-1	207SMY3FQT	"25884515;25036880;23489023"	23489023	01/03/2013	20818844	01/08/2010	2009-2012		1	1	1	Yes	1	"25/11/2014 00:00;31/08/2016 00:00;13/09/2017 00:00;06/11/2017 00:00;17/08/2011 00:00;19/03/2014 00:00;03/07/2013 00:00;06/02/2014 00:00;11/08/2015 00:00;23/09/2014 00:00;09/05/2016 00:00;17/04/2017 00:00"	AP	HOFFMANN LA ROCHE	VEMURAFENIB	17/08/2011	HOFFMANN LA ROCHE	12,5	87	NA	1	1	MELANOMA_BRAF_MUTANT	1	BRAF	0	1	1	32	1	0	0	1	1	0,75	0	1	1	NA	0	0	0	0	0	0	988	0	1
Gefitinib	"gefitinib;zd 1839;zd1839"	"ZD 1839;Gefitinib;N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine;4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;Apo-gefitinib;Iressa"	"DB00317;APRD00997;DB07998"	"N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)-4-quinazolinamine;(3-chloro-4-fluoro-phenyl)-[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine;N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;184475-35-2;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;D01977;Gefitinib (JAN/USAN);Iressa (TN);Gefitinib;Iressa;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;NSC715055;KBioSS_002241;IRE;4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-;Gefitinib [USAN];Irressat;ZD 1839;ZD1839;Gefitini; Iressa;K00240;BCB03_000781;ZD-1839;N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;nchembio866-comp14;NCGC00159455-02;NCGC00159455-03"	"Gefitinib;184475-35-2;Iressa;ZD1839;Irressat;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;ZD 1839;gefitinib (zd1839);Gefitinib [USAN];ZD-1839;N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine;UNII-S65743JHBS;Iressa(TM);Iressa (TN);IRRESSA;CCRIS 9011;4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;CHEMBL939;Gefitinib (JAN/USAN/INN);N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;S65743JHBS;CHEBI:49668;XGALLCVXEZPNRQ-UHFFFAOYSA-N;NCGC00159455-02;DSSTox_CID_21034;DSSTox_RID_79614;DSSTox_GSID_41034;3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline;CU-00000000396-1;Q-201149;Gefitinib; Iressa;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine;N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;IRE;CAS-184475-35-2;SR-00000000262;Gefitini;Gefitinib [USAN:INN:BAN];Gefitinib;;Gefitini; Iressa;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine;gefitinib (iressa);Gefitinib - Iressa;GEFTINIB;Iressa (AstraZeneca);nchembio866-comp14;Kinome_3321;Kinome_3322;D09XZB;Iressa|||ZD 1839;AC1L3X0A;SCHEMBL7866;Gefitinib,Iressa, ZD1839;Gefitinib,ZD-1839,Iressa;Gefitinib/ZD-1839,Iressa;KBioSS_002241;MLS003899193;Gefitinib, Iressa, ZD1839;BDBM5447;cid_123631;EBD446;GTPL4941;ZD-1839, Iressa, Gefitinib;DTXSID8041034;Gefitinib, >=98% (HPLC);CTK7A0364;AOB6917;QCR-105;SYN1042;MolPort-000-883-335;BCPP000221;HMS2089B19;HMS3244M21;HMS3244M22;HMS3244N21;HMS3654A07;HMS3714A05;Pharmakon1600-01502274;AMX10169;Tox21_111683;ABP000855;CG0031;FC0028;GP9843;MFCD04307832;NSC715055;NSC759856;RS0033;s1025;STK621310;ZINC19632614;AKOS000280752;Tox21_111683_1;AB20814;AC-1556;AN-5192;API0002810;BCP9000718;CCG-220642;CS-0124;DB00317;KS-1204;MCULE-6951584187;NSC-715055;NSC-759856;KS-00000E11;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide;NCGC00159455-03;NCGC00159455-04;NCGC00159455-05;NCGC00159455-06;NCGC00159455-08;NCGC00159455-09;4CA-0562;AJ-74091;AK-72948;BC215794;BCB03_000781;BR-72948;CC-28943;CJ-16232;EN002708;H018;HY-50895;KB-52238;SC-18023;SMR002204119;AB0000095;LS-139916;ST2413546;AM20090619;FT-0081035;FT-0602325;D01977;G-4408;J10250;K00240;S-2176;15215-EP2269994A1;15215-EP2272827A1;15215-EP2272832A1;15215-EP2275413A1;15215-EP2277865A1;15215-EP2280006A1;15215-EP2281813A1;15215-EP2281815A1;15215-EP2287156A1;15215-EP2292234A1;15215-EP2292615A1;15215-EP2298768A1;15215-EP2298778A1;15215-EP2301533A1;15215-EP2301933A1;15215-EP2305640A2;15215-EP2305671A1;15215-EP2311807A1;15215-EP2311827A1;15215-EP2311840A1;15215-EP2316832A1;15215-EP2316833A1;32333-EP2281815A1;32333-EP2292615A1;32333-EP2301933A1;32333-EP2305640A2;32333-EP2305671A1;32333-EP2311827A1;AB01273954-01;AB01273954-02;AB01273954-03;AB01273954_04;475G352;A812870;C-22438;I01-1227;SR-00000000262-2;SR-00000000262-3;Gefitinib, EuropePharmacopoeia (EP) Reference Standard;Z1551429741;4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)-quinazoline;4-(3-CHLORO-4-FLUOROANILINO)-7-METHOXY-6-(3-MORPHOLINOPROPOXY)QUINAZOLINE;4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-;Gefitinib for system suitability, EuropePharmacopoeia (EP) Reference Standard;N-(3-chloranyl-4-fluoranyl-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;(3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE"	184475-35-2	S65743JHBS	"26178426;25784657;23182702;22002543;20708924;20458561;20004525;19322567;18594217;18317068;17971583;17967517;16135484;15744591;14581894;12796031;12409327;12228201;11980995;11773160"	11773160	01/01/2002	11980995	01/05/2002	1999-2003		1	1	1	Yes	1	"13/07/2015 00:00;19/11/2004 00:00;05/05/2003 00:00;17/06/2005 00:00;06/05/2004 00:00"	AP	"ASTRAZENECA PHARMS;ASTRAZENECA"	GEFITINIB	05/05/2003	ASTRAZENECA	12,1	64	NA	1	0	NSCLC	1	EGFR	0	1	0	NA	0	0	0	1	1	0,25	0	0	0	0,43	0	0	0	0	0	0	223	1	1
Labetuzumab govitecan	"adc immu-130;hmn14-sn38;immu-130;labetuzumab govitecan;labetuzumab govitecan (anti-ceacam5/sn-38 antibody-drug conjugate);labetuzumab-sn-38"		DB12331		"Labetuzumab govitecan;Labetuzumab-SN38;UNII-8E3HI6QQ9J;hMN14-SN38;Labetuzumab govitecan [USAN];IMMU 130;8E3HI6QQ9J;DB12331;1469876-18-3"	1469876-18-3	8E3HI6QQ9J	28817371	28817371	01/08/2017	28817371	01/08/2017	2013-2017		1	1	0	Yes	1					30/07/2018		11,9	86	NA	0	1	COLORECTAL	1	CEACAM5	0	1	0	NA	0	0	1	1	0	0,38	0	0	0	NA	0	0	0	0	0	0	0	0	1
Trametinib	"gsk1120212;trametinib"	"Trametinibum;GSK 1120212;Trametinib Dimethyl Sulfoxide ;Mekinist"	DB08911		"Trametinib;871700-17-3;GSK1120212;Mekinist;GSK 1120212;GSK-1120212;JTP 74057;Trametinib (GSK1120212);JTP-74057;UNII-33E86K87QN;N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide;Trametinib (GSK1120212JTP 74057);GSK212;CHEBI:75998;33E86K87QN;A1-01871;N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide;Trametinib [USAN:INN];trametinibum;N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide;N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide;N-(3-{3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl}phenyl)acetamide;Trametinib (USAN);cc-37;D04XVN;D0F5RQ;Trametinib (MEK inhibitor);SCHEMBL170938;C26H23FIN5O4;GTPL6495;QCR-39;GSK1120212 (Trametinib);CHEMBL2103875;EX-A022;Trametinib (GSK-1120212);LIRYPHYGHXZJBZ-UHFFFAOYSA-N;MolPort-019-879-136;BCPP000218;HMS3656J11;AOB87707;BCP02307;ABP000312;AN-539;RW4149;s2673;ZINC43100709;AKOS015850628;AM90271;CS-0060;DB08911;EX-5957;RL05418;NCGC00263180-01;4CA-0583;AC-25891;AK174783;AS-19382;BC638742;HY-10999;KB-52302;SC-85458;AB0008115;FT-0688438;X7454;KS-00000002;A25168;D10175;GSK1120212 - JTP-74057;S-7800;GSK-1120212/GSK1120212/;GSK1120212,JTP-74057, GSK212;SR-01000941589;J-523325;SR-01000941589-1;BRD-K12343256-001-01-4;N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amin;JTP-74057, 871700-17-3;1204531-14-5;Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-;Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-;N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide;N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;n-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyr;N-[3-[3-Cyclopropyl-5-[(2-Fluoro-4-Iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2h)-yl]phe nyl]acetamide;N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamide;N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide"	871700-17-3	33E86K87QN	"27392790;27136909;26259955;22805292;22805291"	22805292	01/07/2012	22663011	01/06/2012	2009-2012	DOI: 10.1200/jco.2010.28.15_suppl.2503	1	1	1	Yes	1	"13/08/2014 00:00;24/02/2017 00:00;30/04/2018 00:00;26/09/2014 00:00;22/06/2017 00:00;04/05/2018 00:00;29/05/2013 00:00;09/03/2018 00:00;20/11/2015 00:00;08/01/2014 00:00"	AP	NOVARTIS PHARMS CORP	TRAMETINIB DIMETHYL SULFOXIDE	29/05/2013	NOVARTIS PHARMS CORP	11,9	84	NA	1	1	"MELANOMA;PANCREAS"	1	MEK	0	1	1	77	0	0	0	1	1	0,25	0	0	0	0,73	0	0	0	central serous retinopathy	1	0	26	0	1
Gemtuzumab ozogamicin	"cdp-771;cma-676;gemtuzumab;gemtuzumab ozogamicin;way-cma-676"	Mylotarg	"BIOD00077;BTD00077;DB00056"			220578-59-6	8GZG754X6M	"26785332;19360457"	19360457	01/04/2009	10339474	01/06/1999	1999-2003		1	1	1	Yes	1	"23/06/2004 00:00;19/04/2002 00:00;19/12/2001 00:00;14/06/2005 00:00;04/10/2005 00:00;23/02/2001 00:00;27/10/2000 00:00;25/05/2001 00:00;23/07/2004 00:00;01/09/2017 00:00;23/08/2002 00:00;23/01/2006 00:00;16/04/2004 00:00;09/04/2018 00:00;17/05/2000 00:00"	AP	WYETH PHARMS INC	GEMTUZUMAB OZOGAMICIN	17/05/2000	WYETH PHARMS INC	11,5	40	NA	0	1	AML	1	CD33	0	1	0	NA	0	0	0	1	0	NA	0	NA	0	NA	0	0	0	0	0	0	59	0	1
Copanlisib	copanlisib	Aliqopa	DB12483		"Copanlisib;1032568-63-0;BAY 80-6946;Aliqopa;BAY-80-6946;UNII-WI6V529FZ9;BAY80-6946;WI6V529FZ9;BAY 80-6946 (Copanlisib);2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide;2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide;Copanlisib hydrochloride;BAY 84-1236;copanlisib HCl;Copanlisib (USAN/INN);Copanlisib [USAN:INN];D0S5LD;copanlisib hydrochloride hydrate;GTPL7875;SCHEMBL1655478;CHEMBL3218576;SCHEMBL13084037;Copanlisib (BAY 80-6946);DTXSID00145728;MolPort-035-395-726;PZBCKZWLPGJMAO-UHFFFAOYSA-N;C23H28N8O4;2253AH;s2802;ZINC68247389;AKOS025290222;BAY-806946;CS-0741;DB12483;PB22956;KS-0000079U;NCGC00346457-01;4CA-0259;AC-28438;AK172384;HY-15346;KB-74865;QC-10511;D10867;Q-4031;2-AMINO-N-(7-METHOXY-8-[3-(MORPHOLIN-4-YL)PROPOXY]-2H,3H-IMIDAZO[1,2-C]QUINAZOLIN-5-YL)PYRIMIDINE-5-CARBOXAMIDE;2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide;2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1.2-c]quinazolin-5-yl]pyrimidine-5-carboxamide;BAY-80-6946|||2-Amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide"	1032568-63-0	WI6V529FZ9	27915408	27915408	01/12/2016	27672108	01/10/2016	2013-2017		1	1	1	Yes	1	14/09/2017 00:00	AP	BAYER HEALTHCARE	COPANLISIB DIHYDROCHLORIDE	14/09/2017	BAYER HEALTHCARE	11,4	57	NA	1	1	NHL	1	PI3K	0	1	1	20	1	0	0	1	1	0,33	0	1	1	NA	0	0	0	0	0	0	89	0	1
Gandotinib	"gandotinib;ly 2784544;ly2784544"		DB13040		"LY2784544;1229236-86-5;GANDOTINIB;LY 2784544;LY-2784544;Gandotinib (LY2784544);UNII-ANC71R916O;LY2784544(Gandotinib);ANC71R916O;3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine;C23H25ClFN7O;3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(3-methyl-1H-pyrazol-5-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine;3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine;Gandotinib [USAN:INN];Gandotinib (USAN);cc-18;D05TSJ;LY2784544;Gandotinib;Gandotinib(LY2784544);GTPL7909;SCHEMBL2513132;CHEMBL2107823;SCHEMBL15458955;DTXSID20153789;SYN1196;MolPort-016-633-296;MolPort-042-652-644;SQSZANZGUXWJEA-UHFFFAOYSA-N;HMS3655L06;AOB87108;EX-A1114;KS-000005OJ;ABP000830;IN2286;s2179;ZINC68245097;AKOS026673949;BCP9000875;CS-0426;DB13040;QC-8978;RL01055;NCGC00345461-02;3-((4-Chloro-2-fluorophenyl)methyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8- (morpholin-4-ylmethyl)imidazo(1,2-b)pyridazin-6-amine;3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8- (morpholinomethyl)imidazo(1,2-b)pyridazin-6-amine;4CA-0779;AS-16329;BC659993;HY-13034;Imidazo(1,2-b)pyridazin-6-amine, 3-((4-chloro-2-fluorophenyl)methyl)-2-methyl-N-(5- methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-;KB-78243;SC-85765;FT-0700131;X7498;D10365;W-5804;J-511428;[3-(4-Chloro-2-fluoro-benzyl)-2-methyl-8-morpholin-4-ylmethyl-imidazo[1,2-b]pyridazin-6-yl]-(5-methyl-2h-pyrazol-3-yl)-amine;3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine;N-{3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-yl}-5-methyl-2H-pyrazol-3-amine"	1229236-86-5	ANC71R916O	28934680	28934680	01/09/2017	28934680	01/09/2017	2013-2017		1	1	0	Yes	1					30/07/2018		10,9	38	NA	0	1	MYELOPROLIFERATIVE SYNDROMES	1	JAK2	0	1	0	NA	1	0	0	1	1	0,29	0	0	0	NA	0	0	0	0	0	0	0	0	1
Crizotinib	crizotinib	"Crizotinibum;Crizotinib;(R)-crizotinib;Xalkori"	"DB08865;DB08700"		"Crizotinib;877399-52-5;Xalkori;(R)-crizotinib;PF-2341066;PF-02341066;PF 2341066;crizotinibum;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine;PF 02341066;Xalkori (TN);UNII-53AH36668S;Crizotinib (PF-02341066);(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine;CHEMBL601719;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine;Crizotinib (PF-2341066);CHEBI:64310;53AH36668S;3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-AMINE;PF2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine;2-PYRIDINAMINE, 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]-;3-[(1r)-1-(2,6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Yl-1h-Pyrazol-4-Yl)pyridin-2-Amine;C21H22Cl2FN5O;Crizotinib [USAN:INN];2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-;3-((1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1h-pyrazol-4-yl)pyridin-2-amine;VGH;novel ALK inhibitors;PubChem19322;D03ZBT;SCHEMBL93829;PF-2341066,Crizotinib;Crizotinib (JAN/USAN/INN);PF-2341066(Crizotinib);GTPL4903;QCR-32;Crizotinib, >=98% (HPLC);PF-2341066 (Crizotinib);PF-2341066 - Crizotinib;CTK5F8952;AOB2688;EX-A096;SYN1139;KTEIFNKAUNYNJU-GFCCVEGCSA-N;MolPort-009-679-404;PF-02341066 (Crizotinib);BCPP000116;AMX10152;ABP000131;ANW-47749;BDBM50306682;NSC749005;ZINC35902489;AKOS015901233;AKOS015995207;DB08865;GS-6178;KIN0000318;NSC-749005;PB11015;RL05464;KS-0000075X;NCGC00250400-01;BC622990;EN002685;HY-50878;KB-26391;SC-48062;AB0027203;TX-017903;BB 0261738;FT-0665224;W9013;D09731;Q-3209;399P525;J-510370;BRD-K78431006-001-01-1;BRD-K78431006-001-03-7;I14-14837;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[;877399-52-5, 877399-53-6 (acetate);(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-am ine;3-(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy-5-1-(4-piperidinyl)-1H-pyrazol-4-yl-2-Pyridinamine;3-[(R)-1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine;912279-98-2;PF 2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine"	877399-52-5	53AH36668S	23598171	23598171	01/04/2013	20979469	01/10/2010	2009-2012		1	1	1	Yes	1	"11/03/2016 00:00;14/09/2015 00:00;24/02/2012 00:00;28/04/2017 00:00;07/02/2018 00:00;29/04/2016 00:00;24/01/2017 00:00;20/11/2013 00:00;17/02/2012 00:00;12/03/2013 00:00;26/08/2014 00:00;28/02/2013 00:00;28/05/2014 00:00;21/07/2017 00:00;13/09/2013 00:00;26/08/2011 00:00;20/03/2015 00:00;28/04/2016 00:00;07/10/2013 00:00;14/02/2014 00:00;07/12/2015 00:00"	AP	PF PRISM CV	CRIZOTINIB	26/08/2011	PF PRISM CV	10,8	82	NA	0	1	NSCLC_ALK_MUTANT	1	ALK	0	0	1	NA	1	0	0	1	0	0,57	0	1	1	0,9	0	0	0	0	0	0	701	0	1
Arsenic trioxide	arsenic	"Diarsenic trioxide;Arsenic oxide;Arsenous oxide anhydride;Arsenic Blanc;Acide Arsenieux;White arsenic;Anhydride Arsenieux;Arsenigen Saure;Diarsenic oxide;Arsenous oxide;Arsenic(III) oxide;Arsenolite;Trisenox"	"DB01169;APRD00171"	"A1010_SIGMA;17971_FLUKA;202673_ALDRICH;255483_ALDRICH;311383_SIAL;AIDS-059751;AIDS059751;Arsenous acid;NCGC00164639-01;arsenic trioxide;Arsenic(III) oxide;11099_FLUKA"		1327-53-3	S7V92P67HO	"23460318;17959855;16891241;11435292"	11435292	01/07/2001	10552940	01/11/1999	1999-2003		1	1	1	Yes	1	"07/01/2003 00:00;23/07/2010 00:00;03/10/2008 00:00;25/09/2000 00:00;12/01/2018 00:00;20/02/2015 00:00;13/06/2001 00:00"	"AP;TA"	"TEVA PHARMS;CEPHALON"	ARSENIC TRIOXIDE	25/09/2000	CEPHALON	10,8	58	NA	0	1	AML	1	PML_RAR	0	1	0	NA	0	0	0	1	1	0,85	0	1	1	NA	1	0	0	0	0	0	429	0	1
Ibrutinib	ibrutinib	"1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;Imbruvica"	DB09053		"Ibrutinib;936563-96-1;PCI-32765;IMBRUVICA;PCI 32765;PCI-32765 (Ibrutinib);UNII-1X70OSD4VX;PCI32765;CRA-032765;1X70OSD4VX;Ibrutinib (PCI-32765);CHEBI:76612;(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one;PCI-32765-00;A1-01649;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one;1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-;Ibrutinib [USAN:INN];ibrutinibum;JNJ 02;Imbruvica (TN);1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one;2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;Pc-32765;CRA 032765;Ibrutinib (JAN/USAN);Ibrutinib/PCI-32765;D09KTS;Ibrutinib (BTK inhibitor);Ibrutinib (PCI32765);Ibrutinib(PCI-32765);PCI-32765(Ibrutinib);MLS006010041;SCHEMBL201859;GTPL6912;CHEMBL1873475;HSDB 8260;EX-A066;MolPort-027-806-955;XYFPWWZEPKGCCK-GOSISDBHSA-N;AMX10219;AOB87789;KS-000002KE;ABP000965;BDBM50357312;ZINC35328014;AKOS022185476;ACN-030256;AN-1333;DB09053;EBD2165770;EX-5960;KIN0000174;QC-4573;NCGC00187912-01;NCGC00187912-02;NCGC00187912-03;AC-26942;AJ-91306;HY-10997;KB-79777;SC-96633;SMR004701213;AB0008168;AX8254580;FT-0696693;X7513;D10223;S-7810;J-523872;(R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-ylprop-2-en-1-one;1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2-propen-1-one;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one"	936563-96-1	1X70OSD4VX	"28714866;26588924;25381051;23782158"	23782158	01/06/2013	23045577	01/01/2013	2013-2017		1	1	1	Yes	1	"18/01/2017 00:00;16/02/2018 00:00;08/02/2016 00:00;13/11/2013 00:00;04/03/2016 00:00;25/11/2015 00:00;06/05/2016 00:00;28/07/2014 00:00;29/01/2015 00:00;21/03/2016 00:00;28/06/2016 00:00;12/02/2014 00:00;27/06/2016 00:00;02/08/2017 00:00;13/08/2015 00:00;24/08/2015 00:00;13/04/2016 00:00;20/12/2017 00:00;17/08/2015 00:00"	AP	PHARMACYCLICS INC	IBRUTINIB	13/11/2013	PHARMACYCLICS INC	10,4	56	NA	0	1	LNH_B	1	BTK	0	1	0	NA	0	0	0	1	0	0,6	0	1	1	NA	0	0	0	0	0	0	474	0	1
Depatuxizumab mafodotin	abt-414	Denintuzumab mafodotin	"DB11731;DB12315"			1585973-65-4	F3R7A4P04N	28349167	28349167	01/03/2017	29075855	01/10/2017	2013-2017		1	1	0	Yes	1					30/07/2018		9,9	66	80	0	1	GLIOBLASTOMA	1	EGFR	0	1	1	NA	1	0	0	1	1	0,07	0	0	0	NA	0	0	0	0	0	0	0	0	1
DTS-201	"doxorubicin prodrug;dts-201"		DB06071					29055839	29055839	01/10/2017	29055839	01/10/2017	2013-2017		1	1	0	Yes	1					30/07/2018		9,9	25	72	1	0	NA	1	TOPOISOMERASE	0	1	0	NA	0	0	0	0	1	NA	0	NA	0	NA	0	0	0	0	0	0	0	0	1
Cyanocobalamin	vitamin c	"Cyanocob(III)alamin;Vitamin B12 complex;Vitamin B12 NOS;Vitamin B12;Liqui B Complex Plus;Multiple Vitamins;Vitamine B12 250mcg;Multiple Vitamins & Minerals Tablets;Reno Caps;BiferaRx;Stress B Complex With C,e, Zinc and Copper;Stress B&c Tab;Prenate Essential;Multi-vitamins With Minerals;Vitamin B12 500mcg;Hormodausse Plus Calc Et D Tab;Multiple Vitamins Tab;Nutrifer Plus Tablets;Innersource Tab;Tandem OB;Multiple Vitamins and Minerals Capsules;Children's Chewable Multivitamin and Multimineral;Meplex T 750;Cyanocobalamin Injection, USP;FeRivaFA;Vitamin B12 Tab 100mcg;Right Choice A.M. Multi Formula - Caplet;Vitamin B Complex + C 300mg Cap;Tandem Plus;Chewable Multiple Vitamins for Children;Virt-Pn;Multivitamines Et Mineraux;Multi Vitamin & Minerals;Cyanocobalamin Injection USP 1000mcg/ml;C.R.D.-force;P.R.O. Complex;INATAL Ultra;Vita-B-75 Cap;Hi Potency B52 B Complex Tab;Multivitamines Pour Enfants (chewable Tablets);Avon Nutrivance Vitamin E Plus;Super Stress Capsules;Vimeral Tab;Vitafol Plus;Multi-phyto Capsules;American Eagle Energizer Plus Vitamin Supplement Drink;B Complex Plus C 300mg Tab;Vitamin B12 100mcg;Senior Multi One;Sopalamine/3b Tab;Enrich Core Pack - Children Vitamin and Mineral Supplement;Iron Vitamins B6,b12,c,folic Acid Tab;Prenatal Plus;PRENATE Enhance;Rubion 1000;Energy 80 Prolonged Release Tab;Ultra Enerforce;Multivitamins and Multiminerals Formula Regular Tablet;Multiple Vitamins With Minerals Tablets;Feminique W Iron and Calcium Tab;PNV Prenatal Plus Multivitamin;Vitamin B Compound Tab;Liqui Vita;Paramettes Syrup;Vitamin B Complex Plus 300mg Vitamin C;Vitamin B12 Cyanocobalamin Injection, USP 1000 Mcg/ml;B C Antistress Cap;Tini-cal Ampoules;Heparos Ampoules Buvables;Lipovitan;Prenate Star;Virt-Vite Plus;Vtb Vitamin and Mineral Supplement;Virt-Pn DHA;Sopalamine 3b Plus;Fortamines-10 Comprimes;Av-VITE FB;Replavite;Vitamin B Complex 100 Tab;Multivitamins and Minerals for Women;Multiple Vitamins - Tablet;Daily Balance Tab;Paramettes Multivits Plus Iron Tab (teens);Folet One;Kids Stuff With Iron Tablets;Alkadrenergy Tablets;Folic Acid With Vitamin B12 and Vitamin C;Neutral C + Coenzyme Q10 Plus Vitamins & Minerals;Phytopure;Tozal;Formula D.S.;Phosthenine Vitamines Et Fer (ampoules Buvable);Vitaday Tab;Vitamines Et Mineraux;Derma-force;Wellness Formula;Childrens Chew Multi Vitamin Tab;Poly Vi Flor Chewable Tab;Virt-PN Plus;Vitamin B12 250mcg;Kanga-V Multivitamins & Minerals;Iron Polysaccharides Folic Acid DHA;Hematogen Forte;Vitreat Chewable Vitamin Tab;TriAdvance;Kanga-B Vitamin B Group + C;Chewable Multiple Vit Plus Iron for Children;Children's Chewable Multiple Vit.plus Iron;Pregvit Folic 5;B6, B12 & Folic Acid;Chewable Multivitamins Plus Iron;Balanced B-50 Complex;Spectrum 2 Cap;Central-vite 18 Essential;Vitamin Deficiency Injectable System - B12;B12 Inject Kit;B-complex With Vitamin C, Biotin, Folic Acid;Vitamine Du Groupe B Plus Fer - Liq;FaBB Tablets;Multi-Vitamin Fluoride;Prenatal Vitamins Plus Low Iron;PreferaOB ONE;Stress Complex 600 Avec Vit E Cuivre Zinc;Stress Formula + Iron;Vitamine B-12 Tab 100mcg;B-12 Compliance;Isotonix Advanced B-complex Vitamins With Potassium and Magnesium;Beminal With C Fortis Cap;Gesticare DHA;Kc Vitamin and Mineral Supplement;PreQue 10;Multiple Vitamins With Iron;PreNatal Vitamins Plus;N.U.T. Complex;Puro Sang Tab 1mcg;Pregvit;Divista;Iron 25mg With Vit B-cmplx, Vit C, Cu & Mo;Vitamin B-12 With Folic Acid Tablets;Dialyvite;Stress Formula;Trinatal GT;Vitreat Chewable Vitamins Plus Iron;Multi Vitamines - Liq;Vitamin B12 Tab 250mcg;Mini-B Tab;L.C. Supplement;Pnv-dha;Vita-B;B Stress C + Iron & Vite;Iron Plus Tab;Pregvit Folic 4;Vitamin B12 Tab 5mcg;Forty Plus Vitamin Supplement;Nutrol-B-complex;Maximum Once A Day;C-force;50 Plus;FeRiva;NuFera;Multi #2;Red American Eagle Vitamin Supplement Drink;Formula Pro-B;Women's Change Formula;Super Vitalex Ampoule Buvable;Multiple Vitamins W Minerals Tab;P.N. Vitamin-mineral Drink;Cedevita Plus Vitamin Supplement;Childrens Chewable Multiple Vitamins W.iron;Multicaps;Vitamin B12 100 Mcg Tablets;MaxFe;Stresstabs + Zinc-copper;Cda-21 Vitamins With Non-medicinal Probiotic Complex;Mega Capsules;Kids Stuff Tablets;Animi-3;Vitamine B12 Tab 25mcg;Children's Chewable Multi-vitamin Complete With Minerals;Vitamin B12 Cyanocobalamine 500 Mcg;Fortamines 10 Capsules;Stress Tab With Iron and Vitamin E;Time Release B 100 Compound  -  Tablet;Femitab Tab;B-12 1000mcg Continuous Released Tab;Timed Release B-complex 100;Formula Hh;Tonicol Et A-D-C Ampoules/comprimes;Multiple Vitamin Tab;Animi-3 with Vitamin D;B-plus - Tab;Harvest Of Values All B Complex Tab;Multivitamines Plus Fer Pour Enfants (chewable Tablets);Nrg Plus Liq;Complete Mega B;PNV-First;Usana Megavitamin Tablets - Tab;Mega 13 Multivitamin Formula;V-Natal;Timed Release B Complex 100 Srt;B Complex With C 550mg;O-Cal FA multivitamin;C-Nate DHA;Stress Ctr Srt;Niferex;Prenate Pixie;Adult Infuvite Multiple Vitamins;Iferex 150 Forte;Vitafol Caplet;Se-Natal One;Stress Vitamin B With C Complex Tablets;Prenatal Plus Multivitamin Plus DHA MiniCaps;Tar-end;Menocal Tab;Extra Once A Day;Vitaday Junior Tab;PNV Prenatal Vitamin;Viva Kids - Tab;Multivitamin;Escavite;Feminex 300 Tab;Prenatal Formula Tab;Allbee C 800 Tab;Multiple Vitamin Plus Minerals Tab;Multi-12/k1 Pediatric;Mr. Tumee Multi-vitamin;One A Day Tab;B50 B Complex Tab;Swical-energy-2;Multi Vitamins & Minerals;Isotonix Multitech Vitamin Mineral Supplemen;Fib-C Melts;Multivitamine;Reaphirm Plant Source DHA;Children Choice Multivit Chewable Tab;Fortiplex;Iberet 500;Pour Ma Santé;Liqui B Complex;Balanced B50 Complex;B With C 500 Cap;Multivitamin Drops with Fluoride;Stress Formula Tab;Nestabs ONE;Se-Tan PLUS;Floriva Plus;Myferon 150 Forte;PrePLUS;G.A.S. Complex;Vitamin B Complex Suppl;One A Day Multiple Vit W Minerals;Lipo-B-C Tab;Lysamine Diet Supp Amp-tab;One-A-day Advance Fem - Tablets;B Vitamin Compound With B12 Thunas;Multivitamins for Children;Bugs Bunny Chew Multi Vit Plus Iron;Cedevita Sugar-free Vitamin Supplement;Multi-actin;Prenatal Mega Antioxidant;N.E.U. Complex;Hill.vite;PNV Ferrous Fumarate Docusate Folic Acid;B-100 Hi Potency B Vitamins Tab;Multi-Vit with Fluoride;Fusion Activator Formula Tab;Cyanocobalamine;Supravite Stress Avec Vit E Et Fer;Formula Cp Cap;B-100 Caps;Multivitamins W Minerals Extra Strength;Strovite Forte Caplet;Complete Multivitamins and Minerals for Children;Multi-vitamin Dietary Supplement;PreTAB;Children's Chewable Multiple Vitamins - Tab;Se-Natal 19 Chewable;B-12 1000 Inj 1000mcg/ml;Floriva;BioFerr 90;Multi Vite Liq Junior;Zoo Chews;Formula Ch. Les.;Vitafer - Liq;PreferaOB One;Multi Vitamin Drops with Fluoride;Virt-Bal DHA Plus;Liqui Infant Vitamins;Vigem 12 Liquid;B-50 Hi Potency B Vitamins Tab;Children Choice Multivitamin W Iron Chew Tab;Flintstones Multiple Vitamins;Niron Komplete;Prenatal Vitamins Plus;Prenatal Plus Iron;VP-HEME One;Hematogen FA;Formula Gly;Aj-cyanocobalamin;Liquid B Complex 50;Mvc;PreNatal 19;Z Bec Tab;Fortaplex Inj;H. Formula - Tab;Super Daily No 2;Multisol;Vitogen B Stress C Vit E Zinc & Cop;Alphaligo;Multi-12 Pediatric;Vitamin B12 250mcg Tablets;Dia-vite;Multi Nt-OX;Folbic;Formula Int;Glyco-aide Tab;Vitamin B12 Plus Tablets W Folic Acid;B-plex;B-complex 100;B 50 Capsules;Cyanocobalamin;Hematogen;Hemetab;Multra With Iron;Vitafol OB Caplet;Vita-worth B-complex Tablets;E.S.T. Complex;Stress Tab With Zinc, Copper and Vitamin E;Cataplex B12 Tab 6mcg;Tricare Prenatal;Surbex 500 Filmtab;Vitamin B 12 Tab 25mcg;Body Rox;Golf Vitamin and Mineral Supplement;FeRiva FA;Low Potency B Complex Tab;Multi-vitamines Enfants Comprime;Stress Formula Multi-B Comp + 500mg Vit C Cap;Diaplex;Vitogen Multiple Vitamins W Iron;Multiple Vitamins and Minerals Tab;American Plus Energy & Vitamin Drink;Multi-vitamins;Vitamin B Complex W C Tab;C-B Complex;Century Complete;Supravite Stress Avec Vit E;Vitamines Et Mineraux Enfants 970;B-complex Tablets;Stress Formula B-comp + 500mg Vit C Tab;Toni Com Liq;Vitamin B + C Cap;Childrens Chewable Multiple Vitamins;Cobex Inj 1000mcg/ml;Vitamin B Complex W C 300mg Tab;Essential B Tablets;Iron Plus Manganese, B12, Folic Acid & C;Children's Chewable Multi Vitamins With Iron Tablets;Pediatric Infuvite Multiple Vitamins for Infusion;B-100 Complex Tablets;Complexe B-75;Children's Vitamins Chewable;P.N.P. Vitamin Drink;Chew.multiple Vits.with Extra C for Children;Vit B Complex Plus Vit C 550mg;Balanced B-100 B-complex Vitamins Tab;Livron Plus Tab;Sun-rype Vitaburst;Ferralet 90;NataFort;Complexe B 75mg;Maxi 10 Tab;Concept DHA;Bev 29 Tab;Multi B;Advanced B & T Formula;Balanced B100;Vitamine B12  25 Mcg  -  Tablet;For Kids Only Chewable Multivit. Plus Iron;Insur-all Vitamin Supplement;Kindervites;Multivitamin with Fluoride;B Complex W C Forte Cap;Prevital Tab;Multivitamins and Minerals for Young Women;Chromagen;Calcium Folic Acid Plus D Chewable;M.V.I. Adult;Stress B-complex Plus Iron With Vitamins C&e;Biovim Tab;Vitamin B12;B-complex 50;PureVit DualFe Plus;Hi Potency Stress B Tension With C;Hemarexin Tab;Total Living Concepts Formula One - Tab;B-complex-50 Tab;Prenatal, DHA;Viamon Ampoules Et Comprimes;O-Cal Prenatal Vitamin;Vitamin B Complex Tab;Reebok;Fem - Control;Vit B Complex Ctr;Inatal Advance;Polymine Avec Zinc Et Cuivre;Chewable Multiple Vitamins Tab;Revival 1 Tab;Vitamin B12 Srt 1000mcg;Vitamin B6 & B12 With Folic Acid;Vitalife  -  Capsule;B Complex Tablets;Revit Plus Cap;Se-Natal 19;PNV Prenatal Vitamin Plus Vitamin A;Trace Minerals Et/and B12 Tab;Tricon;Children's Chewable Multi-vitamin;Jamp-cyanocobalamin;Multi Vitamin with Fluoride;Active FE;Childrens Multiple Vit and Min Chew Tab;Myhephron Dialysis and Stress Supplement;Vita Plex Tab;Vitamin B Complex 50;Vitafol One;Vit B12 Tab 500mcg;Chewable Multiple Vitamins Plus Extra C;Sopalamine/3b Plus C;B Virol;Chewable Multiple Vitamins Plus Iron Tab;Neo Bex Elixir;Childrens Chewable Vitamin Tab;24 Multivitamins + Minerals;Multivit Et Fer Ampoules Et Comprimes;B50 Complex;T.R.I. B-plex Src;Multi Vitamin - Mineral;M.V.I. Paediatric;Balanced B 125 Srt;Childrens Chewable Multivitamins;Folic Acid-b12 Tab;Multi - N.T.O.x Formula - Tab;Multivitamines Et Mineraux Junior Regulier;Multivitamins W Iron;Vitamine 110 Liq;Somarexin and C 1000;Stress Formula Vit B With C Complex;B Complex With C 300mg;Concept OB;L.I.P. Complex;Children's Chewable Multiple Vitamins With Extra Vitamin C (chewable Tablets);B-complex Tab;Stress B With 1000 Mg Vitamin C;Tl-hem 150;Iron With Vitamins Tab;Multiple Vitamins Plus Iron Tab;PNV-Omega;Fizz Multivitamins for Kids W C Loz;B Complex 50 Vitamin Cap;Multivitamines Et Mineraux Reguliers / Regular Multivitamins and Minerals;Multivitamins and Minerals for Young Men;Vitamin B Compound W C Tab 500mg;Phytoplex B Liq;B12 250mcg Cyanocobalamin;Children's Chewable Multi Vitamins;Pediatric Infuvite Multiple Vitamins;Palm Springs Multvit and Min Tab;Stress Forte Plus Lipotropic Factors;Super Charged Energy;Multi-11;Vita Day Tab;Vitamin B12 Tab 25mcg;Crystalline Vitamin B12-liq Im Sc 1000mcg/ml;Mvc 9 Plus 3 Inj;B-50 Complex;Everyday Multiple Vitamins;Formula Lf;Supravite 10ml Ampoule;Beminal Fortis Elx;Kanga-kid Vitamins & Iron;Multi Vite Liq Adult;C.E.b12 Complex Pwr;Vitamin B Compound W Vit C 250mg Tab;Vitamin B12 Tab 500mcg;Renal Caps Dialysis/Stress Vitamin Supplement;Carbassist Tablets;One A Day Advance Adults 50+;Cyanocobalamin Injection USP;Balanced B-50 B-complex Vitamins Tab;Vege 1 Daily Tab;Vitafol Ultra;Multiple Vit Plus Iron Tab;B6, B12 & Folic Acid Multi-vitamin Tablets;MVC-Fluoride;Hypo Vites Tab;B12 1000mcg;Prenate AM;Multiple Vitamins Plus Iron for Women;Onccor;Hi Potency B Complex W Chelated Minerals;Prenate Elite;Stress B Complex With C, E & Iron;Formula Statin Support;Vitogen Multiple Vitamins Tab;B Complex W Vit C W Non-med Yeast&liver Tab;Folic Acid Plus;High Potency Vitamin B Complex + C Tab;Rubramin 1000mcg/ml;Multi Vitamin and Fluoride;Children's Vitamins W Iron Chewable;Complex-75;CitraNatal Bloom;Gsf Tab 24mcg;Multi Vitamin-mineral Formula;Super-pote Vitamin Supplement;Multi Rol;Flexadyn Tab;Bacmin;Virt-Caps;Leritone Junior;Kid's Choice Children's Chewable Vitamins - Tab;Sibergin B - Cap;Multivitamins and Minerals With Betacarotene Tablets;Multivitamins and Minerals - Complete;Supravite C 1000;Nephrocaps;Maltlevol 12 Liq;50 Plus Multiple Vitamins & Minerals;Alsimine W Vitamins A D;Kanga Sport Vitamins B & C Plus Minerals;Mvc 9+4 Inj;Chela-chromium 200;Supravite Bouteille 250ml;Daily Energy Brand B-complex;Multivitamin with fluoride;C. Vit-min Formula;Multi-Vitamin With Fluoride;Flinstones Multiple Plus Iron;Hi Potency Balanced B-100 Complex - Tab;Vitamin B-12 500 Mcg  -  Tablets;Childrens Chewable Vitamins;Multi Vitamin Infusion;Deriton;Children's Chewable Tab;Zoo Chews Plus Iron;Children's Chewable Multi Vit W Iron;Vitamin B Compound With Vitamin C Fortis Capsule Dtc;Iron, Vit & Min Supp;Vitamin B Complex + C 600mg Tab;Vitogen B Stress C600;Foltabs 800;B Complex 50+ Caplet;B Compound 50mg Tab;Vita-folic-B Caps;Vitamine B12 Tab 3mcg Chewable;Livron Plus Ampoule;Vitamin B12 Cap 500mcg USP;Multi-Vitamin;Multitabs;Kanga-kid Multi-vitamin & Mineral;Timed Release B-complex 50;Am Caps;Childrens Chewable Multiple Vitamins Plus Fe;Stressmates;Flintstones Multiple Vitamins Plus Iron;Formula Cn;Mynephrocaps Dialysis/stress Vitamin Supplement;Orange Flavored Crystal Chews Tab;Revitex Ampoules Et Comprimes;Multiple Vitamins Plus Iron - Tab;Vitabanks Vitamin Tab;Super Pantoplex;Phytofortis + Calcium A-D;B-complex;Complexe B Compose 75;Infuvite Adult Multiple Vitamins;Virt-Vite;Vitamin B12 500 Mcg;Multivit-liq;Multi Vitamin Plus Iron;Only One - Tablet;Children's Chewable Multiple Vitamins With Iron Tablets (chewable Tablets);Childrens Chewable Multiple Vitamins Tab;B Complex 25mg Vitamin Supplement;Nascobal;PM Caps;Bio-b12;Vit B12 Ctr Srt 1200mcg;Supravite Stress Avec Vit E Cuivre Et Zinc;B Complex W C and B12 Inj;Flintstones Multiple Vitamins Tab;Vitamin B12 Inj 100mcg/ml;Natavite;Super Stress Mega B Plus 1000mg Vit C Tab;Bev B-150;Efferlife Multivitamins and Minerals;Forphyll 3mcg;Vitachrom Gc;Q.T. Vitamin and Mineral Drink Mix;Mangadyn;Sveets;Balanced B-50 B-complex Vitamins, Timed Rele;Ez-flex;M.V.I. 12;Extra P.N. Vitamin-mineral Drink Mix;Stress Formula Multivitamin Tablets USP;Stress B Complex With C, E and Iron Tab;Vitamin B12-folic Acid;Daily Supplement Packs;Multi Tabs;M.V.I. Pediatric;Surbex-500 With Iron;Everyday Multiple Vitamins With Iron;Premium Prenatal;Vital Be-100;FE C Tab Plus;Gestamine Comprimes;Enviroflex - Tab;Flintstones W Extra C Tab;Nutrilite Double X;Stress Tab;Bedoz 1000inj;Cool B;Scheinpharm B12 Injection;Multiple Vitamins With Iron Tablets;Vitaplex;Vita B + C 500 Tab;Mor-vites Tab;Folcaps;Childrens Chewable Multivitamins W Iron;Vitamin B-12 Tablet;Multi Enfants Tab;Spd Tab;Vitamin B12  50mcg Tab;Multi 12 Injection;One A Day Advance Fem;PNV-Select;B Complex W Vitamin C Fortis Cap;One A Day Advance Adults;Isotonix Vitamin B-folic Acid-mineral Supple;Surbex-500 With Zinc;Vitamines Et Mineraux Comprimes;Dynam Ampoule Et Tablet;Ply Vi Sol Chewable Tab;Vitaflex Dietary Suplement;Multivitamins and Minerals for Men;Vitogen B Compound W C Fortis Capsules;Nata Komplete;Foltrate;Homosistrox Capsules;Stress B Complex With C and E Tab;Natural Source Spectrum With Beta Carotene;Vitamin B12 Inj 1000mcg/ml;Super B Compound W 500mg Vit C;Homosistrol Capsules;Floravit - Syr;Vitamin B12 100 Mcg;Women's Formula;Earthpals Children's Chewables Multi-vitamin & Mineral Tablets;Super B12 + Folic Acid;PRENATE Restore;Vitamin B12 Tablets 250mcg;Super Kids Chewable Multivitamin Multimineral (chewable Tablets);Orti B;Chewable Multivitamins;Vita B Complex Tab;For Kids Only Chewable Multivitamins - Tab;Vitafol Nano;Stress B Capsules With Vitamin C;Oncovite;Balanced B-complex Vit + Vit C&e Tab;Premium Prenatal - Tablets;B-50 Complex Tab;Vitamin B12 (cyanocobalamin) 1000mcg Caplet;Bugs Bunny and Friends Multiple Vitamins;Children's Chewable Multiple Vitamins (chewable Tablets);Vitamin B Tablets;Vitamin B12 1000 Mcg"	"DB00115;NUTR00004;APRD00326;EXPT00965"	"Prestwick_564;Cyanocobalamin"	"vitamin B12;cyanocobalamin;cobalamin;68-19-9;Crystamine;Anacobin;Berubigen;Cobavite;Depinar;Nascobal;Redisol;Vibisone;Cyomin;BEROCCA PN;Rubramin PC;Vi-Twel;RUBRATOPE-60 KIT;Vitamine B12;RUBIVITE;RUVITE;DSSTox_CID_24346;DSSTox_RID_80159;DSSTox_GSID_44346;Vitamin B12 complex;cyanoject;Dicopac;Bedoz;Primabalt;Shovite;Vibal;C63H88CoN14O14P;Neuroforte-R;Cobolin-M;CAS-68-19-9;CYANOCOBALAMIN 0.1% IN MANNITOL;NCGC00016302-01;Prestwick_564;Vitabee 12;Crysti-12;0.1% Cobalamin Concentrate Trituration w/Mannitol;DTXSID7044346;MolPort-016-633-264;Cyanocobalamin;Cyanocob(III)alamin;HMS1569G08;HMS2096G08;HMS3713G08;Tox21_110358;Tox21_113664;AKOS015894306;Cobalamin;vitamin B-12;Cyanocobalamin;CCG-220433;NCGC00249888-01;H486;AB2000361;V0344;13408-78-1;alpha-(5,6-Dimethylbenzimidazolyl)cyanocobamide;Cobinamide,dihydrogenphosphate(ester),inner salt,3'-ester with(5,6-Dimethyl-1-a-d-ribofuranosyl-1H-benzimidazole-kn3),ion(1+)(9ci)"	68-19-9	P6YC3EG204	25848948	25848948	01/04/2015	20282179	01/10/1946	Bef. 1989		0	0	1	No	0	"08/08/1985 00:00;05/08/1994 00:00;13/07/2013 00:00;17/01/1983 00:00;15/01/2009 00:00;05/12/1989 00:00;17/06/2015 00:00;03/12/2013 00:00;20/10/1971 00:00;26/02/1998 00:00;23/05/2016 00:00;15/09/1949 00:00;16/09/1985 00:00;02/12/2015 00:00;03/03/1981 00:00;31/03/1994 00:00;02/08/1999 00:00;02/10/2015 00:00;17/01/1986 00:00;09/04/1996 00:00;16/10/1998 00:00;17/06/1983 00:00;28/11/1989 00:00;16/12/1998 00:00;05/06/2017 00:00;16/11/1978 00:00;25/05/1999 00:00;08/01/1999 00:00;12/05/1981 00:00;09/07/1973 00:00;12/05/1978 00:00;03/02/2015 00:00;05/04/1990 00:00;21/02/2001 00:00;14/10/1987 00:00;14/11/2002 00:00;23/01/2014 00:00;29/08/1986 00:00;06/04/1983 00:00;25/06/2001 00:00;02/02/1999 00:00;20/10/1988 00:00;22/08/2006 00:00;01/02/1985 00:00;30/09/1985 00:00;13/08/1999 00:00;24/06/2015 00:00;28/02/1996 00:00;27/06/2013 00:00;20/09/1972 00:00;06/09/2013 00:00;30/03/1998 00:00;29/01/2004 00:00;26/08/1980 00:00;14/07/1995 00:00;17/09/2004 00:00;03/02/1993 00:00;15/11/2012 00:00;14/05/2001 00:00;10/02/1999 00:00;10/04/2001 00:00;12/02/2003 00:00;26/05/1995 00:00;18/05/2000 00:00;30/05/1978 00:00;03/02/1983 00:00;08/12/1986 00:00;27/07/1977 00:00;15/04/1991 00:00;01/07/2014 00:00;02/06/1995 00:00;29/01/1974 00:00;03/08/1988 00:00;31/07/1985 00:00;30/10/1997 00:00;05/12/2008 00:00;22/04/2004 00:00;15/09/2006 00:00;21/03/1994 00:00;25/04/1985 00:00;21/12/1970 00:00;18/02/2004 00:00;14/06/2002 00:00;06/08/1986 00:00;22/09/1997 00:00;28/09/1990 00:00;23/11/1994 00:00;14/10/1994 00:00;16/08/1982 00:00;14/06/2012 00:00;29/07/1992 00:00;24/12/1996 00:00;22/06/1989 00:00;04/09/2014 00:00;09/07/2002 00:00;15/02/1977 00:00;25/04/2016 00:00;27/06/2002 00:00;03/11/1986 00:00;11/09/2000 00:00;12/11/1991 00:00;11/05/1981 00:00;31/01/2005 00:00;19/04/1991 00:00;04/12/2012 00:00;16/07/1998 00:00;21/12/1988 00:00;28/07/1947 00:00;16/02/1984 00:00;03/11/1989 00:00;12/04/2000 00:00;02/11/2000 00:00;20/09/1984 00:00;30/11/2001 00:00;04/09/2013 00:00;14/07/2014 00:00;11/06/2015 00:00;04/06/2002 00:00;17/03/2016 00:00;17/05/1982 00:00;06/08/1979 00:00;21/08/2003 00:00;10/09/1986 00:00;22/02/1993 00:00;04/11/1993 00:00;04/01/2016 00:00;21/06/1968 00:00;01/11/1993 00:00;26/09/1997 00:00;26/10/2015 00:00;25/03/1998 00:00;21/09/2000 00:00;05/11/1996 00:00;29/05/2013 00:00;19/11/1999 00:00;08/11/1979 00:00;02/02/1993 00:00;15/12/2008 00:00;11/03/1983 00:00;26/04/1989 00:00;24/03/2009 00:00;20/06/1973 00:00;17/09/1996 00:00;17/04/2001 00:00;06/07/1984 00:00;30/10/2014 00:00;05/06/2001 00:00;06/06/2014 00:00;14/05/1985 00:00;09/09/2004 00:00;30/01/2004 00:00;11/12/2015 00:00;21/01/2015 00:00;28/11/1995 00:00;27/02/1996 00:00;22/02/1980 00:00;09/05/1989 00:00;11/06/2014 00:00;26/03/2013 00:00;04/05/2000 00:00;10/06/1974 00:00;13/07/1982 00:00;10/07/2002 00:00;22/06/1999 00:00;15/06/1983 00:00;04/12/1996 00:00;10/12/1996 00:00;18/11/1998 00:00;29/09/1950 00:00;27/01/1983 00:00;18/09/2015 00:00;22/01/1980 00:00;11/11/2014 00:00;24/01/1977 00:00;26/06/2001 00:00;13/02/1997 00:00;13/07/2004 00:00;03/10/2001 00:00;04/08/1977 00:00;29/05/1984 00:00;27/07/2007 00:00;03/12/1986 00:00;21/11/1978 00:00;05/05/1986 00:00;18/11/1993 00:00;07/04/1982 00:00;15/12/1983 00:00;27/10/1995 00:00;16/06/2003 00:00;26/04/1972 00:00;20/07/2001 00:00;24/11/2009 00:00;18/10/1995 00:00;08/12/2011 00:00;31/12/1997 00:00;27/10/2000 00:00;14/07/1958 00:00;30/07/1993 00:00;15/05/1985 00:00;21/03/1973 00:00;19/01/1996 00:00;12/09/1979 00:00;01/10/1984 00:00;12/05/1998 00:00;08/09/1997 00:00;14/07/2005 00:00;29/12/1993 00:00;19/02/1999 00:00;23/09/2003 00:00;20/02/1953 00:00;01/12/1971 00:00;19/01/1979 00:00;07/12/1990 00:00;13/10/1976 00:00;13/06/2001 00:00;12/04/1974 00:00;19/03/2013 00:00;16/01/1991 00:00;09/07/1984 00:00;24/04/1985 00:00;23/06/1980 00:00;03/04/1989 00:00;17/12/2008 00:00;24/02/1993 00:00;09/11/2017 00:00"	AP	"MALLINCKRODT;ROCHE;ARMOUR PHARM;BRACCO;ACCORD HLTHCARE;LYPHOMED;BEL MAR;FRESENIUS KABI USA;MYLAN LABS LTD;WEST-WARD PHARMS INT;ENDO PHARMS INC;SOMERSET THERAPS LLC;BRISTOL MYERS SQUIBB;WEST WARD;WATSON LABS;SANDOZ INC;SANOFI AVENTIS US;BAYER HLTHCARE;LILLY;GE HEALTHCARE;LUITPOLD;MYLAN INSTITUTIONAL;HOSPIRA;PAR PHARM;WYETH AYERST"	" VITAMIN A;COBALT CHLORIDE CO-57; CHOLECALCIFEROL; TANNIC ACID; PYRIDOXINE HYDROCHLORIDE;CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; DEXPANTHENOL; ZINC ACETATE; INTRINSIC FACTOR; VITAMIN E; TOCOPHEROL ACETATE; RIBOFLAVIN; VITAMIN K; CYANOCOBALAMIN; ASCORBIC ACID; CYANOCOBALAMIN CO-60;ASCORBIC ACID; BIOTIN; NIACINAMIDE; THIAMINE HYDROCHLORIDE; ERGOCALCIFEROL; PANTOTHENIC ACID; FOLIC ACID; THIAMINE;ALPHA-TOCOPHEROL ACETATE;COBALT CHLORIDE CO-60; PYRIDOXINE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; CYANOCOBALAMIN CO-58; VITAMIN A PALMITATE; PHYTONADIONE"	28/07/1947	ROCHE	9,8	#N/A																							0						1
Brentuximab vedotin	"brentuximab;brentuximab vedotin;sgn-35"	"cAC10-vcMMAE;Adcetris"	DB08870			914088-09-8	7XL5ISS668	"27354476;27115790;24814862;23754575;23719719"	23719719	01/05/2013	21047225	01/11/2010	2009-2012		1	1	1	Yes	1	"19/08/2013 00:00;19/08/2011 00:00;23/11/2014 00:00;09/11/2017 00:00;13/01/2012 00:00;04/03/2016 00:00;28/09/2016 00:00;20/03/2018 00:00;17/08/2015 00:00"	AP	SEATTLE GENETICS	BRENTUXIMAB VEDOTIN	19/08/2011	SEATTLE GENETICS	9,5	45	NA	0	1	"HL;ANAPLASTIC LARGE CELL LYMPHOMA"	1	CD30	0	1	0	NA	1	1	0	1	1	0,86	0	1	1	0,86	0	0	0	0	0	0	353	0	1
Tazarotene	tazarotene	"Tazarotene;Tazarotenum;Tazaroteno;Tazorac;Tazarotene;Fabior;Avage"	"DB00799;APRD01246"	"ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate;6-[2-(4,4-dimethyl-6-thiochromanyl)ethynyl]-3-pyridinecarboxylic acid ethyl ester;6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinic acid ethyl ester;118292-40-3;D01132;Tazarotene (JAN/USAN/INN);C12531;ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate;AGN-190168;Suretin;Tazoral;3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester;AGN 190168;Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;TAZAROTENE;Tazarotene [USAN:INN];Tazorac;Zorac;Avage;Avage (TN)"	"tazarotene;118292-40-3;Tazorac;Zorac;Avage;Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;AGN-190168;Fabior;Tazarotene [USAN:INN];Tazarotene (Avage);tazaroteno;tazarotenum;Suretin;Tazoral;AGN 190168;Zora;UNII-81BDR9Y8PS;Tazorac (TN);C21H21NO2S;Avage (TN);81BDR9Y8PS;CHEMBL1657;Tazarotene (JAN/USAN/INN);CHEBI:32184;OGQICQVSFDPSEI-UHFFFAOYSA-N;3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester;NCGC00167525-01;ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate;ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]nicotinate;DSSTox_CID_26691;DSSTox_RID_81825;ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate;DSSTox_GSID_46691;Q-102516;ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate;3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-,ethyl ester;CAS-118292-40-3;Acnitaz;ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)-ethynyl)nicotinate;Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl]nicotinate;Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate;Tazarotene [USAN:INN:BAN];Zorac|||Tazorac;Tazarotene,(S);Fabior (TN);Zorac (TN);PubChem24431;Tazorac;Avage;Zora;Avage;D0BM5G;SCHEMBL3134;MLS003915630;BIDD:GT0293;AC1L1K88;GTPL6952;DTXSID5046691;CTK8B4490;MolPort-005-932-693;Tazorac, Avage, Zora, Tazarotene;HMS3655K05;ACT06773;EBD38650;ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate;ZINC1542199;Tox21 112522;Tox21_112522;ABP000994;AC-755;ANW-45265;BDBM50265951;s1569;AKOS015902872;Tox21_112522_1;BS-1012;CS-1029;DB00799;RTR-034197;NCGC00167525-02;NCGC00167525-03;4CA-1215;6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester;AJ-26850;AN-15540;BC201578;BR-73028;CC-34651;CJ-24315;HY-15388;KB-80817;SC-19506;SMR002096194;BCP0726000163;AB0012671;AB2000146;AX8041205;LS-130838;ST2419369;TR-034197;FT-0652578;C12531;D01132;S-7551;15146-EP2275420A1;15146-EP2295055A2;15146-EP2295416A2;15146-EP2298748A2;15146-EP2298764A1;15146-EP2298765A1;15146-EP2298768A1;15146-EP2305642A2;15146-EP2308861A1;15146-EP2311453A1;15146-EP2311808A1;15146-EP2311829A1;15146-EP2314590A1;15146-EP2316832A1;15146-EP2316833A1;AB01274801-01;AB01274801_02;292T403;C-23771;SR-01000931253;I14-1992;SR-01000931253-2;6-(4,4-Dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester;6-(4,4-dimethylthiochroman-6-ylethynyl) nicotinic acid ethyl ester;Ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]pyridine-3-carboxylate;6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-pyridinecarboxylic Acid Ethyl Ester;6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester;6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylicacidethylester;Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;6-(4,4-dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester"	118292-40-3	81BDR9Y8PS	12942109	12942109	01/08/2003	9035703	01/10/1996	1994-1998		1	0	1	No	0	"13/12/2013 00:00;16/04/2018 00:00;21/07/2017 00:00;25/02/2011 00:00;16/09/2016 00:00;03/04/2017 00:00;11/10/2001 00:00;29/09/2000 00:00;11/05/2012 00:00;02/12/2003 00:00;30/09/2002 00:00;22/12/2017 00:00;17/06/1999 00:00;13/06/1997 00:00"	AP	"ALLERGAN;MAYNE PHARMA;TARO PHARMS;G AND W LABS INC"	TAZAROTENE	13/06/1997	ALLERGAN	8,4	#N/A																							0						1
Osimertinib	"azd9291;osimertinib"	"N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide;Mereletinib;Tagrisso"	DB09330		"AZD-9291;1421373-65-0;osimertinib;AZD9291;Mereletinib;Tagrisso;AZD 9291;UNII-3C06JJ0Z2O;3C06JJ0Z2O;osimertinib mesilate;N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;Mereletinib [INN];Osimertinib [USAN];Tube720;D0RT2C;mereletinib (obsolete INN);GTPL7719;CHEMBL3353410;SCHEMBL14660911;CHEBI:90943;AOB6268;EX-A314;DUYJMQONPNNFPI-UHFFFAOYSA-N;MolPort-035-395-886;C28H33N7O2;HMS3653E10;KS-000007ZW;ABP001123;BDBM50029668;s7297;ZINC98023177;AKOS025290756;CS-2018;DB09330;2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-;4CA-0243;AC-29019;AK170511;AS-16943;HY-15772;QC-11454;SC-94470;KB-330516;FT-0696828;X3507;Mereletinib pound AZD-9291 Osimertinib pound(c);1610419-47-0;N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide;N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide"	1421373-65-0	3C06JJ0Z2O	"27226351;25923549"	25923549	01/04/2015	25923549	01/04/2015	2013-2017		1	1	1	Yes	1	"12/08/2016 00:00;30/03/2017 00:00;13/11/2015 00:00;28/09/2016 00:00;10/02/2016 00:00;31/10/2017 00:00;18/04/2018 00:00"	AP	ASTRAZENECA PHARMS	OSIMERTINIB MESYLATE	13/11/2015	ASTRAZENECA PHARMS	7,4	253	NA	0	1	NSCLC_EGFR_MUTANT	1	EGFR	0	1	1	222	1	0	0	1	0	0,61	0	0	0	NA	0	0	0	0	0	0	627	0	1
Propylthiouracil	propylthiouracil	"2-Thio-6-propyl-1,3-pyrimidin-4-one;2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone;Propylthiouracil;2-Thio-4-oxo-6-propyl-1,3-pyrimidine;Propylthiouracile;2-Mercapto-6-propylpyrimid-4-one;6-Thio-4-propyluracil;Propylthiouracilum;6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one;Propiltiouracilo;2-Mercapto-6-propyl-4-pyrimidone;6-Propylthiouracil;4-Propyl-2-thiouracil;6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione;Apo-propylthiouracil;Propylthiouracil;Propyl-thyracil;PMS-propylthiouracil"	"DB00550;APRD00297"	"6-propyl-2-sulfanylidene-1H-pyrimidin-4-one;6-propyl-2-thioxo-1H-pyrimidin-4-one;500-50-5;51-52-5;SPECTRUM1500515;NCGC00090881-02;NCGC00090881-03;ZINC00001994;Propyl-Thiorist;Propyl-Thiorit;Propyl-Thyracil;Prothiucil;6-propyl-2-sulfanylidene-1H-pyrimidin-4-one;Prothycil;NINDS_000268;KBio3_002622;MLS000028494;SMR000058275;Prestwick2_000494;Spectrum3_001731;6-(n-Propyl)-2-thiouracil;AIDS-081839;AIDS081839;C07569;Propylthiouracil;ZINC03860490;DivK1c_000268;Prestwick0_000494;Spectrum_000876;IDI1_000268;Spectrum5_001815;4-Hydroxy-2-mercapto-6-propylpyrimidine;46698_RIEDEL;SBB003855;ST5324191;BSPBio_003402;SPBio_002308;Spectrum2_001302;InChI=1/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11;Prestwick1_000494;SPBio_001363;KBioSS_001356;BPBio1_000427;2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone;6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one;6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one;CHEBI:8502;2-Thio-4-oxo-6-propyl-1,3-pyrimidine;KBio1_000268;BSPBio_000387;4-Propyl-2-thiouracil;Prestwick3_000494;6-Propyl-2-thiouracil;6-Propylthiouracil;6-Thio-4-propyluracil;6-n-Propyl-2-thiouracil;6-n-Propylthiouracil;NSC6498;PTU (thyreostatic);Procasil;Propacil;Propycil;D00562;Propylthiouracil (JP15/USP/INN);KBio2_001356;Propylthiorit;KBio2_003924;Prothiurone;KBio2_006492;Prothyran;Protiural;Thiuragyl;Thyreostat II;Uracil, 6-propyl-2-thio-;WLN: T6MYMVJ BUS F3;Spectrum4_000492;T0517-6237;Prestwick_810;2-Mercapto-4-hydroxy-6-n-propylpyrimidine;2-Mercapto-6-propyl-4-pyrimidone;NCGC00090881-01;2-Mercapto-6-propylpyrimid-4-one;Propiltiouracilo [INN-Spanish];2-Thio-6-propyl-1,3-pyrimidin-4-one;P3755_SIGMA;CAS-51-52-5;NCGC00016229-01;NSC70461;6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione;Propylthiouracil (TN);KBioGR_001003;NCGC00022715-03;6-Propil-tiouracile [Italian];6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione;AI3-25477;CCRIS 544;EINECS 200-103-2;HSDB 3390;NSC 6498;PROPYL THIOURACIL;Propilthiouracil;Propiltiouracile [DCIT];4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-;Propylthiouracil [BAN:INN:JAN];Propylthiouracile [INN-French];Propylthiouracilum [INN-Latin];Propythiouracil"	"propylthiouracil;51-52-5;6-Propyl-2-thiouracil;Propacil;Prothiurone;Prothyran;Procasil;Propycil;Prothiucil;Protiural;Thiuragyl;Prothycil;2-Mercapto-6-propylpyrimidin-4-ol;Propyl-Thiorist;Propyl-Thyracil;6-N-Propylthiouracil;Propythiouracil;Propilthiouracil;Propyl-Thiorit;Propylthiorit;6-Propylthiouracil;Propylthiouracile;Thyreostat II;Propiltiouracilo;6-N-Propyl-2-thiouracil;6-Thio-4-propyluracil;6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one;PTU (thyreostatic);Propylthiouracilum;4-Propyl-2-thiouracil;2-Mercapto-6-propyl-4-pyrimidone;6-Propil-tiouracile;Propiltiouracile;Uracil, 6-propyl-2-thio-;2-Thio-6-propyl-1,3-pyrimidin-4-one;2-Thio-4-oxo-6-propyl-1,3-pyrimidine;Propiltiouracile [DCIT];2-Mercapto-6-propylpyrimid-4-one;4-Hydroxy-2-mercapto-6-propylpyrimidine;2-Mercapto-4-hydroxy-6-n-propylpyrimidine;2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone;6-Propil-tiouracile [Italian];Propiltiouracilo [INN-Spanish];PROPYL THIOURACIL;Propylthiouracile [INN-French];Propylthiouracilum [INN-Latin];4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-;thyreos tat ii;ptu(thyreostatic);NSC 6498;6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione;CCRIS 544;CHEBI:8502;UNII-721M9407IY;Propylthiouracil (TN);HSDB 3390;Propylthiouracil [INN:BAN:JAN];6-propyl-2 thiouracil;6-propyl-2-sulfanylidene-1H-pyrimidin-4-one;6-Prop yl-2-thiouracil;thyreostat propyl-thyracil;EINECS 200-103-2;6-(n-Propyl)-2-thiouracil;AI3-25477;MLS000028494;KNAHARQHSZJURB-UHFFFAOYSA-N;6-propyl-2-sulfanylpyrimidin-4-ol;721M9407IY;500-50-5;53939-84-7;6-propyl-2-thioxo-1H-pyrimidin-4-one;CAS-51-52-5;NCGC00022715-03;2-mercapto-6-propylpyrimidin-4(3H)-one;HC210060;SMR000058275;DSSTox_CID_1209;6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione;6-propyl-2-thiopyrimidine-2,4(1H,3H)-dione;DSSTox_RID_76011;6-n-PROPYL-2-MERCAPTO-4-HYDROXYPYRIMIDINE;6-propyl-2-sulfanyl-3,4-dihydropyrimidin-4-one;DSSTox_GSID_21209;WLN: T6MYMVJ BUS F3;6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one;6-Propyl-2-thio-2,3H)-pyrimidinedione;6 Propyl 2 Thiouracil;SR-05000001706;4(1H)-Pyrimidinone,3-dihydro-6-propyl-2-thioxo-;Propyl thiouracile;3CJ;Prestwick_810;Propylthiouracil [USP:INN:BAN:JAN];AC1LCWBA;Spectrum_000876;ACMC-1AMSS;Opera_ID_530;Prestwick0_000494;Prestwick1_000494;Prestwick2_000494;Prestwick3_000494;Spectrum2_001302;Spectrum3_001731;Spectrum4_000492;Spectrum5_001815;D00MIN;D0K2MK;CHEMBL1518;SCHEMBL41239;BSPBio_000387;BSPBio_003402;KBioGR_001003;KBioSS_001356;KSC492M9T;MLS002303010;MLS006011901;DivK1c_000268;SPECTRUM1500515;SPBio_001363;SPBio_002308;BPBio1_000427;GTPL6650;DTXSID5021209;SCHEMBL17375339;CTK1G9150;CTK3J2699;HMS500N10;KBio1_000268;KBio2_001356;KBio2_003924;KBio2_006492;KBio3_002622;KS-00000KWP;NSC6498;MolPort-000-145-889;MolPort-000-664-275;MolPort-004-414-251;NINDS_000268;HMS1569D09;HMS1766D22;HMS1920L22;HMS2092E03;HMS2096D09;HMS2230B22;HMS3259M04;HMS3371D17;HMS3655J07;HMS3713D09;Pharmakon1600-01500515;HY-B0346;NSC-6498;NSC70461;Propylthiouracil (JP15/USP/INN);Propylthiouracil (JP17/USP/INN);ZINC4640636;Tox21_110882;Tox21_201741;Tox21_300280;2-mercapto-6-propyl-pyrimidin-4-ol;ACM500505;AN-733;ANW-75636;BBL003084;BDBM50133597;CCG-39240;HTS000719;LS-158;MFCD00006041;NSC-70461;NSC757302;s1988;SBB003855;STL102645;6-Propyl-2-sulfanyl-4-pyrimidinol #;AKOS000120319;AKOS001053246;AKOS015892537;Tox21_110882_1;2-thio-4-hydroxy-6-n-propylpyrimidine;BS-3928;CS-2390;DB00550;MCULE-9403710688;NC00533;NSC-757302;PS-3436;RTR-036940;4-hydroxy-6-n-propylpyrimidine-2-thiol;IDI1_000268;6-Propyl-2-thiouracil, enzyme inhibitor;NCGC00016229-01;NCGC00016229-02;NCGC00016229-03;NCGC00016229-04;NCGC00016229-05;NCGC00016229-06;NCGC00016229-07;NCGC00016229-08;NCGC00016229-09;NCGC00016229-10;NCGC00016229-11;NCGC00016229-13;NCGC00016229-14;NCGC00090881-01;NCGC00090881-02;NCGC00090881-03;NCGC00178089-01;NCGC00178089-02;NCGC00183321-01;NCGC00254180-01;NCGC00259290-01;2-mercapto-4-hydroxy-6-propyl pyrimidine;6-propyl-2-sulfanyl-3H-pyrimidin-4-one;AC-10795;CC-33983;CPD000058275;KB-24812;KB-45926;propylthiouracil / 6-Propyl-2-thiouracil;SAM002554926;SC-17509;SMR003317355;SBI-0051497.P003;AB2000408;TR-036940;BB 0242498;FT-0621285;FT-0695546;P0533;ST50308196;3052-EP2272832A1;C07569;D00562;K-9466;K-9745;L-4426;2-THIO-4-HYDROXY-6-N-PROPYL-PYRIMIDINE;6-Propyl-2-thiouracil, purum, >=98.0% (T);AB00052082_05;AB00052082_06;AS-871/40901436;C-24421;6-propyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone;I03-0144;SR-05000001706-1;SR-05000001706-2;SR-05000001706-3;W-105881;6-Propyl-2-thioxo-2, 3-dihydropyrimidin-4(1H)-one;6-Propyl-2-thioxo-2,3-dihydro-1H-pyrimidin-4 -one;BRD-K48168960-001-04-4;BRD-K48168960-001-05-1;BRD-K48168960-001-08-5;Z56922173;F1967-1318;F2199-0035;F3097-4245;T0517-6237;4(1H)-PYRIMIDINONE,6-BUTYL-2,3-DIHYDRO-2-THIOXO-;6-Propyl-2-thiouracil, VETRANAL(TM), analytical standard;6-propyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one;Propylthiouracil, European Pharmacopoeia (EP) Reference Standard;Propylthiouracil, United States Pharmacopeia (USP) Reference Standard;InChI=1/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11"	51-52-5	721M9407IY	12680157	12680157	01/04/2003	18920112	01/01/1947	Bef. 1989		0	0	1	No	0	"19/12/1974 00:00;15/01/1986 00:00;11/10/2011 00:00;15/01/2016 00:00;16/07/1987 00:00;02/11/2001 00:00;21/07/1988 00:00;05/02/1990 00:00;31/10/1980 00:00;17/02/1999 00:00;11/12/2000 00:00;15/12/2010 00:00;20/02/1985 00:00;12/03/2001 00:00;04/12/1987 00:00;23/07/1971 00:00;07/01/1986 00:00;29/10/1999 00:00;30/11/2016 00:00;03/04/1992 00:00;22/02/1988 00:00;26/01/1983 00:00;08/08/1986 00:00;11/03/1999 00:00;26/07/1983 00:00;23/01/1987 00:00;22/08/2011 00:00;25/03/2002 00:00;10/08/1973 00:00;21/01/2011 00:00;06/04/1987 00:00;29/12/2010 00:00;24/07/1970 00:00;07/05/1986 00:00;21/11/2002 00:00;19/11/1984 00:00;18/01/1996 00:00;29/06/1990 00:00;05/06/1990 00:00;10/02/2015 00:00;18/01/1990 00:00;28/06/2001 00:00;23/01/1991 00:00;28/10/1988 00:00;01/12/1998 00:00;06/07/1987 00:00;01/04/1996 00:00;26/04/1996 00:00;19/11/1985 00:00;13/10/2011 00:00;28/02/1983 00:00;15/08/1989 00:00;31/08/1990 00:00;23/05/1988 00:00;28/03/1990 00:00;12/03/2002 00:00;02/06/1982 00:00;01/04/2010 00:00;06/05/1974 00:00;09/01/1973 00:00;31/01/1995 00:00;01/10/2001 00:00;02/05/1989 00:00;23/12/1994 00:00;08/10/1985 00:00;29/07/1947 00:00;11/10/1994 00:00;19/12/2013 00:00;14/12/1989 00:00;07/04/1994 00:00;22/09/1986 00:00;28/07/1947 00:00;01/10/1998 00:00;13/05/1976 00:00;11/01/1991 00:00;27/07/2011 00:00"	AP	"LANNETT;HIKMA INTL PHARMS;DAVA PHARMS INC;SUN PHARM INDUSTRIES;ACTAVIS ELIZABETH;LILLY;ANABOLIC;IMPAX LABS"	PROPYLTHIOURACIL	28/07/1947	DAVA PHARMS INC	6,8	#N/A																							0						1
Bortezomib	"bortezomib;ldp 341;mln341;ps-341;ps341"	"[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid;N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE;N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide;Bortezomib Hospira;Bortezomib;Act Bortezomib;Bortezomib Sun;Bortezomib for Injection;PMS-bortezomib;Velcade;Bortezomib Accord"	"DB00188;APRD00828;DB07475"	"[(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;[(1S)-3-methyl-1-[[(2R)-1-oxo-2-[[oxo-(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid;[(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazin-2-ylcarbonylamino)propanoyl]amino]butyl]boronic acid;197730-97-5;[(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-;Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-;Bortezomib;Bortezomib [USAN:INN];LDP 341;MG 341;MLN-341;N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide;PS 341 (pharmaceutical);Velcade"	"Bortezomib;179324-69-7;Velcade;PS-341;LDP-341;Bortezomib (PS-341);Ps 341;DPBA;Pyz-Phe-boroLeu;UNII-69G8BD63PP;Velcade (TN);Bortezomib (Velcade);MLN-341;[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE;MG-341;radiciol;PROSCRIPT BORONIC ACID;69G8BD63PP;CHEMBL325041;CHEBI:52717;LPD 341;LPD-341;NSC681239;((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid;NSC-681239;Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;LDP 341;NCGC00242506-02;S1013;PS 341 (pharmaceutical);DSSTox_CID_20980;DSSTox_RID_79609;DSSTox_GSID_40980;MG 341;NSC 681239;(R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid;N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide;[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid;[(1R)-3-METHYL-1-[[(2S)-1-OXO-3-PHENYL-2-[(PYRAZINYLCARBONYL)AMINO]PROPYL]AMINO]BUTYL]-BORONIC ACID;CAS-179324-69-7;Bortezomib [USAN:INN:BAN];C19H25BN4O4;HSDB 7666;((R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronicacid;Bortezomib,Velcade;NCGC00168751-01;NCGC00181022-01;Velcade (Millenium);BOSUTINB;PubChem17777;3mg0;AC1L8TUW;cc-75;D0SH3I;Bortezomib(JAN/USAN/INN);MLS004774142;Bortezomib (JAN/USAN/INN);SCHEMBL192129;GTPL6391;DTXSID3040980;CTK8B8979;AOB6368;Bortezomib (Proteasome inhibitor);GXJABQQUPOEUTA-RDJZCZTQSA-N;MolPort-003-845-298;((1R)-3-Methyl-1-(((2S)-3-phenyl-2-((pyrazinylcarbonyl)amino)propanoyl)amino)butyl)boronic acid;Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-;Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-;N-((1S)-1-Benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)-2-oxoethyl)pyrazinecarboxamide;N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide;Tox21_112630;Tox21_112672;ABP000234;ANW-61718;BDBM50069989;CB0261;MFCD09056737;AKOS015909706;Tox21_112672_1;ZINC169746649;AM81235;API0001750;CS-1039;DB00188;MG-341; PS-341;PB14673;RL02288;Bortezomib (Velcade MG-341 PS-341);Bortezomib/Velcade, MG-341, PS-341;NCGC00242506-01;AS-15721;BC201423;HY-10227;KB-48452;NCI60_029010;Q425;SC-23571;SMR003500787;Velcade, MG-341, PS-341, Bortezomib;AB0017579;AB2000734;AX8106087;RT-000308;ST2406732;FT-0082488;FT-0602235;KS-00000761;D03150;Q-4365;AB01273951-01;AB01273951-02;AB01273951_03;324B697;SR-01000939863;I14-3268;SR-01000939863-2;BRD-K88510285-001-02-0;Velcade, MG-341, PS-341,179324-69-7;(R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-6-carboxamido)propanamido)butylboronic acid;(1R)-3-Methyl-1-({(2S)-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propanoyl}amino)butylboronic acid, AldrichCPR;(R)-3-METHYL-1-((S)-3-PHENYL-2-(PYRAZINE-2-CARBOXAMIDO)PROPANAMIDO)BUTAN-2-YLBORONIC ACID;(R)-3-METHYL-1-((S)-3-PHENYL-2-(PYRAZINE-5-CARBOXAMIDO)PROPANAMIDO)BUTYLBORONIC ACID;[(1R)-3-METHYL-1-[(2S)-3-PHENYL-2-(PYRAZIN-2-YLFORMAMIDO)PROPANAMIDO]BUTYL]BORONIC ACID;[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]-butyl]boronic acid;197730-97-5;Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide"	179324-69-7	69G8BD63PP	"25765556;24730538;23965287;23018466;22906230;22759762;22534815;22394984;21321571;20378507;20213332;20133082;18645194;17970782;17409841;15867242;15217925;15169797;15161691;12431963;12171876"	12171876	01/08/2002	12431963	01/11/2002	1999-2003		1	1	1	Yes	1	"31/05/2006 00:00;26/10/2012 00:00;20/06/2008 00:00;03/05/2017 00:00;14/09/2015 00:00;25/03/2005 00:00;20/08/2015 00:00;25/05/2004 00:00;12/05/2017 00:00;08/12/2005 00:00;12/07/2018 00:00;03/12/2010 00:00;05/08/2013 00:00;30/12/2009 00:00;13/03/2014 00:00;13/05/2003 00:00;01/04/2013 00:00;08/12/2006 00:00;08/10/2014 00:00;10/10/2007 00:00;01/11/2011 00:00;24/04/2017 00:00;06/11/2017 00:00;02/08/2013 00:00;20/10/2016 00:00;23/01/2012 00:00;09/06/2017 00:00;07/04/2011 00:00;24/04/2009 00:00;08/08/2014 00:00;08/09/2014 00:00"	"AP;TA"	"APOTEX INC;MILLENNIUM PHARMS;ACTAVIS LLC;FRESENIUS KABI USA;PHARMASCIENCE INC;ACCORD HLTHCARE INC;HOSPIRA INC"	BORTEZOMIB	13/05/2003	MILLENNIUM PHARMS	6,3	27	NA	0	1	MYELOMA	1	PROTEASOME	0	1	0	NA	0	0	0	1	1	0,33	0	1	1	NA	0	0	0	0	0	0	836	0	1
Interferon Alfa-2b, Recombinant	"interferon alfa-2b;interferon alpha-2b;interferon-alpha;interferon-alpha-2a;interferon-alpha2b;peg-proline-interferon alpha-2b;pegylated interferon alfa-2b;pegylated interferon-alpha-2b;schering 54031"	"Interferon alfa-2b;Interferon α-2b;Intron (Interferon α2b);Intron A;Intron A (Interferon α2b);Intron A - Kit (pws+diluent) 3000000iu/vial;Intron A - Kit (pws+diluent) 5000000iu/vial;Intron A - Liq 5000000iu/ml;Intron A Inj 10000000unit/vial;Intron A Inj 3000000unit/vial;Intron A Inj 5000000unit/vial;Rebetron Ready To Use Solution (albumin(human)free) (6000000 Iu/ml and 200mg Capsules);Rebetron Solution (albumin (human) Free) (18 Miu Multi-dose Pen / 200mg Capsules);rIFN-alpha-2b"	"BIOD00066;BTD00066;DB00105;DB05600"			98530-12-2	43K1W2T1M6	"10427950;11142476;11535501;12228203;15254058;15358617;18679580;19858763;20512580;21242495;25545244;9547674"	9547674	01/01/1997	3914355	01/12/1985	Bef. 1989		1	0	0	No	0					04/06/1986	SCHERING	6,1	#N/A																							0						1
Regorafenib	regorafenib	"Regorafenibum;Régorafénib;Regorafenib;Stivarga"	DB08896		"Regorafenib;755037-03-7;Regorafenibum;Stivarga;BAY 73-4506;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;BAY73-4506;Regorafenib (BAY 73-4506);UNII-24T2A1DOYB;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;BAY-73-4506;24T2A1DOYB;CHEMBL1946170;CHEBI:68647;anhydrous regorafenib;Stivarga (TN);BAY73-4506 hydrochloride;Regorafenib [USAN:INN];4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl}amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide;Regorafenib (USAN/INN);D09GDD;RegorafenibBAY73-4506;BAY-734506 monohydrate;MLS006010303;C21H15ClF4N4O3;SCHEMBL432230;Regorafenib,BAY 73-4506;GTPL5891;QCR-85;BAY73-4506(Regorafenib)/;Regorafenib(BAY 73-4506);DTXSID60226441;EX-A058;Regorafenib - BAY 73-4506;SYN1169;FNHKPVJBJVTLMP-UHFFFAOYSA-N;MolPort-009-679-472;BCPP000352;HMS3654K16;Regorafenib, 755037-03-7;AOB87754;KS-00000Q4Q;ZINC6745272;ABP000611;BDBM50363397;s1178;AKOS015951107;ACN-036634;AM81251;BAY 734506;BCP9000384;CS-0170;DB08896;RL04875;NCGC00263138-01;4CA-1083;AC-25075;AJ-56815;AS-16304;CJ-13100;HY-10331;KB-80344;SC-28977;SMR004701370;AB0008044;AB1008457;AX8232295;FT-0674338;R0142;ST24023156;cas:835621-07-3;Regorafenib hydrochloride;Regorafenib (BAY73-4506 Fluoro-Sorafenib);A25020;D10138;S-7780;AB01565826_02;SR-01000941571;SR-01000941571-1;BRD-K16730910-001-02-4;2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carbox;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide;835621-08-4;Regorafenib;1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea"	755037-03-7	24T2A1DOYB	"26281907;22568966"	22568966	01/05/2012	22421192	01/05/2012	2009-2012		1	1	1	Yes	1	"07/06/2016 00:00;27/09/2012 00:00;25/02/2013 00:00;13/04/2015 00:00;26/08/2016 00:00;10/11/2014 00:00;29/05/2013 00:00;13/09/2013 00:00;27/04/2017 00:00;14/06/2018 00:00"	AP	"BAYER HEALTHCARE PHARMS;BAYER HLTHCARE"	REGORAFENIB	27/09/2012	BAYER HLTHCARE	4,9	53	NA	1	0	NA	1	"VEGFR;TIE2;PDGFRB;FGFR;KIT;RET;RAF"	0	1	0	NA	0	0	0	1	1	0,06	0	0	0	NA	0	0	0	0	0	0	192	0	1
Pazopanib	pazopanib	"GW 78603;Pazopanibum;Votrient"	DB06589		"Pazopanib;444731-52-6;GW786034;UNII-7RN5DR86CK;790713-33-6;7RN5DR86CK;GW 78603;Pazopanib (GW-786034);CHEBI:71219;NCGC00188865-01;GW-786034;DSSTox_CID_28659;DSSTox_RID_82929;DSSTox_GSID_48733;5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide;5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide;5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;Q-101400;GW 786034;C21H23N7O2S;5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide;5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide;CAS-444731-52-6;Pazopanib [INN:BAN];pazopanibum;HSDB 8210;Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-;Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-;indazolylpyrimidine 13;Pazopanib (free base);Kinome_3790;PubChem22448;GW7 86034;Pazopanib/GW-786034;SCHEMBL588608;CHEMBL477772;GTPL5698;JMC514632 Compound 13;DTXSID8048733;BDBM26474;QCR-110;SYN1058;cid_10113978;CUIHSIWYWATEQL-UHFFFAOYSA-N;MolPort-006-827-156;BCPP000129;HMS3244C21;HMS3244C22;HMS3244D21;HMS3656L14;AOB87179;EX-A1241;Tox21_113174;ABP000868;ABP000882;AN-050;MFCD11616589;NSC752782;RS0094;s3012;ZINC11617039;AKOS005145819;Tox21_113174_1;AC-8522;API0024403;BCP9001053;CS-0269;DB06589;MCULE-2193898201;NSC-752782;NCGC00188865-02;NCGC00188865-03;AS-11066;BC280878;HY-10208;KB-59433;SC-23290;AB0008634;AB1008452;AX8161907;AM20090659;FT-0659928;FT-0684794;ST24031511;Pazopanib Hydrochloride /GW786034,VOTRIENT;A19406;P-6706;Q-1426;S-7750;AB01273967-01;AB01273967-02;AB01273967_05;AB01273967_06;A839572;I09-0358;BRD-K74514084-003-02-7;Z1541638525;5-(3-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)phenylamino)-2-methylbenzenesulfonamide;5-({4-[(2,3-dimethylindazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide"	444731-52-6	7RN5DR86CK	"28662033;25920360;23857966;23653147;21831954;21811833;19509175"	19509175	01/06/2009	19509175	01/06/2009	2009-2012		1	1	1	Yes	1	"20/03/2012 00:00;27/04/2010 00:00;19/10/2009 00:00;21/10/2011 00:00;27/11/2013 00:00;20/05/2016 00:00;15/11/2012 00:00;18/11/2014 00:00;01/04/2015 00:00;12/01/2012 00:00;22/09/2015 00:00;05/08/2016 00:00;31/05/2017 00:00;14/08/2013 00:00;03/06/2014 00:00;26/04/2012 00:00;21/04/2011 00:00"	AP	NOVARTIS PHARMS CORP	PAZOPANIB HYDROCHLORIDE	19/10/2009	NOVARTIS PHARMS CORP	4,6	63	NA	1	0	NA	1	"VEGFR;PDGFR;C-KIT"	0	1	1	20	0	0	0	1	1	0,05	0	0	0	0,27	0	0	0	0	0	0	519	1	1
Venetoclax	venetoclax	"4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide;Venclexta"	DB11581		"ABT-199;Venetoclax;1257044-40-8;Venclexta;ABT199;GDC-0199;ABT 199;UNII-N54AIC43PW;GDC 0199;venclyxto;N54AIC43PW;ABT-199 (GDC-0199);4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide;BDBM189459;2-(1H-Pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(3-nitro-4-((tetrahydro-2H-pyran-4-yl)methy;4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide;Venetoclax [USAN:INN];Venclexta TM;Venclexta (TN);RG7601;Venetoclax(ABT-199);D00PBX;C45H50ClN7O7S;MLS006010298;SCHEMBL523816;Venetoclax (JAN/USAN/INN);GTPL8318;CHEMBL3137309;SCHEMBL19236295;BDBM60828;AOB5080;DTXSID30154863;EX-A168;CHEBI:133021;MolPort-028-720-431;HMS3653J06;BDBM50162774;AKOS025289539;ZINC150338755;CS-1155;DB11581;KS-1470;TRA0049558;KS-0000002C;NCGC00345789-01;4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide;AC-28754;AK170450;BC600499;HY-15531;QC-11704;SMR004701366;KB-145916;FT-0699586;S8048;X3609;J3.516.625D;D10679;US9174982, 5;W-6008;Z-3166;US9174982, 369;J-005269;2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl;ABT-199|||GDC 0199|||4-[4-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide"	1257044-40-8	N54AIC43PW	"29018077;26639348"	26639348	01/12/2015	26639348	01/12/2015	2013-2017		1	1	1	Yes	1	"08/06/2018 00:00;11/04/2016 00:00;20/12/2017 00:00"	AP	ABBVIE INC	VENETOCLAX	11/04/2016	ABBVIE INC	4,3	116	NA	0	1	"CLL;SLL"	1	BCL2	0	1	1	60	0	0	0	1	0	0,79	0	1	1	NA	1	0	0	0	0	0	110	0	1
Vincristine	vincristine	"22-Oxovincaleukoblastine;Vincristin;Vincristina;Vincristinum;22-Oxovincaleukoblastin;Leurocristine;Vincristine Sulfate Inj 1mg/ml USP;Vincristine Sulfate Inj 5mg/vial USP;Vincristine Sulfate Injection USP;VinCRIStine Sulfate;Oncovin Solution 1mg/ml;Vincasar PFS;Marqibo;Vincristine Sulfate Injection"	"DB00541;APRD00495"	"28379-27-3;57-22-7;CCRIS 5763;EINECS 200-318-1;HSDB 3199;NCI-C04864;Onco TCS;Vincaleukoblastine, 22-oxo-;Vincristina [DCIT];Vincristinum [INN-Latin];Vincrystine;Vinkristin;2068-78-2 (SULFATE 1:1 SALT);AIDS-002674;AIDS002674;Lilly 37231 (1:1 sulfate salt);Oncovin (1:1 sulfate salt);VIN;Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine;Vincasar (1:1 sulfate salt);Vincrex (1:1 sulfate salt);CHEBI:28445;NCI60_026703;NCGC00163700-01;22-Oxovincaleukoblastine;C07204;Vincristine"	"vincristine;22-Oxovincaleukoblastine;Leurocristine;57-22-7;Vincrystine;Oncovine;Vinkristin;Indole alkaloid;Vincristina [DCIT];Onco TCS;Vincristina;Vincristinum;Vincristinum [INN-Latin];Vincasar;Vincrstine;Marqibo;Vincristine [INN:BAN];Tecnocris (TN);Vincrisul;Vincristine (INN);Vincasar (1:1 sulfate salt);Liposomal Vincristine;C46H56N4O10;Oncovin (1:1 sulfate salt);Vincrex (1:1 sulfate salt);CHEBI:28445;NSC-67574;Kyocristine;Vincaleukoblastine, 22-oxo-;VIN;LCR;VCR;NCGC00163700-01;Oncovin (TN);Leurocristine sulfate;vincristin;DSSTox_CID_12278;DSSTox_RID_78909;DSSTox_GSID_32278;Vincristine Sulfate PFS;CCRIS 5763;HSDB 3199;NCI-C04864;EINECS 200-318-1;CAS-57-22-7;Sulfate, Vincristine;Tecnocris;22-Oxovincaleukoblastin;AC1L1LJC;D09QVV;SCHEMBL3709;CHEMBL90555;GTPL6785;DTXSID1032278;OGWKCGZFUXNPDA-XQKSVPLYSA-N;HMS2090E19;Lilly37231 (1:1 sulfate salt);Tox21_112067;BDBM50139772;LS-228;ZINC85432549;Lilly 37231 (1:1 sulfate salt);Tox21_112067_1;DB00541;NCGC00163700-02;NCGC00163700-04;NCGC00263543-01;AN-41713;AN-50340;NCI60_026703;SC-19287;SRI-10749-04;SRI-10749-05;N2252;X1247;C07204;D08679;15161-EP2269989A1;15161-EP2270008A1;15161-EP2270014A1;15161-EP2270018A1;15161-EP2272827A1;15161-EP2272832A1;15161-EP2272839A1;15161-EP2272840A1;15161-EP2275413A1;15161-EP2277565A2;15161-EP2277566A2;15161-EP2277567A1;15161-EP2277568A2;15161-EP2277569A2;15161-EP2277570A2;15161-EP2277876A1;15161-EP2280012A2;15161-EP2281815A1;15161-EP2287156A1;15161-EP2289892A1;15161-EP2289893A1;15161-EP2292234A1;15161-EP2292280A1;15161-EP2292614A1;15161-EP2292615A1;15161-EP2292617A1;15161-EP2295412A1;15161-EP2295413A1;15161-EP2295416A2;15161-EP2295426A1;15161-EP2295427A1;15161-EP2298748A2;15161-EP2298768A1;15161-EP2298772A1;15161-EP2298778A1;15161-EP2298780A1;15161-EP2301928A1;15161-EP2301933A1;15161-EP2305640A2;15161-EP2305642A2;15161-EP2305654A1;15161-EP2305671A1;15161-EP2305689A1;15161-EP2308812A2;15161-EP2308833A2;15161-EP2308839A1;15161-EP2308855A1;15161-EP2311807A1;15161-EP2311808A1;15161-EP2311825A1;15161-EP2311827A1;15161-EP2311829A1;15161-EP2311840A1;15161-EP2311842A2;15161-EP2314590A1;15161-EP2316832A1;15161-EP2316833A1;866V483;Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine;Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine;methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0;{4,12}.0;{5,10}]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0;{1,9}.0;{2,7}.0;{16,19}]nonadeca-2(7),3,5,13-tetraene-10-carboxylate"	57-22-7	5J49Q6B70F	"26891067;23894304;10080616;9523729"	9523729	01/04/1998	13968454	01/03/1963	Bef. 1989		0	0	1	Yes	1	"17/05/1999 00:00;06/06/1989 00:00;05/04/1988 00:00;08/07/1993 00:00;29/04/1998 00:00;25/01/2007 00:00;06/10/2015 00:00;03/11/2014 00:00;21/02/1989 00:00;23/07/1987 00:00;15/05/1981 00:00;22/06/1988 00:00;21/08/1992 00:00;06/11/1995 00:00;20/09/1983 00:00;07/07/2014 00:00;02/01/2001 00:00;17/09/1992 00:00;04/03/1991 00:00;23/09/1985 00:00;12/07/1988 00:00;17/04/1991 00:00;23/12/1988 00:00;14/05/2001 00:00;12/05/2000 00:00;02/07/1996 00:00;18/05/2000 00:00;12/03/1976 00:00;24/04/2015 00:00;29/01/1991 00:00;25/11/1991 00:00;30/11/2016 00:00;17/08/1987 00:00;28/03/1996 00:00;13/05/2013 00:00;03/11/1992 00:00;07/03/1984 00:00;17/09/2002 00:00;15/10/2014 00:00;25/04/2016 00:00;02/07/1981 00:00;16/12/1992 00:00;08/04/1982 00:00;20/12/2002 00:00;16/08/1985 00:00;30/06/1992 00:00;10/05/1982 00:00;19/04/1988 00:00;16/04/1997 00:00;02/04/1992 00:00;07/08/1990 00:00;16/07/1991 00:00;09/08/2012 00:00;24/03/1988 00:00;14/07/1989 00:00;19/02/1987 00:00;05/07/1995 00:00;05/03/1993 00:00;16/09/1988 00:00;23/01/2012 00:00;10/07/1963 00:00;13/11/1992 00:00;26/08/1999 00:00;31/05/1985 00:00;14/06/1990 00:00;18/09/2015 00:00;08/08/2000 00:00;02/01/1991 00:00;04/04/1990 00:00;28/10/2003 00:00;09/12/1982 00:00;06/04/1992 00:00;31/08/2015 00:00;07/04/1997 00:00;27/01/1986 00:00;25/09/2001 00:00;07/11/1995 00:00;20/06/1988 00:00;28/04/1995 00:00;17/07/1987 00:00;03/10/1997 00:00;01/07/1994 00:00;23/04/1991 00:00;27/07/1988 00:00;05/08/2014 00:00;07/05/2013 00:00;01/09/1999 00:00;17/03/1986 00:00"	AP	"BRISTOL MYERS SQUIBB;TEVA PHARMS USA;FRESENIUS KABI USA;TEVA PARENTERAL;HOSPIRA;TALON THERAP;LILLY"	VINCRISTINE SULFATE	10/07/1963	LILLY	4,3	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NA		NA			1
Lovastatin	lovastatin	"Lovastatine;Mevinolin;(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate;6alpha-methylcompactin;6α-methylcompactin;Lovastatinum;6-alpha-methylcompactin;Lovastatina;2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone;Dom-lovastatin;Apo-lovastatin - Tab 20mg;PMS-lovastatin;Lovastatin-20;Nu-lovastatin Tablets;Mevacor;Teva-lovastatin;Ratio-lovastatin;Lovastatin;Ran-lovastatin;Pro-lovastatin;Advicor;Altoprev;Mylan-lovastatin;Apo-lovastatin - Tab 40mg;Riva-lovastatin;Act Lovastatin;PHL-lovastatin;Lovastatin-40;Ava-lovastatin;Sandoz Lovastatin"	"DB00227;APRD00370"	"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-tetrahydropyranyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester;(2S)-2-methylbutyric acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-keto-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester;[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-oxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;74133-25-8;81739-26-6;75330-75-5;71949-96-7;MEGxm0_000398;BB_NC-1457;KBio1_001032;Prestwick2_000516;KBio3_002848;(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;Prestwick3_000516;Prestwick1_000516;MLS000069585;SMR000058779;NINDS_001032;BSPBio_003346;[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;Prestwick0_000516;BSPBio_000471;Altoprev;L-154803;Liposcler;Monakolin K;Rextat;(2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester;nchembio790-comp14;D00359;Lovastatin (USP);MK-803;ML-530B;Mevacor (TN);Spectrum3_001873;(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate;(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester;(S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one;1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone;2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone;6-alpha-Methylcompactin;6alpha-Methylcompactin;Artein;BRN 3631989;Belvas;Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-;Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-;Cholestra;Closterol;Colevix;HSDB 6534;Hipolip;Hipovastin;Lestatin;Lipdip;Lipivas;Lipofren;Lovalip;Lovalord;Lovastatin [USAN:BAN:INN];Lovastatina [Spanish];Lovastatine [French];Lovastatinum [Latin];Lovasterol;Lovastin;Lozutin;MK 803;MSD 803;Mevacor;Mevinacor;Mevinolin;Mevlor;Monacolin K;Nergadan;Paschol;Rodatin;Rovacor;Sivlor;Taucor;Tecnolip;Teroltrat;ACon0_000534;(S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester;nchembio742-comp5;SPBio_002392;ZINC03812841;LS-46359;SPECTRUM1503977;C07074;Lovastatin;NCGC00023509-03;AIDS-059059;AIDS059059;Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-;ACon1_000390;BSPBio_001265;DivK1c_001032;IDI1_001032;Prestwick_819;BPBio1_000519;Spectrum5_001294;NCGC00023509-04;CHEBI:40303;nchembio869-comp12;M2147_SIGMA;Mevinolin from Aspergillus sp."	"lovastatin;75330-75-5;mevinolin;Mevacor;Monacolin K;Lovalip;Altoprev;Lovalord;Mevinacor;Nergadan;6alpha-Methylcompactin;Altocor;Artein;MK-803;Hipovastin;Lovastatine;Lovasterol;Cholestra;Closterol;Colevix;Hipolip;Lestatin;Lipivas;Lipofren;Lovastin;Lozutin;Paschol;Rodatin;Rovacor;Tecnolip;Teroltrat;Belvas;Lipdip;Mevlor;Sivlor;Taucor;Lovastatine [French];Lovastatinum [Latin];Lovastatina [Spanish];6-alpha-Methylcompactin;Lovastatinum;Lovastatina;6-Methylcompactin;MSD 803;MK 803;Liposcler;6 alpha-Methylcompactin;Rextat;Monakolin K;UNII-9LHU78OQFD;Mevacor (TN);Lovastatin [USAN:BAN:INN];MLS000069585;Lovastatin & Primycin;HSDB 6534;ML-530B;Lovastatin (USP/INN);9LHU78OQFD;BRN 3631989;lostatin;2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone;SMR000058779;(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;CHEBI:40303;C24H36O5;(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate;(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;NCGC00023509-03;DSSTox_CID_784;EN300-52515;DSSTox_RID_75788;DSSTox_GSID_20784;(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester;[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone;Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-;L-154803;Lovastatin (Mevacor);6 Methylcompactin;butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-;(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate;74133-25-8;Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-;CPD000673570;CHEMBL503;SR-05000001880;(S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one;CCRIS 8092;1cqp;Lovastatin,(S);Lovastatin [USAN:USP:INN:BAN];MK803;(+)-mevinolin;Altoprev (TN);Statosan (TN);(S)-((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate;[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;Prestwick_819;Advicor (TN);Altocor (TN);Lovastatin, (1 alpha(S*))-Isomer;CAS-75330-75-5;Lovastatin [USAN];Opera_ID_1578;Prestwick0_000516;Prestwick1_000516;Prestwick2_000516;Prestwick3_000516;Spectrum3_001873;Spectrum5_001294;Lovastatin (MK-803);Lovastatin, 97%  5g;D06WTZ;EC 616-212-7;AC1L1EI6;AC1Q2C7T;SCHEMBL3136;US9115116, lovastatin;BIDD:PXR0113;BSPBio_000471;BSPBio_001265;BSPBio_003346;cid_53232;KSC377A8D;MLS001055358;MLS006011867;US9353061, Lovastatina;ARONIS24208;BIDD:GT0749;DivK1c_001032;SPECTRUM1503977;SPBio_002392;Mevinolin from Aspergillus sp.;BPBio1_000519;GTPL2739;MEGxm0_000398;DTXSID5020784;SCHEMBL14227102;ACon0_000534;ACon1_000390;BDBM34168;CTK2H7081;HMS503O05;KBio1_001032;KBio3_002848;AOB5269;MolPort-001-739-990;NINDS_001032;PCZOHLXUXFIOCF-BXMDZJJMSA-N;HMS1569H13;HMS1792O07;HMS1923O13;HMS1990O07;HMS2089M06;HMS2093O03;HMS2096H13;HMS2236F07;HMS3039N16;HMS3259F10;HMS3268C03;HMS3403O07;HMS3713H13;Pharmakon1600-01503977;(S)-((1S,3R,7S,8S,8AR)-8-(2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-2H-PYRAN-2-YL)ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL) 2-METHYLBUTANOATE;2-Methyl-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester butanoic acid;ACT02620;ALBB-027272;BB_NC-01457;Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-;HY-N0504;ZINC3812841;Tox21_110888;Tox21_201475;Tox21_300268;ANW-41686;BBL024473;BG0243;CCG-39627;MFCD00072164;NSC633781;NSC758662;s2061;SBB080686;STK801953;AKOS005267139;Tox21_110888_1;CS-1990;DB00227;EBD2126857;KS-1082;MCULE-4740518260;MCULE-7087866108;Mevinolin from Aspergillus sp., powder;NC00713;NSC-633781;NSC-758662;RTR-031803;IDI1_001032;NCGC00023509-04;NCGC00023509-05;NCGC00023509-06;NCGC00023509-07;NCGC00023509-08;NCGC00023509-09;NCGC00023509-10;NCGC00023509-11;NCGC00023509-13;NCGC00023509-14;NCGC00254157-01;NCGC00259026-01;AC-13961;CC-30040;CC-30041;CJ-10768;G226;LS-46359;SAM002589904;SAM002589963;SC-11968;SMR000673570;SBI-0051881.P002;AB0108514;L0214;N1632;C07074;D00359;J10136;S-7779;28048-EP2269989A1;28048-EP2270011A1;28048-EP2272825A2;28048-EP2272841A1;28048-EP2277507A1;28048-EP2277865A1;28048-EP2280006A1;28048-EP2281813A1;28048-EP2284158A1;28048-EP2286795A1;28048-EP2287165A2;28048-EP2287166A2;28048-EP2289892A1;28048-EP2292620A2;28048-EP2295406A1;28048-EP2295409A1;28048-EP2298742A1;28048-EP2298745A1;28048-EP2298772A1;28048-EP2298776A1;28048-EP2298779A1;28048-EP2301923A1;28048-EP2301931A1;28048-EP2301936A1;28048-EP2305648A1;28048-EP2308839A1;28048-EP2311808A1;28048-EP2311829A1;28048-EP2314588A1;96638-EP2287163A1;96638-EP2305678A1;AB00052400-17;AB00052400_18;AB00052400_19;Mevinolin from Aspergillus sp., >=98% (HPLC);117141-EP2272825A2;117141-EP2298776A1;330L755;A838030;C-21799;SR-01000000123;I06-1876;SR-01000000123-3;SR-05000001880-1;SR-05000001880-2;BRD-K09416995-001-06-8;BRD-K09416995-001-21-7;Lovastatin, 1 alpha-Isomer (without R*/S* notation);Z1258578375;(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat;(2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl-2-methyl butanoate;(2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester;(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester;(S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester;[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;71949-96-7;8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl (2S)-2-methylbutanoate;81739-26-6;Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-;Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta,8-beta-(2S*,4S*),8a-beta))-;Butanoic acid, 2-methyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester,(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))"	75330-75-5	9LHU78OQFD	"9856659;9816194"	9816194	01/03/1996	7229037	01/05/1987	Bef. 1989		1	0	1	No	0	"27/03/1997 00:00;14/03/2008 00:00;17/04/2007 00:00;14/12/1988 00:00;15/04/1992 00:00;22/10/2001 00:00;22/08/2000 00:00;01/12/2014 00:00;22/07/2002 00:00;26/04/2012 00:00;11/10/2002 00:00;30/06/2004 00:00;11/03/1999 00:00;01/08/2001 00:00;09/08/1993 00:00;27/02/2014 00:00;15/09/2005 00:00;26/06/2002 00:00;12/02/2007 00:00;26/04/2001 00:00;07/04/2005 00:00;11/09/2002 00:00;22/11/1988 00:00;14/04/2009 00:00;01/03/1999 00:00;28/08/1998 00:00;09/02/1996 00:00;03/03/1988 00:00;19/12/1991 00:00;01/08/1995 00:00;01/11/2007 00:00;04/11/2005 00:00;13/06/2005 00:00;02/11/2014 00:00;24/10/1991 00:00;18/05/2015 00:00;08/08/1995 00:00;23/01/1995 00:00;29/06/1998 00:00;12/12/2002 00:00;03/09/2014 00:00;30/11/2012 00:00;29/04/2013 00:00;22/11/1993 00:00;30/06/2010 00:00;01/02/2007 00:00;17/10/2003 00:00;28/02/2012 00:00;01/03/1988 00:00;17/12/2001 00:00;18/12/2002 00:00;30/04/2014 00:00;28/02/2018 00:00;16/02/2011 00:00;28/02/2007 00:00;10/06/2011 00:00;26/07/2013 00:00;20/12/2002 00:00;16/03/2008 00:00;09/11/2009 00:00;06/07/1988 00:00;13/03/2006 00:00;10/04/1991 00:00;02/03/2006 00:00;28/03/1991 00:00;02/02/2011 00:00;22/04/1998 00:00;21/02/1991 00:00;27/11/1992 00:00;30/05/2012 00:00;29/12/2012 00:00;20/10/1989 00:00;05/10/2007 00:00;20/12/1994 00:00;21/12/2012 00:00;23/11/1993 00:00;30/01/2002 00:00;23/09/2002 00:00;09/03/2009 00:00;22/10/2009 00:00;20/11/1997 00:00;05/06/2002 00:00;26/12/1996 00:00;18/08/2005 00:00;06/06/2003 00:00;11/07/2002 00:00;02/05/2012 00:00;24/11/1993 00:00;31/10/2012 00:00;31/08/1987 00:00;12/10/2012 00:00;20/12/1988 00:00;14/02/2002 00:00;03/05/2010 00:00;09/02/2007 00:00;20/08/2003 00:00;21/12/1994 00:00;07/12/2007 00:00;09/10/2012 00:00;29/05/2012 00:00;24/07/2017 00:00;27/11/1991 00:00;20/09/2002 00:00;14/09/2015 00:00;26/06/2001 00:00;03/05/1995 00:00;28/08/1991 00:00;17/12/1992 00:00;01/05/2012 00:00;21/03/1989 00:00;25/03/2013 00:00;29/05/2007 00:00;21/07/2004 00:00;24/09/2003 00:00;26/03/2012 00:00;15/05/2013 00:00;08/02/1995 00:00;05/02/2008 00:00;29/01/2013 00:00;25/06/1997 00:00;30/04/1996 00:00;04/08/2017 00:00;06/02/1997 00:00;17/05/1994 00:00;20/04/2005 00:00;12/03/1991 00:00;09/09/2014 00:00;14/04/2006 00:00;05/07/1994 00:00;14/09/2000 00:00;12/08/1997 00:00"	AP	"COVIS PHARMA BV;TEVA;SANDOZ;APOTEX INC;MERCK;CARLSBAD;SUN PHARM INDUSTRIES;ACTAVIS ELIZABETH;MYLAN;LUPIN"	LOVASTATIN	31/08/1987	MERCK	4,0	#N/A																							0						1
Celecoxib	celecoxib	"Célécoxib;P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide;Celecoxibum;Celecoxib;Mar-celecoxib;LidoXib;Auro-celecoxib;Bio-celecoxib;Teva-celecoxib;Apo-celecoxib;Ipg-celecoxib;Act Celecoxib;Celecoxib 400 mg;PMS-celecoxib;Riva-celecoxib;Jamp-celecoxib;Accel-celecoxib;Sdz Celecoxib;Mint-celecoxib;Celecoxib 100 mg;Priva-celecoxib;Celecoxib 200 mg;Celecoxib 50 mg;Ran-celecoxib;Gd-celecoxib;Riva-celecox;Onsenal;Mylan-celecoxib;Sandoz Celecoxib;Capxib;Dom-celecoxib;Lupin-celecoxib;Celebrex;Ag-celecoxib;Celecoxib;Rbx-celecoxib"	"DB00482;APRD00373"	"4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide;169590-42-5;184007-95-2;194044-54-7;Spectrum3_001996;4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE;CEL;Spectrum_000432;NCGC00091455-01;KBio2_006048;Spectrum2_001576;KS-1041;KBio2_000912;KBio3_002830;Celebrex (TN);4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-;Celebra;Celebrex;Celecoxib [USAN];HSDB 7038;SC 58635;YM 177;YM177;p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide;SC-58635;SPECTRUM1503678;NCI60_041049;KBio1_000893;DivK1c_000893;KBio2_004919;KBio2_007487;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;Celocoxib;KBioGR_002351;KBioGR_000723;KBioSS_000912;LS-31667;KBio2_003480;Celecoxib (JAN/USAN/INN);NCGC00091455-02;D00567;NCGC00091455-03;CHEBI:41423;Onsenal;Celecox;SPBio_001512;CCRIS 8679;C07589;Celecoxib;Solexa;KBio3_003037;KBio2_002351;YM-177;KBioSS_002354;NINDS_000893;Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;NSC719627;SC58635;Spectrum4_000182"	"celecoxib;169590-42-5;Celebrex;Celebra;Onsenal;Celocoxib;Celecox;SC 58635;Xilebao;YM177;SC-58635;4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE;Celecoxib [USAN];Celecoxib [Old RN];YM 177;Celecoxibum;Celecoxi;Solexa;HSDB 7038;UNII-JCX84Q7J1L;184007-95-2;Celebrex (TN);C17H14F3N3O2S;p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;YM-177;CHEMBL118;SC58635;JCX84Q7J1L;Celecoxib (SC-58635);Celecoxib (JAN/USAN/INN);4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide;CHEBI:41423;TPI-336;RZEKVGVHFLEQIL-UHFFFAOYSA-N;AI-525;CEP-33222;NCGC00091455-01;DSSTox_CID_2777;SC-58553, SC-58635;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;DSSTox_RID_76725;DSSTox_GSID_22777;194044-54-7;4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide;Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-;Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl);SMR000550473;CAS-169590-42-5;SR-01000837528;Eurocox;Medicoxib;Celecoxib [USAN:INN:BAN];CCRIS 8679;CCRIS 9330;Celebra (TN);Onsenal (TN);CELEBCOXIB;Spectrum_000432;1oq5;Pfizer brand of celecoxib;Spectrum2_001576;Spectrum3_001996;Spectrum4_000182;Spectrum5_001324;D03RTS;AC1L1E6K;Celecoxib/Celebrex, Celebra;cid_2662;SCHEMBL3708;BSPBio_003596;Celebrex, Celebra, Celecoxib;KBioGR_000723;KBioGR_002351;KBioSS_000912;KBioSS_002354;MLS001165684;MLS001195656;MLS001304708;MLS006011862;BIDD:GT0408;DivK1c_000893;SPECTRUM1503678;SPBio_001512;GTPL2892;Celecoxib, >=98% (HPLC);DTXSID0022777;BDBM11639;CTK8H4475;HMS502M15;KBio1_000893;KBio2_000912;KBio2_002351;KBio2_003480;KBio2_004919;KBio2_006048;KBio2_007487;KBio3_002830;KBio3_003037;EX-A175;SYN3015;cMAP_000027;MolPort-002-885-815;NINDS_000893;BCPP000290;HMS1922G14;HMS2089L18;HMS2093I07;HMS2234N18;HMS3259L08;HMS3261A14;HMS3373A09;HMS3654H09;HMS3715F11;Pharmakon1600-01503678;ACT02648;EBD24636;KS-00000FW2;ZINC2570895;Tox21_111135;Tox21_201964;Tox21_300599;Tox21_500406;US8741944, Comparative Compound;ABP000291;BBL029086;CCG-39354;MFCD00941298;NSC719627;NSC758624;s1261;STL373576;Celecoxib 1.0 mg/ml in Acetonitrile;AKOS015842517;Tox21_111135_1;AC-4228;AM84588;AT-3762;BCP9000507;Celebrex, Celebra, 169590-42-5;CS-0570;DB00482;KS-1041;MCULE-4750749400;NC00708;NSC-719627;NSC-758624;RL02184;IDI1_000893;NCGC00091455-02;NCGC00091455-03;NCGC00091455-04;NCGC00091455-05;NCGC00091455-06;NCGC00091455-07;NCGC00091455-08;NCGC00091455-09;NCGC00254540-01;NCGC00259513-01;NCGC00261091-01;AN-12211;BC209720;BP-30217;CPD000550473;HY-14398;KB-76000;LS-31667;NCI60_041049;PHA-00846533;SAM002589995;SC-50829;SBI-0051875.P002;AB0012055;CJ-016377;CP-598107;TL8001323;UNM-0000305813;FT-0080064;FT-0601628;FT-0623536;FT-0700357;PF-00345549;A25046;C-6317;C07589;D00567;J10035;AB00052396-07;AB00052396-08;AB00052396-09;AB00052396_10;AB00052396_11;Celecoxib|169590-42-5|Celebrex|SC 58635;590C425;I01-1033;J-010566;J-520011;Q-200816;SR-01000837528-2;SR-01000837528-3;BRD-K02637541-001-02-4;BRD-K02637541-001-06-5;Z2210694606;Celecoxib, European Pharmacopoeia (EP) Reference Standard;Celecoxib, United States Pharmacopeia (USP) Reference Standard;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide;5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole;Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material;Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-"	169590-42-5	JCX84Q7J1L	"20729242;17053988"	17053988	01/10/2006	9751091	01/09/1998	1994-1998		1	0	1	No	0	"31/12/1998 00:00;04/02/2011 00:00;09/05/2016 00:00;16/11/2012 00:00;29/07/2013 00:00;28/06/2018 00:00;29/10/2014 00:00;23/12/2015 00:00;01/12/2000 00:00;10/11/2015 00:00;30/04/2018 00:00;01/02/2016 00:00;23/12/1999 00:00;02/11/2007 00:00;15/09/2016 00:00;09/02/2005 00:00;13/09/2016 00:00;09/06/2015 00:00;07/06/2002 00:00;30/07/2001 00:00;02/06/2015 00:00;18/10/2001 00:00;28/07/2014 00:00;23/09/2015 00:00;31/05/2018 00:00;14/01/2008 00:00;09/01/2004 00:00;11/02/2015 00:00;15/08/2001 00:00;29/08/2002 00:00;16/09/2002 00:00;21/08/2015 00:00;17/02/2000 00:00;29/07/2005 00:00;16/03/2016 00:00;04/04/2017 00:00;31/12/2008 00:00;27/06/2018 00:00;16/09/2016 00:00;13/08/1999 00:00;21/03/2000 00:00;14/09/2016 00:00;30/05/2014 00:00;23/01/2018 00:00;15/12/2006 00:00;01/06/2007 00:00"	AP	"TEVA;APOTEX INC;GD SEARLE LLC;WATSON LABS INC;#N/A;MYLAN PHARMS INC;CIPLA LTD;AUROBINDO PHARMA LTD;LUPIN LTD;MACLEODS PHARMS LTD;TORRENT PHARMS LTD;GD SEARLE;KITOV PHARMS LTD;JUBILANT GENERICS;ALEMBIC PHARMS LTD"	" CELECOXIB;CELECOXIB;AMLODIPINE BESYLATE"	31/12/1998	GD SEARLE	4,0	#N/A																							0						1
Daratumumab	"daratumumab;jnj-54767414"	"HuMax-CD38;Darzalex"	DB09331			945721-28-8	4Z63YK6E0E	26308596	26308596	01/08/2015	26308596	01/08/2015	2013-2017		1	1	1	Yes	1	"16/11/2015 00:00;07/05/2018 00:00;21/11/2016 00:00;18/06/2018 00:00;16/06/2017 00:00"	AP	JANSSEN BIOTECH	DARATUMUMAB	16/11/2015	JANSSEN BIOTECH	3,5	30	NA	0	1	MYELOMA	1	CD38	0	1	1	30	0	0	0	1	0	0,36	0	1	1	NA	0	0	0	0	0	0	46	0	1
Enasidenib	enasidenib	"2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol;Idhifa"	DB13874		"Enasidenib;1446502-11-9;AG-221;Enasidenib mesylate;UNII-3T1SS4E7AG;CC-90007 Free Base;IDHIFA;3T1SS4E7AG;CC-90007;2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol;2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol;2-Propanol, 2-methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-;Enasidenib [INN];2-Methyl-1-[(4-[6-(Trifluoromethyl)pyridin-2-Yl]-6-{[2-(Trifluoromethyl)pyridin-4-Yl]amino}-1,3,5-Triazin-2-Yl)amino]propan-2-Ol;2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol;AG-221(Enasidenib);AG-221; Enasidenib;Enasidenib (USAN/INN);Enasidenib [USAN:INN];AG-221 (Enasidenib);GTPL8960;CHEMBL3989908;SCHEMBL15102202;EX-A654;AG221;KS-000006AW;AG 221;s8205;AKOS026750439;ZINC222731806;CC90007;CS-5017;DB13874;CC 90007;HY-18690;FT-0700204;KB-3356927;D10901;J-690181;69Q"	1446502-11-9	3T1SS4E7AG	28588020	28588020	01/06/2017	28588020	01/06/2017	2013-2017		1	1	1	Yes	1	01/08/2017 00:00	AP	CELGENE CORP	ENASIDENIB MESYLATE	01/08/2017	CELGENE CORP	2,0	176	NA	0	1	AML	1	IDH2	0	1	1	NA	1	0	0	1	0	0,4	0	0	0	NA	0	0	0	0	0	0	233	0	1
Ceritinib	"ceritinib;ldk 378;ldk378"	"céritinib;N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide;Zykadia"	DB09063		"ceritinib;LDK378;1032900-25-6;ZYKADIA;NVP-LDK378-NX;LDK-378;UNII-K418KG2GET;LDK378(Ceritinib);LDK 378;Eritinib (LDK378);Ceritinib (LDK378);5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine;K418KG2GET;CHEMBL2403108;CHEBI:78432;C28H36ClN5O3S;5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrimidine-2,4-diamine;5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine;Ceritinib [USAN:INN];ceritinibum;5-chloro-N2-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine;Zykadia (TN);LDK378 Certinib;Ceritinib(LDK378);LDK-378|||Zykadia;D04LVK;D0KJ9P;Ceritinib (JAN/USAN/INN);GTPL7397;SCHEMBL1014329;DTXSID10725373;EX-A187;SYN1199;MolPort-035-395-774;VERWOWGGCGHDQE-UHFFFAOYSA-N;HMS3652H22;AOB31713;2510AH;BDBM50436850;ZINC96272772;AKOS025396438;CS-1406;DB09063;GS-6356;QC-5183;compound 15b [PMID 23742252];2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-;4CA-0729;AC-27469;AK174337;BC600329;HY-15656;KB-13070;SC-93949;AB0096053;FT-0697208;S7083;D10551;W-6123;J-690011;N-{2-Methyl-5-[(methylamino)methyl]phenyl}-4-[(4-phenyl-2-quinazolinyl)amino]benzamide;1431456-10-8;4MK;5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine;5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine;5-Chloro-N~2~-[5-Methyl-4-(Piperidin-4-Yl)-2-(Propan-2-Yloxy)phenyl]-N~4~-[2-(Propan-2-Ylsulfonyl)phenyl]pyrimidine-2,4-Diamine;5-Chloro-N~2~-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N~4~-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine;5-Chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine;5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide"	1032900-25-6	K418KG2GET	"28424965;26337354;26020125"	26020125	01/05/2015	24670165	01/03/2014	2013-2017		1	1	1	Yes	1	"22/07/2015 00:00;26/05/2017 00:00;29/04/2014 00:00;25/08/2015 00:00;30/10/2014 00:00;24/06/2015 00:00;19/07/2017 00:00;07/09/2016 00:00;20/11/2017 00:00;21/12/2017 00:00"	AP	NOVARTIS PHARMS CORP	CERITINIB	29/04/2014	NOVARTIS PHARMS CORP	1,9	130	NA	0	1	NSCLC_ALK_MUTANT	1	ALK	0	1	1	71	1	0	0	1	1	0,58	0	0	0	NA	0	0	0	0	0	0	827	0	1
Ponatinib	ponatinib	"Ponatinibum;Ponatinib;Iclusig"	"DB08901;DB06300"		"PONATINIB;943319-70-8;AP24534;Ponatinib (AP24534);Iclusig;AP 24534;3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide;AP-24534;UNII-4340891KFS;AP24534(Ponatinib);CHEMBL1171837;CHEBI:78543;4340891KFS;Iclusig (TN);3-(2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide;3-(Imidazo[1,2-B]pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)methyl]-3-(Trifluoromethyl)phenyl}benzamide;C29H27F3N6O;BENZAMIDE, 3-(2-IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-[4-[(4-METHYL-1-PIPERAZINYL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]-;Ponatinib [USAN:INN];ponatinibum;Ponatinb;HSDB 8184;0LI;3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide;AP24534,Ponatinib;Ponatinib (USAN/INN);AP24534 - Ponatinib;D0H0EQ;QCR-6;MLS006010166;SCHEMBL589260;GTPL5890;CTK5H6398;DTXSID50241426;EX-A067;SYN1116;MolPort-009-679-483;PHXJVRSECIGDHY-UHFFFAOYSA-N;BCPP000397;HMS3654H16;AOB87302;ABP000881;BDBM50322535;ZINC36701290;AKOS015995214;AM81261;BCP9000307;CS-0204;DB08901;PB34916;RL05926;AP-24534, Ponatinib, AP24534;NCGC00263152-01;NCGC00263152-02;AC-26973;AS-19133;BC659935;Benzamide, 3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methyl-1- piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-;HY-12047;KB-80068;SC-53014;SMR004701274;AB0008178;RT-011294;FT-0660376;S1490;X4747;KS-00000772;D09950;Q-4579;AB01565847_03;BRD-K44227013-001-02-3;3-(2-(Imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1- yl)methyl)-3-(trifluoromethyl)phenyl)benzamide;3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide;3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide;3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide"	943319-70-8	4340891KFS	23190221	23190221	01/11/2012	23190221	01/11/2012	2009-2012		1	1	1	Yes	1	"31/08/2016 00:00;20/12/2013 00:00;27/03/2014 00:00;25/06/2013 00:00;07/09/2016 00:00;17/04/2015 00:00;29/05/2018 00:00;02/12/2015 00:00;12/08/2013 00:00;20/05/2015 00:00;23/04/2015 00:00;15/08/2014 00:00;03/02/2015 00:00;24/08/2015 00:00;01/12/2015 00:00;02/06/2016 00:00;14/12/2012 00:00;30/01/2014 00:00;09/09/2014 00:00;28/11/2016 00:00;20/01/2015 00:00;20/12/2017 00:00;30/07/2014 00:00;24/07/2014 00:00"	AP	ARIAD	PONATINIB HYDROCHLORIDE	14/12/2012	ARIAD	1,4	81	NA	0	1	CML	1	BCR_ABL	0	1	0	NA	1	0	0	1	1	1	0	1	1	1	0	0	0	0	0	0	190	0	1
Imatinib	"cgp 57148;cgp57148b;imatinib;imatinib imatinib;sti571"	"4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide;Apo-imatinib;Gleevec;Glivec;Imatinib;Imatinib Accord;Imatinib Actavis;Imatinib Medac;Imatinib Mesylate;Imatinib Methansulfonate;Imatinib Teva;Imatinibum;Mylan-imatinib;Nat-imatinib;PMS-imatinib;Ran-imatinib;STI 571;Teva-imatinib;alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide"	"APRD01028;DB00619;DB03261;EXPT02967"	"4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide;152459-95-5;NCGC00159456-02;NCGC00159456-03;4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE;STI;STI-571;Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI);STI571;benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide;CHEBI:45783;alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide;Imatinib;Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-;Cgp 57148"	"Imatinib;152459-95-5;sti-571;STI571;Cgp 57148;Imatinib (STI571);STI 571;Imatinib [INN:BAN];Imatinib free base;N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;Imatinib Methansulfonate;UNII-BKJ8M8G5HI;CGP-57148;Imatinib (INN);Glamox (TN);CCRIS 9076;CGP 57148B;BKJ8M8G5HI;CHEMBL941;4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;CGP57148B;CHEBI:45783;KTUFNOKKBVMGRW-UHFFFAOYSA-N;CGP57148;NSC743414;alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide;N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide;112GI019;Gleevec (TN);Glivec (TN);4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide;Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-;STI;Q-201231;CGP-57-148B;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide;benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;Imatinib base(IMA-3);SR-01000763561;NCGC00159456-02;ST1571;ST 1571;Imatinibum;Glamox;C29H31N7O;imatinib-CD3;1iep;1xbb;Gleevec(TM);4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl)-benzamide;4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide;Imatinib (Gleevec);Imatinib - Gleevec;Imatinib, 21;Imatinib(STI571);Kinome_3724;ACMC-20a8ej;D01UCI;D0AZ3C;Gleevec (TN) (Novartis);AC1L1K0Z;cid_5291;SCHEMBL3827;KSC919A1B;BIDD:GT0047;GTPL5687;DTXSID3037125;BDBM13530;CTK8B9010;EX-A063;QCR-269;MolPort-000-883-342;BCPP000205;HMS2089D03;HMS3244P06;HMS3244P10;HMS3244P14;HMS3656K04;HMS3715P03;Pharmakon1600-01502276;AMX10172;KS-00000GF2;152459-95-5 (free base);AC-524;ANW-61817;NSC759854;STK617705;ZINC19632618;AKOS000280662;AN-1330;API0024674;BCP9000775;CCG-101289;CS-0964;DB00619;ES-0058;MCULE-2384256888;NSC-743414;NSC-759854;RL01949;RP17985;RTC-070813;MRF-0000449;NCGC00159456-03;NCGC00159456-04;NCGC00159456-05;NCGC00159456-06;NCGC00159456-07;NCGC00159456-09;AJ-74092;AK107630;BC215796;EN002706;HY-15463;KB-77842;AB0044023;AB1009645;AX8134347;LS-182208;LS-187106;ST2413554;AM20090646;FT-0083542;FT-0651483;I0906;S2475;D08066;W-3956;12810-EP2269994A1;12810-EP2270008A1;12810-EP2272827A1;12810-EP2275412A1;12810-EP2275413A1;12810-EP2277865A1;12810-EP2287156A1;12810-EP2289892A1;12810-EP2291366A2;12810-EP2292234A1;12810-EP2292617A1;12810-EP2305667A2;12810-EP2308855A1;12810-EP2311807A1;12810-EP2311821A1;12810-EP2311840A1;12810-EP2316831A1;12810-EP2316832A1;12810-EP2316833A1;AB00698388-07;AB00698388-10;AB00698388-11;AB00698388-12;AB00698388-13;AB00698388_15;AB00698388_16;459I955;I01-1232;SR-01000763561-4;SR-01000763561-6;BRD-K92723993-066-02-9;BRD-K92723993-066-04-5;Z1551429727;MCL-1-specific antisense oligonucleotide + Imatinib (STI571);Pyrimidine,4-(bromomethyl)-2-chloro-; 4-(Bromomethyl)pyrimidine;alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3- pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide;4-[(4-methyl-1-piperazinyl)methyl]-n[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide;Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI);Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI)"	152459-95-5	BKJ8M8G5HI	"26537529;26084808;26040495;25887498;24711212;23052406;21865346;21732337;21293953;20605207;19730791;19449194;18235116;18235115;18173550;17473195;17293590;16914578;16775235;16775234;15010069;12957455;12528778;11705489"	11705489	01/11/2001	11287972	01/04/2001	1999-2003		1	1	1	Yes	1	"31/05/2006 00:00;25/01/2013 00:00;19/12/2008 00:00;27/09/2016 00:00;18/05/2005 00:00;10/05/2001 00:00;10/02/2009 00:00;30/04/2008 00:00;13/09/2007 00:00;30/10/2013 00:00;08/12/2003 00:00;30/10/2006 00:00;31/01/2012 00:00;19/05/2005 00:00;21/02/2013 00:00;27/05/2009 00:00;25/08/2016 00:00;13/07/2018 00:00;31/10/2003 00:00;03/12/2015 00:00;04/08/2016 00:00;22/01/2002 00:00;20/10/2005 00:00;19/10/2006 00:00;18/04/2003 00:00;27/09/2006 00:00;22/05/2014 00:00;05/08/2016 00:00;17/08/2016 00:00;24/04/2017 00:00;06/09/2017 00:00;26/09/2008 00:00;23/06/2004 00:00;30/01/2015 00:00;20/12/2002 00:00;01/02/2002 00:00;01/04/2011 00:00;21/06/2017 00:00;29/09/2017 00:00;14/03/2005 00:00;20/05/2003 00:00"	AP	"APOTEX INC;SUN PHARMA GLOBAL;#N/A;MYLAN PHARMS INC;TEVA PHARMS USA;NOVARTIS"	IMATINIB MESYLATE	10/05/2001	NOVARTIS	1,3	54	NA	0	1	CML	1	BCR_ABL	0	1	0	NA	1	0	0	1	0	0,98	0	1	1	1	0	0	0	0	0	0	682	0	1
Dasatinib	"bms-354825;dasatinib"	"N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide;Dasatinibum;Dasatinib (anh.);Dasatinib;BMS dasatinib;dasatinib (anhydrous);anh. dasatinib;Anhydrous dasatinib;Sprycel"	DB01254	"N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;302962-49-8;N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;BMS-354825;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate;NSC732517;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-;D03658;Dasatinib (USAN);Sprycel (TN);Dasatinib [USAN];1N1;BMS354825;Dasatinib;N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide;Sprycel;BCB03_000715;BMS 354825;NSC-732517"	"Dasatinib;302962-49-8;Sprycel;BMS-354825;BMS354825;BMS 354825;dasatinibum;Dasatinib (anhydrous);Dasatinib anhydrous;Dasatinib [USAN];N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE;Spyrcel;Dasatinib (BMS-354825);anh. dasatinib;BMS Dasatinib;UNII-X78UG0A0RN;anhydrous dasatinib;N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;dasatinib (anh.);N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide;CHEMBL1421;X78UG0A0RN;Dasatinib, BMS 354825;N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;CHEBI:49375;Dasatinib (USAN);NSC732517;NSC-732517;NCGC00181129-01;DSSTox_CID_20979;DSSTox_RID_79608;DSSTox_GSID_40979;Q-101345;SPRYCEL (TN);2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide;2-{6-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole-5-carboxylic acid (2-chloro-6-methyl-phenyl)-amide;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;SMR002529551;CAS-302962-49-8;302962-49-8 pound not863127-77-9;Dasatinib [USAN:INN];BMS-354825-03;Dasatinib;;Dasatinib (INN);1N1;n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide;Kinome_3650;AC1MI3ET;Sprycel (Bristol Meyers);D0E6XR;AC1Q2P0C;SCHEMBL8226;Dasatinib BMS-354825;Dasatinib,BMS-354825;MLS003915609;MLS004774145;MLS006010904;BMS 354825|||Sprycel;Dasatinib - BMS-354825;GTPL5678;DTXSID4040979;BDBM13216;cid_3062316;CTK8B4120;EX-A401;QCR-106;SYN1036;MolPort-003-846-143;ZBNZXTGUTAYRHI-UHFFFAOYSA-N;5-Thiazolecarboxamide, monohydrate;BCPP000263;HMS2043N05;HMS3244A05;HMS3244A06;HMS3244B05;HMS3265C19;HMS3265C20;HMS3265D19;HMS3265D20;HMS3654K05;Pharmakon1600-01502275;AOB87355;ZINC3986735;Tox21_112736;2359AH;ANW-43935;CD0138;FC0026;NSC759877;s1021;AKOS015902363;Tox21_112736_1;AN-5289;API0002220;BCP9000589;BMS 345825;CS-0100;DB01254;GS-6548;NSC-759877;RTR-013021;RTR-021205;TRA0075817;KS-0000027F;NCGC00181129-02;NCGC00181129-03;NCGC00181129-05;NCGC00181129-06;(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;AC-22749;BCB03_000715;BMS 35482513;BR-47532;EN002710;HY-10181;KB-76415;OR302638;SC-22079;AB0066750;AX8035158;KB-274688;LS-186641;LS-187028;LS-187773;ST2419212;TR-013021;AM20080877;FT-0084503;FT-0650671;A-2429;D-3307;D03658;49310-EP2270008A1;49310-EP2292617A1;49310-EP2311840A1;AB01273956-01;AB01273956-02;AB01273956_03;BMS-354825, Sprycel, BMS354825, Dasatinib;SR-00000000554;I14-1972;SR-00000000554-5;BRD-K49328571-001-05-1;BRD-K49328571-001-07-7;BMS-354825;BMS354825;BMS 354825;Z2786158251;N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thia;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate"	302962-49-8	X78UG0A0RN	"23715577;21781226;20108303;19789325;19263190;16775234"	16775234	01/06/2006	16775234	01/06/2006	2004-2008		1	1	1	Yes	1	"07/10/2011 00:00;30/05/2008 00:00;28/07/2010 00:00;28/06/2006 00:00;27/09/2016 00:00;12/08/2015 00:00;17/06/2013 00:00;10/06/2016 00:00;28/10/2010 00:00;10/04/2014 00:00;26/01/2015 00:00;10/08/2017 00:00;21/05/2009 00:00;08/11/2007 00:00;09/11/2017 00:00"	AP	"BRISTOL MYERS SQUIBB;APOTEX INC"	DASATINIB	28/06/2006	BRISTOL MYERS SQUIBB	0,9	40	NA	0	1	CML	1	BCR_ABL	0	1	0	NA	1	0	0	1	0	0,93	0	1	1	0,95	0	0	0	0	0	0	782	0	1
ATP	adenosine 5'-triphosphate	"Adenosine 5'-triphosphate;Adenosine triphosphate;Adenosine-5'-triphosphate;ATP"	"DB00171;NUTR00017;EXPT00007"	"[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate;[5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;[5-(6-amino-9-purinyl)-3,4-dihydroxy-2-tetrahydrofuranyl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate;[5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;56-65-5;ATP;adenosine-5'-triphosphate;adenosine-triphosphate;adenylpyrophosphate;Laevadosin;NSC20268"	"Adenosine triphosphate;Adenosine 5'-triphosphate;56-65-5;Myotriphos;Striadyne;Triadenyl;Triphosphaden;Atriphos;ATP;Glucobasin;Adephos;Adetol;Adynol;Atipi;Adenosine 5'-(tetrahydrogen triphosphate);5'-Atp;adenosine-5'-triphosphate;Triphosaden;Adenylpyrophosphoric acid;Triphosphoric acid adenosine ester;ATP (nucleotide);Adenosine 5'-triphosphoric acid;Cardenosine;Fosfobion;Adenosintriphosphorsaeure;Ado-5'-P-P-P;Phosphobion;H4atp;UNII-8L70Q75FXE;9-beta-D-Arabinofuranosyladenine 5'-triphosphate;CHEBI:15422;Adenosine, 5'-(tetrahydrogen triphosphate);C10H16N5O13P3;Ara-ATP;EINECS 200-283-2;adenosine 5' triphosphate;CHEMBL14249;8L70Q75FXE;adenosine-5'-triphosphoric acid;ZKHQWZAMYRWXGA-KQYNXXCUSA-N;((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate;NCGC00163309-01;adenosine-triphosphate;ATP disodium hydrate;Triphosadenine (DCF);Adenosine triphosphate disodium hydrate;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate;ATPace;ATPase;1kxp;1mau;1maw;1vjc;1vjd;1xsc;1yid;2cbz;2fgh;Adenylpyrophosphorate;1gz3;1gz4;1r0x;1y8p;9H-purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl];BDBM2;3h-adenosine triphosphate;AC1L1LHX;[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphonic acid;34369-07-8;DSSTox_CID_2559;bmse000006;bmse000854;bmse000993;D02LMZ;D0O6QI;Epitope ID:135612;Adenosine 5'-triphosphorate;SCHEMBL8979;DSSTox_RID_76629;DSSTox_GSID_22559;GTPL1713;DTXSID6022559;CTK3J3236;1b38;1b39;1m83;1r10;1t44;MolPort-002-533-479;Bio1_000406;Bio1_000895;Bio1_001384;({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid;ACT02649;HY-B2176;ZINC4261765;Tox21_112044;BDBM50366480;AKOS022179934;CS-7674;DB00171;CAS-56-65-5;11016-17-4;5'-(tetrahydrogen triphosphate) Adenosine;AJ-70571;AK-54737;AN-41693;AS-19204;CC-23792;LS-15176;DB-022415;RT-001349;FT-0621909;ST24045923;X5319;C00002;D08646;065A467;C-22981;Adenosine 5'-triphosphate (intravenous, arrhythmia);W-105506;A9788C43-4BC5-46E2-8560-41C5FA7D3AA3;Adenosine 5'-triphosphate (intravenous, arrhythmia), Cordex;Adenosine 5'-triphosphate (intravenous, arrhythmia), Duska;Adenosine 5 inverted exclamation marka-triphosphate (ATP) disodium salt hydrate;Adenosine 5'-triphosphate (intravenous, bradycardia-induced syncopy (fainting)), Duska;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate;10168-83-9;119439-06-4;1259312-93-0;126339-06-8;126827-79-0;16488-07-6;51569-41-6;71800-44-7;84412-18-0;896506-78-8;917074-14-7;9H-Purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-.beta.-D-ribofuranosyl]-;Adenosine 5'-triphosphate (intravenous, paroxysmal supraventricular tachycardia (PSVT)), Duska"	56-65-5	8L70Q75FXE	8699994	8699994	01/09/1996					0	0	1			"23/01/2015 00:00;15/06/2016 00:00;29/09/2016 00:00"	AP	NPS PHARMS INC	PARATHYROID HORMONE	23/01/2015	NPS PHARMS INC		#N/A																							0						1
